PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Koch, DC; Jang, HS; O'Donnell, EF; Punj, S; Kopparapu, PR; Bisson, WH; Kerkvliet, NI; Kolluri, SK				Koch, D. C.; Jang, H. S.; O'Donnell, E. F.; Punj, S.; Kopparapu, P. R.; Bisson, W. H.; Kerkvliet, N. I.; Kolluri, S. K.			Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-beta 1	ONCOGENE			English	Article							BREAST-CANCER CELLS; AH-RECEPTOR; ESTROGEN-RECEPTOR; DIOXIN-RECEPTOR; CYCLE CONTROL; IN-VIVO; EXPRESSION; PROTEIN; GROWTH; MECHANISM	The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and a member of the basic helix-loop-helix PER/ARNT/SIM family of chemosensors and developmental regulators. The AhR is widely known as a mediator of dioxin toxicity; however, it also suppresses cancer cell proliferation and recent findings have implicated its role as a tumor suppressor. We conducted a chemical library screen to identify nontoxic AhR ligands with anti-cancer effects and discovered flutamide (Eulexin) as a putative AhR ligand. Flutamide is an androgen receptor (AR) antagonist approved by the United States Food and Drug Administration for the treatment of prostate cancer. We found that flutamide inhibited the growth of several cancer cell lines independent of AR status, and that suppression of AhR expression reversed the anti-proliferative effects of flutamide. We investigated the AhR-dependent mechanism of action of flutamide in human hepatocellular carcinoma cells and identified that transforming growth factor-beta 1 (TGF-beta 1) is induced by flutamide in an AhR-dependent manner. In contrast, the potent AhR agonist 2,3,7,8-Tetrachlorodibenzo-p-dioxin had no effect on TGF-beta 1 expression, indicating the ligand specificity of AhR activation. We also determined that TGF-beta 1 induction is required for the AhR-dependent growth inhibitory effects of flutamide. Therefore, flutamide may be effective in AhR-positive cancers that are sensitive to TGF-beta 1 signaling, such as hepatocellular carcinoma.	[Koch, D. C.; Jang, H. S.; O'Donnell, E. F.; Punj, S.; Kopparapu, P. R.; Kolluri, S. K.] Oregon State Univ, Dept Environm & Mol Toxicol, Canc Res Lab, Corvallis, OR 97331 USA; [Koch, D. C.; Jang, H. S.; O'Donnell, E. F.; Punj, S.; Kopparapu, P. R.; Bisson, W. H.; Kerkvliet, N. I.; Kolluri, S. K.] Oregon State Univ, Dept Environm & Mol Toxicol, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Kolluri, SK (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Canc Res Lab, 1007 ALS Bldg, Corvallis, OR 97331 USA.	siva.kolluri@oregonstate.edu		Jang, Hyo Sang/0000-0003-0460-9924; /0000-0001-9516-9690	American Cancer Society [RSG-13-132-01-CDD]; National Institute of Environmental Health Sciences (NIEHS) [ES016651, ES019000]; US Army Medical Research and Material Command; Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS [P30 ES00210]; National Cancer Institute [1F31CA144571-01]; Burroughs Wellcome Fund post-doctoral enrichment program; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0160]; NIEHS [T32ES07060]; NATIONAL CANCER INSTITUTE [F31CA144571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016651, R21ES019000, P30ES000210, T32ES007060] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund post-doctoral enrichment program; Department of Defense Breast Cancer Research Program(United States Department of Defense); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by American Cancer Society (RSG-13-132-01-CDD), the National Institute of Environmental Health Sciences (NIEHS) grant numbers ES016651 and ES019000, The US Army Medical Research and Material Command and The Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS grant number P30 ES00210. DCK was supported by a National Research Service Award (1F31CA144571-01) pre-doctoral fellowship from the National Cancer Institute. DCK is currently supported by the Burroughs Wellcome Fund post-doctoral enrichment program. EFO was supported by a pre-doctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-10-1-0160). DCK and EFO were previously supported by NIEHS training grant (T32ES07060). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank Samuel Bradford for excellent flow cytometry assistance, Sammy Khalil, Cathy Duong and Viktor Dikov for laboratory assistance.	ABBOTT BD, 1994, TOXICOL APPL PHARM, V126, P16, DOI 10.1006/taap.1994.1085; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bertazzi PA, 1997, EPIDEMIOLOGY, V8, P646, DOI 10.1097/00001648-199710000-00006; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carver LA, 1997, J BIOL CHEM, V272, P11452; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; DENISON MS, 1988, P NATL ACAD SCI USA, V85, P2528, DOI 10.1073/pnas.85.8.2528; Dohr O, 1997, BIOCHEM BIOPH RES CO, V241, P86, DOI 10.1006/bbrc.1997.7773; EGELAND GM, 1994, AM J EPIDEMIOL, V139, P272, DOI 10.1093/oxfordjournals.aje.a116994; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; Fan YX, 2010, CANCER RES, V70, P212, DOI 10.1158/0008-5472.CAN-09-3090; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Funatake CJ, 2008, J IMMUNOTOXICOL, V5, P81, DOI 10.1080/15476910802019037; Gasiewicz TA, 2008, CRIT REV EUKAR GENE, V18, P279, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.10; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hsu EL, 2007, TOXICOL SCI, V98, P436, DOI 10.1093/toxsci/kfm125; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kolluri SK, 2001, CANCER RES, V61, P8534; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Lai IK, 2012, TOXICOLOGY, V302, P25, DOI 10.1016/j.tox.2012.07.007; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Mitsuhashi T, 2010, P NATL ACAD SCI USA, V107, P16331, DOI 10.1073/pnas.1002960107; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; O'Donnell EF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.549; O'Donnell EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040926; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Perkins Arden, 2014, Biology (Basel), V3, P645, DOI 10.3390/biology3040645; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Punj S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088726; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; RIER SE, 1993, FUND APPL TOXICOL, V21, P433, DOI 10.1006/faat.1993.1119; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0; Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Warner M, 2002, AM J EPIDEMIOL, V155, ps102; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548	56	20	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2015	34	50					6092	6104		10.1038/onc.2015.55	http://dx.doi.org/10.1038/onc.2015.55			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RQ	25867062				2022-12-26	WOS:000366113800006
J	Funcke, JB; Zoller, V; Abd El Hay, M; Debatin, KM; Wabitsch, M; Fischer-Posovszky, P				Funcke, Jan-Bernd; Zoller, Verena; Abd El Hay, Muad; Debatin, Klaus-Michael; Wabitsch, Martin; Fischer-Posovszky, Pamela			TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation	FASEB JOURNAL			English	Article						adipose tissue homeostasis; adipocyte progenitor; noncanonical signaling; death ligand	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRAIL PROMOTES; ADIPOSE-TISSUE; THYMOCYTE APOPTOSIS; BINDING-PROTEINS; PUZZLING ROLE; CELLS; EXPRESSION; SURVIVAL	Upon obesity, adipose tissue is excessively expanded and characterized by pathologic processes like hypoxia, fibrosis, and inflammation. Death ligands belonging to the TNF superfamily such as TNF-alpha are important contributors to these derangements and exert a pronounced influence on the metabolic and cellular homeostasis of adipose tissue. Here, we sought to identify the effect of the death ligand TNF-related apoptosis-inducing ligand (TRAIL) on the adipose tissue precursor cell pool and therefore investigated its influence on preadipocyte proliferation. Treatment of human preadipocytes with TRAIL resulted in a time-and dose-dependent increase in proliferation (EC50 3.4 ng/ml) comparable to IGF-1. Although no apoptosis was observed, TRAIL triggered a rapid cleavage of caspase-8 and -3. Neither inhibition of caspase activity by zVAD.fmk (20 mu M) nor ablation of caspase-8 expression by lentivirus-delivered small hairpin RNA (shRNA) abolished the proliferative response. TRAIL triggered a delayed and sustained activation of ERK1/2, leaving Akt, p38, JNK, and NF-kappa B unaffected. Importantly, inhibition of ERK1/2 activation by PD0325901 (300 nM) or AZD6244 (5 or 10 mu M) completely abolished the proliferative response. We thus reveal a hitherto unknown function of TRAIL in regulating adipose tissue homeostasis by promoting the proliferation of tissue-resident precursor cells.	[Funcke, Jan-Bernd; Zoller, Verena; Abd El Hay, Muad; Wabitsch, Martin; Fischer-Posovszky, Pamela] Ulm Med Ctr, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Debatin, Klaus-Michael] Ulm Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany		Fischer-Posovszky, P (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, Eythstr 24, D-89075 Ulm, Germany.	pamela.fischer@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Abd El Hay, Muad/0000-0002-5082-1216; Funcke, Jan-Bernd/0000-0002-2596-3167; Fischer-Posovszky, Pamela/0000-0003-3402-9840	International Graduate School in Molecular Medicine Ulm (IGradU)	International Graduate School in Molecular Medicine Ulm (IGradU)	The authors thank Alexandra Killian for her outstanding technical assistance and Mike Andrew Westhoff for helpful discussions throughout this project. J.B.F. and V.Z. were funded by the International Graduate School in Molecular Medicine Ulm (IGradU).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Ashley DT, 2011, METABOLISM, V60, P994, DOI 10.1016/j.metabol.2010.10.001; Audo R, 2009, CELL DEATH DIFFER, V16, P1227, DOI 10.1038/cdd.2009.38; Azijli K, 2013, CELL DEATH DIFFER, V20, P858, DOI 10.1038/cdd.2013.28; Baer Patrick C, 2014, World J Stem Cells, V6, P256, DOI 10.4252/wjsc.v6.i3.256; Belyanskaya LL, 2008, LUNG CANCER, V60, P355, DOI 10.1016/j.lungcan.2007.11.005; Bernardi S, 2012, CLIN SCI, V123, P547, DOI 10.1042/CS20120176; Brombo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058225; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; Fischer-Posovszky P, 2004, ENDOCRINOLOGY, V145, P1849, DOI 10.1210/en.2003-0985; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Hauner H, 2000, METH MOL B, V155, P239; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Keuper M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.212; Keuper M., 2011, HORM RES PAEDIAT, V76, P20; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mi QS, 2003, DIABETES, V52, P1967, DOI 10.2337/diabetes.52.8.1967; Morel J, 2005, J BIOL CHEM, V280, P15709, DOI 10.1074/jbc.M414469200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Brien LA, 2008, ARTERIOSCL THROM VAS, V28, pE5, DOI 10.1161/ATVBAHA.107.158949; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Rippo MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.115; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Samocha-Bonet D, 2014, OBES REV, V15, P697, DOI 10.1111/obr.12199; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2008, ARTERIOSCL THROM VAS, V28, pE4, DOI 10.1161/ATVBAHA.107.158451; Spierings DC, 2004, J HISTOCHEM CYTOCHEM, V52, P821, DOI 10.1369/jhc.3A6112.2004; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vilimanovich U, 2008, CELL MOL LIFE SCI, V65, P814, DOI 10.1007/s00018-008-7513-8; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771	55	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3065	3075		10.1096/fj.14-267278	http://dx.doi.org/10.1096/fj.14-267278			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857555	Green Published			2022-12-26	WOS:000356859100033
J	Ruelas, DS; Chan, JK; Oh, E; Heidersbach, AJ; Hebbeler, AM; Chavez, L; Verdin, E; Rape, M; Greene, WC				Ruelas, Debbie S.; Chan, Jonathan K.; Oh, Eugene; Heidersbach, Amy J.; Hebbeler, Andrew M.; Chavez, Leonard; Verdin, Eric; Rape, Michael; Greene, Warner C.			MicroRNA-155 Reinforces HIV Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; T-CELLS; CELLULAR MICRORNA; PROTEIN; TRIM32; REPLICATION; RESERVOIR; DOMAIN; UBIQUITINATION; IDENTIFICATION	The presence of a small number of infected but transcriptionally dormant cells currently thwarts a cure for the more than 35 million individuals infected with HIV. Reactivation of these latently infected cells may result in three fates: 1) cell death due to a viral cytopathic effect, 2) cell death due to immune clearance, or 3) a retreat into latency. Uncovering the dynamics of HIV gene expression and silencing in the latent reservoir will be crucial for developing an HIV-1 cure. Here we identify and characterize an intracellular circuit involving TRIM32, an HIV activator, and miR-155, a microRNA that may promote a return to latency in these transiently activated reservoir cells. Notably, we demonstrate that TRIM32, an E3 ubiquitin ligase, promotes reactivation from latency by directly modifying I kappa B alpha, leading to a novel mechanism of NF-kappa B induction not involving I kappa B kinase activation.	[Chavez, Leonard; Verdin, Eric; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Ruelas, Debbie S.; Heidersbach, Amy J.; Chavez, Leonard] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Verdin, Eric; Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Verdin, Eric; Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Oh, Eugene; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Heidersbach, Amy J.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Rape, Michael/0000-0003-4849-6343; Verdin, Eric/0000-0003-3703-3183; Chavez, Leonard/0000-0003-3226-0897; Oh, Eugene/0000-0003-1970-8423	Martin Delaney CARE Collaboratory (National Institutes of Health) [NIAID U19 AI096113]; UCSF Microbial Pathogenesis and Host Defense Program (National Institutes of Health) [NIAID 5 T32 AI60537-9]; Jane Coffin Childs Postdoctoral Fellowship; Centers for AIDS Research (CFAR), a National Institutes of Health [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI060537, U19AI096113] Funding Source: NIH RePORTER	Martin Delaney CARE Collaboratory (National Institutes of Health); UCSF Microbial Pathogenesis and Host Defense Program (National Institutes of Health); Jane Coffin Childs Postdoctoral Fellowship; Centers for AIDS Research (CFAR), a National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Martin Delaney CARE Collaboratory (National Institutes of Health Grant NIAID U19 AI096113 to W. C. G.), the UCSF Microbial Pathogenesis and Host Defense Program (National Institutes of Health Grant NIAID 5 T32 AI60537-9 to D. S. R.), and the Jane Coffin Childs Postdoctoral Fellowship (to E. O.). This work was also supported by Centers for AIDS Research (CFAR), a National Institutes of Health-funded program (Grant P30 AI027763 to W. C. G.).	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Calvanese V, 2013, VIROLOGY, V446, P283, DOI 10.1016/j.virol.2013.07.037; Chan JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077749; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Descours B, 2012, CLIN INFECT DIS, V54, P1495, DOI 10.1093/cid/cis188; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2013, CURR TOP MICROBIOL, V371, P201, DOI 10.1007/978-3-642-37765-5_8; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kwon H, 1998, J BIOL CHEM, V273, P7431, DOI 10.1074/jbc.273.13.7431; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; So AYL, 2013, IMMUNOL REV, V253, P129, DOI 10.1111/imr.12043; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Swaminathan G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002937; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	50	49	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13736	13748		10.1074/jbc.M115.641837	http://dx.doi.org/10.1074/jbc.M115.641837			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873391	hybrid, Green Published			2022-12-26	WOS:000355313000010
J	Zhang, SY; Bryant, DA				Zhang, Shuyi; Bryant, Donald A.			Biochemical Validation of the Glyoxylate Cycle in the Cyanobacterium Chlorogloeopsis fritschii Strain PCC 9212	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; FLUX BALANCE ANALYSIS; BLUE-GREEN ALGAE; ESCHERICHIA-COLI; CARBON METABOLISM; ISOCITRATE LYASE; ANACYSTIS-NIDULANS; ACETATE; SYNECHOCOCCUS; BACTERIA	Cyanobacteria are important photoautotrophic bacteria with extensive but variable metabolic capacities. The existence of the glyoxylate cycle, a variant of the TCA cycle, is still poorly documented in cyanobacteria. Previous studies reported the activities of isocitrate lyase and malate synthase, the key enzymes of the glyoxylate cycle in some cyanobacteria, but other studies concluded that these enzymes are missing. In this study the genes encoding isocitrate lyase and malate synthase from Chlorogloeopsis fritschii PCC 9212 were identified, and the recombinant enzymes were biochemically characterized. Consistent with the presence of the enzymes of the glyoxylate cycle, C. fritschii could assimilate acetate under both light and dark growth conditions. Transcript abundances for isocitrate lyase and malate synthase increased, and C. fritschii grew faster, when the growth medium was supplemented with acetate. Adding acetate to the growth medium also increased the yield of poly-3-hydroxybutyrate. When the genes encoding isocitrate lyase and malate synthase were expressed in Synechococcus sp. PCC 7002, the acetate assimilation capacity of the resulting strain was greater than that of wild type. Database searches showed that the genes for the glyoxylate cycle exist in only a few other cyanobacteria, all of which are able to fix nitrogen. This study demonstrates that the glyoxylate cycle exists in a few cyanobacteria, and that this pathway plays an important role in the assimilation of acetate for growth in one of those organisms. The glyoxylate cycle might play a role in coordinating carbon and nitrogen metabolism under conditions of nitrogen fixation.	[Zhang, Shuyi; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 403C, University Pk, PA 16802 USA.	dab14@psu.edu		Zhang, Shuyi/0000-0001-8500-5836	National Science Foundation [MCB-1021725]; Air Force Office of Scientific Research MURI [FA9550-05-1-0365, FA9550-11-1-0148]; Div Of Molecular and Cellular Bioscience [1021725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1021725 (to D. A. B.) and Air Force Office of Scientific Research MURI Grants FA9550-05-1-0365 and FA9550-11-1-0148 (to D. A. B.).	Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Bedhomme M, 2009, J BIOL CHEM, V284, P36282, DOI 10.1074/jbc.M109.064428; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Chen ZH, 2000, PLANT CELL PHYSIOL, V41, P960, DOI 10.1093/pcp/pcd021; COMBRES C, 1994, PHYSIOL PLANTARUM, V91, P729, DOI 10.1111/j.1399-3054.1994.tb03012.x; DAVIS WL, 1990, ANAT REC, V227, P271, DOI 10.1002/ar.1092270302; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; ELEY JH, 1988, J PHYCOL, V24, P586, DOI 10.1111/j.1529-8817.1988.tb00111.x; Ensign SA, 2011, SCIENCE, V331, P294, DOI 10.1126/science.1201252; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Feng XY, 2010, J BIOL CHEM, V285, P39544, DOI 10.1074/jbc.M110.162958; Frigaard NU, 2004, METH MOL B, V274, P325; Gan Fei, 2015, Life-Basel, V5, P4, DOI 10.3390/life5010004; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; GIBBS M, 1986, PLANT PHYSIOL, V82, P160, DOI 10.1104/pp.82.1.160; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; GUTOWSKI SJ, 1975, BIOCHEM J, V152, P647, DOI 10.1042/bj1520647; HOARE DS, 1967, J GEN MICROBIOL, V49, P351, DOI 10.1099/00221287-49-3-351; IHLENFELDT MJA, 1977, ARCH MICROBIOL, V113, P231, DOI 10.1007/BF00492030; KAY WW, 1971, EUR J BIOCHEM, V18, P274, DOI 10.1111/j.1432-1033.1971.tb01240.x; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kornberg H, 2000, NAT REV MOL CELL BIO, V1, P225, DOI 10.1038/35043073; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Kreth J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067125; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Madigan MT, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P951, DOI 10.1007/0-387-30744-3_31; McNeely K, 2011, APPL ENVIRON MICROB, V77, P2435, DOI 10.1128/AEM.02792-10; MILLER JS, 1972, ARCH MIKROBIOL, V86, P1, DOI 10.1007/BF00412395; Nakazawa M, 2011, J EUKARYOT MICROBIOL, V58, P128, DOI 10.1111/j.1550-7408.2011.00534.x; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; PEARCE J, 1967, J GEN MICROBIOL, V49, P301, DOI 10.1099/00221287-49-2-301; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; PICKETT MW, 1994, PHOTOSYNTH RES, V41, P75, DOI 10.1007/BF02184147; Pinchuk GE, 2011, APPL ENVIRON MICROB, V77, P8234, DOI 10.1128/AEM.05382-11; Plancke C, 2014, PLANT J, V77, P404, DOI 10.1111/tpj.12392; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Sirevag R., 1995, ANOXYGENIC PHOTOSYNT, P871; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tsang TK, 2013, PHOTOSYNTH RES, V118, P37, DOI 10.1007/s11120-013-9923-1; Wood BJB, 1999, J BIOTECHNOL, V70, P175, DOI 10.1016/S0168-1656(99)00070-X; WRIGHT RT, 1966, ECOLOGY, V47, P447, DOI 10.2307/1932984; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; You L, 2014, BIOTECHNOL J, V9, P684, DOI 10.1002/biot.201300477; Zarzycki J, 2011, APPL ENVIRON MICROB, V77, P6181, DOI 10.1128/AEM.00705-11; Zhang S., 2014, PERSPECT PHYCOL, V1, P73, DOI [10.1127/pip/2014/0016, DOI 10.1127/PIP/2014/0016]; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	58	48	49	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14019	14030		10.1074/jbc.M115.648170	http://dx.doi.org/10.1074/jbc.M115.648170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869135	Green Published, hybrid			2022-12-26	WOS:000355313000032
J	Findling, O; Baltisberger, M; Jung, SM; Kamm, CP; Mattle, HP; Sellner, J				Findling, Oliver; Baltisberger, Magdalena; Jung, Simon; Kamm, Christian P.; Mattle, Heinrich P.; Sellner, Johann			Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study	PLOS ONE			English	Article							EMPLOYMENT STATUS; UNEMPLOYMENT; FATIGUE	Introduction Reduced working capability is one of the most devastating consequences of multiple sclerosis (MS). We aimed to study working capability and related variables in Swiss MS patients. Materials and Methods A cross-sectional analysis of employment status and risk factors for reduced working capability among MS patients treated at our outpatient clinic. A questionnaire was mailed to 644 MS patients and returned by 69.7%. 405 patients (66% female, mean age 44.2 years (SD +/- 10.2), median EDSS 3.0 (SD +/- 1.8))were eligible for subsequent analysis. Results After a mean disease duration of 12.3 years (SD +/- 8.25), full or part time employment was declared by 26.7% and 25.7%, respectively. Incapacity to work was reported by 27.1%. A total of 52.8% specified MS as the cause for altered working capability, whereas 20.5% cited reasons unrelated to the disorder. Even with minimal disability (EDSS< 3) a significant proportion of patients (24%) reported reduced working capability. Among the MS-specific restricting factors were fatigue (47.6%), sensorimotor deficits (31.1%), impaired vision (3.3%) and pain (2.8%). Conclusion MS continues to takes its toll on the professional life of the patients early in the course. While complete incapacity becomes relevant with moderate to severe disability, many patients scale down to part-time even with minimal impairment.	[Findling, Oliver; Baltisberger, Magdalena; Jung, Simon; Kamm, Christian P.; Mattle, Heinrich P.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Sellner, Johann] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria	University of Bern; University Hospital of Bern; Paracelsus Private Medical University	Findling, O (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland.	oliver.findling@gmail.com	Findling, Oliver/AAE-3815-2019; Selllner, Johann/AAB-1263-2019					Bishop M, 2009, J VOCAT REHABIL, V31, P119, DOI 10.3233/JVR-2009-0480; Busche KD, 2003, CAN J NEUROL SCI, V30, P137, DOI 10.1017/S0317167100053403; Cote I, 2013, MULT SCLER J, V19, P480, DOI 10.1177/1352458512455958; DOOLEY D, 1994, AM J COMMUN PSYCHOL, V22, P745, DOI 10.1007/BF02521557; Flachenecker P, 2008, DTSCH ARZTEBL INT, V105, P113, DOI 10.3238/arztebl.2008.0113; Glad SB, 2011, J NEUROL NEUROSUR PS, V82, P78, DOI 10.1136/jnnp.2010.210732; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Kern S, 2013, FORTSCHR NEUROL PSYC, V81, P95, DOI 10.1055/s-0032-1330286; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS24; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS86; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lange R, 2009, J NEUROL, V256, P645, DOI 10.1007/s00415-009-0152-7; LAROCCA N, 1985, J CHRON DIS, V38, P203, DOI 10.1016/0021-9681(85)90093-1; Multiple Sclerosis International Federation, 2010, MSIF SURV EMPL MS; Patti F, 2007, MULT SCLER J, V13, P783, DOI 10.1177/1352458506073511; Polman CH, 2010, NEUROLOGY, V74, pS8, DOI 10.1212/WNL.0b013e3181dbb571; Roessler Richard T, 2003, Work, V21, P17; Rumrill PD, 2009, J VOCAT REHABIL, V31, P83, DOI 10.3233/JVR-2009-0477; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Strober LB, 2012, MULT SCLER J, V18, P647, DOI 10.1177/1352458511426735; Swiss Federal Statistical Office, UN STAT BAS ILO DEF; Van der Hiele K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105673; Veauthier C, 2011, MULT SCLER J, V17, P613, DOI 10.1177/1352458510393772; Weinges-Evers N, 2010, MULT SCLER J, V16, P1134, DOI 10.1177/1352458510374202	26	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121856	10.1371/journal.pone.0121856	http://dx.doi.org/10.1371/journal.pone.0121856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867208	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100050
J	Sesen, J; Dahan, P; Scotland, SJ; Saland, E; Dang, VT; Lemarie, A; Tyler, BM; Brem, H; Toulas, C; Moyal, ECJ; Sarry, JE; Skuli, N				Sesen, Julie; Dahan, Perrine; Scotland, Sarah J.; Saland, Estelle; Van-Thi Dang; Lemarie, Anthony; Tyler, Betty M.; Brem, Henry; Toulas, Christine; Moyal, Elizabeth Cohen-Jonathan; Sarry, Jean-Emmanuel; Skuli, Nicolas			Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ANTIGLIOMA ACTION; FEEDBACK-CONTROL; CYCLE ARREST; IN-VITRO; TEMOZOLOMIDE; APOPTOSIS; AMPK; METABOLISM; MTOR	High-grade gliomas, glioblastomas (GB), are refractory to conventional treatment combining surgery, chemotherapy, mainly temozolomide, and radiotherapy. This highlights an urgent need to develop novel therapies and increase the efficacy of radio/chemotherapy for these very aggressive and malignant brain tumors. Recently, tumor metabolism became an interesting potential therapeutic target in various cancers. Accordingly, combining drugs targeting cell metabolism with appropriate chemotherapeutic agents or radiotherapy has become attractive. In light of these perspectives, we were particularly interested in the anticancer properties of a biguanide molecule used for type 2 diabetes treatment, metformin. In our present work, we demonstrate that metformin decreases mitochondrial-dependent ATP production and oxygen consumption and increases lactate and glycolytic ATP production. We show that metformin induces decreased proliferation, cell cycle arrest, autophagy, apoptosis and cell death in vitro with a concomitant activation of AMPK, Redd1 and inhibition of the mTOR pathway. Cell sensitivity to metformin also depends on the genetic and mutational backgrounds of the different GB cells used in this study, particularly their PTEN status. Interestingly, knockdown of AMPK and Redd1 with siRNA partially, but incompletely, abrogates the induction of apoptosis by metformin suggesting both AMPK/Redd1-dependent and-independent effects. However, the primary determinant of the effect of metformin on cell growth is the genetic and mutational backgrounds of the glioma cells. We further demonstrate that metformin treatment in combination with temozolomide and/or irradiation induces a synergistic anti-tumoral response in glioma cell lines. Xenografts performed in nude mice demonstrate in vivo that metformin delays tumor growth. As current treatments for GB commonly fail to cure, the need for more effective therapeutic options is overwhelming. Based on these results, metformin could represent a potential enhancer of the cytotoxic effects of temozolomide and/or radiotherapy.	[Sesen, Julie; Dahan, Perrine; Scotland, Sarah J.; Saland, Estelle; Van-Thi Dang; Lemarie, Anthony; Toulas, Christine; Moyal, Elizabeth Cohen-Jonathan; Sarry, Jean-Emmanuel; Skuli, Nicolas] Ctr Rech Cancerol Toulouse, INSERM, U1037, Toulouse, France; [Scotland, Sarah J.; Tyler, Betty M.; Brem, Henry] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Johns Hopkins University	Skuli, N (corresponding author), Ctr Rech Cancerol Toulouse, INSERM, U1037, Toulouse, France.	nicolas.skuli@inserm.fr	Sarry, Jean-Emmanuel/P-1633-2014; Sarry, Jean-Emmanuel/AAC-3664-2020; Moyal, Elizabeth/A-9802-2015; SALAND, Estelle/W-7996-2019; LEMARIE, Anthony/G-4018-2017	Sarry, Jean-Emmanuel/0000-0002-6704-2032; Sarry, Jean-Emmanuel/0000-0002-6704-2032; Moyal, Elizabeth/0000-0002-6593-9276; LEMARIE, Anthony/0000-0002-6523-4962; Skuli, Sarah/0000-0001-7711-0732; Dang, Van Thi/0000-0003-2259-6266; Dahan, Perrine/0000-0003-4738-8893	Institut Nationale de la Sante et de la Recherche Medicale [U1037SPDOTSKULI]; Ligue Contre le Cancer [GB/MA/VSP-10443]	Institut Nationale de la Sante et de la Recherche Medicale; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by Institut Nationale de la Sante et de la Recherche Medicale to JS, PD, SJS, AL, CT, ECJM, JES, NS, Grant number: U1037SPDOTSKULI, URL: http://www.inserm.fr; and Ligue Contre le Cancer to JS, CT, ECJM, NS, Grant number: GB/MA/VSP-10443, URL: http://www.liguecancer.net. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2011, J BUON, V16, P409; Aldea MD, 2014, J BUON, V19, P502; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Carmignani M, 2014, J BIOL REG HOMEOS AG, V28, P1; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; Gao LB, 2013, NEUROREPORT, V24, P504, DOI 10.1097/WNR.0b013e32836277fb; Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Icard P, 2012, BBA-REV CANCER, V1826, P423, DOI 10.1016/j.bbcan.2012.07.001; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Janjetovic K, 2010, EUR J PHARMACOL, V651, P41, DOI [10.1016/j.ejphar.2010.11.012, DOI 10.1016/J.EJPHAR.2010.11.012]; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kast RE, 2011, BRIT J PHARMACOL, V164, P1393, DOI 10.1111/j.1476-5381.2011.01320.x; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lemarie A, 2009, MITOCHONDRION, V9, P254, DOI 10.1016/j.mito.2009.03.004; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Najbauer J, 2014, PATHOL ONCOL RES; Pajonk F, 2013, SEMIN RADIAT ONCOL, V23, P237, DOI 10.1016/j.semradonc.2013.05.007; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sato A, 2012, STEM CELL TRANSL MED, V1, P811, DOI 10.5966/sctm.2012-0058; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; Schiff D, 2009, NAT REV CLIN ONCOL, V6, P596, DOI 10.1038/nrclinonc.2009.128; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Sesen J, 2014, INT J MOL SCI, V15, P2172, DOI 10.3390/ijms15022172; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Ucbek A, 2014, EXP THER MED, V7, P1285, DOI 10.3892/etm.2014.1597; Vadysirisack DD, 2011, MOL CELL BIOL, V31, P4356, DOI 10.1128/MCB.05541-11; Valle G, 2011, J BUON, V16, P787; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vucicevic L, 2009, BIOCHEM PHARMACOL, V77, P1684, DOI 10.1016/j.bcp.2009.03.005; Wick W, 2014, CANCER DISCOV, V4, P1120, DOI 10.1158/2159-8290.CD-14-0918; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wurth R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/126586; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264	61	119	125	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123721	10.1371/journal.pone.0123721	http://dx.doi.org/10.1371/journal.pone.0123721			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867026	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100202
J	Zhang, XW; Wang, JR; Ji, MF; Milne, RI; Wang, MH; Liu, JQ; Shi, S; Yang, SL; Zhao, CM				Zhang, Xiao Wei; Wang, Jing Ru; Ji, Ming Fei; Milne, Richard Ian; Wang, Ming Hao; Liu, Jian-Quan; Shi, Sheng; Yang, Shu-Li; Zhao, Chang-Ming			Higher Thermal Acclimation Potential of Respiration but Not Photosynthesis in Two Alpine Picea Taxa in Contrast to Two Lowland Congeners	PLOS ONE			English	Article							PLANT RESPIRATION; TEMPERATURE-DEPENDENCE; NET PHOTOSYNTHESIS; LEAF RESPIRATION; RESPONSES; GROWTH; NORTHERN; SEEDLINGS; TREES; ADAPTATION	The members of the genus Picea form a dominant component in many alpine and boreal forests which are the major sink for atmospheric CO2. However, little is known about the growth response and acclimation of CO2 exchange characteristics to high temperature stress in Picea taxa from different altitudes. Gas exchange parameters and growth characteristics were recorded from four year old seedlings of two alpine (Picea likiangensis vars. rubescens and linzhiensis) and two lowland (P. koraiensis and P. meyeri) taxa. Seedlings were grown at moderate (25 degrees C/15 degrees C) and high (35 degrees C/25 degrees C) day/night temperatures, for four months. The approximated biomass increment (Delta(DH)-H-2) for all taxa decreased under high temperature stress, associated with decreased photosynthesis and increased respiration. However, the two alpine taxa exhibited lower photosynthetic acclimation and higher respiratory acclimation than either lowland taxon. Moreover, higher leaf dry mass per unit area (LMA) and leaf nitrogen content per unit area (N-area), and a smaller change in the nitrogen use efficiency of photosynthesis (PNUE) for lowland taxa indicated that these maintained higher homeostasis of photosynthesis than alpine taxa. The higher respiration rates produced more energy for repair and maintenance biomass, especially for higher photosynthetic activity for lowland taxa, which causes lower respiratory acclimation. Thus, the changes of Delta(DH)-H-2 for alpine spruces were larger than that for lowland spruces. These results indicate that long term heat stress negatively impact on the growth of Picea seedlings, and alpine taxa are more affected than low altitude ones by high temperature stress. Hence the altitude ranges of Picea taxa should be taken into account when predicting changes to carbon fluxes in warmer conditions.	[Zhang, Xiao Wei; Wang, Jing Ru; Ji, Ming Fei; Wang, Ming Hao; Liu, Jian-Quan; Shi, Sheng; Yang, Shu-Li; Zhao, Chang-Ming] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Sch Life Sci, Lanzhou 730000, Peoples R China; [Milne, Richard Ian] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland	Lanzhou University; University of Edinburgh	Zhao, CM (corresponding author), Lanzhou Univ, State Key Lab Grassland Agroecosyst, Sch Life Sci, Lanzhou 730000, Peoples R China.	zhaochm@lzu.edu.cn			National Science Foundation of China [30930072, 31170571, 31370603]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Science Foundation of China (30930072, 31170571 and 31370603).	[Anonymous], 2007, CONTRIBUTION WORKING; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Atkin OK, 2005, ADV PHOTO RESPIRAT, V18, P95; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BILLINGS W D, 1971, Arctic and Alpine Research, V3, P277; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cunningham S, 2003, J BIOGEOGR, V30, P143, DOI 10.1046/j.1365-2699.2003.00811.x; Cunningham SC, 2002, OECOLOGIA, V133, P112, DOI 10.1007/s00442-002-1034-1; Danby RK, 2007, GLOBAL CHANGE BIOL, V13, P437, DOI 10.1111/j.1365-2486.2006.01302.x; Day ME, 2000, TREE PHYSIOL, V20, P57; Dewar RC, 1999, GLOBAL CHANGE BIOL, V5, P615, DOI 10.1046/j.1365-2486.1999.00253.x; Du FK, 2011, NEW PHYTOL, V192, P1024, DOI 10.1111/j.1469-8137.2011.03853.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Farjon A, 2001, WORLD CHECKLIST BIBL; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fu L, 1999, FLORA CHINA, P25; Ghannoum O, 2011, TREE PHYSIOL, V31, P1273, DOI 10.1093/treephys/tpr115; Gratani L, 2012, PHOTOSYNTHETICA, V50, P15, DOI 10.1007/s11099-012-0006-x; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; Hikosaka K, 2009, OECOLOGIA, V160, P443, DOI 10.1007/s00442-009-1315-z; HILL RS, 1988, J BIOGEOGR, V15, P431, DOI 10.2307/2845274; LARIGAUDERIE A, 1995, ANN BOT-LONDON, V76, P245, DOI 10.1006/anbo.1995.1093; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Miehe G, 2007, MT RES DEV, V27, P169, DOI 10.1659/mrd.0792; MOONEY HA, 1978, PLANT PHYSIOL, V61, P406, DOI 10.1104/pp.61.3.406; Nedlo JE, 2009, TREES-STRUCT FUNCT, V23, P751, DOI 10.1007/s00468-009-0317-0; Niu SL, 2008, ENVIRON EXP BOT, V63, P91, DOI 10.1016/j.envexpbot.2007.10.016; Ow LF, 2010, GLOBAL CHANGE BIOL, V16, P288, DOI 10.1111/j.1365-2486.2009.01892.x; Pontailler JY, 1997, ANN SCI FOREST, V54, P335, DOI 10.1051/forest:19970402; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Ryan MG, 2010, TREE PHYSIOL, V30, P667, DOI 10.1093/treephys/tpq033; Smith NG, 2013, GLOBAL CHANGE BIOL, V19, P45, DOI 10.1111/j.1365-2486.2012.02797.x; Tjoelker MG, 2009, NEW PHYTOL, V181, P218, DOI 10.1111/j.1469-8137.2008.02624.x; Tjoelker MG, 1999, GLOB CHANGE BIOL, V5, P679, DOI 10.1046/j.1365-2486.1999.00257.x; Turnbull MH, 2001, TREE PHYSIOL, V21, P571, DOI 10.1093/treephys/21.9.571; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Wertin TM, 2011, TREE PHYSIOL, V31, P1277, DOI 10.1093/treephys/tpr091; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wythers KR, 2005, GLOBAL CHANGE BIOL, V11, P435, DOI 10.1111/j.1365-2486.2005.00922.x; Xiong FSS, 2000, AM J BOT, V87, P700, DOI 10.2307/2656856; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yamori W, 2009, PLANT CELL PHYSIOL, V50, P203, DOI 10.1093/pcp/pcn189; Zhou XH, 2007, J INTEGR PLANT BIOL, V49, P270, DOI 10.1111/j.1744-7909.2007.00374.x; Zhu XG, 2007, PLANT PHYSIOL, V145, P513, DOI 10.1104/pp.107.103713; Zou JB, 2012, J SYST EVOL, V50, P341, DOI 10.1111/j.1759-6831.2012.00207.x	53	19	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123248	10.1371/journal.pone.0123248	http://dx.doi.org/10.1371/journal.pone.0123248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874631	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100155
J	Zhao, DY; Qiu, G; Luo, ZC; Zhang, YJ				Zhao, Dongying; Qiu, Gang; Luo, Zhongcheng; Zhang, Yongjun			Platelet Parameters and (1,3)-beta-D-Glucan as a Diagnostic and Prognostic Marker of Invasive Fungal Disease in Preterm Infants	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BIRTH-WEIGHT INFANTS; MYCOSES STUDY-GROUP; ASPERGILLUS-FUMIGATUS; EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; CANDIDIASIS; INFECTIONS; BACTEREMIA; ACTIVATION	The diagnosis of neonatal invasive fungal disease (IFD) is difficult and often delayed. The platelet parameters and (1, 3)-beta-D-Glucan (BG) may be useful for diagnosing IFD, but their diagnostic performance are not well characterized in neonates. We studied 63 preterm infants with IFD, 160 preterm infants without sepsis (preterm control), and 41 preterm infants with bacterial sepsis. Platelet parameters at the first day of onset of IFD and at the fourteenth day after antifungal treatment were evaluated. Serum BG was measured. Platelet count (PC), plateletcrit (PCT), and platelet distribution width (PDW) values were significantly lower, and mean platelet volume (MPV) values significantly higher in the IFD versus preterm control infants. PC and PCT values were much lower in infants with IFD versus bacterial sepsis, and there were significant differences in BG value between the two groups. After 14 days of antifungal treatment, significant elevations in PC, PCT, PDW and reductions in MPV levels in IFD group were observed. Receiver operating characteristic (ROC) curves showed that PC and PCT were strong predictors of IFD. The PC and PCT cut-offs for predicting IFD were 119.5 (sensitivity 78%, specificity 95%) and 0.21 (sensitivity 83%, specificity 85%), respectively. There were significant differences in PC and PCT levels between deceased and survived patients. The PC and PCT cut-offs for predicting deceased IFD were 39 (sensitivity 62%, specificity 86%) and 0.04 (sensitivity 50%, specificity 95%), respectively. The sensitivity in diagnosing IFD by a BG cutoff of >= 10 pg/ml was 68.3% and specificity was 75.6%. PC and PCT levels in the BG >= 400 pg/ml group were significantly lower compared to the BG<400 pg/ml group. Platelet parameters and BG could be useful biomarkers for the diagnosis and prognosis of neonatal IFD.	[Zhao, Dongying; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China; [Luo, Zhongcheng; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, MOE, Shanghai 200030, Peoples R China; [Luo, Zhongcheng; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Qiu, Gang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn	Zhao, Doreen/HHN-5678-2022; Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	This work was supported by the Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital (to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert O, 2011, EUR J CLIN MICROBIOL, V30, P1453, DOI 10.1007/s10096-011-1244-8; Becchi C, 2006, MINERVA ANESTESIOL, V72, P749; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Benjamin DK, 2003, PEDIATRICS, V112, P543, DOI 10.1542/peds.112.3.543; Brus F, 1997, PEDIATRICS, V99, P672, DOI 10.1542/peds.99.5.672; Cuenca-Estrella M, 2012, CLIN MICROBIOL INFEC, V18, P9, DOI 10.1111/1469-0691.12038; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; De Vlieger G, 2011, J CLIN MICROBIOL, V49, P3783, DOI 10.1128/JCM.00879-11; Ellepola ANB, 2005, J MICROBIOL, V43, P65; Fernandes G, 2012, JPEN-PARENTER ENTER, V36, P407, DOI 10.1177/0148607111434599; Gao YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103761; Goudjil S, 2013, J MATERN-FETAL NEO M, V26, P44, DOI 10.3109/14767058.2012.722716; Greenberg RG, 2012, J PEDIATR-US, V161, P264, DOI 10.1016/j.jpeds.2012.01.053; Guida JD, 2003, PEDIATRICS, V111, P1411, DOI 10.1542/peds.111.6.1411; Gunnink SF, 2014, EXPERT REV HEMATOL, V7, P387, DOI 10.1586/17474086.2014.902301; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Jaijakul S, 2012, CLIN INFECT DIS, V55, P521, DOI 10.1093/cid/cis456; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Koyama K, 2013, J CRIT CARE, V28, P556, DOI 10.1016/j.jcrc.2012.10.069; Lee JH, 2006, PEDIATR INFECT DIS J, V32, P222; Manzoni P, 2011, EARLY HUM DEV, V87, pS59, DOI 10.1016/j.earlhumdev.2011.01.013; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Metan G, 2012, REV IBEROAM MICOL, V29, P169, DOI 10.1016/j.riam.2011.07.003; Mohr JF, 2011, J CLIN MICROBIOL, V49, P58, DOI 10.1128/JCM.01240-10; Oeser C, 2013, J ANTIMICROB CHEMOTH, V68, P2733, DOI 10.1093/jac/dkt297; Osselaer JC, 1997, CLIN CHEM, V43, P1072; PATRICK CH, 1990, AM J CLIN PATHOL, V93, P391, DOI 10.1093/ajcp/93.3.391; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Prina E, 2013, CHEST, V143, P767, DOI 10.1378/chest.12-1235; Racil Z, 2013, MYCOSES, V56, P101, DOI 10.1111/j.1439-0507.2012.02210.x; Rodland EK, 2010, INFECT IMMUN, V78, P1269, DOI 10.1128/IAI.01091-09; Rodriguez D, 2006, PEDIATR INFECT DIS J, V25, P224, DOI 10.1097/01.inf.0000202127.43695.06; Segal BH, 2008, CLIN INFECT DIS, V47, P674, DOI 10.1086/590566; Speth C, 2013, FUTURE MICROBIOL, V8, P1431, DOI 10.2217/fmb.13.104; Speth C, 2013, J INFECT DIS, V207, P823, DOI 10.1093/infdis/jis743	35	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123907	10.1371/journal.pone.0123907	http://dx.doi.org/10.1371/journal.pone.0123907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874376	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100223
J	Chu, ML; Chang, YL; Guo, YJ; Wang, NT; Cui, J; Gao, WQ				Chu, Mingliang; Chang, Yunli; Guo, Yanjing; Wang, Naitao; Cui, Jian; Gao, Wei-Qiang			Regulation and Methylation of Tumor Suppressor MiR-124 by Androgen Receptor in Prostate Cancer Cells	PLOS ONE			English	Article							DNA METHYLATION; MICRORNA GENES; EXPRESSION; MARKERS; METASTASIS; SITES	Prostate cancer (PCa) is the most frequently diagnosed cancer for men in the developed world. Androgen receptor signaling pathway plays an important role in prostate cancer progression. Recent studies show that microRNA miR-124 exerts a tumor suppressive function in prostate cancer. However, the relationship between AR and miR-124 is unclear. In the present study, we found a negative feedback loop between AR and miR-124 expression. On one hand, miR-124 was a positively regulated target gene of the AR, on the other hand, overexpression of miR-124 inhibited the expression of AR. In addition, we found that miR124- 2 and miR-124-3 promoters were hypermethylated in AR-negative PCa cells. Furthermore, overexpression of miR-124 inhibited proliferation rates and invasiveness capacity of PCa cells in vitro, and suppressed xenograft tumor growth in vivo. Taken together, our results support a negative feedback loop between AR and miR-124 expression. Methylation of miR-124-2 and miR-124-3 may serve as a biomarker for AR-negative PCa cells, and overexpression of miR-124 might be of potential therapeutic value for the treatment of PCa.	[Chu, Mingliang; Chang, Yunli; Guo, Yanjing; Wang, Naitao; Cui, Jian; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med,State Key Lab Oncogenes & Related Genes, Ren Ji Med X Clin Stem Cell Res Ctr,Med X Res Ins, Shanghai 200127, Peoples R China; [Chu, Mingliang] Guiyang Med Univ, Affiliated Peoples Hosp, Guizhou Prov Peoples Hosp, Dept Pathol, Guiyang 550002, Peoples R China; [Wang, Naitao; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Wang, Naitao; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Guizhou Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, WQ (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med,State Key Lab Oncogenes & Related Genes, Ren Ji Med X Clin Stem Cell Res Ctr,Med X Res Ins, Shanghai 200127, Peoples R China.	gao.weiqiang@sjtu.edu.cn	Gao, Wei/GXH-0380-2022	Chu, Mingliang/0000-0003-0559-8921	Chinese Ministry of Science and Technology [2012CB966800, 2013CB945600, 2012CB967900]; National Natural Science Foundation of China [81130038, 81372189]; Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Education Committee Key Discipline and Specialty Foundation [J50208]; Key Discipline and Specialty Foundation of Shanghai Health Bureau; KC Wong foundation; Shanghai Postdoctoral Scientific Program of China [12R21415100]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Education Committee Key Discipline and Specialty Foundation; Key Discipline and Specialty Foundation of Shanghai Health Bureau; KC Wong foundation; Shanghai Postdoctoral Scientific Program of China	The study is supported by funds to W.-Q. Gao from the Chinese Ministry of Science and Technology (2012CB966800; 2013CB945600 and 2012CB967900), the National Natural Science Foundation of China (81130038 and 81372189), Science and Technology Commission of Shanghai Municipality (Pujiang program), Shanghai Education Committee Key Discipline and Specialty Foundation (J50208), Key Discipline and Specialty Foundation of Shanghai Health Bureau and KC Wong foundation, and to M. Chu from Shanghai Postdoctoral Scientific Program of China (12R21415100).	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Baldi E, 2003, ENDOCRINOLOGY, V144, P1653, DOI 10.1210/en.2003-0234; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chu ML, 2014, ONCOL REP, V31, P34, DOI 10.3892/or.2013.2810; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; Dai JL, 1996, STEROIDS, V61, P531; Dean L, 1999, PTEN TUMOR SUPPRESSO; Fang YX, 2014, ONCOGENE, V33, P135, DOI 10.1038/onc.2013.54; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gebauer K, 2013, BRIT J CANCER, V108, P131, DOI 10.1038/bjc.2012.537; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Mao HL, 2009, ASIAN J ANDROL, V11, P68, DOI 10.1038/aja.2008.14; Marsit C, 2013, ADV EXP MED BIOL, V754, P233, DOI 10.1007/978-1-4419-9967-2_12; Raynal NJM, 2012, CANCER RES, V72, P1170, DOI 10.1158/0008-5472.CAN-11-3248; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Shimizu T, 2013, EUR UROL, V63, P1091, DOI 10.1016/j.eururo.2012.11.030; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Yamashita R, 2005, GENE, V350, P129, DOI 10.1016/j.gene.2005.01.012; Zhao GS, 2005, FORENSIC SCI INT, V154, P122, DOI 10.1016/j.forsciint.2004.09.123	29	65	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0116197	10.1371/journal.pone.0116197	http://dx.doi.org/10.1371/journal.pone.0116197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860954	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300001
J	Mitra, A; Skrzypczak, M; Ginalski, K; Rowicka, M				Mitra, Abhishek; Skrzypczak, Magdalena; Ginalski, Krzysztof; Rowicka, Maga			Strategies for Achieving High Sequencing Accuracy for Low Diversity Samples and Avoiding Sample Bleeding Using Illumina Platform	PLOS ONE			English	Article								Sequencing microRNA, reduced representation sequencing, Hi-C technology and any method requiring the use of in-house barcodes result in sequencing libraries with low initial sequence diversity. Sequencing such data on the Illumina platform typically produces low quality data due to the limitations of the Illumina cluster calling algorithm. Moreover, even in the case of diverse samples, these limitations are causing substantial inaccuracies in multi-plexed sample assignment (sample bleeding). Such inaccuracies are unacceptable in clinical applications, and in some other fields (e.g. detection of rare variants). Here, we discuss how both problems with quality of low-diversity samples and sample bleeding are caused by incorrect detection of clusters on the flowcell during initial sequencing cycles. We propose simple software modifications (Long Template Protocol) that overcome this problem. We present experimental results showing that our Long Template Protocol remarkably increases data quality for low diversity samples, as compared with the standard analysis protocol; it also substantially reduces sample bleeding for all samples. For comprehensiveness, we also discuss and compare experimental results from alternative approaches to sequencing low diversity samples. First, we discuss how the low diversity problem, if caused by barcodes, can be avoided altogether at the barcode design stage. Second and third, we present modified guidelines, which are more stringent than the manufacturer's, for mixing low diversity samples with diverse samples and lowering cluster density, which in our experience consistently produces high quality data from low diversity samples. Fourth and fifth, we present rescue strategies that can be applied when sequencing results in low quality data and when there is no more biological material available. In such cases, we propose that the flowcell be re-hybridized and sequenced again using our Long Template Protocol. Alternatively, we discuss how analysis can be repeated from saved sequencing images using the Long Template Protocol to increase accuracy.	[Mitra, Abhishek; Rowicka, Maga] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Mitra, Abhishek; Rowicka, Maga] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Skrzypczak, Magdalena; Ginalski, Krzysztof] Univ Warsaw, Ctr New Technol, Lab Bioinformat & Syst Biol, PL-02089 Warsaw, Poland; [Rowicka, Maga] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Warsaw; University of Texas System; University of Texas Medical Branch Galveston	Ginalski, K (corresponding author), Univ Warsaw, Ctr New Technol, Lab Bioinformat & Syst Biol, Zwirki & Wigury 93, PL-02089 Warsaw, Poland.	kginal@cent.uw.edu.pl; merowick@utmb.edu	Skrzypczak, Magdalena/F-2575-2016; Rowicka, Maga/E-2496-2012	Skrzypczak, Magdalena/0000-0002-3336-0403; Rowicka, Maga/0000-0002-4011-071X	national center for advancing translational science (NCATS), National Institutes of Health [UL1 TR000071]; Foundation for Polish Science (TEAM); National Science Centre [2011/02/A/NZ2/00014]; European Regional Development Fund under Innovative Economy Programme [POIG.02.02.00-14-024/08-00]; National Institutes of Health [R01GM112131]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112131] Funding Source: NIH RePORTER	national center for advancing translational science (NCATS), National Institutes of Health; Foundation for Polish Science (TEAM); National Science Centre(National Science Centre, Poland); European Regional Development Fund under Innovative Economy Programme; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant UL1 TR000071 from the national center for advancing translational science (NCATS), National Institutes of Health (M. R. and A. M.) and by grants from the Foundation for Polish Science (TEAM), the National Science Centre (2011/02/A/NZ2/00014) and the European Regional Development Fund under Innovative Economy Programme (POIG.02.02.00-14-024/08-00) (K. G. and M. S.) and National Institutes of Health grant R01GM112131 (M. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Meyer M, 2010, COLD SPRING HARBOR P; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; vanBerkum N.L., 2010, J VISUALIZED EXPT JO; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383	13	67	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120520	10.1371/journal.pone.0120520	http://dx.doi.org/10.1371/journal.pone.0120520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860802	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300013
J	Raza, SEA; Prince, G; Clarkson, JP; Rajpoot, NM				Raza, Shan-e-Ahmed; Prince, Gillian; Clarkson, John P.; Rajpoot, Nasir M.			Automatic Detection of Diseased Tomato Plants Using Thermal and Stereo Visible Light Images	PLOS ONE			English	Article							INFRARED THERMOGRAPHY; DOWNY MILDEW	Accurate and timely detection of plant diseases can help mitigate the worldwide losses experienced by the horticulture and agriculture industries each year. Thermal imaging provides a fast and non-destructive way of scanning plants for diseased regions and has been used by various researchers to study the effect of disease on the thermal profile of a plant. However, thermal image of a plant affected by disease has been known to be affected by environmental conditions which include leaf angles and depth of the canopy areas accessible to the thermal imaging camera. In this paper, we combine thermal and visible light image data with depth information and develop a machine learning system to remotely detect plants infected with the tomato powdery mildew fungus Oidium neolycopersici. We extract a novel feature set from the image data using local and global statistics and show that by combining these with the depth information, we can considerably improve the accuracy of detection of the diseased plants. In addition, we show that our novel feature set is capable of identifying plants which were not originally inoculated with the fungus at the start of the experiment but which subsequently developed disease through natural transmission.	[Raza, Shan-e-Ahmed; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Prince, Gillian; Clarkson, John P.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Rajpoot, Nasir M.] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar	University of Warwick; University of Warwick; Qatar University	Raza, SEA (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	S.E.A.Raza@warwick.ac.uk; Nasir.Rajpoot@ieee.org		Raza, Shan E Ahmed/0000-0002-1097-1738; Rajpoot, Nasir/0000-0002-4706-1308; Clarkson, John/0000-0001-5931-933X	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick [CP60a]	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick	The authors would like to thank Horticultural Development Company (HDC) and the Department of Computer Science, University of Warwick to fund the project (CP60a). The authors would also like to thank the Engineering and Physical Sciences Research Council (EPSRC) for providing the thermal imaging camera Cedip Titanium via their loan pool scheme. The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.	Andersen HJ, 2005, COMPUT ELECTRON AGR, V49, P219, DOI 10.1016/j.compag.2005.02.015; Belin E, 2013, COMPUT ELECTRON AGR, V90, P159, DOI 10.1016/j.compag.2012.09.014; Birchfield S, 1999, INT J COMPUT VISION, V35, P269, DOI 10.1023/A:1008160311296; Biskup B, 2007, PLANT CELL ENVIRON, V30, P1299, DOI 10.1111/j.1365-3040.2007.01702.x; Chaerle L, 1999, NAT BIOTECHNOL, V17, P813, DOI 10.1038/11765; Chaerle L, 2007, J EXP BOT, V58, P773, DOI 10.1093/jxb/erl257; Han J, 2007, PATTERN RECOGN, V40, P1771, DOI 10.1016/j.patcog.2006.11.010; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; IVANOV N, 1995, AGR FOREST METEOROL, V75, P85, DOI 10.1016/0168-1923(94)02204-W; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Kolmogorov V, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P508, DOI 10.1109/ICCV.2001.937668; Konolige K., 1998, SMALL VISION SYSTEMS; Lenthe JH, 2007, PRECIS AGRIC, V8, P15, DOI 10.1007/s11119-006-9025-6; Lindenthal M, 2005, PHYTOPATHOLOGY, V95, P233, DOI 10.1094/PHYTO-95-0233; Mahlein AK, 2012, EUR J PLANT PATHOL, V133, P197, DOI 10.1007/s10658-011-9878-z; Naidu RA, 2009, COMPUT ELECTRON AGR, V66, P38, DOI 10.1016/j.compag.2008.11.007; Oerke EC, 2006, J EXP BOT, V57, P2121, DOI 10.1093/jxb/erj170; Oerke EC, 2011, PRECIS AGRIC, V12, P699, DOI 10.1007/s11119-010-9212-3; Oerke EC, 2010, PRECISION CROP PROTECTION - THE CHALLENGE AND USE OF HETEROGENEITY, P167, DOI 10.1007/978-90-481-9277-9_11; Omasa K, 2007, J EXP BOT, V58, P881, DOI 10.1093/jxb/erl142; Raza SEA, 2015, PATTERN RECOGNITION; Raza SEA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097612; Rosell JR, 2012, COMPUT ELECTRON AGR, V81, P124, DOI 10.1016/j.compag.2011.09.007; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Song Y, 2007, SIXTH INTERNATIONAL; Stoll M, 2008, VITIS, V47, P133; Sun HJ, 2014, EUR J PLANT PATHOL, V139, P125, DOI 10.1007/s10658-013-0371-8; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Verstockt S, 2012, MACH VISION APPL, V23, P1243, DOI 10.1007/s00138-011-0359-3; Yang QX, 2012, PROC CVPR IEEE, P1402, DOI 10.1109/CVPR.2012.6247827; Yang QX, 2010, PROC CVPR IEEE, P1458, DOI 10.1109/CVPR.2010.5539797	32	85	92	11	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123262	10.1371/journal.pone.0123262	http://dx.doi.org/10.1371/journal.pone.0123262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861025	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300087
J	Wang, NY; Hirao, A; Sieber, F				Wang, Nae-Yuh; Hirao, Ai; Sieber, Frederick			Association between Intraoperative Blood Pressure and Postoperative Delirium in Elderly Hip Fracture Patients	PLOS ONE			English	Article							SPINAL-ANESTHESIA; RANDOMIZED-TRIAL; OLDER-ADULTS; SURGERY; RISK; PERFORMANCE; NECK	Background One possible area of intervention to prevent postoperative delirium (PD) is intraoperative blood pressure management. However, the relationship between intraoperative blood pressure and PD is unclear. A secondary analysis of a RCT study examining the PD risk over the range of absolute intraoperative mean arterial blood pressure (MAP) readings and the corresponding relative changes from preoperative baseline level was performed to determine the role of MAP on PD. Methods Nonparametric locally weighted quadratic polynomial smoothing (LOESS) regression explored the pattern of PD risk at postoperative day 2 as a function of mean surgery MAP (msMAP) and percent change of msMAP from baseline in 103 elderly hip fracture patients. Segment-linear logistic regression models were then constructed to determine the odds ratios (OR) of PD over the observed range of these msMAP measures, adjusting for potential confounds. Results Twenty-three patients (22%) developed PD on day 2. LOESS regression revealed a j-shaped association between absolute levels of msMAP and PD risk. When msMAP was >= 80 mmHg, higher msMAP imparted greater PD risk (OR = 2.28 per 10 mmHg msMAP increase; 95% CI: 1.11-4.70), while higher msMAP was associated with lower PD risk (OR = 0.19 per 10 mmHg increase; CI: 0.05-0.76) if msMAP was <80 mmHg. There was no statistically significant relationship between PD risk and average percent change from baseline in these msMAP measures. Conclusion In elderly hip fracture patients, both very high and very low levels of msMAP were associated with significantly increased risk of PD.	[Wang, Nae-Yuh] Johns Hopkins Med Inst, Dept Med Biostat & Epidemiol, Baltimore, MD 21205 USA; [Hirao, Ai; Sieber, Frederick] Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Sieber, F (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21224 USA.	fsieber1@jhmi.edu		Wang, Nae-Yuh/0000-0001-6513-9730	NIH [R01AG033615]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [M01 RR02719, UL1 TR000424, UL1 TR001079]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIH R01AG033615. Funding for statistical support is also received from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Numbers M01 RR02719, UL1 TR000424, and UL1 TR001079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2006, CARDIOL CLIN, V24, P135, DOI 10.1016/j.ccl.2005.09.002; Bijker JB, 2012, ANESTHESIOLOGY, V116, P658, DOI 10.1097/ALN.0b013e3182472320; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Edlund A, 2001, J AM GERIATR SOC, V49, P1335, DOI 10.1046/j.1532-5415.2001.49261.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gruber-Baldini AL, 2013, J AM GERIATR SOC, V61, P1286, DOI 10.1111/jgs.12396; Guenther U, 2011, CURR OPIN ANESTHESIO, V24, P670, DOI 10.1097/ACO.0b013e32834c7b44; Hoppenstein D, 2005, J CLIN ANESTH, V17, P431, DOI 10.1016/j.jclinane.2004.09.013; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Leslie DL, 2011, J AM GERIATR SOC, V59, pS241, DOI 10.1111/j.1532-5415.2011.03671.x; Lien SF, 2012, CURR HYPERTENS REP, V14, P432, DOI 10.1007/s11906-012-0287-2; Minville V, 2009, ANESTH ANALG, V108, P1291, DOI 10.1213/ane.0b013e31819b073b; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Papadopoulos George, 2012, Open Orthop J, V6, P400, DOI 10.2174/1874325001206010400; Patti R, 2011, EUR J ONCOL NURS, V15, P519, DOI 10.1016/j.ejon.2011.01.004; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Williams-Russo P, 1999, ANESTHESIOLOGY, V91, P926, DOI 10.1097/00000542-199910000-00011; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Yocum GT, 2009, ANESTHESIOLOGY, V110, P254, DOI 10.1097/ALN.0b013e3181942c7a	21	51	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123892	10.1371/journal.pone.0123892	http://dx.doi.org/10.1371/journal.pone.0123892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860338	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300121
J	Arras, SDM; Chitty, JL; Blake, KL; Schulz, BL; Fraser, JA				Arras, Samantha D. M.; Chitty, Jessica L.; Blake, Kirsten L.; Schulz, Benjamin L.; Fraser, James A.			A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans	PLOS ONE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; VIRULENCE; YEAST; PATHOGENICITY; IDENTIFICATION; TRANSFORMATION; INFECTIONS; EXPRESSION	Just as Koch's postulates formed the foundation of early infectious disease study, Stanley Falkow's molecular Koch's postulates define best practice in determining whether a specific gene contributes to virulence of a pathogen. Fundamentally, these molecular postulates state that if a gene is involved in virulence, its removal will compromise virulence. Likewise, its reintroduction should restore virulence to the mutant. These approaches are widely employed in Cryptococcus neoformans, where gene deletion via biolistic transformation is a well-established technique. However, the complementation of these mutants is less straightforward. Currently, one of three approaches will be taken: the gene is reintroduced at the original locus, the gene is reintroduced into a random site in the genome, or the mutant is not complemented at all. Depending on which approach is utilized, the mutant may be complemented but other genes are potentially disrupted in the process. To counter the drawbacks of the current approaches to complementation we have created a new tool to assist in this key step in the study of a gene's role in virulence. We have identified and characterized a small gene-free region in the C. neoformans genome dubbed the "safe haven", and constructed a plasmid vector that targets DNA constructs to this preselected site. The plasmid vector integrates with high frequency, effectively complementing a mutant strain without disrupting adjacent genes. qRT-PCR of the flanking genes on either side of the safe haven site following integration of the targeting vector revealed no changes in their expression, and no secondary phenotypes were observed in a range of phenotypic assays including an intranasal murine infection model. Combined, these data confirm that we have successfully created a much-needed molecular resource for the Cryptococcus community, enabling the reliable fulfillment of the molecular Koch's postulates.	[Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	jafraser@uq.edu.au	McMahon, Kirsten/M-8735-2017; Schulz, Benjamin L/B-3911-2009; Fraser, James A/B-4918-2012; Chitty, Jessica/U-6619-2019; Chitty, Jessica/C-8005-2017	McMahon, Kirsten/0000-0001-8254-0235; Schulz, Benjamin L/0000-0002-4823-7758; Fraser, James A/0000-0001-5724-5285; Chitty, Jessica/0000-0003-1776-1618; Chitty, Jessica/0000-0003-1776-1618	National Health and Medical Research Council [APP1049716]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council, http://www.nhmrc.gov.au/, APP1049716 to JAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Chen SCA, 2002, J ANTIMICROB CHEMOTH, V49, P57, DOI 10.1093/jac/49.suppl_1.57; Chow EWL, 2012, MOL BIOL EVOL, V29, P1987, DOI 10.1093/molbev/mss066; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Donovan M, 2001, INFECT IMMUN, V69, P2542, DOI 10.1128/IAI.69.4.2542-2548.2001; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; GOSHORN AK, 1992, INFECT IMMUN, V60, P876, DOI 10.1128/IAI.60.3.876-884.1992; Groisman EA, 2001, PRINCIPLE BACTERICAL; Hegemann JH, 2011, METHODS MOL BIOL, V765, P189, DOI 10.1007/978-1-61779-197-0_12; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Idnurm A, 2009, EUKARYOT CELL, V8, P315, DOI 10.1128/EC.00375-08; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; Koch, 1884, 2 AETIOLOGIE TUBERKU; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; MURRAY JAH, 1987, MOL MICROBIOL, V1, P1, DOI 10.1111/j.1365-2958.1987.tb00519.x; Ormerod KL, 2013, G3-GENES GENOM GENET, V3, P675, DOI 10.1534/g3.113.005660; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sudarshan S, 1999, FUNGAL GENET BIOL, V27, P36, DOI 10.1006/fgbi.1999.1126; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Wills EA, 2001, MOL MICROBIOL, V40, P610, DOI 10.1046/j.1365-2958.2001.02401.x	33	53	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122916	10.1371/journal.pone.0122916	http://dx.doi.org/10.1371/journal.pone.0122916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856300	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500065
J	Preza, GC; Yang, OO; Elliott, J; Anton, PA; Ochoa, MT				Preza, Gloria Cuevas; Yang, Otto O.; Elliott, Julie; Anton, Peter A.; Ochoa, Maria T.			T Lymphocyte Density and Distribution in Human Colorectal Mucosa, and Inefficiency of Current Cell Isolation Protocols	PLOS ONE			English	Article							IMAGE-ANALYSIS; TISSUE; EXPRESSION; INFECTION; CYTOMETRY; RESPONSES; BLOOD	Mucosal tissues are critical immune effector sites containing complex populations of leukocytes in a tissue microenvironment that remains incompletely understood. We identify and quantify in human distal colorectal tissue absolute mucosal CD3(+) lymphocytes, including CD4(+) and CD8(+) subsets, by direct visualization using immunohistochemistry (IHC), immunofluorescence (IF), and an automated counting protocol (r(2)=0.90). Sigmoid and rectal mucosal tissues are both densely packed with T lymphocytes in the mucosal compartment. Both compartments had similar densities of CD3(+) T lymphocytes with 37,400 +/- 2,801 cells/mm(3) and 33,700 +/- 4,324 cell/mm(3), respectively. Sigmoid mucosa contained 57% CD3(+)CD4(+) and 40% CD3(+)CD8(+) T lymphocytes which calculates to 21,300 +/- 1,476/mm(3) and 15,000 +/- 275/mm(3) T lymphocytes, respectively. Rectal mucosa had 57% CD3(+)CD4(+) and 42% CD3(+)CD8(+) or 21,577 +/- 332, and 17,090 +/- 1,206 cells/mm(3), respectively. By comparison, sigmoid mucosal biopsies subjected to conventional collagenase digestion, mononuclear cell (MMC) isolation and staining for flow cytometry yielded 4,549 +/- 381/mm(3) and 2,708 +/- 245/mm(3) CD4+ and CD8+ T lymphocytes. These data suggest only similar to 20.7% recovery compared to IHC results for these markers. Further studies will determine if this reflects a selective bias in only CD3(+), CD4(+) and CD8(+) T cells or can be generalized to all flow-analyzed cells from mucosal tissues for phenotyping and functional testing.	[Preza, Gloria Cuevas; Ochoa, Maria T.] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Yang, Otto O.; Elliott, Julie; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Yang, Otto O.; Elliott, Julie; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Otto O.] AIDS Healthcare Fdn, Los Angeles, CA USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ochoa, MT (corresponding author), Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA.	maritoc@usc.edu		Ochoa, Maria T/0000-0001-6550-5008	UCLA Center for AIDS Research Mucosal Immunology Core Laboratory (MICL) [AI28697]; National Institutes of Health/National Institute of Allergy and Infectious Diseases (MDP) [IPCP U19, AI060614]; National Institutes of Health/NIA grant [R01 AG032422]; Mucosal Immunology Group [UMI AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068618, U01AI068618, U19AI060614, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032422] Funding Source: NIH RePORTER	UCLA Center for AIDS Research Mucosal Immunology Core Laboratory (MICL); National Institutes of Health/National Institute of Allergy and Infectious Diseases (MDP); National Institutes of Health/NIA grant; Mucosal Immunology Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by UCLA Center for AIDS Research Mucosal Immunology Core Laboratory (MICL) (AI28697), to PAA; National Institutes of Health/National Institute of Allergy and Infectious Diseases grants: IPCP U19 AI060614 (MDP), Mucosal Immunology Group (UMI AI068618), to PAA; and National Institutes of Health/NIA grant R01 AG032422, to OOY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Anton PA, 2008, VACCINE, V26, P4617, DOI 10.1016/j.vaccine.2008.05.084; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; CERFBENSUSSAN N, 1991, GASTROENTEROL CLIN N, V20, P549; Diederichsen ACP, 1998, APMIS, V106, P562, DOI 10.1111/j.1699-0463.1998.tb01385.x; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Falo C, 2003, AM J CLIN ONCOL-CANC, V26, P465, DOI 10.1097/01.coc.0000026834.38957.35; Ford AL, 1996, J IMMUNOL METHODS, V194, P71, DOI 10.1016/0022-1759(96)00067-1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Leonhardt H, 1993, COLOR ATLAS TXB HUMA; MacDonald TT, 2013, PRINCIPLES MUCOSAL I; McDonald TT, 1994, GEN BACKGROUND GASTR; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Mulrane L, 2008, EXPERT REV MOL DIAGN, V8, P707, DOI 10.1586/14737159.8.6.707; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; PRESS MF, 1993, CANCER RES, V53, P4960; Preza GC, 2014, AIDS RES HUM RETROV, V30, P241, DOI [10.1089/aid.2013.0145, 10.1089/AID.2013.0145]; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Staniszewski W, 2009, FOLIA HISTOCHEM CYTO, V47, P699, DOI 10.2478/v10042-009-0115-y; TREPEL F, 1974, KLIN WOCHENSCHR, V52, P511, DOI 10.1007/BF01468720; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539	29	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122723	10.1371/journal.pone.0122723	http://dx.doi.org/10.1371/journal.pone.0122723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856343	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500052
J	Sugimoto, C; Konno, T; Wakao, R; Fujita, H; Fujita, H; Wakao, H				Sugimoto, Chie; Konno, Takahiko; Wakao, Rika; Fujita, Hiroko; Fujita, Hiroyoshi; Wakao, Hiroshi			Mucosal-Associated Invariant T Cell Is a Potential Marker to Distinguish Fibromyalgia Syndrome from Arthritis	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; DIAGNOSIS; INFLAMMATION	Background Fibromyalgia (FM) is defined as a widely distributed pain. While many rheumatologists and pain physicians have considered it to be a pain disorder, psychiatry, psychology, and general medicine have deemed it to be a syndrome (FMS) or psychosomatic disorder. The lack of concrete structural and/or pathological evidence has made patients suffer prejudice that FMS is a medically unexplained symptom, implying inauthenticity. Furthermore, FMS often exhibits comorbidity with rheumatoid arthritis (RA) or spondyloarthritis (SpA), both of which show similar indications. In this study, disease specific biomarkers were sought in blood samples from patients to facilitate objective diagnoses of FMS, and distinguish it from RA and SpA. Methods Peripheral blood mononuclear cells (PBMCs) from patients and healthy donors (HD) were subjected to multicolor flow cytometric analysis. The percentage of mucosal-associated invariant T (MAIT) cells in PBMCs and the mean fluorescent intensity (MFI) of cell surface antigen expression in MAIT cells were analyzed. Results There was a decrease in the MAIT cell population in FMS, RA, and SpA compared with HD. Among the cell surface antigens in MAIT cells, three chemokine receptors, CCR4, CCR7, and CXCR1, a natural killer (NK) receptor, NKp80, a signaling lymphocyte associated molecule (SLAM) family, CD150, a degrunulation marker, CD107a, and a coreceptor, CD8 beta emerged as potential biomarkers for FMS to distinguish from HD. Additionally, a memory marker, CD44 and an inflammatory chemokine receptor, CXCR1 appeared possible markers for RA, while a homeostatic chemokine receptor, CXCR4 deserved for SpA to differentiate from FMS. Furthermore, the drug treatment interruption resulted in alternation of the expression of CCR4, CCR5, CXCR4, CD27, CD28, inducible costimulatory molecule (ICOS), CD127 (IL-7 receptor alpha), CD94, NKp80, an activation marker, CD69, an integrin family member, CD49d, and a dipeptidase, CD26, in FMS. Conclusions Combined with the currently available diagnostic procedures and criteria, analysis of MAIT cells offers a more objective standard for the diagnosis of FMS, RA, and SpA, which exhibit multifaceted and confusingly similar clinical manifestations.	[Sugimoto, Chie; Fujita, Hiroko; Fujita, Hiroyoshi; Wakao, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido 0608638, Japan; [Konno, Takahiko] Tokeidai Mem Clin, Dept Rheumatol, Sapporo, Hokkaido 0600031, Japan; [Wakao, Rika] PMDA, Tokyo 1000013, Japan	Hokkaido University	Wakao, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido 0608638, Japan.	hwakao@med.hokudai.ac.jp			Ministry of Science, Culture, and Sport (Japan)	Ministry of Science, Culture, and Sport (Japan)	Funding was provided by Ministry of Science, Culture, and Sport (Japan), Kakenhi B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Brachtl G, 2014, ANN HEMATOL, V93, P361, DOI 10.1007/s00277-013-1967-y; Chiba A, 2012, ARTHRITIS RHEUM-US, V64, P153, DOI 10.1002/art.33314; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Dimsdale JE, 2013, J PSYCHOSOM RES, V75, P223, DOI 10.1016/j.jpsychores.2013.06.033; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Bote ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074524; Garcia JJ, 2014, ANN CLIN BIOCHEM, V51, P576, DOI 10.1177/0004563213506413; Hauser W, 2012, REUMATISMO, V64, P194, DOI 10.4081/reumatismo.2012.194; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Imamura M, 2014, CLIN INTERV AGING, V9, P939, DOI 10.2147/CIA.S60330; Kadetoff D, 2012, J NEUROIMMUNOL, V242, P33, DOI 10.1016/j.jneuroim.2011.10.013; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; Ou X, 2013, BLOOD, V122, P161, DOI 10.1182/blood-2013-02-487470; Paladini F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2860; Pernambuco AP, 2013, CLIN EXP RHEUMATOL, V31, pS60; Rodriguez-Pinto I, 2014, IMMUNOL LETT, V161, P200, DOI 10.1016/j.imlet.2014.01.009; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Sturgill J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/938576; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yunus MB, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/584573; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	29	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121124	10.1371/journal.pone.0121124	http://dx.doi.org/10.1371/journal.pone.0121124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853812	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400028
J	Fakhraldeen, SA; Clark, RJ; Roopra, A; Chin, EN; Huang, W; Castorino, J; Wisinski, KB; Kim, T; Spiegelman, VS; Alexander, CM				Fakhraldeen, Saja A.; Clark, Rod J.; Roopra, Avtar; Chin, Emily N.; Huang, Wei; Castorino, John; Wisinski, Kari B.; Kim, TaeWon; Spiegelman, Vladimir S.; Alexander, Caroline M.			Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYC MESSENGER-RNA; CANCER-CELLS; C-MYC; CRD-BP; STEM-CELLS; KH DOMAINS; ZBP1; TRANSLATION; IGF2BP1; IMP1	CRD-BP/IGF2BP1 has been characterized as an "oncofetal" RNA binding protein typically highly expressed in embryonic tissues, suppressed in normal adult tissues, but induced in many tumor types. In this study, we show that adult breast tissues express ubiquitous but low levels of CRD-BP protein and mRNA. Although CRD-BP mRNA expression is induced in breast tumor cells, levels remain similar to 1000-fold lower than in embryonic tissues. Despite low expression levels, CRD-BP is required for clonogenic growth of breast cancer cells. We reveal that because the most common protein isoform in normal adult breast and breast tumors has an N-terminal deletion (lacking two RNA recognition motif (RRM) domains) and is therefore missing antibody epitopes, CRD-BP expression has been under-reported by previous studies. We show that a CRD-BP mutant mouse strain retains expression of the shorter transcript (Delta N-CRD-BP), which originates in intron 2, suggesting that the impact of complete ablation of this gene in mice is not yet known. Either the full-length CRD-BP or the N-terminally truncated version can rescue the clonogenicity of CRD-BP knockdown breast cancer cells, suggesting that clonogenic function is served by either CRD-BP isoform. In summary, although CRD-BP expression levels are low in breast cancer cells, this protein is necessary for clonogenic activity.	[Fakhraldeen, Saja A.; Clark, Rod J.; Chin, Emily N.; Alexander, Caroline M.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53705 USA; [Roopra, Avtar] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Huang, Wei] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Wisinski, Kari B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA; [Kim, TaeWon; Spiegelman, Vladimir S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53705 USA; [Castorino, John] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alexander, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, 1111 Highland Ave, Madison, WI 53705 USA.	alexander@oncology.wisc.edu		Spiegelman, Vladimir S/0000-0003-4847-155X; Kim, TaeWon/0000-0002-6443-2465; Fakhraldeen, Saja/0000-0003-3919-0270	National Institutes of Health, NCI [T32 CA009135]; Era of Hope Scholars Award [W81XWH-06-1-0491 CDMRP]; Cancer Center Core Support for University of Wisconsin [AR063361, P30 CA014520]; Kuwait Foundation for the Advancement of Sciences [2013-6302-03]; Cancer Center Core Grant [NCI 2P 30CA014520-39]; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063361] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Era of Hope Scholars Award; Cancer Center Core Support for University of Wisconsin; Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health, NCI Grant T32 CA009135 (to S. A. F.), Era of Hope Scholars Award W81XWH-06-1-0491 CDMRP (to C. M. A. and R. J. C.), and Grants AR063361 (to V. S. S. and T. W. K.) and P30 CA014520 from Cancer Center Core Support for University of Wisconsin (to C. M. A. and V. S. S.). This project was also supported in part by the Kuwait Foundation for the Advancement of Sciences under project 2013-6302-03 and by Cancer Center Core Grant, NCI 2P 30CA014520-39 to the Translational Science BioCore Biobank of the University of Wisconsin Carbone Cancer Center.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brackett DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058296; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Craig EA, 2012, PIGM CELL MELANOMA R, V25, P83, DOI 10.1111/j.1755-148X.2011.00921.x; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Doyle GA, 2000, CANCER RES, V60, P2756; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Eyal Y, 1999, BIOTECHNIQUES, V27, P656, DOI 10.2144/99274bm04; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Gu W, 2008, MOL CELL BIOL, V28, P4963, DOI 10.1128/MCB.00266-08; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Gu W, 2009, J CELL SCI, V122, P1895, DOI 10.1242/jcs.045278; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Le HTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033140; Lembo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031129; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahaira LG, 2014, STEM CELLS DEV, V23, P2501, DOI 10.1089/scd.2013.0604; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Moschner K, 2014, J BIOL CHEM, V289, P16814, DOI 10.1074/jbc.M113.541425; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen J, 2000, MECH DEVELOP, V96, P129, DOI 10.1016/S0925-4773(00)00383-X; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nielsen J, 2003, BIOCHEM J, V376, P383, DOI 10.1042/BJ20030943; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2014, J INVEST DERMATOL, V134, P1718, DOI 10.1038/jid.2014.17; Noubissi Felicite K, 2010, Genes Cancer, V1, P1074, DOI 10.1177/1947601910395581; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Yisraeli JK, 2005, BIOL CELL, V97, P87	53	35	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13386	13400		10.1074/jbc.M115.655175	http://dx.doi.org/10.1074/jbc.M115.655175			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861986	Green Published, hybrid			2022-12-26	WOS:000354975700035
J	Chuang, YC; Huang, YL; Tseng, KC; Yen, CH; Yang, LH				Chuang, Ying-Chih; Huang, Ya-Li; Tseng, Kuo-Chien; Yen, Chia-Hsin; Yang, Lin-hui			Social Capital and Health-Protective Behavior Intentions in an Influenza Pandemic	PLOS ONE			English	Article							SELF-RATED HEALTH; POLITICAL-ECONOMY; AVIAN INFLUENZA; TRUST; VACCINATION; COMMUNICATION; ASSOCIATIONS	Health-protective behaviors, such as receiving a vaccine, wearing a face mask, and washing hands frequently, can reduce the risk of contracting influenza. However, little is known about how social capital may influence health-protective behavior in the general population. This study examined whether each of the social capital dimensions (bonding, bridging, and linking) contributed to the intention to adopt any of the health-protective behaviors in an influenza pandemic. The data of this study were from the 2014 Taiwan Social Change Survey. A stratified, three-stage probability proportional-to-size sampling from across the nation, was conducted to select adults aged 20 years and older (N = 1,745). Bonding social capital was measured by the frequency of neighborly contact and support. Bridging social capital was measured based on association membership. Linking social capital was measured according to general government trust and trust in the government's capacity to counter an influenza pandemic. Binary logistic regressions were used to assess the multivariate associations between social capital and behavioral intention. The study results indicate that social capital may influence the response to influenza pandemic. Specifically, the intention to receive a vaccine and to wash hands more frequently were associated with the linking dimension and the bonding dimension of social capital, while the intention to wear a face mask was associated with all forms of social capital. The findings of this study suggest that government credibility and interpersonal networks may play a crucial role in health-protective behavior. This study provides new insights into how to improve the effectiveness of influenza prevention campaigns.	[Chuang, Ying-Chih; Tseng, Kuo-Chien; Yen, Chia-Hsin] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Huang, Ya-Li] Taipei Med Univ, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Yang, Lin-hui] Natl Taiwan Univ, Dept Anthropol, Taipei 10764, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University	Chuang, YC (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	yingchih@tmu.edu.tw			Ministry of Science and Technology in Taiwan	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	The data presented in this study were collected by the "2014 Taiwan Social Change Survey" research project, sponsored by the Ministry of Science and Technology in Taiwan. The Taiwan Social Change Survey was administered by the Institute of Sociology, Academia Sinica. The Center for Survey Research of Academia Sinica is responsible for the data distribution. The authors appreciate the assistance of these institutes and individuals in providing these data.	[Anonymous], 1984, DISTINCTION SOCIAL C; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Cadigan R., 2008, SOCIAL CAPITAL HLTH, P273, DOI DOI 10.1007/978-0-387-71311-3_13; Chan TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101083; Cheng H-L, 2002, TAIWAN J PUBLIC HLTH, V21, P289; Cheung Chau-Kiu, 2008, Soc Work Public Health, V23, P41, DOI 10.1080/19371910802053224; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Chuang YC, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-87; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Derose KP, 2009, MED CARE RES REV, V66, P272, DOI 10.1177/1077558708330428; Earle TC, 2010, RISK ANAL, V30, P541, DOI 10.1111/j.1539-6924.2010.01398.x; Fang D, 2012, INT J ENV RES PUB HE, V9, P2742, DOI 10.3390/ijerph9082742; Fu Y-C, 2014, TAIWAN SOCIAL CHANGE; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Jung M, 2013, VACCINE, V31, P4860, DOI 10.1016/j.vaccine.2013.07.068; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Kobayashi T, 2013, SOC SCI MED, V85, P32, DOI 10.1016/j.socscimed.2013.02.027; Kok G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-174; Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8; Lin N., 2001, SOCIAL CAPITAL THEOR, P57, DOI DOI 10.1017/CBO9780511815447; Liu BM, 2014, SURV METHODOL, V40, P1; Miao YY, 2012, TROP MED INT HEALTH, V17, P604, DOI 10.1111/j.1365-3156.2012.02966.x; Poortinga W, 2003, RISK ANAL, V23, P961, DOI 10.1111/1539-6924.00373; Poortinga W, 2012, HEALTH PLACE, V18, P286, DOI 10.1016/j.healthplace.2011.09.017; Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035; PUTNAM RD, 1995, J DEMOCRACY, V0006; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Rojas Y, 2006, SOC SCI MED, V62, P2732, DOI 10.1016/j.socscimed.2005.11.007; Ronnerstrand B, 2013, SCAND J PUBLIC HEALT, V41, P853, DOI 10.1177/1403494813494975; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Sundquist K, 2014, EXP GERONTOL, V55, P29, DOI 10.1016/j.exger.2014.03.007; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Tsai MC, 2006, J SOC PERS RELAT, V23, P151, DOI 10.1177/0265407506060184; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Waisbord S R, 2008, Glob Public Health, V3, P197, DOI 10.1080/17441690801887620; WHO WHO WHO WHO, 2011, PAND INFL A H1N1	40	80	80	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122970	10.1371/journal.pone.0122970	http://dx.doi.org/10.1371/journal.pone.0122970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874625	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800084
J	Xu, CJ; Zeng, BY; Huang, JM; Huang, W; Liu, YM				Xu, Chuanjun; Zeng, Biyu; Huang, Junmei; Huang, Wen; Liu, Yumei			Genome-Wide Transcriptome and Expression Profile Analysis of Phalaenopsis during Explant Browning	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; CUT LETTUCE; POLYPHENOL; ANTHOCYANINS; PEROXIDASE; DISORDERS; FRUIT	Background Explant browning presents a major problem for in vitro culture, and can lead to the death of the explant and failure of regeneration. Considerable work has examined the physiological mechanisms underlying Phalaenopsis leaf explant browning, but the molecular mechanisms of browning remain elusive. In this study, we used whole genome RNA sequencing to examine Phalaenopsis leaf explant browning at genome-wide level. Methodology/Principal Findings We first used Illumina high-throughput technology to sequence the transcriptome of Phalaenopsis and then performed de novo transcriptome assembly. We assembled 79,434,350 clean reads into 31,708 isogenes and generated 26,565 annotated unigenes. We assigned Gene Ontology (GO) terms, Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations, and potential Pfam domains to each transcript. Using the transcriptome data as a reference, we next analyzed the differential gene expression of explants cultured for 0, 3, and 6 d, respectively. We then identified differentially expressed genes (DEGs) before and after Phalaenopsis explant browning. We also performed GO, KEGG functional enrichment and Pfam analysis of all DEGs. Finally, we selected 11 genes for quantitative real-time PCR (qPCR) analysis to confirm the expression profile analysis. Conclusions/Significance Here, we report the first comprehensive analysis of transcriptome and expression profiles during Phalaenopsis explant browning. Our results suggest that Phalaenopsis explant browning may be due in part to gene expression changes that affect the secondary metabolism, such as: phenylpropanoid pathway and flavonoid biosynthesis. Genes involved in photosynthesis and ATPase activity have been found to be changed at transcription level; these changes may perturb energy metabolism and thus lead to the decay of plant cells and tissues. This study provides comprehensive gene expression data for Phalaenopsis browning. Our data constitute an important resource for further functional studies to prevent explant browning.	[Xu, Chuanjun; Zeng, Biyu; Huang, Junmei; Huang, Wen; Liu, Yumei] Fujian Inst Subtrop Bot, Fujian Key Lab Physiol & Biochem Subtrop Plants, Xiamen 361006, Peoples R China; [Liu, Yumei] Fujian Inst Subtrop Bot, Xiamen Overseas Chinese Subtrop Plant Intro Garde, Xiamen 361002, Peoples R China		Xu, CJ (corresponding author), Fujian Inst Subtrop Bot, Fujian Key Lab Physiol & Biochem Subtrop Plants, Xiamen 361006, Peoples R China.	xcj7099@aliyun.com			Natural Science Foundation in China [31070618]	Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation in China (31070618), http://www.nsfc.gov.cn/(CJX).	Andersen M, 2010, ENCY LIFE SCI, P1; BHAT SR, 1991, PLANT CELL REP, V10, P358, DOI 10.1007/BF00193159; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cascia G, 2013, PHYSIOL PLANTARUM, V147, P121, DOI 10.1111/j.1399-3054.2012.01641.x; [陈冬茵 CHEN Dong-yin], 2009, [亚热带植物科学, Subtropical Plant Science], V38, P15; Chen G, 2012, SCI HORTIC-AMSTERDAM, V141, P17, DOI 10.1016/j.scienta.2012.03.027; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franck C, 2007, POSTHARVEST BIOL TEC, V43, P1, DOI 10.1016/j.postharvbio.2006.08.008; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Gould K., 2009, ANTHOCYANINS BIOSYNT; Hisaminato H, 2001, BIOSCI BIOTECH BIOCH, V65, P1016, DOI 10.1271/bbb.65.1016; Hong MJ, 2014, INT J RADIAT BIOL, V17, P1; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Jiang J, 2012, J AGR FOOD CHEM, V60, P3955, DOI 10.1021/jf205303y; Jiang YM, 2000, J SCI FOOD AGR, V80, P305, DOI 10.1002/1097-0010(200002)80:3&lt;305::AID-JSFA518&gt;3.0.CO;2-H; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071713; Krishna H, 2008, SCI HORTIC-AMSTERDAM, V118, P132, DOI 10.1016/j.scienta.2008.05.040; Laukkanen H, 1999, PHYSIOL PLANTARUM, V106, P337, DOI 10.1034/j.1399-3054.1999.106312.x; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074217; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; Mellidou I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0328-x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oliveros JC., 2007, INTERACTIVE TOOL COM; PARKIN KL, 1989, J FOOD BIOCHEM, V13, P127, DOI 10.1111/j.1745-4514.1989.tb00389.x; Ru ZhiWei, 2013, Journal of Agricultural Science (Toronto), V5, P57; Ruenroengklin N, 2009, FOOD CHEM, V115, P1253, DOI 10.1016/j.foodchem.2009.01.040; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Tanaka E, 2011, J AGR FOOD CHEM, V59, P6705, DOI 10.1021/jf200382e; Veltman RH, 2003, POSTHARVEST BIOL TEC, V28, P295, DOI 10.1016/S0925-5214(02)00198-9; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078484; Xu CJ, 2011, PAK J BOT, V43, P2161; Xu ChuanJun, 2006, Acta Horticulturae Sinica, V33, P671; Xu ChuanJun, 2005, Acta Horticulturae Sinica, V32, P1111; Xu CJ, 2007, J TROP SUBTROP BOT, V5, P50; Xu CJ, 2010, N HORTIC, V21, P90; Ye M, 2004, LETT BIOTEC, V15, P426; YU JJ, 1990, PLANT CELL, V2, P315; Zhou WL., 2009, GENES GENOM GENOMICS, V3, P68	42	16	20	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123356	10.1371/journal.pone.0123356	http://dx.doi.org/10.1371/journal.pone.0123356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874455	Green Submitted, Green Published, gold			2022-12-26	WOS:000353014700029
J	Helmbrecht, MS; Soellner, H; Castiblanco-Urbina, MA; Winzeck, S; Sundermeier, J; Theis, FJ; Fouad, K; Huber, AB				Helmbrecht, Michaela S.; Soellner, Heidi; Castiblanco-Urbina, Maria A.; Winzeck, Stefan; Sundermeier, Julia; Theis, Fabian J.; Fouad, Karim; Huber, Andrea B.			A Critical Period for Postnatal Adaptive Plasticity in a Model of Motor Axon Miswiring	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SEMAPHORIN 3F; ENRICHMENT; EXPERIENCE; CIRCUITRY; NEURONS; CORTEX; EPH	The correct wiring of neuronal circuits is of crucial importance for precise neuromuscular functionality. Therefore, guidance cues provide tight spatiotemporal control of axon growth and guidance. Mice lacking the guidance cue Semaphorin 3F (Sema3F) display very specific axon wiring deficits of motor neurons in the medial aspect of the lateral motor column (LMCm). While these deficits have been investigated extensively during embryonic development, it remained unclear how Sema3F mutant mice cope with these errors postnatally. We therefore investigated whether these animals provide a suitable model for the exploration of adaptive plasticity in a system of miswired neuronal circuitry. We show that the embryonically developed wiring deficits in Sema3F mutants persist until adulthood. As a consequence, these mutants display impairments in motor coordination that improve during normal postnatal development, but never reach wildtype levels. These improvements in motor coordination were boosted to wildtype levels by housing the animals in an enriched environment starting at birth. In contrast, a delayed start of enriched environment housing, at 4 weeks after birth, did not similarly affect motor performance of Sema3F mutants. These results, which are corroborated by neuroanatomical analyses, suggest a critical period for adaptive plasticity in neuromuscular circuitry. Interestingly, the formation of perineuronal nets, which are known to close the critical period for plastic changes in other systems, was not altered between the different housing groups. However, we found significant changes in the number of excitatory synapses on limb innervating motor neurons. Thus, we propose that during the early postnatal phase, when perineuronal nets have not yet been formed around spinal motor neurons, housing in enriched environment conditions induces adaptive plasticity in the motor system by the formation of additional synaptic contacts, in order to compensate for coordination deficits.	[Helmbrecht, Michaela S.; Soellner, Heidi; Castiblanco-Urbina, Maria A.; Winzeck, Stefan; Sundermeier, Julia; Huber, Andrea B.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Theis, Fabian J.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Garching, Germany; [Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Alberta	Huber, AB (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	andrea.huber@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021	Theis, Fabian J/0000-0002-2419-1943; Fouad, Karim/0000-0003-3654-7852	International Foundation for Research in Paraplegia (AHB); German Science Foundation Collaborative Research Centre (CRC) [870]; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; European Research Council (starting grant LatentCauses); Deutsche Forschungsgemeinschaft [SPP 1356]	International Foundation for Research in Paraplegia (AHB); German Science Foundation Collaborative Research Centre (CRC); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association; European Research Council (starting grant LatentCauses); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge the support by the International Foundation for Research in Paraplegia (AHB), the German Science Foundation Collaborative Research Centre (CRC)870 and the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. F.J.T. was supported by the European Research Council (starting grant LatentCauses) and the Deutsche Forschungsgemeinschaft (SPP 1356 Pluripotency and Cellular Reprogramming). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bengoetxea H, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/305693; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Berrocal Y, 2007, J NEUROTRAUM, V24, P1761, DOI 10.1089/neu.2007.0327; Claudepierre T, 2008, DEV DYNAM, V237, P3394, DOI 10.1002/dvdy.21759; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Glasl L, 2012, EXP NEUROL, V235, P214, DOI 10.1016/j.expneurol.2012.01.002; Gould TW, 2009, NEUROSCIENTIST, V15, P105, DOI 10.1177/1073858408324787; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Heyser Charles J, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0818s25; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kao TJ, 2012, SEMIN CELL DEV BIOL, V23, P83, DOI 10.1016/j.semcdb.2011.10.016; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Maya-Vetencourt JF, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/631965; Murphy KM, 2005, DEV PSYCHOBIOL, V46, P209, DOI 10.1002/dev.20053; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Parker D, 2000, MOL NEUROBIOL, V22, P55, DOI 10.1385/MN:22:1-3:055; Pearson KG, 2005, J NEUROSCI METH, V148, P36, DOI 10.1016/j.jneumeth.2005.04.006; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Sahay A, 2003, J NEUROSCI, V23, P6671; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Simonetti T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006780; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; THOMPSON WJ, 1985, CELL MOL NEUROBIOL, V5, P167, DOI 10.1007/BF00711091; Tognini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034815; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Zadicario P, 2005, BEHAV BRAIN RES, V159, P27, DOI 10.1016/j.bbr.2004.09.022	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123643	10.1371/journal.pone.0123643	http://dx.doi.org/10.1371/journal.pone.0123643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874621	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100193
J	Kasonga, AE; Deepak, V; Kruger, MC; Coetzee, M				Kasonga, Abe E.; Deepak, Vishwa; Kruger, Marlena C.; Coetzee, Magdalena			Arachidonic Acid and Docosahexaenoic Acid Suppress Osteoclast Formation and Activity in Human CD14+Monocytes, In vitro	PLOS ONE			English	Article							N-3 FATTY-ACIDS; BONE-MINERAL DENSITY; EICOSAPENTAENOIC ACID; GENE-EXPRESSION; PHOSPHATASE 5B; HIP FRACTURE; CATHEPSIN K; RISK; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION	An unbalanced diet can have adverse effects on health. Long chain polyunsaturated fatty acids (LCPUFAs) have been the focus of research owing to their necessity of inclusion in a healthy diet. However, the effects of LCPUFAs on human osteoclast formation and function have not been explored before. A human CD14+ monocyte differentiation model was used to elucidate the effects of an omega-3 LCPUFA, docosahexaenoic acid (DHA), and an omega-6 LCPUFA, arachidonic acid (AA), on osteoclast formation and activity. CD14+ monocytes were isolated from peripheral blood of healthy donors and stimulated with macrophage colony stimulating factor and receptor activator of nuclear factor kappa-B ligand to generate osteoclasts. Data from this study revealed that both the LCPUFAs decreased osteoclast formation potential of CD14+ monocytes in a dose-dependent manner when treated at an early stage of differentiation. Moreover, when exposed at a late stage of osteoclast differentiation AA and DHA impaired the bone resorptive potential of mature osteoclasts without affecting osteoclast numbers. AA and DHA abrogated vitronectin receptor expression in differentiating as well as mature osteoclasts. In contrast, the degree of inhibition for calcitonin receptor expression varied between the LCPUFAs with only AA causing inhibition during osteoclast differentiation. Furthermore, AA and DHA down regulated the expression of key osteoclast-specific genes in differentiating as well as mature osteoclasts. This study demonstrates for the first time that LCPUFAs can modulate osteoclast formation and function in a human primary osteoclast cell line.	[Kasonga, Abe E.; Deepak, Vishwa; Coetzee, Magdalena] Univ Pretoria, Fac Hlth Sci, Dept Physiol, ZA-0002 Pretoria, South Africa; [Kruger, Marlena C.] Massey Univ, Massey Inst Food Sci & Technol, Sch Food & Nutr, Palmerston North, New Zealand; [Kruger, Marlena C.] Univ Pretoria, Dept Human Nutr, Nutr & Well Being, ZA-0002 Pretoria, South Africa; [Kruger, Marlena C.] Univ Pretoria, Associate Inst Food, Nutr & Well Being, ZA-0002 Pretoria, South Africa	University of Pretoria; Massey University; University of Pretoria; University of Pretoria	Coetzee, M (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Physiol, ZA-0002 Pretoria, South Africa.	magdalena.coetzee@up.ac.za	Kasonga, Abe/I-4548-2019	Kasonga, Abe/0000-0001-7379-6044; Coetzee, Magdalena/0000-0002-5815-9247	South African Medical Research Council (MRC); University of Pretoria School of Medicine Research Committee (RESCOM); University of Pretoria Postgraduate Study Abroad Programme	South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Pretoria School of Medicine Research Committee (RESCOM); University of Pretoria Postgraduate Study Abroad Programme	This work was supported by grants from the South African Medical Research Council (MRC), the University of Pretoria School of Medicine Research Committee (RESCOM) and the University of Pretoria Postgraduate Study Abroad Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed are those of the authors of the manuscript.	Agrawal A, 2012, METHODS MOL BIOL, V806, P357, DOI 10.1007/978-1-61779-367-7_23; Agrawal A, 2010, PURINERG SIGNAL, V6, P307, DOI 10.1007/s11302-010-9181-z; Al-Nouri DM, 2012, J FUNCT FOODS, V4, P584, DOI 10.1016/j.jff.2012.03.004; Allard-Chamard H, 2014, PROSTAG LEUKOTR ESS, V90, P117, DOI 10.1016/j.plefa.2013.12.009; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bassey EJ, 2000, BRIT J NUTR, V83, P629, DOI 10.1017/S0007114500000805; Boeyens JCA, 2014, NUTRIENTS, V6, P2584, DOI 10.3390/nu6072584; Bonnet N, 2011, J NUTR BIOCHEM, V22, P665, DOI 10.1016/j.jnutbio.2010.05.006; Choi HK, 2011, CELL SIGNAL, V23, P1633, DOI 10.1016/j.cellsig.2011.05.017; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Corwin RL, 2003, PROSTAG LEUKOTR ESS, V68, P379, DOI 10.1016/S0952-3278(03)00062-0; Costa-Rodrigues J, 2010, J CELL BIOCHEM, V109, P205, DOI 10.1002/jcb.22398; Deepak V, 2014, CONNECT TISSUE RES, DOI [10.3109/03008207.03002014.03989320, DOI 10.3109/03008207.03002014.03989320]; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Faccio R, 2011, OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS, P141, DOI 10.1016/B978-0-12-375670-1.10006-8; Farina EK, 2011, J NUTR, V141, P1146, DOI 10.3945/jn.110.133728; Farina EK, 2011, AM J CLIN NUTR, V93, P1142, DOI 10.3945/ajcn.110.005926; Ferlin A, 2010, BONE, V46, P504, DOI 10.1016/j.bone.2009.10.007; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Goto T, 2003, J ELECTRON MICROSC, V52, P551, DOI 10.1093/jmicro/52.6.551; Halleen JM, 2006, CLIN LAB, V52, P499; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Henriksen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027482; Hogstrom M, 2007, AM J CLIN NUTR, V85, P803; Hutchins-Wiese HL, 2014, NUTR CANCER, V66, P68, DOI 10.1080/01635581.2014.847964; Johnson MR, 1996, GENOME RES, V6, P1050, DOI 10.1101/gr.6.11.1050; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kruger MC, 2010, PROG LIPID RES, V49, P438, DOI 10.1016/j.plipres.2010.06.002; Kurlak LO, 1999, ARCH DIS CHILD-FETAL, V80, pF148, DOI 10.1136/fn.80.2.F148; Lepidi S, 2001, J VASC SURG, V34, P1111, DOI 10.1067/mva.2001.119401; McLaughlin V, 2013, NUTR REV, V71, P600, DOI 10.1111/nure.12043; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Rahman M, 2008, J CELL PHYSIOL, V214, P201, DOI 10.1002/jcp.21188; Rasband WS, 2014, IMAGEJ; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Sharif PS, 2010, AGE, V32, P179, DOI 10.1007/s11357-009-9122-3; Shomali T, 2009, BASIC CLIN PHARMACOL, V105, P46, DOI 10.1111/j.1742-7843.2009.00393.x; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Tartibian B, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-71; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Vaananen HK, 2000, J CELL SCI, V113, P377; Virtanen JK, 2012, OSTEOPOROSIS INT, V23, P2615, DOI 10.1007/s00198-012-1903-3; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WALSH CA, 1991, J BONE MINER RES, V6, P661; Xing LP, 2013, BONE RES, V1, P336, DOI 10.4248/BR201304004; Yuan JZ, 2010, PROSTAG OTH LIPID M, V92, P85, DOI 10.1016/j.prostaglandins.2010.04.001	54	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125145	10.1371/journal.pone.0125145	http://dx.doi.org/10.1371/journal.pone.0125145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867515	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100292
J	Kosik, I; Praznovska, M; Kosikova, M; Bobisova, Z; Holly, J; Vareckova, E; Kostolansky, F; Russ, G				Kosik, Ivan; Praznovska, Margareta; Kosikova, Martina; Bobisova, Zuzana; Holly, Jaroslav; Vareckova, Eva; Kostolansky, Frantisek; Russ, Gustav			The Ubiquitination of the Influenza A Virus PB1-F2 Protein Is Crucial for Its Biological Function	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE; LYSINE RESIDUES; EXPRESSION; DEGRADATION; CONTRIBUTES; INDUCTION; RNA; PATHOGENICITY; LOCALIZATION; PATHOGENESIS	The aim of the present study was to identify what influences the short half-life of the influenza A virus PB1-F2 protein and whether a prolonged half-life affects the properties of this molecule. We hypothesized that the short half-life of PB1-F2 could conceal the phenotype of the protein. Because proteasome degradation might be involved in PB1-F2 degradation, we focused on ubiquitination, a common label for proteasome targeting. A cluster of lysine residues was demonstrated as an ubiquitination acceptor site in evolutionary and functionally distinct proteins. The PB1-F2 sequence alignment revealed a cluster of lysines on the carboxy terminal end of PB1-F2 in almost all of the GenBank sequences available to date. Using a proximity ligation assay, we identified ubiquitination as a novel posttranslational modification of PB1-F2. Changing the lysines at positions 73, 78, and 85 to arginines suppressed the ubiquitination of A/Puerto Rico/8/1934 (H1N1)-derived PB1-F2. The mutation of the C-terminal lysine residue cluster positively affected the overall expression levels of avian A/Honk Kong/156/1997 (H5N1)- and mammalian A/Puerto Rico/8/1934 (H1N1)derived PB1-F2. Moreover, increased PB1-F2 copy numbers strengthened the functions of this virus in the infected cells. The results of a minigenome luciferase reporter assay revealed an enhancement of viral RNA-dependent RNA polymerase activity in the presence of stabilized PB1-F2, regardless of viral origin. IFN beta antagonism was enhanced in 293T cells transfected with a plasmid expressing stabilized K -> R mutant variants of PB1-F2. Compared with PB1-F2 wt, the loss of ubiquitination enhanced the antibody response after DNA vaccination. In summary, we revealed that PB1-F2 is an ubiquitinated IAV protein, and this posttranslational modification plays a central role in the regulation of the biological functions of this protein.	[Kosik, Ivan; Praznovska, Margareta; Kosikova, Martina; Bobisova, Zuzana; Holly, Jaroslav; Vareckova, Eva; Kostolansky, Frantisek; Russ, Gustav] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia	Slovak Academy of Sciences	Kosik, I (corresponding author), Slovak Acad Sci, Inst Virol, Dubravska Cesta 9, Bratislava 84505, Slovakia.	virukosi@savba.sk	Kostolansky, Frantisek/HHS-1115-2022	Kosik, Ivan/0000-0001-5756-5182	Scientific Grant Agency of the Ministry of Education of the Slovak Republic and Slovak Academy of Sciences [2/0085/10, 2/0124/11 KP, 2/0176/12 EV, 2/0100/13 FK, 02/152/14 IK, 02/153/14 ZB]; Slovak Research and Development Agency [APVV-0250-10 EV, DO7RP-0025-10 EV]	Scientific Grant Agency of the Ministry of Education of the Slovak Republic and Slovak Academy of Sciences(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency)	This work was supported through 2/0085/10, 2/0124/11 KP, 2/0176/12 EV, 2/0100/13 FK, 02/152/14 IK and 02/153/14 ZB grants from the Scientific Grant Agency of the Ministry of Education of the Slovak Republic and Slovak Academy of Sciences, https://www.minedu.sk/vedecka-grantova-agentura-msvvas-sr-a-sav-vega/. This study was also supported through grants no. APVV-0250-10 EV and DO7RP-0025-10 EV from the Slovak Research and Development Agency, http://www.apvv.sk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Belicha-Villanueva A, 2012, J VIROL, V86, P5926, DOI 10.1128/JVI.06384-11; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Buehler J, 2013, J VIROL, V87, P10687, DOI 10.1128/JVI.01520-13; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen JH, 2011, HEPAT MON, V11, P620, DOI 10.5812/kowsar.1735143X.689; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Fu F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-264; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Kosik I, 2013, VIROLOGY, V447, P1, DOI 10.1016/j.virol.2013.08.022; Kosik I, 2013, ACTA VIROL, V57, P138, DOI 10.4149/av_2013_02_138; Kosik I, 2011, ACTA VIROL, V55, P45, DOI 10.4149/av_2011_01_45; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Krejnusova I, 2009, ARCH VIROL, V154, P1599, DOI 10.1007/s00705-009-0479-5; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee JC, 2005, APOPTOSIS, V10, P1483, DOI 10.1007/s10495-005-1833-z; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Meunier I, 2012, J VIROL, V86, P4271, DOI 10.1128/JVI.07243-11; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Pancucharova H, 2006, ACTA VIROL, V50, P269; Pena L, 2012, J VIROL, V86, P5523, DOI 10.1128/JVI.00134-12; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reis AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063852; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Sumita K, 2014, J BIOL CHEM, V289, P3950, DOI 10.1074/jbc.M113.531178; Svastova E, 2012, J BIOL CHEM, V287, P3392, DOI 10.1074/jbc.M111.286062; Trovato R, 1999, J VIROL, V73, P6460, DOI 10.1128/JVI.73.8.6460-6467.1999; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	59	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118477	10.1371/journal.pone.0118477	http://dx.doi.org/10.1371/journal.pone.0118477			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866881	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100007
J	Esapa, CT; Hannan, FM; Babinsky, VN; Potter, P; Thomas, GP; Croucher, PI; Brown, MA; Brown, SDM; Cox, RD; Thakker, RV				Esapa, Christopher T.; Hannan, Fadil M.; Babinsky, Valerie N.; Potter, Paul; Thomas, Gethin P.; Croucher, Peter I.; Brown, Matthew A.; Brown, Steve D. M.; Cox, Roger D.; Thakker, Rajesh V.			N-ethyl-N-Nitrosourea (ENU) Induced Mutations within the Klotho Gene Lead to Ectopic Calcification and Reduced Lifespan in Mouse Models	PLOS ONE			English	Article							FAMILIAL TUMORAL CALCINOSIS; MUTANT MICE; MISSENSE MUTATION; FGF23; GALNT3; PROTEIN; DRIVEN; DIFFERENTIATION; MUTAGENESIS; HOMEOSTASIS	Ectopic calcification (EC), which is the pathological deposition of calcium and phosphate in extra-skeletal tissues, may be associated with hypercalcaemic and hyperphosphataemic disorders, or it may occur in the absence of metabolic abnormalities. In addition, EC may be inherited as part of several monogenic disorders and studies of these have provided valuable insights into the metabolic pathways regulating mineral metabolism. For example, studies of tumoural calcinosis, a disorder characterised by hyperphosphataemia and progressive EC, have revealed mutations of fibroblast growth factor 23 (FGF23), polypeptide N-acetyl galactosaminyltransferase 3 (GALNT3) and klotho (KL), which are all part of a phosphate-regulating pathway. However, such studies in humans are limited by the lack of available large families with EC, and to facilitate such studies we assessed the progeny of mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) for EC. This identified two mutants with autosomal recessive forms of EC, and reduced lifespan, designated Ecalc1 and Ecalc2. Genetic mapping localized the Ecalc1 and Ecalc2 loci to a 11.0 Mb region on chromosome 5 that contained the klotho gene (Kl), and DNA sequence analysis identified nonsense (Gln203Stop) and missense (Ile604Asn) Kl mutations in Ecalc1 and Ecalc2 mice, respectively. The Gln203Stop mutation, located in KL1 domain, was severely hypomorphic and led to a 17-fold reduction of renal Kl expression. The Ile604Asn mutation, located in KL2 domain, was predicted to impair klotho protein stability and in vitro expression studies in COS-7 cells revealed endoplasmic reticulum retention of the Ile604Asn mutant. Further phenotype studies undertaken in Ecalc1 (kl(203X/203X)) mice demonstrated elevations in plasma concentrations of phosphate, FGF23 and 1,25-dihydroxyvitamin D. Thus, two allelic variants of Kl that develop EC and represent mouse models for tumoural calcinosis have been established.	[Esapa, Christopher T.; Hannan, Fadil M.; Babinsky, Valerie N.; Thakker, Rajesh V.] Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England; [Esapa, Christopher T.; Potter, Paul; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, MRC, Mammalian Genet Unit, Harwell, Berks, England; [Esapa, Christopher T.; Potter, Paul; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, Mary Lyon Ctr, Harwell, Berks, England; [Hannan, Fadil M.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Thomas, Gethin P.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; MRC Harwell; MRC Harwell; University of Liverpool; University of Queensland; Garvan Institute of Medical Research	Thakker, RV (corresponding author), Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Brown, Matthew A/E-5749-2010; Potter, Paul Keith/GWU-6398-2022	Brown, Matthew A/0000-0003-0538-8211; Potter, Paul Keith/0000-0003-2689-2361; Croucher, Peter/0000-0002-7102-2413; Cox, Roger/0000-0001-7170-5014; Hannan, Fadil/0000-0002-2975-5170; Thomas, Gethin/0000-0001-9081-3686; Thakker, Rajesh/0000-0002-1438-3220	Medical Research Council UK [G0600702/1, G9825289, G1000467]; MRC [G0600702, MR/K006312/1, MC_U142661184, G9825289, MC_U142684172, G1000467] Funding Source: UKRI; Medical Research Council [MC_U142661184, MR/K006312/1, G9825289, G0600702, MC_U142684172, G1000467] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council UK [grant numbers G0600702/1, G9825289 and G1000467]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bentley L, 2014, ENDOCRINOLOGY, V155, P908, DOI 10.1210/en.2013-1247; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Esapa CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043205; Farrow EG, 2011, BEST PRACT RES CL RH, V25, P735, DOI 10.1016/j.berh.2011.10.020; Ford-Hutchinson AF, 2003, J RHEUMATOL, V30, P2659; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hannan FM, 2008, NAT CLIN PRACT ENDOC, V4, P53, DOI 10.1038/ncpendmet0718; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Ichikawa S, 2010, AM J MED GENET A, V152A, P896, DOI 10.1002/ajmg.a.33337; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Kawaguchi H, 1999, J CLIN INVEST, V104, P229, DOI 10.1172/JCI5705; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kim HJ, 2010, BONE, V47, P657, DOI 10.1016/j.bone.2010.06.018; KROGER H, 1995, BONE, V17, P157, DOI 10.1016/S8756-3282(95)00162-X; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Lindberg K, 2014, J AM SOC NEPHROL; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mian IS, 1998, BLOOD CELL MOL DIS, V24, P83, DOI 10.1006/bcmd.1998.9998; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Noguchi J, 2008, BIOCHEM BIOPH RES CO, V374, P549, DOI 10.1016/j.bbrc.2008.07.089; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; Piret SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045217; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Razzaque MS, 2012, NAT REV ENDOCRINOL, V8, P579, DOI 10.1038/nrendo.2012.75; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Suga T, 2000, AM J RESP CELL MOL, V22, P26, DOI 10.1165/ajrcmb.22.1.3554; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Whyte MP, 2006, EXTRASKELETAL ECTOPI, P436; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726; Zhou TBT, 2013, J BIOL CHEM, V288, P36302, DOI 10.1074/jbc.M113.490052	51	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122650	10.1371/journal.pone.0122650	http://dx.doi.org/10.1371/journal.pone.0122650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860694	Green Published, gold			2022-12-26	WOS:000352590300054
J	Lund, K; Dembinski, JL; Solberg, N; Urbanucci, A; Mills, IG; Krauss, S				Lund, Kaja; Dembinski, Jennifer L.; Solberg, Nina; Urbanucci, Alfonso; Mills, Ian G.; Krauss, Stefan			Slug-Dependent Upregulation of L1CAM Is Responsible for the Increased Invasion Potential of Pancreatic Cancer Cells following Long-Term 5-FU Treatment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ADHESION MOLECULE; PROTEIN EXPRESSION; E-CADHERIN; 5-FLUOROURACIL; GEMCITABINE; GROWTH; RESISTANCE; PROGNOSIS; L1	Background Pancreatic adenocarcinoma is a lethal disease with 5-year survival of less than 5%. 5-fluorouracil (5-FU) is a principal first-line therapy, but treatment only extends survival modestly and is seldom curative. Drug resistance and disease recurrence is typical and there is a pressing need to overcome this. To investigate acquired 5-FU resistance in pancreatic adenocarcinoma, we established chemoresistant monoclonal cell lines from the Panc 03.27 cell line by long-term exposure to increasing doses of 5-FU. Results 5-FU-resistant cell lines exhibited increased expression of markers associated with multidrug resistance explaining their reduced sensitivity to 5-FU. In addition, 5-FU-resistant cell lines showed alterations typical for an epithelial-to-mesenchymal transition (EMT), including upregulation of mesenchymal markers and increased invasiveness. Microarray analysis revealed the L1CAM pathway as one of the most upregulated pathways in the chemoresistant clones, and a significant upregulation of L1CAM was seen on the RNA and protein level. In pancreatic cancer, expression of L1CAM is associated with a chemoresistant and migratory phenotype. Using esiRNA targeting L1CAM, or by blocking the extracellular part of L1CAM with antibodies, we show that the increased invasiveness observed in the chemoresistant cells functionally depends on L1CAM. Using esiRNA targeting beta-catenin and/or Slug, we demonstrate that in the chemoresistant cell lines, L1CAM expression depends on Slug rather than beta-catenin. Conclusion Our findings establish Slug-induced L1CAM expression as a mediator of a chemoresistant and migratory phenotype in pancreatic adenocarcinoma cells.	[Lund, Kaja; Dembinski, Jennifer L.; Solberg, Nina; Krauss, Stefan] Univ Oslo, Rikshosp, Inst Microbiol, Canc Stem Cell Innovat Ctr CAST,Unit Cell Signali, N-0027 Oslo, Norway; [Urbanucci, Alfonso; Mills, Ian G.] Univ Oslo, Nord European Mol Biol Lab Partnership, Ctr Mol Med Norway, Oslo, Norway; [Urbanucci, Alfonso; Mills, Ian G.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Dept Urol, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Ctr Mol Med Urol, Oslo, Norway; [Dembinski, Jennifer L.] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Div Infect Dis Control, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Lund, K (corresponding author), Univ Oslo, Rikshosp, Inst Microbiol, Canc Stem Cell Innovat Ctr CAST,Unit Cell Signali, N-0027 Oslo, Norway.	kaja.lund@rr-research.no	Mills, Ian/AAK-9292-2020; Urbanucci, Alfonso/S-4450-2019	Mills, Ian/0000-0001-5347-5083; Urbanucci, Alfonso/0000-0003-2931-3652; Dembinski, Jennifer/0000-0001-9259-9572; Krauss, Stefan/0000-0001-6992-8091	Research Council of Norway [205783]; Molecular Life Sciences (University of Oslo); Helse Sor-Ost; Norwegian Cancer Society; Research Council of Norway; Affitech Research AS	Research Council of Norway(Research Council of Norway); Molecular Life Sciences (University of Oslo); Helse Sor-Ost; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Affitech Research AS	KL is founded by the Research Council of Norway, grant nr. 205783, and Affitech Research AS. Affitech Research AS partly supported KL during an industrial PhD, together with the Research Council of Norway, grant nr. 205783. AU was funded by Molecular Life Sciences (University of Oslo) and Helse Sor-Ost. NS was funded by the Norwegian Cancer Society. JLD was funded by The Research Council of Norway. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Bergmann F, 2010, ONCOL REP, V24, P909, DOI 10.3892/or_00000936; Bichat F, 1997, ANTICANCER RES, V17, P3393; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; COPUR S, 1995, BIOCHEM PHARMACOL, V49, P1419, DOI 10.1016/0006-2952(95)00067-A; De Iudicibus S, 2008, ANTICANCER RES, V28, P3921; Dembinski Jennifer L, 2010, Cancers (Basel), V2, P2011, DOI 10.3390/cancers2042011; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Geismann C, 2011, INT J ONCOL, V38, P257, DOI 10.3892/ijo_00000846; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Ginnebaugh KR, 2014, EXPERT OPIN THER TAR; Grem JL, 2000, INVEST NEW DRUG, V18, P299, DOI 10.1023/A:1006416410198; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2014, INT J ONCOL, V44, P1302, DOI 10.3892/ijo.2014.2270; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoshino H, 2009, BIOCHEM BIOPH RES CO, V390, P1061, DOI 10.1016/j.bbrc.2009.10.117; Huszar M, 2010, J PATHOL, V220, P551, DOI 10.1002/path.2673; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kato J, 2001, INT J CANCER, V95, P92; Kiefel H, 2012, CARCINOGENESIS, V33, P1919, DOI 10.1093/carcin/bgs220; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Novak-Hofer I, 2008, CANCER LETT, V261, P193, DOI 10.1016/j.canlet.2007.11.012; Olie RA, 2000, CANCER RES, V60, P2805; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Pfeifer M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-64; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Pratt S, 2005, MOL CANCER THER, V4, P855, DOI 10.1158/1535-7163.MCT-04-0291; RATHJEN FG, 1984, EMBO J, V3, P1; Raveh S, 2009, CANCER LETT, V282, P137, DOI 10.1016/j.canlet.2008.12.021; Sebens S, 2012, PANCREATIC CANC MOL, P329; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Tentes IK, 2010, EXP CELL RES, V316, P3172, DOI 10.1016/j.yexcr.2010.09.003; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tischler V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-127; Tsutsumi S, 2011, J SURG ONCOL, V103, P669, DOI 10.1002/jso.21880; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897; Zhang WJ, 2012, BIOCHEM BIOPH RES CO, V417, P679, DOI 10.1016/j.bbrc.2011.11.142	53	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123684	10.1371/journal.pone.0123684	http://dx.doi.org/10.1371/journal.pone.0123684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860483	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300108
J	Shi, QH; Sun, XY; Wang, YL; Hao, JS; Yang, Q				Shi, Qing-Hui; Sun, Xiao-Yan; Wang, Yun-Liang; Hao, Jia-Sheng; Yang, Qun			Morphological Characters Are Compatible with Mitogenomic Data in Resolving the Phylogeny of Nymphalid Butterflies (Lepidoptera: Papilionoidea: Nymphalidae)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; COMPLETE NUCLEOTIDE-SEQUENCE; SATYRINAE BUTTERFLIES; MAXIMUM-LIKELIHOOD; RIBOSOMAL-RNA; EVOLUTION; INSECTA; GENE; UTILITY; ORGANIZATION	Nymphalidae is the largest family of butterflies with their phylogenetic relationships not adequately approached to date. The mitochondrial genomes (mitogenomes) of 11 new nymphalid species were reported and a comparative mitogenomic analysis was conducted together with other 22 available nymphalid mitogenomes. A phylogenetic analysis of the 33 species from all 13 currently recognized nymphalid subfamilies was done based on the mitogenomic data set with three Lycaenidae species as the outgroups. The mitogenome comparison showed that the eleven new mitogenomes were similar with those of other butterflies in gene content and order. The reconstructed phylogenetic trees reveal that the nymphalids are made up of five major clades (the nymphaline, heliconiine, satyrine, danaine and libytheine clades), with sister relationship between subfamilies Cyrestinae and Biblidinae, and most likely between subfamilies Morphinae and Satyrinae. This whole mitogenome-based phylogeny is generally congruent with those of former studies based on nuclear-gene and mitogenomic analyses, but differs considerably from the result of morphological cladistic analysis, such as the basal position of Libytheinae in morpho-phylogeny is not confirmed in molecular studies. However, we found that the mitogenomic phylogeny established herein is compatible with selected morphological characters (including developmental and adult morpho-characters).	[Shi, Qing-Hui; Wang, Yun-Liang; Hao, Jia-Sheng] Anhui Normal Univ, Coll Iife Sci, Wuhu, Peoples R China; [Sun, Xiao-Yan; Hao, Jia-Sheng; Yang, Qun] Chinese Acad Sci, Nanjing Inst Palaeontol & Stratig, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Shi, Qing-Hui] Sanming Coll, Sanming, Peoples R China	Anhui Normal University; Chinese Academy of Sciences; Sanming University	Hao, JS (corresponding author), Anhui Normal Univ, Coll Iife Sci, Wuhu, Peoples R China.	jshaonigpas@sina.com; qunyang@nigpas.ac.cn			National Science Foundation of China [41172004, 41472028]; State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, Chinese Academy of Sciences [104143]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (Grant No. 41172004, 41472028), and a grant from the State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, Chinese Academy of Sciences (Grant No. 104143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery P.R., 1984, S ROYAL ENTOMOLOGICA, P9; Ackery Philip R., 1999, Handbuch der Zoologie (Berlin), V4, P263; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boggs C.L., 2003, BUTTERFLIES ECOLOGY; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; [陈国忠 Chen Guozhong], 2005, [微生物学杂志, Journal of Mirobiology], V25, P54; Chen Na, 2007, Acta Zoologica Sinica, V53, P106; Chou I, 1998, CLASSIICATION IDENTI; DeJong R, 1996, ENTOMOL SCAND, V27, P65, DOI 10.1163/187631296X00205; DeVries PJ, 1987, BUTTERFLIES COSTA RI; EHRLICH PAUL R., 1958, UNIV KANSAS SCI BULL, V39, P305; Feng X, 2010, MOL BIOL REP, V37, P3877, DOI 10.1007/s11033-010-0044-z; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Freitas AVL, 2004, SYST BIOL, V53, P363, DOI 10.1080/10635150490445670; Freitas AVL, 1999, NYMPHALIDAE LEPIDOPT; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hao J., 2013, ISRN GENOMICS, V2013, P1, DOI 10.1155/2013/491636; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; Hao JS, 2007, GENET MOL BIOL, V18, P111; Harvey D.J., 1991, DEV EVOLUTION BUTTER, P255; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; Kim MJ, 2010, AFR J BIOTECHNOL, V9, P735; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KRISTENSEN N P, 1976, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V14, P25; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072410; Marin MA, 2011, NEOTROP ENTOMOL, V40, P1, DOI 10.1590/S1519-566X2011000100001; Muller W., 1886, Zoologische Jahrbuecher, Vi, P417; Niehuis O, 2006, ORG DIVERS EVOL, V6, P17, DOI 10.1016/j.ode.2005.03.001; Niehuis O, 2006, MOL PHYLOGENET EVOL, V39, P812, DOI 10.1016/j.ympev.2006.01.007; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagenstecher A, 1901, TIERREICH, V14, P1; Pagenstecher A, 1902, LEPIDOPTERA RHOPALOC, P1; Pagenstecher A, 1911, LEPIDOPTERORUM CATAL; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Pena C, 2006, MOL PHYLOGENET EVOL, V40, P29, DOI 10.1016/j.ympev.2006.02.007; Penz CM, 2003, SYST ENTOMOL, V28, P451, DOI 10.1046/j.1365-3113.2003.00221.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; SHIELDS O, 1989, Journal of the Lepidopterists' Society, V43, P178; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silva-Brandao KL, 2008, MOL PHYLOGENET EVOL, V46, P515, DOI 10.1016/j.ympev.2007.11.024; Simmons RB, 2001, MOL PHYLOGENET EVOL, V20, P196, DOI 10.1006/mpev.2001.0958; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Li-Li, 2012, Zoological Research, V33, P133, DOI 10.3724/SP.J.1141.2012.02133; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Vane-Wright Richard I., 2003, P477; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wang Xiao-Can, 2011, Zoological Research, V32, P465, DOI 10.3724/SP.J.1141.2011.05465; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wu LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-468; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Yang XS, 2013, GENE, V515, P349, DOI 10.1016/j.gene.2012.11.031; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zhang M, 2008, PROG NAT SCI-MATER, V18, P1357, DOI 10.1016/j.pnsc.2008.03.025	81	21	23	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124349	10.1371/journal.pone.0124349	http://dx.doi.org/10.1371/journal.pone.0124349			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860387	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300135
J	Zhao, XJ; Gao, MM; He, JH; Zou, LQ; Lyu, Y; Zhang, L; Geng, B; Liu, G; Xu, GH				Zhao, Xiaojing; Gao, Mingming; He, Jinhan; Zou, Liangqiang; Lyu, Ying; Zhang, Ling; Geng, Bin; Liu, George; Xu, Guoheng			Perilipin1 Deficiency in Whole Body or Bone Marrow-Derived Cells Attenuates Lesions in Atherosclerosis-Prone Mice	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; CHOLESTERYL ESTER HYDROLASE; HORMONE-SENSITIVE LIPASE; MACROPHAGE FOAM CELLS; LIPID DROPLETS; STORAGE; METABOLISM; LIPOLYSIS; APOLIPOPROTEIN; ADIPOPHILIN	Aims The objective of this study is to determine the role of perilipin 1 (Plin1) in whole body or bone marrow-derived cells on atherogenesis. Methods and Results Accumulated evidence have indicated the role of Plin1 in atherosclerosis, however, these findings are controversial. In this study, we showed that Plin1 was assembled and colocalized with CD68 in macrophages in atherosclerotic plaques of ApoE-/-mice. We further found 39% reduction of plaque size in the aortic roots of Plin1 and ApoE double knockout (Plin1-/-ApoE-/-) females compared with ApoE-/-female littermates. In order to verify whether this reduction was macrophage-specific, the bone marrow cells from wild-type or Plin1 deficient mice (Plin1-/-) were transplanted into LDL receptor deficient mice (LDLR-/-). Mice receiving Plin1-/-bone marrow cells showed also 49% reduction in aortic atherosclerotic lesions compared with LDLR-/-mice received wild-type bone marrow cells. In vitro experiments showed that Plin1-/-macrophages had decreased protein expression of CD36 translocase and an enhanced cholesterol ester hydrolysis upon aggregated-LDL loading, with unaltered expression of many other regulators of cholesterol metabolism, such as cellular lipases, and Plin2 and 3. Given the fundamental role of Plin1 in protecting LD lipids from lipase hydrolysis, it is reasonably speculated that the assembly of Plin1 in microphages might function to reduce lipolysis and hence increase lipid retention in ApoE-/-plaques, but this pro-atherosclerotic property would be abrogated on inactivation of Plin1. Conclusion Plin1 deficiency in bone marrow-derived cells may be responsible for reduced atherosclerotic lesions in the mice.	[Zhao, Xiaojing; Zou, Liangqiang; Lyu, Ying; Geng, Bin; Xu, Guoheng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Gao, Mingming; Zhang, Ling; Liu, George] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [He, Jinhan] Sichuan Univ, West China Hosp, Dept Pharm, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China	Peking University; Sichuan University	Geng, B (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	bingeng@bjmu.edu.cn; georgeliu@bjmu.edu	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	Major National Basic Research Program of China [2012CB517806, 2012CB517505, 2011CB503900]; National Natural Science Foundation of China [91439119, 30821001, 30930037]	Major National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major National Basic Research Program of China (2012CB517806, 2012CB517505 and 2011CB503900) and the National Natural Science Foundation of China (91439119, 30821001 and 30930037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beylot M, 2012, METABOLISM, V61, P415, DOI 10.1016/j.metabol.2011.07.019; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Buchebner M, 2010, J LIPID RES, V51, P2896, DOI 10.1194/jlr.M004259; Buechler C, 2001, BBA-MOL CELL BIOL L, V1532, P97, DOI 10.1016/S1388-1981(01)00121-4; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Faber BCG, 2001, CIRC RES, V89, P547, DOI 10.1161/hh1801.096340; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Forcheron F, 2005, ARTERIOSCL THROM VAS, V25, P1711, DOI 10.1161/01.ATV.0000174123.19103.52; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Griffin EE, 2005, J LIPID RES, V46, P2052, DOI 10.1194/jlr.M500059-JLR200; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; KHOO JC, 1993, J LIPID RES, V34, P1969; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Larigauderie G, 2006, ATHEROSCLEROSIS, V189, P142, DOI 10.1016/j.atherosclerosis.2005.12.016; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; van Berkel TJC, 2005, CURR OPIN LIPIDOL, V16, P525, DOI 10.1097/01.mol.0000183943.20277.26; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zhao B, 2005, J LIPID RES, V46, P2114, DOI 10.1194/jlr.M500207-JLR200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	33	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123738	10.1371/journal.pone.0123738	http://dx.doi.org/10.1371/journal.pone.0123738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855981	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500104
J	DeFaveri, J; Merila, J				DeFaveri, Jacquelin; Merila, Juha			Temporal Stability of Genetic Variability and Differentiation in the Three-Spined Stickleback (Gasterosteus aculeatus)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; CONTEMPORARY EFFECTIVE POPULATION; COD GADUS-MORHUA; FRESH-WATER; THREESPINE STICKLEBACK; LINKAGE DISEQUILIBRIUM; ALLELE FREQUENCIES; ADAPTIVE DIVERGENCE; NATURAL-POPULATIONS; BALTIC SEA	Temporal variation in allele frequencies, whether caused by deterministic or stochastic forces, can inform us about interesting demographic and evolutionary phenomena occurring in wild populations. In spite of the continued surge of interest in the genetics of three-spined stickleback (Gasterosteus aculeatus) populations, little attention has been paid towards the temporal stability of allele frequency distributions, and whether there are consistent differences in effective size (Ne) of local populations. We investigated temporal stability of genetic variability and differentiation in 15 microsatellite loci within and among eight collection sites of varying habitat type, surveyed twice over a six-year time period. In addition, Nes were estimated with the expectation that they would be lowest in isolated ponds, intermediate in larger lakes and largest in open marine sites. In spite of the marked differences in genetic variability and differentiation among the study sites, the temporal differences in allele frequencies, as well as measures of genetic diversity and differentiation, were negligible. Accordingly, the Ne estimates were temporally stable, but tended to be lower in ponds than in lake or marine habitats. Hence, we conclude that allele frequencies in putatively neutral markers in three-spined sticklebacks seem to be temporally stable -at least over periods of few generations - across a wide range of habitat types differing markedly in levels of genetic variability, effective population size and gene flow.	[DeFaveri, Jacquelin; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072	Academy of Finland [s 200940, 108601, 118673]; LUOVA graduate school; European Community [217246]; joint Baltic Sea research and development programme	Academy of Finland(Academy of Finland); LUOVA graduate school; European Community(European Commission); joint Baltic Sea research and development programme	This research was supported by the Academy of Finland (www.aka.fi; grant #:s 200940, 108601 and 118673 to JM) and LUOVA graduate school (JD). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement no 217246 made with BONUS (http://www.bonusportal.org), the joint Baltic Sea research and development programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Barker JSF, 2011, MOL ECOL, V20, P4452, DOI 10.1111/j.1365-294X.2011.05324.x; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bernal-Ramirez JH, 2003, MAR BIOL, V142, P567, DOI 10.1007/s00227-002-0972-9; Berthier P, 2002, GENETICS, V160, P741; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Consuegra S, 2005, CONSERV GENET, V6, P823, DOI 10.1007/s10592-005-9042-4; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cuveliers EL, 2011, MOL ECOL, V20, P3555, DOI 10.1111/j.1365-294X.2011.05196.x; DeFaveri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080866; DeFaveri J, 2013, EVOLUTION, V67, P2530, DOI 10.1111/evo.12097; DeFaveri J, 2012, MAR BIOL, V159, P1659, DOI 10.1007/s00227-012-1951-4; DeFaveri J, 2011, EVOLUTION, V65, P1800, DOI 10.1111/j.1558-5646.2011.01247.x; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Drevecky CJ, 2013, J FISH BIOL, V83, P111, DOI 10.1111/jfb.12154; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Fraser BA, 2010, EVOLUTION, V64, P2086, DOI 10.1111/j.1558-5646.2010.00965.x; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; Garant D, 2000, MOL ECOL, V9, P615, DOI 10.1046/j.1365-294x.2000.00909.x; Garland T., 2009, EXPT EVOLUTION CONCE; Gomez-Uchida D, 2013, ECOL EVOL, V3, P569, DOI 10.1002/ece3.485; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hemmer-Hansen J, 2007, HEREDITY, V99, P592, DOI 10.1038/sj.hdy.6801055; HILL WG, 1979, GENETICS, V92, P317; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hoehn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048464; Hoffman EA, 2004, EVOLUTION, V58, P2536; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jonsdottir ODB, 2001, ICES J MAR SCI, V58, P114, DOI 10.1006/jmsc.2000.0995; JORDE PE, 1995, GENETICS, V139, P1077; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Jorde PE, 2012, MOL ECOL RESOUR, V12, P476, DOI 10.1111/j.1755-0998.2011.03111.x; Jurvelius J, 1996, FISH RES, V27, P227, DOI 10.1016/0165-7836(95)00464-5; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Kennington WJ, 2013, CONSERV GENET, V14, P115, DOI 10.1007/s10592-012-0433-z; Kitano J, 2008, CURR BIOL, V18, P769, DOI 10.1016/j.cub.2008.04.027; Lande R., 1987, VIABLE POPULATIONS C, P87, DOI DOI 10.1017/CBO9780511623400.007; Langella O, 2002, POPULATIONS 1 2 POPU; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Leinonen T, 2016, J EVOL BIOL, V19, P1803; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Makinen HS, 2006, MOL ECOL, V15, P1519, DOI 10.1111/j.1365-294X.2006.02871.x; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; NEI M, 1981, GENETICS, V98, P625; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; Nielsen EE, 2008, FISH FISH, V9, P450, DOI 10.1111/j.1467-2979.2008.00304.x; Palm S, 2003, CONSERV GENET, V4, P249, DOI 10.1023/A:1024064913094; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Peltonen H, 2004, ICES J MAR SCI, V61, P966, DOI 10.1016/j.icesjms.2004.06.008; Peuhkuri N, 1998, ANN ZOOL FENN, V35, P21; POLLAK E, 1983, GENETICS, V104, P531; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Raeymaekers JAM, 2005, MOL ECOL, V14, P1001, DOI 10.1111/j.1365-294X.2005.02456.x; Raeymaekers JAM, 2014, MOL ECOL, V23, P162, DOI 10.1111/mec.12582; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reusch TBH, 2001, MOL ECOL, V10, P2435, DOI 10.1046/j.0962-1083.2001.01366.x; Richards C, 1996, CONSERV BIOL, V10, P832, DOI 10.1046/j.1523-1739.1996.10030832.x; Ruzzante DE, 2001, CONSERV GENET, V2, P257, DOI 10.1023/A:1012247213644; Saillant E, 2006, FISH B-NOAA, V104, P136; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Shimada Y, 2011, MOL BIOL EVOL, V28, P181, DOI 10.1093/molbev/msq181; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Tessier N, 1997, MOL ECOL, V6, P735, DOI 10.1046/j.1365-294X.1997.00244.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walter RP, 2009, CAN J FISH AQUAT SCI, V66, P167, DOI 10.1139/F08-201; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WAPLES RS, 1990, CONSERV BIOL, V4, P144, DOI 10.1111/j.1523-1739.1990.tb00103.x; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whither RE, 1984, CAN J ZOOL, V63, P528; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wootton RJ, 2005, ENVIRON BIOL FISH, V74, P151, DOI 10.1007/s10641-005-7690-3	103	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123891	10.1371/journal.pone.0123891	http://dx.doi.org/10.1371/journal.pone.0123891			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853707	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400126
J	Kuznetsov, NA; Kladova, OA; Kuznetsova, AA; Ishchenko, AA; Saparbaev, MK; Zharkov, DO; Fedorova, OS				Kuznetsov, Nikita A.; Kladova, Olga A.; Kuznetsova, Alexandra A.; Ishchenko, Alexander A.; Saparbaev, Murat K.; Zharkov, Dmitry O.; Fedorova, Olga S.			Conformational Dynamics of DNA Repair by Escherichia coli Endonuclease III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; LESION RECOGNITION; ANALOGS TC; GLYCOSYLASE; DAMAGE; FLUORESCENCE; 8-OXOGUANINE; 2-AMINOPURINE; MECHANISM; EXCISION	Escherichia coli endonuclease III (Endo III or Nth) is a DNA glycosylase with a broad substrate specificity for oxidized or reduced pyrimidine bases. Endo III possesses two types of activities: N-glycosylase (hydrolysis of the N-glycosidic bond) and AP lyase (elimination of the 3'-phosphate of the AP-site). We report a pre-steady-state kinetic analysis of structural rearrangements of the DNA substrates and uncleavable ligands during their interaction with Endo III. Oligonucleotide duplexes containing 5,6-dihydrouracil, a natural abasic site, its tetrahydrofuran analog, and undamaged duplexes carried fluorescent DNA base analogs 2-aminopurine and 1,3-diaza-2-oxophenoxazine as environment-sensitive reporter groups. The results suggest that Endo III induces several fast sequential conformational changes in DNA during binding, lesion recognition, and adjustment to a catalytically competent conformation. A comparison of two fluorophores allowed us to distinguish between the events occurring in the damaged and undamaged DNA strand. Combining our data with the available structures of Endo III, we conclude that this glycosylase uses a multistep mechanism of damage recognition, which likely involves Gln(41) and Leu(81) as DNA lesion sensors.	[Kuznetsov, Nikita A.; Kladova, Olga A.; Kuznetsova, Alexandra A.; Zharkov, Dmitry O.; Fedorova, Olga S.] Inst Chem Biol & Fundamental Med, 8 Lavrentyev Ave, Novosibirsk 630090, Russia; [Kuznetsov, Nikita A.; Kladova, Olga A.; Kuznetsova, Alexandra A.; Zharkov, Dmitry O.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Ishchenko, Alexander A.; Saparbaev, Murat K.] Univ Paris 11, Inst Gustave Roussy, Grp Reparat ADN, CNRS UMR8200, F-94805 Villejuif, France	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Kuznetsov, NA (corresponding author), Inst Chem Biol & Fundamental Med, 8 Lavrentyev Ave, Novosibirsk 630090, Russia.	nikita.kuznetsov@niboch.nsc.ru; fedorova@niboch.nsc.ru	Saparbaev, Murat K/N-3225-2015; Kuznetsov, Nikita/CAA-3889-2022; Kuznetsova, Aleksandra A/G-5119-2013; Kuznetsov, Nikita/AFU-9897-2022; Zharkov, Dmitry/K-2158-2012; Fedorova, Olga/ABE-6637-2020; Kladova, Olga A/J-4564-2018; Fedorova, Olga S./E-1291-2013; Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat/AAC-5478-2020; Kuznetsov, Nikita A/F-3245-2011	Saparbaev, Murat K/0000-0002-4630-1074; Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; Zharkov, Dmitry/0000-0001-5013-0194; Fedorova, Olga/0000-0002-4001-7187; Kladova, Olga A/0000-0002-4157-5244; Fedorova, Olga S./0000-0002-4001-7187; Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat/0000-0002-4630-1074; Kuznetsov, Nikita A/0000-0002-4016-198X; Kuznetsova, Aleksandra/0000-0002-9805-7050	Russian Academy of Sciences "Molecular AMP; Cell Biology" Program [6.11, 6.12]; Russian Foundation for Basic Research [14-04-01879, 13-04-00013, 14-04-31174, 15-04-00467]; Russian Science Foundation [14-14-00063, 14-24-00093]; Russian Ministry of Education and Science [SS-1205.2014.4, SP-4012.2013.4]	Russian Academy of Sciences "Molecular AMP; Cell Biology" Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Academy of Sciences "Molecular & Cell Biology" Program Grants 6.11 (to O. S. F.) and 6.12 (to D. O. Z.), Russian Foundation for Basic Research Grants 14-04-01879 (to D. O. Z.), 13-04-00013 (to O. S. F.), 14-04-31174 (to A. A. K.), and 15-04-00467 (to N. A. K.), Russian Science Foundation Grants 14-14-00063 (stopped-flow experiments) (to N. A. K.) and 14-24-00093 (structural analysis) (to D. O. Z.), and Russian Ministry of Education and Science Grants SS-1205.2014.4 and SP-4012.2013.4.	Asagoshi K, 2000, BIOCHEMISTRY-US, V39, P11389, DOI 10.1021/bi000422l; ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bowman BR, 2010, J BIOL CHEM, V285, P35783, DOI 10.1074/jbc.M110.155663; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Demchenko AP, 2006, FEBS LETT, V580, P2951, DOI 10.1016/j.febslet.2006.03.091; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Dizdaroglu M, 2000, BIOCHEMISTRY-US, V39, P5586, DOI 10.1021/bi9927787; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Dziuba D, 2012, J AM CHEM SOC, V134, P10209, DOI 10.1021/ja3030388; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jurado J, 1998, BIOCHEMISTRY-US, V37, P7757, DOI 10.1021/bi972982z; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P118, DOI 10.1134/S0006297911010123; Kuznetsov N. A., 2014, PLOS ONE, V9; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Kuznetsov NA, 2015, NUCLEIC ACIDS RES, V43, P272, DOI 10.1093/nar/gku1300; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Kuznetsova AA, 2009, RUSS CHEM REV+, V78, P659, DOI 10.1070/RC2009v078n07ABEH004038; Kuznetsova AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100007; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Lee AJ, 2014, DNA REPAIR, V20, P23, DOI 10.1016/j.dnarep.2014.01.007; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE2091, DOI 10.1073/pnas.1400386111; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Qi Y, 2012, P NATL ACAD SCI USA, V109, P1086, DOI 10.1073/pnas.1111237108; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Sandin P, 2008, NUCLEIC ACIDS RES, V36, P157, DOI 10.1093/nar/gkm1006; Sandin P, 2009, NUCLEIC ACIDS RES, V37, P3924, DOI 10.1093/nar/gkp266; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sowers LC, 2000, BIOCHEMISTRY-US, V39, P7613, DOI 10.1021/bi992388k; SOWERS LC, 1986, P NATL ACAD SCI USA, V83, P5434, DOI 10.1073/pnas.83.15.5434; Stengel G, 2009, ANAL CHEM, V81, P9079, DOI 10.1021/ac9017555; Stengel G, 2009, BIOCHEMISTRY-US, V48, P7547, DOI 10.1021/bi9006995; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Sung RJ, 2013, J BIOL CHEM, V288, P10012, DOI 10.1074/jbc.M112.415612; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; WARD DC, 1969, J BIOL CHEM, V244, P1228; Wiederholt CJ, 2005, NUCLEIC ACIDS RES, V33, P3331, DOI 10.1093/nar/gki655; Wilhelmsson LM, 2010, Q REV BIOPHYS, V43, P159, DOI 10.1017/S0033583510000090; Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200; Yang KS, 2008, PHOTOCHEM PHOTOBIOL, V84, P741, DOI 10.1111/j.1751-1097.2007.00251.x; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200	65	35	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14338	14349		10.1074/jbc.M114.621128	http://dx.doi.org/10.1074/jbc.M114.621128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25869130	Green Published, hybrid			2022-12-26	WOS:000355754600007
J	Cai, CX; Lin, PH; Zhu, H; Ko, JK; Hwang, M; Tan, T; Pan, Z; Korichneva, I; Ma, JJ				Cai, Chuanxi; Lin, Peihui; Zhu, Hua; Ko, Jae-Kyun; Hwang, Moonsun; Tan, Tao; Pan, Zui; Korichneva, Irina; Ma, Jianjie			Zinc Binding to MG53 Protein Facilitates Repair of Injury to Cell Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACRODERMATITIS ENTEROPATHICA; HUMAN HEALTH; DEFICIENCY; DYSFERLIN; TRAFFICKING; DISRUPTIONS	Zinc is an essential trace element that participates in a wide range of biological functions, including wound healing. Although Zn2+ deficiency has been linked to compromised wound healing and tissue repair in human diseases, the molecular mechanisms underlying Zn2+-mediated tissue repair remain unknown. Our previous studies established that MG53, a TRIM (tripartite motif) family protein, is an essential component of the cell membrane repair machinery. Domain homology analysis revealed that MG53 contains two Zn2+-binding motifs. Here, we show that Zn2+ binding to MG53 is indispensable to assembly of the cell membrane repair machinery. Live cell imaging illustrated that Zn2+ entry from extracellular space is essential for translocation of MG53-containing vesicles to the acute membrane injury sites for formation of a repair patch. The effect of Zn2+ on membrane repair is abolished in mg53(-/-) muscle fibers, suggesting that MG53 functions as a potential target for Zn2+ during membrane repair. Mutagenesis studies suggested that both RING and B-box motifs of MG53 constitute Zn2+-binding domains that contribute to MG53-mediated membrane repair. Overall, this study establishes a base for Zn2+ interaction with MG53 in protection against injury to the cell membrane.	[Cai, Chuanxi; Lin, Peihui; Zhu, Hua; Ko, Jae-Kyun; Hwang, Moonsun; Ma, Jianjie] Rutgers Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Cai, Chuanxi] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Lin, Peihui; Zhu, Hua; Tan, Tao; Ma, Jianjie] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Pan, Zui] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Dept Internal Med, Columbus, OH 43210 USA; [Korichneva, Irina] Univ Picardie, Dept Sci, Lab Cellular & Mol Physiol, F-80000 Amiens, France	Rutgers State University New Brunswick; Rutgers State University Medical Center; Albany Medical College; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Korichneva, I (corresponding author), Univ Picardie, Dept Sci, Lab Cellular & Mol Physiol, F-80000 Amiens, France.	irina.korichneva@u-picardie.fr; jianjie.ma@osumc.edu	Regan, Clinton/E-6250-2012; Cai, Chuanxi/AAW-1488-2020; Zhu, Hua/G-4409-2010	Pan, Zui/0000-0003-4105-901X; Zhu, Hua/0000-0001-7136-7326	National Institutes of Health [AR061385, HL069000]; American Heart Association; Ohio State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ohio State University(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR061385 and HL069000 (to J. M.). This work was also supported by the American Heart Association (to C. C. and H. Z.) and an Ohio State University intramural Lockwood Early Career Development Award (to P. L.). J. M. has an equity interest in TRIM-edicine, which develops MG53 for treatment of human diseases. Patents on the use of MG53 are held by the Rutgers Robert Wood Johnson Medical School.	Agren MS, 2006, WOUND REPAIR REGEN, V14, P526, DOI 10.1111/j.1743-6109.2006.00159.x; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; BRAUN OH, 1976, EUR J PEDIATR, V121, P247, DOI 10.1007/BF00443018; Brewer GJ, 2013, INT J ALZHEIMERS DIS, V2013; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; Frustaci A, 2012, EUR J HEART FAIL, V14, P202, DOI 10.1093/eurjhf/hfr167; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Grommes J, 2011, INT J COLORECTAL DIS, V26, P295, DOI 10.1007/s00384-010-1070-y; Gupta M, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/709152; Haase H, 2014, METALLOMICS, V6, P1175, DOI 10.1039/c3mt00353a; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Herbein G, 2006, BIOGERONTOLOGY, V7, P409, DOI 10.1007/s10522-006-9056-4; Hwang M, 2011, AM J PHYSIOL-CELL PH, V301, pC106, DOI 10.1152/ajpcell.00382.2010; Ikeda K, 2012, ADV EXP MED BIOL, V770, P27; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Korichneva Irina, 2005, Exp Clin Cardiol, V10, P256; Lansdown A. B. G., 1993, International Journal of Cosmetic Science, V15, P83, DOI 10.1111/j.1467-2494.1993.tb00072.x; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Marger L, 2014, BIOCHEM PHARMACOL, V91, P426, DOI 10.1016/j.bcp.2014.08.002; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Meroni G, 2012, ADV EXP MED BIOL, V770, P1; Micale L, 2012, ADV EXP MED BIOL, V770, P11; MOYNAHAN EJ, 1974, LANCET, V2, P399; MOZZILLO N, 1984, Italian Journal of Surgical Sciences, V14, P229; Park KH, 2014, JOVE-J VIS EXP, DOI 10.3791/50898; Prasad AS, 2013, ADV NUTR, V4, P176, DOI 10.3945/an.112.003210; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Wang C, 2010, PROTEIN SCI, V19, P494, DOI 10.1002/pro.327; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N., 2011, JOVE-J VIS EXP, V52, P2717; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zorrilla P, 2006, WOUND REPAIR REGEN, V14, P119, DOI [10.1111/j.1743-6109.2006.00100.x, 10.1111/j.1743-6109.2006.00100.X]	54	26	28	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13830	13839		10.1074/jbc.M114.620690	http://dx.doi.org/10.1074/jbc.M114.620690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869134	Green Published, hybrid			2022-12-26	WOS:000355313000017
J	Catici, DAM; Horne, JE; Cooper, GE; Pudney, CR				Catici, Dragana A. M.; Horne, James E.; Cooper, Grace E.; Pudney, Christopher R.			Polyubiquitin Drives the Molecular Interactions of the NF-kappa B Essential Modulator (NEMO) by Allosteric Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTRINSIC DISORDER; CONFORMATIONAL SELECTION; UBIQUITIN CHAINS; TRYPTOPHAN FLUORESCENCE; PRESSURE-DEPENDENCE; INDUCED FIT; ACTIVATION; BINDING; IKK; TEMPERATURE	The NF-kappa B essential modulator (NEMO) is the master regulator of NF-kappa B signaling, controlling the immune and nervous systems. NEMO affects the activity of I kappa B kinase-beta (IKK beta), which relieves the inhibition of the NF-kappa B transcriptional regulation machinery. Despite major effort, there is only a very sparse, phenomenological understanding of how NEMO regulates IKK beta and shows specificity in its large range of molecular interactions. We explore the key molecular interactions of NEMO using a molecular biophysics approach, incorporating rapid-mixing stopped-flow, high-pressure, and CD spectroscopies. Our study demonstrates that NEMO has a significant degree of native structural disorder and that molecular flexibility and ligand-induced conformational change are at the heart of the molecular interactions of NEMO. We found that long chain length, unanchored, linear polyubiquitin drives NEMO activity, enhancing the affinity of NEMO for IKK beta and the kinase substrate I kappa B alpha and promoting membrane association. We present evidence that unanchored polyubiquitin achieves this regulation by inducing NEMO conformational change by an allosteric mechanism. We combine our quantitative findings to give a detailed molecular mechanistic model for the activity of NEMO, providing insight into the molecular mechanism of NEMO activity with broad implications for the biological role of free polyubiquitin.	[Catici, Dragana A. M.; Horne, James E.; Cooper, Grace E.; Pudney, Christopher R.] Univ Bath, Dept Biol & Biochem, Fac Sci, Bath BA2 7AY, Avon, England	University of Bath	Pudney, CR (corresponding author), Univ Bath, Dept Biol & Biochem, Fac Sci, Bath BA2 7AY, Avon, England.	c.r.pudney@bath.ac.uk		Pudney, Christopher/0000-0001-6211-0086				AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Brunecky R, 2005, BIOCHEMISTRY-US, V44, P16064, DOI 10.1021/bi051127+; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Pan CP, 2004, BIOPHYS J, V86, P3828, DOI 10.1529/biophysj.103.038901; Pudney CR, 2007, J AM CHEM SOC, V129, P13949, DOI 10.1021/ja074463h; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ravindra R, 2003, CHEMPHYSCHEM, V4, P359, DOI 10.1002/cphc.200390062; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Schulenburg C, 2013, TOP CURR CHEM, V337, P41, DOI 10.1007/128_2012_411; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Tognotti D, 2013, BIOPHYS CHEM, V182, P44, DOI 10.1016/j.bpc.2013.06.005; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Wiedersich J, 2008, P NATL ACAD SCI USA, V105, P5756, DOI 10.1073/pnas.0710409105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zhang J., 2014, BIOCHEM J, V461, P531	40	16	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14130	14139		10.1074/jbc.M115.640417	http://dx.doi.org/10.1074/jbc.M115.640417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25866210	Green Published, hybrid			2022-12-26	WOS:000355313000041
J	Cooper, CDO; Newman, JA; Aitkenhead, H; Allerston, CK; Gileadi, O				Cooper, Christopher D. O.; Newman, Joseph A.; Aitkenhead, Hazel; Allerston, Charles K.; Gileadi, Opher			Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; HEMATOPOIETIC STEM; MOLECULAR-BIOLOGY; PROSTATE-CANCER; FACTOR ER81; FAMILY; METHYLATION; INSIGHTS; CELLS; RECOGNITION	Ets transcription factors, which share the conserved Ets DNA-binding domain, number nearly 30 members in humans and are particularly involved in developmental processes. Their deregulation following changes in expression, transcriptional activity, or by chromosomal translocation plays a critical role in carcinogenesis. Ets DNA binding, selectivity, and regulation have been extensively studied; however, questions still arise regarding binding specificity outside the core GGA recognition sequence and the mode of action of Ets post-translational modifications. Here, we report the crystal structures of Etv1, Etv4, Etv5, and Fev, alone and in complex with DNA. We identify previously unrecognized features of the protein-DNA interface. Interactions with the DNA backbone account for most of the binding affinity. We describe a highly coordinated network of water molecules acting in base selection upstream of the GGAA core and the structural features that may account for discrimination against methylated cytidine residues. Unexpectedly, all proteins crystallized as disulfide-linked dimers, exhibiting a novel interface (distant to the DNA recognition helix). Homodimers of Etv1, Etv4, and Etv5 could be reduced to monomers, leading to a 40-200-fold increase in DNA binding affinity. Hence, we present the first indication of a redox-dependent regulatory mechanism that may control the activity of this subset of oncogenic Ets transcription factors.	[Cooper, Christopher D. O.; Newman, Joseph A.; Aitkenhead, Hazel; Allerston, Charles K.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Oxford	Gileadi, O (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	opher.gileadi@sgc.ox.ac.uk	Cooper, Chris/G-9982-2014; Gileadi, Opher/F-1105-2013	Cooper, Chris/0000-0002-9197-8041; newman, Joseph/0000-0003-4488-0516; Gileadi, Opher/0000-0001-6886-898X	SGC [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; E.P. Abraham Cephalosporin Fund	SGC; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); E.P. Abraham Cephalosporin Fund	This work was supported by the SGC (the SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, Canada Foundation for Innovation, Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, Novartis Research Foundation, Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust Grant 092809/Z/10/Z).; Supported in part by the E.P. Abraham Cephalosporin Fund. Present address: Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom.	Abe H, 2011, P NATL ACAD SCI USA, V108, P12497, DOI 10.1073/pnas.1109940108; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babayeva ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033698; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Baert JL, 2002, J BIOL CHEM, V277, P1002, DOI 10.1074/jbc.M107139200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; BANNISTER AJ, 1991, ONCOGENE, V6, P1243; Barik S, 1996, Methods Mol Biol, V57, P203; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Charlot C, 2010, METHODS MOL BIOL, V647, P3, DOI 10.1007/978-1-60761-738-9_1; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chinenov Y, 1998, J BIOL CHEM, V273, P6203, DOI 10.1074/jbc.273.11.6203; Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9; Cooper CDO, 2014, BIOCHEM SOC T, V42, P130, DOI 10.1042/BST20130227; Coyne HJ, 2012, J MOL BIOL, V421, P67, DOI 10.1016/j.jmb.2012.05.010; Danciu TE, 2010, J CELL BIOCHEM, V109, P417, DOI 10.1002/jcb.22415; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; FISHER RJ, 1992, J BIOL CHEM, V267, P17957; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Legrand AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055883; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Lucas ME, 2009, J BIOL CHEM, V284, P14698, DOI 10.1074/jbc.M901104200; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; Martin ME, 1996, J BIOL CHEM, V271, P25617, DOI 10.1074/jbc.271.41.25617; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahara N, 2011, AMINO ACIDS, V41, P59, DOI 10.1007/s00726-010-0508-4; Newman JA, 2015, J BIOL CHEM, V290, P8539, DOI 10.1074/jbc.M114.619270; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Rahim S., 2011, YK 4 279 INHIBITS ER; Regan MC, 2013, P NATL ACAD SCI USA, V110, P13374, DOI 10.1073/pnas.1301726110; Rooman M, 2002, J MOL BIOL, V319, P67, DOI 10.1016/S0022-2836(02)00263-2; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Sedy J, 2006, DEV DYNAM, V235, P1081, DOI 10.1002/dvdy.20710; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; STRAUSS JK, 1994, SCIENCE, V266, P1829, DOI 10.1126/science.7997878; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Vageli D, 2009, ONCOL RES, V17, P413, DOI 10.3727/096504009788912507; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang Y, 2011, PATHOLOG RES INT, V2011; Wang YC, 2010, ENDOCR-RELAT CANCER, V17, P283, DOI 10.1677/ERC-09-0243; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yan CH, 2013, BBA-REV CANCER, V1835, P76, DOI 10.1016/j.bbcan.2012.11.002	91	27	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13692	13709		10.1074/jbc.M115.646737	http://dx.doi.org/10.1074/jbc.M115.646737			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25866208	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000355313000007
J	Hisaoka-Nakashima, K; Miyano, K; Matsumoto, C; Kajitani, N; Abe, H; Okada-Tsuchioka, M; Yokoyama, A; Uezono, Y; Morioka, N; Nakata, Y; Takebayashi, M				Hisaoka-Nakashima, Kazue; Miyano, Kanako; Matsumoto, Chie; Kajitani, Naoto; Abe, Hiromi; Okada-Tsuchioka, Mami; Yokoyama, Akinobu; Uezono, Yasuhito; Morioka, Norimitsu; Nakata, Yoshihiro; Takebayashi, Minoru			Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive G alpha(i/o) Activation in Astroglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOMA-CELLS; GROWTH-FACTOR RECEPTOR; MAJOR DEPRESSIVE DISORDER; MESSENGER-RNA EXPRESSION; TYROSINE KINASE DOMAIN; PROTEIN ALPHA-SUBUNIT; GTP-BINDING-PROTEIN; SIGNALING PATHWAY; FACTOR GDNF; CYCLIC-AMP	Further elaborating the mechanism of antidepressants, beyond modulation of monoaminergic neurotransmission, this study sought to elucidate the mechanism of amitriptyline-induced production of glial cell line-derived neurotrophic factor (GDNF) in astroglial cells. Previous studies demonstrated that an amitriptyline-evoked matrix metalloproteinase (MMP)/FGF receptor (FGFR)/FGFR substrate 2 alpha (FRS2 alpha)/ERK cascade is crucial for GDNF production, but how amitriptyline triggers this cascade remains unknown. MMP is activated by intracellular mediators such as G proteins, and this study sought to clarify the involvement of G protein signaling in amitriptyline-evoked GDNF production in rat C6 astroglial cells (C6 cells), primary cultured rat astrocytes, and normal human astrocytes. Amitriptyline-evoked GDNF mRNA expression and release were inhibited by pertussis toxin (PTX), a G alpha(i/o) inhibitor, but not by NF449, a G alpha(s) inhibitor, or YM-254890, a G alpha(q) inhibitor. The activation of the GDNF production cascade (FGFR/FRS2 alpha/ERK) was also inhibited by PTX. Deletion of G alpha(o1) and G alpha(i3) by RNAi demonstrated that these G proteins play important roles in amitriptyline signaling. Gprotein activation was directly analyzed by electrical impedance-based biosensors (CellKey (TM) assay), using a label-free (without use of fluorescent proteins/ probes or radioisotopes) and real time approach. Amitriptyline increased impedance, indicating G alpha(i/o) activation that was sup-pressed by PTX treatment. The impedance evoked by amitriptyline was not affected by inhibitors of the GDNF production cascade. Furthermore, FGF2 treatment did not elicit any effect on impedance, indicating that amitriptyline targets PTX-sensitive G alpha(i/o) upstream of the MMP/FGFR/FRS2 alpha/ERK cascade. These results suggest novel targeting for the development of antidepressants.	[Hisaoka-Nakashima, Kazue; Matsumoto, Chie; Kajitani, Naoto; Abe, Hiromi; Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan; [Miyano, Kanako; Yokoyama, Akinobu; Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo 1040045, Japan; [Abe, Hiromi; Okada-Tsuchioka, Mami; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure 7370023, Japan; [Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Dept Psychiat, Kure 7370023, Japan; [Takebayashi, Minoru] Chugoku Canc Ctr, Kure 7370023, Japan	Hiroshima University; National Cancer Center - Japan	Hisaoka-Nakashima, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hisaokak@hiroshima-u.ac.jp; mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Miyano, Kanako/0000-0003-1673-6074; Kajitani, Naoto/0000-0001-7245-9206	Japan Society for the Promotion of Science [25870461, 23591686]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Young Scientists (B) 25870461 and 23591686 from the Japan Society for the Promotion of Science and the Takeda Science Foundation.	Castillo CA, 2007, NEUROCHEM RES, V32, P1056, DOI 10.1007/s11064-006-9273-x; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; CHEN JA, 1995, J NEUROCHEM, V64, P724; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Donati RJ, 2001, MOL PHARMACOL, V59, P1426, DOI 10.1124/mol.59.6.1426; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Galeotti N, 2002, NEUROPSYCHOPHARMACOL, V27, P554; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kowal D, 2002, BIOCHEM BIOPH RES CO, V294, P655, DOI 10.1016/S0006-291X(02)00535-1; Kurino M, 1996, J NEUROCHEM, V67, P2246; Lagriffoul A, 1996, J BIOL CHEM, V271, P31508, DOI 10.1074/jbc.271.49.31508; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; Lin YF, 2006, MOL ENDOCRINOL, V20, P2514, DOI 10.1210/me.2005-0347; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Miyano K, 2014, J PHARMACOL SCI, V126, P302, DOI 10.1254/jphs.14R13CP; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Morioka N, 2014, BRIT J PHARMACOL, V171, P2854, DOI 10.1111/bph.12614; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; O'Donnell JM, 2011, DRUG THERAPY DEPRESS; Ohta M, 2000, BIOCHEM BIOPH RES CO, V272, P18, DOI 10.1006/bbrc.2000.2732; Onali P, 2010, J PHARMACOL EXP THER, V332, P255, DOI 10.1124/jpet.109.159939; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; PEAKMAN MC, 1994, BRIT J PHARMACOL, V113, P1554, DOI 10.1111/j.1476-5381.1994.tb17173.x; Peters MF, 2007, J BIOMOL SCREEN, V12, P312, DOI 10.1177/1087057106298637; Peters MF, 2010, ASSAY DRUG DEV TECHN, V8, P219, DOI 10.1089/adt.2009.0232; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Schmidt Heath D, 2008, Drug Discov Today Ther Strateg, V5, P151, DOI 10.1016/j.ddstr.2008.10.003; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Shen JX, 2013, BIOCHEM J, V455, P47, DOI 10.1042/BJ20130359; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Takebayashi M, 2006, INT J NEUROPSYCHOPH, V9, P607, DOI 10.1017/S1461145705006085; Toki S, 1999, J NEUROCHEM, V73, P1114, DOI 10.1046/j.1471-4159.1999.0731114.x; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Van Kolen K, 2004, J NEUROCHEM, V89, P442, DOI 10.1111/j.1471-4159.2004.02339.x; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Wang J, 1997, J BIOL CHEM, V272, P5732, DOI 10.1074/jbc.272.9.5732; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; WILSON KM, 1990, MOL PHARMACOL, V38, P274; YAMAMOTO H, 1992, NEUROSCI LETT, V139, P194, DOI 10.1016/0304-3940(92)90550-Q; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910; Zysk JR, 2011, SYNAPSE, V65, P64, DOI 10.1002/syn.20817	62	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13678	13691		10.1074/jbc.M114.622415	http://dx.doi.org/10.1074/jbc.M114.622415			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869129	Green Published, hybrid			2022-12-26	WOS:000355313000006
J	Wang, JY; Kuryatov, A; Sriram, A; Jin, Z; Kamenecka, TM; Kenny, PJ; Lindstrom, J				Wang, Jingyi; Kuryatov, Alexander; Sriram, Aarati; Jin, Zhuang; Kamenecka, Theodore M.; Kenny, Paul J.; Lindstrom, Jon			An Accessory Agonist Binding Site Promotes Activation of alpha 4 beta 2*Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATOR; BETA 2; NS9283; POTENTIATION; SUBUNIT; STOICHIOMETRY; MECHANISM; INSIGHTS; DOMAIN	Neuronal nicotinic acetylcholine receptors containing alpha 4, beta 2, and sometimes other subunits (alpha 4 beta 2* nAChRs) regulate addictive and other behavioral effects of nicotine. These nAChRs exist in several stoichiometries, typically with two high affinity acetylcholine (ACh) binding sites at the interface of alpha 4 and beta 2 subunits and a fifth accessory subunit. A third low affinity ACh binding site is formed when this accessory subunit is alpha 4 but not if it is beta 2. Agonists selective for the accessory ACh site, such as 3-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]benzonitrile (NS9283), cannot alone activate a nAChR but can facilitate more efficient activation in combination with agonists at the canonical alpha 4 beta 2 sites. We therefore suggest categorizing agonists according to their site selectivity. NS9283 binds to the accessory ACh binding site; thus it is termed an accessory site-selective agonist. We expressed (alpha 4 beta 2)(2) concatamers in Xenopus oocytes with free accessory subunits to obtain defined nAChR stoichiometries and alpha 4/accessory subunit interfaces. We show that alpha 2, alpha 3, alpha 4, and alpha 6 accessory subunits can form binding sites for ACh and NS9283 at interfaces with alpha 4 subunits, but beta 2 and beta 4 accessory subunits cannot. To permit selective blockage of the accessory site, alpha 4 threonine 126 located on the minus side of alpha 4 that contributes to the accessory site, but not the alpha 4 beta 2 sites, was mutated to cysteine. Alkylation of this cysteine with a thioreactive reagent blocked activity of ACh and NS9283 at the accessory site. Accessory agonist binding sites are promising drug targets.	[Wang, Jingyi; Kuryatov, Alexander; Sriram, Aarati; Lindstrom, Jon] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Jin, Zhuang; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Therapeut, Scripps, FL 33458 USA; [Kenny, Paul J.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai	Lindstrom, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, 217 Stemmler Hall, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu	Regan, Clinton/E-6250-2012; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		National Institutes of Health [DA030929]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA030929.	Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Campling BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079653; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gill-Thind JK, 2015, J BIOL CHEM, V290, P3552, DOI 10.1074/jbc.M114.619221; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Grupe M, 2014, NEUROPHARMACOLOGY, V79, P444, DOI 10.1016/j.neuropharm.2013.12.008; Grupe M, 2013, BIOCHEM PHARMACOL, V86, P1487, DOI 10.1016/j.bcp.2013.09.005; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Jin Z, 2014, BIOORG MED CHEM LETT, V24, P674, DOI 10.1016/j.bmcl.2013.11.049; Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Marotta CB, 2014, ACS CHEM BIOL, V9, P1153, DOI 10.1021/cb400937d; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Mohler EG, 2014, PSYCHOPHARMACOLOGY, V231, P67, DOI 10.1007/s00213-013-3207-5; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Rode F, 2012, BRAIN RES, V1458, P67, DOI 10.1016/j.brainres.2012.03.064; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zhu CZ, 2011, BIOCHEM PHARMACOL, V82, P967, DOI 10.1016/j.bcp.2011.05.007; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	48	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13907	13918		10.1074/jbc.M115.646786	http://dx.doi.org/10.1074/jbc.M115.646786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869137	hybrid, Green Published			2022-12-26	WOS:000355313000023
J	Kayina, V; Kyobe, S; Katabazi, FA; Kigozi, E; Okee, M; Odongkara, B; Babikako, HM; Whalen, CC; Joloba, ML; Musoke, PM; Mupere, E				Kayina, Vincent; Kyobe, Samuel; Katabazi, Fred A.; Kigozi, Edgar; Okee, Moses; Odongkara, Beatrice; Babikako, Harriet M.; Whalen, Christopher C.; Joloba, Moses L.; Musoke, Philippa M.; Mupere, Ezekiel			Pertussis Prevalence and Its Determinants among Children with Persistent Cough in Urban Uganda	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; YOUNG INFANTS; DIAGNOSIS; EPIDEMIOLOGY; RESURGENCE; INFECTION; OUTBREAK; PROTECT; DISEASE; BURDEN	Background We determined prevalence of pertussis infection and its associated host and environmental factors to generate information that would guide strategies for disease control. Methods In a cross-sectional study, 449 children aged 3 months to 12 years with persistent cough lasting >= 14 days were enrolled and evaluated for pertussis using DNA polymerase chain reaction (PCR) and ELISA serology tests. Results Pertussis prevalence was 67 (15% (95% Confidence Interval (CI): 12-18)) and 81 (20% (95% CI: 16-24)) by PCR and ELISA, respectively among 449 participating children. The prevalence was highest in children with >59 months of age despite high vaccination coverage of 94% in this age group. Study demographic and clinical characteristics were similar between pertussis and non-pertussis cases. Of the 449 children, 133 (30%) had a coughing household member and 316 (70%) did not. Among 133 children that had a coughing household member, sex of child, sharing bed with a coughing household member and having a coughing individual in the neighborhood were factors associated with pertussis. Children that had shared a bed with a coughing household individual had seven-fold likelihood of having pertussis compared to children that did not (odds ratio (OR) 7.16 (95% CI: 1.24-41.44)). Among the 316 children that did not have a coughing household member, age <23 months, having or contact with a coughing individual in neighborhood, a residence with one room, and having a caretaker with >40 years of age were the factors associated with pertussis. Age <23 months was three times more likely to be associated with pertussis compared to age 24-59 months (OR 2.97 (95% CI: 1.07-8.28)). Conclusion Findings suggest high prevalence of pertussis among children with persistent cough at a health facility and it was marked in children >59 months of age, suggesting the possibility of waning immunity. The factors associated with pertussis varied by presence or absence of a coughing household member.	[Kayina, Vincent; Musoke, Philippa M.; Mupere, Ezekiel] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [Kyobe, Samuel; Katabazi, Fred A.; Kigozi, Edgar; Okee, Moses; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Odongkara, Beatrice] Gulu Univ, Sch Med, Dept Paediat, Gulu, Uganda; [Babikako, Harriet M.] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Whalen, Christopher C.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	Makerere University; Makerere University; Makerere University; University System of Georgia; University of Georgia	Mupere, E (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda.	mupez@yahoo.com		Joloba, Moses/0000-0002-0334-9983; Mupere, Ezekiel/0000-0002-8746-9009	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust [087540]	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust	This work was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540 funded by the Wellcome Trust. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices.	BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Burns DL, 2014, J INFECT DIS, V209, pS32, DOI 10.1093/infdis/jit491; Cherry JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003418; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS25, DOI 10.1097/01.inf.0000160926.89577.3b; Chuk LMR, 2008, COMMUN DIS INTELL, V32, P449; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; Elliott E, 2004, PEDIATR INFECT DIS J, V23, P246, DOI 10.1097/01.inf.0000116023.56344.46; Gaayeb L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048684; Hallander HO, 1999, CLIN INFECT DIS, V28, pS99, DOI 10.1086/515056; Hallbauer UM, 2011, S AFR FAM PRACT, V53, P495, DOI 10.1080/20786204.2011.10874140; HALPERIN SA, 1989, J PEDIATR-US, V115, P686, DOI 10.1016/S0022-3476(89)80643-2; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; Reizenstein E, 1996, J CLIN MICROBIOL, V34, P810, DOI 10.1128/JCM.34.4.810-815.1996; STREBEL P, 1991, J TROP PEDIATRICS, V37, P71, DOI 10.1093/tropej/37.2.71; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; Uganda Bureau of Statistics [UBOS] ICF International, 2012, UG DEM HLTH SURV; van der Ark AAJ, 2012, EXPERT REV VACCINES, V11, P1121, DOI [10.1586/ERV.12.83, 10.1586/erv.12.83]; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wiley KE, 2013, VACCINE, V31, P618, DOI 10.1016/j.vaccine.2012.11.052; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; Zouari A, 2012, DIAGN MICR INFEC DIS, V72, P303, DOI 10.1016/j.diagmicrobio.2012.01.002	27	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123240	10.1371/journal.pone.0123240	http://dx.doi.org/10.1371/journal.pone.0123240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874411	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800089
J	Yang, JM; Favazza, C; Yao, JJ; Chen, RM; Zhou, QF; Shung, KK; Wang, LHV				Yang, Joon Mo; Favazza, Christopher; Yao, Junjie; Chen, Ruimin; Zhou, Qifa; Shung, K. Kirk; Wang, Lihong V.			Three-Dimensional Photoacoustic Endoscopic Imaging of the Rabbit Esophagus	PLOS ONE			English	Article							MINIMALLY INVASIVE ESOPHAGECTOMY; OPTICAL COHERENCE TOMOGRAPHY; BARRETTS-ESOPHAGUS; MUCOSAL MORPHOLOGY; MICROSCOPY; DYSPLASIA; PATTERNS; RISK	We report photoacoustic and ultrasonic endoscopic images of two intact rabbit esophagi. To investigate the esophageal lumen structure and microvasculature, we performed in vivo and ex vivo imaging studies using a 3.8-mm diameter photoacoustic endoscope and correlated the images with histology. Several interesting anatomic structures were newly found in both the in vivo and ex vivo images, which demonstrates the potential clinical utility of this endoscopic imaging modality. In the ex vivo imaging experiment, we acquired high-resolution motion-artifact-free three-dimensional photoacoustic images of the vasculatures distributed in the walls of the esophagi and extending to the neighboring mediastinal regions. Blood vessels with apparent diameters as small as 190 mu m were resolved. Moreover, by taking advantage of the dual-mode high-resolution photoacoustic and ultrasound endoscopy, we could better identify and characterize the anatomic structures of the esophageal lumen, such as the mucosal and submucosal layers in the esophageal wall, and an esophageal branch of the thoracic aorta. In this paper, we present the first photoacoustic images showing the vasculature of a vertebrate esophagus and discuss the potential clinical applications and future development of photoacoustic endoscopy.	[Yang, Joon Mo; Favazza, Christopher; Yao, Junjie; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA; [Chen, Ruimin; Zhou, Qifa; Shung, K. Kirk] Univ So Calif, Dept Biomed Engn, Natl Inst Hlth Ultrason Transducer Resource Ctr, Los Angeles, CA 90089 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; University of Southern California	Wang, LHV (corresponding author), Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA.	lhwang@biomed.wustl.edu	Chen, Ruimin/K-2854-2018; yao, junjie/G-9226-2014; Yang, Joon-Mo/X-5629-2018	Chen, Ruimin/0000-0002-5338-359X; yao, junjie/0000-0002-2847-5839; 	National Institutes of Health [R01 CA157277, EB016986, R01 CA186567, R01 CA159959]; NATIONAL CANCER INSTITUTE [R01CA159959, R01CA186567, R01CA157277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP1EB016986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health through the following grants: R01 CA157277, EB016986 (NIH Director's Pioneer Award), R01 CA186567 (NIH Director's Transformative Research Award), and R01 CA159959. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Becker V, 2008, ENDOSCOPY, V40, P888, DOI 10.1055/s-2008-1077718; Cai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043999; Chen Y, 2007, ENDOSCOPY, V39, P599, DOI 10.1055/s-2007-966648; Cobb MJ, 2010, GASTROINTEST ENDOSC, V71, P223, DOI 10.1016/j.gie.2009.07.005; Dietrich C, 2011, ENDOSCOPIC ULTRASOUN; Evans JA, 2006, CLIN GASTROENTEROL H, V4, P38, DOI 10.1016/S1542-3565(05)00746-9; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245; Hammoud GM, 2014, WORLD J GASTROENTERO, V20, P14230, DOI 10.3748/wjg.v20.i39.14230; Hawes RH, 2006, ENDOSONOGRAPHY; Kang D, 2010, GASTROINTEST ENDOSC, V71, P35, DOI 10.1016/j.gie.2009.08.026; Kara MA, 2006, GASTROINTEST ENDOSC, V64, P155, DOI 10.1016/j.gie.2005.11.049; Kiesslich R, 2007, NAT CLIN PRACT ONCOL, V4, P480, DOI 10.1038/ncponc0881; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Lee MM, 2009, CAN J GASTROENTEROL, V23, P84, DOI 10.1155/2009/732481; LIEBERMANNMEFFERT DMI, 1987, ANN SURG, V206, P184; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; Palanivelu C, 2006, J AM COLL SURGEONS, V203, P7, DOI 10.1016/j.jamcollsurg.2006.03.016; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; Sato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001890; Shami VM, 2010, CLIN GASTROENT-SER, P1, DOI 10.1007/978-1-60327-480-7; Singh R, 2008, ENDOSCOPY, V40, P457, DOI 10.1055/s-2007-995741; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Suter MJ, 2008, GASTROINTEST ENDOSC, V68, P745, DOI 10.1016/j.gie.2008.05.014; Terry NG, 2011, GASTROENTEROLOGY, V140, P42, DOI 10.1053/j.gastro.2010.09.008; Thekkek N, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026007; Vakoc BJ, 2007, GASTROINTEST ENDOSC, V65, P898, DOI 10.1016/j.gie.2006.08.009; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wilson BC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795688; Yang JM, 2012, OPT EXPRESS, V20, P23944, DOI 10.1364/OE.20.023944; Yang JM, 2012, NAT MED, V18, P1297, DOI 10.1038/nm.2823; Yang JM, 2009, OPT LETT, V34, P1591, DOI 10.1364/OL.34.001591; Yao JJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.080505; Yao JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3594786; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	39	29	33	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120269	10.1371/journal.pone.0120269	http://dx.doi.org/10.1371/journal.pone.0120269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874640	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353015800010
J	Farrar, EJ; Huntley, GD; Butcher, J				Farrar, Emily J.; Huntley, Geoffrey D.; Butcher, Jonathan			Endothelial-Derived Oxidative Stress Drives Myofibroblastic Activation and Calcification of the Aortic Valve	PLOS ONE			English	Article							VALVULAR INTERSTITIAL-CELLS; SUPEROXIDE-DISMUTASE; DEPENDENT REGULATION; ADHESION MOLECULES; DISEASE; STENOSIS; GENERATION; EXPRESSION; HEART; PROGRESSION	Aims Oxidative stress is present in and contributes to calcification of the aortic valve, but the driving factors behind the initiation of valve oxidative stress are not well understood. We tested whether the valve endothelium acts as an initiator and propagator of oxidative stress in aortic valve disease. Methods and Results Calcified human aortic valves showed side-specific elevation of superoxide in the endothelium, co-localized with high VCAM1 expression, linking oxidative stress, inflammation, and valve degeneration. Treatment with inflammatory cytokine TNF alpha increased superoxide and oxidative stress and decreased eNOS and VE-cadherin acutely over 48 hours in aortic valve endothelial cells (VEC) and chronically over 21 days in ex vivo AV leaflets. Co-treatment of VEC with tetrahydrobiopterin (BH4) but not apocynin mitigated TNF alpha-driven VEC oxidative stress. Co-treatment of ex vivo AV leaflets with TNF alpha+BH4 or TNF alpha+peg-SOD rescued endothelial function and mitigated inflammatory responses. Both BH4 and peg-SOD rescued valve leaflets from the pro-osteogenic effects of TNF alpha treatment, but only peg-SOD was able to mitigate the fibrogenic effects, including increased collagen and alpha SMA expression. Conclusions Aortic valve endothelial cells are a novel source of oxidative stress in aortic valve disease. TNF alpha-driven VEC oxidative stress causes loss of endothelial protective function, chronic inflammation, and fibrogenic and osteogenic activation, mitigated differentially by BH4 and peg-SOD. These mechanisms identify new targets for tailored antioxidant therapy focused on mitigation of oxidative stress and restoration of endothelial protection.	[Farrar, Emily J.; Butcher, Jonathan] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Huntley, Geoffrey D.] Mayo Clin, Mayo Med Sch, Rochester, MN USA	Cornell University; Mayo Clinic	Butcher, J (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	jtb47@cornell.edu	Butcher, Jonathan T/D-2280-2012; Butcher, Jonathan/AAE-8239-2020	Butcher, Jonathan T/0000-0002-9309-6296; Butcher, Jonathan/0000-0002-9309-6296; Huntley, Geoffrey/0000-0001-7681-1107; Farrar, Emily/0000-0003-4968-0038	National Science Foundation [CBET-0955172, MRSEC DMR-1120296]; National Institutes of Health [HL110328, HL118672]; National Science Foundation graduate research fellowship; National Science Foundation Research Experience for Undergraduates Site program [DMR-1063059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110328, R21HL118672] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); National Science Foundation Research Experience for Undergraduates Site program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation (nsf.gov, CBET-0955172 and MRSEC DMR-1120296 to JTB), and by the National Institutes of Health (nih.gov, HL110328 and HL118672 to JTB). EJF was supported by a National Science Foundation graduate research fellowship. GDH was supported by the National Science Foundation Research Experience for Undergraduates Site program (DMR-1063059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Bai JX, 2000, J BIOL CHEM, V275, P19241, DOI 10.1074/jbc.M000438200; Bischoff J, 2011, J CARDIOVASC TRANSL, V4, P710, DOI 10.1007/s12265-011-9312-0; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795; Branchetti E, 2013, ARTERIOSCL THROM VAS, V33, pE66, DOI 10.1161/ATVBAHA.112.300177; Butcher JT, 2007, PHILOS T R SOC B, V362, P1445, DOI 10.1098/rstb.2007.2127; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Ciprian AB, 2012, CIRC RES, V111, P1157, DOI [10.1161/CIRCRESAHA.111.261750, DOI 10.1161/CIRCRESAHA.111.261750]; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Farivar RS, 2003, EUR J CARDIO-THORAC, V24, P527, DOI 10.1016/S1010-7940(03)00408-1; Farrar EJ, 2014, ANN BIOMED ENG, V42, P149, DOI 10.1007/s10439-013-0894-3; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Galeone A, 2013, INT J CARDIOL, V169, P296, DOI 10.1016/j.ijcard.2013.09.012; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Ghaisas NK, 2000, J AM COLL CARDIOL, V36, P2257, DOI 10.1016/S0735-1097(00)00998-0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154; Guerraty MA, 2010, ARTERIOSCL THROM VAS, V30, P225, DOI 10.1161/ATVBAHA.109.198549; Heistad DD, 2009, CIRC J, V73, P201, DOI 10.1253/circj.CJ-08-1082; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Kar S, 2012, FREE RADICAL RES, V46, P1496, DOI 10.3109/10715762.2012.731052; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; Mahler GJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/721419; Mahler GJ, 2013, ARTERIOSCL THROM VAS, V33, P121, DOI 10.1161/ATVBAHA.112.300504; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; Mele J, 2006, ANTIOXID REDOX SIGN, V8, P628, DOI 10.1089/ars.2006.8.628; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029; Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Poggianti E, 2003, J AM COLL CARDIOL, V41, P136, DOI 10.1016/S0735-1097(02)02622-0; Pompilio G, 1998, ANN THORAC SURG, V65, P986, DOI 10.1016/S0003-4975(98)00075-7; Rajamannan N., 2013, OXIDATIVE STRESS AND, P265, DOI [10.5772/52275, DOI 10.5772/52275]; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajamannan NM, 2011, CARDIOVASC PATHOL, V20, P168, DOI 10.1016/j.carpath.2010.11.007; Rajamannan NM, 2005, HEART, V91, P806, DOI 10.1136/hrt.2003.029785; Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Shavelle DM, 2002, LANCET, V359, P1125, DOI 10.1016/S0140-6736(02)08161-8; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Stephens EH, 2011, CARDIOVASC PATHOL, V20, P334, DOI [10.1016/j.carpath.2010.10.002, 10.1016/j.carpath.2010.07.004]; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Teo KK, 2011, CAN J CARDIOL, V27, P800, DOI 10.1016/j.cjca.2011.03.012; Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915	57	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123257	10.1371/journal.pone.0123257	http://dx.doi.org/10.1371/journal.pone.0123257			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874717	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100156
J	Jin, JK; Jang, B; Jin, HT; Choi, EK; Jung, CG; Akatsu, H; Kim, JI; Carp, RI; Kim, YS				Jin, Jae-Kwang; Jang, Byungki; Jin, Hyoung Tae; Choi, Eun-Kyoung; Jung, Cha-Gyun; Akatsu, Hiroyasu; Kim, Jae-Il; Carp, Richard I.; Kim, Yong-Sun			Phosphatidylinositol-Glycan-Phospholipase D Is Involved in Neurodegeneration in Prion Disease	PLOS ONE			English	Article							SCRAPIE-INFECTED MICE; NEUROBLASTOMA-CELLS; PHOSPHATIDIC-ACID; OXIDATIVE STRESS; PROTEIN; EXPRESSION; BRAINS; INHIBITION; CONVERSION; COMPLEXES	PrPSc is formed from a normal glycosylphosphatidylinositol (GPI)-anchored prion protein (PrPC) by a posttranslational modification. Most GPI-anchored proteins have been shown to be cleaved by GPI phospholipases. Recently, GPI-phospholipase D (GPI-PLD) was shown to be a strictly specific enzyme for GPI anchors. To investigate the involvement of GPI-PLD in the processes of neurodegeneration in prion diseases, we examined the mRNA and protein expression levels of GPI-PLD in the brains of a prion animal model (scrapie), and in both the brains and cerebrospinal fluids (CSF) of sporadic and familial Creutzfeldt-Jakob disease (CJD) patients. We found that compared with controls, the expression of GPI-PLD was dramatically down-regulated in the brains of scrapie-infected mice, especially in the caveolinenriched membrane fractions. Interestingly, the observed decrease in GPI-PLD expression levels began at the same time that PrPSc began to accumulate in the infected brains and this decrease was also observed in both the brain and CSF of CJD patients; however, no differences in expression were observed in either the brains or CSF specimens from Alzheimer's disease patients. Taken together, these results suggest that the down-regulation of GPI-PLD protein may be involved in prion propagation in the brains of prion diseases.	[Jin, Jae-Kwang; Jang, Byungki; Jin, Hyoung Tae; Choi, Eun-Kyoung; Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, Gyeonggi Do, South Korea; [Jung, Cha-Gyun] Nagoya City Univ Grad, Dept Neurophysiol & Brain Sci, Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Kim, Jae-Il] Pukyong Natl Univ, Dept Food Sci & Nutr, Busan 608737, South Korea; [Carp, Richard I.] New York State Inst Basic Res Dev Disabil, Dept Virol, Staten Isl, NY 10314 USA	Hallym University; Pukyong National University; Institute for Basic Research in Developmental Disabilities	Kim, YS (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, Gyeonggi Do, South Korea.	yskim@hallym.ac.kr		Jung, Cha-Gyun/0000-0002-0225-0658	Korea Research Foundation Grant - Korean Government [KRF-2008-313-E00110, KRF-2011-619-E0001]	Korea Research Foundation Grant - Korean Government(National Research Foundation of KoreaKorean Government)	The present study was supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2008-313-E00110, KRF-2011-619-E0001).	Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bernasconi E, 1996, J CELL SCI, V109, P1195; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRUNNER G, 1994, BLOOD, V83, P2115; CARP RI, 1991, J GEN VIROL, V72, P293, DOI 10.1099/0022-1317-72-2-293; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; Deeg MA, 2001, J LIPID RES, V42, P442; Du XH, 2001, INFECT IMMUN, V69, P3214, DOI 10.1128/IAI.69.5.3214-3223.2001; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; HARMEY JH, 1995, BIOCHEM BIOPH RES CO, V210, P753, DOI 10.1006/bbrc.1995.1723; Jin JK, 2005, J NEUROCHEM, V92, P452, DOI 10.1111/j.1471-4159.2004.02881.x; Kim JI, 1999, MOL BRAIN RES, V73, P17, DOI 10.1016/S0169-328X(99)00229-6; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P1398, DOI 10.1021/bi011579w; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Low MG, 1999, ARCH BIOCHEM BIOPHYS, V371, P332, DOI 10.1006/abbi.1999.1436; LOW MG, 1993, J BIOL CHEM, V268, P8480; LOW MG, 2000, PNH GPI LINKED PROTE, P239; MAGUIRE GA, 1995, ANN CLIN BIOCHEM, V32, P74, DOI 10.1177/000456329503200107; MASTERS CL, 1978, BRAIN, V101, P333, DOI 10.1093/brain/101.2.333; METZ CN, 1994, EMBO J, V13, P1741, DOI 10.1002/j.1460-2075.1994.tb06438.x; METZ CN, 1991, J BIOL CHEM, V266, P17733; Nakashima S, 1999, CHEM PHYS LIPIDS, V98, P153, DOI 10.1016/S0009-3084(99)00027-4; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; SCALLON BJ, 1991, SCIENCE, V252, P446, DOI 10.1126/science.2017684; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945	34	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122120	10.1371/journal.pone.0122120	http://dx.doi.org/10.1371/journal.pone.0122120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867459	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100059
J	Weinberg, A; Muresan, P; Richardson, KM; Fenton, T; Dominguez, T; Bloom, A; Watts, DH; Abzug, MJ; Nachman, SA; Levin, MJ				Weinberg, Adriana; Muresan, Petronella; Richardson, Kelly M.; Fenton, Terence; Dominguez, Teresa; Bloom, Anthony; Watts, D. Heather; Abzug, Mark J.; Nachman, Sharon A.; Levin, Myron J.		P1086 Team	Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMAGGLUTINATION-INHIBITING ANTIBODY; MATERNAL INFLUENZA VACCINATION; BLOOD MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; YOUNG INFANTS; RESPIRATORY ILLNESS; IMMUNE ACTIVATION; UNITED-STATES; A H1N1	Influenza infections have high frequency and morbidity in HIV-infected pregnant women, underscoring the importance of vaccine-conferred protection. To identify the factors that determine vaccine immunogenicity in this group, we characterized the relationship of B-and T-cell responses to pandemic H1N1 (pH1N1) vaccine with HIV-associated immunologic and virologic characteristics. pH1N1 and seasonal-H1N1 (sH1N1) antibodies were measured in 119 HIV-infected pregnant women after two double-strength pH1N1 vaccine doses. pH1N1-IgG and IgA B-cell FluoroSpot, pH1N1-and sH1N1-interferon gamma (IFN gamma) and granzyme B (GrB) T-cell FluoroSpot, and flow cytometric characterization of B-and T-cell subsets were performed in 57 subjects. pH1N1-antibodies increased after vaccination, but less than previously described in healthy adults. pH1N1-IgG memory B cells (Bmem) increased, IFN gamma-effector T-cells (Teff) decreased, and IgA Bmem and GrB Teff did not change. pH1N1-antibodies and Teff were significantly correlated with each other and with sH1N1-HAI and Teff, respectively, before and after vaccination. pH1N1-antibody responses to the vaccine significantly increased with high proportions of CD4+, low CD8+ and low CD8+ HLADR+ CD38+ activated (Tact) cells. pH1N1-IgG Bmem responses increased with high proportions of CD19+ CD27+ CD21-activated B cells (Bact), high CD8+ CD39+ regulatory T cells (Treg), and low CD19+ CD27-CD21-exhausted B cells (Bexhaust). IFN gamma-Teff responses increased with low HIV plasma RNA, CD8+ HLADR+ CD38+ Tact, CD4+ FoxP3+ Treg and CD19+ IL10+ Breg. In conclusion, pre-existing antibody and Teff responses to sH1N1 were associated with increased responses to pH1N1 vaccination in HIV-infected pregnant women suggesting an important role for heterosubtypic immunologic memory. High CD4+% T cells were associated with increased, whereas high HIV replication, Tact and Bexhaust were associated with decreased vaccine immunogenicity. High Treg increased antibody responses but decreased Teff responses to the vaccine. The proportions of immature and transitional B cells did not affect the responses to vaccine. Increased Bact were associated with high Bmem responses to the vaccine.	[Weinberg, Adriana; Richardson, Kelly M.; Dominguez, Teresa; Abzug, Mark J.; Levin, Myron J.] Univ Colorado, Anschutz Med Ctr, Aurora, CO 80045 USA; [Muresan, Petronella; Fenton, Terence] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Stat & Data Anal Ctr, Boston, MA 02115 USA; [Bloom, Anthony] Frontier Sci & Technol Res Fdn Inc, Buffalo, NY USA; [Watts, D. Heather] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, Bethesda, MD USA; [Nachman, Sharon A.] SUNY Hlth Sci Ctr, Stony Brook, NY USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System	Weinberg, A (corresponding author), Univ Colorado, Anschutz Med Ctr, Aurora, CO 80045 USA.	adriana.weinberg@ucdenver.edu		Logan, Latania/0000-0002-3883-2043	National Institute of Allergy and Infectious Diseases [U01 AI068632, U01 AI41110, U01 AI068616]; National Institute of Child Health and Human Development; National Institute of Mental Health [AI068632, N01-DK-9-001/HHSN267200800001C, N01HD33162 (97-07)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068632, UM1AI068616, U01AI068632, U01AI041110, U01AI068616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institute of Allergy and Infectious Diseases, grant number U01 AI068632 & U01 AI41110 & U01 AI068616, http://www.niaid.nih.gov/Pages/default.aspx; and National Institute of Child Health and Human Development and the National Institute of Mental Health, grant number AI068632 & N01-DK-9-001/HHSN267200800001C & N01HD33162 (97-07), https://www.nichd.nih.gov/ Pages/index.aspx and http://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzug MJ, 2013, CLIN INFECT DIS, V56, P1488, DOI 10.1093/cid/cit057; Adedinsewo DA, 2013, VACCINE, V31, P5827, DOI 10.1016/j.vaccine.2013.09.071; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Benne CA, 1998, CLIN DIAGN LAB IMMUN, V5, P114, DOI 10.1128/CDLI.5.1.114-117.1998; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; BLACK SC, 2011, AM POETRY REV, V40, P30, DOI DOI 10.1097/INF.0B013E3182367662; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; CHADWICK EG, 1994, PEDIATR INFECT DIS J, V13, P206, DOI 10.1097/00006454-199403000-00008; Chougnet CA, 2007, AIDS RES HUM RETROV, V23, P945, DOI 10.1089/aid.2006.0259; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cooper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017758; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Dolan GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041638; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; El Sahly HM, 2012, J INFECT DIS, V205, P703, DOI 10.1093/infdis/jir837; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Flynn PM, 2012, J INFECT DIS, V206, P421, DOI 10.1093/infdis/jis360; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Fukushima W, 2012, VACCINE, V30, P7630, DOI 10.1016/j.vaccine.2012.10.027; Fuller JD, 1999, CLIN INFECT DIS, V28, P541, DOI 10.1086/515170; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hammitt LL, 2009, VACCINE, V27, P7359, DOI 10.1016/j.vaccine.2009.09.041; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Jacobsen MC, 2008, J INFECT DIS, V198, P481, DOI 10.1086/590215; Perise-Barrios AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039472; Klein MB, 2007, CLIN INFECT DIS, V45, P234, DOI 10.1086/518986; KROON FP, 1994, AIDS, V8, P469, DOI 10.1097/00002030-199404000-00008; Lagler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036773; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Levin MJ, 2008, VACCINE, V26, P4210, DOI 10.1016/j.vaccine.2008.05.054; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Madhi SA, 2014, PEDIATR INFECT DIS J, V33, P174, DOI 10.1097/INF.0b013e3182a73ebb; Maltezou HC, 2013, CLIN INFECT DIS, V57, P1520, DOI 10.1093/cid/cit599; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Martinez E, 2011, HIV MED, V12, P236, DOI 10.1111/j.1468-1293.2010.00905.x; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Muyanja E, 2014, J CLIN INVEST, V124, P1, DOI [10.1172/JCI72323, DOI 10.1172/JCI72323]; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Noguera-Julian A, 2011, PEDIATR INFECT DIS J, V30, P173, DOI 10.1097/INF.0b013e3181f5358b; Omer SB, 2013, J INFECT DIS, V207, P1144, DOI 10.1093/infdis/jit003; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pensieroso S, 2013, AIDS, V27, P1209, DOI 10.1097/QAD.0b013e32835edc47; Peters PJ, 2011, CLIN INFECT DIS, V52, pS183, DOI 10.1093/cid/ciq036; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Richardson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028172; Richardson K, 2011, AIDS, V25, P595, DOI 10.1097/QAD.0b013e32834411a8; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Viau M, 2007, MOL IMMUNOL, V44, P2124, DOI 10.1016/j.molimm.2006.07.302; Vigano A, 2008, JAIDS-J ACQ IMM DEF, V48, P289, DOI 10.1097/QAI.0b013e3181632cda; Weinberg A, 2004, CLIN INFECT DIS, V39, P107, DOI 10.1086/420931; Weinberg A, 2013, HUM VACC IMMUNOTHER, V9, P957, DOI 10.4161/hv.23774; Weinberg A, 2010, J IMMUNOL METHODS, V363, P42, DOI 10.1016/j.jim.2010.09.032; Weinberg A, 2010, JAIDS-J ACQ IMM DEF, V55, P189, DOI 10.1097/QAI.0b013e3181e46308; Weinberg A, 2010, AIDS RES HUM RETROV, V26, P51, DOI 10.1089/aid.2009.0163; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4	86	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122431	10.1371/journal.pone.0122431	http://dx.doi.org/10.1371/journal.pone.0122431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874544	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100073
J	Blais, SP; Kornblatt, JA; Barbeau, X; Bonnaure, G; Lague, P; Chenevert, R; Lapointe, J				Blais, Sebastien P.; Kornblatt, Jack A.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Chenevert, Robert; Lapointe, Jacques			tRNA(Glu) Increases the Affinity of Glutamyl-tRNA Synthetase for Its Inhibitor Glutamyl-Sulfamoyl-Adenosine, an Analogue of the Aminoacylation Reaction Intermediate Glutamyl-AMP: Mechanistic and Evolutionary Implications	PLOS ONE			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; TITRATION CALORIMETRY; CATALYTIC MECHANISM; COMPLEX; BINDING; RECOGNITION; ACTIVATION; THERMODYNAMICS; PHENYLALANINE	For tRNA-dependent protein biosynthesis, amino acids are first activated by aminoacyl-tRNA synthetases (aaRSs) yielding the reaction intermediates aminoacyl-AMP (aa-AMP). Stable analogues of aa-AMP, such as aminoacyl-sulfamoyl-adenosines, inhibit their cognate aaRSs. Glutamyl-sulfamoyl-adenosine (Glu-AMS) is the best known inhibitor of Escherichia coli glutamyl-tRNA synthetase (GluRS). Thermodynamic parameters of the interactions between Glu-AMS and E. coli GluRS were measured in the presence and in the absence of tRNA by isothermal titration microcalorimetry. A significant entropic contribution for the interactions between Glu-AMS and GluRS in the absence of tRNA or in the presence of the cognate tRNA(Glu) or of the non-cognate tRNA(Phe) is indicated by the negative values of -T Delta S-b, and by the negative value of Delta C-p. On the other hand, the large negative enthalpy is the dominant contribution to Delta G(b) in the absence of tRNA. The affinity of GluRS for Glu-AMS is not altered in the presence of the non-cognate tRNA(Phe), but the dissociation constant K-d is decreased 50-fold in the presence of tRNA(Glu); this result is consistent with molecular dynamics results indicating the presence of an H-bond between Glu-AMS and the 3'-OH oxygen of the 3'-terminal ribose of tRNA(Glu) in the Glu-AMS_GluRS_tRNA(Glu) complex. Glu-AMS being a very close structural analogue of Glu-AMP, its weak binding to free GluRS suggests that the unstable Glu-AMP reaction intermediate binds weakly to GluRS; these results could explain why all the known GluRSs evolved to activate glutamate only in the presence of tRNA(Glu), the coupling of glutamate activation to its transfer to tRNA preventing unproductive cleavage of ATP.	[Blais, Sebastien P.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Lapointe, Jacques] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Blais, Sebastien P.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Lapointe, Jacques] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Barbeau, Xavier; Chenevert, Robert] Univ Laval, Dept Chim, Quebec City, PQ G1K 7P4, Canada; [Blais, Sebastien P.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Chenevert, Robert; Lapointe, Jacques] Quebec Network Res Prot Funct Struct & Engn PROTE, Quebec City, PQ, Canada; [Kornblatt, Jack A.] Concordia Univ, Fac Arts & Sci, Ctr Struct & Funct Gen, Dept Biol, Montreal, PQ H3G 1M8, Canada	Laval University; Laval University; Laval University; Concordia University - Canada	Blais, SP (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.	sebastien.blais@bcm.ulaval.ca; jacques.lapointe@bcm.ulaval.ca		kornblatt, jack/0000-0002-9802-8321; Lague, Patrick/0000-0002-5236-4979	Natural Sciences and Engineering Research Council of Canada (NSERC) [CG051791, 9988]; Fonds de Recherche du Quebec - Nature et Technologies, (FRQNT) [PR-133605]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec - Nature et Technologies, (FRQNT)	This work was supported by grant #CG051791 to JL and grant #9988 to JAK from the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca), and by the grant #PR-133605 to JL and RC from the Fonds de Recherche du Quebec - Nature et Technologies, (FRQNT) (http://www.frqnt.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende JE, 1971, METHOD ENZYMOL, V20, P210; BALTZINGER M, 1983, BIOCHEMISTRY-US, V22, P675, DOI 10.1021/bi00272a023; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Bernier S, 2005, J ENZYM INHIB MED CH, V20, P61, DOI 10.1080/14756360400002007; BLUME A, 1992, BIOCHEMISTRY-US, V31, P4636, DOI 10.1021/bi00134a014; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenevert R, 2003, MOL B INT U, P416; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Dubois DY, 2009, BIOCHEMISTRY-US, V48, P6012, DOI 10.1021/bi801690f; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Finn J, 2005, AMINOACYL TRNA SYNTH, P405; First E.A., 2005, AMINOACYL TRNA SYNTH, P328; Freist W, 1997, BIOL CHEM, V378, P1313; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Gadakh B, 2012, EXPERT OPIN THER PAT, V22, P1453, DOI 10.1517/13543776.2012.732571; Giege R, 2012, CELLULAR MOL BIOL, DOI [10.1128/ecosalplus.ESP-0009-2013, DOI 10.1128/EC0SALPLUS.ESP-0009-2013]; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; HARAYOKOYAMA M, 1986, BIOCHEMISTRY-US, V25, P7031, DOI 10.1021/bi00370a041; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; Karlsson M, 2008, J CHEM THEORY COMPUT, V4, P1021, DOI 10.1021/ct800033x; KERN D, 1980, J BIOL CHEM, V255, P1956; KERN D, 1980, EUR J BIOCHEM, V106, P137; KERN D, 1979, BIOCHEMISTRY-US, V18, P5809, DOI 10.1021/bi00593a010; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; Ling JQ, 2012, J BIOL CHEM, V287, P28518, DOI 10.1074/jbc.M112.372920; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; MEISTER A, 1963, METHOD ENZYMOL, V6, P751, DOI 10.1016/0076-6879(63)06242-X; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NUREKI O, 1995, SCIENCE, V267, P1958, DOI 10.1126/science.7701318; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Brien R, 2005, BIOCALORIMETRY, V2, P3; RAVEL JM, 1965, J BIOL CHEM, V240, P432; Salcedo G, 2014, BBA-BIOENERGETICS, V1837, P44, DOI 10.1016/j.bbabio.2013.08.005; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Schulze JO, 2006, J MOL BIOL, V361, P888, DOI 10.1016/j.jmb.2006.06.054; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Sekine SI, 2006, STRUCTURE, V14, P1791, DOI 10.1016/j.str.2006.10.005; Smith CK, 2007, BIOCHEMISTRY-US, V46, P1358, DOI 10.1021/bi061893w; Thomson J.A., 2004, BIOCALORIMETRY, P37; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Yu HT, 2010, J PHYS CHEM B, V114, P11552, DOI 10.1021/jp104209w	47	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121043	10.1371/journal.pone.0121043	http://dx.doi.org/10.1371/journal.pone.0121043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860020	gold, Green Submitted, Green Published			2022-12-26	WOS:000352590300020
J	Darda, L; Hakami, F; Morgan, R; Murdoch, C; Lambert, DW; Hunter, KD				Darda, Lav; Hakami, Fahad; Morgan, Richard; Murdoch, Craig; Lambert, Daniel W.; Hunter, Keith D.			The Role of HOXB9 and miR-196a in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							ORAL DYSPLASIA; BREAST-CANCER; ABERRANT EXPRESSION; ESTROGEN-RECEPTOR; DOWN-REGULATION; LUNG-CANCER; GENES; MUTATIONS; MICRORNA-196A; PROGRESSION	Background Previous studies have demonstrated that a number of HOX genes, a family of transcription factors with key roles in early development, are up-regulated in head and neck squamous cell carcinoma (HNSCC) and other cancers. The loci of several Homeobox (HOX) genes also contain microRNAs (miRs), including miR-196a. Methods Global miR expression and expression of all 39 HOX genes in normal oral keratinocytes (NOKs), oral pre-malignant (OPM) and HNSCC cells was assessed by expression microarray and qPCR and in tissues by immunohistochemistry (IHC) and qPCR of laser microdissected (LCM) tissues. Expression of miR196a and HOXB9 was reduced using anti-miR-196a and siRNA, respectively. Expression microarray profiles of anti-miR196a and pre-miR196a transfected cells were compared to parental cells in order to identify novel targets of miR196a. Putative miR196a targets were validated by qPCR and were confirmed as binding to the 3'UTR of miR196a by a dual luciferase reporter assay combined with mutational analysis of the miR-196a binding site. Results miR-196a and HOXB9 are highly expressed in HNSCC compared to NOKs, a pattern also seen in HNSCC tissues by HOXB9 IHC and qPCR of miR-196a in LCM tissue. Knock-down of miR-196a expression decreased HNSCC cell migration, invasion and adhesion to fibronectin, but had no effect on proliferation. Furthermore, knock-down of HOXB9 expression decreased migration, invasion and proliferation but did not alter adhesion. We identified a novel primary mRNA transcript containing HOXB9 and miR196a-1 as predicted from in-silico analysis. Expression array analysis identified a number of miR196a targets, including MAMDC2 and HOXC8. We confirmed that MAMDC2 is a novel miR-196a target using a dual luciferase reporter assay with the effect abolished on mutation of the binding site. Conclusions These results show that miR-196a and HOXB9 are overexpressed, perhaps co-ordinately, as HNSCC develops and exert a pro-tumourigenic phenotype in HNSCC and OPM cells.	[Darda, Lav; Hakami, Fahad; Lambert, Daniel W.; Hunter, Keith D.] Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Pathol, Sheffield, S Yorkshire, England; [Morgan, Richard] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England; [Murdoch, Craig] Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Med & Surg, Sheffield, S Yorkshire, England; [Hunter, Keith D.] Univ Pretoria, Dept Oral Pathol & Biol, ZA-0002 Pretoria, South Africa	University of Sheffield; University of Bradford; University of Sheffield; University of Pretoria	Hunter, KD (corresponding author), Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Pathol, Sheffield, S Yorkshire, England.	k.hunter@sheffield.ac.uk	Hunter, Keith/M-9784-2019; Hunter, Keith D/B-5670-2009	Hunter, Keith/0000-0002-7873-0877; Morgan, Richard/0000-0002-8721-4479; Murdoch, Craig/0000-0001-9724-122X				Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Barber BA, 2010, ANN ANAT, V192, P261, DOI 10.1016/j.aanat.2010.07.009; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; BURNS JE, 1994, ORAL ONCOL, V30B, P335, DOI 10.1016/0964-1955(94)90035-3; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Chiba N, 2012, P NATL ACAD SCI USA, V109, P2760, DOI 10.1073/pnas.1018867108; Cismasiu VB, 2004, J BIOL CHEM, V279, P26922, DOI 10.1074/jbc.M313115200; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; Danen-van Oorschot AA, 2012, PEDIATR BLOOD CANCER, V58, P715, DOI 10.1002/pbc.23279; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Diaz-Lopez A, 2011, CANCER MICROENVIRON, V4, P23, DOI 10.1007/s12307-010-0055-2; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hassan NMM, 2006, ONCOL RES, V16, P217, DOI 10.3727/000000006783981080; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Hunter KD, 2006, CANCER RES, V66, P7405, DOI 10.1158/0008-5472.CAN-06-0186; Kanai M, 2010, ONCOL REP, V23, P843, DOI 10.3892/or_00000706; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liu CJ, 2012, ANN SURG ONCOL; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; McGregor F, 1997, CANCER RES, V57, P3886; McGregor F, 2002, CANCER RES, V62, P4757; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Neves JI, 2005, INT J SURG PATHOL, V13, P353, DOI 10.1177/106689690501300407; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Rodriguez BAT, 2008, CARCINOGENESIS, V29, P1459, DOI 10.1093/carcin/bgn115; Seki H, 2012, ANN SURG ONCOL, V19, P1831, DOI 10.1245/s10434-012-2295-5; Severino P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-533; Sha L, 2014, CLIN EXP MED; Sha S, 2013, DIG LIVER DIS; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Taketani T, 2002, CANCER RES, V62, P4571; Tsai KW, 2012, GENE CHROMOSOME CANC, V51, P394, DOI 10.1002/gcc.21924; Tsai MM, 2014, CANCER LETT, V351, P222, DOI 10.1016/j.canlet.2014.06.004; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu JS, 2008, MOL CANCER RES, V6, P1106, DOI 10.1158/1541-7786.MCR-07-2123; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhang P, 2009, CELL COMMUN ADHES, V16, P146, DOI 10.3109/15419061003653771	60	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122285	10.1371/journal.pone.0122285	http://dx.doi.org/10.1371/journal.pone.0122285			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860510	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352590300038
J	Liu, H; Sultan, MARF; Liu, XL; Zhang, J; Yu, F; Zhao, HX				Liu, Hui; Sultan, Muhammad Abdul Rab Faisal; Liu, Xiang Li; Zhang, Jin; Yu, Fei; Zhao, Hui Xian			Physiological and Comparative Proteomic Analysis Reveals Different Drought Responses in Roots and Leaves of Drought-Tolerant Wild Wheat (Triticum boeoticum)	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEIN; WATER-STRESS; RUBISCO ACTIVASE; 2-DIMENSIONAL ELECTROPHORESIS; LIPID-PEROXIDATION; IDENTIFICATION; EXPRESSION; RESISTANCE; PROLINE; ACCUMULATION	To determine the proteomic-level responses of drought tolerant wild wheat (Triticum boeoticum), physiological and comparative proteomic analyses were conducted using the roots and the leaves of control and short term drought-stressed plants. Drought stress was imposed by transferring hydroponically grown seedlings at the 3-leaf stage into 1/2 Hoagland solution containing 20% PEG-6000 for 48 h. Root and leaf samples were separately collected at 0 (control), 24, and 48 h of drought treatment for analysis. Physiological analysis indicated that abscisic acid (ABA) level was greatly increased in the drought-treated plants, but the increase was greater and more rapid in the leaves than in the roots. The net photosynthetic rate of the wild wheat leaves was significantly decreased under short-term drought stress. The deleterious effects of drought on the studied traits mainly targeted photosynthesis. Comparative proteomic analysis identified 98 and 85 differently changed protein spots (DEPs) (corresponding to 87 and 80 unique proteins, respectively) in the leaves and the roots, respectively, with only 6 mutual unique proteins in the both organs. An impressive 86% of the DEPs were implicated in detoxification and defense, carbon metabolism, amino acid and nitrogen metabolism, proteins metabolism, chaperones, transcription and translation, photosynthesis, nucleotide metabolism, and signal transduction. Further analysis revealed some mutual and tissue-specific responses to short-term drought in the leaves and the roots. The differences of drought-response between the roots and the leaves mainly included that signal sensing and transduction-associated proteins were greatly up-regulated in the roots. Photosynthesis and carbon fixation ability were decreased in the leaves. Glycolysis was down-regulated but PPP pathway enhanced in the roots, resulting in occurrence of complex changes in energy metabolism and establishment of a new homeostasis. Protein metabolism was down-regulated in the roots, but enhanced in the leaves. These results will contribute to the existing knowledge on the complexity of root and leaf protein changes that occur in response to drought, and also provide a framework for further functional studies on the identified proteins.	[Liu, Hui; Sultan, Muhammad Abdul Rab Faisal; Liu, Xiang Li; Zhang, Jin; Yu, Fei; Zhao, Hui Xian] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Liu, Xiang Li; Zhang, Jin; Yu, Fei; Zhao, Hui Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Yu, F (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	flyfeiyu@gmail.com; hxzhao212@nwsuaf.edu.cn			Nature Science Foundation of China [30871578, 31471482]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by grants from the Nature Science Foundation of China (30871578 and 31471482).	Abedi T, 2010, CZECH J GENET PLANT, V46, P27, DOI 10.17221/67/2009-CJGPB; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Al-Ghamdi AA, 2009, INT J AGRIC BIOL, V11, P7; Alam I, 2010, PLANT SOIL, V333, P491, DOI 10.1007/s11104-010-0365-7; Anand A, 2003, PLANT BIOTECHNOL J, V1, P241, DOI 10.1046/j.1467-7652.2003.00023.x; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brechenmacher L, 2009, PLANT PHYSIOL, V149, P670, DOI 10.1104/pp.108.131649; Budak Hikmet, 2013, ScientificWorldJournal, V2013, P548246, DOI 10.1155/2013/548246; Budak H, 2013, PLANT MOL BIOL, V83, P89, DOI 10.1007/s11103-013-0024-5; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Caruso G, 2009, PLANT SCI, V177, P570, DOI 10.1016/j.plantsci.2009.08.007; Chen JG, 2006, J PLANT GROWTH REGUL, V25, P69, DOI 10.1007/s00344-005-0049-3; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Chhuneja P, 2012, THEOR APPL GENET, V124, P1051, DOI 10.1007/s00122-011-1768-4; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Datta J. K., 2011, International Journal of Agricultural Technology, V7, P383; Demirevska K., 2008, General and Applied Plant Physiology, V34, P79; Demirevska K, 2009, ACTA PHYSIOL PLANT, V31, P1129, DOI 10.1007/s11738-009-0331-2; Dulai Sandor, 2006, Acta Biologica Szegediensis, V50, P11; EMMERICH WE, 1990, AGRON J, V82, P1103, DOI 10.2134/agronj1990.00021962008200060015x; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Farhad MS, 2011, AUST J CROP SCI, V5, P55; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; Gao Y, 2009, J EXP BOT, V60, P1141, DOI 10.1093/jxb/ern356; Ghaffari M, 2013, FUNCT PLANT BIOL, V40, P609, DOI 10.1071/FP12251; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Hames BD, 1997, INSTANT NOTES BIOCH, P304; HOAGLAND D. R., 1933, PROC AMER SOC HORT SCI, V30, P288; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Hubbard MJ, 1996, FEBS LETT, V391, P323, DOI 10.1016/0014-5793(96)00767-3; Huseynova IM, 2007, BBA-BIOENERGETICS, V1767, P869, DOI 10.1016/j.bbabio.2007.01.014; Jimenez S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-25; JORDAN DB, 1983, J BIOL CHEM, V258, P3752; Jung YC, 2005, PLANT CELL REP, V24, P366, DOI 10.1007/s00299-005-0944-x; Khan R, 2014, MOL BIOTECHNOL, V56, P814, DOI 10.1007/s12033-014-9760-2; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kuwabara C, 2002, PHYSIOL PLANTARUM, V115, P101, DOI 10.1034/j.1399-3054.2002.1150112.x; Larcher W., 2003, PHYSL PLANT ECOLOGY, DOI 10.1007/978-3-662-05214-3; Lee K, 2010, J PLANT PHYSIOL, V167, P161, DOI 10.1016/j.jplph.2009.09.006; Liu WJ, 2006, BIOL PLANTARUM, V50, P597, DOI 10.1007/s10535-006-0094-1; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779; Mohammadi PP, 2012, J PROTEOMICS, V75, P1906, DOI 10.1016/j.jprot.2011.12.041; Mujeeb-Kazi A, 2007, PAK J BOT, V39, P1207; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Nan R, 2002, J PLANT PHYSIOL, V159, P307, DOI 10.1078/0176-1617-00703; Nehemia A, 1977, PLANT PHYSIOL, V59, P1169; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; O'Leary SJB, 2007, TREE PHYSIOL, V27, P1649, DOI 10.1093/treephys/27.12.1649; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492, DOI 10.1093/oxfordjournals.pcp.a029396; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Prinsi B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-113; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Rokka A, 2001, PLANT J, V25, P463, DOI 10.1046/j.1365-313x.2001.00981.x; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; Stylianou IM, 2008, GENETICS, V178, P1795, DOI 10.1534/genetics.107.081216; Sultan MARF, 2012, CZECH J GENET PLANT, V48, P178, DOI 10.17221/21/2012-CJGPB; Tatar Oezguer, 2008, Asian Journal of Plant Sciences, V7, P409; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Valkoun JJ, 2001, EUPHYTICA, V119, P17, DOI 10.1023/A:1017562909881; Vander Jagt D.L., 1989, GLUTATHIONE CHEM, P597; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Yue QX, 2008, MOL CELL PROTEOMICS, V7, P949, DOI 10.1074/mcp.M700259-MCP200; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhou SP, 2011, J AM SOC HORTIC SCI, V136, P288, DOI 10.21273/JASHS.136.4.288	78	103	105	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121852	10.1371/journal.pone.0121852	http://dx.doi.org/10.1371/journal.pone.0121852			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859656	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300032
J	Liu, ZY; Jin, YQ; Chen, LL; Wang, Y; Yang, XN; Cheng, J; Wu, W; Qi, ZL; Shen, ZL				Liu, Zhangyin; Jin, Yu-Qing; Chen, Lulu; Wang, Yang; Yang, Xiaonan; Cheng, Jia; Wu, Wei; Qi, Zuoliang; Shen, Zunli			Specific Marker Expression and Cell State of Schwann Cells during Culture In Vitro	PLOS ONE			English	Article							PERIPHERAL-NERVE; TRANSCRIPTION FACTOR; NEURAL CREST; RAT S100-ALPHA; SOX2; MYELINATION; PROTEIN; DIFFERENTIATION; REGENERATION; DEDIFFERENTIATION	Schwann cells (SCs) in animals exist in different developmental stages or wound repair phases, distinguished mainly by the expression of SC-specific markers. No study has yet determined SC state under in vitro culture conditions, and the specific markers expressed in SC are obscure as well. In this study, we harvested sciatic nerves from newborn mice and isolated SCs by an enzyme-digestion method, then we examined the expression profiles of ten markers (S100, p75(NTR), Sox10, Sox2, GAP43, NCAM, Krox20, Oct6, MBP, and MPZ) at both the RNA and protein levels in in vitro mouse SCs and speculated their relation with in vivo SC stages. We assayed RNA and protein levels of SC specific markers by immunofluorescence, Western Blot, and real-time quantitative RT-PCR. The results show that the expression of most markers (S100, p75(NTR), GAP43, NCAM, Krox20, Oct6, MBP and MPZ) was not detectable in all of early stage cultured SCs. The expression of transcription factors Sox10 and Sox2 was, however, detectable in all SCs. After 8 days, the positive expression rate of all markers except GAP43 and Oct6 was almost 100%. These results indicates Sox10 is a necessary marker for SC identification, while S100 is not reliable. SCs cultured in vitro express Sox2, p75(NTR), NCAM, GAP43, Oct6, and MPZ, suggesting that they are similar to in vivo undifferentiated iSCs or dedifferentiated iSCs after nerve injury.	[Liu, Zhangyin; Jin, Yu-Qing; Chen, Lulu; Wang, Yang; Shen, Zunli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Liu, Zhangyin; Jin, Yu-Qing; Chen, Lulu; Wang, Yang; Shen, Zunli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Ctr Trauma, Shanghai 200030, Peoples R China; [Yang, Xiaonan; Qi, Zuoliang] Chinese Acad Med Sci, Plast Surg Hosp, Beijing 100730, Peoples R China; [Yang, Xiaonan; Qi, Zuoliang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Cheng, Jia; Wu, Wei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University	Jin, YQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	yuqing.jin@gmail.com; zunlishen@163.com			National Natural Science Foundation of China [81000522, 31170932]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant sponsor: National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/), grant numbers 81000522 and 31170932. The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Casella CTB, 1996, GLIA, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chi GF, 2010, EXP NEUROL, V222, P304, DOI 10.1016/j.expneurol.2010.01.008; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; FIELDS KL, 1982, J NEUROIMMUNOL, V2, P155, DOI 10.1016/0165-5728(82)90006-6; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Frob F, 2012, GLIA, V60, P806, DOI 10.1002/glia.22310; Garcia-Suarez O, 2009, J ANAT, V214, P888, DOI 10.1111/j.1469-7580.2009.01078.x; Ghislain J, 2002, DEVELOPMENT, V129, P155; GOULD VE, 1986, LAB INVEST, V55, P463; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Heinen A, 2013, J CLIN IMMUNOL, V33, pS18, DOI 10.1007/s10875-012-9786-9; Hoke A, 2003, J NEUROSCI, V23, P561; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jin YQ, 2008, J NEUROSCI METH, V170, P140, DOI 10.1016/j.jneumeth.2008.01.003; Jung J, 2011, ANAT CELL BIOL, V44, P41, DOI 10.5115/acb.2011.44.1.41; Kirsch M, 2009, CELL TISSUE RES, V338, P19, DOI 10.1007/s00441-009-0837-3; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MONUKI ES, 1993, MECH DEVELOP, V42, P15, DOI 10.1016/0925-4773(93)90095-F; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Pannunzio ME, 2005, J NEUROSCI METH, V149, P74, DOI 10.1016/j.jneumeth.2005.05.004; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; SHEARMAN JD, 1987, CELL TISSUE RES, V249, P459; Shin YH, 2013, BIOCHEM BIOPH RES CO, V430, P852, DOI 10.1016/j.bbrc.2012.11.057; Sommer L, 1998, CELL TISSUE RES, V292, P11, DOI 10.1007/s004410051029; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Turner BJ, 2010, HUM MOL GENET, V19, P815, DOI 10.1093/hmg/ddp550; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Wang Y, 2012, NEUROSCI LETT, V514, P96, DOI 10.1016/j.neulet.2012.02.066; Wei YJ, 2009, CELL TISSUE RES, V337, P361, DOI 10.1007/s00441-009-0836-4; Wu W, 2009, BIOTECHNOL LETT, V31, P1703, DOI 10.1007/s10529-009-0064-8; Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yu WM, 2009, GLIA, V57, P850, DOI 10.1002/glia.20811; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZIMMER DB, 1987, AM J PHYSIOL, V252, pC285, DOI 10.1152/ajpcell.1987.252.3.C285; ZIMMER DB, 1991, BRAIN RES BULL, V27, P157, DOI 10.1016/0361-9230(91)90061-N; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1	59	55	62	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123278	10.1371/journal.pone.0123278	http://dx.doi.org/10.1371/journal.pone.0123278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859851	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300089
J	Dodson, JJ; Bourret, A; Barrette, MF; Turgeon, J; Daigle, G; Legault, M; Lecomte, F				Dodson, Julian J.; Bourret, Audrey; Barrette, Marie France; Turgeon, Julie; Daigle, Gaetan; Legault, Michel; Lecomte, Frederic			Intraspecific Genetic Admixture and the Morphological Diversification of an Estuarine Fish Population Complex	PLOS ONE			English	Article							SMELT OSMERUS-MORDAX; ANADROMOUS RAINBOW SMELT; MULTILOCUS GENOTYPE DATA; LAWRENCE-RIVER ESTUARY; TRANSGRESSIVE SEGREGATION; CHARACTER DISPLACEMENT; SYMPATRIC POPULATIONS; INVASIVE POPULATIONS; ADAPTIVE RADIATION; HYBRID SPECIATION	The North-east American Rainbow smelt (Osmerus mordax) is composed of two glacial races first identified through the spatial distribution of two distinct mtDNA lineages. Contemporary breeding populations of smelt in the St. Lawrence estuary comprise contrasting mixtures of both lineages, suggesting that the two races came into secondary contact in this estuary. The overall objective of this study was to assess the role of intraspecific genetic admixture in the morphological diversification of the estuarine rainbow smelt population complex. The morphology of mixed-ancestry populations varied as a function of the relative contribution of the two races to estuarine populations, supporting the hypothesis of genetic admixture. Populations comprising both ancestral mtDNA races did not exhibit intermediate morphologies relative to pure populations but rather exhibited many traits that exceeded the parental trait values, consistent with the hypothesis of transgressive segregation. Evidence for genetic admixture at the level of the nuclear gene pool, however, provided only partial support for this hypothesis. Variation at nuclear AFLP markers revealed clear evidence of the two corresponding mtDNA glacial races. The admixture of the two races at the nuclear level is only pronounced in mixed-ancestry populations dominated by one of the mtDNA lineages, the same populations showing the greatest degree of morphological diversification and population structure. In contrast, mixed-ancestry populations dominated by the alternate mtDNA lineage showed little evidence of introgression of the nuclear genome, little morphological diversification and little contemporary population genetic structure. These results only partially support the hypothesis of transgressive segregation and may be the result of the differential effects of natural selection acting on admixed genomes from different sources.	[Dodson, Julian J.; Turgeon, Julie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Bourret, Audrey; Barrette, Marie France] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Daigle, Gaetan] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada; [Legault, Michel; Lecomte, Frederic] Minist Forets Faune & Parcs, Faune & Habitats Sect Faune, Direct Gen Expertise, Quebec City, PQ, Canada	Laval University; University of Sherbrooke; Laval University	Dodson, JJ (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	julian.dodson@bio.ulaval.ca	Lecomte, Frederic/AAN-7766-2021	Lecomte, Frederic/0000-0002-8845-1249	Natural Sciences and Engineering Research Council (NSERC, Canada); Ministere des Forets, de la Faune et des Parcs, Quebec; Quebec government	Natural Sciences and Engineering Research Council (NSERC, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere des Forets, de la Faune et des Parcs, Quebec; Quebec government	This study was supported by 1. (a) Discovery research grant; Natural Sciences and Engineering Research Council (NSERC, Canada) (b) research contract; Direction de la faune aquatique, Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs du Quebec (now the Ministere des Forets, de la Faune et des Parcs, Quebec) 2. Quebec government funders, represented by ML and FL, participated instudy design, data collection and preparation of the manuscript.	Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Avise J, 2004, MOL MARKERS NATURAL; BABY MC, 1991, J FISH BIOL, V39, P61, DOI 10.1111/j.1095-8649.1991.tb05068.x; Bachiller E, 2013, ICES J MAR SCI, V70, P232, DOI 10.1093/icesjms/fss171; Barrette MF, 2009, BIOL J LINN SOC, V97, P140, DOI 10.1111/j.1095-8312.2008.01195.x; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Benvenuto C, 2012, EVOL APPL, V5, P498, DOI 10.1111/j.1752-4571.2012.00279.x; Bernatchez L, 1996, CAN J FISH AQUAT SCI, V53, P424, DOI 10.1139/cjfas-53-2-424; Bernatchez L, 1997, MOL ECOL, V6, P73, DOI 10.1046/j.1365-294X.1997.00156.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bradbury IR, 2006, J FISH BIOL, V69, P95, DOI 10.1111/j.1095-8649.2006.01263.x; Bradbury IR, 2011, MAR ECOL PROG SER, V438, P207, DOI 10.3354/meps09286; Buerkle CA, 2005, MOL ECOL NOTES, V5, P684, DOI 10.1111/j.1471-8286.2005.01011.x; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DOUGLAS ME, 1992, OIKOS, V65, P213, DOI 10.2307/3545012; Efron B, 1998, INTRO BOOTSTRAP; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FRECHET A, 1983, CAN J FISH AQUAT SCI, V40, P718, DOI 10.1139/f83-094; Frechet A., 1983, ZOOLOGY, V61, P621; Gardner-Lubbe S, 2008, J APPL STAT, V35, P947, DOI 10.1080/02664760802185399; Gompert Z, 2010, MOL ECOL RESOUR, V10, P378, DOI 10.1111/j.1755-0998.2009.02733.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karpouzi VS, 2003, J FISH BIOL, V62, P1353, DOI 10.1046/j.1095-8649.2003.00118.x; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2007, MOL ECOL, V16, P1579, DOI 10.1111/j.1365-294X.2006.03135.x; Kovach AI, 2013, FISH RES, V141, P95, DOI 10.1016/j.fishres.2012.07.008; Labropoulou M, 1997, J FISH BIOL, V50, P324, DOI 10.1006/jfbi.1996.0297; Lachenbruch PA, 1967, BIOMETRICS, V23, P65; Lecomte F, 2005, J FISH BIOL, V66, P1601, DOI 10.1111/j.0022-1112.2005.00702.x; Lecomte F, 2004, EVOL ECOL RES, V6, P631; Lecomte F, 2005, THESIS U LAVAL; M-F Barrette, 2004, THESIS U LAVAL; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Morris MRJ, 2014, MOL ECOL, V23, P3226, DOI 10.1111/mec.12820; MOTTA PJ, 1995, ENVIRON BIOL FISH, V44, P37, DOI 10.1007/BF00005906; Parsons KJ, 2011, EVOL BIOL, V38, P306, DOI 10.1007/s11692-011-9126-7; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pigeon D, 1998, CAN J FISH AQUAT SCI, V55, P1739, DOI 10.1139/cjfas-55-7-1739; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Roberts RB, 2011, P NATL ACAD SCI USA, V108, P13194, DOI 10.1073/pnas.1018456108; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Scott WB, 1973, BULLETIN OF THE FISH, V184; Searle SR., 1992, VARIANCE COMPONENTS; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stelkens R, 2009, EVOLUTION, V63, P884, DOI 10.1111/j.1558-5646.2008.00599.x; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Therriault J.-C., 1991, CAN SPEC PUBL FISH A; Turgeon J, 2003, CONSERV GENET, V4, P67, DOI 10.1023/A:1021860910719	60	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123172	10.1371/journal.pone.0123172	http://dx.doi.org/10.1371/journal.pone.0123172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856193	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500078
J	Jia, QY; Li, CL; Xia, Y; Zhang, Q; Wu, HM; Du, HM; Liu, L; Wang, CJ; Shi, HB; Guo, XY; Liu, X; Sun, SM; Wang, X; Zhou, M; Zhao, HL; Song, K; Wu, YT; Niu, KJ				Jia, Qiyu; Li, Chunlei; Xia, Yang; Zhang, Qing; Wu, Hongmei; Du, Huanmin; Liu, Li; Wang, Chongjin; Shi, Hongbin; Guo, Xiaoyan; Liu, Xing; Sun, Shaomei; Wang, Xing; Zhou, Ming; Zhao, Honglin; Song, Kun; Wu, Yuntang; Niu, Kaijun			Association between Complement C3 and Prevalence of Fatty Liver Disease in an Adult Population: A Cross-Sectional Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; ASIA-PACIFIC; MICE; PATHOGENESIS; STEATOSIS; PROTEIN; CODAM; ATHEROSCLEROSIS; CONTRIBUTES; ACTIVATION	Activation of the innate immune system plays a key role in the development of fatty liver disease (FLD). The complement system is a major humoral component of the innate immune response and complement C3 plays a central role, implying that C3 may be a powerful predictor or therapeutic target for FLD. However, few studies have assessed the association between C3 and FLD in a large population. Here we use a cross-sectional study to investigate the link between serum C3 levels and FLD. Participants were recruited from Tianjin Medical University's General Hospital-Health Management Centre. Serum C3 was measured using immunoturbidimetry method and FLD was diagnosed by liver ultrasonography. Multiple logistic regression analysis was used to examine the association between quartiles of C3 and FLD prevalence. The overall prevalence of nonalcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) were 37.3% and 10.1%, respectively. After adjusting for covariates, the odds ratio of having NAFLD or AFLD (only in males) in the fourth quartile of C3 compared with the first quartile was 4.13 times greater (95% confidence interval, 2.97-5.77) (trend P values < 0.0001) and 2.09 times greater (95% confidence interval, 1.08-4.18) (trend P values = 0.02). This is the first study to demonstrate that serum C3 levels are independently associated with a higher prevalence of NAFLD and AFLD (only in males) in an adult population. Further studies are needed to establish a causal link and determine the precise role of C3 in FLD.	[Jia, Qiyu; Zhang, Qing; Liu, Li; Wang, Chongjin; Shi, Hongbin; Sun, Shaomei; Wang, Xing; Zhou, Ming; Zhao, Honglin; Song, Kun; Niu, Kaijun] Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Li, Chunlei; Xia, Yang; Wu, Hongmei; Du, Huanmin; Guo, Xiaoyan; Liu, Xing; Wu, Yuntang; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Li, Chunlei; Xia, Yang; Wu, Hongmei; Du, Huanmin; Guo, Xiaoyan; Liu, Xing; Wu, Yuntang; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wu, YT (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.	wuyuntang@tijmu.edu.cn; nkj0809@gmail.com	Xia, Yang/AAW-9116-2021	Xia, Yang/0000-0001-8783-1592; Niu, Kaijun/0000-0002-8772-2481	key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; Technologies development program of Beichen District of Tianjin [bcws2013-21, bc2014-05]; technologies project of Tianjin Binhai New Area [2013-02-04, 2013-02-06]; Science Foundation of Tianjin Medical University, China [2010KY28]	key technologies R&D program of Tianjin; Technologies development program of Beichen District of Tianjin; technologies project of Tianjin Binhai New Area; Science Foundation of Tianjin Medical University, China	This study was supported by grants from the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), the Technologies development program of Beichen District of Tianjin (No. bcws2013-21 and bc2014-05), the technologies project of Tianjin Binhai New Area (No. 2013-02-04 and 2013-02-06), and the Science Foundation of Tianjin Medical University (No. 2010KY28), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; Black J.T, 1992, MULTIVARIATE DATA AN; Bykov I, 2007, J HEPATOL, V46, P907, DOI 10.1016/j.jhep.2006.11.020; Bykov I, 2006, ANN MED, V38, P280, DOI 10.1080/07853890600664608; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; CIANFLONE K, 1995, EUR J CLIN INVEST, V25, P817, DOI 10.1111/j.1365-2362.1995.tb01690.x; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gao X, 2013, J DIABETES, V5, P406, DOI 10.1111/1753-0407.12056; Hertle E, 2014, THROMB HAEMOSTASIS, V111, P1102, DOI 10.1160/TH13-10-0831; Jarvelainen HA, 2002, CLIN IMMUNOL, V105, P57, DOI 10.1006/clim.2002.5267; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Naughton MA, 1996, J IMMUNOL, V156, P3051; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Song K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088701; Sun S, 2014, MEDIAT INFLAMM, V2014, P12, DOI DOI 10.1016/J.INFFUS.2014.12.003; van Greevenbroek MMJ, 2011, EUR J CLIN INVEST, V41, P372, DOI 10.1111/j.1365-2362.2010.02418.x; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Verrijken A, 2013, OBESITY, V21, P2138, DOI 10.1002/oby.20366; Wlazlo N, 2013, EUR J CLIN INVEST, V43, P679, DOI 10.1111/eci.12093; Wu CL, 2014, BIOL REV CAMB PHILOS; Yesilova Z, 2005, AM J GASTROENTEROL, V100, P842, DOI 10.1111/j.1572-0241.2005.40838.x; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053	36	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122026	10.1371/journal.pone.0122026	http://dx.doi.org/10.1371/journal.pone.0122026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856141	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500029
J	Mathiasen, L; Bruckmann, C; Pasqualato, S; Blasi, F				Mathiasen, Lisa; Bruckmann, Chiara; Pasqualato, Sebastiano; Blasi, Francesco			Purification and Characterization of a DNA-Binding Recombinant PREP1: PBX1 Complex	PLOS ONE			English	Article							PROTEINS; HOMEODOMAIN; EXPRESSION; MECHANISM; E2A-PBX1; FUSION; SITES	Human PREP1 and PBX1 are homeodomain transcriptional factors, whose biochemical and structural characterization has not yet been fully described. Expression of full-length recombinant PREP1 (47.6 kDa) and PBX1 (46.6 kDa) in E. coli is difficult because of poor yield, high instability and insufficient purity, in particular for structural studies. We cloned the cDNA of both proteins into a dicistronic vector containing an N-terminal glutathione S-transferase (GST) tag and co-expressed and co-purified a stable PBX1:PREP1 complex. For structural studies, we produced two C-terminally truncated complexes that retain their ability to bind DNA and are more stable than the full-length proteins through various purification steps. Here we report the production of large amounts of soluble and pure recombinant human PBX1: PREP1 complex in an active form capable of binding DNA.	[Mathiasen, Lisa; Bruckmann, Chiara; Blasi, Francesco] Fdn Italian Canc Res, Inst Mol Oncol IFOM, I-20139 Milan, Italy; [Pasqualato, Sebastiano] European Inst Oncol, Dept Expt Oncol, Crystallog Unit, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Blasi, F (corresponding author), Fdn Italian Canc Res, Inst Mol Oncol IFOM, Via Adamello 16, I-20139 Milan, Italy.	francesco.blasi@ifom.eu		bruckmann, chiara/0000-0002-1026-7505; Blasi, Francesco/0000-0001-9406-1784; Pasqualato, Sebastiano/0000-0002-9038-7768	AIRC/Marie Curie International Fellowship in Cancer Research funded; European School of Molecular Medicine (SEMM) funded; AIRC (Italian Association for Cancer Research) [12829]	AIRC/Marie Curie International Fellowship in Cancer Research funded(Fondazione AIRC per la ricerca sul cancro); European School of Molecular Medicine (SEMM) funded; AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	AIRC/Marie Curie International Fellowship in Cancer Research funded C.B., and the European School of Molecular Medicine (SEMM) funded L.M. This work was supported by AIRC (Italian Association for Cancer Research) grant n. 12829 to F.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelsen J, 1996, J BIOL CHEM, V271, P3822; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Chang CP, 1997, MOL CELL BIOL, V17, P5679, DOI 10.1128/MCB.17.10.5679; Cole C, 2008, NUCL ACIDS RES, V36; Farber PJ, 2011, J MOL BIOL, V405, P819, DOI 10.1016/j.jmb.2010.11.016; Ferretti E, 2000, DEVELOPMENT, V127, P155; Jabet C, 1999, J MOL BIOL, V291, P521, DOI 10.1006/jmbi.1999.2983; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; Kilstrup-Nielsen C, 2003, EMBO J, V22, P89, DOI 10.1093/emboj/cdg010; Knoepfler PS, 1997, ONCOGENE, V14, P2521, DOI 10.1038/sj.onc.1201097; LEBRUN DP, 1994, ONCOGENE, V9, P1641; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Longobardi E, 2014, DEV DYNAMICS OFFICIA, V243; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Saleh M, 2000, EXP CELL RES, V260, P105, DOI 10.1006/excr.2000.5010; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sprules T, 2000, BIOCHEMISTRY-US, V39, P9943, DOI 10.1021/bi0001067; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0125789	10.1371/journal.pone.0125789	http://dx.doi.org/10.1371/journal.pone.0125789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856340	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500128
J	Wille, T; Barlag, B; Jakovljevic, V; Hensel, M; Sourjik, V; Gerlach, RG				Wille, Thorsten; Barlag, Britta; Jakovljevic, Vladimir; Hensel, Michael; Sourjik, Victor; Gerlach, Roman G.			A Gateway-Based System for Fast Evaluation of Protein-Protein Interactions in Bacteria	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; GAUSSIA LUCIFERASE; GENE-EXPRESSION; 2-HYBRID SYSTEM; FUSION PROTEINS; LIVING CELLS; PCR PRODUCTS	Protein-protein interactions are important layers of regulation in all kingdoms of life. Identification and characterization of these interactions is one challenging task of the post-genomic era and crucial for understanding of molecular processes within a cell. Several methods have been successfully employed during the past decades to identify protein-protein interactions in bacteria, but most of them include tedious and time-consuming manipulations of DNA. In contrast, the MultiSite Gateway system is a fast tool for transfer of multiple DNA fragments between plasmids enabling simultaneous and site directed cloning of up to four fragments into one construct. Here we developed a new set of Gateway vectors including custom made entry vectors and modular Destination vectors for studying protein-protein interactions via Fluorescence Resonance Energy Transfer (FRET), Bacterial two Hybrid (B2H) and split Gaussia luciferase (Gluc), as well as for fusions with SNAP-tag and HaloTag for dual-color super-resolution microscopy. As proof of principle, we characterized the interaction between the Salmonella effector SipA and its chaperone InvB via split Gluc and B2H approach. The suitability for FRET analysis as well as functionality of fusions with SNAP- and HaloTag could be demonstrated by studying the transient interaction between chemotaxis response regulator CheY and its phosphatase CheZ.	[Wille, Thorsten; Gerlach, Roman G.] Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany; [Barlag, Britta; Hensel, Michael] Univ Osnabruck, Sch Biol Chem, Div Microbiol, Osnabruck, Germany; [Jakovljevic, Vladimir; Sourjik, Victor] Univ Heidelberg ZMBH, DKFZ German Canc Res Ctr, Ctr Mol Biol, ZMBH Alliance, Heidelberg, Germany; [Sourjik, Victor] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Sourjik, Victor] LOEWE State Offens Dev Sci & Econ Excellence, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany	Robert Koch Institute; University Osnabruck; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Gerlach, RG (corresponding author), Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany.	gerlachr@rki.de		Hensel, Michael/0000-0001-6604-6253; Jakovljevic, Vladimir/0000-0002-6082-4867	DFG [GE2533/1-1, SFB 944]; ERC [294761]	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	This work was supported in part by the DFG through project P4 of the collaborative research centre SFB 944 'Physiology and dynamics of cellular microcompartments' at the University of Osnabruck (to M.H.) and GE2533/1-1 (to R.G.G.) and an ERC grant 294761 (to V.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Kim SB, 2009, ANAL CHEM, V81, P67, DOI 10.1021/ac801658y; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lu J-P, 2008, NATURE PRECEDINGS; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; Pelletier DA, 2008, J PROTEOME RES, V7, P3319, DOI 10.1021/pr8001832; Perehinec TM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-80; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; SHUMAN S, 1994, J BIOL CHEM, V269, P32678; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wille T, 2014, CELL MICROBIOL, V16, P161, DOI 10.1111/cmi.12222; Wille T, 2012, APPL ENVIRON MICROB, V78, P250, DOI 10.1128/AEM.06670-11; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; You CJ, 2013, ACS CHEM BIOL, V8, P320, DOI 10.1021/cb300543t	47	7	7	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123646	10.1371/journal.pone.0123646	http://dx.doi.org/10.1371/journal.pone.0123646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856398	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500102
J	Silva-Rocha, I; Salvi, D; Sillero, N; Mateo, JA; Carretero, MA				Silva-Rocha, Iolanda; Salvi, Daniele; Sillero, Neftali; Mateo, Jose A.; Carretero, Miguel A.			Snakes on the Balearic Islands: An Invasion Tale with Implications for Native Biodiversity Conservation	PLOS ONE			English	Article							PLANT INVASIONS; COLUBRIDAE; IMPACTS; NICHE; TEMPERATURE; POPULATIONS; EXTINCTION; PREDICTION; SERPENTES; PATTERNS	Biological invasions are a major conservation threat for biodiversity worldwide. Islands are particularly vulnerable to invasive species, especially Mediterranean islands which have suffered human pressure since ancient times. In the Balearic archipelago, reptiles represent an outstanding case with more alien than native species. Moreover, in the last decade a new wave of alien snakes landed in the main islands of the archipelago, some of which were originally snake-free. The identification of the origin and colonization pathways of alien species, as well as the prediction of their expansion, is crucial to develop effective conservation strategies. In this study, we used molecular markers to assess the allochthonous status and the putative origin of the four introduced snake species (Hemorrhois hippocrepis, Malpolon monspessulanus, Macroprotodon mauritanicus and Rhinechis scalaris) as well as ecological niche models to infer their patterns of invasion and expansion based on current and future habitat suitability. For most species, DNA sequence data suggested the Iberian Peninsula as the potential origin of the allochthonous populations, although the shallow phylogeographic structure of these species prevented the identification of a restricted source-area. For all of them, the ecological niche models showed a current low habitat suitability in the Balearic, which is however predicted to increase significantly in the next few decades under climate change scenarios. Evidence from direct observations and spatial distribution of the first-occurrence records of alien snakes (but also lizards and worm lizards) suggest the nursery trade, and in particular olive tree importation from Iberian Peninsula, as the main pathway of introduction of alien reptiles in the Balearic islands. This trend has been reported also for recent invasions in NE Spain, thus showing that olive trees transplantation may be an effective vector for bioinvasion across the Mediterranean. The combination of molecular and ecological tools used in this study reveals a promising approach for the understanding of the complex invasion process, hence guiding conservation management actions.	[Silva-Rocha, Iolanda; Salvi, Daniele; Carretero, Miguel A.] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal; [Sillero, Neftali] Univ Porto, Fac Ciencias, CICGE, Vila Nova De Gaia, Portugal; [Mateo, Jose A.] Govern Illes Balears, Serv Proteccio Especies, Palma de Mallorca, Spain	Universidade do Porto; Universidade do Porto	Salvi, D (corresponding author), Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal.	danielesalvi.bio@gmail.com	Carretero, Miguel A/A-1472-2013; Sillero, Neftali/C-1803-2008; Salvi, Daniele/I-6360-2013; Silva-Rocha, Iolanda/I-1989-2014	Carretero, Miguel A/0000-0002-2335-7198; Sillero, Neftali/0000-0002-3490-3780; Salvi, Daniele/0000-0002-3804-2690; Silva-Rocha, Iolanda/0000-0001-8451-4460	FEDER; FCT [PTDC/BIA-BEC/101256/2008]; North Portugal Regional Operational Programme, through the European Regional Development Fund [ON.2]; FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) [SFRH/BPD/66592/2009, SFRH/BD/95745/2013]; European Social Fund; Portuguese Ministerio da Educacao e Ciencia	FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); North Portugal Regional Operational Programme, through the European Regional Development Fund; FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	The molecular work of this study was funded by FEDER through the COMPETE program; by the FCT project PTDC/BIA-BEC/101256/2008; and by the project 'Genomics and Evolutionary Biology' cofinanced by North Portugal Regional Operational Programme (ON.2), through the European Regional Development Fund. DS is supported by the FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) post-doctoral grant SFRH/BPD/66592/2009 and IS-R by the FCT PhD grant SFRH/BD/95745/2013 under the Programa Operacional Potencial Humano-Quadro de Referencia Estrategico Nacional funds from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Carmen, 2010, Boletin de la Asociacion Herpetologica Espanola, V21, P126; Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; [Anonymous], 2005, EC HUN WELL BEING CU; Ayllon E, 2014, 13 IB C HERP AV PORT; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blondel J., 2010, MEDITERRANEAN REGION; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; Bons J, 1996, ANFIBIOS REPTILES MA; Bover P, 2014, INTEGR ZOOL, V9, P183, DOI 10.1111/1749-4877.12049; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Bruekers Jaco, 2003, Lacerta, V61, P203; Bruno S, 1990, SERPENTI ITALIA EURO, DOI [10.3748/wjg.v20.i43, DOI 10.3748/WJG.V20.I43]; BUSACK S D, 1990, Annals of Carnegie Museum, V59, P261; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Carranza S, 2006, MOL PHYLOGENET EVOL, V40, P532, DOI 10.1016/j.ympev.2006.03.028; Carranza S, 2004, MOL PHYLOGENET EVOL, V33, P523, DOI 10.1016/j.ympev.2004.07.009; Cavazza W, 2003, EPISODES, V26, P160, DOI 10.18814/epiiugs/2003/v26i3/002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Diamond J., 1989, P37; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Feriche M, 2008, COPEIA, P279, DOI 10.1643/CH-06-272; Ficetola GF, 2009, GLOBAL ECOL BIOGEOGR, V18, P214, DOI 10.1111/j.1466-8238.2008.00433.x; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2003, EVOL ECOL RES, V5, P159; Kraus Fred, 2009, V4, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; MARCONI Marina de A., 2010, FUNDAMENTOS METODOLO, V7; MATEO JA, 2011, BOL ASOC HERPETOL ES, V22, P2; Mateo JA, 2012, AYLLON ENRIQUE RELAT; Mayol J, 1985, MANUALES INTRO NATUR, V6; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moreno-Rueda G, 2007, HERPETOL J, V17, P204; Moreno-Rueda G, 2009, CLIMATIC CHANGE, V92, P235, DOI 10.1007/s10584-008-9469-y; Nulchis V, 2008, NORTH-WEST J ZOOL, V4, P119; Oliver JA, 2010, SEM SPEC INTR INV IL; Perez-Mellado V., 1998, FAUNA IBERICA, P272; PerezMellado V, 1997, J ZOOL, V243, P533, DOI 10.1111/j.1469-7998.1997.tb02799.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinya S, 2011, ACTA HERPETOL, V6, P59; Pitt WC, 2005, P 11 WILDF DAM MAN C; Pleguezuelos J.M., 2002, ATLAS LIBRO ROJO ANF; PLEGUEZUELOS JM, 1994, HERPETOL J, V4, P98; Pleguezuelos JM, 2004, ATLAS LIBRO ROJO ANF, P502; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Reynolds RG, 2010, IRCF REPT AMPH, V17, P117; Rivera X, 2011, BOTLLETI SOC CATALAN, V19, P79; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Silva-Rocha I, 2012, ITAL J ZOOL, V79, P502, DOI 10.1080/11250003.2012.680983; Silva-Rocha I, 2012, THESIS U PORTO; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Stell R, 2006, PUBLIC PRIVATE RELIG; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tome B, 2014, SYST PARASITOL, V87, P249, DOI 10.1007/s11230-014-9477-4; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Utiger U, 2004, REV SUISSE ZOOL, V111, P225, DOI 10.5962/bhl.part.80236; Valdeon Aitor, 2010, Boletin de la Asociacion Herpetologica Espanola, V21, P122; Vasconcelos Raquel, 2006, Herpetozoa, V19, P77; Vigne JD, 1985, ACT 110 C NAT SOC SA, V2, P79; Vitousek Peter M., 1996, SCOPE, V55, P245; Wade E., 2001, Bulletin of the Natural History Museum Zoology Series, V67, P85; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Zamora-Camacho FJ, 2010, ACTA HERPETOL, V5, P143	70	28	28	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121026	10.1371/journal.pone.0121026	http://dx.doi.org/10.1371/journal.pone.0121026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853711	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400027
J	Suzuki, M; Chiwaki, F; Sawada, Y; Ashikawa, M; Aoyagi, K; Fujita, T; Yanagihara, K; Komatsu, M; Narita, M; Suzuki, T; Nagase, H; Kushima, R; Sakamoto, H; Fukagawa, T; Katai, H; Nakagama, H; Yoshida, T; Uezono, Y; Sasaki, H				Suzuki, Masami; Chiwaki, Fumiko; Sawada, Yumi; Ashikawa, Maho; Aoyagi, Kazuhiko; Fujita, Takeshi; Yanagihara, Kazuyoshi; Komatsu, Masayuki; Narita, Minoru; Suzuki, Tsutomu; Nagase, Hiroshi; Kushima, Ryoji; Sakamoto, Hiromi; Fukagawa, Takeo; Katai, Hitoshi; Nakagama, Hitoshi; Yoshida, Teruhiko; Uezono, Yasuhito; Sasaki, Hiroki			Peripheral Opioid Antagonist Enhances the Effect of Anti-Tumor Drug by Blocking a Cell Growth-Suppressive Pathway In Vivo	PLOS ONE			English	Article							PERITONEAL MESOTHELIAL CELLS; FACTOR RECEPTOR OGFR; GASTRIC-CANCER; PANCREATIC-CANCER; STEM-CELLS; CARCINOMATOSIS; DISSEMINATION; PROGRESSION; METASTASIS; MECHANISMS	The dormancy of tumor cells is a major problem in chemotherapy, since it limits the therapeutic efficacy of anti-tumor drugs that only target dividing cells. One potential way to overcome chemo-resistance is to "wake up" these dormant cells. Here we show that the opioid antagonist methylnaltrexone (MNTX) enhances the effect of docetaxel (Doc) by blocking a cell growth-suppressive pathway. We found that PENK, which encodes opioid growth factor (OGF) and suppresses cell growth, is predominantly expressed in diffuse-type gastric cancers (GCs). The blockade of OGF signaling by MNTX releases cells from their arrest and boosts the effect of Doc. In comparison with the use of Doc alone, the combined use of Doc and MNTX significantly prolongs survival, alleviates abdominal pain, and diminishes Docresistant spheroids on the peritoneal membrane in model mice. These results suggest that blockade of the pathways that suppress cell growth may enhance the effects of antitumor drugs.	[Suzuki, Masami; Sawada, Yumi; Ashikawa, Maho; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Tokyo, Japan; [Chiwaki, Fumiko; Aoyagi, Kazuhiko; Fujita, Takeshi; Komatsu, Masayuki; Sakamoto, Hiromi; Yoshida, Teruhiko; Sasaki, Hiroki] Natl Canc Ctr, Div Genet, Tokyo, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Tokyo, Japan; [Chiwaki, Fumiko; Aoyagi, Kazuhiko; Komatsu, Masayuki; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Chiba, Japan; [Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Tokyo 142, Japan; [Suzuki, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Toxicol, Tokyo 142, Japan; [Sakamoto, Hiromi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Kushima, Ryoji] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Fukagawa, Takeo; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Hoshi University; Hoshi University; University of Tsukuba; National Cancer Center - Japan; National Cancer Center - Japan	Sasaki, H (corresponding author), Natl Canc Ctr, Div Genet, Tokyo, Japan.	hksasaki@ncc.go.jp			National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme) [ID10-41, ID12-01]; National Cancer Center Research and Development Fund [23-A-7, 23-B-6, 23-B-18, 25-A-6]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25860432, 23501322]; Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [15K21745] Funding Source: KAKEN	National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme ID10-41, ID12-01), National Cancer Center Research and Development Fund (23-A-7, 23-B-6, 23-B-18, 25-A-6), The Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25860432 and No. 23501322), and The Princess Takamatsu Cancer Research Fund. Drs. Suzuki and Fujita are the recipients of Research Resident Fellowships from the Foundation of Promotion of Cancer Research in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Aoyagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018196; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Castells M, 2012, INT J MOL SCI, V13, P9545, DOI 10.3390/ijms13089545; Cheng F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-5; Cheng F, 2007, CANCER RES, V67, P10511, DOI 10.1158/0008-5472.CAN-07-1922; Coccolini F, 2013, WORLD J GASTROENTERO, V19, P6979, DOI 10.3748/wjg.v19.i41.6979; Donahue RN, 2009, AM J PHYSIOL-REG I, V296, pR1716, DOI 10.1152/ajpregu.00075.2009; Fujita T, 2013, CANCER SCI, V104, P214, DOI 10.1111/cas.12054; Glockzin G, 2012, SURG ONCOL CLIN N AM, V21, P625, DOI 10.1016/j.soc.2012.07.002; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; IKEGUCHI M, 1994, ANTICANCER RES, V14, P2131; Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Mitsui H, 2012, GYNECOL ONCOL, V124, P303, DOI 10.1016/j.ygyno.2011.10.006; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Sevcik MA, 2006, GASTROENTEROLOGY, V131, P900, DOI 10.1053/j.gastro.2006.06.021; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suzuki M, 2012, ANESTHESIOLOGY, V117, P847, DOI 10.1097/ALN.0b013e31826a4ac8; Tamburrino A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00056; Thibault B, 2014, CANCER METAST REV, V33, P17, DOI 10.1007/s10555-013-9456-2; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Yan TD, 2010, WORLD J GASTRO ONCOL, V2, P109, DOI 10.4251/wjgo.v2.i2.109; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Zagon IS, 2000, BRAIN RES, V856, P75, DOI 10.1016/S0006-8993(99)02330-6; Zagon IS, 2002, BRAIN RES REV, V38, P351, DOI 10.1016/S0165-0173(01)00160-6	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123407	10.1371/journal.pone.0123407	http://dx.doi.org/10.1371/journal.pone.0123407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853862	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400101
J	Xue, PP; Zheng, MM; Gong, P; Lin, CM; Zhou, JJ; Li, YJ; Shen, L; Diao, ZY; Yan, GJ; Sun, HX; Hu, YL				Xue, Pingping; Zheng, Mingming; Gong, Ping; Lin, Caimei; Zhou, Jianjun; Li, Yujing; Shen, Li; Diao, Zhenyu; Yan, Guijun; Sun, Haixiang; Hu, Yali			Single Administration of Ultra-Low-Dose Lipopolysaccharide in Rat Early Pregnancy Induces TLR4 Activation in the Placenta Contributing to Preeclampsia	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; NITRIC-OXIDE SYNTHASE; TROPHOBLAST INVASION; HTR-8/SVNEO CELLS; DECIDUAL CELLS; ANIMAL-MODEL; EXPRESSION; PATHOPHYSIOLOGY; MICRORNA-155; CYTOKINES	Balanced immune responses are essential for the maintenance of successful pregnancy. Aberrant responses of immune system during pregnancy increase the risk of preeclampsia. Toll-like receptor 4 (TLR4) plays a crucial role in the activation of immune system at the maternal-fetal interface. This study aimed to generate a rat model of preeclampsia by lipopolysaccharide (LPS, a TLR4 agonist) administration on gestational day (GD) 5 as rats are subjected to placentation immediately after implantation between GDs 4 and 5, and to assess the contribution of TLR4 signaling to the development of preeclampsia. Single administration of 0.5 mu g/kg LPS significantly increased blood pressure of pregnant rats since GD 6 (systolic blood pressure, 124.89 +/- 1.79 mmHg versus 119.02 +/- 1.80 mmHg, P < 0.05) and urinary protein level since GD 9 (2.02 +/- 0.29 mg versus 1.11 +/- 0.18 mg, P < 0.01), but barely affected blood pressure or proteinuria of virgin rats compared with those of saline-treated pregnant rats. This was accompanied with adverse pregnancy outcomes including fetal growth restriction. The expression of TLR4 and NF-kappa B p65 were both increased in the placenta but not the kidney from LPS-treated pregnant rats, with deficient trophoblast invasion and spiral artery remodeling. Furthermore, the levels of inflammatory cytokines were elevated systemically and locally in the placenta from pregnant rats treated with LPS. TLR4 signaling in the placenta was activated, to which that in the placenta of humans with preeclampsia changed similarly. In conclusion, LPS administration to pregnant rats in early pregnancy could elicit TLR4-mediated immune response at the maternal-fetal interface contributing to poor early placentation that may culminate in the preeclampsia-like syndrome.	[Xue, Pingping; Lin, Caimei; Shen, Li; Hu, Yali] Nanjing Med Univ, Drum Tower Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zheng, Mingming; Zhou, Jianjun; Diao, Zhenyu; Yan, Guijun; Sun, Haixiang] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing 210008, Jiangsu, Peoples R China; [Gong, Ping] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Li, Yujing] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Southeast University - China	Sun, HX (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing 210008, Jiangsu, Peoples R China.	stevensunz@163.com; dtylhu@126.com	li, yu/HGL-9518-2022; Li, yujing/GQA-4109-2022		Chinese National Natural Science Foundation [81370724, 81070508]; Maternal and Fetus Medicine Key Lab of Jiangsu Province, China [XK 201102]; Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province [CXLX13_568]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Maternal and Fetus Medicine Key Lab of Jiangsu Province, China; Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province	This study was supported by the following grants: Chinese National Natural Science Foundation (81370724, 81070508); Maternal and Fetus Medicine Key Lab of Jiangsu Province, China (XK 201102); Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province for the year 2013 (CXLX13_568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Al-Ofi E, 2014, J REPROD IMMUNOL, V103, P23, DOI 10.1016/j.jri.2014.02.004; Anton L, 2012, HUM REPROD, V27, P61, DOI 10.1093/humrep/der362; BULMER JN, 1992, BAILLIERE CLIN OB GY, V6, P461, DOI 10.1016/S0950-3552(05)80006-9; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Dai AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039950; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Equils O, 2006, J IMMUNOL, V177, P1257, DOI 10.4049/jimmunol.177.2.1257; Faas MM, 2004, AM J OBSTET GYNECOL, V191, P1192, DOI 10.1016/j.ajog.2004.03.041; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Fonseca BM, 2012, REPROD BIOL, V12, P97, DOI 10.1016/S1642-431X(12)60080-1; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Li M, 2009, THROMB RES, V124, P656, DOI 10.1016/j.thromres.2009.07.012; Liu SF, 1996, CRIT CARE MED, V24, P1219, DOI 10.1097/00003246-199607000-00026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2006, AM J PATHOL, V168, P445, DOI 10.2353/ajpath.2006.050082; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Ma YH, 2006, AM J REPROD IMMUNOL, V55, P12, DOI 10.1111/j.1600-0897.2005.00347.x; Moraloglu O, 2012, J MATERN-FETAL NEO M, V25, P845, DOI 10.3109/14767058.2011.599081; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Riley JK, 2010, CLIN REV ALLERG IMMU, V39, P185, DOI 10.1007/s12016-009-8178-2; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; van der Graaf AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079884; Verlohren S, 2010, HYPERTENSION, V56, P304, DOI 10.1161/HYPERTENSIONAHA.110.153163; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Xue P, 2013, PLACENTA, V34, P650, DOI 10.1016/j.placenta.2013.04.015; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Yeh CC, 2013, REPROD SCI, V20, P339, DOI 10.1177/1933719112450330; Zhang Y, 2009, PLACENTA, V30, P1065, DOI 10.1016/j.placenta.2009.09.004; Zhou JJ, 2013, HYPERTENSION, V62, P599, DOI 10.1161/HYPERTENSIONAHA.113.01449	37	61	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124001	10.1371/journal.pone.0124001	http://dx.doi.org/10.1371/journal.pone.0124001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853857	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400128
J	Bailly, A; Perrin, A; Malhab, LJB; Pion, E; Larance, M; Nagala, M; Smith, P; O'Donohue, MF; Gleizes, PE; Zomerdijk, J; Lamond, AI; Xirodimas, DP				Bailly, A.; Perrin, A.; Malhab, L. J. Bou; Pion, E.; Larance, M.; Nagala, M.; Smith, P.; O'Donohue, M-F; Gleizes, P-E; Zomerdijk, J.; Lamond, A. I.; Xirodimas, D. P.			The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway	ONCOGENE			English	Article							CANCER-SPECIFIC ACTIVATION; RNA-POLYMERASE I; NEDD8-ACTIVATING ENZYME; PROTEIN NEDDYLATION; DNA-DAMAGE; MDM2; TRANSCRIPTION; REPLICATION; DISRUPTION; ACTINOMYCIN	The ubiquitin-like molecule NEDD8 is essential for viability, growth and development, and is a potential target for therapeutic intervention. We found that the small molecule inhibitor of NEDDylation, MLN4924, alters the morphology and increases the surface size of the nucleolus in human and germline cells of Caenorhabditis elegans in the absence of nucleolar fragmentation. SILAC proteomics and monitoring of rRNA production, processing and ribosome profiling shows that MLN4924 changes the composition of the nucleolar proteome but does not inhibit RNA Pol I transcription. Further analysis demonstrates that MLN4924 activates the p53 tumour suppressor through the RPL11/RPL5-Mdm2 pathway, with characteristics of nucleolar stress. The study identifies the nucleolus as a target of inhibitors of NEDDylation and provides a mechanism for p53 activation upon NEDD8 inhibition. It also indicates that targeting the nucleolar proteome without affecting nucleolar transcription initiates the required signalling events for the control of cell cycle regulators.	[Bailly, A.; Perrin, A.; Malhab, L. J. Bou; Pion, E.; Xirodimas, D. P.] CNRS, Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France; [Larance, M.; Nagala, M.; Zomerdijk, J.; Lamond, A. I.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland; [Smith, P.] Millennium Pharmaceut Inc, Cambridge, MA USA; [O'Donohue, M-F; Gleizes, P-E] UMR CNRS 5099, Lab Biol Mol Eucaryote, Batiment IBCG, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Dundee; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Xirodimas, DP (corresponding author), CRBM, 1919 Route Mende, F-34293 Montpellier, Langeudoc, France.	dimitris.xirodimas@crbm.cnrs.fr	Gleizes, Pierre-Emmanuel/H-3821-2014; Bailly, Aymeric P/AAA-3141-2021; Gleizes, Pierre-Emmanuel/ABB-9653-2021; Larance, Mark/AAG-8613-2019	Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Bailly, Aymeric P/0000-0002-0842-5631; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Perrin, Aurelien/0000-0001-5895-3064; O'Donohue, Marie-Francoise/0000-0002-1204-8285; Xirodimas, Dimitris/0000-0001-9275-1140; Zomerdijk, Joost/0000-0003-1865-729X; Larance, Mark/0000-0002-8579-2267	ANR (National Agency for Research) postdoctoral fellowship awarded; ATIP/AVENIR; Marie Curie Career Integration (FP7) grants	ANR (National Agency for Research) postdoctoral fellowship awarded(French National Research Agency (ANR)); ATIP/AVENIR; Marie Curie Career Integration (FP7) grants	We are grateful to Dr Yanping Zhang for providing the wild- type and mutant Mdm2 C305F MEFs, the Montpellier RIO Imaging facility and Stefano Fumagalli for critical reading of the manuscript. AB and AP are supported by an ANR (National Agency for Research) postdoctoral fellowship awarded to AB. The project in DPX laboratory was supported by ATIP/AVENIR and Marie Curie Career Integration (FP7) grants.	Abidi N, 2015, ENDOCR-RELAT CANCER, V22, pT55, DOI 10.1530/ERC-14-0315; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Baker NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058266; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blank JL, 2013, CANCER RES, V73, P225, DOI 10.1158/0008-5472.CAN-12-1729; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Donati G, 2013, CELL REP, V4, P87, DOI 10.1016/j.celrep.2013.05.045; Drygin D, 2014, DRUG DISCOV TODAY, V19, P259, DOI 10.1016/j.drudis.2013.08.012; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Duncan K, 2012, FUTURE ONCOL, V8, P1461, DOI [10.2217/FON.12.131, 10.2217/fon.12.131]; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Hannan RD, 2013, EXPERT OPIN THER TAR, V17, P873, DOI 10.1517/14728222.2013.818658; Harper JW, 2012, MOL CELL PROTEOMICS, V11, P1541, DOI 10.1074/mcp.R112.021154; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Larance M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014407; Lee LW, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601274; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Teng T, 2013, MOL CELL BIOL, V33, P4660, DOI 10.1128/MCB.01174-13; Vlatkovic N, 2014, CELL MOL LIFE SCI, V71, P771, DOI 10.1007/s00018-013-1361-x; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	67	26	28	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					415	426		10.1038/onc.2015.104	http://dx.doi.org/10.1038/onc.2015.104			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25867069	Green Submitted			2022-12-26	WOS:000369056700002
J	van Wijk, XM; Lawrence, R; Thijssen, VL; van den Broek, SA; Troost, R; van Scherpenzeel, M; Naidu, N; Oosterhof, A; Griffioen, AW; Lefeber, DJ; van Delft, FL; van Kuppevelt, TH				van Wijk, Xander M.; Lawrence, Roger; Thijssen, Victor L.; van den Broek, Sebastiaan A.; Troost, Ran; van Scherpenzeel, Monique; Naidu, Natasha; Oosterhof, Arie; Griffioen, Arjan W.; Lefeber, Dirk J.; van Delft, Floris L.; van Kuppevelt, Toin H.			A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino) glycan biosynthesis, as evidenced by 6F-GalNAc (Ac-3)	FASEB JOURNAL			English	Article						sugar analog; angiogenesis; growth factor signaling; glycobiology	LYMPHOCYTE-ASSOCIATED ANTIGEN; HEPARAN-SULFATE EXPRESSION; ENDOTHELIAL GROWTH-FACTOR; GALNAC SALVAGE PATHWAY; IN-VIVO; DISACCHARIDE COMPOSITION; DEVELOPING ZEBRAFISH; FACTOR BINDING; CANCER; CELLS	Glycosaminoglycan (GAG) polysaccharides have been implicated in a variety of cellular processes, and alterations in their amount and structure have been associated with diseases such as cancer. In this study, we probed 11 sugar analogs for their capacity to interfere with GAG biosynthesis. One analog, with a modification not directly involved in the glycosidic bond formation, 6F-N-acetyl-D-galactosamine (GalNAc) (Ac-3), was selected for further study on its metabolic and biologic effect. Treatment of human ovarian carcinoma cells with 50 mM 6F-GalNAc (Ac-3) inhibited biosynthesis of GAGs (chondroitin/dermatan sulfate by similar to 50-60%, heparan sulfate by similar to 35%), N-acetyl-D-glucosamine (GlcNAc)/GalNAc containing glycans recognized by the lectins Datura stramonium and peanut agglutinin (by similar to 74 and similar to 43%, respectively), and O-GlcNAc protein modification. With respect to function, 6F-GalNAc (Ac-3) treatment inhibited growth factor signaling and reduced in vivo angiogenesis by similar to 33%. Although the analog was readily transformed in cells into the uridine 59-diphosphate (UDP)-activated form, it was not incorporated into GAGs. Rather, it strongly reduced cellular UDP-GalNAc and UDP-GlcNAc pools. Together with data from the literature, these findings indicate that nucleotide sugar depletion without incorporation is a common mechanism of sugar analogs for inhibiting GAG/glycan biosynthesis.	[van Wijk, Xander M.; Troost, Ran; Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [van den Broek, Sebastiaan A.; van Delft, Floris L.] Radboud Univ Nijmegen, Med Ctr, Inst Mol & Mat, Dept Synthet Organ Chem, NL-6500 HB Nijmegen, Netherlands; [van Scherpenzeel, Monique; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Lawrence, Roger] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, San Diego, CA 92103 USA; [Naidu, Natasha] Univ Calif San Diego, Glycotechnol Core, San Diego, CA 92103 USA; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California San Diego; University of California System; University of California San Diego; Vrije Universiteit Amsterdam	van Kuppevelt, TH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.	toin.vankuppevelt@radboudumc.nl	Lefeber, Dirk DJ/A-2146-2014; Thijssen, Victor LJL/B-2792-2009; van Kuppevelt, A.H.M.S.M./L-4463-2015; van Scherpenzeel, Monique/N-7008-2015	Thijssen, Victor LJL/0000-0002-6146-1842; van Scherpenzeel, Monique/0000-0002-9696-4562	Dutch Cancer Society [2008-4058]; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM093131]; Dutch Organization for Scientific Research [40-00506-98-9001, 91713359]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093131] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. ten Dam, J. Esko, B. Choudhury, F. Bonetto, A. Pistorius, A. Swolfs, R. Wismans, E. van de Westerlo, and T. van der Velden for their analytical and technical support. Lectins were generous gifts from the Departments of Nephrology/Cell Biology (Radboud University Medical Centre, Nijmegen, The Netherlands). This work was supported by the Dutch Cancer Society (Grant 2008-4058), the U.S. National Institutes of Health, National Institute of General Medical Sciences (Grant GM093131 to R.L.), and the Dutch Organization for Scientific Research (NWO Medium Investment Grant 40-00506-98-9001 and VIDI Grant 91713359 to D.J.L.). The authors declare no conflicts of interest.	Ambrosius M, 2008, J CHROMATOGR A, V1201, P54, DOI 10.1016/j.chroma.2008.06.007; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Beahm BJ, 2014, ANGEW CHEM INT EDIT, V53, P3347, DOI 10.1002/anie.201310569; Berkin A, 2000, CARBOHYD RES, V326, P250, DOI 10.1016/S0008-6215(00)00049-5; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Dimitroff CJ, 2003, BLOOD, V101, P602, DOI 10.1182/blood-2002-06-1736; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hart G. W., 2009, ESSENTIALS GLYCOBIOL, P263; Kisilevsky R, 2004, AM J PATHOL, V164, P2127, DOI 10.1016/S0002-9440(10)63771-6; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Nishimura SI, 2012, ANGEW CHEM INT EDIT, V51, P3386, DOI 10.1002/anie.201108742; Pothacharoen P, 2006, J BIOCHEM, V140, P517, DOI 10.1093/jb/mvj181; Pouilly S, 2012, ACS CHEM BIOL, V7, P753, DOI 10.1021/cb200511t; Pouilly S, 2012, FEBS J, V279, P586, DOI 10.1111/j.1742-4658.2011.08448.x; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Song K, 2011, BIOCHEM J, V436, P271, DOI 10.1042/BJ20110297; SORRELL JM, 1993, MATRIX, V13, P351, DOI 10.1016/S0934-8832(11)80040-5; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Theocharis AD, 2002, BIOMED CHROMATOGR, V16, P157, DOI 10.1002/bmc.145; van Wijk XM, 2013, ACS CHEM BIOL, V8, P2331, DOI 10.1021/cb4004332; van Wijk XMR, 2014, BIOCHEM J, V461, P461, DOI 10.1042/BJ20140355; van Wijk XMR, 2014, ANGIOGENESIS, V17, P443, DOI 10.1007/s10456-013-9401-6; van Wijk XMR, 2012, GLYCOBIOLOGY, V22, P1666, DOI 10.1093/glycob/cws119; van Wijk XMR, 2010, EXP CELL RES, V316, P2504, DOI 10.1016/j.yexcr.2010.04.025; Zandberg WF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.403568	38	23	23	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2993	3002		10.1096/fj.14-264226	http://dx.doi.org/10.1096/fj.14-264226			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25868729	Green Published			2022-12-26	WOS:000356859100027
J	Antonenkov, VD; Isomursu, A; Mennerich, D; Vapola, MH; Weiher, H; Kietzmann, T; Hiltunen, JK				Antonenkov, Vasily D.; Isomursu, Antti; Mennerich, Daniela; Vapola, Miia H.; Weiher, Hans; Kietzmann, Thomas; Hiltunen, J. Kalervo			The Human Mitochondrial DNA Depletion Syndrome Gene MPV17 Encodes a Non-selective Channel That Modulates Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; INNER MEMBRANE; CELL-DEATH; AUTOPHAGY; PROTEIN; FUSION; TRANSLOCATION; FISSION; DISEASE; MTDNA	The human MPV17-related mitochondrial DNA depletion syndrome is an inherited autosomal recessive disease caused by mutations in the inner mitochondrial membrane protein MPV17. Although more than 30 MPV17 gene mutations were shown to be associated with mitochondrial DNA depletion syndrome, the function of MPV17 is still unknown. Mice deficient in Mpv17 show signs of premature aging. In the present study, we used electrophysiological measurements with recombinant MPV17 to reveal that this protein forms a non-selective channel with a pore diameter of 1.8 nm and located the channel's selectivity filter. The channel was weakly cation-selective and showed several subconductance states. Voltage-dependent gating of the channel was regulated by redox conditions and pH and was affected also in mutants mimicking a phosphorylated state. Likewise, the mitochondrial membrane potential (Delta psi(m)) and the cellular production of reactive oxygen species were higher in embryonic fibroblasts from Mpv17(-/-) mice. However, despite the elevated Delta psi(m), the Mpv17-deficient mitochondria showed signs of accelerated fission. Together, these observations uncover the role of MPV17 as a Delta psi(m)-modulating channel that apparently contributes to mitochondrial homeostasis under different conditions.	[Antonenkov, Vasily D.; Isomursu, Antti; Mennerich, Daniela; Vapola, Miia H.; Kietzmann, Thomas; Hiltunen, J. Kalervo] Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Weiher, Hans] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany	University of Oulu; Heinrich Pette Institute	Antonenkov, VD (corresponding author), Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, POB 3000, FI-90014 Oulu, Finland.	vasily.antonenkov@oulu.fi; kalervo.hiltunen@oulu.fi		Kietzmann, Thomas/0000-0003-0242-8636; Salo, Miia/0000-0003-2085-7880; Hiltunen, Kalervo/0000-0002-3073-9602	Academy of Finland; Sigrid Juselius Foundation; Biocenter Oulu	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Oulu	This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation, and Biocenter Oulu.	Antonenkov V. D., 2011, 3 EMBO M B108 VIENN, P115; Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Binder CJ, 1999, AM J PATHOL, V154, P1067, DOI 10.1016/S0002-9440(10)65359-X; Bolter B, 1999, EMBO J, V18, P5505, DOI 10.1093/emboj/18.20.5505; Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230; Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013; Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513; Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581; De Marchi U, 2008, BBA-BIOENERGETICS, V1777, P1438, DOI 10.1016/j.bbabio.2008.08.007; Dishon M, 2011, LANGMUIR, V27, P12977, DOI 10.1021/la202533s; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Edwards JC, 2010, FEBS LETT, V584, P2102, DOI 10.1016/j.febslet.2010.01.037; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; El-Hattab A. W., 2012, GENEREVIEWS; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gorlach A, 2007, METHOD ENZYMOL, V435, P421, DOI 10.1016/S0076-6879(07)35022-2; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Heinen A, 2007, AM J PHYSIOL-HEART C, V293, pH1400, DOI 10.1152/ajpheart.00198.2007; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kadenbach B, 2010, BBA-GEN SUBJECTS, V1800, P205, DOI 10.1016/j.bbagen.2009.04.019; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; MORAN O, 1990, J BIOL CHEM, V265, P908; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112; Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wanagat J, 2010, MECH AGEING DEV, V131, P527, DOI 10.1016/j.mad.2010.06.002; Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	65	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13840	13861		10.1074/jbc.M114.608083	http://dx.doi.org/10.1074/jbc.M114.608083			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25861990	Green Published, hybrid			2022-12-26	WOS:000355313000018
J	Yuan, FH; Dutta, T; Wang, L; Song, L; Gu, LY; Qian, LY; Benitez, A; Ning, SB; Malhotra, A; Deutscher, MP; Zhang, YB				Yuan, Fenghua; Dutta, Tanmay; Wang, Ling; Song, Lei; Gu, Liya; Qian, Liangyue; Benitez, Anaid; Ning, Shunbin; Malhotra, Arun; Deutscher, Murray P.; Zhang, Yanbin			Human DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; DEGRADATION ACTIVITY; DOMINANT MUTATIONS; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; PROTEIN; GENE; SPECIFICITY; EXPRESSION	3' repair exonuclease 1 (TREX1) is a known DNA exonuclease involved in autoimmune disorders and the antiviral response. In this work, we show that TREX1 is also a RNA exonuclease. Purified TREX1 displays robust exoribonuclease activity that degrades single-stranded, but not double-stranded, RNA. TREX1-D200N, an Aicardi-Goutieres syndrome disease-causing mutant, is defective in degrading RNA. TREX1 activity is strongly inhibited by a stretch of pyrimidine residues as is a bacterial homolog, RNase T. Kinetic measurements indicate that the apparent K-m of TREX1 for RNA is higher than that for DNA. Like RNase T, human TREX1 is active in degrading native tRNA substrates. Previously reported TREX1 crystal structures have revealed that the substrate binding sites are open enough to accommodate the extra hydroxyl group in RNA, further supporting our conclusion that TREX1 acts on RNA. These findings indicate that its RNase activity needs to be taken into account when evaluating the physiological role of TREX1.	[Yuan, Fenghua; Dutta, Tanmay; Song, Lei; Qian, Liangyue; Benitez, Anaid; Malhotra, Arun; Deutscher, Murray P.; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Wang, Ling; Ning, Shunbin] E Tennessee State Univ, Dept Med, Quillen Coll Med, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA; [Gu, Liya] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA	University of Miami; East Tennessee State University; University of Kentucky	Zhang, YB (corresponding author), Gautier Bldg,Rm 311,1011 NW 15th St, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Zhang, Yanbin/F-2998-2011; Regan, Clinton/E-6250-2012; Ning, Shunbin/AAC-6895-2021; Ning, Shunbin/I-3961-2019; Malhotra, Arun/Z-5140-2019	Zhang, Yanbin/0000-0002-7263-5510; Ning, Shunbin/0000-0001-5484-5779; Malhotra, Arun/0000-0001-6656-7841; Benitez, Anaid/0000-0002-5861-588X	National Institutes of Health [HL105631, GM16317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105631 (to Y. Z.) and GM16317 (to M. D.).	Bailey SL, 2012, DNA REPAIR, V11, P65, DOI 10.1016/j.dnarep.2011.10.007; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Benitez A, 2014, NUCLEIC ACIDS RES, V42, P1671, DOI 10.1093/nar/gkt975; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEUTSCHER MP, 1978, NUCLEIC ACIDS RES, V5, P3821, DOI 10.1093/nar/5.10.3821; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Geijtenbeek TBH, 2010, NAT IMMUNOL, V11, P979, DOI 10.1038/ni1110-979; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Li ZW, 1996, J BIOL CHEM, V271, P1133, DOI 10.1074/jbc.271.2.1133; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Driscoll M, 2008, DNA REPAIR, V7, P997, DOI 10.1016/j.dnarep.2008.02.010; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Reijns MAM, 2014, BIOCHEM SOC T, V42, P717, DOI 10.1042/BST20140079; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zuo YH, 1999, NUCLEIC ACIDS RES, V27, P4077, DOI 10.1093/nar/27.20.4077; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	34	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13344	13353		10.1074/jbc.M115.653915	http://dx.doi.org/10.1074/jbc.M115.653915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855793	Green Published, hybrid			2022-12-26	WOS:000354975700032
J	Pai, HC; Kumar, S; Shen, CC; Liou, JP; Pan, SL; Teng, CM				Pai, Hui Chen; Kumar, Sunil; Shen, Chien Chang; Liou, Jing Ping; Pan, Shiow Lin; Teng, Che Ming			MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ACTIVATION; APOPTOSIS; HEAT-SHOCK-PROTEIN-27; CELLS; EXPRESSION; TUMOR; PACLITAXEL	Objective In this study, the anticancer mechanisms of MT-4 were examined in A2780 and multidrug-resistant NCI-ADR/res human ovarian cancer cell lines. Methods To evaluate the activity of MT-4, we performed in vitro cell viability and cell cycle assays and in vivo xenograft assays. Immunoblotting analysis was carried out to evaluate the effect of MT-4 on ovarian cancer. Tubulin polymerization was determined using a tubulin binding assay. Results MT-4 (2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-phenol), a derivative of moscatilin, can inhibit both sensitive A2780 and multidrug-resistant NCI-ADR/res cell growth and viability. MT-4 inhibited tubulin polymerization to induce G2/M arrest followed by caspase-mediated apoptosis. Further studies indicated that MT-4 is not a substrate of P-glycoprotein (pgp). MT-4 also caused G2/M cell cycle arrest, accompanied by the upregulation of cyclin B, p-Thr161 Cdc2/p34, polo-like kinase 1 (PLK1), Aurora kinase B, and phospho-Ser10-histone H3 protein levels. In addition, we found that p38 MAPK pathway activation was involved in MT-4-induced apoptosis. Most importantly, MT-4 also decreased heat shock protein 27 expression and reduced its interaction with caspase-3, which inured cancer cells to chemotherapy resistance. Treatment of cells with SB203580 or overexpression of dominant negative (DN)-p38 or wild-type HSP27 reduced PARP cleavage caused by MT-4. MT4 induced apoptosis through regulation of p38 and HSP27. Our xenograft models also show the in vivo efficacy of MT-4. MT-4 inhibited both A2780 and NCI-ADR/res cell growth in vitro and in vivo. Conclusion These findings indicate that MT-4 could be a potential lead compound for the treatment of multidrug-resistant ovarian cancer.	[Pai, Hui Chen; Teng, Che Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei 10764, Taiwan; [Kumar, Sunil; Liou, Jing Ping] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Shen, Chien Chang] Natl Res Inst Chinese Med, Taipei, Taiwan; [Pan, Shiow Lin] Coll Med Sci & Technol, Canc Biol & Drug Discovery, Taipei, Taiwan	National Taiwan University; Taipei Medical University; National Research Institute of Chinese Medicine	Pan, SL (corresponding author), Coll Med Sci & Technol, Canc Biol & Drug Discovery, Taipei, Taiwan.	sipan@tmu.edu.tw; cmteng@ntu.edu.tw		Kumar, Sunil/0000-0001-7627-3740	National Science Council of Taiwan [NSC99-2628-B002-024-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC99-2628- B002-024-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chen TH, 2008, CLIN CANCER RES, V14, P4250, DOI 10.1158/1078-0432.CCR-07-4578; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Elpek GO, 2003, APMIS, V111, P523, DOI 10.1034/j.1600-0463.2003.1110411.x; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hill KS, 2014, ONCOGENE, V33, P2134, DOI 10.1038/onc.2013.147; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Langdon SP, 1995, CLIN CANCER RES, V1, P1603; Liu YN, 2010, SHOCK, V33, P70, DOI 10.1097/SHK.0b013e3181a7ff4a; Ma WB, 2013, FEBS J, V280, P4612, DOI 10.1111/febs.12432; Pai HC, 2013, J MOL MED, V91, P347, DOI 10.1007/s00109-012-0945-5; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Pavan S, 2014, INT J CANCER, V134, P1289, DOI 10.1002/ijc.28464; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Song TF, 2009, J INT MED RES, V37, P1375, DOI 10.1177/147323000903700512; Tanaka Y, 2004, INT J GYNECOL CANCER, V14, P616, DOI 10.1111/j.1048-891X.2004.14409.x; Tsai AC, 2010, CANCER LETT, V292, P163, DOI 10.1016/j.canlet.2009.11.020; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Yamamoto K, 2001, CANCER LETT, V168, P173, DOI 10.1016/S0304-3835(01)00532-8; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	26	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123819	10.1371/journal.pone.0123819	http://dx.doi.org/10.1371/journal.pone.0123819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874627	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700045
J	Senthil, K; Thirugnanasambantham, P; Oh, TJ; Kim, SH; Choi, HK				Senthil, Kalaiselvi; Thirugnanasambantham, Pankajavalli; Oh, Taek Joo; Kim, So Hyun; Choi, Hyung Kyoon			Free Radical Scavenging Activity and Comparative Metabolic Profiling of In Vitro Cultured and Field Grown Withania somnifera Roots	PLOS ONE			English	Article							WITHANOLIDE PRODUCTION; NATURAL-PRODUCT; PROLINE; PLANT; MS	Free radical scavenging activity (FRSA), total phenolic content (TPC), and total flavonoid content (TFC) of in vitro cultured and field grown Withania somnifera (Ashwagandha) roots were investigated. Withanolides analysis and comprehensive metabolic profiling between 100% methanol extracts of in vitro and field grown root tissues was performed using high performance thin layer chromatography (HPTLC) and gas chromatography-mass spectrometry (GC-MS), respectively. Significantly higher levels of FRSA, TPC, and TFC were observed in in-vitro cultured roots compared with field grown samples. In addition, 30 day-cultured in vitro root samples (1MIR) exhibited a significantly higher FRSA (IC50 81.01 mu g/mL), TPC (118.91 mg GAE/g), and TFC (32.68 mg CE/g) compared with those in 45 day-cultured samples (1.5MIR). Total of 29 metabolites were identified in in vitro cultured and field grown roots by GC-MS analysis. The metabolites included alcohols, organic acids, purine, pyrimidine, sugars, and putrescine. Vanillic acid was only observed in the in vitro cultured root samples, and higher level of the vanillic acid was observed in 1MIR when compared to 1.5MIR. Therefore, it is suggested that 1MIR might serve as an alternative to field grown roots for the development of medicinal and functional food products.	[Senthil, Kalaiselvi; Thirugnanasambantham, Pankajavalli] Avinashilingam Univ Women, Dept Biochem Biotechnol & Bioinformat, Coimbatore 641043, Tamil Nadu, India; [Oh, Taek Joo; Kim, So Hyun; Choi, Hyung Kyoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Avinashilingam University for Women; Chung Ang University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	hykychoi@cau.ac.kr	Senthil, kalaiselvi/AAQ-3730-2020	Senthil, kalaiselvi/0000-0002-8276-4607; k, selvi/0000-0002-9912-8586	Mid-career Researcher Program through NRF grant - MSIP of Republic of Korea [NRF-2012R1A2A2A02011748]; Major Research Project by University Grants Commission Government of India [34-278/2008]	Mid-career Researcher Program through NRF grant - MSIP of Republic of Korea; Major Research Project by University Grants Commission Government of India	This work was supported by Mid-career Researcher Program (NRF-2012R1A2A2A02011748) through NRF grant funded by the MSIP of Republic of Korea and Major Research Project by University Grants Commission Government of India (F.No. 34-278/2008 (SR)).	Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Cho SK, 2009, J PHARMACEUT BIOMED, V49, P567, DOI 10.1016/j.jpba.2008.11.037; Cox DG, 2014, BBA-GEN SUBJECTS, V1840, P3460, DOI 10.1016/j.bbagen.2014.08.007; Davis L, 2001, J ETHNOPHARMACOL, V75, P165, DOI 10.1016/S0378-8741(00)00404-9; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Demiray S., 2009, WORLD ACAD SCI ENG T, V3, P312; Dewir YH, 2010, BIOL PLANTARUM, V54, P357, DOI 10.1007/s10535-010-0063-6; Frederich M, 2011, PLANTA MED, V77, P81, DOI 10.1055/s-0030-1250132; Gupta G. L., 2007, Pharmacognosy Reviews, V1, P129; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Hithamani G, 2014, FOOD CHEM, V164, P55, DOI 10.1016/j.foodchem.2014.04.107; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jayaprakasam B, 2003, TETRAHEDRON, V59, P841, DOI 10.1016/S0040-4020(02)01601-0; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kim Y, 2012, PROCESS BIOCHEM, V47, P62, DOI 10.1016/j.procbio.2011.10.010; Kumar A, 2007, GENET RESOUR CROP EV, V54, P655, DOI 10.1007/s10722-006-9129-x; Lahouar L, 2014, FOOD CHEM, V145, P578, DOI 10.1016/j.foodchem.2013.08.102; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Li XG, 2013, INT J BIOL SCI, V9, P164, DOI 10.7150/ijbs.5579; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Murch SJ, 2004, PLANT CELL REP, V23, P419, DOI 10.1007/s00299-004-0862-3; Murthy HN, 2008, J INTEGR PLANT BIOL, V50, P975, DOI 10.1111/j.1744-7909.2008.00680.x; Praveen N., 2010, International Journal of Pharma and Bio Sciences, V1, pBS26; Praveen N, 2010, ACTA PHYSIOL PLANT, V32, P1017, DOI 10.1007/s11738-010-0489-7; RAJENDRAKUMAR CSV, 1994, BIOCHEM BIOPH RES CO, V201, P957, DOI 10.1006/bbrc.1994.1795; Ray A B, 1994, Fortschr Chem Org Naturst, V63, P1; Sabir F, 2008, Z NATURFORSCH C, V63, P409; Sang SM, 2002, J AGR FOOD CHEM, V50, P2459, DOI 10.1021/jf011533+; Sapropoulou V, 2013, TURK J AGRIC FOR, V37, P688; SARADHI PP, 1995, BIOCHEM BIOPH RES CO, V209, P1, DOI 10.1006/bbrc.1995.1461; Satyapal Singh, 2011, Advances in Applied Science Research, V2, P47; Sharada M, 2007, BIOL PLANTARUM, V51, P161, DOI 10.1007/s10535-007-0031-y; Sharma S., 1985, INDIAN DRUGS, V22, P133; Shetty K, 1997, Asia Pac J Clin Nutr, V6, P162; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sumner LW, 2015, NAT PROD REP, V32, P212, DOI 10.1039/c4np00072b; Tai A, 2012, BIOSCI BIOTECH BIOCH, V76, P314, DOI 10.1271/bbb.110700; Tarachiwin L, 2008, J PHARMACEUT BIOMED, V48, P42, DOI 10.1016/j.jpba.2008.04.025; van der Kooy F, 2009, PLANTA MED, V75, P763, DOI 10.1055/s-0029-1185450; Vaz JA, 2011, FOOD CHEM, V126, P610, DOI 10.1016/j.foodchem.2010.11.063; VERNON DM, 1992, EMBO J, V11, P2077, DOI 10.1002/j.1460-2075.1992.tb05266.x; Visweswari G, 2013, INT J PHARM SCI RES, V4, P2770, DOI 10.13040/IJPSR.0975-8232.4(7).2770-76; Wasnik Neha G., 2009, [Korean Journal of Plant Reources., 한국자원식물학회지], V22, P584; Wolfender JL, 2009, NAT PROD COMMUN, V4, P1417; Yadava S. A., 2011, Journal of Pharmacy Research, V4, P1428	48	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123360	10.1371/journal.pone.0123360	http://dx.doi.org/10.1371/journal.pone.0123360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874568	Green Submitted, gold, Green Published			2022-12-26	WOS:000353014700030
J	Dave, P; Vadera, B; Kumar, AMV; Chinnakali, P; Modi, B; Solanki, R; Patel, P; Patel, P; Pujara, K; Nimavat, P; Shah, A; Bharaswadkar, S; Rade, K; Parmar, M; Nair, SA				Dave, Paresh; Vadera, Bhavin; Kumar, Ajay M. V.; Chinnakali, Palanivel; Modi, Bhavesh; Solanki, Rajesh; Patel, Pranav; Patel, Prakash; Pujara, Kirit; Nimavat, Pankaj; Shah, Amar; Bharaswadkar, Sandeep; Rade, Kiran; Parmar, Malik; Nair, Sreenivas Achuthan			Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; PROGRAM	Background Revised National TB Control Programme (RNTCP) in India recommends that all previouslytreated TB (PT) patients are offered drug susceptibility testing (DST) at diagnosis, using rapid diagnostics and screened out for rifampicin resistance before being treated with standardized, eight-month, retreatment regimen. This is intended to improve the early diagnosis of rifampicin resistance and its appropriate management and improve the treatment outcomes among the rest of the patients. In this state-wide study from Gujarat, India, we assess proportion of PT patients underwent rapid DST at diagnosis and the impact of this intervention on their treatment outcomes. Methods This is a retrospective cohort study involving review of electronic patient-records maintained routinely under RNTCP. All PT patients registered for treatment in Gujarat during January-June 2013 were included. Information on DST and treatment outcomes were extracted from 'presumptive DR-TB patient register' and TB treatment register respectively. We performed a multivariate analysis to assess if getting tested is independently associated with unfavourable outcomes (death, loss-to-follow-up, failure, transfer out). Results Of 5,829 PT patients, 5306(91%) were tested for drug susceptibility with rapid diagnostics. Overall, 71% (4,113) TB patients were successfully treated - 72% among tested versus 60% among non-tested. Patients who did not get tested at diagnosis had a 34% higher risk of unsuccessful outcomes as compared to those who got tested (aRR - 1.34; 95% CI 1.20-1.50) after adjusting for age, sex, HIV status and type of TB. Unfavourable outcomes (particularly failure and switched to category IV) were higher among INH-resistant patients (39%) as compared to INH-sensitive (29%). Conclusion Offering DST at diagnosis improved the treatment outcomes among PT patients. However, even among tested, treatment outcomes remained suboptimal and were related to INH resistance and high loss-to-follow-up. These need to be addressed urgently for further progress.	[Dave, Paresh; Patel, Pranav; Patel, Prakash; Pujara, Kirit; Nimavat, Pankaj] Minist Hlth & FamilyWelfare, State TB Cell Commissionerate Hlth, Med Serv & Med Educ, Gandhinagar, Gujarat, India; [Vadera, Bhavin; Shah, Amar; Bharaswadkar, Sandeep; Rade, Kiran; Parmar, Malik; Nair, Sreenivas Achuthan] WHO, Country Off India, New Delhi, India; [Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Modi, Bhavesh] GMERS Med Coll, Dept Community Med, Gandhinagar, Gujarat, India; [Solanki, Rajesh] BJ Med Coll, Dept Pulm Med, Ahmadabad, Gujarat, India; [Chinnakali, Palanivel] Jawaharlal Inst Postgraduate Med Educ & Res, Dept Prevent & Social Med, Pondicherry, India; [Vadera, Bhavin] Civil Hosp Campus, Near TB & Chest Dept, State TB Training & Demonstrat Ctr, Ahmadabad, Gujarat, India	World Health Organization; B. J. Medical College & Civil Hospital, Ahmedabad; Jawaharlal Institute of Postgraduate Medical Education & Research	Vadera, B (corresponding author), WHO, Country Off India, New Delhi, India.	dr.vadera@gmail.com	Rade, Kiran/AAU-9564-2020; Chinnakali, Palanivel/AAV-7708-2020	Rade, Kiran/0000-0001-7601-0780; Chinnakali, Palanivel/0000-0001-8320-1016; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797	American People through United States Agency for International Development (USAID)	American People through United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres. The specific SORT IT programme which resulted in this publication was jointly developed and implemented by: the The Union South-East Asia Regional Office, New Delhi, India, the Centre for Operational Research, The Union, Paris, France and Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, India. Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this paper do not necessarily reflect the views of USAID, the United States Government, or International Union Against Tuberculosis and Lung Disease (The Union). The funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript.	Abeygunawardena SC, 2014, PUBLIC HEALTH ACTION, V4, P105, DOI 10.5588/pha.13.0111; Central TB Division, 2013, TB IND 2013 REV NAT; Central TB Division, 2012, NAT STRAT PLAN TUB C, DOI [10.1097/QAI.0b013e31825f313b, DOI 10.1097/QAI.0B013E31825F313B]; Central TB Division, 2012, GUID PROGR MAN DRUG; Central TB Division Ministry of Health and Family Welfare, 2011, REV NAT TB CONTR PRO; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Deepa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076189; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Frieden TR, 2014, GLOBAL TUBERCULOSIS, P30333, DOI [10.1001/jama.2014.11450.Conflict, DOI 10.1001/JAMA.2014.11450.CONFLICT]; Furin J, 2012, B WORLD HEALTH ORGAN, V90, P63, DOI 10.2471/BLT.11.092320; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Joseph P., 2006, Indian Journal of Tuberculosis, V53, P141; Khann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059903; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Paramasivan C. N., 2000, Indian Journal of Tuberculosis, V47, P27; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P7; Santha T, 2006, INT J TUBERC LUNG D, V10, P52; Singla N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102989; State TB Cell Gujarat, 2014, REV NAT TB CONTR PRO; State TB Cell Gujarat, 2013, REV NAT TB CONTR PRO; State TB Cell Gujarat, 2013, TB GUJ 2013 REV NAT; Stop TB Partnership World Health Organization, 2006, GLOB PLAN STOP TB 20; Vijay S, 2002, RETREATMENT OUTCOME; World Health Organization, 2009, TREATM TIB GUID	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121996	10.1371/journal.pone.0121996	http://dx.doi.org/10.1371/journal.pone.0121996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874545	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100055
J	Helland, T; Gjerde, J; Dankel, S; Fenne, IS; Skartveit, L; Drangevag, A; Bozickovic, O; Flageng, MH; Soiland, H; Mellgren, G; Lien, EA				Helland, Thomas; Gjerde, Jennifer; Dankel, Simon; Fenne, Ingvild S.; Skartveit, Linn; Drangevag, Andreas; Bozickovic, Olivera; Flageng, Marianne Hauglid; Soiland, Havard; Mellgren, Gunnar; Lien, Ernst A.			The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; SERUM CONCENTRATIONS; EXPRESSION; QUANTIFICATION; COACTIVATOR; PROLIFERATION; METASTASIS; CARCINOMA; KERATIN-6; BINDING	Introduction Tamoxifen is an anti-estrogen drug used in treatment of Estrogen Receptor (ER) positive breast cancer. Effects and side effects of tamoxifen is the sum of tamoxifen and all its metabolites. 4-Hydroxytamoxifen (4OHtam) and 4-hydroxy-N-demethyltamoxifen (4OHNDtam, endoxifen) both have ER affinity exceeding that of the parent drug tamoxifen. 4OHNDtam is considered the main active metabolite of tamoxifen. Ndesmethyltamoxifen (NDtam) is the major tamoxifen metabolite. It has low affinity to the ER and is not believed to influence tumor growth. However, NDtam might mediate adverse effects of tamoxifen treatment. In this study we investigated the gene regulatory effects of the three metabolites of tamoxifen in MCF-7 breast cancer cells. Material and Methods Using concentrations that mimic the clinical situation we examined effects of 4OHtam, 4OHNDtam and NDtam on global gene expression in 17 beta-estradiol (E-2) treated MCF-7 cells. Transcriptomic responses were assessed by correspondence analysis, differential expression, gene ontology analysis and quantitative real time PCR (Q-rt-PCR). E-2 deprivation and knockdown of Steroid Receptor Coactivator-3 (SRC-3)/Amplified in Breast Cancer 1 (AIB1) mRNA in MCF-7 cells were performed to further characterize specific effects on gene expression. Results 4OHNDtam and 4OHtam caused major changes in gene expression compared to treatment with E-2 alone, with a stronger effect of 4OHNDtam. NDtam had nearly no effect on the global gene expression profile. Treatment of MCF-7 cells with 4OHNDtam led to a strong down-regulation of the CytoKeratin 6 isoforms (KRT6A, KRT6B and KRT6C). The CytoKeratin 6 mRNAs were also down-regulated in MCF-7 cells after E-2 deprivation and after SRC-3/AIB1 knockdown. Conclusion Using concentrations that mimic the clinical situation we report global gene expression changes that were most pronounced with 4OHNDtam and minimal with NDtam. Genes encoding CytoKeratin 6, were highly down-regulated by 4OHNDtam, as well as after E-2 deprivation and knockdown of SRC-3/AIB1, indicating an estrogen receptor-dependent regulation.	[Helland, Thomas; Gjerde, Jennifer; Dankel, Simon; Fenne, Ingvild S.; Skartveit, Linn; Drangevag, Andreas; Bozickovic, Olivera; Flageng, Marianne Hauglid; Mellgren, Gunnar; Lien, Ernst A.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Gjerde, Jennifer; Dankel, Simon; Fenne, Ingvild S.; Skartveit, Linn; Drangevag, Andreas; Bozickovic, Olivera; Flageng, Marianne Hauglid; Soiland, Havard; Mellgren, Gunnar; Lien, Ernst A.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Soiland, Havard] Stavanger Univ Hosp, Sect Breast & Endocrine Surg, Stavanger, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Stavanger University Hospital	Lien, EA (corresponding author), Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway.	Ernst.Lien@k2.uib.no	Mellgren, Gunnar/AAG-6573-2020; Gjerde, Jennifer/AAZ-5811-2021	Mellgren, Gunnar/0000-0001-6282-4986; Dankel, Simon/0000-0001-6972-1824; Gjerde, Jennifer/0000-0001-5329-2666	Western Norway Regional Health Authority; Norwegian Cancer Society; University of Bergen	Western Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); University of Bergen	This study has received support from The Western Norway Regional Health Authority (http://www.helse-vest.no/fagfolk/forskning/det-regionalesamarbeidsorganet/Sider/helse-vests-forskingsmidlar.aspx), the Norwegian Cancer Society (www.kreftforeningen.no) and the University of Bergen (www.uib.no). Authors who recieved funding are EAL, GM, JG and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P579, DOI 10.1007/s10549-009-0704-7; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonanni B, 2009, CLIN CANCER RES, V15, P7053, DOI 10.1158/1078-0432.CCR-09-1354; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Casetta B, 2010, EUR J MASS SPECTROM, V16, P81, DOI 10.1255/ejms.1024; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Endo T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001211; Fabian CJ, 2004, CLIN CANCER RES, V10, P5403, DOI 10.1158/1078-0432.CCR-04-0171; Fadare O, 2008, HUM PATHOL, V39, P331, DOI 10.1016/j.humpath.2007.07.014; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fenne IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070096; Gallicchio L, 2004, BREAST CANCER RES TR, V85, P89, DOI 10.1023/B:BREA.0000021050.92539.b0; Gjerde J, 2005, J CHROMATOGR A, V1082, P6, DOI 10.1016/j.chroma.2005.01.004; Gjerde J, 2008, THESIS; Gjerde J, 2012, BREAST CANCER RES TR, V134, P693, DOI 10.1007/s10549-012-2074-9; Gong IY, 2013, BREAST CANCER RES TR, V139, P61, DOI 10.1007/s10549-013-2530-1; Grimm SL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1504; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawse JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054613; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Jaremko M, 2010, ANAL CHEM, V82, P10186, DOI 10.1021/ac102337d; JORDAN VC, 1982, ENDOCRINOLOGY, V110, P1281, DOI 10.1210/endo-110-4-1281; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; KATZENELLENBOGEN JA, 1985, J STEROID BIOCHEM, V22, P589, DOI 10.1016/0022-4731(85)90210-9; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; Klinke DJ, 2014, BIOTECHNOL BIOENG, V111, P1853, DOI 10.1002/bit.25238; LIEN EA, 1989, CANCER RES, V49, P2175; LIEN EA, 1991, CANCER RES, V51, P4837; LIEN EA, 1990, CANCER RES, V50, P5851; Lien EA, 2013, BREAST CANCER RES TR, V141, P243, DOI 10.1007/s10549-013-2677-9; Lim JSL, 2011, BRIT J CLIN PHARMACO, V71, P737, DOI 10.1111/j.1365-2125.2011.03905.x; Lim YC, 2006, J PHARMACOL EXP THER, V318, P503, DOI 10.1124/jpet.105.100511; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Lorizio W, 2012, BREAST CANCER RES TR, V132, P1107, DOI 10.1007/s10549-011-1893-4; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; MacGregor JI, 1998, PHARMACOL REV, V50, P151; McGowan K, 1998, Subcell Biochem, V31, P173; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nayfield SG, 1996, J CLIN ONCOL, V14, P1018, DOI 10.1200/JCO.1996.14.3.1018; Paganini-Hill A, 2000, BREAST CANCER RES TR, V60, P167, DOI 10.1023/A:1006342300291; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peyrade F, 1996, CLIN PHARMACOL THER, V59, P401, DOI 10.1016/S0009-9236(96)90108-3; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; REDDEL RR, 1983, EUR J CANCER CLIN ON, V19, P1179, DOI 10.1016/0277-5379(83)90047-0; ROBERTSON DW, 1982, J MED CHEM, V25, P167, DOI 10.1021/jm00344a015; Romano S, 2010, CELL DEATH DIFFER, V17, P145, DOI 10.1038/cdd.2009.115; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Sun GG, 2014, TUMOR BIOL, V35, P3455, DOI 10.1007/s13277-013-1456-x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656	52	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122339	10.1371/journal.pone.0122339	http://dx.doi.org/10.1371/journal.pone.0122339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867603	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100064
J	Hu, T; Li, X; Zhang, QH; Huang, KC; Jia, Y; Yang, R; Tang, FX; Tian, Q; Ma, D; Li, S				Hu, Ting; Li, Xiong; Zhang, Qinghua; Huang, Kecheng; Jia, Yao; Yang, Ru; Tang, Fangxu; Tian, Qiang; Ma, Ding; Li, Shuang			Could the Extent of Lymphadenectomy Be Modified by Neoadjuvant Chemotherapy in Cervical Cancer? A Large-Scale Retrospective Study	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CELL CARCINOMA ANTIGEN; STAGE-IB; CYCLOOXYGENASE-2 EXPRESSION; PROGNOSTIC-SIGNIFICANCE; RADICAL HYSTERECTOMY; RANDOMIZED-TRIAL; FOLLOW-UP; IIA; CISPLATIN	Background The effect of neoadjuvant chemotherapy (NACT) on topographical distribution patterns of lymph node metastasis in cervical cancer was unknown. Methods Patients with FIGO stage IB1-IIB who underwent radical surgery with or without NACT were enrolled (3527 patients). A matched-case comparison design was used to compare the effects of NACT on lymph node metastasis. Results We analyzed groups of 167 and 140 patients who were diagnosed with lymph node metastasis in the matched primary surgery group and NACT group, respectively, and no significant difference was observed (p = 0.081). The incidence of lymph node metastasis was significantly decreased in the NACT-responsive group compared to the non-responsive group (18.4% vs. 38.6%, P < 0.001). The metastatic rates for every lymph node group also declined in the NACT-responsive group except for the deep inguinal and the para-aortic lymph node groups. Clinical response, deep stromal, parametrial and lymph vascular invasions were independent risk factors for lymph node metastasis in the NACT group. Furthermore, deep stromal invasion and lymph vascular invasion, but not the response to NACT, were independently associated with upper LNM. The number of lymph nodes involved, response to NACT, tumor histology and a positive vaginal margin were independent prognostic factors affecting DFS or OS rates in node-positive patients treated with NACT plus radical surgery. Conclusion The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.	[Hu, Ting; Li, Xiong; Zhang, Qinghua; Huang, Kecheng; Jia, Yao; Yang, Ru; Tang, Fangxu; Ma, Ding; Li, Shuang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhang, Qinghua] Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan, Peoples R China; [Tian, Qiang] Inst Syst Biol, Seattle, WA 98109 USA	Huazhong University of Science & Technology; Institute for Systems Biology (ISB)	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.	lee5190008@126.com; dma@tjh.tjmu.edu.cn	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Li, Shuang/0000-0002-9193-0320	Key Basic Research and Development Program Foundation of China (973 Program) [2009CB521808]; National Natural Science Foundation of China [81230038, 81230052, 30973472, 81001151, 81071663, 30973205, 30973184, 81172464, 81101964]; National Major Science and Technology Project [2009ZX09103-739]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Project	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2009CB521808) and was supported by grants from the National Natural Science Foundation of China (Nos. 81230038; 81230052; 30973472; 81001151; 81071663; 30973205; 30973184; 81172464; 81101964) and National Major Science and Technology Project (No. 2009ZX09103-739).	Behtash N, 2006, EJSO-EUR J SURG ONC, V32, P1226, DOI 10.1016/j.ejso.2006.07.012; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; BenedettiPanici P, 1996, GYNECOL ONCOL, V62, P19, DOI 10.1006/gyno.1996.0184; Chen HJ, 2008, GYNECOL ONCOL, V110, P308, DOI 10.1016/j.ygyno.2008.05.026; Duk JM, 1996, J CLIN ONCOL, V14, P111, DOI 10.1200/JCO.1996.14.1.111; Eddy GL, 2007, GYNECOL ONCOL, V106, P362, DOI 10.1016/j.ygyno.2007.04.007; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Gien LT, 2009, J SURG ONCOL, V99, P242, DOI 10.1002/jso.21199; Goff BA, 1999, GYNECOL ONCOL, V74, P436, DOI 10.1006/gyno.1999.5472; HENRIKSEN E, 1949, AM J OBSTET GYNECOL, V58, P924, DOI 10.1016/0002-9378(49)90200-8; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Huang H, 2011, EJSO-EUR J SURG ONC, V37, P978, DOI 10.1016/j.ejso.2011.08.128; INOUE T, 1990, CANCER, V65, P1923, DOI 10.1002/1097-0142(19900501)65:9<1923::AID-CNCR2820650909>3.0.CO;2-M; Kim HS, 2011, GYNECOL ONCOL, V121, P551, DOI 10.1016/j.ygyno.2011.01.024; Kim HS, 2010, GYNECOL ONCOL, V119, P217, DOI 10.1016/j.ygyno.2010.06.017; Kim K, 2009, MED HYPOTHESES, V73, P1005, DOI 10.1016/j.mehy.2009.05.026; Lee JM, 2007, J OBSTET GYNAECOL RE, V33, P288, DOI 10.1111/j.1447-0756.2007.00526.x; Lee JY, 2011, ARCH GYNECOL OBSTET, V284, P477, DOI 10.1007/s00404-010-1685-9; MONK BJ, 1994, GYNECOL ONCOL, V54, P4, DOI 10.1006/gyno.1994.1157; Mossa B, 2010, EUR J GYNAECOL ONCOL, V31, P497; NAMKOONG SE, 1995, GYNECOL ONCOL, V59, P136, DOI 10.1006/gyno.1995.1280; Organization WH, WHO HDB REP RES CANC; Park TK, 2001, INT J GYNECOL CANCER, V11, P475, DOI 10.1046/j.1525-1438.2001.01057.x; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; PILLERON JP, 1974, AM J OBSTET GYNECOL, V119, P458, DOI 10.1016/0002-9378(74)90201-4; Ryu HS, 2007, INT J GYNECOL CANCER, V17, P132, DOI 10.1111/j.1525-1438.2007.00803.x; Ryu HS, 2000, GYNECOL ONCOL, V76, P320, DOI 10.1006/gyno.1999.5690; Sakuragi N, 1999, CANCER, V85, P1547, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2; Sardi JE, 1997, GYNECOL ONCOL, V67, P61, DOI 10.1006/gyno.1997.4812; SCAMBIA G, 1994, J CLIN ONCOL, V12, P2309, DOI 10.1200/JCO.1994.12.11.2309; STEHMAN FB, 1991, CANCER, V67, P2776, DOI 10.1002/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L; Xiong Y, 2011, GYNECOL ONCOL, V123, P99, DOI 10.1016/j.ygyno.2011.06.011	32	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123539	10.1371/journal.pone.0123539	http://dx.doi.org/10.1371/journal.pone.0123539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859857	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300103
J	Kim, KR; Kim, HJ; Lee, SK; Ma, GT; Park, KK; Chung, WY				Kim, Ki Rim; Kim, Hyun Jeong; Lee, Sun Kyoung; Ma, Gwang Taek; Park, Kwang Kyun; Chung, Won Yoon			15-Deoxy-Delta(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; MEDIATED OSTEOCLAST DIFFERENTIATION; PPAR-GAMMA LIGANDS; HEME OXYGENASE-1; ZOLEDRONIC ACID; PROSTATE-CANCER; CELLS; ACTIVATION; EXPRESSION; APOPTOSIS	Breast cancer is the major cause of cancer death in women worldwide. The most common site of metastasis is bone. Bone metastases obstruct the normal bone remodeling process and aberrantly enhance osteoclast-mediated bone resorption, which results in osteolytic lesions. 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is an endogenous ligand of peroxisome proliferator-activated receptor gamma (PPAR.) that has anti-inflammatory and antitumor activity at micromolar concentrations through PPAR.-dependent and/or PPAR.-independent pathways. We investigated the inhibitory activity of 15d-PGJ(2) on the bone loss that is associated with breast cancer bone metastasis and estrogen deficiency caused by cancer treatment. 15d-PGJ2 dose-dependently inhibited viability, migration, invasion, and parathyroid hormone-related protein (PTHrP) production in MDA-MB-231 breast cancer cells. 15d-PGJ(2) suppressed receptor activator of nuclear factor kappa-B ligand (RANKL) mRNA levels and normalized osteoprotegerin (OPG) mRNA levels in hFOB1.19 osteoblastic cells treated with culture medium from MDA-MB-231 cells or PTHrP, which decreased the RANKL/OPG ratio. 15d-PGJ(2) blocked RANKL-induced osteoclastogenesis and inhibited the formation of resorption pits by decreasing the activities of cathepsin K and matrix metalloproteinases, which are secreted by mature osteoclasts. 15d-PGJ(2) exerted its effects on breast cancer and bone cells via PPAR.-independent pathways. In Balb/c nu/nu mice that received an intracardiac injection of MDA-MB-231 cells, subcutaneously injected 15d-PGJ(2) substantially decreased metastatic progression, cancer cell-mediated bone destruction in femora, tibiae, and mandibles, and serum PTHrP levels. 15d-PGJ(2) prevented the destruction of femoral trabecular structures in estrogen-deprived ICR mice as measured by bone morphometric parameters and serum biochemical data. Therefore, 15d-PGJ(2) may be beneficial for the prevention and treatment of breast cancer-associated bone diseases.	[Kim, Ki Rim] Kyungpook Natl Univ, Dept Dent Hyg, Sangju 742711, South Korea; [Kim, Ki Rim; Kim, Hyun Jeong; Lee, Sun Kyoung; Park, Kwang Kyun; Chung, Won Yoon] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Biol,PLUS Project BK21, Seoul 120752, South Korea; [Kim, Hyun Jeong; Lee, Sun Kyoung; Ma, Gwang Taek; Park, Kwang Kyun; Chung, Won Yoon] Yonsei Univ, Grad Sch, Dept Appl Life Sci, Seoul 120749, South Korea	Kyungpook National University; Yonsei University; Yonsei University Health System; Yonsei University	Chung, WY (corresponding author), Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Biol,PLUS Project BK21, Seoul 120752, South Korea.	wychung@yuhs.ac		Kim, Hyun Jeong/0000-0003-4608-2120; Chung, Won-Yoon/0000-0001-8428-9005; Lee, Sun Kyoung/0000-0002-3707-8050	Yonsei University College of Dentistry [6-2009-0025]	Yonsei University College of Dentistry	This work was supported by a faculty research grant from Yonsei University College of Dentistry for 2009 (6-2009-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Azim HA, 2012, J EGYPT NATL CANCER, V24, P107, DOI 10.1016/j.jnci.2012.06.002; Brufsky AM, 2008, ONCOLOGIST, V13, P187, DOI 10.1634/theoncologist.2007-0152; Bundred N, 2012, CANCER TREAT REV, V38, P776, DOI 10.1016/j.ctrv.2012.02.002; Campbell JP, 2012, JOVE-J VIS EXP, DOI 10.3791/4260; Ciucci A, 2006, MOL PHARMACOL, V70, P1812, DOI 10.1124/mol.106.025759; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Daubine F, 2007, J NATL CANCER I, V99, P322, DOI 10.1093/jnci/djk054; Diez-Dacal B, 2010, THESCIENTIFICWORLDJO, V10, P655, DOI 10.1100/tsw.2010.69; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Guise TA, 2002, BONE, V30, P670, DOI 10.1016/S8756-3282(02)00685-3; Guise TA, 2010, CURR MED RES OPIN, V26, P6; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Inada Masaki, 2011, Clin Calcium, V21, P164, DOI CliCa1102164170; Ishihara Shunji, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P379, DOI 10.2174/1568011043352902; Jeong J, 2011, J KOREAN MED SCI, V26, P1569, DOI 10.3346/jkms.2011.26.12.1569; Jun AY, 2012, FITOTERAPIA, V83, P1523, DOI 10.1016/j.fitote.2012.08.020; Kaikkonen S, 2013, MOL ENDOCRINOL, V27, P212, DOI 10.1210/me.2012-1313; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Karaplis A C, 2000, Rev Endocr Metab Disord, V1, P331, DOI 10.1023/A:1026526703898; Kim DH, 2009, CARCINOGENESIS, V30, P645, DOI 10.1093/carcin/bgp012; Kim EH, 2006, ANN NY ACAD SCI, V1090, P375, DOI 10.1196/annals.1378.041; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lee SK, 2013, PHYTOTHER RES, V27, P1776, DOI 10.1002/ptr.4930; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Luo KW, 2013, CANC LETT, V339, P1569; Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Oiao L, 2008, MOL CANCER THER, V7, P2203, DOI 10.1158/1535-7163.MCT-08-0326; Okazaki R, 1999, ENDOCRINOLOGY, V140, P5060, DOI 10.1210/en.140.11.5060; Park SY, 2014, TOXICOL APPL PHARM, V275, P152, DOI 10.1016/j.taap.2014.01.009; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Safina A, 2011, MOL CANCER RES, V9, P1042, DOI 10.1158/1541-7786.MCR-10-0196; Shen ZN, 2005, BIOCHEM BIOPH RES CO, V328, P375, DOI 10.1016/j.bbrc.2004.12.186; Surh YJ, 2011, BIOCHEM PHARMACOL, V82, P1335, DOI 10.1016/j.bcp.2011.07.100; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Thudi NK, 2008, PROSTATE, V68, P1116, DOI 10.1002/pros.20776; Wang JJ, 2011, PROSTAG OTH LIPID M, V94, P104, DOI 10.1016/j.prostaglandins.2011.01.004; Wei W, 2011, PPAR RES, V2011, DOI 10.1155/2011/867180; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738	45	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122764	10.1371/journal.pone.0122764	http://dx.doi.org/10.1371/journal.pone.0122764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859665	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300060
J	Sreenivasa, M; Mombaur, K; Laumond, JP				Sreenivasa, Manish; Mombaur, Katja; Laumond, Jean-Paul			Walking Paths to and from a Goal Differ: On the Role of Bearing Angle in the Formation of Human Locomotion Paths	PLOS ONE			English	Article							OBSTACLE AVOIDANCE; TRAJECTORY FORMATION; ORIENTED LOCOMOTION; CURVED PATHS; HEAD; BODY; DIRECTION	The path that humans take while walking to a goal is the result of a cognitive process modulated by the perception of the environment and physiological constraints. The path shape and timing implicitly embeds aspects of the architecture behind this process. Here, locomotion paths were investigated during a simple task of walking to and from a goal, by looking at the evolution of the position of the human on a horizontal (x,y) plane. We found that the path while walking to a goal was not the same as that while returning from it. Forward-return paths were systematically separated by 0.5-1.9m, or about 5% of the goal distance. We show that this path separation occurs as a consequence of anticipating the desired body orientation at the goal while keeping the target in view. The magnitude of this separation was strongly influenced by the bearing angle (difference between body orientation and angle to goal) and the final orientation imposed at the goal. This phenomenon highlights the impact of a trade-off between a directional perceptual apparatus-eyes in the head on the shoulders-and and physiological limitations, in the formation of human locomotion paths. Our results give an insight into the influence of environmental and perceptual variables on human locomotion and provide a basis for further mathematical study of these mechanisms.	[Sreenivasa, Manish; Mombaur, Katja] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Optimizat Robot & Biomech, Heidelberg, Germany; [Laumond, Jean-Paul] Univ Toulouse, LAAS CNRS, Toulouse, France	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Sreenivasa, M (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Optimizat Robot & Biomech, Heidelberg, Germany.	manish.sreenivasa@iwr.uni-heidelberg.de	Sreenivasa, Manish/P-6311-2018	Sreenivasa, Manish/0000-0002-0979-5706	European Union within the KoroiBot project [GA 611909]; Alexander von Humboldt foundation [3.3-FRA/1152261 STP]; European Research Council [ERC-ADG 340050]; German Universities Excellence Initiative	European Union within the KoroiBot project; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); European Research Council(European Research Council (ERC)European Commission); German Universities Excellence Initiative	This research was supported by the European Union within the KoroiBot project (GA 611909, cordis.europa.eu). MS was funded by a postdoctoral fellowship from the Alexander von Humboldt foundation (3.3-FRA/1152261 STP, www.humboldt-foundation.de). JPL received funding from the European Research Council for the project Actanthrope (ERC-ADG 340050, erc.europa.eu). KM received funding from the 3rd line of the German Universities Excellence Initiative (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta G, 2008, AUTON ROBOT, V25, P25, DOI 10.1007/s10514-007-9075-2; Belmonti V, 2013, EXP BRAIN RES, V227, P131, DOI 10.1007/s00221-013-3495-3; Bernardin D, 2012, EXP BRAIN RES, V223, P65, DOI 10.1007/s00221-012-3241-2; Brogan DC, 2003, COMP ANIM CONF PROC, P94, DOI 10.1109/CASA.2003.1199309; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; CRATTY BJ, 1967, AM FDN BLIND RES B, V14, P31; Fajen BR, 2003, INT J COMPUT VISION, V54, P13, DOI 10.1023/A:1023701300169; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Frissen Ilja, 2013, HUMAN WALKING VIRTUA, P113; Grasso R, 1996, NEUROREPORT, V7, P1170, DOI 10.1097/00001756-199604260-00015; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hicheur H, 2005, NEUROSCI LETT, V383, P87, DOI 10.1016/j.neulet.2005.03.046; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Huang WH, 2006, ROBOT AUTON SYST, V54, P288, DOI 10.1016/j.robot.2005.11.004; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Laumond JP, 1998, LECT NOTES CONTROL I, V229; Luo N, 1999, P 55 ANN M I NAV CAM; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mombaur K, 2010, AUTON ROBOT, V28, P369, DOI 10.1007/s10514-009-9170-7; Olivier AH, 2007, NEUROSCI LETT, V412, P148, DOI 10.1016/j.neulet.2006.11.005; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Pettre J., 2009, SCA 09 P 2009 ACM SI, P189, DOI [10.1145/1599470.1599495, DOI 10.1145/1599470.1599495]; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Prevost P, 2003, NEUROSCI LETT, V339, P243, DOI 10.1016/S0304-3940(02)01390-3; Rushton SK, 2013, DISPLAYS, V34, P105, DOI 10.1016/j.displa.2012.10.006; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Sreenivasa MN, 2008, EXP BRAIN RES, V191, P313, DOI 10.1007/s00221-008-1525-3; Steinicke F, 2013, HUMAN WALKING IN VIR; Terrier P, 2000, J BIOMECH, V33, P1717, DOI 10.1016/S0021-9290(00)00133-0; Vielledent S, 2001, NEUROSCI LETT, V305, P65, DOI 10.1016/S0304-3940(01)01798-0; Wilkie RM, 2010, EXP BRAIN RES, V204, P539, DOI 10.1007/s00221-010-2321-4	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121714	10.1371/journal.pone.0121714	http://dx.doi.org/10.1371/journal.pone.0121714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860941	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300029
J	Bianco, MS; Ceclio, AB; de Carvalho, LB				Bianco, Matheus Saraiva; Ceclio Filho, Arthur Bernardes; de Carvalho, Leonardo Bianco			Nutritional Status of the Cauliflower Cultivar 'Verona' Grown with Omission of out Added Macronutrients	PLOS ONE			English	Article							MINERAL-NUTRITION; PHOSPHORUS; NITROGEN; YIELD; ACCUMULATION; DEFICIENCY; NUTRIENTS; CALCIUM; STRESS	Knowledge of plant nutritional status allows an understanding of the physiological responses of plants to crop fertilization. A hydroponic experiment evaluated the symptoms of macronutrient deficiency in cauliflower 'Verona' and determined: a) the macronutrient contents of foliar tissues when visual symptoms were observed, b) macronutrients content of foliar and inflorescence tissues at harvest. The effect of nutrient deficiency on inflorescence mass was also evaluated. Nitrogen deficiency caused chlorosis followed by purple color in the old leaves, while P deficiency caused only chlorosis in old leaves. Chlorosis at the edge of old leaves progressing to the center of the leaves was observed with the omission of K, and after was observed necrosis in the chlorotic areas. Ca deficiency caused tip burn in new leaves, while Mg deficiency caused internerval chlorosis in old leaves. The omission of eachmacronutrient reduced inflorescence dry matter. This deleterious effect was larger for N, P, and K deficiencies, reducing inflorescence dry matter by 87, 49, and 42%, respectively. When the nutrient solutions without N, P, K, Ca, or Mg were supplied to cauliflower plants, the macronutrient contents at harvest were 8.8, 0.6, 3.5, 13.0, and 0.8 g kg(-1) in the foliar tissues and 27.3, 2.2, 21.6, 1.1, and 0.7 g kg(-1) in the inflorescence tissues, respectively.	[Bianco, Matheus Saraiva; Ceclio Filho, Arthur Bernardes] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Plant Prod Dept, Sao Paulo, Brazil; [de Carvalho, Leonardo Bianco] Univ Estado Santa Catarina, Dept Agron, Ctr Ciencias Agrovet, Lages, Santa Catarina, Brazil	Universidade Estadual Paulista; Universidade do Estado de Santa Catarina	Bianco, MS (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Plant Prod Dept, Sao Paulo, Brazil.	matbianco2004@yahoo.com.br	Cecílio Filho, Arthur/D-7237-2012	Cecílio Filho, Arthur/0000-0002-6706-5496; Bianco de Carvalho, Leonardo/0000-0001-8110-3471				Alves AU, 2011, CIENC AGROTEC, V35, P45, DOI 10.1590/S1413-70542011000100005; Avalhaes CC, 2009, NUCLEUS, V6, P250, DOI DOI 10.3738/1982.2278.162; Bergmann W., 1992, NUTR DISORDERS PLANT; Berry W., 2014, PLANT PHYSL ONLINE; Bianco S, 2010, PLANTA DANINHA, V28, P293, DOI 10.1590/S0100-83582010000200008; BOTTRILL DE, 1970, PLANT SOIL, V32, P424, DOI 10.1007/BF01372881; Carvalho LB, 2009, PLANTA DANINHA, V27, P283, DOI 10.1590/S0100-83582009000200010; Castoldi R, 2009, HORTIC BRAS, V27, P438, DOI 10.1590/S0102-05362009000400007; Cavalcante LF, 2012, J PLANT NUTR, V35, P176, DOI 10.1080/01904167.2012.636121; Chatterjee C, 2004, DIS MANAG FRUITS VEG, V1, P145; CONROY JP, 1986, PLANT PHYSIOL, V81, P423, DOI 10.1104/pp.81.2.423; CUTCLIFFE JA, 1976, CAN J PLANT SCI, V56, P127, DOI 10.4141/cjps76-019; Camargo Mônica Sartori de, 2008, Bragantia, V67, P371, DOI 10.1590/S0006-87052008000200012; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Faquin V., 2005, NUTR MINERAL PLANTAS; da Mota GMF, 2009, ACTA SCI-AGRON, V31, P321, DOI 10.4025/actasciagron.v31i2.844; Fontes P.C.R., 2011, NUTR MINERAL PLANTAS; Furlani A. M. C., 1978, Bragantia, V37, P33, DOI 10.1590/S0006-87051978000100005; Furlani PR, 1998, FUNDACAO IAC B TECNI; Kano C, 2010, HORTIC BRAS, V28, P453, DOI 10.1590/S0102-05362010000400013; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; LAUER MJ, 1989, PLANT PHYSIOL, V91, P848, DOI 10.1104/pp.91.3.848; LYNCH J, 1991, CROP SCI, V31, P380, DOI 10.2135/cropsci1991.0011183X003100020031x; Malavolta E., 2006, MANUAL NUTR MINERAL; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mello Simone da Costa, 2009, Bragantia, V68, P761, DOI 10.1590/S0006-87052009000300024; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Sanchez LR, 2001, INVEST AGRAR-SIST R, V16, P119, DOI [10.4269/ajtmh. 14- 0145, DOI 10.4269/AJTMH.14-0145]; Stephens CT, 1983, DISORDERS COLE CROPS, pE; Sturmer SLK, 2002, REUN BRAS FERT SOL N; Taiz L., 2006, PLANT PHYSIOL; Takeishi J, 2009, BIOSCI J, V25, P1; TRANI PE, 1997, B TECNICO, V100, P157; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Zanão Júnior Luiz Antônio, 2005, Hortic. Bras., V23, P76, DOI 10.1590/S0102-05362005000100016	35	14	18	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123500	10.1371/journal.pone.0123500	http://dx.doi.org/10.1371/journal.pone.0123500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856380	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500093
J	Moreira, EF; Boscolo, D; Viana, BF				Moreira, Eduardo Freitas; Boscolo, Danilo; Viana, Blandina Felipe			Spatial Heterogeneity Regulates Plant-Pollinator Networks across Multiple Landscape Scales	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; ECOLOGICAL-SYSTEMS; HONEY-BEE; BIODIVERSITY; NESTEDNESS; DIVERSITY; SPECIALIZATION; STABILITY; SERVICES; PATTERN	Mutualistic plant-pollinator interactions play a key role in biodiversity conservation and ecosystem functioning. In a community, the combination of these interactions can generate emergent properties, e.g., robustness and resilience to disturbances such as fluctuations in populations and extinctions. Given that these systems are hierarchical and complex, environmental changes must have multiple levels of influence. In addition, changes in habitat quality and in the landscape structure are important threats to plants, pollinators and their interactions. However, despite the importance of these phenomena for the understanding of biological systems, as well as for conservation and management strategies, few studies have empirically evaluated these effects at the network level. Therefore, the objective of this study was to investigate the influence of local conditions and landscape structure at multiple scales on the characteristics of plant-pollinator networks. This study was conducted in agri-natural lands in Chapada Diamantina, Bahia, Brazil. Pollinators were collected in 27 sampling units distributed orthogonally along a gradient of proportion of agriculture and landscape diversity. The Akaike information criterion was used to select models that best fit the metrics for network characteristics, comparing four hypotheses represented by a set of a priori candidate models with specific combinations of the proportion of agriculture, the average shape of the landscape elements, the diversity of the landscape and the structure of local vegetation. The results indicate that a reduction of habitat quality and landscape heterogeneity can cause species loss and decrease of networks nestedness. These structural changes can reduce robustness and resilience of plant-pollinator networks what compromises the reproductive success of plants, the maintenance of biodiversity and the pollination service stability. We also discuss the possible explanations for these relationships and the implications for landscape planning in agricultural areas.	[Moreira, Eduardo Freitas; Viana, Blandina Felipe] Univ Fed Bahia, Dept Zool, Salvador, Bahia, Brazil; [Boscolo, Danilo] Univ Sao Paulo, FFCLRP, Fac Philosophy Sci & Literature Ribeirao Preto, Sao Paulo, Brazil	Universidade Federal da Bahia; Universidade de Sao Paulo	Moreira, EF (corresponding author), Univ Fed Bahia, Dept Zool, Salvador, Bahia, Brazil.	eduardofreitasmoreira@gmail.com	Viana, Blandina/M-6537-2013; Felipe Viana, Blandina Felipe/AAH-2606-2022; Moreira, Eduardo Freitas/J-5630-2016; Moreira, Eduardo/AAF-6779-2020; Felipe Viana, Blandina Felipe/AFM-0275-2022; Boscolo, Danilo/I-8655-2019	Viana, Blandina/0000-0002-4924-1257; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Moreira, Eduardo Freitas/0000-0001-7754-9585; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Boscolo, Danilo/0000-0002-0741-501X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq) [24/2009]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present work had funding support from the Brazilian governmental agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq - URL: http://www.cnpq.br/ - Edital MCT/CNPq/CT-AGRO - No 24/2009), who financed the purchase of equipment and field data collections campaigns; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - URL: http://www.capes.gov.br/index.php), who granted a scholarship during the master's degree course of Eduardo Freitas Moreira (first author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chittka L, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P106, DOI 10.1017/CBO9780511542268.007; Diekotter T, 2014, GCB BIOENERGY, V6, P219, DOI 10.1111/gcbb.12080; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Ferreira PA, 2013, ECOL INDIC, V31, P35, DOI 10.1016/j.ecolind.2012.07.025; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Fortuna MA, 2013, OIKOS, V122, P938, DOI 10.1111/j.1600-0706.2012.00042.x; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Hagen M, 2010, BIOL CONSERV, V143, P1654, DOI 10.1016/j.biocon.2010.03.036; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; INMET, 2013, BANC DAD MET ENS PES; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Keitt TH, 2009, ECOL APPL, V19, P1561, DOI 10.1890/08-0117.1; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; PARRISH JAD, 1979, ECOLOGY, V60, P597, DOI 10.2307/1936080; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Thomson D, 2004, ECOLOGY, V85, P458, DOI 10.1890/02-0626; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Veloso HP, 1991, CLASSIFICACAO VEGETA, DOI [10.5681/joddd.2014.003, DOI 10.5681/JODDD.2014.003]; Viana Blandina F., 2012, Journal of Pollination Ecology, V7, P31; Weng Q, 2011, T&F SER REMOTE SENS, P1, DOI 10.1201/b10599; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wu JG, 2002, ECOL MODEL, V153, P7, DOI 10.1016/S0304-3800(01)00499-9; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x	56	75	79	4	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123628	10.1371/journal.pone.0123628	http://dx.doi.org/10.1371/journal.pone.0123628			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856293	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500100
J	Sun, Y; Zhang, TT; Wang, CP; Jin, XL; Jia, CW; Yu, SN; Chen, J				Sun, Yang; Zhang, Tingting; Wang, Cuiping; Jin, Xianglan; Jia, Congwei; Yu, Shuangni; Chen, Jie			MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2	PLOS ONE			English	Article							MICRORNA EXPRESSION; COLORECTAL-CANCER; K-RAS; GENES; OVEREXPRESSION; PROLIFERATION; AMPLIFICATION; DIAGNOSIS; CELLS; RISK	Background Aberrant microRNA (miRNA) expression is associated with tumor development. This study aimed to elucidate the role of miR-615-5p in the development of pancreatic ductal adenocarcinoma (PDAC). Methods Locked nucleic acid in situ hybridization (LNA-ISH) was performed to compare miR-615-5p expression in patients between PDAC and matched adjacent normal tissues. Effects of miR-615-5p overexpression on cell proliferation, apoptosis, colony formation, migration, and invasion were determined in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2. Effects of miR-615-5p on AKT2 were examined by dual-luciferase reporter assay. Lentivirus expressing miR-615 was used to create stable overexpression cell lines, which were subsequently used in mouse xenograft and metastasis models to assess tumor growth, apoptosis and metastasis. Results miR-615-5p expression was significantly lower in PDAC than in adjacent normal tissues. Low levels of miR-615-5p were independently associated with poor prognosis (HR:2.243, 95% CI: 1.190-4.227, P=0.013). AKT2 protein expression was inversely correlated with miR-615-5p expression (r=-0.3, P=0.003). miR-615-5p directly targeted the 3'-untranslated region of AKT2 mRNA and repressed its expression. miR-615-5p overexpression inhibited pancreatic cancer cell proliferation, migration, and invasion in vitro, and tumor growth and metastasis in vivo. Furthermore, miR-615-5p overexpression also induced pancreatic cancer cell apoptosis both in vitro and in vivo. Conclusions These results show that miR-615-5p inhibits pancreatic cancer cell proliferation, migration, and invasion by targeting AKT2. The data implicate miR-615-5p in the prognosis and treatment of PDAC.	[Chen, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; Tsinghua Univ, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, 1 Shuai Fu Yuan Hu Tong, Beijing 100730, Peoples R China.	xhblk@163.com			National Nature Science Foundation of China [30973470, 81172334]; National Science and Technology Support Project (the 11th Five-Year Plan) of China [2006BAI02A14]; Scientific Research Special Projects of Health Industry of China [200802011]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Project (the 11th Five-Year Plan) of China(National Key Technology R&D Program); Scientific Research Special Projects of Health Industry of China	This study was supported by the National Nature Science Foundation of China (grant 30973470, 81172334), the National Science and Technology Support Project (the 11th Five-Year Plan) of China (grant 2006BAI02A14), and the Scientific Research Special Projects of Health Industry of China (grant 200802011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2003, J CELL BIOCHEM, V88, P470, DOI 10.1002/jcb.10287; Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; El Tayebi HM, 2012, FEBS LETT, V586, P3309, DOI 10.1016/j.febslet.2012.06.054; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gao W., 2014, ONCOGENE; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gray S, 2011, J PANCREAS, V12, P216; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Han ZY, 2012, CARCINOGENESIS, V33, P131, DOI 10.1093/carcin/bgr226; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jung HM, 2013, MOL BIOL CELL, V24, P1638, DOI 10.1091/mbc.E12-12-0891; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Liao WT, 2013, CLIN CANCER RES, V19, P4662, DOI 10.1158/1078-0432.CCR-13-0244; Lindsay TH, 2005, PAIN, V119, P233, DOI 10.1016/j.pain.2005.10.019; Lohr M, 2000, INT J PANCREATOL, V27, P93, DOI 10.1385/IJGC:27:2:093; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Nelson PT, 2009, NEUROSCI LETT, V466, P69, DOI 10.1016/j.neulet.2009.04.044; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; Sempere LF, 2010, CLIN CANCER RES, V16, P4246, DOI 10.1158/1078-0432.CCR-10-1152; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; VERHEIJEN R, 1989, J CELL SCI, V92, P123; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T; Zhao LQ, 2011, ACTA BIOCH BIOPH SIN, V43, P831, DOI 10.1093/abbs/gmr080; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	48	36	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119783	10.1371/journal.pone.0119783	http://dx.doi.org/10.1371/journal.pone.0119783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856297	gold, Green Published			2022-12-26	WOS:000352588500009
J	Virbickas, T; Stakenas, S; Steponenas, A				Virbickas, Tomas; Stakenas, Saulius; Steponenas, Andrius			Impact of Beaver Dams on Abundance and Distribution of Anadromous Salmonids in Two Lowland Streams in Lithuania	PLOS ONE			English	Article							ATLANTIC SALMON; BROOK TROUT; HABITAT USE; ECOLOGICAL STATUS; FISH ASSEMBLAGES; CUTTHROAT TROUT; CASTOR-FIBER; RIVERS; COMMUNITIES; MOVEMENTS	European beaver dams impeded movements of anadromous salmonids as it was established by fishing survey, fish tagging and redd counts in two lowland streams in Lithuania. Significant differences in abundancies of other litophilic fish species and evenness of representation by species in the community were detected upstream and downstream of the beaver dams. Sea trout parr marked with RFID tags passed through several successive beaver dams in upstream direction, but no tagged fish were detected above the uppermost dam. Increase in abundances of salmonid parr in the stream between the beaver dams and decrease below the dams were recorded in November, at the time of spawning of Atlantic salmon and sea trout, but no significant changes were detected in the sections upstream of the dams. After construction of several additional beaver dams in the downstream sections of the studied streams, abundance of Atlantic salmon parr downstream of the dams decreased considerably in comparison with that estimated before construction.	[Virbickas, Tomas; Stakenas, Saulius; Steponenas, Andrius] Nat Res Ctr, Dept Freshwater Biol, Vilnius, Lithuania	Nature Research Center - Lithuania	Stakenas, S (corresponding author), Nat Res Ctr, Dept Freshwater Biol, Vilnius, Lithuania.	saulius.stakenas@gmail.com	Stakėnas, Saulius/B-2361-2019	Stakėnas, Saulius/0000-0001-5424-9221	Research Council of Lithuania [MIP-120/2010]; Nature Research Centre and Lithuanian Society of Hydrobiologists	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Nature Research Centre and Lithuanian Society of Hydrobiologists(Research Council of Lithuania (LMTLT))	The study was funded by Research Council of Lithuania (project No. MIP-120/2010), Nature Research Centre and Lithuanian Society of Hydrobiologists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 2013ACOM082013 ICES, P3; BALON EK, 1979, ARCH HYDROBIOL, V85, P543; Bertolo A, 2008, FRESHWATER BIOL, V53, P304, DOI 10.1111/j.1365-2427.2007.01895.x; Birzaks Janis, 2012, Zoology and Ecology, V22, P9, DOI 10.1080/21658005.2012.680744; Bohlin T, 1975, 54 I FRESHW RES; Broberg MM, 2000, J FISH BIOL, V57, P1610, DOI 10.1111/j.1095-8649.2000.tb02237.x; Brower J.A., 1977, FIELD LAB METHODS GE; Bryant M.D., 1983, P OL WILD FISH C FIS, P183; CHISHOLM IM, 1987, T AM FISH SOC, V116, P176, DOI 10.1577/1548-8659(1987)116<176:WSCAUO>2.0.CO;2; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Cunjak R. A., 1998, Fisheries Management and Ecology, V5, P209, DOI 10.1046/j.1365-2400.1998.00094.x; Cunjak RA, 1996, CAN J FISH AQUAT SCI, V53, P267, DOI 10.1139/cjfas-53-S1-267; Elmeros Morten, 2003, Lutra, V46, P153; Fieseler C, 2006, LIMNOLOGICA, V36, P2, DOI 10.1016/j.limno.2005.10.001; France RL, 1997, CAN J ZOOL, V75, P1009, DOI 10.1139/z97-121; Gailiusis B., 2001, LIETUVOS UPES HIDROG; Guignion D, 2009, CONSERVATION STRATEG; Hagglund A, 1999, FOREST ECOL MANAG, V115, P259, DOI 10.1016/S0378-1127(98)00404-6; Halley Duncan J., 2003, Lutra, V46, P91; Halley Duncan J., 2001, P122; HANSON WILLIS D., 1963, AMER MIDLAND NAT, V69, P136, DOI 10.2307/2422849; Hay DW, 1989, P SALM MIGR DISTR S, P93; HELCOM, 2011, BALT SEA ENV; HUTCHINGS JA, 1987, CAN J ZOOL, V65, P766, DOI 10.1139/z87-120; Jakober MJ, 1998, T AM FISH SOC, V127, P223, DOI 10.1577/1548-8659(1998)127<0223:ROSIOF>2.0.CO;2; JOHNSON J, 2006, CATALOG WATERS IMPOR; Kemp PS, 2012, FISH FISH, V13, P158, DOI 10.1111/j.1467-2979.2011.00421.x; Kesminas V, 2000, BALTIJOS LASISA LIET; Kesminas V., 1999, HYDROBIOLOGICAL RE 1, P66; Lindstrom JW, 2004, N AM J FISH MANAGE, V24, P1341, DOI 10.1577/M03-223.1; Melcher A, 2007, FISHERIES MANAG ECOL, V14, P453, DOI 10.1111/j.1365-2400.2007.00583.x; Mitchell SC, 2007, J ANIM ECOL, V76, P1062, DOI 10.1111/j.1365-2656.2007.01286.x; MOORE A, 1990, J FISH BIOL, V37, P713, DOI 10.1111/j.1095-8649.1990.tb02535.x; NICKELSON TE, 1992, CAN J FISH AQUAT SCI, V49, P783, DOI 10.1139/f92-088; Nika N, 2011, THESIS KLAIPEDA U; Parker H, 2007, RIVER RES APPL, V23, P752, DOI 10.1002/rra.1008; Pedersen S., 2011, 2482012 DTU NAT I AQ; Rosell F, 2005, MAMMAL REV, V35, P248, DOI 10.1111/j.1365-2907.2005.00067.x; Sarauskiene D, 2008, ENV RES ENG MANAG, V46, P13; SCHLOSSER IJ, 1995, ECOLOGY, V76, P908, DOI 10.2307/1939356; Schlosser IJ, 2000, ECOLOGY, V81, P1371, DOI 10.2307/177214; Scruton DA, 1998, AQUAT CONSERV, V8, P145, DOI 10.1002/(SICI)1099-0755(199801/02)8:1<145::AID-AQC257>3.0.CO;2-7; Sigourney DB, 2006, T AM FISH SOC, V135, P1068, DOI 10.1577/T05-159.1; Skrupskelis Kestutis, 2012, Archives of Polish Fisheries, V20, P257; Snodgrass JW, 1998, ECOLOGY, V79, P928, DOI 10.2307/176590; Stakenas S, 2009, ECOL FRESHW FISH, V18, P167, DOI 10.1111/j.1600-0633.2008.00339.x; Steinmetz B, 1991, ATLAS FISH SCALES OT; SWANSTON DN, 1991, AM FISHERIES SOC SPE, V19, P139; Tambets M, 2005, J FISH BIOL, V67, P275, DOI 10.1111/j.0022-1112.2005.0955b.x; Taylor BR, 2010, RIVER RES APPL, V26, P183, DOI 10.1002/rra.1252; Taylor JE, 1999, ENVIRON HIST, V4, P54, DOI 10.2307/3985328; Ulevicius A, 2008, UPINI BEBR CASTOR FI; Virbickas T, 2007, FISHERIES MANAG ECOL, V14, P531, DOI 10.1111/j.1365-2400.2007.00572.x	53	8	8	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123107	10.1371/journal.pone.0123107	http://dx.doi.org/10.1371/journal.pone.0123107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856377	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500073
J	Almeida, CD; Andrade-Oliveira, V; Camara, NOS; Jacysyn, JF; Faquim-Mauro, EL				Almeida, Caroline de Souza; Andrade-Oliveira, Vinicius; Saraiva Camara, Niels Olsen; Jacysyn, Jacqueline F.; Faquim-Mauro, Eliana L.			Crotoxin from Crotalus durissus terrificus Is Able to Down-Modulate the Acute Intestinal Inflammation in Mice	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; GROWTH-FACTOR-BETA; ACID-INDUCED COLITIS; BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; LAMINA PROPRIA; T-CELLS; IL-12 PRODUCTION; LIPOXIN A(4)	Inflammatory bowel diseases (IBD) is the result of dysregulation of mucosal innate and adaptive immune responses. Factors such as genetic, microbial and environmental are involved in the development of these disorders. Accordingly, animal models that mimic human diseases are tools for the understanding the immunological processes of the IBD as well as to evaluate new therapeutic strategies. Crotoxin (CTX) is the main component of Crotalus durissus terrificus snake venom and has an immunomodulatory effect. Thus, we aimed to evaluate the modulatory effect of CTX in a murine model of colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS). The CTX was administered intraperitoneally 18 hours after the TNBS intrarectal instillation in BALB/c mice. The CTX administration resulted in decreased weight loss, disease activity index (DAI), macroscopic tissue damage, histopathological score and myeloperoxidase (MPO) activity analyzed after 4 days of acute TNBS colitis. Furthermore, the levels of TNF-alpha, IL-1 beta and IL-6 were lower in colon tissue homogenates of TNBS-mice that received the CTX when compared with untreated TNBS mice. The analysis of distinct cell populations obtained from the intestinal lamina propria showed that CTX reduced the number of group 3 innate lymphoid cells (ILC3) and Th17 population; CTX decreased IL-17 secretion but did not alter the frequency of CD4(+) Tbet(+) T cells induced by TNBS instillation in mice. In contrast, increased CD4(+) FoxP3(+) cell population as well as secretion of TGF-beta, prostaglandin E-2 (PGE(2)) and lipoxin A(4) (LXA(4)) was observed in TNBS-colitis mice treated with CTX compared with untreated TNBS-colitis mice. In conclusion, the CTX is able to modulate the intestinal acute inflammatory response induced by TNBS, resulting in the improvement of clinical status of the mice. This effect of CTX is complex and involves the suppression of the pro-inflammatory environment elicited by intrarectal instillation of TNBS due to the induction of a local anti-inflammatory profile in mice.	[Almeida, Caroline de Souza; Faquim-Mauro, Eliana L.] Butantan Inst, Immunopathol Lab, Sao Paulo, SP, Brazil; [Andrade-Oliveira, Vinicius; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil; [Jacysyn, Jacqueline F.] Univ Sao Paulo, Fac Med, LIM62, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Faquim-Mauro, EL (corresponding author), Butantan Inst, Immunopathol Lab, Sao Paulo, SP, Brazil.	eliana.faquim@butantan.gov.br	Faquim-Mauro, Eliana L/C-9636-2012; camara, niels olsen saraiva/AAX-3269-2020; Faquim-Mauro, Eliana/M-2489-2017; Camara, Niels OS/G-8336-2011; de Andrade Oliveira, Vinicius/S-1176-2019	camara, niels olsen saraiva/0000-0001-5436-1248; Faquim-Mauro, Eliana/0000-0001-8083-4272; Camara, Niels OS/0000-0001-5436-1248; de Andrade Oliveira, Vinicius/0000-0002-0426-1828	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/23735-0, 2012/022070-2]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP [2010/05701-9]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2011/23735-0 and 2012/022070-2) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). Caroline de Souza Almeida was receipt of a fellowship from FAPESP (2010/05701-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Awane M, 1999, J IMMUNOL, V162, P5337; Azevedo-Marques M, 2003, ANIMAIS PECONHENTOS, P91, DOI DOI 10.1016/J.TTBDIS.2014.03.010; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Bolanos R, 1978, DEV BIOL STAND, V41, P907; Bon C, 1998, NEUROTOXINS IN NEURO, P52; BRADFORD HF, 1976, BRAIN RES, V105, P168, DOI 10.1016/0006-8993(76)90933-1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brandtzaeg P, 2001, ACTA ODONTOL SCAND, V59, P235, DOI 10.1080/00016350152509265; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cardoso DF, 1997, TOXICON, V35, P607, DOI 10.1016/S0041-0101(96)00134-1; Cardoso DF, 2001, MEDIAT INFLAMM, V10, P125, DOI 10.1080/09629350120072699; Castro FR, 2007, TOXICON, V49, P299, DOI 10.1016/j.toxicon.2006.09.028; Chen HY, 2009, PROSTAG LEUKOTR ESS, V80, P195, DOI 10.1016/j.plefa.2009.01.006; Chen H, 2011, J ZHEJIANG UNIV-SC B, V12, P712, DOI 10.1631/jzus.B1000362; Chen Y, 2004, SCIENCE, V265, P1237; Costa LA, 2001, IMMUNOL LETT, V75, P137, DOI 10.1016/S0165-2478(00)00293-5; da Silva NG, 2013, TOXICON, V63, P98, DOI 10.1016/j.toxicon.2012.12.003; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; DAVIES MDJ, 1981, GUT, V22, P481, DOI 10.1136/gut.22.6.481; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Ermann J, 2014, P NATL ACAD SCI USA, V111, pE2559, DOI 10.1073/pnas.1408540111; FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x; Favoretto BC, 2011, TOXICON, V57, P600, DOI 10.1016/j.toxicon.2010.12.023; Fiorucci S, 2002, P NATL ACAD SCI USA, V99, P15770, DOI 10.1073/pnas.232583599; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garcia F, 2003, TOXICON, V42, P433, DOI 10.1016/S0041-0101(03)00198-3; GEBOES K, 1994, ACTA GASTRO-ENT BELG, V57, P273; Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484; Guan QD, 2013, J LEUKOCYTE BIOL, V94, P803, DOI 10.1189/jlb.0113050; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; HAWGOOD BJ, 1977, BRIT J PHARMACOL, V61, P597, DOI 10.1111/j.1476-5381.1977.tb07553.x; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Holtmann MH, 2004, LANGENBECK ARCH SURG, V389, P341, DOI 10.1007/s00423-003-0448-5; Holtmann MH, 2001, EXPERT OPIN BIOL TH, V1, P455, DOI 10.1517/14712598.1.3.455; Jin Y, 2012, J INTERF CYTOK RES, V32, P548, DOI 10.1089/jir.2012.0030; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kh Slotta, 1938, ESTUDOS QUIMICOS VEN; Killig M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00142; Kolios G, 1998, HEPATO-GASTROENTEROL, V45, P1601; Kraus TA, 2005, CURR OPIN GASTROEN, V21, P692, DOI 10.1097/01.mog.0000182862.88798.28; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Lima TS, 2002, EXPBIOL MED, V23, P1219; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Monteleone G, 1999, J IMMUNOL, V163, P143; Monteleone I, 2002, GUT, V50, P60; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Natsui M, 1997, J GASTROEN HEPATOL, V12, P801, DOI 10.1111/j.1440-1746.1997.tb00375.x; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nunes FPB, 2010, TOXICON, V55, P1100, DOI 10.1016/j.toxicon.2009.12.011; Ogino H, 2011, DIGEST DIS SCI, V56, P376, DOI 10.1007/s10620-010-1286-2; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Parronchi P, 1997, AM J PATHOL, V150, P823; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rangel-Santos A, 2004, TOXICON, V44, P609, DOI 10.1016/j.toxicon.2004.07.004; Rolim-Rosa R., 1980, MEM INST BUTANTAN, V44, P259; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sampaio SC, 2006, TOXICON, V47, P313, DOI 10.1016/j.toxicon.2005.11.008; Sampaio SC, 2005, TOXICON, V45, P671, DOI 10.1016/j.toxicon.2005.01.009; Sampaio SC, 2003, TOXICON, V41, P899, DOI 10.1016/S0041-0101(03)00069-2; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; SCHAEFFER RC, 1988, TOXICON, V26, P67, DOI 10.1016/0041-0101(88)90138-9; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Silva MCCD, 1996, MEDIAT INFLAMM, V5, P18, DOI 10.1155/S0962935196000038; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsukada Y, 2002, AM J GASTROENTEROL, V97, P2820; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; YAMADA T, 1991, INFLAMMATION, V15, P399, DOI 10.1007/BF00917356; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Zambelli VO, 2008, TOXICON, V51, P1357, DOI 10.1016/j.toxicon.2008.03.004; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	97	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121427	10.1371/journal.pone.0121427	http://dx.doi.org/10.1371/journal.pone.0121427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853847	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400038
J	Lin, C; Liu, SY; Lee, EHY				Lin, Ch; Liu, S. Y.; Lee, E. H. Y.			SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1	ONCOGENE			English	Article							CELL-PROLIFERATION; E3; TUMORIGENESIS; CONJUGATION; EXPRESSION; STABILITY; PATHWAY	SUMOylation is an important post-translational modification, and Akt SUMOylation was found to regulate cell proliferation, tumorigenesis and cell cycle, but the molecular mechanism of Akt SUMOylation is less well known. Here, we show both endogenous and ectopic Akt SUMOylation and Lys276 is the major SUMO acceptor on Akt. Further, Akt SUMOylation is Akt phosphorylation dependent and Akt SUMOylation increases Akt kinase activity without affecting the phosphorylation level of Akt. Moreover, endogenous Akt SUMOylation is enhanced by insulin treatment and this is Akt activity dependent. Heat-shock stimulus also increases Akt SUMOylation and it is also Akt activity dependent. Endogenous Akt SUMOylation is also found in the rat brain and it is enhanced by insulin-like growth factor-1 stimulation. In addition, Akt directly phosphorylates Ubc9 at Thr35 and phosphorylates SUMO1 at Thr76. Ubc9 phosphorylation at Thr35 promotes Ubc9 thioester bond formation and SUMO1 phosphorylation at Thr76 stabilizes the SUMO1 protein. Through these distinct mechanisms, Akt SUMOylation regulates global SUMOylation, including Akt and Ubc9 SUMOylation, and substrate SUMOylation specificity, including STAT1 and CREB SUMOylation, in different manners. Akt SUMOylation also enhances phosphatase and tensin homolog (PTEN) SUMOylation through Akt phosphorylation of Ubc9 and SUMO1, which serves as an endogenous mechanism to stop the positive feedback loop resulted from Akt activation. Further, Akt SUMOylation increases cyclin D1 expression and cell proliferation, and these effects are also mediated through Ubc9 phosphorylation at Thr35 and SUMO1 phosphorylation at Thr76. Here, we have identified a novel mechanism for SUMOylation regulation. Because of the important role Akt plays in tumorigenesis, this mechanism may also be involved in Akt-regulated tumorigenesis.	[Lin, Ch; Liu, S. Y.; Lee, E. H. Y.] Acad Sinica, Inst Biomed Sci, Div Neurosci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Lee, EHY (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	eminy@gate.sinica.edu.tw	Lee, Eminy H.Y./S-7014-2018	Lee, Eminy/0000-0001-6342-0940; Ma, Yun Li/0000-0002-6321-8889	Ministry of Science and Technology in Taiwan [MOST 102-2321-B-001-004]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a Grant from the Ministry of Science and Technology in Taiwan (MOST 102-2321-B-001-004). Thank is given to the Proteomics Core Facility of the Institute of Biomedical Sciences, Academia Sinica, Taiwan.	Chen YC, 2014, J NEUROSCI, V34, P9574, DOI 10.1523/JNEUROSCI.4302-13.2014; Chiou HYC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-53; de la Cruz-Herrera CF, 2014, ONCOGENE, P1; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Risso G, 2013, CELL CYCLE, V12, P3165, DOI 10.4161/cc.26183; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Su YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034250; Tai DJC, 2011, EMBO J, V30, P205, DOI 10.1038/emboj.2010.290; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	26	40	46	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					595	607		10.1038/onc.2015.115	http://dx.doi.org/10.1038/onc.2015.115			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25867063				2022-12-26	WOS:000369548800007
J	Oneyama, C; Yoshikawa, Y; Ninomiya, Y; Iino, T; Tsukita, S; Okada, M				Oneyama, C.; Yoshikawa, Y.; Ninomiya, Y.; Iino, T.; Tsukita, S.; Okada, M.			Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression	ONCOGENE			English	Article							C-SRC; CORTACTIN PHOSPHORYLATION; CARCINOMA CELLS; FAMILY KINASES; SARCOMA VIRUS; HUMAN CANCER; EXPRESSION; ACTIVATION; EZRIN; TRANSFORMATION	c-Src is upregulated in various human cancers, suggesting its role in malignant progression. However, the molecular circuits of c-Src oncogenic signaling remain elusive. Here we show that Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression. Previously, we showed that transformation of fibroblasts is promoted by the relocation of c-Src to non-raft membranes. In this study, we identified Fer and ezrin as non-raft c-Src targets. c-Src directly activated Fer by initiating its autophosphorylation, which was further amplified by Fer oligomerization. Fer interacted with active c-Src at focal adhesion membranes and activated Fer-phosphorylated ezrin to induce cell transformation. Fer was also crucial for cell transformation induced by v-Src or epidermal growth-factor receptor activation. Furthermore, Fer activation was required for tumorigenesis and invasiveness in some cancer cells in which c-Src is upregulated. We propose that the Src-Fer axis represents a new therapeutic target for treatment of a subset of human cancers.	[Oneyama, C.; Yoshikawa, Y.; Ninomiya, Y.; Iino, T.; Okada, M.] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Tsukita, S.] Osaka Univ, Grad Sch Frontier Biosci, Lab Biol Sci, Osaka, Japan; [Tsukita, S.] Osaka Univ, Grad Sch Med, Osaka, Japan	Osaka University; Osaka University; Osaka University	Oneyama, C (corresponding author), Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	coneyama@biken.osaka-u.ac.jp			Exciting Leading-Edge Research Project; MEET Project at Osaka University; Ministry of Education, Culture, Sports, Science and Technology of Japan for Young Scientists; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [25117716, 26640078] Funding Source: KAKEN	Exciting Leading-Edge Research Project; MEET Project at Osaka University; Ministry of Education, Culture, Sports, Science and Technology of Japan for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T Akagi for pCX4 vector, N Mochizuki for a series of Fer expression vectors, A Imamoto for SFC - cells, K Saito for technical assistance with the LC-MS/MS analysis and JA Cooper for critical reading and editing of the manuscript. LC-MS/MS analysis was performed in the DNA-chip Development Centre for Infectious Diseases (RIMD, Osaka University). This work was supported by the Exciting Leading-Edge Research Project and the MEET Project at Osaka University; grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Young Scientists (A); and The Yasuda Medical Foundation.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Allard P, 2000, MOL CELL ENDOCRINOL, V159, P63, DOI 10.1016/S0303-7207(99)00205-1; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Craig AWB, 1999, J BIOL CHEM, V274, P19934, DOI 10.1074/jbc.274.28.19934; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Elliott BE, 2004, J CELL BIOCHEM, V92, P16, DOI 10.1002/jcb.20033; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Guo CH, 2011, P NATL ACAD SCI USA, V108, P7968, DOI 10.1073/pnas.1105369108; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Heiska L, 2011, ONCOGENE, V30, P4953, DOI 10.1038/onc.2011.207; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Inoue K, 2009, GENE THER, V16, P1383, DOI 10.1038/gt.2009.105; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kawakami M, 2013, INT J CLIN EXP PATHO, V6, P598; Kim L, 1998, J BIOL CHEM, V273, P23542, DOI 10.1074/jbc.273.36.23542; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kogata N, 2003, MOL BIOL CELL, V14, P3553, DOI 10.1091/mbc.E03-02-0080; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Lennartsson J, 2013, J BIOL CHEM, V288, P15736, DOI 10.1074/jbc.M113.476424; Li HY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-366; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Mak H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-82; Menges Craig W, 2010, Genes Cancer, V1, P493; Miyata Y, 2013, CANCER SCI, V104, P681, DOI 10.1111/cas.12140; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Senis YA, 2003, J THROMB HAEMOST, V1, P1062, DOI 10.1046/j.1538-7836.2003.t01-1-00124.x; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; TAKEYA T, 1982, J VIROL, V44, P1; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	47	17	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					501	512		10.1038/onc.2015.110	http://dx.doi.org/10.1038/onc.2015.110			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25867068				2022-12-26	WOS:000369056700010
J	Cvetesic, N; Bilus, M; Gruic-Sovulj, I				Cvetesic, Nevena; Bilus, Mirna; Gruic-Sovulj, Ita			The tRNA A76 Hydroxyl Groups Control Partitioning of the tRNA-dependent Pre- and Post-transfer Editing Pathways in Class I tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; AMINO-ACID; PROTEIN-SYNTHESIS; QUALITY-CONTROL; STRUCTURAL BASIS; TRNA SYNTHETASE; SITE; AMINOACYLATION; ISOLEUCYL	Aminoacyl-tRNA synthetases catalyze ATP-dependent covalent coupling of cognate amino acids and tRNAs for ribosomal protein synthesis. Escherichia coli isoleucyl-tRNA synthetase (IleRS) exploits both the tRNA-dependent pre- and post-transfer editing pathways to minimize errors in translation. However, the molecular mechanisms by which tRNA(Ile) organizes the synthetic site to enhance pre-transfer editing, an idiosyncratic feature of IleRS, remains elusive. Here we show that tRNA(Ile) affects both the synthetic and editing reactions localized within the IleRS synthetic site. In a complex with cognate tRNA, IleRS exhibits a 10-fold faster aminoacyl-AMP hydrolysis and a 10-fold drop in amino acid affinity relative to the free enzyme. Remarkably, the specificity against non-cognate valine was not improved by the presence of tRNA in either of these processes. Instead, amino acid specificity is determined by the protein component per se, whereas the tRNA promotes catalytic performance of the synthetic site, bringing about less error-prone and kinetically optimized isoleucyl-tRNA(Ile) synthesis under cellular conditions. Finally, the extent to which tRNA(Ile) modulates activation and pre-transfer editing is independent of the intactness of its 3'-end. This finding decouples aminoacylation and pre-transfer editing within the IleRS synthetic site and further demonstrates that the A76 hydroxyl groups participate in post-transfer editing only. The data are consistent with a model whereby the 3'-end of the tRNA remains free to sample different positions within the IleRS.tRNA complex, whereas the fine-tuning of the synthetic site is attained via conformational rearrangement of the enzyme through the interactions with the remaining parts of the tRNA body.	[Cvetesic, Nevena; Bilus, Mirna; Gruic-Sovulj, Ita] Univ Zagreb, Fac Sci, Dept Chem, Zagreb 10000, Croatia	University of Zagreb	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102a, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Cvetesic, Nevena/0000-0002-1575-5612	Unity through Knowledge Fund Grant [8/13]; European Community [315997]	Unity through Knowledge Fund Grant; European Community(European Commission)	This work was supported by Unity through Knowledge Fund Grant 8/13 (to I. G. S.) and in part by a grant from the European Community's Seventh Framework Programme (FP7RegPot/IntegraLife, 315997).	Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; ANSELME J, 1991, FEBS LETT, V280, P163, DOI 10.1016/0014-5793(91)80228-U; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERGMANN F, 1961, J BIOL CHEM, V236, P1735; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439; BUONOCOR.V, 1972, J BIOL CHEM, V247, P4843; BUONOCORE V, 1972, J BIOL CHEM, V247, P1343; Carter Charles W. Jr., 2015, Life-Basel, V5, P294, DOI 10.3390/life5010294; CRAMER F, 1975, FEBS LETT, V56, P212, DOI 10.1016/0014-5793(75)81093-3; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; Cvetesic N, 2012, J BIOL CHEM, V287, P25381, DOI 10.1074/jbc.M112.372151; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dulic M, 2014, BIOCHEMISTRY-US, V53, P6189, DOI 10.1021/bi5007699; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ERIANI G, 1990, NUCLEIC ACIDS RES, V18, P1475, DOI 10.1093/nar/18.6.1475; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farrow MA, 1999, BIOCHEMISTRY-US, V38, P16898, DOI 10.1021/bi9920782; Fersht A., 1999, STRUCTURE MECH PROTE, P349; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FILLEY SJ, 1993, ARCH BIOCHEM BIOPHYS, V307, P46, DOI 10.1006/abbi.1993.1558; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2002, EUR J BIOCHEM, V269, P5271, DOI 10.1046/j.1432-1033.2002.03241.x; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guo AC, 2013, NUCLEIC ACIDS RES, V41, pD625, DOI 10.1093/nar/gks992; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hendrickson TL, 2000, BIOCHEMISTRY-US, V39, P8180, DOI 10.1021/bi0004798; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Johnson K. A, 1992, TRANSIENT STATE KINE, P1; KATZE JR, 1970, J BIOL CHEM, V245, P923; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2012, J BIOL CHEM, V287, P28518, DOI 10.1074/jbc.M112.372920; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; MADERN D, 1992, FEBS LETT, V299, P85, DOI 10.1016/0014-5793(92)80106-Q; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; OSTREM DL, 1974, BIOCHEMISTRY-US, V13, P1338, DOI 10.1021/bi00704a006; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Ruan BF, 2005, J BIOL CHEM, V280, P571, DOI 10.1074/jbc.M411039200; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; SPRINZL M, 1975, P NATL ACAD SCI USA, V72, P3049, DOI 10.1073/pnas.72.8.3049; Stehlin C, 1997, BIOCHEMISTRY-US, V36, P2932, DOI 10.1021/bi962295s; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; WU MX, 1994, BIOCHEMISTRY-US, V33, P12260, DOI 10.1021/bi00206a032; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; YANIV M, 1969, J MOL BIOL, V44, P1, DOI 10.1016/0022-2836(69)90401-X; YARUS M, 1969, J MOL BIOL, V42, P171, DOI 10.1016/0022-2836(69)90037-0; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; Zuniga R, 2002, FEBS LETT, V532, P387, DOI 10.1016/S0014-5793(02)03720-1	75	17	17	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13981	13991		10.1074/jbc.M115.648568	http://dx.doi.org/10.1074/jbc.M115.648568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873392	Green Published, hybrid			2022-12-26	WOS:000355313000029
J	Maeda, A; Ono, M; Holmbeck, K; Li, L; Kilts, TM; Kram, V; Noonan, ML; Yoshioka, Y; McNerny, EMB; Tantillo, MA; Kohn, DH; Lyons, KM; Robey, PG; Young, MF				Maeda, Azusa; Ono, Mitsuaki; Holmbeck, Kenn; Li, Li; Kilts, Tina M.; Kram, Vardit; Noonan, Megan L.; Yoshioka, Yuya; McNerny, Erin M. B.; Tantillo, Margaret A.; Kohn, David H.; Lyons, Karen M.; Robey, Pamela G.; Young, Marian F.			WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; CCN FAMILY PROTEINS; OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; CAUSES OSTEOPENIA; MICE; OSTEOGENESIS; EXPRESSION; PATHWAYS; GENES	WISP1/CCN4 (hereafter referred to as WISP1), a member of the CCN family, is found in mineralized tissues and is produced by osteoblasts and their precursors. In this study, Wisp1-deficient (Wisp1(-/-)) mice were generated. Using dual-energy x-ray absorptiometry, we showed that by 3 months, the total bone mineral density of Wisp1(-/-) mice was significantly lower than that of WT mice. Further investigation by micro-computed tomography showed that female Wisp1(-/-) mice had decreased trabecular bone volume/total volume and that both male and female Wisp1(-/-) mice had decreased cortical bone thickness accompanied by diminished biomechanical strength. The molecular basis for decreased bone mass in Wisp1(-/-) mice arises from reduced bone formation likely caused by osteogenic progenitors that differentiate poorly compared with WT cells. Osteoclast precursors from Wisp1(-/-) mice developed more tartrate-resistant acid phosphatase-positive cells in vitro and in transplants, suggesting that WISP1 is also a negative regulator of osteoclast differentiation. When bone turnover (formation and resorption) was induced by ovariectomy, Wisp1(-/-) mice had lower bone mineral density compared WT mice, confirming the potential for multiple roles for WISP1 in controlling bone homeostasis. Wisp1(-/-) bone marrow stromal cells had reduced expression of beta-catenin and its target genes, potentially caused by WISP1 inhibition of SOST binding to LRP6. Taken together, our data suggest that the decreased bone mass found in Wisp1(-/-) mice could potentially be caused by an insufficiency in the osteodifferentiation capacity of bone marrow stromal cells arising from diminished Wnt signaling, ultimately leading to altered bone turnover and weaker biomechanically compromised bones.	[Maeda, Azusa; Ono, Mitsuaki; Holmbeck, Kenn; Li, Li; Kilts, Tina M.; Kram, Vardit; Noonan, Megan L.; Yoshioka, Yuya; Robey, Pamela G.; Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; [McNerny, Erin M. B.; Tantillo, Margaret A.; Kohn, David H.] Univ Michigan, Biol & Mat Sci, Ann Arbor, MI 48109 USA; [McNerny, Erin M. B.; Tantillo, Margaret A.; Kohn, David H.] Univ Michigan, Div Prosthodont, Ann Arbor, MI 48109 USA; [Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Orthoped Hosp, Los Angeles, CA 90095 USA; [Lyons, Karen M.] Univ Calif Los Angeles, Orthoped Hosp, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Maeda, Azusa; Ono, Mitsuaki; Yoshioka, Yuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama, Okayama 7008558, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Okayama University	Young, MF (corresponding author), NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bldg 30,Rm 225, Bethesda, MD 20892 USA.	myoung@dir.nidcr.nih.gov	Robey, Pamela Gehron/H-1429-2011; Kohn, David/AAJ-4131-2020	Robey, Pamela Gehron/0000-0002-5316-5576; Young, Marian F/0000-0003-0929-8854; Noonan, Megan/0000-0002-1763-1867; McNerny, Erin/0000-0002-1825-9657; Holmbeck, Kenn/0000-0002-4472-3257	National Institutes of Health from NIDCR [1 Z01 DE000379-21]; NIAMS [R01 AR056657, AR052686]; NIDCR [T32 DE007057]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056657, R01AR052686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057, ZIADE000380, ZIADE000379, ZIADE000676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000379] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant 1 Z01 DE000379-21 from NIDCR (to M. O., K. H., L. L., T. M. K., V. K., M. L. N., P. G. R., and M. F. Y.), Award R01 AR056657 from NIAMS and Award T32 DE007057 from NIDCR (to E. M., B. M., M. A. T., and D. H. K.), and Award AR052686 from NIAMS (to K. M. L.). This work was also supported by a fellowship from the Japan Society for the Promotion of Science (to A. M.).	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Canalis E, 2010, ENDOCRINOLOGY, V151, P3490, DOI 10.1210/en.2010-0145; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Drake MT, 2014, CURR OPIN RHEUMATOL, V26, P447, DOI 10.1097/BOR.0000000000000073; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kawaki H, 2008, J BONE MINER RES, V23, P1751, DOI 10.1359/JBMR.080615; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Matsushita Y, 2013, J BIOL CHEM, V288, P19973, DOI 10.1074/jbc.M113.454652; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Smerdel-Ramoya' A, 2008, ENDOCRINOLOGY, V149, P4374, DOI 10.1210/en.2008-0254; Takigawa M, 2013, J CELL COMMUN SIGNAL, V7, P191, DOI 10.1007/s12079-013-0204-8; Tan TW, 2012, J CELL PHYSIOL, V227, P2531, DOI 10.1002/jcp.22991; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; WANG SJ, 2012, J NONPARAMETR STAT, V24, P1	27	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14004	14018		10.1074/jbc.M114.628818	http://dx.doi.org/10.1074/jbc.M114.628818			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25864198	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000355313000031
J	Rajbhandari, P; Ozers, MS; Solodin, NM; Warren, CL; Alarid, ET				Rajbhandari, Prashant; Ozers, Mary Szatkowski; Solodin, Natalia M.; Warren, Christopher L.; Alarid, Elaine T.			Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TRANSCRIPTION FACTORS; PROLYL ISOMERIZATION; INTRINSIC DISORDER; RESPONSE ELEMENTS; STRUCTURAL BASIS; PHOSPHORYLATION SITES; ACTIVATION FUNCTIONS; STEROID-RECEPTOR; GENE-EXPRESSION	The transcriptional activity of estrogen receptor alpha (ER alpha), the key driver of breast cancer proliferation, is enhanced by multiple cellular interactions, including phosphorylation-dependent interaction with Pin1, a proline isomerase, which mediates cis-trans isomerization of the N-terminal Ser(P)(118)-Pro(119) in the intrinsically disordered AF1 (activation function 1) domain of ER alpha. Because both ER alpha and Pin1 have multiple cellular partners, it is unclear how Pin1 assists in the regulation of ER alpha transactivation mechanisms and whether the functional effects of Pin1 on ER alpha signaling are direct or indirect. Here, we tested the specific action of Pin1 on an essential step in ER alpha transactivation, binding to specific DNA sites. DNA binding analysis demonstrates that stable overexpression of Pin1 increases endogenous ER alpha DNA binding activity when activated by estrogen but not by tamoxifen or EGF. Increased DNA binding affinity is a direct effect of Pin1 on ER alpha because it is observed in solution-based assays with purified components. Further, our data indicate that isomerization is required for Pin1-modulation of ER alpha DNA interactions. In an unbiased in vitro DNA binding microarray with hundreds of thousands of permutations of ER alpha-binding elements, Pin1 selectively enhances the binding affinity of ER alpha to consensus DNA elements. These studies reveal that Pin1 isomerization of phosphorylated ER alpha can directly regulate the function of the adjacent DNA binding domain, and this interaction is further modulated by ligand binding in the ligand-binding domain, providing evidence for Pin1-dependent allosteric regulation of ER alpha function.	[Rajbhandari, Prashant; Ozers, Mary Szatkowski; Solodin, Natalia M.; Alarid, Elaine T.] Univ Wisconsin, Dept Oncol, McArdle Labs Canc Res, Madison, WI 53705 USA; [Rajbhandari, Prashant; Ozers, Mary Szatkowski; Solodin, Natalia M.; Alarid, Elaine T.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53705 USA; [Warren, Christopher L.] Proteovista LLC, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alarid, ET (corresponding author), Univ Wisconsin, Carbone Comprehens Canc Ctr, Dept Oncol, Wisconsin Inst Med Res 6151, 1111 Highland Ave, Madison, WI 53705 USA.	alarid@oncology.wisc.edu		Rajbhandari, Prashant/0000-0002-8146-3861; Alarid, Elaine/0000-0002-9426-7974	McArdle Laboratories for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA159578, T32CA009135] Funding Source: NIH RePORTER	McArdle Laboratories for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank McArdle Laboratories for Cancer Research for support of this project. We also thank the University of Wisconsin Carbone Comprehensive Cancer Center for use of its shared services to complete this research. We thank Dr. Kun Ping Lu (Harvard Medical School) for Pin1 reagents and Dr. Yongna Xing (University of Wisconsin, Madison, WI) for purified PP2A holoenzyme.	Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Brondani V, 2005, BIOCHEM BIOPH RES CO, V328, P6, DOI 10.1016/j.bbrc.2004.12.130; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; El Marzouk S, 2008, J STEROID BIOCHEM, V110, P186, DOI 10.1016/j.jsbmb.2008.03.034; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Fujimoto Y, 2010, J BIOL CHEM, V285, P3126, DOI 10.1074/jbc.M109.055095; FURLOW JD, 1990, ENDOCRINOLOGY, V127, P1028, DOI 10.1210/endo-127-3-1028; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Handel AE, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-45; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; Khanal P, 2012, ONCOGENE, V31, P3845, DOI 10.1038/onc.2011.548; KLEINHITPASS L, 1989, MOL CELL BIOL, V9, P43, DOI 10.1128/MCB.9.1.43; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2013, J BIOL CHEM, V288, P30285, DOI 10.1074/jbc.M113.491787; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; La Montagna R, 2012, CELL CYCLE, V11, P3415, DOI 10.4161/cc.21730; Laity JH, 2000, BIOCHEMISTRY-US, V39, P5341, DOI 10.1021/bi9926678; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2006, MOL CARCINOGEN, V45, P397, DOI 10.1002/mc.20216; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Lucchetti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055355; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Ozers MS, 2009, METHODS MOL BIOL, V544, P637, DOI 10.1007/978-1-59745-483-4_41; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Poolman TM, 2013, NUCLEIC ACIDS RES, V41, P8515, DOI 10.1093/nar/gkt624; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Pursglove SE, 2004, BIOCHEM BIOPH RES CO, V323, P750, DOI 10.1016/j.bbrc.2004.08.166; Rajbhandari P, 2014, ONCOGENE, V33, P1438, DOI 10.1038/onc.2013.78; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Tzeng DZ, 1996, BIOCHEM BIOPH RES CO, V223, P554, DOI 10.1006/bbrc.1996.0933; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005	87	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13749	13762		10.1074/jbc.M114.621698	http://dx.doi.org/10.1074/jbc.M114.621698			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25866209	Green Published, hybrid			2022-12-26	WOS:000355313000011
J	Cheyuo, C; Aziz, M; Yang, WL; Jacob, A; Zhou, M; Wang, P				Cheyuo, Cletus; Aziz, Monowar; Yang, Weng-Lang; Jacob, Asha; Zhou, Mian; Wang, Ping			Milk Fat Globule-EGF Factor VIII Attenuates CNS Injury by Promoting Neural Stem Cell Proliferation and Migration after Cerebral Ischemia	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; CYCLIN D2; RAT; NEUROGENESIS; PHAGOCYTOSIS; INFLAMMATION; OSTEOPONTIN; LACTADHERIN; STRIATUM; NEURONS	The mediators in activating neural stem cells during the regenerative process of neurogenesis following stroke have not been fully identified. Milk fat globule-EGF Factor VIII (MFGE8), a secreted glycoprotein serves several cellular functions by binding to its receptor, alpha(v)beta(3)-integrin. However, its role in regulating neural stem cells after stroke has not been determined yet. We therefore, aim to reveal whether MFG-E8 promotes neural stem cell proliferation and migration during stroke. Stroke was induced in wild-type (Wt) and MFG-E8-deficinet (Mfge8(-/-)) mice by transient middle cerebral artery occlusion (tMCAO). Commercially available recombinant mouse MFG-E8 (rmMFG-E8) was used for mechanistic assays in neural stem cell line, while the in house prepared recombinant human MFG-E8 (rhMFG-E8) was used for in vivo administration into rats with tMCAO. The in vitro effects of recombinant rmMFG-E8 for the neural stem cell proliferation and migration were determined by BrdU and transwell migration assay, respectively. The expression of cyclin D2, p53 and netrin-1, was analyzed by qPCR. We report that the treatment of rhMFG-E8 significantly improved the neurological deficit score, body weight lost and neural stem cell proliferation in a rat model of tMCAO. Conversely, decreased neural stem cell proliferation was observed in Mfge8(-/-) mice in comparison with the Wt counterparts underwent tMCAO. rmMFG-E8 stimulated the proliferation of mouse embryonic neural stem cells via upregulation of cyclin D2 and downregulation of p53, which is mediated by alpha(v)beta(3)- integrin. rmMFG-E8 also promoted mouse embryonic neural stem cell migration via alpha(v)beta(3)-integrin dependent manner in upregulating netrin-1. Our findings suggest MFG-E8 to promote neural stem cell proliferation and migration, which therefore establishes a promising therapeutic strategy for cerebral ischemia.	[Cheyuo, Cletus; Aziz, Monowar; Yang, Weng-Lang; Jacob, Asha; Zhou, Mian; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA; [Aziz, Monowar; Yang, Weng-Lang; Jacob, Asha; Zhou, Mian; Wang, Ping] Hofstra North Shore Long Isl Jewish Sch Med, Dept Surg, Manhasset, NY USA	Northwell Health; Hofstra University	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY 11030 USA.	pwang@nshs.edu	Cheyuo, Cletus/AAM-5785-2021; Varghese, Asha/AAK-4922-2021	Wang, Ping/0000-0002-1557-0394; Cheyuo, Cletus/0000-0002-9717-3738	National Institutes of Health (NIH) [R01 GM 057468, R01 HL076179, R01 GM 053008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057468, R01GM053008] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH) grants, R01 GM 057468, R01 HL076179 and R01 GM 053008 (PW). PW is co-founder of TheraSource LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046540; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2012, J IMMUNOL, V189, P393, DOI 10.4049/jimmunol.1200262; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Cayre M, 2013, DEVELOPMENT, V140, P3107, DOI 10.1242/dev.092999; Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018; Deroide N, 2013, J CLIN INVEST, V123, P1176, DOI 10.1172/JCI65167; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jiang P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3196; Kerever A, 2014, STEM CELL RES, V12, P492, DOI 10.1016/j.scr.2013.12.009; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Ortega FJ, 2013, J CEREBR BLOOD F MET, V33, P356, DOI 10.1038/jcbfm.2012.166; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Shah KG, 2012, INTENS CARE MED, V38, P128, DOI 10.1007/s00134-011-2353-7; SHIOIDE M, 1993, J CELL BIOCHEM, V53, P176, DOI 10.1002/jcb.240530211; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Vande Velde G, 2012, NEUROIMAGE, V62, P367, DOI 10.1016/j.neuroimage.2012.04.040; Wang P., 2014, MFG E8 INFLAMMATION, Vxv; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Zhang J, 2013, EXPERT OPIN BIOL TH, V13, P1229, DOI 10.1517/14712598.2013.804507; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	40	14	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122833	10.1371/journal.pone.0122833	http://dx.doi.org/10.1371/journal.pone.0122833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867181	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100107
J	Ignacio, DL; Silvestre, DHD; Cavalcanti-de-Albuquerque, JPA; Louzada, RA; Carvalho, DP; Werneck-de-Castro, JP				Ignacio, Daniele Leao; Silvestre, Diego H. da S.; Albuquerque Cavalcanti-de-Albuquerque, Joao Paulo; Louzada, Ruy Andrade; Carvalho, Denise P.; Werneck-de-Castro, Joao Pedro			Thyroid Hormone and Estrogen Regulate Exercise-Induced Growth Hormone Release	PLOS ONE			English	Article							OBESITY; GENDER; INTENSITY; SECRETION; AXIS; SEX; PATHOPHYSIOLOGY; REPLACEMENT; DEIODINASE; METABOLISM	Growth hormone (GH) regulates whole body metabolism, and physical exercise is the most potent stimulus to induce its secretion in humans. The mechanisms underlying GH secretion after exercise remain to be defined. The aim of this study was to elucidate the role of estrogen and pituitary type 1 deiodinase (D1) activation on exercise-induced GH secretion. Ten days after bilateral ovariectomy, animals were submitted to 20 min of treadmill exercise at 75% of maximum aerobic capacity and tissues were harvested immediately or 30 min after exercise. Non-exercised animals were used as controls. A significant increase in D1 activity occurred immediately after exercise (similar to 60%) in sham-operated animals and GH was higher (similar to 6-fold) 30 min after exercise. Estrogen deficient rats exhibited basal levels of GH and D1 activity comparable to those found in control rats. However, after exercise both D1 activity and serum GH levels were blunted compared to sedentary rats. To understand the potential cause-effect of D1 activation in exercise-induced GH release, we pharmacologically blocked D1 activity by propylthiouracil (PTU) injection into intact rats and submitted them to the acute exercise session. D1 inhibition blocked exercise-induced GH secretion, although basal levels were unaltered. In conclusion, estrogen deficiency impairs the induction of thyroid hormone activating enzyme D1 in the pituitary, and GH release by acute exercise. Also, acute D1 activation is essential for exercise-induced GH response.	[Ignacio, Daniele Leao; Silvestre, Diego H. da S.; Albuquerque Cavalcanti-de-Albuquerque, Joao Paulo; Louzada, Ruy Andrade; Carvalho, Denise P.; Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Ignacio, Daniele Leao; Silvestre, Diego H. da S.; Albuquerque Cavalcanti-de-Albuquerque, Joao Paulo; Louzada, Ruy Andrade; Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Sch Phys Educ & Sports, Rio De Janeiro, Brazil; [Werneck-de-Castro, Joao Pedro] Rush Univ, Med Ctr, Dept Endocrinol & Metab, Chicago, IL 60612 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Rush University	Werneck-de-Castro, JP (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.	joaopedrowerneck@yahoo.com.br	Louzada, Ruy Andrade AN/T-2494-2017; de Albuquerque, João Paulo Cavalcanti/B-4097-2017; Carvalho, Denise P/H-6306-2012; Cavalcanti-de-Albuquerque, João Paulo A/B-4753-2017	Louzada, Ruy Andrade AN/0000-0003-1789-4234; Carvalho, Denise P/0000-0001-6933-6424; Cavalcanti-de-Albuquerque, Joao Paulo/0000-0002-1894-9658; Werneck-de-Castro, Joao Pedro/0000-0001-9242-7930	CNPq; FAPERJ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by research grants from CNPq, FAPERJ and CAPES. Daniele Leao Ignacio is recipient of a fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur A, 1999, EUR J ENDOCRINOL, V140, P367, DOI 10.1530/eje.0.1400367; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Birzniece V, 2012, J CLIN ENDOCR METAB, V97, pE521, DOI 10.1210/jc.2011-3347; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRILLON D, 1986, ENDOCR RES, V12, P137, DOI 10.1080/07435808609035433; BUTKUS JA, 1995, ENDOCRINOLOGY, V136, P2664, DOI 10.1210/en.136.6.2664; Cavalcanti-de-Albuquerque JPA, 2014, J APPL PHYSIOL, V116, P779, DOI 10.1152/japplphysiol.00121.2013; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Fanciulli G, 2009, HUM REPROD UPDATE, V15, P341, DOI 10.1093/humupd/dmp005; FELSING NE, 1992, J CLIN ENDOCR METAB, V75, P157, DOI 10.1210/jcem.75.1.1619005; Fortunato RS, 2008, J ENDOCRINOL, V198, P347, DOI 10.1677/JOE-08-0174; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; GORDON SE, 1994, J APPL PHYSIOL, V76, P821, DOI 10.1152/jappl.1994.76.2.821; HERVAS F, 1975, ENDOCRINOLOGY, V97, P91, DOI 10.1210/endo-97-1-91; Ignacio DL, 2012, HORM METAB RES, V44, P797, DOI 10.1055/s-0032-1314875; Ippoliti F, 2013, J NEUROIMMUNE PHARM, V8, P212, DOI 10.1007/s11481-012-9432-6; Jorgensen JOL, 2010, PEDIATR NEPHROL, V25, P705, DOI 10.1007/s00467-009-1334-3; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kanaley JA, 1999, J CLIN ENDOCR METAB, V84, P3156, DOI 10.1210/jc.84.9.3156; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Moreno M, 2002, ENDOCRINOLOGY, V143, P504, DOI 10.1210/en.143.2.504; Nappi RE, 2012, CLIMACTERIC, V15, P36, DOI 10.3109/13697137.2011.647840; Percegoni N, 2009, HORM METAB RES, V41, P50, DOI 10.1055/s-0028-1087173; Poehlman ET, 2002, ACTA OBSTET GYNECOL, V84, P1131; Pritzlaff-Roy CJ, 2002, J APPL PHYSIOL, V92, P2053, DOI 10.1152/japplphysiol.01018.2001; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; RUSSELLJONES DL, 1993, CLIN ENDOCRINOL, V38, P427, DOI 10.1111/j.1365-2265.1993.tb00525.x; SNEL YEM, 1995, AM J CLIN NUTR, V61, P1290, DOI 10.1093/ajcn/61.6.1290; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; Veldhuis JD, 1997, J CLIN ENDOCR METAB, V82, P3414, DOI 10.1210/jc.82.10.3414; Weltman A, 1997, MED SCI SPORT EXER, V29, P669, DOI 10.1097/00005768-199705000-00013; Weltman A, 2008, J CLIN ENDOCR METAB, V93, P4711, DOI 10.1210/jc.2008-0998; Werneck-De-Castro JPS, 2006, BASIC RES CARDIOL, V101, P494, DOI 10.1007/s00395-006-0605-4; Wheldon A, 2006, GROWTH HORM IGF RES, V16, P125, DOI 10.1016/j.ghir.2006.02.005; Wideman L, 1999, J APPL PHYSIOL, V87, P1154, DOI 10.1152/jappl.1999.87.3.1154; Wideman L, 2006, J APPL PHYSIOL, V101, P1641, DOI 10.1152/japplphysiol.00518.2006	37	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122556	10.1371/journal.pone.0122556	http://dx.doi.org/10.1371/journal.pone.0122556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874614	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100083
J	Castellani, J; Mihaylova, B; Evers, SMAA; Paulus, ATG; Mrango, ZE; Kimbute, O; Shishira, JP; Mulokozi, F; Petzold, M; Singlovic, J; Gomes, M				Castellani, Joelle; Mihaylova, Borislava; Evers, Silvia M. A. A.; Paulus, Aggie T. G.; Mrango, Zakayo E.; Kimbute, Omari; Shishira, Joseph P.; Mulokozi, Francis; Petzold, Max; Singlovic, Jan; Gomes, Melba			Out-of-Pocket Costs and Other Determinants of Access to Healthcare for Children with Febrile Illnesses: A Case-Control Study in Rural Tanzania	PLOS ONE			English	Article							MALARIA; DISTRICT	Objectives To study private costs and other determinants of access to healthcare for childhood fevers in rural Tanzania. Methods A case-control study was conducted in Tanzania to establish factors that determine access to a health facility in acute febrile illnesses in children less than 5 years of age. Carers of eligible children were interviewed in the community; cases were represented by patients who went to a facility and controls by those who did not. A Household Wealth Index was estimated using principal components analysis. A multivariable logistic regression analysis was performed to understand the factors which influenced attendance of healthcare facility including severity of the illness and household wealth/socio-demographic indicators. To complement the data on costs from community interviews, a hospital-based study obtained details of private expenditures for hospitalised children under the age of 5. Results Severe febrile illness is strongly associated with health facility attendance (OR: 35.76, 95% CI: 3.68-347.43, p = 0.002 compared with less severe febrile illness). Overall, the private costs of an illness for patients who went to a hospital were six times larger than private costs of controls ($5.68 vs. $0.90, p<0.0001). Household wealth was not significantly correlated with total costs incurred. The separate hospital based cost study indicated that private costs were three times greater for admissions at the mission versus public hospital: $13.68 mission vs. $4.47 public hospital (difference $9.21 (95% CI: 7.89 - 10.52), p<0.0001). In both locations, approximately 50% of the cost was determined by the duration of admission, with each day in hospital increasing private costs by about 12% (95% CI: 5% - 21%). Conclusion The more severely ill a child, the higher the probability of attending hospital. We did not find association between household wealth and attending a health facility; nor was there an association between household wealth and private cost.	[Castellani, Joelle; Evers, Silvia M. A. A.; Paulus, Aggie T. G.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands; [Mihaylova, Borislava] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Mrango, Zakayo E.; Kimbute, Omari; Shishira, Joseph P.; Mulokozi, Francis] Natl Inst Med Res, Kilosa Stn, Kilosa, Tanzania; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Singlovic, Jan] World Hlth Org Consultant, Libochovany, Czech Republic; [Gomes, Melba] WHO, UNICEF UNDP World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	Maastricht University; University of Oxford; University of Gothenburg; World Health Organization; The World Bank; World Health Organization	Castellani, J (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands.	j.castellani@maastrichtuniversity.nl	Evers, Silvia/ABG-2128-2020; Evers, Silvia MAA/K-9720-2015	Evers, Silvia/0000-0003-1026-570X; Evers, Silvia MAA/0000-0003-1026-570X; Kimbute, Omari/0000-0002-0067-5783; Castellani, Joelle/0000-0002-8176-0903; Mihaylova, Borislava/0000-0002-0951-1304	Pan American Health and Education Foundation through EUROHEALTH	Pan American Health and Education Foundation through EUROHEALTH	This work was supported by the Pan American Health and Education Foundation through EUROHEALTH. URL: http://www.pahef.org/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikaeli J, 2010, 104 RES POV ALL; Alilio MS, 2004, AM J TROP MED HYG, V71, P205, DOI 10.4269/ajtmh.2004.71.205; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Jowett M, 2000, MALARIA EXPENDITURE; Kalyango JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060481; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Mboera LEG, 2010, GEOSPATIAL HEALTH, V4, P167, DOI 10.4081/gh.2010.198; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Ministry of Health and AMMP team, 1997, POL IMPL AD MORB MOR; Mubyazi G. M., 2004, East African Journal of Public Health, V1, P11; Muela SH, 2000, HEALTH POLICY PLANN, V15, P296, DOI 10.1093/heapol/15.3.296; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Saksena P, 2010, HEALTH POLICY PLANN, V25, P328, DOI 10.1093/heapol/czq003; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Tanzania Turiani-Hospital Foundation, 2007, TUR HOSP HLTH ALL MV; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2008, INT MAN CHILDH ILLN	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122386	10.1371/journal.pone.0122386	http://dx.doi.org/10.1371/journal.pone.0122386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25861012	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300044
J	Chen, SY; Meng, FJ; Chen, ZZ; Tomlinson, BN; Wesley, JM; Sun, GY; Whaley-Connell, AT; Sowers, JR; Cui, JK; Gu, ZZ				Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Whaley-Connell, Adam T.; Sowers, James R.; Cui, Jiankun; Gu, Zezong			Two-Dimensional Zymography Differentiates Gelatinase Isoforms in Stimulated Microglial Cells and in Brain Tissues of Acute Brain Injuries	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; POSTTRANSLATIONAL MODIFICATIONS; NADPH OXIDASE; MMP-9; PROTEIN; ROLES; ACTIVATION; INHIBITION; INDUCTION; RAT	Excessive activation of gelatinases (MMP-2/-9) is a key cause of detrimental outcomes in neurodegenerative diseases. A single-dimension zymography has been widely used to determine gelatinase expression and activity, but this method is inadequate in resolving complex enzyme isoforms, because gelatinase expression and activity could be modified at transcriptional and posttranslational levels. In this study, we investigated gelatinase isoforms under in vitro and in vivo conditions using two-dimensional (2D) gelatin zymography electrophoresis, a protocol allowing separation of proteins based on isoelectric points (pI) and molecular weights. We observed organomercuric chemical 4-aminophenylmercuric acetate-induced activation of MMP-2 isoforms with variant pI values in the conditioned medium of human fibrosarcoma HT1080 cells. Studies with murine BV-2 microglial cells indicated a series of proform MMP-9 spots separated by variant pI values due to stimulation with lipopolysaccharide (LPS). The MMP-9 pI values were shifted after treatment with alkaline phosphatase, suggesting presence of phosphorylated isoforms due to the proinflammatory stimulation. Similar MMP-9 isoforms with variant pI values in the same molecular weight were also found in mouse brains after ischemic and traumatic brain injuries. In contrast, there was no detectable pI differentiation of MMP-9 in the brains of chronic Zucker obese rats. These results demonstrated effective use of 2D zymography to separate modified MMP isoforms with variant pI values and to detect posttranslational modifications under different pathological conditions.	[Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Chen, Shanyan] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Tomlinson, Brittany N.] Univ Missouri, Grad Sch, Pathol Program, Columbia, MO USA; [Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Whaley-Connell, Adam T.; Sowers, James R.] Univ Missouri, Sch Med, Dept Internal Med, Diabet & Cardiovasc Ctr, Columbia, MO USA; [Sowers, James R.; Cui, Jiankun; Gu, Zezong] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	guze@health.missouri.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Whaley-Connell, Adam/0000-0001-8955-5560	American Heart Association National Scientist Development award [09SDG2260983]; Dana Foundation; National Football Leagues (NFL) Charities Foundation; University of Missouri Mizzou Advantage One Health One Medicine Program; Department of Pathology Research funds	American Heart Association National Scientist Development award(American Heart Association); Dana Foundation; National Football Leagues (NFL) Charities Foundation; University of Missouri Mizzou Advantage One Health One Medicine Program; Department of Pathology Research funds	Funding was provided by American Heart Association National Scientist Development award (09SDG2260983) to ZG; The Dana Foundation to ZG, http://www.dana.org/grants/; The National Football Leagues (NFL) Charities Foundation to ZG, https://www.nflcharities.org/; The University of Missouri Mizzou Advantage One Health One Medicine Program, http://mizzouadvantage.missouri.edu/medicine/; and the Department of Pathology Research funds to ZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chander PN, 2004, J AM SOC NEPHROL, V15, P2391, DOI 10.1097/01.ASN.0000135971.88164.2C; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Choi NS, 2004, J BIOCHEM MOL BIOL, V37, P298; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Chuang DY, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554946; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayden MR, 2013, CARDIORENAL MED, V3, P265, DOI 10.1159/000357113; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jacob Archana M., 2008, V446, P21, DOI 10.1007/978-1-60327-084-7_2; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Labrie M, 2013, CELL MOL LIFE SCI, V70, P3109, DOI 10.1007/s00018-012-1214-z; Larocca M, 2010, J SCI FOOD AGR, V90, P2411, DOI 10.1002/jsfa.4100; Launer LJ, 2009, STROKE, V40, pS53, DOI 10.1161/STROKEAHA.108.533075; Lee EJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-116; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; Lodemel JB, 2004, COMP BIOCHEM PHYS B, V139, P253, DOI 10.1016/j.cbpc.2004.08.004; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Leme AFP, 2009, PROTEOMICS, V9, P733, DOI 10.1002/pmic.200800484; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rossano R, 2014, J CELL MOL MED, V18, P242, DOI 10.1111/jcmm.12181; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Tsioufis C, 2012, CURR TOP MED CHEM, V12, P1159, DOI 10.2174/1568026611208011159; Tyagi SC, 1996, J MOL CELL CARDIOL, V28, P1415, DOI 10.1006/jmcc.1996.0132; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wilkesman JG, 2007, ELECTROPHORESIS, V28, P429, DOI 10.1002/elps.200600332; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Yim HE, 2012, J NUTR BIOCHEM, V23, P937, DOI 10.1016/j.jnutbio.2011.04.020; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123852	10.1371/journal.pone.0123852	http://dx.doi.org/10.1371/journal.pone.0123852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859655	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300116
J	Lanaspa, MA; Epperson, LE; Li, NX; Cicerchi, C; Garcia, GE; Roncal-Jimenez, CA; Trostel, J; Jain, S; Mant, CT; Rivard, CJ; Ishimoto, T; Shimada, M; Sanchez-Lozada, LG; Nakagawa, T; Jani, A; Stenvinkel, P; Martin, SL; Johnson, RJ				Lanaspa, Miguel A.; Epperson, L. Elaine; Li, Nanxing; Cicerchi, Christina; Garcia, Gabriela E.; Roncal-Jimenez, Carlos A.; Trostel, Jessica; Jain, Swati; Mant, Colin T.; Rivard, Christopher J.; Ishimoto, Takuji; Shimada, Michiko; Sanchez-Lozada, Laura Gabriela; Nakagawa, Takahiko; Jani, Alkesh; Stenvinkel, Peter; Martin, Sandra L.; Johnson, Richard J.			Opposing Activity Changes in AMP Deaminase and AMP-Activated Protein Kinase in the Hibernating Ground Squirrel	PLOS ONE			English	Article							MAMMALIAN HIBERNATION; MITOCHONDRIAL METABOLISM; LIQUID-CHROMATOGRAPHY; BODY-TEMPERATURE; ENERGY SENSOR; CELL-FUNCTION; DAILY TORPOR; AROUSAL; MUSCLE; ACCUMULATION	Hibernating animals develop fatty liver when active in summertime and undergo a switch to a fat oxidation state in the winter. We hypothesized that this switch might be determined by AMP and the dominance of opposing effects: metabolism through AMP deaminase (AMPD2) (summer) and activation of AMP-activated protein kinase (AMPK) (winter). Liver samples were obtained from 13-lined ground squirrels at different times during the year, including summer and multiples stages of winter hibernation, and fat synthesis and beta-fatty acid oxidation were evaluated. Changes in fat metabolism were correlated with changes in AMPD2 activity and intrahepatic uric acid (downstream product of AMPD2), as well as changes in AMPK and intrahepatic beta-hydroxybutyrate (a marker of fat oxidation). Hepatic fat accumulation occurred during the summer with relatively increased enzymes associated with fat synthesis (FAS, ACL and ACC) and decreased enoyl CoA hydratase (ECH1) and carnitine palmitoyltransferase 1A (CPT1A), rate limiting enzymes of fat oxidation. In summer, AMPD2 activity and intrahepatic uric acid levels were high and hepatic AMPK activity was low. In contrast, the active phosphorylated form of AMPK and beta-hydroxybutyrate both increased during winter hibernation. Therefore, changes in AMPD2 and AMPK activity were paralleled with changes in fat synthesis and fat oxidation rates during the summer-winter cycle. These data illuminate the opposing forces of metabolism of AMP by AMPD2 and its availability to activate AMPK as a switch that governs fat metabolism in the liver of hibernating ground squirrel.	[Lanaspa, Miguel A.; Li, Nanxing; Cicerchi, Christina; Garcia, Gabriela E.; Roncal-Jimenez, Carlos A.; Trostel, Jessica; Jain, Swati; Rivard, Christopher J.; Ishimoto, Takuji; Shimada, Michiko; Sanchez-Lozada, Laura Gabriela; Nakagawa, Takahiko; Jani, Alkesh; Johnson, Richard J.] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Epperson, L. Elaine; Martin, Sandra L.] Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Mant, Colin T.] Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Sanchez-Lozada, Laura Gabriela] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Sanchez-Lozada, Laura Gabriela] INC Ignacio Chavez, Dept Nephrol, Mexico City, DF, Mexico; [Stenvinkel, Peter] Karolinska Inst, Dept Clin Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Johnson, Richard J.] Eastern Colorado Hlth Syst, Div Nephrol, Dept Vet Affairs, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Karolinska Institutet	Lanaspa, MA (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	Miguel.Lanaspagarcia@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020; Ishimoto, Takuji/M-4873-2014; Sanchez-Lozada, Laura/AAS-2104-2021	Ishimoto, Takuji/0000-0002-9861-5331; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617; Stenvinkel, Peter/0000-0002-8785-4820	NIH [HL68607, RC4 DK90859]; University of Colorado [HL089049]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607, R01HL089049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082509, RC4DK090859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by NIH grants HL68607, RC4 DK90859 and startup funds from the University of Colorado to RJJ and grant HL089049 to SLM for support of the animal samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Badry KS, COMP BIOCH PHYSL A, V74, P435; ALBADRY KS, 1983, COMP BIOCHEM PHYS A, V74, P143, DOI 10.1016/0300-9629(83)90725-9; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Bairlein F, 2002, NATURWISSENSCHAFTEN, V89, P1, DOI 10.1007/s00114-001-0279-6; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Brown JCL, 2010, BBA-BIOENERGETICS, V1797, P476, DOI 10.1016/j.bbabio.2010.01.009; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; CHANEY AL, 1962, CLIN CHEM, V8, P130; Cicerchi C, 2014, FASEB J, V28, P3339, DOI 10.1096/fj.13-243634; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Epperson LE, 2011, PHYSIOL GENOMICS, V43, P799, DOI 10.1152/physiolgenomics.00028.2011; FLORANT GL, 1985, AM J PHYSIOL, V249, pR159, DOI 10.1152/ajpregu.1985.249.2.R159; Florant GL, 2012, J COMP PHYSIOL B, V182, P451, DOI 10.1007/s00360-011-0630-y; Hampton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085157; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Healy JE, 2011, COMP BIOCHEM PHYS A, V159, P322, DOI 10.1016/j.cbpa.2011.03.026; Hindle AG, 2015, J EXP BIOL, V218, P276, DOI 10.1242/jeb.109512; Hindle AG, 2014, PHYSIOL GENOMICS, V46, P348, DOI 10.1152/physiolgenomics.00190.2013; Horman S, 2005, COMP BIOCHEM PHYS B, V142, P374, DOI 10.1016/j.cbpb.2005.08.010; Horwitz BA, 2013, AM J PHYSIOL-REG I, V305, pR759, DOI 10.1152/ajpregu.00450.2012; Jani A, 2013, AM J PHYSIOL-RENAL, V305, pF1521, DOI 10.1152/ajprenal.00675.2012; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Johnson RJ, 2013, OBESITY, V21, P659, DOI 10.1002/oby.20026; Keesey RE, 1997, J NUTR, V127, pS1875, DOI 10.1093/jn/127.9.1875S; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Lanaspa MA, 2009, J BIOL CHEM, V284, P19974, DOI 10.1074/jbc.M109.001792; Lee CC, 2008, ANNU REV MED, V59, P177, DOI 10.1146/annurev.med.59.061506.110403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lushchak VI, 2008, COMP BIOCHEM PHYS B, V149, P362, DOI 10.1016/j.cbpb.2007.10.008; Martin SL, 2008, DIABETES VASC DIS RE, V5, P76, DOI 10.3132/dvdr.2008.013; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nelson CJ, 2009, PHYSIOL GENOMICS, V37, P43, DOI 10.1152/physiolgenomics.90323.2008; Okamoto I, 2006, COMP BIOCHEM PHYS C, V144, P47, DOI 10.1016/j.cbpc.2006.05.003; Ortmann S, 2000, AM J PHYSIOL-REG I, V278, pR698, DOI 10.1152/ajpregu.2000.278.3.R698; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Plaideau C, 2012, FASEB J, V26, P2685, DOI 10.1096/fj.11-198168; Robin JP, 1998, AM J PHYSIOL-REG I, V274, pR746, DOI 10.1152/ajpregu.1998.274.3.R746; Rouble AN, 2014, MOL CELL BIOCHEM, V393, P271, DOI 10.1007/s11010-014-2070-y; Shaw NM, 1979, BIOCHEM SOC T, V7, P1250, DOI 10.1042/bst0071250; Sheriff MJ, 2012, J COMP PHYSIOL B, V182, P841, DOI 10.1007/s00360-012-0661-z; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Staples JF, 2008, J COMP PHYSIOL B, V178, P811, DOI 10.1007/s00360-008-0282-8; Staples JF, 2014, J EXP BIOL, V217, P2032, DOI 10.1242/jeb.092973; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Valente A, 2015, BIOL REV, V90, P77, DOI 10.1111/brv.12099; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374	49	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123509	10.1371/journal.pone.0123509	http://dx.doi.org/10.1371/journal.pone.0123509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856396	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500094
J	Pan, J; Li, H; Zhang, B; Xiong, R; Zhang, Y; Kang, WY; Chen, W; Zhao, ZB; Chen, SD				Pan, Jing; Li, Hui; Zhang, Bei; Xiong, Ran; Zhang, Yu; Kang, Wen-Yan; Chen, Wei; Zhao, Zong-Bo; Chen, Sheng-Di			Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway	PLOS ONE			English	Article							N-TERMINAL KINASE; PARKINSONS-DISEASE; MOUSE MODEL; APOPTOSIS; ACTIVATION; BRAIN; AP-1; NEURODEGENERATION; EXPRESSION; INDUCTION	Introduction and Aims The ASK1-JNK3 signaling pathway plays a pivotal role in the pathogenesis of Parkinson's disease (PD). The specific binding of beta-arrestin2 to JNK3 is essential for activation of the ASK1-JNK3 cascade, representing a potential therapeutic target for preventing dopaminergic neuronal death in PD. The aim of this study was to identify a novel strategy for the prevention of dopaminergic neuronal death in PD. Methods Based on the specific binding of beta-arrestin2 to JNK3, a 21-amino-acid fusion peptide, termed JNK3-N-Tat, was synthesized. We evaluated the ability of this peptide to inhibit the binding of beta-arrestin2 to its target domain in JNK3 in vitro and in vivo. Results The JNK3-N-Tat peptide inhibited activation of the ASK1-JNK3 cascade by disrupting the interaction between beta-arrestin2 and JNK3. JNK3-N-Tat exerted beneficial effects through pathways downstream of JNK3 and improved mitochondrial function, resulting in attenuated MPP+/MPTP-induced damage. JNK3-N-Tat protected mesencephalic dopaminergic neurons against MPTP-induced toxicity. Conclusions JNK3-N-Tat, a JNK3-inhibitory peptide, protects dopaminergic neurons against MPP+/MPTP-induced injury by inhibiting the ASK1-JNK3 signaling pathway.	[Pan, Jing; Li, Hui; Zhang, Bei; Xiong, Ran; Zhang, Yu; Kang, Wen-Yan; Chen, Wei; Zhao, Zong-Bo; Chen, Sheng-Di] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Pan, Jing; Li, Hui; Zhang, Bei; Xiong, Ran; Zhang, Yu; Kang, Wen-Yan; Chen, Wei; Zhao, Zong-Bo; Chen, Sheng-Di] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China; [Chen, Sheng-Di] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China; [Chen, Sheng-Di] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Neurodegenerat Dis, Shanghai 200030, Peoples R China; [Chen, Sheng-Di] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Chen, SD (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China.	chen_sd@medmail.com.cn			National Key Program of Basic Research of China [2011CB504104]; National Natural Science Foundation of China [81430022, 81371407, 81371409, 30900454]	National Key Program of Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Key Program of Basic Research (2011CB504104) of China, the National Natural Science Foundation of China (81430022, 81371407, 81371409, 30900454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Antoniou X, 2011, J ALZHEIMERS DIS, V24, P633, DOI 10.3233/JAD-2011-091567; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kuan CY, 2005, CNS NEUROL DISORD-DR, V4, P63, DOI 10.2174/1568007053005145; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Li X, 2009, FEBS LETT, V583, P3310, DOI 10.1016/j.febslet.2009.09.035; Liedhegner EAS, 2011, CHEM RES TOXICOL, V24, P1644, DOI 10.1021/tx200082h; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pan J, 2009, NEUROCHEM INT, V54, P418, DOI 10.1016/j.neuint.2009.01.013; Resnick L, 2004, DRUG DISCOV TODAY, V9, P932, DOI 10.1016/S1359-6446(04)03251-9; Ries V, 2008, J NEUROCHEM, V107, P1578, DOI 10.1111/j.1471-4159.2008.05713.x; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Wang LH, 2008, NEUROLOGY, V71, P462, DOI 10.1212/01.wnl.0000324506.93877.5e; Wang WY, 2004, NEUROSCI RES, V48, P195, DOI 10.1016/j.neures.2003.10.012; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119204	10.1371/journal.pone.0119204	http://dx.doi.org/10.1371/journal.pone.0119204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856433	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500005
J	Wang, MG; Liu, YJ; Zhang, CC; Liu, JP; Liu, X; Wang, LC; Wang, WY; Chen, H; Wei, CC; Ye, XF; Li, XY; Tu, JM				Wang, Mugui; Liu, Yujun; Zhang, Cuicui; Liu, Jianping; Liu, Xin; Wang, Liangchao; Wang, Wenyi; Chen, Hao; Wei, Chuchu; Ye, Xiufen; Li, Xinyuan; Tu, Jumin			Gene Editing by Co-Transformation of TALEN and Chimeric RNA/DNA Oligonucleotides on the Rice OsEPSPS Gene and the Inheritance of Mutations	PLOS ONE			English	Article							TARGETED MUTAGENESIS; DNA; ARABIDOPSIS; RNA; REPAIR; PLANTS; FREQUENCY	Although several site-specific nucleases (SSNs), such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas, have emerged as powerful tools for targeted gene editing in many organisms, to date, gene targeting (GT) in plants remains a formidable challenge. In the present study, we attempted to substitute a single base in situon the rice OsEPSPSgene by co-transformation of TALEN with chimeric RNA/DNA oligonucleotides (COs), including different strand composition such as RNA/DNA (C1) or DNA/RNA (C2) but contained the same target base to be substituted. In contrast to zero GT event obtained by the co-transformation of TALEN with homologous recombination plasmid (HRP), we obtained one mutant showing target base substitution although accompanied by undesired deletion of 12 bases downstream the target site from the co-transformation of TALEN and C1. In addition to this typical event, we also obtained 16 mutants with different length of base deletions around the target site among 105 calli lines derived from transformation of TALEN alone (4/19) as well as co-transformation of TELAN with either HRP (5/30) or C1 (2/25) or C2 (5/31). Further analysis demonstrated that the homozygous gene-edited mutants without foreign gene insertion could be obtained in one generation. The induced mutations in transgenic generation were also capable to pass to the next generation stably. However, the genotypes of mutants did not segregate normally in T1 population, probably due to lethal mutations. Phenotypic assessments in T1 generation showed that the heterozygous plants with either one or three bases deletion on target sequence, called d(1) and d(3), were more sensitive to glyphosate and the heterozygous d1 plants had significantly lower seed-setting rate than wild-type.	[Wang, Mugui; Liu, Yujun; Zhang, Cuicui; Liu, Jianping; Liu, Xin; Wang, Liangchao; Wang, Wenyi; Chen, Hao; Wei, Chuchu; Ye, Xiufen; Li, Xinyuan; Tu, Jumin] Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University	Tu, JM (corresponding author), Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	jtu@zju.edu.cn	Tu, Jumin/AAI-6310-2020		Genetically Modified Organism Breeding Major Project [2011ZX08001001-001-002]	Genetically Modified Organism Breeding Major Project	This work was financially supported by "Genetically Modified Organism Breeding Major Project (2011ZX08001001-001-002)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 1998, NAT BIOTECHNOL, V16, P1343, DOI 10.1038/4322; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; CHU CC, 1975, SCI SINICA, V18, P659; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gamper HB, 2000, BIOCHEMISTRY-US, V39, P5808, DOI 10.1021/bi9921891; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gurushidze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092046; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; KMIEC EB, 1994, MOL CELL BIOL, V14, P7163, DOI 10.1128/MCB.14.11.7163; Kren BT, 1998, NAT MED, V4, P285, DOI 10.1038/nm0398-285; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mach J, 2014, PLANT CELL, V26, P2, DOI 10.1105/tpc.114.122606; Okuzaki A, 2004, PLANT CELL REP, V22, P509, DOI 10.1007/s00299-003-0698-2; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Puchta H, 2012, PLANT CELL, V24, P4324, DOI 10.1105/tpc.112.101824; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; WILSON JH, 1994, P NATL ACAD SCI USA, V91, P177, DOI 10.1073/pnas.91.1.177; Xu JW, 2002, SCI CHINA SER C, V45, P251, DOI 10.1360/02yc9028; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768; Zhu T, 2000, NAT BIOTECHNOL, V18, P555, DOI 10.1038/75435	41	28	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122755	10.1371/journal.pone.0122755	http://dx.doi.org/10.1371/journal.pone.0122755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856577	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500054
J	Peterson, SW; Jurjevic, Z; Frisvad, JC				Peterson, Stephen W.; Jurjevic, Zeljko; Frisvad, Jens C.			Expanding the Species and Chemical Diversity of Penicillium Section Cinnamopurpurea	PLOS ONE			English	Article							SEXUAL REPRODUCTION; EUPENICILLIUM-OCHROSALMONEUM; ASPERGILLUS-FLAVUS; CONIDIAL HEADS; SP NOV.; CITREOVIRIDIN; RECOGNITION; METABOLITES; FUNGUS; IDENTIFICATION	A set of isolates very similar to or potentially conspecific with an unidentified Penicillium isolate NRRL 735, was assembled using a BLAST search of ITS similarity among described (GenBank) and undescribed Penicillium isolates in our laboratories. DNA was amplified from six loci of the assembled isolates and sequenced. Two species in section Cinnamo-purpurea are self-compatible sexual species, but the asexual species had polymorphic loci suggestive of sexual reproduction and variation in conidium size suggestive of ploidy level differences typical of heterothallism. Accordingly we use genealogical concordance analysis, a technique valid only in heterothallic organisms, for putatively asexual species. Seven new species were revealed in the analysis and are described here. Extrolite analysis showed that two of the new species, P. colei and P. monsserratidens produce the mycotoxin citreoviridin that has demonstrated pharmacological activity against human lung tumors. These isolates could provide leads in pharmaceutical research.	[Peterson, Stephen W.] USDA ARS, Natl Ctr Agr Utilizat Res, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL 61604 USA; [Jurjevic, Zeljko] EMSL Analytical Inc, Cinnaminson, NJ 08077 USA; [Frisvad, Jens C.] Tech Univ Denmark, DK-2800 Lyngby, Denmark	United States Department of Agriculture (USDA); Technical University of Denmark	Peterson, SW (corresponding author), USDA ARS, Natl Ctr Agr Utilizat Res, Bacterial Foodborne Pathogens & Mycol Res Unit, 1815 N Univ St, Peoria, IL 61604 USA.	Stephen.peterson@ars.usda.gov	Frisvad, Jens C/K-2818-2017	Frisvad, Jens C/0000-0002-0573-4340				Almeida MI, 2012, FOOD ADDIT CONTAM A, V29, P694, DOI 10.1080/19440049.2011.651750; Asai T, 2013, ORG LETT, V15, P1020, DOI 10.1021/ol303506t; BERNY JF, 1990, NATO ADV SCI I A-LIF, V185, P49; Bohm J, 2013, P NATL ACAD SCI USA, V110, P1476, DOI 10.1073/pnas.1217943110; Bugni TS, 2004, J NAT PROD, V67, P1396, DOI 10.1021/np049973t; COLE RJ, 1981, APPL ENVIRON MICROB, V42, P677, DOI 10.1128/AEM.42.4.677-681.1981; CONSTANTINESCU O, 1990, NATO ADV SCI I A-LIF, V185, P17; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2721; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; FILTENBORG O, 1990, NATO ADV SCI I A-LIF, V185, P433; FRANCK B, 1980, ANGEW CHEM INT EDIT, V19, P461, DOI 10.1002/anie.198004611; Frisvad JC, 2007, STUD MYCOL, P31, DOI 10.3114/sim.2007.59.04; FRISVAD JC, 1990, NATO ADV SCI I A-LIF, V185, P159; Gebhardt K, 2004, J ANTIBIOT, V57, P707, DOI 10.7164/antibiotics.57.707; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hind HG, 1940, BIOCHEM J, V34, P577, DOI 10.1042/bj0340577; Hirata Y., 1947, CHEM SOC JAPAN, V68, P104; Holtzel A, 2004, J ANTIBIOT, V57, P715; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063769; Horn BW, 2008, MYCOLOGIA, V100, P12, DOI 10.3852/mycologia.100.1.12; Horn BW, 2014, PHYTOPATHOLOGY, V104, P75, DOI 10.1094/PHYTO-05-13-0129-R; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Horn BW, 1999, APPL ENVIRON MICROB, V65, P1444; Houbraken J, 2011, STUD MYCOL, P53, DOI 10.3114/sim.2011.70.02; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Houbraken J, 2011, INT J SYST EVOL MICR, V61, P1462, DOI 10.1099/ijs.0.025098-0; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Jadulco R, 2002, J NAT PROD, V65, P730, DOI 10.1021/np010390i; Janso JE, 2005, MYCOLOGIA, V97, P444, DOI 10.3852/mycologia.97.2.444; Jayasuriya H, 2005, CHEM BIODIVERS, V2, P112, DOI 10.1002/cbdv.200490162; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; LEISTNER L, 1979, FLEISCHWIRTSCHAFT, V59, P1892; LOCCI R, 1965, GIORN MICROBIOL, V13, P271; Lopez-Villavicencio M, 2010, FUNGAL GENET BIOL, V47, P693, DOI 10.1016/j.fgb.2010.05.002; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marin P, 2014, INT DAIRY J, V36, P89, DOI 10.1016/j.idairyj.2014.01.012; Mayr E., 1942, P1; McNeill J., 2012, 18 INT BOT C MELB AU; NAGEL DW, 1972, PHYTOCHEMISTRY, V11, P627, DOI 10.1016/0031-9422(72)80022-0; Nelson P., 1983, FUSARIUM SPECIES ILL; NISHIYAMA S, 1987, CHEM LETT, P515, DOI 10.1246/cl.1987.515; NISHIYAMA S, 1985, TETRAHEDRON LETT, V26, P6239, DOI 10.1016/S0040-4039(00)95062-7; NIWA M, 1981, CHEM LETT, P1285, DOI 10.1246/cl.1981.1285; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ogawa K, 2000, BIOSCI BIOTECH BIOCH, V64, P833, DOI 10.1271/bbb.64.833; Okuda T, 2000, INTEGRATION MODERN T, P83; Osmundson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062419; Peterson SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078084; Peterson SW, 2011, IMA FUNGUS, V2, P121, DOI 10.5598/imafungus.2011.02.02.02; Peterson SW, 2009, MYCOLOGIA, V101, P71, DOI 10.3852/08-036; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; RAMIREZ C, 1978, MYCOPATHOLOGIA, V66, P77, DOI 10.1007/BF00429597; Raper KB, 1949, MANUAL PENICILLIA; REBUFFAT S, 1980, PHYTOCHEMISTRY, V19, P427, DOI 10.1016/0031-9422(80)83194-3; Ridgway R., 1912, COLOR STANDARDS COLO; Rosa CAR, 2010, FOOD ADDIT CONTAM A, V27, P241, DOI 10.1080/19440040903289712; SAKABE N, 1964, TETRAHEDRON LETT, P1825; SAKABE N, 1977, TETRAHEDRON, V33, P3077, DOI 10.1016/0040-4020(77)80452-3; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Samson RA, 2011, STUD MYCOL, P39, DOI 10.3114/sim.2011.69.04; SAMSON RA, 1989, STUD MYCOL, P133; SAMSON RA, 2004, STUD MYCOL, V49, P1; Samson RA, 2010, FOOD INDOOR FUNGI; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sugui JA, 2014, J CLIN MICROBIOL, V52, P3707, DOI 10.1128/JCM.01704-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Toyama H, 2004, APPL BIOCHEM BIOTECH, V113, P325; URAGUCHI K, 1969, J STORED PROD RES, V5, P227, DOI 10.1016/0022-474X(69)90037-X; van der Walt L, 2010, PLANT DIS, V94, P666, DOI 10.1094/PDIS-94-6-0666; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; Wang Long, 2000, Mycosystema, V19, P463; WICKLOW DT, 1988, APPL ENVIRON MICROB, V54, P1096, DOI 10.1128/AEM.54.5.1096-1098.1988; WICKLOW DT, 1984, MYCOLOGIA, V76, P959, DOI 10.2307/3793157; WICKLOW DT, 1984, MYCOLOGIA, V76, P943, DOI 10.2307/3793151; Wigmann EF, 2015, FOOD RES INT, V67, P219, DOI 10.1016/j.foodres.2014.11.025; Wu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070642; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	81	22	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121987	10.1371/journal.pone.0121987	http://dx.doi.org/10.1371/journal.pone.0121987			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853891	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400057
J	Razzouk, D; Kayo, M; Sousa, A; Gregorio, G; Cogo-Moreira, H; Cardoso, AA; Mari, JD				Razzouk, Denise; Kayo, Monica; Sousa, Aglae; Gregorio, Guilherme; Cogo-Moreira, Hugo; Cardoso, Andrea Alves; Mari, Jair de Jesus			The Impact of Antipsychotic Polytherapy Costs in the Public Health Care in Sao Paulo, Brazil	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; SCHIZOPHRENIA; POLYPHARMACY; PRESCRIPTION; GUIDELINES; MANAGEMENT; EFFICACY; DRUGS	Introduction Guidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, the rate of antipsychotic polytherapy has increased over the last decade, reaching up to 60% in some settings. Studies evaluating the costs and impact of antipsychotic polytherapy in the health system are scarce. Objective To estimate the costs of antipsychotic polytherapy and its impact on public health costs in a sample of subjects with psychotic disorders living in residential facilities in the city of Sao Paulo, Brazil. Method A cross-sectional study that used a bottom-up approach for collecting costs data in a public health provider's perspective. Subjects with psychosis living in 20 fully-staffed residential facilities in the city of Sao Paulo were assessed for clinical and psychosocial profile, severity of symptoms, quality of life, use of health services and pharmacological treatment. The impact of polytherapy on total direct costs was evaluated. Results 147 subjects were included, 134 used antipsychotics regularly and 38% were in use of antipsychotic polytherapy. There were no significant differences in clinical and psychosocial characteristics between polytherapy and monotherapy groups. Four variables explained 30% of direct costs: the number of antipsychotics, location of the residential facility, time living in the facility and use of olanzapine. The costs of antipsychotics corresponded to 94.4% of the total psychotropic costs and to 49.5% of all health services use when excluding accommodation costs. Olanzapine costs corresponded to 51% of all psychotropic costs. Conclusion Antipsychotic polytherapy is a huge economic burden to public health service, despite the lack of evidence supporting this practice. Great variations on antipsychotic costs explicit the need of establishing protocols for rational antipsychotic prescriptions and consequently optimising resource allocation. Cost-effectiveness studies are necessary to estimate the best value for money among antipsychotics, especially in low and middle income countries.	[Razzouk, Denise; Kayo, Monica; Sousa, Aglae; Gregorio, Guilherme; Cardoso, Andrea Alves] Univ Fed Sao Paulo, Dept Psychiat, CESM, Sao Paulo, SP, Brazil; [Cogo-Moreira, Hugo; Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Razzouk, D (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, CESM, Sao Paulo, SP, Brazil.	drazzouk@gmail.com	de Jesus Mari, Jair/A-7309-2008; Cogo-Moreira, Hugo/E-4602-2011; Kayo, Monica/C-8224-2015; Cogo-Moreira, Hugo/GSD-6132-2022; Razzouk, Denise/A-2336-2011; Cogo-Moreira, Hugo/U-6442-2019	de Jesus Mari, Jair/0000-0002-5403-0112; Cogo-Moreira, Hugo/0000-0001-9411-9237; Kayo, Monica/0000-0003-4859-8593; Cogo-Moreira, Hugo/0000-0001-9411-9237; Razzouk, Denise/0000-0003-4228-8949; Cogo-Moreira, Hugo/0000-0001-9411-9237	FAPESP, Grant PPSUS [2009/53286-3]; Ministry of Health of Brazil; CNPQ, Secretary of Health of the State of Sao Paulo	FAPESP, Grant PPSUS(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Health of Brazil; CNPQ, Secretary of Health of the State of Sao Paulo	The data collection of this study was funded by FAPESP (http://www.fapesp.br/, Grant PPSUS 2009 - number 2009/53286-3), Ministry of Health of Brazil, and by CNPQ(http://www.cnpq.br/), Secretary of Health of the State of Sao Paulo. No author was paid to write this article by a pharmaceutical company or any other agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini S, 2008, PSYCHIAT SERV, V59, P547, DOI 10.1176/ps.2008.59.5.547; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Aranha e Silva A, 2008, DESAFIOS DESINSTITUC; Baandrup L, 2012, EUR J HEALTH ECON, V13, P355, DOI 10.1007/s10198-011-0308-0; Bandeira Marina, 2003, Arch. Clin. Psychiatry (São Paulo), V30, P121; Barbui C, 2009, SCHIZOPHRENIA BULL, V35, P458, DOI 10.1093/schbul/sbn030; Barnes TRE, 2011, CNS DRUGS, V25, P383, DOI 10.2165/11587810-000000000-00000; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Cardoso CS, 2002, J BRASILEIRO PSIQUIA, V51, P31; Chisholm D, 2000, BRIT J PSYCHIAT, V177, pS28, DOI 10.1192/bjp.177.39.s28; Correll CU, 2012, PSYCHIAT CLIN N AM, V35, P661, DOI 10.1016/j.psc.2012.06.007; de Lima MS, 2007, REV BRAS PSIQUIATR, V29, P246, DOI 10.1590/S1516-44462007000300010; Elkis H, 2007, PSYCHIAT CLIN N AM, V30, P511, DOI 10.1016/j.psc.2007.04.001; Essock SM, 2011, AM J PSYCHIAT, V168, P702, DOI 10.1176/appi.ajp.2011.10060908; Fleischhacker WW, 2014, INT J NEUROPSYCHOPH, V17, P1083, DOI 10.1017/S1461145712000399; Goodwin G, 2009, EUR NEUROPSYCHOPHARM, V19, P520, DOI 10.1016/j.euroneuro.2009.04.003; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Hasan A, 2013, WORLD J BIOL PSYCHIA, V14, P2, DOI 10.3109/15622975.2012.739708; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Huffman JC, 2011, GEN HOSP PSYCHIAT, V33, P501, DOI 10.1016/j.genhosppsych.2011.05.012; IPAP, 2006, SCHIZ ALG; Knapp M, 2009, SCHIZOPRENIA BIOPSYC, P347; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lima LA, 2006, INT J SOC PSYCHIATR, V52, P101, DOI 10.1177/0020764006062091; Lindner Leandro Mendonça, 2009, Rev. Saúde Pública, V43, P62; Loosbrock Danielle L, 2003, J Ment Health Policy Econ, V6, P67; Ministerio da Saude, 2011, BANC DE PREC; Ministerio da Saude [MS], 2005, C REG REF SERV SAUD; Moore TA, 2007, J CLIN PSYCHIAT, V68, P1751, DOI 10.4088/JCP.v68n1115; Razzouk D, 2013, VALUE HEALTH, V16, pA694, DOI 10.1016/j.jval.2013.08.2086; Roh D, 2014, AUST NZ J PSYCHIAT, V48, P52, DOI 10.1177/0004867413488221; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sousa A, 2013, ISPOR 4 LAT AM C; Souza JS, 2013, CNS SPECTRUMS, V18, P82, DOI 10.1017/S1092852912000806; Tomasi R, 2006, ACTA PSYCHIAT SCAND, V113, P212, DOI 10.1111/j.1600-0447.2005.00657.x; Wallace CJ, 2000, SCHIZOPHRENIA BULL, V26, P631, DOI 10.1093/oxfordjournals.schbul.a033483; WYKES T, 1986, BRIT J PSYCHIAT, V148, P1, DOI 10.1192/bjp.148.1.1; Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025	39	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124791	10.1371/journal.pone.0124791	http://dx.doi.org/10.1371/journal.pone.0124791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853709	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400144
J	Dillon, J; Franks, CJ; Murray, C; Edwards, RJ; Calahorro, F; Ishihara, T; Katsura, I; Holden-Dye, L; O'Connor, V				Dillon, James; Franks, Christopher J.; Murray, Caitriona; Edwards, Richard J.; Calahorro, Fernando; Ishihara, Takeshi; Katsura, Isao; Holden-Dye, Lindy; O'Connor, Vincent			Metabotropic Glutamate Receptors MODULATORS OF CONTEXT-DEPENDENT FEEDING BEHAVIOUR IN C. ELEGANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; NEURONS; STARVATION; CIRCUIT; PATHWAY; EXCITATION/INHIBITION; GENERATION; EVOLUTION; CURRENTS; PHARYNX	Glutamatergic neurotransmission is evolutionarily conserved across animal phyla. A major class of glutamate receptors consists of the metabotropic glutamate receptors (mGluRs). In C. elegans, three mGluR genes, mgl-1, mgl-2, and mgl-3, are organized into three subgroups, similar to their mammalian counterparts. Cellular reporters identified expression of the mgls in the nervous system of C. elegans and overlapping expression in the pharyngeal microcircuit that controls pharyngeal muscle activity and feeding behavior. The overlapping expression of mgls within this circuit allowed the investigation of receptor signaling per se and in the context of receptor interactions within a neural network that regulates feeding. We utilized the pharmacological manipulation of neuronally regulated pumping of the pharyngeal muscle in the wild-type and mutants to investigate MGL function. This defined a net mgl-1-dependent inhibition of pharyngeal pumping that is modulated by mgl-3 excitation. Optogenetic activation of the pharyngeal glutamatergic inputs combined with electrophysiological recordings from the isolated pharyngeal preparations provided further evidence for a presynaptic mgl-1-dependent regulation of pharyngeal activity. Analysis of mgl-1, mgl-2, and mgl-3 mutant feeding behavior in the intact organism after acute food removal identified a significant role for mgl-1 in the regulation of an adaptive feeding response. Our data describe the molecular and cellular organization of mgl-1, mgl-2, and mgl-3. Pharmacological analysis identified that, in these paradigms, mgl-1 and mgl-3, but not mgl-2, can modulate the pharyngeal microcircuit. Behavioral analysis identified mgl-1 as a significant determinant of the glutamate-dependent modulation of feeding, further highlighting the significance of mGluRs in complex C. elegans behavior.	[Dillon, James; Franks, Christopher J.; Calahorro, Fernando; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Murray, Caitriona] Univ New S Wales, Ramaciotti Ctr Genom, Kensington, NSW 2052, Australia; [Edwards, Richard J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW 2052, Australia; [Ishihara, Takeshi] Kyushu Univ, Grad Sch Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; [Katsura, Isao] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	University of Southampton; University of New South Wales Sydney; University of New South Wales Sydney; Kyushu University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	O'Connor, V (corresponding author), Univ Southampton, Ctr Biol Sci, Univ Rd, Southampton SO17 1BJ, Hants, England.	voconno@soton.ac.uk	Calahorro, Fernando/H-3294-2013; Edwards, Richard/C-8755-2011	Edwards, Richard/0000-0002-3645-5539; Holden-Dye, Lindy/0000-0002-9704-1217; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483; Franks, C/0000-0002-5412-7037	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Biotechnology and Biological Sciences Research Council [BB/F009208/1] Funding Source: researchfish; BBSRC [BB/F009208/1] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains were provided by the CGC, which is funded by National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1; Awad H, 2000, J NEUROSCI, V20, P7871; BRENNER S, 1974, GENETICS, V77, P71; Brockie Penelope J, 2006, WormBook, P1; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Conn PJ, 2009, NEUROPSYCHOPHARMACOL, V34, P248, DOI 10.1038/npp.2008.156; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dalliere N., 2014, NEUR DEV SYN FUNCT B, P66; Dillon J, 2006, BIOCHEM SOC T, V34, P942, DOI 10.1042/BST0340942; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Franks C. J., 2010, EUR C EL NEUR M FOD, P40; Franks CJ, 2009, INVERTEBR NEUROSCI, V9, P43, DOI 10.1007/s10158-009-0088-8; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heidinger V, 2002, J NEUROSCI, V22, P5452; Herman E J, 2012, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-642-25758-2_11; Ishihara T., 1996, WORM BREEDERS GAZETT, V14, P40; Jorgensen EM, 2004, NAT NEUROSCI, V7, P1019, DOI 10.1038/nn1004-1019; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Krenz WD, 2000, J NEUROPHYSIOL, V83, P1188, DOI 10.1152/jn.2000.83.3.1188; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Oberman LM, 2012, EXPERT OPIN INV DRUG, V21, P1819, DOI 10.1517/13543784.2012.729819; Parmentier ML, 1996, J NEUROSCI, V16, P6687; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Tharmalingam S, 2012, NEUROPHARMACOLOGY, V63, P667, DOI 10.1016/j.neuropharm.2012.05.029; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; Washio H, 2002, ZOOL SCI, V19, P153, DOI 10.2108/zsj.19.153; Watkins J C, 1981, Adv Biochem Psychopharmacol, V27, P263; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Zheng N, 2011, J NEUROSCI, V31, P10283, DOI 10.1523/JNEUROSCI.1834-11.2011	48	18	18	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15052	15065		10.1074/jbc.M114.606608	http://dx.doi.org/10.1074/jbc.M114.606608			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25869139	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000356177300021
J	Cai, WL; Goswami, A; Yang, ZY; Liu, XD; Green, KD; Barnard-Britson, S; Baba, S; Funabashi, M; Nonaka, K; Sunkara, M; Morris, AJ; Spork, AP; Ducho, C; Garneau-Tsodikova, S; Thorson, JS; Van Lanen, SG				Cai, Wenlong; Goswami, Anwesha; Yang, Zhaoyong; Liu, Xiaodong; Green, Keith D.; Barnard-Britson, Sandra; Baba, Satoshi; Funabashi, Masanori; Nonaka, Koichi; Sunkara, Manjula; Morris, Andrew J.; Spork, Anatol P.; Ducho, Christian; Garneau-Tsodikova, Sylvie; Thorson, Jon S.; Van Lanen, Steven G.			The Biosynthesis of Capuramycin-type Antibiotics IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5 '-CARBOXAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSLOCASE-I; STREPTOMYCES-VENEZUELAE ISP5230; ALPHA-KETOGLUTARATE DIOXYGENASE; GENE-CLUSTER; ANTIMYCOBACTERIAL ACTIVITY; ESCHERICHIA-COLI; IDENTIFICATION; INHIBITORS; A-500359S; POLYKETIDE	A-500359s, A-503083s, and A-102395 are capuramycin-type nucleoside antibiotics that were discovered using a screen to identify inhibitors of bacterial translocase I, an essential enzyme in peptidoglycan cell wall biosynthesis. Like the parent capuramycin, A-500359s and A-503083s consist of three structural components: a uridine-5'-carboxamide (CarU), a rare unsaturated hexuronic acid, and an aminocaprolactam, the last of which is substituted by an unusual arylamine-containing polyamide in A-102395. The biosynthetic gene clusters for A-500359s and A-503083s have been reported, and two genes encoding a putative non-heme Fe(II)-dependent alpha-ketoglutarate: UMP dioxygenase and an L-Thr: uridine-5'-aldehyde transaldolase were uncovered, suggesting that C-C bond formation during assembly of the high carbon (C6) sugar backbone of CarU proceeds from the precursors UMP and L-Thr to form 5'-C-glycyluridine (C7) as a biosynthetic intermediate. Here, isotopic enrichment studies with the producer of A-503083s were used to indeed establish L-Thr as the direct source of the carboxamide of CarU. With this knowledge, the A-102395 gene cluster was subsequently cloned and characterized. A genetic system in the A-102395-producing strain was developed, permitting the inactivation of several genes, including those encoding the dioxygenase (cpr19) and transaldolase (cpr25), which abolished the production of A-102395, thus confirming their role in biosynthesis. Heterologous production of recombinant Cpr19 and CapK, the transaldolase homolog involved in A-503083 biosynthesis, confirmed their expected function. Finally, a phosphotransferase (Cpr17) conferring self-resistance was functionally characterized. The results provide the opportunity to use comparative genomics along with in vivo and in vitro approaches to probe the biosynthetic mechanism of these intriguing structures.	[Cai, Wenlong; Goswami, Anwesha; Liu, Xiaodong; Green, Keith D.; Barnard-Britson, Sandra; Garneau-Tsodikova, Sylvie; Thorson, Jon S.; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA; [Yang, Zhaoyong] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 1000050, Peoples R China; [Yang, Zhaoyong] Peking Union Med Coll, Beijing 1000050, Peoples R China; [Baba, Satoshi] Daiichi Sankyo Co Ltd, New Modal Res Labs, R&D Div, Tokyo 1038426, Japan; [Funabashi, Masanori] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Tokyo, Japan; [Nonaka, Koichi] Daiichi Sankyo Co Ltd, Biol Technol Res Labs, R&D Div, Tokyo 1038426, Japan; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40506 USA; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA; [Spork, Anatol P.; Ducho, Christian] Univ Saarland, Dept Pharm Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany	University of Kentucky; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; University of Kentucky; University of Kentucky; Saarland University	Van Lanen, SG (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 S Limestone, Lexington, KY 40506 USA.	svanlanen@uky.edu	sunkara, Manjula/H-7944-2016; Garneau-Tsodikova, Sylvie/ABH-5882-2020; Cai, Wenlong/AAH-7945-2019; Goswami, Anwesha/J-7628-2019; Thorson, Jon S/L-3696-2013; Ducho, Christian/I-4085-2019; Funabashi, Masanori/GQZ-8735-2022	sunkara, Manjula/0000-0001-6151-1929; Garneau-Tsodikova, Sylvie/0000-0002-7961-5555; Goswami, Anwesha/0000-0002-3107-6417; Thorson, Jon S/0000-0002-7148-0721; Ducho, Christian/0000-0002-0629-9993; 	National Institutes of Health, NIAID [AI087849]; National Center for Advancing Translational Sciences [UL1TR000117]; NSF CAREER [MCB-1149427]; Kentucky Science and Education Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026884, S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087849] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Kentucky Science and Education Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI087849 (to S.V. L.). This work was also supported by National Center for Advancing Translational Sciences Grant UL1TR000117, NSF CAREER award MCB-1149427 (to S. G.-T.), and the Kentucky Science and Education Foundation (to S. V. L.).	Barnard-Britson S, 2012, J AM CHEM SOC, V134, P18514, DOI 10.1021/ja308185q; Blanc V, 1997, MOL MICROBIOL, V23, P191, DOI 10.1046/j.1365-2958.1997.2031574.x; Bogatcheva E, 2011, BIOORG MED CHEM LETT, V21, P5353, DOI 10.1016/j.bmcl.2011.07.015; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Boyle DS, 1998, J BACTERIOL, V180, P6429; Brown MP, 1996, MICROBIOL-UK, V142, P1345, DOI 10.1099/13500872-142-6-1345; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Campelo AB, 2002, MICROBIOL-SGM, V148, P51, DOI 10.1099/00221287-148-1-51; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; Chi XL, 2013, MEDCHEMCOMM, V4, P239, DOI 10.1039/c2md20245j; Chi XL, 2011, J AM CHEM SOC, V133, P14452, DOI 10.1021/ja206304k; Cociancich S, 2015, NAT CHEM BIOL, V11, P195, DOI 10.1038/nchembio.1734; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Fortin PD, 2007, NATURE, V448, P824, DOI 10.1038/nature06068; Fujita Y, 2011, J ANTIBIOT, V64, P495, DOI 10.1038/ja.2011.38; Funabashi M, 2013, ANGEW CHEM INT EDIT, V52, P11607, DOI 10.1002/anie.201305546; Funabashi M, 2010, NAT CHEM BIOL, V6, P581, DOI [10.1038/NCHEMBIO.393, 10.1038/nchembio.393]; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; GOULD SJ, 1980, J AM CHEM SOC, V102, P1707, DOI 10.1021/ja00525a040; GOULD SJ, 1991, J ORG CHEM, V56, P6666, DOI 10.1021/jo00023a036; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; He J, 2003, CHEM BIOL, V10, P1225, DOI 10.1016/j.chembiol.2003.11.009; He J, 2001, MICROBIOL-SGM, V147, P2817, DOI 10.1099/00221287-147-10-2817; Hiratsuka T, 2014, ANGEW CHEM INT EDIT, V53, P5423, DOI 10.1002/anie.201402623; Hotoda H, 2003, BIOORG MED CHEM LETT, V13, P2829, DOI 10.1016/S0960-894X(03)00596-1; Hotoda H, 2003, BIOORG MED CHEM LETT, V13, P2833, DOI 10.1016/S0960-894X(03)00597-3; IKEDA M, 1991, J BACTERIOL, V173, P1021, DOI 10.1128/jb.173.3.1021-1026.1991; Isono K., 1978, J AM CHEM SOC, DOI 10.1021/ja00480a052; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; KANEOKE M, 1993, BIOSCI BIOTECH BIOCH, V57, P814, DOI 10.1271/bbb.57.814; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Keller U, 2010, J BACTERIOL, V192, P2583, DOI 10.1128/JB.01526-09; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miranzo D, 2010, APPL MICROBIOL BIOT, V85, P1809, DOI 10.1007/s00253-009-2195-1; Murakami R, 2007, J ANTIBIOT, V60, P690, DOI 10.1038/ja.2007.88; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Nikonenko BV, 2010, INFECT GENET EVOL, V10, P1151, DOI 10.1016/j.meegid.2010.07.014; Nikonenko BV, 2009, ANTIMICROB AGENTS CH, V53, P3138, DOI 10.1128/AAC.00366-09; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; Palaniappan N, 2006, CHEM BIOL, V13, P753, DOI 10.1016/j.chembiol.2006.05.013; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Reddy V. M., 2011, DRUG DEL LETT, V1, P150, DOI [10.2174/2210304x11101020150, DOI 10.2174/2210304X11101020150]; Reddy VM, 2008, ANTIMICROB AGENTS CH, V52, P719, DOI 10.1128/AAC.01469-07; Reddy VM, 2012, J ANTIMICROB CHEMOTH, V67, P1163, DOI 10.1093/jac/dkr589; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Seco EM, 2010, APPL MICROBIOL BIOT, V85, P1797, DOI 10.1007/s00253-009-2193-3; SETO H, 1988, TETRAHEDRON LETT, V29, P2343, DOI 10.1016/S0040-4039(00)86055-4; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shen B, 2000, TOP CURR CHEM, V209, P1; Shi K, 2012, J BIOL CHEM, V287, P13094, DOI 10.1074/jbc.M112.349670; Smith CA, 2012, J BIOL CHEM, V287, P12893, DOI 10.1074/jbc.M112.341206; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; TOOMEY RE, 1966, BIOCHIM BIOPHYS ACTA, V116, P189, DOI 10.1016/0005-2760(66)90001-4; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Wong EB, 2013, TRENDS MICROBIOL, V21, P493, DOI 10.1016/j.tim.2013.05.002; YAMAGUCHI H, 1986, J ANTIBIOT, V39, P1047, DOI 10.7164/antibiotics.39.1047; Yanai K, 2004, NAT BIOTECHNOL, V22, P848, DOI 10.1038/nbt978; Yang ZY, 2011, J BIOL CHEM, V286, P7885, DOI 10.1074/jbc.M110.203562; Yang ZY, 2010, J BIOL CHEM, V285, P12899, DOI 10.1074/jbc.M110.104141; YE QZ, 1990, P NATL ACAD SCI USA, V87, P9391, DOI 10.1073/pnas.87.23.9391; Zhang GY, 2012, APPL ENVIRON MICROB, V78, P2393, DOI 10.1128/AEM.07185-11; Zhang WJ, 2006, APPL ENVIRON MICROB, V72, P2573, DOI 10.1128/AEM.72.4.2573-2580.2006	73	22	22	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13710	13724		10.1074/jbc.M115.646414	http://dx.doi.org/10.1074/jbc.M115.646414			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25855790	Green Published, hybrid			2022-12-26	WOS:000355313000008
J	Salian-Mehta, S; Xu, M; McKinsey, TA; Tobet, S; Wierman, ME				Salian-Mehta, Smita; Xu, Mei; McKinsey, Timothy A.; Tobet, Stuart; Wierman, Margaret E.			Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; GENE-EXPRESSION; IN-VIVO; MIGRATION; PROTEIN; ACETYLATION; DEATH; AXL; INHIBITION; CLONING	The impact of histone deacetylases (HDACs) in the control of gonadotropin releasing hormone (GnRH) neuronal development is unknown. We identified an increase in many HDACs in GT1-7 (differentiated) compared with NLT (undifferentiated) GnRH neuronal cell lines. Increased HDAC9 mRNA and protein and specific deacetylase activity in GT1-7 cells suggested a functional role. Introduction of HDAC9 in NLT cells protected from serum withdrawal induced apoptosis and impaired basal neuronal cell movement. Conversely, silencing of endogenous HDAC 9 in GT 1-7 cells increased apoptosis and cell movement. Comparison of WT and mutant HDAC9 constructs demonstrated that the HDAC9 pro-survival effects required combined cytoplasmic and nuclear localization, whereas the effects on cell movement required a cytoplasmic site of action. Co-immunoprecipitation demonstrated a novel interaction of HDAC9 selectively with the Class IIb HDAC6. HDAC6 was also up-regulated at the mRNA and protein levels, and HDAC6 catalytic activity was significantly increased in GT1-7 compared with NLT cells. HDAC9 interacted with HDAC6 through its second catalytic domain. Silencing of HDAC6, HDAC9, or both, in GT1-7 cells augmented apoptosis compared with controls. HDAC6 and -9 had additive effects to promote cell survival via modulating the BAX/BCL2 pathway. Silencing of HDAC6 resulted in an activation of movement of GT1-7 cells with induction in acetylation of alpha-tubulin. Inhibition of HDAC6 and HDAC9 together resulted in an additive effect to increase cell movement but did not alter the acetylation of alpha tubulin. Together, these studies identify a novel interaction of Class IIa HDAC9 with Class IIb HDAC6 to modulate cell movement and survival in GnRH neurons.	[Salian-Mehta, Smita; Xu, Mei; Wierman, Margaret E.] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA; [McKinsey, Timothy A.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO 80045 USA; [Wierman, Margaret E.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Tobet, Stuart] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Colorado State University	Wierman, ME (corresponding author), Univ Colorado Denver, Endocrinol MS8106, 12801 East 17th Ave,RC1 South, Aurora, CO 80045 USA.	margaret.wierman@ucdenver.edu	Salian-Mehta, Smita/AAE-4677-2021		National Center for Advancing Translational Sciences, National Institutes of Health Colorado Clinical and Translational Sciences Institute [UL1 TR001082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD031191, R01HD031191] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043822] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health Colorado Clinical and Translational Sciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Todd Horn for performing the HDAC catalytic activity assays. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core supported in part by National Center for Advancing Translational Sciences, National Institutes of Health Colorado Clinical and Translational Sciences Institute Grant UL1 TR001082.	Aizawa S, 2012, NEUROSCIENCE, V205, P63, DOI 10.1016/j.neuroscience.2011.12.024; Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Beier U.H., 2012, SCI SIGNAL, V5, pra45; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bhatia U., 2002, U. S. Patent, Patent No. [WO2002030970A2, 2002030970]; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chatterjee TK, 2011, J BIOL CHEM, V286, P27836, DOI 10.1074/jbc.M111.262964; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fenic I, 2004, J ANDROL, V25, P811; Gan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039770; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Kurian Joseph R, 2013, Front Endocrinol (Lausanne), V4, P61, DOI 10.3389/fendo.2013.00061; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Li Y, 2013, FEBS J, V280, P775, DOI 10.1111/febs.12079; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Maggi R, 2000, ENDOCRINOLOGY, V141, P2105, DOI 10.1210/en.141.6.2105; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Pierce A, 2011, MOL CELL ENDOCRINOL, V339, P151, DOI 10.1016/j.mce.2011.04.007; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Salian-Mehta S, 2014, J CLIN ENDOCR METAB, V99, P1452, DOI 10.1210/jc.2013-3426; Salian-Mehta S, 2013, MOL CELL ENDOCRINOL, V374, P92, DOI 10.1016/j.mce.2013.04.018; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Terasawa E, 2010, J NEUROENDOCRINOL, V22, P630, DOI 10.1111/j.1365-2826.2010.02027.x; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Tobet SA, 2006, ENDOCRINOLOGY, V147, P1159, DOI 10.1210/en.2005-1275; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	47	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14045	14056		10.1074/jbc.M115.640482	http://dx.doi.org/10.1074/jbc.M115.640482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873389	hybrid, Green Published			2022-12-26	WOS:000355313000034
J	Hunter, ME; Oyler-McCance, SJ; Dorazio, RM; Fike, JA; Smith, BJ; Hunter, CT; Reed, RN; Hart, KM				Hunter, Margaret E.; Oyler-McCance, Sara J.; Dorazio, Robert M.; Fike, Jennifer A.; Smith, Brian J.; Hunter, Charles T.; Reed, Robert N.; Hart, Kristen M.			Environmental DNA (eDNA) Sampling Improves Occurrence and Detection Estimates of Invasive Burmese Pythons	PLOS ONE			English	Article							EVERGLADES NATIONAL-PARK; MOLURUS-BIVITTATUS; FLORIDA; OCCUPANCY; RATES	Environmental DNA (eDNA) methods are used to detect DNA that is shed into the aquatic environment by cryptic or low density species. Applied in eDNA studies, occupancy models can be used to estimate occurrence and detection probabilities and thereby account for imperfect detection. However, occupancy terminology has been applied inconsistently in eDNA studies, and many have calculated occurrence probabilities while not considering the effects of imperfect detection. Low detection of invasive giant constrictors using visual surveys and traps has hampered the estimation of occupancy and detection estimates needed for population management in southern Florida, USA. Giant constrictor snakes pose a threat to native species and the ecological restoration of the Florida Everglades. To assist with detection, we developed species-specific eDNA assays using quantitative PCR (qPCR) for the Burmese python (Python molurus bivittatus), Northern African python (P. sebae), boa constrictor (Boa constrictor), and the green (Eunectes murinus) and yellow anaconda (E. notaeus). Burmese pythons, Northern African pythons, and boa constrictors are established and reproducing, while the green and yellow anaconda have the potential to become established. We validated the python and boa constrictor assays using laboratory trials and tested all species in 21 field locations distributed in eight southern Florida regions. Burmese python eDNA was detected in 37 of 63 field sampling events; however, the other species were not detected. Although eDNA was heterogeneously distributed in the environment, occupancy models were able to provide the first estimates of detection probabilities, which were greater than 91%. Burmese python eDNA was detected along the leading northern edge of the known population boundary. The development of informative detection tools and eDNA occupancy models can improve conservation efforts in southern Florida and support more extensive studies of invasive constrictors. Generic sampling design and terminology are proposed to standardize and clarify interpretations of eDNA-based occupancy models.	[Hunter, Margaret E.; Dorazio, Robert M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA; [Oyler-McCance, Sara J.; Fike, Jennifer A.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Smith, Brian J.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Hunter, Charles T.] Univ Florida, Inst Food & Agr Sci, Hort Sci, Gainesville, FL 32611 USA; [Hart, Kristen M.] US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey	Hunter, ME (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA.	mhunter@usgs.gov	Smith, Brian J./AAV-7609-2020	Smith, Brian J./0000-0002-0531-0492; Oyler-McCance, Sara/0000-0003-1599-8769	U.S. Geological Survey, Priority Ecosystems Science Program; U.S. Geological Survey, Southeast Ecological Science Center	U.S. Geological Survey, Priority Ecosystems Science Program; U.S. Geological Survey, Southeast Ecological Science Center	This work was funded through the U.S. Geological Survey, Priority Ecosystems Science Program and the U.S. Geological Survey, Southeast Ecological Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Diaz-Ferguson E, 2014, MANAG BIOL INVASION, V5, P121, DOI 10.3391/mbi.2014.5.2.05; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Dorcas ME, 2011, BIOL INVASIONS, V13, P793, DOI 10.1007/s10530-010-9869-6; Dove CJ, 2011, WILSON J ORNITHOL, V123, P126, DOI 10.1676/10-092.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Greene Daniel U., 2007, Herpetological Review, V38, P355; Hunter ME, 2012, CONSERV GENET, V13, P1623, DOI 10.1007/s10592-012-0414-2; Hyatt A, 2007, DIS AQUAT ORGAN, V73; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kolar CS, 2010, INLAND FISHERIES MANAGEMENT IN NORTH AMERICA, THIRD EDITION, P213; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Mazzotti FJ, 2011, BIOL INVASIONS, V13, P143, DOI 10.1007/s10530-010-9797-5; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Phalen D., 2011, DEV VALIDATION RAPID; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Reed RN, 2010, IRCF REPTILES AMPHIB, V17, P52; Reed RN, 2011, WILDLIFE RES, V38, P114, DOI 10.1071/WR10202; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Snow Ray W., 2007, P416; Snow Ray W., 2007, Herpetological Bulletin, P5; Stuart B., 2012, IUCN RED LIST THREAT; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	37	149	155	6	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121655	10.1371/journal.pone.0121655	http://dx.doi.org/10.1371/journal.pone.0121655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874630	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800027
J	Mishra, EK; Corcoran, JP; Hallifax, RJ; Stradling, J; Maskell, NA; Rahman, NM				Mishra, Eleanor K.; Corcoran, John P.; Hallifax, Robert J.; Stradling, John; Maskell, Nicholas A.; Rahman, Najib M.			Defining the Minimal Important Difference for the Visual Analogue Scale Assessing Dyspnea in Patients with Malignant Pleural Effusions	PLOS ONE			English	Article								Background The minimal important difference (MID) is essential for interpreting the results of randomised controlled trials (RCTs). Despite a number of RCTs in patients with malignant pleural effusions (MPEs) which use the visual analogue scale for dyspnea (VASD) as an outcome measure, the MID has not been established. Methods Patients with suspected MPE undergoing a pleural procedure recorded their baseline VASD and their post-procedure VASD (24 hours after the pleural drainage), and in parallel assessed their breathlessness on a 7 point Likert scale. Findings The mean decrease in VASD in patients with a MPE reporting a 'small but just worthwhile decrease' in their dyspnea (i.e. equivalent to the MID) was 19mm (95% CI 14-24mm). The mean drainage volume required to produce a change in VASD of 19mm was 760ml. Interpretation The mean MID for the VASD in patients with a MPE undergoing a pleural procedure is 19mm (95% CI 14-24mm). Thus choosing an improvement of 19mm in the VASD would be justifiable in the design and analysis of future MPE studies.	[Mishra, Eleanor K.; Corcoran, John P.; Hallifax, Robert J.; Stradling, John; Rahman, Najib M.] Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; [Mishra, Eleanor K.; Corcoran, John P.; Hallifax, Robert J.; Stradling, John; Rahman, Najib M.] Churchill Hosp, Oxford Biomed Res Ctr, Oxford Resp Trials Unit, Oxford OX3 7LJ, England; [Maskell, Nicholas A.] Univ Bristol, Bristol, Avon, England	University of Oxford; University of Oxford; University of Bristol	Mishra, EK (corresponding author), Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England.	eleanor.mishra@gmail.com		maskell, nick/0000-0002-1276-6500; Rahman, Najib M/0000-0003-1195-1680; Stradling, John/0000-0003-4971-5018; Mishra, Eleanor/0000-0002-5903-3005; Hallifax, Rob/0000-0002-9467-668X	National Cancer Research Institute; Marie Curie [MCCC-RP-14-A17178] Funding Source: researchfish	National Cancer Research Institute; Marie Curie(European Commission)	This research was funded by a grant from the National Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ander Douglas S, 2004, Congest Heart Fail, V10, P188, DOI 10.1111/j.1527-5299.2004.03475.x; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; de Torres JP, 2002, CHEST, V121, P1092, DOI 10.1378/chest.121.4.1092; GUYATT GH, 1989, J CLIN EPIDEMIOL, V42, P913, DOI 10.1016/0895-4356(89)90105-4; Karras DJ, 2000, ACAD EMERG MED, V7, P327, DOI 10.1111/j.1553-2712.2000.tb02231.x; Paul-Dauphin A, 1999, AM J EPIDEMIOL, V150, P1117, DOI 10.1093/oxfordjournals.aje.a009937; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Ries Andrew L, 2005, COPD, V2, P105; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; RODRIGUEZPANADERO F, 1989, EUR RESPIR J, V2, P366; Schunemann Holger J, 2005, COPD, V2, P81; Sloan J A, 2004, J Biopharm Stat, V14, P73, DOI 10.1081/BIP-120028507; Tu YK, 2007, STAT MED, V26, P443, DOI 10.1002/sim.2538; Yost KJ, 2005, J CLIN EPIDEMIOL, V58, P1241, DOI 10.1016/j.jclinepi.2005.07.008	14	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123798	10.1371/journal.pone.0123798	http://dx.doi.org/10.1371/journal.pone.0123798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874452	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000353015800116
J	Ballak, DB; van Asseldonk, EJP; van Diepen, JA; Jansen, H; Hijmans, A; Joosten, LAB; Tack, CJ; Netea, MG; Stienstra, R				Ballak, Dov B.; van Asseldonk, Edwin J. P.; van Diepen, Janna A.; Jansen, Henry; Hijmans, Anneke; Joosten, Leo A. B.; Tack, Cees J.; Netea, Mihai G.; Stienstra, Rinke			TLR-3 is Present in Human Adipocytes, but Its Signalling is Not Required for Obesity-Induced Inflammation in Adipose Tissue In Vivo	PLOS ONE			English	Article							INSULIN-RESISTANCE; FATTY-ACIDS; RECOGNITION; MACROPHAGES; INHIBITION; STEATOSIS; INDUCTION; CELLS; RNA	Innate immunity plays a pivotal role in obesity-induced low-grade inflammation originating from adipose tissue. Key receptors of the innate immune system including Toll-like receptors- 2 and -4 (TLRs) are triggered by nutrient excess to promote inflammation. The role of other TLRs in this process is largely unknown. In addition to double-stranded viral mRNA, TLR-3 can also recognize mRNA from dying endogenous cells, a process that is frequently observed within obese adipose tissue. Here, we identified profound expression of TLR-3 in adipocytes and investigated its role during diet-induced obesity. Human adipose tissue biopsies (n=80) and an adipocyte cell-line were used to study TLR-3 expression and function. TLR-3-/- and WT animals were exposed to a high-fat diet (HFD) for 16 weeks to induce obesity. Expression of TLR-3 was significantly higher in human adipocytes compared to the non-adipocyte cells part of the adipose tissue. In vitro, TLR-3 expression was induced during differentiation of adipocytes and stimulation of the receptor led to elevated expression of pro-inflammatory cytokines. In vivo, TLR-3 deficiency did not significantly influence HFD-induced obesity, insulin sensitivity or inflammation. In humans, TLR-3 expression in adipose tissue did not correlate with BMI or insulin sensitivity (HOMA-IR). Together, our results demonstrate that TLR-3 is highly expressed in adipocytes and functionally active. However, TLR-3 appears to play a redundant role in obesity-induced inflammation and insulin resistance.	[Ballak, Dov B.; van Asseldonk, Edwin J. P.; van Diepen, Janna A.; Jansen, Henry; Hijmans, Anneke; Joosten, Leo A. B.; Tack, Cees J.; Netea, Mihai G.; Stienstra, Rinke] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Stienstra, Rinke] Univ Wageningen & Res Ctr, Dept Human Nutr, Wageningen, Netherlands	Radboud University Nijmegen; Wageningen University & Research	Ballak, DB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	duby.ballak@radboudumc.nl	Joosten, Leo AB/H-3138-2015; van Diepen, Janna/E-9485-2010; Tack, Cees J/A-2368-2014; Netea, Mihai/N-5155-2014; Stienstra, Rinke/A-4763-2015; Ballak, Dov B/E-1188-2017	Joosten, Leo AB/0000-0001-6166-9830; van Diepen, Janna/0000-0001-9091-1075; Stienstra, Rinke/0000-0001-6729-7193; 	Ruby Grant of the Dutch Diabetes Research Foundation; Netherlands Organization for Scientific Research (NWO)	Ruby Grant of the Dutch Diabetes Research Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	RS was supported by a Ruby Grant of the Dutch Diabetes Research Foundation (http://www.diabetesfonds.nl). MN was supported by a Vici Grant from the Netherlands Organization for Scientific Research (NWO) (http://www.nwo.nl/onze-financieringsinstrumenten/nwo/vernieuwingsimpuls/vici/index.html) (http://www.nwo.nl/onderzoek-en-resultaten/programmas/vernieuwingsimpuls/toekenningen/alle+vici+toekenningen/Toekenningen+ Vici+2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Ballak DB, 2013, CYTOKINE, V62, P96, DOI 10.1016/j.cyto.2013.02.009; Brenner C, 2012, SCAND J IMMUNOL, V76, P359, DOI 10.1111/j.1365-3083.2012.02744.x; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Franchini M, 2010, HORM METAB RES, V42, P703, DOI 10.1055/s-0030-1261872; Gregor MF, 2011, ANN REV IMMUNOL; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jansen HJ, 2012, CLIN ENDOCRINOL OXF; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Joosten LA, 2010, ARTHRITIS RHEUM; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHO, 2010, WHO FACT FIL 10 FACT; Wu LDH, 2012, METABOLISM, V61, P1633, DOI 10.1016/j.metabol.2012.04.015; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu LL, 2014, IMMUNOL CELL BIOL, V92, P105, DOI 10.1038/icb.2013.66	29	23	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123152	10.1371/journal.pone.0123152	http://dx.doi.org/10.1371/journal.pone.0123152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867514	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100140
J	Koribanics, NM; Tuorto, SJ; Lopez-Chiaffarelli, N; McGuinness, LR; Haggblom, MM; Williams, KH; Long, PE; Kerkhof, LJ				Koribanics, Nicole M.; Tuorto, Steven J.; Lopez-Chiaffarelli, Nora; McGuinness, Lora R.; Haeggblom, Max M.; Williams, Kenneth H.; Long, Philip E.; Kerkhof, Lee J.			Spatial Distribution of an Uranium-Respiring Betaproteobacterium at the Rifle, CO Field Research Site	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; MICROBIAL REDUCTION; SUBSURFACE SEDIMENT; U(VI) REDUCTION; SP-NOV.; BIOREMEDIATION; NITRATE; ACETATE; FE(III); GROWTH	The Department of Energy's Integrated Field-Scale Subsurface Research Challenge Site (IFRC) at Rifle, Colorado was created to address the gaps in knowledge on the mechanisms and rates of U(VI) bioreduction in alluvial sediments. Previous studies at the Rifle IFRC have linked microbial processes to uranium immobilization during acetate amendment. Several key bacteria believed to be involved in radionuclide containment have been described; however, most of the evidence implicating uranium reduction with specific microbiota has been indirect. Here, we report on the cultivation of a microorganism from the Rifle IFRC that reduces uranium and appears to utilize it as a terminal electron acceptor for respiration with acetate as electron donor. Furthermore, this bacterium constitutes a significant proportion of the subsurface sediment community prior to biostimulation based on TRFLP profiling of 16S rRNA genes. 16S rRNA gene sequence analysis indicates that the microorganism is a betaproteobacterium with a high similarity to Burkholderia fungorum. This is, to our knowledge, the first report of a betaproteobacterium capable of uranium respiration. Our results indicate that this microorganism occurs commonly in alluvial sediments located between 3-6 m below ground surface at Rifle and may play a role in the initial reduction of uranium at the site.	[Koribanics, Nicole M.; Tuorto, Steven J.; Lopez-Chiaffarelli, Nora; McGuinness, Lora R.; Kerkhof, Lee J.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Lopez-Chiaffarelli, Nora; Haeggblom, Max M.] Rutgers State Univ, Cook Coll, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Williams, Kenneth H.; Long, Philip E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kerkhof, LJ (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	lkerkhof@rutgers.edu	Williams, Kenneth Hurst/O-5181-2014; Long, Philip E/F-5728-2013; Haggblom, Max M/E-7597-2010	Williams, Kenneth Hurst/0000-0002-3568-1155; Long, Philip E/0000-0003-4152-5682; Haggblom, Max M/0000-0001-6307-7863; Kerkhof, Lee/0000-0001-9107-8695	Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy [DE-AC0676RLO-1830]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	The Rifle IFC is funded by the Subsurface Biogeochemical Research (SBR) program, Biological and Environmental Research, Office of Science, U.S. Department of Energy (Contract Number DE-AC0676RLO-1830; managed by the Pacific Northwest National Laboratory and Battelle Memorial Institute). Currently, the Rifle IFC is managed by the Lawrence Berkeley National Laboratory under Contract No. DE-AC02-05CH11231 to the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SW, 2012, WORLD J MICROB BIOT, V28, P39, DOI 10.1007/s11274-011-0790-7; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Andreolli M, 2011, FEMS MICROBIOL LETT, V319, P11, DOI 10.1111/j.1574-6968.2011.02259.x; Bargar JR, 2013, P NATL ACAD SCI USA, V110, P4506, DOI 10.1073/pnas.1219198110; Blakeney MD, 2000, MICROBIOL RES, V155, P87; Boonchayaanant B, 2008, BIOTECHNOL BIOENG, V99, P1107, DOI 10.1002/bit.21670; Brooks SC, 2003, ENVIRON SCI TECHNOL, V37, P1850, DOI 10.1021/es0210042; Campbell KM, 2011, APPL GEOCHEM, V26, pS167, DOI 10.1016/j.apgeochem.2011.03.094; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chang YJ, 2005, ENVIRON SCI TECHNOL, V39, P9039, DOI 10.1021/es051218u; Chaudhary HJ, 2012, MICROB ECOL, V63, P813, DOI 10.1007/s00248-011-9978-5; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1099, DOI 10.1099/00207713-51-3-1099; Corredor Jorge E., 2004, Applied and Environmental Microbiology, V70, P5559; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Fennell DE, 2004, APPL ENVIRON MICROB, V70, P1169, DOI 10.1128/AEM.70.2.1169-1175.2004; Finneran KT, 2002, ENVIRON MICROBIOL, V4, P510, DOI 10.1046/j.1462-2920.2002.00317.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Istok JD, 2004, ENVIRON SCI TECHNOL, V38, P468, DOI 10.1021/es034639p; Kerkhof LJ, 2011, ENVIRON SCI TECHNOL, V45, P1250, DOI 10.1021/es102893r; Khijniak TV, 2005, APPL ENVIRON MICROB, V71, P6423, DOI 10.1128/AEM.71.10.6423-6426.2005; King GM, 2006, FEMS MICROBIOL ECOL, V56, P1, DOI 10.1111/j.1574-6941.2006.00065.x; Knight VK, 2002, GEOMICROBIOL J, V19, P77, DOI 10.1080/014904502317246183; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kotik M, 2013, SCI TOTAL ENVIRON, V454, P517, DOI 10.1016/j.scitotenv.2013.02.082; Long PE, 2015, GEOCHIM COSMOCHIM AC, V150, P106, DOI 10.1016/j.gca.2014.11.013; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1992, APPL ENVIRON MICROB, V58, P850, DOI 10.1128/AEM.58.3.850-856.1992; McGuinness LM, 2006, ENVIRON SCI TECHNOL, V40, P509, DOI 10.1021/es050900l; Moon HS, 2010, WATER RES, V44, P4015, DOI 10.1016/j.watres.2010.05.003; Moreels D, 2008, ENVIRON SCI POLLUT R, V15, P481, DOI 10.1007/s11356-008-0034-z; Mueller JG, 1997, ANTON LEEUW INT J G, V71, P329, DOI 10.1023/A:1000277008064; Nevin KP, 2005, INT J SYST EVOL MICR, V55, P1667, DOI 10.1099/ijs.0.63417-0; Newsome L, 2014, CHEM GEOL, V363, P164, DOI 10.1016/j.chemgeo.2013.10.034; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Peacock AD, 2004, MICROBIAL ECOL, V47, P284, DOI 10.1007/s00248-003-1024-9; Plangklang P, 2013, CHEM ECOL, V29, P44, DOI 10.1080/02757540.2012.686609; Prakash O, 2010, INT J SYST EVOL MICR, V60, P546, DOI 10.1099/ijs.0.010843-0; Qafoku NP, 2014, APPL GEOCHEM, V42, P77, DOI 10.1016/j.apgeochem.2013.12.001; Sakano Y, 1998, APPL ENVIRON MICROB, V64, P4877; Sanford RA, 2007, ENVIRON MICROBIOL, V9, P2885, DOI 10.1111/j.1462-2920.2007.01405.x; Senko JM, 2002, ENVIRON SCI TECHNOL, V36, P1491, DOI 10.1021/es011240x; Shelobolina ES, 2008, INT J SYST EVOL MICR, V58, P1075, DOI 10.1099/ijs.0.65377-0; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Smith WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062423; Spear JR, 2000, APPL ENVIRON MICROB, V66, P3711, DOI 10.1128/AEM.66.9.3711-3721.2000; Tanase AM, 2013, INT BIODETER BIODEGR, V84, P150, DOI 10.1016/j.ibiod.2012.05.022; Tebo BM, 1998, FEMS MICROBIOL LETT, V162, P193, DOI 10.1111/j.1574-6968.1998.tb12998.x; Vishnivetskaya TA, 2010, APPL ENVIRON MICROB, V76, P5728, DOI 10.1128/AEM.00308-10; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Wang JL, 2001, CHEMOSPHERE, V44, P1041, DOI 10.1016/S0045-6535(00)00469-0; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Williams KH, 2010, ENVIRON SCI TECHNOL, V44, P47, DOI 10.1021/es9017464	56	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123378	10.1371/journal.pone.0123378	http://dx.doi.org/10.1371/journal.pone.0123378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874721	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100168
J	Gao, XN; Lin, J; Gao, L; Deng, AL; Lu, XL; Li, YH; Wang, LL; Yu, L				Gao, Xiaoning; Lin, Ji; Gao, Li; Deng, Ailing; Lu, Xiaolin; Li, Yonghui; Wang, Lili; Yu, Li			High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t (8;21) Acute Myeloid Leukemia	PLOS ONE			English	Article							T(8/21); CANCER; AML; MUTATIONS; AML1-ETO; DISEASE; T(8/21)(Q22,Q22); LEUKEMOGENESIS; PROGNOSIS; INV(16)	The reason that a certain subgroup of acute myeloid leukemia (AML) patients with t(8; 21) translocation (generating the AML1/ETO fusion gene) displays a poor survival remains elusive. The proto-oncogene c-kit is expressed in approximately 80% of AML cases. The kinase domain mutation of the c-kit gene, one of the most common gain-of-function mutations associated with t(8; 21) AML, predicts higher relapse risk and poor prognosis. However, the role of c-kit high expression in t(8; 21) AML remains poorly understood. Here we evaluated the prognostic significance of c-kit expression levels in AML patients. The mRNA expression of c-kit was determined by real-time quantitative reverse transcription PCR in 132 adult AML patients. Patients were grouped into quartiles according to c-kit expression levels (Q1-Q4, each quartile containing 25% of patients) and divided into c-kit high (Q4; n = 33) and c-kit low (Q1-Q3; n = 99). High c-kit expression was associated with AML1/ETO-positive and with c-kit mutation. Of note, 35.8% of the AML1/ETO-positive AML patients carrying wild-type c-kit expressed high levels of c-kit, suggesting that other factors are involved in c-kit overexpression. High c-kit expression was associated with inferior overall and event-free survival in AML1/ETO-positive patients and was independently predictive for overall and event-free survival in multivariate analyses in a c-kit mutation-independent manner. Thus, high c-kit expression serves as a reliable molecular marker for poor prognosis, supporting a pathogenetic role of c-kit signaling in AML1/ETO-positive AML. AML1/ETO-positive patients with high c-kit expression might benefit from early treatment modifications and molecular target therapies.	[Gao, Xiaoning; Deng, Ailing; Lu, Xiaolin; Li, Yonghui; Wang, Lili; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Hematol, Beijing, Peoples R China; [Lin, Ji] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Inst Basic Med, Beijing, Peoples R China; [Gao, Li] China Japan Friendship Hosp, Dept Hematol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; China-Japan Friendship Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Hematol, Beijing, Peoples R China.	liyu301@vip.163.com	wang, lili/HDL-7210-2022; lu, xl/HDO-8340-2022	Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81170518, 81000221, 81370010, 81171820, 81370635]; National Public Health Grand Research Foundation [201202017]; Capital Public Health Project [Z111107067311070]; Beijing Natural Science Foundation [7122169, 7112126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; Capital Public Health Project; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was partially supported by grants from the National Natural Science Foundation of China (81170518 to LY; 81000221 and 81370010 to XNG; 81171820 to JL and 81370635 to YHL), the National Public Health Grand Research Foundation (201202017 to LY), the Capital Public Health Project (Z111107067311070 to LY), and the Beijing Natural Science Foundation (7122169 to XNG and 7112126 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Byrd JC, 1999, J CLIN ONCOL, V17, P3767, DOI 10.1200/JCO.1999.17.12.3767; CHESON BD, 1990, J CLIN ONCOL, V8, P813, DOI 10.1200/JCO.1990.8.5.813; de Jonge HJM, 2010, BLOOD, V116, P1747, DOI 10.1182/blood-2010-03-270991; Ferrara F, 2002, HAEMATOLOGICA, V87, P306; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Gao XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055481; Gorin NC, 2008, J CLIN ONCOL, V26, P3183, DOI 10.1200/JCO.2007.15.3106; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; IKEDA H, 1991, BLOOD, V78, P2962; Jiao B, 2009, LEUKEMIA, V23, P1598, DOI 10.1038/leu.2009.104; Krystal GW, 1996, CANCER RES, V56, P370; Kuchenbauer F, 2006, BRIT J HAEMATOL, V134, P616, DOI 10.1111/j.1365-2141.2006.06229.x; Kuhnl A, 2011, BLOOD, V118, P6362, DOI 10.1182/blood-2011-04-350850; Leroy H, 2005, LEUKEMIA, V19, P367, DOI 10.1038/sj.leu.2403627; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Lin P, 2008, MODERN PATHOL, V21, P1029, DOI 10.1038/modpathol.2008.92; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; Narimatsu H, 2008, LEUKEMIA, V22, P428, DOI 10.1038/sj.leu.2404905; Nguyen S, 2002, BLOOD, V99, P3517, DOI 10.1182/blood.V99.10.3517; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schlenk RF, 2004, J CLIN ONCOL, V22, P3741, DOI 10.1200/JCO.2004.03.012; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Shimada A, 2006, BLOOD, V107, P1806, DOI 10.1182/blood-2005-08-3408; Viehmann S, 2003, LEUKEMIA, V17, P1130, DOI 10.1038/sj.leu.2402959; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Yoo SJ, 2005, HAEMATOLOGICA, V90, P1493; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298	35	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124241	10.1371/journal.pone.0124241	http://dx.doi.org/10.1371/journal.pone.0124241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860287	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300134
J	Moghadamtousi, SZ; Rouhollahi, E; Karimian, H; Fadaeinasab, M; Firoozinia, M; Abdulla, MA; Kadir, HA				Moghadamtousi, Soheil Zorofchian; Rouhollahi, Elham; Karimian, Hamed; Fadaeinasab, Mehran; Firoozinia, Mohammad; Abdulla, Mahmood Ameen; Kadir, Habsah Abdul			The Chemopotential Effect of Annona muricata Leaves against Azoxymethane-Induced Colonic Aberrant Crypt Foci in Rats and the Apoptotic Effect of Acetogenin Annomuricin E in HT-29 Cells: A Bioassay-Guided Approach	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; LIPID-PEROXIDATION; OXIDATIVE STRESS; ANTIOXIDANT STATUS; MEDIATED PATHWAY; NATURAL-PRODUCTS; CANCER-CELLS; EXTRACT; EXPRESSION; FAMILY	Annona muricata has been used in folk medicine for the treatment of cancer and tumors. This study evaluated the chemopreventive properties of an ethyl acetate extract of Annona muricata leaves (EEAML) on azoxymethane-induced colonic aberrant crypt foci (ACF) in rats. Moreover, the cytotoxic compound of EEAML (Annomuricin E) was isolated, and its apoptosis-inducing effect was investigated against HT-29 colon cancer cell line using a bioassay-guided approach. This experiment was performed on five groups of rats: negative control, cancer control, EEAML (250 mg/kg), EEAML (500 mg/kg) and positive control (5-fluorouracil). Methylene blue staining of colorectal specimens showed that application of EEAML at both doses significantly reduced the colonic ACF formation compared with the cancer control group. Immunohistochemistry analysis showed the down-regulation of PCNA and Bcl-2 proteins and the up-regulation of Bax protein after administration of EEAML compared with the cancer control group. In addition, an increase in the levels of enzymatic antioxidants and a decrease in the malondialdehyde level of the colon tissue homogenates were observed, suggesting the suppression of lipid peroxidation. Annomuricin E inhibited the growth of HT-29 cells with an IC50 value of 1.62 +/- 0.24 mu g/ml after 48 h. The cytotoxic effect of annomuricin E was further substantiated by G1 cell cycle arrest and early apoptosis induction in HT-29 cells. Annomuricin E triggered mitochondria-initiated events, including the dissipation of the mitochondrial membrane potential and the leakage of cytochrome c from the mitochondria. Prior to these events, annomuricin E activated caspase 3/7 and caspase 9. Upstream, annomuricin E induced a time-dependent upregulation of Bax and downregulation of Bcl-2 at the mRNA and protein levels. In conclusion, these findings substantiate the usage of Annona muricata leaves in ethnomedicine against cancer and highlight annomuricin E as one of the contributing compounds in the anticancer activity of Annona muricata leaves.	[Moghadamtousi, Soheil Zorofchian; Kadir, Habsah Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Biochem Program,Biomol Res Grp, Kuala Lumpur, Malaysia; [Rouhollahi, Elham; Karimian, Hamed; Abdulla, Mahmood Ameen] Univ Malaya, Fac Sci, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Fadaeinasab, Mehran] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Kadir, HA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Biochem Program,Biomol Res Grp, Kuala Lumpur, Malaysia.	habsah@um.edu.my	ABDUL KADIR, HABSAH/B-8561-2010; Fadaeinasab, Mehran/A-8810-2016	Fadaeinasab, Mehran/0000-0002-2501-894X	University of Malaya High Impact Research Chancellery [UM.C/625/1/HIR/175]; University of Malaya Research Grant [RP001-2012C]; Postgraduate Research Fund [PG118-2013A]	University of Malaya High Impact Research Chancellery; University of Malaya Research Grant; Postgraduate Research Fund	This research was supported by the University of Malaya High Impact Research Chancellery (UM.C/625/1/HIR/175), University of Malaya Research Grant (RP001-2012C), and Postgraduate Research Fund (PG118-2013A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Adewole SO, 2006, AFR J BIOMED RES, V9, P173, DOI [10.4314/ajbr.v9i3.48903, DOI 10.4314/AJBR.V9I3.48903]; Adewole SO, 2009, AFR J TRADIT COMPLEM, V6, P30; Alali FQ, 1999, J NAT PROD, V62, P504, DOI 10.1021/np980406d; Almagrami AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096004; Alrawi SJ, 2006, ANTICANCER RES, V26, P107; Bardi DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109424; Bardi DA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918460; Baskar R, 2007, INDIAN J EXP BIOL, V45, P480; Bermejo A, 2005, NAT PROD REP, V22, P269, DOI 10.1039/b500186m; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brumatti G, 2008, METHODS, V44, P235, DOI 10.1016/j.ymeth.2007.11.010; Cerea G, 2003, ANTICANCER RES, V23, P1951; Chen WL, 2003, AM J CHINESE MED, V31, P523, DOI 10.1142/S0192415X0300120X; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DELEON MP, 1988, CANCER RES, V48, P4121; Demircan B, 2005, PAIN CLINIC, V17, P383; DESCHNER EE, 1983, J NATL CANCER I, V70, P279; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ezirim A., 2013, INDIAN J DRUGS DIS, V2, P241; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Fenoglio-Preiser CM, 1999, TOXICOL PATHOL, V27, P632, DOI 10.1177/019262339902700604; Foong CP, 2012, REV BRAS FARMACOGN, V22, P1301, DOI 10.1590/S0102-695X2012005000096; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Fulda S, 2010, PLANTA MED, V76, P1075, DOI 10.1055/s-0030-1249961; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Garber JC, 2011, GUIDE CARE USE LAB A; George VC, 2012, ASIAN PAC J CANCER P, V13, P699, DOI 10.7314/APJCP.2012.13.2.699; George VC, 2014, J FOOD SCI TECHNOL, P1; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Gourineni VP, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/983038; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo Y.W., 2013, ISRN ONCOL, DOI DOI 10.1155/2013/645817; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hajrezaie M, 2014, SCI WORLD J, DOI 10.1155/2014/540463; Hajrezaie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091246; HENDRICKSE CW, 1994, BRIT J SURG, V81, P1219, DOI 10.1002/bjs.1800810849; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; ISOZAKI H, 1994, SURG TODAY, V24, P494, DOI 10.1007/BF01884567; Karimian H, 2014, DRUG DES DEV THER, V8, P1481, DOI 10.2147/DDDT.S68818; Karimian H, 2014, MOLECULES, V19, P9478, DOI 10.3390/molecules19079478; Kim G, 1998, J NAT PROD, V61, P432, DOI 10.1021/np970534m; Komiya M, 2013, JPN J CLIN ONCOL, V43, P685, DOI 10.1093/jjco/hyt053; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LEWIS MA, 1993, PESTIC BIOCHEM PHYS, V45, P15, DOI 10.1006/pest.1993.1003; Liaw CC, 2010, PLANTA MED, V76, P1390, DOI 10.1055/s-0030-1250006; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Liochev SI, 2011, FREE RADIC BIOL MED, V60, P1; LIPKIN M, 1983, CANCER RES, V43, P1899; Lissoni P, 1999, EUR J CANCER, V35, P1688, DOI 10.1016/S0959-8049(99)00159-8; Lovborg H, 2004, MOL CANCER THER, V3, P521; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MAYER A, 1993, CANCER, V71, P2454, DOI 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2; Meguid NA, 2011, BIOL TRACE ELEM RES, V143, P58, DOI 10.1007/s12011-010-8840-9; Minari J, 2014, EGYPT J MED HUM GENE, V15, P327, DOI DOI 10.1016/J.EJMHG.2014.05.001; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Mishra S, 2013, GLOB J PHARM RES, V2, P1613; Moghadamtousi SZ, 2014, J ETHNOPHARMACOL, V156, P277, DOI 10.1016/j.jep.2014.08.011; Moghadamtousi SZ, 2014, DRUG DES DEV THER, V8, P2099, DOI 10.2147/DDDT.S70096; Moghadamtousi SZ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-299; Moghadamtousi SZ, 2014, SCI WORLD J, DOI 10.1155/2014/768323; MORRE DJ, 1994, LIFE SCI, V56, P343; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi Y, 2003, J MED CHEM, V46, P3185, DOI 10.1021/jm020548b; Naryzhny SN, 2007, FEBS LETT, V581, P4917, DOI 10.1016/j.febslet.2007.09.022; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P134, DOI 10.3109/10799893.2012.672994; Nirmala P, 2011, EUR J PHARMACOL, V654, P75, DOI 10.1016/j.ejphar.2010.11.034; Oberlies NH, 1997, CANCER LETT, V115, P73, DOI 10.1016/S0304-3835(97)04716-2; Oberlies NH, 1997, J MED CHEM, V40, P2102, DOI 10.1021/jm9700169; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Pandurangan AK, 2012, ASIAN PAC J CANCER P, V13, P1569, DOI 10.7314/APJCP.2012.13.4.1569; Park MT, 2003, J BIOCHEM MOL BIOL, V36, P60; Raju J, 2008, WORLD J GASTROENTERO, V14, P6632, DOI 10.3748/wjg.14.6632; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; RUPPRECHT JK, 1990, J NAT PROD, V53, P237, DOI 10.1021/np50068a001; Shin HR, 2000, CANCER CAUSE CONTROL, V11, P565, DOI 10.1023/A:1008980200583; Shwter AN, 2014, J ETHNOPHARMACOL, V151, P1194, DOI 10.1016/j.jep.2013.12.044; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P403, DOI 10.3748/wjg.v11.i3.403; Sturm I, 2001, J CLIN ONCOL, V19, P2272, DOI 10.1200/JCO.2001.19.8.2272; Taylor P, 2014, J ETHNOPHARMACOL, V158, P246, DOI 10.1016/j.jep.2014.10.034; Thomson M, 2003, CURR CANCER DRUG TAR, V3, P67, DOI 10.2174/1568009033333736; VACA CE, 1988, MUTAT RES, V195, P137, DOI 10.1016/0165-1110(88)90022-X; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; Venkateshwarlu Eggadi, 2014, World Applied Sciences Journal, V32, P444; Wang ZY, 2011, J ETHNOPHARMACOL, V133, P751, DOI 10.1016/j.jep.2010.11.004; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yuan SSF, 2003, LIFE SCI, V72, P2853, DOI 10.1016/S0024-3205(03)00190-5	93	49	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122288	10.1371/journal.pone.0122288	http://dx.doi.org/10.1371/journal.pone.0122288			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860620	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300039
J	Nerandzic, MM; Donskey, CJ				Nerandzic, Michelle M.; Donskey, Curtis J.			Induced Sporicidal Activity of Chlorhexidine against Clostridium difficile Spores under Altered Physical and Chemical Conditions	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; BLOOD-STREAM INFECTIONS; WORKERS HANDS; GLUCONATE; RESISTANCE; ENVIRONMENT; REDUCE; UNIT	Background Chlorhexidine is a broad-spectrum antimicrobial commonly used to disinfect the skin of patients to reduce the risk of healthcare-associated infections. Because chlorhexidine is not sporicidal, it is not anticipated that it would have an impact on skin contamination with Clostridium difficile, the most important cause of healthcare-associated diarrhea. However, although chlorhexidine is not sporicidal as it is used in healthcare settings, it has been reported to kill spores of Bacillus species under altered physical and chemical conditions that disrupt the spore's protective barriers (e.g., heat, ultrasonication, alcohol, or elevated pH). Here, we tested the hypothesis that similarly altered physical and chemical conditions result in enhanced sporicidal activity of chlorhexidine against C. difficile spores. Principal Findings C. difficile spores became susceptible to heat killing at 80 degrees C within 15 minutes in the presence of chlorhexidine, as opposed to spores suspended in water which remained viable. The extent to which the spores were reduced was directly proportional to the concentration of chlorhexidine in solution, with no viable spores recovered after 15 minutes of incubation in 0.04%-0.0004% w/v chlorhexidine solutions at 80 degrees C. Reduction of spores exposed to 4% w/v chlorhexidine solutions at moderate temperatures (37 degrees C and 55 degrees C) was enhanced by the presence of 70% ethanol. However, complete elimination of spores was not achieved until 3 hours of incubation at 55 degrees C. Elevating the pH to >= 9.5 significantly enhanced the killing of spores in either aqueous or alcoholic chlorhexidine solutions. Conclusions Physical and chemical conditions that alter the protective barriers of C. difficile spores convey sporicidal activity to chlorhexidine. Further studies are necessary to identify additional agents that may allow chlorhexidine to reach its target within the spore.	[Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA.	michellenerandzi@aim.com			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review grant from the Department of Veterans Affairs to CJD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 2008, E105408 AM SOC TEST; Beausoleil CM, 2012, J HOSP INFECT, V81, P283, DOI 10.1016/j.jhin.2012.05.003; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; DAVIES GE, 1954, BRIT J PHARM CHEMOTH, V9, P192, DOI 10.1111/j.1476-5381.1954.tb00840.x; Denton GW, 2001, DISINFECTION STERILI, P321; Evans HL, 2010, ARCH SURG-CHICAGO, V145, P240, DOI 10.1001/archsurg.2010.5; Gardner JF, 1983, DISINFECTION STERILI, P251; GORMAN SP, 1990, INT J PHARM, V65, P127, DOI 10.1016/0378-5173(90)90017-X; GORMAN SP, 1987, J APPL BACTERIOL, V63, P183, DOI 10.1111/j.1365-2672.1987.tb02701.x; Gorman SP, 1987, J APPL BACTERIOL, V63, P193; HUGO WB, 1964, J PHARM PHARMACOL, V16, P655, DOI 10.1111/j.2042-7158.1964.tb07384.x; JONES DS, 1995, INT J PHARM, V119, P247, DOI 10.1016/0378-5173(94)00409-X; Jury LA, 2011, INFECT CONT HOSP EP, V32, P181, DOI 10.1086/657911; Landelle C, 2014, INFECT CONT HOSP EP, V35, P10, DOI 10.1086/674396; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MACHEBOEUF M, 1953, B SOC CHIM BIOL, V35, P399; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Nishihara Y, 2012, J INFUS MURS, V35, P44, DOI 10.1097/NAN.0b013e31823d79ba; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Pop-Vicas A, 2014, INFECT CONT HOSP EP, V35, P16, DOI 10.1086/674397; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Rodriguez-Palacios A, 2011, APPL ENVIRON MICROB, V77, P3085, DOI 10.1128/AEM.01589-10; Rupp ME, 2012, INFECT CONT HOSP EP, V33, P1094, DOI 10.1086/668024; RUSSELL AD, 1986, INFECTION, V14, P212, DOI 10.1007/BF01644264; SCHINDLER PRG, 1978, J BACTERIOL, V135, P198, DOI 10.1128/JB.135.1.198-206.1978; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123809	10.1371/journal.pone.0123809	http://dx.doi.org/10.1371/journal.pone.0123809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861057	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300115
J	Osaki, T; Kakegawa, T; Kageyama, T; Enomoto, J; Nittami, T; Fukuda, J				Osaki, Tatsuya; Kakegawa, Takahiro; Kageyama, Tatsuto; Enomoto, Junko; Nittami, Tadashi; Fukuda, Junji			Acceleration of Vascular Sprouting from Fabricated Perfusable Vascular-Like Structures	PLOS ONE			English	Article							IN-VITRO MODEL; ELECTROCHEMICAL DETACHMENT; SKELETAL-MUSCLE; PHORBOL ESTERS; CELLS; ANGIOGENESIS; PROLIFERATION; CONSTRUCTS; ACTIVATION; APOPTOSIS	Fabrication of vascular networks is essential for engineering three-dimensional thick tissues and organs in the emerging fields of tissue engineering and regenerative medicine. In this study, we describe the fabrication of perfusable vascular-like structures by transferring endothelial cells using an electrochemical reaction as well as acceleration of subsequent endothelial sprouting by two stimuli: phorbol 12-myristate 13-acetate (PMA) and fluidic shear stress. The electrochemical transfer of cells was achieved using an oligopeptide that formed a dense molecular layer on a gold surface and was then electrochemically desorbed from the surface. Human umbilical vein endothelial cells (HUVECs), adhered to gold-coated needles (phi 600 mu m) via the oligopeptide, were transferred to collagen gel along with electrochemical desorption of the molecular layer, resulting in the formation of endothelial cell-lined vascular-like structures. In the following culture, the endothelial cells migrated into the collagen gel and formed branched luminal structures. However, this branching process was strikingly slow (> 14 d) and the cell layers on the internal surfaces became disrupted in some regions. To address these issues, we examined the effects of the protein kinase C (PKC) activator, PMA, and shear stress generated by medium flow. Addition of PMA at an optimum concentration significantly accelerated migration, vascular network formation, and its stabilization. Exposure to shear stress reoriented the cells in the direction of the medium flow and further accelerated vascular network formation. Because of the synergistic effects, HUVECs began to sprout as early as 3 d of perfusion culture and neighboring vascular-like structures were bridged within 5 d. Although further investigations of vascular functions need to be performed, this approach may be an effective strategy for rapid fabrication of perfusable microvascular networks when engineering three-dimensional fully vascularized tissues and organs.	[Osaki, Tatsuya; Kakegawa, Takahiro] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Osaki, Tatsuya; Kakegawa, Takahiro; Kageyama, Tatsuto; Enomoto, Junko; Nittami, Tadashi; Fukuda, Junji] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 240, Japan	University of Tsukuba; Yokohama National University	Fukuda, J (corresponding author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan.	fukuda@ynu.ac.jp	Fukuda, Junji/R-6620-2019; Fukuda, Junji/B-9257-2011	Fukuda, Junji/0000-0002-7194-8099; Fukuda, Junji/0000-0002-7194-8099; Kageyama, Tatsuto/0000-0001-6248-3755; Osaki, Tatsuya/0000-0001-7174-0629; Enomoto, Junko/0000-0002-4177-7380	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25289291, 26630423, 26106712]; New Energy and Industrial Technology Development Organization [11B09003d]; ALCA, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [15J02349, 26106712] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); ALCA, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, 25289291, 26630423, 26106712 (http://www.mext.go.jp/english/) to (JF) and New Energy and Industrial Technology Development Organization, 11B09003d (http://www.nedo.go.jp/english/index.html) to (JF) and ALCA, Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html) to (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014; Baum O, 2004, AM J PHYSIOL-HEART C, V287, pH2300, DOI 10.1152/ajpheart.00065.2004; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bellan LM, 2009, SOFT MATTER, V5, P1354, DOI 10.1039/b819905a; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Busuttil V, 2002, ONCOGENE, V21, P3213, DOI 10.1038/sj.onc.1205433; Chen SF, 2009, BIOMATERIALS, V30, P5892, DOI 10.1016/j.biomaterials.2009.07.001; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Folkman J., 1984, BIOL ENDOTHELIAL CEL, P412; Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; GROSS JL, 1983, P NATL ACAD SCI-BIOL, V80, P2623, DOI 10.1073/pnas.80.9.2623; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huang X, 2010, ANN BIOMED ENG, V38, P1965, DOI 10.1007/s10439-010-9986-5; Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045; Kakegawa T, 2013, TISSUE ENG PT A, V19, P290, DOI [10.1089/ten.tea.2011.0739, 10.1089/ten.TEA.2011.0739]; Karsan A, 1997, AM J PATHOL, V151, P1775; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LANGILLE BL, 1993, J CARDIOVASC PHARM, V21, pS11; Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g; Martou G, 2006, J APPL PHYSIOL, V101, P1335, DOI 10.1152/japplphysiol.00278.2006; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Miller J.S., 2012, NAT MATER, V11; Mochizuki N, 2013, J TISSUE ENG REGEN M, V7, P236, DOI 10.1002/term.519; MONTESANO R, 1985, CELL, V42, P469, DOI 10.1016/0092-8674(85)90104-7; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Okano T, 1998, CELL TRANSPLANT, V7, P435, DOI 10.1016/S0963-6897(98)00030-X; Park IC, 2001, INT J ONCOL, V18, P1077; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; PRIES AR, 1995, CIRC RES, V77, P1017, DOI 10.1161/01.RES.77.5.1017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Seano G, 2013, BLOOD, V121, pE129, DOI 10.1182/blood-2012-08-452292; Seto Y, 2010, BIOMATERIALS, V31, P2209, DOI 10.1016/j.biomaterials.2009.11.104; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Takei T, 2006, BIOTECHNOL BIOENG, V95, P1, DOI 10.1002/bit.20903; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Tkachenko E, 2009, LAB CHIP, V9, P1085, DOI 10.1039/b812184b; Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	51	28	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123735	10.1371/journal.pone.0123735	http://dx.doi.org/10.1371/journal.pone.0123735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860890	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300112
J	Rausa, M; Pagani, A; Nai, A; Campanella, A; Gilberti, ME; Apostoli, P; Camaschella, C; Silvestri, L				Rausa, Marco; Pagani, Alessia; Nai, Antonella; Campanella, Alessandro; Gilberti, Maria Enrica; Apostoli, Pietro; Camaschella, Clara; Silvestri, Laura			Bmp6 Expression in Murine Liver Non Parenchymal Cells: A Mechanism to Control their High Iron Exporter Activity and Protect Hepatocytes from Iron Overload?	PLOS ONE			English	Article							HEPCIDIN EXPRESSION; GENE-EXPRESSION; HEMOJUVELIN; RECEPTORS; TMPRSS6	Bmp6 is the main activator of hepcidin, the liver hormone that negatively regulates plasma iron influx by degrading the sole iron exporter ferroportin in enterocytes and macrophages. Bmp6 expression is modulated by iron but the molecular mechanisms are unknown. Although hepcidin is expressed almost exclusively by hepatocytes (HCs), Bmp6 is produced also by non-parenchymal cells (NPCs), mainly sinusoidal endothelial cells (LSECs). To investigate the regulation of Bmp6 in HCs and NPCs, liver cells were isolated from adult wild type mice whose diet was modified in iron content in acute or chronic manner and in disease models of iron deficiency (Tmprss6 KO mouse) and overload (Hjv KO mouse). With manipulation of dietary iron in wild-type mice, Bmp6 and Tfr1 expression in both HCs and NPCs was inversely related, as expected. When hepcidin expression is abnormal in murine models of iron overload (Hjv KO mice) and deficiency (Tmprss6 KO mice), Bmp6 expression in NPCs was not related to Tfr1. Despite the low Bmp6 in NPCs from Tmprss6 KO mice, Tfr1 mRNA was also low. Conversely, despite body iron overload and high expression of Bmp6 in NPCs from Hjv KO mice, Tfr1 mRNA and protein were increased. However, in the same cells ferritin L was only slightly increased, but the iron content was not, suggesting that Bmp6 in these cells reflects the high intracellular iron import and export. We propose that NPCs, sensing the iron flux, not only increase hepcidin through Bmp6 with a paracrine mechanism to control systemic iron homeostasis but, controlling hepcidin, they regulate their own ferroportin, inducing iron retention or release and further modulating Bmp6 production in an autocrine manner. This mechanism, that contributes to protect HC from iron loading or deficiency, is lost in disease models of hepcidin production.	[Rausa, Marco; Pagani, Alessia; Nai, Antonella; Campanella, Alessandro; Camaschella, Clara; Silvestri, Laura] Ist Sci San Raffaele, IRCCS, Div Genet & Cell Biol, I-20132 Milan, Italy; [Rausa, Marco; Pagani, Alessia; Nai, Antonella; Campanella, Alessandro; Camaschella, Clara; Silvestri, Laura] Univ Vita Salute San Raffaele, Milan, Italy; [Gilberti, Maria Enrica; Apostoli, Pietro] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Unit Occupat Hlth & Ind Hyg, Brescia, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Brescia	Camaschella, C (corresponding author), Ist Sci San Raffaele, IRCCS, Div Genet & Cell Biol, I-20132 Milan, Italy.	camaschella.clara@hsr.it; silvestri.laura@hsr.it	Pagani, Alessia/AAN-4301-2020; Nai, Antonella/AAB-8749-2019; Silvestri, Laura/A-1417-2015; Campanella, Alessandro/N-8315-2015	Pagani, Alessia/0000-0003-2374-4988; Nai, Antonella/0000-0002-0739-5282; Silvestri, Laura/0000-0002-8726-9808; Campanella, Alessandro/0000-0002-3463-1199	Telethon Fondazione Onlus [GGP12025]; Ministero Sanita, MIUR-PRIN (Progetto di Rilevante Interesse Nazionale); Ricerca Finalizzata [RF-2010-2312048]	Telethon Fondazione Onlus(Fondazione Telethon); Ministero Sanita, MIUR-PRIN (Progetto di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was partially supported by the "Telethon Fondazione Onlus" Grant GGP12025; the Ministero Sanita, MIUR-PRIN (Progetto di Rilevante Interesse Nazionale) 2010-2011; and the Ricerca Finalizzata RF-2010-2312048 to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Campanella A, 2004, BIOCHEMISTRY-US, V43, P195, DOI 10.1021/bi035386f; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Knittel T, 1997, EXP CELL RES, V232, P263, DOI 10.1006/excr.1997.3504; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Riba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069694; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084906	29	50	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122696	10.1371/journal.pone.0122696	http://dx.doi.org/10.1371/journal.pone.0122696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860887	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300056
J	Brown, KA; Parks, KE; Bethell, CA; Johnson, SE; Mulligan, M				Brown, Kerry A.; Parks, Katherine E.; Bethell, Colin A.; Johnson, Steig E.; Mulligan, Mark			Predicting Plant Diversity Patterns in Madagascar: Understanding the Effects of Climate and Land Cover Change in a Biodiversity Hotspot	PLOS ONE			English	Article							NO-ANALOG COMMUNITIES; SPECIES DISTRIBUTIONS; TROPICAL FORESTS; RANGE SHIFTS; DEFORESTATION; CONSERVATION; PRECIPITATION; TEMPERATURE; FUTURE; VULNERABILITY	Climate and land cover change are driving a major reorganization of terrestrial biotic communities in tropical ecosystems. In an effort to understand how biodiversity patterns in the tropics will respond to individual and combined effects of these two drivers of environmental change, we use species distribution models (SDMs) calibrated for recent climate and land cover variables and projected to future scenarios to predict changes in diversity patterns in Madagascar. We collected occurrence records for 828 plant genera and 2186 plant species. We developed three scenarios, (i.e., climate only, land cover only and combined climate-land cover) based on recent and future climate and land cover variables. We used this modelling framework to investigate how the impacts of changes to climate and land cover influenced biodiversity across ecoregions and elevation bands. There were large-scale climate- and land cover-driven changes in plant biodiversity across Madagascar, including both losses and gains in diversity. The sharpest declines in biodiversity were projected for the eastern escarpment and high elevation ecosystems. Sharp declines in diversity were driven by the combined climate-land cover scenarios; however, there were subtle, region-specific differences in model outputs for each scenario, where certain regions experienced relatively higher species loss under climate or land cover only models. We strongly caution that predicted future gains in plant diversity will depend on the development and maintenance of dispersal pathways that connect current and future suitable habitats. The forecast for Madagascar's plant diversity in the face of future environmental change is worrying: regional diversity will continue to decrease in response to the combined effects of climate and land cover change, with habitats such as ericoid thickets and eastern lowland and sub-humid forests particularly vulnerable into the future.	[Brown, Kerry A.] Univ Kingston, Sch Geog Geol & Environm, Ctr Earth & Environm Sci Res, London, England; [Parks, Katherine E.] Univ Southampton, Fac Engn & Environm, Ctr Environm Sci, Southampton, Hants, England; [Bethell, Colin A.] Univ Kingston, High Performance Comp Cluster, Fac Sci Engn & Comp, Fac Sci, London, England; [Johnson, Steig E.] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Mulligan, Mark] Univ London, Kings Coll London, Dept Geog, London SW3 6LX, England	Kingston University; University of Southampton; Kingston University; University of Calgary; University of London; King's College London	Brown, KA (corresponding author), Univ Kingston, Sch Geog Geol & Environm, Ctr Earth & Environm Sci Res, London, England.	k.brown@kingston.ac.uk	Mulligan, Mark/V-9275-2019; Brown, Kerry/U-5082-2019	Mulligan, Mark/0000-0002-0132-0888; Johnson, Steig/0000-0003-2257-8949; BROWN, KERRY/0000-0002-6342-8966	Madagascar National Parks (MNP); Madagascar Institute pour la Conservation des Ecosystemes Tropicaux (MICET); Institute for the Conservation of Tropical Environments (ICTE); Madagascar Biodiversity Partnership (MBP); Natural Environment Research Council [NE/K010417/1] Funding Source: researchfish; NERC [NE/K010417/1] Funding Source: UKRI	Madagascar National Parks (MNP); Madagascar Institute pour la Conservation des Ecosystemes Tropicaux (MICET); Institute for the Conservation of Tropical Environments (ICTE); Madagascar Biodiversity Partnership (MBP); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank Madagascar National Parks (MNP), Madagascar Institute pour la Conservation des Ecosystemes Tropicaux (MICET), Institute for the Conservation of Tropical Environments (ICTE), and Madagascar Biodiversity Partnership (MBP) for valuable support. We thank six anonymous reviewers for comments on the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Asner GP, 2010, CONSERV LETT, V3, P395, DOI 10.1111/j.1755-263X.2010.00133.x; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; BRIEGLEB BP, 1992, J GEOPHYS RES-ATMOS, V97, P7603, DOI 10.1029/92JD00291; Brown KA, 2013, BIOL CONSERV, V161, P118, DOI 10.1016/j.biocon.2013.03.014; Busch J, 2012, CONSERV BIOL, V26, P408, DOI 10.1111/j.1523-1739.2012.01838.x; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Coe MT, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0155; Coe MT, 2009, J HYDROL, V369, P165, DOI 10.1016/j.jhydrol.2009.02.043; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Elmqvist T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000402; ESRI, 2012, ARCGIS REL 10 1; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Ferrer-Paris JR, 2013, DIVERS DISTRIB, V19, P215, DOI 10.1111/ddi.12012; Freeman E., 2012, PRESENCEABSENCE 1 1; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Grinand C, 2013, REMOTE SENS ENVIRON, V139, P68, DOI 10.1016/j.rse.2013.07.008; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Hansen M., 2006, VEGETATION CONTINUOU; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hong-Wa C, 2012, PLANT ECOL EVOL, V145, P302, DOI 10.5091/plecevo.2012.742; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kreyling J, 2010, DIVERS DISTRIB, V16, P593, DOI 10.1111/j.1472-4642.2010.00675.x; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lathuilliere MJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024024; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Liu FD, 2010, EUR J FOREST RES, V129, P1093, DOI 10.1007/s10342-010-0394-z; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McConnell WJ, 2014, EARTH CONSERV DEV, P67; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Moat J., 2007, ATLAS VEGETATION MAD; Mulligan M., 2010, SIMTERRA CONSISTENT; Mulligan M, 2010, WATER INT, V35, P472, DOI 10.1080/02508060.2010.516330; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nobre P, 2009, J CLIMATE, V22, P5686, DOI 10.1175/2009JCLI2757.1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Platts PJ, 2013, ECOGRAPHY, V36, P518, DOI 10.1111/j.1600-0587.2012.07805.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Rodriguez-Castaneda G, 2013, GLOBAL ECOL BIOGEOGR, V22, P118, DOI 10.1111/j.1466-8238.2012.00795.x; Sagar R, 2003, FOREST ECOL MANAG, V186, P61, DOI 10.1016/S0378-1127(03)00235-4; Satake A, 2008, GLOBAL ENVIRON CHANG, V18, P768, DOI 10.1016/j.gloenvcha.2008.07.007; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Tadross M, 2008, CLIMATE CHANGE MADGA; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Vieilledent G, 2013, ECOL EVOL, V3, P1702, DOI 10.1002/ece3.550; Watson JEM, 2014, CONSERV LETT, V7, P1, DOI 10.1111/conl.12083; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	70	32	33	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122721	10.1371/journal.pone.0122721	http://dx.doi.org/10.1371/journal.pone.0122721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856241	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000352588500051
J	Komarnitki, I; Tomczyk, J; Ciszek, B; Zalewska, M				Komarnitki, Iulian; Tomczyk, Jacek; Ciszek, Bogdan; Zalewska, Marta			Proposed Classification of Auriculotemporal Nerve, Based on the Root System	PLOS ONE			English	Article							INFRATEMPORAL FOSSA; ANATOMY	The topography of the auriculotemporal nerve (ATN) root system is the main criterion of this nerve classification. Previous publications indicate that ATN may have between one and five roots. Most common is a one-or two-root variant of the nerve structure. The problem of many publications is the inconsistency of nomenclature which concerns the terms "roots", "connecting branches", or "branches" that are used to identify the same structures. This study was performed on 80 specimens (40 adults and 40 fetuses) to propose a classification based on: (i) the number of roots, (ii) way of root division, and (iii) configuration of interradicular fibers that form the ATN trunk. This new classification is a remedy for inconsistency of nomenclature of ATN in the infratemporal fossa. This classification system has proven beneficial when organizing all ATN variants described in previous studies and could become a helpful tool for surgeons and dentists. Examination of ATN from the infratemporal fossa of fetuses (the youngest was at 18 weeks gestational age) showed that, at that stage, the nerve is fully developed.	[Komarnitki, Iulian; Ciszek, Bogdan] Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland; [Tomczyk, Jacek] Cardinal Stefan Wyszynski Univ, Dept Biol Anthropol, Warsaw, Poland; [Zalewska, Marta] Med Univ Warsaw, Dept Environm Hazard Prevent & Allergol, Warsaw, Poland	Medical University of Warsaw; Cardinal Stefan Wyszynski University in Warsaw; Medical University of Warsaw	Komarnitki, I (corresponding author), Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland.	anatomy@onet.eu	Ciszek, Bogdan/N-7879-2018	Ciszek, Bogdan/0000-0002-0740-5049; Zalewska, Marta/0000-0002-8163-961X				Agur A.M., 2013, GRANTS ATLAS ANATOMY; Andersen NB, 2001, SURG RADIOL ANAT, V23, P97; Anil A, 2003, BRIT J ORAL MAX SURG, V41, P236, DOI 10.1016/S0266-4356(03)00113-X; BAUMEL JJ, 1971, AM J ANAT, V130, P431, DOI 10.1002/aja.1001300405; Chim H, 2012, PLAST RECONSTR SURG, V130, P336, DOI 10.1097/PRS.0b013e3182589dd5; Dias GJ, 2015, ANAT SCI INT, V90, P216, DOI 10.1007/s12565-014-0247-9; Fernandes PRB, 2003, CRANIO, V21, P165, DOI 10.1080/08869634.2003.11746246; GRAY H, 1995, GRAYS ANATOMY; Gulekon N, 2005, CLIN ANAT, V18, P15, DOI 10.1002/ca.20068; Janis JE, 2010, PLAST RECONSTR SURG, V125, P1422, DOI 10.1097/PRS.0b013e3181d4fb05; Kim HK, 2003, J ORAL REHABIL, V30, P189, DOI 10.1046/j.1365-2842.2003.01020.x; Komarnitki I, 2012, FOLIA MORPHOL, V71, P187; KRIZAN Z, 1956, Pract Otorhinolaryngol (Basel), V18, P144; Kwak HH, 2004, SURG RADIOL ANAT, V26, P494, DOI 10.1007/s00276-004-0259-6; McCoul ED, 2011, OPER TECH OTOLARYNGO, V22, P285; Murayama RA, 2009, INT ENDOD J, V42, P845, DOI 10.1111/j.1365-2591.2009.01599.x; Ngeow WC, 2009, BRIT DENT J, V207, P19, DOI 10.1038/sj.bdj.2009.559; Prades JM, 2003, SURG RADIOL ANAT, V25, P180, DOI 10.1007/s00276-003-0126-x; RIESSNER D, 1952, AMA ARCH SURG, V65, P831, DOI 10.1001/archsurg.1952.01260020825006; Riva N, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00041; ROBERT R, 1989, SURG RADIOL ANAT, V11, P307, DOI 10.1007/BF02098703; Sabit I, 2002, SURG NEUROL, V58, P21, DOI 10.1016/S0090-3019(02)00764-4; Schmalfuss IM, 2002, AM J NEURORADIOL, V23, P303; Schmidt BL, 1998, ORAL SURG ORAL MED O, V86, P165, DOI 10.1016/S1079-2104(98)90119-6; SHAHINIAN H, 1995, SKULL BASE SURG, V5, P73, DOI 10.1055/s-2008-1058937; Soni S, 2009, J ORAL MAXIL SURG, V67, P448, DOI 10.1016/j.joms.2008.09.012; Speciali Jose Geraldo, 2005, Curr Pain Headache Rep, V9, P277; Stuginski-Barbosa J, 2012, J HEADACHE PAIN, V13, P415, DOI 10.1007/s10194-012-0439-4; Thotakura B, 2003, SINGAP MED J, V54, P149; Wei Y, 2007, AM J ROENTGENOL, V189, P488, DOI 10.2214/AJR.07.2212	30	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123120	10.1371/journal.pone.0123120	http://dx.doi.org/10.1371/journal.pone.0123120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856464	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500075
J	Lau, YM; Cheung, TH; Yeo, WN; Mo, F; Yu, MY; Lee, KM; Ho, WCS; Yeung, ACM; Law, PTY; Chan, PKS				Lau, Yat Ming; Cheung, Tak Hong; Yeo, Winnie; Mo, Frankie; Yu, Mei Yung; Lee, Kun Min; Ho, Wendy C. S.; Yeung, Apple C. M.; Law, Priscilla T. Y.; Chan, Paul K. S.			Prognostic Implication of Human Papillomavirus Types and Species in Cervical Cancer Patients Undergoing Primary Treatment	PLOS ONE			English	Article							RISK HPV INFECTION; SOUTHERN CHINESE; RADICAL SURGERY; NEOPLASIA; CARCINOMA; ASSOCIATION; GENOTYPE; CLASSIFICATION; METAANALYSIS; POPULATION	High-risk human papillomavirus (HPV) types are associated with cervical cancer. It is well established that individual HPV types vary in oncogenicity, but current data on their prognostic implication remain controversial. We examined the association between HPV types/species and the survival of 236 Chinese women aged 26-87 (mean 54.4) years after receiving primary treatment for cervical cancer. Overall, 45.8% were of FIGO stage I, 41.9% stage II, and 12.3% stage III. The four most prevalent types found were HPV-16 (60.2%), HPV-18 (21.6%), HPV-52 (11.9%), and HPV-58 (9.3%). Overall, 19.5% of patients had multiple-type infections, 78.4% harboured one or more alpha-9 species, and 28.8% harboured one or more alpha-7 species. After a median follow-up of 8.0 years, 156 (66.1%) patients survived. The 3-year overall survival rate was 75.5%. Factors independently associated with a poorer 3-year overall survival were age >60 years, tumour size >4 cm, lymph node involvement and treatment with radiotherapy+/-chemotherapy. Univariate analysis showed HPV-16 single-type infection was associated with a marginally poorer disease-specific survival (71.6% vs. 87.0%, HR: 1.71, 95% CI = 1.01-2.90), whereas non-HPV-16 alpha-9 species was associated with a better disease-specific survival (90.0% vs. 76.2%, HR: 0.36, 95% CI = 0.16-0.79). However, on multivariate analysis, HPV infection status irrespective of different grouping methods, including individual types, species, single-type or co-infection, did not carry any significant prognostic significance. In conclusion, we did not observe anyassociation between infection with a particular HPV type/species and survival. An HPV type-based stratification in treatment and follow-up plan could not be recommended.	[Lau, Yat Ming] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Cheung, Tak Hong] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Hong Kong Canc Inst, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Yu, Mei Yung] Chinese Univ Hong Kong, Fac Med, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ho, Wendy C. S.; Yeung, Apple C. M.; Law, Priscilla T. Y.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	United Christian Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Mo, Frankie/AAG-8079-2021; Chan, Paul KS/J-9360-2013; Yeo, Winnie/R-4792-2018; Mo, Frankie/AAC-9230-2022; Lau, Yat-Ming/ABE-3515-2020	Chan, Paul KS/0000-0002-6360-4608; Yeo, Winnie/0000-0002-0863-8469; Mo, Frankie/0000-0002-0566-3212; Lau, Yat-Ming/0000-0002-9888-0207	GlaxoSmithKline; F. Hoffmann-La Roche	GlaxoSmithKline(GlaxoSmithKline); F. Hoffmann-La Roche(Hoffmann-La Roche)	The authors have read the journal's policy and they have the following competing interests: Paul K. S. Chan is participating in clinical trials supported by GlaxoSmithKline and F. Hoffmann-La Roche, and has received honoraria as advisory board member, and travel support to attend academic conferences from GlaxoSmithKline. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Briolat J, 2007, INT J CANCER, V121, P2198, DOI 10.1002/ijc.22959; Burger RA, 1996, JNCI-J NATL CANCER I, V88, P1361, DOI 10.1093/jnci/88.19.1361; Zampronha RDC, 2013, CLINICS, V68, P809, DOI 10.6061/clinics/2013(06)14; Chan DPC, 2005, J INFECT DIS, V192, P1749, DOI 10.1086/497342; Chan PKS, 2007, J MED VIROL, V79, P970, DOI 10.1002/jmv.20805; Chan PKS, 2007, GYNECOL ONCOL, V105, P736, DOI 10.1016/j.ygyno.2007.02.013; Chan PKS, 2012, INT J CANCER, V131, P692, DOI 10.1002/ijc.26404; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Chan PKS, 2006, INT J CANCER, V118, P1430, DOI 10.1002/ijc.21528; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; de Cremoux P, 2009, INT J CANCER, V124, P778, DOI 10.1002/ijc.24075; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; EIFEL PJ, 1995, GYNECOL ONCOL, V59, P38, DOI 10.1006/gyno.1995.1265; Fauquet CM, 2005, VIRUS TAXONOMY CLASS; Huang LW, 2004, CANCER-AM CANCER SOC, V100, P327, DOI 10.1002/cncr.20003; IKENBERG H, 1994, INT J CANCER, V59, P322, DOI 10.1002/ijc.2910590306; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; Lai CH, 2007, J CLIN ONCOL, V25, P3628, DOI 10.1200/JCO.2007.11.2995; Lai HC, 1999, INT J CANCER, V84, P553, DOI 10.1002/(SICI)1097-0215(19991222)84:6&lt;553::AID-IJC2&gt;3.0.CO;2-4; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Li Y, 2013, J VIROL, V87, P9313, DOI 10.1128/JVI.01154-13; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Pilch H, 2001, INT J GYNECOL CANCER, V11, P39, DOI 10.1046/j.1525-1438.2001.011001039.x; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schwartz SM, 2001, J CLIN ONCOL, V19, P1906, DOI 10.1200/JCO.2001.19.7.1906; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Tong SY, 2007, INT J GYNECOL CANCER, V17, P1307, DOI 10.1111/j.1525-1438.2007.00933.x; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Wang CC, 2010, INT J RADIAT ONCOL, V78, P1111, DOI 10.1016/j.ijrobp.2009.09.021; Wright JD, 2005, GYNECOL ONCOL, V98, P84, DOI 10.1016/j.ygyno.2005.03.038; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122557	10.1371/journal.pone.0122557	http://dx.doi.org/10.1371/journal.pone.0122557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855986	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500041
J	Pascoal-Xavier, MA; Figueiredo, ACC; Gomes, LI; Peruhype-Magalhaes, V; Calzavara-Silva, CE; Costa, MA; Reis, IA; Bonjardim, CA; Kroon, EG; de Oliveira, JG; Ferreira, PCP				Pascoal-Xavier, Marcelo Antonio; Cancado Figueiredo, Anna Carolina; Gomes, Luciana Inacia; Peruhype-Magalhaes, Vanessa; Calzavara-Silva, Carlos Eduardo; Costa, Marcelo Azevedo; Reis, Ilka Afonso; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; de Oliveira, Jaquelline G.; Peregrino Ferreira, Paulo Cesar			RAP1 GTPase Overexpression is Associated with Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; G-PROTEINS; EXPRESSION; CANCER; BRD4; RAS; TUMORIGENESIS; P16(INK4A); ACTIVATION	RAP1 (RAS proximate 1), a small GTP-binding protein of the RAS superfamily, is a putative oncogene that is highly expressed in several malignant cell lines and types of cancers, including some types of squamous cell carcinoma. However, the participation of RAP1 in cervical carcinogenesis is unknown. We conducted a cross-sectional study of paraffin-embedded cervical biopsies to determine the association of RAP1 with cervical intraepithelial neoplasia (CIN). Standard and quantitative immunohistochemistry assessment of RAP1 expression in fixed tissue was performed on 183 paraffin-embedded cervical biopsies that were classified as normal or non-dysplastic mucosa (NDM) (n = 33); CIN grade 1 (n = 84) and CIN grade 2/3 (n = 66). A gradual increase in RAP1 expression in NDM < CIN 1 < CIN 2/3 (p<0.001) specimens was observed and was in agreement with the histopathologic diagnosis. A progressive increase in the RAP1 expression levels increased the risk of CIN 1 [ odds ratio (OR) = 3.50; 95% confidence interval (CI) 1.30-10.64] 3.5 fold and the risk of CIN 2/3 (OR=19.86, 95% CI 6.40-70.79) nearly 20 fold when compared to NDM. In addition, stereotype ordinal regression analysis showed that this progressive increase in RAP1 expression more strongly impacted CIN 2/3 than CIN 1. Our findings suggest that RAP1 may be a useful biomarker for the diagnosis of CIN.	[Pascoal-Xavier, Marcelo Antonio; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Peregrino Ferreira, Paulo Cesar] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Cancado Figueiredo, Anna Carolina; Gomes, Luciana Inacia; Peruhype-Magalhaes, Vanessa; Calzavara-Silva, Carlos Eduardo; de Oliveira, Jaquelline G.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Costa, Marcelo Azevedo] Univ Fed Minas Gerais, Escola Engn, Dept Engn Prod, Belo Horizonte, MG, Brazil; [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Oliveira, JG (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	jaque@cpqrr.fiocruz.br	Reis, Ilka Afonso/AAG-8007-2019; Calzavara-Silva, Carlos/ABF-2829-2021; Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; De Oliveira, Jaquelline/ABE-3725-2021; Reis, Ilka Afonso/AAO-5375-2021	Calzavara-Silva, Carlos/0000-0002-1406-6401; Kroon, Erna Geessien/0000-0003-2721-3826; Reis, Ilka Afonso/0000-0001-7199-8590; Costa, Marcelo/0000-0002-2330-5056	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - www.capes.gov.br), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu Mery Natali Silva, 2008, Cad. Saúde Pública, V24, ps581, DOI 10.1590/S0102-311X2008001600010; Ahn J, 2009, STAT MED, V28, P3139, DOI 10.1002/sim.3693; ANDERSON JA, 1984, J R STAT SOC B, V46, P1; Banerjee Rajat, 2012, Small GTPases, V3, P192, DOI 10.4161/sgtp.20413; Banerjee R, 2011, CELL SIGNAL, V23, P1110, DOI 10.1016/j.cellsig.2011.02.002; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Furstenau DK, 2011, BREAST CANCER RES TR, V129, P361, DOI 10.1007/s10549-010-1227-y; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gao QS, 1999, MOL CELL BIOL, V19, P733; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Tiburcio MGS, 2014, EUR J GYNAECOL ONCOL, V35, P284; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Husnjak K, 2000, J VIROL METHODS, V88, P125, DOI 10.1016/S0166-0934(00)00194-4; Kim WJ, 2012, CANCER LETT, V320, P65, DOI 10.1016/j.canlet.2012.01.022; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lafuente EM, 2007, LEUKEMIA LYMPHOMA, V48, P987, DOI 10.1080/10428190701242341; Lobato S, 2012, J GYNECOL ONCOL, V23, P11, DOI 10.3802/jgo.2012.23.1.11; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; McBride AA, 2004, TRENDS MICROBIOL, V12, P527, DOI 10.1016/j.tim.2004.10.002; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; Mendoza-Catalan MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-116; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Nonogaki Suely, 2005, J Low Genit Tract Dis, V9, P219, DOI 10.1097/01.lgt.0000179861.67574.6b; Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6; Schmid MC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060226, 10.1371/journal.pone.0061623]; Singh L, 2003, J VIROL, V77, P1614, DOI 10.1128/JVI.77.2.1614-1620.2003; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; von Knebel Doeberitz M, 2012, EXPERT REV PROTEOMIC, V9, P149, DOI [10.1586/epr.12.13, DOI 10.1586/EPR.12.13]; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123531	10.1371/journal.pone.0123531	http://dx.doi.org/10.1371/journal.pone.0123531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856570	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500096
J	Yu, XY; Zhang, DD; Shi, BS; Ren, GX; Peng, XH; Fang, Z; Kozlowski, M; Zhou, XH; Zhang, XN; Wu, M; Wang, C; Yuan, ZH				Yu, Xiaoyu; Zhang, Dandan; Shi, Bisheng; Ren, Guangxu; Peng, Xiuhua; Fang, Zhong; Kozlowski, Maya; Zhou, Xiaohui; Zhang, Xiaonan; Wu, Min; Wang, Cong; Yuan, Zhenghong			Oral Administered Particulate Yeast-Derived Glucan Promotes Hepatitis B Virus Clearance in a Hydrodynamic Injection Mouse Model	PLOS ONE			English	Article							BIOLOGICAL RESPONSE MODIFIERS; BETA-GLUCANS; IMMUNE-RESPONSES; DENDRITIC CELLS; HBV INFECTION; RECEPTOR; DECTIN-1; CANCER; LIVER; DISCOVERY	Hepatitis B virus (HBV) persistent infection is associated with ineffective immune response for the clearance of virus. Immunomodulators represent an important class of therapeutics, which potentially could be beneficial for the treatment of HBV infection. The particulate yeast-derived glucan (PYDG) has been shown to enhance the innate and adaptive immune responses. We therefore, assessed the efficacy of PYDG in enhancing HBV specific immune responses by employing the hydrodynamic injection-based (HDI) HBV transfection mouse model. Mice were intragatric administered PYDG daily for 9 weeks post pAAV/HBV1.2 hydrodynamic injection. PYDG treatment significantly promoted HBV DNA clearance and production of HBsAb compared to control mice. PYDG treatment resulted in recruitment of macrophages, dendritic cells (DCs) and effector T cells to the liver microenvironment, accompanied by a significantly augmented DCs maturation and HBV-specific IFN-gamma and TNF-alpha production by T cell. In addition, enhanced production of Th1 cytokines in liver tissue interstitial fluid (TIF) was associated with PYDG administration. Live imaging showed the accumulation of PYDG in the mouse liver. Our results demonstrate that PYDG treatment significantly enhances HBV-specific Th1 immune responses, accompanied by clearance of HBV DNA, and therefore holds promise for further development of therapeutics against chronic hepatitis B.	[Yu, Xiaoyu; Zhang, Dandan; Peng, Xiuhua; Zhou, Xiaohui; Zhang, Xiaonan; Wu, Min; Wang, Cong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Yu, Xiaoyu; Shi, Bisheng; Ren, Guangxu; Fang, Zhong; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Kozlowski, Maya] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	Fudan University; Fudan University; University of Ottawa	Yuan, ZH (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org		Zhang, Xiaonan/0000-0002-1286-7280; Ren, Guangxu/0000-0003-2378-260X	National Program on Key Basic Research Project of China [2012CB519005]; National Natural Science Foundation of China [81101242]	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Program on Key Basic Research Project of China (2012CB519005) and National Natural Science Foundation of China (81101242).	Albeituni SH, 2013, ANTI-CANCER AGENT ME, V13, P689, DOI 10.2174/1871520611313050003; Bauer T, 2011, DIGEST DIS, V29, P423, DOI 10.1159/000329809; Bertoletti A, 2013, POSTGRAD MED J, V89, P294, DOI 10.1136/postgradmedj-2011-301073rep; Bian GL, 2009, VACCINE, V28, P187, DOI 10.1016/j.vaccine.2009.09.101; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen Z, 2008, CLIN IMMUNOL, V128, P400, DOI 10.1016/j.clim.2008.04.006; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kulka ACaM, 2010, RECENT PATENTS ENDOC, P175; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Li B, 2010, CLIN CANCER RES, V16, P5153, DOI 10.1158/1078-0432.CCR-10-0820; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Luca G, 1999, SCIENCE, V284, P825; Mantovani MS, 2008, MUTAT RES-REV MUTAT, V658, P154, DOI 10.1016/j.mrrev.2007.07.002; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Schurich A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003208; Seto WK, 2014, J GASTROEN HEPATOL, V29, P1028, DOI 10.1111/jgh.12476; Sun W, 2010, J PROTEOME RES, V9, P1020, DOI 10.1021/pr9009172; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Vetvicka V, 2011, WORLD J CLIN ONCOL, V2, P115, DOI 10.5306/wjco.v2.i2.115; WILTROUT RH, 1984, J EXP MED, V160, P1431, DOI 10.1084/jem.160.5.1431; Wursthorn K, 2010, GUT, V59, P1430, DOI 10.1136/gut.2009.195834; Zhang XY, 2012, J HEPATOL, V57, P522, DOI 10.1016/j.jhep.2012.05.004	30	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123559	10.1371/journal.pone.0123559	http://dx.doi.org/10.1371/journal.pone.0123559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856080	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500098
J	Ayala, DC; Morin, D; Buckpitt, AR				Ayala, Daniel C.; Morin, Dexter; Buckpitt, Alan R.			Simultaneous Quantification of Multiple Urinary Naphthalene Metabolites by Liquid Chromatography Tandem Mass Spectrometry	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AFLATOXIN BIOMARKERS; EXPOSURE; STEREOSELECTIVITY; NAPHTHOLS; NASAL; OXIDE; LUNG; AIR	Naphthalene is an environmental toxicant to which humans are exposed. Naphthalene causes dose-dependent cytotoxicity to murine airway epithelial cells but a link between exposure and human pulmonary disease has not been established. Naphthalene toxicity in rodents depends on P450 metabolism. Subsequent biotransformation results in urinary elimination of several conjugated metabolites. Glucuronide and sulfate conjugates of naphthols have been used as markers of naphthalene exposure but, as the current studies demonstrate, these assays provide a limited view of the range of metabolites generated from the parent hydrocarbon. Here, we present a liquid chromatography tandem mass spectrometry method for measurement of the glucuronide and sulfate conjugates of 1-naphthol as well as the mercapturic acids and N-acetyl glutathione conjugates from naphthalene epoxide. Standard curves were linear over 2 log orders. On column detection limits varied from 0.91 to 3.4 ng; limits of quantitation from 1.8 to 6.4 ng. The accuracy of measurement of spiked urine standards was -13.1 to + 5.2% of target and intra-day and inter-day variability averaged 7.2 (+/- 4.5) and 6.8 (+/- 5.0) %, respectively. Application of the method to urine collected from mice exposed to naphthalene at 15 ppm (4 hrs) showed that glutathione-derived metabolites accounted for 60-70% of the total measured metabolites and sulfate and glucuronide conjugates were eliminated in equal amounts. The method is robust and directly measures several major naphthalene metabolites including those derived from glutathione conjugation of naphthalene epoxide. The assays do not require enzymatic deconjugation, extraction or derivatization thus simplifying sample work up.	[Ayala, Daniel C.; Morin, Dexter; Buckpitt, Alan R.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Ayala, Daniel C.] Univ Calif Davis, Grad Program, Forens Sci, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis	Buckpitt, AR (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	arbuckpitt@ucdavis.edu			NIEHS Superfund Basic Science Research Program [P42 04699]	NIEHS Superfund Basic Science Research Program	These studies were supported by the NIEHS Superfund Basic Science Research Program P42 04699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolucci G, 2000, RAPID COMMUN MASS SP, V14, P967, DOI 10.1002/(SICI)1097-0231(20000615)14:11<967::AID-RCM973>3.0.CO;2-C; Bernabei M, 2003, J CHROMATOGR A, V985, P197, DOI 10.1016/S0021-9673(02)01826-5; Bieniek G, 1997, SCAND J WORK ENV HEA, V23, P414, DOI 10.5271/sjweh.263; Bieniek G, 1998, AM J IND MED, V34, P445, DOI 10.1002/(SICI)1097-0274(199811)34:5<445::AID-AJIM5>3.0.CO;2-P; BOYLAND E, 1958, BIOCHEM J, V68, P440, DOI 10.1042/bj0680440; BUCKPITT A, 1992, J PHARMACOL EXP THER, V261, P364; Buckpitt A, 2002, DRUG METAB REV, V34, P791, DOI 10.1081/DMR-120015694; Buckpitt A, 2013, TOXICOL APPL PHARM, V270, P97, DOI 10.1016/j.taap.2013.04.006; BUCKPITT AR, 1986, TOXICOLOGY, V41, P333, DOI 10.1016/0300-483X(86)90186-1; Chao YCE, 2006, ENVIRON HEALTH PERSP, V114, P182, DOI 10.1289/ehp.8288; Cho TM, 2006, DRUG METAB DISPOS, V34, P176, DOI 10.1124/dmd.105.005785; DOROUGH HW, 1964, J AGR FOOD CHEM, V12, P294, DOI 10.1021/jf60134a001; HORNING MG, 1980, DRUG METAB DISPOS, V8, P404; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Kitteringham NR, 1996, J PHARMACOL EXP THER, V278, P1018; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2006, ANAL CHEM, V78, P5744, DOI 10.1021/ac0606094; Pakenham G, 2002, DRUG METAB DISPOS, V30, P247, DOI 10.1124/dmd.30.3.247; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; ROZMAN K, 1982, DRUG CHEM TOXICOL, V5, P265, DOI 10.3109/01480548209041057; Scinicariello F, 2014, ENVIRON HEALTH PERSP, V122, P299, DOI 10.1289/ehp.1307234; Serdar B, 2003, ENVIRON HEALTH PERSP, V111, P1760, DOI 10.1289/ehp.6275; Sobus JR, 2009, ANN OCCUP HYG, V53, P551, DOI 10.1093/annhyg/mep041; Tang LL, 2008, CARCINOGENESIS, V29, P411, DOI 10.1093/carcin/bgn008; TSURUDA LS, 1995, DRUG METAB DISPOS, V23, P129; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Walton M, 2001, CHEM RES TOXICOL, V14, P919, DOI 10.1021/tx010063a; WARREN DL, 1982, CHEM-BIOL INTERACT, V40, P287, DOI 10.1016/0009-2797(82)90152-1; West JAA, 2003, TOXICOL SCI, V75, P161, DOI 10.1093/toxsci/kfg156; YAGI H, 1975, J AM CHEM SOC, V97, P3185, DOI 10.1021/ja00844a044; Yuan W, 2007, CHEM RES TOXICOL, V20, P316, DOI 10.1021/tx600340c; Zielinska B, 2004, ENVIRON SCI TECHNOL, V38, P2557, DOI 10.1021/es030518d	32	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121937	10.1371/journal.pone.0121937	http://dx.doi.org/10.1371/journal.pone.0121937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853821	Green Submitted, gold, Green Published			2022-12-26	WOS:000352478400055
J	Miyamoto, N; Hirata, K; Kanehisa, H; Yoshitake, Y				Miyamoto, Naokazu; Hirata, Kosuke; Kanehisa, Hiroaki; Yoshitake, Yasuhide			Validity of Measurement of Shear Modulus by Ultrasound Shear Wave Elastography in Human Pennate Muscle	PLOS ONE			English	Article							ELASTIC-MODULUS; TISSUE ELASTICITY; CONTRACTION; FORCE; VIVO; FEASIBILITY; HARDNESS	Ultrasound shear wave elastography is becoming a valuable tool for measuring mechanical properties of individual muscles. Since ultrasound shear wave elastography measures shear modulus along the principal axis of the probe (i.e., along the transverse axis of the imaging plane), the measured shear modulus most accurately represents the mechanical property of the muscle along the fascicle direction when the probe's principal axis is parallel to the fascicle direction in the plane of the ultrasound image. However, it is unclear how the measured shear modulus is affected by the probe angle relative to the fascicle direction in the same plane. The purpose of the present study was therefore to examine whether the angle between the principal axis of the probe and the fascicle direction in the same plane affects the measured shear modulus. Shear modulus in seven specially-designed tissue-mimicking phantoms, and in eleven human in-vivo biceps brachii and medial gastrocnemius were determined by using ultrasound shear wave elastography. The probe was positioned parallel or 20 degrees obliquely to the fascicle across the B-mode images. The reproducibility of shear modulus measurements was high for both parallel and oblique conditions. Although there was a significant effect of the probe angle relative to the fascicle on the shear modulus in human experiment, the magnitude was negligibly small. These findings indicate that the ultrasound shear wave elastography is a valid tool for evaluating the mechanical property of pennate muscles along the fascicle direction.	[Miyamoto, Naokazu; Hirata, Kosuke; Kanehisa, Hiroaki; Yoshitake, Yasuhide] Natl Inst Fitness & Sports Kanoya, Kagoshima, Japan	National Institute Fitness & Sports Kanoya	Miyamoto, N (corresponding author), Natl Inst Fitness & Sports Kanoya, Kagoshima, Japan.	miyamoto@nifs-k.jp	Yoshitake, Yasuhide/X-4181-2018	Hirata, Kosuke/0000-0001-9142-6717	JSPS KAKENHI [25702038]; Grants-in-Aid for Scientific Research [15K12646] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25702038. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Couade M, 2011, IEEE T MED IMAGING, V30, P295, DOI 10.1109/TMI.2010.2076829; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lee WN, 2012, IEEE T MED IMAGING, V31, P554, DOI 10.1109/TMI.2011.2172690; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Niitsu M, 2011, ACTA RADIOL, V52, P99, DOI 10.1258/ar.2010.100190; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Taniguchi K, 2014, SCAND J MED SCI SPOR; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012; Yoshitake Y, 2014, MUSCLE NERVE, V50, P103, DOI 10.1002/mus.24104	20	72	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124311	10.1371/journal.pone.0124311	http://dx.doi.org/10.1371/journal.pone.0124311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853777	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400136
J	Obregon, C; Graf, L; Chung, KF; Cesson, V; Nicod, LP				Obregon, Carolina; Graf, Lukas; Chung, Kian Fan; Cesson, Valerie; Nicod, Laurent P.			Nitric Oxide Sustains IL-1 beta Expression in Human Dendritic Cells Enhancing Their Capacity to Induce IL-17-Producing T-Cells	PLOS ONE			English	Article							IFN-GAMMA; DIFFERENTIATION; MACROPHAGES; ACTIVATION; RELEASE; IL-17; SIPB; MATURATION; MECHANISM; DEFENSE	The role played by lung dendritic cells (DCs) which are influenced by external antigens and by their redox state in controlling inflammation is unclear. We studied the role played by nitric oxide (NO) in DC maturation and function. Human DCs were stimulated with a long-acting NO donor, DPTA NONOate, prior to exposure to lipopolysaccharide (LPS). Dose- and time-dependent experiments were performed with DCs with the aim of measuring the release and gene expression of inflammatory cytokines capable of modifying T-cell differentiation, towardsTh1, Th2 and Th17 cells. NO changed the pattern of cytokine release by LPS-matured DCs, dependent on the concentration of NO, as well as on the timing of its addition to the cells during maturation. Addition of NO before LPS-induced maturation strongly inhibited the release of IL-12, while increasing the expression and release of IL-23, IL-1 beta and IL-6, which are all involved in Th17 polarization. Indeed, DCs treated with NO efficiently induced the release of IL-17 by T-cells through IL-1 beta. Our work highlights the important role that NO may play in sustaining inflammation during an infection through the preferential differentiation of the Th17 lineage.	[Obregon, Carolina; Cesson, Valerie; Nicod, Laurent P.] Ctr Hospitalier Univ Vaudois, Serv Pneumol, Lausanne, Switzerland; [Obregon, Carolina; Cesson, Valerie; Nicod, Laurent P.] Univ Lausanne, Lausanne, Switzerland; [Graf, Lukas] Univ Hosp Bern, Clin & Polyclin Pneumol, CH-3010 Bern, Switzerland; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, London, England	University of Lausanne; University of Bern; University Hospital of Bern; Imperial College London	Obregon, C (corresponding author), Ctr Hospitalier Univ Vaudois, Serv Pneumol, Lausanne, Switzerland.	carolina.obregon-espinel@chuv.ch	Chung, Kian Fan/B-1872-2012; Nicod, Laurent/ABD-3360-2020	Chung, Kian Fan/0000-0001-7101-1426; Nicod, Laurent P/0000-0002-0905-916X	Swiss National Science Foundation [310030-120210]; Swiss Society of Pneumology grant; National Institute for Health Research [NF-SI-0509-10080] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society of Pneumology grant; National Institute for Health Research(National Institute for Health Research (NIHR))	Support for this work was provided by Swiss National Science Foundation grant: 310030-120210, http://www.snf.ch/en/theSNSF/profile/Pages/default.aspx (LN CO); and the Swiss Society of Pneumology grant, http://www.pneumo.ch/nc/fr/pagedaccueil.html (CO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Brindicci C, 2005, EUR RESPIR J, V26, P52, DOI 10.1183/09031936.04.00125304; Chang Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-43; Chun E, 2010, J CLIN IMMUNOL, V30, P459, DOI 10.1007/s10875-009-9363-z; Corinti S, 2003, J INTERF CYTOK RES, V23, P423, DOI 10.1089/107999003322277838; Dreher D, 2002, J LEUKOCYTE BIOL, V72, P743; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kim YM, 1998, J IMMUNOL, V161, P4122; Lee SW, 2011, J IMMUNOL, V186, P6972, DOI 10.4049/jimmunol.1100485; Lim KG, 2008, CHEST, V133, P1232, DOI 10.1378/chest.07-1712; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Mulrennan Siobhan A, 2004, Treat Respir Med, V3, P79, DOI 10.2165/00151829-200403020-00002; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; Niedbala W, 2013, J IMMUNOL, V191, P164, DOI 10.4049/jimmunol.1202580; Obermajer N, 2013, J EXP MED, V210, P1433, DOI 10.1084/jem.20121277; Obregon C, 2003, INFECT IMMUN, V71, P4382, DOI 10.1128/IAI.71.8.4382-4388.2003; Obregon C, 2009, AM J PATHOL, V175, P696, DOI 10.2353/ajpath.2009.080716; Paolucci C, 2003, J LEUKOCYTE BIOL, V73, P253, DOI 10.1189/jlb.0902447; Roelen DL, 2008, TRANSPL IMMUNOL, V19, P220, DOI 10.1016/j.trim.2008.06.004; Saini D, 2011, J HEART LUNG TRANSPL, V30, P624, DOI 10.1016/j.healun.2011.01.708; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Searing DA, 2011, CURR OPIN PEDIATR, V23, P314, DOI 10.1097/MOP.0b013e3283461926; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shirahata S, 1997, BIOCHEM BIOPH RES CO, V234, P269, DOI 10.1006/bbrc.1997.6622; Turpaev K, 2005, FREE RADICAL BIO MED, V38, P1392, DOI 10.1016/j.freeradbiomed.2005.02.002; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Xu WL, 2006, FREE RADICAL BIO MED, V41, P19, DOI 10.1016/j.freeradbiomed.2006.01.037; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494	47	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120134	10.1371/journal.pone.0120134	http://dx.doi.org/10.1371/journal.pone.0120134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853810	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400010
J	Steinmann, ME; Gonzalez-Salgado, A; Butikofer, P; Maser, P; Sigel, E				Steinmann, Michael E.; Gonzalez-Salgado, Amaia; Buetikofer, Peter; Maeser, Pascal; Sigel, Erwin			A heteromeric potassium channel involved in the modulation of the plasma membrane potential is essential for the survival of African trypanosomes	FASEB JOURNAL			English	Article						Trypanosoma brucei; electrophysiology; Xenopus laevis oocytes	BLOOD-STREAM FORMS; DRUG-RESISTANCE; GENE-EXPRESSION; SODIUM; BRUCEI; TRANSPORTER; GROWTH; SENSITIVITY; SELECTION; CLONING	Discovery of novel drug targetsmay lead to improved treatment of trypanosomiasis. We characterize here 2 gene products of Trypanosoma brucei that are essential for the growth of bloodstream form (BSF) parasites, as shown by RNA interference (RNAi)-mediated down-regulation of the individual mRNAs. The primary sequences of the 2 proteins-protein encoded by gene Tb927.1.4450 (TbK1) and protein encoded by gene Tb927.9.4820 (TbK2)-indicate that both belong to the family of putative, Ca2+-activated potassium channels. The proteins were expressed in Xenopus laevis oocytes and their functions investigated by use of electrophysiological techniques. Only combined expression of TbK1 and TbK2 results in the formation of sizeable currents, indicating that these proteins probably assemble into a heteromeric ion channel. The current mediated by this channel shows little time and voltage dependence and displays a permeability ratio of K+/Na+ of > 20. The known potassium channel blocker barium inhibits this channel with a half-maximal inhibitory concentration (IC50) of 98 +/- 15 mu M. The membrane potential of trypanosomes was measured with a fluorescent dye. Individual RNAi-mediated downregulation of TbK1 or TbK2 eliminates a potassium conductance in the plasma membrane of BSF. Thus, this heteromeric potassium channel is involved in the modulation of the plasma membrane potential and represents a novel drug target in T. brucei.	[Steinmann, Michael E.; Gonzalez-Salgado, Amaia; Buetikofer, Peter; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Maeser, Pascal] Univ Basel, Basel, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	sigel@ibmm.unibe.ch		Maser, Pascal/0000-0003-3122-1941	Swiss National Science Foundation [CRSII3_141913/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. V. Niggli for help with microscopy and carefully reading the manuscript and Dr. J. Gertsch for help with flow cytometry experiments. This work was supported by Sinergia Grant CRSII3_141913/1 from the Swiss National Science Foundation.	Alexander S. P. H., 2008, BRIT J PHARMACOL, V153, pS112, DOI [10.1038/sj.bjp.0707755, DOI 10.1038/SJ.BJP.0707755]; Anene BM, 2001, VET PARASITOL, V96, P83, DOI 10.1016/S0304-4017(00)00427-1; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burchmore RJS, 2003, J BIOL CHEM, V278, P23502, DOI 10.1074/jbc.M301252200; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; DefriseQuertain F, 1996, BIOCHEM J, V314, P595, DOI 10.1042/bj3140595; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEE JD, 1975, J EXP BIOL, V63, P381; GEE JD, 1976, J EXP BIOL, V64, P357; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Gonzalez-Salgado A, 2012, J BIOL CHEM, V287, P13313, DOI 10.1074/jbc.M112.344812; Greganova E, 2013, GENOME BIOL EVOL, V5, P1902, DOI 10.1093/gbe/evt134; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; Jimenez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002750; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Mosimann M, 2010, EUKARYOT CELL, V9, P539, DOI 10.1128/EC.00314-09; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ortiz D, 2009, MOL BIOCHEM PARASIT, V163, P67, DOI 10.1016/j.molbiopara.2008.09.011; PRATAP PR, 1990, BIOPHYS J, V57, P835, DOI 10.1016/S0006-3495(90)82603-5; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; TETAUD E, 1994, P NATL ACAD SCI USA, V91, P8278, DOI 10.1073/pnas.91.17.8278; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van der Heyden N, 2002, J EUKARYOT MICROBIOL, V49, P407, DOI 10.1111/j.1550-7408.2002.tb00220.x; Van Der Heyden N, 2002, MOL BIOCHEM PARASIT, V120, P127, DOI 10.1016/S0166-6851(01)00444-3; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	49	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3228	3237		10.1096/fj.15-271353	http://dx.doi.org/10.1096/fj.15-271353			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25868728				2022-12-26	WOS:000358796900012
J	Krumova, P; Reyniers, L; Meyer, M; Lobbestael, E; Stauffer, D; Gerrits, B; Muller, L; Hoving, S; Kaupmann, K; Voshol, J; Fabbro, D; Bauer, A; Rovelli, G; Taymans, JM; Bouwmeester, T; Baekelandt, V				Krumova, Petranka; Reyniers, Lauran; Meyer, Marc; Lobbestael, Evy; Stauffer, Daniela; Gerrits, Bertran; Muller, Lionel; Hoving, Sjouke; Kaupmann, Klemens; Voshol, Johannes; Fabbro, Doriano; Bauer, Andreas; Rovelli, Giorgio; Taymans, Jean-Marc; Bouwmeester, Tewis; Baekelandt, Veerle			Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate	FASEB JOURNAL			English	Article						cellular signaling; gatekeeper kinase; neuroscience; Parkinson's disease	PARKINSONS-DISEASE; DOMINANT PARKINSONISM; LRRK2 PHOSPHORYLATES; TAU; MUTATIONS; PROTEINS; STABILITY; PATHOGENESIS; INHIBITORS; ISOFORMS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of autosomal-dominant forms of Parkinson's disease. LRRK2 is a modular, multidomain protein containing 2 enzymatic domains, including a kinase domain, as well as several protein-protein interaction domains, pointing to a role in cellular signaling. Although enormous efforts have been made, the exact pathophysiologic mechanisms of LRRK2 are still not completely known. In this study, we used a chemical genetics approach to identify LRRK2 substrates from mouse brain. This approach allows the identification of substrates of 1 particular kinase in a complex cellular environment. Several of the identified peptides are involved in the regulation of microtubule (MT) dynamics, including microtubule-associating protein (MAP)/microtubule affinity-regulating kinase 1 (MARK1). MARK1 is a serine/threonine kinase known to phosphorylate MT-binding proteins such as Tau, MAP2, and MAP4 at KXGS motifs leading to MT destabilization. In vitro kinase assays and metabolic-labeling experiments in living cells confirmed MARK1 as an LRRK2 substrate. Moreover, we also showed that LRRK2 and MARK1 are interacting in eukaryotic cells. Our findings contribute to the identification of physiologic LRRK2 substrates and point to a potential mechanism explaining the reported effects of LRRK2 on neurite morphology.	[Krumova, Petranka; Meyer, Marc; Stauffer, Daniela; Gerrits, Bertran; Muller, Lionel; Hoving, Sjouke; Kaupmann, Klemens; Voshol, Johannes; Fabbro, Doriano; Bauer, Andreas; Rovelli, Giorgio; Bouwmeester, Tewis] Novartis Inst Biomed Res, Basel, Switzerland; [Reyniers, Lauran; Lobbestael, Evy; Taymans, Jean-Marc; Baekelandt, Veerle] Katholieke Univ KU Leuven, Res Grp Neurobiol & Gene Therapy, Dept Neurosci, Leuven, Belgium	Novartis; KU Leuven	Taymans, JM (corresponding author), Katholieke Univ Leuven, Res Grp Neurobiol & Gene Therapy, Dept Neurosci, Kapucijnenvoer 33 VCTB 5, B-3000 Louvain, Flanders, Belgium.	jean-marc.taymans@inserm.fr; veerle.baekelandt@med.kuleuven.be	Taymans, Jean-Marc/M-9175-2018; Lobbestael, Evy/H-7537-2018; Baekelandt, Veerle/ABB-9736-2020	Taymans, Jean-Marc/0000-0001-5503-5524; Lobbestael, Evy/0000-0002-6417-4670; Baekelandt, Veerle/0000-0001-8966-2921; Kaupmann, Klemens/0000-0001-8903-2508	Fonds Wetenschappelijk Onderzoek-Vlaanderen (Research Foundation-Flanders) [G.0666.09, KAN2012 1.5.216.12]; Agency for Innovation by Science and Technology [SBO/100042]; European Community under the 7th Framework Programme for RTD-Grant [HEALTH-2009-241791]; Fund Druwe-Eerdekens-managed by the King Baudouin Foundation	Fonds Wetenschappelijk Onderzoek-Vlaanderen (Research Foundation-Flanders)(FWO); Agency for Innovation by Science and Technology; European Community under the 7th Framework Programme for RTD-Grant; Fund Druwe-Eerdekens-managed by the King Baudouin Foundation	Cyclin-dependent kinase 2F80A gatekeeper kinase was kindly provided by Yong Chi (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). The authors thank the Leuven Viral Vector Core (http://www.kuleuven.be/molmed/lvvc/vectorproduction.html) for the production of lentiviral vectors. The authors also thank the Fonds Wetenschappelijk Onderzoek-Vlaanderen (Research Foundation-Flanders)-project G.0666.09, research credit KAN2012 1.5.216.12, and fellowships to L.R. and J.-M.T., and the Agency for Innovation by Science and Technology SBO/100042. This study was supported by the European Community under the 7th Framework Programme for RTD-Grant Agreement HEALTH-2009-241791 (European Project on Mendelian Forms of Parkinson's Disease). This research was also supported in part by the Fund Druwe-Eerdekens-managed by the King Baudouin Foundation.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Biernacka JM, 2011, PARKINSONISM RELAT D, V17, P730, DOI 10.1016/j.parkreldis.2011.07.001; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Chen HF, 2012, J MED CHEM, V55, P5536, DOI 10.1021/jm300452p; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cravatt BF, 2005, NAT METHODS, V2, P411, DOI 10.1038/nmeth0605-411; Dachsel JC, 2010, PARKINSONISM RELAT D, V16, P650, DOI 10.1016/j.parkreldis.2010.08.018; Daniels V, 2011, NEUROSIGNALS, V19, P1, DOI 10.1159/000324488; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Gan-Or Z, 2012, J MOL NEUROSCI, V46, P541, DOI 10.1007/s12031-011-9641-0; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2012, BIOCHEM SOC T, V40, P1058, DOI 10.1042/BST20120054; Herzig MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036581; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; HIRIYANNA KT, 1994, ANAL BIOCHEM, V223, P51, DOI 10.1006/abio.1994.1545; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Law BMH, 2014, J BIOL CHEM, V289, P895, DOI 10.1074/jbc.M113.507913; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lobbestael E, 2012, BIOCHEM SOC T, V40, P1102, DOI 10.1042/BST20120128; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Ohta E, 2011, FEBS LETT, V585, P2165, DOI 10.1016/j.febslet.2011.05.044; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Puschmann A, 2012, PARKINSONISM RELAT D, V18, P332, DOI 10.1016/j.parkreldis.2011.11.019; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Schulte C, 2011, APPL CLIN GENET, V4, P67, DOI 10.2147/TACG.S11639; Sengle G, 2000, BIOORGAN MED CHEM, V8, P1317, DOI 10.1016/S0968-0896(00)00080-8; Sepulveda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061986; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Taymans JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50523; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Tsuboi Yoshio, 2012, Exp Neurobiol, V21, P123, DOI 10.5607/en.2012.21.3.123; Ujiie S, 2012, PARKINSONISM RELAT D, V18, P819, DOI 10.1016/j.parkreldis.2012.03.024; Vancraenenbroeck R, 2011, CNS NEUROL DISORD-DR, V10, P724, DOI 10.2174/187152711797247858; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	68	14	14	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2980	2992		10.1096/fj.14-262329	http://dx.doi.org/10.1096/fj.14-262329			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25854701				2022-12-26	WOS:000356859100026
J	Zhu, L; Cronan, JE				Zhu, Lei; Cronan, John E.			The Conserved Modular Elements of the Acyl Carrier Proteins of Lipid Synthesis Are Only Partially Interchangeable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-FLIPPING MECHANISM; FATTY-ACID SYNTHESIS; IN-VIVO; GENES; MUTATIONS	Prior work showed that expression of acyl carrier proteins (ACPs) of a diverse set of bacteria replaced the function of Escherichia coli ACP in lipid biosynthesis. However, the AcpAs of Lactococcus lactis and Enterococcus faecalis were inactive. Both failed to support growth of an E. coli acpP mutant strain. This defect seemed likely because of the helix II sequences of the two AcpAs, which differed markedly from those of the proteins that supported growth. To test this premise, chimeric ACPs were constructed in which L. lactis helix II replaced helix II of E. coli AcpP and vice versa. Expression of the AcpP protein L. lactis AcpA helix II allowed weak growth, whereas the L. lactis AcpA-derived protein that contained E. coli AcpP helix II failed to support growth of the E. coli mutant strain. Replacement of the L. lactis AcpA helix II residues in this protein showed that substitution of valine for the phenylalanine residue four residues downstream of the phosphopanthetheine-modified serine gave robust growth and allowed modification by the endogenous AcpS phosphopantetheinyl transferase (rather than the promiscuous Sfp transferase required to modify the L. lactis AcpA and the chimera of L. lactis AcpA helix II in AcpP). Further chimera constructs showed that the lack of function of the L. lactis AcpA-derived protein containing E. coli AcpP helix II was due to incompatibility of L. lactis AcpA helix I with the downstream elements of AcpP. Therefore, the origins of ACP incompatibility can reside in either helix I or in helix II.	[Zhu, Lei; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Regan, Clinton/E-6250-2012; Cronan, John/V-6626-2019	Zhu, Lei/0000-0003-2178-4740	National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; Beld J, 2014, ANGEW CHEM INT EDIT, V53, P14456, DOI 10.1002/anie.201408576; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; CRONAN JE, 1981, P NATL ACAD SCI-BIOL, V78, P5440, DOI 10.1073/pnas.78.9.5440; CRONAN JE, 1980, ANAL BIOCHEM, V103, P377, DOI 10.1016/0003-2697(80)90626-0; CRONAN JE, 1988, GENE, V70, P161, DOI 10.1016/0378-1119(88)90114-X; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; GRANA D, 1988, GENETICS, V120, P319; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; TAKIFF HE, 1992, J BACTERIOL, V174, P1544, DOI 10.1128/jb.174.5.1544-1553.1992; Volkmann G, 2010, J BIOL CHEM, V285, P8605, DOI 10.1074/jbc.M109.060863; Wang HH, 2004, BIOCHEMISTRY-US, V43, P11782, DOI 10.1021/bi0487600; Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhou Z, 2008, J AM CHEM SOC, V130, P9925, DOI 10.1021/ja802657n; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k; Zhu L, 2013, MBIO, V4, DOI 10.1128/mBio.00613-13	27	9	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13791	13799		10.1074/jbc.M115.648402	http://dx.doi.org/10.1074/jbc.M115.648402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25861991	Green Published, hybrid			2022-12-26	WOS:000355313000014
J	Black, AP; Vilivong, K; Nouanthong, P; Souvannaso, C; Hubschen, JM; Muller, CP				Black, Antony P.; Vilivong, Keooudomphone; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Huebschen, Judith M.; Muller, Claude P.			Serosurveillance of Vaccine Preventable Diseases and Hepatitis C in Healthcare Workers from Lao PDR	PLOS ONE			English	Article							SELF-REPORTED HISTORY; B-VIRUS; MEDICAL-STUDENTS; ANTI-HBC; INFECTIONS; RISK; RECOMMENDATIONS; IMMUNIZATION; MANAGEMENT; IMMUNITY	Background and Aims Healthcare workers (HCW) have an increased risk of exposure to infectious diseases and are a potential source of infections for their patients. The Lao People's Democratic Republic (Lao PDR) has no national policy regarding HCW vaccinations and routine vaccination coverage is low within the general population. This cross-sectional serostudy determines the level of exposure and risk of infection in Lao HCW against 6 vaccine preventable diseases and hepatitis C. Methods 1128 HCW were recruited from 3 central, 2 provincial and 8 district hospitals. Sera were tested by ELISA for the presence of antibodies and antigens to hepatitis B, hepatitis C, measles, rubella, varicella zoster, tetanus and diphtheria. Results Only 53.1% of the HCW had protective anti-hepatitis B surface antigen antibodies (anti-HBs) with 48.8% having anti- hepatitis B core antibodies (anti-HBc), indicating previous exposure and 8.0% were hepatitis B surface antigen carriers. 3.9% were hepatitis C seropositive. Measles and rubella antibodies were detected in 95.4% and 86.2% of the HCW, with 11.9% of females being unprotected against rubella. Antibodies against varicella zoster, tetanus and diphtheria were detected in 95%, 78.8% and 55.3%, respectively. Seroprevalence varied according to age, gender and number of children. Conclusion An unacceptably high proportion of Lao HCW remain susceptible to infection with hepatitis B, diphtheria, tetanus and rubella. Furthermore, a high number of healthcare workers are chronically infected with hepatitis B and C viruses. These data emphasize the need for a robust HCW vaccination policy in addition to increased awareness within this subpopulation.	[Black, Antony P.; Huebschen, Judith M.; Muller, Claude P.] Luxembourg Inst Hlth, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg; [Black, Antony P.; Vilivong, Keooudomphone; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Huebschen, Judith M.; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos	Luxembourg Institute of Health	Muller, CP (corresponding author), Luxembourg Inst Hlth, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg.	Claude.Muller@LiH.lu	Hübschen, Judith/ABA-7931-2021; Hübschen, Judith/AAF-5113-2020	Hübschen, Judith/0000-0002-5001-2128; 	Ministry of Cooperation [5-BI-2010-1071]; Centre de Recherche Public de la Sante in Luxembourg	Ministry of Cooperation; Centre de Recherche Public de la Sante in Luxembourg	This study was funded by the Ministry of Cooperation (n<SUP>o</SUP>5-BI-2010-1071) and the Centre de Recherche Public de la Sante in Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT HLTH STAT REP FY; [Anonymous], 2007, COMPR MULT PLAN 2007; Baldo V, 2002, INFECT CONT HOSP EP, V23, P325, DOI 10.1086/502059; Black AP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-457; De Juanes JR, 2005, VACCINE, V23, P1434, DOI 10.1016/j.vaccine.2004.10.003; Fitzsimons D, 2008, OCCUP ENVIRON MED, V65, P446, DOI 10.1136/oem.2006.032334; Jutavijittum P, 2014, VOX SANG, V106, P31, DOI 10.1111/vox.12073; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Kabir A, 2008, HUM VACCINES, V4, P379, DOI 10.4161/hv.4.5.6010; Kaltsas A, 2013, CURR OPIN INFECT DIS, V26, P366, DOI 10.1097/QCO.0b013e3283630ee5; Leung V, 2014, AUST NZ J PUBL HEAL, V38, P83, DOI 10.1111/1753-6405.12163; Mele A, 2001, DIGEST LIVER DIS, V33, P795, DOI 10.1016/S1590-8658(01)80698-8; Nanthavong N, DIPHTHERIA LAO UNPUB; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Pathoumthong K, 2014, VACCINE, V32, P4993, DOI 10.1016/j.vaccine.2014.07.022; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Pruss-Ustun AR E, 2003, WHO ENV BURDEN DIS S, P3; Rose VL, 1998, AM FAM PHYSICIAN, V57, P1426; Shefer A, 2011, MMWR-MORBID MORTAL W, P60; Shefer A, 2012, INFECT CONT HOSP EP, V33, P71, DOI 10.1086/662715; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; Srichomkwun P, 2009, INFECT CONT HOSP EP, V30, P585, DOI 10.1086/597508; Sukriti, 2008, J GASTROEN HEPATOL, V23, P1710, DOI 10.1111/j.1440-1746.2008.05483.x; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Sunbul M, 2000, SCAND J INFECT DIS, V32, P315, DOI 10.1080/00365540050165983; Sydnor E, 2014, VACCINE, V32, P4814, DOI 10.1016/j.vaccine.2014.03.097; Trevisan A, 2007, INFECT CONT HOSP EP, V28, P564, DOI 10.1086/516657; WHO, 2012, INT REV EXP PROGR IM; WHO, 2011, COUNTRY HLTH INFORM, P162; Wicker S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-121; Wiwanitkit V, 2002, ANN TROP MED PARASIT, V96, P627, DOI 10.1179/000349802125001672; Yen YH, 2005, LIVER INT, V25, P1162, DOI 10.1111/j.1478-3231.2005.01157.x	32	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123647	10.1371/journal.pone.0123647	http://dx.doi.org/10.1371/journal.pone.0123647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874696	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700035
J	Aguirre-Rueda, D; Guerra-Ojeda, S; Aldasoro, M; Iradi, A; Obrador, E; Mauricio, MD; Vila, JM; Marchio, P; Valles, SL				Aguirre-Rueda, Diana; Guerra-Ojeda, Sol; Aldasoro, Martin; Iradi, Antonio; Obrador, Elena; Mauricio, Maria D.; Vila, Jose Ma; Marchio, Patricia; Valles, Soraya L.			WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid beta(1-42) Effects on Astrocytes in Primary Culture	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PPAR-GAMMA; OXIDATIVE STRESS; IN-VITRO; ENDOCANNABINOID SYSTEM; INDUCED NEUROINFLAMMATION; LIPID-PEROXIDATION; CELL-DEATH	Alzheimer's disease (AD), a neurodegenerative illness involving synaptic dysfunction with extracellular accumulation of A beta(1-42) toxic peptide, glial activation, inflammatory response and oxidative stress, can lead to neuronal death. Endogenous cannabinoid system is implicated in physiological and physiopathological events in central nervous system (CNS), and changes in this system are related to many human diseases, including AD. However, studies on the effects of cannabinoids on astrocytes functions are scarce. In primary cultured astrocytes we studied cellular viability using MTT assay. Inflammatory and oxidative stress mediators were determined by ELISA and Western-blot techniques both in the presence and absence of A beta(1-42) peptide. Effects of WIN 55,212-2 (a synthetic cannabinoid) on cell viability, inflammatory mediators and oxidative stress were also determined. A beta(1-42) diminished astrocytes viability, increased TNF-alpha and IL-1 beta levels and p-65, COX-2 and iNOS protein expression while decreased PPAR-gamma and antioxidant enzyme Cu/Zn SOD. WIN 55,212-2 pretreatment prevents all effects elicited by A beta(1-42). Furthermore, cannabinoid WIN 55,212-2 also increased cell viability and PPAR-gamma expression in control astrocytes. In conclusion cannabinoid WIN 55,212-2 increases cell viability and anti-inflammatory response in cultured astrocytes. Moreover, WIN 55,212-2 increases expression of anti-oxidant Cu/Zn SOD and is able to prevent inflammation induced by A beta(1-42) in cultured astrocytes. Further studies would be needed to assess the possible beneficial effects of cannabinoids in Alzheimer's disease patients.	[Aguirre-Rueda, Diana; Guerra-Ojeda, Sol; Aldasoro, Martin; Iradi, Antonio; Obrador, Elena; Mauricio, Maria D.; Vila, Jose Ma; Marchio, Patricia; Valles, Soraya L.] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain	University of Valencia	Valles, SL (corresponding author), Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain.	lilian.valles@uv.es	Guerra, Solanye/AAX-2891-2021; Guerra, Solanye/GXH-1600-2022; Mauricio, Maria D/AAN-7412-2020; OBRADOR, ELENA/H-4069-2015; ALDASORO, MARTIN/AAB-3344-2019; Valles, Soraya L./H-9320-2019	Mauricio, Maria D/0000-0002-7695-2898; OBRADOR, ELENA/0000-0002-5934-5543; ALDASORO, MARTIN/0000-0001-6630-0493; Valles, Soraya L./0000-0003-4861-4266; Aguirre Rueda, Diana/0000-0003-2019-0457; Guerra, Solanye/0000-0003-3018-4683; Estan Capell, Nuria/0000-0001-8768-3139; Vila Salinas/0000-0001-8589-9307; Aguirre Rueda, Diana/0000-0003-1166-5780	Generalitat Valenciana [AP-073/09]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	Generalitat Valenciana AP-073/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2012, NEUROCHEM RES, V37, P2589, DOI 10.1007/s11064-012-0895-x; Aguirre-Rueda D, 2015, INT J MED SCI, V12, P48, DOI 10.7150/ijms.10035; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Bondareff W, 2013, J ALZHEIMERS DIS, V35, P1, DOI 10.3233/JAD-122305; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; De Petrocellis L, 2013, BRIT J PHARMACOL, V168, P79, DOI 10.1111/j.1476-5381.2012.02027.x; del Pulgar TG, 2002, J BIOL CHEM, V277, P36527, DOI 10.1074/jbc.M205797200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Eikelenboom P, 2004, J NEURAL TRANSM, V111, P281, DOI 10.1007/s00702-003-0055-1; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Esposito G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028668; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fakhfouri G, 2012, NEUROPHARMACOLOGY, V63, P653, DOI 10.1016/j.neuropharm.2012.05.013; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Griffin WST, 2002, J LEUKOCYTE BIOL, V72, P233; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hampson AJ, 2001, EUR J NEUROSCI, V13, P1529, DOI 10.1046/j.0953-816x.2001.01536.x; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Ho Gilbert J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P247, DOI 10.2174/1568010053586237; Inestrosa NC, 2005, NEUROBIOL AGING, V26, P1023, DOI 10.1016/j.neurobiolaging.2004.09.016; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Jimenez-Jimenez FJ, 2006, REV NEUROLOGIA, V42, P419, DOI 10.33588/rn.4207.2005225; KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Keller JN, 1998, J NEUROSCI, V18, P687; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Krishnan S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007204.pub2; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li CH, 2011, CELL MOL IMMUNOL, V8, P67, DOI 10.1038/cmi.2010.55; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Rocha FCM, 2014, J NEURO-ONCOL, V116, P11, DOI 10.1007/s11060-013-1277-1; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Pacher P, 2013, FEBS J, V280, P1918, DOI 10.1111/febs.12260; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Palanca JM, 2013, INT J MED SCI, V10, P1278, DOI 10.7150/ijms.6254; Palmer SL, 2002, CHEM PHYS LIPIDS, V121, P3, DOI 10.1016/S0009-3084(02)00143-3; Pappolla MA, 1998, AM J PATHOL, V152, P871; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pourkhalili N, 2013, TOXICOL MECH METHOD, V23, P120, DOI 10.3109/15376516.2012.730559; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Quintanilla RA, 2012, ARCH MED RES, V43, P632, DOI 10.1016/j.arcmed.2012.10.016; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Sanchez C, 1998, FEBS LETT, V436, P6, DOI 10.1016/S0014-5793(98)01085-0; Scuderi C, 2011, J CELL MOL MED, V15, P2664, DOI 10.1111/j.1582-4934.2011.01267.x; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Strohmeyer R, 2001, J ALZHEIMERS DIS, V3, P131, DOI 10.3233/JAD-2001-3118; Sun Y, 2007, PPAR RES, V2007, DOI 10.1155/2007/23513; Valles S, 1999, J BIOL CHEM, V274, P20103, DOI 10.1074/jbc.274.29.20103; Valles SL, 2008, AGING CELL, V7, P112, DOI 10.1111/j.1474-9726.2007.00356.x; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; van Kralingen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084269; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Volicer L, 1997, INT J GERIATR PSYCH, V12, P913, DOI 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.3.CO;2-4; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Walther S, 2006, PSYCHOPHARMACOLOGY, V185, P524, DOI 10.1007/s00213-006-0343-1; Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhu Xiongwei, 2004, Am J Alzheimers Dis Other Demen, V19, P345, DOI 10.1177/153331750401900611	92	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122843	10.1371/journal.pone.0122843	http://dx.doi.org/10.1371/journal.pone.0122843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874692	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100108
J	Hu, MB; Bai, PD; Wu, YS; Zhang, LM; Xu, H; Na, R; Jiang, HW; Ding, Q				Hu, Meng-Bo; Bai, Pei-De; Wu, Yi-Shuo; Zhang, Li-Min; Xu, Hua; Na, Rong; Jiang, Hao-Wen; Ding, Qiang			Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; OBESITY; ANTIGEN; TESTOSTERONE; ASSOCIATION; POPULATION; IMPACT; SIZE; PSA	Objective To investigate the relationship between body mass index (BMI) and prostate cancer (PCa) risk at biopsy in Chinese men. Patients and Methods We retrospectively reviewed the records of 1,807 consecutive men who underwent initial multicore (>= 10) prostate biopsy under transrectal ultrasound guidance between Dec 2004 and Feb 2014. BMI was categorised based on the Asian classification of obesity as follows: <18.5 (underweight), 18.5-22.9 (normal weight), 23-24.9 (overweight), 25-29.9 (moderately obese), and >= 30 kg/m2 (severely obese). The odds ratios (OR) of each BMI category for risk of PCa and high-grade prostate cancer (HGPCa, Gleason score >= 4+ 3) detection were estimated in crude, age-adjusted and multivariate-adjusted models. Prevalence ratios and accuracies of PSA predicted PCa were also estimated across BMI groups. Results In total, PCa was detected by biopsy in 750 (45.4%) men, and HGPCa was detected in 419 (25.4%) men. Compared with men of normal weight, underweight men and obese men were older and had higher prostate specific antigen levels. The risk of overall PCa detection via biopsy presented an obvious U-shaped relationship with BMI in crude analysis. Overall, 50.0%, 37.4%, 45.6% 54.4% and 74.1% of the men in the underweight, normal weight, overweight, moderately obese and severely obese groups, respectively, were diagnosed with PCa via biopsy. In multivariate analysis, obesity was significantly correlated with a higher risk of PCa detection (OR = 1.17, 95% CI 1.10-1.25, P<0.001). However, higher BMI was not correlated with HGPCa detection (OR = 1.03, 95% CI 0.97-1.09, P = 0.29). There were no significant differences in the accuracy of using PSA to predict PCa or HGPCa detection across different BMI categories. Conclusion Obesity was associated with higher risk of PCa detection in the present Chinese biopsy population. No significant association was detected between obesity and HGPCa.	[Hu, Meng-Bo; Bai, Pei-De; Wu, Yi-Shuo; Zhang, Li-Min; Xu, Hua; Na, Rong; Jiang, Hao-Wen; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Jiang, HW (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	haowenj@gmail.com; qiangd_urol@126.com	Na, Rong/AAN-8655-2021; Xu, Hua/AAH-2453-2019; Hu, Meng-Bo/HDL-7502-2022	Na, Rong/0000-0001-7470-5108; 	National Natural Science Foundation of China [81272835]; Program for New Century Excellent Talents in University, China [NCET-13-0136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University, China(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Natural Science Foundation of China (Grant No. 81272835, received by HWJ, www.nsfc.gov.cn) and Program for New Century Excellent Talents in University, China (NCET-13-0136, received by HWJ, http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banez LL, 2007, JAMA-J AM MED ASSOC, V298, P2275, DOI 10.1001/jama.298.19.2275; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Chen WQ, 2014, CHINESE J CANCER RES, V26, P48, DOI 10.3978/j.issn.1000-9604.2014.01.08; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fowke JH, 2007, PROSTATE CANCER P D, V10, P137, DOI 10.1038/sj.pcan.4500924; Freedland SJ, 2009, PROSTATE CANCER P D, V12, P259, DOI 10.1038/pcan.2009.11; Freedland SJ, 2006, J UROLOGY, V175, P500, DOI 10.1016/S0022-5347(05)00162-X; Hisasue S, 2008, JPN J CLIN ONCOL, V38, P129, DOI 10.1093/jjco/hym162; Hu MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106677; Hu MB, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0829-8; Isom-Batz G, 2005, J UROLOGY, V173, P1935, DOI 10.1097/01.ju.0000158040.33531.e7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaaks R, 2014, NAT REV ENDOCRINOL, V10, P644, DOI 10.1038/nrendo.2014.168; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Kim YJ, 2007, INT J UROL, V14, P1009, DOI 10.1111/j.1442-2042.2007.01879.x; Kobayashi T, 2005, UROLOGY, V66, P130, DOI 10.1016/j.urology.2005.01.041; Lee SE, 2011, BJU INT, V107, P1250, DOI 10.1111/j.1464-410X.2010.09592.x; Lee SE, 2010, UROLOGY, V76, P1063, DOI 10.1016/j.urology.2010.03.069; Lovasi Gina S, 2012, Open Epidemiol J, V5, P13; Masuda H, 2013, INT J UROL, V20, P701, DOI 10.1111/iju.12023; Nandeesha H, 2009, INT UROL NEPHROL, V41, P267, DOI 10.1007/s11255-008-9440-x; Narita S, 2013, PROSTATE CANCER P D, V16, P271, DOI 10.1038/pcan.2013.16; Oh JJ, 2013, BJU INT, V112, pE265, DOI 10.1111/j.1464-410X.2012.11766.x; Park JH, 2009, J UROLOGY, V182, P106, DOI 10.1016/j.juro.2009.02.130; Park J, 2014, BJU INT, V114, P891, DOI 10.1111/bju.12600; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Price RS, 2012, PROSTATE CANCER P D, V15, P135, DOI 10.1038/pcan.2011.54; Qu YY, 2013, ASIAN J ANDROL, V15, P747, DOI 10.1038/aja.2013.104; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588; Yang Chao-Yang, 2011, Chang Gung Med J, V34, P1	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124668	10.1371/journal.pone.0124668	http://dx.doi.org/10.1371/journal.pone.0124668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861033	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300143
J	Karisnan, K; Bakker, AJ; Song, Y; Noble, PB; Pillow, JJ; Pinniger, GJ				Karisnan, Kanakeswary; Bakker, Anthony J.; Song, Yong; Noble, Peter B.; Pillow, J. Jane; Pinniger, Gavin J.			Interleukin-1 Receptor Antagonist Protects against Lipopolysaccharide Induced Diaphragm Weakness in Preterm Lambs	PLOS ONE			English	Article							MUSCLE FATIGUE RESISTANCE; NECROSIS-FACTOR-ALPHA; INTRAAMNIOTIC ENDOTOXIN; IL-6 PRODUCTION; FETAL; CHORIOAMNIONITIS; INFLAMMATION; DYSFUNCTION; ACTIVATION; MATURATION	Chorioamnionitis (inflammation of the fetal membranes) is strongly associated with preterm birth and in utero exposure to inflammation significantly impairs contractile function in the preterm lamb diaphragm. The fetal inflammatory response to intra-amniotic (IA) lipopolysaccharide (LPS) is orchestrated via interleukin 1 (IL-1). We aimed to determine if LPS induced contractile dysfunction in the preterm diaphragm is mediated via the IL-1 pathway. Pregnant ewes received IA injections of recombinant human IL-1 receptor antagonist (rhIL-1ra) (Anakinra; 100 mg) or saline (Sal) 3 h prior to second IA injections of LPS (4 mg) or Sal at 119d gestational age (GA). Preterm lambs were killed after delivery at 121d GA (term = 150 d). Muscle fibres dissected from the right hemi-diaphragm were mounted in an in vitro muscle test system for assessment of contractile function. The left hemi-diaphragm was snap frozen for molecular and biochemical analyses. Maximum specific force in lambs exposed to IA LPS (Sal/LPS group) was 25% lower than in control lambs (Sal/Sal group; p= 0.025). LPS-induced diaphragm weakness was associated with higher plasma IL-6 protein, diaphragm IL-1 beta mRNA and oxidised glutathione levels. Pre-treatment with rhIL-1ra (rhIL-1ra/LPS) ameliorated the LPS-induced diaphragm weakness and blocked systemic and local inflammatory responses, but did not prevent the rise in oxidised glutathione. These findings indicate that LPS induced diaphragm dysfunction is mediated via IL-1 and occurs independently of oxidative stress. Therefore, the IL-1 pathway represents a potential therapeutic target in the management of impaired diaphragm function in preterm infants.	[Karisnan, Kanakeswary; Bakker, Anthony J.; Song, Yong; Noble, Peter B.; Pillow, J. Jane; Pinniger, Gavin J.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Song, Yong; Noble, Peter B.; Pillow, J. Jane] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Paediat & Child Hlth, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Pinniger, GJ (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia.	gavin.pinniger@uwa.edu.au	Pillow, Jane/A-3335-2009; Pinniger, Gavin/F-1421-2013	Pillow, Jane/0000-0002-6500-0138; Pinniger, Gavin/0000-0002-4400-0817; Song, Yong/0000-0002-8178-5641; Noble, Peter/0000-0001-9028-7751	National Health and Medical Research Council (NHMRC) Project [APP1010665]; NHMRC Career Development Fellowship (PNB) [1045824]	National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship (PNB)(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by National Health and Medical Research Council (NHMRC) Project Grant APP1010665 and a NHMRC Career Development Fellowship (PNB, 1045824) URL: www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry CA, 2011, REPROD SCI, V18, P1092, DOI 10.1177/1933719111404609; Callahan LA, 2001, AM J RESP CELL MOL, V24, P210, DOI 10.1165/ajrcmb.24.2.4075; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Dimitriou G, 2003, PEDIATR PULM, V35, P17, DOI 10.1002/ppul.10209; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; El Khoury N, 2014, J BIOL CHEM, V289, P21896, DOI 10.1074/jbc.M114.549642; ELIAS JA, 1990, J IMMUNOL, V145, P161; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Friedrich O, 2014, AM J RESP CELL MOL, V50, P1096, DOI 10.1165/rcmb.2013-0059OC; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Hudock KM, 2012, AM J RESP CELL MOL, V47, P436, DOI 10.1165/rcmb.2012-0104OC; Javen I, 1996, J PHYSIOL-LONDON, V494, P839, DOI 10.1113/jphysiol.1996.sp021537; JIRIK FR, 1989, J IMMUNOL, V142, P144; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; KEENS TG, 1978, J APPL PHYSIOL, V44, P909, DOI 10.1152/jappl.1978.44.6.909; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Labbe K, 2010, CRIT CARE, V14, DOI 10.1186/cc9295; Lavin T, 2013, PEDIATR PULM, V48, P640, DOI 10.1002/ppul.22762; LESOUEF PN, 1988, J APPL PHYSIOL, V65, P1040, DOI 10.1152/jappl.1988.65.3.1040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; MAXWELL LC, 1983, J APPL PHYSIOL, V54, P551, DOI 10.1152/jappl.1983.54.2.551; Oishi K, 1997, Environ Health Prev Med, V2, P89, DOI 10.1007/BF02931972; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SIECK GC, 1991, J APPL PHYSIOL, V71, P458, DOI 10.1152/jappl.1991.71.2.458; Song Y, 2013, AM J RESP CELL MOL, V49, P866, DOI 10.1165/rcmb.2013-0107OC; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073457; Song Y, 2012, ANAT REC, V295, P864, DOI 10.1002/ar.22436; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Supinski GS, 2014, RESP PHYSIOL NEUROBI, V196, P63, DOI 10.1016/j.resp.2014.02.015; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; WATCHKO JF, 1993, J APPL PHYSIOL, V75, P1341, DOI 10.1152/jappl.1993.75.3.1341; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P19, DOI 10.1016/S0002-9378(97)70432-0	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124390	10.1371/journal.pone.0124390	http://dx.doi.org/10.1371/journal.pone.0124390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860718	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300138
J	Sadasivan, S; Zanin, M; O'Brien, K; Schultz-Cherry, S; Smeyne, RJ				Sadasivan, Shankar; Zanin, Mark; O'Brien, Kevin; Schultz-Cherry, Stacey; Smeyne, Richard J.			Induction of Microglia Activation after Infection with the Non-Neurotropic A/CA/04/2009 H1N1 Influenza Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; UP-REGULATION; CELLS; NEUROINFLAMMATION; MACROPHAGES; SURVIVAL; MODEL; CNS; ENCEPHALOPATHY; INFLAMMATION	Although influenza is primarily a respiratory disease, it has been shown, in some cases, to induce encephalitis, including people acutely infected with the pandemic A/California/04/ 2009 (CA/09) H1N1 virus. Based on previous studies showing that the highly pathogenic avian influenza (HPAI) A/Vietnam/1203/2004 H5N1 virus was neurotropic, induced CNS inflammation and a transient parkinsonism, we examined the neurotropic and inflammatory potential of the CA/09 H1N1 virus in mice. Following intranasal inoculation, we found no evidence for CA/09 H1N1 virus neurotropism in the enteric, peripheral or central nervous systems. We did, however, observe a robust increase in microglial activity in the brain characterized by an increase in the number of activated Iba-1-positive microglia in the substantia nigra (SN) and the hippocampus, despite the absence of virus in the brain. qPCR analysis in SN tissue showed that the induction of microgliosis was preceded by reduced gene expression of the neurotrophic factors bdnf, and gdnf and increases in the immune modulatory chemokine chemokine (C-C motif) ligand 4 (ccl4). We also noted changes in the expression of transforming growth factor-1 (tgf beta 1) in the SN starting at 7 days post-infection (dpi) that was sustained through 21 dpi, coupled with increases in arginase-1 (arg1) and csf1, M2 markers for microglia. Given that neuroinflammation contributes to generation and progression of a number of neurodegenerative disorders, these findings have significant implications as they highlight the possibility that influenza and perhaps other non-neurotropic viruses can initiate inflammatory signals via microglia activation in the brain and contribute to, but not necessarily be the primary cause of, neurodegenerative disorders.	[Sadasivan, Shankar; Smeyne, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Zanin, Mark; O'Brien, Kevin; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Smeyne, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA.	Richard.smeyne@stjude.org	Schultz-Cherry, Stacey/N-2506-2018	Smeyne, Richard/0000-0002-8459-5472; Zanin, Mark/0000-0003-3158-1744	National Institute of Health [NS075840-01]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075840] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institute of Health NS075840-01 and American Lebanese Syrian Associated Charities (www.stjude.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Chen XX, 2014, VET MICROBIOL, V170, P48, DOI 10.1016/j.vetmic.2014.01.031; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x; Ekstrand JJ, 2012, SEMIN PEDIATR NEUROL, V19, P96, DOI 10.1016/j.spen.2012.02.004; Frisullo G, 2011, HUM IMMUNOL, V72, P632, DOI 10.1016/j.humimm.2011.04.006; Fuchigami T, 2012, PEDIATR EMERG CARE, V28, P998, DOI 10.1097/PEC.0b013e31826ca999; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09; Hayakawa K, 2014, J NEUROSCI RES; Henry J, 2010, PARKINSONISM RELAT D; Jang H, 2012, J NEUROSCI, V32, P1545, DOI 10.1523/JNEUROSCI.5123-11.2012; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; KIEFER R, 1993, J NEUROSCI RES, V36, P391, DOI 10.1002/jnr.490360405; KLEMPT ND, 1992, MOL BRAIN RES, V13, P93, DOI 10.1016/0169-328X(92)90048-G; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Louboutin JP, 2013, CNS NEUROL DISORD-DR, V12, P815, DOI 10.2174/18715273113126660173; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Lyck R, 2012, J VASC RES, V49, P497, DOI 10.1159/000341232; Madore C, 2013, BRAIN BEHAV IMMUN, V34, P151, DOI 10.1016/j.bbi.2013.08.008; Maeda K, 2012, INTERNAL MED, V51, P1931, DOI 10.2169/internalmedicine.51.7487; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Manes TD, 2008, J IMMUNOL, V180, P8386, DOI 10.4049/jimmunol.180.12.8386; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Canabal A, 2014, INT J NEUROSCI; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Mitchell K, 2014, J NEUROCHEM, V129, P155, DOI 10.1111/jnc.12612; Mizoguchi Y, 2014, J BIOL CHEM, V289, P18549, DOI 10.1074/jbc.M114.555334; Moehle MS, 2014, NEUROSCIENCE; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muhammad Ismail HI, 2014, BRAIN DEV; Mukherjee A, 2011, ACTA NEUROPATHOL, V122, P371, DOI 10.1007/s00401-011-0854-7; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980; Nakajima K, 2001, BRAIN RES, V916, P76, DOI 10.1016/S0006-8993(01)02866-9; Neumann H, 1998, P NATL ACAD SCI USA, V95, P5779, DOI 10.1073/pnas.95.10.5779; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sadasivan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033693; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Studahl M, 2003, J CLIN VIROL, V28, P225, DOI 10.1016/S1386-6532(03)00119-7; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Thomas PG, 2010, J IMMUNOL, V184, P1721, DOI 10.4049/jimmunol.0901427; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xue QS, 2010, BRAIN RES, V1319, P131, DOI 10.1016/j.brainres.2009.12.089; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396	65	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124047	10.1371/journal.pone.0124047	http://dx.doi.org/10.1371/journal.pone.0124047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861024	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300129
J	Tang, YL; Jiang, JH; Wang, S; Liu, Z; Tang, XQ; Peng, J; Yang, YZ; Gu, HF				Tang, Ya Ling; Jiang, Jian Hong; Wang, Shuang; Liu, Zhu; Tang, Xiao Qing; Peng, Juan; Yang, Yong-Zong; Gu, Hong-Feng			TLR4/NF-kappa B Signaling Contributes to Chronic Unpredictable Mild Stress-Induced Atherosclerosis in ApoE(-/-) Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; PSYCHOSOCIAL FACTORS; ACCELERATES ATHEROSCLEROSIS; PSYCHOLOGICAL STRESS; DENDRITIC CELLS; INFLAMMATION; DISEASE; TOLL-LIKE-RECEPTOR-4; DIFFERENTIATION; ASSOCIATIONS	Objective Chronic stress is an important risk factor for atherosclerotic diseases. Our previous studies have shown that chronic unpredictable mild stress (CUMS) accelerates atherosclerosis and up-regulates TLR4/NF-kappa B expression in apoE(-/-) mice. However, TLR4/NF-kappa B signaling whether directly contributes to the development of atherosclerosis in CUMS mice is unclear. We hypothesized that the interference of TLR4/NF-kappa B can ameliorate CUMS-induced inflammation and atherosclerosis in apoE(-/-) mice. Methods ApoE(-/-) mice were exposed to 12 weeks CUMS. Ad-siRNA TLR4 was given by tail vein injection (10 mu l/mouse, every 5 days), and PDTC (an inhibitor of NF-kappa B) was given by intraperitoneal injection (60 mg/kg, once a day). Plasma corticosterone concentrations were determined by solid-phase I-125 radioimmunoassay. Atherosclerosis lesions in aortic sinuses were evaluated and quantified by IMAGEPRO PLUS. Western blotting was used to detect the expression of TLR4, NF-kappa B, and IL-1 beta in aortas of the mice. Plasma lipid profiles, IL-1 beta, TNF-alpha, and MCP-1 were measured by ELISA. Results Our results indicated that CUMS apoE(-/-) mice treatment with siRNA TLR4 significantly decreased atherosclerosis and down-regulated TLR4, NF-kappa B, and inflammatory cytokines. PDTC also remarkably reduced atherosclerosis and the levels of IL-1 beta, TNF-alpha and MCP-1 in plasma. However, Treatment with siRNA TLR4 or PDTC had no effect on plasma corticosterone levels, and lipid profiles. Conclusions TLR4/NF-kappa B pathway may participate in CUMS-induced atherosclerosis through activation of proinflammatory cytokines in apoE(-/-) mice. Our data may provide a new potential therapeutic target for prevention of CUMS-induced atherosclerosis.	[Tang, Ya Ling; Wang, Shuang; Peng, Juan; Yang, Yong-Zong; Gu, Hong-Feng] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Peoples R China; [Jiang, Jian Hong; Liu, Zhu] Univ South China, Chuanshan Coll, Hengyang 421001, Peoples R China; [Tang, Xiao Qing; Gu, Hong-Feng] Univ South China, Dept Physiol, Hengyang 421001, Peoples R China; [Tang, Xiao Qing; Gu, Hong-Feng] Univ South China, Inst Neurosci, Hengyang 421001, Peoples R China	University of South China; University of South China; University of South China; University of South China	Gu, HF (corresponding author), Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Peoples R China.	ghf513@sina.com			National Natural Science Foundation of China [81170278]; construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee [09C835, 2012cshcx3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81170278), the construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China), and the Foundation of Hunan Educational Committee (09C835, 2012cshcx3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernberg E, 2012, ATHEROSCLEROSIS, V221, P359, DOI 10.1016/j.atherosclerosis.2011.11.041; Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Castro-Diehl C, 2014, PSYCHONEUROENDOCRINO, V41, P132, DOI 10.1016/j.psyneuen.2013.12.013; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Everson-Rose SA, 2014, STROKE, V45, P2318, DOI 10.1161/STROKEAHA.114.004815; Gu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112683; [顾洪丰 Gu Hongfeng], 2011, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V19, P6; Gu HF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/613879; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hu ZP, 2013, J PINEAL RES, V55, P388, DOI 10.1111/jpi.12085; KAPLAN JR, 1983, SCIENCE, V220, P733; Kiechl S, 2003, ANN MED, V35, P164, DOI 10.1080/07853890310008215; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lu XT, 2013, J CARDIOVASC PHARM, V62, P6, DOI 10.1097/FJC.0b013e3182858fac; Lu XT, 2012, PSYCHOSOM MED, V74, P604, DOI 10.1097/PSY.0b013e31825d0b71; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Ohira T, 2008, PSYCHOSOM MED, V70, P141, DOI 10.1097/PSY.0b013e318160686a; Pasterkamp G, 2004, EUR J CLIN INVEST, V34, P328, DOI 10.1111/j.1365-2362.2004.01338.x; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Roemmich JN, 2009, PSYCHOPHYSIOLOGY, V46, P293, DOI 10.1111/j.1469-8986.2008.00776.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Tramullas M, 2014, BIOL PSYCHIAT, V76, P340, DOI 10.1016/j.biopsych.2013.11.004; Wang HX, 2007, J INTERN MED, V261, P245, DOI 10.1111/j.1365-2796.2006.01759.x; Wang RP, 2011, STRESS, V14, P567, DOI 10.3109/10253890.2011.571729; Weber MD, 2013, BRAIN BEHAV IMMUN, V32, P112, DOI 10.1016/j.bbi.2013.03.004; Xing SS, 2014, J INT MED RES, V42, P958, DOI 10.1177/0300060514534645; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Zhai JX, 2012, MOL BIOL REP, V39, P6763, DOI 10.1007/s11033-012-1501-7; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	40	36	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123685	10.1371/journal.pone.0123685	http://dx.doi.org/10.1371/journal.pone.0123685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860573	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300109
J	Mckay, AJ; Patel, RKK; Majeed, A				Mckay, Ailsa J.; Patel, Raju K. K.; Majeed, Azeem			Strategies for Tobacco Control in India: A Systematic Review	PLOS ONE			English	Review							PREVENTION PROGRAM; DENTAL STUDENTS; SMOKING-CESSATION; CONTROL POLICY; HEALTH; ADOLESCENTS; KNOWLEDGE; KERALA; INTERVENTION; INTENTIONS	Background Tobacco control needs in India are large and complex. Evaluation of outcomes to date has been limited. Aim To review the extent of tobacco control measures, and the outcomes of associated trialled interventions, in India. Methods Information was identified via database searches, journal hand-searches, reference and citation searching, and contact with experts. Studies of any population resident in India were included. Studies where outcomes were not yet available, not directly related to tobacco use, or not specific to India, were excluded. Pre-tested proformas were used for data extraction and quality assessment. Studies with reliability concerns were excluded from some aspects of analysis. The Framework Convention on Tobacco Control (FCTC) was use as a framework for synthesis. Heterogeneity limited meta-analysis options. Synthesis was therefore predominantly narrative. Results Additional to the Global Tobacco Surveillance System data, 80 studies were identified, 45 without reliability concerns. Most related to education (FCTC Article 12) and tobacco-use cessation (Article 14). They indicated widespread understanding of tobacco-related harm, but less knowledge about specific consequences of use. Healthcare professionals reported low confidence in cessation assistance, in keeping with low levels of training. Training for schoolteachers also appeared suboptimal. Educational and cessation assistance interventions demonstrated positive impact on tobacco use. Studies relating to smoke-free policies (Article 8), tobacco advertisements and availability (Articles 13 and 16) indicated increasingly widespread smoke-free policies, but persistence of high levels of SHS exposure, tobacco promotions and availability-including to minors. Data relating to taxation/pricing and packaging (Articles 6 and 11) were limited. We did not identify any studies of product regulation, alternative employment strategies, or illicit trade (Articles 9, 10, 15 and 17). Conclusions Tobacco-use outcomes could be improved by school/community-based and adult education interventions, and cessation assistance, facilitated by training for health professionals and schoolteachers. Additional tobacco control measures should be assessed.	[Mckay, Ailsa J.; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Patel, Raju K. K.] London North West Healthcare NHS Trust, London, England	Imperial College London	Mckay, AJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	ailsa.mckay08@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	Department of Primary Care AMP; Public Health at Imperial College London from NW London NIHR Collaboration for Leadership in Applied Health Research Care (CLAHRC); Imperial NIHR Biomedical Research Centre	Department of Primary Care AMP; Public Health at Imperial College London from NW London NIHR Collaboration for Leadership in Applied Health Research Care (CLAHRC); Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	The Department of Primary Care & Public Health at Imperial College London is grateful for support from the NW London NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) and the Imperial NIHR Biomedical Research Centre. The views expressed in this publication are those of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora M, 2008, AM J HEALTH BEHAV, V32, P283; Arora M, 2012, TOB CONTROL, V21, P482, DOI 10.1136/tc.2011.043539; Arora M, 2011, GLOB HEALTH PROMOT, V18, P9, DOI 10.1177/1757975910393163; Arora M, 2010, HEALTH PROMOT INT, V25, P143, DOI 10.1093/heapro/daq008; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001480; Bate SL, 2009, PREV SCI, V10, P116, DOI 10.1007/s11121-008-0113-x; Bedi RS, 1995, LUNG INDIA, V13, P51; Bhatia V, 2009, 14TH WORLD CONFERENC; Brown HS, 2013, HEALTH PROMOT INT, V28, P178, DOI 10.1093/heapro/dar095; Centre for Reviews and Dissemination, 2008, SYSTEMATIC REV CRDS; Chandrashekar J, 2011, ORAL HLTH PREV DENT, V9, P243; Dongre A. R., 2008, Indian Journal of Cancer, V45, P100; Effective Public Health Practice Project, QUAL ASS TOOL QUANT; ERC Statistics International Plc, THE WORLD CIGARETTE; Eriksen M, 2012, TOBACCO ATLAS; Flay Brian R, 2009, Tob Induc Dis, V5, P7, DOI 10.1186/1617-9625-5-7; Goel S, 2012, TOB CONTROL, V21, P458; Goenka S, 2010, HEALTH EDUC RES, V25, P917, DOI 10.1093/her/cyq042; Goswami H., 2006, TOBACCO MOVIES IMPAC; Halawany HS, 2013, ASIAN PAC J CANCER P, V14, P3619, DOI 10.7314/APJCP.2013.14.6.3619; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Jha P, 2008, NEW ENGL J MED, V358, P1, DOI [10.1056/, DOI 10.1056/NEJMP0707917]; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; John RM, 2007, INDIAN J MED RES, V125, P599; Kashiwabara Mina, 2011, Indian J Public Health, V55, P234, DOI 10.4103/0019-557X.89937; Kaur Jagdish, 2011, Indian J Public Health, V55, P220, DOI 10.4103/0019-557X.89941; Kumar MS, 2012, J SUBST ABUSE TREAT, V43, P53, DOI 10.1016/j.jsat.2011.10.026; Lal PG, 2011, INT J TUBERC LUNG D, V15, P565, DOI 10.5588/ijtld.10.0372; Mathew JL, 2011, INDIAN PEDIATR, V48, P191, DOI 10.1007/s13312-011-0051-8; Mekemson C, 2002, TOB CONTROL, V11, pI81, DOI 10.1136/tc.11.suppl_1.i81; Mohanty VR, 2013, ASIAN PAC J CANCER P, V14, P2673, DOI 10.7314/APJCP.2013.14.4.2673; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mony Prem K, 2011, Indian J Community Med, V36, P104, DOI 10.4103/0970-0218.84127; Murugaboopathy V, 2013, J DENT EDUC, V77, P510; Murukutla N, 2012, TOB CONTROL, V21, P12, DOI 10.1136/tc.2010.039438; NOTANI PN, 1991, HEALTH EDUC RES, V6, P121, DOI 10.1093/her/6.1.121; Panda R, 2013, AUSTRALAS MED J, V6, P115, DOI 10.4066/AMJ.2013.1617; Pednekar Mangesh S, 2004, Indian J Public Health, V48, P147; Perry CL, 2009, AM J PUBLIC HEALTH, V99, P899, DOI 10.2105/AJPH.2008.145433; Planning Commission Government of India, 2013, TWELFTH FIVE YEAR PL, VIII; Planning Commission Government of India, 2008, ELEVENTH FIVE YEAR P, VII; Pradeepkumar AS, 2008, INT J TUBERC LUNG D, V12, P1139; Public Health Foundation of India, 2013, SHORT TERM COURS TOB; Quazi Syed Z, 2011, ANN TROP MED PUBLIC, V4, P74, DOI 10.4103/1755-6783.85756; Rajasundaram P, 2011, J DENT EDUC, V75, P1603; Raute LJ, 2011, ASIAN PAC J CANCER P, V12, P1233; Reddy KS, 2002, AM J HEALTH BEHAV, V26, P173, DOI 10.5993/AJHB.26.3.2; Resource Centre for Tobacco Free India, 2007, GOV IND IN NAT PROGR; Sansone GC, 2012, INT J ENV RES PUB HE, V9, P564, DOI 10.3390/ijerph9020564; Sharma I, 2010, Indian J Cancer, V47 Suppl 1, P63, DOI 10.4103/0019-509X.63874; Sharma Rameshwar, 2004, Indian J Cancer, V41, P162; Singh P, 2010, LUNG INDIA, V27, P11, DOI 10.4103/0970-2113.59262; Singh V, 2012, LUNG INDIA, V29, P203, DOI 10.4103/0970-2113.99095; Sinha DN, 2012, INDIAN J CANCER, V49, P379, DOI 10.4103/0019-509X.107743; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P132; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P111; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P123; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P144; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P128; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P118; Sinha DN, 2008, J SCHOOL HEALTH, V78, P368, DOI 10.1111/j.1746-1561.2008.00316.x; Sorensen G, 2005, PREV MED, V41, P417, DOI 10.1016/j.ypmed.2004.09.048; Sorensen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034982; Srivastava S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-263; Stead LF, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005231.pub2; Stigler MH, 2011, HEALTH EDUC BEHAV, V38, P231, DOI 10.1177/1090198110372330; Sunley EM, 2008, INDIA THE TAX TREATM; Thankappan KR, 2013, NATL MED J INDIA, V26, P18; Thankappan KR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-47; Thankappan KR, 2009, INDIAN J MED RES, V129, P249; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Thresia CU, 2009, HEALTH EDUC RES, V24, P839, DOI 10.1093/her/cyp020; Tiwari RR, 2006, REGIONAL HLTH FORUM, V3, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2011, SMOK FREE MOV EV ACT; World Health Organization, 2013, WHO REPORT ON THE GL; World Health Organization, 2011, WHO REPORT ON THE GL; World Health Organization Centers for Disease Control and Prevention and the Canadian Public Health Association, 2013, GLOBAL TOBACCO SURVE	78	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122610	10.1371/journal.pone.0122610	http://dx.doi.org/10.1371/journal.pone.0122610			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856462	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500046
J	Mofakham, S; Zochowski, M				Mofakham, Sima; Zochowski, Michal			Measuring Predictability of Autonomous Network Transitions into Bursting Dynamics	PLOS ONE			English	Article							EPILEPTIC SEIZURES; SMALL-WORLD; FIRING PATTERNS; HUMAN BRAIN; SYNCHRONIZATION; CONNECTIVITY; COMPUTATION; NEURONS; WAVES; TIME	Understanding spontaneous transitions between dynamical modes in a network is of significant importance. These transitions may separate pathological and normal functions of the brain. In this paper, we develop a set of measures that, based on spatio-temporal features of network activity, predict autonomous network transitions from asynchronous to synchronous dynamics under various conditions. These metrics quantify spike-timing distributions within a narrow time window as a function of the relative location of the active neurons. We applied these metrics to investigate the properties of these transitions in excitatory-only and excitatory-and-inhibitory networks and elucidate how network topology, noise level, and cellular heterogeneity affect both the reliability and the timeliness of the predictions. The developed measures can be calculated in real time and therefore potentially applied in clinical situations.	[Mofakham, Sima; Zochowski, Michal] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Zochowski, Michal] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Zochowski, Michal] RB Zajonc Inst Social Studies, PL-00183 Warsaw, Poland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Warsaw	Zochowski, M (corresponding author), Univ Michigan, Biophys Program, 930N Univ, Ann Arbor, MI 48109 USA.	michalz@umich.edu		Zochowski, Michal/0000-0002-1722-986X	National Science foundation [CMMI 1029388, PoLS 1058034]	National Science foundation(National Science Foundation (NSF))	This work was supported by the National Science foundation (CMMI 1029388 and PoLS 1058034).	Abeles M., 1991, CORTICONICS; Andrzejak RG, 2009, CLIN NEUROPHYSIOL, V120, P1465, DOI 10.1016/j.clinph.2009.05.019; Andrzejak RG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.010901; Ansmann G, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052911; Aschenbrenner-Scheibe R, 2003, BRAIN, V126, P2616, DOI 10.1093/brain/awg265; BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; Braun HA, 2011, CHAOS, V21, DOI 10.1063/1.3671326; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Campbell SR, 1999, NEURAL COMPUT, V11, P1595, DOI 10.1162/089976699300016160; Chaovalitwongse W, 2005, EPILEPSY RES, V64, P93, DOI 10.1016/j.eplepsyres.2005.03.009; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; FRANASZCZUK PJ, 1994, ELECTROEN CLIN NEURO, V91, P413, DOI 10.1016/0013-4694(94)90163-5; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; GOLOMB D, 1993, PHYS REV E, V48, P4810, DOI 10.1103/PhysRevE.48.4810; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; HANSEL D, 1992, PHYS REV LETT, V68, P718, DOI 10.1103/PhysRevLett.68.718; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hong H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026139; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Karnatak R, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022917; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Le Van Quyen M, 1999, NEUROREPORT, V10, P2149; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Newman MEJ, 2000, PHYS REV LETT, V84, P3201, DOI 10.1103/PhysRevLett.84.3201; Osorio I, 2011, INITIATION TERMINATI, P341; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Schelter B, 2006, CHAOS, V16, DOI 10.1063/1.2137623; Schiff SJ, 2000, CLIN NEUROPHYSIOL, V111, P953, DOI 10.1016/S1388-2457(00)00259-5; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Tsodyks M, 2000, J NEUROSCI, V20; Tuckwell H.C., 1988, LINEAR CABLE THEORY, V1; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Wu JY, 1999, J NEUROSCI, V19, P5005; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	51	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122225	10.1371/journal.pone.0122225	http://dx.doi.org/10.1371/journal.pone.0122225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855975	Green Published, gold			2022-12-26	WOS:000352588500034
J	Tamburo, E; Varrica, D; Dongarra, G; Grimaldi, LME				Tamburo, Elisa; Varrica, Daniela; Dongarra, Gaetano; Grimaldi, Luigi Maria Edoardo			Trace Elements in Scalp Hair Samples from Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; REFERENCE VALUES; CEREBROSPINAL-FLUID; ALUMINUM; METALS; ZINC; IRON; EPIDEMIOLOGY; HYPOTHESIS; TOXICITY	Background Epidemiological studies have suggested a possible role of trace elements (TE) in the etiology of several neurological diseases including Multiple Sclerosis (MS). Hair analysis provides an easy tool to quantify TE in human subjects, including patients with neurodegenerative diseases. Objective To compare TE levels in scalp hair from patients with MS and healthy controls from the same geographic area (Sicily). Methods ICP-MS was used to determine the concentrations of 21 elements (Ag, Al, As, Ba, Cd, Co, Cr, Cu, Fe, Li, Mn, Mo, Ni, Pb, Rb, Sb, Se, Sr, U, V and Zn) in scalp hair of 48 patients with relapsing-remitting Multiple Sclerosis compared with 51 healthy controls. Results MS patients showed a significantly lower hair concentration of aluminum and rubidium (median values: Al = 3.76 mu g/g vs. 4.49 mu g/g and Rb = 0.007 mu g/g vs. 0.01 mu g/g;) and higher hair concentration of U (median values U: 0.014 mu g/g vs. 0.007 mu g/g) compared to healthy controls. The percentages of MS patients showing hair elemental concentrations greater than the 95th percentile of controls were 20% for Ni, 19% for Ba and U, and 15% for Ag, Mo and Se. Conversely, the percentages of MS patients showing hair elemental concentrations lower than the 5th percentile of healthy controls were 27% for Al, 25% for Rb, 22% for Ag, 19% for Fe, and 16% for Pb. No significant association was found between levels of each TE and age, disease duration or Expanded Disability Status Scale (EDSS) score. After stratification by gender, healthy subjects did not show any significant difference in trace element levels, while MS patients showed significant differences (p<0.01) for the concentrations of Ag, Cr, Fe, Ni and Sr. No significant differences were also found, at p<0.01, in relation to the use of cigarettes, consume of water, vegetables and place of living. Conclusion The different distributions of TE in hair of MS patients compared to controls provides an additional indirect evidence of metabolic imbalance of chemical elements in the pathogenesis of this disease. The increase in U and decrease in Al and Rb levels in MS compared to controls require further assessments as well as the observed different distributions of other elements.	[Tamburo, Elisa; Varrica, Daniela; Dongarra, Gaetano] Univ Palermo, Dipartimento Sci Terra & Mare DiSTeM, Palermo, Sicily, Italy; [Grimaldi, Luigi Maria Edoardo] Fdn Ist San Raffaele G Giglio Cefalu, UO Neurol, Cefalu, Sicily, Italy	University of Palermo	Tamburo, E (corresponding author), Univ Palermo, Dipartimento Sci Terra & Mare DiSTeM, Palermo, Sicily, Italy.	elisatamburo@libero.it	Grimaldi, Luigi/L-2614-2019; Tamburo, Elisa/O-6523-2016	Varrica, Daniela/0000-0003-1491-8325; Tamburo, Elisa/0000-0002-5713-4398				Barnett V., 1984, OUTLIERS STAT DATA; BETTS RP, 1978, J NEUROL NEUROSUR PS, V41, P791, DOI 10.1136/jnnp.41.9.791; Birke M, 2010, J GEOCHEM EXPLOR, V107, P217, DOI 10.1016/j.gexplo.2010.05.005; Bomboi Giuseppe, 2005, Ann Ist Super Sanita, V41, P205; Bondy SC, 2014, TOXICOLOGY, V315, P1, DOI 10.1016/j.tox.2013.10.008; Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V29, P314, DOI 10.1016/j.etap.2010.03.010; CLAUSEN J, 1988, BIOL TRACE ELEM RES, V15, P179, DOI 10.1007/BF02990136; CREASON JP, 1975, CLIN CHEM, V21, P603; Daxon EG., 2005, DEPLETED URANIUM AER; De Prisco PP, 2010, BIOMED RES-INDIA, V21, P131; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; DOMINGO JL, 2000, REV TOXICOL, V17, P3; Dongarra G, 2012, ENVIRON TOXICOL PHAR, V34, P160, DOI 10.1016/j.etap.2012.03.005; Dongarra G, 2011, ENVIRON TOXICOL PHAR, V32, P27, DOI 10.1016/j.etap.2011.03.003; EBERS GC, 1994, J NEUROIMMUNOL, V54, P1, DOI 10.1016/0165-5728(94)90225-9; Ebers GC, 1998, MULTIPLE SCLEROSIS; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Exley C, 2005, SUB CELL BIOCHEM, V38, P225; Exley C, 2006, MULT SCLER J, V12, P533, DOI 10.1177/1352458506071323; Exley C, 2011, MONATSH CHEM, V142, P357, DOI 10.1007/s00706-010-0417-y; Falchuk KH, 1998, MOL CELL BIOCHEM, V188, P41, DOI 10.1023/A:1006808119862; Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2; Forte G, 2005, J TRACE ELEM MED BIO, V19, P195, DOI 10.1016/j.jtemb.2005.08.003; Forte G, 2004, J NEURAL TRANSM, V111, P1031, DOI 10.1007/s00702-004-0124-0; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Fulgenzi A, 2012, BIOMETALS, V25, P569, DOI 10.1007/s10534-012-9537-7; Fung YK, 1997, J TOXICOL-CLIN TOXIC, V35, P49, DOI 10.3109/15563659709001165; Giacoppo S, 2014, BIOL TRACE ELEM RES, V161, P151, DOI 10.1007/s12011-014-0094-5; Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X; Goncalves PP, 2007, J INORG BIOCHEM, V101, P1291, DOI 10.1016/j.jinorgbio.2007.06.002; Gonzalez-Munoz MJ, 2008, FOOD CHEM TOXICOL, V46, P49, DOI 10.1016/j.fct.2007.06.036; GOOD PF, 1992, BRAIN RES, V593, P343, DOI 10.1016/0006-8993(92)91334-B; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; Kurttio P, 2005, ENV HLTH PERSP, V113, P1; LEGGETT RW, 1994, HEALTH PHYS, V67, P589, DOI 10.1097/00004032-199412000-00002; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; LOMBECK I, 1980, BIOL TRACE ELEM RES, V2, P193, DOI 10.1007/BF02785354; Matsuzaki S, 2004, J NEUROCHEM, V88, P1345, DOI 10.1111/j.1471-4159.2004.02290.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; Mikulewicz M, 2013, ENVIRON TOXICOL PHAR, V36, P1077, DOI 10.1016/j.etap.2013.09.012; Murray RK, 2000, HARPERS BIOCH, V25th; Nicoletti A, 2014, PLOS ONE, V8, P1; Nicoletti A, 2011, MULT SCLER J, V17, P273, DOI 10.1177/1352458510386995; Nowak B, 1998, SCI TOTAL ENVIRON, V209, P59, DOI 10.1016/S0048-9697(97)00298-2; Percy ME, 2011, J INORG BIOCHEM, V105, P1505, DOI 10.1016/j.jinorgbio.2011.08.001; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Purdey M, 2004, MED HYPOTHESES, V62, P746, DOI 10.1016/j.mehy.2003.12.034; Rivera-Mancia S, 2010, CHEM-BIOL INTERACT, V186, P184, DOI 10.1016/j.cbi.2010.04.010; Rodella LF, 2008, HISTOL HISTOPATHOL, V23, P433, DOI 10.14670/HH-23.433; Rodushkin I, 2000, SCI TOTAL ENVIRON, V262, P21, DOI 10.1016/S0048-9697(00)00531-3; Rondeau Virginie, 2002, Rev Environ Health, V17, P107; Ryabukin, 1978, IAEARL50; RYAN DE, 1978, CLIN CHEM, V24, P1996; SADOVNICK AD, 1993, CAN J NEUROL SCI, V20, P17, DOI 10.1017/S0317167100047351; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sayre LM, 2000, CELL MOL BIOL, V46, P731; SCHIFFER RB, 1994, NEUROLOGY, V44, P1987, DOI 10.1212/WNL.44.10.1987-a; SCHULTEN HR, 1983, EXPERIENTIA, V39, P736, DOI 10.1007/BF01990300; Sela H, 2007, INT J MASS SPECTROM, V261, P199, DOI 10.1016/j.ijms.2006.09.018; Senofonte O, 2000, J TRACE ELEM MED BIO, V14, P6, DOI 10.1016/S0946-672X(00)80017-6; Soetan K. O., 2010, African Journal of Food Science, V4, P200; StatSoft Inc, STATISTICA DAT AN SO; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Subramanian KS, 1996, SPECTROCHIM ACTA B, V51, P291, DOI 10.1016/0584-8547(95)01425-X; Valera P, 2014, ENVIRON GEOCHEM HLTH, V36, P79, DOI 10.1007/s10653-013-9520-4; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Varrica D, 2014, SCI TOTAL ENVIRON, V470, P117, DOI 10.1016/j.scitotenv.2013.09.058; Vinceti M, 2013, NEUROTOXICOLOGY, V38, P25, DOI 10.1016/j.neuro.2013.05.016; Visconti Andrea, 2005, Ann Ist Super Sanita, V41, P217; Walton JR, 2013, J ALZHEIMERS DIS, V35, P7, DOI 10.3233/JAD-121909; Walton JR, 2009, J INORG BIOCHEM, V103, P1548, DOI 10.1016/j.jinorgbio.2009.07.027; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; WATTS DL, 2010, TRACE ELEM NEWSLETTE, V21, P1; Zapadniuk B V, 1992, Lik Sprava, P111	78	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122142	10.1371/journal.pone.0122142	http://dx.doi.org/10.1371/journal.pone.0122142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856388	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500032
J	Reimund, M; Larsson, M; Kovrov, O; Kasvandik, S; Olivecrona, G; Lookene, A				Reimund, Mart; Larsson, Mikael; Kovrov, Oleg; Kasvandik, Sergo; Olivecrona, Gunilla; Lookene, Aivar			Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; ENDOTHELIAL-CELL TRANSPORTER; HEPARIN-BINDING; TERMINAL DOMAIN; DIRECTED MUTAGENESIS; PANCREATIC LIPASE; IDENTIFICATION; CHYLOMICRONEMIA; CAPILLARIES; PEPTIDES	GPIHBP1 is an endothelial membrane protein that transports lipoprotein lipase (LPL) from the subendothelial space to the luminal side of the capillary endothelium. Here, we provide evidence that two regions of GPIHBP1, the acidic N-terminal domain and the central Ly6 domain, interact with LPL as two distinct binding sites. This conclusion is based on comparative binding studies performed with a peptide corresponding to the N-terminal domain of GPIHBP1, the Ly6 domain of GPIHBP1, wild type GPIHBP1, and the Ly6 domain mutant GPIHBP1 Q114P. Although LPL and the N-terminal domain formed a tight but short lived complex, characterized by fast on-and off-rates, the complex between LPL and the Ly6 domain formed more slowly and persisted for a longer time. Unlike the interaction of LPL with the Ly6 domain, the interaction of LPL with the N-terminal domain was significantly weakened by salt. The Q114P mutant bound LPL similarly to the N-terminal domain of GPIHBP1. Heparin dissociated LPL from the N-terminal domain, and partially from wild type GPIHBP1, but was unable to elute the enzyme from the Ly6 domain. When LPL was in complex with the acidic peptide corresponding to the N-terminal domain of GPIHBP1, the enzyme retained its affinity for the Ly6 domain. Furthermore, LPL that was bound to the N-terminal domain interacted with lipoproteins, whereas LPL bound to the Ly6 domain did not. In summary, our data suggest that the two domains of GPIHBP1 interact independently with LPL and that the functionality of LPL depends on its localization on GPIHBP1.	[Reimund, Mart; Lookene, Aivar] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Larsson, Mikael; Kovrov, Oleg; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci, SE-90187 Umea, Sweden; [Kasvandik, Sergo] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	Tallinn University of Technology; Umea University; University of Tartu	Lookene, A (corresponding author), Akad Tee 15, EE-12618 Tallinn, Estonia.	aivar.lookene@ttu.ee	Reimund, Mart/A-2426-2019; Olivecrona, Gunilla/D-2127-2018	Reimund, Mart/0000-0002-9280-5409; Olivecrona, Gunilla/0000-0002-8876-6048; Kasvandik, Sergo/0000-0003-0218-2410	Estonian Ministry of Education and Research [IUT 19-9]; Swedish Science Council [12203]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Swedish Science Council	This work was supported by Estonian Ministry of Education and Research Grant IUT 19-9 and Swedish Science Council Grant 12203.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2011, J BIOL CHEM, V286, P19735, DOI 10.1074/jbc.M111.242024; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; BENGTSSON G, 1980, BIOCHEM J, V189, P625, DOI 10.1042/bj1890625; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; Boren J, 2001, J BIOL CHEM, V276, P26916, DOI 10.1074/jbc.M011090200; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; Charriere S, 2011, J CLIN ENDOCR METAB, V96, pE1675, DOI 10.1210/jc.2011-1444; Coca-Prieto I, 2011, J INTERN MED, V270, P224, DOI 10.1111/j.1365-2796.2011.02361.x; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Gin P, 2011, ARTERIOSCL THROM VAS, V31, P176, DOI 10.1161/ATVBAHA.110.214718; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; HATA A, 1993, J BIOL CHEM, V268, P8447; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HIDE WA, 1992, J LIPID RES, V33, P167; Holmes RS, 2012, 3 BIOTECH, V2, P37, DOI 10.1007/s13205-011-0026-4; Holmes RS, 2011, COMP BIOCHEM PHYS D, V6, P224, DOI 10.1016/j.cbd.2011.04.003; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Lookene A, 2000, BIOCHEM BIOPH RES CO, V271, P15, DOI 10.1006/bbrc.2000.2530; Lookene A, 1997, BIOCHEMISTRY-US, V36, P5267, DOI 10.1021/bi962699k; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; MA YH, 1994, J LIPID RES, V35, P2049; Nyren Rakel, 2012, BMC Physiology, V12, P14, DOI 10.1186/1472-6793-12-14; Olivecrona G, 1997, METHOD ENZYMOL, V286, P102; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Olivecrona T, 1999, LIPOPROTEINS IN HEALTH AND DISEASE, P223; Olivecrona T, 2009, CELLULAR LIPID METABOLISM, P315, DOI 10.1007/978-3-642-00300-4_13; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plengpanich W, 2014, J BIOL CHEM, V289, P19491, DOI 10.1074/jbc.M114.558528; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rios JJ, 2012, J INHERIT METAB DIS, V35, P531, DOI 10.1007/s10545-011-9406-5; Robal T, 2012, J BIOL CHEM, V287, P29739, DOI 10.1074/jbc.M111.303529; Sendak RA, 1998, J LIPID RES, V39, P1310; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Voss CV, 2011, P NATL ACAD SCI USA, V108, P7980, DOI 10.1073/pnas.1100992108; Xiang SQ, 1999, J LIPID RES, V40, P1655; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Young SG, 2011, J LIPID RES, V52, P1869, DOI 10.1194/jlr.R018689; Zhou HX, 2013, CURR OPIN STRUC BIOL, V23, P887, DOI 10.1016/j.sbi.2013.06.014	51	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13919	13934		10.1074/jbc.M114.634626	http://dx.doi.org/10.1074/jbc.M114.634626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873395	Green Published, hybrid			2022-12-26	WOS:000355313000024
J	Jang, WG; Jeong, BC; Kim, EJ; Choi, H; Oh, SH; Kim, DK; Koo, SH; Choi, HS; Koh, JT				Jang, Won-Gu; Jeong, Byung-Chul; Kim, Eun-Jung; Choi, Hyuck; Oh, Sin-Hye; Kim, Don-Kyu; Koo, Seung-Hoi; Choi, Hueng-Sik; Koh, Jeong-Tae			Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor alpha in Osteoblast Differentiation by Stimulating Smad1 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; STRESS TRANSDUCER OASIS; NUCLEAR RECEPTOR SHP; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; TNF-ALPHA; INFLAMMATORY RESPONSE; TRANSCRIPTION FACTOR; CELLS; MECHANISMS	Endoplasmic reticulum (ER) stress transducers, such as old astrocyte specifically induced substance (OASIS) and activating transcription factor 6 (ATF6), which are induced by bone morphogenetic protein 2 (BMP2), regulate bone formation and osteoblast differentiation. Here, we examined the role of cAMP response element-binding protein H(CREBH), a member of the same family of ER membrane-bound basic leucine zipper (bZIP) transcription factors as OASIS and ATF6, in osteoblast differentiation and bone formation. Proinflammatory cytokine TNF alpha increased CREBH expression by up-regulating the nuclear factor-kappa B (NF-kappa B) signaling pathway in osteoblasts, increased the level of N-terminal fragment of CREBH in the nucleus, and inhibited BMP2 induction of osteoblast specific gene expression. Overexpression of CREBH suppressed BMP2-induced up-regulation of the osteogenic markers runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), and osteocalcin (OC) in MC3T3-E1 cells and primary osteoblasts, as well as BMP2-induced ALP activity and OC protein production. In contrast, knockdown of CREBH attenuated the inhibitory effect of TNF alpha on BMP2-induced osteoblast differentiation. Mechanistic studies revealed that CREBH increased the expression of Smad ubiquitination regulatory factor 1 (Smurf1), leading to ubiquitin-dependent degradation of Smad1, whereas knock-down of CREBH inhibited TNF alpha-mediated degradation of Smad1 by Smurf1. Consistent with these in vitro findings, administration of Ad-CREBH inhibited BMP2-induced ectopic and orthotopic bone formation in vivo. Taken together, these results suggest that CREBH is a novel negative regulator of osteoblast differentiation and bone formation.	[Jang, Won-Gu; Jeong, Byung-Chul; Kim, Eun-Jung; Choi, Hyuck; Oh, Sin-Hye; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Res Ctr Biomineralizat Disorders, Gwangju 500757, South Korea; [Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju 500757, South Korea; [Jang, Won-Gu] Daegu Univ, Sch Engn, Dept Biotechnol, Gyongsan 712714, South Korea; [Koo, Seung-Hoi] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, Seoul 136701, South Korea	Chonnam National University; Chonnam National University; Daegu University; Korea University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju 500757, South Korea.	hsc@chonnam.ac.kr; jtkoh@chonnam.ac.kr			National Research Foundation of Korea (NRF) - Korea government [MSIP 2011-0030121]; National Creative Research Initiatives from the NRF - Ministry of Science, ICT & Future Planning of the Korean government [20110018305]; NRF - Ministry of Education, Science and Technology [2014R1A1A2055844]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); National Creative Research Initiatives from the NRF - Ministry of Science, ICT & Future Planning of the Korean government; NRF - Ministry of Education, Science and Technology	This work was supported in part by grants from the National Research Foundation of Korea (NRF) funded by Korea government Grant MSIP 2011-0030121 (to J. T. K.) and National Creative Research Initiatives Grant 20110018305 from the NRF (funded by Ministry of Science, ICT & Future Planning of the Korean government) (to H. S. C.).; Supported by the Basic Science Research Program through the NRF funded by Ministry of Education, Science and Technology Grant 2014R1A1A2055844.	Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Chanda D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377978; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Huang RL, 2014, STEM CELLS DEV, V23, P277, DOI 10.1089/scd.2013.0345; Jang WG, 2011, BMB REP, V44, P735, DOI 10.5483/BMBRep.2011.44.11.735; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Jeong BC, 2010, J BONE MINER RES, V25, P262, DOI 10.1359/jbmr.090718; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kusumoto K, 2002, J INT MED RES, V30, P251, DOI 10.1177/147323000203000305; Lee AH, 2012, CURR OPIN LIPIDOL, V23, P141, DOI 10.1097/MOL.0b013e3283508fed; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; Lee KB, 2011, SPINE J, V11, P568, DOI 10.1016/j.spinee.2011.02.001; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ratanavaraporn J, 2012, BIOMATERIALS, V33, P304, DOI 10.1016/j.biomaterials.2011.09.050; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2014, ANAT SCI INT, V89, P11, DOI 10.1007/s12565-013-0214-x; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	45	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13556	13566		10.1074/jbc.M114.587923	http://dx.doi.org/10.1074/jbc.M114.587923			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25873397	hybrid, Green Published			2022-12-26	WOS:000354975700049
J	Pallan, PS; Wang, CX; Lei, L; Yoshimoto, FK; Auchus, RJ; Waterman, MR; Guengerich, FP; Egli, M				Pallan, Pradeep S.; Wang, Chunxue; Lei, Li; Yoshimoto, Francis K.; Auchus, Richard J.; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin			Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase STRUCTURE OF THE ENZYME.PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C-H BOND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYP21A2 MUTATIONS; PROGESTERONE; PURIFICATION; EXPRESSION; P450C17; DEFICIENCY; MICROSOMES; DEUTERIUM; SEQUENCE; SYSTEM	Cytochrome P450 (P450) 21A2 is the major steroid 21-hydroxylase, and deficiency of this enzyme is involved in similar to 95% of cases of human congenital adrenal hyperplasia, a disorder of adrenal steroidogenesis. A structure of the bovine enzyme that we published previously (Zhao, B., Lei, L., Kagawa, N., Sundaramoorthy, M., Banerjee, S., Nagy, L. D., Guengerich, F. P., and Waterman, M. R. (2012) Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants. J. Biol. Chem. 287, 10613-10622), containing two molecules of the substrate 17 alpha-hydroxyprogesterone, has been used as a template for understanding genetic deficiencies. We have now obtained a crystal structure of human P450 21A2 in complex with progesterone, a substrate in adrenal 21-hydroxylation. Substrate binding and release were fast for human P450 21A2 with both substrates, and pre-steady-state kinetics showed a partial burst but only with progesterone as substrate and not 17 alpha-hydroxyprogesterone. High intermolecular non-competitive kinetic deuterium isotope effects on both k(cat) and k(cat)/K-m, from 5 to 11, were observed with both substrates, indicative of rate-limiting C-H bond cleavage and suggesting that the juxtaposition of the C21 carbon in the active site is critical for efficient oxidation. The estimated rate of binding of the substrate progesterone (k(on) 2.4 x 10(7) M-1 s(-1)) is only similar to 2-fold greater than the catalytic efficiency (k(cat)/K-m = 1.3 x 10(7) M-1 s(-1)) with this substrate, sug-gesting that the rate of substrate binding may also be partially rate-limiting. The structure of the human P450 21A2-substrate complex provides direct insight into mechanistic effects of genetic variants.	[Pallan, Pradeep S.; Wang, Chunxue; Lei, Li; Yoshimoto, Francis K.; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; martin.egli@vanderbilt.edu	Wang, Chunxue/E-1840-2018	Wang, Chunxue/0000-0002-7462-9077; Yoshimoto, Francis/0000-0002-2308-2999	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596, R01GM103937] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Trisler for assistance in the preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source (Argonne, IL). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; Auchus RJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P134, DOI 10.1016/S0003-9861(02)00491-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billerbeck AEC, 1999, J CLIN ENDOCR METAB, V84, P2870, DOI 10.1210/jc.84.8.2870; Bratland E, 2009, J AUTOIMMUN, V33, P58, DOI 10.1016/j.jaut.2009.02.018; Daniels F., 1966, PHYS CHEM, P330; DIETER HH, 1982, BIOCHEM BIOPH RES CO, V105, P515, DOI 10.1016/0006-291X(82)91465-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A., 1999, STRUCTURE MECH PROTE, P164; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Haider S, 2013, P NATL ACAD SCI USA, V110, P2605, DOI 10.1073/pnas.1221133110; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kishimoto W, 2004, ENDOCRINOLOGY, V145, P699, DOI 10.1210/en.2003-1109; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; Kominami S, 2001, J BIOL CHEM, V276, P10753, DOI 10.1074/jbc.M006043200; Krissinel EB, 2004, ACTA CRYSTALLOGR D, V60, P2250, DOI 10.1107/S0907444904027167; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mizrachi D, 2011, BIOCHEMISTRY-US, V50, P3968, DOI 10.1021/bi102078e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Nunez BS, 1999, BIOCHEM BIOPH RES CO, V262, P635, DOI 10.1006/bbrc.1999.1271; Ohlsson G, 1999, HUM MUTAT, V13, P482, DOI 10.1002/(SICI)1098-1004(1999)13:6<482::AID-HUMU8>3.0.CO;2-0; OMURA T, 1964, J BIOL CHEM, V239, P2370; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; Tardy V, 2010, J CLIN ENDOCR METAB, V95, P1288, DOI 10.1210/jc.2009-1202; Therrell BL, 1998, PEDIATRICS, V101, P583, DOI 10.1542/peds.101.4.583; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; Yoshimoto FK, 2014, BIOCHEMISTRY-US, V53, P7531, DOI 10.1021/bi5011865; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Yu YG, 2011, GENET TEST MOL BIOMA, V15, P137, DOI 10.1089/gtmb.2010.0131; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	46	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13128	13143		10.1074/jbc.M115.646307	http://dx.doi.org/10.1074/jbc.M115.646307			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855791	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000354975700016
J	Jiang, HB; He, CG; Sheng, LX; Tang, ZH; Wen, Y; Yan, TT; Zou, CL				Jiang, Haibo; He, Chunguang; Sheng, Lianxi; Tang, Zhanhui; Wen, Yang; Yan, Tingting; Zou, Changlin			Hydrological Modelling for Siberian Crane Grus Leucogeranus Stopover Sites in Northeast China	PLOS ONE			English	Article							HABITAT SUITABILITY; FOREST RESTORATION; MOMOGE WETLAND; RIVER ESTUARY; CONSERVATION; POPULATION; TRENDS; BIRDS; BASIN; LAKE	Habitat loss is one of the key factors underlying the decline of many waterbird species, including Siberian Crane (Grus leucogeranus), a threatened species worldwide. Wetlands are the primary stopover for many waterbirds and restoration of these wetlands involves both hydrological restoration and water resource management. To protect the stopover sites of Siberian Cranes, we collected Siberian Crane stopover numbers, meteorological and hydrological data, and remote sensing data from 2008 to 2011 in Momoge National Nature Reserve, one of the largest wetlands in northeastern China. A model was developed to estimate the suitability of Siberian Crane stopover sites. According to our results, the most suitable daily water level for Siberian Cranes between 2008 and 2012 occurred in the spring of 2008 and in the Scirpus planiculmis growing season and autumn of 2010. We suggest a season-dependent water management strategy in order to provide suitable conditions at Siberian Crane stopover sites.	[Jiang, Haibo; He, Chunguang; Sheng, Lianxi; Tang, Zhanhui; Wen, Yang; Yan, Tingting] NE Normal Univ, Sch Environm, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China; [Zou, Changlin] Momoge Natl Nat Reserve Jilin, Zhenlai, Peoples R China	Northeast Normal University - China	He, CG (corresponding author), NE Normal Univ, Sch Environm, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China.	he-cg@nenu.edu.cn; shenglx@nenu.edu.cn			China National special funds of science and technology for control and remediation of water pollution [2012ZX07201-001-03]; Scientific Research Project - Special Funds of the State Environmental Protection Public Welfare Industry [2011467032]	China National special funds of science and technology for control and remediation of water pollution; Scientific Research Project - Special Funds of the State Environmental Protection Public Welfare Industry	This study was supported by the China National special funds of science and technology for control and remediation of water pollution (Project NO. 2012ZX07201-001-03) and the Scientific Research Project Sponsored by Special Funds of the State Environmental Protection Public Welfare Industry (Project NO. 2011467032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BirdLife International, IUCN RED LIST THREAT; Bysykatova IP, 2010, CONTEMP PROBL ECOL, V3, P86, DOI 10.1134/S1995425510010145; Cai TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089913; Convertino M, 2011, ECOL ENG, V37, P1184, DOI 10.1016/j.ecoleng.2011.02.019; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Cui BS, 2009, J NAT CONSERV, V17, P129, DOI 10.1016/j.jnc.2009.01.003; Debeljak M, 2001, ECOL MODEL, V138, P321, DOI 10.1016/S0304-3800(00)00411-7; Desgranges JL, 2006, ENVIRON MONIT ASSESS, V113, P329, DOI 10.1007/s10661-005-9087-3; Dong ZY, 2013, ECOL ENG, V55, P94, DOI 10.1016/j.ecoleng.2013.02.006; Gabbe AP, 2002, CONSERV BIOL, V16, P462, DOI 10.1046/j.1523-1739.2002.00460.x; Gaines WL, 2007, RESTOR ECOL, V15, P670, DOI 10.1111/j.1526-100X.2007.00279.x; Gilbert AJ, 2004, REG ENVIRON CHANGE, V4, P118, DOI 10.1007/s10113-004-0071-1; Gray A, 2002, RESTOR ECOL, V10, P514, DOI 10.1046/j.1526-100X.2002.01039.x; Hamel PB, 2003, FORESTRY, V76, P189, DOI 10.1093/forestry/76.2.189; He CG, 2002, BIO SCI, V3, P286; He CG, 2009, HYDROL PROCESS, V23, P612, DOI 10.1002/hyp.7189; Jia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065843; Kanai Y, 2002, BIOL CONSERV, V106, P339, DOI 10.1016/S0006-3207(01)00259-2; Kang XG, 1993, CHIN B BOT, V35, P466; Khan MA, 2004, RESTOR ECOL, V9, P125; Konisky RA, 2006, RESTOR ECOL, V14, P516, DOI 10.1111/j.1526-100X.2006.00163.x; Li Fengshan, 2012, Chinese Birds, V3, P180; Liu Chun-Yue, 2013, Chinese Journal of Zoology, V48, P382; Ma ZJ, 2009, ENVIRON MANAGE, V43, P1187, DOI 10.1007/s00267-008-9247-7; MacGregor-Fors I, 2010, ECOL ENG, V36, P1492, DOI 10.1016/j.ecoleng.2010.06.001; Majer JD, 2009, RESTOR ECOL, V17, P315, DOI 10.1111/j.1526-100X.2009.00528.x; Min Q, 2005, ADV SCI TEC WAT RESO, V25, P17; Mitsch WJ, 2005, ECOL ENG, V24, P243, DOI 10.1016/j.ecoleng.2005.02.006; Mitsch WJ, 2006, ECOL ENG, V26, P55, DOI 10.1016/j.ecoleng.2005.09.005; Ortega-Alvarez R, 2013, ECOL ENG, V53, P275, DOI 10.1016/j.ecoleng.2012.12.058; Passell HD, 2000, RESTOR ECOL, V8, P112, DOI 10.1046/j.1526-100x.2000.80017.x; Phurba L, 2009, FORKTAIL, V25, P125; Shokoohi A, 2011, HYDROL PROCESS, V25, P3490, DOI 10.1002/hyp.8076; Sun YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098690; Twedt DJ, 2006, CONSERV BIOL, V20, P100, DOI 10.1111/j.1523-1739.2005.00303.x; Wang XY, 2010, ENVIRON MONIT ASSESS, V161, P271, DOI 10.1007/s10661-008-0744-1; Wang Y, 2013, CHINESE GEOGR SCI, V23, P708, DOI 10.1007/s11769-013-0641-6; Xiang Gui-quang, 2010, Dongbei Shida Xuebao (Ziran Kexue Ban), V42, P126; Yan DH, 2012, HYDROL EARTH SYST SC, V16, P2469, DOI 10.5194/hess-16-2469-2012	39	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122687	10.1371/journal.pone.0122687	http://dx.doi.org/10.1371/journal.pone.0122687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874552	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800071
J	Bennion, BJ; Essiz, SG; Lau, EY; Fattebert, JL; Emigh, A; Lightstone, FC				Bennion, Brian J.; Essiz, Sebnem G.; Lau, Edmond Y.; Fattebert, Jean-Luc; Emigh, Aiyana; Lightstone, Felice C.			A Wrench in the Works of Human Acetylcholinesterase: Soman Induced Conformational Changes Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							ACTIVE-SITE GORGE; X-RAY CRYSTALLOGRAPHY; BACK DOOR HYPOTHESIS; CRYSTAL-STRUCTURES; TORPEDO-CALIFORNICA; PRODUCT CLEARANCE; SUBSTRATE; MECHANISM; BINDING; PROTEIN	Irreversible inactivation of human acetylcholinesterase (hAChE) by organophosphorous pesticides (OPs) and chemical weapon agents (CWA) has severe morbidity and mortality consequences. We present data from quantum mechanics/molecular mechanics (QM/MM) and 80 classical molecular dynamics (MD) simulations of the apo and soman-adducted forms of hAChE to investigate the effects on the dynamics and protein structure when the catalytic Serine 203 is phosphonylated. We find that the soman phosphonylation of the active site Ser203 follows a water assisted addition-elimination mechanism with the elimination of the fluoride ion being the highest energy barrier at 6.5 kcal/mole. We observe soman-dependent changes in backbone and sidechain motions compared to the apo form of the protein. These alterations restrict the soman-adducted hAChE to a structural state that is primed for the soman adduct to be cleaved and removed from the active site. The altered motions and resulting structures provide alternative pathways into and out of the hAChE active site. In the soman-adducted protein both side and back door pathways are viable for soman adduct access. Correlation analysis of the apo and soman adducted MD trajectories shows that the correlation of gorge entrance and back door motion is disrupted when hAChE is adducted. This supports the hypothesis that substrate and product can use two different pathways as entry and exit sites in the apo form of the protein. These alternative pathways have important implications for the rational design of medical countermeasures.	[Bennion, Brian J.; Lau, Edmond Y.; Emigh, Aiyana; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Essiz, Sebnem G.] Kadir Has Univ, Fac Engn & Nat Sci, Bioinformat & Genet Dept, Istanbul 34083, Turkey; [Fattebert, Jean-Luc] Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Kadir Has University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lightstone, FC (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, 7000 East Ave, Livermore, CA 94550 USA.	Lightstone@llnl.gov	Emigh, Aiyana/AAD-2851-2019	Lau, Edmond/0000-0003-0619-7249; Essiz, Sebnem/0000-0002-5476-4722; Fattebert, Jean-Luc/0000-0002-1455-6160	United States Army Medical Research Institute of Chemical Defense [MIPR1AAAM10158]; Department of Energy STEM Teacher and Researcher program AE	United States Army Medical Research Institute of Chemical Defense; Department of Energy STEM Teacher and Researcher program AE(United States Department of Energy (DOE))	United States Army Medical Research Institute of Chemical Defense (MIPR1AAAM10158) BJB, SGE, JLF, EL, and FCL, and Department of Energy STEM Teacher and Researcher program AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisaraie L, 2006, J MOL MODEL, V12, P348, DOI 10.1007/s00894-005-0051-5; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Ariel N, 1998, BIOCHEM J, V335, P95, DOI 10.1042/bj3350095; Artursson E, 2013, BIOCHEM PHARMACOL, V85, P1389, DOI 10.1016/j.bcp.2013.01.016; Bai F, 2013, P NATL ACAD SCI USA, V110, P4273, DOI 10.1073/pnas.1301814110; Bartolucci C, 1999, BIOCHEMISTRY-US, V38, P5714, DOI 10.1021/bi982723p; BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019; Beck JM, 2010, CHEM-BIOL INTERACT, V187, P220, DOI 10.1016/j.cbi.2010.02.012; Bennion B.J., 2013, MIL MED SCI LETT, V8, P102, DOI [10.31482/mmsl.2013.015, DOI 10.31482/MMSL.2013.015]; Bennion BJ, 2004, BIOCHEMISTRY-US, V43, P12955, DOI 10.1021/bi0486379; Bennion BJ, 2004, P NATL ACAD SCI USA, V101, P6433, DOI 10.1073/pnas.0308633101; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Boyd AE, 2004, J BIOL CHEM, V279, P26612, DOI 10.1074/jbc.M401482200; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bui JM, 2003, BIOPHYS J, V85, P2267, DOI 10.1016/S0006-3495(03)74651-7; Carletti E, 2008, J AM CHEM SOC, V130, P16011, DOI 10.1021/ja804941z; Case DA, 2012, AMBER12 AND AMBER TO; Colletier JP, 2007, ACTA CRYSTALLOGR D, V63, P1115, DOI 10.1107/S0907444907044472; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Dolgin E, 2013, NAT MED, V19, P1194, DOI 10.1038/nm1013-1194; Dvir H, 2002, BIOCHEMISTRY-US, V41, P10810, DOI 10.1021/bi020151+; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; Faerman C, 1996, FEBS LETT, V386, P65, DOI 10.1016/0014-5793(96)00374-2; Fang L, 2011, J PHYS CHEM B, V115, P8797, DOI 10.1021/jp112030p; Fattebert JL, 2009, J CHEM THEORY COMPUT, V5, P2257, DOI 10.1021/ct900209y; Fattebert JL, 2004, COMPUT PHYS COMMUN, V162, P24, DOI 10.1016/j.cpc.2004.06.068; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fuxreiter M, 1998, J AM CHEM SOC, V120, P183, DOI 10.1021/ja972326m; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Gora A, 2013, CHEM REV, V113, P5871, DOI 10.1021/cr300384w; Greenblatt HM, 2004, J AM CHEM SOC, V126, P15405, DOI 10.1021/ja0466154; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Habtemariam B, 2005, NUCLEIC ACIDS RES, V33, P4212, DOI 10.1093/nar/gki724; Hornberg A, 2010, BIOCHEM PHARMACOL, V79, P507, DOI 10.1016/j.bcp.2009.08.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kovach IM, 2004, J PHYS ORG CHEM, V17, P602, DOI 10.1002/poc.778; Kovarik Z, 1999, BBA-PROTEIN STRUCT M, V1433, P261, DOI 10.1016/S0167-4838(99)00124-7; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; KRONMAN C, 1994, J BIOL CHEM, V269, P27819; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; LARSSON L, 1957, ACTA CHEM SCAND, V11, P1131, DOI 10.3891/acta.chem.scand.11-1131; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Liu JJ, 2009, J PHYS CHEM B, V113, P16226, DOI 10.1021/jp9055335; Luo CY, 2010, BIOCHEM PHARMACOL, V80, P1427, DOI 10.1016/j.bcp.2010.07.020; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; Masson P, 2011, TOXICOL LETT, V206, P5, DOI 10.1016/j.toxlet.2011.04.006; McCammon JA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-4; MICHEL HO, 1967, ARCH BIOCHEM BIOPHYS, V121, P29, DOI 10.1016/0003-9861(67)90006-9; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Millard CB, 1999, J AM CHEM SOC, V121, P9883, DOI 10.1021/ja992704i; Munoz FJ, 1999, NEUROREPORT, V10, P3621, DOI 10.1097/00001756-199911260-00029; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Niu CY, 2005, J PHYS CHEM B, V109, P23730, DOI 10.1021/jp0552877; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Peters J, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4825199; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porschke D, 1996, BIOPHYS J, V70, P1603, DOI 10.1016/S0006-3495(96)79759-X; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RADIC Z, 1991, MOL PHARMACOL, V39, P98; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; Sanson B, 2009, J MED CHEM, V52, P7593, DOI 10.1021/jm900433t; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; SHAFFERMAN A, 1994, EMBO J, V13, P3448, DOI 10.1002/j.1460-2075.1994.tb06650.x; Silva GR, 2012, QUIM NOVA, V35, P2083, DOI 10.1590/S0100-40422012001000033; Sirin GS, 2014, THE JOURNAL OF PHYSI; Sirin GS, 2012, J PHYS CHEM B, V116, P12199, DOI 10.1021/jp307790v; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stone J, 1998, EFFICIENT LIBRARY FO; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; TAN RC, 1993, BIOCHEMISTRY-US, V32, P401, DOI 10.1021/bi00053a003; Trapp M, 2012, THE JOURNAL OF PHYSI; Van Belle D, 2000, J MOL BIOL, V298, P705, DOI 10.1006/jmbi.2000.3698; Viragh C, 1999, BIOCHEMISTRY-US, V38, P9557, DOI 10.1021/bi991112+; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WILSON IB, 1961, J BIOL CHEM, V236, P2292; Wlodek ST, 2000, BIOPOLYMERS, V53, P265, DOI 10.1002/(SICI)1097-0282(200003)53:3<265::AID-BIP6>3.3.CO;2-E; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Worek F, 2013, PHARMACOL THERAPEUT, V139, P249, DOI 10.1016/j.pharmthera.2013.04.009; Xu YC, 2003, J AM CHEM SOC, V125, P11340, DOI 10.1021/ja029775t; Xu YC, 2008, BIOPHYS J, V95, P2500, DOI 10.1529/biophysj.108.129601; Xu YC, 2008, PROTEIN SCI, V17, P601, DOI 10.1110/ps.083453808; Xu YC, 2010, BIOPHYS J, V99, P4003, DOI 10.1016/j.bpj.2010.10.047; Zhao Y, 2005, J PHYS CHEM A, V109, P2012, DOI 10.1021/jp045141s; Zhou HX, 1998, P NATL ACAD SCI USA, V95, P9280, DOI 10.1073/pnas.95.16.9280; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	93	25	26	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121092	10.1371/journal.pone.0121092	http://dx.doi.org/10.1371/journal.pone.0121092			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874456	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100035
J	Zheng, YZ; Cao, X; Wen, J; Yang, H; Luo, KJ; Liu, QW; Huang, QY; Chen, JY; Fu, JH				Zheng, Yuzhen; Cao, Xun; Wen, Jing; Yang, Hong; Luo, Kongjia; Liu, Qianwen; Huang, Qingyuan; Chen, Junying; Fu, Jianhua			Smoking Affects Treatment Outcome in Patients with Resected Esophageal Squamous Cell Carcinoma Who Received Chemotherapy	PLOS ONE			English	Article							EPIDEMIOLOGIC EVIDENCE; CIGARETTE-SMOKING; ALCOHOL-DRINKING; CANCER PROGNOSIS; TOBACCO SMOKING; GASTRIC-CANCER; SURVIVAL; NICOTINE; RISK; CHEMORADIOTHERAPY	Background Cigarette smoking is reported to decrease survival and induce chemotherapy resistance in patients with various cancers. However, the impact of cigarette smoking on patients with esophageal squamous cell carcinoma (ESCC) remains unknown. Methods A total of 1,084 ESCC patients were retrospectively enrolled from a southern Chinese institution. Patients were divided into two groups according to their treatment modalities: the SC group (surgery with chemotherapy) (n = 306) and the S group (surgery without chemotherapy) (n = 778). Smoking status was quantified as smoking history (non-smoker, ex-smoker, and current smoker) and cumulative smoking (0, between 0 and 20, and greater than 20 pack-years). The association between cigarette smoking and overall survival (OS) was evaluated using the Kaplan-Meier method and univariate/multivariate regression analysis. Results Among 1,084 patients, 702 (64.8%) reported a cigarette smoking history, and the 5-year OS for non-smokers and smokers was 45.8% and 37.3%, respectively. In the SC group, compared with non-smoker, the adjusted HRs of ex-smoker and current smoker were 1.540 (95% CI, 1.1-2.2) and 2.110 (95% CI, 1.4-3.1), respectively; there is a correlative trend of decreased OS with increased cigarette smoking (P-trend = 0.001). These associations were insignificant in the S group. In subgroup analysis of the SC group, the lower OS conferred by smoking was not significantly modified by age, gender, body mass index, alcohol drinking, or chemotherapy method (chemotherapy and chemoradiotherapy). Conclusion Our results suggest that smoking may affect treatment outcome in patients with resected ESCC who received chemotherapy.	[Zheng, Yuzhen; Yang, Hong; Luo, Kongjia; Liu, Qianwen; Huang, Qingyuan; Chen, Junying; Fu, Jianhua] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Xun] Sun Yat Sen Univ, Ctr Canc, Dept Intens Care Unit, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Jing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yuzhen; Wen, Jing; Yang, Hong; Luo, Kongjia; Liu, Qianwen; Huang, Qingyuan; Chen, Junying; Fu, Jianhua] Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Fu, JH (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Thorac Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510275, Guangdong, Peoples R China.	fu_jianhua@126.com	wen, jing/HDM-2205-2022		Chinese Ministry of Health Key Program [179]; National Natural Science Foundation of China [81272635]	Chinese Ministry of Health Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Chinese Ministry of Health Key Program (grant number 179) and National Natural Science Foundation of China General Program (grant number 81272635).	Aksoy S, 2007, BREAST J, V13, P431, DOI 10.1111/j.1524-4741.2007.00459.x; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Castellsague X, 1999, INT J CANCER, V82, P657, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;657::AID-IJC7&gt;3.0.CO;2-C; Chen RJ, 2010, TOXICOL SCI, V115, P118, DOI 10.1093/toxsci/kfq028; Cooke JP, 2004, ANN MED, V36, P33, DOI 10.1080/07853890310017576; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Edge SB, 2010, AJCC CANC STAGING MA, P67; FOUNTZILAS G, 1992, ANN ONCOL, V3, P553, DOI 10.1093/oxfordjournals.annonc.a058260; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Han MA, 2013, CANCER EPIDEM BIOMAR, V22, P1805, DOI 10.1158/1055-9965.EPI-13-0385; Ji XM, 2011, INT J CANCER, V129, P724, DOI 10.1002/ijc.25696; Jiang JM, 2006, INT J CANCER, V119, P1427, DOI 10.1002/ijc.21887; JOHNSTONEARLY A, 1980, JAMA-J AM MED ASSOC, V244, P2175, DOI 10.1001/jama.244.19.2175; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Kofoed SC, 2012, SCAND J SURG, V101, P26, DOI 10.1177/145749691210100106; Liu JG, 2012, ANN THORAC SURG, V93, P423, DOI 10.1016/j.athoracsur.2011.10.011; Liu Y, 2011, WORLD J GASTROENTERO, V17, P2674, DOI 10.3748/wjg.v17.i21.2674; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Mariette C, 2014, J CLIN ONCOL; Oze I, 2012, JPN J CLIN ONCOL, V42, P63, DOI 10.1093/jjco/hyr170; Rice TW, 2009, DIS ESOPHAGUS, V22, P1, DOI 10.1111/j.1442-2050.2008.00901.x; Seibold P, 2014, CANCER EPIDEMIOL, V38, P419, DOI 10.1016/j.canep.2014.05.006; Sharp L, 2014, CANCER EPIDEMIOL BIO; Shitara K, 2010, CANCER SCI, V101, P1001, DOI 10.1111/j.1349-7006.2009.01466.x; Tsao AS, 2006, CANCER, V106, P2428, DOI 10.1002/cncr.21884; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wakai K, 2006, JPN J CLIN ONCOL, V36, P309, DOI 10.1093/jjco/hyl025; Walter V, 2014, ANN ONCOL, V25, P1517, DOI 10.1093/annonc/mdu040; Wang S, 2013, J THORAC ONCOL, V8, P719, DOI 10.1097/JTO.0b013e31828b51d4; Wang ZW, 2014, NEOPLASMA, V61, P732, DOI 10.4149/neo_2014_089; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yaegashi Y, 2014, ASIAN PAC J CANCER P, V15, P1023, DOI 10.7314/APJCP.2014.15.2.1023; Yoshioka A, 2008, ONCOL REP, V19, P1099; Zhang F, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-249; Zhang SS, 2013, DIS ESOPHAGUS	37	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123246	10.1371/journal.pone.0123246	http://dx.doi.org/10.1371/journal.pone.0123246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874561	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100154
J	Bojovic, O; Panja, D; Bittins, M; Bramham, CR; Tjolsen, A				Bojovic, Ognjen; Panja, Debabrata; Bittins, Margarethe; Bramham, Clive R.; Tjolsen, Arne			Time Course of Immediate Early Gene Protein Expression in the Spinal Cord following Conditioning Stimulation of the Sciatic Nerve in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DORSAL-HORN; FOS EXPRESSION; SYNAPTIC PLASTICITY; LASTING ALLODYNIA; DYNORPHIN-A; LTP; ZIF268; ARC; CONSOLIDATION	Long-term potentiation induced by conditioning electrical stimulation of afferent fibers is a widely studied form of synaptic plasticity in the brain and the spinal cord. In the spinal cord dorsal horn, long-term potentiation is induced by a series of high-frequency trains applied to primary afferent fibers. Conditioning stimulation (CS) of sciatic nerve primary afferent fibers also induces expression of immediate early gene proteins in the lumbar spinal cord. However, the time course of immediate early gene expression and the rostral-caudal distribution of expression in the spinal cord have not been systematically studied. Here, we examined the effects of sciatic nerve conditioning stimulation (10 stimulus trains, 0.5 ms stimuli, 7.2 mA, 100 Hz, train duration 2 s, 8 s intervals between trains) on cellular expression of immediate early genes, Arc, c-Fos and Zif268, in anesthetized rats. Immunohistochemical analysis was performed on sagittal sections obtained from Th13-L5 segments of the spinal cord at 1, 2, 3, 6 and 12 h post-CS. Strikingly, all immediate early genes exhibited a monophasic increase in expression with peak increases detected in dorsal horn neurons at 2 hours post-CS. Regional analysis showed peak increases at the location between the L3 and L4 spinal segments. Both Arc, c-Fos and Zif268 remained significantly elevated at 2 hours, followed by a sharp decrease in immediate early gene expression between 2 and 3 hours post-CS. Colocalization analysis performed at 2 hours post-CS showed that all c-Fos and Zif268 neurons were positive for Arc, while 30% and 43% of Arc positive neurons were positive for c-Fos and Zif268, respectively. The present study identifies the spinal cord level and time course of immediate early gene (IEGP) expression of relevance for analysis of IEGPs function in neuronal plasticity and nociception.	[Bojovic, Ognjen; Panja, Debabrata; Bittins, Margarethe; Bramham, Clive R.; Tjolsen, Arne] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Bojovic, O (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	ognjen.bojovic@biomed.uib.no	Bramham, Clive/Q-1854-2018; Panja, Debabrata/E-8595-2010	Bramham, Clive/0000-0001-5958-7115; Panja, Debabrata/0000-0003-4774-1167	University of Bergen, Dept. of Biomedicine	University of Bergen, Dept. of Biomedicine	The University of Bergen, Dept. of Biomedicine, is financing the Ph.D. project of Ognjen Bojovic who is employeed as a Ph.D. student (www.uib.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Ahmad Asma Hayati, 2002, Malays J Med Sci, V9, P3; Bliss T. V., 2007, HIPPOCAMPUS BOOK; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; COGHILL RC, 1993, J NEUROPHYSIOL, V69, P703, DOI 10.1152/jn.1993.69.3.703; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Dolan S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-91; Gill KM, 2007, NEUROBIOL LEARN MEM, V87, P583, DOI 10.1016/j.nlm.2006.12.011; GOBEL S, 1979, BRAIN RES, V175, P335, DOI 10.1016/0006-8993(79)91012-6; Haugan F, 2008, NEUROSCIENCE, V154, P1568, DOI 10.1016/j.neuroscience.2008.05.010; Hossaini M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-43; Hu NW, 2003, J NEUROPHYSIOL, V89, P2354, DOI 10.1152/jn.01027.2002; Hughes DI, 2013, NEUROSCIENCE, V237, P7, DOI 10.1016/j.neuroscience.2013.01.028; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Ko SW, 2005, J PAIN, V6, P12, DOI 10.1016/j.jpain.2004.10.001; Korb E, 2013, NAT NEUROSCI, V16, P874, DOI 10.1038/nn.3429; Langlet C, 2001, BRAIN RES, V905, P72, DOI 10.1016/S0006-8993(01)02507-0; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Liang FY, 1996, BRAIN RES, V729, P246, DOI 10.1016/0006-8993(96)00552-5; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Liu YP, 2013, MED HYPOTHESES, V81, P192, DOI 10.1016/j.mehy.2013.05.006; MAO JR, 1992, PAIN, V50, P89, DOI 10.1016/0304-3959(92)90116-S; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; MUNGLANI R, 1995, BRIT J ANAESTH, V75, P186, DOI 10.1093/bja/75.2.186; Nyberg F, 1995, NEUROPEPTIDES SPINAL; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; RICHTER D, 2001, CELL POLARITY SUBCEL; Rodriguez JJ, 2008, J CELL MOL MED, V12, P671, DOI 10.1111/j.1582-4934.2007.00105.x; Rygh LJ, 2006, EUR J NEUROSCI, V24, P761, DOI 10.1111/j.1460-9568.2006.04968.x; Sandkuhler J, 2007, LONG TERM POTENTIATI, P1058; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Svendsen F, 1997, NEUROREPORT, V8, P3427, DOI 10.1097/00001756-199711100-00002; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Waibl H, 1973, ADV ANATOMY EMBRIOLO; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; Zou X, 2001, NEUROSCIENCE, V106, P171, DOI 10.1016/S0306-4522(01)00175-0	46	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123604	10.1371/journal.pone.0123604	http://dx.doi.org/10.1371/journal.pone.0123604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860146	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300105
J	Falcone, M; Russo, A; Giannella, M; Cangemi, R; Scarpellini, MG; Bertazzoni, G; Alarcon, JM; Taliani, G; Palange, P; Farcomeni, A; Vestri, A; Bouza, E; Violi, F; Venditti, M				Falcone, Marco; Russo, Alessandro; Giannella, Maddalena; Cangemi, Roberto; Scarpellini, Maria Gabriella; Bertazzoni, Giuliano; Martinez Alarcon, Jose; Taliani, Gloria; Palange, Paolo; Farcomeni, Alessio; Vestri, Annarita; Bouza, Emilio; Violi, Francesco; Venditti, Mario			Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia	PLOS ONE			English	Article							CARE-ASSOCIATED PNEUMONIA; HEALTH; MANAGEMENT; SURVEILLANCE; INFECTIONS; GUIDELINES; CRITERIA; OUTCOMES; SCORE	Introduction The diffusion of multidrug-resistant (MDR) bacteria has created the need to identify risk factors for acquiring resistant pathogens in patients living in the community. Objective To analyze clinical features of patients with community-onset pneumonia due to MDR pathogens, to evaluate performance of existing scoring tools and to develop a bedside risk score for an early identification of these patients in the Emergency Department. Patients and Methods This was an open, observational, prospective study of consecutive patients with pneumonia, coming from the community, from January 2011 to January 2013. The new score was validated on an external cohort of 929 patients with pneumonia admitted in internal medicine departments participating at a multicenter prospective study in Spain. Results A total of 900 patients were included in the study. The final logistic regression model consisted of four variables: 1) one risk factor for HCAP, 2) bilateral pulmonary infiltration, 3) the presence of pleural effusion, and 4) the severity of respiratory impairment calculated by use of PaO2/FiO(2) ratio. A new risk score, the ARUC score, was developed; compared to Aliberti, Shorr, and Shindo scores, this point score system has a good discrimination performance (AUC 0.76, 95% CI 0.71-0.82) and calibration (Hosmer-Lemeshow, chi(2) = 7.64; p = 0.469). The new score outperformed HCAP definition in predicting etiology due to MDR organism. The performance of this bedside score was confirmed in the validation cohort (AUC 0.68, 95% CI 0.60-0.77). Conclusion Physicians working in ED should adopt simple risk scores, like ARUC score, to select the most appropriate antibiotic regimens. This individualized approach may help clinicians to identify those patients who need an empirical broad-spectrum antibiotic therapy.	[Falcone, Marco; Russo, Alessandro; Palange, Paolo; Venditti, Mario] Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Falcone, Marco; Scarpellini, Maria Gabriella; Bertazzoni, Giuliano] Univ Roma La Sapienza, Policlin Umberto I, Dept Emergency Med, I-00185 Rome, Italy; [Giannella, Maddalena] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Infect Dis Unit, St Orsola Malpighi Hosp, Bologna, Italy; [Cangemi, Roberto; Violi, Francesco] Univ Roma La Sapienza, Policlin Umberto I, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Martinez Alarcon, Jose] Gen Hosp, Dept Microbiol, Ciudad Real, Spain; [Taliani, Gloria] Univ Roma La Sapienza, Policlin Umberto I, Dept Clin Med, I-00185 Rome, Italy; [Farcomeni, Alessio; Vestri, Annarita] Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, Stat Sect, I-00185 Rome, Italy; [Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain	Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; General University Gregorio Maranon Hospital	Falcone, M (corresponding author), Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marcofalc@libero.it	Torres, OH/D-2215-2012; GIANNELLA, MADDALENA/K-9090-2016; Violi, Francesco/K-1509-2016; RUSSO, ALESSANDRO/K-5381-2016; Bouza, Emilio/D-8661-2014; Falcone, Marco/K-7614-2016; Farcomeni, Alessio/K-8719-2016	Torres, OH/0000-0002-0305-8211; GIANNELLA, MADDALENA/0000-0001-8273-7601; Violi, Francesco/0000-0002-6610-7068; RUSSO, ALESSANDRO/0000-0003-3846-4620; Bouza, Emilio/0000-0001-6967-9267; Falcone, Marco/0000-0003-3813-8796; Farcomeni, Alessio/0000-0002-7104-5826; VENDITTI, Mario/0000-0003-2639-0281; Cangemi, Roberto/0000-0002-4097-2061	Programa de Centros de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias [CB06/06/0058]	Programa de Centros de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias	The ENEMI-II study was partially supported by the Programa de Centros de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias CB06/06/0058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Aliberti S, 2013, THORAX; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Corrao S, 2014, CLIN INFECT DIS; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ewig S, 2012, CURR OPIN INFECT DIS, V25, P166, DOI 10.1097/QCO.0b013e32835023fb; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Falcone M, 2014, THORAX; Falcone M, 2012, INTERN EMERG MED, V7, P523, DOI 10.1007/s11739-012-0795-8; Falcone M, 2012, INTERN EMERG MED, V7, P415, DOI 10.1007/s11739-012-0796-7; Falcone M, 2011, INT J INFECT DIS, V15, pE545, DOI 10.1016/j.ijid.2011.04.005; Falcone M, 2011, INTERN EMERG MED, V6, P431, DOI 10.1007/s11739-011-0521-y; Falcone M, 2011, LANCET INFECT DIS, V11, P11, DOI 10.1016/S1473-3099(10)70301-7; Giannella M, 2012, CLIN MICROBIOL INFEC, V18, P786, DOI 10.1111/j.1469-0691.2011.03757.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Khawaja A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-94; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maruyama T, 2013, CLIN INFECT DIS, V57, P1373, DOI 10.1093/cid/cit571; Orsi GB, 2011, EXPERT REV ANTI-INFE, V9, P653, DOI [10.1586/ERI.11.77, 10.1586/eri.11.77]; Russo A, 2013, INTERN EMERG MED; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shorr AF, 2008, ARCH INTERN MED, V168, P2205, DOI 10.1001/archinte.168.20.2205; Shorr AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-268; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; VISSER MR, 1992, EUR J CLIN MICROBIOL, V11, P979, DOI 10.1007/BF01967786; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	28	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119528	10.1371/journal.pone.0119528	http://dx.doi.org/10.1371/journal.pone.0119528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860142	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300007
J	He, F; Nie, WC; Tong, ZT; Yuan, SM; Gong, T; Liao, Y; Bi, EF; Gao, XD				He, Fei; Nie, Wen-Chao; Tong, Zongtian; Yuan, Si-Min; Gong, Ting; Liao, Yuan; Bi, Erfei; Gao, Xiang-Dong			The GTPase-Activating Protein Rga1 Interacts with Rho3 GTPase and May Regulate Its Function in Polarized Growth in Budding Yeast	PLOS ONE			English	Article							RAS SUPERFAMILY GENES; SACCHAROMYCES-CEREVISIAE; SNARE COMPLEX; CELL POLARIZATION; CDC42P GTPASE; SEPTIN RING; EXOCYTOSIS; FAMILY; DISTINCT; EXOCYST	In budding yeast, Rga1 negatively regulates the Rho GTPase Cdc42 by acting as a GTPase-activating protein (GAP) for Cdc42. To gain insight into the function and regulation of Rga1, we overexpressed Rga1 and an N-terminally truncated Rga1-C538 (a.a. 538-1007) segment. Overexpression of Rga1-C538 but not full-length Rga1 severely impaired growth and cell morphology in wild-type cells. We show that Rga1 is phosphorylated during the cell cycle. The lack of phenotype for full-length Rga1 upon overexpression may result from a negative regulation by G1-specific Pho85, a cyclin-dependent kinase (CDK). From a high-copy suppressor screen, we isolated RHO3, SEC9, SEC1, SSO1, SSO2, and SRO7, genes involved in exocytosis, as suppressors of the growth defect caused by Rga1-C538 overexpression. Moreover, we detected that Rga1 interacts with Rho3 in two-hybrid and bimolecular fluorescence complementation (BiFC) assays. Rga1 preferentially interacts with the GTP-bound form of Rho3 and the interaction requires the GAP domain and additional sequence upstream of the GAP domain. Our data suggest that the interaction of Rga1 with Rho3 may regulate Rho3's function in polarized bud growth.	[He, Fei; Nie, Wen-Chao; Yuan, Si-Min; Gong, Ting; Liao, Yuan; Gao, Xiang-Dong] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China; [Gao, Xiang-Dong] Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China; [Tong, Zongtian; Bi, Erfei] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Wuhan University; University of Pennsylvania; Pennsylvania Medicine	Gao, XD (corresponding author), Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324	National Natural Science Foundation of China [30871347, 31370124]; National Institutes of Health [GM59216]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2014-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Infrastructure of Natural Resources for Science and Technology Program of China	work was supported by the National Natural Science Foundation of China (grant no. 30871347 and 31370124) to XDG, and by the National Institutes of Health (grant GM59216) to EB, and by National Infrastructure of Natural Resources for Science and Technology Program of China (no. NIMR-2014-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Aguilar RC, 2006, P NATL ACAD SCI USA, V103, P4116, DOI 10.1073/pnas.0510513103; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bi EF, 1996, MOL CELL BIOL, V16, P5264; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Chen GC, 1996, MOL CELL BIOL, V16, P1376; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Doignon F, 1999, FEBS LETT, V459, P458, DOI 10.1016/S0014-5793(99)01293-4; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gong T, 2013, EUKARYOT CELL, V12, P368, DOI 10.1128/EC.00277-12; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; James P, 1996, GENETICS, V144, P1425; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; MATSUI Y, 1992, GENE, V114, P43, DOI 10.1016/0378-1119(92)90705-T; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Prouzet-Mauleon V, 2008, J BIOL CHEM, V283, P33249, DOI 10.1074/jbc.M805161200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Rose A H, 1975, Methods Cell Biol, V12, P1; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Smith GR, 2002, EUKARYOT CELL, V1, P469, DOI 10.1128/EC.1.3.469-480.2002; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; STEVENSON BJ, 1995, GENE DEV, V9, P2949, DOI 10.1101/gad.9.23.2949; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; ZHENG Y, 1994, J BIOL CHEM, V269, P2369; ZHENG Y, 1993, J BIOL CHEM, V268, P24629	53	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123326	10.1371/journal.pone.0123326	http://dx.doi.org/10.1371/journal.pone.0123326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860339	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300093
J	Kashou, NH; Zampini, AR				Kashou, Nasser H.; Zampini, Angelica R.			Oculomotor Neurocircuitry, a Structural Connectivity Study of Infantile Nystagmus Syndrome	PLOS ONE			English	Article							RETICULARIS TEGMENTI-PONTIS; DOMINANT CONGENITAL NYSTAGMUS; EYE-MOVEMENTS; OPTIC TRACT; WAVE-FORMS; CEREBELLAR ACTIVATION; EFFERENT CONNECTIONS; AFFERENT-PROJECTIONS; RETROGRADE TRANSPORT; SPATIAL ORIENTATION	Infantile Nystagmus Syndrome (INS) is one of the leading causes of significant vision loss in children and affects about 1 in 1000 to 6000 births. In the present study, we are the first to investigate the structural pathways of patients and controls using diffusion tensor imaging (DTI). Specifically, three female INS patients from the same family were scanned, two sisters and a mother. Six regions of interest (ROIs) were created manually to analyze the number of tracks. Additionally, three ROI masks were analyzed using TBSS (Tract-Based Spatial Statistics). The number of fiber tracks was reduced in INS subjects, compared to normal subjects, by 15.9%, 13.9%, 9.2%, 18.6%, 5.3%, and 2.5% for the pons, cerebellum (right and left), brainstem, cerebrum, and thalamus. Furthermore, TBSS results indicated that the fractional anisotropy (FA) values for the patients were lower in the superior ventral aspects of the pons of the brainstem than in those of the controls. We have identified some brain regions that may be actively involved in INS. These novel findings would be beneficial to the neuroimaging clinical and research community as they will give them new direction in further pursuing neurological studies related to oculomotor function and provide a rational approach to studying INS.	[Kashou, Nasser H.; Zampini, Angelica R.] Wright State Univ, BioMed Imaging Lab, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Kashou, NH (corresponding author), Wright State Univ, BioMed Imaging Lab, Dayton, OH 45435 USA.	nasser.kashou@wright.edu	Kashou, Nasser/D-6535-2018	Kashou, Nasser/0000-0001-5639-9637				Abadi RV, 2002, J ROY SOC MED, V95, P231, DOI 10.1258/jrsm.95.5.231; Abadi RV, 2002, BRIT J OPHTHALMOL, V86, P1152, DOI 10.1136/bjo.86.10.1152; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; BLANKS RHI, 1983, EXP BRAIN RES, V52, P293; BLANKS RHI, 1990, J NEUROCYTOL, V19, P628, DOI 10.1007/BF01188032; BRODAL P, 1980, EXP BRAIN RES, V38, P19; BRODAL P, 1980, EXP BRAIN RES, V38, P29; BRODAL P, 1982, J COMP NEUROL, V204, P44, DOI 10.1002/cne.902040106; Brooks VB., 1981, HDB PHYSL 1, P1480, DOI DOI 10.1002/CPHY.CP010228; Broomhead DS, 2000, BIOL CYBERN, V82, P391, DOI 10.1007/s004220050593; ButtnerEnnever JA, 1996, J COMP NEUROL, V373, P90, DOI 10.1002/(SICI)1096-9861(19960909)373:1<90::AID-CNE8>3.0.CO;2-8; Cabot A, 1999, AM J HUM GENET, V64, P1141, DOI 10.1086/302324; Cesarelli Mario, 2000, Documenta Ophthalmologica, V101, P59, DOI 10.1023/A:1002702609387; Clement RA, 2002, VISION RES, V42, P2123, DOI 10.1016/S0042-6989(02)00124-4; Cohen B, 1999, J VESTIBUL RES-EQUIL, V9, P163; COHEN B, 1972, EXP NEUROL, V36, P101, DOI 10.1016/0014-4886(72)90139-2; Dell'Osso L. F., 2002, Documenta Ophthalmologica, V104, P249, DOI 10.1023/A:1015299930849; Dell'Osso LF, 2005, DUANES CLIN OPHTHALM; DELLOSSO LF, 1979, ARCH OPHTHALMOL-CHIC, V97, P462, DOI 10.1001/archopht.1979.01020010212004; DELLOSSO LF, 1975, DOC OPHTHALMOL, V39, P155, DOI 10.1007/BF00578761; DELLOSSO LF, 1992, DOC OPHTHALMOL, V79, P1, DOI 10.1007/BF00160130; DICKINSON CM, 1986, OPHTHAL PHYSL OPT, V6, P303, DOI 10.1111/j.1475-1313.1986.tb00720.x; Dieterich M, 2000, NEUROLOGY, V54, P148, DOI 10.1212/WNL.54.1.148; FORT P, 1989, J COMP NEUROL, V283, P285, DOI 10.1002/cne.902830209; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; GLICKSTEIN M, 1994, J COMP NEUROL, V349, P51, DOI 10.1002/cne.903490105; GONZALORUIZ A, 1990, EXP BRAIN RES, V80, P600; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Helmchen C, 2003, NEUROLOGY, V61, P412, DOI 10.1212/01.WNL.0000073271.66866.51; Hertle RW, 2004, J AAPOS, V8, P539, DOI 10.1016/j.jaapos.2004.08.005; Hertle RW, 2003, OPHTHALMOLOGY, V110, P2097, DOI 10.1016/S0161-6420(03)00802-9; Hoffmann S, 2004, AM J OPHTHALMOL, V138, P439, DOI 10.1016/j.ajo.2004.04.065; HOLSTEGE G, 1986, BRAIN RES, V374, P306, DOI 10.1016/0006-8993(86)90425-7; HOLSTEGE G, 1984, BRAIN RES, V311, P7, DOI 10.1016/0006-8993(84)91393-3; HOLSTEGE G, 1982, J COMP NEUROL, V209, P139, DOI 10.1002/cne.902090204; Hufner K, 2007, NEUROLOGY, V69, P1128, DOI 10.1212/01.wnl.0000276953.00969.48; ITOH K, 1983, BRAIN RES, V274, P332, DOI 10.1016/0006-8993(83)90713-8; Jacobs JB, 2004, J VISION, V4, P604, DOI 10.1167/4.7.7; Jacobs JB, 2009, INVEST OPHTH VIS SCI, V50, P4685, DOI 10.1167/iovs.09-3387; JANSEN J, 1954, ASPECTS CEREBELLAR A; Kalla R, 2006, NEUROLOGY, V66, P281, DOI 10.1212/01.wnl.0000194242.28018.d9; Kashou NH, 2010, BRAIN RES, V1336, P10, DOI 10.1016/j.brainres.2010.04.017; Kato I, 1995, BRAIN RES, V705, P109, DOI 10.1016/0006-8993(95)01145-5; Kerrison JB, 1998, AM J OPHTHALMOL, V125, P64, DOI 10.1016/S0002-9394(99)80236-0; Kheradmand Amir, 2011, Front Neurol, V2, P53, DOI 10.3389/fneur.2011.00053; LANGER T, 1985, J COMP NEUROL, V235, P1, DOI 10.1002/cne.902350102; Leguire L E, 1990, J Pediatr Ophthalmol Strabismus, V27, P32; Leguire L E, 1998, J AAPOS, V2, P257, DOI 10.1016/S1091-8531(98)90080-5; Liu P, 2008, J NEUROPHYSIOL, V100, P1098, DOI 10.1152/jn.01043.2007; Maybodi Mitra, 2003, Curr Opin Ophthalmol, V14, P276, DOI 10.1097/00055735-200310000-00008; Mellott ML, 1999, ARCH OPHTHALMOL-CHIC, V117, P1630; MUSTARI MJ, 1994, J COMP NEUROL, V349, P111, DOI 10.1002/cne.903490108; Nagao S, 1997, J COMP NEUROL, V382, P480, DOI 10.1002/(SICI)1096-9861(19970616)382:4<480::AID-CNE5>3.0.CO;2-Z; Nagao S, 2004, CEREBELLUM, V3, P11, DOI 10.1080/14734220310012181; Nakahara H, 2003, OTOLARYNG HEAD NECK, V128, P598, DOI 10.1016/S0194-5998(02)23210-6; Oetting W S, 2000, Ophthalmic Genet, V21, P227, DOI 10.1076/1381-6810(200012)21:4;1-H;FT227; Pierrot-Deseilligny C, 2005, BRAIN, V128, P1237, DOI 10.1093/brain/awh532; Purves D, 2012, PRINCIPLES COGNITIVE; Rafal R, 2004, J NEUROL NEUROSUR PS, V75, P1602, DOI 10.1136/jnnp.2003.017038; Reinecke R D, 1997, J AAPOS, V1, P67, DOI 10.1016/S1091-8531(97)90002-1; RON S, 1973, J NEUROPHYSIOL, V36, P1004, DOI 10.1152/jn.1973.36.6.1004; Rucker Janet C, 2005, Curr Treat Options Neurol, V7, P69, DOI 10.1007/s11940-005-0008-0; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SCALIA F, 1972, J COMP NEUROL, V145, P223, DOI 10.1002/cne.901450208; SCALIA F, 1972, Brain Behavior and Evolution, V6, P237, DOI 10.1159/000123712; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Sharma P, 2000, J AAPOS, V4, P287, DOI 10.1067/mpa.2000.107900; Simmers AJ, 1999, CURR EYE RES, V18, P194, DOI 10.1076/ceyr.18.3.194.5374; Simpson J I, 1988, Rev Oculomot Res, V2, P335; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2007, AM J NEURORADIOL, V28, P1354, DOI 10.3174/ajnr.A0538; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Staempfli P, 2008, NEUROIMAGE, V39, P119, DOI 10.1016/j.neuroimage.2007.08.025; Stahl J S, 2001, Curr Neurol Neurosci Rep, V1, P471, DOI 10.1007/s11910-001-0109-4; Taibbi G, 2008, CLIN OPHTHALMOL, V2, P585; TAKADA M, 1984, NEUROSCI LETT, V50, P251, DOI 10.1016/0304-3940(84)90494-4; THIELERT CD, 1993, J COMP NEUROL, V337, P113, DOI 10.1002/cne.903370108; Thier P, 2006, PROG BRAIN RES, V151, P293, DOI 10.1016/S0079-6123(05)51010-0; TOMASCH J, 1969, BRAIN RES, V13, P476, DOI 10.1016/0006-8993(69)90261-3; Voogd J, 2006, PROG BRAIN RES, V151, P231, DOI 10.1016/S0079-6123(05)51008-2; Wang ZI, 2008, VISION RES, V48, P1409, DOI 10.1016/j.visres.2008.03.007; Wang Z, 2006, J AAPOS, V10, P552, DOI 10.1016/j.jaapos.2006.08.021; Wang ZI, 2007, J AAPOS, V11, P135, DOI 10.1016/j.jaapos.2006.10.012; Wang ZI, ADV UNDERSTANDING ME; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Watkins RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/460956; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; WEBER JT, 1985, BRAIN BEHAV EVOLUT, V26, P117, DOI 10.1159/000118771; YAMADA J, 1987, J COMP NEUROL, V265, P224, DOI 10.1002/cne.902650207	94	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0125380	10.1371/journal.pone.0125380	http://dx.doi.org/10.1371/journal.pone.0125380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860806	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300153
J	Takashima, T; Kishi, T; Onozawa, K; Rikitake, S; Miyazono, M; Otsuka, T; Irie, H; Iwakiri, R; Fujimoto, K; Ikeda, Y				Takashima, Tsuyoshi; Kishi, Tomoya; Onozawa, Koji; Rikitake, Shuichi; Miyazono, Motoaki; Otsuka, Takateru; Irie, Hiroyuki; Iwakiri, Ryuichi; Fujimoto, Kazuma; Ikeda, Yuji			Significance of Technetium-99m Human Serum Albumin Diethylenetriamine Pentaacetic Acid Scintigraphy in Patients with Nephrotic Syndrome	PLOS ONE			English	Article							INTERSTITIAL NEPHRITIS; PROXIMAL TUBULE; GENE-EXPRESSION; RAT; HOMEOSTASIS; KIDNEY; CATABOLISM; CELLS	It is thought that a large amount of albumin leaking from the glomerulus in nephrotic syndrome (NS) is reabsorbed at the proximal tubule and catabolized. Therefore, it is possible the final quantity of urinary protein does not always reflect the amount of leakage of protein from the glomerulus. We experienced two cases without nephrotic range proteinuria thought to involve hypoproteinemia due to the same pathophysiology as NS. On these patients, we performed protein leakage scintigraphy with technetium-99m human serum albumin diethylenetriamine pentaacetic acid ((99)mTc-HSAD) to exclude a diagnosis of protein-losing gastro-enteropathy and observed diffuse positive accumulation in the kidneys with more intense uptake in the kidney than the liver on the anterior view 24 hours after (99)mTc-HSAD administration. In healthy adults intravenously given 99mTc-HSAD, the same dynamics are observed as in albumin metabolism, and the organ radioactivity of the liver and kidneys after 24 hours is equal. Therefore, we thought it was possible that the renal uptake 24 hours after (99)mTc-HSAD administration was a characteristic finding of NS. In order to confirm it, the subjects were divided into two groups: the NS group (n = 10) and the non-NS group (n = 7). We defined more intense uptake in the kidney than the liver on the anterior view 24 hours after (99)mTc-HSAD administration as Dense Kidney (+). Furthermore, we designed regions of interest in the right and left kidneys and liver on anterior and posterior images, then calculated the kidney-liver ratio. Nine of the ten patients had Dense Kidney (+) in the NS group, compared to none in the non-NS group. And the kidney-liver ratio was significantly higher in the NS group than in the non-NS group on each view in the bilateral kidneys. In conclusion, our results suggest that the renal uptake 24 hours after (99)mTc-HSAD administration is a characteristic finding of NS.	[Takashima, Tsuyoshi; Kishi, Tomoya; Rikitake, Shuichi; Miyazono, Motoaki; Iwakiri, Ryuichi; Fujimoto, Kazuma; Ikeda, Yuji] Saga Univ, Dept Internal Med, Fac Med, Saga 840, Japan; [Onozawa, Koji] Ureshino Med Ctr, Dept Nephrol, Ureshino, Japan; [Otsuka, Takateru; Irie, Hiroyuki] Saga Univ, Dept Radiol, Fac Med, Saga 840, Japan	Saga University; Saga University	Takashima, T (corresponding author), Saga Univ, Dept Internal Med, Fac Med, Saga 840, Japan.	takashim@cc.saga-u.ac.jp		Rikitake, Shuichi/0000-0002-7533-2961				Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; GALASKE RG, 1978, PFLUG ARCH EUR J PHY, V375, P269, DOI 10.1007/BF00582441; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Glassock RJ, 2015, NEPHROL DIAL TRANSPL, V30, P12, DOI 10.1093/ndt/gfu077; HAMADA S, 1988, Kaku Igaku, V25, P381; HAYASHIDA K, 1988, Kaku Igaku, V25, P1155; ISHII K, 1989, Kaku Igaku, V26, P35; KATZ J, 1964, J LAB CLIN MED, V63, P680; KATZ J, 1960, AM J PHYSIOL, V198, P814, DOI 10.1152/ajplegacy.1960.198.4.814; KAWAMURA Y, 1989, Kaku Igaku, V26, P433; KAYSEN GA, 1984, KIDNEY INT, V25, P107, DOI 10.1038/ki.1984.15; KAYSEN GA, 1984, AM J PHYSIOL, V247, pF192, DOI 10.1152/ajprenal.1984.247.1.F192; KAYSEN GA, 1986, KIDNEY INT, V29, P572, DOI 10.1038/ki.1986.36; Kelepouris E, 2014, UPTODATE; Komatsu Y, 1990, Nihon Jinzo Gakkai Shi, V32, P1243; LINTON AL, 1980, ANN INTERN MED, V93, P735, DOI 10.7326/0003-4819-93-5-735; LINTON AL, 1985, CLIN NEPHROL, V24, P84; MOSHAGE HJ, 1987, J CLIN INVEST, V79, P1635, DOI 10.1172/JCI113000; NISHIZAWA S, 1988, Kaku Igaku, V25, P1189; PIETRANGELO A, 1992, J CLIN INVEST, V89, P1755, DOI 10.1172/JCI115778; PRAGA M, 1991, AM J KIDNEY DIS, V17, P330, DOI 10.1016/S0272-6386(12)80483-5; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sato Tomoyasu, 1996, Kaku Igaku, V33, P1091; SHIRAKAMI Y, 1987, Kaku Igaku, V24, P475; Slattery C, 2008, KIDNEY INT, V74, P1480, DOI 10.1038/ki.2008.463; Suehiro T, 2006, NIHON SHONI JINZOBYO, V19, P141; SUN XH, 1993, AM J PHYSIOL, V264, pF441, DOI 10.1152/ajprenal.1993.264.3.F441; SUN XH, 1994, KIDNEY INT, V45, P1381, DOI 10.1038/ki.1994.180; Takashima T, 2014, CEN CASE REP, V3, P172, DOI 10.1007/s13730-014-0112-7; TAMAKI N, 1988, Kaku Igaku, V25, P579; TORIZUKA K, 1988, Kaku Igaku, V25, P1201; WOOD BC, 1978, ARCH INTERN MED, V138, P1665, DOI 10.1001/archinte.138.11.1665; YAMADA M, 1988, Kaku Igaku, V25, P1291	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123036	10.1371/journal.pone.0123036	http://dx.doi.org/10.1371/journal.pone.0123036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859658	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300074
J	Zhang, JY; Liu, HL; Liang, X; Zhang, M; Wang, RK; Peng, G; Li, JY				Zhang, Jingyang; Liu, Hongling; Liang, Xue; Zhang, Min; Wang, Renke; Peng, Guang; Li, Jiyao			Investigation of Salivary Function and Oral Microbiota of Radiation Caries-Free People with Nasopharyngeal Carcinoma	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INTENSITY-MODULATED RADIOTHERAPY; FLOW-RATE; WHOLE SALIVA; PYROSEQUENCING ANALYSIS; BACTERIAL COMMUNITIES; DENTAL-CARIES; CANCER; HEAD; HYPOSALIVATION	Radiation caries have been reported to be correlated with radiotherapy-induced destruction of salivary function and changes in oral microbiota. There have been no published reports detailing patients who have remained radiation caries-free following radiotherapy for nasopharyngeal carcinoma. The aim of this study was to investigate the relationship between salivary function, oral microbiota and the absence of radiation caries. Twelve radiation caries-free patients and nine patients exhibiting radiation caries following irradiated nasopharyngeal carcinoma were selected. V40, the dose at which the volume of the contralateral parotid gland receives more than 40 Gy, was recorded. Stimulated saliva flow rate, pH values and buffering capacity were examined to assess salivary function. Stimulated saliva was used for molecular profiling by Denaturing Gradient Gel Electrophoresis. Mutans streptococci and Lactobacilli in saliva were also cultivated. There were no significant differences in V40 between radiation caries-free individuals and those with radiation caries. Compared with normal values, the radiation caries-free group had significantly decreased simulated saliva flow rate, while there were no significant differences in the saliva pH value and buffering capacity. Similar results were observed in the radiation caries group. There was no statistical difference in microbial diversity, composition and log CFU counts in cultivation from the radiation caries-free group and the radiation caries group. Eleven genera were detected in these two groups, among which Streptococcus spp. and Neisseria spp. had the highest distribution. Our results suggest that changes in salivary function and in salivary microbiota do not explain the absence of radiation caries in radiation caries-free individuals.	[Zhang, Jingyang; Liu, Hongling; Liang, Xue; Zhang, Min; Wang, Renke; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China; [Zhang, Jingyang; Liu, Hongling; Zhang, Min; Wang, Renke; Li, Jiyao] Sichuan Univ, Dept Operat Dent & Endodont, West China Sch Stomatol, Chengdu 610041, Peoples R China; [Liang, Xue; Peng, Guang] Sichuan Univ, Radiat Phys Ctr, Ctr Canc, West China Hosp, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, JY (corresponding author), West China Coll Stomatol, Dept Operat Dent & Endodont, Chengdu, Peoples R China.	jiyaoliscu@163.com		Zhang, Jingyang/0000-0003-4236-6222	National Science & Technology Pillar Program during the 12th Five-year Plan Period [20911BAZ03171]; Chinese National Natural Science Fund for Young Scholars [31200389]; Chinese National Natural Science Fund [81371135]	National Science & Technology Pillar Program during the 12th Five-year Plan Period; Chinese National Natural Science Fund for Young Scholars; Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This investigation was supported by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (No. 20911BAZ03171), the Chinese National Natural Science Fund for Young Scholars (No. 31200389), and the Chinese National Natural Science Fund (No. 81371135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar Gabrielle P, 2009, J Contemp Dent Pract, V10, P83; Al-Nawas B, 2006, SUPPORT CARE CANCER, V14, P291, DOI 10.1007/s00520-005-0895-3; Almstahl A, 2008, ORAL DIS, V14, P541, DOI 10.1111/j.1601-0825.2007.01416.x; Almstahl A, 2003, ARCH ORAL BIOL, V48, P337, DOI 10.1016/S0003-9969(02)00200-5; Almstahl A, 2003, ORAL MICROBIOL IMMUN, V18, P1, DOI 10.1034/j.1399-302X.2003.180101.x; Almstahl A, 1999, J DENT RES, V78, P1410, DOI 10.1177/00220345990780080601; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; BENARYEH H, 1975, INT J ORAL MAXILLOF, V4, P205, DOI 10.1016/S0300-9785(75)80027-5; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; BROWN LR, 1978, J DENT RES, V57, P882, DOI 10.1177/00220345780570090901; Campus G, 2012, CARIES RES, V46, P16, DOI 10.1159/000334932; Chao K, 2001, RADIOTHERAPY ONCOLOG, V61; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Dal Bello F, 2006, SYST APPL MICROBIOL, V29, P69, DOI 10.1016/j.syapm.2005.07.002; DREIZEN S, 1977, J DENT RES, V56, P99, DOI 10.1177/00220345770560022101; DREIZEN S, 1976, CANCER, V38, P273, DOI 10.1002/1097-0142(197607)38:1<273::AID-CNCR2820380141>3.0.CO;2-8; Eliasson L, 2005, ARCH ORAL BIOL, V50, P293, DOI 10.1016/j.archoralbio.2004.08.009; Epstein J B, 1992, J Can Dent Assoc, V58, P217; Epstein JB, 1998, ORAL SURG ORAL MED O, V86, P286, DOI 10.1016/S1079-2104(98)90173-1; GOLD OG, 1973, ARCH ORAL BIOL, V18, P1357, DOI 10.1016/0003-9969(73)90109-X; Haffajee AD, 2009, J PERIODONTAL RES, V44, P511, DOI 10.1111/j.1600-0765.2008.01154.x; Hu YJ, 2013, INT J ORAL SCI, V5, P21, DOI 10.1038/ijos.2013.15; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056343; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; JANSMA J, 1992, INT J RADIAT ONCOL, V24, P359, DOI 10.1016/0360-3016(92)90692-B; Jham Bruno Correia, 2006, Rev. Bras. Otorrinolaringol., V72, P704, DOI 10.1590/S0034-72992006000500019; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; Joyston-Bechal S, 1992, Int Dent J, V42, P47; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kielbassa A, 2001, J CLIN DENT, V13, P104; Kielbassa A M, 2001, Schweiz Monatsschr Zahnmed, V111, P1060; Kielbassa AM, 2006, LANCET ONCOL, V7, P326, DOI 10.1016/S1470-2045(06)70658-1; Kielbassa AM, 2006, CARIES RES, V40, P130, DOI 10.1159/000091059; Kielbassa AM, 2000, CARIES RES, V34, P41, DOI 10.1159/000016568; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Li Y, 2005, J DENT RES, V84, P559, DOI 10.1177/154405910508400614; Li Y, 2007, J CLIN MICROBIOL, V45, P3082, DOI 10.1128/JCM.00771-07; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LIZI EC, 1992, BRIT DENT J, V173, P24, DOI 10.1038/sj.bdj.4807926; Llena-Puy Carmen, 2006, Med Oral Patol Oral Cir Bucal, V11, pE449; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; Meng LY, 2005, CARIES RES, V39, P484, DOI 10.1159/000088184; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ono K, 2006, ARCH ORAL BIOL, V51, P345, DOI 10.1016/j.archoralbio.2005.09.001; Ortholan C, 2009, INT J RADIAT ONCOL, V73, P178, DOI 10.1016/j.ijrobp.2008.03.068; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Roesink JM, 2000, RADIOTHER ONCOL, V55, P131, DOI 10.1016/S0167-8140(00)00154-7; Rudney JD, 2003, ARCH ORAL BIOL, V48, P475, DOI 10.1016/S0003-9969(03)00043-8; SHANNON IL, 1977, J DENT RES, V56, P693, DOI 10.1177/00220345770560062201; Shao ZY, 2011, J RADIAT RES, V52, P834, DOI 10.1269/jrr.11085; Silverman S, 1999, ORAL SURG ORAL MED O, V88, P122, DOI 10.1016/S1079-2104(99)70103-4; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; SPAK CJ, 1994, CARIES RES, V28, P388, DOI 10.1159/000262007; Tao Y, 2013, ARCH ORAL BIOL, V58, P1129, DOI 10.1016/j.archoralbio.2013.04.005; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P213, DOI 10.1177/154411130301400306; Wang RK, 2012, MICROB ECOL, V64, P152, DOI 10.1007/s00248-012-0013-2; WATANABE K, 1993, J DENT RES, V72, P1040, DOI 10.1177/00220345930720060801; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x; Zhang W, 2013, MICROB ECOL, V66, P385, DOI 10.1007/s00248-012-0160-5	64	11	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123137	10.1371/journal.pone.0123137	http://dx.doi.org/10.1371/journal.pone.0123137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860481	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300080
J	Ebshiana, AA; Snowden, SG; Thambisetty, M; Parsons, R; Hye, A; Legido-Quigley, C				Ebshiana, Amera A.; Snowden, Stuart G.; Thambisetty, Madhav; Parsons, Richard; Hye, Abdul; Legido-Quigley, Cristina			Metabolomic Method: UPLC-q-ToF Polar and Non-Polar Metabolites in the Healthy Rat Cerebellum Using an In-Vial Dual Extraction	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; LIQUID-CHROMATOGRAPHY; ION SUPPRESSION; ELECTROSPRAY-IONIZATION; LC-MS; DIAGNOSIS; DISORDERS; PLASMA; PHASE	Unbiased metabolomic analysis of biological samples is a powerful and increasingly commonly utilised tool, especially for the analysis of bio-fluids to identify candidate biomarkers. To date however only a small number of metabolomic studies have been applied to studying the metabolite composition of tissue samples, this is due, in part to a number of technical challenges including scarcity of material and difficulty in extracting metabolites. The aim of this study was to develop a method for maximising the biological information obtained from small tissue samples by optimising sample preparation, LC-MS analysis and metabolite identification. Here we describe an in-vial dual extraction (IVDE) method, with reversed phase and hydrophilic liquid interaction chromatography (HILIC) which reproducibly measured over 4,000 metabolite features from as little as 3mg of brain tissue. The aqueous phase was analysed in positive and negative modes following HILIC separation in which 2,838 metabolite features were consistently measured including amino acids, sugars and purine bases. The non-aqueous phase was also analysed in positive and negative modes following reversed phase separation gradients respectively from which 1,183 metabolite features were consistently measured representing metabolites such as phosphatidylcholines, sphingolipids and triacylglycerides. The described metabolomics method includes a database for 200 metabolites, retention time, mass and relative intensity, and presents the basal metabolite composition for brain tissue in the healthy rat cerebellum.	[Ebshiana, Amera A.; Parsons, Richard; Legido-Quigley, Cristina] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Snowden, Stuart G.; Hye, Abdul] Kings Coll London, Inst Psychiat, Dept Old Age Psychiat, London SE5 8AF, England; [Thambisetty, Madhav] Natl Inst Aging, Lab Behav Neurosci, Clin & Translat Neurosci Unit, Baltimore, MD USA	University of London; King's College London; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Legido-Quigley, C (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	cristina.legido_quigley@kcl.ac.uk		Legido-Quigley, Cristina/0000-0002-4018-214X; Snowden, Stuart/0000-0002-9419-5819; Parsons, Richard Bramwell/0000-0001-5618-3780; Hye, Abdul/0000-0003-2237-4823	Butterfield Trust; Libyan Cultural Bureau London; NATIONAL INSTITUTE ON AGING [ZIAAG000200, P50AG005146] Funding Source: NIH RePORTER	Butterfield Trust; Libyan Cultural Bureau London; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by grants from the Butterfield Trust and the Libyan Cultural Bureau London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Antignac JP, 2005, ANAL CHIM ACTA, V529, P129, DOI 10.1016/j.aca.2004.08.055; Crockford DJ, 2006, ANAL CHEM, V78, P363, DOI 10.1021/ac051444m; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Inoue K, 2013, SCI REP, P3; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kleijn RJ, 2007, FEMS YEAST RES, V7, P216, DOI 10.1111/j.1567-1364.2006.00180.x; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Llorach R, 2009, J PROTEOME RES, V8, P5060, DOI 10.1021/pr900470a; Mallet CR, 2004, RAPID COMMUN MASS SP, V18, P49, DOI 10.1002/rcm.1276; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Muller C, 2002, J CHROMATOGR B, V773, P47, DOI 10.1016/S1570-0232(02)00142-3; NIEDERMEYER E, 1985, J NEUROL, V232, P1, DOI 10.1007/BF00314032; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Proitsi P, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.127; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rice ML, 2005, APPL PSYCHOLINGUIST, V26, P7, DOI 10.1017/S0142716405050034; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Snowden S, 2012, BIOANALYSIS, V4, P2265, DOI [10.4155/bio.12.218, 10.4155/BIO.12.218]; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; US Department of Health and Human Services FaDA Centre for Drug Evaluation and Research (CDER) Centre for Veterinary Medicine (CVM), 2001, BIO METH VAL; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Whiley L, 2012, ANAL CHEM, V84, P5992, DOI 10.1021/ac300716u; Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738	32	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122883	10.1371/journal.pone.0122883	http://dx.doi.org/10.1371/journal.pone.0122883			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853858	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400083
J	Palekar, RU; Jallouk, AP; Goette, MJ; Chen, JJ; Myerson, JW; Allen, JS; Akk, A; Yang, LH; Tu, YZ; Miller, MJ; Pham, CTN; Wickline, SA; Pan, H				Palekar, Rohun U.; Jallouk, Andrew P.; Goette, Matthew J.; Chen, Junjie; Myerson, Jacob W.; Allen, John S.; Akk, Antonina; Yang, Lihua; Tu, Yizheng; Miller, Mark J.; Pham, Christine T. N.; Wickline, Samuel A.; Pan, Hua			Quantifying progression and regression of thrombotic risk in experimental atherosclerosis	FASEB JOURNAL			English	Article						nanoparticles; endothelium; thrombosis; MRI	CIRCULATING ENDOTHELIAL-CELLS; EVANS-BLUE UPTAKE; PERMEABILITY; DYSFUNCTION; MORPHOLOGY; ANGIOGENESIS; AREAS; AORTA	Currently, there are no generally applicable noninvasive methods for defining the relationship between atherosclerotic vascular damage and risk of focal thrombosis. Herein, we demonstrate methods to delineate the progression and regression of vascular damage in response to an atherogenic diet by quantifying the in vivo accumulation of semipermeable 200-300 nm perfluorocarbon core nanoparticles (PFC-NP) in ApoE null mouse plaques with [F-19] magnetic resonance spectroscopy (MRS). Permeability to PFC-NP remained minimal until 12 weeks on diet, then increased rapidly following 12 weeks, but regressed to baseline within 8 weeks after diet normalization. Markedly accelerated clotting (53.3% decrease in clotting time) was observed in carotid artery preparations of fat-fed mice subjected to photochemical injury as defined by the time to flow cessation. For all mice on and off diet, an inverse linear relationship was observed between the permeability to PFC-NP and accelerated thrombosis (P = 0.02). Translational feasibility for quantifying plaque permeability and vascular damage in vivo was demonstrated with clinical 3 T MRI of PFC-NP accumulating in plaques of atherosclerotic rabbits. These observations suggest that excessive permeability to PFC-NPmay indicate prothrombotic risk in damaged atherosclerotic vasculature, which resolves within weeks after dietary wtherapy.	[Palekar, Rohun U.; Goette, Matthew J.; Myerson, Jacob W.; Wickline, Samuel A.] Washington Univ, Dept Biomed Engn, St Louis, MO 63108 USA; [Jallouk, Andrew P.; Chen, Junjie; Allen, John S.; Akk, Antonina; Yang, Lihua; Tu, Yizheng; Miller, Mark J.; Pham, Christine T. N.; Wickline, Samuel A.; Pan, Hua] Washington Univ, Dept Med, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Wickline, SA (corresponding author), Washington Univ, Ctr Translat Res Adv Imaging & Nanomed C TRAIN, Campus Box 8215,4320 Forest Pk Ave, St Louis, MO 63108 USA.	wicklines@aol.com; hpan@dom.wustl.edu	Pan, Hua/C-7662-2011		U.S. National Institutes of Healthn (National Heart, Lung, and Blood Institute) [HL073646, HL112303]; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK095555]; U.S. National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [AR056223]; James R. Hornsby Family Dream Garden Investment Partnership; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R01HL073646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056223, R01AR067491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK095555, R01DK102691] Funding Source: NIH RePORTER	U.S. National Institutes of Healthn (National Heart, Lung, and Blood Institute); U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); James R. Hornsby Family Dream Garden Investment Partnership; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Todd A. Williams for MRI assistance; Mike Scott, Xiaoxia Yang, and Chandu Vemuri for animal experiment and NP formulation assistance; and Noriko Yanaba for cryostat sectioning. This work was supported in part by U.S. National Institutes of Health Grants HL073646 and HL112303 (National Heart, Lung, and Blood Institute), DK095555 (National Institute of Diabetes and Digestive and Kidney Diseases), and AR056223 (National Institute of Arthritis and Musculoskeletal and Skin Diseases); and the James R. Hornsby Family Dream Garden Investment Partnership (to S.A.W.).	Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Ambrose JA, 2008, J AM COLL CARDIOL, V51, P1539, DOI 10.1016/j.jacc.2007.12.041; Arbustini E, 2000, TRANSPLANTATION, V69, P1095, DOI 10.1097/00007890-200003270-00013; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; CAPLAN BA, 1974, EXP MOL PATHOL, V21, P102, DOI 10.1016/0014-4800(74)90082-3; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Damani S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003451; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Demetz G, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/860301; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; GERRITY RG, 1977, AM J PATHOL, V89, P313; Hockett FD, 2011, IEEE T MED IMAGING, V30, P22, DOI 10.1109/TMI.2010.2056689; Keupp J, 2011, MAGN RESON MED, V66, P1116, DOI 10.1002/mrm.22877; Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765; Lampka M, 2010, KARDIOL POL, V68, P1100; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Makin AJ, 2004, EUR HEART J, V25, P371, DOI 10.1016/j.ehj.2003.04.001; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Mousa SA, 2010, METHODS MOL BIOL, V663, P29, DOI 10.1007/978-1-60761-803-4_2; Myerson J, 2011, J THROMB HAEMOST, V9, P1292, DOI 10.1111/j.1538-7836.2011.04339.x; Palekar RU, 2013, MOL PHARMACEUT, V10, P4168, DOI 10.1021/mp400210q; Pham CTN, 2011, J BIOL CHEM, V286, P123, DOI 10.1074/jbc.M110.180760; Phinikaridou A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000402; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; Poredos R, 2007, INT ANGIOL, V26, P306; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Saric M, 2012, CURR CARDIOL REP, V14, P342, DOI 10.1007/s11886-012-0261-2; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95; Zhang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026385; ZIMMERMAN M, 1986, ATHEROSCLEROSIS, V59, P277, DOI 10.1016/0021-9150(86)90123-1; Zinselmeyer BH, 2009, METHOD ENZYMOL, V461, P349, DOI 10.1016/S0076-6879(09)05416-0	37	14	15	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3100	3109		10.1096/fj.14-269084	http://dx.doi.org/10.1096/fj.14-269084			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857553	Green Published			2022-12-26	WOS:000356859100036
J	Palomba, L; Silvestri, C; Imperatore, R; Morello, G; Piscitelli, F; Martella, A; Cristino, L; Di Marzo, V				Palomba, Letizia; Silvestri, Cristoforo; Imperatore, Roberta; Morello, Giovanna; Piscitelli, Fabiana; Martella, Andrea; Cristino, Luigia; Di Marzo, Vincenzo			Negative Regulation of Leptin-induced Reactive Oxygen Species (ROS) Formation by Cannabinoid CB1 Receptor Activation in Hypothalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; GENE-EXPRESSION; PPAR-GAMMA; IDENTIFICATION; GLUCOSE; OBESITY; CELLS; BETA; TONE	The adipocyte-derived, anorectic hormone leptin was recently shown to owe part of its regulatory effects on appetite-regulating hypothalamic neuropeptides to the elevation of reactive oxygen species (ROS) levels in arcuate nucleus (ARC) neurons. Leptin is also known to exert a negative regulation on hypothalamic endocannabinoid levels and hence on cannabinoid CB1 receptor activity. Here we investigated the possibility of a negative regulation by CB1 receptors of leptin-mediated ROS formation in the ARC. Through pharmacological and molecular biology experiments we report data showing that leptin-induced ROS accumulation is 1) blunted by arachidonyl-2'-chloroethylamide (ACEA) in a CB1-dependent manner in both the mouse hypothalamic cell line mHypoE-N41 and ARC neuron primary cultures, 2) likewise blocked by a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, troglitazone, in a manner inhibited by T0070907, a PPAR-gamma antagonist that also inhibited the ACEA effect on leptin, 3) blunted under conditions of increased endocannabinoid tone due to either pharmacological or genetic inhibition of endocannabinoid degradation in mHypoE-N41 and primary ARC neuronal cultures from MAGL(-/-) mice, respectively, and 4) associated with reduction of both PPAR-gamma and catalase activity, which are reversed by both ACEA and troglitazone. We conclude that CB1 activation reverses leptin-induced ROS formation and hence possibly some of the ROS-mediated effects of the hormone by preventing PPAR-gamma inhibition by leptin, with subsequent increase of catalase activity. This mechanism might underlie in part CB1 orexigenic actions under physiopathological conditions accompanied by elevated hypothalamic endocannabinoid levels.	[Palomba, Letizia] Univ Urbino Carlo Bo, Dept Biomol Sci, I-61029 Urbino, Italy; [Palomba, Letizia; Silvestri, Cristoforo; Imperatore, Roberta; Morello, Giovanna; Piscitelli, Fabiana; Martella, Andrea; Cristino, Luigia; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, I-80078 Pozzuoli, NA, Italy; [Silvestri, Cristoforo; Imperatore, Roberta; Morello, Giovanna; Piscitelli, Fabiana; Martella, Andrea; Cristino, Luigia; Di Marzo, Vincenzo] CNR, Ist Chim Biomol, I-80078 Pozzuoli, NA, Italy	University of Urbino; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR)	Di Marzo, V (corresponding author), CNR, Ist Chim Biomol, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy.	vdimarzo@icb.cnr.it	Silvestri, Cristoforo/Y-2504-2019; Cristino, Luigia/AAE-3934-2020; Di Marzo, Vincenzo/AAD-7742-2019; Piscitelli, Fabiana/A-7100-2014	Silvestri, Cristoforo/0000-0001-5635-1545; Cristino, Luigia/0000-0002-0182-4699; Di Marzo, Vincenzo/0000-0002-1490-3070; Martella, Andrea/0000-0002-4680-7702; Piscitelli, Fabiana/0000-0001-9343-4622; IMPERATORE, Roberta/0000-0003-3609-2771				Bisogno T, 2013, BRIT J PHARMACOL, V169, P784, DOI 10.1111/bph.12013; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chen T, 2012, FREE RADICAL BIO MED, V53, P208, DOI 10.1016/j.freeradbiomed.2012.05.014; Chen X, 2011, NEUROSCIENCE, V178, P159, DOI 10.1016/j.neuroscience.2011.01.024; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Garretson JT, 2015, J NEUROSCI, V35, P4571, DOI 10.1523/JNEUROSCI.2129-14.2015; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gray E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-63; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Igaz P, 2006, ENDOCRINOLOGY, V147, P1037, DOI 10.1210/en.2005-0729; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Mates J M, 1999, Front Biosci, V4, pD339; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200	38	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13669	13677		10.1074/jbc.M115.646885	http://dx.doi.org/10.1074/jbc.M115.646885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869131	Green Published, hybrid			2022-12-26	WOS:000355313000005
J	Yan, L; Lai, XJ; Li, XD; Wei, CH; Tan, XM; Zhang, YZ				Yan, Lang; Lai, Xianjun; Li, Xuedan; Wei, Changhe; Tan, Xuemei; Zhang, Yizheng			Analyses of the Complete Genome and Gene Expression of Chloroplast of Sweet Potato [Ipomoea batata]	PLOS ONE			English	Article							REAL-TIME PCR; DNA-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; PLASTID GENOMES; HIGH-THROUGHPUT; ORGANIZATION; DIVERSIFICATION; TRANSCRIPTION; ANGIOSPERMS; ANNOTATION	Sweet potato [Ipomoea batatas (L.) Lam] ranks among the top seven most important food crops cultivated worldwide and is hexaploid plant (2n=6x=90) in the Convolvulaceae family with a genome size between 2,200 to 3,000 Mb. The genomic resources for this crop are deficient due to its complicated genetic structure. Here, we report the complete nucleotide sequence of the chloroplast (cp) genome of sweet potato, which is a circular molecule of 161,303 bp in the typical quadripartite structure with large (LSC) and small (SSC) single-copy regions separated by a pair of inverted repeats (IRs). The chloroplast DNA contains a total of 145 genes, including 94 protein-encoding genes of which there are 72 single-copy and 11 double-copy genes. The organization and structure of the chloroplast genome (gene content and order, IR expansion/contraction, random repeating sequences, structural rearrangement) of sweet potato were compared with those of Ipomoea (L.) species and some basal important angiosperms, respectively. Some boundary gene-flow and gene gain-and-loss events were identified at intra-and inter-species levels. In addition, by comparing with the transcriptome sequences of sweet potato, the RNA editing events and differential expressions of the chloroplast functional-genes were detected. Moreover, phylogenetic analysis was conducted based on 77 protein-coding genes from 33 taxa and the result may contribute to a better understanding of the evolution progress of the genus Ipomoea (L.), including phylogenetic relationships, intraspecific differentiation and interspecific introgression.	[Yan, Lang; Li, Xuedan; Wei, Changhe; Tan, Xuemei; Zhang, Yizheng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China; [Lai, Xianjun] Sichuan Agr Univ, Maize Res Inst, Key Lab Crop Genet Resource & Improvement, Minist Educ, Chengdu, Peoples R China	Sichuan University; Sichuan Agricultural University	Tan, XM (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China.	txmyyf@scu.edu.cn; yizzhang@scu.edu.cn			National Science & Technology Pillar Program of China [2007BAD78B03]; "Eleventh-Five" Key Project of Sichuan Province, China [07SG111-003-1]	National Science & Technology Pillar Program of China; "Eleventh-Five" Key Project of Sichuan Province, China	This work is supported by grants from the National Science & Technology Pillar Program of China (No. 2007BAD78B03, http://kjzc.jhgl.org/) and the "Eleventh-Five" Key Project of Sichuan Province, China (No. 07SG111-003-1, http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, NUCLEIC ACIDS RES, V39, pD210, DOI 10.1093/nar/gkq1007; Berg S, 2004, PLANTA, V219, P541, DOI 10.1007/s00425-004-1260-3; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Carpena A. L., 2009, P27, DOI 10.1007/978-1-4020-9475-0_4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DeCoste NJ, 2011, APPL ENVIRON MICROB, V77, P41, DOI 10.1128/AEM.01387-10; del Campo EM, 2009, GENE REGUL SYST BIO, V3, P31; Dixit R, 1999, CURR GENET, V36, P165, DOI 10.1007/s002940050487; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eserman LA, 2014, AM J BOT, V101, P92, DOI 10.3732/ajb.1300207; Favory JJ, 2005, NUCLEIC ACIDS RES, V33, P5991, DOI 10.1093/nar/gki908; Firon LD, 2009, BOT PHYSL STORAGE RO, P13; Gaba V., 2009, P65, DOI 10.1007/978-1-4020-9475-0_6; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He XJ ZT, 2010, CHINESE J TROPICAL A, P-10; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenz H, 2010, CURR GENET, V56, P189, DOI 10.1007/s00294-009-0283-5; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma J, 2013, GENE, V528, P120, DOI 10.1016/j.gene.2013.07.037; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Naito K, 2013, BREEDING SCI, V63, P176, DOI 10.1270/jsbbs.63.176; Navidshad B, 2012, INT J MOL SCI, V13, P2119, DOI 10.3390/ijms13022119; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shiina T, 1998, PLANT CELL, V10, P1713, DOI 10.1105/tpc.10.10.1713; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Thottappilly G., 2009, P3, DOI 10.1007/978-1-4020-9475-0_1; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073946; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	29	36	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124083	10.1371/journal.pone.0124083	http://dx.doi.org/10.1371/journal.pone.0124083			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874767	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800132
J	Lam, V; Takechi, R; Pallabage-Gamarallage, M; Giles, C; Mamo, JCL				Lam, Virginie; Takechi, Ryusuke; Pallabage-Gamarallage, Menuka; Giles, Corey; Mamo, John C. L.			The Vitamin D, Ionised Calcium and Parathyroid Hormone Axis of Cerebral Capillary Function: Therapeutic Considerations for Vascular-Based Neurodegenerative Disorders	PLOS ONE			English	Article							CEREBROSPINAL-FLUID CALCIUM; 25-HYDROXYVITAMIN D CONCENTRATIONS; ALZHEIMERS-DISEASE; D-RECEPTOR; COGNITIVE FUNCTION; OLDER-ADULTS; CHRONIC HYPOCALCEMIA; LESION VOLUMES; SATURATED FAT; SERUM-CALCIUM	Blood-brain barrier dysfunction characterised by brain parenchymal extravasation of plasma proteins may contribute to risk of neurodegenerative disorders, however the mechanisms for increased capillary permeability are not understood. Increasing evidence suggests vitamin D confers central nervous system benefits and there is increasing demand for vitamin D supplementation. Vitamin D may influence the CNS via modulation of capillary function, however such effects may be indirect as it has a central role in maintaining calcium homeostasis, in concert with calcium regulatory hormones. This study utilised an integrated approach and investigated the effects of vitamin D supplementation, parathyroid tissue ablation (PTX), or exogenous infusion of parathyroid hormone (PTH) on cerebral capillary integrity. Parenchymal extravasation of immunoglobulin G (IgG) was used as a marker of cerebral capillary permeability. In C57BL/6J mice and Sprague Dawley rats, dietary vitamin D was associated with exaggerated abundance of IgG within cerebral cortex (CTX) and hippocampal formation (HPF). Vitamin D was also associated with increased plasma ionised calcium (iCa) and decreased PTH. A response to dose was suggested and parenchymal effects persisted for up to 24 weeks. Ablation of parathyroid glands increased CTX- and HPF-IgG abundance concomitant with a reduction in plasma iCa. With the provision of PTH, iCa levels increased, however the PTH treated animals did not show increased cerebral permeability. Vitamin D supplemented groups and rats with PTH-tissue ablation showed modestly increased parenchymal abundance of glial-fibrillary acidic protein (GFAP), a marker of astroglial activation. PTH infusion attenuated GFAP abundance. The findings suggest that vitamin D can compromise capillary integrity via a mechanism that is independent of calcium homeostasis. The effects of exogenous vitamin D supplementation on capillary function and in the context of prevention of vascular neurodegenerative conditions should be considered in the context of synergistic effects with calcium modulating hormones.	[Lam, Virginie; Takechi, Ryusuke; Pallabage-Gamarallage, Menuka; Giles, Corey; Mamo, John C. L.] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia; [Lam, Virginie; Takechi, Ryusuke; Pallabage-Gamarallage, Menuka; Giles, Corey; Mamo, John C. L.] Curtin Univ, Curtin Hlth Innovat Res Inst Ageing & Chron Dis, Perth, WA 6845, Australia	Curtin University; Curtin University	Mamo, JCL (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia.	J.Mamo@Curtin.edu.au	Takechi, Ryusuke/D-3692-2012; Takechi, Ryu/T-9970-2019; Giles, Corey/AAM-9003-2020	Takechi, Ryusuke/0000-0001-6359-3382; Takechi, Ryu/0000-0001-6359-3382; Giles, Corey/0000-0002-6050-1259; Mamo, John/0000-0002-5741-7849; Lam, Virginie/0000-0001-8463-645X	Australian National Health and Medical Research Council [1064567]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Research was supported by the Australian National Health and Medical Research Council www.nhmrc.gov.au. Project grant 1064567. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Afzal S, 2014, ALZHEIMERS DEMENT, V10, P296, DOI 10.1016/j.jalz.2013.05.1765; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Batista DG, 2010, CALCIFIED TISSUE INT, V87, P60, DOI 10.1007/s00223-010-9367-y; Berdud I, 1998, CALCIFIED TISSUE INT, V62, P457, DOI 10.1007/s002239900460; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Bjorkman MP, 2008, EUR J ENDOCRINOL, V158, P749, DOI 10.1530/EJE-07-0849; Bollerslev J, 2011, IBMS BONEKEY, V8, P342; Braverman ER, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-21; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; de Groot JC, 2000, ANN NEUROL, V47, P145; Durk MR, 2012, J NEUROCHEM, V123, P944, DOI 10.1111/jnc.12041; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Eyles DW, 2014, NEUROSCIENCE, V268, P1, DOI 10.1016/j.neuroscience.2014.02.042; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Farid K, 2012, NUCL MED COMMUN, V33, P1048, DOI 10.1097/MNM.0b013e32835674c4; Feldman D, 2011, TWO VOLUME SET; Feldman F, 2014, J AM GERIATR SOC, V62, P1546, DOI 10.1111/jgs.12927; Freeman LR, 2012, J CEREBR BLOOD F MET, V32, P643, DOI 10.1038/jcbfm.2011.168; GASCONBARRE M, 1983, AM J PHYSIOL, V244, pE266, DOI 10.1152/ajpendo.1983.244.3.E266; GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8; Goodman WG, 2002, NEPHROL DIAL TRANSPL, V17, P1731, DOI 10.1093/ndt/17.10.1731; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hirasawa T, 2000, BRIT J PHARMACOL, V129, P21, DOI 10.1038/sj.bjp.0702949; JOBORN C, 1991, PSYCHONEUROENDOCRINO, V16, P311, DOI 10.1016/0306-4530(91)90017-N; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Khudaverian D N, 1996, Biull Eksp Biol Med, V122, P484; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; MURPHY VA, 1986, J NEUROCHEM, V47, P1735, DOI 10.1111/j.1471-4159.1986.tb13082.x; MURPHY VA, 1988, J NEUROCHEM, V51, P1777, DOI 10.1111/j.1471-4159.1988.tb01159.x; Payne ME, 2008, NUTR RES, V28, P285, DOI 10.1016/j.nutres.2008.02.013; Payne ME, 2014, BRIT J NUTR, V112, P220, DOI 10.1017/S0007114514000828; Payne ME, 2013, NUTRIENTS, V5, P2192, DOI 10.3390/nu5062192; Rashid G, 2008, EUR J CLIN INVEST, V38, P798, DOI 10.1111/j.1365-2362.2008.02033.x; Rashid G, 2007, NEPHROL DIAL TRANSPL, V22, P2831, DOI 10.1093/ndt/gfm269; Rezic-Muzinic N, 2013, J PHYSIOL BIOCHEM, V69, P199, DOI 10.1007/s13105-012-0202-y; SAPORITO MS, 1994, BRAIN RES, V633, P189, DOI 10.1016/0006-8993(94)91539-3; Schlogl M, 2014, CLIN INTERV AGING, V9, P559, DOI 10.2147/CIA.S51785; Schram MT, 2007, J AM GERIATR SOC, V55, P1786, DOI 10.1111/j.1532-5415.2007.01418.x; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; TAI CY, 1986, BRAIN RES, V385, P227, DOI 10.1016/0006-8993(86)91068-1; Takechi R, 2013, NEURODEGENER DIS, V12, P125, DOI 10.1159/000343211; Takechi R, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-91; Takechi R, 2013, CLIN EXP PHARMACOL P, V40, P45, DOI 10.1111/1440-1681.12032; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Throckmorton D, 2002, PEPTIDES, V23, P79, DOI 10.1016/S0196-9781(01)00582-4; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; TOVERUD SU, 1986, BONE MINER, V1, P145; Tuohimaa P, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS278, DOI 10.1016/j.psyneuen.2009.07.003; van Vliet P, 2009, NEUROLOGY, V72, P821, DOI 10.1212/01.wnl.0000343852.10018.24; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Walker MD, 2009, J CLIN ENDOCR METAB, V94, P1951, DOI 10.1210/jc.2008-2574; Wang-Fischer Y, 2009, MANUAL STROKE MODELS, P315; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	64	9	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125504	10.1371/journal.pone.0125504	http://dx.doi.org/10.1371/journal.pone.0125504			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874538	gold, Green Published			2022-12-26	WOS:000352845100297
J	Yoshihara, N; Sakamoto, T; Yamashita, T; Yamashita, T; Yamakiri, K; Sonoda, S; Ishibashi, T				Yoshihara, Naoya; Sakamoto, Taiji; Yamashita, Takehiro; Yamashita, Toshifumi; Yamakiri, Keita; Sonoda, Shozo; Ishibashi, Tatsuro			Wider Retinal Artery Trajectories in Eyes with Macular Hole Than in Fellow Eyes of Patients with Unilateral Idiopathic Macular Hole	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; NERVE-FIBER; AXIAL LENGTH	Purpose To determine whether the width of the retinal artery (RA) trajectory was associated with the presence of a macular hole (MH). Methods A retrospective cross sectional case-control study was performed. The fundus photographs were rotated 90 degrees, and the coordinates of the best fit curve of the RA trajectory were determined automatically based on these plots using the ImageJ program. The converted coordinates were fit to a second degree polynomial (ax(2)/100 + bx + c) equation. The width and steepness of the RA trajectory, "a", of the eyes with a MH eye were compared to that of the fellow eyes. Results One hundred and ten eyes of 55 consecutive patients (30 women) with a unilateral MH and healthy fellow eyes were analyzed. The mean age was 64.9 years (range 47-81 years). The constant 'a' was significantly smaller in eyes with a MH than that of the fellow eyes (0.379 +/- 0.094 vs 0.416 +/- 0.121, P = 0.001, paired t test), indicating that the RA trajectory was wider in the MH eyes than in the fellow eyes. There was a significant correlation between the axial length and 'a' of the RA trajectory in the MH eyes (R = 0.273, P = 0.044) and in the fellow eyes (R = 0.356, P = 0.008; Spearman's rank correlation coefficient). Conclusions Because eyes with a MH have a significantly wider and flatter RA trajectory, there may be greater traction on the fovea which is located between the RA arches. The causative role of this finding is still unclear.	[Yoshihara, Naoya; Sakamoto, Taiji; Yamashita, Takehiro; Yamashita, Toshifumi; Yamakiri, Keita; Sonoda, Shozo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan; [Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Fukuoka 812, Japan	Kagoshima University; Kyushu University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Grants-in-Aid for Scientific Research [26462643] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BENGTSSON B, 1980, ACTA OPHTHALMOL, V58, P726; BRONSTEIN MA, 1981, AM J OPHTHALMOL, V92, P757, DOI 10.1016/S0002-9394(14)75625-9; Chew EY, 1999, ARCH OPHTHALMOL-CHIC, V117, P242, DOI 10.1001/archopht.117.2.242; Ezra E, 1998, OPHTHALMOLOGY, V105, P353, DOI 10.1016/S0161-6420(98)93562-X; GASS JDM, 1988, ARCH OPHTHALMOL-CHIC, V106, P629, DOI 10.1001/archopht.1988.01060130683026; GASS JDM, 1995, AM J OPHTHALMOL, V119, P752, DOI 10.1016/S0002-9394(14)72781-3; Gaudric A, 1999, ARCH OPHTHALMOL-CHIC, V117, P744; HEE MR, 1995, OPHTHALMOLOGY, V102, P748, DOI 10.1016/S0161-6420(95)30959-1; Hoh ST, 2006, OPHTHALMOLOGY, V113, P773, DOI 10.1016/j.ophtha.2006.01.058; Hong SW, 2012, INVEST OPHTH VIS SCI, V51, P3515; Johnson Mark W, 2005, Trans Am Ophthalmol Soc, V103, P537; Johnson MW, 2001, ARCH OPHTHALMOL-CHIC, V119, P215; Kishi S, 2000, AM J OPHTHALMOL, V130, P65, DOI 10.1016/S0002-9394(00)00383-4; Kishi S, 1996, AM J OPHTHALMOL, V122, P622, DOI 10.1016/S0002-9394(14)70480-5; Kumagai K, 2013, AM J OPHTHALMOL, V156, P140, DOI 10.1016/j.ajo.2012.11.029; Kumagai K, 2012, ARCH OPHTHALMOL-CHIC, V130, P393, DOI 10.1001/archopthalmol.2011.1427; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Lewis ML, 1996, GRAEF ARCH CLIN EXP, V234, P241, DOI 10.1007/BF00430416; Ryan SJ, 2001, RETINA, V3, P1882; Singh A. J., 2012, International Ophthalmology, V32, P393, DOI 10.1007/s10792-012-9568-7; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Spaide RF, 2002, AM J OPHTHALMOL, V133, P226, DOI 10.1016/S0002-9394(01)01377-0; Steel DHW, 2013, EYE, V27, pS1, DOI 10.1038/eye.2013.212; Takahashi A, 2011, AM J OPHTHALMOL, V151, P981, DOI 10.1016/j.ajo.2011.01.011; Uchino E, 2001, ARCH OPHTHALMOL-CHIC, V119, P1475; Yamashita T, 2014, INVEST OPHTH VIS SCI, V55, P5176, DOI 10.1167/iovs.14-14105; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P5481, DOI 10.1167/iovs.12-11008; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836; YANNUZZI LA, 1994, AM J OPHTHALMOL, V118, P754; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008; Zangwill LM, 2000, OPHTHALMOLOGY, V107, P1309, DOI 10.1016/S0161-6420(00)00168-8	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122876	10.1371/journal.pone.0122876	http://dx.doi.org/10.1371/journal.pone.0122876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867212	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100113
J	Pec, GJ; Karst, J; Sywenky, AN; Cigan, PW; Erbilgin, N; Simard, SW; Cahill, JF				Pec, Gregory J.; Karst, Justine; Sywenky, Alexandra N.; Cigan, Paul W.; Erbilgin, Nadir; Simard, Suzanne W.; Cahill, James F., Jr.			Rapid Increases in Forest Understory Diversity and Productivity following a Mountain Pine Beetle (Dendroctonus ponderosae) Outbreak in Pine Forests	PLOS ONE			English	Article							BOREAL FOREST; PLANT-COMMUNITIES; TREE REGENERATION; VEGETATION; DYNAMICS; FIRE; MORTALITY; COMPETITION; MECHANISMS; SUCCESSION	The current unprecedented outbreak of mountain pine beetle (Dendroctonus ponderosae) in lodgepole pine (Pinus contorta) forests of western Canada has resulted in a landscape consisting of a mosaic of forest stands at different stages of mortality. Within forest stands, understory communities are the reservoir of the majority of plant species diversity and influence the composition of future forests in response to disturbance. Although changes to stand composition following beetle outbreaks are well documented, information on immediate responses of forest understory plant communities is limited. The objective of this study was to examine the effects of D. ponderosae-induced tree mortality on initial changes in diversity and productivity of understory plant communities. We established a total of 110 1-m(2) plots across eleven mature lodgepole pine forests to measure changes in understory diversity and productivity as a function of tree mortality and below ground resource availability across multiple years. Overall, understory community diversity and productivity increased across the gradient of increased tree mortality. Richness of herbaceous perennials increased with tree mortality as well as soil moisture and nutrient levels. In contrast, the diversity of woody perennials did not change across the gradient of tree mortality. Understory vegetation, namely herbaceous perennials, showed an immediate response to improved growing conditions caused by increases in tree mortality. How this increased pulse in understory richness and productivity affects future forest trajectories in a novel system is unknown.	[Pec, Gregory J.; Karst, Justine; Sywenky, Alexandra N.; Cahill, James F., Jr.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Karst, Justine; Cigan, Paul W.; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Simard, Suzanne W.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada	University of Alberta; University of Alberta; University of British Columbia	Pec, GJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	gpec@ualberta.ca	Pec, Gregory/L-8542-2013; Erbilgin, Nadir/F-3675-2014; Cahill, James/B-6147-2015	Pec, Gregory/0000-0002-6781-9112; Erbilgin, Nadir/0000-0001-9912-8095; Karst, Justine/0000-0003-0497-1552; Cahill, James/0000-0002-4110-1516	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery Grant; University of Alberta Doctoral Recruitment Scholarship; University of Alberta Undergraduate Research Initiative (URI) award; Alberta Conservation Association (ACA) Biodiversity Grant	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta Doctoral Recruitment Scholarship; University of Alberta Undergraduate Research Initiative (URI) award; Alberta Conservation Association (ACA) Biodiversity Grant	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Grant awarded to JFC Jr., SWS, NE, and J. Cooke and an NSERC Discovery Grant awarded to JFC Jr., SWS, and NE. GJP was supported by a University of Alberta Doctoral Recruitment Scholarship, AS by a University of Alberta Undergraduate Research Initiative (URI) award and PWC was supported by an Alberta Conservation Association (ACA) Biodiversity Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman GD, 1977, ROLE MOUNTAIN PINE B; Amoroso MM, 2013, FOREST ECOL MANAG, V310, P300, DOI 10.1016/j.foreco.2013.08.037; Astrup R, 2008, FOREST ECOL MANAG, V256, P1743, DOI 10.1016/j.foreco.2008.07.025; Axelson JN, 2009, FOREST ECOL MANAG, V257, P1874, DOI 10.1016/j.foreco.2009.01.047; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Barton K, 2009, R PACKAGE VERSION 1; Beckingham J.D., 1996, 9 CAN FOR SERV NW RE; Bock MD, 2002, CAN J FOREST RES, V32, P713, DOI 10.1139/X02-014; Bradbury S, 2004, CAN J FOREST RES, V34, P1220, DOI 10.1139/X04-010; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton P. J., 2008, BC Journal of Ecosystems and Management, V9, P9; Cater TC, 2000, ECOLOGY, V81, P1086, DOI 10.1890/0012-9658(2000)081[1086:DEOCOM]2.0.CO;2; Chen Han Y. H., 2002, Environmental Reviews, V10, P137, DOI 10.1139/a02-007; Chipman SJ, 2002, ECOL APPL, V12, P588, DOI 10.1890/1051-0761(2002)012[0588:UVPSDI]2.0.CO;2; Cigan P, 2015, PLANT SOIL, P1; Coates KD, 2009, ABUNDANCE SECONDARY; Collins BJ, 2011, FOREST ECOL MANAG, V261, P2168, DOI 10.1016/j.foreco.2011.03.016; Diskin M, 2011, CAN J FOREST RES, V41, P782, DOI [10.1139/X10-247, 10.1139/x10-247]; Dordel J, 2008, FOREST ECOL MANAG, V255, P3563, DOI 10.1016/j.foreco.2008.02.018; Edburg SL, 2012, FRONT ECOL ENVIRON, V10, P416, DOI 10.1890/110173; EHRENFELD JG, 1980, B TORREY BOT CLUB, V107, P29, DOI 10.2307/2484848; Fornwalt PJ, 2014, J VEG SCI, V25, P805, DOI 10.1111/jvs.12128; Greene DF, 1999, CAN J FOREST RES, V29, P824, DOI 10.1139/cjfr-29-6-824; Griffin JM, 2013, FOREST ECOL MANAG, V291, P228, DOI 10.1016/j.foreco.2012.11.029; Haeussler S, 2004, CAN J FOREST RES, V34, P274, DOI [10.1139/x03-274, 10.1139/X03-274]; Hart SA, 2008, ECOL MONOGR, V78, P123, DOI 10.1890/06-2140.1; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Huisinga KD, 2005, J TORREY BOT SOC, V132, P590, DOI 10.3159/1095-5674(2005)132[590:EOAIPF]2.0.CO;2; Kayes LJ, 2012, FOREST ECOL MANAG, V263, P57, DOI 10.1016/j.foreco.2011.09.035; Klutsch JG, 2009, FOREST ECOL MANAG, V258, P641, DOI 10.1016/j.foreco.2009.04.034; KOVACIC DA, 1985, FOREST ECOL MANAG, V13, P53, DOI 10.1016/0378-1127(85)90005-2; Lewis K, 2011, WOOD FIBER SCI, V43, P130; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McIntosh ACS, 2013, FOREST ECOL MANAG, V295, P11, DOI 10.1016/j.foreco.2012.12.050; MESSIER C, 1993, FOREST ECOL MANAG, V60, P181, DOI 10.1016/0378-1127(93)90080-7; Mitchell Russel G., 1998, Western Journal of Applied Forestry, V13, P23; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; PUTZ FE, 1992, FOREST ECOL MANAG, V49, P267, DOI 10.1016/0378-1127(92)90140-5; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randall MJ, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400069; Rhoades CC, 2013, P NATL ACAD SCI USA, V110, P1756, DOI 10.1073/pnas.1221029110; ROMME WH, 1986, AM NAT, V127, P484, DOI 10.1086/284497; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Safranyik L, 2006, THE MOUNTAIN PINE BE, P304; Stone WE, 1996, VEGETATIO, V122, P1, DOI 10.1007/BF00052811; STUART JD, 1989, CAN J FOREST RES, V19, P1096, DOI 10.1139/x89-166; Treu R, 2014, ECOLOGY, V95, P1096, DOI 10.1890/13-1233.1; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Zuur Alain F., 2009, P1	51	39	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124691	10.1371/journal.pone.0124691	http://dx.doi.org/10.1371/journal.pone.0124691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859663	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300144
J	Eells, JB; Varela-Stokes, A; Guo-Ross, SX; Kummari, E; Smith, HM; Cox, E; Lindsay, DS				Eells, Jeffrey B.; Varela-Stokes, Andrea; Guo-Ross, Shirley X.; Kummari, Evangel; Smith, Holly M.; Cox, Erin; Lindsay, David S.			Chronic Toxoplasma gondii in Nurr1-Null Heterozygous Mice Exacerbates Elevated Open Field Activity	PLOS ONE			English	Article							PREPULSE INHIBITION DEFICITS; VENTRAL TEGMENTAL AREA; KNOCK-OUT MICE; ENDOGENOUS KYNURENIC ACID; DOPAMINE NEURONS; GENE-EXPRESSION; BEHAVIORAL ABNORMALITIES; PREFRONTAL CORTEX; INFECTIOUS AGENTS; ACOUSTIC STARTLE	Latent infection with Toxoplasma gondii is common in humans (approximately 30% of the global population) and is a significant risk factor for schizophrenia. Since prevalence of T. gondii infection is far greater than prevalence of schizophrenia (0.5-1%), genetic risk factors are likely also necessary to contribute to schizophrenia. To test this concept in an animal model, Nurr1-null heterozygous (+/-) mice and wild-type (+/+) mice were evaluate using an emergence test, activity in an open field and with a novel object, response to bobcat urine and prepulse inhibition of the acoustic startle response (PPI) prior to and 6 weeks after infection with T. gondii. In the emergence test, T. gondii infection significantly decreased the amount of time spent in the cylinder. Toxoplasma gondii infection significantly elevated open field activity in both +/+ and +/- mice but this increase was significantly exacerbated in +/- mice. T. gondii infection reduced PPI in male +/- mice but this was not statistically significant. Aversion to bobcat urine was abolished by T. gondii infection in +/+ mice. In female +/- mice, aversion to bobcat urine remained after T. gondii infection while the male +/- mice showed no aversion to bobcat urine. Antibody titers of infected mice were a critical variable associated with changes in open field activity, such that an inverted U shaped relationship existed between antibody titers and the percent change in open field activity with a significant increase in activity at low and medium antibody titers but no effect at high antibody titers. These data demonstrate that the Nurr1 +/- genotype predisposes mice to T. gondii-induced alterations in behaviors that involve dopamine neurotransmission and are associated with symptoms of schizophrenia. We propose that these alterations in murine behavior were due to further exacerbation of the altered dopamine neurotransmission in Nurr1 +/- mice.	[Eells, Jeffrey B.; Varela-Stokes, Andrea; Guo-Ross, Shirley X.; Kummari, Evangel; Smith, Holly M.; Cox, Erin] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Lindsay, David S.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	Mississippi State University; Virginia Polytechnic Institute & State University	Eells, JB (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	eells@cvm.msstate.edu	Lindsay, David S/G-8891-2016; Kummari, Evangel/J-6019-2019; Varela-Stokes, Andrea/AAA-7417-2020	Lindsay, David S/0000-0002-0592-8321; Cox, Eric/0000-0003-4281-2990	NIH HHS [T35 OD010432] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010432] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abi-Dargham A, 2004, INT J NEUROPSYCHOPH, V7, pS1, DOI 10.1017/S1461145704004110; Ancin I, 2013, SCHIZOPHRENIA BULL, V39, P555, DOI 10.1093/schbul/sbr176; Arias I, 2012, SCHIZOPHR RES, V136, P128, DOI 10.1016/j.schres.2011.10.026; Ayhan Y, 2009, BEHAV BRAIN RES, V204, P274, DOI 10.1016/j.bbr.2009.04.010; Blomstrom A, 2012, SCHIZOPHR RES, V140, P25, DOI 10.1016/j.schres.2012.06.035; BRAFF DL, 1995, CLIN NEUROSCI, V3, P131; Braff DL, 1999, AM J PSYCHIAT, V156, P596; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen YH, 2001, AM J MED GENET, V105, P753, DOI 10.1002/ajmg.10036; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Duncan EJ, 2003, PSYCHOPHARMACOLOGY, V167, P63, DOI 10.1007/s00213-002-1372-z; Eastwood SL, 1997, MOL PSYCHIATR, V2, P322, DOI 10.1038/sj.mp.4000238; Eells JB, 2006, NEUROSCIENCE, V140, P1117, DOI 10.1016/j.neuroscience.2005.12.065; Eells JB, 2002, NEUROSCI RES COMMUN, V30, P173, DOI 10.1002/nrc.10029; Eells JB, 2002, BEHAV BRAIN RES, V136, P267, DOI 10.1016/S0166-4328(02)00185-7; Eells JB, 2006, BRAIN RES BULL, V70, P186, DOI 10.1016/j.brainresbull.2006.05.004; Eells JB, 2012, J MOL NEUROSCI, V46, P545, DOI 10.1007/s12031-011-9642-z; Erhardt S, 2004, BIOL PSYCHIAT, V56, P255, DOI 10.1016/j.biopsych.2004.06.006; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Fernagut PO, 2002, EUR J NEUROSCI, V15, P2053, DOI 10.1046/j.1460-9568.2002.02047.x; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gulinello M, 2010, MICROBES INFECT, V12, P528, DOI 10.1016/j.micinf.2010.03.009; HAY J, 1984, Z PARASITENKD, V70, P575, DOI 10.1007/BF00926588; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; HAY J, 1985, Z PARASITENKD, V71, P459, DOI 10.1007/BF00928348; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hinze-Selch D, 2007, SCHIZOPHRENIA BULL, V33, P782, DOI 10.1093/schbul/sbm010; Holub D, 2013, ACTA PSYCHIAT SCAND, V127, P227, DOI 10.1111/acps.12031; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P337, DOI 10.1080/00034983.1980.11687350; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Keller WR, 2013, J PSYCHOPHARMACOL, V27, P337, DOI 10.1177/0269881112467089; Kuepper R, 2012, HANDB EXP PHARMACOL, V212, P1, DOI 10.1007/978-3-642-25761-2_1; Lacroix L, 2000, BEHAV BRAIN RES, V107, P111, DOI 10.1016/S0166-4328(99)00118-7; Lau CI, 2013, REV NEUROSCIENCE, V24, P389, DOI 10.1515/revneuro-2013-0011; LIEBERMAN JA, 1993, SCHIZOPHRENIA BULL, V19, P371, DOI 10.1093/schbul/19.2.371; Light G A, 1999, Curr Psychiatry Rep, V1, P31, DOI 10.1007/s11920-999-0008-y; Linderholm KR, 2007, NEUROPHARMACOLOGY, V53, P918, DOI 10.1016/j.neuropharm.2007.09.003; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Lodge DJ, 2011, TRENDS PHARMACOL SCI, V32, P507, DOI 10.1016/j.tips.2011.05.001; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Ludewig K, 2002, SCHIZOPHR RES, V55, P129, DOI 10.1016/S0920-9964(01)00198-0; Mackeprang T, 2002, BIOL PSYCHIAT, V52, P863, DOI 10.1016/S0006-3223(02)01409-9; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; Miller CL, 2006, BRAIN RES, V1073, P25, DOI 10.1016/j.brainres.2005.12.056; Miyake N, 2011, CNS NEUROSCI THER, V17, P104, DOI 10.1111/j.1755-5949.2010.00230.x; Moore TM, 2008, SYNAPSE, V62, P764, DOI 10.1002/syn.20550; Mortensen PB, 2007, SCHIZOPHRENIA BULL, V33, P741, DOI 10.1093/schbul/sbm009; Mouri A, 2013, NEUROBIOL DIS, V53, P61, DOI 10.1016/j.nbd.2012.10.025; Muller N, 2006, NEUROTOX RES, V10, P131; Muller N, 2013, PSYCHIAT DANUB, V25, P292; Nagai T, 2011, BIOL PHARM BULL, V34, P1364, DOI 10.1248/bpb.34.1364; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Notarangelo FM, 2014, SCHIZOPHR RES, V152, P261, DOI 10.1016/j.schres.2013.11.011; Olsson SK, 2009, INT J NEUROPSYCHOPH, V12, P501, DOI 10.1017/S1461145708009383; Parsons CG, 1997, J PHARMACOL EXP THER, V283, P1264; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Ralph RJ, 2001, J PHARMACOL EXP THER, V298, P148; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ramanathan S, 2014, J CLIN NEUROSCI, V21, P722, DOI 10.1016/j.jocn.2013.07.017; Rojas P, 2007, MOL PSYCHIATR, V12, P756, DOI 10.1038/sj.mp.4001993; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Seeman MV, 2014, PROG NEURO-PSYCHOPH, V48, P155, DOI 10.1016/j.pnpbp.2013.10.003; Seeman P, 2013, EUR NEUROPSYCHOPHARM, V23, P999, DOI 10.1016/j.euroneuro.2013.06.005; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; SIMS TA, 1990, ANN TROP MED PARASIT, V84, P141, DOI 10.1080/00034983.1990.11812447; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; SWERDLOW NR, 1990, PSYCHOPHARMACOLOGY, V101, P414, DOI 10.1007/BF02244063; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Vuillermot S, 2011, GENES BRAIN BEHAV, V10, P589, DOI 10.1111/j.1601-183X.2011.00698.x; Vuillermot S, 2011, BRAIN BEHAV IMMUN, V25, P1316, DOI 10.1016/j.bbi.2011.06.012; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Wonodi I, 2011, ARCH GEN PSYCHIAT, V68, P665, DOI 10.1001/archgenpsychiatry.2011.71; Xiao J, 2014, NEUROSCIENCE, V268, P128, DOI 10.1016/j.neuroscience.2014.03.015; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	114	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119280	10.1371/journal.pone.0119280	http://dx.doi.org/10.1371/journal.pone.0119280			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855987	Green Published, gold			2022-12-26	WOS:000352588500006
J	Hanke, K; Hartz, A; Manz, M; Bendiks, M; Heitmann, F; Orlikowsky, T; Muller, A; Olbertz, D; Kuhn, T; Siegel, J; von der Wense, A; Wieg, C; Kribs, A; Stein, A; Pagel, J; Herting, E; Gopel, W; Hartel, C				Hanke, Kathrin; Hartz, Annika; Manz, Maike; Bendiks, Meike; Heitmann, Friedhelm; Orlikowsky, Thorsten; Mueller, Andreas; Olbertz, Dirk; Kuehn, Thomas; Siegel, Jens; von der Wense, Axel; Wieg, Christian; Kribs, Angela; Stein, Anja; Pagel, Julia; Herting, Egbert; Goepel, Wolfgang; Haertel, Christoph		German Neonatal Network GNN	Preterm Prelabor Rupture of Membranes and Outcome of Very-Low-Birth-Weight Infants in the German Neonatal Network	PLOS ONE			English	Article							27 WEEKS GESTATION; PREMATURE RUPTURE; INTENTIONAL DELIVERY; SURVEILLANCE SYSTEM; RISK-FACTOR; MANAGEMENT; DIAGNOSIS; SURVIVAL; CARE; CHORIOAMNIONITIS	Objective It was the aim of our study to evaluate the independent effect of preterm prelabor rupture of membranes (PPROM) as a cause of preterm delivery on mortality during primary hospital stay and significant morbidities in very-low-birth-weight (VLBW) infants <32 weeks of gestation. Design Observational, epidemiological study design. Setting Population-based cohort, German Neonatal Network (GNN). Population 6102 VLBW infants were enrolled in GNN from 2009-2012, n=4120 fulfilled criteria for primary analysis (<32 gestational weeks, no pre-eclampsia, HELLP (highly elevated liver enzymes and low platelets syndrome) or placental abruption as cause of preterm birth). Methods Multivariable logistic regression analyses included PPROM as potential risk factors for adverse outcomes and well established items such as gestational age in weeks, birth weight, antenatal steroids, center, inborn delivery, multiple birth, gender and being small-for-gestational-age. Results PPROM as cause of preterm delivery had no independent effect on the risk of early-onset sepsis, clinical sepsis and blood-culture proven sepsis, while gestational age proved to be the most important contributor to sepsis risk. The diagnosis of PPROM was associated with an increased risk for bronchopulmonary dysplasia (BPD; OR: 1.25, 95% CI: 1.02-1.55, p=0.03) but not with other major outcomes. Conclusions The diagnosis of PPROM per se is not associated with adverse outcome in VLBW infants <32 weeks apart from a moderately increased risk for BPD. Randomized controlled trials with primary neonatal outcomes are needed to determine which subgroup of VLBW infants benefit from expectant or intentional management of PPROM.	[Hanke, Kathrin; Hartz, Annika; Pagel, Julia; Herting, Egbert; Goepel, Wolfgang; Haertel, Christoph] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Manz, Maike] Univ Lubeck, Dept Womens Hlth & Obstet, Lubeck, Germany; [Bendiks, Meike] Univ Kiel, Dept Pediat, Kiel, Germany; [Heitmann, Friedhelm] Childrens Hosp Dortmund, Dortmund, Germany; [Orlikowsky, Thorsten] Univ Aachen, Dept Pediat, Aachen, Germany; [Olbertz, Dirk] Childrens Hosp, Rostock, Germany; [Kuehn, Thomas] Vivantes Childrens Hosp Berlin Neukolln, Berlin, Germany; [Siegel, Jens] Childrens Hosp Auf der Bult Hanover, Hannover, Germany; [von der Wense, Axel] Childrens Hosp Hamburg Altona, Hamburg, Germany; [Wieg, Christian] Childrens Hosp Aschaffenburg, Aschaffenburg, Germany; [Kribs, Angela] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany; [Stein, Anja] Univ Essen Gesamthsch, Dept Pediat, Essen, Germany	University of Lubeck; University of Lubeck; University of Kiel; RWTH Aachen University; University of Rostock; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Duisburg Essen	Hartel, C (corresponding author), Univ Lubeck, Dept Pediat, Lubeck, Germany.	christoph.haertel@uksh.de	Härtel, Christoph/ABD-8841-2020	Stein, Anja/0000-0002-0497-4609	German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research)	German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research)	This study is supported by a grant of the German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mandeel H, 2013, J MATERN-FETAL NEO M, V26, P83, DOI 10.3109/14767058.2012.718388; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; BLOTT M, 1988, ARCH DIS CHILD, V63, P683, DOI 10.1136/adc.63.6.683-a; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; Finnstrom O, 1997, ACTA PAEDIATR, V86, P503, DOI 10.1111/j.1651-2227.1997.tb08921.x; Furman B, 2000, EUR J OBSTET GYN R B, V92, P209, DOI 10.1016/S0301-2115(99)00257-2; Furman B, 2001, J Matern Fetal Med, V10, P107; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Hartling L, 2006, J MATERN-FETAL NEO M, V19, P177, DOI 10.1080/14767050500451470; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Manuck TA, 2009, OBSTET GYNECOL, V114, P29, DOI 10.1097/AOG.0b013e3181ab6fd3; Medina TM, 2006, AM FAM PHYSICIAN, V73, P659; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Messerschmidt A, 2011, NEONATOLOGY, V99, P146, DOI 10.1159/000313969; Newman DE, 2009, ARCH GYNECOL OBSTET, V280, P7, DOI 10.1007/s00404-008-0836-8; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts D, 2014, ULTRASOUND OBST GYN, V43, P490, DOI 10.1002/uog.13258; Schleussner E, 2013, DTSCH ARZTEBL INT, V110, P227, DOI 10.3238/arztebl.2013.0227; Schucker JL, 1996, SEMIN PERINATOL, V20, P389, DOI 10.1016/S0146-0005(96)80006-1; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Simhan HN, 2005, BJOG-INT J OBSTET GY, V112, P32, DOI 10.1111/j.1471-0528.2005.00582.x; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; van der Ham DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001208; van der Heyden JL, 2013, EUR J OBSTET GYN R B, V170, P125, DOI 10.1016/j.ejogrb.2013.06.012; van Teeffelen ASP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-128; Van Teeffelen S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009952.pub2; Verspyck E, 2014, ACTA PAEDIATR, V103, P256, DOI 10.1111/apa.12489; Voigt M, 2010, J PERINAT MED, V38, P289, DOI [10.1515/JPM.2010.031, 10.1515/jpm.2010.031]; Waters TP, 2009, AM J OBSTET GYNECOL, V201, P230, DOI 10.1016/j.ajog.2009.06.049; Williams O, 2012, NEONATOLOGY, V101, P83, DOI 10.1159/000329445	34	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122564	10.1371/journal.pone.0122564	http://dx.doi.org/10.1371/journal.pone.0122564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856083	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500042
J	Salinero-Fort, MA; Andres-Rebollo, FJS; de Burgos-Lunar, C; Gomez-Campelo, P; Chico-Moraleja, RM; de Andres, AL; Jimenez-Garcia, R				Salinero-Fort, Miguel A.; San Andres-Rebollo, Francisco J.; de Burgos-Lunar, Carmen; Gomez-Campelo, Paloma; Chico-Moraleja, Rosa M.; Lopez de Andres, Ana; Jimenez-Garcia, Rodrigo		MADIABETES Grp	Five-Year Incidence of Chronic Kidney Disease (Stage 3-5) and Associated Risk Factors in a Spanish Cohort: The MADIABETES Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; DIABETES-MELLITUS; RENAL-FUNCTION; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS RISK; METABOLIC SYNDROME; ESTIMATED GFR; ALBUMINURIA; POPULATION	Objective To evaluate the incidence rate of Chronic Kidney Disease (CKD) stage 3-5 (persistent decreased kidney function under 60 mL/min per 1.73 m(2)) among patients with type 2 diabetes over five years, to identify the risk factors associated with CKD, and develop a risk table to predict five-year CKD stage 3-5 risk stratification for clinical use. Design The MADIABETES Study is a prospective cohort study of 3,443 outpatients with type 2 diabetes mellitus, sampled from 56 primary health care centers (131 general practitioners) in Madrid (Spain). Results The cumulative incidence of CKD stage 3-5 at five-years was 10.23% (95% CI = 9.12-11.44) and the incidence density was 2.07 (95% CI = 1.83-2.33) cases per 1,000 patient-months or 2.48 (95% CI = 2.19-2.79) cases per 100 patient-years. The highest hazard ratio (HR) for developing CKD stage 3-5 was albuminuria >= 300 mg/g (HR = 4.57; 95% CI=2.46-8.48). Furthermore, other variables with a high HR were age over 74 years (HR = 3.20; 95% CI = 2.13-4.81), a history of Hypertension (HR = 2.02; 95% CI = 1.42-2.89), Myocardial Infarction (HR = 1.72; 95% IC = 1.25-2.37), Dyslipidemia (HR = 1.68; 95% CI = 1.30-2.17), duration of diabetes mellitus >= 10 years (HR = 1.46; 95% CI = 1.14-1.88) and Systolic Blood Pressure > 149 mmHg (HR = 1.52; 95% CI = 1.02-2.24). Conclusions After a five-year follow-up, the cumulative incidence of CKD is concordant with rates described in Spain and other countries. Albuminuria >= 300 mg/g and age over 74 years were the risk factors more strongly associated with developing CKD (Stage 3-5). Blood Pressure, lipid and albuminuria control could reduce CKD incidence of CKD in patients with T2DM.	[Salinero-Fort, Miguel A.] Inst Invest Hosp Univ La Paz IdiPAZ, Red Invest Serv Salud Enfermedades Cronicas REDIS, Serv Madrileno Salud, Gerencia Atenc Primaria Gerencia Adjunta Planific, Madrid, Spain; [San Andres-Rebollo, Francisco J.] Serv Madrileno Salud, Ctr Salud Las Calesas, Madrid, Spain; [de Burgos-Lunar, Carmen] Inst Invest Hosp Univ La Paz IdiPAZ, Red Invest Serv Salud Enfermedades Cronicas REDIS, Serv Med Prevent, Hosp Univ La Paz,Serv Madrileno Salud, Madrid, Spain; [Gomez-Campelo, Paloma] Inst Invest Hosp Univ La Paz IdiPAZ, Plataforma Apoyo Invest Novel, Madrid, Spain; [Chico-Moraleja, Rosa M.; Lopez de Andres, Ana] Hosp Cent Def Gomez Ulla, Unidad Med Interna, Serv Madrileno Salud, Madrid, Spain; [Jimenez-Garcia, Rodrigo] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Universidad Rey Juan Carlos	Salinero-Fort, MA (corresponding author), Inst Invest Hosp Univ La Paz IdiPAZ, Red Invest Serv Salud Enfermedades Cronicas REDIS, Serv Madrileno Salud, Gerencia Atenc Primaria Gerencia Adjunta Planific, Madrid, Spain.	miguel.salinero@salud.madrid.org	Lopez-de-Andres, Ana/AAD-8703-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; de Santa Pau, Enrique Carrillo/AAV-7544-2021; ALVAREZ EMBARBA, BEATRIZ/AHE-8612-2022; Lopez-de-Andres, Ana/D-4498-2019; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Garcia-Garcia, Francisco Jose/R-9258-2017	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; ALVAREZ EMBARBA, BEATRIZ/0000-0002-2084-3051; Lopez-de-Andres, Ana/0000-0001-5551-5181; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Serrano Serrano, Maria Encarnacion/0000-0003-3150-2348; Vich Perez, Pilar/0000-0002-6702-909X; Garcia-Garcia, Francisco Jose/0000-0003-3690-6069; Gomez Campelo, Paloma/0000-0003-2299-1741	National R+D+I (Research + Development + Innovation) Plan of the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III [PI10/02796, PI12/01806]	National R+D+I (Research + Development + Innovation) Plan of the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III	This work was supported by a grant from the 2008-2011 National R+D+I (Research + Development + Innovation) Plan of the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III (PI10/02796 and PI12/01806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535; Agarwal R, 2006, KIDNEY INT, V69, P1175, DOI 10.1038/sj.ki.5000247; Arauz-Pacheco Carlos, 2003, Diabetes Care, V26 Suppl 1, pS80; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Bosomworth NJ, 2011, CAN FAM PHYSICIAN, V57, P417; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Diaz-Lopez A, 2012, AM J KIDNEY DIS, V60, P380, DOI 10.1053/j.ajkd.2012.02.334; Domenech JM, 2008, ANALISIS SUPERVIVENC; Drury PL, 2011, DIABETOLOGIA, V54, P32, DOI 10.1007/s00125-010-1854-1; Dunkler D, 2013, JAMA INTERN MED, V173, P1682, DOI 10.1001/jamainternmed.2013.9051; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunzler D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-124; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herget-Rosenthal S, 2013, PREV MED, V57, P357, DOI 10.1016/j.ypmed.2013.06.010; Hillege HL, 2003, EUR HEART J, V24, P412, DOI 10.1016/S0195-668X(02)00526-2; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Jenkins AJ, 2003, KIDNEY INT, V64, P817, DOI 10.1046/j.1523-1755.2003.00164.x; Jerums G, 2008, AM J NEPHROL, V28, P614, DOI 10.1159/000117461; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Kshirsagar AV, 2008, ARCH INTERN MED, V168, P2466, DOI 10.1001/archinte.168.22.2466; LANE PH, 1992, DIABETES, V41, P581, DOI 10.2337/diabetes.41.5.581; LEE ET, 1994, DIABETES, V43, P572, DOI 10.2337/diabetes.43.4.572; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MacIsaac R, 2004, DIABETES CARE, V27, P195, DOI 10.2337/diacare.27.1.195; Marrugat J, 2003, REV ESP CARDIOL, V56, P253, DOI 10.1157/13043951; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Newman DJ, 2005, HLTH TECHNOLOGY ASSE, V9, pxiii; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; O'Seaghdha CM, 2012, AM J MED, V125, P270, DOI 10.1016/j.amjmed.2011.09.009; Parving H.-H, 2004, BRENNER RECTORS KIDN, P1777; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Rodriguez-Poncelas A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-46; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; Salinero-Fort MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076417; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; So WY, 2006, DIABETES CARE, V29, P2046, DOI 10.2337/dc06-0248; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stewart JH, 2006, DIABETIC MED, V23, P1364; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2002, KIDNEY INT, V62, P1743, DOI 10.1046/j.1523-1755.2002.00626.x; TSALAMANDRIS C, 1994, DIABETES, V43, P649, DOI 10.2337/diabetes.43.5.649; Wassink AMJ, 2008, EUR HEART J, V29, P213, DOI 10.1093/eurheartj/ehm582; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Zoppini G, 2009, NUTR METAB CARDIOVAS, V19, P580, DOI 10.1016/j.numecd.2008.11.003; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	59	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122030	10.1371/journal.pone.0122030	http://dx.doi.org/10.1371/journal.pone.0122030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856231	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500030
J	Wang, S; Parthasarathy, S; Nishiyama, Y; Endo, Y; Nemoto, T; Yamauchi, K; Asakura, T; Takeda, M; Terauchi, T; Kainosho, M; Ishii, Y				Wang, Songlin; Parthasarathy, Sudhakar; Nishiyama, Yusuke; Endo, Yuki; Nemoto, Takahiro; Yamauchi, Kazuo; Asakura, Tetsuo; Takeda, Mitsuhiro; Terauchi, Tsutomu; Kainosho, Masatsune; Ishii, Yoshitaka			Nano-Mole Scale Side-Chain Signal Assignment by H-1-Detected Protein Solid-State NMR by Ultra-Fast Magic-Angle Spinning and Stereo-Array Isotope Labeling	PLOS ONE			English	Article							HIGH-RESOLUTION; STRUCTURAL-CHARACTERIZATION; MOLECULAR-STRUCTURE; SECONDARY-STRUCTURE; INVERSE DETECTION; AMYLOID FIBRILS; SPECTROSCOPY; MAS; RESONANCE; DYNAMICS	We present a general approach in H-1-detected C-13 solid-state NMR (SSNMR) for side-chain signal assignments of 10-50 nmol quantities of proteins using a combination of a high magnetic field, ultra-fast magic-angle spinning (MAS) at similar to 80 kHz, and stereo-array-isotope-labeled (SAIL) proteins [Kainosho M. et al., Nature 440, 52-57, 2006]. First, we demonstrate that H-1 indirect detection improves the sensitivity and resolution of C-13 SSNMR of SAIL proteins for side-chain assignments in the ultra-fast MAS condition. H-1-detected SSNMR was performed for micro-crystalline ubiquitin (similar to 55 nmol or similar to 0.5mg) that was SAIL-labeled at seven isoleucine (Ile) residues. Sensitivity was dramatically improved by H-1-detected 2D H-1/C-13 SSNMR by factors of 5.4-9.7 and 2.1-5.0, respectively, over C-13-detected 2D H-1/C-13 SSNMR and 1D C-13 CPMAS, demonstrating that 2D H-1-detected SSNMR offers not only additional resolution but also sensitivity advantage over 1D C-13 detection for the first time. High H-1 resolution for the SAIL-labeled side-chain residues offered reasonable resolution even in the 2D data. A H-1-detected 3D C-13/C-13/H-1 experiment on SAIL-ubiquitin provided nearly complete H-1 and C-13 assignments for seven Ile residues only within similar to 2.5 h. The results demonstrate the feasibility of side-chain signal assignment in this approach for as little as 10 nmol of a protein sample within similar to 3 days. The approach is likely applicable to a variety of proteins of biological interest without any requirements of highly efficient protein expression systems.	[Wang, Songlin; Parthasarathy, Sudhakar; Ishii, Yoshitaka] Dept Chem, Chicago, IL 60637 USA; [Wang, Songlin; Parthasarathy, Sudhakar; Ishii, Yoshitaka] Univ Illinois, Chicago, IL USA; [Nishiyama, Yusuke; Endo, Yuki; Nemoto, Takahiro] JEOL RESONANCE Inc, Akishima, Tokyo, Japan; [Nishiyama, Yusuke] RIKEN, CLST JEOL Collaborat Ctr, Yokohama, Kanagawa, Japan; [Yamauchi, Kazuo] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan; [Yamauchi, Kazuo] King Abdullah Univ Sci & Technol, Nucl Magnet Resonance Core Lab, Thuwal, Saudi Arabia; [Asakura, Tetsuo] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 184, Japan; [Takeda, Mitsuhiro; Kainosho, Masatsune] Nagoya Univ, Struct Biol Res Ctr, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Terauchi, Tsutomu] SAIL Technol Co Inc, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kainosho, Masatsune] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 158, Japan; [Ishii, Yoshitaka] Univ Illinois, Struct Biol Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Jeol Ltd; JEOL Japan; RIKEN; Nazarbayev University; King Abdullah University of Science & Technology; Tokyo University of Agriculture & Technology; Nagoya University; Tokyo Metropolitan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ishii, Y (corresponding author), Dept Chem, Chicago, IL 60637 USA.	yishii@uic.edu	Asakura, Tetsuo/B-9970-2013; Ishii, Yoshitaka/F-4558-2014; Wang, Songlin/M-8088-2017	Asakura, Tetsuo/0000-0003-4472-6105; Ishii, Yoshitaka/0000-0002-7724-6469; Nishiyama, Yusuke/0000-0001-7136-1127	U.S. National Science Foundation [CHE 957793, CHE 1310363]; Dreyfus Foundation Teacher-Scholar Award program; National Institutes of Health HEI grant [1S10 RR025105]; JEOL RESONANCE Inc.; SAIL Technologies Co., Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025105] Funding Source: NIH RePORTER; Division Of Chemistry [1310363] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [26119005, 26248050] Funding Source: KAKEN	U.S. National Science Foundation(National Science Foundation (NSF)); Dreyfus Foundation Teacher-Scholar Award program; National Institutes of Health HEI grant; JEOL RESONANCE Inc.; SAIL Technologies Co., Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported primarily by grants to YI from the U.S. National Science Foundation (CHE 957793 and CHE 1310363) and the Dreyfus Foundation Teacher-Scholar Award program. The instrumentation of the 750 MHz SSNMR at UIC was supported by an National Institutes of Health HEI grant (1S10 RR025105) to YI. JEOL RESONANCE Inc. and SAIL Technologies Co., Inc. provided support in the form of salaries for authors YN, YE, TN and TT, but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated above.	Althaus SM, 2014, SOLID STATE NUCL MAG, V57-58, P17, DOI 10.1016/j.ssnmr.2013.11.001; Barbet-Massin E, 2014, J AM CHEM SOC, V136, P12489, DOI 10.1021/ja507382j; Chevelkov V, 2006, ANGEW CHEM INT EDIT, V45, P3878, DOI 10.1002/anie.200600328; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103; Guo CM, 2014, J BIOMOL NMR, V60, P219, DOI 10.1007/s10858-014-9870-y; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; Huber M, 2012, PHYS CHEM CHEM PHYS, V14, P5239, DOI 10.1039/c2cp23872a; Igumenova TI, 2004, J AM CHEM SOC, V126, P6720, DOI 10.1021/ja030547o; Ishii Y, 2000, J MAGN RESON, V142, P199, DOI 10.1006/jmre.1999.1976; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Ishii Y, 2001, J AM CHEM SOC, V123, P2921, DOI 10.1021/ja015505j; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kainosho M, 2009, Q REV BIOPHYS, V42, P247, DOI 10.1017/S0033583510000016; Knight MJ, 2011, ANGEW CHEM INT EDIT, V50, P11697, DOI 10.1002/anie.201106340; Kobayashi T, 2013, ANGEW CHEM INT EDIT, V52, P14108, DOI 10.1002/anie.201305475; Kotecha M, 2007, MAGN RESON CHEM, V45, pS221, DOI 10.1002/mrc.2151; Lange A, 2009, CHEM PHYS LETT, V468, P100, DOI 10.1016/j.cplett.2008.11.089; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Marchetti A, 2012, ANGEW CHEM INT EDIT, V51, P10756, DOI 10.1002/anie.201203124; Nadaud PS, 2010, J AM CHEM SOC, V132, P9561, DOI 10.1021/ja103545e; Nishiyama Y, 2014, J MAGN RESON, V244, P1, DOI 10.1016/j.jmr.2014.04.008; Parthasarathy S, 2013, ACCOUNTS CHEM RES, V46, P2127, DOI 10.1021/ar4000482; Paulson EK, 2003, J AM CHEM SOC, V125, P15831, DOI 10.1021/ja037315+; Reif B, 2012, J MAGN RESON, V216, P1, DOI 10.1016/j.jmr.2011.12.017; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Schnell I, 2002, J AM CHEM SOC, V124, P10938, DOI 10.1021/ja026657x; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; Suiter CL, 2014, J BIOMOL NMR, V59, P57, DOI 10.1007/s10858-014-9824-4; Takahashi H, 2010, J MAGN RESON, V203, P253, DOI 10.1016/j.jmr.2010.01.005; TORII K, 1971, ACTA CRYSTALL B-STRU, VB 27, P2237, DOI 10.1107/S0567740871005612; VARUGHESE KI, 1976, PRAMANA, V6, P189, DOI 10.1007/BF02875209; Vyalikh A, 2014, J PHYS CHEM B, V118, P724, DOI 10.1021/jp410299x; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wickramasinghe NP, 2009, NAT METHODS, V6, P215, DOI [10.1038/nmeth.1300, 10.1038/NMETH.1300]; Zhou DH, 2007, J AM CHEM SOC, V129, P11791, DOI 10.1021/ja073462m	40	12	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122714	10.1371/journal.pone.0122714	http://dx.doi.org/10.1371/journal.pone.0122714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856081	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500049
J	Meena, MK; Ghawana, S; Sardar, A; Dwivedi, V; Khandal, H; Roy, R; Chattopadhyay, D				Meena, Mukesh Kumar; Ghawana, Sanjay; Sardar, Atish; Dwivedi, Vikas; Khandal, Hitaishi; Roy, Riti; Chattopadhyay, Debasis			Investigation of Genes Encoding Calcineurin B-Like Protein Family in Legumes and Their Expression Analyses in Chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; CALCIUM SENSOR CBL10; ABIOTIC STRESS; SALT TOLERANCE; TRANSCRIPTOME ANALYSIS; SIGNALING NETWORK; COLD-ACCLIMATION; ION HOMEOSTASIS; ARABIDOPSIS; KINASE	Calcium ion (Ca2+) is a ubiquitous second messenger that transmits various internal and external signals including stresses and, therefore, is important for plants' response process. Calcineurin B-like proteins (CBLs) are one of the plant calcium sensors, which sense and convey the changes in cytosolic Ca2+-concentration for response process. A search in four leguminous plant (soybean, Medicago truncatula, common bean and chickpea) genomes identified 9 to 15 genes in each species that encode CBL proteins. Sequence analyses of CBL peptides and coding sequences (CDS) suggested that there are nine original CBL genes in these legumes and some of them were multiplied during whole genome or local gene duplication. Coding sequences of chickpea CBL genes (CaCBL) were cloned from their cDNAs and sequenced, and their annotations in the genome assemblies were corrected accordingly. Analyses of protein sequences and gene structures of CBL family in plant kingdom indicated its diverse origin but showed a remarkable conservation in overall protein structure with appearance of complex gene structure in the course of evolution. Expression of CaCBL genes in different tissues and in response to different stress and hormone treatment were studied. Most of the CaCBL genes exhibited high expression in flowers. Expression profile of CaCBL genes in response to different abiotic stresses and hormones related to development and stresses (ABA, auxin, cytokinin, SA and JA) at different time intervals suggests their diverse roles in development and plant defence in addition to abiotic stress tolerance. These data not only contribute to a better understanding of the complex regulation of chickpea CBL gene family, but also provide valuable information for further research in chickpea functional genomics.	[Meena, Mukesh Kumar; Ghawana, Sanjay; Sardar, Atish; Dwivedi, Vikas; Khandal, Hitaishi; Roy, Riti; Chattopadhyay, Debasis] Natl Inst Plant Genome Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	debasis@nipgr.ac.in	Meena, Mukesh/GNH-5631-2022	Meena, Mukesh Kumar/0000-0002-8847-2023; Sardar, Atish/0000-0002-8737-1175; Chattopadhyay, Debasis/0000-0002-5754-4987	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The work was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India under the project 'Next generation challenge program in chickpea genomics' (BT/PR12919/AGR/02/676/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Boominathan P, 2004, PLANT PHYSIOL, V135, P1608, DOI 10.1104/pp.104.043141; Buchel AS, 1999, PLANT MOL BIOL, V40, P387, DOI 10.1023/A:1006144505121; Chen L, 2012, J EXP BOT, V63, P6211, DOI 10.1093/jxb/ers273; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cuellar T, 2013, PLANT J, V73, P1006, DOI 10.1111/tpj.12092; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; de la Torre F, 2013, PLANT CELL, V25, P2748, DOI 10.1105/tpc.113.113530; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Eckert C, 2014, PLANT J, V78, P146, DOI 10.1111/tpj.12456; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; Kurusu T, 2010, PLANT SIGNAL BEHAV, V5, P1045, DOI [10.4161/psb.5.8.12407, 10.1104/pp.109.151852]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Z, 2013, REGEN MED, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0056412; Li ZY, 2012, BIOCHEM BIOPH RES CO, V427, P731, DOI 10.1016/j.bbrc.2012.09.128; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lyzenga WJ, 2013, J EXP BOT, V64, P2779, DOI 10.1093/jxb/ert123; Mahs A, 2013, MOL PLANT, V6, P1149, DOI 10.1093/mp/sst095; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MONROY AF, 1993, PLANT PHYSIOL, V102, P1227, DOI 10.1104/pp.102.4.1227; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; MONTGOMERY J, 1993, P NATL ACAD SCI USA, V90, P5939, DOI 10.1073/pnas.90.13.5939; Nagae M, 2003, J BIOL CHEM, V278, P42240, DOI 10.1074/jbc.M303630200; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Piao HL, 2010, MOL CELLS, V30, P19, DOI 10.1007/s10059-010-0084-1; Ren XL, 2013, PLANT J, V74, P258, DOI 10.1111/tpj.12123; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang RJ, 2012, CELL RES, V22, P1650, DOI 10.1038/cr.2012.161; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Tsou PL, 2012, PLANTA, V235, P539, DOI 10.1007/s00425-011-1522-9; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang HC, 2013, PLANT CELL REP, V32, P611, DOI 10.1007/s00299-013-1394-5	66	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123640	10.1371/journal.pone.0123640	http://dx.doi.org/10.1371/journal.pone.0123640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853855	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400111
J	Pereira, LA; Hugo, HJ; Malaterre, J; Xu, HL; Sonza, S; Cures, A; Purcell, DFJ; Ramsland, PA; Gerondakis, S; Gonda, TJ; Ramsay, RG				Pereira, Lloyd A.; Hugo, Honor J.; Malaterre, Jordane; Xu Huiling; Sonza, Secondo; Cures, Alina; Purcell, Damian F. J.; Ramsland, Paul A.; Gerondakis, Steven; Gonda, Thomas J.; Ramsay, Robert G.			MYB Elongation Is Regulated by the Nucleic Acid Binding of NF kappa B p50 to the Intronic Stem-Loop Region	PLOS ONE			English	Article							RNA-POLYMERASE-II; HIV-1 TAT PROTEIN; C-MYB; P-TEFB; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; MESSENGER-RNA; HIGH-AFFINITY; IN-VITRO; P50/P65 HETERODIMER	MYB transcriptional elongation is regulated by an attenuator sequence within intron 1 that has been proposed to encode a RNA stem loop (SLR) followed by a polyU tract. We report that NF kappa Bp50 can bind the SLR polyU RNA and promote MYB transcriptional elongation together with NF kappa Bp65. We identified a conserved lysine-rich motif within the Rel homology domain (RHD) of NF kappa Bp50, mutation of which abrogated the interaction of NF kappa Bp50 with the SLR polyU and impaired NF kappa Bp50 mediated MYB elongation. We observed that the TAR RNA-binding region of Tat is homologous to the NF kappa Bp50 RHD lysine-rich motif, a finding consistent with HIV Tat acting as an effector of MYB transcriptional elongation in an SLR dependent manner. Furthermore, we identify the DNA binding activity of NF kappa Bp50 as a key component required for the SLR polyU mediated regulation of MYB. Collectively these results suggest that the MYB SLR polyU provides a platform for proteins to regulate MYB and reveals novel nucleic acid binding properties of NF kappa Bp50 required for MYB regulation.	[Pereira, Lloyd A.; Malaterre, Jordane; Xu Huiling; Cures, Alina; Ramsay, Robert G.] Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Melbourne, Vic 8006, Australia; [Pereira, Lloyd A.; Malaterre, Jordane; Xu Huiling; Ramsay, Robert G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia; [Xu Huiling; Ramsay, Robert G.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Hugo, Honor J.] St Vincents Inst Med Res, Victorian Breast Canc Consortium, Invas & Metastasis Unit, Fitzroy, Vic 3065, Australia; [Sonza, Secondo; Purcell, Damian F. J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Ramsland, Paul A.] Burnet Inst, Ctr Immunol, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Melbourne, Vic 3084, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Gerondakis, Steven] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Gonda, Thomas J.] Univ Queensland, Sch Pharm, Woolloongabba, Qld 4102, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; Burnet Institute; Austin Research Institute; University of Melbourne; Monash University; Monash University; University of Queensland	Ramsay, RG (corresponding author), Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Locked Bag 1, Melbourne, Vic 8006, Australia.	rob.ramsay@petermac.org	Ramsay, Robert G/C-3291-2015; Purcell, Damian F/G-5068-2011	Ramsay, Robert G/0000-0001-5003-0433; Ramsland, Paul/0000-0002-2107-2738; Hugo, Honor/0000-0001-9436-5286	National Health and Medical Research Council of Australia [487922]; Australian Research Council [DP0985025]; National Institutes of Health [5-R21-AI-54158-2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054158] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Health and Medical Research Council of Australia, https://www.nhmrc.gov.au/, 487922, RR, Australian Research Council, DP0985025, http://www.arc.gov.au/, RR and National Institutes of Health grant, 5-R21-AI-54158-2, http://www.nih.gov/, RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BARNETT RW, 1993, NUCLEIC ACIDS RES, V21, P151, DOI 10.1093/nar/21.1.151; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Cheasley D, 2011, STEM CELLS, V29, P2042, DOI 10.1002/stem.761; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Ciznadija D, 2009, CELL DEATH DIFFER, V16, P1530, DOI 10.1038/cdd.2009.94; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Fromm G, 2013, CELL, V153, P930, DOI 10.1016/j.cell.2013.04.011; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Hugo H, 2006, GENE CHROMOSOME CANC, V45, P1143, DOI 10.1002/gcc.20378; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Khan MTH, 2012, CURR TOP MED CHEM, V12, P814; Lauder A, 2001, MOL CELL BIOL, V21, P5797, DOI 10.1128/MCB.21.17.5797-5805.2001; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Mathews DH, 2007, CURR PROTOC NUCL ACI; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; Mitra P, 2012, NUCLEIC ACIDS RES, V40, P5988, DOI 10.1093/nar/gks286; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; REDDY CD, 1989, P NATL ACAD SCI USA, V86, P7326, DOI 10.1073/pnas.86.19.7326; Reiter NJ, 2008, NUCLEIC ACIDS RES, V36, P1227, DOI 10.1093/nar/gkm1141; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shilatifard A, 1998, FASEB J, V12, P1437, DOI 10.1096/fasebj.12.14.1437; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Suhasini M, 1997, ONCOGENE, V15, P1859, DOI 10.1038/sj.onc.1201530; Suhasini M, 1999, ONCOGENE, V18, P7360, DOI 10.1038/sj.onc.1203158; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Thompson MA, 1997, ONCOGENE, V14, P1715, DOI 10.1038/sj.onc.1201007; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; TOTH CR, 1995, J BIOL CHEM, V270, P7661, DOI 10.1074/jbc.270.13.7661; WATSON RJ, 1988, ONCOGENE, V2, P267; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wurster SE, 2008, RNA, V14, P1037, DOI 10.1261/rna.878908; Wurster SE, 2009, NUCLEIC ACIDS RES, V37, P6214, DOI 10.1093/nar/gkp670; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	59	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122919	10.1371/journal.pone.0122919	http://dx.doi.org/10.1371/journal.pone.0122919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853889	gold, Green Published			2022-12-26	WOS:000352478400084
J	Rice, J; Roberts, H; Burton, J; Pan, J; States, V; Rai, SN; Galandiuk, S				Rice, Jonathan; Roberts, Henry; Burton, James; Pan, Jianmin; States, Vanessa; Rai, Shesh N.; Galandiuk, Susan			Assay Reproducibility in Clinical Studies of Plasma miRNA	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; DIAGNOSTIC BIOMARKER; COLORECTAL-CANCER; HEART-FAILURE; MARKERS; BLOOD; EXPRESSION; SIGNATURE	There are increasing reports of plasma miRNAs as biomarkers of human disease but few standards in methodologic reporting, leading to inconsistent data. We systematically reviewed plasma miRNA studies published between July 2013-June 2014 to assess methodology. Six parameters were investigated: time to plasma extraction, methods of RNA extraction, type of miRNA, quantification, cycle threshold (Ct) setting, and methods of statistical analysis. We compared these data with a proposed standard methodologic technique. Beginning with initial screening for 380 miRNAs using microfluidic array technology and validation in an additional cohort of patients, we compared 11 miRNAs that exhibited differential expression between 16 patients with benign colorectal neoplasms (advanced adenomas) and 16 patients without any neoplasm (controls). Plasma was isolated immediately, 12, 24, 48, or 72 h following phlebotomy. miRNA was extracted using two different techniques (Trizol LS with pre-amplification or modified miRNeasy). We performed Taq-man- based RT-PCR assays for the 11 miRNAs with subsequent analyses using a variable Ct setting or a fixed Ct set at 0.01, 0.03, 0.05, or 0.5. Assays were performed in duplicate by two different operators. RNU6 was the internal reference. Systematic review yielded 74 manuscripts meeting inclusion criteria. One manuscript (1.4%) documented all 6 methodological parameters, while < 5% of studies listed Ct setting. In our proposed standard technique, plasma extraction <= 12 h provided consistent Delta Ct. miRNeasy extraction yielded higher miRNA concentrations and fewer non-expressed miRNAs compared to Trizol LS (1/704 miRNAs [0.14%] vs 109/704 miRNAs [15%], not expressed, respectively). A fixed Ct bar setting of 0.03 yielded the most reproducible data, provided that < 10% miRNA were non-expressed. There was no significant intra-operator variability. There was significant inter-operator variation using Trizol LS extraction, while this was negligible using modified miRNeasy. For standardized reporting, we recommend plasma extraction <= 12 h, using modified miRNeasy extraction and utilizing a 0.03 Ct.	[Rice, Jonathan; Roberts, Henry; Burton, James; States, Vanessa; Galandiuk, Susan] Univ Louisville, Sch Med, Price Inst Surg Res, Hiram C Polk Jr MD Dept Surg, Louisville, KY 40292 USA; [Pan, Jianmin; Rai, Shesh N.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Galandiuk, S (corresponding author), Univ Louisville, Sch Med, Price Inst Surg Res, Hiram C Polk Jr MD Dept Surg, Louisville, KY 40292 USA.	s0gala01@louisville.edu			Wendell Cherry Chair Clinical Trial Research Fund	Wendell Cherry Chair Clinical Trial Research Fund	This publication is made possible in part by the John W. and Caroline Price Family Trust as well as gifts from Donald and Irene Dizney and the Alagia Family Foundation. Dr. Rai is partly supported by the Wendell Cherry Chair Clinical Trial Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achberger S, 2014, MOL IMMUNOL, V58, P182, DOI 10.1016/j.molimm.2013.11.018; Aushev VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078649; Ayaz L, 2013, J CANCER RES CLIN, V139, P1499, DOI 10.1007/s00432-013-1469-2; Benson EA, 2013, DRUG METAB DISPOS, V41, P1778, DOI 10.1124/dmd.113.052357; Bhatnagar S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00002; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cambon AC BK, 2014, MODEL ASSISTED STATI; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069239; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Cho WCS, 2012, EXPERT REV MOL DIAGN, V12, P315, DOI [10.1586/ERM.12.21, 10.1586/erm.12.21]; Cho William C. S., 2011, Frontiers in Genetics, V2, P7, DOI 10.3389/fgene.2011.00007; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Dmitrienko A MG, 2005, ANALYSIS OF CLINICAL; Dong Y, 2011, BRIT J CANCER, V104, P893, DOI 10.1038/bjc.2011.57; Du J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063390; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Fan Kuan-Lu, 2013, Indian Heart J, V65, P12, DOI 10.1016/j.ihj.2012.12.022; Fayyad-Kazan H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-31; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fleiss JL, 1986, DESIGN AND ANALYSIS; Freedman Jane E, 2012, F1000Res, V1, P50, DOI 10.12688/f1000research.1-50.v1; Gandhi R, 2013, ANN NEUROL, V73, P729, DOI 10.1002/ana.23880; Ganepola GAP, 2014, WORLD J GASTRO ONCOL, V6, P22, DOI 10.4251/wjgo.v6.i1.22; Garcia R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000211; Ge QY, 2011, CLIN CHIM ACTA, V412, P1989, DOI 10.1016/j.cca.2011.07.010; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Gonen M, 2006, THIRTY FIRST ANNUAL, P210; Gorur A, 2013, MOL BIOL REP, V40, P2091, DOI 10.1007/s11033-012-2267-7; Gourzones C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-119; Hirajima S, 2013, BRIT J CANCER, V108, P1822, DOI 10.1038/bjc.2013.148; Huang JJ, 2012, MED ONCOL, V29, P2402, DOI 10.1007/s12032-012-0210-3; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Ichikawa Makiko, 2013, Methods Mol Biol, V1024, P247, DOI 10.1007/978-1-62703-453-1_20; Jia SZ, 2013, HUM REPROD, V28, P322, DOI 10.1093/humrep/des413; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kawano Y, 2013, J INFECT DIS, V208, P771, DOI 10.1093/infdis/jit222; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kishimoto T, 2013, CANCER SCI, V104, P1626, DOI 10.1111/cas.12300; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Kumar S, 2013, INDIAN J BIOCHEM BIO, V50, P210; Laterza OF, 2013, BIOMARK MED, V7, P205, DOI [10.2217/bmm.12.107, 10.2217/BMM.12.107]; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Leuenberger N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066309; Li C, 2013, J SURG ONCOL, V108, P89, DOI 10.1002/jso.23358; Li HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970265; Li YQ, 2013, CLINICS, V68, P75, DOI 10.6061/clinics/2013(01)OA12; Lu J, 2014, BRIT J CANCER, V110, P392, DOI 10.1038/bjc.2013.751; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Marfella R, 2013, EUR J HEART FAIL, V15, P1277, DOI 10.1093/eurjhf/hft088; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Moret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082753; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Nair N, 2013, MOL CELL BIOCHEM, V376, P33, DOI 10.1007/s11010-012-1546-x; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Olivieri F, 2013, INT J CARDIOL, V167, P531, DOI 10.1016/j.ijcard.2012.01.075; Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7; Parikh Victoria N, 2013, Methods Mol Biol, V1024, P157, DOI 10.1007/978-1-62703-453-1_12; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pepe MS, 2003, THE STATISTICAL EVAL; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Quackenbush JF, 2014, METHODS MOL BIOL, V1102, P641, DOI 10.1007/978-1-62703-727-3_34; Rai SN RH, 2012, OPEN ACCESS MEDICAL; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Shimizu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058159; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Soeda S, 2013, INT J MOL MED, V31, P533, DOI 10.3892/ijmm.2013.1251; Sozzi G, 2014, J CLIN ONCOL, V32, P768, DOI 10.1200/JCO.2013.50.4357; Suryawanshi S, 2013, CLIN CANCER RES, V19, P1213, DOI 10.1158/1078-0432.CCR-12-2726; Szabo DR, 2014, LAB INVEST, V94, P331, DOI 10.1038/labinvest.2013.148; Takahashi K, 2013, TOXICOL APPL PHARM, V272, P154, DOI 10.1016/j.taap.2013.05.018; Technologies L, 2013, PROTOCOL FOR CREATIN; Technologies L, 2010, TRIZOL LS REAGENT; Teixeira AL, 2014, TUMOR BIOL, V35, P4057, DOI 10.1007/s13277-013-1531-3; Tian Q, 2014, EJSO-EUR J SURG ONC, V40, P67, DOI 10.1016/j.ejso.2013.08.024; Tsukamoto O, 2014, GYNECOL ONCOL, V132, P715, DOI 10.1016/j.ygyno.2014.01.029; Wang ES, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-165; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Westermann AM, 2014, ANTICANCER RES, V34, P665; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Winther TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058236; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Yamamoto M, 2013, ENVIRON HEALTH PERSP, V121, P670, DOI 10.1289/ehp.1205963; Yu H, 2014, GENE, V534, P60, DOI 10.1016/j.gene.2013.10.024; Zanutto S, 2014, BRIT J CANCER, V110, P1001, DOI 10.1038/bjc.2013.819; Zeng RC, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0477-z; Zhao J, 2013, BIOCHEM BIOPH RES CO, V438, P439, DOI 10.1016/j.bbrc.2013.07.095; Zheng WD, 2013, CLIN BIOCHEM, V46, P1566, DOI 10.1016/j.clinbiochem.2013.06.024	101	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121948	10.1371/journal.pone.0121948	http://dx.doi.org/10.1371/journal.pone.0121948			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853871	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400056
J	Koban, F; El-Kasaby, A; Hausler, C; Stockner, T; Simbrunner, BM; Sitte, HH; Freissmuth, M; Sucic, S				Koban, Florian; El-Kasaby, Ali; Haeusler, Cornelia; Stockner, Thomas; Simbrunner, Benedikt M.; Sitte, Harald H.; Freissmuth, Michael; Sucic, Sonja			A Salt Bridge Linking the First Intracellular Loop with the C Terminus Facilitates the Folding of the Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; ENDOPLASMIC-RETICULUM; ADENOSINE RECEPTOR; STARTLE DISEASE; QUALITY-CONTROL; PROTEIN; MUTATIONS; EFFICIENT; COMPONENT; MECHANISM	The folding trajectory of solute carrier 6 (SLC6) family members is of interest because point mutations result in misfolding and thus cause clinically relevant phenotypes in people. Here we examined the contribution of the C terminus in supporting folding of the serotonin transporter (SERT; SLC6A4). Our working hypothesis posited that the amphipathic nature of the C-terminal alpha-helix (Thr(603)-Thr(613)) was important for folding of SERT. Accordingly, we disrupted the hydrophobic moment of the alpha-helix by replacing Phe(604), Ile(608), or Ile(612) by Gln. The bulk of the resulting mutants SERT-F604Q, SERT-I608Q, and SERT-I612Q were retained in the endoplasmic reticulum, but their residual delivery to the cell surface still depended on SEC24C. This indicates that the amphipathic nature of the C-terminal alpha-helix was dispensable to endoplasmic reticulum export. The folding trajectory of SERT is thought to proceed through the inward facing conformation. Consistent with this conjecture, cell surface expression of the misfolded mutants was restored by (i) introducing second site suppressor mutations, which trap SERT in the inward facing state, or (ii) by the pharmacochaperone noribogaine, which binds to the inward facing conformation. Finally, mutation of Glu(615) at the end of the C-terminal alpha-helix to Lys reduced surface expression of SERT-E615K. A charge reversal mutation in intracellular loop 1 restored surface expression of SERT-R152E/E615K to wild type levels. These observations support a mechanistic model where the C-terminal amphipathic helix is stabilized by an intramolecular salt bridge between residues Glu(615) and Arg(152). This interaction acts as a pivot in the conformational search associated with folding of SERT.	[Koban, Florian; El-Kasaby, Ali; Haeusler, Cornelia; Stockner, Thomas; Simbrunner, Benedikt M.; Sitte, Harald H.; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Dept Pharmacol, Fac Vet Med, Mansoura 35516, Egypt	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University	Sucic, S (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	sonja.sucic@meduniwien.ac.at	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; Stockner, Thomas/A-9509-2014	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Stockner, Thomas/0000-0002-7071-8283; Koban, Florian/0000-0003-0912-3114; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765	Fonds zur Forderung der Wissenschaflichen Forschung (FWF) [SFB35-10]; Austrian Science Fund/FWF [P27518-B27]; doctoral program Cell Communication in Health and Disease - Austrian Science Fund/FWF [W1205]; Medical University of Vienna	Fonds zur Forderung der Wissenschaflichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund/FWF(Austrian Science Fund (FWF)); doctoral program Cell Communication in Health and Disease - Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by Fonds zur Forderung der Wissenschaflichen Forschung (FWF) Project Program Grant SFB35-10 (to M. F.), Austrian Science Fund/FWF Grant P27518-B27 (to S. S.), and the doctoral program Cell Communication in Health and Disease, which was jointly funded by grants from the Austrian Science Fund/FWF (W1205) and the Medical University of Vienna.	Arribas-Gonzalez E, 2015, J BIOL CHEM, V290, P2150, DOI 10.1074/jbc.M114.587055; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Kusek J, 2015, MOL PHARMACOL, V87, P39, DOI 10.1124/mol.114.094045; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Montgomery TR, 2014, J NEUROSCI, V34, P6344, DOI 10.1523/JNEUROSCI.2991-13.2014; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qi YP, 1997, J NEUROSCI, V17, P1217; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	45	31	31	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13263	13278		10.1074/jbc.M115.641357	http://dx.doi.org/10.1074/jbc.M115.641357			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869136	Green Published, hybrid			2022-12-26	WOS:000354975700027
J	Calderaro, A; Piergianni, M; Buttrini, M; Montecchini, S; Piccolo, G; Gorrini, C; Rossi, S; Chezzi, C; Arcangeletti, MC; Medici, MC; De Conto, F				Calderaro, Adriana; Piergianni, Maddalena; Buttrini, Mirko; Montecchini, Sara; Piccolo, Giovanna; Gorrini, Chiara; Rossi, Sabina; Chezzi, Carlo; Arcangeletti, Maria Cristina; Medici, Maria Cristina; De Conto, Flora			MALDI-TOF Mass Spectrometry for the Detection and Differentiation of Entamoeba histolytica and Entamoeba dispar	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CRYPTOSPORIDIUM-PARVUM; GIARDIA-LAMBLIA; BRUMPT 1925; DIAGNOSIS; PCR; CULTIVATION; SCHAUDINN; SAMPLES; DNA	Detection of Entamoeba histolytica and its differentiation from Entamoeba dispar is an important goal of the clinical parasitology laboratory. The aim of this study was the identification and differentiation of E. histolytica and E. dispar by MALDI-TOF MS, in order to evaluate the application of this technique in routine diagnostic practice. MALDI-TOF MS was applied to 3 amebic reference strains and to 14 strains isolated from feces that had been differentiated by molecular methods in our laboratory. Protein extracts from cultures of these strains (axenic cultures for the 3 reference strains and monoxenic cultures for the 14 field isolates) were analyzed by MALDI-TOF MS and the spectra obtained were analyzed by statistical software. Five peaks discriminating between E. histolytica and E. dispar reference strains were found by protein profile analysis: 2 peaks (8,246 and 8,303 Da) specific for E. histolytica and 3 (4,714; 5,541; 8,207 Da) for E. dispar. All clinical isolates except one showed the discriminating peaks expected for the appropriate species. For 2 fecal samples from which 2 strains (1 E. histolytica and 1 E. dispar) out of the 14 included in this study were isolated, the same discriminating peaks found in the corresponding isolated amebic strains were detected after only 12h (E. histolytica) and 24h (E. dispar) of incubation of the fecal samples in Robinson's medium without serum. Our study shows that MALDI-TOF MS can be used to discriminate between E. histolytica and E. dispar using in vitro xenic cultures and it also could have potential for the detection of these species in clinical samples.	[Calderaro, Adriana; Piergianni, Maddalena; Buttrini, Mirko; Montecchini, Sara; Piccolo, Giovanna; Gorrini, Chiara; Rossi, Sabina; Chezzi, Carlo; Arcangeletti, Maria Cristina; Medici, Maria Cristina; De Conto, Flora] Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, I-43100 Parma, Italy	University of Parma; University Hospital of Parma	Calderaro, A (corresponding author), Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, I-43100 Parma, Italy.	adriana.calderaro@unipr.it	De Conto, Flora/H-9760-2019; piccolo, giovanna/HHZ-8454-2022; ROSSI, Sabina/ABD-2601-2020	De Conto, Flora/0000-0002-0493-2353; 	Ministry of University and Scientific Research Grant FIL, Parma, Italy	Ministry of University and Scientific Research Grant FIL, Parma, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministry of University and Scientific Research Grant FIL, Parma, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IKM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000219; Ali IKM, 2008, INFECT GENET EVOL, V8, P698, DOI 10.1016/j.meegid.2008.05.004; Ali IKM, 2003, EMERG INFECT DIS, V9, P580, DOI 10.3201/eid0905.020548; Blessmann J, 2002, J CLIN MICROBIOL, V40, P4413, DOI 10.1128/JCM.40.12.4413-4417.2002; Calderaro A, 2006, T ROY SOC TROP MED H, V100, P450, DOI 10.1016/j.trstmh.2005.07.015; Calderaro A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06803; Calderaro Adriana, 2014, BMC Res Notes, V7, P330, DOI 10.1186/1756-0500-7-330; Calderaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088895; Calderaro A, 2013, J PROTEOMICS, V78, P273, DOI 10.1016/j.jprot.2012.09.027; Cassagne C, 2014, CLIN MICROBIOL INFEC, V20, P551, DOI 10.1111/1469-0691.12387; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; CLARK CG, 1995, J EUKARYOT MICROBIOL, V42, P590, DOI 10.1111/j.1550-7408.1995.tb05912.x; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Heredia RD, 2012, ACTA TROP, V123, P139, DOI 10.1016/j.actatropica.2012.05.012; DIAMOND LS, 1993, J EUKARYOT MICROBIOL, V40, P340, DOI 10.1111/j.1550-7408.1993.tb04926.x; Gitau EN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-205; Gonin P, 2003, J CLIN MICROBIOL, V41, P237, DOI 10.1128/JCM.41.1.237-241.2003; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Magnuson ML, 2000, APPL ENVIRON MICROB, V66, P4720, DOI 10.1128/AEM.66.11.4720-4724.2000; Makioka A, 2007, PARASITOL RES, V102, P103, DOI 10.1007/s00436-007-0736-z; Martiny D, 2014, EUR J CLIN MICROBIOL, V33, P529, DOI 10.1007/s10096-013-1980-z; Moura H, 2003, J EUKARYOT MICROBIOL, V50, P156, DOI 10.1111/j.1550-7408.2003.tb00110.x; Nunez YO, 2001, AM J TROP MED HYG, V64, P293, DOI 10.4269/ajtmh.2001.64.293; PETITHORY JC, 1994, B SOC PATHOL EXOT, V87, P231; Sedo O, 2011, SYST APPL MICROBIOL, V34, P30, DOI 10.1016/j.syapm.2010.11.008; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Villegas EN, 2006, J EUKARYOT MICROBIOL, V53, pS179, DOI 10.1111/j.1550-7408.2006.00223.x; Wang YH, 2009, EXP PARASITOL, V123, P162, DOI 10.1016/j.exppara.2009.06.014; WHO: World Health Organization/ Pan American Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P97	31	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122448	10.1371/journal.pone.0122448	http://dx.doi.org/10.1371/journal.pone.0122448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874612	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800057
J	Flores-Felix, JD; Silva, LR; Rivera, LP; Marcos-Garcia, M; Garcia-Fraile, P; Martinez-Molina, E; Mateos, PF; Velazquez, E; Andrade, P; Rivas, R				David Flores-Felix, Jose; Silva, Luis R.; Rivera, Lina P.; Marcos-Garcia, Marta; Garcia-Fraile, Paula; Martinez-Molina, Eustoquio; Mateos, Pedro F.; Velazquez, Encarna; Andrade, Paula; Rivas, Raul			Plants Probiotics as a Tool to Produce Highly Functional Fruits: The Case of Phyllobacterium and Vitamin C in Strawberries	PLOS ONE			English	Article							GROWTH PROMOTION; ORGANIC-ACIDS; SP-NOV; ERYTHROCYTE; ENDOPHYTES; NODULES; STRAIN; L.	The increasing interest in the preservation of the environment and the health of consumers is changing production methods and food consumption habits. Functional foods are increasingly demanded by consumers because they contain bioactive compounds involved in health protection. In this sense biofertilization using plant probiotics is a reliable alternative to the use of chemical fertilizers, but there are few studies about the effects of plant probiotics on the yield of functional fruits and, especially, on the content of bioactive compounds. In the present work we reported that a strain of genus Phyllobacterium able to produce biofilms and to colonize strawberry roots is able to increase the yield and quality of strawberry plants. In addition, the fruits from plants inoculated with this strain have significantly higher content in vitamin C, one of the most interesting bioactive compounds in strawberries. Therefore the use of selected plant probiotics benefits the environment and human health without agronomical losses, allowing the production of highly functional foods.	[David Flores-Felix, Jose; Rivera, Lina P.; Marcos-Garcia, Marta; Garcia-Fraile, Paula; Martinez-Molina, Eustoquio; Mateos, Pedro F.; Velazquez, Encarna; Rivas, Raul] Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Silva, Luis R.; Andrade, Paula] Univ Porto, Fac Farm, Dept Quim, REQUIMTE,Lab Farmacognosia, P-4100 Porto, Portugal; [Rivera, Lina P.; Martinez-Molina, Eustoquio; Mateos, Pedro F.] Univ Salamanca, Ctr Hispano Luso Invest Agr CIALE, E-37008 Salamanca, Spain; [Martinez-Molina, Eustoquio; Mateos, Pedro F.; Velazquez, Encarna; Rivas, Raul] Unidad Asociada Univ Salamanca CSIC IRNASA, Salamanca, Spain	University of Salamanca; Universidade do Porto; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA)	Rivas, R (corresponding author), Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	raulrg@usal.es	Silva, Luís R./D-5485-2013; Mateos, Pedro/L-6001-2014; Velázquez, Encarna/B-3669-2017; Flores-Félix, Jose David/B-2082-2017; Rivas, Raúl/B-1869-2017; Fraile, Paula Garcia/N-8193-2014; Andrade, Paula/A-5900-2008	Silva, Luís R./0000-0001-5264-3516; Mateos, Pedro/0000-0003-1628-598X; Velázquez, Encarna/0000-0002-5946-7241; Flores-Félix, Jose David/0000-0003-2200-4400; Rivas, Raúl/0000-0003-2202-1470; Fraile, Paula Garcia/0000-0002-9576-2184; Andrade, Paula/0000-0002-9764-3920; Martinez-Molina, Eustoquio/0000-0002-0983-9780; Marcos Garcia, Marta/0000-0002-6791-9893	"Junta de Castilla y Leon" (Regional Government) [SA183A11-2]; MINECO (Central Government) [AGL2011-29227]; Academy of Sciences of the Czech Republic; Salamanca University; Fundacion Miguel Casado San Jose; European Union (FEDER funds through COMPETE); FCT, Fundacao para a Ciencia e Tecnologia [Pest-C/EQB/LA0006/2013]; European Union (FEDER funds) under the framework of QREN [NORTE-07-0124-FEDER-000069]	"Junta de Castilla y Leon" (Regional Government)(Junta de Castilla y Leon); MINECO (Central Government); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Salamanca University; Fundacion Miguel Casado San Jose; European Union (FEDER funds through COMPETE); FCT, Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Union (FEDER funds) under the framework of QREN	This work was granted by "Junta de Castilla y Leon" (Regional Government, Grant SA183A11-2) and MINECO (Central Government, Grant AGL2011-29227). Paula Garcia-Fraile is recipient of a postdoctoral researcher contract from Academy of Sciences of the Czech Republic. Jose David Flores-Felix was supported by a fellowship of Salamanca University. Marta Marcos Garcia was supported by a fellowship of Fundacion Miguel Casado San Jose. Luis R. Silva is grateful to the financial support from the European Union (FEDER funds through COMPETE) and National Funds (FCT, Fundacao para a Ciencia e Tecnologia) through project Pest-C/EQB/LA0006/2013 and from the European Union (FEDER funds) under the framework of QREN through Project NORTE-07-0124-FEDER-000069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Azzini E, 2010, BRIT J NUTR, V104, P1165, DOI 10.1017/S000711451000187X; Basu A, 2014, CRIT REV FOOD SCI, V54, P790, DOI 10.1080/10408398.2011.608174; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Berlec A, 2012, PLANT SCI, V193, P96, DOI 10.1016/j.plantsci.2012.05.010; Bertrand H, 2001, BIOL FERT SOILS, V33, P152, DOI 10.1007/s003740000305; Bona E, 2015, MYCORRHIZA, V25, P181, DOI 10.1007/s00572-014-0599-y; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Contesto C, 2010, PLANTA, V232, P1455, DOI 10.1007/s00425-010-1264-0; Dopico-Garcia MS, 2007, ANAL CHIM ACTA, V583, P15, DOI 10.1016/j.aca.2006.09.056; Esitken A, 2010, SCI HORTIC-AMSTERDAM, V124, P62, DOI 10.1016/j.scienta.2009.12.012; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flores-Felix JD, 2013, INT J SYST EVOL MICR, V63, P821, DOI 10.1099/ijs.0.038497-0; Gaiero JR, 2013, AM J BOT, V100, P1738, DOI 10.3732/ajb.1200572; Garcia-Fraile P, 2013, FOOD CHEM, V139, P31, DOI 10.1016/j.foodchem.2012.12.043; Garcia-Fraile P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038122; Giampieri F, 2012, NUTRITION, V28, P9, DOI 10.1016/j.nut.2011.08.009; Kechid M, 2013, NEW PHYTOL, V198, P514, DOI 10.1111/nph.12158; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; KNOSEL D, 1984, BERGEYS MANUAL SYSTE, V1, P254; Larcher M, 2003, NEW PHYTOL, V160, P119, DOI 10.1046/j.1469-8137.2003.00862.x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; OGARA F, 1976, BIOCHIM BIOPHYS ACTA, V451, P342, DOI 10.1016/0304-4165(76)90129-X; OHARA GW, 1989, APPL ENVIRON MICROB, V55, P1870, DOI 10.1128/AEM.55.8.1870-1876.1989; Peix A, 2001, SOIL BIOL BIOCHEM, V33, P103, DOI 10.1016/S0038-0717(00)00120-6; Robledo M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-125; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Rojas A, 2001, FEMS MICROBIOL ECOL, V35, P181, DOI 10.1111/j.1574-6941.2001.tb00802.x; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Sanchez M, 2014, INT J SYST EVOL MICR, V64, P781, DOI 10.1099/ijs.0.052993-0; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Silva LR, 2014, J AGR FOOD CHEM, V62, P557, DOI 10.1021/jf4046649; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Spence C, 2012, BACTERIA AGROBIOLOGY, P1; Sun-Waterhouse D, 2011, INT J FOOD SCI TECH, V46, P899, DOI 10.1111/j.1365-2621.2010.02499.x; Tulipani S, 2014, FOOD CHEM, V156, P87, DOI 10.1016/j.foodchem.2014.01.098; Tulipani S, 2011, FOOD CHEM, V128, P180, DOI 10.1016/j.foodchem.2011.03.025; VINCENT J. M., 1970, A manual for the practical study of the root-nodule bacteria.; Wang H, 2004, ARCH MICROBIOL, V182, P520, DOI 10.1007/s00203-004-0735-8; Wentland EJ, 1996, BIOTECHNOL PROGR, V12, P316, DOI 10.1021/bp9600243	42	68	70	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122281	10.1371/journal.pone.0122281	http://dx.doi.org/10.1371/journal.pone.0122281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874563	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800049
J	Ullah, H; Islam, S; Khan, I; Shafie, S; Fiza, M				Ullah, Hakeem; Islam, Saeed; Khan, Ilyas; Shafie, Sharidan; Fiza, Mehreen			Formulation and Application of Optimal Homotopty Asymptotic Method to Coupled Differential - Difference Equations	PLOS ONE			English	Article							SYMMETRIES; FLOW	In this paper we applied a new analytic approximate technique Optimal Homotopy Asymptotic Method (OHAM) for treatment of coupled differential-difference equations (DDEs). To see the efficiency and reliability of the method, we consider Relativistic Toda coupled nonlinear differential-difference equation. It provides us a convenient way to control the convergence of approximate solutions when it is compared with other methods of solution found in the literature. The obtained solutions show that OHAM is effective, simpler, easier and explicit.	[Ullah, Hakeem; Islam, Saeed; Fiza, Mehreen] Abdul Wali Khan Univ Mardan, Dept Math, Mardan 23200, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Shafie, Sharidan] Univ Teknol Malayisa, Fac Sci, Dept Math Sci, Johar Bohru 81310, Johor, Malaysia	Majmaah University	Shafie, S (corresponding author), Univ Teknol Malayisa, Fac Sci, Dept Math Sci, Johar Bohru 81310, Johor, Malaysia.	sharidan@utm.my	Khan, Ilyas/C-8770-2019; Saeed, Islam/AAD-6067-2020	Khan, Ilyas/0000-0002-2056-9371; Saeed, Islam/0000-0001-5263-4871				Abdou M.A., 2011, INT J NONLINEAR SCI, V12, P29; Baldwin D, 2004, COMPUT PHYS COMMUN, V162, P203, DOI 10.1016/j.cpc.2004.07.002; CHERDANTSEV IY, 1995, PHYSICA D, V87, P140, DOI 10.1016/0167-2789(95)00167-3; Herisanu N, 2010, MECCANICA, V45, P847, DOI 10.1007/s11012-010-9293-0; Idrees M, 2010, COMPUT MATH APPL, V59, P3858, DOI 10.1016/j.camwa.2010.04.023; Idrees M., 2012, COMPUT MATH APPL, V63, P695; Levi D, 1997, J MATH PHYS, V38, P6648, DOI 10.1063/1.532230; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2010, J SOUND VIB, V329, P1450, DOI 10.1016/j.jsv.2009.11.005; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; NARITA K, 1993, CHAOS SOLITON FRACT, V3, P279, DOI 10.1016/0960-0779(93)90011-O; Nawaz R, 2013, J APPL MATH, DOI 10.1155/2013/387478; Shabat A. B., 1991, LENINGRAD MATH J, V2, P377; Ullah H, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/520467; Ullah H, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/362816; Ullah H, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/324869; Ullah H., 2014, SCI INT, V26, P567; Ullah H, 2014, INT J DIFFER EQUAT, V2014, DOI 10.1155/2014/106934; Wang Z, 2007, PHYS LETT A, V369, P77, DOI 10.1016/j.physleta.2007.04.070; Wang Z, 2006, CHINESE PHYS, V15, P2210, DOI 10.1088/1009-1963/15/10/004; Wang Z, 2011, APPL MATH COMPUT, V218, P1371, DOI 10.1016/j.amc.2011.06.019; YAMILOV RI, 1994, J PHYS A-MATH GEN, V27, P6839, DOI 10.1088/0305-4470/27/20/020; Zhang DJ, 2005, CHAOS SOLITON FRACT, V23, P1333, DOI 10.1016/j.chaos.2004.06.034; Zhen W, 2006, APPL MATH COMPUT, V178, P431, DOI 10.1016/j.amc.2005.11.060; Zou L, 2008, COMPUT MATH APPL, V56, P2289, DOI 10.1016/j.camwa.2008.03.052	25	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120127	10.1371/journal.pone.0120127	http://dx.doi.org/10.1371/journal.pone.0120127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874457	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700003
J	Khannoon, ER; Evans, SE				Khannoon, Eraqi R.; Evans, Susan E.			The Development of the Skull of the Egyptian Cobra Naja h. haje (Squamata: Serpentes: Elapidae)	PLOS ONE			English	Article							INCUBATION-TEMPERATURE; EMBRYONIC-DEVELOPMENT; SNAKE; MOBILIZATION; CALCIUM; PATTERNS	Background The study of craniofacial development is important in understanding the ontogenetic processes behind morphological diversity. A complete morphological description of the embryonic skull development of the Egyptian cobra, Naja h. haje, is lacking and there has been little comparative discussion of skull development either among elapid snakes or between them and other snakes. Methodology/Principal Findings We present a description of skull development through a full sequence of developmental stages of the Egyptian cobra, and compare it to other snakes. Associated soft tissues of the head are noted where relevant. The first visible ossification centres are in the supratemporal, prearticular and surangular, with slight ossification visible in parts of the maxilla, prefrontal, and dentary. Epiotic centres of ossification are present in the supraoccipital, and the body of the supraoccipital forms from the tectum posterior not the tectum synoticum. The venom glands are visible as distinct bodies as early at stage 5 and enlarge later to extend from the otic capsule to the maxilla level with the anterior margin of the eye. The gland becomes more prominent shortly before hatching, concomitant with the development of the fangs. The tongue shows incipient forking at stage 5, and becomes fully bifid at stage 6. Conclusions/Significance We present the first detailed staging series of cranial development for the Egyptian cobra, Naja h. haje. This is one of the first studies since the classical works of G. de Beer and W. Parker that provides a detailed description of cranial development in an advanced snake species. It allows us to correct errors and misinterpretations in previous accounts which were based on a small sample of specimens of uncertain age. Our results highlight potentially significant variation in supraoccipital formation among squamates and the need for further research in this area.	[Khannoon, Eraqi R.] Fayoum Univ, Fac Sci, Dept Zool, Al Fayyum 63514, Egypt; [Evans, Susan E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	Egyptian Knowledge Bank (EKB); Fayoum University; University of London; University College London	Khannoon, ER (corresponding author), Fayoum Univ, Fac Sci, Dept Zool, Al Fayyum 63514, Egypt.	err00@fayoum.edu.eg	Evans, Susan/C-1888-2008	Evans, Susan/0000-0002-0799-4154				Boback SM, 2012, ZOOLOGY, V115, P38, DOI 10.1016/j.zool.2011.09.001; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Boughner JC, 2007, ZOOLOGY, V110, P212, DOI 10.1016/j.zool.2007.01.005; BURGER J, 1990, J HERPETOL, V24, P158, DOI 10.2307/1564223; Carroll RL, 1988, VERTEBRATE PALEONTOL; Cundall David, 2008, Contributions to Herpetology, V23, P349; d'A Bellairs A, 1981, MORPHOLOGY F, V11, P1; de Beer G., 1937, DEV VERTEBRATE SKULL; Deeming DC., 1991, EGG INCUBATION ITS E; Deiques CH, 2002, ACTA ZOOL-STOCKHOLM, V83, P175; El Toubi MR, 1965, PROC EGYPT ACAD SCI, V18, P73; El-Toubi M. R, 1970, Anat. Anz., V127, P233; ELTOUBI MR, 1973, ACTA ANAT, V85, P593; FRANKLIN MA, 1945, COPEIA, P68; HALUSKA F, 1983, J MORPHOL, V178, P37, DOI 10.1002/jmor.1051780104; Hanken J., 1981, Functional Photography, V16, P22; Hofstadler-Deiques C, 2005, ANAT REC PART A, V286A, P938, DOI 10.1002/ar.a.20227; Jackson K, 2002, ZOOLOGY, V105, P203, DOI 10.1078/0944-2006-00077; Kamal A. M, 1970, Acta zool., Stockh., V51, P31; KAMAL AM, 1965, J MORPHOL, V116, P247, DOI 10.1002/jmor.1051160206; Kamal AM, 1970, ACTA ZOOLOGICA, P19; Kamal AM, 1970, ACTA ZOOLOGICA, P1; Khannoon E, 2013, ACTA ZOOLOGICA, V95, P472; KORNEVA L G, 1969, Zoologicheskii Zhurnal, V48, P110; PACKARD MJ, 1994, ISR J ZOOL, V40, P481; Parker W. K., 1879, PHILOS T ROY SOC LON, V170, P595, DOI [10. 1098/rstl. 1879. 0075, DOI 10.1098/RSTL.1879.0075]; Parker W. K., 1879, PHILOS T ROY SOC LON, V169, P385, DOI DOI 10.1098/RSTL.1878.0012; Polachowski KM, 2013, ZOOLOGY, V116, P36, DOI 10.1016/j.zool.2012.07.003; Rieppel O, 2001, J MORPHOL, V249, P252, DOI 10.1002/jmor.1053; Stewart JR, 2010, HERPETOL CONSERV BIO, V5, P341; Stewart JR, 2004, COMP BIOCHEM PHYS A, V139, P335, DOI 10.1016/j.cbpb.2004.09.016	31	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122185	10.1371/journal.pone.0122185	http://dx.doi.org/10.1371/journal.pone.0122185			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860015	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300034
J	Ul-Haq, Z; Saeed, M; Halim, SA; Khan, W				Ul-Haq, Zaheer; Saeed, Maria; Halim, Sobia Ahsan; Khan, Waqasuddin			3D Structure Prediction of Human beta 1-Adrenergic Receptor via Threading-Based Homology Modeling for Implications in Structure-Based Drug Designing	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; I-TASSER; IDENTIFICATION; INHIBITORS; RHODOPSIN	Dilated cardiomyopathy is a disease of left ventricular dysfunction accompanied by impairment of the beta(1)-adrenergic receptor (beta(1)-AR) signal cascade. The disturbed beta(1)-AR function may be based on an elevated sympathetic tone observed in patients with heart failure. Prolonged adrenergic stimulation may induce metabolic and electrophysiological disturbances in the myocardium, resulting in tachyarrhythmia that leads to the development of heart failure in human and sudden death. Hence, beta(1)-AR is considered as a promising drug target but attempts to develop effective and specific drug against this tempting pharmaceutical target is slowed down due to the lack of 3D structure of Homo sapiens beta(1)-AR (hs beta ADR1). This study encompasses elucidation of 3D structural and physicochemical properties of hs beta ADR1 via threading-based homology modeling. Furthermore, the docking performance of several docking programs including Surflex-Dock, FRED, and GOLD were validated by re-docking and cross-docking experiments. GOLD and Surflex-Dock performed best in re-docking and cross docking experiments, respectively. Consequently, Surflex-Dock was used to predict the binding modes of four hs beta ADR1 agonists. This study provides clear understanding of hs beta ADR1 structure and its binding mechanism, thus help in providing the remedial solutions of cardiovascular, effective treatment of asthma and other diseases caused by malfunctioning of the target protein.	[Ul-Haq, Zaheer; Saeed, Maria; Khan, Waqasuddin] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Halim, Sobia Ahsan] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	University of Karachi; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Ul-Haq, Z (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.	zaheer.qasmi@iccs.edu	Halim, Sobia Ahsan/ADO-2156-2022; Khan, Waqasuddin/AAF-7771-2019; Saeed, Maria/D-6703-2015; Ul-Haq, Zaheer/E-3061-2010; Saeed, Maria/AAJ-3530-2020	Halim, Sobia Ahsan/0000-0001-8526-7799; Ul-Haq, Zaheer/0000-0002-8530-8711; Saeed, Maria/0000-0001-6223-6375; Khan, Waqasuddin/0000-0001-7995-8163	Higher Education Commission, Pakistan	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This work was funded by Higher Education Commission, Pakistan (http://www.hec.gov.pk/Pages/HECMain.aspx).	Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2006, SYBYL MOLECULAR MODE; [Anonymous], 2012, 10 CHEM COMP GROUP I; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; *CAMBR CRYT DAT CT, 2006, GOLD VERS 3 0; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Congreve M, 2010, BRIT J PHARMACOL, V159, P986, DOI 10.1111/j.1476-5381.2009.00476.x; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Dolan MA, 2008, PROTEINS, V72, P1243, DOI 10.1002/prot.22022; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Dror O, 2004, CURR MED CHEM, V11, P71, DOI 10.2174/0929867043456287; Eichhorn EJ, 1996, CIRCULATION, V94, P2285, DOI 10.1161/01.CIR.94.9.2285; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Halim SA, 2013, MOL DIVERS, V17, P345, DOI 10.1007/s11030-013-9431-4; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Khan KM, 2014, J COMPUT AID MOL DES, V28, P577, DOI 10.1007/s10822-014-9745-z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Muthumala A, 2008, EUR J HEART FAIL, V10, P3, DOI 10.1016/j.ejheart.2007.11.008; Patny A, 2006, CURR MED CHEM, V13, P1667, DOI 10.2174/092986706777442002; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sandilands A, 2004, PHARMACOGENETICS, V14, P343, DOI 10.1097/00008571-200406000-00003; Santos N. M. D., 2006, J BIOL CHEM, V281, P12896; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Sirois S, 2004, J CHEM INF COMP SCI, V44, P1111, DOI 10.1021/ci034270n; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; Ul-Haq Z, 2012, J MOL GRAPH MODEL, V36, P48, DOI 10.1016/j.jmgm.2012.02.003; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weinstein H, 2005, DRUG ADDICTION AAPS, P265; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122223	10.1371/journal.pone.0122223	http://dx.doi.org/10.1371/journal.pone.0122223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860348	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300037
J	Xu, YA; Cao, JL; Huang, S; Feng, D; Zhang, W; Zhu, XL; Yan, XM				Xu, Yanan; Cao, Jingli; Huang, Shan; Feng, Di; Zhang, Wei; Zhu, Xueliang; Yan, Xiumin			Characterization of Tetratricopeptide Repeat-Containing Proteins Critical for Cilia Formation and Function	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; ZEBRAFISH PRONEPHROS; CORE COMPLEX; CILIOGENESIS; GENES; CELLS; EXPRESSION; MECHANISM; MOTILITY; DEFECTS	Cilia formation and function require a special set of trafficking machinery termed intraflagellar transport (IFT), consisting mainly of protein complexes IFT-A, IFT-B, BBSome, and microtubule- dependent molecular motors. Tetratricopeptide repeat-containing (TTC) proteins are widely involved in protein complex formation. Nine of them are known to serve as components of the IFT or BBSome complexes. How many TTC proteins are cilia-related and how they function, however, remain unclear. Here we show that twenty TTC genes were upregulated by at least 2-fold during the differentiation of cultured mouse tracheal epithelial cells (MTECs) into multiciliated cells. Our systematic screen in zebrafish identified four novel TTC genes, ttc4, -9c, -36, and -39c, that are critical for cilia formation and motility. Accordingly, their zebrafish morphants displayed typical ciliopathy-related phenotypes, including curved body, abnormal otolith, hydrocephalus, and defective left-right patterning. The morphants of ttc4 and ttc25, a known cilia-related gene, additionally showed pronephric cyst formation. Immunoprecipitation indicated associations of TTC4, -9c, -25, -36, and -39c with components or entire complexes of IFT-A, IFT-B, or BBSome, implying their participations in IFT or IFT-related activities. Our results provide a global view for the relationship between TTC proteins and cilia.	[Xu, Yanan; Cao, Jingli; Huang, Shan; Zhang, Wei; Zhu, Xueliang; Yan, Xiumin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Feng, Di; Zhu, Xueliang] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhu, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yueyang Rd, Shanghai, Peoples R China.	yanx@sibcb.ac.cn; xlzhu@sibcb.ac.cn		Cao, Jingli/0000-0001-5938-6604	National Basic Research Program of China [2012CB945003]; National Natural Science Foundation of China [31330045, 31271427, 31471323]; Shanghai Municipal Science and Technology Commission [12JC1409900]; Chinese Academy of Sciences [XDA01010107]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Chinese Academy of Sciences (XDA01010107), National Basic Research Program of China (2012CB945003), National Natural Science Foundation of China (31330045, 31271427 and 31471323), and Shanghai Municipal Science and Technology Commission (12JC1409900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Borovina A, 2013, CELL REP, V5, P37, DOI 10.1016/j.celrep.2013.08.043; Burgess S, 2002, DEVELOPMENT, V129, P905; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Crevel G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001737; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Franklin JB, 2010, MOL MICROBIOL, V78, P173, DOI 10.1111/j.1365-2958.2010.07322.x; Gao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023386; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Hao LM, 2009, J CELL SCI, V122, P889, DOI 10.1242/jcs.023861; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Hostetter CL, 2003, DEV DYNAM, V228, P514, DOI 10.1002/dvdy.10371; Ishikawa H, 2014, ELIFE, V3, DOI 10.7554/eLife.01566; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Liu QH, 2008, MOL BIOTECHNOL, V40, P231, DOI 10.1007/s12033-008-9080-5; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Renaud O, 2011, NAT PROTOC, V6, P1897, DOI 10.1038/nprot.2011.408; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhang Q, 2012, MOL BIOL CELL, V23, P3069, DOI 10.1091/mbc.E12-01-0019; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004; Zhao HJ, 2013, NAT CELL BIOL, V15, P1434, DOI 10.1038/ncb2880	56	31	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124378	10.1371/journal.pone.0124378	http://dx.doi.org/10.1371/journal.pone.0124378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860617	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300137
J	Bhadra, S; Jiang, YS; Kumar, MR; Johnson, RF; Hensley, LE; Ellington, AD				Bhadra, Sanchita; Jiang, Yu Sherry; Kumar, Mia R.; Johnson, Reed F.; Hensley, Lisa E.; Ellington, Andrew D.			Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)	PLOS ONE			English	Article							RECOMBINASE POLYMERASE AMPLIFICATION; CLINICAL-FEATURES; SAUDI-ARABIA; QUANTIFICATION; INFECTION; DIAGNOSIS; ALIGNMENT; SPECIFICITY; COMPUTATION; IMPROVES	The Middle East respiratory syndrome coronavirus (MERS-CoV),an emerging human coronavirus, causes severe acute respiratory illness with a 35% mortality rate. In light of the recent surge in reported infections we have developed asymmetric five-primer reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays for detection of MERS-CoV. Isothermal amplification assays will facilitate the development of portable point-of-care diagnostics that are crucial for management of emerging infections. The RT-LAMP assays are designed to amplify MERS-CoV genomic loci located within the open reading frame (ORF) 1a and ORF1b genes and upstream of the E gene. Additionally we applied one-step strand displacement probes (OSD) for real-time sequence-specific verification of LAMP amplicons. Asymmetric amplification effected by incorporating a single loop primer in each assay accelerated the time-to-result of the OSD-RT-LAMP assays. The resulting assays could detect 0.02 to 0.2 plaque forming units (PFU) (5 to 50 PFU/ml) of MERS-CoV in infected cell culture supernatants within 30 to 50 min and did not cross-react with common human respiratory pathogens.	[Bhadra, Sanchita; Jiang, Yu Sherry; Ellington, Andrew D.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Chem & Biochem, Austin, TX 78712 USA; [Kumar, Mia R.; Johnson, Reed F.] NIAID, Emerging Viral Pathogens Sect, NIH, Ft Detrick, MD USA; [Hensley, Lisa E.] NIAID, Integrated Res Facil, NIH, Ft Detrick, MD USA	University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ellington, AD (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Chem & Biochem, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Hensley, Lisa/0000-0003-1188-4342; Bhadra, Sanchita/0000-0002-4956-2405	Welch Foundation [F-1654]; Defense Advanced Research Projects Agency [HR0011-11-2-0018]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); Integrated Research Facility (NIAID, Division of Clinical Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001025] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Integrated Research Facility (NIAID, Division of Clinical Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Welch Foundation (F-1654) and by the Defense Advanced Research Projects Agency (HR0011-11-2-0018). This work was also supported, in part, by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) the Integrated Research Facility (NIAID, Division of Clinical Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, PLOS CURR, V5, DOI [10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8, DOI 10.1371/CURRENTS.OUTBREAKS.0BF719E352E7478F8AD85FA30127DDB8]; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bialek SR, 2014, MMWR-MORBID MORTAL W, V63, P431; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Chen X, 2010, CURR OPIN BIOTECH, V21, P392, DOI 10.1016/j.copbio.2010.05.003; Chou PH, 2011, J VIROL METHODS, V173, P67, DOI 10.1016/j.jviromet.2011.01.009; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Corman VM, 2014, J CLIN VIROL, V60, P168, DOI 10.1016/j.jcv.2014.03.012; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauci AS, 2008, NAT REV DRUG DISCOV, V7, P12, DOI 10.1038/nrd2491; Fuchs B, 1999, MOL BIOTECHNOL, V12, P237, DOI 10.1385/MB:12:3:237; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Holmes D, 2014, LANCET, V383, P1793, DOI 10.1016/S0140-6736(14)60866-7; Hoshika Shuichi, 2008, Nucleic Acids Symp Ser (Oxf), P129, DOI 10.1093/nass/nrn066; JET Schanke, 2000, US patent Appl No, Patent No. [PCT/US2000/013960, 2000013960]; Jiang YS, 2015, ANAL CHEM, V87, P3314, DOI 10.1021/ac504387c; Jung C, 2010, ANAL CHEM, V82, P5937, DOI 10.1021/ac100606m; Lambert D, 2007, J MOL BIOL, V370, P993, DOI 10.1016/j.jmb.2007.03.080; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Li BL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr504; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c; Mahony J, 2013, J CLIN VIROL, V58, P127, DOI 10.1016/j.jcv.2013.06.006; Mailles A, 2013, Euro Surveill, V18; Memish ZA, 2014, CLIN MICROBIOL INFEC, V20, P469, DOI 10.1111/1469-0691.12562; Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Pyrc K, 2011, J VIROL METHODS, V175, P133, DOI 10.1016/j.jviromet.2011.04.024; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Raj VS, 2014, CURR OPIN VIROL, V5, P58, DOI 10.1016/j.coviro.2014.01.010; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Shen F, 2011, ANAL CHEM, V83, P3533, DOI 10.1021/ac200247e; Shirato K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-139; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Sun B, 2013, ANAL CHEM, V85, P1540, DOI 10.1021/ac3037206; Tani H, 2007, ANAL CHEM, V79, P5608, DOI 10.1021/ac070041e; Weissensteiner T, 1996, BIOTECHNIQUES, V21, P1102; World Health Organization, MIDDL E RESP SYNDR C; World Health Organization, 2015, LAB TEST MIDDL E RES; Yan L, 2014, CHEM COMMUN, V50, P7147, DOI 10.1039/c4cc02532f; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	68	86	92	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123126	10.1371/journal.pone.0123126	http://dx.doi.org/10.1371/journal.pone.0123126			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856093	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500077
J	Rizos, E; Siafakas, N; Katsantoni, E; Skourti, E; Salpeas, V; Rizos, I; Tsoporis, JN; Kastania, A; Filippopoulou, A; Xiros, N; Margaritis, D; Parker, TG; Papageorgiou, C; Zoumpourlis, V				Rizos, Emmanouil; Siafakas, Nikolaos; Katsantoni, Eleni; Skourti, Eleni; Salpeas, Vassilios; Rizos, Ioannis; Tsoporis, James N.; Kastania, Anastasia; Filippopoulou, Anastasia; Xiros, Nikolaos; Margaritis, Demetrios; Parker, Thomas G.; Papageorgiou, Charalabos; Zoumpourlis, Vassilios			Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia	PLOS ONE			English	Article							LUNG-CANCER; EXPRESSION; MICRORNAS; NEURODEGENERATION; DISORDERS; PROGNOSIS; MIGRATION; ONCOGENE; INVASION; TARGETS	Recent evidence supports a role of microRNAs in cancer and psychiatric disorders such as schizophrenia and bipolar disorder, through their regulatory role on the expression of multiple genes. The rather rare co-morbidity of cancer and schizophrenia is an old hypothesis which needs further research on microRNAs as molecules that might exert their oncosuppressive or oncogenic activity in the context of their role in psychiatric disorders. The expression pattern of a variety of different microRNAs was investigated in patients (N = 6) suffering from schizophrenia termed control, patients with a solid tumor (N = 10) and patients with both schizophrenia and tumor (N = 8). miRNA profiling was performed on whole blood samples using the miRCURY LNA microRNA Array technology (6th & 7th generation). A subset of 3 microRNAs showed a statistically significant differential expression between the control and the study groups. Specifically, significant down-regulation of the let-7p-5p, miR-98-5p and of miR-183-5p in the study groups (tumor alone and tumorand schizophrenia) was observed (p<0.05). The results of the present study showed that let-7, miR-98 and miR-183 may play an important oncosuppressive role through their regulatory impact in gene expression irrespective of the presence of schizophrenia, although a larger sample size is required to validate these results. Nevertheless, further studies are warranted in order to highlight a possible role of these and other micro-RNAs in the molecular pathways of schizophrenia.	[Rizos, Emmanouil; Filippopoulou, Anastasia; Margaritis, Demetrios; Papageorgiou, Charalabos] Univ Athens, Sch Med, Dept Psychiat 2, Univ ATTIKON Gen Hosp, Athens 11528, Greece; [Siafakas, Nikolaos] Univ Athens, Sch Med, Microbiol Lab, Univ ATTIKON Gen Hosp, Athens 11528, Greece; [Katsantoni, Eleni] Acad Athens, Div Hematol & Oncol, Biomed Res Fdn, Athens, Greece; [Skourti, Eleni; Zoumpourlis, Vassilios] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Unit Biomed Applicat, Athens, Greece; [Salpeas, Vassilios; Rizos, Ioannis] Univ Athens, Cardiol Dept 2, Univ Gen Hosp ATTIKON, Athens 11528, Greece; [Tsoporis, James N.; Parker, Thomas G.] St Michaels Hosp, Li Ka Shing Knowledge Inst Biomed Sci, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Kastania, Anastasia] Athens Univ Econ & Business, Dept Informat, Athens, Greece; [Xiros, Nikolaos] Attikon Univ Hosp, Oncol Unit, Dept Propaedeut Internal Med 2, Athens, Greece; [Filippopoulou, Anastasia] Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Psychiat, Alexandroupolis, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Academy of Athens; National Hellenic Research Foundation; National & Kapodistrian University of Athens; University Hospital Attikon; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Athens University of Economics & Business; University Hospital Attikon; Democritus University of Thrace	Rizos, E (corresponding author), Univ Athens, Sch Med, Dept Psychiat 2, Univ ATTIKON Gen Hosp, Athens 11528, Greece.	erizos@med.uoa.gr	Siafakas, Nikolaos/ABA-6124-2021; Siafakas, Nikolas/AAI-3324-2020	Siafakas, Nikolaos/0000-0002-0088-143X; Papageorgiou, Charalabos/0000-0001-7635-1956; Katsantoni, Eleni/0000-0001-8249-6035; SKOURTI, ELENI/0000-0001-6008-0549				Abraham D, 2011, CLIN CANCER RES, V17, P4772, DOI 10.1158/1078-0432.CCR-11-0242; Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Asikainen S, 2010, J MOL NEUROSCI, V41, P210, DOI 10.1007/s12031-009-9325-1; Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BUYSSE DJ, 1994, AM J PSYCHIAT, V151, P1351; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chang S, 2009, HUM MOL GENET, V18, pR18, DOI 10.1093/hmg/ddp072; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; Day E, 2013, INT J EXP PATHOL, V94, P203, DOI 10.1111/iep.12021; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; First MR, 1997, SEMIN NEPHROL, V17, P373; Fu LL, 2012, INT J BIOCHEM CELL B, V44, P733, DOI 10.1016/j.biocel.2012.02.004; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Iacoangeli A, 2010, BRAIN RES, V1338, P36, DOI 10.1016/j.brainres.2010.03.042; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Le HTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033140; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Mercer TR, 2008, NEUROSCIENTIST, V14, P434, DOI 10.1177/1073858408319187; Miller BH, 2010, BRAIN RES, V1338, P89, DOI 10.1016/j.brainres.2010.03.035; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; Patel K, 2014, CANCER LETT, V347, P54, DOI 10.1016/j.canlet.2014.01.020; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rizos E, 2012, ONCOL REP, V28, P2200, DOI 10.3892/or.2012.2052; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; Tang HF, 2014, PHARMAZIE, V69, P287, DOI 10.1691/ph.2014.3849; Thumar J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-45; Xia Y, 2014, TUMOR BIOL, V35, P5143, DOI 10.1007/s13277-014-1663-0; Xiao JA, 2011, INT J CARDIOL, V148, P110, DOI 10.1016/j.ijcard.2011.01.029; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	40	19	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123522	10.1371/journal.pone.0123522	http://dx.doi.org/10.1371/journal.pone.0123522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856466	Green Published, gold			2022-12-26	WOS:000352588500095
J	Zhai, H; Mu, YM; Wang, CM; Yan, X				Zhai Hong; Mu Yuming; Wang Chunmei; Yan Xue			The Value of Myocardial Torsion and Aneurysm Volume for Evaluating Cardiac Function in Rabbit with Left Ventricular Aneurysm	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; MAGNETIC-RESONANCE; SYSTOLIC FUNCTION; HEART-FAILURE; INFARCTION; DEFORMATION; CATECHOLAMINES; HYPERTENSION; VALIDATION; ISCHEMIA	Objective This study aimed to investigate the effect of left ventricular aneurysm (LVA) volume and left ventricular global torsion on cardiac function by real time three-dimensional echocardiography (RT-3DE) and two-dimensional speckle tracking imaging(2D-STI), to determine the accuracy of RT-3DE and 2D-STI in assessing LV function. Methods Thirty New Zealand rabbit models of with LVA were prepared by ligation of the middle segment of the left anterior descending and left circumflex arteries. Four weeks postprocedure, RT-3DE was conducted to obtain data on LVEF, left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and LVA volume (LVAV), Peak rotation angles at the mitral valve annulus level (MV-ROT), peak rotation angles at the apical level (AP-ROT), and left ventricular global torsion angles (LV-TOR) were measured by 2D-STI. Results Compared with controls, LVEDV and LVESV were significantly increased in the LVA group, while LVEF, MV-ROT, AP-ROT, and LV-TOR were consistently reduced (p<0.01). Moreover, LVEF correlated with LVA volume and LV torsion angle (r=-0.778 and 0.821, p<0.01). LVA volume/LVEDV had the strongest inverse relationship with LVEF (r=-0.911, p<0.01). Conclusion LVA volume, LVA volume/LVEDV, and LV torsion may be used as an indicator for evaluation of cardiac function after LVA. Moreover, LVA volume/LVEDV may be a more sensitive and reliable marker of cardiac function after LVA formation.	[Zhai Hong] Xinjiang Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Ultrasonog, Urumqi, Xinjiang Uygur, Peoples R China; [Mu Yuming; Wang Chunmei; Yan Xue] Xinjiang Med Univ, Affiliated Hosp 1, Dept Echocardiog, Urumqi, Xinjiang Uygur, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Mu, YM (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Echocardiog, Urumqi, Xinjiang Uygur, Peoples R China.	zhaishuanghai@sina.com	Mu, Yuming/AAO-9354-2020					Altay H, 2011, CASE REPORTS MED, V7, P1; Anwar AM, 2008, ECHOCARDIOGR-J CARD, V25, P983, DOI 10.1111/j.1540-8175.2008.00746.x; Bansal M, 2008, J AM SOC ECHOCARDIOG, V21, P887, DOI 10.1016/j.echo.2008.01.011; Battaloglu B, 2007, TEX HEART I J, V34, P154; Bu LP, 2005, J AM SOC ECHOCARDIOG, V18, P299, DOI 10.1016/j.echo.2004.11.002; BUCHALTER MB, 1994, CARDIOVASC RES, V28, P629, DOI 10.1093/cvr/28.5.629; Chen OD, 2012, CHINESE MED J-PEKING, V125, P3416, DOI 10.3760/cma.j.issn.0366-6999.2012.19.010; Corsi C, 2005, CIRCULATION, V112, P1161, DOI 10.1161/CIRCULATIONAHA.104.513689; Fan HG, 2009, CHINESE MED J-PEKING, V122, P1963, DOI 10.3760/cma.j.issn.0366-6999.2009.17.001; Fuchs E, 2004, EUR J HEART FAIL, V6, P715, DOI 10.1016/j.ejheart.2003.12.018; Gutierrez-Chico JL, 2005, AM J CARDIOL, V95, P809, DOI 10.1016/j.amjcard.2004.11.046; Han W, 2008, CHINESE MED J-PEKING, V121, P1543, DOI 10.1097/00029330-200808020-00008; Ikeda M, 2001, Ann Thorac Cardiovasc Surg, V7, P346; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; KROEKER CAG, 1993, AM J PHYSIOL, V265, pH1444, DOI 10.1152/ajpheart.1993.265.4.H1444; Lang RM, 2006, J AM COLL CARDIOL, V48, P2053, DOI 10.1016/j.jacc.2006.07.047; Langeland S, 2005, CIRCULATION, V112, P2157, DOI 10.1161/CIRCULATIONAHA.105.554006; Li XC, 2009, CHINESE MED J-PEKING, V122, P2981, DOI 10.3760/cma.j.issn.0366-6999.2009.24.012; Liang HY, 2006, AM J CARDIOL, V98, P1581, DOI 10.1016/j.amjcard.2006.07.038; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; Mu YM, 2010, ECHOCARDIOGR-J CARD, V27, P415, DOI 10.1111/j.1540-8175.2009.01028.x; Mu YM, 2010, ECHOCARDIOGR-J CARD, V27, P146, DOI 10.1111/j.1540-8175.2009.00984.x; Nucifora G, 2010, CIRC-CARDIOVASC IMAG, V3, P433, DOI 10.1161/CIRCIMAGING.109.926196; Prakash K, 2004, ECHOCARDIOGR-J CARD, V21, P257, DOI 10.1111/j.0742-2822.2004.03071.x; RADEMAKERS FE, 1992, CIRCULATION, V85, P1572, DOI 10.1161/01.CIR.85.4.1572; Ran H, 2012, ECHOCARDIOGR-J CARD, V29, P688, DOI 10.1111/j.1540-8175.2012.01690.x; Sengupta Partho P, 2008, Heart Fail Clin, V4, P315, DOI 10.1016/j.hfc.2008.03.001; Sugeng L, 2006, CIRCULATION, V114, P654, DOI 10.1161/CIRCULATIONAHA.106.626143; Takeuchi M, 2007, EUR HEART J, V28, P2756, DOI 10.1093/eurheartj/ehm440; Takeuchi M, 2007, J AM SOC ECHOCARDIOG, V20, P36, DOI 10.1016/j.echo.2006.06.019; Tibayan FA, 2004, CIRCULATION, V110, pII109, DOI 10.1161/01.CIR.0000138385.05471.41; Yao J, 2012, CHINESE MED J-PEKING, V125, P214, DOI 10.3760/cma.j.issn.0366-6999.2012.02.010; Zhang P, 2005, J THORAC CARDIOV SUR, V130, P1032, DOI 10.1016/j.jtcvs.2005.05.039; Zheng Zhe, 2009, Interact Cardiovasc Thorac Surg, V9, P431, DOI 10.1510/icvts.2009.207134	34	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121876	10.1371/journal.pone.0121876	http://dx.doi.org/10.1371/journal.pone.0121876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855970	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500027
J	Hamilton, RJ; Bird, T; Gereniu, C; Pita, J; Ramohia, PC; Walter, R; Goerlich, C; Limpus, C				Hamilton, Richard J.; Bird, Tomas; Gereniu, Collin; Pita, John; Ramohia, Peter C.; Walter, Richard; Goerlich, Clara; Limpus, Colin			Solomon Islands Largest Hawksbill Turtle Rookery Shows Signs of Recovery after 150 Years of Excessive Exploitation	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ERETMOCHELYS-IMBRICATA; FISHERIES; GEORGIA	The largest rookery for hawksbill turtles in the oceanic South Pacific is the Arnavon Islands, which are located in the Manning Strait between Isabel and Choiseul Province, Solomon Islands. The history of this rookery is one of overexploitation, conflict and violence. Throughout the 1800s Roviana headhunters from New Georgia repeatedly raided the Manning Strait to collect hawksbill shell which they traded with European whalers. By the 1970s the Arnavons hawksbill population was in severe decline and the national government intervened, declaring the Arnavons a sanctuary in 1976. But this government led initiative was short lived, with traditional owners burning down the government infrastructure and resuming intensive harvesting in 1982. In 1991 routine beach monitoring and turtle tagging commenced at the Arnavons along with extensive community consultations regarding the islands' future, and in 1995 the Arnavon Community Marine Conservation Area (ACMCA) was established. Around the same time national legislation banning the sale of all turtle products was passed. This paper represents the first analysis of data from 4536 beach surveys and 845 individual turtle tagging histories obtained from the Arnavons between 1991-2012. Our results and the results of others, reveal that many of the hawksbill turtles that nest at the ACMCA forage in distant Australian waters, and that nesting on the Arnavons occurs throughout the year with peak nesting activity coinciding with the austral winter. Our results also provide the first known evidence of recovery for a western pacific hawksbill rookery, with the number of nests laid at the ACMCA and the remigration rates of turtles doubling since the establishment of the ACMCA in 1995. The Arnavons case study provides an example of how changes in policy, inclusive community-based management and long term commitment can turn the tide for one of the most charismatic and endangered species on our planet.	[Hamilton, Richard J.; Goerlich, Clara] Nature Conservancy, Asia Pacific Div, Brisbane, Qld 4101, Australia; [Hamilton, Richard J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bird, Tomas] Univ Southampton, Sch Geog & Environm, Southampton SO17 1BJ, Hants, England; [Gereniu, Collin] Nature Conservancy, Solomon Islands Field Off, Honiara, Solomon Islands; [Pita, John] Nature Conservancy, Isabel Environm Off, Buala, Isabel Province, Solomon Islands; [Ramohia, Peter C.] Minist Environm Climate Change Disaster Managemen, ADB Coral Triangle Pacific Project, Honiara, Solomon Islands; [Walter, Richard] Univ Otago, Dept Anthropol & Archaeol, Dunedin, New Zealand; [Goerlich, Clara] Univ Wurzburg, D-97070 Wurzburg, Germany; [Limpus, Colin] Queensland Govt, Dept Environm & Heritage Protect, Threatened Species Unit, Brisbane, Qld 4102, Australia	James Cook University; University of Southampton; University of Otago; University of Wurzburg	Hamilton, RJ (corresponding author), Nature Conservancy, Asia Pacific Div, 245 Riverside Dr, Brisbane, Qld 4101, Australia.	rhamilton@tnc.org		Hamilton, Richard/0000-0002-0076-4276	community of Katupika; community of Kia; community of Wagina	community of Katupika; community of Kia; community of Wagina	The success of the ACMCA would not be possible without the dedication and commitment of the ACMCA conservation officers of past and present who have devoted so much of their life's towards preserving this small but precious part of the world. This paper is dedicated to them. We also acknowledge the ACMCA board members and the support of the communities of Katupika, Kia and Wagina. We thank N. Peterson for producing Figs. 1 and 2. Finally we thank W. Atu, H. Kaniki, Chief L. Mikie, P. Thomas and C. Siota for their efforts over the years to ensure that the ACMCA is a success.	Allen MS, 2007, CORAL REEFS, V26, P959, DOI 10.1007/s00338-007-0234-x; Allen Zoe C., 2010, Endangered Species Research, V11, P195, DOI 10.3354/esr00281; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bell I, 2012, AQUAT CONSERV, V22, P673, DOI 10.1002/aqc.2245; Bell I, 2012, MAR ECOL PROG SER, V446, P275, DOI 10.3354/meps09481; Bennett Judith A., 1987, WEALTH SOLOMONS HIST; BRODERICK D, 1997, P 17 ANN S SEA TURTL, P15; Delcroix E, 2014, ORYX, V48, P95, DOI 10.1017/S0030605311000792; Hamilton R, 2008, IMPACT POACHING MARI; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Horrocks Julia A., 2001, Chelonian Conservation and Biology, V4, P107; Humber F, 2014, DIVERS DISTRIB, V20, P579, DOI 10.1111/ddi.12183; James R., 2012, RIDGES REEFS CONSERV; Kinch Jeff, 2009, Traffic Bulletin, V22, P62; Leary T, 1992, HAWKSBILL GREEN TURT; Limpus C.J., 2008, AUSTR HAWKSBILL TURT; LIMPUS CJ, 1992, WILDLIFE RES, V19, P457, DOI 10.1071/WR9920457; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Mahanty S., 2002, DEV B, V58, P88; McKeown A., 1977, MARINE TURTLES SOLOM; MCKINNON JM, 1975, OCEANIA, V45, P290, DOI 10.1002/j.1834-4461.1975.tb01872.x; Miller JD, 1998, WILDLIFE RES, V25, P89, DOI 10.1071/WR96086; Milliken T, 1987, JAPANESE SEA TURTLE; Moncada FG, 2012, BIOL CONSERV, V148, P191, DOI 10.1016/j.biocon.2012.01.011; Mortimer J.A., 2002, SEA TURTLE BIOL CONS; Mortimer J.A., 2008, IUCN 2008 RED LIST T; Parker DM, 2009, PAC SCI, V63, P371, DOI 10.2984/049.063.0306; PARMENTER CJ, 1983, COPEIA, P271, DOI 10.2307/1444731; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pike DA, 2014, GLOBAL CHANGE BIOL, V20, P7, DOI 10.1111/gcb.12397; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramohia P, 2000, SUMMARY RESULTS PEAK; Ramohia P, 1992, HAWKSBILL GREEN TURT; Ramohia PC., 1994, REPORT SREEP REGIONA; Ramohia PC, 1996, REPORT SPREP REGIONA; RICHARDS AH, 1994, MAR POLLUT BULL, V29, P90, DOI 10.1016/0025-326X(94)90431-6; Sheppard PJ, 2000, J POLYNESIAN SOC, V109, P9; VAUGHAN P, 1980, MARINE TURTLE NEWSLE, V16, P6; VAUGHAN P. W., 1981, MARINE TURTLES REV T; Walter R., 2011, REPORT CULTURAL HERI; Walter RK, 2014, ECOL SOC, V19, DOI 10.5751/ES-06646-190441; Watson JT, 2014, CONSERV BIOL, V28, P1012, DOI 10.1111/cobi.12268; Zelenietz Martin, 1979, PACIFICATION MELANES, P91	44	27	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121435	10.1371/journal.pone.0121435	http://dx.doi.org/10.1371/journal.pone.0121435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853880	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000352478400039
J	Kenney, SP; Meng, XJ				Kenney, Scott P.; Meng, Xiang-Jin			Identification and Fine Mapping of Nuclear and Nucleolar Localization Signals within the Human Ribosomal Protein S17	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; RNA-POLYMERASE; EUKARYOTIC RIBOSOME; DOMAINS; COMPLEX; BIOGENESIS; SEQUENCE; SUBUNIT; REVEALS; IMPORT	Human ribosomal protein S17 (RPS17) is mutated in Diamond-Blackfan Anemia (DBA), a bone marrow disorder that fails to produce sufficient red blood cells leading to anemia. Recently, an RPS17 protein sequence was also found to be naturally inserted in the genome of hepatitis E virus (HEV) from patients chronically-infected by HEV. The role of RPS17 in HEV replication and pathogenesis remains unknown due to the lack of knowledge about how RPS17 functions at a molecular level. Understanding the biological function of RPS17 is critical for elucidating its role in virus infection and DBA disease processes. In this study we probed the subcellular distribution of normal and mutant RPS17 proteins in a human liver cell line (Huh7). RPS17 was primarily detected within the nucleus, and more specifically within the nucleoli. Using a transient expression system in which RPS17 or truncations were expressed as fusions with enhanced yellow fluorescent protein (eYFP), we were able to identify and map, for the first time, two separate nuclear localization signals (NLSs), one to the first 13 amino acids of the amino-terminus of RPS17 and the other within amino acids 30-60. Additionally, we mapped amino acid sequences required for nucleolar accumulation of RPS17 to amino acids 60-70. Amino acids 60-70 possess a di-RG motif that may be necessary for nucleolar retention of RPS17. The results from this study enhance our knowledge of RSP17 and will facilitate future mechanistic studies about the roles of RSP17 in hepatitis E and DBA disease processes.	[Kenney, Scott P.; Meng, Xiang-Jin] Virginia Polytech Inst & State Univ, Coll Vet Med, Virginia Tech, Ctr Mol Med & Infect Dis,Dept Biomed Sci & Pathob, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Meng, XJ (corresponding author), Virginia Polytech Inst & State Univ, Coll Vet Med, Virginia Tech, Ctr Mol Med & Infect Dis,Dept Biomed Sci & Pathob, Blacksburg, VA 24061 USA.	xjmeng@vt.edu	Meng, X.J./B-8769-2009	Meng, X.J./0000-0002-2739-1334; Kenney, Scott/0000-0002-7449-2066	National Institutes of Health [R01 AI074667, R01 AI050611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050611, R01AI074667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants (R01 AI074667, and R01 AI050611) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annilo T, 1998, BIOCHEM BIOPH RES CO, V249, P759, DOI 10.1006/bbrc.1998.9187; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Aspesi A, 2014, GENE, V545, P282, DOI 10.1016/j.gene.2014.04.077; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Beyer AR, 2013, J VIROL, V87, P1069, DOI 10.1128/JVI.02463-12; BOMMER UA, 1988, FEBS LETT, V233, P114, DOI 10.1016/0014-5793(88)81366-8; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FILIPENKO ML, 1995, BIOORG KHIM+, V21, P349; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Gregory LA, 2007, NUCLEIC ACIDS RES, V35, P5913, DOI 10.1093/nar/gkm626; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Kundu-Michalik S, 2008, MOL BIOL EVOL, V25, P580, DOI 10.1093/molbev/msn002; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LISCHWE MA, 1982, J BIOL CHEM, V257, P4600; Lochmann TL, 2013, VIRUS RES, V171, P304, DOI 10.1016/j.virusres.2012.09.011; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; OLSON MOJ, 1975, J MOL BIOL, V97, P611, DOI 10.1016/S0022-2836(75)80062-3; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Wu B, 2008, PROTEIN SCI, V17, P583, DOI 10.1110/ps.073272208; Zirwes RF, 1997, MOL BIOL CELL, V8, P231, DOI 10.1091/mbc.8.2.231	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124396	10.1371/journal.pone.0124396	http://dx.doi.org/10.1371/journal.pone.0124396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853866	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400138
J	Oh, YT; Deng, J; Yue, P; Owonikoko, TK; Khuri, FR; Sun, SY				Oh, Y-T; Deng, J.; Yue, P.; Owonikoko, T. K.; Khuri, F. R.; Sun, S-Y			Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing	ONCOGENE			English	Article							RECEPTOR 5 EXPRESSION; AZD6244 ARRY-142886; BRAF; RAF; MEK; COACTIVATION; CARCINOMAS; BENCH	Inhibition of B-Raf/MEK/ERK signaling is an effective therapeutic strategy against certain types of cancers such as melanoma and thyroid cancer. While demonstrated to be effective anticancer agents, B-Raf or MEK inhibitors have also been associated with early tumor progression and development of secondary neoplasms. The ligation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with its receptor, death receptor 5 (DR5), leading to induction of apoptosis, offers a promising anticancer strategy. Importantly, this is also a natural immunosurveillance mechanism against cancer development. We previously demonstrated that activated B-Raf/MEK/ERK signaling positively regulates DR5 expression. Hence, our current work sought to address whether B-Raf/MEK/ERK inhibition and the consequent suppression of DR5 expression impede cancer cell response to DR5 activation-induced apoptosis and activated immune cell-induced killing. We found that both B-Raf (for example, PLX4032) and MEK inhibitors (for example, AZD6244 and PD0325901) effectively inhibited ERK1/2 phosphorylation and reduced DR5 levels in both human thyroid cancer and melanoma cells. Similar to the observed effect of genetic knockdown of the B-Raf gene, pre-treatment of cancer cell lines with either B-Raf or MEK inhibitors attenuated or abolished cellular apoptotic response induced by TRAIL or the DR5 agonistic antibody AMG655 or cell killing by activated T cells. Our findings clearly show that inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs DR5 activation-induced apoptosis and T cell-mediated killing of cancer cells. These findings suggest a potential negative impact of B-Raf or MEK inhibition on TRAIL-or DR5-mediated anticancer therapy and on TRAIL/DR5-mediated immune-clearance of cancer cells.	[Oh, Y-T; Deng, J.; Yue, P.; Owonikoko, T. K.; Khuri, F. R.; Sun, S-Y] Emory Univ Sch Med & Winship Canc Inst, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,Suite C3088, Atlanta, GA 30332 USA		Sun, SY (corresponding author), Emory Univ Sch Med & Winship Canc Inst, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,Suite C3088, Atlanta, GA 30332 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618	NIH/NCI SPORE P50 grant [CA128613]; Emory Winship Cancer Institute Robbins Scholar awards; Melanoma Research Fund; Halpern Research Scholar award; Halpern Research Scholar; NATIONAL CANCER INSTITUTE [P30CA138292, P50CA128613] Funding Source: NIH RePORTER	NIH/NCI SPORE P50 grant; Emory Winship Cancer Institute Robbins Scholar awards; Melanoma Research Fund; Halpern Research Scholar award; Halpern Research Scholar; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs P Giannakakou, J Arbiser and R Schweppes for providing cancer cell lines and Amgen Inc. for the generous provision of AMG655. We are also thankful to Dr A Hammond for editing the manuscript. This study was supported by the NIH/NCI SPORE P50 grant CA128613 (to S-Y Sun for Project 2) and Emory Winship Cancer Institute Robbins Scholar awards (to Y-T Oh and to J Deng), Melanoma Research Fund (to J Deng) and Halpern Research Scholar award (to S-Y Sun). FR Khuri, TK Owonikoko and S-Y Sun are Georgia Research Alliance Distinguished Cancer Scientists. S-Y Sun is a Halpern Research Scholar.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Arnault JP, 2009, J CLIN ONCOL, V27, pE59, DOI 10.1200/JCO.2009.23.4823; Banerji U, 2010, CLIN CANCER RES, V16, P1613, DOI 10.1158/1078-0432.CCR-09-2483; Berger A, 2014, J INVEST DERMATOL, V134, P430, DOI 10.1038/jid.2013.347; Breaker K, 2013, DERMATOL SURG, V39, P981, DOI 10.1111/dsu.12184; Dhandapani L, 2011, CANCER RES, V71, P5245, DOI 10.1158/0008-5472.CAN-10-4180; Dubauskas Z, 2009, CLIN GENITOURIN CANC, V7, P20, DOI 10.3816/CGC.2009.n.003; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Hersey P, 2009, CANCER IMMUNOL IMMUN, V58, P1751, DOI 10.1007/s00262-009-0732-5; Huang TG, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-30; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Llobet D, 2010, EUR J CANCER, V46, P836, DOI 10.1016/j.ejca.2009.12.025; Oh YT, 2012, J BIOL CHEM, V287, P257, DOI 10.1074/jbc.M111.304006; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Rafei M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-121; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smalley KSM, 2013, NAT REV CLIN ONCOL, V10, P5, DOI 10.1038/nrclinonc.2012.215; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sun SY, 1997, CANCER RES, V57, P4931; Weeraratna AT, 2012, NEW ENGL J MED, V366, P271, DOI 10.1056/NEJMe1111636; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Zitzmann K, 2011, ENDOCR-RELAT CANCER, V18, P277, DOI 10.1530/ERC-10-0108	27	12	13	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					459	467		10.1038/onc.2015.97	http://dx.doi.org/10.1038/onc.2015.97			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25867065	Green Accepted			2022-12-26	WOS:000369056700006
J	Adapala, RK; Thoppil, RJ; Ghosh, K; Cappelli, HC; Dudley, AC; Paruchuri, S; Keshamouni, V; Klagsbrun, M; Meszaros, JG; Chilian, WM; Ingber, DE; Thodeti, CK				Adapala, R. K.; Thoppil, R. J.; Ghosh, K.; Cappelli, H. C.; Dudley, A. C.; Paruchuri, S.; Keshamouni, V.; Klagsbrun, M.; Meszaros, J. G.; Chilian, W. M.; Ingber, D. E.; Thodeti, C. K.			Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy	ONCOGENE			English	Article							RECEPTOR POTENTIAL VANILLOID-4; VESSEL NORMALIZATION; ANTI-ANGIOGENESIS; ENDOTHELIAL-CELLS; BLOOD-VESSELS; INTEGRIN; DELIVERY; RHO; DIFFERENTIATION; CHEMOTHERAPY	Tumor vessels are characterized by abnormal morphology and hyperpermeability that together cause inefficient delivery of chemotherapeutic agents. Although vascular endothelial growth factor has been established as a critical regulator of tumor angiogenesis, the role of mechanical signaling in the regulation of tumor vasculature or tumor endothelial cell (TEC) function is not known. Here we show that the mechanosensitive ion channel transient receptor potential vanilloid 4 (TRPV4) regulates tumor angiogenesis and tumor vessel maturation via modulation of TEC mechanosensitivity. We found that TECs exhibit reduced TRPV4 expression and function, which is correlated with aberrant mechanosensitivity towards extracellular matrix stiffness, increased migration and abnormal angiogenesis by TEC. Further, syngeneic tumor experiments revealed that the absence of TRPV4 induced increased vascular density, vessel diameter and reduced pericyte coverage resulting in enhanced tumor growth in TRPV4 knockout mice. Importantly, overexpression or pharmacological activation of TRPV4 restored aberrant TEC mechanosensitivity, migration and normalized abnormal angiogenesis in vitro by modulating Rho activity. Finally, a small molecule activator of TRPV4, GSK1016790A, in combination with anticancer drug cisplatin, significantly reduced tumor growth in wild-type mice by inducing vessel maturation. Our findings demonstrate TRPV4 channels to be critical regulators of tumor angiogenesis and represent a novel target for antiangiogenic and vascular normalization therapies.	[Adapala, R. K.; Thoppil, R. J.; Cappelli, H. C.; Meszaros, J. G.; Chilian, W. M.; Thodeti, C. K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Adapala, R. K.; Thoppil, R. J.; Cappelli, H. C.; Meszaros, J. G.; Chilian, W. M.; Thodeti, C. K.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Ghosh, K.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Ghosh, K.; Dudley, A. C.; Klagsbrun, M.; Ingber, D. E.; Thodeti, C. K.] Childrens Hosp, Vasc Biol Program, 300 Longwood Ave, Boston, MA 02115 USA; [Ghosh, K.; Dudley, A. C.; Klagsbrun, M.; Ingber, D. E.; Thodeti, C. K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Dudley, A. C.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Paruchuri, S.] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Keshamouni, V.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ingber, D. E.] Wyss Inst Biol Inspired Engn, Cambridge, MA USA; [Ingber, D. E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of California System; University of California Riverside; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Akron; University of Michigan System; University of Michigan; Harvard University	Thodeti, CK (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.	cthodeti@neomed.edu	Adapala, Ravi kumar/AAD-1282-2020; Ingber, Donald E/AAC-5894-2019	Adapala, Ravi kumar/0000-0002-4082-5301; Keshamouni, Venkateshwar/0000-0003-1947-791X	NEOMED; AHA [14GRNT20380935]; NIH [CA55833, CA45548]; NATIONAL CANCER INSTITUTE [P01CA045548, P30CA016086, R01CA055833, R01CA177875] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL106442, R01HL115114, R01HL119705] Funding Source: NIH RePORTER	NEOMED; AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the start-up funds from NEOMED and AHA (14GRNT20380935) (CKT) and NIH grants CA55833 and CA45548 (DI).	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Baylie RL, 2011, ACTA PHYSIOL, V203, P99, DOI 10.1111/j.1748-1716.2010.02217.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brackenbury WJ, 2006, J PHYSIOL-LONDON, V573, P343, DOI 10.1113/jphysiol.2006.106906; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Cuevas I, 2009, ADV CANCER RES, V103, P25, DOI 10.1016/S0065-230X(09)03002-4; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Duda DG, 2007, TRENDS MOL MED, V13, P223, DOI 10.1016/j.molmed.2007.04.001; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Folkman J, 2003, CANCER BIOL THER, V2, pS127; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Fraser SP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0105; Fukumura D, 2008, APMIS, V116, P695, DOI 10.1111/j.1600-0463.2008.01148.x; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hu F, 2013, ARCH ORAL BIOL, V58, P192, DOI 10.1016/j.archoralbio.2012.08.013; Ingber D E, 1997, Gravit Space Biol Bull, V10, P49; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; Jain RK, 2012, CELL, V149, P1408, DOI 10.1016/j.cell.2012.05.025; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Liedtke W, 2005, J PHYSIOL-LONDON, V567, P53, DOI 10.1113/jphysiol.2005.088963; Liu JQ, 2011, CLIN CANCER RES, V17, P3638, DOI 10.1158/1078-0432.CCR-10-2456; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; MATTHEWS BD, INTEGR BIOL CAMB, V2, P435; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Shakibael M, 2003, HISTOL HISTOPATHOL, V18, P343, DOI 10.14670/HH-18.343; Sukharev Sergei, 2004, Sci STKE, V2004, pre4, DOI 10.1126/stke.2192004re4; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thodeti CK, 2002, BIOCHEM J, V365, P157, DOI 10.1042/BJ20020248; Troidl C, 2009, J CELL MOL MED, V13, P2613, DOI 10.1111/j.1582-4934.2008.00579.x; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Wilson PD, 1999, LAB INVEST, V79, P1311; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005	57	98	105	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					314	322		10.1038/onc.2015.83	http://dx.doi.org/10.1038/onc.2015.83			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25867067	Green Accepted, Green Submitted			2022-12-26	WOS:000369055300005
J	Kim, MS; Jang, J; Rahman, NBAB; Pethe, K; Berry, EA; Huang, LS				Kim, Mi-Sun; Jang, Jichan; Rahman, Nurlilah Binte A. B.; Pethe, Kevin; Berry, Edward A.; Huang, Li-Shar			Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM-GLUTAMICUM; BC(1)-AA(3) BRANCH; OXIDASE ACTIVITY; ATP HOMEOSTASIS; C(1); PURIFICATION; MITOCHONDRIA; FLEXIBILITY; COMPLEXES; REDUCTASE	Recently, energy production pathways have been shown to be viable antitubercular drug targets to combat multidrug-resistant tuberculosis and eliminate pathogen in the dormant state. One family of drugs currently under development, the imidazo[1,2-a]pyridine derivatives, is believed to target the pathogen's homolog of the mitochondrial bc(1) complex. This complex, denoted cytochrome bcc, is highly divergent from mitochondrial Complex III both in subunit structure and inhibitor sensitivity, making it a good target for drug development. There is no soluble cytochrome c in mycobacteria to transport electrons from the bcc complex to cytochrome oxidase. Instead, the bcc complex exists in a "supercomplex" with a cytochrome aa(3)-type cytochrome oxidase, presumably allowing direct electron transfer. We describe here purification and initial characterization of the mycobacterial cytochrome bcc-aa(3) supercomplex using a strain of M. smegmatis that has been engineered to express the M. tuberculosis cytochrome bcc. The resulting hybrid super-complex is stable during extraction and purification in the presence of dodecyl maltoside detergent. It is hoped that this purification procedure will potentiate functional studies of the complex as well as crystallographic studies of drug binding and provide structural insight into a third class of the bc complex superfamily.	[Kim, Mi-Sun; Berry, Edward A.; Huang, Li-Shar] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Jang, Jichan; Pethe, Kevin] Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea; [Rahman, Nurlilah Binte A. B.; Pethe, Kevin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Rahman, Nurlilah Binte A. B.; Pethe, Kevin] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Institut Pasteur Korea; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Berry, EA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	berrye@upstate.edu; berryl@upstate.edu	Berry, Edward A./D-5640-2013; Pethe, Kevin/F-9495-2015	Berry, Edward A./0000-0001-8929-0259; Huang, Li-Shar/0000-0003-1427-2544; Pethe, Kevin/0000-0003-0916-8873	National Research Foundation of Korea [NRF-2013R1A6A3A03026543, 2014R1A1A1007464]; National Research foundation of Korea (NRF) - Korean government (MSIP) [2007-00559]; Gyeonggi-do; KISTI; NRF - Korean government (MSIP) [2007-00559]; Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant; State University of New York	National Research Foundation of Korea(National Research Foundation of Korea); National Research foundation of Korea (NRF) - Korean government (MSIP); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI)); NRF - Korean government (MSIP); Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant(Nanyang Technological University); State University of New York	Supported by National Research Foundation of Korea Grant NRF-2013R1A6A3A03026543. Present address: College of Pharmacy, Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea 120-750.r Supported by a National Research foundation of Korea (NRF) grant funded by the Korean government (MSIP) 2007-00559, Gyeonggi-do, KISTI, and National Research Foundation of Korea Grant 2014R1A1A1007464.r Supported by an NRF grant funded by the Korean government (MSIP) 2007-00559, Gyeonggi-do, KISTI, and a Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant.r Supported by the State University of New York.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Arora K, 2014, ANTIMICROB AGENTS CH, V58, P6962, DOI 10.1128/AAC.03486-14; Berney M., 2014, ADV PHOTOSYNTHESIS R, P277; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Cheng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087483; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hasan SS, 2011, J MOL BIOL, V414, P145, DOI 10.1016/j.jmb.2011.09.023; Horvath A, 2000, SCIENCE, V287, P1639, DOI 10.1126/science.287.5458.1639; Kakkar AK, 2014, TUBERCULOSIS, V94, P357, DOI 10.1016/j.tube.2014.04.001; Kusumoto K, 2000, ARCH MICROBIOL, V173, P390, DOI 10.1007/s002030000161; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; MARRES CAM, 1977, BIOCHIM BIOPHYS ACTA, V462, P531, DOI 10.1016/0005-2728(77)90099-8; Matsoso LG, 2005, J BACTERIOL, V187, P6300, DOI 10.1128/JB.187.18.6300-6308.2005; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; Sone N, 1996, J BIOL CHEM, V271, P12457, DOI 10.1074/jbc.271.21.12457; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; YAMANAKA T, 1981, J BIOCHEM, V89, P265, DOI 10.1093/oxfordjournals.jbchem.a133190; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	32	31	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14350	14360		10.1074/jbc.M114.624312	http://dx.doi.org/10.1074/jbc.M114.624312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25861988	Green Published, hybrid			2022-12-26	WOS:000355754600008
J	Zhang, WJ; Qian, PX; Zhang, X; Zhang, M; Wang, H; Wu, MM; Kong, XJ; Tan, S; Ding, KS; Perry, JK; Wu, ZS; Cao, Y; Lobie, PE; Zhu, T				Zhang, Weijie; Qian, Pengxu; Zhang, Xiao; Zhang, Min; Wang, Hong; Wu, Mingming; Kong, Xiangjun; Tan, Sheng; Ding, Keshuo; Perry, Jo K.; Wu, Zhengsheng; Cao, Yuan; Lobie, Peter E.; Zhu, Tao			Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL CARCINOMA-CELLS; GENE-EXPRESSION; MAMMARY-GLAND; PHENOTYPIC CONVERSION; TRANSCRIPTION FACTOR; METASTASIS; IDENTIFICATION; RECEPTOR; TARGET; STAT5	Human growth hormone (hGH) plays critical roles in pubertal mammary gland growth, development, and sexual maturation. Accumulated studies have reported that autocrine/paracrine hGH is an orthotopically expressed oncoprotein that promotes normal mammary epithelial cell oncogenic transformation. Autocrine/paracrine hGH has also been reported to promote mammary epithelial cell epithelial-mesenchymal transition (EMT) and invasion. However, the underlying mechanism remains largely obscure. MicroRNAs (miRNAs) are reported to be involved in regulation of multiple cellular functions of cancer. To determine whether autocrine/paracrine hGH promotes EMT and invasion through modulation of miRNA expression, we performed microarray profiling using MCF-7 cells stably expressing wild type or a translation-deficient hGH gene and identified miR-96-182-183 as an autocrine/paracrine hGH-regulated miRNA cluster. Forced expression of miR-96-182-183 conferred on epithelioid MCF-7 cells a mesenchymal phenotype and promoted invasive behavior in vitro and dissemination in vivo. Moreover, we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L (breast cancer metastasis suppressor 1-like) gene expression. miR-96 and miR-182 also targeted GHR, providing a potential negative feedback loop in the hGH-GHR signaling pathway. We further demonstrated that autocrine/paracrine hGH stimulated miR-96-182-183 expression and facilitated EMT and invasion via STAT3 and STAT5 signaling. Consistent with elevated expression of autocrine/paracrine hGH in metastatic breast cancer tissue, miR-96-182-183 expression was also remarkably enhanced. Hence, we delineate the roles of the miRNA-96-182-183 cluster and elucidate a novel hGH-GHR-STAT3/STAT5-miR-96-182-183-BRMS1L-ZEB1/E47-EMT/ invasion axis, which provides further understanding of the mechanism of autocrine/paracrine hGH-stimulated EMT and invasion in breast cancer.	[Zhang, Weijie; Qian, Pengxu; Zhang, Xiao; Zhang, Min; Wang, Hong; Wu, Mingming; Kong, Xiangjun; Tan, Sheng; Ding, Keshuo; Wu, Zhengsheng; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Zhang, Weijie; Qian, Pengxu; Zhang, Xiao; Zhang, Min; Wang, Hong; Wu, Mingming; Kong, Xiangjun; Tan, Sheng; Ding, Keshuo; Wu, Zhengsheng; Zhu, Tao] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Zhang, Weijie; Zhang, Min; Zhu, Tao] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Perry, Jo K.] Univ Auckland, Liggins Inst, Auckland 1023, New Zealand; [Perry, Jo K.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1023, New Zealand; [Wu, Zhengsheng; Cao, Yuan] Anhui Med Univ, Dept Pathol, Hefei 230027, Anhui, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Auckland; University of Auckland; Anhui Medical University; National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med MD6, 11-01K,14 Med Dr, Singapore 117599, Singapore.	csipel@nus.edu.sg; zhut@ustc.edu.cn	Zhu, Tao/H-3495-2018; wu, mingming/GXN-1864-2022; tan, sheng/GSN-2599-2022; Zhang, Xiao/H-2702-2018; cao, yuan/GRR-9461-2022; Qian, Pengxu/B-9376-2016	Perry, Jo/0000-0002-4418-947X; Qian, Pengxu/0000-0001-5636-6704; Mingming, Wu/0000-0001-8420-3750; Zhang, Weijie/0000-0002-6462-6067; Zhang, Xiao/0000-0003-1706-2868	National Key Scientific Program of China [2012CB934002]; Chinese Academy of Science [XDA01040410]; National Natural Science Foundation of China [81272925, 81472494, 81302322, 81402191]; CAS President's International Fellowship Initiative [2015VBA031]; Cancer Science Institute of Singapore from the ministry of education; National Research Foundation of Singapore	National Key Scientific Program of China; Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS President's International Fellowship Initiative; Cancer Science Institute of Singapore from the ministry of education(Ministry of Education, Singapore); National Research Foundation of Singapore(National Research Foundation, Singapore)	This work was supported by the National Key Scientific Program of China (2012CB934002), the Chinese Academy of Science (XDA01040410), National Natural Science Foundation of China (81272925, 81472494, 81302322, 81402191), CAS President's International Fellowship Initiative (2015VBA031) and the Cancer Science Institute of Singapore through grants from the ministry of education and the National Research Foundation of Singapore.	Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Hurst DR, 2011, FEBS LETT, V585, P3185, DOI 10.1016/j.febslet.2011.07.045; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaulsay KK, 1999, EXP CELL RES, V250, P35, DOI 10.1006/excr.1999.4492; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Kleinberg DL, 1997, J MAMMARY GLAND BIOL, V2, P49, DOI 10.1023/A:1026373513521; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krell J, 2012, MOL DIAGN THER, V16, P167, DOI 10.2165/11632740-000000000-00000; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Oberley C. C., 2014, MOL CARCINOG, DOI [10.1002/mc.22165, DOI 10.1002/MC.22165]; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Perry JK, 2008, J MAMMARY GLAND BIOL, V13, P131, DOI 10.1007/s10911-008-9070-z; Perry JK, 2013, CURR OPIN ENDOCRINOL, V20, P307, DOI 10.1097/MED.0b013e328363183a; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Raccurt M, 2002, J ENDOCRINOL, V175, P307, DOI 10.1677/joe.0.1750307; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Tang JZ, 2010, ENDOCRINOLOGY, V151, P4133, DOI 10.1210/en.2010-0273; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Tavassoeli FA, 2003, PATHOLOGY GENETICS T; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Walden PD, 1998, ENDOCRINOLOGY, V139, P659, DOI 10.1210/en.139.2.659; Waters MJ, 1999, CLIN EXP PHARMACOL P, V26, P760, DOI 10.1046/j.1440-1681.1999.03129.x; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wu ZS, 2011, J CLIN ENDOCR METAB, V96, pE1619, DOI 10.1210/jc.2011-1245; Xu J, 2011, MOL ENDOCRINOL, V25, P597, DOI 10.1210/me.2010-0255; Zhang L, 2012, NEOPLASMA, V59, P302, DOI 10.4149/neo_2012_039; Zhu T, 2005, CANCER RES, V65, P317; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	56	66	70	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13812	13829		10.1074/jbc.M115.653261	http://dx.doi.org/10.1074/jbc.M115.653261			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873390	Green Published, hybrid			2022-12-26	WOS:000355313000016
J	Singer, K; Maley, N; Mergian, T; DelProposto, J; Cho, KW; Zamarron, BF; Martinez-Santibanez, G; Geletka, L; Muir, L; Wachowiak, P; Demirjian, C; Lumeng, CN				Singer, Kanakadurga; Maley, Nidhi; Mergian, Taleen; DelProposto, Jennifer; Cho, Kae Won; Zamarron, Brian F.; Martinez-Santibanez, Gabriel; Geletka, Lynn; Muir, Lindsey; Wachowiak, Phillip; Demirjian, Chaghig; Lumeng, Carey N.			Differences in Hematopoietic Stem Cells Contribute to Sexually Dimorphic Inflammatory Responses to High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE MACROPHAGES; CARDIOVASCULAR-DISEASE; PROMOTES MYELOPOIESIS; EXPRESSION; GENDER; SEX; TRAFFICKING; ADIPONECTIN; SENSITIVITY; DEFICIENCY	Women of reproductive age are protected from metabolic disease relative to postmenopausal women and men. Most preclinical rodent studies are skewed toward the use of male mice to study obesity-induced metabolic dysfunction because of a similar protection observed in female mice. How sex differences in obesity-induced inflammatory responses contribute to these observations is unknown. We have compared and contrasted the effects of high fat diet-induced obesity on glucose metabolism and leukocyte activation in multiple depots in male and female C57Bl/6 mice. With both short term and long term high fat diet, male mice demonstrated increased weight gain and CD11c(+) adipose tissue macrophage content compared with female mice despite similar degrees of adipocyte hypertrophy. Competitive bone marrow transplant studies demonstrated that obesity induced a preferential contribution of male hematopoietic cells to circulating leukocytes and adipose tissue macrophages compared with female cells independent of the sex of the recipient. Sex differences in macrophage and hematopoietic cell in vitro activation in response to obesogenic cues were observed to explain these results. In summary, this report demonstrates that male and female leukocytes and hematopoietic stem cells have cell-autonomous differences in their response to obesity that contribute to an amplified response in males compared with females.	[Singer, Kanakadurga; Maley, Nidhi; Mergian, Taleen; DelProposto, Jennifer; Zamarron, Brian F.; Geletka, Lynn; Muir, Lindsey; Lumeng, Carey N.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Zamarron, Brian F.; Lumeng, Carey N.] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Martinez-Santibanez, Gabriel; Lumeng, Carey N.] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Cho, Kae Won] Soonchunhyang Univ, Soonchunhyang Inst Medi Bio Sci SIMS, Cheonan Si 330930, Chungcheongnam, South Korea; [Wachowiak, Phillip; Demirjian, Chaghig] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Soonchunhyang University; University of Michigan System; University of Michigan	Singer, K (corresponding author), Dept Pediat & Communicable Dis, Div Pediat Endocrinol, D1205 MPB,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	ksinger@umich.edu	Regan, Clinton/E-6250-2012; Muir, Lindsey/AAJ-9256-2021	Singer, Kanakadurga/0000-0001-8278-3800; Muir, Lindsey/0000-0002-1756-0325	National Institutes of Health [DK089503]; National Institutes of Health, NIDDK [2P30-DK20572]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, T32DK094775, F31DK103524, R01DK090262, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322, T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work utilized Core Services from the Michigan Nutrition and Obesity Research Center (supported by National Institutes of Health Grant DK089503 to the University of Michigan). This work also utilized the Microscopy Core of the Michigan Diabetes Research Center (supported by National Institutes of Health, NIDDK, Grant 2P30-DK20572).	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Barrett-Connor E, 2009, J CARDIOVASC TRANSL, V2, P256, DOI 10.1007/s12265-009-9110-0; Bolego C, 2013, ARTERIOSCL THROM VAS, V33, P1127, DOI 10.1161/ATVBAHA.113.301328; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Estrany ME, 2013, CELL BIOCHEM FUNCT, V31, P504, DOI 10.1002/cbf.2927; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Gui YT, 2004, OBES RES, V12, P1481, DOI 10.1038/oby.2004.185; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Iwasa T, 2014, ENDOCR J, V61, P891, DOI 10.1507/endocrj.EJ14-0042; Iwasa T, 2014, CYTOKINE, V65, P65, DOI 10.1016/j.cyto.2013.10.004; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kim WK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072108; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nteeba J, 2013, MOL REPROD DEV, V80, P948, DOI 10.1002/mrd.22231; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Pratt GM, 2009, SURG ENDOSC, V23, P795, DOI 10.1007/s00464-008-0077-8; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vander Lugt B, 2013, J IMMUNOL, V191, P3119, DOI 10.4049/jimmunol.1200938; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	43	65	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13250	13262		10.1074/jbc.M114.634568	http://dx.doi.org/10.1074/jbc.M114.634568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869128	Green Published, hybrid			2022-12-26	WOS:000354975700026
J	Kapheim, KM; Rao, VD; Yeoman, CJ; Wilson, BA; White, BA; Goldenfeld, N; Robinson, GE				Kapheim, Karen M.; Rao, Vikyath D.; Yeoman, Carl J.; Wilson, Brenda A.; White, Bryan A.; Goldenfeld, Nigel; Robinson, Gene E.			Caste-Specific Differences in Hindgut Microbial Communities of Honey Bees (Apis mellifera)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOTA; POLLEN CONSUMPTION; ANIMAL BEHAVIOR; DIVERSITY; BACTERIA; CHIMPANZEES; DIGESTION; CARNICA; SEARCH	Host-symbiont dynamics are known to influence host phenotype, but their role in social behavior has yet to be investigated. Variation in life history across honey bee (Apis mellifera) castes may influence community composition of gut symbionts, which may in turn influence caste phenotypes. We investigated the relationship between host-symbiont dynamics and social behavior by characterizing the hindgut microbiome among distinct honey bee castes: queens, males and two types of workers, nurses and foragers. Despite a shared hive environment and mouth-to-mouth food transfer among nestmates, we detected separation among gut microbiomes of queens, workers, and males. Gut microbiomes of nurses and foragers were similar to previously characterized honey bee worker microbiomes and to each other, despite differences in diet, activity, and exposure to the external environment. Queen microbiomes were enriched for bacteria that may enhance metabolic conversion of energy from food to egg production. We propose that the two types of workers, which have the highest diversity of operational taxonomic units (OTUs) of bacteria, are central to the maintenance of the colony microbiome. Foragers may introduce new strains of bacteria to the colony from the environment and transfer them to nurses, who filter and distribute them to the rest of the colony. Our results support the idea that host-symbiont dynamics influence microbiome composition and, reciprocally, host social behavior.	[Kapheim, Karen M.; Rao, Vikyath D.; Yeoman, Carl J.; Wilson, Brenda A.; White, Bryan A.; Goldenfeld, Nigel; Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kapheim, Karen M.; Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Kapheim, Karen M.] Utah State Univ, Dept Biol, Logan, UT 84341 USA; [Rao, Vikyath D.; Goldenfeld, Nigel] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Utah System of Higher Education; Utah State University; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kapheim, KM (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	karen.kapheim@usu.edu	Yeoman, Carl/ABA-1906-2021; Kapheim, Karen Marie/AAA-6124-2019	Yeoman, Carl/0000-0002-8775-7879; Kapheim, Karen Marie/0000-0002-8140-7712	NIH [1DP1OD006416]; UIUC Institute for Genomic Biology Post-doctoral Fellowship; UIUC Sociogenomics Initiative Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006416] Funding Source: NIH RePORTER; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UIUC Institute for Genomic Biology Post-doctoral Fellowship; UIUC Sociogenomics Initiative Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	NIH Director's Pioneer Award (http://commonfund.nih.gov/pioneer/index) #1DP1OD006416 to GER, UIUC Institute for Genomic Biology Post-doctoral Fellowship to CJY (http://www.igb.illinois.edu/content/postdoctoral-fellowships-genomic-biology), and UIUC Sociogenomics Initiative Award to VDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Anderson MJ, 2008, PERMANOVA PRIMER GUI; [Anonymous], 1971, INSECT SOC; Archie EA, 2011, ANIM BEHAV, V82, P425, DOI 10.1016/j.anbehav.2011.05.029; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Dillon RJ, 2010, ANTON LEEUW INT J G, V97, P69, DOI 10.1007/s10482-009-9389-5; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2013, GUT MICROBES, V4, P60, DOI 10.4161/gmic.22517; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Hansen AK, 2009, NORTHWEST SCI, V83, P348, DOI 10.3955/046.083.0406; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; Moeller AH, 2013, GENOME RES, V23, P1715, DOI 10.1101/gr.154773.113; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; NIXON HL, 1952, PROC R SOC SER B-BIO, V140, P43, DOI 10.1098/rspb.1952.0042; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Powell JE, 2014, APPL ENVIRON MICROB, V80, P7378, DOI 10.1128/AEM.01861-14; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; Schachtschneider KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053969; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; SZOLDERITS MJ, 1993, J INSECT PHYSIOL, V39, P877, DOI 10.1016/0022-1910(93)90120-G; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vilo C., 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235551; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Winston M., 1987, The biology of the honey bee.; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86	60	64	72	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123911	10.1371/journal.pone.0123911	http://dx.doi.org/10.1371/journal.pone.0123911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874551	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800123
J	Chen, YY; Lin, YJ; Chong, E; Chen, PC; Chao, TF; Chen, SA; Chien, KL				Chen, Yun-Yu; Lin, Yenn-Jiang; Chong, Eric; Chen, Pei-Chun; Chao, Taz-Fan; Chen, Shih-Ann; Chien, Kuo-Liong			The Impact of Diabetes Mellitus and Corresponding HbA1c Levels on the Future Risks of Cardiovascular Disease and Mortality: A Representative Cohort Study in Taiwan	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; GLYCATED HEMOGLOBIN; TASK-FORCE; ASSOCIATION; GUIDELINES; HBA(1C); EVENTS; ESC	Background This study explored the relationship between the glycated hemoglobin (HbA1c) level in patients with or without diabetes mellitus and future risks of cardiovascular disease and death. Methods Based on a national representative cohort, a total of 5277 participants (7% with diabetes) were selected from Taiwan's Triple High Survey in 2002. The comorbidities, medication usages, and outcomes of cardiovascular disease and death, were extracted from the Taiwan's National Health Insurance Research Database and National Death Registry. Results After a median follow-up of 9.7 years, participants with diabetes had higher incidence of new onset cardiovascular disease (17.9 versus 3.16 cases per 1000 person-years) and death (20.1 versus 4.96 cases per 1000 person-years) than those without diabetes (all P < 0.001). Diabetes showed increased risk of all-cause death after adjusting for all con-founders (adjusted hazard ratio [HR]: 2.29, 95% confidence interval [CI]: 1.52-3.45). Every 1% increment of HbA1c was positively associated with the risk of total cardiovascular disease (HR: 1.2, 95% CI: 1.08-1.34) and the risk of death (HR: 1.14, 95% CI: 1.03-1.26) for all participants. As compared to the reference group with HbA1c below 5.5%, participants with HbA1c levels >= 7.5% had significantly elevated future risks of total cardiovascular disease (HR: 1.82, 95% CI: 1.01-3.26) and all-cause death (HR: 2.45, 95% CI: 1.45-4.14). Conclusions/Interpretation Elevated HbA1C levels were associated with increased risks of cardiovascular disease and death, the suboptimal glycemic control with HbA1c level over 7.5% (58.5 mmol/mol) was strongly associated with increased risks of cardiovascular disease and all-cause death.	[Chen, Yun-Yu; Lin, Yenn-Jiang; Chong, Eric; Chao, Taz-Fan; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chen, Yun-Yu; Chen, Pei-Chun; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Yenn-Jiang; Chao, Taz-Fan; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Lin, Yenn-Jiang; Chao, Taz-Fan; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chong, Eric] Jurong Hlth Private Ltd, Dept Cardiol, Singapore, Singapore	Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw		Chen, Pei-Chun/0000-0002-8713-8816; CHIEN, KUO-LIONG/0000-0003-4979-8351	Ministry of Science and Technology [NSC102-2314-B-010-056-MY2]; Taipei Veterans General Hospital [V102E7-001]; Jurong Health Private Limited	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Jurong Health Private Limited	The authors appreciate the financial support from Ministry of Science and Technology (NSC102-2314-B-010-056-MY2), and Taipei Veterans General Hospital (V102E7-001). Jurong Health Private Limited provided support in the form of a salary for author E.C., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Cannon CP, 2008, AM J CARDIOL, V102, p5L, DOI 10.1016/j.amjcard.2008.09.067; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng J, 2014, JAMA INTERN MED, V174, P773, DOI 10.1001/jamainternmed.2014.348; Cosentino F, 1997, CIRCULATION, V96, P25; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Deo R K, 2008, Kathmandu Univ Med J (KUMJ), V6, P476; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Oh HG, 2011, DIABETES METAB J, V35, P551, DOI 10.4093/dmj.2011.35.5.551; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sakurai M, 2013, DIABETES CARE, V36, P3759, DOI 10.2337/dc12-2412; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Su TC, 2008, J HYPERTENS, V26, P600, DOI 10.1097/HJH.0b013e3282f3b352; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0	24	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123116	10.1371/journal.pone.0123116	http://dx.doi.org/10.1371/journal.pone.0123116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874454	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100137
J	Li, FG; Wang, LX; Lan, QJ; Yang, H; Li, Y; Liu, XL; Yang, ZX				Li, Fenggang; Wang, Lixin; Lan, Qingjing; Yang, Hui; Li, Yang; Liu, Xiaolin; Yang, Zhaoxia			RNA-Seq Analysis and Gene Discovery of Andrias davidianus Using Illumina Short Read Sequencing	PLOS ONE			English	Article							LYMPHOTOXIN-BETA; TRANSCRIPTOME; EXPRESSION; PEPTIDES; GENOME; GALECTIN-3; TOOL	The Chinese giant salamander, Andrias davidianus, is an important species in the course of evolution; however, there is insufficient genomic data in public databases for understanding its immunologic mechanisms. High-throughput transcriptome sequencing is necessary to generate an enormous number of transcript sequences from A. davidianus for gene discovery. In this study, we generated more than 40 million reads from samples of spleen and skin tissue using the Illumina paired-end sequencing technology. De novo assembly yielded 87,297 transcripts with a mean length of 734 base pairs (bp). Based on the sequence similarities, searching with known proteins, 38,916 genes were identified. Gene enrichment analysis determined that 981 transcripts were assigned to the immune system. Tissue-specific expression analysis indicated that 443 of transcripts were specifically expressed in the spleen and skin. Among these transcripts, 147 transcripts were found to be involved in immune responses and inflammatory reactions, such as fucolectin, beta-defensins and lymphotoxin beta. Eight tissue-specific genes were selected for validation using real time reverse transcription quantitative PCR (qRT-PCR). The results showed that these genes were significantly more expressed in spleen and skin than in other tissues, suggesting that these genes have vital roles in the immune response. This work provides a comprehensive genomic sequence resource for A. davidianus and lays the foundation for future research on the immunologic and disease resistance mechanisms of A. davidianus and other amphibians.	[Li, Fenggang; Wang, Lixin; Lan, Qingjing; Yang, Hui; Li, Yang; Liu, Xiaolin; Yang, Zhaoxia] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China; [Li, Fenggang] Chinese Acad Fishery Sci, Yellow River Fisheries Res Inst, Xian 710086, Peoples R China	Northwest A&F University - China; Chinese Academy of Fishery Sciences	Li, FG (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China.	lifenggang.123@163.com			Agricultural science and technology research project [2012K01-18]; Houji Scholar Project of Northwest AF University [Z11021007]	Agricultural science and technology research project; Houji Scholar Project of Northwest AF University	Agricultural science and technology research project (2012K01-18) Houji Scholar Project of Northwest A&F University (Z11021007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyekum S, 2003, J PATHOL, V199, P115, DOI 10.1002/path.1249; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Das S, 2008, P NATL ACAD SCI USA, V105, P16647, DOI 10.1073/pnas.0808800105; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hoyer KK, 2004, AM J PATHOL, V164, P893, DOI 10.1016/S0002-9440(10)63177-X; KELLY C, 1984, BIOCHEM J, V220, P221, DOI 10.1042/bj2200221; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LICHTENSTEIN A, 1991, J CLIN INVEST, V88, P93, DOI 10.1172/JCI115310; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu YH, 2009, AM J PHYSIOL-HEART C, V296, pH404, DOI 10.1152/ajpheart.00747.2008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Mizukawa N, 1999, ANTICANCER RES, V19, P2969; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy RW, 2000, MOL ECOL, V9, P1539, DOI 10.1046/j.1365-294x.2000.01036.x; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Ondov BD, 2008, BIOINFORMATICS, V24, P2776, DOI 10.1093/bioinformatics/btn512; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Sun LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069441; UHLENBRUCK G, 1982, IMMUNOBIOLOGY, V163, P36, DOI 10.1016/S0171-2985(82)80104-6; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang XMM, 2004, ORYX, V38, P197, DOI 10.1017/S0030605304000341; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U; Zhang M, 2013, J GENET GENOMICS, V40, P137, DOI 10.1016/j.jgg.2013.01.004	46	22	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123730	10.1371/journal.pone.0123730	http://dx.doi.org/10.1371/journal.pone.0123730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874626	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100204
J	Daqrouq, K; Alhmouz, R; Balamesh, A; Memic, A				Daqrouq, Khaled; Alhmouz, Rami; Balamesh, Ahmed; Memic, Adnan			Application of Wavelet Transform for PDZ Domain Classification	PLOS ONE			English	Article							PREDICTION; RECOGNITION; TRAFFICKING; COMPLEX; ORGANIZATION; SPECIFICITY; AFFINITY	PDZ domains have been identified as part of an array of signaling proteins that are often unrelated, except for the well-conserved structural PDZ domain they contain. These domains have been linked to many disease processes including common Avian influenza, as well as very rare conditions such as Fraser and Usher syndromes. Historically, based on the interactions and the nature of bonds they form, PDZ domains have most often been classified into one of three classes (class I, class II and others - class III), that is directly dependent on their binding partner. In this study, we report on three unique feature extraction approaches based on the bigram and trigram occurrence and existence rearrangements within the domain's primary amino acid sequences in assisting PDZ domain classification. Wavelet packet transform (WPT) and Shannon entropy denoted by wavelet entropy (WE) feature extraction methods were proposed. Using 115 unique human and mouse PDZ domains, the existence rearrangement approach yielded a high recognition rate (78.34%), which outperformed our occurrence rearrangements based method. The recognition rate was (81.41%) with validation technique. The method reported for PDZ domain classification from primary sequences proved to be an encouraging approach for obtaining consistent classification results. We anticipate that by increasing the database size, we can further improve feature extraction and correct classification.	[Daqrouq, Khaled; Alhmouz, Rami; Balamesh, Ahmed] King Abdulaziz Univ, Fac Engn, Dept Elect & Comp Engn, Jeddah 21589, Saudi Arabia; [Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Memic, A (corresponding author), King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia.	amemic@kau.edu.sa	Al-Hmouz, Rami/K-1233-2012; Balamesh, Ahmed S/A-1602-2012; Memić, Adnan/I-6138-2013	Al-Hmouz, Rami/0000-0001-8710-0706; Balamesh, Ahmed S/0000-0002-0901-2847; Memić, Adnan/0000-0003-4639-8168	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia [903-004-D1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia; DSR	This study was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia under Grant no. (903-004-D1434). The authors thank the DSR for the technical and financial support.	Atal BS, 2006, IEEE SIGNAL PROC MAG, V23, P154, DOI 10.1109/MSP.2006.1598091; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Daqrouq K, 2013, SPEECH COMMUN, V55, P641, DOI 10.1016/j.specom.2013.01.002; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Gujral TS, 2013, CHEM BIOL, V20, P816, DOI 10.1016/j.chembiol.2013.04.021; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris BZ, 2001, J CELL SCI, V114, P3219; Hui S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-27; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Jin RZ, 2013, PROTEIN PEPTIDE LETT, V20, P1018; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; LAINE A, 1993, IEEE T PATTERN ANAL, V15, P1186, DOI 10.1109/34.244679; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088286; Nakariyakul S, 2014, BBA-PROTEINS PROTEOM, V1844, P165, DOI 10.1016/j.bbapap.2013.04.008; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Rashid M, 2010, CURR PROTEIN PEPT SC, V11, P589, DOI 10.2174/138920310794109120; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Shao XJ, 2011, BIOINFORMATICS, V27, P383, DOI 10.1093/bioinformatics/btq657; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122873	10.1371/journal.pone.0122873	http://dx.doi.org/10.1371/journal.pone.0122873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860375	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300065
J	Laas, P; Simm, J; Lips, I; Lips, U; Kisand, V; Metsis, M				Laas, Peeter; Simm, Jaak; Lips, Inga; Lips, Urmas; Kisand, Veljo; Metsis, Madis			Redox-Specialized Bacterioplankton Metacommunity in a Temperate Estuary	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; CENTRAL BALTIC SEA; PELAGIC REDOXCLINES; WATER COLUMN; GOTLAND DEEP; DIVERSITY; DYNAMICS; BLACK; SUCCESSION; GULF	This study explored the spatiotemporal dynamics of the bacterioplankton community composition in the Gulf of Finland (easternmost sub-basin of the Baltic Sea) based on phylogenetic analysis of 16S rDNA sequences acquired from community samples via pyrosequencing. Investigations of bacterioplankton in hydrographically complex systems provide good insight into the strategies by which microbes deal with spatiotemporal hydrographic gradients, as demonstrated by our research. Many ribotypes were closely affiliated with sequences isolated from environments with similar steep physiochemical gradients and/or seasonal changes, including seasonally anoxic estuaries. Hence, one of the main conclusions of this study is that marine ecosystems where oxygen and salinity gradients co-occur can be considered a habitat for a cosmopolitan metacommunity consisting of specialized groups occupying niches universal to such environments throughout the world. These niches revolve around functional capabilities to utilize different electron receptors and donors (including trace metal and single carbon compounds). On the other hand, temporal shifts in the bacterioplankton community composition at the surface layer were mainly connected to the seasonal succession of phytoplankton and the inflow of freshwater species. We also conclude that many relatively abundant populations are indigenous and well-established in the area.	[Laas, Peeter; Lips, Inga; Lips, Urmas] Tallinn Univ Technol, Marine Syst Inst, EE-19086 Tallinn, Estonia; [Simm, Jaak] Katholieke Univ Leuven, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Dept Elect Engn ESAT, Leuven, Belgium; [Simm, Jaak] iMinds Med IT, Leuven, Belgium; [Simm, Jaak] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Kisand, Veljo] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Metsis, Madis] Univ Tartu, Inst Math & Nat Sci, EE-50090 Tartu, Estonia	Tallinn University of Technology; KU Leuven; IMEC; Tallinn University of Technology; University of Tartu; University of Tartu	Laas, P (corresponding author), Tallinn Univ Technol, Marine Syst Inst, EE-19086 Tallinn, Estonia.	peeter.laas@msi.ttu.ee	Kisand, Veljo/H-2466-2012; Lips, Inga/N-5000-2019; Lips, Urmas/F-8628-2011; Metsis, Madis/F-7080-2016; Laas, Peeter/O-1466-2019	Kisand, Veljo/0000-0002-5535-1639; Lips, Inga/0000-0001-6556-6281; Lips, Urmas/0000-0002-9823-6294; Metsis, Madis/0000-0003-1667-677X; Laas, Peeter/0000-0001-9393-9022	Estonian Ministry of Education and Research [IUT19-6]; Estonian Science Foundation [8930, 9023]; Research Council KU Leuven [GOA/10/09 MaNet, CoE PFV/10/016 SymBioSys]; Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO); Intel, Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Research Council KU Leuven(KU Leuven); Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO); Intel, Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was funded by the Institutional research funding IUT (IUT19-6) of the Estonian Ministry of Education and Research and by the Estonian Science Foundation grants no. 8930 and 9023. Jaak Simm was also funded by Research Council KU Leuven (GOA/10/09 MaNet, CoE PFV/10/016 SymBioSys) and PhD/Postdoc grants from Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO 2014), by Intel, Janssen Pharmaceutica and by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenius P., 1998, BOREAL ENVIRON RES, V3, P97; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Berndmeyer C, 2013, ORG GEOCHEM, V55, P103, DOI 10.1016/j.orggeochem.2012.11.010; Brettar I, 2006, APPL ENVIRON MICROB, V72, P1364, DOI 10.1128/AEM.72.2.1364-1372.2006; Brown MV, 2014, MAR GENOM, V15, P17, DOI 10.1016/j.margen.2014.03.002; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; DETMER AE, 1993, MAR ECOL PROG SER, V99, P197, DOI 10.3354/meps099197; Eckert EM, 2012, ENVIRON MICROBIOL, V14, P794, DOI 10.1111/j.1462-2920.2011.02639.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00140; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Funkey CP, 2014, ENVIRON SCI TECHNOL, V48, P2598, DOI 10.1021/es404395a; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Glaubitz S, 2013, APPL ENVIRON MICROB, V79, P2767, DOI 10.1128/AEM.03777-12; Glaubitz S, 2010, FEMS MICROBIOL ECOL, V74, P32, DOI 10.1111/j.1574-6941.2010.00944.x; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grote J, 2007, APPL ENVIRON MICROB, V73, P7155, DOI 10.1128/AEM.00466-07; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Heyer J, 2002, MICROBIOL-SGM, V148, P2831, DOI 10.1099/00221287-148-9-2831; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Hubbell Stephen P., 2001, V32, pi; Itoh T, 2011, INT J SYST EVOL MICR, V61, P1281, DOI 10.1099/ijs.0.023044-0; Jakobs G, 2013, BIOGEOSCIENCES, V10, P7863, DOI 10.5194/bg-10-7863-2013; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P905, DOI 10.1111/j.1462-2920.2008.01814.x; Kemp PF, 2004, LIMNOL OCEANOGR-METH, V2, P114, DOI 10.4319/lom.2004.2.114; Kisand V, 2005, LIMNOL OCEANOGR, V50, P945, DOI 10.4319/lo.2005.50.3.0945; Kisand V, 2003, APPL ENVIRON MICROB, V69, P3607, DOI 10.1128/AEM.69.6.3607-3616.2003; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Laas P, 2014, J MARINE SYST, V129, P127, DOI 10.1016/j.jmarsys.2013.07.016; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lindstrom ES, 2006, LIMNOL OCEANOGR, V51, P339, DOI 10.4319/lo.2006.51.1.0339; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Lips I, 2014, J MARINE SYST, V129, P135, DOI 10.1016/j.jmarsys.2013.06.002; Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Lyra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054326; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Pernthaler J, 2001, APPL ENVIRON MICROB, V67, P2145, DOI 10.1128/AEM.67.5.2145-2155.2001; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Pinhassi J, 1999, AQUAT MICROB ECOL, V17, P13, DOI 10.3354/ame017013; Pitkaenen H., 2008, V197, P285, DOI 10.1007/978-3-540-73524-3_13; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Riemann L, 2008, APPL ENVIRON MICROB, V74, P503, DOI 10.1128/AEM.01983-07; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmale O, 2012, BIOGEOSCIENCES, V9, P4969, DOI 10.5194/bg-9-4969-2012; Schmale O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043115; Simek K, 2001, MICROB ECOL, V42, P359, DOI 10.1007/s00248-001-0014-z; Sjostedt J, 2012, APPL ENVIRON MICROB, V78, P1361, DOI 10.1128/AEM.05542-11; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Thureborn P, 2013, PLOS ONE, P8, DOI [10.1371/journal.pone.0074983, DOI 10.1371/J0URNAL.P0NE.0074983]; Trouwborst RE, 2006, SCIENCE, V313, P1955, DOI 10.1126/science.1132876; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Yakushev EV, 2007, MAR CHEM, V107, P388, DOI 10.1016/j.marchem.2007.06.003; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x	93	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122304	10.1371/journal.pone.0122304	http://dx.doi.org/10.1371/journal.pone.0122304			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860812	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300041
J	Bagci, E; Heijlen, M; Vergauwen, L; Hagenaars, A; Houbrechts, AM; Esguerra, CV; Blust, R; Darras, VM; Knapen, D				Bagci, Enise; Heijlen, Marjolein; Vergauwen, Lucia; Hagenaars, An; Houbrechts, Anne M.; Esguerra, Camila V.; Blust, Ronny; Darras, Veerle M.; Knapen, Dries			Deiodinase Knockdown during Early Zebrafish Development Affects Growth, Development, Energy Metabolism, Motility and Phototransduction	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; THYROID-HORMONE ACTION; EMBRYONIC-DEVELOPMENT; MUSCLE DEVELOPMENT; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; GENE-EXPRESSION; MESSENGER-RNA; STRIPED BASS; MYOSIN HEAVY	Thyroid hormone (TH) balance is essential for vertebrate development. Deiodinase type 1 (D1) and type 2 (D2) increase and deiodinase type 3 (D3) decreases local intracellular levels of T-3, the most important active TH. The role of deiodinase-mediated TH effects in early vertebrate development is only partially understood. Therefore, we investigated the role of deiodinases during early development of zebrafish until 96 hours post fertilization at the level of the transcriptome (microarray), biochemistry, morphology and physiology using morpholino (MO) knockdown. Knockdown of D1+ D2 (D1D2MO) and knockdown of D3 (D3MO) both resulted in transcriptional regulation of energy metabolism and (muscle) development in abdomen and tail, together with reduced growth, impaired swim bladder inflation, reduced protein content and reduced motility. The reduced growth and impaired swim bladder inflation in D1D2MO could be due to lower levels of T3 which is known to drive growth and development. The pronounced upregulation of a large number of transcripts coding for key proteins in ATP-producing pathways in D1D2MO could reflect a compensatory response to a decreased metabolic rate, also typically linked to hypothyroidism. Compared to D1D2MO, the effects were more pronounced or more frequent in D3MO, in which hyperthyroidism is expected. More specifically, increased heart rate, delayed hatching and increased carbohydrate content were observed only in D3MO. An increase of the metabolic rate, a decrease of the metabolic efficiency and a stimulation of gluconeogenesis using amino acids as substrates may have been involved in the observed reduced protein content, growth and motility in D3MO larvae. Furthermore, expression of transcripts involved in purine metabolism coupled to vision was decreased in both knockdown conditions, suggesting that both may impair vision. This study provides new insights, not only into the role of deiodinases, but also into the importance of a correct TH balance during vertebrate embryonic development.	[Bagci, Enise; Knapen, Dries] Univ Antwerp, Dept Biol, System Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium; [Bagci, Enise; Vergauwen, Lucia; Hagenaars, An; Blust, Ronny; Knapen, Dries] Univ Antwerp, Dept Vet Sci, Vet Physiol & Biochem, Zebrafishlab, B-2160 Antwerp, Belgium; [Heijlen, Marjolein; Houbrechts, Anne M.; Darras, Veerle M.] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol Sect, Lab Comparat Endocrinol, B-3000 Louvain, Belgium; [Esguerra, Camila V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, B-3000 Louvain, Belgium	University of Antwerp; University of Antwerp; KU Leuven; KU Leuven	Knapen, D (corresponding author), Univ Antwerp, Dept Biol, System Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium.	dries.knapen@uantwerpen.be	Hagenaars, An/AAS-1914-2021; Esguerra, Camila/N-6159-2015; Vergauwen, Lucia/AAP-5933-2021	Esguerra, Camila/0000-0002-2271-8094; Vergauwen, Lucia/0000-0002-6534-7473; Knapen, Dries/0000-0003-0472-8114	FWO Research Project (Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek-Vlaanderen) [G.0528.10N]; Cefic Long-range Research Initiative [LRI-ECO20-UA]; ECETOC; FWO Research Project; Cefic-LRI project; Industrial Research Fund of the KU Leuven	FWO Research Project (Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek-Vlaanderen)(FWO); Cefic Long-range Research Initiative; ECETOC; FWO Research Project(FWO); Cefic-LRI project; Industrial Research Fund of the KU Leuven	This work was funded by an FWO Research Project (Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek-Vlaanderen, http://www.fwo.be/) [A functional genomics study in zebrafish to elucidate the role of thyroid hormones and deiodinases in early embryonic development; G.0528.10N], and by the Cefic Long-range Research Initiative (http://www.cefic-lri.org/) [Development of an alternative testing strategy for the fish early life-stage test for predicting chronic toxicity; LRI-ECO20-UA] with support of ECETOC. Enise Bagci and Marjolein Heijlen were supported by the FWO Research Project. Lucia Vergauwen was supported by the Cefic-LRI project. Camila V. Esguerra was funded by the Industrial Research Fund of the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Blanton ML, 2007, CRIT REV TOXICOL, V37, P97, DOI 10.1080/10408440601123529; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CL, 1988, J EXP ZOOL, V248, P168, DOI 10.1002/jez.1402480207; BROWN CL, 1989, FISH PHYSIOL BIOCHEM, V7, P295, DOI 10.1007/BF00004720; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; BUTLERBROWNE GS, 1990, ANAT EMBRYOL, V181, P513; Campinho MA, 2014, MOL ENDOCRINOL, V28, P1136, DOI 10.1210/me.2014-1032; Campos-Barros A, 2000, P NATL ACAD SCI USA, V97, P1287, DOI 10.1073/pnas.97.3.1287; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; De Coen WM, 2003, ENVIRON TOXICOL CHEM, V22, P1632, DOI [10.1897/1551-5028(2003)22&lt;1632:TMBLRB&gt;2.0.CO;2, 10.1002/etc.5620220727]; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Dong W, 2013, AQUAT TOXICOL, V132, P190, DOI 10.1016/j.aquatox.2013.02.008; Giordano N, 2001, CLIN EXP RHEUMATOL, V19, P661; Goglia F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P164, DOI 10.1007/s10541-005-0097-0; Goglia F, 2002, BIOSCIENCE REP, V22, P17, DOI 10.1023/A:1016056905347; Guo CC, 2014, ENDOCRINOLOGY, V155, P4069, DOI 10.1210/en.2013-2029; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Harrison AP, 1996, BRIT J NUTR, V76, P841, DOI 10.1079/BJN19960091; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; Heijlen M, 2014, ENDOCRINOLOGY, V155, P1547, DOI 10.1210/en.2013-1660; Heijlen M, 2013, GEN COMP ENDOCR, V188, P289, DOI 10.1016/j.ygcen.2013.04.004; HOLT J, 1993, INT J DEV BIOL, V37, P467; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; KREINES K, 1965, DIABETES, V14, P740, DOI 10.2337/diab.14.11.740; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lindsey BW, 2010, ZEBRAFISH, V7, P85, DOI 10.1089/zeb.2009.0616; Liu CR, 2007, J ENDOCRINOL, V195, P429, DOI 10.1677/JOE-07-0253; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; MAXON HR, 1975, ARCH INTERN MED, V135, P1477, DOI 10.1001/archinte.135.11.1477; Mohn A, 2002, DIABETIC MED, V19, P70, DOI 10.1046/j.1464-5491.2002.00635.x; MORGAN HE, 1991, CIRCULATION, V83, P13, DOI 10.1161/01.CIR.83.1.13; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Oommen O. V, 2006, Journal of Endocrinology and Reproduction, V10, P96; Opitz R, 2006, TOXICOL APPL PHARM, V212, P1, DOI 10.1016/j.taap.2005.06.014; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Potenza M, 2009, ENDOCR PRACT, V15, P254, DOI 10.4158/EP.15.3.254; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; REDDY PK, 1991, GEN COMP ENDOCR, V81, P484, DOI 10.1016/0016-6480(91)90176-7; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; Saini V, 2012, CLIN BIOCHEM, V45, P212, DOI 10.1016/j.clinbiochem.2011.10.012; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; Shimizu Y, 2002, J VET MED SCI, V64, P677, DOI 10.1292/jvms.64.677; SINGH SP, 1978, ENDOCRINOLOGY, V102, P182, DOI 10.1210/endo-102-1-182; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Thisse C, 2003, GENE EXPR PATTERNS, V3, P525, DOI 10.1016/S1567-133X(03)00054-1; Torrance CJ, 1997, ENDOCRINOLOGY, V138, P1204, DOI 10.1210/en.138.3.1204; Vatine GD, 2013, J BIOL CHEM, V288, P169, DOI 10.1074/jbc.M112.413831; Vergauwen L, 2010, COMP BIOCHEM PHYS A, V157, P149, DOI 10.1016/j.cbpa.2010.06.160; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2010, GEN COMP ENDOCR, V166, P134, DOI 10.1016/j.ygcen.2009.09.011; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Yehuda-Shnaidman E, 2014, ENDOCR REV, V35, P35, DOI 10.1210/er.2013-1006; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	66	36	36	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123285	10.1371/journal.pone.0123285	http://dx.doi.org/10.1371/journal.pone.0123285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855985	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500083
J	Sung, JE				Sung, Jee Eun			Age-Related Changes in Sentence Production Abilities and Their Relation to Working-Memory Capacity: Evidence from a Verb-Final Language	PLOS ONE			English	Article							WORD-ORDER; COMPREHENSION	Objectives This study investigated the best predictor to capture age-related changes in passive-sentence production using a constrained sentence-production paradigm and explored the role of working-memory capacity in relation to the task demands of the sentence-production tasks. Methods A total of 60 participants participated in the study ranging in age from 21 to 86. All were administered a syntactic-priming and a sentence-completion task under either canonical or noncanonical word-order conditions. Results Age was significantly and negatively correlated with sentence-production tasks, and the most demanding condition with a noncanonical word order under the syntactic priming paradigm was the best predictor of aging. Working-memory capacity was significantly and positively correlated with all conditions, but the significant correlation remained only for the most demanding condition (the priming task with a noncanonical word order) after controlling for age. Discussion Sentence-production abilities were vulnerable to aging, and these effects manifested most clearly when the task demands were high enough to tax individuals' cognitive capacity. Working-memory capacity partially accounted for age-related changes in sentence-production abilities.	Ewha Womans Univ, Dept Commun Disorders, Seoul, South Korea	Ewha Womans University	Sung, JE (corresponding author), Ewha Womans Univ, Dept Commun Disorders, Seoul, South Korea.	jeesung@ewha.ac.kr			National Research Foundation of Korea Grant - Korean Government [NRF-2014-S1A5A8018080]; EWHA Womans University EWHA Global Top 5 Grant	National Research Foundation of Korea Grant - Korean Government; EWHA Womans University EWHA Global Top 5 Grant	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2014-S1A5A8018080); EWHA Womans University under 2012 EWHA Global Top 5 Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann LJP, 2006, LANG COGNITIVE PROC, V21, P322, DOI 10.1080/0169096054400006; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; BOCK K, 1990, COGNITION, V35, P1, DOI 10.1016/0010-0277(90)90035-I; Bornkessel I, 2002, COGNITION, V85, pB21, DOI 10.1016/S0010-0277(02)00076-8; Cho S, 2002, J CHILD LANG, V29, P897, DOI 10.1017/S0305000902005317; Cho SW, 1981, THESIS U CALGARY CAN; Chung GyeongheeNo, 1994, THESIS U TEXAS AUSTI; DAVIS GA, 1989, J SPEECH HEAR RES, V32, P143, DOI 10.1044/jshr.3201.143; DeDe G, 2004, PSYCHOL AGING, V19, P601, DOI 10.1037/0882-7974.19.4.601; Fanselow G, 2000, CONSTRAINTS LANGUAGE, P171; Fiebach CJ, 2001, J PSYCHOLINGUIST RES, V30, P321, DOI 10.1023/A:1010447102554; Hagiwara H, 2007, J COGNITIVE NEUROSCI, V19, P175, DOI 10.1162/jocn.2007.19.2.175; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kang Yeonwook, 2006, [Korean Journal of Psychology: General, 한국심리학회지:일반], V25, P1; Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600; Kemper S, 2004, J GERONTOL B-PSYCHOL, V59, P220, DOI [10.1093/geronb/59.5.P220, DOI 10.1093/GERONB/59.5.P220]; Kemper S., 2001, HDB PSYCHOL AGING, V5th, P378; Kemper S, PSYCH SOC NEW ORL LA; Kemper S, 2003, J GERONTOL B-PSYCHOL, V58, P260, DOI [10.1093/geronb/58.5.P260, DOI 10.1093/GERONB/58.5.P260]; Kemper S, 2006, J GERONTOL B-PSYCHOL, V61, pP327, DOI 10.1093/geronb/61.6.P327; Kemtes KA, 1997, PSYCHOL AGING, V12, P362, DOI 10.1037/0882-7974.12.2.362; Kim Seongchan., 1995, LANG RES, V31, P687; Light L. L., 1990, HDB PSYCHOL AGING, P275, DOI [DOI 10.1016/B978-0-12-101280-9.50022-X, 10.1016/b978-0-12-101280-9. 50022-x]; Martin S.E., 1992, ACID DREAMS COMPLETE; MORRIS RG, 1988, MEM COGNITION, V16, P362, DOI 10.3758/BF03197047; No G, 2009, HDB E ASIAN PSYCHOLI, P50; NORMAN S, 1991, J GERONTOL, V46, pP346, DOI 10.1093/geronj/46.6.P346; OBLER LK, 1991, APPL PSYCHOLINGUIST, V12, P433, DOI 10.1017/S0142716400005865; Park S, 2005, THESIS CORNELL U ITH; Perfect TJ, 2000, DEBATES PSYCHOL, P1; Rochon E, 2000, J SPEECH LANG HEAR R, V43, P395, DOI 10.1044/jslhr.4302.395; Segaert K, 2013, BRAIN LANG, V124, P174, DOI 10.1016/j.bandl.2012.12.003; Sung JE, 2011, COMMUN SCI DISORD-CS, V16, P185; Waters G, 2005, MEMORY, V13, P403, DOI 10.1080/09658210344000459; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; WATERS GS, 1995, COGN NEUROPSYCHOL, V12, P1, DOI 10.1080/02643299508251990; Waters GS, 2001, PSYCHOL AGING, V16, P128, DOI 10.1037/0882-7974.16.1.128; Yeom TH, 1992, A MANUAL FOR K WAIS	40	22	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119424	10.1371/journal.pone.0119424	http://dx.doi.org/10.1371/journal.pone.0119424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856161	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500008
J	Yin, HY; Ben-Abu, Y; Wang, HW; Li, AF; Nevo, E; Kong, LR				Yin, Huayan; Ben-Abu, Yuval; Wang, Hongwei; Li, Anfei; Nevo, Eviatar; Kong, Lingrang			Natural Selection Causes Adaptive Genetic Resistance in Wild Emmer Wheat against Powdery Mildew at "Evolution Canyon" Microsite, Mt. Carmel, Israel	PLOS ONE			English	Article							CHROMOSOMAL LOCATION; TRITICUM-DICOCCOIDES; HORDEUM-SPONTANEUM; ECOLOGICAL STRESS; COMMON WHEAT; BARLEY; DIVERSITY; MICROSATELLITES; HISTORY	Background "Evolution Canyon" (ECI) at Lower Nahal Oren, Mount Carmel, Israel, is an optimal natural microscale model for unraveling evolution in action highlighting the basic evolutionary processes of adaptation and speciation. A major model organism in ECI is wild emmer, Triticum dicoccoides, the progenitor of cultivated wheat, which displays dramatic interslope adaptive and speciational divergence on the tropical-xeric "African" slope (AS) and the temperate-mesic "European" slope (ES), separated on average by 250 m. Methods We examined 278 single sequence repeats (SSRs) and the phenotype diversity of the resistance to powdery mildew between the opposite slopes. Furthermore, 18 phenotypes on the AS and 20 phenotypes on the ES, were inoculated by both Bgt E09 and a mixture of powdery mildew races. Results In the experiment of genetic diversity, very little polymorphism was identified intra-slope in the accessions from both the AS or ES. By contrast, 148 pairs of SSR primers (53.23%) amplified polymorphic products between the phenotypes of AS and ES. There are some differences between the two wild emmer wheat genomes and the inter-slope SSR polymorphic products between genome A and B. Interestingly, all wild emmer types growing on the south-facing slope (SFS=AS) were susceptible to a composite of Blumeria graminis, while the ones growing on the north-facing slope (NFS=ES) were highly resistant to Blumeria graminis at both seedling and adult stages. Conclusion/Significance Remarkable inter-slope evolutionary divergent processes occur in wild emmer wheat, T. dicoccoidesat EC I, despite the shot average distance of 250 meters. The AS, a dry and hot slope, did not develop resistance to powdery mildew, whereas the ES, a cool and humid slope, did develop resistance since the disease stress was strong there. This is a remarkable demonstration in host-pathogen interaction on how resistance develops when stress causes an adaptive result at a micro-scale distance.	[Yin, Huayan; Wang, Hongwei; Li, Anfei; Kong, Lingrang] Shandong Agr Univ, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Coll Agron, Tai An 271018, Shandong, Peoples R China; [Ben-Abu, Yuval] Sapir Acad Coll, Projects & Phys Sect, IL-79165 Dn Hof Ashkelon, Israel; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel	Shandong Agricultural University; University of Haifa	Nevo, E (corresponding author), Univ Haifa, Inst Evolut, 199 Aba Khoushy Ave, IL-3498838 Haifa, Israel.	nevo@research.haifa.ac.il; lkong@sdau.edu.cn	Abu, Yuval Ben/AAD-1402-2020	Wang, Hongwei/0000-0002-6611-7813	Ancell-Teicher Research Foundation of Genetics and Molecular Evolution; National Natural Science Foundation of China (NSFC) [31471488]; 973 developmental program [2014CB138100]; Advanced Seed Engineering Project of Shandong Province	Ancell-Teicher Research Foundation of Genetics and Molecular Evolution; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 developmental program(National Basic Research Program of China); Advanced Seed Engineering Project of Shandong Province	This study was funded by Ancell-Teicher Research Foundation of Genetics and Molecular Evolution, National Natural Science Foundation of China (NSFC) (31471488), 973 developmental program (2014CB138100) and Advanced Seed Engineering Project of Shandong Province provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David R, 2010, THEOR APPL GENET, V121, P499, DOI 10.1007/s00122-010-1326-5; Chen XM, 2005, PLANT BREEDING, V124, P225, DOI 10.1111/j.1439-0523.2005.01094.x; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gupta PK, 2002, THEOR APPL GENET, V104, P473, DOI 10.1007/s001220100690; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Inda LA, 2008, MOL PHYLOGENET EVOL, V46, P932, DOI 10.1016/j.ympev.2007.11.022; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KASHI Y, 1999, MICROSATELLITES EVOL, P10; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; King DG, 1999, EVOLUTIONARY THEORY AND PROCESSES: MODERN PERSPECTIVES, P65; Korol A, 2006, ISR J ECOL EVOL, V52, P507, DOI 10.1560/IJEE_52_3-4_507; Li GQ, 2009, THEOR APPL GENET, V119, P531, DOI 10.1007/s00122-009-1061-y; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2003, HEREDITY, V90, P150, DOI 10.1038/sj.hdy.6800190; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Li YC, 1998, BARLEY GENETICS NEWS, V28, P58; Liu ZY, 2002, EUPHYTICA, V123, P21, DOI 10.1023/A:1014471113511; McIntosh R. A., 2007, CATALOGUE GENE SYMBO; Mohler V, 2005, EUPHYTICA, V142, P161, DOI 10.1007/s10681-005-1251-x; MOSEMAN JG, 1984, EUPHYTICA, V33, P41, DOI 10.1007/BF00022748; Nevo E, 2005, BIOL J LINN SOC, V84, P205, DOI 10.1111/j.1095-8312.2005.00425.x; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, HEREDITY, V78, P373, DOI 10.1038/hdy.1997.60; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 2004, DYNAMICAL GENETICS, V81, P7736; Nevo E, 2014, ISRAEL J EC IN PRESS; NEVO E, 2002, TRITICUM DICOCCOIDES, P364; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2006, ISR J PLANT SCI, V54, P1, DOI 10.1560/G56R-340J-5624-015N; Nevo E, 2014, J SYST EVOL, V52, P673, DOI 10.1111/jse.12124; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; Owuor ED, 1997, MOL ECOL, V6, P1177, DOI 10.1046/j.1365-294X.1997.00296.x; READER SM, 1991, EUPHYTICA, V53, P57, DOI 10.1007/BF00032033; Roder MS, 1998, GENETICS, V149, P2007; Rong JK, 2000, EUPHYTICA, V115, P121, DOI 10.1023/A:1003950431049; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Urban K., 2011, ADV GENETIC RES, P67; Xie WL, 2008, EUPHYTICA, V164, P603, DOI 10.1007/s10681-008-9703-8; Xie WL, 2012, THEOR APPL GENET, V124, P911, DOI 10.1007/s00122-011-1756-8; Yang ZJ, 2009, MOL ECOL, V18, P2063, DOI 10.1111/j.1365-294X.2009.04140.x	44	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122344	10.1371/journal.pone.0122344	http://dx.doi.org/10.1371/journal.pone.0122344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856164	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500036
J	Burzynska, AZ; Wong, CN; Voss, MW; Cooke, GE; McAuley, E; Kramer, AF				Burzynska, Agnieszka Z.; Wong, Chelsea N.; Voss, Michelle W.; Cooke, Gillian E.; McAuley, Edward; Kramer, Arthur F.			White Matter Integrity Supports BOLD Signal Variability and Cognitive Performance in the Aging Human Brain	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; EPISODIC MEMORY; PHYSIOLOGICAL NOISE; VOXELWISE ANALYSIS; AGE; DIFFUSION; FMRI; ABILITIES; WORKING	Decline in cognitive performance in old age is linked to both suboptimal neural processing in grey matter (GM) and reduced integrity of white matter (WM), but the whole-brain structure-function-cognition associations remain poorly understood. Here we apply a novel measure of GM processing-moment-to-moment variability in the blood oxygenation level-dependent signal (SDBOLD)-to study the associations between GM function during resting state, performance on four main cognitive domains (i.e., fluid intelligence, perceptual speed, episodic memory, vocabulary), and WM microstructural integrity in 91 healthy older adults (aged 60-80 years). We modeled the relations between whole-GM SDBOLD with cognitive performance using multivariate partial least squares analysis. We found that greater SDBOLD was associated with better fluid abilities and memory. Most of regions showing behaviorally relevant SDBOLD (e.g., precuneus and insula) were localized to inter-or intra-network "hubs" that connect and integrate segregated functional domains in the brain. Our results suggest that optimal dynamic range of neural processing in hub regions may support cognitive operations that specifically rely on the most flexible neural processing and complex cross-talk between different brain networks. Finally, we demonstrated that older adults with greater WM integrity in all major WM tracts had also greater SDBOLD and better performance on tests of memory and fluid abilities. We conclude that SDBOLD is a promising functional neural correlate of individual differences in cognition in healthy older adults and is supported by overall WM integrity.	[Burzynska, Agnieszka Z.; Wong, Chelsea N.; Cooke, Gillian E.; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Voss, Michelle W.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign	Burzynska, AZ (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, 405 N Mathews Ave, Urbana, IL 61801 USA.	agaburza@illinois.edu	burzynska, agnieszka/ACX-5166-2022; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging (NIA) grant [R37-AG025667]; Abbott Nutrition through Center of Nutrition, Learning and Memory at the University of Illinois; "Changing Viewpoints" grant from Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING [R37AG025667] Funding Source: NIH RePORTER	National Institute on Aging (NIA) grant; Abbott Nutrition through Center of Nutrition, Learning and Memory at the University of Illinois; "Changing Viewpoints" grant from Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIA) grant (R37-AG025667) and a grant from Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois. AZB was supported by the "Changing Viewpoints" grant from the Robert Bosch Foundation.	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bennett G.K., 1997, DIFFERENTIAL APTITUD; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Birren JE., 2006, HDB PSYCHOL AGING, V6th; Borghesani PR, 2013, NEUROPSYCHOLOGIA, V51, P1435, DOI 10.1016/j.neuropsychologia.2013.03.005; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burzynska AZ, 2013, J NEUROSCI, V 33, P17150, DOI 10.1523/JNEUROSCI.1426-13.2013; Burzynska AZ, 2011, CEREB CORTEX; Burzynska AZ, 2011, HUM BRAIN MAPP; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Cavanaugh J.C., 2006, ADULT DEV AGING; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Charlton RA, 2010, NEUROPSYCHOLOGIA, V48, P114, DOI 10.1016/j.neuropsychologia.2009.08.018; Charlton RA, 2013, PSYCHOL AGING, V28, P768, DOI 10.1037/a0032668; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Craik FIM, 2000, HDB AGING COGNITION; de Munck JC, 2008, NEUROIMAGE, V42, P112, DOI 10.1016/j.neuroimage.2008.04.244; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Garrett DD, 2013, CEREB CORTEX; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Grayson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088297; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Haasz J, 2013, NEUROIMAGE, V83, P372, DOI 10.1016/j.neuroimage.2013.06.040; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lockhart SN, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00056; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; McIntosh AR, 2010, ARCH ITAL BIOL, V148, P323; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Raven J., 1962, ADV PROGR MATRICES S; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Salthouse TA, 1996, NEUROPSYCHOLOGY, V10, P272, DOI 10.1037/0894-4105.10.2.272; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 1993, J GERONTOL, V48; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Salthouse TA, 2010, NEUROPSYCHOLOGY, V24, P563, DOI 10.1037/a0019026; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Woodcock R. W., 1990, WOODCOCK JOHNSON PSY; Zachary R, 1986, SHIPLEY I LIVING SCA; Zhu Z, 2013, CEREB CORTEX, DOI 10.1093/cercor/bht212; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	86	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120315	10.1371/journal.pone.0120315	http://dx.doi.org/10.1371/journal.pone.0120315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853882	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400012
J	Santos, JI; Pereda, M; Zurro, D; Alvarez, M; Caro, J; Galan, JM; Godino, IBI				Ignacio Santos, Jose; Pereda, Maria; Zurro, Debora; Alvarez, Myrian; Caro, Jorge; Manuel Galan, Jose; Briz i Godino, Ivan			Effect of Resource Spatial Correlation and Hunter-Fisher-Gatherer Mobility on Social Cooperation in Tierra del Fuego	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; EVOLUTIONARY GAMES; PRISONERS-DILEMMA; LEVY FLIGHTS; RECIPROCITY; ALTRUISM; NETWORKS; MODELS	This article presents an agent-based model designed to explore the development of cooperation in hunter-fisher-gatherer societies that face a dilemma of sharing an unpredictable resource that is randomly distributed in space. The model is a stylised abstraction of the Yamana society, which inhabited the channels and islands of the southernmost part of Tierra del Fuego (Argentina-Chile). According to ethnographic sources, the Yamana developed cooperative behaviour supported by an indirect reciprocity mechanism: whenever someone found an extraordinary confluence of resources, such as a beached whale, they would use smoke signals to announce their find, bringing people together to share food and exchange different types of social capital. The model provides insight on how the spatial concentration of beachings and agents' movements in the space can influence cooperation. We conclude that the emergence of informal and dynamic communities that operate as a vigilance network preserves cooperation and makes defection very costly.	[Ignacio Santos, Jose; Pereda, Maria; Manuel Galan, Jose] Univ Burgos, INSISOC, Escuela Politecn Super, Burgos, Spain; [Zurro, Debora] CSIC, IMF, CaSEs, Dept Archaeol & Anthropol, Barcelona, Spain; [Alvarez, Myrian] Consejo Nacl Invest Cient & Tecn, CADIC, Ushuaia, Argentina; [Caro, Jorge] Univ Autonoma Barcelona, Dept Sociol, GSADI, CaSEs, E-08193 Barcelona, Spain; [Caro, Jorge] Nexus IC Gran Capita, Barcelona Supercomputing Ctr, CNS, Barcelona, Spain; [Briz i Godino, Ivan] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England	Universidad de Burgos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Autonomous University of Barcelona; University of York - UK	Santos, JI (corresponding author), Univ Burgos, INSISOC, Escuela Politecn Super, Edif La Milanera, Burgos, Spain.	jisantos@ubu.es	Santos, José I/K-5924-2014; Alvarez, Myrian/ACH-5015-2022; Pereda, María/K-1865-2014; Galán, José Manuel/B-9782-2009; Briz Godino, Ivan/C-2119-2015; Zurro, Debora/L-3965-2014	Santos, José I/0000-0002-6653-043X; Pereda, María/0000-0002-6151-1176; Galán, José Manuel/0000-0003-3360-7602; Briz Godino, Ivan/0000-0002-6262-9360; Zurro, Debora/0000-0003-2498-9338; Caro Saiz, Jorge/0000-0002-5065-4841	Spanish MICINN [CSD2010-00034, HAR2009-06996]; government of Castilla y Leon [GREX251-2009]; Argentine CONICET [PIP-0706]; Wenner-Gren Foundation for Anthropological Research "Social Aggregation: A Yamana Society's Short Term Episode to Analyse Social Interaction, Tierra del Fuego, Argentina"	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); government of Castilla y Leon; Argentine CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Wenner-Gren Foundation for Anthropological Research "Social Aggregation: A Yamana Society's Short Term Episode to Analyse Social Interaction, Tierra del Fuego, Argentina"	The authors acknowledge support from the following projects: the Spanish MICINN http://www.idi.mineco.gob.es/ CSD2010-00034 (SimulPast CONSOLIDER-INGENIO 2010) and HAR2009-06996; the government of Castilla y Leon http://www.jcyl.es/ GREX251-2009; the Argentine CONICET http://www.conicet.gov.ar/ PIP-0706; and the Wenner-Gren Foundation for Anthropological Research http://www.wennergren.org/ "Social Aggregation: A Yamana Society's Short Term Episode to Analyse Social Interaction, Tierra del Fuego, Argentina". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 2008, COMPANION PHILOS BIO; Ames K.M., 2002, FORAGING COLLECTING, P19; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axtell RL, 2001, SOCIAL DYNAMICS, P191; Barlett W, 1870, S AM MISSIONARY MAGA, V1970, P99; Baronchelli A, 2013, CHAOS SOLITON FRACT, V56, P101, DOI 10.1016/j.chaos.2013.07.013; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Bowles S, 1998, EVOL HUM BEHAV, V19, P3, DOI 10.1016/S1090-5138(98)00015-4; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2004, J ECON BEHAV ORGAN, V55, P1, DOI 10.1016/j.jebo.2003.06.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bridges Lucas., 1952, ULTIMO CONFIN TIERRA; Bridges T, 1877, COMMUNICATION; Bridges T, 1872, S AM MISSIONARY MAGA, V1872, P123; Bridges T., 1933, YAMANA ENGLISH DICT; Bridges T, 1875, S AM MISSIONARY MAGA, V1875, P158; Bridges T, 1882, COMMUNICATION UNPUB; Briz I, 2011, ANAL ETNOARCHEOLOGIA, P169; Briz I, 2009, ANTIQUITY, P83; Briz I, 2013, BRIT ARCHAEOLOGICAL, V2472, P81; Godino IBI, 2014, J ARCHAEOL METHOD TH, V21, P343, DOI 10.1007/s10816-013-9194-3; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; David N, 2001, ETHNOARCHAEOLOGY ACT; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Estevez J, 1996, TREBALLS ETNOARQUEOL, V1, P17; Fort H, 2005, JASSS-J ARTIF SOC S, V8; Galan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020474; Goodall NP, 2014, PRESENCE SO RIGHT WH, P1987; Gotts NM, 2003, ARTIF INTELL REV, V19, P3, DOI 10.1023/A:1022120928602; GOULD RA, 1985, AM ANTIQUITY, V50, P117, DOI 10.2307/280637; Gould RA, 1980, LIVING ARCHAEOLOGY N; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grove M, 2009, J ANTHROPOL ARCHAEOL, V28, P222, DOI 10.1016/j.jaa.2009.01.003; Gusinde M, 1937, FEUERLAND INDIANER, VII; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; HIRSHLEIFER J, 1978, AM ECON REV, V68, P238; Hyades P, 1884, B SOC ANTHROPOL PAR, VVII, P147; Hyades P, 1891, ANTROP ETHNOGRAPHIE; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; James Alex, 2011, J R Soc Interface, V8, P1233, DOI 10.1098/rsif.2011.0200; Jimenez R, 2008, J THEOR BIOL, V250, P475, DOI 10.1016/j.jtbi.2007.10.010; KELLY RL, 1992, ANNU REV ANTHROPOL, V21, P43, DOI 10.1146/annurev.an.21.100192.000355; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Letter Bridges T., 1876, S AM MISSIONARY MAGA, V1876, P79; Liaw A., 2002, R NEWS, V2, P118; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; Lothrop S. K., 1928, INDIANS TIERRA FUEGO; MacLeod C. D., 2005, Journal of Cetacean Research and Management, V7, P309; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Martial LF., 1888, MISSION SCI CAP HORN; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Morgan C, 2009, J ANTHROPOL ARCHAEOL, V28, P382, DOI 10.1016/j.jaa.2009.07.004; Nemeth A, 2007, JASSS-J ARTIF SOC S, V10; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Orquera L., 1999, VIDA MAT SOCIAL YAMA; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perreault C, 2011, J ANTHROPOL ARCHAEOL, V30, P62, DOI 10.1016/j.jaa.2010.10.003; Poza DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017661; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029910; Raichlen David A, 2014, Proc Natl Acad Sci U S A, V111, P728, DOI 10.1073/pnas.1318616111; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Santos JI, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/482481; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Therneau TM., 1997, INTRO RECURSIVE PART, V61; Ushuwia Bridges T., 1872, S AM MISSIONARY MAGA, V1872, P87; Ushuwia Bridges T., 1876, S AM MISSIONARY MAGA, V1876, P56; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2011, PHYS FORAGING INTRO, DOI [10.1073/pnas.1318616111, DOI 10.1073/PNAS.1318616111]; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Whallon R, 2006, J ANTHROPOL ARCHAEOL, V25, P259, DOI 10.1016/j.jaa.2005.11.004; Wilensky U., 1999, NETLOGO; Zurro D, 2010, REV ARQUEOLOGIA AM, V28, P171	84	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121888	10.1371/journal.pone.0121888	http://dx.doi.org/10.1371/journal.pone.0121888			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853728	Green Published, gold			2022-12-26	WOS:000352478400054
J	Vishwanathan, SA; Morris, MR; Wolitski, RJ; Luo, W; Rose, CE; Blau, DM; Tsegaye, T; Zaki, SR; Garber, DA; Jenkins, LT; Henning, TC; Patton, DL; Hendry, RM; McNicholl, JM; Kersh, EN				Vishwanathan, Sundaram A.; Morris, Monica R.; Wolitski, Richard J.; Luo, Wei; Rose, Charles E.; Blau, Dianna M.; Tsegaye, Theodros; Zaki, Sherif R.; Garber, David A.; Jenkins, Leecresia T.; Henning, Tara C.; Patton, Dorothy L.; Hendry, R. Michael; McNicholl, Janet M.; Kersh, Ellen N.			Rectal Application of a Highly Osmolar Personal Lubricant in a Macaque Model Induces Acute Cytotoxicity but Does Not Increase Risk of SHIV Infection	PLOS ONE			English	Article							ANAL INTERCOURSE; HIV; SEX; MEN; TRANSMISSION; MICROBICIDES; EFFICACY; TRIALS; SAFETY; DAMAGE	Background Personal lubricant use is common during anal intercourse. Some water-based products with high osmolality and low pH can damage genital and rectal tissues, and the polymer polyquaternium 15 (PQ15) can enhance HIV replication in vitro. This has raised concerns that lubricants with such properties may increase STD/HIV infection risk, although in vivo evidence is scarce. We use a macaque model to evaluate rectal cytotoxicity and SHIV infection risk after use of a highly osmolar (>8,000 mOsm/kg) water-based lubricant with pH of 4.4, and containing PQ15. Methods Cytotoxicity was documented by measuring inflammatory cytokines and epithelial tissue sloughing during six weeks of repeated, non-traumatic lubricant or control buffer applications to rectum and anus. We measured susceptibility to SHIVSF162P3 infection by comparing virus doses needed for rectal infection in twenty-one macaques treated with lubricant or control buffer 30 minutes prior to virus exposure. Results Lubricant increased pro-inflammatory cytokines and tissue sloughing while control buffer (phosphate buffered saline; PBS) did not. However, the estimated AID(50) (50% animal infectious dose) was not different in lubricant-and control buffer-treated macaques (p = 0.4467; logistic regression models). Conclusions Although the test lubricant caused acute cytotoxicity in rectal tissues, it did not increase susceptibility to infection in this macaque model. Thus neither the lubricant-induced type/extent of inflammation nor the presence of PQ15 affected infection risk. This study constitutes a first step in the in vivo evaluation of lubricants with regards to HIV transmission.	[Vishwanathan, Sundaram A.; Morris, Monica R.; Wolitski, Richard J.; Luo, Wei; Rose, Charles E.; Tsegaye, Theodros; Garber, David A.; Jenkins, Leecresia T.; Henning, Tara C.; Hendry, R. Michael; McNicholl, Janet M.; Kersh, Ellen N.] Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; [Blau, Dianna M.] Natl Ctr Emerging & Zoonot Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA USA; [Patton, Dorothy L.] Univ Washington, Seattle, WA 98195 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle	Kersh, EN (corresponding author), Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	ekersh@cdc.gov			Centers for Disease Control (CDC)	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2008, SEX TRANSM DIS, V35, P512, DOI 10.1097/OLQ.0b013e3181644669; Begay O, 2011, AIDS RES HUM RETROV, V27, P1019, DOI [10.1089/aid.2010.0252, 10.1089/AID.2010.0252]; Calabrese SK, 2013, AIDS PATIENT CARE ST, V27, P77, DOI 10.1089/apc.2012.0355; Carballo-Dieguez A, 2000, AM J PUBLIC HEALTH, V90, P1117, DOI 10.2105/AJPH.90.7.1117; Chenine AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000265; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Gorbach PM, 2012, SEX TRANSM DIS, V39, P59, DOI 10.1097/OLQ.0b013e318235502b; Gross M, 1998, SEX TRANSM DIS, V25, P296, DOI 10.1097/00007435-199807000-00005; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Henning T, 2014, J MED PRIMATOL, V43, P135, DOI 10.1111/jmp.12103; Herbenick D, 2013, J SEX MED, V10, P474, DOI 10.1111/jsm.12021; Javanbakht M, 2010, SEX HEALTH, V7, P193, DOI 10.1071/SH09062; Jozkowski KN, 2013, J SEX MED, V10, P484, DOI 10.1111/jsm.12022; Kinsler JJ, 2010, INT J STD AIDS, V21, P567, DOI 10.1258/ijsa.2010.010134; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Nguyen D, 2004, J BIOL REG HOMEOS AG, V18, P268; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Patton DL, 2009, SEX TRANSM DIS, V36, P350, DOI 10.1097/OLQ.0b013e318195c31a; Pickett J, 2008, LESS SILENCE MORE SC; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Sudol KM, 2004, SEX TRANSM DIS, V31, P346, DOI 10.1097/00007435-200406000-00005; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; WHO FHI UNFPA, 2012, WHORHR1233 FHI UNFPA; World Health Organization, 2014, POL BRIEF CONS GUID	28	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120021	10.1371/journal.pone.0120021	http://dx.doi.org/10.1371/journal.pone.0120021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853710	Green Submitted, gold, Green Published			2022-12-26	WOS:000352478400009
J	Zhao, XM; Hao, HS; Du, WH; Zhu, HB				Zhao, Xueming; Hao, Haisheng; Du, Weihua; Zhu, Huabin			Effect of Vitrification on the MicroRNA Transcriptome in Mouse Blastocysts	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; STRAW OPS VITRIFICATION; IN-VIVO; MITOCHONDRIAL-FUNCTION; BOVINE EMBRYOS; KEY REGULATOR; VITRO; CRYOPRESERVATION; METHYLATION; KINASE	Vitrification is commonly used in the cryopreservation of mammalian blastocysts to overcome the temporal and spatial limitations of embryo transfer. Previous studies have shown that the implantation ability of vitrified blastocysts is impaired and that microRNAs (miRNAs) regulate the critical genes for embryo implantation. However, little information is available about the effect of vitrification on the miRNA transcriptome in blastocysts. In the present study, the miRNA transcriptomes in fresh and vitrified mouse blastocysts were analyzed by miRNA Taqman assay based method, and the results were validated using quantitative real-time PCR (qRT-PCR). Then, the differentially expressed miRNAs were assessed using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Overall, 760 known mouse miRNAs were detected in the vitrified and fresh mouse blastocysts. Of these, the expression levels of five miRNAs differed significantly: in the vitrified blastocysts, four miRNAs (mmu-miR-199a-5p, mmu-miR-329-3p, mmu-miR-136-5p and mmu-miR-16-1-3p) were upregulated, and one (mmu-miR-212-3p) was downregulated. The expression levels of all miRNAs measured by the miRNA Taqman assay based method and qRT-PCR were consistent. The four upregulated miRNAs were predicted to regulate 877 candidate target genes, and the downregulated miRNA was predicted to regulate 231 genes. The biological analysis further showed that the differentially expressed miRNAs mainly regulated the implantation of embryos. In conclusion, the results of our study showed that vitrification significantly altered the miRNA transcriptome in mouse blastocysts, which may decrease the implantation potential of vitrified blastocysts.	[Zhao, Xueming; Hao, Haisheng; Du, Weihua; Zhu, Huabin] Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhu, HB (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China.	zhuhuabin@caas.cn			National Natural Science Foundation of China [31472100]; Basic Research Fund of IAS, CAAS [2014ywf-yb-2]; Agricultural Science and Technology Innovation Program [ASTIP-IAS06-2014, ASTIP-IAS-TS-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Fund of IAS, CAAS; Agricultural Science and Technology Innovation Program	This work was supported by grants from the National Natural Science Foundation of China (31472100), the Basic Research Fund of IAS, CAAS (2014ywf-yb-2) and The Agricultural Science and Technology Innovation Program (ASTIP-IAS06-2014, ASTIP-IAS-TS-5).	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aksu DA, 2012, MOL REPROD DEV, V79, P613, DOI 10.1002/mrd.22068; Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chaen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048933; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chatzimeletiou K, 2012, HUM REPROD, V27, P106, DOI 10.1093/humrep/der344; Cruz JR, 1999, FERTIL STERIL, V72, P218, DOI 10.1016/S0015-0282(99)00258-7; Dammer EB, 2008, J BIOL CHEM, V283, P6925, DOI 10.1074/jbc.M708432200; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fabian D, 2005, MOL REPROD DEV, V70, P155, DOI 10.1002/mrd.20129; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Gomez E, 2009, REPROD DOMEST ANIM, V44, P194, DOI 10.1111/j.1439-0531.2007.01026.x; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hawkins SM, 2010, ANN ENDOCRINOL-PARIS, V71, P144, DOI 10.1016/j.ando.2010.02.020; Huang CC, 2005, HUM REPROD, V20, P122, DOI 10.1093/humrep/deh540; Kaneko Y, 2012, J MORPHOL, V273, P639, DOI 10.1002/jmor.20010; Kemp CR, 2007, FUNC DEV EMBRYOL, V1, P1; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Li LF, 2012, MOL REPROD DEV, V79, P229, DOI 10.1002/mrd.22018; Lin PY, 2009, FERTIL STERIL, V92, P1764, DOI 10.1016/j.fertnstert.2009.05.011; Louden E, 2008, REPRODUCTION, V136, P335, DOI 10.1530/REP-08-0161; Mamo S, 2006, MOL REPROD DEV, V73, P1380, DOI 10.1002/mrd.20588; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; McCallie B, 2010, FERTIL STERIL, V93, P2374, DOI 10.1016/j.fertnstert.2009.01.069; Milroy C, 2011, FERTIL STERIL, V95, P2094, DOI 10.1016/j.fertnstert.2011.02.011; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Mondou E, 2012, MOL HUM REPROD, V18, P425, DOI 10.1093/molehr/gas015; Murphy CR, 2000, HUM REPROD, V15, P182, DOI 10.1093/humrep/15.suppl_3.182; Nedambale TL, 2004, THERIOGENOLOGY, V62, P437, DOI 10.1016/j.theriogenology.2003.10.020; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Roa W, 2010, CLIN INVEST MED, V33, pE124; Saenz-de-Juano MD, 2014, REPRODUCTION, V147, P789, DOI 10.1530/REP-14-0019; Salvetti P, 2010, THERIOGENOLOGY, V74, P847, DOI 10.1016/j.theriogenology.2010.04.009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen XH, 2009, J REPROD DEVELOP, V55, P534, DOI 10.1262/jrd.20231; Sommerfeld V, 1999, CRYOBIOLOGY, V38, P95, DOI 10.1006/cryo.1999.2159; Son WY, 2003, HUM REPROD, V18, P137, DOI 10.1093/humrep/deg029; Spinaci M, 2012, VET RES COMMUN, V36, P165, DOI 10.1007/s11259-012-9527-9; Stinshoff H, 2011, THERIOGENOLOGY, V76, P1433, DOI 10.1016/j.theriogenology.2011.06.013; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vicente JS, 2013, CRYOBIOLOGY, V67, P321, DOI 10.1016/j.cryobiol.2013.09.165; Wang YM, 2013, CELL REP, V4, P99, DOI 10.1016/j.celrep.2013.05.027; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang ZY, 2010, FERTIL STERIL, V93, P2729, DOI 10.1016/j.fertnstert.2010.03.025; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Wikland M, 2010, HUM REPROD, V25, P1699, DOI 10.1093/humrep/deq117; Xiao BX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-172; Yan LY, 2010, REPROD FERT DEVELOP, V22, P920, DOI 10.1071/RD09312; Zhao XM, 2007, ANIM BIOTECHNOL, V18, P203, DOI 10.1080/10495390701201663; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052; Zhao XM, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.014; Zhao XM, 2012, J INTEGR AGR, V11, P446, DOI 10.1016/S2095-3119(12)60030-6; Zhao XM, 2011, MOL REPROD DEV, V78, P942, DOI 10.1002/mrd.21389; Zhao XM, 2011, FERTIL STERIL, V95, P2786, DOI 10.1016/j.fertnstert.2011.04.089	71	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123451	10.1371/journal.pone.0123451	http://dx.doi.org/10.1371/journal.pone.0123451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853900	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400102
J	Gaffin, DD; Dewar, A; Graham, P; Philippides, A				Gaffin, Douglas D.; Dewar, Alexander; Graham, Paul; Philippides, Andrew			Insect-Inspired Navigation Algorithm for an Aerial Agent Using Satellite Imagery	PLOS ONE			English	Article							AUSTRALIAN DESERT ANT; PATH-INTEGRATION; HONEY-BEES; SNAPSHOTS; MAP	Humans have long marveled at the ability of animals to navigate swiftly, accurately, and across long distances. Many mechanisms have been proposed for how animals acquire, store, and retrace learned routes, yet many of these hypotheses appear incongruent with behavioral observations and the animals' neural constraints. The "Navigation by Scene Familiarity Hypothesis" proposed originally for insect navigation offers an elegantly simple solution for retracing previously experienced routes without the need for complex neural architectures and memory retrieval mechanisms. This hypothesis proposes that an animal can return to a target location by simply moving toward the most familiar scene at any given point. Proof of concept simulations have used computer-generated ant's-eye views of the world, but here we test the ability of scene familiarity algorithms to navigate training routes across satellite images extracted from Google Maps. We find that Google satellite images are so rich in visual information that familiarity algorithms can be used to retrace even tortuous routes with low-resolution sensors. We discuss the implications of these findings not only for animal navigation but also for the potential development of visual augmentation systems and robot guidance algorithms.	[Gaffin, Douglas D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Dewar, Alexander; Graham, Paul] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Philippides, Andrew] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Oklahoma System; University of Oklahoma - Norman; University of Sussex; University of Sussex	Gaffin, DD (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	ddgaffin@ou.edu	Philippides, Andrew/E-7240-2010	Philippides, Andrew/0000-0001-5503-0467; Graham, Paul/0000-0002-3745-0940; Gaffin, Douglas/0000-0003-3340-9147	Research Council of the University of Oklahoma Norman Campus; Biotechnology and Biological Sciences Research Council [BB/F015925/1, BB/H013644]; Engineering and Physical Sciences Research Council [EP/I031758/1]; EU [ICT 308943]; EPSRC [EP/I031758/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1090672] Funding Source: researchfish	Research Council of the University of Oklahoma Norman Campus; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DG was supported by a grant from the Research Council of the University of Oklahoma Norman Campus. AD and PG are both funded by the Biotechnology and Biological Sciences Research Council (grant codes: BB/F015925/1 and BB/H013644). AP is funded by the Engineering and Physical Sciences Research Council (EP/I031758/1) and an EU FP7 grant (ICT 308943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Baddeley B, 2011, ADAPT BEHAV, V19, P3, DOI 10.1177/1059712310395410; CARTWRIGHT BA, 1987, BIOL CYBERN, V57, P85, DOI 10.1007/BF00318718; Chittka L, 2012, PHILOS T R SOC B, V367, P2677, DOI 10.1098/rstb.2012.0215; Collett TS, 2003, CURR OPIN NEUROBIOL, V13, P718, DOI 10.1016/j.conb.2003.10.004; GOULD JL, 1986, SCIENCE, V232, P861, DOI 10.1126/science.232.4752.861; Graham P, 2012, ENCY NANOTECHNOLOGY, P1122; Hentschel M, 2010, IEEE INT C INT TRANS, DOI [10.1109/ITSC.2010.5625092, DOI 10.1109/ITSC.2010.5625092]; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Majdik AL, 2013, IEEE INT C INT ROBOT, P3979, DOI 10.1109/IROS.2013.6696925; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Muser B, 2005, AUST J ZOOL, V53, P301, DOI 10.1071/ZO05023; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Santschi F., 1911, Revue Suisse de Zoologie, V19; Senlet T, 2012, IEEE INT CONF ROBOT, P2647, DOI 10.1109/ICRA.2012.6225352; Smith L, 2007, ADAPT BEHAV, V15, P257, DOI 10.1177/1059712307082091; Sommer S, 2008, P NATL ACAD SCI USA, V105, P317, DOI 10.1073/pnas.0710157104; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Sturzl W, 2006, ROBOT AUTON SYST, V54, P300, DOI 10.1016/j.robot.2005.12.001; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wehner R, 2004, ECOL ENTOMOL, V29, P240, DOI 10.1111/j.0307-6946.2004.00591.x; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; Wystrach A, 2014, J COMP PHYSIOL A, V200, P615, DOI 10.1007/s00359-014-0900-8; Wystrach A, 2014, CURR BIOL, V24, pR78, DOI 10.1016/j.cub.2013.11.054; Wystrach A, 2013, J EXP BIOL, V216, P1766, DOI 10.1242/jeb.082941; Wystrach A, 2012, ANIM BEHAV, V84, P13, DOI 10.1016/j.anbehav.2012.04.017; Zeil J, 1996, J EXP BIOL, V199, P245; Zeil J, 2003, J OPT SOC AM A, V20, P450, DOI 10.1364/JOSAA.20.000450	31	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122077	10.1371/journal.pone.0122077	http://dx.doi.org/10.1371/journal.pone.0122077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874764	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800036
J	Jiang, JJ; Lee, CL; Fang, MD; Boyd, KG; Gibb, SW				Jiang, Jheng Jie; Lee, Chon Lin; Fang, Meng Der; Boyd, Kenneth G.; Gibb, Stuart W.			Source Apportionment and Risk Assessment of Emerging Contaminants: An Approach of Pharmaco-Signature in Water Systems	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; POLYCYCLIC AROMATIC-HYDROCARBONS; WASTE-WATER; SURFACE WATERS; ILLICIT DRUGS; RIVER-BASIN; PHARMACEUTICAL RESIDUES; ENVIRONMENTAL RELEASE; ENDOCRINE DISRUPTORS; URBAN ATMOSPHERE	This paper presents a methodology based on multivariate data analysis for characterizing potential source contributions of emerging contaminants (ECs) detected in 26 river water samples across multi-scape regions during dry and wet seasons. Based on this methodology, we unveil an approach toward potential source contributions of ECs, a concept we refer to as the "Pharmaco-signature." Exploratory analysis of data points has been carried out by unsupervised pattern recognition (hierarchical cluster analysis, HCA) and receptor model (principal component analysis-multiple linear regression, PCA-MLR) in an attempt to demonstrate significant source contributions of ECs in different land-use zone. Robust cluster solutions grouped the database according to different EC profiles. PCA-MLR identified that 58.9% of the mean summed ECs were contributed by domestic impact, 9.7% by antibiotics application, and 31.4% by drug abuse. Diclofenac, ibuprofen, codeine, ampicillin, tetracycline, and erythromycin-H2O have significant pollution risk quotients (RQ>1), indicating potentially high risk to aquatic organisms in Taiwan.	[Jiang, Jheng Jie; Lee, Chon Lin] Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan; [Lee, Chon Lin] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Lee, Chon Lin] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan; [Lee, Chon Lin] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Fang, Meng Der] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan; [Boyd, Kenneth G.; Gibb, Stuart W.] Univ Highlands & Isl, North Highland Coll, ERI, Thurso, Caithness, Scotland	National Sun Yat Sen University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Industrial Technology Research Institute - Taiwan; UHI Millennium Institute	Lee, CL (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan.	linnohc@mail.nsysu.edu.tw	Jiang, Jheng-Jie/H-6031-2016; PRAZERES, KELLY C/O-7715-2015	Jiang, Jheng-Jie/0000-0002-2887-723X; Lee, Chon-Lin/0000-0003-0521-1440; Gibb, Stuart/0000-0003-3882-338X; Boyd, Kenneth/0000-0002-6501-6324	Ministry of Science and Technology (MOST) [NSC 97-2911-I-110-012, NSC 99-2611-M-110-004]; Ministry of Education of Taiwan, R.O.C. [DOE 98C030219, DOE 01C030703]; Kaohsiung Medical University "Aim for the Top University Grant [KMU-TP103A27]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Education of Taiwan, R.O.C.; Kaohsiung Medical University "Aim for the Top University Grant	This study was funded by the Ministry of Science and Technology (MOST), Grant NSC 97-2911-I-110-012 and NSC 99-2611-M-110-004, and by the Ministry of Education of Taiwan, R.O.C., project DOE 98C030219 and DOE 01C030703. This study was also supported partially by Kaohsiung Medical University "Aim for the Top University Grant (Grant No. KMU-TP103A27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DR, 2011, J CHROMATOGR A, V1218, P1620, DOI 10.1016/j.chroma.2011.01.060; Bartelt-Hunt SL, 2009, ENVIRON POLLUT, V157, P786, DOI 10.1016/j.envpol.2008.11.025; Cao JL, 2010, CHINESE SCI BULL, V55, P3138, DOI 10.1007/s11434-010-3158-8; Chang H, 2009, ENVIRON SCI TECHNOL, V43, P7691, DOI 10.1021/es803653j; Chang SCCM, 2003, INFECT CONTROL J, V13, P334; Daneshvar A, 2012, CHEMOSPHERE, V88, P131, DOI 10.1016/j.chemosphere.2012.03.016; Daughton CG, 2004, ENVIRON IMPACT ASSES, V24, P711, DOI 10.1016/j.eiar.2004.06.003; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Duan YP, 2013, ENVIRON SCI POLLUT R, V20, P108, DOI 10.1007/s11356-012-1000-3; EMEA, 2005, CPMPSEP444700 EMEA; Fernandez C, 2010, SCI TOTAL ENVIRON, V408, P543, DOI 10.1016/j.scitotenv.2009.10.009; da Silva BF, 2011, CHEMOSPHERE, V85, P1331, DOI 10.1016/j.chemosphere.2011.07.051; Gobel A, 2005, ENVIRON SCI TECHNOL, V39, P3981, DOI 10.1021/es048550a; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Heeb F, 2012, ENVIRON SCI TECHNOL, V46, P8680, DOI 10.1021/es301912q; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Hollender J, 2009, ENVIRON SCI TECHNOL, V43, P7862, DOI 10.1021/es9014629; Hopke PK, 2003, J CHEMOMETR, V17, P255, DOI 10.1002/cem.796; Jiang JJ, 2014, MAR POLLUT BULL, V85, P391, DOI 10.1016/j.marpolbul.2013.12.045; Jones-Lepp TL, 2012, SCI TOTAL ENVIRON, V430, P237, DOI 10.1016/j.scitotenv.2012.04.053; Joss A, 2005, WATER RES, V39, P3139, DOI 10.1016/j.watres.2005.05.031; Kasprzyk-Hordern B, 2008, WATER RES, V42, P3498, DOI 10.1016/j.watres.2008.04.026; Kim SD, 2007, WATER RES, V41, P1013, DOI 10.1016/j.watres.2006.06.034; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Larsen RK, 2003, ENVIRON SCI TECHNOL, V37, P1873, DOI 10.1021/es0206184; Li WH, 2012, CHEMOSPHERE, V89, P1307, DOI 10.1016/j.chemosphere.2012.05.079; Lin AYC, 2009, SCI TOTAL ENVIRON, V407, P3793, DOI 10.1016/j.scitotenv.2009.03.009; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Nakada N, 2007, WATER SCI TECHNOL, V56, P133, DOI 10.2166/wst.2007.801; Pal A, 2014, ENVIRON INT, V71, P46, DOI 10.1016/j.envint.2014.05.025; Postigo C, 2010, ENVIRON INT, V36, P75, DOI 10.1016/j.envint.2009.10.004; Santos JL, 2007, ENVIRON INT, V33, P596, DOI 10.1016/j.envint.2006.09.014; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Diaz-Cruz MS, 2012, ANAL BIOANAL CHEM, V402, P2325, DOI 10.1007/s00216-011-5560-8; Singh KP, 2005, ANAL CHIM ACTA, V538, P355, DOI 10.1016/j.aca.2005.02.006; Singh KP, 2008, ENVIRON MONIT ASSESS, V136, P183, DOI 10.1007/s10661-007-9674-6; Spongberg AL, 2008, SCI TOTAL ENVIRON, V397, P148, DOI 10.1016/j.scitotenv.2008.02.042; Stout SA, 2010, ENVIRON SCI TECHNOL, V44, P2932, DOI 10.1021/es903353z; Stuart M, 2012, SCI TOTAL ENVIRON, V416, P1, DOI 10.1016/j.scitotenv.2011.11.072; Thomaidis NS, 2012, GLOBAL NEST J, V14, P72; Thomas KV, 2012, SCI TOTAL ENVIRON, V432, P432, DOI 10.1016/j.scitotenv.2012.06.069; van der Aa M, 2013, WATER RES, V47, P1848, DOI 10.1016/j.watres.2013.01.013; Vazquez-Roig P, 2010, ANAL BIOANAL CHEM, V397, P2851, DOI 10.1007/s00216-010-3720-x; Vazquez-Roig P, 2012, ENVIRON SCI POLLUT R, V19, P971, DOI 10.1007/s11356-011-0617-y; Vidal-Dorsch DE, 2012, ENVIRON TOXICOL CHEM, V31, P2674, DOI 10.1002/etc.2004; Wick A, 2009, WATER RES, V43, P1060, DOI 10.1016/j.watres.2008.11.031; Yoon Y, 2010, SCI TOTAL ENVIRON, V408, P636, DOI 10.1016/j.scitotenv.2009.10.049; Yu Y, 2013, SCI TOTAL ENVIRON, V442, P310, DOI 10.1016/j.scitotenv.2012.10.001; Zhang SY, 2007, CHEMOSPHERE, V66, P1057, DOI 10.1016/j.chemosphere.2006.06.067	51	17	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122813	10.1371/journal.pone.0122813	http://dx.doi.org/10.1371/journal.pone.0122813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874375	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800078
J	Gadhoumi, K; Gotman, J; Lina, JM				Gadhoumi, Kais; Gotman, Jean; Lina, Jean Marc			Scale Invariance Properties of Intracerebral EEG Improve Seizure Prediction in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							PREICTAL DISCHARGES; DYNAMICAL DISEASES; INTRACRANIAL EEG; WAVELET ANALYSIS; BRAIN SYSTEMS; LONG; SIGNALS; REST; CONNECTIVITY; TRANSITION	Although treatment for epilepsy is available and effective for nearly 70 percent of patients, many remain in need of new therapeutic approaches. Predicting the impending seizures in these patients could significantly enhance their quality of life if the prediction performance is clinically practical. In this study, we investigate the improvement of the performance of a seizure prediction algorithm in 17 patients with mesial temporal lobe epilepsy by means of a novel measure. Scale-free dynamics of the intracerebral EEG are quantified through robust estimates of the scaling exponents-the first cumulants-derived from a wavelet leader and bootstrap based multifractal analysis. The cumulants are investigated for the discriminability between preictal and interictal epochs. The performance of our recently published patient-specific seizure prediction algorithm is then out-of-sample tested on long-lasting data using combinations of cumulants and state similarity measures previously introduced. By using the first cumulant in combination with state similarity measures, up to 13 of 17 patients had seizures predicted above chance with clinically practical levels of sensitivity (80.5%) and specificity (25.1% of total time under warning) for prediction horizons above 25 min. These results indicate that the scale-free dynamics of the preictal state are different from those of the interictal state. Quantifiers of these dynamics may carry a predictive power that can be used to improve seizure prediction performance.	[Gadhoumi, Kais; Gotman, Jean] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Lina, Jean Marc] Ecole Technol Super, Dept Genie Elect, Montreal, PQ, Canada; [Lina, Jean Marc] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada	McGill University; University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal	Gadhoumi, K (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	kais.gadhoumi@mail.mcgill.ca	Gadhoumi, Kais/AAG-2184-2020	Gadhoumi, Kais/0000-0003-4148-6118	Canadian Institutes of Health Research (CIHR) [MOP-10189/102710]; Royal Society of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [CHRPJ 323490-06]; joint NSERC/CIHR grant [CHRP-CPG-80098]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Royal Society of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); joint NSERC/CIHR grant	This work was supported by the Canadian Institutes of Health Research (CIHR) grants MOP-10189/102710 (http://www.cihr-irsc.gc.ca), by the Royal Society of Canada and the Natural Sciences and Engineering Research Council of Canada (NSERC) grant CHRPJ 323490-06 (http://www.nserc-crsng.gc.ca), and by the joint NSERC/CIHR grant CHRP-CPG-80098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2011, IEEE ENG MED BIO, P2566, DOI 10.1109/IEMBS.2011.6090709; Abry P, 2002, IEEE SIGNAL PROC MAG, V19, P28, DOI 10.1109/79.998080; Abry P., 2000, SELF SIMILAR NETWORK; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Aschenbrenner-Scheibe R, 2003, BRAIN, V126, P2616, DOI 10.1093/brain/awg265; BACRY E, 1993, J STAT PHYS, V70, P635, DOI 10.1007/BF01053588; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beran J., 1994, STAT LONG MEMORY PRO; Brodu N, 2012, NEUROCOMPUTING, V79, P87, DOI 10.1016/j.neucom.2011.10.010; Buzsaki G., 2006, RHYTHMS BRAIN, P111; Cai SM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061903; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Ciuciu P, 2014, NEUROIMAGE, V95, P248, DOI 10.1016/j.neuroimage.2014.03.047; Ciuciu P, 2008, IEEE J-STSP, V2, P929, DOI 10.1109/JSTSP.2008.2006663; D'Alessandro M, 2005, CLIN NEUROPHYSIOL, V116, P506, DOI 10.1016/j.clinph.2004.11.014; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Falconer K., 2014, FRACTAL GEOMETRY MAT; Feldwisch-Drentrup H, 2010, EPILEPSIA, V51, P1598, DOI 10.1111/j.1528-1167.2009.02497.x; Gadhoumi K, 2013, CLIN NEUROPHYSIOL, V124, P1745, DOI 10.1016/j.clinph.2013.04.006; Gadhoumi K, 2012, CLIN NEUROPHYSIOL, V123, P1906, DOI 10.1016/j.clinph.2012.03.001; Haut SR, 2002, EPILEPSIA, V43, P711, DOI 10.1046/j.1528-1157.2002.26401.x; He BYJ, 2014, TRENDS COGN SCI, V18, P480, DOI 10.1016/j.tics.2014.04.003; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Jaffard S., 2006, WAVELET ANAL APPL, P219, DOI DOI 10.1007/978-3-7643-7778-6; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Lashermes B, 2005, INT CONF ACOUST SPEE, P161; Le Van Quyen M, 2005, CLIN NEUROPHYSIOL, V116, P559, DOI 10.1016/j.clinph.2004.10.014; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mandelbrot B. B., 1999, MULTIFRACTALS NOISE, P317, DOI 10.1371/journal.pone.0024791; Martis RJ, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500238; Mirowski P, 2009, CLIN NEUROPHYSIOL, V120, P1927, DOI 10.1016/j.clinph.2009.09.002; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Perucca P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080972; Poupard L, 2001, BIOL CYBERN, V85, P19, DOI 10.1007/PL00007993; RIEDI R, 1995, J MATH ANAL APPL, V189, P462, DOI 10.1006/jmaa.1995.1030; Samorodnitsky G., 1994, STABLE NONGAUSSIAN R; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Stafstrom CE, 2011, EPILEPSY CURR, V11, P200, DOI 10.5698/1535-7511-11.6.200; Valderrama M, 2010, 12 MED C MED BIOL EN, P77; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Varsavsky A, 2011, EPILEPTIC SEIZURES E, P263; Wendt H, 2009, INT CONF ACOUST SPEE, P2913, DOI 10.1109/ICASSP.2009.4960233; Wendt H, 2007, IEEE T SIGNAL PROCES, V55, P4811, DOI 10.1109/TSP.2007.896269; Wendt H, 2007, IEEE SIGNAL PROC MAG, V24, P38, DOI 10.1109/MSP.2007.4286563; Winterhalder M, 2003, EPILEPSY BEHAV, V4, P318, DOI 10.1016/S1525-5050(03)00105-7; Zilber N, 2013, I S BIOMED IMAGING, P998; Zilber N, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1531, DOI 10.1109/ISBI.2012.6235864	53	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121182	10.1371/journal.pone.0121182	http://dx.doi.org/10.1371/journal.pone.0121182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867083	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100037
J	Marti-Fabregas, J; Delgado-Mederos, R; Crespo, J; Pena, E; Marin, R; Jimenez-Xarrie, E; Fernandez-Arcos, A; Perez-Perez, J; Martinez-Domeno, A; Camps-Renom, P; Prats-Sanchez, L; Casoni, F; Badimon, L				Marti-Fabregas, Joan; Delgado-Mederos, Raquel; Crespo, Javier; Pena, Esther; Marin, Rebeca; Jimenez-Xarrie, Elena; Fernandez-Arcos, Ana; Perez-Perez, Jesus; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Prats-Sanchez, Luis; Casoni, Francesca; Badimon, Lina			Circulating Endothelial Progenitor Cells and the Risk of Vascular Events after Ischemic Stroke	PLOS ONE			English	Article							PLATELET ACTIVATION; DYSFUNCTION; MARKERS; DISEASE	Background and Purpose We evaluated the hypothesis that the number of circulating EPC could be associated with the risk of stroke recurrence (SR) or vascular events (VE) after an ischemic stroke. Methods We studied prospectively consecutive patients with cerebral infarction within the first 48 hours after the onset. We recorded demographic factors, vascular risk factors, previous Rankin scale (RS) score, and etiology. We analyzed EPC counts by flow cytometry in blood collected at day 7 and defined EPC as CD34+/CD133+/KDR+ cells. Mean follow-up was 29.3 +/- 16 months. We evaluated SR as well as VE. Patients were classified as to the presence or absence of EPC in the circulation (either EPC+ or EPC-). Bivariate analyses, Kaplan-Meier survival curves and Cox regression models were used. Results We included 121 patients (mean age 70.1 +/- 12.6 years; 65% were men). The percentage of EPC+ patients was 47.1%. SR occurred in 12 (9.9%) and VE in 18 (14.9%) patients. SR was associated significantly with a worse prior RS score, previous stroke and etiology, but not with EPC count. VE were associated significantly with EPC-, worse prior RS score, previous stroke, high age, peripheral artery disease and etiology. Cox regression model showed that EPC-(HR 7.07, p=0.003), age (HR 1.08, p=0.004) and a worse prior RS score (HR 5.8, p=0.004) were associated significantly with an increased risk of VE. Conclusions The absence of circulating EPC is not associated with the risk of stroke recurrence, but is associated with an increased risk of future vascular events.	[Marti-Fabregas, Joan; Delgado-Mederos, Raquel; Marin, Rebeca; Jimenez-Xarrie, Elena; Fernandez-Arcos, Ana; Perez-Perez, Jesus; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Prats-Sanchez, Luis; Casoni, Francesca] Hosp Santa Creu & Sant Pau, Dept Neurol, IIB St Pau, Barcelona, Spain; [Crespo, Javier; Pena, Esther; Badimon, Lina] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr, IIB St Pau, Barcelona, Spain	Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Marti-Fabregas, J (corresponding author), Hosp Santa Creu & Sant Pau, Dept Neurol, IIB St Pau, Barcelona, Spain.	jmarti@santpau.cat	BADIMON, LINA/S-2950-2019; Peña, Esther/AAB-8217-2019; Martí-Fàbregas, Joan/I-5933-2019; Badimon, Lina/O-4711-2014	Martí-Fàbregas, Joan/0000-0001-9229-8649; Perez-Perez, Jesus/0000-0002-9835-0484; CAMPS-RENOM, POL/0000-0001-6587-6271; Martinez-Domeno, Alejandro/0000-0002-9933-3192; Crespo, Javier/0000-0001-8248-0172; Pena, Esther/0000-0003-2750-0614; Badimon, Lina/0000-0002-9162-2459	Spanish Ministery of Health - Instituto Carlos III; Fondo de Investigaciones Sanitarias [PI071062]; Redes Tematicas de Investigacion Cooperativa [RETICS-RENEVAS RD06/0026/0019, RETICS-INVICTUS RD012/0014]; FEDER (Fondo Europeo de Desarrollo Regional)	Spanish Ministery of Health - Instituto Carlos III; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Redes Tematicas de Investigacion Cooperativa(Instituto de Salud Carlos III); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This study was funded by the Spanish Ministery of Health - Instituto Carlos III, Fondo de Investigaciones Sanitarias PI071062, Redes Tematicas de Investigacion Cooperativa (RETICS-RENEVAS RD06/0026/0019 and RETICS-INVICTUS RD012/0014). The study also received funding from FEDER (Fondo Europeo de Desarrollo Regional). JM-F received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Cherian P, 2003, STROKE, V34, P2132, DOI 10.1161/01.STR.0000086466.32421.F4; Chu K, 2008, STROKE, V39, P1441, DOI 10.1161/STROKEAHA.107.499236; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Du FY, 2012, FRONT BIOSCI-LANDMRK, V17, P2327, DOI 10.2741/4055; Dunac A, 2007, J NEUROL, V254, P327, DOI 10.1007/s00415-006-0362-1; Fadini GP, 2007, ATHEROSCLEROSIS, V194, P46, DOI 10.1016/j.atherosclerosis.2007.03.046; Freestone B, 2005, THROMB HAEMOSTASIS, V94, P702, DOI 10.1160/TH05-02-0093; Fuentes B, 2014, NEUROLOGIA, V29, P168, DOI 10.1016/j.nrl.2011.06.003; Fuentes B, 2012, NEUROLOGIA, V27, P560, DOI 10.1016/j.nrl.2011.06.002; Gutierrez E, 2013, EUR HEART J, V34, P3175, DOI 10.1093/eurheartj/eht351; Hassan A, 2003, BRAIN, V126, P424, DOI 10.1093/brain/awg040; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Jung KH, 2008, J CLIN NEUROL, V4, P139, DOI 10.3988/jcn.2008.4.4.139; Lambiase PD, 2004, CIRCULATION, V109, P2986, DOI 10.1161/01.CIR.0000130639.97284.EC; Lapergue B, 2007, PROG NEUROBIOL, V83, P349, DOI 10.1016/j.pneurobio.2007.08.001; Lavallee PC, 2013, CEREBROVASC DIS, V36, P131, DOI 10.1159/000353671; Marti-Fabregas J, 2013, BRAIN BEHAV, V3, P649, DOI 10.1002/brb3.175; Mohammad A, 2010, NEUROLOGY, V75, P2050, DOI 10.1212/WNL.0b013e318200d822; Roquer J, 2009, CEREBROVASC DIS, V27, P25, DOI 10.1159/000200439; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Rustemeyer P, 2006, J IMMUNOASS IMMUNOCH, V27, P77, DOI 10.1080/15321810500403789; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Taguchi A, 2009, J CEREBR BLOOD F MET, V29, P34, DOI 10.1038/jcbfm.2008.92; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	31	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124895	10.1371/journal.pone.0124895	http://dx.doi.org/10.1371/journal.pone.0124895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874380	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100280
J	Borst, LB; Suyemoto, MM; Scholl, EH; Fuller, FJ; Barnes, HJ				Borst, Luke B.; Suyemoto, M. Mitsu; Scholl, Elizabeth H.; Fuller, Fredrick J.; Barnes, H. John			Comparative Genomic Analysis Identifies Divergent Genomic Features of Pathogenic Enterococcus cecorum Including a Type IC CRISPR-Cas System, a Capsule Locus, an epa-Like Locus, and Putative Host Tissue Binding Proteins	PLOS ONE			English	Article							EXPERIMENTAL REPRODUCTION; GENE-CLUSTER; FAECALIS; BROILER; SPONDYLITIS; RESISTANCE; EVOLUTION; CLASSIFICATION; OSTEOMYELITIS; PERITONITIS	Enterococcus cecorum (EC) is the dominant enteric commensal of adult chickens and contributes to the gut consortia of many avian and mammalian species. While EC infection is an uncommon zoonosis, like other enterococcal species it can cause life-threating nosocomial infection in people. In contrast to other enterococci which are considered opportunistic pathogens, emerging pathogenic strains of EC cause outbreaks of musculoskeletal disease in broiler chickens. Typical morbidity and mortality is comparable to other important infectious diseases of poultry. In molecular epidemiologic studies, pathogenic EC strains were found to be genetically clonal. These findings suggested acquisition of specific virulence determinants by pathogenic EC. To identify divergent genomic features and acquired virulence determinants in pathogenic EC; comparative genomic analysis was performed on genomes of 3 pathogenic and 3 commensal strains of EC. Pathogenic isolates had smaller genomes with a higher GC content, and they demonstrated large regions of synteny compared to commensal isolates. A molecular phylogenetic analysis demonstrated sequence divergence in pathogenic EC genomes. At a threshold of 98% identity, 414 predicted proteins were identified that were highly conserved in pathogenic EC but not in commensal EC. Among these, divergent CRISPR-cas defense loci were observed. In commensal EC, the type IIA arrangement typical for enterococci was present; however, pathogenic EC had a type IC locus, which is novel in enterococci but commonly observed in streptococci. Potential mediators of virulence identified in this analysis included a polysaccharide capsular locus similar to that recently described for E. faecium, an epa-like locus, and cell wall associated proteins which may bind host extracellular matrix. This analysis identified specific genomic regions, coding sequences, and predicted proteins which may be related to the divergent evolution and increased virulence of emerging pathogenic strains of EC.	[Borst, Luke B.; Suyemoto, M. Mitsu; Fuller, Fredrick J.; Barnes, H. John] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Scholl, Elizabeth H.] N Carolina State Univ, Coll Agr & Life Sci, Coll Sci, Bioinformat Consulting & Serv Core,Bioinformat Re, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Borst, LB (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	luke_borst@ncsu.edu		Fuller, Frederick/0000-0002-6650-4186; Borst, Luke/0000-0002-2736-1960	NCSU-CVM funds	NCSU-CVM funds	This study was funded through internal NCSU-CVM funds. The funders had no role in study design, data collection and anaylsis, decision to publish, or preparation of the manuscript.	Ahmed FZ, 2011, DIAGN MICR INFEC DIS, V70, P525, DOI 10.1016/j.diagmicrobio.2011.04.001; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; [Anonymous], 2014, ENT COMM LEAD CAUS D; ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Armour N.K., 2011, POULT INF PROF, V117, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz T., 2007, World Poultry, V23, P44; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; Borst LB, 2014, AVIAN DISEASES IN PR; Borst LB, 2012, AVIAN PATHOL, V41, P479, DOI 10.1080/03079457.2012.718070; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Brede DA, 2011, J BACTERIOL, V193, P2377, DOI 10.1128/JB.00183-11; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; De Baere T, 2000, J CLIN MICROBIOL, V38, P3511, DOI 10.1128/JCM.38.9.3511-3512.2000; De Herdt P, 2009, VLAAMS DIERGEN TIJDS, V78, P44; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46; DEVRIESE LA, 1983, INT J SYST BACTERIOL, V33, P772, DOI 10.1099/00207713-33-4-772; Devriese LA, 2002, VLAAMS DIERGEN TIJDS, V71, P219; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; Gilmore MS, 2014, ENTEROCOCCI COMMENSA; Gingerich E, 2009, SPINAL ABSCESSES HIT; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Greub G, 1997, EUR J CLIN MICROBIOL, V16, P594, DOI 10.1007/BF02447923; Hendrickx APA, 2009, INFECT IMMUN, V77, P5097, DOI 10.1128/IAI.00275-09; Hsueh PR, 2000, J CLIN MICROBIOL, V38, P2450; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Jung A, 2012, TIERAERZTL PRAX G N, V40, P94; Jung A, 2013, AVIAN PATHOL, V42, P552, DOI 10.1080/03079457.2013.850151; Kense MJ, 2011, AVIAN PATHOL, V40, P603, DOI 10.1080/03079457.2011.619165; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makrai L, 2011, ACTA VET HUNG, V59, P11, DOI 10.1556/AVet.59.2011.1.2; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Martin LT, 2011, AVIAN DIS, V55, P273, DOI 10.1637/9614-121410-Reg.1; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Ozawa Y, 2000, SYST APPL MICROBIOL, V23, P230, DOI 10.1016/S0723-2020(00)80009-0; PALMER K, 2012, APPL ENVIRON MICROB, V78, DOI DOI 10.1128/MBIO.00318-11; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, J BACTERIOL, V192, P2469, DOI 10.1128/JB.00153-10; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peppoloni S, 2011, MICROBIOL-SGM, V157, P1816, DOI 10.1099/mic.0.047381-0; Poyart C, 2000, J CLIN MICROBIOL, V38, P415; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rakita RM, 2000, FEMS IMMUNOL MED MIC, V28, P291, DOI 10.1111/j.1574-695X.2000.tb01489.x; Robbins KM, 2012, AVIAN DIS, V56, P768, DOI 10.1637/10253-052412-Case.1; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; System CAHaFSL, 2009, 2008 ANN REP; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan CK, 2010, J INFECTION, V61, P34, DOI 10.1016/j.jinf.2010.04.007; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vandamme P, 1996, J CLIN MICROBIOL, V34, P2572, DOI 10.1128/JCM.34.10.2572-2576.1996; Wijetunge DS, 2012, J VET DIAGN INVEST, V24, P1166, DOI 10.1177/1040638712463563; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Woo PCY, 2004, J CLIN MICROBIOL, V42, P919, DOI 10.1128/JCM.42.2.919-922.2004; Wood AM, 2002, VET REC, V150, P27; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 1997, INFECT IMMUN, V65, P4207, DOI 10.1128/IAI.65.10.4207-4215.1997; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000; Zeng J, 2004, J CLIN MICROBIOL, V42, P1149, DOI 10.1128/JCM.42.3.1149-1154.2004	73	23	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121294	10.1371/journal.pone.0121294	http://dx.doi.org/10.1371/journal.pone.0121294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860249	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300022
J	Daft, PG; Yang, Y; Napierala, D; Zayzafoon, M				Daft, Paul G.; Yang, Yang; Napierala, Dobrawa; Zayzafoon, Majd			The Growth and Aggressive Behavior of Human Osteosarcoma Is Regulated by a CaMKII-Controlled Autocrine VEGF Signaling Mechanism	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; PROTEIN-KINASE-II; CELL-CYCLE ARREST; INDUCIBLE FACTOR-1; ANGIOGENIC FACTORS; FACTOR EXPRESSION; ALPHA; BEVACIZUMAB; ACTIVATION; RECEPTORS	Osteosarcoma (OS) is a hyperproliferative malignant tumor that requires a high vascular density to maintain its large volume. Vascular Endothelial Growth Factor (VEGF) plays a crucial role in angiogenesis and acts as a paracrine and autocrine agent affecting both endothelial and tumor cells. The alpha-Ca2+/Calmodulin kinase two (alpha-CaMKII) protein is an important regulator of OS growth. Here, we investigate the role of alpha-CaMKII-induced VEGF in the growth and tumorigenicity of OS. We show that the pharmacologic and genetic inhibition of alpha-CaMKII results in decreases in VEGF gene expression (50%) and protein secretion (55%), while alpha-CaMKII overexpression increases VEGF gene expression (250%) and protein secretion (1,200%). We show that aggressive OS cells (143B) express high levels of VEGF receptor 2 (VEGFR-2) and respond to exogenous VEGF (100nm) by increasing intracellular calcium (30%). This response is ameliorated by the VEGFR inhibitor CBO-P11, suggesting that secreted VEGF results in autocrine stimulated alpha-CaMKII activation. Furthermore, we show that VEGF and alpha-CaMKII inhibition decreases the transactivation of the HIF-1 alpha and AP-1 reporter constructs. Additionally, chromatin immunoprecipitation assay shows significantly decreased binding of HIF-1 alpha and AP-1 to their responsive elements in the VEGF promoter. These data suggest that alpha-CaMKII regulates VEGF transcription by controlling HIF-1 alpha and AP-1 transcriptional activities. Finally, CBO-P11, KN-93 (CaMKII inhibitor) and combination therapy significantly reduced tumor burden in vivo. Our results suggest that VEGF-induced OS tumor growth is controlled by CaMKII and dual therapy by CaMKII and VEGF inhibitors could be a promising therapy against this devastating adolescent disease.	[Daft, Paul G.; Yang, Yang; Zayzafoon, Majd] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Napierala, Dobrawa] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Inst Oral Hlth Res, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zayzafoon, M (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	majd@uab.edu		Napierala, Dobrawa/0000-0002-7383-1011	National Institutes of Health/National Cancer Institute [2P01CA098912]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R01AR053898-05]; NATIONAL CANCER INSTITUTE [R01CA151538, P01CA098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053898] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health/National Cancer Institute (#2P01CA098912 to MZ; http://www.cancer.gov/) and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (#5R01AR053898-05 to MZ; http://www.niams.nih.gov/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai J, 2009, PEDIATR BLOOD CANCER, V53, P1035, DOI 10.1002/pbc.22178; Bellamy WT, 1999, CANCER RES, V59, P728; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chandra A, 2005, SURGERY, V138, P780, DOI 10.1016/j.surg.2005.07.010; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Daft PG, 2013, MOL CANCER RES, V11, P349, DOI 10.1158/1541-7786.MCR-12-0572; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Ferrer FA, 1999, UROLOGY, V54, P567, DOI 10.1016/S0090-4295(99)00156-9; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Guidi AJ, 1996, CANCER-AM CANCER SOC, V78, P454; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Huang Z, 2004, WORLD J GASTROENTERO, V10, P463, DOI 10.3748/wjg.v10.i4.463; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz Herbert, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS62, DOI 10.3816/CCC.2004.s.010; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Garcia JMJ, 2008, CLIN TRANSL ONCOL, V10, P583, DOI 10.1007/s12094-008-0254-7; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Klettner A, 2010, CUTAN OCUL TOXICOL, V29, P122, DOI 10.3109/15569521003745685; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Ma SL, 2009, J BIOL CHEM, V284, P24773, DOI 10.1074/jbc.M109.028621; Mattern J, 1996, BRIT J CANCER, V73, P931, DOI 10.1038/bjc.1996.166; Najdi R, 2009, ONCOGENE, V28, P4133, DOI 10.1038/onc.2009.271; Ohba T, 2014, MOL CANCER RES, V12, P1100, DOI 10.1158/1541-7786.MCR-14-0037; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Reardon DA, 2009, BRIT J CANCER, V101, P1986, DOI 10.1038/sj.bjc.6605412; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Rubin P, 2010, SEMIN RADIAT ONCOL, V20, P3, DOI 10.1016/j.semradonc.2009.08.001; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Shi Q, 2001, CANCER RES, V61, P4143; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Suzuki K, 1996, CANCER RES, V56, P3004; TISCHER E, 1991, J BIOL CHEM, V266, P11947; URIBEBOTERO G, 1977, AM J CLIN PATHOL, V67, P427; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wang ES, 2004, BLOOD, V104, P2893, DOI 10.1182/blood-2004-01-0226; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Westra J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-61; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Yoshiji H, 1996, CANCER RES, V56, P2013; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Yuan KY, 2007, LAB INVEST, V87, P938, DOI 10.1038/labinvest.3700658; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200	52	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121568	10.1371/journal.pone.0121568	http://dx.doi.org/10.1371/journal.pone.0121568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860662	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300026
J	Wang, X; Chen, DJ; Wang, YQ; Xie, J				Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun			De novo Transcriptome Assembly and the Putative Biosynthetic Pathway of Steroidal Sapogenins of Dioscorea composita	PLOS ONE			English	Article							SAPONIN BIOSYNTHESIS; BETA-AMYRIN; PLANT	The plant Dioscorea composita has important applications in the medical and energy industries, and can be used for the extraction of steroidal sapogenins (important raw materials for the synthesis of steroidal drugs) and bioethanol production. However, little is known at the genetic level about how sapogenins are biosynthesized in this plant. Using Illumina deep sequencing, 62,341 unigenes were obtained by assembling its transcriptome, and 27,720 unigenes were annotated. Of these, 8,022 unigenes were mapped to 243 specific pathways, and 531 unigenes were identified to be involved in 24 secondary metabolic pathways. 35 enzymes, which were encoded by 79 unigenes, were related to the biosynthesis of steroidal sapogenins in this transcriptome database, covering almost all the nodes in the steroidal pathway. The results of real-time PCR experiments on ten related transcripts (HMGR, MK, SQLE, FPPS, DXS, CAS, HMED, CYP51, DHCR7, and DHCR24) indicated that sapogenins were mainly biosynthesized by the mevalonate pathway. The expression of these ten transcripts in the tuber and leaves was found to be much higher than in the stem. Also, expression in the shoots was low. The nucleotide and protein sequences and conserved domains of four related genes (HMGR, CAS, SQS, and SMT1) were highly conserved between D. composita and D. zingiberensis; but expression of these four genes is greater in D. composita. However, there is no expression of these key enzymes in potato and no steroidal sapogenins are synthesized.	[Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun] South China Agr Univ, Inst New Energy & New Mat, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun] Guangdong Regular Higher Educ Inst, Key Lab Biomass Energy, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun] Minist Agr, Key Lab Energy Plants Resource & Utilizat, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs	Xie, J (corresponding author), South China Agr Univ, Inst New Energy & New Mat, Guangzhou 510642, Guangdong, Peoples R China.	xiejun@scau.edu.cn			"Twelfth Five-Year" National Science and Technology Support Project of China [2015BAD15B03, 2011BAD22B01]; DongGuan Innovative Research Team Program [2014607101005]; Key Science & Technology Project of Guangdong Province of China [2011B090400437]	"Twelfth Five-Year" National Science and Technology Support Project of China; DongGuan Innovative Research Team Program; Key Science & Technology Project of Guangdong Province of China	The work was supported by "Twelfth Five-Year" National Science and Technology Support Project of China (2015BAD15B03), the DongGuan Innovative Research Team Program (2014607101005), the Key Science & Technology Project of Guangdong Province of China (2011B090400437), and the "Twelfth Five-Year" National Science and Technology Support Project of China (2011BAD22B01).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chappell J, 2002, CURR OPIN PLANT BIOL, V5, P151, DOI 10.1016/S1369-5266(02)00241-8; Deying T, 2003, TROPICAL AGR SCI TEC, V26, P16; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huilan Z., 1990, ACTA BOT YUNNANICA, V12, P75; Jenner H, 2005, PLANTA, V220, P503, DOI 10.1007/s00425-004-1434-z; Kohara A, 2007, PHYTOCHEMISTRY, V68, P478, DOI 10.1016/j.phytochem.2006.11.020; Laurent P, 2003, NATURWISSENSCHAFTEN, V90, P524, DOI 10.1007/s00114-003-0471-y; Li R, 2006, J MASS SPECTROM, V41, P1, DOI 10.1002/jms.988; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Minato D, 2013, TETRAHEDRON, V69, P8019, DOI 10.1016/j.tet.2013.06.105; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Osbourn AE, 2003, NEW PHYTOL, V159, P101, DOI 10.1046/j.1469-8137.2003.00759.x; Osbourn AE, 2003, PHYTOCHEMISTRY, V62, P1, DOI 10.1016/S0031-9422(02)00393-X; Palazon J, 2006, FITOTERAPIA, V77, P216, DOI 10.1016/j.fitote.2006.02.005; Perez-Labrada K, 2011, TETRAHEDRON, V67, P7713, DOI 10.1016/j.tet.2011.08.003; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Sautour M, 2007, J NAT MED, V61, P91, DOI 10.1007/s11418-006-0126-3; Sawai S, 2006, PLANT SCI, V170, P247, DOI 10.1016/j.plantsci.2005.08.027; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; Shunli Y, 2004, CHINESE TRANDITIONAL, V35, P1213; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Szakiel Anna, 2005, Phytochemistry Reviews, V4, P151, DOI 10.1007/s11101-005-4053-9; Takagi K, 2011, PLANT CELL REP, V30, P1835, DOI 10.1007/s00299-011-1091-1; Tava A, 2011, PHYTOCHEM REV, V10, P459, DOI 10.1007/s11101-010-9169-x; Wang YB, 2007, BIOORGAN MED CHEM, V15, P2528, DOI 10.1016/j.bmc.2007.01.058; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang Chunqiu, 2008, Food Science, China, V29, P302; Zhang XX, 2013, J PHARMACEUT BIOMED, V84, P117, DOI 10.1016/j.jpba.2013.02.005	33	16	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124560	10.1371/journal.pone.0124560	http://dx.doi.org/10.1371/journal.pone.0124560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860891	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300140
J	Kubiak, BB; Galiano, D; de Freitas, TRO				Kubiak, Bruno Busnello; Galiano, Daniel; Ochotorena de Freitas, Thales Renato			Sharing the Space: Distribution, Habitat Segregation and Delimitation of a New Sympatric Area of Subterranean Rodents	PLOS ONE			English	Article							CTENOMYS-AUSTRALIS; FOSSORIAL RODENTS; POCKET GOPHERS; TUCO-TUCOS; OCTODONTIDAE; TALARUM; MINUTUS; DIVERGENCE; SYSTEMS; MAMMALS	Subterranean rodents of the genus Ctenomys usually present an allopatric or parapatric distribution. Currently, two cases of sympatry have been recognized for the genus in the coastal dunes of southern Argentina and southern Brazil. In this context, they are ideal models to test hypotheses about the factors that delimit the patterns of space use and to understand interspecific interactions in small mammals. We investigated the vegetation structure, plant biomass and soil hardness selected by two species of subterranean rodents (Ctenomys flamarioni and C. minutus) when distributed in sympatry and allopatry from nine different areas along the line of coastal dunes in southern Brazil. In addition, our work presents a new record of a third area of sympatry for the genus Ctenomys. Ctenomys flamarioni and C. minutus show habitat segregation in the area where they occur in sympatry. These species show segregation in their selection of microhabitats, differing in relation to soil hardness, plant biomass, and plant cover. Ctenomys flamarioni showed a distinction in habitat selection when occurring in allopatry and sympatry, whereas C. minutus selected the same habitat characteristics under both conditions. A possible explanation to the observed pattern is that these species have acquired different adaptations over time which allows them the ability to exploit different resources and thus avoid competitive interactions all together.	[Kubiak, Bruno Busnello; Ochotorena de Freitas, Thales Renato] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Galiano, Daniel] Univ Reg Alto Uruguai & Missoes, Programa Posgrad Ecol, Erechim, RS, Brazil; [Ochotorena de Freitas, Thales Renato] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal do Rio Grande do Sul	Kubiak, BB (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil.	busnelo@hotmail.com	Kubiak, Bruno Busnello/B-5883-2016; Galiano, Daniel/ABV-4574-2022; Freitas, Thales Renato Ochotorena de/G-1160-2012; Galiano, Daniel/O-1671-2013	Kubiak, Bruno Busnello/0000-0002-3996-5411; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Galiano, Daniel/0000-0003-1428-8634	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Ministry of Science and Technology; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology, and the Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, REV BRASILEIRA GEOCI, DOI DOI 10.25249/0375-7536.2000303474476; BORGHI CE, 1994, Z SAUGETIERKD, V59, P52; BUSCH C, 1989, COMP BIOCHEM PHYS A, V93, P345, DOI 10.1016/0300-9629(89)90048-0; Busch C, 2000, LIFE UNDERGROUND, P183; Cameron GN, 2000, LIFE UNDERGROUND, P227; Choate JR, 1998, J MAMMAL, V79, P1416; COMPARATORE VM, 1992, Z SAUGETIERKD, V57, P47; Contreras J. R., 1965, Physis Buenos Aires, V25, P169; CONTRERAS LC, 1990, PROG CLIN BIOL RES, V335, P231; Cutrera AP, 2010, J MAMMAL, V91, P1425, DOI 10.1644/10-MAMM-A-057.1; DEFREITAS TRO, 1994, CYTOGENET CELL GENET, V67, P193, DOI 10.1159/000133821; DEFREITAS TRO, 1995, STUD NEOTROP FAUNA E, V30, P53, DOI 10.1080/01650529509360941; Freygang CC, 2004, GENETICA, V121, P125, DOI 10.1023/B:GENE.0000040376.56321.be; Galiano D, 2014, ACTA THERIOL, V59, P583, DOI 10.1007/s13364-014-0193-x; Galiano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097301; Gause G. F., 1934, STRUGGLE EXISTENCE; HICKMAN GC, 1977, TEX J SCI, V29, P235; KENNERLY TE, 1959, EVOLUTION, V13, P247, DOI 10.2307/2405877; LACEY EA, 2000, LIFE UNDERGROUND; LESSA EP, 1989, J MAMMAL, V70, P689, DOI 10.2307/1381704; Lopes CM, 2015, HEREDITY, V114, P525, DOI 10.1038/hdy.2014.109; Lopes CM, 2013, HEREDITY, V111, P293, DOI 10.1038/hdy.2013.49; Lovy M, 2012, J ZOOL, V286, P145, DOI 10.1111/j.1469-7998.2011.00860.x; MALIZIA AI, 1991, ACTA THERIOL, V36, P87, DOI 10.4098/AT.arch.91-5; Massarini IA, 2005, CARYOLOGIA, V58, P21; MILLER RS, 1964, ECOLOGY, V45, P256, DOI 10.2307/1933839; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; PEARSON OP, 1984, J ZOOL, V202, P225; R Development Core Team, 2012, R LANG ENV STAT COMP; REICHMAN OJ, 1972, J MAMMAL, V53, P21, DOI 10.2307/1378824; Reig O.A., 1990, Progress in Clinical and Biological Research, V335, P71; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Stolf R, 1991, REV BRAS CIENC SOLO, V15, P229, DOI DOI 10.1590/S0100-06832014000300009; THAELER C S JR, 1968, University of California Publications in Zoology, V86, P1; Tilman D, 1997, SPATIAL ECOLOGY ROLE; VASSALLO AI, 1992, BEHAVIOUR, V120, P40, DOI 10.1163/156853992X00192; VASSALLO AI, 1993, BEHAVIOUR, V127, P247, DOI 10.1163/156853993X00047; Villwock J.A, 1986, QUATERNARY S AM ANTA, P79	39	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123220	10.1371/journal.pone.0123220	http://dx.doi.org/10.1371/journal.pone.0123220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856399	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500080
J	Lorin, C; Vanloubbeeck, Y; Baudart, S; Ska, M; Bayat, B; Brauers, G; Clarinval, G; Donner, MN; Marchand, M; Koutsoukos, M; Mettens, P; Cohen, J; Voss, G				Lorin, Clarisse; Vanloubbeeck, Yannick; Baudart, Sebastien; Ska, Michael; Bayat, Babak; Brauers, Geoffroy; Clarinval, Geraldine; Donner, Marie-Noelle; Marchand, Martine; Koutsoukos, Marguerite; Mettens, Pascal; Cohen, Joe; Voss, Gerald			Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYPROTEIN HIV-1 VACCINE; MUCOSAL IMMUNE-RESPONSES; HIGHLY PATHOGENIC SIV; RHESUS-MONKEYS; CENTRAL MEMORY; LYMPHOCYTE-RESPONSES; ELITE CONTROLLERS; EFFICACY TRIAL; DOUBLE-BLIND	HIV-1-specific CD4(+) and CD8(+) T lymphocytes are important for HIV-1 replication control. F4/AS01 consists of F4 recombinant fusion protein (containing clade B Gag/p24, Pol/RT, Nef and Gag/p17) formulated in AS01 Adjuvant System, and was shown to induce F4-specific polyfunctional CD4(+) T-cell responses in humans. While replication-incompetent recombinant HIV-1/SIV antigen-expressing human adenoviral vectors can elicit highfrequency antigen-specific CD8(+) T-cell responses, their use is hampered by widespread pre-existing immunity to human serotypes. Non-human adenovirus serotypes associated with lower prevalence may offer an alternative strategy. We evaluated the immunogenicity of AdC7-GRN ('A'), a recombinant chimpanzee adenovirus type 7 vector expressing clade B Gag, RT and Nef, and F4/AS01 ('P'), when delivered intramuscularly in homologous (PP or AA) and heterologous (AAPP or PPAA) prime-boost regimens, in macaques and mice. Vaccine-induced HIV-1-antigen-specific T cells in peripheral blood (macaques), liver, spleen, and intestinal and genital mucosa (mice) were characterized by intracellular cytokine staining. Vaccine-specific IgG antibodies (macaques) were detected using ELISA. In macaques, only the heterologous prime-boost regimens induced polyfunctional, persistent and balanced CD4(+) and CD8(+) T-cell responses specific to each HIV-1 vaccine antigen. AdC7-GRN priming increased the polyfunctionality of F4/AS01-induced CD4+ T cells. Approximately 50% of AdC7-GRN-induced memory CD8(+) T cells exhibited an effectormemory phenotype. HIV-1-specific antibodies were detected with each regimen. In mice, antigen-specific CD4(+) and CD8(+) T-cell responses were detected in the mucosal and systemic anatomical compartments assessed. When administered in heterologous primeboost regimens, AdC7-GRN and F4/AS01 candidate vaccines acted complementarily in inducing potent and persistent peripheral blood HIV-1-specific CD4(+) and CD8(+) T-cell responses and antibodies in macaques. Besides, adenoviral vector priming modulated the cytokine-expression profile of the protein-induced CD4(+) T cells. Each regimen induced HIV-1-specific T-cell responses in systemic/local tissues in mice. This suggests that prime-boost regimens combining adjuvanted protein and low-seroprevalent chimpanzee adenoviral vectors represent an attractive vaccination strategy for clinical evaluation.	[Lorin, Clarisse; Vanloubbeeck, Yannick; Baudart, Sebastien; Ska, Michael; Bayat, Babak; Brauers, Geoffroy; Clarinval, Geraldine; Donner, Marie-Noelle; Marchand, Martine; Koutsoukos, Marguerite; Mettens, Pascal; Cohen, Joe; Voss, Gerald] GSK Vaccines, Rixensart, Belgium	GlaxoSmithKline	Lorin, C (corresponding author), GSK Vaccines, Rixensart, Belgium.	clarisse.m.lorin@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This study was funded by GlaxoSmithKline Biologicals SA, the employer of all authors at the time of the study. GlaxoSmithKline Biologicals SA was involved in: design and conduct of the study; data collection, analysis and interpretation; manuscript preparation, review and the decision to submit for publication. There are no products in development or marketed products to declare.	Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Capone S, 2013, EXPERT REV VACCINES, V12, P379, DOI [10.1586/erv.13.15, 10.1586/ERV.13.15]; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Cervasi B, 2013, J VIROL, V87, P9420, DOI 10.1128/JVI.01456-13; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Genesca M, 2009, J INTERN MED, V265, P67, DOI 10.1111/j.1365-2796.2008.02051.x; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harrer T, 2014, VACCINE, V32, P2657, DOI 10.1016/j.vaccine.2013.10.030; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Jansen CA, 2006, TRENDS IMMUNOL, V27, P119, DOI 10.1016/j.it.2006.01.004; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Kaufman DR, 2010, J VIROL, V84, P5986, DOI 10.1128/JVI.02563-09; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kulkarni V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086254; Leroux-Roels G, 2014, CLIN VACCINE IMMUNOL, V21, P302, DOI 10.1128/CVI.00617-13; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Masek-Hammerman K, 2010, J VIROL, V84, P9810, DOI 10.1128/JVI.01157-10; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Penaloza-MacMaster P, 2013, J VIROL, V87, P1373, DOI 10.1128/JVI.02058-12; Pillai VKB, 2011, VACCINE, V29, P5399, DOI 10.1016/j.vaccine.2011.05.083; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reyes-Sandoval A, 2004, J VIROL, V78, P7392, DOI 10.1128/JVI.78.14.7392-7399.2004; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roshorm Y, 2012, EUR J IMMUNOL, V42, P3243, DOI 10.1002/eji.201242624; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Schultheiss T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-24; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tatsis N, 2006, GENE THER, V13, P421, DOI 10.1038/sj.gt.3302675; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Van Braeckel E, 2013, VACCINE, V31, P3739, DOI 10.1016/j.vaccine.2013.05.021; Van Braeckel E, 2012, HUM VACC IMMUNOTHER, V8, P1795, DOI 10.4161/hv.21760; Van Braeckel E, 2011, CLIN INFECT DIS, V52, P522, DOI 10.1093/cid/ciq160; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhi Y, 2006, HUM GENE THER, V17, P500, DOI 10.1089/hum.2006.17.500	86	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122835	10.1371/journal.pone.0122835	http://dx.doi.org/10.1371/journal.pone.0122835			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856308	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500058
J	Rother, DC; Pizo, MA; Siqueira, T; Rodrigues, RR; Jordano, P				Rother, Debora Cristina; Pizo, Marco Aurelio; Siqueira, Tadeu; Rodrigues, Ricardo Ribeiro; Jordano, Pedro			Community-Wide Spatial and Temporal Discordances of Seed-Seedling Shadows in a Tropical Rainforest	PLOS ONE			English	Article							DISPERSAL; PATTERNS; RECRUITMENT; DYNAMICS	Several factors decrease plant survival throughout their lifecycles. Among them, seed dispersal limitation may play a major role by resulting in highly aggregated (contagious) seed and seedling distributions entailing increased mortality. The arrival of seeds, furthermore, may not match suitable environments for seed survival and, consequently, for seedling establishment. In this study, we investigated spatio-temporal patterns of seed and seedling distribution in contrasting microhabitats (bamboo and non-bamboo stands) from the Brazilian Atlantic Forest. Spatial distribution patterns, spatial concordance between seed rain and seedling recruitment between subsequent years in two fruiting seasons (2004-2005 and 2007-2009), and the relation between seeds and seedlings with environmental factors were examined within a spatially-explicit framework. Density and species richness of both seeds and seedlings were randomly distributed in non-bamboo stands, but showed significant clustering in bamboo stands. Seed and seedling distributions showed across-year inconsistency, suggesting a marked spatial decoupling of the seed and seedling stages. Generalized linear mixed effects models indicated that only seed density and seed species richness differed between stand types while accounting for variation in soil characteristics. Our analyses provide evidence of marked recruitment limitation as a result of the interplay between biotic and abiotic factors. Because bamboo stands promote heterogeneity in the forest, they are important components of the landscape. However, at high densities, bamboos may limit recruitment for the plant community by imposing marked discordances of seed arrival and early seedling recruitment.	[Rother, Debora Cristina] Univ Estadual Paulista, Dept Bot, Sao Paulo, Brazil; [Pizo, Marco Aurelio] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [Siqueira, Tadeu] Univ Estadual Paulista, Dept Ecol, Sao Paulo, Brazil; [Rother, Debora Cristina; Rodrigues, Ricardo Ribeiro] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Ciencias Biol, Lab Ecol & Restauracao Florestal, Sao Paulo, Brazil; [Jordano, Pedro] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Rother, DC (corresponding author), Univ Estadual Paulista, Dept Bot, Sao Paulo, Brazil.	deborarother@gmail.com	Rother, Débora/AAL-4792-2020; Rodrigues, Ricardo Ribeiro/D-5557-2012; Jordano, Pedro/A-5162-2008; Rother, Débora/F-5646-2012; Siqueira, Tadeu/A-6978-2009	Rother, Débora/0000-0002-3670-8372; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Jordano, Pedro/0000-0003-2142-9116; Rother, Débora/0000-0002-3670-8372; Siqueira, Tadeu/0000-0001-5069-2904	Sao Paulo Research Foundation (FAPESP) [03/11073-7, 99/09635-0]; Brazilian National Research Council (CNPq) [143107/2006-2]; Junta de Andalucia, Spain [RNM2010-5731]; CYTED-XII project [409AC0369]; Ciencia sem Fronteiras grant [CNPq 401258/2012-2]; Ministerio de Economia y Competitividad [SEV-2012-0262]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); CYTED-XII project; Ciencia sem Fronteiras grant; Ministerio de Economia y Competitividad(Spanish Government)	This study received financial support from the Sao Paulo Research Foundation (FAPESP 03/11073-7) and from the Brazilian National Research Council (CNPq 143107/2006-2) to DCR, and was framed within the Biota project supported by Sao Paulo Research Foundation (FAPESP 99/09635-0) granted to RRR (project leader). MAP received a research grant from CNPq (303559/2008-0), and PJ was granted by an Excellence grant from Junta de Andalucia, Spain (RNM2010-5731), CYTED-XII project 409AC0369, a Ciencia sem Fronteiras grant CNPq 401258/2012-2), as well as a Severo Ochoa Excellence Award from the Ministerio de Economia y Competitividad (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G. T. R., 2007, THESIS U FEDERAL SAO; Balcomb SR, 2003, ECOL MONOGR, V73, P625, DOI 10.1890/02-4036; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; BOTREL REJANE T., 2002, Braz. J. Bot., V25, P195, DOI 10.1590/S0100-84042002000200008; Carvalho Douglas Antônio de, 2005, Acta Bot. Bras., V19, P91, DOI 10.1590/S0102-33062005000100010; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Conrad K. F., 2001, SADIESHELL VERSION 1; CUSTODIO FILHO A., 2002, THESIS U SAO PAULO S; dos Reis MS, 2000, BIOTROPICA, V32, P894, DOI 10.1646/0006-3606(2000)032[0894:MACONP]2.0.CO;2; EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA (Embrapa), 1997, MANUAL METODOS ANALI, V2; Fantini AC, 2007, FOREST ECOL MANAG, V242, P185, DOI 10.1016/j.foreco.2007.01.005; Galetti M, 1998, J APPL ECOL, V35, P286, DOI 10.1046/j.1365-2664.1998.00294.x; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Giulietti AM, 2001, FLORA FANEROGAMICA E, P38; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hampe A, 2008, J ECOL, V96, P668, DOI 10.1111/j.1365-2745.2008.01364.x; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; JORDANO P, 1995, ECOSCIENCE, V2, P230, DOI 10.1080/11956860.1995.11682288; Jordano P., 2004, ECOLOG A BOSQUE MEDI, P229, DOI DOI 10.1016/J.WATRES.2013.08.031; Lima RAF, 2012, BIOL CONSERV, V147, P32, DOI 10.1016/j.biocon.2012.01.015; Londono X, 2002, NOVON, V12, P64, DOI 10.2307/3393241; Manhaes AP, 2007, AN 8 C EC BRAS CAX M, DOI [10.1016/S0176-1617(85)80065-1, DOI 10.1016/S0176-1617(85)80065-1]; Montti L, 2014, ACTA OECOL, V54, P36, DOI 10.1016/j.actao.2013.03.004; Muler AE, 2014, FOREST ECOL MANAG, V324, P117, DOI 10.1016/j.foreco.2013.09.001; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Oliveira-Filho A. T., 2001, Edinburgh Journal of Botany, V58, P139; Ouborg NJ, 1999, J ECOL, V87, P551, DOI 10.1046/j.1365-2745.1999.00389.x; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Raven P.H., 2005, BIOL PLANTS; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rother DC, 2009, FOREST ECOL MANAG, V257, P885, DOI 10.1016/j.foreco.2008.10.022; Rother DC, 2013, PERSPECT PLANT ECOL, V15, P86, DOI 10.1016/j.ppees.2012.12.004; Rother DC, 2013, EMU, V113, P52, DOI 10.1071/MU12017; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schupp E. W., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P19, DOI 10.1079/9780851995250.0019; SCHUPP EW, 1989, ECOLOGY, V70, P562, DOI 10.2307/1940206; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; Silveira M, 2005, FLORESTA ABERTA COM; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wenny DG, 1998, P NATL ACAD SCI USA, V95, P6204, DOI 10.1073/pnas.95.11.6204; Wenny DG, 2001, EVOL ECOL RES, V3, P51; Winder L, 2001, ECOL LETT, V4, P568, DOI 10.1046/j.1461-0248.2001.00269.x; Zuur Alain F., 2009, P1; [No title captured]	54	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123346	10.1371/journal.pone.0123346	http://dx.doi.org/10.1371/journal.pone.0123346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856393	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500088
J	Hudspith, VA; Belcher, CM; Kelly, R; Hu, FS				Hudspith, Victoria A.; Belcher, Claire M.; Kelly, Ryan; Hu, Feng Sheng			Charcoal Reflectance Reveals Early Holocene Boreal Deciduous Forests Burned at High Intensities	PLOS ONE			English	Article							FIRE SEVERITY; TEMPERATURE; HISTORY; REGIMES; BIOMASS; LITTER; CARBON; WOOD	Wildfire size, frequency, and severity are increasing in the Alaskan boreal forest in response to climate warming. One of the potential impacts of this changing fire regime is the alteration of successional trajectories, from black spruce to mixed stands dominated by aspen, a vegetation composition not experienced since the early Holocene. Such changes in vegetation composition may consequently alter the intensity of fires, influencing fire feedbacks to the ecosystem. Paleorecords document past wildfire-vegetation dynamics and as such, are imperative for our understanding of how these ecosystems will respond to future climate warming. For the first time, we have used reflectance measurements of macroscopic charcoal particles (>180 mu m) from an Alaskan lake-sediment record to estimate ancient charring temperatures (termed pyrolysis intensity). We demonstrate that pyrolysis intensity increased markedly from an interval of birch tundra 11 ky ago (mean 1.52% Ro; 485 degrees C), to the expansion of trees on the landscape similar to 10.5 ky ago, remaining high to the present (mean 3.54%Ro; 640 degrees C) irrespective of stand composition. Despite differing flammabilities and adaptations to fire, the highest pyrolysis intensities derive from two intervals with distinct vegetation compositions. 1) the expansion of mixed aspen and spruce woodland at 10 cal. kyr BP, and 2) the establishment of black spruce, and the modern boreal forest at 4 cal. kyr BP. Based on our analysis, we infer that predicted expansion of deciduous trees into the boreal forest in the future could lead to high intensity, but low severity fires, potentially moderating future climate-fire feedbacks.	[Hudspith, Victoria A.; Kelly, Ryan; Hu, Feng Sheng] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [Belcher, Claire M.] Univ Exeter, Dept Geog, Hatherly Labs, PalaeoFire Lab, Exeter EX4 4QJ, Devon, England	University of Illinois System; University of Illinois Urbana-Champaign; University of Exeter	Hudspith, VA (corresponding author), Univ Exeter, Dept Geog, Hatherly Labs, PalaeoFire Lab, Exeter EX4 4QJ, Devon, England.	v.a.hudspith@exeter.ac.uk			National Science Foundation Grant [ARC-0612366]; European Research Council Starter Grant [ERC-2013-StG-335891-ECOFLAM]	National Science Foundation Grant(National Science Foundation (NSF)); European Research Council Starter Grant	This research was supported by a National Science Foundation Grant ARC-0612366 (awarded to FSH) and a European Research Council Starter Grant ERC-2013-StG-335891-ECOFLAM to CMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PM, 1994, QUATERNARY SCI REV, V13, P71, DOI 10.1016/0277-3791(94)90125-2; Ascough PL, 2011, GEOCHIM COSMOCHIM AC, V75, P2361, DOI 10.1016/j.gca.2011.02.002; Barrett K, 2013, REMOTE SENS ENVIRON, V130, P171, DOI 10.1016/j.rse.2012.11.017; Beck PSA, 2011, GLOBAL CHANGE BIOL, V17, P2853, DOI 10.1111/j.1365-2486.2011.02412.x; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Blanchette RA, 2000, INT BIODETER BIODEGR, V46, P189, DOI 10.1016/S0964-8305(00)00077-9; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chapin III FS, 2006, ALASKAS CHANGING BOR, P285; Clegg BF, 2011, P NATL ACAD SCI USA, V108, P19299, DOI 10.1073/pnas.1110913108; Davies GM, 2009, J APPL ECOL, V46, P1054, DOI 10.1111/j.1365-2664.2009.01681.x; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; Dibble AC, 2007, INT J WILDLAND FIRE, V16, P426, DOI 10.1071/WF05103; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hu F. S., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P829, DOI 10.1007/s11027-005-9015-4; Hudspith VA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00714; HUGGETT C, 1980, FIRE MATER, V4, P61, DOI 10.1002/fam.810040202; Inoue J, 2003, J GEOSCI-OSAKA CITY, V46, P127; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Johnstone JF, 2011, LANDSCAPE ECOL, V26, P487, DOI 10.1007/s10980-011-9574-6; JONES TP, 1991, B SOC GEOL FR, V162, P193; Kasischke E. S., 2006, ALASKAS CHANGING BOR, P285; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kelly R, 2013, P NATL ACAD SCI USA, V110, P13055, DOI 10.1073/pnas.1305069110; Lynch JA, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000332; Lynch JA, 2004, J ECOL, V92, P477, DOI 10.1111/j.0022-0477.2004.00879.x; Mack MC, 2008, ECOSYSTEMS, V11, P209, DOI 10.1007/s10021-007-9117-9; Margolis EQ, 2007, CAN J FOREST RES, V37, P2227, DOI 10.1139/X07-079; Mcparland LC, 2007, PALAIOS, V22, P528, DOI 10.2110/palo.2005.p05-138r; McParland LC, 2009, ARCHAEOL ANTHROP SCI, V1, P249, DOI 10.1007/s12520-009-0018-z; Nossov DR, 2013, ENVIRON RES LETT, V8, P1; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; R Core Team, 2021, R LANGUAGE ENV STAT; Rundel P. W., 1981, Encyclopedia of Plant Physiology. New Series. Volume 12A. Physiological plant ecology I. Responses to the physical environment. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P501; Schemel CF, 2008, EXP THERM FLUID SCI, V32, P1381, DOI 10.1016/j.expthermflusci.2007.11.011; SCOTT AC, 1994, PALAEOGEOGR PALAEOCL, V106, P91, DOI 10.1016/0031-0182(94)90005-1; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P11, DOI 10.1016/j.palaeo.2009.12.012; Shenoy A, 2011, FOREST ECOL MANAG, V261, P381, DOI 10.1016/j.foreco.2010.10.021; Smith T, 2008, 170 ONT FOR RES I; Stocks BJ, 2004, CAN J FOREST RES, V34, P1548, DOI 10.1139/X04-054; Stocks BJ, 2001, ADV GLOB CHANGE RES, V7, P233; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Urbas J., 1993, FIRE MATER, V17, P205; Viereck LA, 1980, 6 BLM DEP INT; Virkkula A, 2013, ATMOS CHEM PHYS DISC, V13, P21703	45	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120835	10.1371/journal.pone.0120835	http://dx.doi.org/10.1371/journal.pone.0120835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853712	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400018
J	Zhu, X; Shen, H; Yin, X; Long, L; Xie, C; Liu, Y; Hui, L; Lin, X; Fang, Y; Cao, Y; Xu, Y; Li, M; Xu, W; Li, Y				Zhu, X.; Shen, H.; Yin, X.; Long, L.; Xie, C.; Liu, Y.; Hui, L.; Lin, X.; Fang, Y.; Cao, Y.; Xu, Y.; Li, M.; Xu, W.; Li, Y.			miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; DOWN-REGULATION; TUMOR-SUPPRESSOR; PROSTATE-CANCER; POOR SURVIVAL; RESISTANCE; CELLS; EXPRESSION; EMT; MODULATION	Epithelial-mesenchymal transition (EMT) has an established role in promoting tumor progression and the acquisition of therapeutic resistance. Here, the EMT phenotype was detected in cisplatin-resistant ovarian cancer tissues and cell lines, and correlated with decreased miR-186 expression, increased Twist1 expression, chemoresistance and poor prognosis in epithelial ovarian cancer (EOC) patients. Introducing miR-186 into EOC cells led to a reduction in twist family bHLH transcription factor 1 (Twist1) expression along with morphological, functional and molecular changes consistent with mesenchymal-to-epithelial transition, G1 cell-cycle arrest and enhanced cell apoptosis, which consequently rendered the cells more sensitive to cisplatin in vitro and in vivo. Furthermore, luciferase reporter and rescue assay results showed that the EMT and drug resistance reversal in response to miR-186 was mediated by Twist1. Collectively, these findings implicate miR-186 as an attractive candidate for overcoming chemoresistance in ovarian cancer therapy.	[Zhu, X.; Yin, X.; Liu, Y.; Lin, X.; Xu, Y.; Xu, W.] Jiangsu Univ, Affiliated Hosp 4, Zhenjiang, Jiangsu, Peoples R China; [Zhu, X.; Shen, H.; Xie, C.; Hui, L.; Cao, Y.] Jiangsu Univ, Zhenjiang, Jiangsu, Peoples R China; [Shen, H.; Fang, Y.] Jiangsu Univ, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China; [Long, L.; Li, M.; Li, Y.] Jiangsu Univ, Affiliated Hosp, Zhenjiang 212001, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University	Li, Y (corresponding author), Jiangsu Univ, Affiliated Hosp, Zhenjiang 212001, Jiangsu, Peoples R China.; Xu, W (corresponding author), Jiangsu Univ, Affiliated Hosp 4, Cent Lab, 20 Zhengdong Rd, Zhenjiang 212001, Jiangsu, Peoples R China.	zxl0122721@sina.com; xwl630806@126.com		ZHU, XIAOLAN/0000-0002-0499-8045; Zhu, Xiaolan/0000-0001-7034-8617	Natural Science Foundation of China [81402165/81301194]; Natural Science Foundation of Jiangsu Province [BK20131241]; Clinical Special Projects of Science and Technology Department of Jiangsu Province [BL2012059]; Research Projects of Jiangsu Provincial Health Department [H201451]; Maternal and Child Health Research Projects of Jiangsu Province [F201437/F201350/F201215]; Social Development of Zhenjiang [SH2012057/SH2013025]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Clinical Special Projects of Science and Technology Department of Jiangsu Province; Research Projects of Jiangsu Provincial Health Department; Maternal and Child Health Research Projects of Jiangsu Province; Social Development of Zhenjiang	This work was supported by the Natural Science Foundation of China (81402165/81301194), the Natural Science Foundation of Jiangsu Province (BK20131241), the Clinical Special Projects of Science and Technology Department of Jiangsu Province (BL2012059), the Research Projects of Jiangsu Provincial Health Department (H201451), the Maternal and Child Health Research Projects of Jiangsu Province (F201437/F201350/F201215) and the Social Development of Zhenjiang (SH2012057/SH2013025).	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Baribeau S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086987; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Chen DH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004177; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82; Farrand L, 2013, J BIOL CHEM, V288, P23740, DOI 10.1074/jbc.M113.487686; Gardi NL, 2014, CLIN CANCER RES, V20, P87, DOI 10.1158/1078-0432.CCR-13-2063; Goeppert B, 2010, HEPATOLOGY, V52, P2023, DOI 10.1002/hep.23939; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Jia LZ, 2012, CANCER LETT, V326, P176, DOI 10.1016/j.canlet.2012.08.004; Konecny GE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju249; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Li J, 2007, ONCOGENE, V26, P2860, DOI 10.1038/sj.onc.1210086; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Miow QH, 2015, ONCOGENE, V34, P1899, DOI 10.1038/onc.2014.136; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nuti SV, 2014, ONCOTARGET, V5, P7260, DOI 10.18632/oncotarget.2428; Parikh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3977; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ries J, 2014, ONCOL REP, V31, P1429, DOI 10.3892/or.2014.2983; Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zhu XL, 2014, INT J CANCER, V135, P1286, DOI 10.1002/ijc.28774; Zhu XL, 2013, FEBS LETT, V587, P73, DOI 10.1016/j.febslet.2012.11.004	38	116	127	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					323	332		10.1038/onc.2015.84	http://dx.doi.org/10.1038/onc.2015.84			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25867064	Bronze			2022-12-26	WOS:000369055300006
J	Saupe, F; Huijbers, EJM; Hein, T; Femel, J; Cedervall, J; Olsson, AK; Hellman, L				Saupe, Falk; Huijbers, Elisabeth J. M.; Hein, Tobias; Femel, Julia; Cedervall, Jessica; Olsson, Anna-Karin; Hellman, Lars			Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters	FASEB JOURNAL			English	Article						cancer; ED-B of fibronectin; adjuvant; CpG; type I IFN	THERAPEUTIC VACCINATION; TUMOR; FIBRONECTIN; CANCER; IMMUNOCYTOKINE; NEOVASCULATURE; INTERLEUKIN-12; INTERFERONS; COMBINATION; PROGRESSION	We recently showed that it is possible to compromise tumor vessel function and, as a consequence, suppress growth of aggressive preclinical tumors by immunizing against the tumor vascular markers extra domain-A (ED-A) or -B (ED-B) of fibronectin, using a fusion protein consisting of the ED-A or ED-B peptide fused to bacterial thioredoxin. To address the mechanism behind fusion protein-induced immunization and the specific contribution of the different vaccine constituents to elicit an anti-self-antibody response, we immunized mice with modified or unmodified self-antigens, combined with different adjuvant components, and analyzed antibody responses by ELISA in sera. Several essential requirements to circumvent tolerance were identified: (1) a potent pattern recognition receptor agonist like an oligonucleotide containing unmethylated cytosine and guanine dinucleotides (CpG); (2) a depot adjuvant to keep the CpG at the site of injection; and (3) the presence of foreign sequences in the vaccine protein. Lack of either of these factors abolished the anti-self-response (P = 0.008). In mice genetically deficient for type I IFN signaling, there was a 60% reduction in the anti-self-response compared with wildtype (P = 0.011), demonstrating a key role of this pathway in CpG-induced circumvention of self-tolerance. Identification of these mechanistic requirements to generate a potent anti-self-immune response should significantly aid the design of efficient, specific, and safe therapeutic cancer vaccines.	[Saupe, Falk; Huijbers, Elisabeth J. M.; Femel, Julia; Cedervall, Jessica; Olsson, Anna-Karin] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Hein, Tobias; Hellman, Lars] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University	Olsson, AK (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Biomed Ctr, Husargatan 3, S-75123 Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	Huijbers, Elisabeth J.M./K-7764-2013	Huijbers, Elisabeth J.M./0000-0002-7742-9839	Swedish Research Council (Medicine and Health); Swedish Cancer Society; Medical Faculty, Uppsala University	Swedish Research Council (Medicine and Health)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty, Uppsala University	This work was supported by grants to A.-K.O. from the Swedish Research Council (Medicine and Health), the Swedish Cancer Society, and the Medical Faculty, Uppsala University, and by grants to L.H. from the Swedish Research Council (Medicine and Health). The authors declare no conflicts of interest.	Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Berndt A, 2010, HISTOCHEM CELL BIOL, V133, P467, DOI 10.1007/s00418-010-0685-y; Borg FAY, 2007, CURR OPIN RHEUMATOL, V19, P61, DOI 10.1097/BOR.0b013e328010c547; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Danielli R, 2015, CANCER IMMUNOL IMMUN, V64, P113, DOI 10.1007/s00262-014-1621-0; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Eigentler TK, 2011, CLIN CANCER RES, V17, P7732, DOI 10.1158/1078-0432.CCR-11-1203; Erba PA, 2012, J NUCL MED, V53, P922, DOI 10.2967/jnumed.111.101006; Femel J, 2014, ONCOTARGET, V5, P12418, DOI 10.18632/oncotarget.2628; Halin C, 2003, CANCER RES, V63, P3202; Hancz A, 2012, IMMUNOL LETT, V143, P77, DOI 10.1016/j.imlet.2012.02.006; HELLMAN L, 1994, EUR J IMMUNOL, V24, P415, DOI 10.1002/eji.1830240222; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Joester A, 1999, J BIOL CHEM, V274, P17144, DOI 10.1074/jbc.274.24.17144; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; Matejuk A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-7; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Moschetta M, 2012, CANCER RES, V72, P1814, DOI 10.1158/0008-5472.CAN-11-1919; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Olsson AK, 2014, BIOCHEM SOC T, V42, P1653, DOI 10.1042/BST20140196; Ozcan E, 2011, J ALLERGY CLIN IMMUN, V128, P601, DOI 10.1016/j.jaci.2011.04.052; Papadia F, 2013, J SURG ONCOL, V107, P173, DOI 10.1002/jso.23168; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Ruiz C, 2004, CANCER RES, V64, P7377, DOI 10.1158/0008-5472.CAN-04-1234; Schoenfeld JD, 2011, HUM VACCINES, V7, P976, DOI 10.4161/hv.7.9.16407; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Viti F, 1999, CANCER RES, V59, P347	35	12	13	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3253	3262		10.1096/fj.15-271502	http://dx.doi.org/10.1096/fj.15-271502			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25868727				2022-12-26	WOS:000358796900014
J	Albatsh, FM; Ahmad, S; Mekhilef, S; Mokhlis, H; Hassan, MA				Albatsh, Fadi M.; Ahmad, Shameem; Mekhilef, Saad; Mokhlis, Hazlie; Hassan, M. A.			Optimal Placement of Unified Power Flow Controllers to Improve Dynamic Voltage Stability Using Power System Variable Based Voltage Stability Indices	PLOS ONE			English	Article							ALLOCATION; UPFC; GA	This study examines a new approach to selecting the locations of unified power flow controllers (UPFCs) in power system networks based on a dynamic analysis of voltage stability. Power system voltage stability indices (VSIs) including the line stability index (LQP), the voltage collapse proximity indicator (VCPI), and the line stability index (L-mn) are employed to identify the most suitable locations in the system for UPFCs. In this study, the locations of the UPFCs are identified by dynamically varying the loads across all of the load buses to represent actual power system conditions. Simulations were conducted in a power system computer-aided design (PSCAD) software using the IEEE 14-bus and 39-bus benchmark power system models. The simulation results demonstrate the effectiveness of the proposed method. When the UPFCs are placed in the locations obtained with the new approach, the voltage stability improves. A comparison of the steady-state VSIs resulting from the UPFCs placed in the locations obtained with the new approach and with particle swarm optimization (PSO) and differential evolution (DE), which are static methods, is presented. In all cases, the UPFC locations given by the proposed approach result in better voltage stability than those obtained with the other approaches.	[Albatsh, Fadi M.; Ahmad, Shameem; Mekhilef, Saad] Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia; [Mokhlis, Hazlie] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia; [Hassan, M. A.] Univ Malaya, Dept Engn Design & Mfg, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Albatsh, FM (corresponding author), Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia.	fbatsh83@yahoo.com	MOKHLIS, HAZLIE/B-8616-2010; Abu Bakar, Ab Halim/B-8085-2010; Albatsh, Fadi M./I-9249-2017; Hassan, Mohsen A./J-9534-2012; Saad, Mekhilef/B-9652-2010; Ahmad, Shameem/ABI-3356-2020	MOKHLIS, HAZLIE/0000-0002-1166-1934; Abu Bakar, Ab Halim/0000-0001-8390-0204; Albatsh, Fadi M./0000-0002-2999-9458; Hassan, Mohsen A./0000-0001-8599-7732; Saad, Mekhilef/0000-0001-8544-8995; 	Ministry of Higher Education of Malaysia [UM.C/HIR/MOHE/ENG/16001-00-D000024]	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	The authors would like to thank the Ministry of Higher Education of Malaysia for providing financial support under the research grant No. UM.C/HIR/MOHE/ENG/16001-00-D000024.	Ahmad S., 2014, P 2014 IEEE 6 INDIA, P1, DOI [DOI 10.1109/IICPE.2014.7145018, DOI 10.1109/EPE.2014.6910863]; Ahmad S., 2014, P SAUD AR SMART GRID, P1; Ahmad S, 2014, 2014 IEEE INNOVATIVE SMART GRID TECHNOLOGIES - ASIA (ISGT ASIA), P249, DOI 10.1109/ISGT-Asia.2014.6873798; Ahmad S, 2014, ENERG CONVERS MANAGE, V79, P652, DOI 10.1016/j.enconman.2013.12.042; Albatsh F.M., 2014, P 7 IET INT C POW EL, P5, DOI DOI 10.1049/CP.2014.0397; Albatsh F M, 2015, APPL MATH I IN PRESS; Ameli M. T., 2010, 2010 Second Pacific-Asia Conference on Circuits,Communications and System (PACCS 2010), P429, DOI 10.1109/PACCS.2010.5626960; Arya LD, 2008, ENERG CONVERS MANAGE, V49, P267, DOI 10.1016/j.enconman.2007.06.018; Baghace HR, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT, VOL I, P209; Banu RN, 2012, APPL SOFT COMPUT, V12, P2756, DOI 10.1016/j.asoc.2012.03.057; Benabid R, 2009, ELECTR POW SYST RES, V79, P1668, DOI 10.1016/j.epsr.2009.07.004; Cupelli M., 2012, P1; Ghahremani E, 2013, IEEE T POWER SYST, V28, P764, DOI 10.1109/TPWRS.2012.2210253; Hingorani N.G., 2000, UNDERSTANDING FACTS; Islam M., 2014, 7 IET INT C POW EL M; Jafarzadeh J., 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P345, DOI 10.1109/ICCRD.2011.5764210; Jazebi S, 2011, ENERG CONVERS MANAGE, V52, P2777, DOI 10.1016/j.enconman.2011.01.006; Kumar BK, 2007, IET GENER TRANSM DIS, V1, P209, DOI 10.1049/iet-gtd:20050529; Laifa A., 2010, 2010 IEEE International Energy Conference (ENERGYCON 2010), P205, DOI 10.1109/ENERGYCON.2010.5771677; Lee D, 2008, GLOB TELECOMM CONF, DOI 10.1109/GLOCOM.2008.ECP.462; Lim JU, 2002, 2002 IEEE POWER ENGINEERING SOCIETY SUMMER MEETING, VOLS 1-3, CONFERENCE PROCEEDINGS, P610, DOI 10.1109/PESS.2002.1043312; Made Wartana I., 2011, INT C UT EXH POW EN, P1, DOI 10.1109/ICUEPES.2011.6497710; Messina AR, 2003, INT J ELEC POWER, V25, P259, DOI 10.1016/S0142-0615(02)00093-5; Nireekshana T, 2011, 3 INT C EL COMP TECH, P209; Phadke AR, 2012, INT J ELEC POWER, V40, P46, DOI 10.1016/j.ijepes.2012.02.004; Rabiee A, 2012, ENERG CONVERS MANAGE, V59, P66, DOI 10.1016/j.enconman.2012.02.017; Rajani B., 2012, J THEORETICAL APPL I, V41, P192; Rezazad M., 2005, INT J COLORECTAL DIS; Shaheen HI, 2010, ENG APPL ARTIF INTEL, V23, P203, DOI 10.1016/j.engappai.2009.12.002; Shaheen HI, 2011, INT J ELEC POWER, V33, P94, DOI 10.1016/j.ijepes.2010.06.023; Shayeghi H, 2010, ENERG CONVERS MANAGE, V51, P2299, DOI 10.1016/j.enconman.2010.04.002; Shayeghi H, 2009, ENERG CONVERS MANAGE, V50, P2554, DOI 10.1016/j.enconman.2009.06.005; Sirjani R, 2012, INT J ELEC POWER, V43, P562, DOI 10.1016/j.ijepes.2012.05.068; Taher SA, 2012, INT J ELEC POWER, V43, P899, DOI 10.1016/j.ijepes.2012.05.064; Visakha K, 2004, ELECTR POW SYST RES, V70, P46, DOI 10.1016/j.epsr.2003.11.011; Wang KY, 2010, IEEE T POWER SYST, V25, P1892, DOI 10.1109/TPWRS.2010.2045664; Wibowo RS, 2011, IEEE T POWER SYST, V26, P2302, DOI 10.1109/TPWRS.2011.2106806; Ya-Chin Chang, 2009, 2009 4th IEEE Conference on Industrial Electronics and Applications, P2661, DOI 10.1109/ICIEA.2009.5138690; Zeraatzade Mahbube, 2010, THESIS BRUNEL U UK; Zhang Y, 2006, ELECTR POW SYST RES, V76, P1003, DOI 10.1016/j.epsr.2005.12.005; Zhang YJ, 2010, ELECTR POW SYST RES, V80, P1520, DOI 10.1016/j.epsr.2010.06.016	41	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123802	10.1371/journal.pone.0123802	http://dx.doi.org/10.1371/journal.pone.0123802			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874560	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800117
J	Noguchi, S; Mukae, H; Kawanami, T; Yamasaki, K; Fukuda, K; Akata, K; Ishimoto, H; Taniguchi, H; Yatera, K				Noguchi, Shingo; Mukae, Hiroshi; Kawanami, Toshinori; Yamasaki, Kei; Fukuda, Kazumasa; Akata, Kentarou; Ishimoto, Hiroshi; Taniguchi, Hatsumi; Yatera, Kazuhiro			Bacteriological Assessment of Healthcare-Associated Pneumonia Using a Clone Library Analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; HOSPITALIZED-PATIENTS; ASPIRATION PNEUMONIA; ANTIBIOTIC-THERAPY; CLINICAL-OUTCOMES; LUNG-DISEASE; RISK-FACTORS; PATHOGENS; EPIDEMIOLOGY	Background The causative pathogens of healthcare-associated pneumonia (HCAP) remain controversial, and the use of conventional cultivation of sputum samples is occasionally inappropriate due to the potential for oral bacterial contamination. It is also sometimes difficult to determine whether methicillin-resistant Staphylococcus aureus (MRSA) is a true causative pathogen of HCAP. Methods We evaluated the bacterial diversity in bronchoalveolar lavage fluid (BALF) using molecular and cultivation methods in 82 HCAP patients. BALF specimens were obtained from the lesions of pneumonia using bronchoscopy. The bacterial flora was analyzed according to the clone library method using amplified fragments of the 16S ribosomal RNA gene with universal primers. In addition, sputum cultures and the above specimens were assessed. Results Eighty (97.6%) of the 82 BALF samples obtained from the patients with HCAP showed positive polymerase chain reaction results. The predominant phylotypes detected in the BALF in this study included bacteria common in cases of community-and hospital-acquired pneumonia. In addition, the phylotypes of streptococci and anaerobes were detected in 19 (23.2%) and 8 (9.8%) cases, respectively. In particular, phylotypes of streptococci were highly detected among the patients 75 of age or older. Staphylococcus aureus was cultured in 23 (28.0%) cases using conventional cultivation methods and detected in only 6 (7.3%) cases as predominant phylotypes according to the clone library method. Conclusions The clone library analysis of BALF in the HCAP patients detected heterogeneous bacteria and a high incidence of streptococci compared with that observed using cultivation methods. In addition, the results of our study may indicate a lower incidence of MRSA than previously expected in HCAP patients.	[Noguchi, Shingo; Mukae, Hiroshi; Kawanami, Toshinori; Yamasaki, Kei; Akata, Kentarou; Ishimoto, Hiroshi; Yatera, Kazuhiro] Univ Occupat & Environm Hlth, Dept Resp Med, Fukuoka, Japan; [Fukuda, Kazumasa; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Mukae, H (corresponding author), Univ Occupat & Environm Hlth, Dept Resp Med, Fukuoka, Japan.	hmukae@med.uoeh-u.ac.jp		Ishimoto, Hiroshi/0000-0002-4374-2894	High Altitude Research Grant from the University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture [23591173]	High Altitude Research Grant from the University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by a High Altitude Research Grant from the University of Occupational and Environmental Health, Japan, and a Research Grant from the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 23591173, 2011.	Ahmed RA, 2006, AM J MED, V119, P877, DOI 10.1016/j.amjmed.2006.03.042; Akiyama T, 2010, ORAL SURG ORAL MED O, V109, P669, DOI 10.1016/j.tripleo.2009.10.045; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Aoki R, 2013, OPHTHALMOLOGY, V120, P668, DOI 10.1016/j.ophtha.2012.10.001; Attridge RT, 2011, EUR RESPIR J, V38, P878, DOI 10.1183/09031936.00141110; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Carrabba M, 2012, EUR RESPIR J, V40, P1201, DOI 10.1183/09031936.00187811; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Chalmers JD, 2014, CLIN INFECT DIS, V58, P330, DOI 10.1093/cid/cit734; Chalmers JD, 2011, CLIN INFECT DIS, V53, P107, DOI 10.1093/cid/cir274; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cilloniz C, 2013, CHEST, V144, P999, DOI 10.1378/chest.13-0062; El-Solh AA, 2003, AM J RESP CRIT CARE, V167, P1650, DOI 10.1164/rccm.200212-1543OC; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Garcia-Vidal C, 2011, CLIN MICROBIOL INFEC, V17, P1659, DOI 10.1111/j.1469-0691.2011.03484.x; Garzoni C, 2013, THORAX, V68, P1150, DOI 10.1136/thoraxjnl-2012-202917; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Jeong BH, 2013, CLIN INFECT DIS, V56, P625, DOI 10.1093/cid/cis970; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; Kishimoto T, 2009, JPN J INFECT DIS, V62, P260; Kohno S, 2013, RESPIR INVESTIG, V51, P103, DOI 10.1016/j.resinv.2012.11.001; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Leone Marc, 2013, Crit Care, V17, pR170, DOI 10.1186/cc12849; Lescure FX, 2006, INFECT CONT HOSP EP, V27, P1213, DOI 10.1086/507920; Lim WS, 2001, EUR RESPIR J, V18, P362, DOI 10.1183/09031936.01.00204401; Madison JM, 2004, ARCH INTERN MED, V164, P1725, DOI 10.1001/archinte.164.16.1725; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Oshitani Y, 2013, J INFECT CHEMOTHER, V19, P579, DOI 10.1007/s10156-012-0517-1; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Shinzato T, 1995, CLIN INFECT DIS, V21, pS238, DOI 10.1093/clind/21.Supplement_3.S238; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; Sugisaki M, 2012, J INFECT CHEMOTHER, V18, P352, DOI 10.1007/s10156-011-0344-9; Takayanagi N, 2010, RESPIRATION, V80, P98, DOI 10.1159/000312404; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Yamasaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063103	40	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124697	10.1371/journal.pone.0124697	http://dx.doi.org/10.1371/journal.pone.0124697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874715	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800148
J	Chin, MP; Patrick, HWC; Cheong, AMY; Chan, HHL				Chin, Man Pan; Chu, Patrick H. W.; Cheong, Allen M. Y.; Chan, Henry H. L.			Human Electroretinal Responses to Grating Patterns and Defocus Changes by Global Flash Multifocal Electroretinogram	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; SPATIAL-FREQUENCY; EYE GROWTH; REFRACTIVE ERROR; OPTICAL DEFOCUS; DEPENDENT CHANGES; GANGLION-CELLS; AMACRINE CELLS; AXIAL LENGTH; LENS	The electrical response of the retina was examined as a function of retinal region, using stimuli of various spatial frequencies in the first experiment. In the second experiment, the regional response of the retina to defocus at high and low spatial frequencies was investigated. Twenty three subjects were recruited for global flash multifocal electroretinogram (mfERG) in experiment 1. Black and white gratings (printed on plastic transparent sheets) of four spatial frequencies (SF), 0.24, 1.2, 2.4 and 4.8 cycle per degree were presented in front of the mfERG stimulation. The amplitudes and implicit times of the direct (DC) and induced (IC) components of mfERG responses were pooled into six concentric rings for analysis. There was low amplitude DC at low SF, which increased with increasing SF, and which decreased with increasing eccentricity. The IC was high in amplitude at all SF and reduced in amplitude with increasing eccentricity. Our findings suggested that outer and inner retina had different characteristics in processing spatial details. In experiment 2, Twenty-three young adults were recruited for mfERG measurement. The retinal electrical responses for low (0.24cpd) and high (4.8cpd) SF under fully corrected conditions of shortterm negative defocus (-2D) and short term positive defocus (+2D) conditions were measured. There was a sign-dependent response to defocus in the DC response, mainly in peripheral regions. The sign dependent response at low SF was more obvious than that at high SF, and was located more peripherally. The IC response showed no clear trends for either defocus condition. The human retina seems to have a decoding system for optical defocus, which was tuned for low spatial frequency, and was located in the retinal near periphery.	[Chin, Man Pan; Chu, Patrick H. W.; Cheong, Allen M. Y.; Chan, Henry H. L.] Hong Kong Polytech Univ, Sch Optometry, Lab Expt Optometry Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Chan, HHL (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Lab Expt Optometry Neurosci, Hong Kong, Hong Kong, Peoples R China.	henryhl.chan@polyu.edu.hk	Chu, Patrick HW/H-5532-2011; Cheong, Allen Ming Yan/L-9008-2013	Chu, Patrick HW/0000-0003-0547-2675; Cheong, Allen Ming Yan/0000-0002-6746-3902; CHAN, Henry HL/0000-0002-8516-4711	General Research Fund from Research Grants Committee of the Hong Kong SAR [PolyU 5605/13M]; associated fund (Research Postgraduate) from Hong Kong Polytechnic University	General Research Fund from Research Grants Committee of the Hong Kong SAR; associated fund (Research Postgraduate) from Hong Kong Polytechnic University	This study was supported by the General Research Fund (PolyU 5605/13M) from The Research Grants Committee of the Hong Kong SAR and the associated fund (Research Postgraduate) from The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SJ, 1991, J PHYSIOL-LONDON, V442, P47, DOI 10.1113/jphysiol.1991.sp018781; Atchison DA, 2006, VISION RES, V46, P1450, DOI 10.1016/j.visres.2005.10.023; BERNINGER T, 1985, DOC OPHTHALMOL, V61, P17, DOI 10.1007/BF00143211; Brown B, 1996, OPHTHAL PHYSL OPT, V16, P42, DOI 10.1016/0275-5408(95)00043-7; Buck C, 2004, INVEST OPHTH VIS SCI, V45, P402, DOI 10.1167/iovs.03-0789; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chen JC, 2006, VISION RES, V46, P4096, DOI 10.1016/j.visres.2006.07.033; Chen JC, 2006, VISION RES, V46, P3413, DOI 10.1016/j.visres.2006.03.013; Chen X, 2010, VISION RES, V50, P31, DOI 10.1016/j.visres.2009.10.004; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Chu PHW, 2008, VISION RES, V48, P1726, DOI 10.1016/j.visres.2008.05.006; Chu PHW, 2007, INVEST OPHTH VIS SCI, V48, P2626, DOI 10.1167/iovs.06-0962; Chu PH, 2011, CLIN EXP OPTOM, V94, P259, DOI 10.1111/j.1444-0938.2011.00583.x; Chu PHW, 2006, INVEST OPHTH VIS SCI, V47, P929, DOI 10.1167/iovs.05-0891; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Day M, 2011, SCANDINAVIAN J OPTOM, V4, P1; Diether S, 2005, INVEST OPHTH VIS SCI, V46, P2242, DOI 10.1167/iovs.04-1200; Diether S, 1997, VISION RES, V37, P659, DOI 10.1016/S0042-6989(96)00224-6; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FALSINI B, 1991, GRAEF ARCH CLIN EXP, V229, P262, DOI 10.1007/BF00167881; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; Fortune B, 2002, INVEST OPHTH VIS SCI, V43, P2638; GREEN DG, 1965, J OPT SOC AM, V55, P1154, DOI 10.1364/JOSA.55.001154; Grosvenor Theodore, 2003, Clin Exp Optom, V86, P273; GUO SS, 1995, CURR EYE RES, V14, P385, DOI 10.3109/02713689508999936; Hess RF, 2006, CURR BIOL, V16, P687, DOI 10.1016/j.cub.2006.02.065; Ho WC, 2012, INVEST OPHTH VIS SCI, V53, P5320, DOI 10.1167/iovs.12-10185; Ho WC, 2012, VISION RES, V52, P47, DOI 10.1016/j.visres.2011.10.017; Ho WC, 2011, VISION RES, V51, P367, DOI 10.1016/j.visres.2010.12.001; HODOS W, 1984, INVEST OPHTH VIS SCI, V25, P652; Howlett MHC, 2006, VISION RES, V46, P267, DOI 10.1016/j.visres.2005.06.036; Liu Y, 2012, INVEST OPHTH VIS SCI, V53, P5085, DOI 10.1167/iovs.12-9628; Lung JCY, 2010, GRAEF ARCH CLIN EXP, V248, P1117, DOI 10.1007/s00417-010-1346-5; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Mok AKH, 2011, CLIN OPTOM, V3, P1, DOI 10.2147/OPTO.S16599; NORTON TT, 1994, VISUAL NEUROSCI, V11, P143, DOI 10.1017/S0952523800011184; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Park TW, 2003, VISION RES, V43, P1519, DOI 10.1016/S0042-6989(03)00180-9; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SACHS MB, 1971, J OPT SOC AM, V61, P1176, DOI 10.1364/JOSA.61.001176; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schaeffel F, 2004, OPTOMETRY VISION SCI, V81, P99, DOI 10.1097/00006324-200402000-00008; Schaeffel F, 1999, VISION RES, V39, P1585, DOI 10.1016/S0042-6989(98)00304-6; Schmid KL, 1997, VISION RES, V37, P2011, DOI 10.1016/S0042-6989(97)00014-X; Shaikh AW, 1999, OPTOMETRY VISION SCI, V76, P308, DOI 10.1097/00006324-199905000-00019; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; Shen W, 2005, INVEST OPHTH VIS SCI, V46, P1797, DOI 10.1167/iovs.04-1318; Shimada Y, 2005, GRAEF ARCH CLIN EXP, V243, P132, DOI 10.1007/s00417-004-1072-y; Shimada Y, 2001, BRIT J OPHTHALMOL, V85, P414, DOI 10.1136/bjo.85.4.414; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; Smith EL, 2010, INVEST OPHTH VIS SCI, V51, P3864, DOI 10.1167/iovs.09-4969; Smith EL, 2009, VISION RES, V49, P2386, DOI 10.1016/j.visres.2009.07.011; Smith EL, 1998, OPTOMETRY VISION SCI, V75, P388, DOI 10.1097/00006324-199806000-00023; Smith EL, 1999, OPTOMETRY VISION SCI, V76, P428, DOI 10.1097/00006324-199906000-00023; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; SUTTER EE, 1992, VISION RES, V32, P433, DOI 10.1016/0042-6989(92)90235-B; Sutter EE, 1999, OSA TECHNICAL DIGEST, P52; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; Tran N, 2008, VISION RES, V48, P1655, DOI 10.1016/j.visres.2008.03.022; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; VAEGAN, 1987, VISION RES, V27, P883, DOI 10.1016/0042-6989(87)90004-6; VONNOORDEN GK, 1987, INVEST OPHTH VIS SCI, V28, P750; Walker L, 1978, SCIENCE, V201, P29; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Wang YZ, 1997, INVEST OPHTH VIS SCI, V38, P2134; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P62, DOI 10.1085/jgp.63.1.62; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Winawer J, 2005, VISION RES, V45, P1667, DOI 10.1016/j.visres.2004.12.013; Winawer J, 2002, VISION RES, V42, P2651, DOI 10.1016/S0042-6989(02)00300-0; Yamada K, 2006, DOC OPHTHALMOL, V113, P83, DOI 10.1007/s10633-006-9017-x; Zhang Z, 1996, Yan Ke Xue Bao, V12, P135; Zhi ZN, 2013, INVEST OPHTH VIS SCI, V54, P890, DOI 10.1167/iovs.11-8064; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046; Zhu XY, 2003, INVEST OPHTH VIS SCI, V44, P2818, DOI 10.1167/iovs.02-0606	80	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123480	10.1371/journal.pone.0123480	http://dx.doi.org/10.1371/journal.pone.0123480			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874564	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100181
J	Gu, HG; Zhao, ZG; Jia, B; Chen, SG				Gu Huaguang; Zhao Zhiguo; Jia Bing; Chen Shenggen			Dynamics of On-Off Neural Firing Patterns and Stochastic Effects near a Sub-Critical Hopf Bifurcation	PLOS ONE			English	Article							SUBTHRESHOLD MEMBRANE OSCILLATIONS; MESENCEPHALIC-V NEURONS; PHASE-RESETTING CURVES; ROOT GANGLION NEURONS; COHERENCE RESONANCE; PYRAMIDAL NEURONS; CORTICAL-NEURONS; IN-VITRO; NOISE; RAT	On-off firing patterns, in which repetition of clusters of spikes are interspersed with epochs of subthreshold oscillations or quiescent states, have been observed in various nervous systems, but the dynamics of this event remain unclear. Here, we report that on-off firing patterns observed in three experimental models (rat sciatic nerve subject to chronic constrictive injury, rat CA1 pyramidal neuron, and rabbit blood pressure baroreceptor) appeared as an alternation between quiescent state and burst containing multiple period-1 spikes over time. Burst and quiescent state had various durations. The interspike interval (ISI) series of on-off firing pattern was suggested as stochastic using nonlinear prediction and autocorrelation function. The resting state was changed to a period-1 firing pattern via on-off firing pattern as the potassium concentration, static pressure, or depolarization current was changed. During the changing process, the burst duration of on-off firing pattern increased and the duration of the quiescent state decreased. Bistability of a limit cycle corresponding to period-1 firing and a focus corresponding to resting state was simulated near a sub-critical Hopf bifurcation point in the deterministic Morris-Lecar (ML) model. In the stochastic ML model, noise-induced transitions between the coexisting regimes formed an on-off firing pattern, which closely matched that observed in the experiment. In addition, noise-induced exponential change in the escape rate from the focus, and noise-induced coherence resonance were identified. The distinctions between the on-off firing pattern and stochastic firing patterns generated near three other types of bifurcations of equilibrium points, as well as other viewpoints on the dynamics of on-off firing pattern, are discussed. The results not only identify the on-off firing pattern as noise-induced stochastic firing pattern near a sub-critical Hopf bifurcation point, but also offer practical indicators to discriminate bifurcation types and neural excitability types.	[Gu Huaguang; Zhao Zhiguo; Chen Shenggen] Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China; [Jia Bing] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Gu, HG (corresponding author), Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China.	guhuaguang@tongji.edu.cn	Zhiguo, Zhao/Q-8480-2018; Gu, Huaguang/E-3562-2013; Gu, Huaguang/ABA-5898-2020	Zhiguo, Zhao/0000-0002-0041-724X; Gu, Huaguang/0000-0003-0815-1447; Gu, Huaguang/0000-0003-0815-1447; Jia, Bing/0000-0003-4266-7228	National Natural Science Foundation of China [11372224, 11072135, 10772101]; Fundamental Research Funds for Central Universities [1330219127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China under grant Nos. 11372224, 11072135 and 10772101 and the Fundamental Research Funds for Central Universities under grant No. 1330219127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHARA K, 1984, J THEOR BIOL, V109, P249, DOI 10.1016/S0022-5193(84)80005-3; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; Amir R, 2005, J NEUROSCI, V25, P2576, DOI 10.1523/JNEUROSCI.4118-04.2005; Amir R, 2002, J NEUROSCI, V22, P1187, DOI 10.1523/JNEUROSCI.22-03-01187.2002; Amir R, 2002, BRAIN, V125, P421, DOI 10.1093/brain/awf037; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berglund N, 2006, PROB APPL S; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; BRAUN HA, 1994, NATURE, V367, P270, DOI 10.1038/367270a0; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Chacron MJ, 2000, PHYS REV LETT, V85, P1576, DOI 10.1103/PhysRevLett.85.1576; Chacron MJ, 2001, PHYS REV LETT, V92; Clay JR, 2002, J MEMBRANE BIOL, V187, P213, DOI 10.1007/s00232-001-0165-3; Del Negro CA, 1998, BIOPHYS J, V75, P174, DOI 10.1016/S0006-3495(98)77504-6; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Feng JF, 1999, BIOL CYBERN, V80, P291, DOI 10.1007/s004220050526; Galan RF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158101; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao JB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066204; Gao JB, 1999, PHYS REV LETT, V83, P3178, DOI 10.1103/PhysRevLett.83.3178; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; Greenwood PE, 2000, PHYS REV LETT, V84, P4773, DOI 10.1103/PhysRevLett.84.4773; Gu HG, 2001, PHYS LETT A, V285, P63, DOI 10.1016/S0375-9601(01)00278-X; Gu HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081759; Gu HG, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413501952; Gu HG, 2013, CHAOS, V23, DOI 10.1063/1.4810932; Gu HG, 2011, INT J MOD PHYS B, V25, P3977, DOI 10.1142/S0217979211101673; Gu HG, 2011, COGN NEURODYNAMICS, V5, P87, DOI 10.1007/s11571-010-9145-6; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; Gutkin BS, 1998, NEURAL COMPUT, V10, P1047, DOI 10.1162/089976698300017331; HAYASHI H, 1982, PHYS LETT A, V88, P435, DOI 10.1016/0375-9601(82)90674-0; HAYASHI H, 1983, PHYS LETT A, V98, P474, DOI 10.1016/0375-9601(83)90267-0; Hirata Y, 2012, CHAOS, V22, DOI 10.1063/1.4738191; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; Izhikevich E. M, 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Jia B, 2012, COGN NEURODYNAMICS, V6, P485, DOI 10.1007/s11571-012-9209-x; Jia B, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/9/090507; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Lee SG, 1998, PHYS REV E, V57, P3292, DOI 10.1103/PhysRevE.57.3292; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Ma C, 2007, J NEUROSCI, V27, P14059, DOI 10.1523/JNEUROSCI.3699-07.2007; MANNELLA R, 1989, PHYS REV A, V40, P3381, DOI 10.1103/PhysRevA.40.3381; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/20007; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; Pedroarena CM, 1999, J NEUROPHYSIOL, V82, P1465, DOI 10.1152/jn.1999.82.3.1465; Phoka E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000768; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Reboreda A, 2003, J PHYSIOL-LONDON, V551, P191, DOI 10.1113/jphysiol.2003.039917; RINZEL J., 1987, P INT C MATHEMATICIA, P1578; Rinzel J., 1989, METHODS NEURONAL MOD, P135; SAUER T, 1994, PHYS REV LETT, V72, P3811, DOI 10.1103/PhysRevLett.72.3811; SEJNOWSKI TJ, 1995, NATURE, V376, P21, DOI 10.1038/376021a0; Serafin M, 1996, NEUROSCIENCE, V75, P671, DOI 10.1016/0306-4522(96)00349-1; Song Y, 2012, PAIN, V153, P657, DOI 10.1016/j.pain.2011.11.030; Sun W, 2012, BRAIN, V135, P359, DOI 10.1093/brain/awr345; Suzuki H, 2000, BIOL CYBERN, V82, P305, DOI 10.1007/s004220050584; Tal M, 1996, PAIN, V64, P511, DOI 10.1016/0304-3959(95)00175-1; Tateno T, 2006, J NEUROPHYSIOL, V95, P2650, DOI 10.1152/jn.00683.2005; Tateno T, 2004, CHAOS, V14, P511, DOI 10.1063/1.1756118; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x; Tsumoto K, 2006, NEUROCOMPUTING, V69, P293, DOI 10.1016/j.neucom.2005.03.006; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang YY, 2011, NEUROSIGNALS, V19, P54, DOI 10.1159/000324519; Wu NP, 2005, J NEUROPHYSIOL, V93, P2710, DOI 10.1152/jn.00636.2004; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; Xie RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018681; Xie WR, 2005, PAIN, V116, P243, DOI 10.1016/j.pain.2005.04.017; Xing JL, 2003, PAIN, V105, P177, DOI 10.1016/S0304-3959(03)00200-8; Xing JL, 2001, NEUROREPORT, V12, P1311, DOI 10.1097/00001756-200105080-00051; Xing JL, 2001, BRAIN RES, V901, P128, DOI 10.1016/S0006-8993(01)02329-0; Yang H, 2014, CHAOS, V24, DOI 10.1063/1.4869306; Yang MH, 2006, NEUROREPORT, V17, P995, DOI 10.1097/01.wnr.0000224770.74528.d6; Yang MH, 2009, INT J BIFURCAT CHAOS, V19, P453, DOI 10.1142/S0218127409023135; Yang RH, 2009, PAIN, V143, P48, DOI 10.1016/j.pain.2009.01.020; Zhu ZR, 2009, NEUROSIGNALS, V17, P181, DOI 10.1159/000209279	94	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121028	10.1371/journal.pone.0121028	http://dx.doi.org/10.1371/journal.pone.0121028			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867027	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100033
J	Tang, LQ; Hu, DP; Chen, QY; Zhang, L; Lai, XP; He, Y; Xu, YXX; Wen, SH; Peng, YT; Chen, WH; Guo, SS; Liu, LT; Qian, CN; Guo, X; Zeng, MS; Mai, HQ				Tang, Lin Quan; Hu, Dong Peng; Chen, Qiu Yan; Zhang, Lu; Lai, Xiao Ping; He, Yun; Xu, Yun-Xiu-Xiu; Wen, Shi-Hua; Peng, Yu-Tuan; Chen, Wen-Hui; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang			Elevated High-Sensitivity C-Reactive Protein Levels Predict Decreased Survival for Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era	PLOS ONE			English	Article							BARR-VIRUS DNA; CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; VIRAL-DNA; EBV DNA; PLASMA; DIAGNOSIS; SERUM; CHEMORADIOTHERAPY; QUANTITATION; METASTASIS	Purpose This study aimed to clarify the prognostic utility of high-sensitivity C-reactive protein (hs-CRP) in nasopharyngeal carcinoma (NPC) patients in the Intensity-Modulated Radiotherapy (IMRT) era. Patients and Methods In this observational study, 1,589 non-metastatic NPC patients treated with IMRT were recruited. Blood samples were collected before treatment for examination of hs-CRP levels. We evaluated the association of pretreatment hs-CRP levels with overall survival rate (OS), progression free survival rate (PFS), locoregional relapse free survival rate (LRFS) and distant metastasis free survival rate (DMFS). Results Baseline hs-CRP levels were correlated with sex, clinical stage, body mass index, smoking status, and EBV DNA level. Multivariate analysis showed that hs-CRP had significant association with OS (HR:1.723; 95% CI:1.238-2.398; p = 0.001), PFS (HR:1.621; 95% CI:1.273-2.064; p < 0.001) and DMFS (HR: 1.879; 95% CI: 1.394-2.531; p < 0.001). In subgroups such as advanced-stage group, low EBV DNA group and high EBV DNA group, elevated hs-CRP levels still predicted poor clinical outcomes. Furthermore, in patients with chronic HBV infection, decreased 4-year survival was observed in the cohort of high hs-CRP levels, with 87.4% vs. 94.9% (p = 0.023) for OS, 65.2% vs. 90.8% (p < 0.001) for PFS, and 67.6% vs. 95.0% (p < 0.001) for DMFS. A similar finding was observed for patients with cardiovascular disease, with 79.1% vs. 90.2% (p = 0.020) for PFS, and 71.4% vs. 97.6% (p = 0.002) for DMFS. Conclusion Elevated serum hs-CRP levels were correlated with poor survival for NPC patients in the IMRT era, playing a complementary role to TNM stage and EBV DNA. In addition, elevated hs-CRP level was still an effective indicator for patients with chronic HBV infection and cardiovascular disease.	[Tang, Lin Quan; Chen, Qiu Yan; Chen, Wen-Hui; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Chen, Wen-Hui; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Dong Peng; Lai, Xiao Ping; He, Yun; Xu, Yun-Xiu-Xiu; Wen, Shi-Hua; Peng, Yu-Tuan] Sun Yat Sen Univ, ZhongShan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zeng, MS (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zengmsh@mail.sysu.edu.cn; maihq@mail.sysu.edu.cn			National Natural Science Foundation of China [81072226]; 863 Project [2012AA02A501]; National Key Basic Research Program of China [2013CB910304]; Sci-Tech Project Foundation of Guangdong Province [2011B080701034, 2011B031800161]; Sci-Tech Project Foundation of Guangzhou City [2011J4300100]; Sun Yatsen University Clinical Research 5010 Program; Fundamental Research Funds for the central universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Sci-Tech Project Foundation of Guangdong Province; Sci-Tech Project Foundation of Guangzhou City; Sun Yatsen University Clinical Research 5010 Program; Fundamental Research Funds for the central universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the National Natural Science Foundation of China (No: 81072226, http://www.nsfc.gov.cn), the 863 Project (No: 2012AA02A501, http://www.863.gov.cn/), the National Key Basic Research Program of China (No: 2013CB910304, http://www.973.gov.cn), the Sci-Tech Project Foundation of Guangdong Province (No: 2011B080701034, and 2011B031800161, http://www.gdstc.gov.cn/), the Sci-Tech Project Foundation of Guangzhou City (No: 2011J4300100, http://www.gzsi.gov.cn), the Sun Yatsen University Clinical Research 5010 Program, and the Fundamental Research Funds for the central universities (http://www.sysu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; ATONO Y, 1989, Gastroenterologia Japonica, V24, P655; Boncler M, 2009, ACTA BIOCHIM POL, V56, P17; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chan KCA, 2003, CANCER RES, V63, P2028; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Hu QF, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.07.016; Huang PY, 2013, EUR J CANCER, V49, P1923, DOI 10.1016/j.ejca.2013.01.027; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Lee NY, 2008, J SURG ONCOL, V97, P691, DOI 10.1002/jso.21014; Leung SF, 2014, ANN ONCOL, V25, P1204, DOI 10.1093/annonc/mdu117; Leung SF, 2003, CANCER, V98, P288, DOI 10.1002/cncr.11496; Leung SF, 2006, J CLIN ONCOL, V24, P5414, DOI 10.1200/JCO.2006.07.7982; Liao Q, 2014, ONCOGENE, V33, P2098, DOI 10.1038/onc.2013.161; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Liu X, 2014, CANCER-AM CANCER SOC, V120, P68, DOI 10.1002/cncr.28377; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Liu ZQ, 2014, ASIAN J ANDROL, V16, P467, DOI 10.4103/1008-682X.123686; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; Lo YMD, 2000, ANN NY ACAD SCI, V906, P99; Ma BBY, 2006, INT J RADIAT ONCOL, V66, P714, DOI 10.1016/j.ijrobp.2006.05.064; Mutirangura A, 1998, CLIN CANCER RES, V4, P665; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Quetier I, 2013, J HEPATOL, V59, P285, DOI 10.1016/j.jhep.2013.03.021; Salazar J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/605810; Shibutani M, 2015, SURG TODAY, V45, P315, DOI 10.1007/s00595-014-0909-1; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Song CX, 2013, PAK J MED SCI, V29, P885, DOI 10.12669/pjms.293.2907; Strang F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/757123; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Xia WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076958; Xia WX, 2013, EUR J CANCER, V49, P2152, DOI 10.1016/j.ejca.2013.03.003; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Yi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094632; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122965	10.1371/journal.pone.0122965	http://dx.doi.org/10.1371/journal.pone.0122965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874450	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100121
J	Fryxell, RTT; Freyman, K; Ulloa, A; Hendricks, B; Paulsen, D; Odoi, A; Moncayo, A				Fryxell, Rebecca T. Trout; Freyman, Kimberly; Ulloa, Armando; Hendricks, Brian; Paulsen, Dave; Odoi, Agricola; Moncayo, Abelardo			Cemeteries Are Effective Sites For Monitoring La Crosse Virus (LACv) and these Environments May Play a Role in LACv Infection	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; HABITAT PREFERENCES; LARVAL COMPETITION; MOSQUITOS DIPTERA; EASTERN TENNESSEE; CULICIDAE; ENCEPHALITIS; TRISERIATUS; TRANSMISSION; ABUNDANCE	La Crosse encephalitis (LAC) is the leading arboviral disease among children, and was previously limited to the upper Midwest. In 2012 nine pediatric cases of LAC occurred in eastern Tennessee, including one fatal case. In an attempt to identify sites near an active LACv infection and describe the abundance and distribution of potential LACv vectors near a fatal LAC case in the Appalachian region, we initiated an end of season study using a combination of questing and oviposition mosquito traps placed at forty-nine sites consisting of cemeteries and houses within 16 radial kilometers of two pediatric infections. LACv was isolated from three Aedes triseriatus pools collected from cemeteries and spatial clustering analysis identified clusters of Ae. triseriatus and Ae. albopictus populations that overlapped in the same area as the 2012 LACv cases. Results indicate cemeteries are effective sites for monitoring LACv. The role of cemeteries and specific environmental features will be the focus of future investigations.	[Fryxell, Rebecca T. Trout; Hendricks, Brian; Paulsen, Dave] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Freyman, Kimberly; Moncayo, Abelardo] Tennessee Dept Hlth, Nashville, TN USA; [Ulloa, Armando] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Odoi, Agricola] Univ Tennessee, Dept Biomed & Diagnost Serv, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Tennessee Department Health; Instituto Nacional de Salud Publica; University of Tennessee System; University of Tennessee Knoxville	Fryxell, RTT (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	RFryxell@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737; Trout Fryxell, Rebecca/0000-0003-2133-0220	University of Tennessee Institute of Agriculture (Hatch project) [TENN00433]; Tennessee Department of Health	University of Tennessee Institute of Agriculture (Hatch project); Tennessee Department of Health	Funding for this project was provided by the University of Tennessee Institute of Agriculture (Hatch project TENN00433) and the Tennessee Department of Health.	Armistead JS, 2012, J MED ENTOMOL, V49, P1318, DOI 10.1603/ME11261; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; BEIER JC, 1983, J MED ENTOMOL, V20, P76, DOI 10.1093/jmedent/20.1.76; BEIER JC, 1983, ENVIRON ENTOMOL, V12, P434, DOI 10.1093/ee/12.2.434; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; Borucki MK, 2002, MICROBES INFECT, V4, P341, DOI 10.1016/S1286-4579(02)01547-2; Centers for Disease Control and Prevention, 2012, CROSS ENC; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Haddow AD, 2009, J VECTOR ECOL, V34, P70, DOI [10.1111/j.1948-7134.2009.00009.x, 10.3376/038.034.0109]; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; Hughes MT, 2006, J MED ENTOMOL, V43, P757, DOI 10.1603/0022-2585(2006)43[757:CPOATA]2.0.CO;2; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2014, SATSCAN USER GUIDE V; Kulldorff M, 2005, INFORM MANAGEMENT SE, V2005; Kuno G, 1996, J CLIN MICROBIOL, V34, P1184, DOI 10.1128/JCM.34.5.1184-1188.1996; Lambert A, 2015, J EMERG INF IN PRESS; Lambert AJ, 2005, J CLIN MICROBIOL, V43, P1885, DOI 10.1128/JCM.43.4.1885-1889.2005; Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Nasci RS, 2000, J MED ENTOMOL, V37, P559, DOI 10.1603/0022-2585-37.4.559; NOVAK MG, 1993, ENVIRON ENTOMOL, V22, P311, DOI 10.1093/ee/22.2.311; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Reese SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-76; Sanford MR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-225; Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635; SAUL SH, 1978, AM NAT, V112, P333, DOI 10.1086/283276; Szumlas DE, 1996, J MED ENTOMOL, V33, P598, DOI 10.1093/jmedent/33.4.598; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; United States Geological Survey, 2013, CROSS ENC HUM 2013; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; WOODRUFF BA, 1992, AM J EPIDEMIOL, V136, P320, DOI 10.1093/oxfordjournals.aje.a116497; Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122895	10.1371/journal.pone.0122895	http://dx.doi.org/10.1371/journal.pone.0122895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860584	Green Published, gold			2022-12-26	WOS:000352590300067
J	Krammer, EM; Vu, GT; Homble, F; Prevost, M				Krammer, Eva-Maria; Giang Thi Vu; Homble, Fabrice; Prevost, Martine			Dual Mechanism of Ion Permeation through VDAC Revealed with Inorganic Phosphate Ions and Phosphate Metabolites	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; MOLECULAR-DYNAMICS; MITOCHONDRIAL CHANNEL; OUTER-MEMBRANE; ATP TRANSPORT; SELECTIVE CHANNEL; ALPHA-HEMOLYSIN; BINDING-SITES; PROTEIN; PERMEABILITY	In the exchange of metabolites and ions between the mitochondrion and the cytosol, the voltage-dependent anion channel (VDAC) is a key element, as it forms the major transport pathway for these compounds through the mitochondrial outer membrane. Numerous experimental studies have promoted the idea that VDAC acts as a regulator of essential mitochondrial functions. In this study, using a combination of molecular dynamics simulations, free-energy calculations, and electrophysiological measurements, we investigated the transport of ions through VDAC, with a focus on phosphate ions and metabolites. We showed that selectivity of VDAC towards small anions including monovalent phosphates arises from short-lived interactions with positively charged residues scattered throughout the pore. In dramatic contrast, permeation of divalent phosphate ions and phosphate metabolites (AMP and ATP) involves binding sites along a specific translocation pathway. This permeation mechanism offers an explanation for the decrease in VDAC conductance measured in the presence of ATP or AMP at physiological salt concentration. The binding sites occur at similar locations for the divalent phosphate ions, AMP and ATP, and contain identical basic residues. ATP features a marked affinity for a central region of the pore lined by two lysines and one arginine of the N-terminal helix. This cluster of residues together with a few other basic amino acids forms a "charged brush" which facilitates the passage of the anionic metabolites through the pore. All of this reveals that VDAC controls the transport of the inorganic phosphates and phosphate metabolites studied here through two different mechanisms.	[Krammer, Eva-Maria; Giang Thi Vu; Homble, Fabrice; Prevost, Martine] Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat, Struct & Fonct Membranes Biol, Brussels, Belgium	Universite Libre de Bruxelles	Prevost, M (corresponding author), Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat, Struct & Fonct Membranes Biol, Brussels, Belgium.	mprevost@ulb.ac.be	Krammer, Eva-Maria/H-2543-2013	Krammer, Eva-Maria/0000-0002-4821-2550	ARC grant from the Federation Wallonie-Bruxelles [AUWB 2010-15-2, 20052]; Fonds de la Recherche Scientifique; Universite Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB)	ARC grant from the Federation Wallonie-Bruxelles; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB)	The funders of this study are the ARC grant (AUWB 2010-15-2) from the Federation Wallonie-Bruxelles (grant number 20052), and the Fonds de la Recherche Scientifique (http://www1.frs-fnrs.be/). FH is a Research Director, MP is a Senior Research Associate, and EMK is a Postdoctoral Researcher at the Fonds de la Recherche Scientifique (F.R.S.-FNRS) (Belgium). Computational resources were provided by the Computing Centre HPC cluster, co-funded by the Universite Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB), the Consortium des Equipments de Calcul Intensif (CECI), and the Fonds de la Recherche Scientifique de Belgique (F.R.S.-F.N.R.S.) under convention 2.5020.11, together with the supercomputing facilities of the Universite catholique de Louvain (CISM/UCL) and the ULB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrecht H, 2000, PLANT PHYSIOL, V124, P1181, DOI 10.1104/pp.124.3.1181; Abrecht H, 2000, J BIOL CHEM, V275, P40992, DOI 10.1074/jbc.M006437200; Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Aksimentiev A, 2004, BIOPHYS J, V87, P2086, DOI 10.1529/biophysj.104.042960; Amodeo GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103879; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Choudhary OP, 2014, NAT STRUCT MOL BIOL, V21, P626, DOI 10.1038/nsmb.2841; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; COHN M, 1962, J BIOL CHEM, V237, P176; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Corry B, 2005, EUR BIOPHYS J BIOPHY, V34, P208, DOI 10.1007/s00249-004-0442-z; Crozier PS, 2001, BIOPHYS J, V81, P3077, DOI 10.1016/S0006-3495(01)75946-2; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Gumbart J, 2012, BBA-BIOMEMBRANES, V1818, P294, DOI 10.1016/j.bbamem.2011.09.030; GUO XW, 1993, BIOPHYS J, V64, P545, DOI 10.1016/S0006-3495(93)81399-7; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Homble F., 2010, MEMBRANE ACTIVE PEPT, V1st ed., P273; Homble F, 2012, BBA-BIOMEMBRANES, V1818, P1486, DOI 10.1016/j.bbamem.2011.11.028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krammer E- M, 2014, MITOCHONDRION, V2014, DOI [10. 1016/ j. mito. 2014. 04. 003, DOI 10.1016/J.MIT0.2014.04.003]; Krammer EM, 2013, BBA-BIOMEMBRANES, V1828, P1284, DOI 10.1016/j.bbamem.2012.12.018; Krammer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027994; Lackey SWK, 2014, J BIOL CHEM, V289, P21640, DOI 10.1074/jbc.M114.578765; Lee AC, 1996, J BIOL CHEM, V271, P26724, DOI 10.1074/jbc.271.43.26724; Lee K, 2011, BIOPHYS J, V100, p156a, DOI [10. 1016/ j. bpj. 2010. 12. 1068, DOI 10.1016/J.BPJ.2010.12.1068]; Liao JC, 2004, EUR BIOPHYS J BIOPHY, V33, P29, DOI 10.1007/s00249-003-0339-2; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Luo Y, 2010, J PHYS CHEM B, V114, P952, DOI 10.1021/jp906790f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Modi N, 2012, NANOSCALE, V4, P6166, DOI 10.1039/c2nr31024d; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pongprayoon P, 2012, J PHYS CHEM B, V116, P462, DOI 10.1021/jp206754w; Pongprayoon P, 2009, P NATL ACAD SCI USA, V106, P21614, DOI 10.1073/pnas.0907315106; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; Rostovtseva TK, 2002, BIOPHYS J, V82, P193, DOI 10.1016/S0006-3495(02)75386-1; Rostovtseva TK, 2002, J MEMBRANE BIOL, V187, P147, DOI 10.1007/s00232-001-0159-1; Roux B, 2004, Q REV BIOPHYS, V37, P15, DOI 10.1017/S0033583504003968; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Schredelseker J, 2014, J BIOL CHEM, V289, P12566, DOI 10.1074/jbc.M113.497438; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; STORER AC, 1976, BIOCHEM J, V159, P1; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Tsoulos IG, 2011, COMPUT PHYS COMMUN, V182, P834, DOI 10.1016/j.cpc.2010.11.032; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Villinger S, 2014, J BIOL CHEM, V289, P13397, DOI 10.1074/jbc.M113.524173; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a; Wells DB, 2010, J CHEM PHYS, V127, P1, DOI [10. 1063/ 1. 2770738. Exploring, DOI 10.1063/1.2770738.EXPL0RING]; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; ZIZI M, 1994, J BIOL CHEM, V269, P1614	77	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121746	10.1371/journal.pone.0121746	http://dx.doi.org/10.1371/journal.pone.0121746			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860993	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300030
J	Tran-Gia, J; Wech, T; Bley, T; Kostler, H				Tran-Gia, Johannes; Wech, Tobias; Bley, Thorsten; Koestler, Herbert			Model-Based Acceleration of Look-Locker T1 Mapping	PLOS ONE			English	Article							RELAXATION-TIMES; HUMAN BRAIN; GOLDEN-RATIO; T-1; RECONSTRUCTION; QUANTIFICATION; FLASH	Mapping the longitudinal relaxation time T-1 has widespread applications in clinical MRI as it promises a quantitative comparison of tissue properties across subjects and scanners. Due to the long scan times of conventional methods, however, the use of quantitative MRI in clinical routine is still very limited. In this work, an acceleration of Inversion-Recovery Look-Locker (IR-LL) T-1 mapping is presented. A model-based algorithm is used to iteratively enforce an exponential relaxation model to a highly undersampled radially acquired IR-LL dataset obtained after the application of a single global inversion pulse. Using the proposed technique, a T-1 map of a single slice with 1.6mm in-plane resolution and 4mm slice thickness can be reconstructed from data acquired in only 6s. A time-consuming segmented IR experiment was used as gold standard for T-1 mapping in this work. In the subsequent validation study, the model-based reconstruction of a single-inversion IR-LL dataset exhibited a T-1 difference of less than 2.6% compared to the segmented IR-LL reference in a phantom consisting of vials with T1 values between 200ms and 3000ms. In vivo, the T-1 difference was smaller than 5.5% in WM and GM of seven healthy volunteers. Additionally, the T-1 values are comparable to standard literature values. Despite the high acceleration, all model-based reconstructions were of a visual quality comparable to fully sampled references. Finally, the reproducibility of the T-1 mapping method was demonstrated in repeated acquisitions. In conclusion, the presented approach represents a promising way for fast and accurate T-1 mapping using radial IR-LL acquisitions without the need of any segmentation.	[Tran-Gia, Johannes; Wech, Tobias; Bley, Thorsten; Koestler, Herbert] Univ Wurzburg, Dept Diagnost & Intervent Radiol, D-97070 Wurzburg, Germany; [Wech, Tobias; Bley, Thorsten; Koestler, Herbert] Univ Wurzburg, CHFC Wurzburg, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Tran-Gia, J (corresponding author), Univ Wurzburg, Dept Diagnost & Intervent Radiol, D-97070 Wurzburg, Germany.	E_Tran_J@ukw.de	Köstler, Herbert/B-2089-2010	Köstler, Herbert/0000-0001-6207-9226; Tran-Gia, Johannes/0000-0001-9552-7750	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG); University of Wurzburg	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	JT-G was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. Also, the costs for the open access publication itself will be borne by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Ehses P, 2013, MAGN RESON MED, V69, P71, DOI 10.1002/mrm.24225; Ethofer T, 2003, MAGN RESON MED, V50, P1296, DOI 10.1002/mrm.10640; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Preibisch C, 2009, MAGN RESON MED, V61, P125, DOI 10.1002/mrm.21776; Rubinstein R., 2008, EFFICIENT IMPLEMENTA; Seiberlich N, 2008, MAGN RESON MED, V59, P930, DOI 10.1002/mrm.21565; Seiberlich N, 2007, MAGN RESON MED, V58, P1257, DOI 10.1002/mrm.21435; Shah NJ, 2001, NEUROIMAGE, V14, P1175, DOI 10.1006/nimg.2001.0886; Steinhoff S, 2001, MAGN RESON MED, V46, P131, DOI 10.1002/mrm.1168; Sumpf TJ, 2011, J MAGN RESON IMAGING, V34, P420, DOI 10.1002/jmri.22634; Tran-Gia J, 2014, MAGN RESON IMAGING, V32, P1021, DOI 10.1016/j.mri.2014.05.012; Tran-Gia J, 2013, MAGN RESON MED, V70, P1524, DOI 10.1002/mrm.24600; Venkatesan R, 1998, MAGNET RESON MED, V40, P592, DOI 10.1002/mrm.1910400412; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Zhu DC, 2005, MAGNET RESON MED, V54, P725, DOI 10.1002/mrm.20602; ZUR Y, 1991, MAGNET RESON MED, V21, P251, DOI 10.1002/mrm.1910210210	25	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122611	10.1371/journal.pone.0122611	http://dx.doi.org/10.1371/journal.pone.0122611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860381	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300051
J	Wang, Q; Zheng, W; Wang, ZC; Yang, JW; Hussein, S; Tang, JF; Chen, XZ				Wang, Qian; Zheng, Wang; Wang, Zuocheng; Yang, JungWoo; Hussein, Shaimaa; Tang, Jingfeng; Chen, Xing-Zhen			Filamin-A Increases the Stability and Plasma Membrane Expression of Polycystin-2	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; KIDNEY-DISEASE; CHANNEL; RECEPTOR; GENE; PKD2; PROLIFERATION; CYTOSKELETON; DEGRADATION; INTERACTS	Polycystin-2 (PC2), encoded by the PKD2 gene, is mutated in similar to 15% of autosomal dominant polycystic kidney disease. Filamins are actin-binding proteins implicated in scaffolding and membrane stabilization. Here we studied the effects of filamin on PC2 stability using filamindeficient human melanoma M2, filamin-A (FLNA)-replete A7, HEK293 and IMCD cells together with FLNA siRNA/shRNA knockdown (KD). We found that the presence of FLNA is associated with higher total and plasma membrane PC2 protein expression. Western blotting analysis in combination with FLNA KD showed that FLNA in A7 cells represses PC2 degradation, prolonging the half-life from 2.3 to 4.4 hours. By co-immunoprecipitation and Far Western blotting we found that the FLNA C-terminus (FLNAC) reduces the FLNA-PC2 binding and PC2 expression, presumably through competing with FLNA for binding PC2. We further found that FLNA mediates PC2 binding with actin through forming complex PC2-FLNA-actin. FLNAC acted as a blocking peptide and disrupted the link of PC2 with actin through disrupting the PC2-FLNA-actin complex. Finally, we demonstrated that the physical interaction of PC2-FLNA is Ca-dependent. Taken together, our current study indicates that FLNA anchors PC2 to the actin cytoskeleton through complex PC2-FLNA-actin to reduce degradation and increase stability, and possibly regulate PC2 function in a Ca-dependent manner.	[Wang, Qian; Zheng, Wang; Wang, Zuocheng; Yang, JungWoo; Hussein, Shaimaa; Tang, Jingfeng; Chen, Xing-Zhen] Univ Alberta, Membrane Prot Dis Res Grp, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada; [Tang, Jingfeng; Chen, Xing-Zhen] Hubei Univ Technol, Membrane Prot Dis & Canc Res Ctr, Wuhan, Peoples R China	University of Alberta; Hubei University of Technology	Tang, JF (corresponding author), Hubei Univ Technol, Membrane Prot Dis & Canc Res Ctr, Wuhan, Peoples R China.	jingfeng@whu.edu.cn; xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Tang, jingfeng/0000-0002-5524-4518; Hussein, Shaimaa/0000-0003-0849-9670	Canadian Institutes of Health Research [MOP 89977]; Kidney Foundation of Canada [KFOC090004]; Alberta Innovates [201200922] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Alberta Innovates	This work was supported by grants from the Canadian Institutes of Health Research [MOP 89977] http://www.cihr-irsc.gc.ca/e/193.html and Kidney Foundation of Canada [KFOC090004] http://www.kidney.ca/page.aspx?pid=183 to XZC. The funders had no role in study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Beekman JM, 2008, J IMMUNOL, V180, P3938, DOI 10.4049/jimmunol.180.6.3938; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen XZ, 2008, FEBS J, V275, P4675, DOI 10.1111/j.1742-4658.2008.06616.x; de Wit MCY, 2009, J NEUROL NEUROSUR PS, V80, P426, DOI 10.1136/jnnp.2008.149419; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Ibraghimov-Beskrovnaya Oxana, 2006, Nephrol Ther, V2 Suppl 2, pS109; Kim EJ, 2007, BIOCHEM BIOPH RES CO, V362, P1101, DOI 10.1016/j.bbrc.2007.08.148; Kley RA, 2013, AUTOPHAGY, V9, P422, DOI 10.4161/auto.22921; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Lanoix J, 1996, ONCOGENE, V13, P1153; Lantinga-van Leeuwen IS, 2005, EUR J HUM GENET, V13, P649, DOI 10.1038/sj.ejhg.5201392; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Markowitz GS, 1999, AM J PHYSIOL-RENAL, V277, pF17, DOI 10.1152/ajprenal.1999.277.1.F17; Miyakawa A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-34; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montalbetti N, 2005, PFLUG ARCH EUR J PHY, V451, P294, DOI 10.1007/s00424-005-1458-7; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Obermuller N, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018402.33620.C7; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; PERRONE RD, 1985, J CLIN INVEST, V76, P1688, DOI 10.1172/JCI112155; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Prasad S, 2009, AM J PATHOL, V175, P1493, DOI 10.2353/ajpath.2009.090227; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun H, 2010, MOL BIOL REP, V37, P2951, DOI 10.1007/s11033-009-9861-3; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wang Q, 2013, J BIOL CHEM, V288, P264, DOI 10.1074/jbc.M112.396408; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040448; WILSON PD, 1986, KIDNEY INT, V30, P371, DOI 10.1038/ki.1986.194; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Yuan YH, 2009, CIRC RES, V105, P1177, DOI 10.1161/CIRCRESAHA.109.204669; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhao Y, 2002, NEPHROL DIAL TRANSPL, V17, P2138, DOI 10.1093/ndt/17.12.2138; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	57	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123018	10.1371/journal.pone.0123018	http://dx.doi.org/10.1371/journal.pone.0123018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861040	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300073
J	Witteveen, A; Kwast, ABG; Sonke, GS; IJzerman, MJ; Siesling, S				Witteveen, Annemieke; Kwast, Annemiek B. G.; Sonke, Gabe S.; IJzerman, Maarten J.; Siesling, Sabine			Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; LOCAL RECURRENCE; CONSERVING THERAPY; CONSERVATIVE SURGERY; TUMOR RECURRENCE; RISK-FACTORS; RELEVANCE; WOMEN	The association between the disease-free interval (DFI) and survival after a locoregional recurrence (LRR) or second primary (SP) breast cancer remains uncertain. The objective of this study is to clarify this association to obtain more information on expected prognosis. Women first diagnosed with early breast cancer between 2003-2006 were selected from the Netherlands Cancer Registry. LRRs and SP tumours within five years of first diagnosis were examined. The five-year period was subsequently divided into three equal intervals. Prognostic significance of the DFI on survival after a LRR or SP tumour was determined using Kaplan-Meier estimates and multivariable Cox regression analysis. Follow-up was complete until January 1, 2014. A total of 37,278 women was included in the analysis. LRRs or SP tumours were diagnosed in 890 (2,4%) and 897 (2,4%) respectively. Longer DFI was strongly and independently related to an improved survival after a LRR (long versus short: HR 0.65, 95% CI 0.48-0.88; medium versus short HR 0.81, 95% CI 0.65-1.01). Other factors related to improved survival after LRR were younger age (<70 years) and surgical removal of the recurrence. No significant association was found between DFI and survival after SP tumours. This is the first study to explore the association between the DFI and survival after recurrence in a nationwide population-based cancer registry. The DFI before a LRR is an independent prognostic factor for survival, with a longer DFI predicting better prognosis.	[Witteveen, Annemieke; IJzerman, Maarten J.; Siesling, Sabine] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, NL-7500 AE Enschede, Netherlands; [Kwast, Annemiek B. G.; Siesling, Sabine] Comprehens Canc Ctr Netherlands IKNL, Dept Registrat & Res, Utrecht, Netherlands; [Sonke, Gabe S.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	University of Twente; Netherlands Cancer Institute	Witteveen, A (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, POB 217, NL-7500 AE Enschede, Netherlands.	a.witteveen@utwente.nl	IJzerman, Maarten/AAB-6894-2020; IJzerman, Maarten J/Q-8963-2016	IJzerman, Maarten/0000-0001-5788-5805; IJzerman, Maarten J/0000-0001-5788-5805; Witteveen, Annemieke/0000-0001-5581-6478; Sonke, Gabe/0000-0001-8088-9628				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Bantema-Joppe EJ, 2013, BREAST CANCER RES TR, V140, P577, DOI 10.1007/s10549-013-2650-7; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Ciatto S, 2004, EUR J CANCER, V40, P1496, DOI 10.1016/j.ejca.2004.03.010; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies E., 2013, SURGERY, V31, P41; Dawood S, 2010, ANN ONCOL, V21, P2169, DOI 10.1093/annonc/mdq220; Doyle T, 2001, INT J RADIAT ONCOL, V51, P74, DOI 10.1016/S0360-3016(01)01625-X; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fredriksson I, 2002, EUR J CANCER, V38, P1860, DOI 10.1016/S0959-8049(02)00219-8; Grillo IM, 2005, CLIN ONCOL-UK, V17, P111, DOI 10.1016/j.clon.2004.10.005; Hastings J, 2013, AM J CLIN ONCOL-CANC, P1; Holzel D, 2011, CANCER METAST REV, V30, P161, DOI 10.1007/s10555-011-9275-2; Komoike Y, 2006, CANCER-AM CANCER SOC, V106, P35, DOI 10.1002/cncr.21551; Kwast A, 2014, BREAST CANCER RES TR; Kwast ABG, 2012, BREAST CANCER RES TR, V135, P271, DOI 10.1007/s10549-012-2160-z; Li HR, 2013, ACTA PHARMACOL SIN, V34, P870, DOI 10.1038/aps.2013.35; Livi L, 2012, CANCER-AM CANCER SOC, V118, P3236, DOI 10.1002/cncr.26647; Lu WL, 2009, BREAST CANCER RES TR, V114, P403, DOI 10.1007/s10549-008-0023-4; Min SY, 2011, INT J RADIAT ONCOL, V81, pE697, DOI 10.1016/j.ijrobp.2010.10.014; Nederlandse Kankerregistratie, 2013, CODEERHANDLEIDING NE; Neri A, 2007, WORLD J SURG, V31, P36, DOI 10.1007/s00268-006-0097-2; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Panet-Raymond V, 2011, INT J RADIAT ONCOL, V81, P409, DOI 10.1016/j.ijrobp.2010.05.063; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Tanis E, 2012, EUR J CANCER, V48, P1751, DOI 10.1016/j.ejca.2012.02.051; van der Sangen MJC, 2006, EJSO-EUR J SURG ONC, V32, P34, DOI 10.1016/j.ejso.2005.10.005; van Laar C, 2013, EUR J CANCER, V49, P3093, DOI 10.1016/j.ejca.2013.05.030; van Tienhoven G, 1999, EUR J CANCER, V35, P32, DOI 10.1016/S0959-8049(98)00301-3; Vichapat V, 2011, BREAST CANCER RES TR, V130, P609, DOI 10.1007/s10549-011-1618-8; Voogd AC, 2005, EUR J CANCER, V41, P2637, DOI 10.1016/j.ejca.2005.04.040; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yadav BS, 2008, RADIOTHER ONCOL, V86, P171, DOI 10.1016/j.radonc.2007.10.002	35	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120832	10.1371/journal.pone.0120832	http://dx.doi.org/10.1371/journal.pone.0120832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861031	Green Published, gold			2022-12-26	WOS:000352590300017
J	Antwerpen, MH; Prior, K; Mellmann, A; Hoppner, S; Splettstoesser, WD; Harmsen, D				Antwerpen, Markus H.; Prior, Karola; Mellmann, Alexander; Hoeppner, Sebastian; Splettstoesser, Wolf D.; Harmsen, Dag			Rapid High Resolution Genotyping of Francisella tularensis by Whole Genome Sequence Comparison of Annotated Genes ("MLST+")	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SUBSP HOLARCTICA; MULTIPLE-LOCUS; TULAREMIA; PHYLOGEOGRAPHY; REEMERGENCE; GERMANY; AGENT	The zoonotic disease tularemia is caused by the bacterium Francisella tularensis. This pathogen is considered as a category A select agent with potential to be misused in bioterrorism. Molecular typing based on DNA-sequence like canSNP-typing or MLVA has become the accepted standard for this organism. Due to the organism's highly clonal nature, the current typing methods have reached their limit of discrimination for classifying closely related sub-populations within the subspecies F. tularensis ssp. holarctica. We introduce a new gene-by- gene approach, MLST+, based on whole genome data of 15 sequenced F. tularensis ssp. holarctica strains and apply this approach to investigate an epidemic of lethal tularemia among non-human primates in two animal facilities in Germany. Due to the high resolution of MLST+ we are able to demonstrate that three independent clones of this highly infectious pathogen were responsible for these spatially and temporally restricted outbreaks.	[Antwerpen, Markus H.; Splettstoesser, Wolf D.] Bundeswehr, Inst Microbiol, D-80937 Munich, Germany; [Prior, Karola; Hoeppner, Sebastian; Harmsen, Dag] Univ Munster, Dept Periodontol, D-48149 Munster, Germany; [Mellmann, Alexander] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Splettstoesser, Wolf D.] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany	Bundeswehr Institute of Microbiology (IMB); University of Munster; University of Munster; University of Rostock	Antwerpen, MH (corresponding author), Bundeswehr, Inst Microbiol, Neuherbergstr 12, D-80937 Munich, Germany.	markusantwerpen@bundeswehr.org		Antwerpen, Markus/0000-0003-4013-8808; Mellmann, Alexander/0000-0002-0649-5185	German Ministry of Health [BMG]; Robert-Koch-Institute [FKZ 1369-372]; European Community's Seventh Framework Program [278864]	German Ministry of Health [BMG]; Robert-Koch-Institute; European Community's Seventh Framework Program(European Commission)	This work was supported in part by the German Ministry of Health [BMG] and the Robert-Koch-Institute under contract FKZ 1369-372 and by the European Community's Seventh Framework Program [grant number FP7/2007-2013 to DH] under Grant Agreement No 278864 in the framework of the EU PathoNGenTrace project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antwerpen M, 2011, EUR J CLIN MICROBIOL, V30, P923, DOI 10.1007/s10096-011-1177-2; Chanturia G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-139; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cody AJ, 2013, J CLIN MICROBIOL, V51, P2526, DOI 10.1128/JCM.00066-13; Dempsey MP, 2007, APPL ENVIRON MICROB, V73, P7465, DOI 10.1128/AEM.00646-07; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P1379, DOI 10.3201/eid1808.111826; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2001, J CLIN MICROBIOL, V39, P3140, DOI 10.1128/JCM.39.9.3140-3146.2001; Johansson A, 2010, J AOAC INT, V93, P1930; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Kaysser P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-157; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Kuroda M, 2012, J CLIN MICROBIOL, V50, P1810, DOI 10.1128/JCM.06715-11; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Matz-Rensing K, 2007, VET PATHOL, V44, P327, DOI 10.1354/vp.44-3-327; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nubel U, 2006, J BACTERIOL, V188, P5319, DOI 10.1128/JB.01662-05; Petersen JM, 2008, EMERG INFECT DIS, V14, P1928, DOI 10.3201/eid1412.080482; Pilo P, 2009, EMERG INFECT DIS, V15, P2049, DOI 10.3201/eid1512.080805; Raoult D, 2011, EUR J CLIN MICROBIOL, V30, P935, DOI 10.1007/s10096-010-1151-4; Sjodin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-268; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Splettstoesser WD, 2007, EPIDEMIOL INFECT, V135, P1256, DOI 10.1017/S0950268807008035; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vogler AJ, 2009, LETT APPL MICROBIOL, V48, P140, DOI 10.1111/j.1472-765X.2008.02484.x; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08	37	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123298	10.1371/journal.pone.0123298	http://dx.doi.org/10.1371/journal.pone.0123298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856198	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500085
J	Kwon, HJ; Xing, WM; Chan, K; Niedziela-Majka, A; Brendza, KM; Kirschberg, T; Kato, D; Link, JO; Cheng, GF; Liu, XH; Sakowicz, R				Kwon, Hyock Joo; Xing, Weimei; Chan, Katie; Niedziela-Majka, Anita; Brendza, Katherine M.; Kirschberg, Thorsten; Kato, Darryl; Link, John O.; Cheng, Guofeng; Liu, Xiaohong; Sakowicz, Roman			Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN 5A; CRYSTAL-STRUCTURE; RNA REPLICATION; INHIBITOR; DOMAIN; PHOSPHORYLATION; SOFOSBUVIR; MODES	Ledipasvir, a direct acting antiviral agent (DAA) targeting the Hepatitis C Virus NS5A protein, exhibits picomolar activity in replicon cells. While its mechanism of action is unclear, mutations that confer resistance to ledipasvir in HCV replicon cells are located in NS5A, suggesting that NS5A is the direct target of ledipasvir. To date co-precipitation and cross-linking experiments in replicon or NS5A transfected cells have not conclusively shown a direct, specific interaction between NS5A and ledipasvir. Using recombinant, full length NS5A, we show that ledipasvir binds directly, with high affinity and specificity, to NS5A. Ledipasvir binding to recombinant NS5A is saturable with a dissociation constant in the low nanomolar range. A mutant form of NS5A (Y93H) that confers resistance to ledipasvir shows diminished binding to ledipasvir. The current study shows that ledipasvir inhibits NS5A through direct binding and that resistance to ledipasvir is the result of a reduction in binding affinity to NS5A mutants.	[Kwon, Hyock Joo; Xing, Weimei; Chan, Katie; Niedziela-Majka, Anita; Brendza, Katherine M.; Kirschberg, Thorsten; Kato, Darryl; Link, John O.; Cheng, Guofeng; Liu, Xiaohong; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Kwon, HJ (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	HyockJoo.Kwon@gilead.com			Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	Gilead Sciences, Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Belda O, 2012, VIRUS RES, V170, P1, DOI 10.1016/j.virusres.2012.09.007; Bhattacharya D, 2014, J GEN VIROL, V95, P363, DOI 10.1099/vir.0.054569-0; Cheng G, 2012, J HEPATOL, V56, pS464, DOI 10.1016/S0168-8278(12)61184-2; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lee C, 2011, VIROLOGY, V414, P10, DOI 10.1016/j.virol.2011.03.026; Link JO, 2014, J MED CHEM, V57, P2033, DOI 10.1021/jm401499g; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; O'Boyle DR, 2013, VIROLOGY, V444, P343, DOI 10.1016/j.virol.2013.06.032; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Qiu DK, 2011, J GEN VIROL, V92, P2502, DOI 10.1099/vir.0.034801-0; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Wong KA, 2013, ANTIMICROB AGENTS CH, V57, P6333, DOI 10.1128/AAC.02193-12	36	31	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122844	10.1371/journal.pone.0122844	http://dx.doi.org/10.1371/journal.pone.0122844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856426	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500060
J	Rac, J; Haas, F; Schumacher, A; Middeldorp, JM; Delecluse, HJ; Speck, RF; Bernasconi, M; Nadal, D				Rac, Juergen; Haas, Florian; Schumacher, Andrina; Middeldorp, Jaap M.; Delecluse, Henri-Jacques; Speck, Roberto F.; Bernasconi, Michele; Nadal, David			Telomerase Activity Impacts on Epstein-Barr Virus Infection of AGS Cells	PLOS ONE			English	Article							NORMAL EPITHELIAL-CELLS; ORAL HAIRY LEUKOPLAKIA; MEMBRANE-PROTEIN 1; B-CELLS; NUCLEAR ANTIGEN-2; EBV INFECTION; TERMINAL DIFFERENTIATION; STABLE REPLICATION; VIRAL GENOME; LINES HNE-1	The Epstein-Barr virus (EBV) is transmitted from host-to-host via saliva and is associated with epithelial malignancies including nasopharyngeal carcinoma (NPC) and some forms of gastric carcinoma (GC). Nevertheless, EBV does not transform epithelial cells in vitro where it is rapidly lost from infected primary epithelial cells or epithelial tumor cells. Longterm infection by EBV, however, can be established in hTERT-immortalized nasopharyngeal epithelial cells. Here, we hypothesized that increased telomerase activity in epithelial cells enhances their susceptibility to infection by EBV. Using HONE-1, AGS and HEK293 cells we generated epithelial model cell lines with increased or suppressed telomerase activity by stable ectopic expression of hTERT or of a catalytically inactive, dominant negative hTERT mutant. Infection experiments with recombinant prototypic EBV (rB95.8), recombinant NPC EBV (rM81) with increased epithelial cell tropism compared to B95.8, or recombinant B95.8 EBV with BZLF1-knockout that is not able to undergo lytic replication, revealed that infection frequencies positively correlate with telomerase activity in AGS cells but also partly depend on the cellular background. AGS cells with increased telomerase activity showed increased expression mainly of latent EBV genes, suggesting that increased telomerase activity directly acts on the EBV infection of epithelial cells by facilitating latent EBV gene expression early upon virus inoculation. Thus, our results indicate that infection of epithelial cells by EBV is a very selective process involving, among others, telomerase activity and cellular background to allow for optimized host-to-host transmission via saliva.	[Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Expt Infect Dis & Canc Res, Zurich, Switzerland; [Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Div Infect Dis, Zurich, Switzerland; [Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland; [Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Amsterdam, Netherlands; [Delecluse, Henri-Jacques] German Canc Res Ctr, Div Pathogenesis Virus Associated Tumors, Heidelberg, Germany; [Speck, Roberto F.] Univ Zurich, Univ Zurich Hosp, Dept Med, Div Infect Dis, Zurich, Switzerland; [Speck, Roberto F.] Univ Zurich, Univ Zurich Hosp, Dept Med, Hosp Epidemiol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Expt Infect Dis & Canc Res, Zurich, Switzerland.	david.nadal@kispi.uzh.ch	Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/C-6734-2008; Speck, Roberto F/O-2433-2016; Bernasconi, Michele/CAG-2492-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Speck, Roberto/0000-0002-8453-1137; Middeldorp, Jaap Michiel/0000-0002-0765-4125; Delecluse, Henri-Jacques/0000-0002-1744-6274	Olga-Mayenfisch Foundation; Velux Foundation; Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; Hermann Klaus Foundation; Kurt and Senta Herrmann Foundation; Foundation for Scientific Research of the University of Zurich	Olga-Mayenfisch Foundation; Velux Foundation(Velux Fonden); Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; Hermann Klaus Foundation; Kurt and Senta Herrmann Foundation; Foundation for Scientific Research of the University of Zurich	This work was supported by Olga-Mayenfisch Foundation (RS), Velux Foundation (veluxstiftung. ch, DN), Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation (DN), Hermann Klaus Foundation (DN), Kurt and Senta Herrmann Foundation (DN) and the Foundation for Scientific Research of the University of Zurich (DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; BARRANCO SC, 1983, CANCER RES, V43, P1703; Bernasconi M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-43; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Buettner M, 2012, J GEN VIROL, V93, P1059, DOI 10.1099/vir.0.038661-0; Crowe DL, 2005, INT J ONCOL, V27, P847; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; Dirmeier U, 2003, CANCER RES, V63, P2982; Dorner M, 2008, J VIROL, V82, P4400, DOI 10.1128/JVI.02630-07; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Feederle R, 2007, INT J CANCER, V121, P588, DOI 10.1002/ijc.22727; Feller LL, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-31; Frangou P, 2005, J INFECT DIS, V191, P238, DOI 10.1086/426823; Fukayama M, 2011, PATHOL RES PRACT, V207, P529, DOI 10.1016/j.prp.2011.07.004; Giunco S, 2013, CLIN CANCER RES, V19, P2036, DOI 10.1158/1078-0432.CCR-12-2537; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrmann K, 2002, J GEN VIROL, V83, P2995, DOI 10.1099/0022-1317-83-12-2995; Hoebe EK, 2012, J VIROL, V86, P11322, DOI 10.1128/JVI.01161-12; Hoebe EK, 2013, REV MED VIROL, V23, P367, DOI 10.1002/rmv.1758; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Hutt-Fletcher LM, 2014, P NATL ACAD SCI USA, V111, P16242, DOI 10.1073/pnas.1418974111; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Ishii Hiroshi, 2007, NEPALIS INSIDE OUTSI, V1, P1, DOI DOI 10.1002/JMV.20853; Iskra S, 2010, J VIROL, V84, P3612, DOI 10.1128/JVI.01400-09; Jeon JP, 2009, MOL CELLS, V27, P143, DOI 10.1007/s10059-009-0018-y; Jochum S, 2012, P NATL ACAD SCI USA, V109, pE1396, DOI 10.1073/pnas.1115906109; Kataoka H, 1997, DIFFERENTIATION, V62, P203; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kumar SKS, 2005, J EXP CLIN CANC RES, V24, P639; Ladell K, 2007, CELL MICROBIOL, V9, P2055, DOI 10.1111/j.1462-5822.2007.00937.x; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lee KH, 2008, PATHOBIOLOGY, V75, P364, DOI 10.1159/000164221; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mei YP, 2006, CANCER LETT, V232, P189, DOI 10.1016/j.canlet.2005.02.010; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; NIEDERMAN JC, 1976, NEW ENGL J MED, V294, P1355, DOI 10.1056/NEJM197606172942501; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P37, DOI 10.1136/mp.53.1.37; NIEDOBITEK G, 1991, J GEN VIROL, V72, P3035, DOI 10.1099/0022-1317-72-12-3035; O'Flatharta C, 2002, J CLIN PATHOL, V55, P602, DOI 10.1136/jcp.55.8.602; Patel V, 2012, ADV EXP MED BIOL, V720, P27, DOI 10.1007/978-1-4614-0254-1_3; Pegtel DM, 2004, J VIROL, V78, P12613, DOI 10.1128/JVI.78.22.12613-12624.2004; Port RJ, 2013, J PATHOL, V231, P367, DOI 10.1002/path.4245; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Shannon-Lowe C, 2009, J VIROL, V83, P7749, DOI 10.1128/JVI.00108-09; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; SUNG NS, 1991, J VIROL, V65, P2164, DOI 10.1128/JVI.65.5.2164-2169.1991; Temple RM, 2014, P NATL ACAD SCI USA, V111, P16544, DOI 10.1073/pnas.1400818111; Terrin L, 2008, J VIROL, V82, P10175, DOI 10.1128/JVI.00321-08; Terrin L, 2007, INT J CANCER, V121, P576, DOI 10.1002/ijc.22661; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Walling DM, 2003, J INFECT DIS, V188, P883, DOI 10.1086/378072; Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992; Wiech T, 2008, VIRCHOWS ARCH, V452, P621, DOI 10.1007/s00428-008-0594-9; WOISETSCHLAEGER M, 1991, P NATL ACAD SCI USA, V88, P3942, DOI 10.1073/pnas.88.9.3942; Wu HC, 2003, LAB INVEST, V83, P797, DOI 10.1097/01.LAB.0000074896.03561.FB; Xiao JQ, 2007, VIROLOGY, V359, P382, DOI 10.1016/j.virol.2006.09.047; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116; Yasumoto S, 1996, ONCOGENE, V13, P433; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yip YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078395; Yoshizaki T, 2013, CANCER LETT, V337, P1, DOI 10.1016/j.canlet.2013.05.018; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991; ZIMBERSTROBL U, 1991, J VIROL, V65, P415, DOI 10.1128/JVI.65.1.415-423.1991; ZIMBERSTROBL U, 1993, EMBO J, V12, P167, DOI 10.1002/j.1460-2075.1993.tb05642.x; zur Hausen A, 2004, J CLIN PATHOL, V57, P487, DOI 10.1136/jcp.2003.014068	85	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123645	10.1371/journal.pone.0123645	http://dx.doi.org/10.1371/journal.pone.0123645			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856387	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352588500101
J	Trong, TT; Riera, F; Rinaldi, K; Briki, W; Hue, O				Than Tran Trong; Riera, Florence; Rinaldi, Kevin; Briki, Walid; Hue, Olivier			Ingestion of a Cold Temperature/Menthol Beverage Increases Outdoor Exercise Performance in a Hot, Humid Environment	PLOS ONE			English	Article							CYCLING TIME-TRIAL; ICE SLURRY INGESTION; CORE TEMPERATURE; THERMOREGULATORY RESPONSES; RUNNING PERFORMANCE; BODY-TEMPERATURE; HEAT-STORAGE; CAPACITY; WARM	Purpose A recent laboratory study demonstrated that the ingestion of a cold/menthol beverage improved exercise performance in a hot and humid environment during 20 km of all-out cycling. Therefore, the aim of this study was to determine whether the ingestion of cold water/ice-slurry with menthol would improve performance in hot and humid outdoor conditions. Methods Ten trained males completed three trials of five blocks consisting of 4-km cycling and 1.5-km running. During warm-up, every block and recovery, the athletes drank 190 ml of aromatized (i.e., with 0.05 mL of menthol) beverage at three temperatures: Neutral (ambient temperature) (28.7 degrees C +/- 0.5 degrees C), Cold (3.1 degrees C +/- 0.6 degrees C) or Ice-slurry (0.17 degrees C +/- 0.07 degrees C). Trial time,core temperature (T-co), heart rate (HR), rate of perceived exertion (RPE), thermal sensation (TS) and thermal comfort (TC) were assessed. Results Ice-slurry/menthol increased performance by 6.2% and 3.3% compared with neutral water/menthol and cold water/menthol, respectively. No between-trial differences were noted for Tco, HR, RPE, TC and TS was lower with ice-slurry/menthol and cold water/menthol compared with neutral water/menthol. Conclusion A low drink temperature combined with menthol lessens the performance decline in hot/humid outdoor conditions (i.e., compared with cold water alone). Performances were better with no difference in psycho-physiological stress (Tco, HR and RPE) between trials. The changes in perceptual parameters caused by absorbing a cold/menthol beverage reflect the psychological impact. The mechanism leading to these results seems to involve brain integration of signals from physiological and psychological sources.	[Than Tran Trong; Riera, Florence; Rinaldi, Kevin; Briki, Walid; Hue, Olivier] Univ Antilles Guyane, Lab ACTES EA 3596, Point A Pitre, France		Riera, F (corresponding author), Univ Antilles Guyane, Lab ACTES EA 3596, Campus Fouillole, Point A Pitre, France.	florence.riera@gmail.com	Riera, Florence/AAG-5588-2020	Riera, Florence/0000-0002-3778-7295; Hue, Olivier/0000-0002-2155-0816; Briki, Walid/0000-0002-6298-811X				Barwood MJ, 2012, BRIT J SPORT MED, V46, P936, DOI 10.1136/bjsports-2011-090536; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Briki W, 2014, PSYCHOL SPORT EXERC, V15, P216, DOI 10.1016/j.psychsport.2013.11.006; Brotherhood JR, 2008, J SCI MED SPORT, V11, P6, DOI 10.1016/j.jsams.2007.08.017; Burdon C, 2010, J SPORT SCI, V28, P1147, DOI 10.1080/02640414.2010.489197; Burdon CA, 2013, INT J SPORT NUTR EXE, V23, P458, DOI 10.1123/ijsnem.23.5.458; Castle PC, 2012, EUR J APPL PHYSIOL, V112, P377, DOI 10.1007/s00421-011-1988-y; Cheung SS, 2007, PROG BRAIN RES, V162, P45, DOI 10.1016/S0079-6123(06)62004-9; Dugas JP, 2010, INT J SPORT PHYSIOL, V5, P559, DOI 10.1123/ijspp.5.4.559; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; GREEN BG, 1985, PERCEPT PSYCHOPHYS, V38, P110, DOI 10.3758/BF03198847; Guest S, 2007, PHYSIOL BEHAV, V92, P975, DOI 10.1016/j.physbeh.2007.07.004; Hodder SG, 2007, INT J BIOMETEOROL, V51, P233, DOI 10.1007/s00484-006-0050-y; Hue O, 2012, J SPORT SCI MED, V11, P156; Hue O, 2011, INT J SPORT PHYSIOL, V6, P443, DOI 10.1123/ijspp.6.4.443; Ihsan M, 2010, INT J SPORT PHYSIOL, V5, P140, DOI 10.1123/ijspp.5.2.140; Lee JKW, 2008, MED SCI SPORT EXER, V40, P1637, DOI 10.1249/MSS.0b013e318178465d; Lee JKW, 2008, J SPORT SCI, V26, P583, DOI 10.1080/02640410701697388; Levels K, 2013, INT J SPORT PHYSIOL, V8, P307, DOI 10.1123/ijspp.8.3.307; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Mundel T, 2010, EUR J APPL PHYSIOL, V109, P59, DOI 10.1007/s00421-009-1180-9; Periard JD, 2011, EUR J APPL PHYSIOL, V111, P1561, DOI 10.1007/s00421-010-1781-3; Pryor RR, 2014, PREHOSPITAL EMERGENC; Riera F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103718; Ross MLR, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-55; Saunders AG, 2005, ACTA PHYSIOL SCAND, V183, P241, DOI 10.1111/j.1365-201X.2004.01400.x; Siegel R, 2010, MED SCI SPORT EXER, V42, P717, DOI 10.1249/MSS.0b013e3181bf257a; Stanley J, 2010, EUR J APPL PHYSIOL, V110, P1163, DOI 10.1007/s00421-010-1607-3; Stevens CJ, 2013, J SPORT SCI, V31, P1271, DOI 10.1080/02640414.2013.779740; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Tyler CJ, 2010, EUR J APPL PHYSIOL, V110, P1063, DOI 10.1007/s00421-010-1567-7; Voltaire B, 2003, J SPORT MED PHYS FIT, V43, P306; Voltaire B, 2002, CAN J APPL PHYSIOL, V27, P551, DOI 10.1139/h02-031; Yeo ZW, 2012, INT J SPORTS MED, V33, P859, DOI 10.1055/s-0032-1304643	34	27	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123815	10.1371/journal.pone.0123815	http://dx.doi.org/10.1371/journal.pone.0123815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856401	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500107
J	Wee, YS; Weis, JJ; Gahring, LC; Rogers, SW; Weis, JH				Wee, Yin Shen; Weis, Janis J.; Gahring, Lorise C.; Rogers, Scott W.; Weis, John H.			Age-Related Onset of Obesity Corresponds with Metabolic Dysregulation and Altered Microglia Morphology in Mice Deficient for Ifitm Proteins	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR EXPRESSION; INDUCED TRANSMEMBRANE PROTEIN-3; WEST NILE VIRUS; INSULIN-RESISTANCE; GENE-EXPRESSION; NEUROPEPTIDE-Y; BLOOD-GLUCOSE; LEPTIN ACTION; SENSITIVITY; REVEALS	The IfitmDel mouse lacks all five of the Ifitm genes via LoxP deletion. This animal breeds normally with no obvious defect in development. The IfitmDel animals exhibit a steady and significantly enhanced weight gain relative to wild-type controls beginning about three months of age and under normal feeding conditions. The increased weight corresponds with elevated fat mass, and in tolerance tests they are hyporesponsive to insulin but respond normally to glucose. Both young (4 mo) and older (12 mo) IfitmDel mice have enhanced levels of serum leptin suggesting a defect in leptin/ leptin receptor signaling. Analysis of the gene expression profiles in the hypothalamus of IfitmDel animals, compared to WT, demonstrated an altered ratio of Pomc and Npy neuropeptide expression, which likely impairs the satiation response of the IfitmDel animal leading to an increased eating behavior. Also elevated in hypothalamus of IfitmDel mice were pro-inflammatory cytokine expression and reduced IL-10. Anatomical analysis of the hypothalamus using immunohistochemistry revealed that microglia exhibit an abnormal morphology in IfitmDel animals and respond abnormally to Poly: IC challenge. These abnormalities extend the phenotype of the IfitmDel mouse beyond abnormal responses to viral challenge to include a metabolic phenotype and weight gain. Further, this novel phenotype for the IfitmDel mouse could be related to abnormal neuropeptide production, inflammatory status and microglia status in the hypothalamus.	[Wee, Yin Shen; Weis, Janis J.; Weis, John H.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Gahring, Lorise C.; Rogers, Scott W.] Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA; [Gahring, Lorise C.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA; [Rogers, Scott W.] Dept Neurobiol & Anat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Weis, JH (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.	john.weis@path.utah.edu			National Institutes of Health [AI32773, AI45521, DA025057]; VA Merit grant [I01BX001798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI045521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health grants AI32773 (JHW) and AI45521 (JJW), DA025057 (LCG, SWR) and a VA Merit grant I01BX001798 (LCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff Irina, 2000, Journal of Alzheimer's Disease, V2, P37; Alver A, 2004, J ENZYM INHIB MED CH, V19, P181, DOI 10.1080/14756360310001650228; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Arion D, 2007, EUR J NEUROSCI, V25, P1843, DOI 10.1111/j.1460-9568.2007.05396.x; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bowles NE, 2014, MOL GENET GENOM MED, V2, P356, DOI 10.1002/mgg3.79; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brown CR, 2008, INFECT IMMUN, V76, P5500, DOI 10.1128/IAI.00808-08; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chan YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034508; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gahring LC, 2004, J COMP NEUROL, V468, P334, DOI 10.1002/cne.10943; Gahring LC, 2008, HIPPOCAMPUS, V18, P737, DOI 10.1002/hipo.20430; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ibi D, 2013, GLIA, V61, P679, DOI 10.1002/glia.22461; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; JAFFE EA, 1989, J IMMUNOL, V143, P3961; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Klymiuk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044609; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Rogers SW, 2008, HIPPOCAMPUS, V18, P750, DOI 10.1002/hipo.20454; Roundy K, 2003, J BONE MINER RES, V18, P278, DOI 10.1359/jbmr.2003.18.2.278; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Supuran CT, 2008, EXPERT OPIN EMERG DR, V13, P383, DOI [10.1517/14728214.13.2.383, 10.1517/14728214.13.2.383 ]; Tanaka Satomi S., 2002, Gene Expression Patterns, V2, P297, DOI 10.1016/S0925-4773(02)00384-2; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tanaka SS, DEV DYN; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	58	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123218	10.1371/journal.pone.0123218	http://dx.doi.org/10.1371/journal.pone.0123218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856311	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500079
J	Pan, BP; Ren, YP; Gao, J; Gao, H				Pan, Baoping; Ren, Yipeng; Gao, Jing; Gao, Hong			De novo RNA-Seq Analysis of the Venus Clam, Cyclina sinensis, and the Identification of Immune-Related Genes	PLOS ONE			English	Article							CDNA CLONING; EXPRESSION; DISCOVERY; PHYLOGENIES; HEMOCYTES; GENOMICS	The Venus clam, Cyclina sinensis, is one of the most important bivalves in China. In recent years, increasing expansive morbidity has occurred in breeding areas, imposing significant losses on the national economy. To understand the molecular mechanisms of immune-related genes, we analyzed and sequenced hemolymph samples that were injected with two pathogenic microorganisms using the Illumina Miseq system. After trimming, more than 12 M PE reads with an average length greater than 410 bp were assembled into 70,079 transcripts with a mean length of 980 bp. Using a homology analysis, 102 (135 transcripts) potentially immune-related genes were identified, and most of them exhibited a similar pattern in both samples. These data indicated that the response of the clam to both types of bacterial infection might follow a similar molecular mechanism. Using the TreeFam method, 9,904 gene families and 1,031 unique families of the clam were preliminarily classified in comparison to five related species. A significant number of SSRs were identified, which could facilitate the identification of polymorphisms in Venus clam populations. These data-sets will improve our knowledge of the molecular mechanisms driving the immune response to bacterial infection in clam populations and will provide basic data about clam breeding and disease control.	[Pan, Baoping; Ren, Yipeng; Gao, Jing; Gao, Hong] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China	Tianjin Normal University	Pan, BP (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China.	baopingpan@126.com		Ren, Yipeng/0000-0001-8890-022X	Applied Basic Research Programs of the Science and Technology Commission Foundation of Tianjin P.R. China [12JCZDJC22800, 09JCZDJC19300, 14JCZDJC34200]	Applied Basic Research Programs of the Science and Technology Commission Foundation of Tianjin P.R. China	This work was supported by the Applied Basic Research Programs of the Science and Technology Commission Foundation of Tianjin P.R. China (Key program 12JCZDJC22800, 09JCZDJC19300 and 14JCZDJC34200), http://www.tstc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Benjamini Y, 2001, ANN STAT, V29, P1165; Cao H, 2004, SCI FISH FARMING, V6, P403; Carroll RL, 1997, PATTERNS PROCESSES V; Castoe TA, 2009, CYTOGENET GENOME RES, V127, P112, DOI 10.1159/000295342; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; [戈蕾 GE Lei], 2007, [微生物学通报, Microbiology], V34, P584; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Liang Y.B., 2000, MARINE ENV SCI, V19, P5, DOI 10.3969/j.issn.1007-6336.2000.01.002; Liu Ke-jun, 2011, Sichuan Journal of Zoology, V30, P802; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Bao-Ping, 2010, Oceanologia et Limnologia Sinica, V41, P901; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Song LS, 2006, DEV COMP IMMUNOL, V30, P265, DOI 10.1016/j.dci.2005.04.001; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HB, 2012, J HYDROECOLOGY, V3, P330; Wang HZ, 1991, ZHEJINAG FAUNA; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang RC, 1993, SHELLFISH AQUACULTUR, P208; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang YP, 2014, PLOS ONE, V9, DOI [10.5339/gcsp.2014.19, DOI 10.5339/GCSP.2014.19]; Zhu L, 2008, FISH SHELLFISH IMMUN, V25, P231, DOI 10.1016/j.fsi.2008.05.004	38	14	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123296	10.1371/journal.pone.0123296	http://dx.doi.org/10.1371/journal.pone.0123296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853714	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400099
J	Price, BW; Henry, CS; Hall, AC; Mochizuki, A; Duelli, P; Brooks, SJ				Price, Ben W.; Henry, Charles S.; Hall, Andie C.; Mochizuki, Atsushi; Duelli, Peter; Brooks, Stephen J.			Singing from the Grave: DNA from a 180 Year Old Type Specimen Confirms the Identity of Chrysoperla carnea (Stephens)	PLOS ONE			English	Article							COMMON GREEN LACEWINGS; NEUROPTERA CHRYSOPIDAE; MUSEUM SPECIMENS; EVOLUTION; BARCODES	Historically serving as repositories for morphologically-based taxonomic research, natural history collections are now increasingly being targeted in studies utilizing DNA data. The development of advanced molecular techniques has facilitated extraction of useable DNA from old specimens, including type material. Sequencing diagnostic molecular markers from type material enables accurate species designation, especially where modern taxonomic hypotheses confirm morphologically cryptic species complexes. One such example is Chrysoperla carnea (Stephens), which belongs to a complex of about 20 cryptic species, most of which can only be reliably distinguished by their pre-mating courtship songs or by DNA analysis. The subtle morphological variation in the group has led to disagreement over the previous designation of the lectotype for C. carnea, an issue that has been further compounded because Chrysoperla carnea is a highly valued biological control agent in arable crops. Archival DNA extraction and sequencing from the 180 year old lectotype specimen, combined with Bayesian and Likelihood based phylogenetic analyses of modern specimens from the entire complex, were used to establish unambiguously the true identity of Chrysoperla carnea.	[Price, Ben W.; Brooks, Stephen J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Henry, Charles S.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Hall, Andie C.] Nat Hist Museum, Core Res Labs, London SW7 5BD, England; [Mochizuki, Atsushi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Duelli, Peter] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland	Natural History Museum London; University of Connecticut; Natural History Museum London; National Institute for Agro-Environmental Sciences (NIAES) Japan; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Henry, CS (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	charles.henry@uconn.edu	Price, Benjamin/Y-5971-2019	Price, Benjamin/0000-0001-5497-4087; Duelli, Peter/0000-0001-8862-8262; Hall, Andie/0000-0001-5546-7255	Natural History Museum Life Sciences Departmental Investment Fund [SDF13002]	Natural History Museum Life Sciences Departmental Investment Fund	Funding for the molecular analyses was provided through the Natural History Museum Life Sciences Departmental Investment Fund (SDF13002) to BWP and SJB.	Andersen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045549; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bluemel JK, 2011, MOL ECOL RESOUR, V11, P770, DOI 10.1111/j.1755-0998.2011.03008.x; Brooks S.J., 1994, Bulletin of the Natural History Museum Entomology Series, V63, P137; Canard Michel, 2007, Annali del Museo Civico di Storia Naturale di Ferrara, V8, P173; Duelli P, 2014, ANN ENTOMOL SOC AM, V107, P382, DOI 10.1603/AN13139; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Han T, 2014, J ASIA-PAC ENTOMOL, V17, P679, DOI 10.1016/j.aspen.2014.06.007; Haruyama N, 2008, ANN ENTOMOL SOC AM, V101, P971, DOI 10.1603/0013-8746-101.6.971; Hausmann A, 2011, SPIXIANA, V34, P47; Heintzman PD, 2014, MOL ECOL RESOUR, V14, P606, DOI 10.1111/1755-0998.12205; Henry C.S., 2001, P29, DOI 10.1017/CBO9780511666117.004; Henry CS, 2014, SYST ENTOMOL, V39, P380, DOI 10.1111/syen.12061; Henry CS, 2013, BIOL REV, V88, P787, DOI 10.1111/brv.12027; Henry CS, 2012, BIOL J LINN SOC, V105, P776, DOI 10.1111/j.1095-8312.2011.01845.x; Henry CS, 1996, SYST ENTOMOL, V21, P205, DOI 10.1046/j.1365-3113.1996.d01-11.x; Henry CS, 2002, ANN ENTOMOL SOC AM, V95, P172, DOI 10.1603/0013-8746(2002)095[0172:DTTCCI]2.0.CO;2; Hernandez-Triana LM, 2014, MOL ECOL RESOUR, V14, P508, DOI 10.1111/1755-0998.12208; Kirchman JJ, 2010, BIOL LETTERS, V6, P112, DOI 10.1098/rsbl.2009.0545; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leraut P., 1991, Entomologica Gallica, V2, P75; Miller MA, 2012, 1 C EXTR SCI ENG DIS; Moriniere J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109719; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sonet G, 2011, BONN ZOOL MONOGR, P117; STEPHENS J. F, 1835, ILLUSTRATIONS BRIT E, V6; Strutzenberger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049710; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thierry Dominique, 2013, Acoreana, P73; Thierry D, 2011, BIOL J LINN SOC, V102, P292, DOI 10.1111/j.1095-8312.2010.01569.x; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Wells MM, 1998, ENDLESS FORMS, P217; Zwickl D. J, 2006, GENETIC ALGORITHM AP	35	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121127	10.1371/journal.pone.0121127	http://dx.doi.org/10.1371/journal.pone.0121127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853856	Green Published, gold			2022-12-26	WOS:000352478400029
J	Ding, ZJ; Chen, X; Tang, XX; Wang, X; Song, YL; Chen, XD; Mi, WJ; Wang, J; Lin, Y; Chen, FQ; Qiu, JH				Ding, Zhong-Jia; Chen, Xin; Tang, Xiao-Xu; Wang, Xi; Song, Yong-Li; Chen, Xiao-Dong; Mi, Wen-Juan; Wang, Jian; Lin, Ying; Chen, Fu-Quan; Qiu, Jian-Hua			Calpain Inhibitor PD150606 Attenuates Glutamate Induced Spiral Ganglion Neuron Apoptosis through Apoptosis Inducing Factor Pathway In Vitro	PLOS ONE			English	Article							HAIR CELL-DEATH; FACTOR AIF; SENSORY CELLS; ACTIVATION; TRANSLOCATION; MITOCHONDRIA; RELEASE; CA2+	Objective This research aimed to investigate whether glutamate induced spiral ganglion neurons (SGNs) apoptosis through apoptosis inducing factor (AIF) pathway. And verify whether PD150606, a calpain inhibitor could prevent apoptosis by inhibiting cleaving and releasing AIF in mitochondrion. Methods SGNs of postnatal days 0-3 were harvested and cultured in dishes. 20 mM Glu, the caspase inhibitor Z-VAD-FMK and calpain inhibitor PD150606 were added into cultured dishes separately. We used optical microscope and immunofluoresence staining to observe cell morphology and AIF distribution, RT-PCR and Westernblot to analyse AIF and calpain expression in SGNs. TUNEL assay was used to test cell apoptosis. Results Cell morphology and nuclear translocation of AIF were altered in SGNs by 20 mM Glu treated in vitro. The axon of SGN shortened, more apoptosis SGN were observed and the expression of AIF and calpain were up-regulated in Glu-treated group than the normal one (P<0.05). The same experiments were conducted in 20 mM+PD150606 treated group and 20 mM+Z-VAD-FMK group. Obviously AIF were located from cytoplasm to the nuclear and the expressions of AIF and calpain were down-regulated by PD150606 (P<0.05). Positive cells in TUNEL staining decreased after PD150606 treating. However, Z-VAD-FMK had no influence on AIF, calpain expression or cell apoptosis. Conclusion The AIF-related apoptosis pathway is involved in the process of Glu-induced SGN injury. Furthermore, the inhibition of calpain can prevent AIF from releasing the nuclear or inducing SGN apoptosis.	[Ding, Zhong-Jia; Chen, Xin; Wang, Xi; Song, Yong-Li; Chen, Xiao-Dong; Mi, Wen-Juan; Wang, Jian; Lin, Ying; Chen, Fu-Quan; Qiu, Jian-Hua] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China; [Tang, Xiao-Xu] Logist Acad, Outpatient Dept, Beijing, Peoples R China	Air Force Military Medical University	Chen, FQ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China.	Chenfq2@yahoo.com; qiujh@fmmu.edu.cn	chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; Chen, Fuquan/AAL-2322-2021	Chen, Fuquan/0000-0002-4625-073X	Major State Basic Research Development Program of China [2011CB504505]; National Natural Science Foundation of China [81120108008, 30930098, 81100715, 81271069]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Major State Basic Research Development Program of China No. 2011CB504505 and National Natural Science Foundation of China Nos. 81120108008, 30930098, 81100715 and 81271069 provided support to design the research, purchase reagents, and help publish the manuscript.	Chen Hao, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P329; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Han WJ, 2006, HEARING RES, V211, P85, DOI 10.1016/j.heares.2005.10.004; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Kwon CH, 2009, TOXICOLOGY, V257, P1, DOI 10.1016/j.tox.2008.11.019; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Liu WW, 2012, NEUROL RES, V34, P915, DOI 10.1179/1743132812Y.0000000098; Lu HT, 2010, ACTA OTO-LARYNGOL, V130, P1316, DOI 10.3109/00016489.2010.495133; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Steiger-Barraissoul S, 2009, APOPTOSIS, V14, P1274, DOI 10.1007/s10495-009-0396-9; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang DG, 2012, ORL-J OTO-RHIN-LARYN, V74, P1, DOI 10.1159/000333251; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49	19	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123130	10.1371/journal.pone.0123130	http://dx.doi.org/10.1371/journal.pone.0123130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874633	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800086
J	Underwood, CJ; Johanson, Z; Welten, M; Metscher, B; Rasch, LJ; Fraser, GJ; Smith, MM				Underwood, Charlie J.; Johanson, Zerina; Welten, Monique; Metscher, Brian; Rasch, Liam J.; Fraser, Gareth J.; Smith, Moya Meredith			Development and Evolution of Dentition Pattern and Tooth Order in the Skates And Rays (Batoidea; Chondrichthyes)	PLOS ONE			English	Article							PHYLOGENY; JAWS	Shark and ray (elasmobranch) dentitions are well known for their multiple generations of teeth, with isolated teeth being common in the fossil record. However, how the diverse dentitions characteristic of elasmobranchs form is still poorly understood. Data on the development and maintenance of the dental patterning in this major vertebrate group will allow comparisons to other morphologically diverse taxa, including the bony fishes, in order to identify shared pattern characters for the vertebrate dentition as a whole. Data is especially lacking from the Batoidea (skates and rays), hence our objective is to compile data on embryonic and adult batoid tooth development contributing to ordering of the dentition, from cleared and stained specimens and micro-CT scans, with 3D rendered models. We selected species (adult and embryonic) spanning phylogenetically significant batoid clades, such that our observations may raise questions about relationships within the batoids, particularly with respect to current molecular-based analyses. We include developmental data from embryos of recent model organisms Leucoraja erinacea and Raja clavata to evaluate the earliest establishment of the dentition. Characters of the batoid dentition investigated include alternate addition of teeth as offset successional tooth rows (versus single separate files), presence of a symphyseal initiator region (symphyseal tooth present, or absent, but with two parasymphyseal teeth) and a restriction to tooth addition along each jaw reducing the number of tooth families, relative to addition of successor teeth within each family. Our ultimate aim is to understand the shared characters of the batoids, and whether or not these dental characters are shared more broadly within elasmobranchs, by comparing these to dentitions in shark outgroups. These developmental morphological analyses will provide a solid basis to better understand dental evolution in these important vertebrate groups as well as the general plesiomorphic vertebrate dental condition.	[Underwood, Charlie J.] Univ London, Dept Earth & Planetary Sci, London WC1E 7HX, England; [Johanson, Zerina; Welten, Monique; Smith, Moya Meredith] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Rasch, Liam J.; Fraser, Gareth J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Smith, Moya Meredith] Kings Coll London, Inst Dent, Craniofacial Dev, London SE1 9RT, England; [Metscher, Brian] Univ Vienna, Dept Theoret Biol, A-1090 Vienna, Austria	University of London; Natural History Museum London; University of Sheffield; University of London; King's College London; University of Vienna	Underwood, CJ (corresponding author), Univ London, Dept Earth & Planetary Sci, Malet St, London WC1E 7HX, England.	c.underwood@bbk.ac.uk	Metscher, Brian/I-1238-2019; Welten, Monique/ABC-2988-2020; Fraser, Gareth/I-3457-2019	Metscher, Brian/0000-0002-6514-4406; Fraser, Gareth/0000-0002-7376-0962; Welten, Monique/0000-0001-8675-5700; Johanson, Zerina/0000-0002-8444-6776; Meredith Smith, Moya/0000-0002-3397-873X	Natural Environmental Research Council [NE/K01434X1, NE/K014595/1, NE/K0122071/1]; Natural Environment Research Council [NE/K01434X/1, NE/K014595/1, NE/K014293/1] Funding Source: researchfish; NERC [NE/K014595/1, NE/K01434X/1, NE/K014293/1] Funding Source: UKRI	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Natural Environmental Research Council; NE/K01434X1 (ZJ); NE/K014595/1 (GJF); NE/K0122071/1 (MMS) www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschliman NC, 2012, MOL PHYLOGENET EVOL, V63, P28, DOI 10.1016/j.ympev.2011.12.012; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Capetta H, 2012, HDB PALEOICHTHYOLOGY, V3E, P1; Geniz JLC, 2007, ZOOTAXA, P1; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; Fraser GJ, 2013, DEV BIOL, V377, P399, DOI 10.1016/j.ydbio.2013.02.007; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Kajiura SM, 1996, J EXP BIOL, V199, P2297; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; McEachran JD, 2004, CRC MAR BIOL SER, P79; McEachran John D., 1996, P63, DOI 10.1016/B978-012670950-6/50005-9; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Naylor Gavin J.P., 2005, P1; Owen R, 1840, ODONTOGRAPHY, P1; Pavan-Kumar A, 2014, MOL BIOL REP, V41, P447, DOI 10.1007/s11033-013-2879-6; Peyer B., 1968, COMP ODONTOLOGY, P1; Reif W.-E., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V157, P107; REIF WE, 1982, EVOL BIOL, V15, P287; Rocco L, 2007, GENE, V389, P80, DOI 10.1016/j.gene.2006.09.024; Shirai Shigeru, 1996, P9, DOI 10.1016/B978-012670950-6/50003-5; Smith BG, 1937, ARCHAIC FISHES, P333; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; Smith MM, 2009, P ROY SOC B-BIOL SCI, V276, P1225, DOI 10.1098/rspb.2008.1526; Smith MM, 2013, HIST BIOL, V25, P127, DOI 10.1080/08912963.2012.662228; TAYLOR W R, 1985, Cybium, V9, P107; Underwood CJ, 2004, PALAEONTOLOGY, V47, P447, DOI 10.1111/j.0031-0239.2004.00386.x; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617	30	43	44	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122553	10.1371/journal.pone.0122553	http://dx.doi.org/10.1371/journal.pone.0122553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874547	Green Accepted, Green Published, gold			2022-12-26	WOS:000353015800064
J	Guo, SX; Jin, YY; Fang, Q; You, CG; Wang, XG; Hu, XL; Han, CM				Guo, Song Xue; Jin, Yun Yun; Fang, Quan; You, Chuan Gang; Wang, Xin Gang; Hu, Xin Lei; Han, Chun-Mao			Beneficial Effects of Hydrogen-Rich Saline on Early Burn-Wound Progression in Rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; DUAL ROLES; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSE; MOLECULAR-HYDROGEN; AUTOPHAGY; APOPTOSIS; PROTECTS; SKIN	Introduction Deep burn wounds undergo a dynamic process known as wound progression that results in a deepening and extension of the initial burn area. The zone of stasis is more likely to develop more severe during wound progression in the presence of hypoperfusion. Hydrogen has been reported to alleviate injury triggered by ischaemia/reperfusion and burns in various organs by selectively quenching oxygen free radicals. The aim of this study was to investigate the possible protective effects of hydrogen against early burn-wound progression. Methods Deep-burn models were established through contact with a boiled, rectangular, brass comb for 20 s. Fifty-six Sprague-Dawley rats were randomly divided into sham, burn plus saline, and burn plus hydrogen-rich saline (HS) groups with sacrifice and analysis at various time windows (6 h, 24 h, 48 h) post burn. Indexes of oxidative stress, apoptosis and autophagy were measured in each group. The zone of stasis was evaluated using immunofluorescence staining, ELISA, and Western blot to explore the underlying effects and mechanisms post burn. Results The burn-induced increase in malondialdehyde was markedly reduced with HS, while the activities of endogenous antioxidant enzymes were significantly increased. Moreover, HS treatment attenuated increases in apoptosis and autophagy postburn in wounds, according to the TUNEL staining results and the expression analysis of Bax, Bcl-2, caspase-3, Beclin-1 and Atg-5 proteins. Additionally, HS lowered the level of myeloperoxidase and expression of TNF-alpha, IL-1 beta, and IL-6 in the zone of stasis while augmenting IL-10. The elevated levels of Akt phosphorylation and NF-kappa B p65 expression post burn were also downregulated by HS management. Conclusion Hydrogen can attenuate early wound progression following deep burn injury. The beneficial effect of hydrogen was mediated by attenuating oxidative stress, which inhibited apoptosis and inflammation, and the Akt/NF-kappa B signalling pathway may be involved in regulating the release of inflammatory cytokines.	[Guo, Song Xue; Jin, Yun Yun; You, Chuan Gang; Wang, Xin Gang; Han, Chun-Mao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Burns, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Quan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast Surg,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xin Lei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Han, CM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Burns, Hangzhou 310003, Zhejiang, Peoples R China.	hanchunmao1@163.com	jin, yun/GQZ-6618-2022					Al-Jawad F H, 2008, Ann Burns Fire Disasters, V21, P186; Arturson G, 1996, BURNS, V22, P255, DOI 10.1016/0305-4179(95)00153-0; Aw TY, 2012, SEMIN CELL DEV BIOL, V23, P721, DOI 10.1016/j.semcdb.2012.08.002; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Dalboni MA, 2013, CLIN EXP IMMUNOL, V173, P242, DOI 10.1111/cei.12100; Eckermann JM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-7; Eski M, 2012, BURNS, V38, P283, DOI 10.1016/j.burns.2011.08.008; Fang Y, 2011, J BURN CARE RES, V32, pE82, DOI 10.1097/BCR.0b013e318217f84f; Feng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054593; Gauglitz GG, 2008, SHOCK, V30, P503, DOI 10.1097/SHK.0b013e31816e3373; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Giles N, 2008, WOUND REPAIR REGEN, V16, P58, DOI 10.1111/j.1524-475X.2007.00331.x; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gravante G, 2007, J SURG RES, V141, P141, DOI 10.1016/j.jss.2006.07.031; Guo Z, 2012, J BIOMED RES, V26, P365, DOI 10.7555/JBR.26.20110037; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hong Y, 2012, J NEUROSCI RES, V90, P1670, DOI 10.1002/jnr.22739; Ipaktchi K, 2007, SURGERY, V142, P86, DOI 10.1016/j.surg.2007.02.007; Iseri SO, 2008, BURNS, V34, P361, DOI 10.1016/j.burns.2007.03.022; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; Jia G, 2014, BIOCH BIOPHYSICA ACT; Johnson R Michael, 2003, Adv Skin Wound Care, V16, P178, DOI 10.1097/00129334-200307000-00010; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Kaminskyy VO, 2014, ANTIOXID REDOX SIGN, V21, P86, DOI 10.1089/ars.2013.5746; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Lanier ST, 2011, WOUND REPAIR REGEN, V19, P622, DOI 10.1111/j.1524-475X.2011.00725.x; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu W, 2013, WORLD J GASTROENTERO, V19, P492, DOI 10.3748/wjg.v19.i4.492; Mei Y, 2014, BIOCH BIOPHYSICA ACT; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nagane N S, 2003, Indian J Med Sci, V57, P7; Nilsson P, 2014, BIOESSAYS, V36, P570, DOI 10.1002/bies.201400002; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; REGAS FC, 1992, J TRAUMA, V32, P557, DOI 10.1097/00005373-199205000-00004; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Scheibye-Knudsen M, 2014, AUTOPHAGY, V10, P1468, DOI 10.4161/auto.29321; Schwacha MG, 2010, J SURG RES, V158, P112, DOI 10.1016/j.jss.2008.07.034; Sener G, 2007, BURNS, V33, P587, DOI 10.1016/j.burns.2006.10.381; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shupp JW, 2010, J BURN CARE RES, V31, P849, DOI 10.1097/BCR.0b013e3181f93571; Singer AJ, 2008, ACAD EMERG MED, V15, P549, DOI 10.1111/j.1553-2712.2008.00115.x; Singh V, 2007, ANN PLAS SURG, V59, P109, DOI 10.1097/01.sap.0000252065.90759.e6; Sun YX, 2013, J SURG RES, V185, P477, DOI 10.1016/j.jss.2013.06.039; Tan JQ, 2013, BURNS, V39, P1551, DOI 10.1016/j.burns.2013.04.018; Tian R, 2014, SCI WORLD J, DOI 10.1155/2014/780616; Viry E, 2014, BIOCHEMICAL PHARMACO; Wu Tianfu, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P145; Xiao MJ, 2014, ACAD EMERG MED, V21, P383, DOI 10.1111/acem.12352; Xie K, 2013, BRIT J ANAESTH, V110, P148; Xie KL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807635; Xie KL, 2012, SHOCK, V37, P548, DOI 10.1097/SHK.0b013e31824ddc81; Yu P, 2011, BIOCHEM BIOPH RES CO, V409, P350, DOI 10.1016/j.bbrc.2011.05.024; Zhao L, 2013, J ZHEJIANG UNIV-SC B, V14, P382, DOI 10.1631/jzus.B1200317; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	65	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124897	10.1371/journal.pone.0124897	http://dx.doi.org/10.1371/journal.pone.0124897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874619	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100282
J	Li, LY; Yoshitomi, H; Wei, Y; Qin, LL; Zhou, JX; Xu, TH; Wu, XL; Zhou, T; Sun, W; Guo, XY; Wu, LL; Wang, HY; Zhang, Y; Li, CN; Liu, T; Gao, M				Li, Linyi; Yoshitomi, Hisae; Wei, Ying; Qin, Lingling; Zhou, Jingxin; Xu, Tunhai; Wu, Xinli; Zhou, Tian; Sun, Wen; Guo, Xiangyu; Wu, Lili; Wang, Haiyan; Zhang, Yan; Li, Chunna; Liu, Tonghua; Gao, Ming			Tang-Nai-Kang Alleviates Pre-diabetes and Metabolic Disorders and Induces a Gene Expression Switch toward Fatty Acid Oxidation in SHR.Cg-Leprcp/NDmcr Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; MITOCHONDRIAL-FUNCTION; ENERGY HOMEOSTASIS; RECEPTOR-ALPHA; DIABETIC-RATS; LIFE-STYLE; SIRT1	Increased energy intake and reduced physical activity can lead to obesity, diabetes and metabolic syndrome. Transcriptional modulation of metabolic networks has become a focus of current drug discovery research into the prevention and treatment of metabolic disorders associated with energy surplus and obesity. Tang-Nai-Kang (TNK), a mixture of five herbal plant extracts, has been shown to improve abnormal glucose metabolism in patients with prediabetes. Here, we report the metabolic phenotype of SHR.Cg-Leprcp/NDmcr (SHR/cp) rats treated with TNK. Pre-diabetic SHR/cp rats were randomly divided into control, TNK low-dose (1.67 g/kg) and TNK high-dose (3.24 g/kg) groups. After high-dose treatment for 2 weeks, the serum triglycerides and free fatty acids in SHR/cp rats were markedly reduced compared to controls. After 3 weeks of administration, the high dose of TNK significantly reduced the body weight and fat mass of SHR/cp rats without affecting food consumption. Serum fasting glucose and insulin levels in the TNK-treated groups decreased after 6 weeks of treatment. Furthermore, TNK-treated rats exhibited obvious improvements in glucose intolerance and insulin resistance. The improved glucose metabolism may be caused by the substantial reduction in serum lipids and body weight observed in SHR/cp rats starting at 3 weeks of TNK treatment. The mRNA expression of NAD+-dependent deacetylase sirtuin 1 (SIRT1) and genes related to fatty acid oxidation was markedly up-regulated in the muscle, liver and adipose tissue after TNK treatment. Furthermore, TNK promoted the deacetylation of two well-established SIRT1 targets, PPAR. coactivator 1 alpha (PGC1 alpha) and forkhead transcription factor 1 (FOXO1), and induced the phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) in different tissues. These observations suggested that TNK may be an alternative treatment for pre-diabetes and metabolic syndrome by inducing a gene expression switch toward fat oxidation through the activation of SIRT1 and AMPK signaling.	[Li, Linyi; Wei, Ying; Qin, Lingling; Xu, Tunhai; Wu, Xinli; Sun, Wen; Wu, Lili; Wang, Haiyan; Zhang, Yan; Li, Chunna; Liu, Tonghua] Beijing Univ Chinese Med, Hlth Cultivat Lab, Minist Educ, Beijing, Peoples R China; [Yoshitomi, Hisae; Gao, Ming] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Zhou, Jingxin] Beijing Univ Chinese Med, Dongzhimen Hosp Eastern, Beijing, Peoples R China; [Zhou, Tian; Guo, Xiangyu] Beijing Univ Chinese Med, Dongfang Hosp, Beijing, Peoples R China	Beijing University of Chinese Medicine; Mukogawa Women's University; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Liu, T (corresponding author), Beijing Univ Chinese Med, Hlth Cultivat Lab, Minist Educ, Beijing, Peoples R China.	thliu@vip.163.com; gaoming@mukogawa-u.ac.jp		Zhou, Jingxin/0000-0003-0471-1961	International Scientific and Technological Coorperation Program of China [2010DFB33260]; key project of Chinese Ministry of Education [311011]; Cooperation Program of Beijing Municipal Education Commission and the Innovative team of Beijing TCM University [2011-CXTD-19]	International Scientific and Technological Coorperation Program of China; key project of Chinese Ministry of Education(Ministry of Education, China); Cooperation Program of Beijing Municipal Education Commission and the Innovative team of Beijing TCM University	Support was provided by: 1) The International Scientific and Technological Coorperation Program of China (2010DFB33260). Source: Ministry of Science and Technology of the People's Republic of China to author TX [http://www.istcp.org.cn/]; 2) The key project of Chinese Ministry of Education (311011). Source: Ministry of Education of the People's Republic of China to author TL [http://www.moe.gov.cn/]; 3) The Cooperation Program of Beijing Municipal Education Commission and the Innovative team of Beijing TCM University (2011-CXTD-19). Source: Beijing University of Chinese Medicine to author TX [http://kjc.bucm.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson LL, 2002, J BIOL CHEM, V277, P29424, DOI 10.1074/jbc.M203813200; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chiolero A, 2012, LANCET, V380, P1225, DOI 10.1016/S0140-6736(12)61704-8; Deedwania P, 2012, LANCET, V380, P1225, DOI 10.1016/S0140-6736(12)61705-X; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Florez H, 2014, DIABETES OBES METAB, V16, P326, DOI 10.1111/dom.12220; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Grant SJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-104; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guo Xiang-Yu, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P535, DOI 10.3736/jcim20100605; Guo XY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-52; Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hwang SM, 2012, AM J CHINESE MED, V40, P937, DOI 10.1142/S0192415X12500693; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kawai K, 2012, EXP TOXICOL PATHOL, V64, P333, DOI 10.1016/j.etp.2010.09.006; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li JB, 2013, J HUAZHONG U SCI-MED, V33, P877, DOI 10.1007/s11596-013-1215-7; Li LY, 2013, BIOL TRACE ELEM RES, V153, P329, DOI 10.1007/s12011-013-9689-5; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu TH, 2011, CHINA SCI TECHNOLOGY, V12, P79; Liu TH, 2004, PR China Patent, Patent No. [CN02153751.8, 021537518]; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menendez-Gutierrez MP, 2012, CURR TOP MED CHEM, V12, P548; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shishtar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107391; Smith Dl Jr, 2009, Int J Body Compos Res, V7, P21; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang HJ, 2012, FOOD FUNCT, V3, P1161, DOI 10.1039/c2fo30139c; Wang L, 2013, INT J BIOCHEM CELL B, V45, P1155, DOI 10.1016/j.biocel.2013.03.007; Wang LS, 2009, J ETHNOPHARMACOL, V126, P487, DOI 10.1016/j.jep.2009.09.009; Wang Y, 2012, PHARMACOL THERAPEUT, V136, P305, DOI 10.1016/j.pharmthera.2012.08.009; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xia JN, 2013, J ETHNOPHARMACOL, V150, P692, DOI 10.1016/j.jep.2013.09.038; Yuan HD, 2012, J GINSENG RES, V36, P27, DOI 10.5142/jgr.2012.36.1.27; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	60	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122024	10.1371/journal.pone.0122024	http://dx.doi.org/10.1371/journal.pone.0122024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874615	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100056
J	Chen, ZQ; Wu, B; Zhai, X; Bai, YS; Zhu, XD; Luo, B; Chen, X; Li, C; Yang, MY; Xu, KL; Liu, CC; Wang, CF; Zhao, YC; Wei, XZ; Chen, K; Yang, W; Ta, D; Li, M				Chen, Ziqiang; Wu, Bing; Zhai, Xiao; Bai, Yushu; Zhu, Xiaodong; Luo, Beier; Chen, Xiao; Li, Chao; Yang, Mingyuan; Xu, Kailiang; Liu, Chengcheng; Wang, Chuanfeng; Zhao, Yingchuan; Wei, Xianzhao; Chen, Kai; Yang, Wu; Ta, Dean; Li, Ming			Basic Study for Ultrasound-Based Navigation for Pedicle Screw Insertion Using Transmission and Backscattered Methods	PLOS ONE			English	Article							CANCELLOUS BONE; INTRAOSSEOUS ULTRASOUND; X-RAY; PROPAGATION; PLACEMENT; WAVES; COEFFICIENT; ATTENUATION; DEPENDENCE; MARROW	The purpose of this study was to understand the acoustic properties of human vertebral cancellous bone and to study the feasibility of ultrasound-based navigation for posterior pedicle screw fixation in spinal fusion surgery. Fourteen human vertebral specimens were disarticulated from seven un-embalmed cadavers (four males, three females, 73.14 +/- 9.87 years, two specimens from each cadaver). Seven specimens were used to measure the transmission, including tests of attenuation and phase velocity, while the other seven specimens were used for backscattered measurements to inspect the depth of penetration and A-Mode signals. Five pairs of unfocused broadband ultrasonic transducers were used for the detection, with center frequencies of 0.5 MHz, 1 MHz, 1.5 MHz, 2.25 MHz, and 3.5 MHz. As a result, good and stable results were documented. With increased frequency, the attenuation increased (P<0.05), stability of the speed of sound improved (P<0.05), and penetration distance decreased (P>0.05). At about 0.6 cm away from the cortical bone, warning signals were easily observed from the backscattered measurements. In conclusion, the ultrasonic system proved to be an effective, moveable, and real-time imaging navigation system. However, how ultrasonic navigation will benefit pedicle screw insertion in spinal surgery needs to be determined. Therefore, ultrasound-guided pedicle screw implantation is theoretically effective and promising.	[Chen, Ziqiang; Bai, Yushu; Zhu, Xiaodong; Luo, Beier; Chen, Xiao; Li, Chao; Yang, Mingyuan; Xu, Kailiang; Wang, Chuanfeng; Zhao, Yingchuan; Wei, Xianzhao; Chen, Kai; Yang, Wu; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Wu, Bing] 401st Hosp Ctr, Dept Orthoped, Qingdao, Shandong, Peoples R China; [Zhai, Xiao] Second Mil Med Univ, Changhai Hosp, Grad Management Unit, Shanghai, Peoples R China; [Liu, Chengcheng; Ta, Dean] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fudan University	Ta, D (corresponding author), Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China.	jsjyzx8@qq.com; tda@fudan.edu.cn	Xu, Kailiang/HDM-0051-2022; Xu, Kailiang/AGN-4164-2022	Xu, Kailiang/0000-0002-1819-4101; Ta, Dean/0000-0001-6651-4491	National Natural Science Foundation of China [81101396, 11327405]; Biomedical Key Subject Foundation of Shanghai [12411950800]; Science and Technology Support Program of Shanghai [13441901900]; Creativity and Innovation Training Program of Second Military Medical University [ZD2013005]; Natural Science Foundation of Shanghai [15ZR1412700]; Fund of the Second Military Medical University [2014QN15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biomedical Key Subject Foundation of Shanghai; Science and Technology Support Program of Shanghai; Creativity and Innovation Training Program of Second Military Medical University; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Fund of the Second Military Medical University	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81101396 and 11327405; http://www.nsfc.gov.cn/), Biomedical Key Subject Foundation of Shanghai (Grant No. 12411950800; http://www.shanghai.gov.cn/shanghai/node2314/node2319/node12344/u26ai38195.html), the Science and Technology Support Program of Shanghai (Grant No. 13441901900; http://www.shanghai.gov.cn/shanghai/node2314/node2319/node12344/u26ai38195.html), the Creativity and Innovation Training Program of Second Military Medical University (Grant No. ZD2013005), the Natural Science Foundation of Shanghai (Grant No. 15ZR1412700), and the Fund of the Second Military Medical University (Grant No. 2014QN15).	Allam Y, 2013, EUR SPINE J, V22, P648, DOI 10.1007/s00586-012-2505-7; Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; Bakhsh WR, 2013, SPINE, V38, pE1166, DOI 10.1097/BRS.0b013e31829d43a5; Belmont PJ, 2001, SPINE, V26, P2340, DOI 10.1097/00007632-200111010-00010; Chaynes P, 2001, SURG RADIOL ANAT, V23, P85, DOI 10.1007/s00276-001-0085-z; Diakov G, 2010, HNO, V58, P1067, DOI 10.1007/s00106-010-2171-1; Federspil PA, 2009, HNO, V57, P983, DOI 10.1007/s00106-009-1986-0; Goodwin M, 2005, INTRAOSTEAL ULTRASOU; Hoffmeister BK, 2002, PHYS MED BIOL, V47, P3419, DOI 10.1088/0031-9155/47/18/310; Hughes ER, 1999, ULTRASOUND MED BIOL, V25, P811, DOI 10.1016/S0301-5629(99)00034-4; Kantelhardt SR, 2009, SPINE, V34, P400, DOI 10.1097/BRS.0b013e31819286ca; Kantelhardt SR, 2010, ACTA NEUROCHIR, V152, P655, DOI 10.1007/s00701-009-0447-6; Kondoh T, 2014, APPL OPTICS, V53, P2602, DOI 10.1364/AO.53.002602; Langton C M, 1984, Eng Med, V13, P89, DOI 10.1243/EMED_JOUR_1984_013_022_02; Laugier P, 2011, ONE QUANTITATIVE ULT; Li G, 2010, EUR SPINE J, V19, P1576, DOI 10.1007/s00586-010-1316-y; LI HP, 1985, J BONE JOINT SURG AM, V67A, P1202, DOI 10.2106/00004623-198567080-00009; Manbachi A, 2014, SPINE J, V14, P165, DOI 10.1016/j.spinee.2013.03.029; Micali S, 2011, UROLOG J, V78, P52, DOI 10.5301/RU.2011.6438; Michler Ralf Peter, 2013, Tidsskr Nor Laegeforen, V133, P306, DOI 10.4045/tidsskr.11.1542; Mujagic M, 2008, IEEE T ULTRASON FERR, V55, P1267, DOI 10.1109/TUFFC.2008.789; Nelson EM, 2014, SPINE J, V14, P2985, DOI 10.1016/j.spinee.2014.06.003; Nicholson PHF, 1996, PHYS MED BIOL, V41, P2421, DOI 10.1088/0031-9155/41/11/013; NICHOLSON PHF, 1994, PHYS MED BIOL, V39, P1013, DOI 10.1088/0031-9155/39/6/007; Nicholson PHF, 2002, ULTRASOUND MED BIOL, V28, P369, DOI 10.1016/S0301-5629(01)00508-7; Raphael DT, 2010, SPINE J, V10, P422, DOI 10.1016/j.spinee.2010.02.008; Sproul M, 2004, ULTRASONIC CANNULA S; Strelitzki R., 1996, EUR J ULTRASOUND, V4, P205; Ta DA, 2005, P ANN INT IEEE EMBS, P1131; Ta D, 2008, J ACOUST SOC AM, V124, P4083, DOI 10.1121/1.3001705; Tsiklauri D, 2002, J ACOUST SOC AM, V112, P843, DOI 10.1121/1.1499134; Wear KA, 2001, IEEE T ULTRASON FERR, V48, P602, DOI 10.1109/58.911743; Wear KA, 2008, IEEE T ULTRASON FERR, V55, P1432, DOI 10.1109/TUFFC.2008.818; Xu KL, 2014, ULTRASONICS, V54, P1210, DOI 10.1016/j.ultras.2013.09.015; Xu KL, 2014, ULTRASONICS, V54, P395, DOI 10.1016/j.ultras.2013.07.011; Zhang C, 2011, J ACOUST SOC AM, V129, P3317, DOI 10.1121/1.3562560; Zhang HL, 2014, ULTRASONICS, V54, P1203, DOI 10.1016/j.ultras.2013.10.020	37	7	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122392	10.1371/journal.pone.0122392	http://dx.doi.org/10.1371/journal.pone.0122392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861053	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300045
J	Faure, B; Schaeffer, SW; Fisher, CR				Faure, Baptiste; Schaeffer, Stephen W.; Fisher, Charles R.			Species Distribution and Population Connectivity of Deep-Sea Mussels at Hydrocarbon Seeps in the Gulf of Mexico	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; BATHYMODIOLUS-CHILDRESSI; CHARACTER DISPLACEMENT; INTEGRATED SOFTWARE; BIVALVIA; VENT; DIVERSITY; MYTILIDAE; GENETICS; ENDOSYMBIONTS	Hydrocarbon seepage is widespread and patchy in the Gulf of Mexico, and six species of symbiont containing bathymodiolin mussels are found on active seeps over wide and overlapping depth and geographic ranges. We use mitochondrial genes to discriminate among the previously known and a newly discovered species and to assess the connectivity among populations of the same species in the northern Gulf of Mexico (GoM). Our results generally validate the morphologically based distribution of the three previously known GoM species of Bathymodiolus, although we found that approximately 10% of the morphologically based identifications were incorrect and this resulted in some inaccuracies with respect to their previously assigned depth and geographical distribution patterns. These data allowed us to confirm that sympatry of two species of Bathymodiolus within a single patch of mussels is common. A new species of bathymodiolin, Bathymodiolus sp. nov., closely related to B. heckerae was also discovered. The two species live at the same depths but have not been found in sympatry and both have small effective population sizes. We found evidence for genetic structure within populations of the three species of Bathymodiolinae for which we had samples from multiple sites and suggest limited connectivity for populations at some sites. Despite relatively small sample sizes, genetic diversity indices suggest the largest population sizes for B. childressi and Tamu fisheri and the smallest for B. heckerae and B. sp. nov. among the GoM bathymodiolins. Moreover, we detected an excess of rare variants indicating recent demographic changes and population expansions for the four species of bathymodiolins from the Gulf of Mexico.	[Faure, Baptiste; Schaeffer, Stephen W.; Fisher, Charles R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Faure, B (corresponding author), Serv Rech & Dev, Biotope, Meze, France.	bfaure@biotope.fr	Schaeffer, Stephen/AAA-2303-2021	Schaeffer, Stephen/0000-0003-2070-5342	French Ministry of Foreign Affairs; BOEM [1435-01-05-39187, M08PC20038]; National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research	French Ministry of Foreign Affairs; BOEM; National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research	This work was supported by a Lavoisier grant from the French Ministry of Foreign Affairs and by subcontracts to CRF from BOEM contracts 1435-01-05-39187 and M08PC20038 to TDI Brooks, with vessel and submergence facilities support provided by National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Becker EL, 2010, DEEP-SEA RES PT II, V57, P1957, DOI 10.1016/j.dsr2.2010.05.002; Bergquist DC, 2004, LIMNOL OCEANOGR, V49, P706, DOI 10.4319/lo.2004.49.3.0706; Bergquist DC, 2003, MAR ECOL-P S Z N I, V24, P31, DOI 10.1046/j.1439-0485.2003.03800.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; CRADDOCK C, 1995, MAR BIOL, V121, P477, DOI 10.1007/BF00349456; Dobzhansky T., 1937; Doyle J. J., 1987, PHYTOCHEM B, P11; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faure B, 2007, GENE, V406, P99, DOI 10.1016/j.gene.2007.06.025; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; FELSENSTEIN J, 1985, SYST ZOOL, V34, P300, DOI 10.2307/2413149; FISHER C, 2007, OCEANOGRAPHY, V20, P68; FISHER CR, 1993, PSZNI MAR ECOL, V14, P277; FISHER CR, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P606; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 2000, GENETICS, V155, P981; Gause GF, 1932, J EXP BIOL, V9, P389; Gavrilets S, 2003, EVOLUTION, V57, P2197; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Gustafson RG, 1998, MALACOLOGIA, V40, P63; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUDSON RR, 1987, GENETICS, V116, P153; Iwasaki H, 2006, MAR BIOL, V149, P1111, DOI 10.1007/s00227-006-0268-6; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LI WH, 1991, FUNDAMENTALS MOL EVO; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mayr E, 1942, SYSTEMATICS ORIGIN S; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nei M., 1987, MOL EVOLUTIONARY GEN; NIX ER, 1995, MAR BIOL, V122, P605, DOI 10.1007/BF00350682; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Plouviez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081555; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rice AM, 2007, J EVOLUTION BIOL, V20, P448, DOI 10.1111/j.1420-9101.2006.01187.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schaeffer SW, 2002, GENET RES, V80, P163, DOI 10.1017/S0016672302005955; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; Smith EB, 2000, ECOLOGY, V81, P2392, DOI 10.1890/0012-9658(2000)081[2392:GACOSM]2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; van der Heijden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039994; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Won YJ, 2002, CAH BIOL MAR, V43, P387; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2	63	21	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0118460	10.1371/journal.pone.0118460	http://dx.doi.org/10.1371/journal.pone.0118460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859657	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300004
J	Hu, Y; Sun, QW; Li, XL; Wang, M; Cai, DM; Li, X; Zhao, RQ				Hu, Yun; Sun, Qinwei; Li, Xiaoliang; Wang, Min; Cai, Demin; Li, Xi; Zhao, Ruqian			In Ovo Injection of Betaine Affects Hepatic Cholesterol Metabolism through Epigenetic Gene Regulation in Newly Hatched Chicks	PLOS ONE			English	Article							CORTICOSTERONE CORT; PECTORALIS MAJOR; DNA METHYLATION; SUPPLEMENTATION; EXPRESSION; CHOLINE; HYPERMETHYLATION; DEFICIENCY; METHIONINE; TRANSPORT	Betaine is reported to regulate hepatic cholesterol metabolism in mammals. Chicken eggs contain considerable amount of betaine, yet it remains unknown whether and how betaine in the egg affects hepatic cholesterol metabolism in chicks. In this study, eggs were injected with betaine at 2.5 mg/egg and the hepatic cholesterol metabolism was investigated in newly hatched chicks. Betaine did not affect body weight or liver weight, but significantly increased the serum concentration (P < 0.05) and the hepatic content (P < 0.01) of cholesterol. Accordingly, the cholesterol biosynthetic enzyme HMGCR was up-regulated (P < 0.05 for both mRNA and protein), while CYP7A1 which converts cholesterol to bile acids was down-regulated (P < 0.05 for mRNA and P = 0.07 for protein). Moreover, hepatic protein content of the sterol-regulatory element binding protein 1 which regulates cholesterol and lipid biosynthesis, and the mRNA abundance of ATP binding cassette sub-family A member 1 (ABCA1) which mediates cholesterol counter transport were significantly (P < 0.05) increased in betaine-treated chicks. Meanwhile, hepatic protein contents of DNA methyltransferases 1 and adenosylhomocysteinase-like 1 were increased (P < 0.05), which was associated with global genomic DNA hypermethylation (P < 0.05) and diminished gene repression mark histone H3 lysine 27 trimethylation (P < 0.05). Furthermore, CpG methylation level on gene promoters was found to be increased (P < 0.05) for CYP7A1 yet decreased (P < 0.05) for ABCA1. These results indicate that in ovo betaine injection regulates hepatic cholesterol metabolism in chicks through epigenetic mechanisms including DNA and histone methylations.	[Hu, Yun; Sun, Qinwei; Li, Xiaoliang; Wang, Min; Cai, Demin; Li, Xi; Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Sun, QW (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	sqw@njau.edu.cn	Cai, Demin/AAT-7742-2021	Cai, Demin/0000-0003-0500-5292	Special Fund for Agro-scientific Research in the Public Interest [201003011]; Fundamental Research Funds for the Central Universities [KYZ201212]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Fundamental Research Funds for the Central Universities (KYZ201212) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2014, HORM BEHAV, V65, P97, DOI 10.1016/j.yhbeh.2013.12.002; Alirezaei M, 2012, BRIT POULTRY SCI, V53, P699, DOI 10.1080/00071668.2012.728283; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Cai DM, 2014, BRIT J NUTR, V112, P1459, DOI 10.1017/S0007114514002402; Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Duan YJ, 2014, COMP BIOCHEM PHYS A, V176, P59, DOI 10.1016/j.cbpa.2014.07.010; Duan YJ, 2014, COMP BIOCHEM PHYS A, V169, P90, DOI 10.1016/j.cbpa.2013.12.019; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; Fernandez-Figares I, 2012, ANIMAL, V6, P1058, DOI 10.1017/S1751731111002308; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; Khesht FA, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-20; Kim SK, 2005, J HEPATOL, V42, P907, DOI 10.1016/j.jhep.2005.01.017; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Levinson SS, 2015, CLIN CHIM ACTA, V439, P154, DOI 10.1016/j.cca.2014.10.018; Li X, 2014, EUR J NUTR; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; Mulligan JD, 2003, J BIOL CHEM, V278, P13356, DOI 10.1074/jbc.M212377200; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; Sayed MAM, 2011, POULTRY SCI, V90, P157, DOI 10.3382/ps.2009-00594; Schwab U, 2011, EUR J CLIN NUTR, V65, P70, DOI 10.1038/ejcn.2010.230; Schwab U, 2002, AM J CLIN NUTR, V76, P961, DOI 10.1093/ajcn/76.5.961; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Su L, 2012, DOMEST ANIM ENDOCRIN, V43, P26, DOI 10.1016/j.domaniend.2012.01.007; SUGIYAMA K, 1986, J NUTR SCI VITAMINOL, V32, P537, DOI 10.3177/jnsv.32.537; Szyf M, 2001, FRONT BIOSCI-LANDMRK, V6, pD599, DOI 10.2741/szyf; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang YQ, 2004, J NUTR, V134, P2205, DOI 10.1093/jn/134.9.2205	40	33	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122643	10.1371/journal.pone.0122643	http://dx.doi.org/10.1371/journal.pone.0122643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860502	gold, Green Submitted, Green Published			2022-12-26	WOS:000352590300052
J	Pathak, R; Shao, LJ; Ghosh, SP; Zhou, DH; Boerma, M; Weiler, H; Hauer-Jensen, M				Pathak, Rupak; Shao, Lijian; Ghosh, Sanchita P.; Zhou, Daohong; Boerma, Marjan; Weiler, Hartmut; Hauer-Jensen, Martin			Thrombomodulin Contributes to Gamma Tocotrienol-Mediated Lethality Protection and Hematopoietic Cell Recovery in Irradiated Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TOTAL-BODY IRRADIATION; ACTIVATED PROTEIN-C; ENDOTHELIAL THROMBOMODULIN; SEVERE SEPSIS; DEPENDENT MECHANISM; RADIATION-INJURY; UP-REGULATION; ANTIOXIDANT; DYSFUNCTION	Systemic administration of recombinant thrombomodulin (TM) confers radiation protection partly by accelerating hematopoietic recovery. The uniquely potent radioprotector gamma tocotrienol (GT3), in addition to being a strong antioxidant, inhibits the enzyme hydroxymethyl-glutaryl-coenzyme A reductase (HMGCR) and thereby likely modulates the expression of TM. We hypothesized that the mechanism underlying the exceptional radioprotective properties of GT3 partly depends on the presence of endothelial TM. In vitro studies confirmed that ionizing radiation suppresses endothelial TM (about 40% at 4 hr after 5 Gy gamma-irradiation) and that GT3 induces TM expression (about 2 fold at the mRNA level after 5 mu M GT3 treatment for 4 hr). In vivo survival studies showed that GT3 was significantly more effective as a radioprotector in TM wild type (TM+/+) mice than in mice with low TM function (TMPro/-). After exposure to 9 Gy TBI, GT3 pre-treatment conferred 85% survival in TM+/+ mice compared to only 50% in TMPro/-. Thus, GT3-mediated radiation lethality protection is partly dependent on endothelial TM. Significant post-TBI recovery of hematopoietic cells, particularly leukocytes, was observed in TM+/+ mice (p = 0.003), but not in TMPro/- mice, despite the fact that GT3 induced higher levels of granulocyte colony stimulating factor (GCSF) in TMPro/- mice (p = 0.0001). These data demonstrate a critical, G-CSF-independent, role for endothelial TM in GT3-mediated lethality protection and hematopoietic recovery after exposure to TBI and may point to new strategies to enhance the efficacy of current medical countermeasures in radiological/nuclear emergencies.	[Pathak, Rupak; Shao, Lijian; Zhou, Daohong; Boerma, Marjan; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Coll Pharm, Little Rock, AR 72205 USA; [Ghosh, Sanchita P.] USUHS, Armed Forces Radiobiol Res Inst, Bethesda, MD USA; [Weiler, Hartmut] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Weiler, Hartmut] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; United States Department of Defense; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Pathak, R (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Coll Pharm, Little Rock, AR 72205 USA.	rpathak@uams.edu	Shao, Lijian/AAA-1074-2020	Ghosh, Sanchita/0000-0002-0261-460X	National Institutes of Health (NIH) [R37 CA71382, U19 AI67798]; US Veterans Administration; Arkansas Space Grant Consortium through National Aeronautics and Space Administration [NNX13AB29A]; National Space Biomedical Research Institute through National Aeronautics and Space Administration [RE03701, NCC 9-58]; NIH [R01 CA148679, R01 CA122023]; Edward P. Evans Foundation; NATIONAL CANCER INSTITUTE [R37CA071382, R01CA148679, R01CA122023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration(US Department of Veterans Affairs); Arkansas Space Grant Consortium through National Aeronautics and Space Administration; National Space Biomedical Research Institute through National Aeronautics and Space Administration; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grants R37 CA71382 and U19 AI67798 (MH-J), the US Veterans Administration (MH-J), Arkansas Space Grant Consortium through National Aeronautics and Space Administration grant NNX13AB29A (RP), National Space Biomedical Research Institute (RE03701) through National Aeronautics and Space Administration NCC 9-58 (MB), NIH grant R01 CA148679 (MB), NIH grant R01 CA122023 (DZ), and the Edward P. Evans Foundation (DZ and MH-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; Andrulis M, 2012, HAEMATOL-HEMATOL J, V97, P1674, DOI 10.3324/haematol.2011.061051; Basu S, 2000, BLOOD, V95, P3725; Berbee M, 2012, GENES NUTR, V7, P75, DOI 10.1007/s12263-011-0228-8; Berbee M, 2009, RADIAT RES, V171, P596, DOI 10.1667/RR1632.1; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Califano F, 2000, Eur Rev Med Pharmacol Sci, V4, P59; Casserly B, 2012, CRIT CARE MED, V40, P1417, DOI 10.1097/CCM.0b013e31823e9f45; CONWAY EM, 1988, MOL CELL BIOL, V8, P5588, DOI 10.1128/MCB.8.12.5588; Fu Q, 2008, CIRC RES, V103, P369, DOI 10.1161/CIRCRESAHA.108.174607; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; Grinnell BW, 2001, CRIT CARE MED, V29, pS53, DOI 10.1097/00003246-200107001-00020; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Hauer-Jensen M, 1999, RADIAT ONCOL INVESTI, V7, P238, DOI 10.1002/(SICI)1520-6823(1999)7:4<238::AID-ROI5>3.0.CO;2-4; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; Kulkarni S, 2013, CYTOKINE, V62, P278, DOI 10.1016/j.cyto.2013.03.009; Kulkarni S, 2010, RADIAT RES, V173, P738, DOI 10.1667/RR1824.1; Kulkarni SS, 2012, INT IMMUNOPHARMACOL, V14, P495, DOI 10.1016/j.intimp.2012.09.001; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; Ogawa Y, 2012, J TRAUMA ACUTE CARE, V72, P1150, DOI 10.1097/TA.0b013e3182516ab5; Palframan RT, 1998, J EXP MED, V188, P1621, DOI 10.1084/jem.188.9.1621; PARKER RA, 1993, J BIOL CHEM, V268, P11230; PEARCE BC, 1992, J MED CHEM, V35, P3595, DOI 10.1021/jm00098a002; Qureshi SH, 2009, BIOCHEMISTRY-US, V48, P8261, DOI 10.1021/bi900921t; Richter KK, 1997, RADIOTHER ONCOL, V44, P65, DOI 10.1016/S0167-8140(97)00063-7; Ross CC, 2008, RADIAT RES, V169, P408, DOI 10.1667/RR1148.1; Shi JM, 2003, BLOOD COAGUL FIBRIN, V14, P575, DOI 10.1097/00001721-200309000-00010; TANIKAWA S, 1990, BLOOD, V76, P445; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Williams JP, 2004, RADIAT RES, V161, P560, DOI 10.1667/RR3168; Yan SB, 2001, CHEST, V120, P915, DOI 10.1378/chest.120.3.915; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0	34	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122511	10.1371/journal.pone.0122511	http://dx.doi.org/10.1371/journal.pone.0122511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860286	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300050
J	Peng, X; Qi, W; Huang, RL; Su, RX; He, ZM				Peng, Xin; Qi, Wei; Huang, Renliang; Su, Rongxin; He, Zhimin			Elucidating the Influence of Gold Nanoparticles on the Binding of Salvianolic Acid B and Rosmarinic Acid to Bovine Serum Albumin	PLOS ONE			English	Article							FLUORESCENCE; FLAVONOIDS; CHEMISTRY; PROTECTS; BIOLOGY; PLASMA; BRAIN; SIZE	Salvianolic acid B and rosmarinic acid are two main water-soluble active ingredients from Salvia miltiorrhiza with important pharmacological activities and clinical applications. The interactions between salvianolic acid B (or rosmarinic acid) and bovine serum albumin (BSA) in the presence and absence of gold nanoparticles (Au NPs) with three different sizes were investigated by using biophysical methods for the first time. Experimental results proved that two components quenched the fluorescence of BSA mainly through a static mechanism irrespective of the absence or presence of Au NPs. The presence of Au NPs decreased the binding constants of salvianolic acid B with BSA from 27.82% to 10.08%, while Au NPs increased the affinities of rosmarinic acid for BSA from 0.4% to 14.32%. The conformational change of BSA in the presence of Au NPs (caused by a noncompetitive binding between Au NPs and drugs at different albumin sites) induced changeable affinity and binding distance between drugs and BSA compared with no Au NPs. The competitive experiments revealed that the site I (subdomain IIA) of BSA was the primary binding site for salvianolic acid B and rosmarinic acid. Additionally, two compounds may induce conformational and micro-environmental changes of BSA. The results would provide valuable binding information between salvianolic acid B (or rosmarinic acid) and BSA, and also indicated that the Au NPs could alter the interaction mechanism and binding capability of drugs to BSA, which might be beneficial to understanding the pharmacokinetics and biological activities of the two drugs.	[Peng, Xin] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China; [Peng, Xin; Qi, Wei; Su, Rongxin; He, Zhimin] Tianjin Univ, Sch Chem Engn & Technol, Chem Engn Res Ctr, Tianjin 300072, Peoples R China; [Qi, Wei; Su, Rongxin; He, Zhimin] Tianjin Univ, State Key Lab Chem Engn, Tianjin 300072, Peoples R China; [Qi, Wei; Su, Rongxin] Tianjin Univ, Tianjin Key Lab Membrane Sci & Desalinat Technol, Tianjin 300072, Peoples R China; [Qi, Wei; Su, Rongxin] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Huang, Renliang] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University; Tianjin University; Tianjin University; Tianjin University	Qi, W (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Chem Engn Res Ctr, Tianjin 300072, Peoples R China.	qiwei@tju.edu.cn	Su, Rongxin/AAA-7967-2021; Su, Rongxin/B-6634-2014; Qi, Wei/I-2550-2018; Huang, Renliang/C-2037-2013	Su, Rongxin/0000-0001-9778-9113; Su, Rongxin/0000-0001-9778-9113; Peng, Xin/0000-0003-1654-2130; Huang, Renliang/0000-0003-0797-3473	Natural Science Foundation of China [21476165, 51173128, 21306134]; 863 Program of China [2013AA102204]; Ministry of Science and Technology of China [2012YQ090194]; Ministry of Education [20130032120029]; Beiyang Young Scholar of Tianjin University; Program of Introducing Talents of Discipline to Universities of China [B06006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; Beiyang Young Scholar of Tianjin University; Program of Introducing Talents of Discipline to Universities of China(Ministry of Education, China - 111 Project)	This work was supported by the Natural Science Foundation of China (Nos. 21476165, 51173128, 21306134), the 863 Program of China (No. 2013AA102204), the Ministry of Science and Technology of China (No. 2012YQ090194), the Ministry of Education (No. 20130032120029), the Beiyang Young Scholar of Tianjin University (2012) and the Program of Introducing Talents of Discipline to Universities of China (No. B06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin S, 2014, J LUMIN, V151, P219, DOI 10.1016/j.jlumin.2014.02.028; Barreca D, 2013, BIOCHIMIE, V95, P2042, DOI 10.1016/j.biochi.2013.07.014; Belatik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036723; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Cheng ZJ, 2013, J SOLUTION CHEM, V42, P1238, DOI 10.1007/s10953-013-0022-x; Chi ZX, 2010, J AGR FOOD CHEM, V58, P10262, DOI 10.1021/jf101417w; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Ding F, 2009, J LUMIN, V129, P650, DOI 10.1016/j.jlumin.2009.01.011; Dominguez-Medina S, 2012, LANGMUIR, V28, P9131, DOI 10.1021/la3005213; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Feroz SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076067; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Garg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063805; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hemmateenejad B, 2012, J PHARMACEUT BIOMED, V67-68, P201, DOI 10.1016/j.jpba.2012.04.012; Ibrahim N, 2010, BIOMACROMOLECULES, V11, P3341, DOI 10.1021/bm100814n; Jiang Baohong, 2010, BMC Pharmacology, V10, P10, DOI 10.1186/1471-2210-10-10; Kamtekar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053499; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lay IS, 2003, J SURG RES, V115, P279, DOI 10.1016/S0022-4804(03)00226-9; Lee HJ, 2013, J MED FOOD, V16, P239, DOI 10.1089/jmf.2012.2456; Lee J, 2008, J DERMATOL, V35, P768, DOI 10.1111/j.1346-8138.2008.00565.x; Liu BS, 2012, J LUMIN, V132, P1133, DOI 10.1016/j.jlumin.2011.12.082; Liu Y, 2013, FOOD CHEM TOXICOL, V58, P264, DOI 10.1016/j.fct.2013.04.048; Lu DW, 2011, FOOD CHEM TOXICOL, V49, P3158, DOI 10.1016/j.fct.2011.09.011; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Mandal S, 2005, CURR APPL PHYS, V5, P118, DOI 10.1016/j.cap.2004.06.006; Ozturk M, 2010, FOOD CHEM, V123, P1352, DOI 10.1016/j.foodchem.2010.06.021; Pan XR, 2011, J AGR FOOD CHEM, V59, P6650, DOI 10.1021/jf200907x; Peng X, 2014, J SOLUTION CHEM, V43, P585, DOI 10.1007/s10953-014-0146-7; Psotova J, 2006, J PHOTOCH PHOTOBIO B, V84, P167, DOI 10.1016/j.jphotobiol.2006.02.012; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Tang JH, 2013, J SOLUTION CHEM, V42, P226, DOI 10.1007/s10953-012-9938-9; Tewtrakul S, 2003, PHYTOTHER RES, V17, P232, DOI 10.1002/ptr.1111; Thakor AS, 2011, NANO LETT, V11, P4029, DOI 10.1021/nl202559p; Tian FF, 2012, RSC ADV, V2, P501, DOI 10.1039/c1ra00521a; Toneatto J, 2011, J INORG BIOCHEM, V105, P645, DOI 10.1016/j.jinorgbio.2010.10.018; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang YQ, 2011, INORG CHEM, V50, P12661, DOI 10.1021/ic201712e; Xiao JB, 2012, ANALYST, V137, P195, DOI 10.1039/c1an15457e; Xiao JB, 2011, NANOMED-NANOTECHNOL, V7, P850, DOI 10.1016/j.nano.2011.02.003; Xiao JB, 2010, J INORG BIOCHEM, V104, P1148, DOI 10.1016/j.jinorgbio.2010.07.003; Xu Y. Y., 2007, ASIAN J PHARMACODYN, V7, P99; Yeh YC, 2012, NANOSCALE, V4, P1871, DOI 10.1039/c1nr11188d; Zhang GW, 2012, J AGR FOOD CHEM, V60, P2721, DOI 10.1021/jf205260g; Zhang J, 2011, J AGR FOOD CHEM, V59, P7506, DOI 10.1021/jf2005194; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059106; Zhang YP, 2011, J INORG BIOCHEM, V105, P1529, DOI 10.1016/j.jinorgbio.2011.08.007; Zhang YP, 2011, J AGR FOOD CHEM, V59, P8499, DOI 10.1021/jf201796x; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	58	29	33	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0118274	10.1371/journal.pone.0118274	http://dx.doi.org/10.1371/journal.pone.0118274			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861047	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300003
J	Simamura, E; Arikawa, T; Ikeda, T; Shimada, H; Shoji, H; Masuta, H; Nakajima, Y; Otani, H; Yonekura, H; Hatta, T				Simamura, Eriko; Arikawa, Tomohiro; Ikeda, Takayuki; Shimada, Hiroki; Shoji, Hiroki; Masuta, Hiroko; Nakajima, Yuriko; Otani, Hiroki; Yonekura, Hideto; Hatta, Toshihisa			Melanocortins Contribute to Sequential Differentiation and Enucleation of Human Erythroblasts via Melanocortin Receptors 1, 2 and 5	PLOS ONE			English	Article							RED-BLOOD-CELLS; MOLECULAR-CLONING; EX-VIVO; ERYTHROPOIETIN RECEPTOR; HEMATOPOIETIC STEM; ERYTHROID-CELLS; PRECURSOR CELLS; IN-VITRO; EXPRESSION; PROTEIN	In this study, we showed that adrenocorticotropic hormone (ACTH) promoted erythroblast differentiation and increased the enucleation ratio of erythroblasts. Because ACTH was contained in hematopoietic medium as contamination, the ratio decreased by the addition of anti-ACTH antibody (Ab). Addition of neutralizing Abs (nAbs) for melanocortin receptors (MCRs) caused erythroblast accumulation at specific stages, i.e., the addition of anti-MC2R nAb led to erythroblast accumulation at the basophilic stage (baso-E), the addition of anti-MC1R nAb caused accumulation at the polychromatic stage (poly-E), and the addition of anti-MC5R nAb caused accumulation at the orthochromatic stage (ortho-E). During erythroblast differentiation, ERK, STAT5, and AKT were consecutively phosphorylated by erythropoietin (EPO). ERK, STAT5, and AKT phosphorylation was inhibited by blocking MC2R, MC1R, and MC5R, respectively. Finally, the phosphorylation of myosin light chain 2, which is essential for the formation of contractile actomyosin rings, was inhibited by anti-MC5R nAb. Taken together, our study suggests that MC2R and MC1R signals are consecutively required for the regulation of EPO signal transduction in erythroblast differentiation, and that MC5R signal transduction is required to induce enucleation. Thus, melanocortin induces proliferation and differentiation at baso-E, and polarization and formation of an actomyosin contractile ring at ortho-E are required for enucleation.	[Simamura, Eriko; Shimada, Hiroki; Masuta, Hiroko; Nakajima, Yuriko; Hatta, Toshihisa] Kanazawa Med Univ, Sch Med, Dept Anat, Uchinada, Ishikawa 9200293, Japan; [Arikawa, Tomohiro; Shoji, Hiroki] Kanazawa Med Univ, Sch Med, Dept Biol, Uchinada, Ishikawa 9200293, Japan; [Ikeda, Takayuki; Yonekura, Hideto] Kanazawa Med Univ, Sch Med, Dept Biochem, Uchinada, Ishikawa 9200293, Japan; [Otani, Hiroki] Shimane Univ, Fac Med, Dept Dev Biol, Izumo, Shimane 6938601, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Shimane University	Hatta, T (corresponding author), Kanazawa Med Univ, Sch Med, Dept Anat, Uchinada, Ishikawa 9200293, Japan.	thatta@kanazawa-med.ac.jp		Ikeda, Takayuki/0000-0001-9546-2248	Japan Society for the Promotion of Science [23591606, 22390216, 20238025, 23592423, 24590245, 25293241, 24659512, 24791726]; Research for Promoting Technological Seeds [07-035]; High-Technology Research Centre of Kanazawa Medical University [H2010-14]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; Kanazawa Medical University [C2009-3, C2010-2, S2010-8, S2008-10, S1201022]; Grants-in-Aid for Scientific Research [24590245, 25293241, 24659512] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research for Promoting Technological Seeds(Japan Science & Technology Agency (JST)); High-Technology Research Centre of Kanazawa Medical University; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Kanazawa Medical University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (23591606, 22390216, 20238025, 23592423 and 24590245, 25293241, 24659512, 24791726), by Research for Promoting Technological Seeds (07-035), by a grant for project research from the High-Technology Research Centre of Kanazawa Medical University (H2010-14), by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan and by grants for promoting research from Kanazawa Medical University (C2009-3, C2010-2, S2010-8, S2008-10 and S1201022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Andersen GN, SCAND J IMMUNOL; Bagley RG, 2003, CANCER RES, V63, P5866; Becher E, 1999, ANN NY ACAD SCI, V885, P188; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Chhajlani V, 1996, BIOCHEM MOL BIOL INT, V38, P73; CHHAJLANI V, 1993, BIOCHEM BIOPH RES CO, V195, P866, DOI 10.1006/bbrc.1993.2125; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Chin H, 1998, BLOOD, V91, P3734; Chute JP, 2006, STEM CELLS, V24, P1315, DOI 10.1634/stemcells.2005-0029; FATHI Z, 1995, NEUROCHEM RES, V20, P107, DOI 10.1007/BF00995160; Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hadley ME, 1999, ANN NY ACAD SCI, V885, P1; Haseyama Y, 1999, BLOOD, V94, P1568, DOI 10.1182/blood.V94.5.1568.417a07_1568_1577; Hebiguchi M, 2008, INT J HEMATOL, V88, P498, DOI 10.1007/s12185-008-0200-6; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; LABBE O, 1994, BIOCHEMISTRY-US, V33, P4543, DOI 10.1021/bi00181a015; Lindberg C, 2005, NEUROTOX RES, V8, P267, DOI 10.1007/BF03033980; LIOTTA AS, 1984, J NEUROSCI, V4, P956; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Moller CL, 2011, MOL CELL ENDOCRINOL, V341, P9, DOI 10.1016/j.mce.2011.03.010; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Nimura M, 2006, ANAT EMBRYOL, V211, P109, DOI 10.1007/s00429-005-0066-9; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Oda A, 1998, BLOOD, V92, P443, DOI 10.1182/blood.V92.2.443.414k25_443_451; Ohmizono Y, 1997, LEUKEMIA, V11, P524, DOI 10.1038/sj.leu.2400588; Ratajczak J, 2001, BRIT J HAEMATOL, V115, P195, DOI 10.1046/j.1365-2141.2001.03058.x; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Sakamoto H, 2000, J BIOL CHEM, V275, P35857, DOI 10.1074/jbc.M006317200; Sato Y, 2010, BIOCHEM BIOPH RES CO, V403, P253, DOI 10.1016/j.bbrc.2010.11.002; Simamura E, 2011, CONGENIT ANOM, V51, P47, DOI 10.1111/j.1741-4520.2011.00316.x; Simamura E, 2010, ENDOCRINOLOGY, V151, P1853, DOI 10.1210/en.2009-0985; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; SKUTELSKY E, 1970, EXP CELL RES, V60, P427, DOI 10.1016/0014-4827(70)90536-7; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; TARBUTT RG, 1970, J EMBRYOL EXP MORPH, V24, P429; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Kraan M, 1998, ENDOCRINOLOGY, V139, P2348, DOI 10.1210/en.139.5.2348; Van Handel B, 2010, BLOOD, V116, P3321, DOI 10.1182/blood-2010-04-279489; Wang JX, 2012, J CELL SCI, V125, P340, DOI 10.1242/jcs.088286; Webb TR, 2009, ENDOCRINOLOGY, V150, P720, DOI 10.1210/en.2008-0941	59	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123232	10.1371/journal.pone.0123232	http://dx.doi.org/10.1371/journal.pone.0123232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860801	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300083
J	An, K; Elkassabany, NM; Liu, JB				An, Ke; Elkassabany, Nabil M.; Liu, Jiabin			Dexamethasone as Adjuvant to Bupivacaine Prolongs the Duration of Thermal Antinociception and Prevents Bupivacaine-Induced Rebound Hyperalgesia via Regional Mechanism in a Mouse Sciatic Nerve Block Model	PLOS ONE			English	Article							BRACHIAL-PLEXUS BLOCKADE; LOCAL-ANESTHETICS; WALLERIAN DEGENERATION; SCHWANN-CELLS; ROPIVACAINE; NEUROTOXICITY; INJURY; RAT; LIDOCAINE; ANALGESIA	Background Dexamethasone has been studied as an effective adjuvant to prolong the analgesia duration of local anesthetics in peripheral nerve block. However, the route of action for dexamethasone and its potential neurotoxicity are still unclear. Methods A mouse sciatic nerve block model was used. The sciatic nerve was injected with 60ul of combinations of various medications, including dexamethasone and/or bupivacaine. Neurobehavioral changes were observed for 2 days prior to injection, and then continuously for up to 7 days after injection. In addition, the sciatic nerves were harvested at either 2 days or 7 days after injection. Toluidine blue dyeing and immunohistochemistry test were performed to study the short-term and long-term histopathological changes of the sciatic nerves. There were six study groups: normal saline control, bupivacaine (10mg/kg) only, dexamethasone (0.5mg/kg) only, bupivacaine (10mg/kg) combined with low-dose (0.14mg/kg) dexamethasone, bupivacaine (10mg/kg) combined with high-dose (0.5mg/kg) dexamethasone, and bupivacaine (10mg/kg) combined with intramuscular dexamethasone (0.5mg/kg). Results High-dose perineural dexamethasone, but not systemic dexamethasone, combined with bupivacaine prolonged the duration of both sensory and motor block of mouse sciatic nerve. There was no significant difference on the onset time of the sciatic nerve block. There was "rebound hyperalgesia" to thermal stimulus after the resolution of plain bupivacaine sciatic nerve block. Interestingly, both low and high dose perineural dexamethasone prevented bupivacaine-induced hyperalgesia. There was an early phase of axon degeneration and Schwann cell response as represented by S-100 expression as well as the percentage of demyelinated axon and nucleus in the plain bupivacaine group compared with the bupivacaine plus dexamethasone groups on post-injection day 2, which resolved on post-injection day 7. Furthermore, we demonstrated that perineural dexamethasone, but not systemic dexamethasone, could prevent axon degeneration and demyelination. There was no significant caspase-dependent apoptosis process in the mouse sciatic nerve among all study groups during our study period. Conclusions Perineural, not systemic, dexamethasone added to a clinical concentration of bupivacaine may not only prolong the duration of sensory and motor blockade of sciatic nerve, but also prevent the bupivacaine-induced reversible neurotoxicity and short-term "rebound hyperalgesia" after the resolution of nerve block.	[An, Ke; Elkassabany, Nabil M.; Liu, Jiabin] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [An, Ke] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Sun Yat Sen University	Liu, JB (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	Jiabin.Liu@uphs.upenn.edu		LIU, JIABIN/0000-0002-1029-2786				Bailard NS, 2014, AM J HEALTH-SYST PH, V71, P373, DOI 10.2146/ajhp130336; Brummett CM, 2009, ANESTHESIOLOGY, V111, P1111, DOI 10.1097/ALN.0b013e3181bbcc26; Bulka CM, 2014, REGIONAL ANESTHESIA; Chang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089563; Clark RD, 2008, CURR TOP MED CHEM, V8, P813, DOI 10.2174/156802608784535011; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Cummings KC, 2011, BRIT J ANAESTH, V107, P446, DOI 10.1093/bja/aer159; Desmet M, 2013, BRIT J ANAESTHESIA; Drasner K, 2002, REGION ANESTH PAIN M, V27, P576, DOI 10.1053/rapm.2002.37410; Fredrickson MJ, 2013, REGION ANESTH PAIN M, V38, P300, DOI 10.1097/AAP.0b013e318292c121; Gordon SM, 2008, ANESTH ANALG, V106, P321, DOI 10.1213/01.ane.0000296474.79437.23; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; Hulata D, 2008, J NEUROSCI METH, V172, P236, DOI 10.1016/j.jneumeth.2008.05.002; Janda A, 2013, REGION ANESTH PAIN M, V38, P151, DOI 10.1097/AAP.0b013e3182813aae; JOHANSSON A, 1990, ACTA ANAESTH SCAND, V34, P335, DOI 10.1111/j.1399-6576.1990.tb03097.x; Kawanishi R, 2014, LOCAL REG ANESTH, V7, P5, DOI 10.2147/LRA.S59158; Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9; Kim HJ, 2014, KOREAN J PAIN, V27, P112, DOI 10.3344/kjp.2014.27.2.112; Kolarczyk LM, 2011, REGION ANESTH PAIN M, V36, P220, DOI 10.1097/AAP.0b013e3182176f5a; Kroin JS, 2010, REGION ANESTH PAIN M, V35, P343, DOI 10.1097/AAP.0b013e3181e82df0; Long TR, 2002, J CLIN ANESTH, V14, P546, DOI 10.1016/S0952-8180(02)00408-7; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Martinez V, 2014, BRIT J ANAESTHESIA; MATA M, 1990, J NEUROCYTOL, V19, P432, DOI 10.1007/BF01188409; Merritt CK, 2014, BEST PRACT RES-CLIN, V28, P41, DOI 10.1016/j.bpa.2014.02.002; Movafegh A, 2006, ANESTH ANALG, V102, P263, DOI 10.1213/01.ane.0000189055.06729.0a; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; MYERS RR, 1986, ANESTHESIOLOGY, V64, P29, DOI 10.1097/00000542-198601000-00006; Parrington SJ, 2010, REGION ANESTH PAIN M, V35, P422, DOI 10.1097/AAP.0b013e3181e85eb9; Rahangdale R, 2014, ANESTH ANALG, V118, P1113, DOI 10.1213/ANE.0000000000000137; Cereda CMS, 2012, ANESTH ANALG, V115, P1234, DOI 10.1213/ANE.0b013e318266f3d9; Salzer James L, 2012, J Peripher Nerv Syst, V17 Suppl 3, P14, DOI 10.1111/j.1529-8027.2012.00425.x; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; SELANDER D, 1993, REGION ANESTH, V18, P461; Shishido H, 2002, SPINE, V27, P581, DOI 10.1097/00007632-200203150-00005; Tandoc MN, 2011, J ANESTH, V25, P704, DOI 10.1007/s00540-011-1180-x; Tang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091571, 10.1371/journal.pone.0073402]; Williams BA, 2007, REGION ANESTH PAIN M, V32, P186, DOI 10.1016/j.rapm.2006.10.011; Williams BA, 2012, INT ANESTHESIOL CLIN, V50, P126, DOI 10.1097/AIA.0b013e31821a00d0; Williams BA, 2011, REGION ANESTH PAIN M, V36, P225, DOI 10.1097/AAP.0b013e3182176f70; Zink W, 2008, CURR OPIN ANESTHESIO, V21, P645, DOI 10.1097/ACO.0b013e32830c214c	41	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123459	10.1371/journal.pone.0123459	http://dx.doi.org/10.1371/journal.pone.0123459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856078	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500091
J	Ferreira, VH; Nazli, A; Dizzell, SE; Mueller, K; Kaushic, C				Ferreira, Victor H.; Nazli, Aisha; Dizzell, Sara E.; Mueller, Kristen; Kaushic, Charu			The Anti-Inflammatory Activity of Curcumin Protects the Genital Mucosal Epithelial Barrier from Disruption and Blocks Replication of HIV-1 and HSV-2	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; TUMOR-NECROSIS-FACTOR; NEISSERIA-GONORRHOEAE; IMMUNE ACTIVATION; CELL-LINE; MICROBIAL TRANSLOCATION; GENE-EXPRESSION; FACTOR-ALPHA	Inflammation is a known mechanism that facilitates HIV acquisition and the spread of infection. In this study, we evaluated whether curcumin, a potent and safe anti-inflammatory compound, could be used to abrogate inflammatory processes that facilitate HIV-1 acquisition in the female genital tract (FGT) and contribute to HIV amplification. Primary, human genital epithelial cells (GECs) were pretreated with curcumin and exposed to HIV-1 or HIV glycoprotein 120 (gp120), both of which have been shown to disrupt epithelial tight junction proteins, including ZO-1 and occludin. Pre-treatment with curcumin prevented disruption of the mucosal barrier by maintaining ZO-1 and occludin expression and maintained trans-epithelial electric resistance across the genital epithelium. Curcumin pre-treatment also abrogated the gp120-mediated upregulation of the proinflammatory cytokines tumor necrosis factor-a and interleukin (IL)-6, which mediate barrier disruption, as well as the chemokines IL-8, RANTES and interferon gamma-induced protein-10 (IP-10), which are capable of recruiting HIV target cells to the FGT. GECs treated with curcumin and exposed to the sexually transmitted co-infecting microbes HSV-1, HSV-2 and Neisseria gonorrhoeae were unable to elicit innate inflammatory responses that indirectly induced activation of the HIV promoter and curcumin blocked Toll-like receptor (TLR)-mediated induction of HIV replication in chronically infected T-cells. Finally, curcumin treatment resulted in significantly decreased HIV-1 and HSV-2 replication in chronically infected T-cells and primary GECs, respectively. All together, our results suggest that the use of anti-inflammatory compounds such as curcumin may offer a viable alternative for the prevention and/or control of HIV replication in the FGT.	[Ferreira, Victor H.; Nazli, Aisha; Dizzell, Sara E.; Mueller, Kristen; Kaushic, Charu] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ferreira, Victor H.; Nazli, Aisha; Dizzell, Sara E.; Mueller, Kristen; Kaushic, Charu] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University	Kaushic, C (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	kaushic@mcmaster.ca	Ferreira, Victor H/AAY-8861-2021	Ferreira, Victor H/0000-0002-1472-9711; Kaushic, Charu/0000-0002-7088-2569; Nazli, Aisha/0000-0001-7410-9963	Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR); Canadian Foundation for AIDS Research (CANFAR); CIHR New Investigator Award; OHTN	Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for AIDS Research (CANFAR); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); OHTN	This study was supported by operating grants from Ontario HIV Treatment Network (OHTN), Canadian Institutes of Health Research (CIHR) and Canadian Foundation for AIDS Research (CANFAR). CK was supported by a CIHR New Investigator Award and an Applied HIV Chair Award from OHTN. VHF received an OHTN Studentship Award and holds a Banting & Best CIHR Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Barthelemy S, 1998, RES VIROLOGY, V149, P43, DOI 10.1016/S0923-2516(97)86899-9; Basnet P, 2012, J PHARM SCI-US, V101, P598, DOI 10.1002/jps.22785; Berginc K, 2012, AAPS PHARMSCITECH, V13, P1045, DOI 10.1208/s12249-012-9837-9; Bourne KZ, 1999, ANTIVIR RES, V42, P219, DOI 10.1016/S0166-3542(99)00020-0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CHAN MMY, 1995, BIOCHEM PHARMACOL, V49, P1551, DOI 10.1016/0006-2952(95)00171-U; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Di Santo R., 2005, Farmaco (Lausanne), V60, P409, DOI 10.1016/j.farmac.2005.03.008; Ferreira VH, 2011, J INFECT DIS, V204, P299, DOI 10.1093/infdis/jir260; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gandapu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023388; Gillgrass AE, 2005, J VIROL, V79, P3117, DOI 10.1128/JVI.79.5.3117-3126.2005; Gota VS, 2010, J AGR FOOD CHEM, V58, P2095, DOI 10.1021/jf9024807; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; James J S, 1996, AIDS Treat News, P1; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Jordan WC, 1996, J NATL MED ASSOC, V88, P333; Kaushic C, 2011, METHODS; Kaushic C, 2011, METHODS, V55, P114, DOI 10.1016/j.ymeth.2011.09.022; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; LI CJ, 1993, P NATL ACAD SCI USA, V90, P1839, DOI 10.1073/pnas.90.5.1839; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; McClelland RS, 2002, AIDS, V16, P2425, DOI 10.1097/00002030-200212060-00007; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Qiu M, 2013, J VIROL, V87, P8675, DOI 10.1128/JVI.00869-13; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Riva DA, 2008, ARCH VIROL, V153, P561, DOI 10.1007/s00705-007-0023-4; Rotchford K, 2000, SEX TRANSM DIS, V27, P243, DOI 10.1097/00007435-200005000-00001; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Sui Z, 1993, Bioorg Med Chem, V1, P415, DOI 10.1016/S0968-0896(00)82152-5; UNAIDS, 2011, WORLD REF DAY 2019 H; Vlietinck AJ, 1998, PLANTA MED, V64, P97, DOI 10.1055/s-2006-957384; Wessler S, 2005, BIOL CHEM, V386, P481, DOI 10.1515/BC.2005.057; WESTMORELAND D, 1976, J VIROL, V18, P92, DOI 10.1128/JVI.18.1.92-102.1976; Wira C. R, 2015, NAT REV IMMUNOL; Zandi K, 2010, NAT PROD COMMUN, V5, P1935; Zhang HS, 2011, J CELL PHYSIOL, V226, P3385, DOI 10.1002/jcp.22691; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995	70	64	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124903	10.1371/journal.pone.0124903	http://dx.doi.org/10.1371/journal.pone.0124903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856395	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500123
J	Jue, NK; Brule, T; Coleman, FC; Koenig, CC				Jue, Nathaniel K.; Brule, Thierry; Coleman, Felicia C.; Koenig, Christopher C.			From Shelf to Shelf: Assessing Historical and Contemporary Genetic Differentiation and Connectivity across the Gulf of Mexico in Gag, Mycteroperca microlepis	PLOS ONE			English	Article							WEST FLORIDA SHELF; EFFECTIVE POPULATION-SIZE; SNAPPER LUTJANUS-CAMPECHANUS; MITOCHONDRIAL-DNA DIVERSITY; EPINEPHELUS-MORIO; UNITED-STATES; RED GROUPER; COMPARATIVE PHYLOGEOGRAPHY; UNSAMPLED POPULATIONS; MICROSATELLITE LOCI	Describing patterns of connectivity among populations of species with widespread distributions is particularly important in understanding the ecology and evolution of marine species. In this study, we examined patterns of population differentiation, migration, and historical population dynamics using microsatellite and mitochondrial loci to test whether populations of the epinephelid fish, Gag, Mycteroperca microlepis, an important fishery species, are genetically connected across the Gulf of Mexico and if so, whether that connectivity is attributable to either contemporary or historical processes. Populations of Gag on the Campeche Bank and the West Florida Shelf show significant, but low magnitude, differentiation. Time since divergence/expansion estimates associated with historical population dynamics indicate that any population or spatial expansions indicated by population genetics would have likely occurred in the late Pleistocene. Using coalescent-based approaches, we find that the best model for explaining observed spatial patterns of contemporary genetic variation is one of asymmetric gene flow, with movement from Campeche Bank to the West Florida Shelf. Both estimated migration rates and ecological data support the hypothesis that Gag populations throughout the Gulf of Mexico are connected via present day larval dispersal. Demonstrating this greatly expanded scale of connectivity for Gag highlights the influence of "ghost" populations (sensu Beerli) on genetic patterns and presents a critical consideration for both fisheries management and conservation of this and other species with similar genetic patterns.	[Jue, Nathaniel K.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32303 USA; [Brule, Thierry] CINVESTAV Merida, Merida 97310, Mexico; [Coleman, Felicia C.; Koenig, Christopher C.] Florida State Univ, Coastal & Marine Lab, St Teresa, FL 32358 USA	State University System of Florida; Florida State University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; State University System of Florida; Florida State University	Jue, NK (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32303 USA.	n.jue@uconn.edu		Koenig, Christopher/0000-0002-2592-7975; Jue, Nathaniel/0000-0003-3769-5638	National Oceanic and Atmospheric Assocation National Marine Fisheries Service [NA04NMF4540213, NA07NMF4330120, NA17FF2876]; U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program; Disney National Wildlife Refuge Centennial Scholar program; Department of Biological Science at Florida State University	National Oceanic and Atmospheric Assocation National Marine Fisheries Service; U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program(United States Environmental Protection Agency); Disney National Wildlife Refuge Centennial Scholar program; Department of Biological Science at Florida State University	This research was supported by grants from the National Oceanic and Atmospheric Assocation National Marine Fisheries Service (Grant numbers: NA04NMF4540213, NA07NMF4330120, NA17FF2876), the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program, the Disney National Wildlife Refuge Centennial Scholar program, and small grants from the Department of Biological Science at Florida State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bagley MJ, 1999, MAR BIOL, V134, P609, DOI 10.1007/s002270050576; Ball AO, 2007, MAR BIOL, V150, P1321, DOI 10.1007/s00227-006-0425-y; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Beerli P., 2008, MIGRATE VERSION 3 0; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bilodeau AL, 2005, EVOLUTION, V59, P2125; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; BOWEN BW, 1990, MAR BIOL, V107, P371, DOI 10.1007/BF01313418; Buonaccorsi VP, 2001, MAR BIOL, V138, P37, DOI 10.1007/s002270000439; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Chapman RW, 1999, MAR BIOTECHNOL, V1, P137, DOI 10.1007/PL00011761; Coleman FC, 1996, ENVIRON BIOL FISH, V47, P129, DOI 10.1007/BF00005035; Coleman FC, 2011, PROF GEOGR, V63, P456, DOI 10.1080/00330124.2011.585076; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cornuet JM, 1996, GENETICS, V144, P2001; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cunningham C.W., 1994, Experientia Supplementum (Basel), V69, P405; Cushman EL, 2009, CAN J FISH AQUAT SCI, V66, P1821, DOI 10.1139/F09-140; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fauvelot C, 2002, MAR BIOL, V141, P773, DOI 10.1007/s00227-002-0869-7; Fitzhugh GR, 2005, B MAR SCI, V77, P377; Fu YX, 1997, GENETICS, V147, P915; Garber AF, 2004, MAR BIOTECHNOL, V6, P175, DOI 10.1007/s10126-003-0023-7; Gold JR, 1998, J HERED, V89, P404, DOI 10.1093/jhered/89.5.404; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; HARPENDING HC, 1994, HUM BIOL, V66, P591; He RY, 2003, J PHYS OCEANOGR, V33, P465, DOI 10.1175/1520-0485(2003)033<0465:ALCICS>2.0.CO;2; Hetland RD, 1999, GEOPHYS RES LETT, V26, P2239, DOI 10.1029/1999GL900463; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Johnson DR, 2013, T AM FISH SOC, V142, P50, DOI 10.1080/00028487.2012.720630; Jue NK, 2006, J FISH BIOL, V69, P217, DOI 10.1111/j.1095-8649.2006.01273.x; Jue NK, 2014, MAR BIOL, V161, P1905, DOI 10.1007/s00227-014-2473-z; Karlsson S, 2009, MAR BIOL, V156, P1841, DOI 10.1007/s00227-009-1217-y; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KEENER P, 1988, B MAR SCI, V42, P376; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koenig CC, 1998, T AM FISH SOC, V127, P44, DOI 10.1577/1548-8659(1998)127<0044:AAASOJ>2.0.CO;2; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lee T, 2005, EVOLUTION, V59, P2139; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Lombardi-Carlson L, 2008, FISH RES, V91, P239, DOI 10.1016/j.fishres.2007.12.001; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; McGovern JC, 2005, B MAR SCI, V76, P47; McGovern JC, 1998, FISH B-NOAA, V96, P797; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McMillen-Jackson AL, 2003, MOL ECOL, V12, P2895, DOI 10.1046/j.1365-294X.2003.01955.x; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Mobley KB, 2010, J BIOGEOGR, V37, P1363, DOI 10.1111/j.1365-2699.2010.02288.x; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pruett C, 2005, MAR BIOL, V147, P593, DOI 10.1007/s00227-005-1615-8; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rezak R., 1985, REEFS BANKS NW GULF; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Richardson LR, 1997, FISH B-NOAA, V95, P174; Rivera MAJ, 2003, MAR BIOTECHNOL, V5, P126, DOI 10.1007/s10126-002-0093-y; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; Rocha-Olivares A, 2000, J FISH BIOL, V57, P1134, DOI 10.1006/jfbi.2000.1379; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ryman N, 2006, MOL ECOL NOTES, V6, P285, DOI 10.1111/j.1471-8286.2005.01146.x; Ryman N, 2001, MOL ECOL, V10, P2361, DOI 10.1046/j.0962-1083.2001.01345.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Schneider S, 1999, GENETICS, V152, P1079; SEDAR, 2006, SEDAR SE DAT ASS REV; SEDAR, 2009, SEDAR SE DAT ASS REV; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; Switzer TS, 2012, T AM FISH SOC, V141, P707, DOI 10.1080/00028487.2012.675913; TAJIMA F, 1989, GENETICS, V123, P585; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; van OosterHout C, 2003, MICROCHECKER 2 2 1; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White TA, 2009, MOL ECOL, V18, P2563, DOI 10.1111/j.1365-294X.2009.04218.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zatcoff MS, 2004, MAR BIOL, V144, P769, DOI 10.1007/s00227-003-1236-z; Zatcoff MS, 2002, MOL ECOL NOTES, V2, P217, DOI 10.1046/j.1471-8286.2002.00194.x	90	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120676	10.1371/journal.pone.0120676	http://dx.doi.org/10.1371/journal.pone.0120676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856095	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500014
J	Otto, S; Mensel, B; Friedrich, N; Schafer, S; Mahlke, C; von Bernstorff, W; Bock, K; Hosten, N; Kuhn, JP				Otto, Stephan; Mensel, Birger; Friedrich, Nele; Schaefer, Sophia; Mahlke, Christoph; von Bernstorff, Wolfram; Bock, Karen; Hosten, Norbert; Kuehn, Jens-Peter			Predictors of Technical Success and Rate of Complications of Image-Guided Percutaneous Transthoracic Lung Needle Biopsy of Pulmonary Tumors	PLOS ONE			English	Article							ASPIRATION BIOPSY; RISK-FACTORS; DIAGNOSTIC-ACCURACY; CT; PNEUMOTHORAX	Purpose To investigate predictors of technical success and complications of computed tomography (CT)-guided percutaneous transthoracic needle biopsy of potentially malignant pulmonary tumors. Material and Methods From 2008 to 2009, technical success and rate of complications of CT-guided percutaneous transthoracic lung needle biopsies of patients with suspicious pulmonary tumors were retrospectively evaluated. The influence on technical success and rate of complications was assessed for intervention-related predictors (lesion diameter, length of biopsy pathway, number of pleural transgressions, and needle size) and patient-related predictors (age, gender, reduced lung function). In addition, technical success and rate of complications were compared between different interventional radiologists. Results One hundred thirty-eight patients underwent biopsies by 15 interventional radiologists. The overall technical success rate was 84.1% and was significantly different between interventional radiologists (range 25%-100%; p<0.01). Intervention-related and patient-related predictors did not influence the technical success rate. The overall complication rate was 59.4% with 39.1% minor complications and 21.0% major complications. The rate of complications was influenced by lesion diameter and distance of biopsy pathway. Interventional radiologist-related rates of complications were not statistically different. Conclusions Technical success of percutaneous, transthoracic lung needle biopsies of pulmonary tumors is probably dependent on the interventional radiologist. In addition, lesion diameter and length of biopsy pathway are predictors of the rate of complications.	[Otto, Stephan; Mensel, Birger; Schaefer, Sophia; Mahlke, Christoph; Bock, Karen; Hosten, Norbert; Kuehn, Jens-Peter] Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [von Bernstorff, Wolfram] Univ Med Greifswald, Dept Surg, Div Gen Visceral Thorac & Vasc Surg, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kuhn, JP (corresponding author), Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany.	kuehn@uni-greifswald.de						Asai N, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-196; Choi CM, 2004, CHEST, V126, P1516, DOI 10.1378/chest.126.5.1516; Chojniak R, COMPUT TOMOGR, DOI [10.1148/radiol.11103506, DOI 10.1148/RADIOL.11103506]; Chojniak Rubens, 2006, Sao Paulo Med. J., V124, P10, DOI 10.1590/S1516-31802006000100003; Collings CL, 1999, RADIOLOGY, V210, P59, DOI 10.1148/radiology.210.1.r99ja1759; Cox JE, 1999, RADIOLOGY, V212, P165, DOI 10.1148/radiology.212.1.r99jl33165; Guimaraes MD, 2013, CLIN RADIOL, V68, pE353, DOI 10.1016/j.crad.2013.02.002; Guimaraes MD, 2014, CLINICS, V69, P335, DOI 10.6061/clinics/2014(05)07; Guimaraes MD, 2011, EUR J RADIOL, V80, pE488, DOI 10.1016/j.ejrad.2010.09.038; Guimaraes MD, 2009, CLINICS, V64, P1139, DOI 10.1590/S1807-59322009001200002; Herth FJF, 2006, RESPIRATION, V73, P399, DOI 10.1159/000093369; Kazerooni EA, 1996, RADIOLOGY, V198, P371, DOI 10.1148/radiology.198.2.8596834; Klein JS, 1996, RADIOLOGY, V198, P715, DOI 10.1148/radiology.198.3.8628859; Li HQ, 1996, AM J ROENTGENOL, V167, P105, DOI 10.2214/ajr.167.1.8659351; Loh SE, 2013, ANN ACAD MED SINGAP, V42, P285; Montaudon M, 2004, EUR RADIOL, V14, P1234, DOI 10.1007/s00330-004-2250-3; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; SINNER WN, 1980, FORTSCHR RONTG NEUEN, V132, P363, DOI 10.1055/s-2008-1056580; Tsukada H, 2000, AM J ROENTGENOL, V175, P239, DOI 10.2214/ajr.175.1.1750239; WESTCOTT JL, 1988, RADIOLOGY, V169, P593, DOI 10.1148/radiology.169.3.3055026; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Winn N, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-53; Wu CC, 2011, AM J ROENTGENOL, V196, pW678, DOI 10.2214/AJR.10.4659; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Yeow KM, 2001, J VASC INTERV RADIOL, V12, P1305, DOI 10.1016/S1051-0443(07)61556-5; Yildirim E, 2009, EUR J RADIOL, V70, P57, DOI 10.1016/j.ejrad.2008.01.006; Yu Liao Shin, 2002, Rev. Hosp. Clin., V57, P15, DOI 10.1590/S0041-87812002000100003	28	20	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124947	10.1371/journal.pone.0124947	http://dx.doi.org/10.1371/journal.pone.0124947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855983	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500125
J	Fladseth, K; Gafos, M; Newell, ML; McGrath, N				Fladseth, Kristin; Gafos, Mitzy; Newell, Marie Louise; McGrath, Nuala			The Impact of Gender Norms on Condom Use among HIV-Positive Adults in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							SEXUAL RISK BEHAVIOR; CAPE-TOWN; ANTIRETROVIRAL TREATMENT; WOMEN; INFECTION; PREVENTION; POWER; MEN; PERSPECTIVES; DISCLOSURE	Critical to preventing the spread of HIV is promoting condom use among HIV-positive individuals. Previous studies suggest that gender norms (social and cultural constructions of the ways that women and men are expected to behave) may be an important determinant of condom use. However, the relationship has not been evaluated among HIV-positive women and men in South Africa. We examined gender norms and condom use at last sex among 550 partnerships reported by 530 sexually-active HIV-positive women (372) and men (158) who had sought care, but not yet initiated antiretroviral therapy in a high HIV-prevalence rural setting in KwaZulu-Natal, South Africa between January 2009 and March 2011. Participants enrolled in the cohort study completed a baseline questionnaire that detailed their socio-demographic characteristics, socio-economic circumstances, religion, HIV testing history and disclosure of HIV status, stigma, social capital, gender norms and self-efficacy. Gender norms did not statistically differ between women and men (p = 0.18). Overall, condoms were used at last sex in 58% of partnerships. Although participants disclosed their HIV status in 66% of the partnerships, 60% did not have knowledge of their partner's HIV status. In multivariable logistic regression, run separately for each sex, women younger than 26 years with more equitable gender norms were significantly more likely to have used a condom at last sex than those of the same age group with inequitable gender norms (OR = 8.88, 95% CI 2.95-26.75); the association between condom use and gender norms among women aged 26+ years and men of all ages was not statistically significant. Strategies to address gender inequity should be integrated into positive prevention interventions, particularly for younger women, and supported by efforts at a societal level to decrease gender inequality.	[Fladseth, Kristin] London Sch Hyg & Trop Med, London WC1, England; [Gafos, Mitzy] UCL, Med Res Council Clin Trials Unit, London, England; [Newell, Marie Louise; McGrath, Nuala] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Newell, Marie Louise; McGrath, Nuala] Univ Southampton, Fac Med & Social & Human Sci, Southampton, Hants, England	University of London; London School of Hygiene & Tropical Medicine; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Kwazulu Natal; University of Southampton	McGrath, N (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa.	N.McGrath@soton.ac.uk	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; McGrath, Nuala/0000-0002-1039-0159; Gafos, Mitzy/0000-0002-7894-1498	Wellcome Trust [WT083495MA, 065377/Z01/H]; Medical Research Council [MC_UU_12023/23] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NM was supported by a Wellcome Trust (http://www.wellcome.ac.uk/) fellowship grant (#WT083495MA); the Africa Centre receives core support from the Wellcome Trust (#065377/Z01/H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Chimbindi Natsayi Z, 2010, Open AIDS J, V4, P88, DOI 10.2174/1874613601004010088; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cutrona C.E., 1987, ADV PERSONAL RELATIO, V1, P37; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Eisele TP, 2008, AIDS BEHAV, V12, P570, DOI 10.1007/s10461-007-9279-7; Eisele TP, 2009, AIDS BEHAV, V13, P1097, DOI 10.1007/s10461-008-9473-2; Gafos M, 2010, HOW MANY WOMEN REALL, P22; Gilbert C, 2008, PROCEEDINGS OF MICRO; Hallman, 2004, SOCIOECONOMIC DISADV; Houlihan CF, 2010, INTJ EPIDEMIOL; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; Hunter Mark., 2010, LOVE TIME AIDS INEQU; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson LF, 2012, S AFR J HIV MED, P22; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kalichman SC, 2010, EUR J PUBLIC HEALTH, V20, P202, DOI 10.1093/eurpub/ckp127; Kiene SM, 2006, AIDS, V20, P1781, DOI 10.1097/01.aids.0000242827.05120.55; Langen Tabitha T, 2005, Afr Health Sci, V5, P188; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; MacPhail C, 2009, CULT HEALTH SEX, V11, P485, DOI 10.1080/13691050902803537; Maharaj P, 2004, STUD FAMILY PLANN, V35, P116, DOI 10.1111/j.1728-4465.2004.00013.x; Mantell JE, 2011, HEALTH EDUC RES, V26, P859, DOI 10.1093/her/cyr041; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; McGrath N, 2013, AIDS; McGrath N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18048; McGrath N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-121; Mugoya GC, 2013, AIDS CARE; Nattrass N, 2008, FEM ECON, V14, P19, DOI 10.1080/13545700802266452; Ncube N, 2010, INT J LEARNING, V16, P489; Noar SM, 2006, ARCH SEX BEHAV, V35, P327, DOI 10.1007/s10508-006-9028-4; O'Sullivan LF, 2006, CULT HEALTH SEX, V8, P99, DOI 10.1080/13691050600665048; Olley BO, 2005, AIDS CARE, V17, P550, DOI 10.1080/09540120412331319741; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pettifor A, 2012, CULT HEALTH SEX, V14, P477, DOI 10.1080/13691058.2012.667575; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011632; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Shisana O, 2010, SOUTH AFRICAN NATION; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; South African National AIDS Commission (SANAC), 2012, GLOB AIDS RESP PROGR; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Susser I, 2009, AIDS SEX AND CULTURE; The South African Department of Health, 2013, THE SOUTH AFRICAN AN; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Venkatesh KK, 2012, AIDS BEHAV, V16, P139, DOI 10.1007/s10461-011-9941-y; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Wechsberg WM, 2010, J PREV INTERV COMMUN, V38, P132, DOI 10.1080/10852351003640799; Wong LH, 2009, JAIDS-J ACQ IMM DEF, V50, P215, DOI 10.1097/QAI.0b013e3181900172; Younge SN, 2008, ADOLESCENCE, V43, P927; Zaidi J, 2013, AIDS	55	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122671	10.1371/journal.pone.0122671	http://dx.doi.org/10.1371/journal.pone.0122671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853870	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000352478400075
J	He, W; Pedersen, SC; Gupta, AK; Simmons, JA; Muller, R				He, Weikai; Pedersen, Scott C.; Gupta, Anupam K.; Simmons, James A.; Mueller, Rolf			Lancet Dynamics in Greater Horseshoe Bats, Rhinolophus ferrumequinum	PLOS ONE			English	Article							FORAGING BEHAVIOR; ACOUSTIC FOVEA; ECHOLOCATION; CHIROPTERA; WIDTH	Echolocating greater horseshoe bats (Rhinolophus ferrumequinum) emit their biosonar pulses nasally, through nostrils surrounded by fleshy appendages ('noseleaves') that diffract the outgoing ultrasonic waves. Movements of one noseleaf part, the lancet, were measured in live bats using two synchronized high speed video cameras with 3D stereo reconstruction, and synchronized with pulse emissions recorded by an ultrasonic microphone. During individual broadcasts, the lancet briefly flicks forward (flexion) and is then restored to its original position. This forward motion lasts tens of milliseconds and increases the curvature of the affected noseleaf surfaces. Approximately 90% of the maximum displacements occurred within the duration of individual pulses, with 70% occurring towards the end. Similar lancet motions were not observed between individual pulses in a sequence of broadcasts. Velocities of the lancet motion were too small to induce Doppler shifts of a biologically-meaningful magnitude, but the maximum displacements were significant in comparison with the overall size of the lancet and the ultrasonic wavelengths. Three finite element models were made from micro-CT scans of the noseleaf post mortem to investigate the acoustic effects of lancet displacement. The broadcast beam shapes were found to be altered substantially by the observed small lancet movements. These findings demonstrate that-in addition to the previously described motions of the anterior leaf and the pinna-horseshoe bat biosonar has a third degree of freedom for fast changes that can happen on the time scale of the emitted pulses or the returning echoes and could provide a dynamic mechanism for the encoding of sensory information.	[He, Weikai; Mueller, Rolf] Shandong Univ, Sch Phys, SDU VT Int Lab, Jinan, Shandong, Peoples R China; [Pedersen, Scott C.] S Dakota State Univ, Dept Biol Microbiol, Brookings, SD 57007 USA; [Gupta, Anupam K.; Mueller, Rolf] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Shandong University; South Dakota State University; Virginia Polytechnic Institute & State University; Brown University	Muller, R (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	rolf.mueller@vt.edu			National Natural Science Foundation of China [451069]; NSF [1053130]; Ministry of Education of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); Ministry of Education of the People's Republic of China(Ministry of Education, China)	Funding provided by National Natural Science Foundation of China, http://www.nsfc.gov.cn, grant number: 451069, RM, NSF, http://www.nsf.gov, award id 1053130, RM and Ministry of Education of the People's Republic of China, http://www.moe.gov.cn, RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulagnier S, 2008, IUCN RED LIST THREAT; Bradski G., 2008, LEARNING OPENCV COMP; BRUNS V, 1980, HEARING RES, V3, P27, DOI 10.1016/0378-5955(80)90006-4; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034685; Gao L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.214301; HARTLEY DJ, 1988, J ACOUST SOC AM, V84, P1201, DOI 10.1121/1.396621; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Matsuta N, 2013, J EXP BIOL, V216, P1210, DOI 10.1242/jeb.081398; NEUWEILER G, 1987, BEHAV ECOL SOCIOBIOL, V20, P53, DOI 10.1007/BF00292166; SCHNEIDER H, 1960, Z VERGL PHYSIOL, V44, P1, DOI 10.1007/BF00297861; SCHNITZLER HU, 1977, J COMP PHYSIOL, V116, P51, DOI 10.1007/BF00605516; SCHNITZLER HU, 1973, J COMP PHYSIOL, V82, P79, DOI 10.1007/BF00714171; SCHNITZLER HU, 1983, ADV VERTEBRATE NEURO, P801, DOI DOI 10.1007/978-1-4684-4412-4_39; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; Siemers BM, 2004, BEHAV ECOL SOCIOBIOL, V56, P464, DOI 10.1007/s00265-004-0807-4; Vanderelst D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00191; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701; Zhuang Q, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051902	21	20	21	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121700	10.1371/journal.pone.0121700	http://dx.doi.org/10.1371/journal.pone.0121700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853738	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400045
J	Jiang, YD; Thakran, S; Bheemreddy, R; Coppess, W; Walker, RJ; Steinle, JJ				Jiang, Youde; Thakran, Shalini; Bheemreddy, Rajini; Coppess, William; Walker, Robert J.; Steinle, Jena J.			Sodium Salicylate Reduced Insulin Resistance in the Retina of a Type 2 Diabetic Rat Model	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TNF-ALPHA; INDUCED APOPTOSIS; ADIPOSE-TISSUE; IKK-BETA; INHIBIT; SOCS-3; CELLS	Sodium salicylate has been reported to reduce markers of diabetic retinopathy in a type 1 rat model. Because rates of type 2 diabetes are on the rise, we wanted to determine whether salicylate could improve insulin resistance in a type 2 rat model, as well as improve retinal function. We treated lean and obese BBZDR/Wor type 2 diabetic rats with salicylate in their chow for 2 months. Prior to salicylate treatment, rats underwent an electroretinogram to measure retinal function. After 2 months of treatment, rats underwent an additional electroretinogram prior to sacrifice. In addition to the animal model, we also treated retinal endothelial cells (REC) and rat Muller cells with salicylate and performed the same analyses as done for the rat retinal lysates. To investigate the role of salicylate in insulin signaling, we measured TNF alpha and caspase 3 levels by ELISA, as well as performed Western blotting for insulin receptor substrate 1, insulin receptor, SOCS3, and pro- and anti-apoptotic markers. Data demonstrated that salicylate significantly improved retinal function, as well as reduced TNF alpha and SOCS3-induced insulin resistance in all samples. Overall, results suggest that salicylate is effective in reducing insulin resistance in the retina of type 2 diabetic rat models.	[Jiang, Youde; Steinle, Jena J.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Steinle, Jena J.] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA; [Thakran, Shalini; Bheemreddy, Rajini; Coppess, William; Walker, Robert J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Jiang, Youde; Steinle, Jena J.] VA Med Ctr, Memphis, TN USA; [Walker, Robert J.] Philder Smith Coll, Little Rock, AR USA	Wayne State University; Wayne State University; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Steinle, JJ (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA.	jsteinle@med.wayne.edu		Steinle, Jena/0000-0002-7539-2892	National Eye Institute [R01EY022330]; VA Merit Award [IBX001585A, P30EY04068]; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL EYE INSTITUTE [P30EY004068, R01EY022330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); VA Merit Award(US Department of Veterans Affairs); Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Eye Institute (R01EY022330 to JJS); VA Merit Award IBX001585A (JJS), P30EY04068 (PI: Hazlett) and an Unrestricted Grant to the Department of Ophthalmology from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Dinis-Oliveira RJ, 2007, FREE RADICAL BIO MED, V43, P48, DOI 10.1016/j.freeradbiomed.2007.03.014; Ellis EA, 1998, FREE RADICAL BIO MED, V24, P111, DOI 10.1016/S0891-5849(97)00202-5; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Feng H, 2010, NEUROSCI LETT, V479, P34, DOI 10.1016/j.neulet.2010.05.023; He B, 2010, DIABETES RES CLIN PR, V89, P150, DOI 10.1016/j.diabres.2010.04.004; Hu SS, 2014, INFLAMMATION, V37, P365, DOI 10.1007/s10753-013-9748-2; Hwang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-30; Ismail WIW, 2013, J CELL BIOCHEM, V114, P1729, DOI 10.1002/jcb.24513; Ito I, 2006, INVEST OPHTH VIS SCI, V47, P683, DOI 10.1167/iovs.05-1012; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jiang YD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-96; Jiang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070555; Jiang Y, 2013, MOL VIS, V19, P804; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2009, MOL VIS, V15, P1418; Klampfer L, 1999, BLOOD, V93, P2386, DOI 10.1182/blood.V93.7.2386.407k15_2386_2394; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Lee EJ, 2003, INT J ONCOL, V23, P503; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Liu K, 2012, ATHEROSCLEROSIS, V223, P350, DOI 10.1016/j.atherosclerosis.2012.06.012; Madathil SK, 2013, SYNAPSE, V67, P502, DOI 10.1002/syn.21658; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Park E, 2007, J ENDOCRINOL, V195, P323, DOI 10.1677/JOE-07-0005; Park S, 2013, ARCH PHARM RES, V36, P880, DOI 10.1007/s12272-013-0116-4; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Thakur P, 2013, NEUROSCIENCE, V231, P420, DOI 10.1016/j.neuroscience.2012.11.006; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Walker RJ, 2012, MOL VIS, V18, P271; Walker RJ, 2011, INVEST OPHTH VIS SCI, V52, P9527, DOI 10.1167/iovs.11-8631; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P3052, DOI 10.1167/iovs.12-11533; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125505	10.1371/journal.pone.0125505	http://dx.doi.org/10.1371/journal.pone.0125505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874611	Green Submitted, gold, Green Published			2022-12-26	WOS:000353014700076
J	Murphy, K; O' Shea, CA; Ryan, CA; Dempsey, EM; O' Toole, PW; Stanton, C; Ross, RP				Murphy, Kiera; O' Shea, Carol Anne; Ryan, C. Anthony; Dempsey, Eugene M.; O' Toole, Paul W.; Stanton, Catherine; Ross, R. Paul			The Gut Microbiota Composition in Dichorionic Triplet Sets Suggests a Role for Host Genetic Factors	PLOS ONE			English	Article							EARLY-LIFE; ANTIBIOTICS; ASTHMA; GENERATION; DIVERSITY; EXPOSURE; HEALTH; RISK; TOOL	Monozygotic and dizygotic twin studies investigating the relative roles of host genetics and environmental factors in shaping gut microbiota composition have produced conflicting results. In this study, we investigated the gut microbiota composition of a healthy dichorionic triplet set. The dichorionic triplet set contained a pair of monozygotic twins and a fraternal sibling, with similar pre- and post-natal environmental conditions including feeding regime. V4 16S rRNA and rpoB amplicon pyrosequencing was employed to investigate microbiota composition, and the species and strain diversity of the culturable bifidobacterial population was also examined. At month 1, the monozygotic pair shared a similar microbiota distinct to the fraternal sibling. By month 12 however, the profile was more uniform between the three infants. Principal coordinate analysis (PCoA) of the microbiota composition revealed strong clustering of the monozygotic pair at month 1 and a separation of the fraternal infant. At months 2 and 3 the phylogenetic distance between the monozygotic pair and the fraternal sibling has greatly reduced and by month 12 the monozygotic pair no longer clustered separately from the fraternal infant. Pulse field gel electrophoresis (PFGE) analysis of the bifidobacterial population revealed a lack of strain diversity, with identical strains identified in all three infants at month 1 and 12. The microbiota of two antibiotic-treated dichorionic triplet sets was also investigated. Not surprisingly, in both triplet sets early life antibiotic administration appeared to be a major determinant of microbiota composition at month 1, irrespective of zygosity. By month 12, early antibiotic administration appeared to no longer exert such a strong influence on gut microbiota composition. We hypothesize that initially host genetics play a significant role in the composition of an individual's gut microbiota, unless an antibiotic intervention is given, but by month 12 environmental factors are the major determinant.	[Murphy, Kiera; Stanton, Catherine] Teagasc Food Res Ctr, Food Biosci Dept, Fermoy, Co Cork, Ireland; [Murphy, Kiera; O' Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [O' Shea, Carol Anne; Ryan, C. Anthony; Dempsey, Eugene M.] Cork Univ, Dept Neonatol, Matern Hosp, Cork, Ireland; [O' Shea, Carol Anne; Ryan, C. Anthony; O' Toole, Paul W.; Stanton, Catherine; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Dempsey, Eugene M.] Natl Univ Ireland Univ Coll Cork, Infant Ctr, Cork, Ireland; [Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Coll Sci Engn & Food Sci, Cork, Ireland	Teagasc; University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Ross, RP (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	p.ross@ucc.ie	Dempsey, Eugene/AAG-3037-2021; Ross, Paul/A-7584-2015; O'Toole, Paul W/G-1593-2012; Stanton, Catherine/A-9549-2015; Dempsey, Eugene Michael/H-8051-2015	Ross, Paul/0000-0003-4876-8839; O'Toole, Paul W/0000-0001-5377-0824; Stanton, Catherine/0000-0002-6724-7011; Dempsey, Eugene Michael/0000-0002-6266-3462; Murphy, Kiera/0000-0002-6543-5158	INFANTMET project [10/RD/Infantmet/MFRC/705]; Government of Ireland's Department of Agriculture Fisheries; Alimentary Pharmabiotic Centre; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [02/CE/B124, 07/CE/B1368]	INFANTMET project; Government of Ireland's Department of Agriculture Fisheries; Alimentary Pharmabiotic Centre(Science Foundation Ireland); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	This study was performed as part of the INFANTMET project (10/RD/Infantmet/MFRC/705) and was funded by the Government of Ireland's Department of Agriculture Fisheries and in part by Alimentary Pharmabiotic Centre. KM is a Teagasc Walsh Fellow. CS, RPR and PWOT are members of The Alimentary Pharmabiotic Centre, which is a Centre for Science and Technology (CSET) funded by the Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant no. 02/CE/B124 and 07/CE/B1368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI [10.1126/scitranslmed.3008639, DOI 10.1126/SCITRANSLMED.3008639]; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres A, 2012, PEDIATRICS, V129, P1134, DOI 10.1542/peds.2011-3121; Barrett E, 2014, ARCH DIS CHILD FETAL; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Kim BJ, 2010, INT J SYST EVOL MICR, V60, P2697, DOI 10.1099/ijs.0.020339-0; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Lakshminarayanan B, 2013, J MED MICROBIOL, V62, P457, DOI 10.1099/jmm.0.052258-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marques TM, 2014, INNOV FOOD SCI EMERG, V22, P239, DOI 10.1016/j.ifset.2013.10.016; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Muc M, 2013, ADV EXP MED BIOL, V788, P393, DOI 10.1007/978-94-007-6627-3_53; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rodriguez JM, 2014, MICROBIAL ECOLOGY HL; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stewart CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073465; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2001, MICROBIAL ECOLOGY IN, V13	41	25	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122561	10.1371/journal.pone.0122561	http://dx.doi.org/10.1371/journal.pone.0122561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874766	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700020
J	Ben Messaoud, N; Yue, JC; Valent, D; Katzarova, I; Lopez, JM				Ben Messaoud, Nabil; Yue, Jicheng; Valent, Daniel; Katzarova, Ilina; Lopez, Jose M.			Osmostress-Induced Apoptosis in Xenopus Oocytes: Role of Stress Protein Kinases, Calpains and Smac/DIABLO	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; N-TERMINAL KINASE; CYTOCHROME-C; MITOCHONDRIAL RELEASE; HYPEROSMOTIC STRESS; NEURONAL APOPTOSIS; POTASSIUM CHANNELS; CELL-DEATH; ACTIVATION; INHIBITOR	Hyperosmotic shock induces cytochrome c release and capase-3 activation in Xenopus oo-cytes, but the regulators and signaling pathways involved are not well characterized. Here we show that hyperosmotic shock induces rapid calpain activation and high levels of Smac/DIABLO release from the mitochondria before significant amounts of cytochrome c are released to promote caspase-3 activation. Calpain inhibitors or EGTA microinjection delays osmostress-induced apoptosis, and blockage of Smac/DIABLO with antibodies markedly reduces cytochrome c release and caspase-3 activation. Hyperosmotic shock also activates the p38 and JNK signaling pathways very quickly. Simultaneous inhibition of both p38 and JNK pathways reduces osmostress-induced apoptosis, while sustained activation of these kinases accelerates the release of cytochrome c and caspase-3 activation. Therefore, at least four different pathways early induced by osmostress converge on the mitochondria to trigger apoptosis. Deciphering the mechanisms of hyperosmotic shock-induced apoptosis gives insight for potential treatments of human diseases that are caused by perturbations in fluid osmolarity.	[Ben Messaoud, Nabil; Yue, Jicheng; Valent, Daniel; Katzarova, Ilina; Lopez, Jose M.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.cat	Lopez, Jose/AAF-3798-2020; Lopez, Jose M/D-1654-2011	Lopez, Jose/0000-0002-4104-6262; Lopez, Jose M/0000-0002-4104-6262; Valent, Daniel/0000-0001-6927-3099	Spanish Ministerio de Economia y Competitividad [BFU2009-10765, BFU2010-15978]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (grant numbers BFU2009-10765 and BFU2010-15978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Brocker Chad, 2012, Biomol Concepts, V3, P345; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cortese JD, 1998, BIOCHEMISTRY-US, V37, P6402, DOI 10.1021/bi9730543; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DASCALU A, 1995, J PHYSIOL-LONDON, V486, P97, DOI 10.1113/jphysiol.1995.sp020793; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Erickson GR, 2001, J BIOMECH, V34, P1527, DOI 10.1016/S0021-9290(01)00156-7; Friis MB, 2005, J PHYSIOL-LONDON, V567, P427, DOI 10.1113/jphysiol.2005.087130; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gorbenko GP, 1999, BBA-BIOMEMBRANES, V1420, P1, DOI 10.1016/S0005-2736(99)00082-6; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lang KS, 2004, CELL DEATH DIFFER, V11, P231, DOI 10.1038/sj.cdd.4401311; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Reinehr R, 2006, J BIOL CHEM, V281, P23150, DOI 10.1074/jbc.M601451200; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Rudy A, 2008, CELL DEATH DIFFER, V15, P1930, DOI 10.1038/cdd.2008.125; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Thomas D, 2004, CARDIOVASC RES, V64, P467, DOI 10.1016/j.cardiores.2004.07.023; Thomas D, 2001, J PHARMACOL EXP THER, V297, P753; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Zhou LL, 2005, APOPTOSIS, V10, P289, DOI 10.1007/s10495-005-0803-9	52	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124482	10.1371/journal.pone.0124482	http://dx.doi.org/10.1371/journal.pone.0124482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866890	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100262
J	Birle, A; Nebe, CT; Hill, S; Hartmann, K; Poeschl, J; Koch, L				Birle, Alexandra; Nebe, C. Thomas; Hill, Sandra; Hartmann, Karin; Poeschl, Johannes; Koch, Lutz			Neutrophil Chemotaxis in Cord Blood of Term and Preterm Neonates Is Reduced in Preterm Neonates and Influenced by the Mode of Delivery and Anaesthesia	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTE FUNCTION; LOCAL-ANESTHETICS; NEWBORN-INFANTS; SHAPE CHANGE; IN-VITRO; MIGRATION; ADHESION; CHEMOKINES; LIDOCAINE; INFECTION	Bacterial infections, even without any perinatal risk factors, are common in newborns, especially in preterm neonates. The aim of this study was to evaluate possible impairment of neutrophil chemotaxis in term and preterm neonates compared with adults as well as neonates with different modes of delivery and anaesthesia. We analysed the expression of the adhesion molecule L-Selectin as well as shape change, spontaneous and N-formylmethionyl-leucyl-phenylalanine (fMLP)-induced transmigration of neutrophils in a flow cytometric assay of chemotaxis after spontaneous delivery with Cesarian Section (CS) under spinal anaesthesia (mepivacaine, sufentanil), epidural anaesthesia (ropivacaine or bupivacaine, sufentanil) or general anaesthesia (ketamine, thiopental, succinylcholine). Chemokinesis was higher (p=0.008) in cord blood neutrophils than in the adult ones, whereas those could be more stimulated by fMLP (p=0.02). After vaginal delivery neutrophils showed a higher spontaneous and fMLP-stimulated chemotactic response compared to neonates after CS without labor. Comparing different types of anaesthesia for CS, spinal anaesthesia resulted in less impairment on chemotaxis than general anaesthesia or epidural anaesthesia. The new flow cytometric assay of neutrophil chemotaxis is an appropriate and objective method to analyse functional differences even in very small volumes of blood, essential in neonatology. Term neonates do not show reduced chemotaxis compared to adults. Preterm neonates present with reduced chemotaxis and chemokinesis, confirming the well known deficits in their neutrophil function. The side effects of maternal drugs on the neonatal immune system have to be considered especially when the immune response is already impaired, as in preterm infants.	[Birle, Alexandra; Hill, Sandra; Poeschl, Johannes; Koch, Lutz] Univ Childrens Hosp, Sch Med, Dept Neonatol, Heidelberg, Germany; [Nebe, C. Thomas; Hartmann, Karin] Hamatol Lab Mannheim, Mannheim, Germany; [Koch, Lutz] Catholic Childrens Hosp Wilhelmstift, Dept Neonatol, Hamburg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Birle, A (corresponding author), Univ Childrens Hosp, Sch Med, Dept Neonatol, Heidelberg, Germany.	alexandra.birle@gmail.com			Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DC, 1981, J CLIN INVEST, V68, P863, DOI 10.1172/JCI110341; Andrews WW, 2000, AM J PERINAT, V17, P357, DOI 10.1055/s-2000-13448; Baggiolini M, 1995, Clin Exp Immunol, V101 Suppl 1, P5; BEKTAS S, 1990, ACTA PAEDIATR SCAND, V79, P1031, DOI 10.1111/j.1651-2227.1990.tb11379.x; BUHRER C, 1994, PEDIATR RES, V36, P799; CARR R, 1992, ARCH DIS CHILD-FETAL, V67, P813, DOI 10.1136/adc.67.7_Spec_No.813; Cazzola G A, 1990, Pediatr Med Chir, V12, P25; Chen Wu-Yuan, 1996, Kaohsiung Journal of Medical Sciences, V12, P83; COLE AT, 1995, CLIN SCI, V89, P549, DOI 10.1042/cs0890549; De Amici D, 1990, MINERVA ANESTESIOL, V6, P175; Fischer LG, 2001, ANESTH ANALG, V92, P1041; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; FUENFER MM, 1987, PEDIATR RES, V22, P150, DOI 10.1203/00006450-198708000-00009; Gasparoni A, 1998, J CLIN IMMUNOL, V18, P210, DOI 10.1023/A:1020583022614; GASPARONI A, 1991, EUR J PEDIATR, V150, P481, DOI 10.1007/BF01958427; Gessler P, 1996, INTENS CARE MED, V22, P252, DOI 10.1007/BF01712246; HERSON VC, 1992, AM J PERINAT, V9, P285, DOI 10.1055/s-2007-994791; HILL HR, 1987, PEDIATR RES, V22, P375, DOI 10.1203/00006450-198710000-00001; HOGG N, 1992, IMMUNOL TODAY, V13, P113, DOI 10.1016/0167-5699(92)90103-E; IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9; KRAUSE PJ, 1989, PEDIATR RES, V25, P519, DOI 10.1203/00006450-198905000-00019; Mikawa K, 2003, EUR J ANAESTH, V20, P104, DOI 10.1097/00003643-200302000-00004; Nicholson GC, 2007, PULM PHARMACOL THER, V20, P52, DOI 10.1016/j.pupt.2005.11.009; SASAGAWA S, 1991, IMMUNOPHARM IMMUNOT, V13, P607, DOI 10.3109/08923979109019726; USMANI SS, 1991, PEDIATRICS, V87, P675; USMANI SS, 1993, PEDIATR RES, V33, P466, DOI 10.1203/00006450-199305000-00009; Yektaei-Karin E, 2007, PEDIAT ALLERG IMM-UK, V18, P643, DOI 10.1111/j.1399-3038.2007.00578.x; Zentay Z, 1999, PEDIATR RES, V46, P406, DOI 10.1203/00006450-199910000-00008	28	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120341	10.1371/journal.pone.0120341	http://dx.doi.org/10.1371/journal.pone.0120341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867529	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100022
J	Guo, Y; Yan, KP; Qu, Q; Qu, J; Chen, ZG; Song, T; Luo, XY; Sun, ZY; Bi, CL; Liu, JF				Guo, Yong; Yan, Kui Po; Qu, Qiang; Qu, Jian; Chen, Zi Gui; Song, Tao; Luo, Xiang-Ying; Sun, Zhong-Yi; Bi, Chang-Long; Liu, Jin-Fang			Common Variants of KCNJ10 Are Associated with Susceptibility and Anti-Epileptic Drug Resistance in Chinese Genetic Generalized Epilepsies	PLOS ONE			English	Article							RECTIFYING K+ CHANNEL; SENSORINEURAL DEAFNESS; SEIZURE SUSCEPTIBILITY; POLYMORPHISMS; ATAXIA; TUBULOPATHY; MUTATIONS; KIR4.1; ABCC2	To explore genetic mechanism of genetic generalized epilepsies (GGEs) is challenging because of their complex heritance pattern and genetic heterogeneity. KCNJ10 gene encodes Kir4.1 channels and plays a major role in modulating resting membrane potentials in excitable cells. It may cause GGEs if mutated. The purpose of this study was to investigate the possible association between KCNJ10 common variants and the susceptibility and drug resistance of GGEs in Chinese population. The allele-specific MALDI-TOF mass spectrometry method was used to assess 8 single nucleotide polymorphisms (SNPs) of KCNJ10 in 284 healthy controls and 483 Chinese GGEs patients including 279 anti-epileptic drug responsive patients and 204 drug resistant patients. We found the rs6690889 TC+TT genotypes were lower frequency in the GGEs group than that in the healthy controls (6.7% vs 9.5%, p = 0.01, OR = 0.50[0.29-0.86]). The frequency of rs1053074 G allele was lower in the childhood absence epilepsy (CAE) group than that in the healthy controls (28.4% vs 36.2%, p = 0.01, OR = 0.70[0.53-0.93]). The frequency of rs12729701 G allele and AG+GG genotypes was lower in the CAE group than that in the healthy controls (21.2% vs 28.4%, p = 0.01, OR = 0.74[0.59-0.94] and 36.3% vs 48.1%, p = 0.01, OR = 0.83[0.72-0.96], respectively). The frequency of rs12402969 C allele and the CC+CT genotypes were higher in the GGEs drug responsive patients than that in the drug resistant patients (9.3% vs 5.6%, OR = 1.73[1.06-2.85], p = 0.026 and 36.3% vs 48.1%, p = 0.01, OR = 0.83[0.72-0.96], respectively). This study identifies potential SNPs of KCNJ10 gene that may contribute to seizure susceptibility and anti-epileptic drug resistance.	[Guo, Yong; Chen, Zi Gui; Song, Tao; Luo, Xiang-Ying; Sun, Zhong-Yi; Bi, Chang-Long; Liu, Jin-Fang] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China; [Yan, Kui Po] Henan Collede TCM, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450008, Peoples R China; [Qu, Qiang] Cent South Univ, Xiangya Hosp, Dept Pharmacol, Changsha 410008, Hunan, Peoples R China; [Qu, Jian] Cent South Univ, Inst Clin Pharmacol, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University	Liu, JF (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China.	1612455489@qq.com			Research Innovation Foundation of Graduate Student in Hunan Province, P.R.C [CX2011B056]; Hunan Provincial Innovation Foundation for Postgraduates [CX2013B102]	Research Innovation Foundation of Graduate Student in Hunan Province, P.R.C; Hunan Provincial Innovation Foundation for Postgraduates	This study was supported by grants from the Research Innovation Foundation of Graduate Student in Hunan Province, P.R.C (CX2011B056) and the Hunan Provincial Innovation Foundation for Postgraduates (CX2013B102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Dai AI, 2014, J CHILD NEUROLOGY; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Greenberg DA, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02734.x; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Kwan P, 2011, PHARMACOGENOMICS, V12, P319, DOI [10.2217/pgs.10.183, 10.2217/PGS.10.183]; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Lucarini N, 2007, PEDIATR NEUROL, V37, P157, DOI 10.1016/j.pediatrneurol.2007.06.001; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Nagao Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00104; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Phani NM, 2014, GENE, V536, P247, DOI 10.1016/j.gene.2013.12.026; Qu J, 2012, CNS NEUROSCI THER, V18, P647, DOI 10.1111/j.1755-5949.2012.00336.x; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Shang LJ, 2005, MOL BRAIN RES, V139, P178, DOI 10.1016/j.molbrainres.2005.05.003; Sicca F, 2011, NEUROBIOL DIS, V43, P239, DOI 10.1016/j.nbd.2011.03.016; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; Tan NCK, 2010, EPILEPSIA, V51, P686, DOI 10.1111/j.1528-1167.2009.02423.x; Weber YG, 2008, DEV MED CHILD NEUROL, V50, P648, DOI 10.1111/j.1469-8749.2008.03058.x	31	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124896	10.1371/journal.pone.0124896	http://dx.doi.org/10.1371/journal.pone.0124896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874548	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100281
J	Sapmak, A; Boyce, KJ; Andrianopoulos, A; Vanittanakom, N				Sapmak, Ariya; Boyce, Kylie J.; Andrianopoulos, Alex; Vanittanakom, Nongnuch			The pbrB Gene Encodes a Laccase Required for DHN-Melanin Synthesis in Conidia of Talaromyces (Penicillium) marneffei	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BIOSYNTHESIS; OXIDASE; TRICYCLAZOLE; INFECTION; PATHWAY; DOPA	Talaromyces marneffei (Basionym: Penicillium marneffei) is a significant opportunistic fungal pathogen in patients infected with human immunodeficiency virus in Southeast Asia. T. marneffei cells have been shown to become melanized in vivo. Melanins are pigment biopolymers which act as a non-specific protectant against various stressors and which play an important role during virulence in fungi. The synthesis of the two most commonly found melanins in fungi, the eumelanin DOPA-melanin and the allomelanin DHN-melanin, requires the action of laccase enzymes. The T. marneffei genome encodes a number of lac-cases and this study describes the characterization of one of these, pbrB, during growth and development. A strain carrying a PbrB-GFP fusion shows that pbrB is expressed at high levels during asexual development (conidiation) but not in cells growing vegetatively. The pbrB gene is required for the synthesis of DHN-melanin in conidia and when deleted results in brown pigmented conidia, in contrast to the green conidia of the wild type.	[Sapmak, Ariya; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Boyce, Kylie J.; Andrianopoulos, Alex] Univ Melbourne, Fac Sci, Dept Genet, Melbourne, Vic 3010, Australia	Chiang Mai University; University of Melbourne	Vanittanakom, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	drnongnuch@gmail.com		Boyce, Kylie J./0000-0002-7167-5414	Royal Golden Jubilee PhD Research Assistant Fellowship of the Thailand Research Fund [PHD/0024/2549]; National Research University Project of the Thai Ministry of Education; National Health and Medical Research Council of Australia [566926]	Royal Golden Jubilee PhD Research Assistant Fellowship of the Thailand Research Fund; National Research University Project of the Thai Ministry of Education; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Royal Golden Jubilee PhD Research Assistant Fellowship of the Thailand Research Fund (Grant no. PHD/0024/2549; http://www.trf.or.th/), the National Research University Project of the Thai Ministry of Education (http://www.inter.mua.go.th/main2/index.php), and the National Health and Medical Research Council of Australia (Grant no. 566926; http://www.nhmrc.gov.au/). All funders supported in the study design, experiments, and publication.	Andrianopoulos A, 2002, INT J MED MICROBIOL, V292, P331, DOI 10.1078/1438-4221-00217; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Borneman AR, 2002, MOL MICROBIOL, V44, P621, DOI 10.1046/j.1365-2958.2002.02906.x; Borneman AR, 2001, GENETICS, V157, P1003; Boyce KJ, 2012, FUNGAL GENET REP, V59, P1, DOI DOI 10.4148/1941-4765.1009; Bugeja HE, 2012, FUNGAL BIOL-UK, V116, P145, DOI 10.1016/j.funbio.2011.10.009; Canovas D, 2011, EUKARYOT CELL, V10, P302, DOI 10.1128/EC.00201-10; Cooper CR, 2008, FUTURE MICROBIOL, V3, P43, DOI 10.2217/17460913.3.1.43; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Kanjanahaluethai A, 2007, VIROLOGY, V361, P391, DOI 10.1016/j.virol.2006.12.009; Kawamura C, 1997, MOL PLANT MICROBE IN, V10, P446, DOI 10.1094/MPMI.1997.10.4.446; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Kurahashi Y, 2001, MOL BIOL REP, V37, P3583, DOI [10.1007/s11033-010-0007-4, DOI 10.1007/S11033-010-0007-4]; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lee JK, 2003, APPL ENVIRON MICROB, V69, P3427, DOI 10.1128/AEM.69.6.3427-3434.2003; Lee PPW, 2012, CLIN INFECT DIS, V54, pe8, DOI 10.1093/cid/cir754; Liu DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092610; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; MAYORGA ME, 1990, GENETICS, V126, P73; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; OHARA EB, 1989, GENETICS, V121, P249; Pal AK, 2014, MED MYCOL, V52, P10, DOI 10.3109/13693786.2013.826879; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Shraddha, 2011, Enzyme Res, V2011, P217861, DOI 10.4061/2011/217861; Sugareva V, 2006, ARCH MICROBIOL, V186, P345, DOI 10.1007/s00203-006-0144-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thirach S., 2008, Journal of Infectious Diseases and Antimicrobial Agents, V25, P81; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; TOKOUSBALIDES MC, 1979, PESTIC BIOCHEM PHYS, V11, P64, DOI 10.1016/0048-3575(79)90048-8; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom N, 2002, J CLIN MICROBIOL, V40, P1739, DOI 10.1128/JCM.40.5.1739-1742.2002; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; WHEELER MH, 1995, PESTIC BIOCHEM PHYS, V52, P125, DOI 10.1006/pest.1995.1037; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0	50	26	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122728	10.1371/journal.pone.0122728	http://dx.doi.org/10.1371/journal.pone.0122728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25866870	gold, Green Published			2022-12-26	WOS:000352845100096
J	Das, L; Vinayak, M				Das, Laxmidhar; Vinayak, Manjula			Long Term Effect of Curcumin in Restoration of Tumour Suppressor p53 and Phase-II Antioxidant Enzymes via Activation of Nrf2 Signalling and Modulation of Inflammation in Prevention of Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GLUTATHIONE-S-TRANSFERASE; NITRIC-OXIDE SYNTHASE; TGF-BETA; NAD(P)H-QUINONE OXIDOREDUCTASE-1; NRF2-MEDIATED ANTIOXIDANT; SULFHYDRYL-GROUPS; IN-VIVO; EXPRESSION; INDUCTION	Inhibition of carcinogenesis may be a consequence of attenuation of oxidative stress via activation of antioxidant defence system, restoration and stabilization of tumour suppressor proteins along with modulation of inflammatory mediators. Previously we have delineated significant role of curcumin during its long term effect in regulation of glycolytic pathway and angiogenesis, which in turn results in prevention of cancer via modulation of stress activated genes. Present study was designed to investigate long term effect of curcumin in regulation of Nrf2 mediated phase-II antioxidant enzymes, tumour suppressor p53 and inflammation under oxidative tumour microenvironment in liver of T-cell lymphoma bearing mice. Inhibition of Nrf2 signalling observed during lymphoma progression, resulted in down regulation of phase-II antioxidant enzymes, p53 as well as activation of inflammatory signals. Curcumin potentiated significant increase in Nrf2 activation. It restored activity of phase-II antioxidant enzymes like GST, GR, NQO1, and tumour suppressor p53 level. In addition, curcumin modulated inflammation via upregulation of TGF-beta and reciprocal regulation of iNOS and COX2. The study suggests that during long term effect, curcumin leads to prevention of cancer by inducing phase-II antioxidant enzymes via activation of Nrf2 signalling, restoration of tumour suppressor p53 and modulation of inflammatory mediators like iNOS and COX2 in liver of lymphoma bearing mice.	[Das, Laxmidhar; Vinayak, Manjula] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Ctr Adv Study, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Vinayak, M (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Ctr Adv Study, Varanasi 221005, Uttar Pradesh, India.	manjulavinayak@rediffmail.com			Department of Science and Technology, Government of India [SR/S0/AS-97/2007]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The work was supported by grants from the Department of Science and Technology (Grant No.-SR/S0/AS-97/2007), Government of India to MV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Andorfer JH, 2004, CARCINOGENESIS, V25, P359, DOI 10.1093/carcin/bgh023; Are C, 2010, HPB, V12, P498, DOI 10.1111/j.1477-2574.2010.00219.x; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Churchman AT, 2009, J CELL MOL MED, V13, P2282, DOI 10.1111/j.1582-4934.2009.00874.x; Cianchi F., 2005, CURR ENZYM INHIB, V1, P97, DOI [10.2174/1573408054022207, DOI 10.2174/1573408054022207]; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; Das L, 2014, LEUKEMIA LYMPHOMA, V55, P2627, DOI 10.3109/10428194.2014.889824; Das L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099583; Das L, 2014, INT IMMUNOPHARMACOL, V20, P141, DOI 10.1016/j.intimp.2014.02.024; Das L, 2012, BIOSCIENCE REP, V32, P161, DOI 10.1042/BSR20110043; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Elston R, 2012, CROSSTALK P53 TGF BE, P1; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; GOLDIE H, 1951, CANCER RES, V11, P73; Gundala SR, 2013, CARCINOGENESIS, V34, P2039, DOI 10.1093/carcin/bgt141; Hahm KB, 2002, ALIMENT PHARM THERAP, V16, P115, DOI 10.1046/j.1365-2036.16.s2.3.x; Han C, 2004, J BIOL CHEM, V279, P44344, DOI 10.1074/jbc.M404852200; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hirst DG, 2007, FRONT BIOSCI-LANDMRK, V12, P3406, DOI 10.2741/2322; Hou WC, 2004, ELECTROPHORESIS, V25, P2926, DOI 10.1002/elps.200406041; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JONES DA, 1993, J BIOL CHEM, V268, P9049; Kalo E, 2012, J CELL SCI, V125, P5578, DOI 10.1242/jcs.106815; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Lim SC, 2007, YONSEI MED J, V48, P495, DOI 10.3349/ymj.2007.48.3.495; Lohm S, 2005, CLIN EXP METASTAS, V22, P341, DOI 10.1007/s10585-005-0431-3; Mani H, 2002, BIOFACTORS, V16, P29, DOI 10.1002/biof.5520160104; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Perez JL, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-51; Reisman D, 1998, SEMIN CANCER BIOL, V8, P317, DOI 10.1006/scbi.1998.0094; RICCI G, 1984, ANAL BIOCHEM, V143, P226, DOI 10.1016/0003-2697(84)90657-2; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sebestyen A, 2005, CYTOKINE, V30, P228, DOI 10.1016/j.cyto.2005.01.013; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shin J-W, 2011, CANC PREVENTION RE S, V4, pB67; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Sonveaux P, 2009, EUR J CANCER, V45, P1352, DOI 10.1016/j.ejca.2008.12.018; Takai E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076346; Tandoan B., 2006, FABAD J PHARM SCI, V31, P230; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Uotila P, 2001, UROL RES, V29, P25, DOI 10.1007/s002400000148; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang HM, 2000, CANCER RES, V60, P5862; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Wrobel RL, 2002, PLANT PHYSIOL BIOCH, V40, P265, DOI 10.1016/S0981-9428(02)01361-X; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304	62	72	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124000	10.1371/journal.pone.0124000	http://dx.doi.org/10.1371/journal.pone.0124000			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860911	gold, Green Submitted, Green Published			2022-12-26	WOS:000352590300127
J	Gutjahr, C; Siegler, H; Haga, K; Iino, M; Paszkowski, U				Gutjahr, Caroline; Siegler, Heike; Haga, Ken; Iino, Moritoshi; Paszkowski, Uta			Full Establishment of Arbuscular Mycorrhizal Symbiosis in Rice Occurs Independently of Enzymatic Jasmonate Biosynthesis	PLOS ONE			English	Article							ALLENE-OXIDE-CYCLASE; PLANT DEFENSE; ACID; COLONIZATION; PHYTOCHROME; PATHWAY; ROOTS; IDENTIFICATION; SALICYLATE; INDUCTION	Development of the mutualistic arbuscular mycorrhiza (AM) symbiosis between most land plants and fungi of the Glomeromycota is regulated by phytohormones. The role of jasmonate (JA) in AM colonization has been investigated in the dicotyledons Medicago truncatula, tomato and Nicotiana attenuata and contradicting results have been obtained with respect to a neutral, promotive or inhibitory effect of JA on AM colonization. Furthermore, it is currently unknown whether JA plays a role in AM colonization of monocotyledonous roots. Therefore we examined whether JA biosynthesis is required for AM colonization of the monocot rice. To this end we employed the rice mutant constitutive photomorphogenesis 2 (cpm2), which is deficient in JA biosynthesis. Through a time course experiment the amount and morphology of fungal colonization did not differ between wild-type and cpm2 roots. Furthermore, no significant difference in the expression of AM marker genes was detected between wild type and cpm2. However, treatment of wild-type roots with 50 mu M JA lead to a decrease of AM colonization and this was correlated with induction of the defense gene PR4. These results indicate that JA is not required for AM colonization of rice but high levels of JA in the roots suppress AM development likely through the induction of defense.	[Gutjahr, Caroline; Siegler, Heike; Paszkowski, Uta] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Gutjahr, Caroline] Univ Munich LMU, Inst Genet, Bioctr Martinsried, Martinsried, Germany; [Haga, Ken; Iino, Moritoshi] Osaka City Univ, Grad Sch Sci, Bot Gardens, Katano, Osaka, Japan	University of Lausanne; University of Munich; Osaka Metropolitan University	Gutjahr, C (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore Bldg, Lausanne, Switzerland.	caroline.gutjahr@lmu.de	Gutjahr, Caroline/H-8390-2013	Gutjahr, Caroline/0000-0001-6163-745X; Paszkowski, Uta/0000-0002-7279-7632	German National Merit Foundation; Roche Foundation (Switzerland); SNF 'professeur boursier' [PP00A-110874, PP00P3-130704]	German National Merit Foundation; Roche Foundation (Switzerland); SNF 'professeur boursier'	CG was supported by a PhD fellowship of the German National Merit Foundation (Studienstiftung des Deutschen Volkes); http://www.studienstiftung.de/ and the Roche Foundation (Switzerland). Research in the UP laboratory was supported by the SNF 'professeur boursier' grants PP00A-110874 and PP00P3-130704; http://www.snf.ch/en/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Carbonnel S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00462; Fernandez I, 2014, J CHEM ECOL, V40, P791, DOI 10.1007/s10886-014-0473-6; Foo E, 2013, ANN BOT-LONDON, V111, P769, DOI 10.1093/aob/mct041; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Gutjahr C, 2014, CURR OPIN PLANT BIOL, V20, P26, DOI 10.1016/j.pbi.2014.04.003; Gutjahr C, 2013, ANNU REV CELL DEV BI, V29, P593, DOI 10.1146/annurev-cellbio-101512-122413; Gutjahr C, 2009, MOL PLANT MICROBE IN, V22, P763, DOI 10.1094/MPMI-22-7-0763; Gutjahr C, 2008, PLANT CELL, V20, P2989, DOI 10.1105/tpc.108.062414; Haga K, 2004, PLANT CELL PHYSIOL, V45, P119, DOI 10.1093/pcp/pch025; Hause B, 2002, PLANT PHYSIOL, V130, P1213, DOI 10.1104/pp.006007; Hause B, 2007, PHYTOCHEMISTRY, V68, P101, DOI 10.1016/j.phytochem.2006.09.025; Hause B, 2009, PHYTOCHEMISTRY, V70, P1589, DOI 10.1016/j.phytochem.2009.07.003; Isayenkov S, 2005, PLANT PHYSIOL, V139, P1401, DOI 10.1104/pp.105.069054; Isayenkov S, 2004, J PLANT PHYSIOL, V161, P1379, DOI 10.1016/j.jplph.2004.04.012; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Herrera-Medina MJ, 2008, J PLANT GROWTH REGUL, V27, P221, DOI 10.1007/s00344-008-9049-4; Landgraf R, 2012, PLANT CELL ENVIRON, V35, P1344, DOI 10.1111/j.1365-3040.2012.02495.x; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Riemann M, 2003, PLANT PHYSIOL, V133, P1820, DOI 10.1104/pp.103.027490; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Sawers RJH, 2008, TRENDS PLANT SCI, V13, P93, DOI 10.1016/j.tplants.2007.11.006; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Suzuki A, 2011, P NATL ACAD SCI USA, V108, P16837, DOI 10.1073/pnas.1105892108; Tejeda-Sartorius M, 2008, PHYSIOL PLANTARUM, V133, P339, DOI 10.1111/j.1399-3054.2008.01081.x; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Zhou GX, 2009, PLANT J, V60, P638, DOI 10.1111/j.1365-313X.2009.03988.x	39	28	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123422	10.1371/journal.pone.0123422	http://dx.doi.org/10.1371/journal.pone.0123422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860838	gold, Green Submitted, Green Published			2022-12-26	WOS:000352590300098
J	Peixoto, RB; Machado-Silva, F; Marotta, H; Enrich-Prast, A; Bastviken, D				Peixoto, Roberta B.; Machado-Silva, Fausto; Marotta, Humberto; Enrich-Prast, Alex; Bastviken, David			Spatial versus Day-To-Day Within-Lake Variability in Tropical Floodplain Lake CH4 Emissions - Developing Optimized Approaches to Representative Flux Measurements	PLOS ONE			English	Article							METHANE EMISSIONS; CARBON-DIOXIDE; WETLANDS; RELEASE	Inland waters (lakes, rivers and reservoirs) are now understood to contribute large amounts of methane (CH4) to the atmosphere. However, fluxes are poorly constrained and there is a need for improved knowledge on spatiotemporal variability and on ways of optimizing sampling efforts to yield representative emission estimates for different types of aquatic ecosystems. Low-latitude floodplain lakes and wetlands are among the most high-emitting environments, and here we provide a detailed investigation of spatial and day-to-day variability in a shallow floodplain lake in the Pantanal in Brazil over a five-day period. CH4 flux was dominated by frequent and ubiquitous ebullition. A strong but predictable spatial variability (decreasing flux with increasing distance to the shore or to littoral vegetation) was found, and this pattern can be addressed by sampling along transects from the shore to the center. Although no distinct day-to-day variability were found, a significant increase in flux was identified from measurement day 1 to measurement day 5, which was likely attributable to a simultaneous increase in temperature. Our study demonstrates that representative emission assessments requires consideration of spatial variability, but also that spatial variability patterns are predictable for lakes of this type and may therefore be addressed through limited sampling efforts if designed properly (e.g., fewer chambers may be used if organized along transects). Such optimized assessments of spatial variability are beneficial by allowing more of the available sampling resources to focus on assessing temporal variability, thereby improving overall flux assessments.	[Peixoto, Roberta B.; Machado-Silva, Fausto; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, Biogeochem Lab, BR-68020 Rio De Janeiro, Brazil; [Marotta, Humberto] Univ Fed Fluminense, Sedimentary & Environm Proc Lab LAPSA UFF, Dept Geog, Inst Geosci, Niteroi, RJ, Brazil; [Enrich-Prast, Alex; Bastviken, David] Linkoping Univ, Dept Themat Studies Environm Change, S-58183 Linkoping, Sweden	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Linkoping University	Peixoto, RB (corresponding author), Univ Fed Rio de Janeiro, Dept Ecol, Biogeochem Lab, BR-68020 Rio De Janeiro, Brazil.	bbpeixoto34@hotmail.com	Marotta, Humberto/F-9554-2012; Peixoto, Roberta B/P-6303-2017; Prast, Alex Enrich/AAL-4722-2021; Enrich-Prast, Alex/H-5391-2012	Marotta, Humberto/0000-0002-2828-6595; Peixoto, Roberta B/0000-0002-8053-2730; Prast, Alex Enrich/0000-0003-3561-0936; Bastviken, David/0000-0003-0038-2152; Machado-Silva, Fausto/0000-0002-2165-3284	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Capes; Swedish Research Council Vetenskapsradet; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swedish Research Council Vetenskapsradet(Swedish Research Council); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research is a product from the Coordenacao de Aperfeicoamento de Pessoal de Novel Superior and Swedish Foundation for International Cooperation in Research and Higher Education (Capes/Stint) exchange program. The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Capes for financing different projects to AEP and the Swedish Research Council Vetenskapsradet for funding DB. AEP received a research grant from CNPq.	Alvala PC, 1999, BIOTECNOL CIENCIA DE, V7, P40; Aura Christopher Mulanda, 2011, Lakes & Reservoirs Research and Management, V16, P265, DOI 10.1111/j.1440-1770.2011.00485.x; BARTLETT KB, 1990, J GEOPHYS RES-ATMOS, V95, P16773, DOI 10.1029/JD095iD10p16773; BARTLETT KB, 1988, J GEOPHYS RES-ATMOS, V93, P1571, DOI 10.1029/JD093iD02p01571; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Calheiros D. F., 2003, THESIS; Caraco N, 2006, BIOSCIENCE, V56, P219, DOI 10.1641/0006-3568(2006)056[0219:VPAEOO]2.0.CO;2; Casper P, 2000, BIOGEOCHEMISTRY, V49, P1, DOI 10.1023/A:1006269900174; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 2010, LIMNOL OCEANOGR-METH, V8, P285, DOI 10.4319/lom.2010.8.285; Conrad R, 2011, BIOGEOSCIENCES, V8, P795, DOI 10.5194/bg-8-795-2011; DelSontro T, 2011, ENVIRON SCI TECHNOL, V45, P9866, DOI 10.1021/es2005545; DEVOL AH, 1988, J GEOPHYS RES-ATMOS, V93, P1583, DOI 10.1029/JD093iD02p01583; Galfalk M, 2013, J GEOPHYS RES-BIOGEO, V118, P770, DOI 10.1002/jgrg.20064; Hamilton S. K., 2002, The ecohydrology of South American rivers and wetlands, P133; Hamilton SK, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000306; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Juutinen S, 2009, BIOGEOSCIENCES, V6, P209, DOI 10.5194/bg-6-209-2009; Juutinen S, 2003, BIOL FERT SOILS, V38, P10, DOI 10.1007/s00374-003-0618-1; Juutinen S, 2003, GLOBAL CHANGE BIOL, V9, P413, DOI 10.1046/j.1365-2486.2003.00595.x; Mann CJ, 1996, AQUAT BOT, V53, P61, DOI 10.1016/0304-3770(95)01012-2; Marani L, 2007, ATMOS ENVIRON, V41, P1627, DOI 10.1016/j.atmosenv.2006.10.046; Marotta H, 2014, NAT CLIM CHANGE, V4, P467, DOI [10.1038/NCLIMATE2222, 10.1038/nclimate2222]; Methane Bastviken D., 2009, ENCYCLOPEDIA OF INLA, P783; Natchimuthu S, 2014, BIOGEOCHEMISTRY, V119, P403, DOI 10.1007/s10533-014-9976-z; Nguyen TD, 2010, BIOGEOCHEMISTRY, V100, P185, DOI 10.1007/s10533-010-9415-8; Reeburgh W.S., 2003, TREATISE GEOCHEM, V4, P347; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; SALAS HJ, 1991, WATER RES, V25, P341, DOI 10.1016/0043-1354(91)90015-I; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; SORRELL BK, 1994, AQUAT BOT, V47, P197, DOI 10.1016/0304-3770(94)90053-1; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164	36	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123319	10.1371/journal.pone.0123319	http://dx.doi.org/10.1371/journal.pone.0123319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860229	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300092
J	Rijlaarsdam, MA; Tax, DMJ; Gillis, AJM; Dorssers, LCJ; Koestler, DC; de Ridder, J; Looijenga, LHJ				Rijlaarsdam, Martin A.; Tax, David M. J.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Koestler, Devin C.; de Ridder, Jeroen; Looijenga, Leendert H. J.			Genome Wide DNA Methylation Profiles Provide Clues to the Origin and Pathogenesis of Germ Cell Tumors	PLOS ONE			English	Article							CARCINOMA IN-SITU; YOLK-SAC TUMOR; INACTIVE X-CHROMOSOME; C-KIT PROTOONCOGENE; EMBRYONAL CARCINOMA; SPERMATOCYTIC SEMINOMA; DIFFERENTIAL EXPRESSION; CHROMATIN MODIFICATIONS; PROMOTER METHYLATION; IMPRINTING ANALYSIS	The cell of origin of the five subtypes (I-V) of germ cell tumors (GCTs) are assumed to be germ cells from different maturation stages. This is (potentially) reflected in their methylation status as fetal maturing primordial germ cells are globally demethylated during migration from the yolk sac to the gonad. Imprinted regions are erased in the gonad and later become uniparentally imprinted according to fetal sex. Here, 91 GCTs (type I-IV) and four cell lines were profiled (Illumina's HumanMethylation450BeadChip). Data was pre-processed controlling for cross hybridization, SNPs, detection rate, probe-type bias and batch effects. The annotation was extended, covering snRNAs/microRNAs, repeat elements and imprinted regions. A Hidden Markov Model-based genome segmentation was devised to identify differentially methylated genomic regions. Methylation profiles allowed for separation of clusters of non-seminomas (type II), seminomas/dysgerminomas (type II), spermatocytic seminomas (type III) and teratomas/dermoid cysts (type I/IV). The seminomas, dysgerminomas and spermatocytic seminomas were globally hypomethylated, in line with previous reports and their demethylated precursor. Differential methylation and imprinting status between subtypes reflected their presumed cell of origin. Ovarian type I teratomas and dermoid cysts showed (partial) sex specific uniparental maternal imprinting. The spermatocytic seminomas showed uniparental paternal imprinting while testicular teratomas exhibited partial imprinting erasure. Somatic imprinting in type II GCTs might indicate a cell of origin after global demethylation but before imprinting erasure. This is earlier than previously described, but agrees with the totipotent/embryonic stem cell like potential of type II GCTs and their rare extra-gonadal localization. The results support the common origin of the type I teratomas and show strong similarity between ovarian type I teratomas and dermoid cysts. In conclusion, we identified specific and global methylation differences between GCT subtypes, providing insight into their developmental timing and underlying developmental biology. Data and extended annotation are deposited at GEO (GSE58538 and GPL18809).	[Rijlaarsdam, Martin A.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Tax, David M. J.; de Ridder, Jeroen] Delft Univ Technol, Delft Bioinformat Lab, Fac Elect Engn Math & Comp Sci Intelligent Syst, Delft, Netherlands; [Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Delft University of Technology; University of Kansas; University of Kansas Medical Center	Looijenga, LHJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911; de Ridder, Jeroen/0000-0002-0828-3477; Rijlaarsdam, Martin/0000-0002-2528-8077	Translational Grant, Erasmus MC	Translational Grant, Erasmus MC	MR is supported by a Translational Grant, Erasmus MC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, J BIOL CHEM, V288, P22460, DOI 10.1074/jbc.M113.474072; Almstrup K, 2010, BRIT J CANCER, V103, P1269, DOI 10.1038/sj.bjc.6605880; Amatruda JF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-313; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; Azevedo MF, 2013, J CLIN ENDOCRINOL ME; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnard C, 2012, NAT GENET, V44, P709, DOI 10.1038/ng.2259; Boublikova L, 2014, CRIT REV ONCOL HEMAT, V89, P366, DOI 10.1016/j.critrevonc.2013.10.001; Bremmer F, 2012, ANTICANCER RES, V32, P341; Bussey KJ, 2001, GENE CHROMOSOME CANC, V32, P342, DOI 10.1002/gcc.1199; Chen YT, 2011, HUM REPROD, V26, P3232, DOI 10.1093/humrep/der330; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; de Haas EC, 2010, CANCER-AM CANCER SOC, V116, P5628, DOI 10.1002/cncr.25300; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; De Jong J, 2007, ONCOL REP, V18, P127; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Deuve JL, 2011, ANNU REV CELL DEV BI, V27, P611, DOI 10.1146/annurev-cellbio-092910-154020; Devouassoux-Shisheboran M, 2003, APMIS, V111, P212, DOI 10.1034/j.1600-0463.2003.11101251.x; DEVOUASSOUXSHIS.M, 2003, APMIS, V111, P224; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Ebisch IMW, 2007, FERTIL STERIL, V87, P619, DOI 10.1016/j.fertnstert.2006.07.1510; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Eini R, 2013, INT J DEV BIOL, V57, P319, DOI 10.1387/ijdb.130020re; Fan R, 2012, FETAL PEDIATR PATHOL, V31, P21, DOI 10.3109/15513815.2011.618874; Farini D, 2007, DEV BIOL, V306, P572, DOI 10.1016/j.ydbio.2007.03.031; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Fogh J, 1978, NATL CANC I MONOGR, V5-9; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Fukushima S, 2014, ACTA NEUROPATHOL; FUNK CD, 1992, P NATL ACAD SCI USA, V89, P3962, DOI 10.1073/pnas.89.9.3962; Furukawa S, 2009, CANCER SCI, V100, P698, DOI 10.1111/j.1349-7006.2009.01102.x; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Gobel U, 2000, ANN ONCOL, V11, P263, DOI 10.1023/A:1008360523160; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; GRAHAM PL, 1993, DEV GENET, V14, P471, DOI 10.1002/dvg.1020140608; GRAHAM PL, 1993, GENETICS, V133, P919; Griffeth RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062103; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Honecker F, 2006, J PATHOL, V208, P395, DOI 10.1002/path.1872; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; IZQUIERDO MA, 1995, J PATHOL, V177, P253, DOI 10.1002/path.1711770307; Jeyapalan JN, 2011, BRIT J CANCER, V105, P575, DOI 10.1038/bjc.2011.218; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Kato N, 2006, HUM PATHOL, V37, P48, DOI 10.1016/j.humpath.2005.09.008; Kato N, 2003, AM J PATHOL, V163, P387, DOI 10.1016/S0002-9440(10)63668-1; Kawakami T, 2006, ONCOGENE, V25, P3225, DOI 10.1038/sj.onc.1209362; Kawakami T, 2004, LANCET, V363, P40, DOI 10.1016/S0140-6736(03)15170-7; Kawasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03658; Kempkensteffen C, 2006, J CANCER RES CLIN, V132, P765, DOI 10.1007/s00432-006-0124-6; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Koul S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-16; Kratz CP, 2011, INT J ANDROL, V34, pE98, DOI 10.1111/j.1365-2605.2011.01156.x; Kratz CP, 2011, J MED GENET, V48, P473, DOI 10.1136/jmedgenet-2011-100001; Kratz CP, 2010, BEST PRACT RES CL EN, V24, P503, DOI 10.1016/j.beem.2010.01.005; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Kristensen DG, 2013, INT J DEV BIOL, V57, P309, DOI 10.1387/ijdb.130142ka; Kristensen DG, 2012, CANCER GENET-NY, V205, P425, DOI 10.1016/j.cancergen.2012.05.003; Le Bouffant R, 2011, DEVELOPMENT, V138, P5393, DOI 10.1242/dev.068452; Leman ES, 2010, INDIAN J UROL, V26, P76, DOI 10.4103/0970-1591.60450; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Leroy X, 2002, J HISTOCHEM CYTOCHEM, V50, P283, DOI 10.1177/002215540205000216; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; Lind GE, 2006, J PATHOL, V210, P441, DOI 10.1002/path.2064; Lind GE, 2007, APMIS, V115, P1147, DOI 10.1111/j.1600-0463.2007.apm_660.xml.x; Looijenga LHJ, 2013, INT J DEV BIOL, V57, P241, DOI 10.1387/ijdb.130026ll; Looijenga LHJ, 2011, J PATHOL, V224, P431, DOI 10.1002/path.2939; Looijenga LHJ, 2009, J PATHOL, V218, P146, DOI 10.1002/path.2522; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Looijenga LHJ, 1997, AM J PATHOL, V151, P581; Mamsen LS, 2012, INT J DEV BIOL, V56, P771, DOI 10.1387/ijdb.120202lm; Manton KJ, 2005, BRIT J CANCER, V92, P760, DOI 10.1038/sj.bjc.6602373; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Matsui Y, 2014, MOL REPROD DEV, V81, P160, DOI 10.1002/mrd.22214; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Messerschmidt DM, 2012, EPIGENETICS-US, V7, P969, DOI 10.4161/epi.21337; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Mirabello L, 2012, INT J MOL EPIDEMIOL, V3, P213; Mithraprabhu S, 2009, REPRODUCTION, V138, P743, DOI 10.1530/REP-08-0537; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Nettersheim D, 2012, GENE CHROMOSOME CANC, V51, P717, DOI 10.1002/gcc.21958; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Ohhata T, 2013, CELL MOL LIFE SCI, V70, P2443, DOI 10.1007/s00018-012-1174-3; Oosterhuis JW, 2007, INT J ANDROL, V30, P256, DOI 10.1111/j.1365-2605.2007.00793.x; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Orso F, 2004, BIOCHEM J, V377, P429, DOI 10.1042/BJ20031133; Payer B, 2011, HUM GENET, V130, P265, DOI 10.1007/s00439-011-1024-7; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rajpert-De Meyts E, 2003, HISTOPATHOLOGY, V42, P217, DOI 10.1046/j.1365-2559.2003.01587.x; Rapley EA, 2004, BRIT J CANCER, V90, P2397, DOI 10.1038/sj.bjc.6601880; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rathi A, 2003, CLIN CANCER RES, V9, P3674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rescorla FJ, 1999, SEMIN SURG ONCOL, V16, P144, DOI 10.1002/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.3.CO;2-D; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Rijlaarsdam MA, 2014, SEMIN CANC BIOL; Rijlaarsdam MA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-141; Rorth M, 2000, SCAND J UROL NEPHROL, V34, P166, DOI 10.1080/00365590050509896; Ross JA, 1999, CANCER, V85, P1389, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1389::AID-CNCR24>3.0.CO;2-V; Rossi P, 2003, ANDROLOGIA, V35, P71, DOI 10.1046/j.1439-0272.2003.00539.x; Ruark E, 2013, NAT GENET; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Salpea P, 2012, NUCLEIC ACIDS RES, V40, P6477, DOI 10.1093/nar/gks312; Sarkardeh H, 2014, J ASSIST REPROD GENE; Schneider DT, 2001, CANCER RES, V61, P7268; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sievers S, 2005, GENE CHROMOSOME CANC, V44, P256, DOI 10.1002/gcc.20237; Smiraglia DJ, 2002, ONCOGENE, V21, P3909, DOI 10.1038/sj.onc.1205488; Sonne SB, 2010, INT J DEV BIOL, V54, P755, DOI 10.1387/ijdb.082668ss; STROHMEYER T, 1995, J UROLOGY, V153, P511, DOI 10.1097/00005392-199502000-00073; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; TESHIMA S, 1988, LAB INVEST, V59, P328; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turnbull C, 2011, INT J ANDROL, V34, pE86, DOI 10.1111/j.1365-2605.2011.01162.x; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Ushida H, 2012, MOL CARCINOGEN, V51, P711, DOI 10.1002/mc.20831; van der Zwan YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098330; Van der Zwan YG, 2013, INT J DEV BIOL, V57, P299, DOI 10.1387/ijdb.130017ll; VANGURP RJHLM, 1994, JNCI-J NATL CANCER I, V86, P1070, DOI 10.1093/jnci/86.14.1070; Verdorfer R, 2004, J PATHOL, V204, P277, DOI 10.1002/path.1634; Verkerk AJMH, 1997, ONCOGENE, V14, P95, DOI 10.1038/sj.onc.1200802; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; WANG N, 1980, CANCER RES, V40, P796; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Woodward PJ, 2004, WHO CLASSIFICATION T, P17; Wu JW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-64; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yang S, 2012, CELL PROLIFERAT, V45, P299, DOI 10.1111/j.1365-2184.2012.00827.x; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang C, 2005, GENE CHROMOSOME CANC, V43, P104, DOI 10.1002/gcc.20160; Zimmerman DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081962	161	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122146	10.1371/journal.pone.0122146	http://dx.doi.org/10.1371/journal.pone.0122146			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859847	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300033
J	Shi, Y; Wang, JH; Xin, ZY; Duan, ZP; Wang, GQ; Li, F				Shi, Yue; Wang, Jihan; Xin, Zhuoyuan; Duan, Zipeng; Wang, Guoqing; Li, Fan			Transcription Factors and microRNA-Co-Regulated Genes in Gastric Cancer Invasion in Ex Vivo	PLOS ONE			English	Article							COLORECTAL-CANCER; CELL SURVIVAL; METASTASIS; EXPRESSION; CARCINOGENESIS; IDENTIFICATION; MORTALITY; CARCINOMA; NETWORK; GROWTH	Aberrant miRNA expression abnormally modulates gene expression in cells and can contribute to tumorigenesis in humans. This study identified functionally relevant differentially expressed genes using the transcription factors and miRNA-co-regulated network analysis for gastric cancer. The TF-miRNA co-regulatory network was constructed based on data obtained from cDNA microarray and miRNA expression profiling of gastric cancer tissues. The network along with their co-regulated genes was analyzed using Database for Annotation, Visualization and Integrated Discovery (DAVID) and Transcriptional Regulatory Element Database (TRED). We found eighteen (17 up-regulated and 1 down-regulated) differentially expressed genes that were co-regulated by transcription factors and miRNAs. KEGG pathway analysis revealed that these genes were part of the extracellular matrix-receptor interaction and focal adhesion signaling pathways. In addition, qRT-PCR and Western blot data showed an increase in COL1A1 and decrease in NCAM1 mRNA and protein levels in gastric cancer tissues. Thus, these data provided the first evidence to illustrate that altered gene network was associated with gastric cancer invasion. Further study with a large sample size and more functional experiments is needed to confirm these data and contribute to diagnostic and treatment strategies for gastric cancer.	[Shi, Yue; Wang, Jihan; Xin, Zhuoyuan; Duan, Zipeng; Wang, Guoqing; Li, Fan] Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China; [Wang, Guoqing; Li, Fan] Jilin Univ, Key Lab Bion Engn, Minist Educ China, Changchun 130023, Peoples R China	Jilin University; Jilin University; Ministry of Education, China	Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China.	qing8110@gmail.com; lifan@jlu.edu.cn			National Natural Science Foundation of China [81320108025, 81472662, 81271897, 81401712]; Jilin Key Laboratory of Biomedical Materials; Foundation of Jilin Province Science and Technology Department [20130522013JH, 20140414048GH]; Norman Bethune Program of Jilin University [2012219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Key Laboratory of Biomedical Materials; Foundation of Jilin Province Science and Technology Department; Norman Bethune Program of Jilin University	This work was supported by grants from National Natural Science Foundation of China (#81320108025 and #81472662). It is also supported in part by National Natural Science Foundation of China (#81271897 and #81401712), Jilin Key Laboratory of Biomedical Materials, Foundation of Jilin Province Science and Technology Department (#20130522013JH and #20140414048GH) and the Norman Bethune Program of Jilin University (#2012219).	Almeida MI, 2012, GASTROENTEROLOGY, V142, P886, DOI 10.1053/j.gastro.2011.12.047; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aytes A, 2013, P NATL ACAD SCI USA, V110, pE3506, DOI 10.1073/pnas.1303558110; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard W, 2014, WORLD CANC REPORT 20; Bijian K, 2004, AM J PHYSIOL-RENAL, V286, pF255, DOI 10.1152/ajprenal.00259.2003; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; EDVARDSEN K, 1994, INT J CANCER, V58, P116, DOI 10.1002/ijc.2910580119; Fischer H, 2001, CARCINOGENESIS, V22, P875, DOI 10.1093/carcin/22.6.875; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; HAVENITH MG, 1988, CANCER-AM CANCER SOC, V62, P2207, DOI 10.1002/1097-0142(19881115)62:10<2207::AID-CNCR2820621023>3.0.CO;2-L; Hayashi Y, 2013, GUT, V62, P1536, DOI 10.1136/gutjnl-2011-301625; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Keld R, 2011, BRIT J CANCER, V105, P124, DOI 10.1038/bjc.2011.187; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee YS, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r55; Lipsick JS, 2010, P NATL ACAD SCI USA, V107, P17067, DOI 10.1073/pnas.1012402107; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Shi DB, 2014, CANCER PREV RES, V7, P266, DOI 10.1158/1940-6207.CAPR-13-0271; St Croix B, 2000, SCIENCE, V289, P1197; Stepanenko I, 2003, ANN NY ACAD SCI, V1010, P16, DOI 10.1196/annals.1299.003; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tsuzuki T, 1998, J CLIN PATHOL, V51, P13, DOI 10.1136/jcp.51.1.13; Wang M, 2012, FEBS LETT, V586, P2382, DOI 10.1016/j.febslet.2012.05.050; Wu P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.13; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581	37	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122882	10.1371/journal.pone.0122882	http://dx.doi.org/10.1371/journal.pone.0122882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860484	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300066
J	Parikh, PJ; Cole, KJ				Parikh, Pranav J.; Cole, Kelly J.			Effects of Transcranial Direct Current Stimulation on the Control of Finger Force during Dexterous Manipulation in Healthy Older Adults	PLOS ONE			English	Article							DIGIT-OBJECT INTERFACE; HUMAN PRIMARY MOTOR; AGE-RELATED-CHANGES; SKILL ACQUISITION; GRIP; MECHANISMS; FRICTION; YOUNG	The contribution of poor finger force control to age-related decline in manual dexterity is above and beyond ubiquitous behavioral slowing. Altered control of the finger forces can impart unwanted torque on the object affecting its orientation, thus impairing manual performance. Anodal transcranial direct current stimulation (tDCS) over primary motor cortex (M1) has been shown to improve the performance speed on manual tasks in older adults. However, the effects of anodal tDCS over M1 on the finger force control during object manipulation in older adults remain to be fully explored. Here we determined the effects of anodal tDCS over M1 on the control of grip force in older adults while they manipulated an object with an uncertain mechanical property. Eight healthy older adults were instructed to grip and lift an object whose contact surfaces were unexpectedly made more or less slippery across trials using acetate and sandpaper surfaces, respectively. Subjects performed this task before and after receiving anodal or sham tDCS over M1 on two separate sessions using a cross-over design. We found that older adults used significantly lower grip force following anodal tDCS compared to sham tDCS. Friction measured at the finger-object interface remained invariant after anodal and sham tDCS. These findings suggest that anodal tDCS over M1 improved the control of grip force during object manipulation in healthy older adults. Although the cortical networks for representing objects and manipulative actions are complex, the reduction in grip force following anodal tDCS over M1 might be due to a cortical excitation yielding improved processing of object-specific sensory information and its integration with the motor commands for production of manipulative forces. Our findings indicate that tDCS has a potential to improve the control of finger force during dexterous manipulation in older adults.	[Parikh, Pranav J.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85226 USA; [Cole, Kelly J.] Univ Iowa, Dept Hlth & Human Physiol, Motor Control Labs, Iowa City, IA 52242 USA	Arizona State University; Arizona State University-Tempe; University of Iowa	Parikh, PJ (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85226 USA.	pranavjp@gmail.com						Aoki T, 2006, EXP BRAIN RES, V172, P425, DOI 10.1007/s00221-006-0350-9; Chouinard PA, 2005, J NEUROSCI, V25, P2277, DOI 10.1523/JNEUROSCI.4649-04.2005; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; Cole KJ, 2010, EXP BRAIN RES, V201, P239, DOI 10.1007/s00221-009-2030-z; COLE KJ, 1993, EXP BRAIN RES, V95, P523; Cole KJ, 2002, EXP BRAIN RES, V143, P35, DOI 10.1007/s00221-001-0965-9; Cole KJ, 1998, EXP BRAIN RES, V121, P263, DOI 10.1007/s002210050459; Cole KJ, 2001, EXP BRAIN RES, V136, P535, DOI 10.1007/s002210000613; Cole KJ, 1999, J NEUROSCI, V19, P3238; Dayanidhi S., 2014, J GERONTOL A-BIOL, V1, P1, DOI DOI 10.1093/GER0NA/GLU009; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; Kornatz KW, 2005, J APPL PHYSIOL, V98, P2072, DOI 10.1152/japplphysiol.01149.2004; Latash ML, 2012, J APPL PHYSIOL, V112, P1093, DOI 10.1152/japplphysiol.00160.2012; Lauro LJR, 2014, CORTEX, V58, P99, DOI 10.1016/j.cortex.2014.05.003; Lawrence EL, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00053; Martina ISJ, 1998, J NEUROL NEUROSUR PS, V65, P743, DOI 10.1136/jnnp.65.5.743; McFadden JL, 2011, BRAIN STIMUL, V4, P38, DOI 10.1016/j.brs.2010.05.002; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Niu X, 2008, EXP BRAIN RES, V190, P225, DOI 10.1007/s00221-008-1466-x; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Nowak DA, 2009, CORTEX, V45, P473, DOI 10.1016/j.cortex.2007.11.010; Olafsdottir H, 2007, J APPL PHYSIOL, V102, P1490, DOI 10.1152/japplphysiol.00966.2006; Parikh PJ, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.255; Parikh PJ, 2013, EXP BRAIN RES, V227, P9, DOI 10.1007/s00221-013-3451-2; Parikh PJ, 2012, J APPL PHYSIOL, V112, P1095, DOI 10.1152/japplphysiol.01385.2011; Parikh PJ, 2011, NEUROSCI LETT, V494, P94, DOI 10.1016/j.neulet.2011.02.066; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Zimerman M, 2013, ANN NEUROL, V73, P10, DOI 10.1002/ana.23761	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124137	10.1371/journal.pone.0124137	http://dx.doi.org/10.1371/journal.pone.0124137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855984	Green Published, gold			2022-12-26	WOS:000352588500111
J	Pizarro, C; Schueler, R; Hammerstingl, C; Tuleta, I; Nickenig, G; Skowasch, D				Pizarro, Carmen; Schueler, Robert; Hammerstingl, Christoph; Tuleta, Izabela; Nickenig, Georg; Skowasch, Dirk			Impact of Endoscopic Lung Volume Reduction on Right Ventricular Myocardial Function	PLOS ONE			English	Article							SEVERE EMPHYSEMA; ENDOBRONCHIAL VALVES; RISK-FACTORS; PULMONARY; EXERCISE; THERAPY; STRAIN; COPD; PREDICTORS; MORTALITY	Introduction Endoscopic lung volume reduction (ELVR) provides a minimally invasive therapy for patients with severe lung emphysema. As its impact on right ventricular (RtV) function is undefined, we examined the extent of RtV functional changes following ELVR, as assessed by use of speckle tracking-based RtV deformation analysis. Methods We enrolled 32 patients with severe emphysematous COPD scheduled for bronchoscopic LVR using endobronchial valves (Zephyr, PulmonX, Inc.), comprising 16 matched clinical responders and 16 non-responders. Echocardiography was conducted one day prior to ELVR and at an eight-week postprocedural interval. Results Patients were predominantly of late middle-age (65.8 +/- 8.7yrs), male (62.5%) and presented advanced COPD emphysema (means FEV1 and RV: 32.6% and 239.1% of predicted, respectively). After ELVR, RtV apical longitudinal strain improved significantly in the total study cohort (-7.96 +/- 7.02% vs. -13.35 +/- 11.48%, p=0.04), whereas there were no significant changes in other parameters of RtV function such as RtV global longitudinal strain, TAPSE or pulmonary arterial systolic pressure. In responding patients, 6MWT-improvement correlated with a decrease in NT-proBNP (Pearson's r: -0.53, p=0.03). However, clinical non-responders did not exhibit any RtV functional improvement. Discussion ELVR beneficially impacts RtV functional parameters. Speckle tracking-based RtV apical longitudinal strain analysis allows early determination of RtV contractile gain and identification of clinical responsiveness.	[Pizarro, Carmen; Schueler, Robert; Hammerstingl, Christoph; Tuleta, Izabela; Nickenig, Georg; Skowasch, Dirk] Univ Hosp Bonn, Dept Internal Med 2, Cardiol Pneumol & Angiol, Bonn, Germany	University of Bonn	Pizarro, C (corresponding author), Univ Hosp Bonn, Dept Internal Med 2, Cardiol Pneumol & Angiol, Bonn, Germany.	carmen.pizarro@ukb.uni-bonn.de	Schueler, Robert/D-7407-2017; Hammerstingl, Christoph/GQQ-3316-2022		Pulmonx, Inc., Redwood City, Calif., USA	Pulmonx, Inc., Redwood City, Calif., USA	This study has been funded by Pulmonx, Inc., Redwood City, Calif., USA. None of the authors had any ownership interest in the Company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2006, RESPIRATION, V73, P311, DOI 10.1159/000088092; Argula RG, 2013, CHEST, V144, P1578, DOI 10.1378/chest.12-2826; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Burgess MI, 2002, J AM SOC ECHOCARDIOG, V15, P633, DOI 10.1067/mje.2002.118526; Danbrauskaite V, 2007, J AM SOC ECHOCARDIOG, V20, P1172, DOI 10.1016/j.echo.2007.02.005; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Eberhardt R, 2015, RESPIRATION, V89, P41, DOI 10.1159/000368369; Fine NM, 2015, ECHOCARDIOGR-J CARD, V32, P787, DOI 10.1111/echo.12806; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Hammerstingl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038519; Hardegree EL, 2013, AM J CARDIOL, V111, P143, DOI 10.1016/j.amjcard.2012.08.061; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Hilde JM, 2013, J AM COLL CARDIOL, V62, P1103, DOI 10.1016/j.jacc.2013.04.091; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hopkinson NS, 2005, AM J RESP CRIT CARE, V171, P453, DOI 10.1164/rccm.200407-961OC; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mantri S, 2009, J BRONCHOL INTERN PU, V16, P141, DOI 10.1097/LBR.0b013e3181a40a3e; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; Martinez FJ, 2005, SEMIN RESP CRIT CARE, V26, P167, DOI 10.1055/s-2005-869537; Mineo TC, 2002, AM J RESP CRIT CARE, V165, P489, DOI 10.1164/ajrccm.165.4.2108129; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naunheim KS, 2006, J THORAC CARDIOV SUR, V131, P43, DOI 10.1016/j.jtcvs.2005.09.006; O'Donnell DE, 2008, J APPL PHYSIOL, V105, P753, DOI 10.1152/japplphysiol.90336.2008b; QUANJER PH, 1994, REV MAL RESPIR, V11, P5; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Weitzenblum E, 2009, Chron Respir Dis, V6, P177, DOI 10.1177/1479972309104664; WISE RA, 1995, AM J RESP CRIT CARE, V151, P675	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121377	10.1371/journal.pone.0121377	http://dx.doi.org/10.1371/journal.pone.0121377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856379	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500017
J	Snajder, M; Mihelic, M; Turk, D; Ulrih, NP				Snajder, Marko; Mihelic, Marko; Turk, Dusan; Ulrih, Natasa Poklar			Codon Optimisation Is Key for Pernisine Expression in Escherichia coli	PLOS ONE			English	Article							HYPERTHERMOPHILIC ARCHAEON; AEROPYRUM-PERNIX; BIOCHEMICAL FUNDAMENTALS; PROTEIN EXPRESSION; SUBTILISIN; PURIFICATION; SUPERFAMILY; CLONING; GENE	Background Pernisine is an extracellular serine protease from the hyperthermophilic Archaeon Aeropyrum pernix K1. Low yields from the natural host and expression problems in heterologous hosts have limited the potential applications of pernisine in industry. Methodology/Principal Findings The challenges of pernisine overexpression in Escherichia coli were overcome by codon preference optimisation and de-novo DNA synthesis. The following forms of the pernisine gene were cloned into the pMCSGx series of vectors and expressed in E. coli cells: wildtype (pernisine(wt)), codon-optimised (pernisine(co)), and codon-optimised with a S355A mutation of a predicted active site (pernisine(S355Aco)). The fusion-tagged pernisines were purified using fast protein liquid chromatography equipped with Ni2+ chelate and gel filtration chromatography columns. The identities of the resultant proteins were confirmed with N-terminal sequencing, tandem mass spectrometry analysis, and immunodetection. Pernisine(wt) was not expressed in E. coli at detectable levels, while pernisineco and pernisineS355Aco were expressed and purified as 55-kDa proforms with yields of around 10 mg per litre E. coli culture. After heat activation of purified pernisine, the proteolytic activity of the mature pernisineco was confirmed using zymography, at a molecular weight of 36 kDa, while the mutant pernisineS355Aco remained inactive. Enzymatic performances of pernisine evaluated under different temperatures and pHs demonstrate that the optimal enzymatic activity of the recombinant pernisine is ca. 100 degrees C and pH 7.0, respectively. Conclusions/Significance These data demonstrate that codon optimisation is crucial for pernisine overexpression in E. coli, and that the proposed catalytic Ser355 has an important role in pernisine activity, but not in its activation process. Pernisine is activated by autoproteolytical cleavage of its N-terminal proregion. We have also confirmed that the recombinant pernisine retains the characteristics of native pernisine, as a calcium modulated thermostable serine protease.	[Snajder, Marko; Ulrih, Natasa Poklar] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Mihelic, Marko; Turk, Dusan; Ulrih, Natasa Poklar] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Mihelic, Marko; Turk, Dusan] Jozef Stefan Inst, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Ulrih, NP (corresponding author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	natasa.poklar@bf.uni-lj.si	Ulrih, Natasa Poklar/B-2015-2008	, marko/0000-0003-2494-2222; Turk, Dusan/0000-0003-0205-6609; Poklar Ulrih, Natasa/0000-0002-2731-9973	Research Programme (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds) [P4-0121]; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBIP);  [OP13.2.1.8.01.0037]	Research Programme (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds); Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBIP); 	This study was funded by the Research Programme P4-0121 (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds), the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBIP) and the operation number OP13.2.1.8.01.0037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Beynon RJ, 1996, BUFFER SOLUTIONS, Vviii; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Catara G, 2003, EXTREMOPHILES, V7, P391, DOI 10.1007/s00792-003-0337-4; Dominy BN, 2004, PROTEINS, V57, P128, DOI 10.1002/prot.20190; Elena C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00021; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hirata A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-19; Hu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058393; Koga Y, 2014, APPL MICROBIOL BIOT, V98, P2113, DOI 10.1007/s00253-013-5091-7; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Milek I, 2005, CAN J MICROBIOL, V51, P805, DOI 10.1139/W05-060; Palmieri G, 2009, MOL CELL PROTEOMICS, V8, P2570, DOI 10.1074/mcp.M900012-MCP200; Pulido M, 2006, APPL ENVIRON MICROB, V72, P4154, DOI 10.1128/AEM.02696-05; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070, DOI 10.1099/00207713-46-4-1070; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Smith CA, 1999, J MOL BIOL, V294, P1027, DOI 10.1006/jmbi.1999.3291; Snajder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039548; Song HF, 2014, CURR MICROBIOL, V68, P293, DOI 10.1007/s00284-013-0476-5; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Volonte F, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-53; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang Q, 2012, J BIOMED BIOTECHNOL, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0035344; Wang YR, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-30; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zylicz-Stachula A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-7	31	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123288	10.1371/journal.pone.0123288	http://dx.doi.org/10.1371/journal.pone.0123288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856104	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500084
J	Lee, JH; Asakawa, DS; Dennerlein, JT; Jindrich, DL				Lee, Jong Hwa; Asakawa, Deanna S.; Dennerlein, Jack T.; Jindrich, Devin L.			Finger Muscle Attachments for an OpenSim Upper-Extremity Model	PLOS ONE			English	Article							FLEXOR DIGITORUM SUPERFICIALIS; MOMENT ARMS; INDEX FINGER; BIOMECHANICAL MODEL; KINEMATIC MODEL; DYNAMIC-MODEL; TENDON; FORCES; OPTIMIZATION; PATTERNS	We determined muscle attachment points for the index, middle, ring and little fingers in an OpenSim upper-extremity model. Attachment points were selected to match both experimentally measured locations and mechanical function (moment arms). Although experimental measurements of finger muscle attachments have been made, models differ from specimens in many respects such as bone segment ratio, joint kinematics and coordinate system. Likewise, moment arms are not available for all intrinsic finger muscles. Therefore, it was necessary to scale and translate muscle attachments from one experimental or model environment to another while preserving mechanical function. We used a two-step process. First, we estimated muscle function by calculating moment arms for all intrinsic and extrinsic muscles using the partial velocity method. Second, optimization using Simulated Annealing and Hooke-Jeeves algorithms found muscle-tendon paths that minimized root mean square (RMS) differences between experimental and modeled moment arms. The partial velocity method resulted in variance accounted for (VAF) between measured and calculated moment arms of 75.5% on average (range from 48.5% to 99.5%) for intrinsic and extrinsic index finger muscles where measured data were available. RMS error between experimental and optimized values was within one standard deviation (S.D) of measured moment arm (mean RMS error = 1.5 mm < measured S.D = 2.5 mm). Validation of both steps of the technique allowed for estimation of muscle attachment points for muscles whose moment arms have not been measured. Differences between modeled and experimentally measured muscle attachments, averaged over all finger joints, were less than 4.9 mm (within 7.1% of the average length of the muscle-tendon paths). The resulting non-proprietary musculoskeletal model of the human fingers could be useful for many applications, including better understanding of complex multi-touch and gestural movements.	[Lee, Jong Hwa] Arizona State Univ, Dept Mech & Aerosp Engn, Tempe, AZ 85287 USA; [Asakawa, Deanna S.; Jindrich, Devin L.] Calif State Univ, Dept Kinesiol, San Marcos, CA 92078 USA; [Dennerlein, Jack T.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement & Rehabil Sci, Boston, MA 02115 USA	Arizona State University; Arizona State University-Tempe; California State University System; California State University San Marcos; Northeastern University	Jindrich, DL (corresponding author), Calif State Univ, Dept Kinesiol, San Marcos, CA 92078 USA.	djindrich@csusm.edu		Dennerlein, Jack/0000-0001-7703-643X	National Science Foundation [NSF 0964220]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF 0964220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1979, J BIOMECH, V12, P775, DOI 10.1016/0021-9290(79)90163-5; AN KN, 1983, J BIOMECH, V16, P419, DOI 10.1016/0021-9290(83)90074-X; AN KN, 1981, J BIOMECH, V14, P659, DOI 10.1016/0021-9290(81)90048-8; ARMSTRONG TJ, 1978, J BIOMECH, V11, P119, DOI 10.1016/0021-9290(78)90004-0; Arnold A S, 2000, Comput Aided Surg, V5, P108, DOI 10.3109/10929080009148877; Biggs J, 1999, MED ENG PHYS, V21, P625, DOI 10.1016/S1350-4533(99)00095-8; Brand P. W., 1999, CLIN MECH HAND; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; BROOK N, 1995, MED ENG PHYS, V17, P54, DOI 10.1016/1350-4533(95)90378-O; BUCHNER HJ, 1988, J BIOMECH, V21, P459, DOI 10.1016/0021-9290(88)90238-2; Chao E.Y., 1989, BIOMECHANICS HAND BA; CHOLEWICKI J, 1994, J BIOMECH, V27, P1287, DOI 10.1016/0021-9290(94)90282-8; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1995, COMPUT BIOL MED, V25, P21, DOI 10.1016/0010-4825(95)98882-E; Dennerlein JT, 1999, J ORTHOPAED RES, V17, P178, DOI 10.1002/jor.1100170205; Dennerlein JT, 1998, J BIOMECH, V31, P295, DOI 10.1016/S0021-9290(98)00006-2; Fowler NK, 2001, J BIOMECH, V34, P791, DOI 10.1016/S0021-9290(01)00021-5; Franko OI, 2011, J BIOMECH, V44, P1987, DOI 10.1016/j.jbiomech.2011.04.025; Garner BA, 2003, ANN BIOMED ENG, V31, P207, DOI 10.1114/1.1540105; Garner BRIAN A., 2000, Comput Methods Biomech Biomed Engin, V3, P1, DOI 10.1080/10255840008915251; Gatti CJ, 2009, ANN BIOMED ENG, V37, P1342, DOI 10.1007/s10439-009-9710-5; Gorden CC, 1989, ANTHROPOMETIC SURVEY; Greiner T.M., 1991, ECONOMICS; HOLLISTER A, 1992, J ORTHOPAED RES, V10, P454, DOI 10.1002/jor.1100100319; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Hu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094533; Hu X, 2011, J NEUROPHYSIOL, V105, P1633, DOI 10.1152/jn.00537.2010; JACOBSON MD, 1992, J HAND SURG-AM, V17A, P804, DOI 10.1016/0363-5023(92)90446-V; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; Kamper DG, 2006, CLIN BIOMECH, V21, P361, DOI 10.1016/j.clinbiomech.2005.11.005; Kane T. R., 1985, DYNAMICS THEORY APPL; Kelley C.T., 1999, ITERATIVE METHODS OP; Kinney AL, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023255; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kociolek AM, 2011, J BIOMECH, V44, P1967, DOI 10.1016/j.jbiomech.2011.05.002; Lee J.H., 2014, ANN BIOMED ENG; Lee J W, 1990, Proc Inst Mech Eng H, V204, P169, DOI 10.1243/PIME_PROC_1990_204_251_02; LEIJNSE JNAL, 1995, J BIOMECH, V28, P237, DOI 10.1016/0021-9290(94)00070-K; Li ZZ, 2008, ERGONOMICS, V51, P1672, DOI 10.1080/00140130802287280; LIEBER RL, 1990, J HAND SURG-AM, V15A, P244, DOI 10.1016/0363-5023(90)90103-X; LIEBER RL, 1992, J HAND SURG-AM, V17A, P787, DOI 10.1016/0363-5023(92)90444-T; Lopes MM, 2011, CLIN BIOMECH, V26, P930, DOI 10.1016/j.clinbiomech.2011.03.014; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; Martin JR, 2012, CLIN BIOMECH, V27, P453, DOI 10.1016/j.clinbiomech.2011.11.008; Murray WM, 2002, J BIOMECH, V35, P19, DOI 10.1016/S0021-9290(01)00173-7; Novick A., 1995, CLIN ORTHOP RELTAT R, V320, P188; Oh S, 2007, J ULTRAS MED, V26, P149, DOI 10.7863/jum.2007.26.2.149; Rankin JW, 2012, J BIOMECH, V45, P1739, DOI 10.1016/j.jbiomech.2012.03.010; Sancho-Bru JL, 2001, J BIOMECH, V34, P1491, DOI 10.1016/S0021-9290(01)00106-3; Saul K., 2014, COMPUT METHOD BIOMEC, P1; Shin GS, 2011, ERGONOMICS, V54, P733, DOI 10.1080/00140139.2011.592604; SPOOR CW, 1976, J BIOMECH, V9, P561, DOI 10.1016/0021-9290(76)90096-8; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Valero-Cuevas FJ, 2003, J BIOMECH, V36, P1019, DOI 10.1016/S0021-9290(03)00061-7; Vilimek M, 2007, ACTA BIOENG BIOMECH, V9, P41; Wang KM, 2014, J HAND SURG-AM, V39, P149, DOI 10.1016/j.jhsa.2013.06.029; Wohlman SJ, 2013, J BIOMECH, V46, P1014, DOI 10.1016/j.jbiomech.2012.10.044; Wu JZ, 2008, J BIOMECH, V41, P668, DOI 10.1016/j.jbiomech.2007.09.025; Yoshii Y, 2011, J ORTHOP RES, V29, P1465, DOI 10.1002/jor.21428	59	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121712	10.1371/journal.pone.0121712	http://dx.doi.org/10.1371/journal.pone.0121712			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853869	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400047
J	Li, AM; Zhang, JY; Zhou, ZY; Wang, L; Liu, YJ; Liu, YJ				Li, Aimin; Zhang, Junying; Zhou, Zhongyin; Wang, Lei; Liu, Yujuan; Liu, Yajun			ALDB: A Domestic-Animal Long Noncoding RNA Database	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENOME-WIDE IDENTIFICATION; GENE; GENERATION; EVOLUTION; TRANSCRIPTOME; ANNOTATION; BLAST	Background Long noncoding RNAs (lncRNAs) have attracted significant attention in recent years due to their important roles in many biological processes. Domestic animals constitute a unique resource for understanding the genetic basis of phenotypic variation and are ideal models relevant to diverse areas of biomedical research. With improving sequencing technologies, numerous domestic-animal lncRNAs are now available. Thus, there is an immediate need for a database resource that can assist researchers to store, organize, analyze and visualize domestic-animal lncRNAs. Results The domestic-animal lncRNA database, named ALDB, is the first comprehensive database with a focus on the domestic-animal lncRNAs. It currently archives 12,103 pig intergenic lncRNAs (lincRNAs), 8,923 chicken lincRNAs and 8,250 cow lincRNAs. In addition to the annotations of lincRNAs, it offers related data that is not available yet in existing lncRNA databases (lncRNAdb and NONCODE), such as genome-wide expression profiles and animal quantitative trait loci (QTLs) of domestic animals. Moreover, a collection of interfaces and applications, such as the Basic Local Alignment Search Tool (BLAST), the Generic Genome Browser (GBrowse) and flexible search functionalities, are available to help users effectively explore, analyze and download data related to domestic-animal lncRNAs. Conclusions ALDB enables the exploration and comparative analysis of lncRNAs in domestic animals. A user-friendly web interface, integrated information and tools make it valuable to researchers in their studies.	[Li, Aimin; Zhang, Junying; Liu, Yajun] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Li, Aimin] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China; [Zhou, Zhongyin] Univ Sci & Technol China, Sch Life Sci, Dept Mol & Cell Biol, Hefei 230026, Peoples R China; [Zhou, Zhongyin] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Liu, Yujuan] CMST Dev Co Ltd, Xian DongXing Branch, Xian, Shaanxi, Peoples R China; [Liu, Yajun] Xian Univ Technol, Higher Technol Coll, Xian, Shaanxi, Peoples R China	Xidian University; Xi'an University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Xi'an University of Technology	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	jyzhang@mail.xidian.edu.cn		Zhou, Zhong-Yin/0000-0002-9715-9821; Li, Aimin/0000-0002-6983-2310	Natural Science Foundation of China [61070137, 91130006, 61201312, 61303122]; Research Fund for the Doctoral Program of Higher Education of China [20130203110017]; Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grants 61070137, 91130006, 61201312 and 61303122; and the Research Fund for the Doctoral Program of Higher Education of China (http://www.moe.edu.cn/, 20130203110017); and the Fundamental Research Funds for the Central Universities of China (http://www.moe.edu. cn/, BDY171416 and JB140306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Aboyoun P. H., 2013, GENOMICRANGES REPRES; Albert FW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002962; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang W, 2012, ANIM GENET, V43, P674, DOI 10.1111/j.1365-2052.2012.02325.x; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Jin JJ, 2013, BIOINFORMATICS, V29, P1068, DOI 10.1093/bioinformatics/btt107; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042638; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang H, 2014, GENOME RES; Warren ST, 1993, NAT GENET, V3; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yang J-H, 2012, NUCLEIC ACIDS RES; Zhou ZY, 2014, GENOME BIOL EVOL, V6, P1387, DOI 10.1093/gbe/evu113	48	67	73	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124003	10.1371/journal.pone.0124003	http://dx.doi.org/10.1371/journal.pone.0124003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853886	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400129
J	Witas, HW; Ploszaj, T; Jedrychowska-Danska, K; Witas, PJ; Maslowska, A; Jerszynska, B; Kozlowski, T; Osipowicz, G				Witas, Henryk W.; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna; Witas, Piotr J.; Maslowska, Alicja; Jerszynska, Blandyna; Kozlowski, Tomasz; Osipowicz, Grzegorz			Hunting for the LCT-13910*T Allele between the Middle Neolithic and the Middle Ages Suggests Its Absence in Dairying LBK People Entering the Kuyavia Region in the 8th Millennium BP	PLOS ONE			English	Article							LACTASE-PERSISTENCE; POSITIVE SELECTION; ANCIENT DNA; EVOLUTIONARY GENETICS; LACTOSE DIGESTION; HUMAN GENOME; POPULATION; FREQUENCY; HISTORY; ADAPTATION	Populations from two medieval sites in Central Poland, Stary Brzesc Kujawski-4 (SBK-4) and Gruczno, represented high level of lactase persistence (LP) as followed by the LCT-13910*T allele's presence (0.86 and 0.82, respectively). It was twice as high as in contemporaneous Cedynia (0.4) and Srodka (0.43), both located outside the region, higher than in modern inhabitants of Poland (0.51) and almost as high as in modern Swedish population (0.9). In an attempt to explain the observed differences its frequency changes in time were followed between the Middle Neolithic and the Late Middle Ages in successive dairying populations on a relatively small area (radius similar to 60km) containing the two sites. The introduction of the T allele to Kuyavia 7.4 Ka BP by dairying LBK people is not likely, as suggested by the obtained data. It has not been found in any of Neolithic samples dated between 6.3 and 4.5 Ka BP. The identified frequency profile indicates that both the introduction and the beginning of selection could have taken place approx. 4 millennia after first LBK people arrived in the region, shifting the value of LP frequency from 0 to more than 0.8 during less than 130 generations. We hypothesize that the selection process of the T allele was rather rapid, starting just after its introduction into already milking populations and operated via high rates of fertility and mortality on children after weaning through life-threatening conditions, favoring lactose-tolerant individuals. Facing the lack of the T allele in people living on two great European Neolithization routes, the Danubian and Mediterranean ones, and based on its high frequency in northern Iberia, its presence in Scandinavia and estimated occurrence in Central Poland, we propose an alternative Northern Route of its spreading as very likely. None of the successfully identified nuclear alleles turned out to be deltaF508 CFTR.	[Witas, Henryk W.; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna; Maslowska, Alicja] Med Univ Lodz, Dept Mol Biol, Lodz, Poland; [Witas, Piotr J.] Nicholas Copernicus Univ, Inst Phys, PL-87100 Torun, Poland; [Jerszynska, Blandyna] Adam Mickiewicz Univ, Dept Anthropol, Poznan, Poland; [Kozlowski, Tomasz] Nicholas Copernicus Univ, Dept Anthropol, Torun, Poland; [Osipowicz, Grzegorz] Nicholas Copernicus Univ, Dept Archaeol, Torun, Poland	Medical University Lodz; Nicolaus Copernicus University; Adam Mickiewicz University; Nicolaus Copernicus University; Nicolaus Copernicus University	Witas, HW (corresponding author), Med Univ Lodz, Dept Mol Biol, Lodz, Poland.	henryk.witas@umed.lodz.pl	Kozłowski, Tomasz/O-3284-2015; Osipowicz, Grzegorz/O-5013-2015; Ploszaj, Tomasz/S-9849-2016; Witas, Henryk Wlodzimierz/S-9450-2016	Osipowicz, Grzegorz/0000-0002-4393-655X; Ploszaj, Tomasz/0000-0002-9503-278X; Witas, Henryk Wlodzimierz/0000-0002-8402-2084; Jedrychowska-Danska, Krystyna/0000-0001-9262-4010; Kozlowski, Tomasz/0000-0001-5242-6095	Polish Ministry of Science and Higher Education [N N109 286737]; National Science Center (NCN) [N 2013/08/M/HS3/00379]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center (NCN)(National Science Centre, Poland)	The work was funded by the scientific project no. N N109 286737 from the Polish Ministry of Science and Higher Education and the National Science Center (NCN) under the scientific project no. N 2013/08/M/HS3/00379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon R, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5141; Angel J.L., 1984, PALEOPATHOLOGY ORIGI, P51; ASHWORTH A, 1982, HUM NUTR-CLIN NUTR, V36, P279; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2014, J HUM EVOL, DOI [10.1016/j.jhevol.2014.1006.1017, DOI 10.1016/J.JHEVOL.2014.1006.1017]; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Chudziak W, 2000, ARCHEOLOGIA BYDGOSKO, P55; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Copley MS, 2005, J ARCHAEOL SCI, V32, P523, DOI 10.1016/j.jas.2004.08.006; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Cramp LJE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2372; Dabney J, 2013, COLD SPRING HARB PER, V5; Deguilloux MF, 2012, EVOL ANTHROPOL, V21, P24, DOI 10.1002/evan.20341; Dittmann K, 2000, Anthropol Anz, V58, P345; ENARD D, 2014, GENOME RES; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLATZ G, 1973, LANCET, V2, P76; Fung T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085925; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gronenborn D, 2009, DOC PRAEHIST, V36, P97, DOI 10.4312/dp.36.5; GRYGIEL R, 1986, J FIELD ARCHAEOL, V13, P121, DOI 10.1179/009346986791535762; Grygiel R, 2004, NEOLIT POCZ TKI EPOK; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Henneberg M, 1975, PRZEGL ANTROPOLOGICZ, V41, P159; Holden C, 1997, HUM BIOL, V69, P605; Hu M, 2012, HUM GENET, V131, P665, DOI 10.1007/s00439-011-1111-9; Huhne-Osterloh G, 1989, Anthropol Anz, V47, P11; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Isaksson S, 2012, J ARCHAEOL SCI, V39, P3600, DOI 10.1016/j.jas.2012.06.018; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Kapica Z., 1970, MONOGRAFIA BRZESCIA, P7; Kelley JL, 2008, ANNU REV GENOM HUM G, V9, P143, DOI 10.1146/annurev.genom.9.081307.164411; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kruttli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086251; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Leonardi M, 2012, INT DAIRY J, V22, P88, DOI 10.1016/j.idairyj.2011.10.010; Lorkiewicz W, 2012, BIOL WCZESNOROLNICZY; Malmstrom H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-89; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nowak M, 2013, IANSA, VIV, P85; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Plantinga TS, 2012, EUR J HUM GENET, V20, P778, DOI 10.1038/ejhg.2011.254; Ploszaj T, 2011, CENT EUR J BIOL, V6, P176, DOI 10.2478/s11535-010-0114-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Shennan S, 2007, J ARCHAEOL SCI, V34, P1339, DOI 10.1016/j.jas.2006.10.031; SMITH G, 2008, BALLET REV, V36, P17, DOI DOI 10.1038/EJHG.2008.156; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sverrisdottir OO, 2014, MOL BIOL EVOL, V31, P975, DOI 10.1093/molbev/msu049; Sverrisdottir OO, 2014, THESIS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wilde S., 2014, P NATL ACAD SCI US; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Witas HW, 2010, INT J IMMUNOGENET, V37, P155, DOI 10.1111/j.1744-313X.2010.00896.x; Witas HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073682; Witas Henryk W., 2006, Anthropologischer Anzeiger, V64, P41; Zawicki P, 2008, INFECT GENET EVOL, V8, P146, DOI 10.1016/j.meegid.2007.11.003	78	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122384	10.1371/journal.pone.0122384	http://dx.doi.org/10.1371/journal.pone.0122384			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3WA	25853887	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400066
J	Han, XR; Yang, F; Cao, HQ; Liang, ZC				Han, Xiaorui; Yang, Feng; Cao, Huiqing; Liang, Zicai			Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis	FASEB JOURNAL			English	Article						long noncoding RNA; microRNA; sponge	LONG NONCODING RNA; CARDIAC-MUSCLE DEVELOPMENT; NUCLEAR SPECKLES; GENE-EXPRESSION; LNCRNA MALAT1; LUNG-CANCER; MICRORNAS; SKELETAL; CELLS; DIFFERENTIATION	Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) is an example of a functional long noncoding RNA involved in many biologic processes. However, the mechanisms for Malat1 in myogenesis are unclear. Serum response factor (SRF) is a pivotal transcription factor for muscle proliferation and differentiation and is reported to be a target gene for muscle-specific microRNA-133 (miR-133). In this study, we initially found that silencing Malat1 in the mouse myoblast C2C12 cell line inhibited myocyte differentiation and decreased Srf at both the RNA and protein levels. Srf silencing decreased Malat1 expression as well. Further study revealed that Malat1 contained an miR-133 functional target site, and the interplay between Malat1 and Srf was miR-133 dependent. We demonstrated that Malat1 modulates Srf through miR-133 as a competing endogenous RNA and established a novel connection among Malat1, miR-133, and Srf in myoblast differentiation.	[Han, Xiaorui; Yang, Feng; Cao, Huiqing; Liang, Zicai] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Peking University	Yang, F (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	feng_yang@pku.edu.cn; caohuiqing@pku.edu.cn	Yang, Feng/A-4770-2017		National High-Tech R&D Program of China [2012AA022501]; National Natural Science Foundation of China [81273422, 81170097]	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Chujun Liu for her contribution to the bioinformatics analysis in this article. This work was supported by the National High-Tech R&D Program of China (Grant 2012AA022501) and the National Natural Science Foundation of China (Grants 81273422 and 81170097). The authors declare no conflicts of interest.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bradley RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006478; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dodd DW, 2013, NUCLEIC ACID THER, V23, P188, DOI 10.1089/nat.2013.0427; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fang L, 2013, FASEB J, V27, P907, DOI 10.1096/fj.12-220905; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li BZ, 2014, J BIOL CHEM, V289, P29365, DOI 10.1074/jbc.M114.572693; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watts R, 2013, AM J PHYSIOL-CELL PH, V304, pC995, DOI 10.1152/ajpcell.00392.2012; Yang F, 2013, FEBS LETT, V587, P3175, DOI 10.1016/j.febslet.2013.07.048; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003	49	103	120	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3054	3064		10.1096/fj.14-259952	http://dx.doi.org/10.1096/fj.14-259952			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25868726				2022-12-26	WOS:000356859100032
J	Beeden, R; Maynard, J; Puotinen, M; Marshall, P; Dryden, J; Goldberg, J; Williams, G				Beeden, Roger; Maynard, Jeffrey; Puotinen, Marjetta; Marshall, Paul; Dryden, Jen; Goldberg, Jeremy; Williams, Gareth			Impacts and Recovery from Severe Tropical Cyclone Yasi on the Great Barrier Reef	PLOS ONE			English	Article							CORAL-REEFS; PHASE-SHIFTS; DISTURBANCE; HURRICANES; RECRUITMENT; RESILIENCE; FREQUENCY; DECLINE; SPACE; MODEL	Full recovery of coral reefs from tropical cyclone (TC) damage can take decades, making cyclones a major driver of habitat condition where they occur regularly. Since 1985, 44 TCs generated gale force winds (>= 17 metres/second) within the Great Barrier Reef Marine Park (GBRMP). Of the hurricane strength TCs (>= H1-Saffir Simpson scale; >= category 3 Australian scale), TC Yasi (February, 2011) was the largest. In the weeks after TC Yasi crossed the GBRMP, participating researchers, managers and rangers assessed the extent and severity of reef damage via 841 Reef Health and Impact Surveys at 70 reefs. Records were scaled into five damage levels representing increasingly widespread colony-level damage (1, 2, 3) and reef structural damage (4, 5). Average damage severity was significantly affected by direction (north vs south of the cyclone track), reef shelf position (mid-shelf vs outershelf) and habitat type. More outer-shelf reefs suffered structural damage than mid-shelf reefs within 150 km of the track. Structural damage spanned a greater latitudinal range for mid-shelf reefs than outer-shelf reefs (400 vs 300 km). Structural damage was patchily distributed at all distances, but more so as distance from the track increased. Damage extended much further from the track than during other recent intense cyclones that had smaller circulation sizes. Just over 15% (3,834 km(2)) of the total reef area of the GBRMP is estimated to have sustained some level of coral damage, with >= 4% (949 km(2)) sustaining a degree of structural damage. TC Yasi likely caused the greatest loss of coral cover on the GBR in a 24-hour period since 1985. Severely impacted reefs have started to recover; coral cover increased an average of 4% between 2011 and 2013 at re-surveyed reefs. The in situ assessment of impacts described here is the largest in scale ever conducted on the Great Barrier Reef following a reef health disturbance.	[Beeden, Roger; Dryden, Jen] Great Barrier Reef Marine Pk Author, Townsville, Qld 4810, Australia; [Beeden, Roger; Goldberg, Jeremy] James Cook Univ, Coll Business, Townsville, Qld 4810, Australia; [Beeden, Roger; Goldberg, Jeremy] James Cook Univ, Coll Law & Governance, Townsville, Qld 4810, Australia; [Beeden, Roger; Goldberg, Jeremy] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4810, Australia; [Maynard, Jeffrey] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Maynard, Jeffrey] CRIOBE, USR CNRS EPHE 3278, Labs Excellence CORAIL, Papetoai, Moorea, France; [Puotinen, Marjetta] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Puotinen, Marjetta] Australian Inst Marine Sci, Perth, WA 6009, Australia; [Marshall, Paul] Reef Ecol, Alligator Creek, Qld 4814, Australia; [Goldberg, Jeremy] CSIRO Land & Water Flagship, Townsville, Qld 4811, Australia; [Williams, Gareth] Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92037 USA	James Cook University; James Cook University; James Cook University; Cornell University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Wollongong; Australian Institute of Marine Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California San Diego; Scripps Institution of Oceanography	Beeden, R (corresponding author), Great Barrier Reef Marine Pk Author, Townsville, Qld 4810, Australia.	roger.beeden@gbrmpa.gov.au		Williams, Dr Gareth J./0000-0001-7837-1619; Maynard, Dr Jeffrey/0000-0002-6444-6373; Puotinen, Marji/0000-0002-1383-697X	Great Barrier Reef Marine Park Authority; Queensland Parks and Wildlife Service; Scripps Institution of Oceanography; EPHE/CNRS AMP; CRIOBE of Paris, France; French Polynesia	Great Barrier Reef Marine Park Authority; Queensland Parks and Wildlife Service; Scripps Institution of Oceanography(University of California System); EPHE/CNRS AMP; CRIOBE of Paris, France; French Polynesia	Fieldwork, data analysis and manuscript preparation were all supported by the Great Barrier Reef Marine Park Authority, Queensland Parks and Wildlife Service, Scripps Institution of Oceanography, and EPHE/CNRS & CRIOBE of Paris, France and French Polynesia using departmental funding and not grants. The lead author works for the GBRMPA and his role at the Authority facilitated the authors' team being able to complete the described assessments of impacts and recovery following tropical cyclone Yasi. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbs D, 2011, 11 CSIRO; Australian Bureau of Meteorology, 2011, SEV TROP CYCL YAS; Beeden RJ, 2014, ENVIRON MONIT ASSESS, V186, P8527, DOI 10.1007/s10661-014-4022-0; Carrigan AD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049722; Coles SL, 2007, CORAL REEFS, V26, P705, DOI 10.1007/s00338-007-0257-3; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CSIRO-Australian Bureau of Meteorology, 2007, CLIM CHANG AUSTR TEC; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hayne M, 2001, PALAEOGEOGR PALAEOCL, V168, P207, DOI 10.1016/S0031-0182(00)00217-0; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Knaff JA, 2014, J CLIMATE, V27, P455, DOI 10.1175/JCLI-D-13-00096.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Leslie LM, 2007, METEOROL ATMOS PHYS, V97, P171, DOI 10.1007/s00703-006-0250-3; Lukoschek V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065363; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; McClanahan TR, 2002, RESILIENCE BEHAV LAR; MERRILL RT, 1984, MON WEATHER REV, V112, P1408, DOI 10.1175/1520-0493(1984)112<1408:ACOLAS>2.0.CO;2; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nott J, 2001, NATURE, V413, P508, DOI 10.1038/35097055; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Perry CT, 2014, GEOMORPHOLOGY, V222, P92, DOI 10.1016/j.geomorph.2014.03.012; Powell MD, 2007, B AM METEOROL SOC, V88, P513, DOI 10.1175/BAMS-88-4-513; Puotinen ML, 2007, INT J GEOGR INF SCI, V21, P97, DOI 10.1080/1365SS10600852230; Puotinen ML, 1997, 19 CRC REEF RES CTR; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; Uychiaoco AJ, 2005, BIODIVERS CONSERV, V14, P2775, DOI 10.1007/s10531-005-8414-x; Walsh KJE, 2004, CLIM DYNAM, V22, P47, DOI 10.1007/s00382-003-0362-0; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Young IR, 2003, MAR STRUCT, V16, P201, DOI 10.1016/S0951-8339(02)00054-0; YOUNG IR, 1993, CORAL REEFS, V12, P85, DOI 10.1007/BF00302108	47	53	54	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121272	10.1371/journal.pone.0121272	http://dx.doi.org/10.1371/journal.pone.0121272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874718	Green Published, Green Accepted, gold			2022-12-26	WOS:000353015800016
J	Dey, T; Gogoi, K; Unni, B; Bharadwaz, M; Kalita, M; Ozah, D; Kalita, M; Kalita, J; Baruah, PK; Bora, T				Dey, Tapan; Gogoi, Kabita; Unni, Balagopalan; Bharadwaz, Moonmee; Kalita, Munmi; Ozah, Dibyajyoti; Kalita, Manoj; Kalita, Jatin; Baruah, Pranab Kumar; Bora, Thaneswar			Role of Environmental Pollutants in Liver Physiology: Special References to Peoples Living in the Oil Drilling Sites of Assam	PLOS ONE			English	Article							NITROGEN-DIOXIDE; AIR-POLLUTION; RESPIRATORY SYMPTOMS; PARTICULATE MATTER; EXPOSURE; OZONE; RESPONSIVENESS; MORTALITY; EXERCISE; ASTHMA	The populations residing near polluted sites are more prone to various types of diseases. The important causes of air pollution are the suspended particulate matter, respirable suspended particulate matter, sulfur dioxide and nitrogen dioxide. As limited information is available enumerating the effect of these pollutants on liver physiology of the population living near the polluted sites; in the present study, we tried to investigate their effect on liver of the population residing near the oil drilling sites since birth. In this study, a randomly selected 105 subjects (46 subjects from oil drilling site and 61 subjects from control site) aged above 30 years were taken under consideration. The particulate matter as well as the gaseous pollutants, sulfur dioxide and nitrogen dioxide, were analyzed through a respirable dust sampler. The level of alkaline phosphatase, alanine transaminase and aspartate transaminase enzymes in serum were measured by spectrophotometer. The generalized regression model studies suggests a higher concentration of respirable suspended particulate matter, suspended particulate matter and nitrogen dioxide lowers the alkaline phosphatase level (p<0.0001) by 3.5 times (95% CI 3.1-3.9), 1.5 times (95% CI 1.4 - 1.6) and 12 times (95% CI 10.74 - 13.804), respectively in the exposed group. The higher concentration of respirable suspended particulate matter and nitrogen dioxide in air was associated with increase in alanine transaminase level (p<0.0001) by 0.8 times (95% CI 0.589-1.049) and by 2.8 times (95% CI 2.067-3.681) respectively in the exposed group. The increase in nitrogen dioxide level was also associated with increase in aspartate transaminase level (p<0.0001) by 2.5 times (95% CI 1.862 - 3.313) in the exposed group as compared to control group. Thus, the study reveals that long-term exposure to the environmental pollutants may lead to liver abnormality or injury of populations living in polluted sites.	[Dey, Tapan; Gogoi, Kabita; Unni, Balagopalan; Bharadwaz, Moonmee; Kalita, Munmi; Ozah, Dibyajyoti; Kalita, Manoj; Kalita, Jatin; Baruah, Pranab Kumar; Bora, Thaneswar] CSIR, North East Inst Sci & Technol, Div Biotechnol, Jorhat, Assam, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST)	Unni, B (corresponding author), CSIR, North East Inst Sci & Technol, Div Biotechnol, Jorhat, Assam, India.	bgunni@yahoo.com	Kalita, Jatin/HCH-1167-2022; Dey, Tapan/M-7856-2019	Dey, Tapan/0000-0003-3497-8624; Kalita, Jatin/0000-0002-1369-2005	Council of Scientific and Industrial Research, Department of Scientific & Industrial Research. New Delhi, Government of India	Council of Scientific and Industrial Research, Department of Scientific & Industrial Research. New Delhi, Government of India	The project was entirely funded by Council of Scientific and Industrial Research, Department of Scientific & Industrial Research. New Delhi, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WC, 1987, J APPL PHYSIOL, V62, P1698, DOI 10.1152/jappl.1987.62.4.1698; AMDUR MO, 1953, LANCET, V265, P758; Bai JY, 2004, ZHONGHUA BING LI XUE, V33, P155; BAUER MA, 1986, AM REV RESPIR DIS, V134, P1203; Belanger K, 2013, EPIDEMIOLOGY, V24, P320, DOI 10.1097/EDE.0b013e318280e2ac; Bhattacharjee M., 2011, International Journal for Biotechnology and Molecular Biology Research, V2, P195, DOI 10.5897/IJBMBR11.051; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cave M, 2010, ENVIRON HEALTH PERSP, V118, P1735, DOI 10.1289/ehp.1002720; Cendon S, 2006, REV SAUDE PUBL, V40, P414, DOI 10.1590/S0034-89102006000300008; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Das Chutia A, 2011, RES J CHEM ENVIRON, V15, P91; Deng Q, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-30; DERITIS F, 1965, B WORLD HEALTH ORGAN, V32, P59; Dey T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096739; Faiz AS, 2012, AM J EPIDEMIOL, V176, P308, DOI 10.1093/aje/kws029; Filho MAP, 2008, BRAZ J MED BIOL RES, V41, P526, DOI 10.1590/S0100-879X2008005000020; FOLINSBEE LJ, 1981, AM IND HYG ASSOC J, V42, P534, DOI 10.1080/15298668191420206; Goldstein BD, 2011, NEW ENGL J MED, V364, P1334, DOI 10.1056/NEJMra1007197; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Kan HD, 2010, ENVIRON RES, V110, P258, DOI 10.1016/j.envres.2010.01.006; Kim JJ, 2004, AM J RESP CRIT CARE, V170, P520, DOI 10.1164/rccm.200403-281OC; KOENIG JQ, 1988, TOXICOL IND HEALTH, V4, P521, DOI 10.1177/074823378800400410; Krier M, 2009, CLIN LIVER DIS, V13, P167, DOI 10.1016/j.cld.2009.02.001; Lepeule J, 2010, ENVIRON HEALTH PERSP, V118, P1483, DOI 10.1289/ehp.0901509; Loscalzo J., 2011, HARRISONS PRINCIPLES, V18th; Minuk GY, 1998, CAN J GASTROENTEROL, V12, P417, DOI 10.1155/1998/943498; Modig L, 2006, EUR RESPIR J, V28, P75, DOI 10.1183/09031936.06.00071505; OSTERMAN JW, 1989, BRIT J IND MED, V46, P629; Raaschou-Nielsen O, 2001, AM J EPIDEMIOL, V153, P433, DOI 10.1093/aje/153.5.433; ROGER LJ, 1990, TOXICOL IND HEALTH, V6, P155, DOI 10.1177/074823379000600110; SCHWARTZ J, 1992, AM REV RESPIR DIS, V145, P600, DOI 10.1164/ajrccm/145.3.600; Smargiassi A, 2009, ENVIRON HEALTH PERSP, V117, P653, DOI 10.1289/ehp.0800010; TAKAHASHI Y, 1986, ENVIRON RES, V41, P184, DOI 10.1016/S0013-9351(86)80180-3; Tan HH, 2009, J IMMUNOTOXICOL, V6, P266, DOI [10.3109/15476910903241704, 10.1080/15476910903241704]; Tao YB, 2012, ENVIRON HEALTH PERSP, V120, P393, DOI 10.1289/ehp.1103715; Tseng CY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-4; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; Williams R, 2012, INT J ENVIRON HEAL R, V22, P71, DOI 10.1080/09603123.2011.588437; WROBLEWSKI F, 1959, AM J MED, V27, P911, DOI 10.1016/0002-9343(59)90175-5; Zock JP, 2014, ENVIRON INT, V62, P72, DOI 10.1016/j.envint.2013.09.020	41	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123370	10.1371/journal.pone.0123370	http://dx.doi.org/10.1371/journal.pone.0123370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874634	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100166
J	Calderon, R; Hernandez, CL; Cuesta, P; Dugoujon, JM				Calderon, Rosario; Hernandez, Candela L.; Cuesta, Pedro; Dugoujon, Jean Michel			Surnames and Y-Chromosomal Markers Reveal Low Relationships in Southern Spain	PLOS ONE			English	Article							POPULATION STRUCTURES; FAMILY NAMES; GENETIC DIVERSITY; MIGRATORY EVENTS; HAPLOGROUP-J; EUROPE; DIFFERENTIATION; ANDALUSIANS; SIGNATURE; IRELAND	A sample of 416 males from western and eastern Andalusia has been jointly analyzed for surnames and Y-chromosome haplogroups and haplotypes. The observed number of different surnames was 222 (353 when the second surname of the Spanish system of naming is considered). The great majority of recorded surnames have a Castilian-Leonese origin, while Catalan or Basque surnames have not been found. A few Arab-related surnames appear but none discernible of Sephardic-Jewish descent. Low correlation among surnames with different population frequencies and Y-chromosome markers, at different levels of genetic resolution, has been observed in Andalusia. This finding could be explained mainly by the very low rate of monophyletic surnames because of the historical process of surname ascription and the resulting high frequencies of the most common Spanish surnames. The introduction of surnames in Spain during the Middle Ages coincided with Reconquest of the territories under Islamic rule, and Muslims and Jews progressively adopted the present male line surname system. Sampled surnames and Y-chromosome lineages fit well a power-law distribution and observed isonymy is very close to that of the general population. Besides, our data and results show that the reliability of the isonymy method should be questioned because of the high rate of polyphyletic surnames, even in small geographic regions and autochthonous populations. Random isonymy would be consistently dependent of the most common surname frequencies in the population.	[Calderon, Rosario; Hernandez, Candela L.] Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain; [Cuesta, Pedro] Univ Complutense, Ctr Proc Datos, E-28040 Madrid, Spain; [Dugoujon, Jean Michel] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropol Mol & Imagerie Synth AMIS, F-31062 Toulouse, France	Complutense University of Madrid; Complutense University of Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Calderon, R (corresponding author), Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain.	rcalfer@bio.ucm.es	Hernández, Candela L/K-3713-2014; Cuesta, Pedro/L-1157-2014; Calderon, Rosario/K-2514-2014	Hernández, Candela L/0000-0002-0816-7169; Calderon, Rosario/0000-0001-9196-5323	Spanish Ministry of Economy and Competitiveness (MINECO) [CGL2010-15191/BOS]; Complutense University of Madrid	Spanish Ministry of Economy and Competitiveness (MINECO); Complutense University of Madrid	This research was funded by the Spanish Ministry of Economy and Competitiveness (MINECO, http://www.mineco.gob.es/portal/site/mineco/idi) Project CGL2010-15191/BOS to RC. CLH has a predoctoral fellowship granted by Complutense University of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Ambrosio B, 2010, ANN HUM BIOL, V37, P86, DOI 10.3109/03014460903229155; Ambrosio B, 2012, FORENSIC SCI INT-GEN, V6, pE66, DOI 10.1016/j.fsigen.2011.05.007; Ambrosio B, 2010, COLLEGIUM ANTROPOL, V34, P1215; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Boattini A, 2012, HUM BIOL, V84, P235, DOI 10.3378/027.084.0302; Bowden GR, 2008, MOL BIOL EVOL, V25, P301, DOI 10.1093/molbev/msm255; Calderon R, 2006, HUM BIOL, V78, P663, DOI 10.1353/hub.2007.0008; Calvo Baeza J, 1991, APELLIDOS ESPANOLES; Colantonio SE, 2003, HUM BIOL, V75, P785, DOI 10.1353/hub.2004.0004; CROW JF, 1983, HUM BIOL, V55, P383; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; Darlu P, 2012, HUM BIOL, V84, P169, DOI 10.3378/027.084.0205; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Diez Melcon G, 1957, APELLIDOS CASTELLANO; Ewens W.J., MATH POPULATION GENE; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P35, DOI 10.1016/0040-5809(74)90030-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fienberg S, 2001, SELECTED PALERS ISBA, P135; Fortes-Lima C, 2014, CR BIOL, V337, P646, DOI 10.1016/j.crvi.2014.08.004; Garcia- Carraffa A, ENCICLOPEDIA HERALDI; Hartl D., 1989, PRINCIPLES POPULATIO; Hernandez CL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-11; Jobling MA, 2001, TRENDS GENET, V17, P353, DOI 10.1016/S0168-9525(01)02284-3; King TE, 2006, CURR BIOL, V16, P384, DOI 10.1016/j.cub.2005.12.048; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Larmuseau MHD, 2012, HEREDITY, V109, P90, DOI 10.1038/hdy.2012.17; Lasker Gabriel, 1985, SURNAMES GENETIC STR; Lasker GW, 1988, HUMAN MATING PATTERN; Manni F, 2005, AM J PHYS ANTHROPOL, V126, P214, DOI 10.1002/ajpa.10429; McEvoy B, 2006, HUM GENET, V119, P212, DOI 10.1007/s00439-005-0131-8; McEvoy B, 2008, AM J PHYS ANTHROPOL, V136, P415, DOI 10.1002/ajpa.20823; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Miyazima S, 2000, PHYSICA A, V278, P282, DOI 10.1016/S0378-4371(99)00546-4; Moore LT, 2006, AM J HUM GENET, V78, P334, DOI 10.1086/500055; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Neuhauser C, 2003, HDB STAT GENETICS; Reales G, 2014, ANN HUM BIOL, V41, P443, DOI 10.3109/03014460.2013.877966; Reed WJ, 2003, PHYSICA A, V319, P579, DOI 10.1016/S0378-4371(02)01455-3; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127; Zanette DH, 2001, PHYSICA A, V295, P1, DOI 10.1016/S0378-4371(01)00046-2; ZEI G, 1983, ANN HUM GENET, V47, P329, DOI 10.1111/j.1469-1809.1983.tb01003.x	49	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123098	10.1371/journal.pone.0123098	http://dx.doi.org/10.1371/journal.pone.0123098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860017	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300076
J	Chang, GJ; Zhang, K; Xu, TL; Jin, D; Guo, JF; Zhuang, S; Shen, XZ				Chang, Guangjun; Zhang, Kai; Xu, Tianle; Jin, Di; Guo, Junfei; Zhuang, Su; Shen, Xiangzhen			Epigenetic Mechanisms Contribute to the Expression of Immune Related Genes in the Livers of Dairy Cows Fed a High Concentrate Diet	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; INFLAMMATORY RESPONSE; HISTONE DEMETHYLASE; VITAMIN-D; LIPOPOLYSACCHARIDE; PROMOTER; TRANSCRIPTION; APOPTOSIS; ENDOTOXIN; PROTEINS	Purpose Epigenetic modifications critically regulate the expression of immune-related genes in response to inflammatory stimuli. It has been extensively reported that a high concentrate (HC) diet can trigger systemic inflammation in dairy cows, yet it is unclear whether epigenetic regulation is involved in the expression of immune genes in the livers of dairy cows. This study aimed to investigate the impact of epigenetic modifications on the expression of immune-related genes. Experimental Design In eight mid-lactating cows, we installed a rumen cannula and catheters of the portal and hepatic veins. Cows were randomly assigned to either the treatment group fed a high concentrate (HC) diet (60% concentrate + 40% forage, n = 4) or a control group fed a low concentrate (LC) diet (40% concentrate + 60% forage, n = 4). Results After 10 weeks of feeding, the rumen pH was reduced, and levels of lipopolysaccharide (LPS) in the rumen, and portal and hepatic veins were notably increased in the HC group compared with the LC group. The expression levels of detected immune response-related genes, including Toll-like receptor 4 (TLR4), cytokines, chemokines, and acute phase proteins, were significantly up-regulated in the livers of cows fed a HC diet. Chromatin loosening at the promoter region of four candidate immune-related genes (TLR4, LPS-binding protein, haptoglobin, and serum amyloid A3) was elicited, and was strongly correlated with enhanced expression of these genes in the HC group. Demethylation at the promoter region of all four candidate immune-related genes was accompanied by chromatin decompaction. Conclusion After HC diet feeding, LPS derived from the digestive tract translocated to the liver via the portal vein, enhancing hepatic immune gene expression. The up-regulation of these immune genes was mediated by epigenetic mechanisms, which involve chromatin remodeling and DNA methylation. Our findings suggest that modulating epigenetic mechanisms could provide novel ways to treat systemic inflammatory responses elicited by the feeding of a HC diet.	[Chang, Guangjun; Zhang, Kai; Xu, Tianle; Jin, Di; Guo, Junfei; Shen, Xiangzhen] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhuang, Su] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Shen, XZ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	xzshen@njau.edu.cn			National Basic Research Program of China [2011CB100802]; National Natural Science Foundation of China [31172371]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The study was supported by funds from the National Basic Research Program of China (2011CB100802), the National Natural Science Foundation of China (31172371) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambasic J, 2010, IUBMB LIFE, V62, P227, DOI 10.1002/iub.313; Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang GJ, 2015, VET J IN PRESS; Amormino SAD, 2013, HUM IMMUNOL, V74, P1231, DOI 10.1016/j.humimm.2013.04.037; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Doherty R, 2013, VET IMMUNOL IMMUNOP, V154, P102, DOI 10.1016/j.vetimm.2013.05.004; Dong GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107659; Dong GZ, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-48; Dong HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082850; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gozho GN, 2007, J DAIRY SCI, V90, P856, DOI 10.3168/jds.S0022-0302(07)71569-2; Gozho GN, 2005, J DAIRY SCI, V88, P1399, DOI 10.3168/jds.S0022-0302(05)72807-1; Green BB, 2014, VET IMMUNOL IMMUNOP, V157, P49, DOI 10.1016/j.vetimm.2013.10.015; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Jourdan T, 2009, J NUTR, V139, P1901, DOI 10.3945/jn.109.111062; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kirschning CJ, 1997, IMMUNOBIOLOGY, V198, P124; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Larson MA, 2006, GENE, V380, P104, DOI 10.1016/j.gene.2006.05.019; Liaskou E., 2012, MEDIAT INFLAMM, V2012, P1, DOI DOI 10.1155/2012/949157; Liu JH, 2014, VET J, V201, P95, DOI 10.1016/j.tvjl.2014.03.025; Liu JH, 2014, BRIT J NUTR, V112, P416, DOI 10.1017/S0007114514000993; Liu SZ, 2011, MOL IMMUNOL, V48, P895, DOI 10.1016/j.molimm.2010.12.018; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; De Oliveira NFP, 2011, J CLIN PERIODONTOL, V38, P975, DOI 10.1111/j.1600-051X.2011.01765.x; Pereira F, 2012, CELL CYCLE, V11, P1081, DOI 10.4161/cc.11.6.19508; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Plaizier JC, 2012, ANIM FEED SCI TECH, V172, P9, DOI 10.1016/j.anifeedsci.2011.12.004; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao SY, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0235-2; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Vels L, 2009, J DAIRY SCI, V92, P922, DOI 10.3168/jds.2008-1209; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Yoshioka M, 1998, VET IMMUNOL IMMUNOP, V66, P301, DOI 10.1016/S0165-2427(98)00206-2; Zebeli Q, 2009, J DAIRY SCI, V92, P3800, DOI 10.3168/jds.2009-2178; Zhong J, 2006, BBA-MOL BASIS DIS, V1762, P468, DOI 10.1016/j.bbadis.2005.12.012; Zhou J, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0172-0	48	20	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123942	10.1371/journal.pone.0123942	http://dx.doi.org/10.1371/journal.pone.0123942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860644	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300124
J	Egli, A; Tschudin-Sutter, S; Oberle, M; Goldenberger, D; Frei, R; Widmer, AF				Egli, Adrian; Tschudin-Sutter, Sarah; Oberle, Michael; Goldenberger, Daniel; Frei, Reno; Widmer, Andreas F.			Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass-Spectrometry (MALDI-TOF MS) Based Typing of Extended-Spectrum beta-Lactamase Producing E. coli - A Novel Tool for Real-Time Outbreak Investigation	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; DESORPTION IONIZATION-TIME; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IDENTIFICATION	Epidemiologically linked clusters are confirmed by typing strains with molecular typing such as pulsed-field gel electrophoresis (PFGE). We compared six extended-spectrum beta-lactamase producing E. coli of a PFGE-related cluster with Matrix-assisted laser desorption/ionization-time of flight mass-spectrometry based typing that confirmed relatedness faster and more cost-effective, but as reliable as PFGE.	[Egli, Adrian; Goldenberger, Daniel; Frei, Reno] Univ Basel Hosp, Div Clin Microbiol, CH-4031 Basel, Switzerland; [Egli, Adrian] Univ Basel, Infect Biol Lab, Dept Biomed, Basel, Switzerland; [Tschudin-Sutter, Sarah; Widmer, Andreas F.] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Oberle, Michael] Cantonal Hosp Aarau, Clin Microbiol, Aarau, Switzerland	University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA)	Egli, A (corresponding author), Univ Basel Hosp, Div Clin Microbiol, CH-4031 Basel, Switzerland.	a.egli@usb.ch	Tschudin-Sutter, Sarah/K-2212-2019; Goldenberger, Daniel/S-8952-2019	Tschudin-Sutter, Sarah/0000-0003-4875-5368; 	University of Basel "Nachwuchsforderung"	University of Basel "Nachwuchsforderung"	A.E. research was supported by a grant from the University of Basel "Nachwuchsforderung". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babouee B, 2011, J CLIN MICROBIOL, V49, P1549, DOI 10.1128/JCM.02254-10; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Lasch P, 2014, J MICROBIOL METH, V100, P58, DOI 10.1016/j.mimet.2014.02.015; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Stranden A, 2003, J CLIN MICROBIOL, V41, P3181, DOI 10.1128/JCM.41.7.3181-3186.2003; Suarez S, 2013, J MICROBIOL METH, V94, P390, DOI 10.1016/j.mimet.2013.07.021; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tschudin-Sutter S, 2010, EMERG INFECT DIS, V16, P1758, DOI 10.3201/eid1611.100366; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Xiao D, 2014, J PROTEOMICS, V98, P112, DOI 10.1016/j.jprot.2013.11.021	14	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120624	10.1371/journal.pone.0120624	http://dx.doi.org/10.1371/journal.pone.0120624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860943	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300015
J	Zhang, L; McCarthy, DM; Sharma, N; Bhide, PG				Zhang, Lin; McCarthy, Deirdre M.; Sharma, Nutan; Bhide, Pradeep G.			Dopamine Receptor and Ga(olf) Expression in DYT1 Dystonia Mouse Models during Postnatal Development	PLOS ONE			English	Article							D2 RECEPTOR; CEREBRAL-CORTEX; GENE DYT1; TORSINA; HYPERACTIVITY; LOCALIZATION; BINDING; G(OLF)	Background DYT1 dystonia is a heritable, early-onset generalized movement disorder caused by a GAG deletion (Delta GAG) in the DYT1 gene. Neuroimaging studies and studies using mouse models suggest that DYT1 dystonia is associated with dopamine imbalance. However, whether dopamine imbalance is key to DYT1 or other forms of dystonia continues to be debated. Methodology/Principal Findings We used Dyt1 knock out (Dyt1 KO), Dyt1 Delta GAG knock-in (Dyt1 KI), and transgenic mice carrying one copy of the human DYT1 wild type allele (DYT1hWT) or human Delta GAG mutant allele (DYT1hMT). D1R, D2R, and Ga(olf) protein expression was analyzed by western blot in the frontal cortex, caudate-putamen and ventral midbrain in young adult (postnatal day 60; P60) male mice from all four lines; and in the frontal cortex and caudate putamen in juvenile (postnatal day 14; P14) male mice from the Dyt1 KI and KO lines. Dopamine receptor and Ga(olf) protein expression were significantly decreased in multiple brain regions of Dyt1 KI and Dyt1 KO mice and not significantly altered in the DYT1hMT or DYT1hWT mice at P60. The only significant change at P14 was a decrease in D1R expression in the caudate-putamen of the Dyt1KO mice. Conclusion/Significance We found significant decreases in key proteins in the dopaminergic system in multiple brain regions of Dyt1 KO and Dyt1 KI mouse lines at P60. Deletion of one copy of the Dyt1 gene (KO mice) produced the most pronounced effects. These data offer evidence that impaired dopamine receptor signaling may be an early and significant contributor to DYT1 dystonia pathophysiology.	[Zhang, Lin; McCarthy, Deirdre M.; Bhide, Pradeep G.] Florida State Univ, Dept Biomed Sci, Ctr Brain Repair, Coll Med, Tallahassee, FL 32306 USA; [Sharma, Nutan] Massachusetts Gen Hosp, Neurol, Boston, MA 02114 USA; [Sharma, Nutan] Harvard Univ, Sch Med, Boston, MA USA	State University System of Florida; Florida State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, L (corresponding author), Florida State Univ, Dept Biomed Sci, Ctr Brain Repair, Coll Med, Tallahassee, FL 32306 USA.	lin.zhang@med.fsu.edu; pradeep.bhide@med.fsu.edu		Bhide, Pradeep/0000-0003-4236-9415	Brian Jackson Dystonia Research and Discovery Fund; NINDS [P01NS037409]	Brian Jackson Dystonia Research and Discovery Fund; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the Brian Jackson Dystonia Research and Discovery Fund and NINDS P01NS037409.	Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; [Anonymous], 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0033669; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Asanuma K, 2005, NEUROLOGY, V64, P347, DOI 10.1212/01.WNL.0000149764.34953.BF; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bhide PG, 1996, J NEUROSCI, V16, P5523; BOUNDY VA, 1993, J NEUROCHEM, V60, P2181, DOI 10.1111/j.1471-4159.1993.tb03504.x; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bressman, 2000, Curr Treat Options Neurol, V2, P275, DOI 10.1007/s11940-000-0009-y; Cao SS, 2010, DIS MODEL MECH, V3, P386, DOI 10.1242/dmm.003715; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Fahn S, 1991, Int J Neurol, V25-26, P70; Fahn S, 1988, Adv Neurol, V50, P1; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fuller J, 2013, STEREOT FUNCT NEUROS, V91, P190, DOI 10.1159/000345113; Granata A, 2009, J NEUROCHEM, V109, P1596, DOI 10.1111/j.1471-4159.2009.06095.x; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; KEEPERS GA, 1987, J CLIN PSYCHOPHARM, V7, P342; Marrero-Gonzalez PC, 2014, CURR DRUG SAF, V9, P60, DOI 10.2174/18715249113136660060; McCarthy DM, 2011, J NEUROSCI, V31, P13400, DOI 10.1523/JNEUROSCI.2944-11.2011; Mengual E, 2002, SYNAPSE, V43, P151, DOI 10.1002/syn.10033; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; Nishimura K, 2014, J STROKE CEREBROVASC, V23, P1267, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.028; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027; Sako W, 2010, NEUROSCIENCE, V170, P497, DOI 10.1016/j.neuroscience.2010.06.072; Sciamanna G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024261; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; STAEDT J, 1995, EUR ARCH PSY CLIN N, V245, P8, DOI 10.1007/BF02191538; Vasudevan A, 2006, BRAIN RES, V1073, P139, DOI 10.1016/j.brainres.2005.12.087; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Vemula SR, 2013, HUM MOL GENET, V22, P2510, DOI 10.1093/hmg/ddt102; Warner TT, 2010, BIOCHEM SOC T, V38, P452, DOI 10.1042/BST0380452; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2015, BEHAV BRAIN RES, V279, P202, DOI 10.1016/j.bbr.2014.11.037; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Zhang L, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-469; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	46	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123104	10.1371/journal.pone.0123104	http://dx.doi.org/10.1371/journal.pone.0123104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860259	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300078
J	Vivien, R; Wyler, S; Lafont, M; Pawlowski, J				Vivien, Regis; Wyler, Sofia; Lafont, Michel; Pawlowski, Jan			Molecular Barcoding of Aquatic Oligochaetes: Implications for Biomonitoring	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; WORMS ANNELIDA; CLITELLATA; SEDIMENTS; PHYLOGENY; IDENTIFICATION; ASSEMBLAGES; DIVERSITY; RECOVERY; QUALITY	Aquatic oligochaetes are well recognized bioindicators of quality of sediments and water in watercourses and lakes. However, the difficult taxonomic determination based on morphological features compromises their more common use in eco-diagnostic analyses. To overcome this limitation, we investigated molecular barcodes as identification tool for broad range of taxa of aquatic oligochaetes. We report 185 COI and 52 ITS2 rDNA sequences for specimens collected in Switzerland and belonging to the families Naididae, Lumbriculidae, Enchytraeidae and Lumbricidae. Phylogenetic analyses allowed distinguishing 41 lineages separated by more than 10 % divergence in COI sequences. The lineage distinction was confirmed by Automatic Barcode Gap Discovery (ABGD) method and by ITS2 data. Our results showed that morphological identification underestimates the oligochaete diversity. Only 26 of the lineages could be assigned to morphospecies, of which seven were sequenced for the first time. Several cryptic species were detected within common morphospecies. Many juvenile specimens that could not be assigned morphologically have found their home after genetic analysis. Our study showed that COI barcodes performed very well as species identifiers in aquatic oligochaetes. Their easy amplification and good taxonomic resolution might help promoting aquatic oligochaetes as bioindicators for next generation environmental DNA biomonitoring of aquatic ecosystems.	[Vivien, Regis; Wyler, Sofia; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva	Vivien, R (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	regisvivien@hotmail.com	Pawlowski, Jan/AAO-3306-2021; Vivien, Régis/AAN-2549-2020	Pawlowski, Jan/0000-0003-2421-388X; 	SWISSBOL; UNITEC; Fondation Schmidheiny	SWISSBOL; UNITEC; Fondation Schmidheiny	This work was supported by SWISSBOL (www.swissbol.ch), UNITEC (www.unige.ch/unitec/presentation.html) and the Fondation Schmidheiny (www.fondation-schmidheiny.ch/informations.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achurra A, 2013, INVERTEBR SYST, V27, P118, DOI 10.1071/IS12049; AFNOR, 2005, NF T 90 391; AFNOR, 2002, NF T 90 390; Armendariz L, 2012, LIMNOLOGICA, V42, P118, DOI 10.1016/j.limno.2011.09.005; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beauchamp KA, 2001, MOL PHYLOGENET EVOL, V19, P216, DOI 10.1006/mpev.2001.0923; Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; Brinkhurst RO, 1971, GUIDE IDENTIFICATION; Brinkhurst RO, 1966, WATER SEWAGE WORKS, V113, P434; Brodin Y, 2013, MOL ECOL RESOUR, V13, P996, DOI 10.1111/1755-0998.12053; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Crottini A, 2008, MOL PHYLOGENET EVOL, V48, P1189, DOI 10.1016/j.ympev.2008.06.012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Envall I, 2012, ZOOL J LINN SOC-LOND, V165, P495, DOI 10.1111/j.1096-3642.2012.00828.x; Erseus C, 2010, MOL PHYLOGENET EVOL, V57, P849, DOI 10.1016/j.ympev.2010.07.005; Erseus C, 2009, ANNELIDS IN MODERN BIOLOGY, P31; Erseus Christer, 2008, Zootaxa, V1744, P66; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gustafsson DR, 2009, MOL PHYLOGENET EVOL, V51, P182, DOI 10.1016/j.ympev.2008.12.016; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hallett SL, 2005, HYDROBIOLOGIA, V543, P305, DOI 10.1007/s10750-004-6954-9; Kvist S, 2010, MOL PHYLOGENET EVOL, V57, P687, DOI 10.1016/j.ympev.2010.08.018; Lafont M, 2006, HYDROBIOLOGIA, V564, P171, DOI 10.1007/s10750-005-1717-9; Lafont M., 2010, Ecohydrology and Hydrobiology, V10, P3, DOI 10.2478/v10104-009-0047-3; Lafont M., 1989, THESIS; Lafont Michel, 2012, Ecohydrology & Hydrobiology, V12, P9, DOI [10.2478/v10104-012-0004-4, 10.2478/v10104-011-0032-5]; Lang C, 1997, AQUAT SCI, V59, P26, DOI 10.1007/PL00001303; Lang Claude, 2009, Bulletin de la Societe Vaudoise des Sciences Naturelles, V91, P283; Lods-Crozet B, 2005, REV SUISSE ZOOL, V112, P543, DOI 10.5962/bhl.part.80313; Martinsson S, 2013, ZOOL SCR, V42, P612, DOI 10.1111/zsc.12032; Milbrink G, 2002, HYDROBIOLOGIA, V468, P53, DOI 10.1023/A:1015274323026; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Prygiel J, 1999, HYDROBIOLOGIA, V410, P25, DOI 10.1023/A:1003799224961; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rodriguez P, 2011, THE POLLUTION BIOLOG; Rodriguez Pilar, 2010, Zootaxa, V2332, P21; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; Sarka J, 1994, HYDROBIOLOGIA, V322, P29, DOI DOI 10.1007/978-94-011-0842-3_26; Schmelz Ruediger M., 2010, Soil Organisms, V82, P1; SPERBER CHRISTINA, 1950, ZOOL BIDRAG UPPSALA, V29, P45; Sturmbauer C, 1999, MOL BIOL EVOL, V16, P967, DOI 10.1093/oxfordjournals.molbev.a026186; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm T, 2001, HYDROBIOLOGIA, V463, P223, DOI 10.1023/A:1013176229631; TIMM T., 2002, FRESHWATER OLIGOCHAE; Timm Tarmo, 2009, Lauterbornia, V66, P1; Tixier G, 2011, WATER SCI TECHNOL, V64, P1503, DOI 10.2166/wst.2011.155; Tkach V, 1999, ACTA PARASITOL, V44, P147; Verdonschot PFM, 2006, HYDROBIOLOGIA, V564, P127, DOI 10.1007/s10750-005-1714-z; Vivien R, 2015, REV SUISSE ZOOL IN P, V122; Vivien Regis, 2014, Ecohydrology & Hydrobiology, V14, P142, DOI 10.1016/j.ecohyd.2014.03.003; Vivien R, 2013, REV SUISSE ZOOL, V120, P415; Vivien R, 2013, REV SUISSE ZOOL, V120, P161; Vivien Regis, 2011, Bulletin de la Societe Vaudoise des Sciences Naturelles, V92, P153; Zhou H, 2010, ZOOL SCR, V39, P378, DOI 10.1111/j.1463-6409.2010.00429.x	57	32	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0125485	10.1371/journal.pone.0125485	http://dx.doi.org/10.1371/journal.pone.0125485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856230	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500127
J	Hosokawa, H; Kato, M; Tohyama, H; Tamaki, Y; Endo, Y; Kimura, MY; Tumes, DJ; Motohashi, S; Matsumoto, M; Nakayama, KI; Tanaka, T; Nakayama, T				Hosokawa, Hiroyuki; Kato, Miki; Tohyama, Hiroyuki; Tamaki, Yuuki; Endo, Yusuke; Kimura, Motoko Y.; Tumes, Damon John; Motohashi, Shinichiro; Matsumoto, Masaki; Nakayama, Keiichi I.; Tanaka, Tomoaki; Nakayama, Toshinori			Methylation of Gata3 Protein at Arg-261 Regulates Transactivation of the Il5 Gene in T Helper 2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; ARGININE METHYLATION; INTERLEUKIN-5 GENE; TH2 CELLS; HISTONE HYPERACETYLATION; RNA-POLYMERASE; T-CELLS; DIFFERENTIATION; EXPRESSION; LOCUS	Gata3 acts as a master regulator for T helper 2 (Th2) cell differentiation by inducing chromatin remodeling of the Th2 cytokine loci, accelerating Th2 cell proliferation, and repressing Th1 cell differentiation. Gata3 also directly transactivates the interleukin-5 (Il5) gene via additional mechanisms that have not been fully elucidated. We herein identified a mechanism whereby the methylation of Gata3 at Arg-261 regulates the transcriptional activation of the Il5 gene in Th2 cells. Although the methylation-mimicking Gata3 mutant retained the ability to induce IL-4 and repress IFN gamma production, the IL-5 production was selectively impaired. We also demonstrated that heat shock protein (Hsp) 60 strongly associates with the methylation- mimicking Gata3 mutant and negatively regulates elongation of the Il5 transcript by RNA polymerase II. Thus, arginine methylation appears to play a pivotal role in the organization of Gata3 complexes and the target gene specificity of Gata3.	[Hosokawa, Hiroyuki; Kato, Miki; Tohyama, Hiroyuki; Tamaki, Yuuki; Endo, Yusuke; Kimura, Motoko Y.; Tumes, Damon John; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Motohashi, Shinichiro] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chuo Ku, Chiba 2608670, Japan; [Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chuo Ku, Chiba 2608670, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Div Endocrinol & Metab, Chuo Ku, Chiba 2608670, Japan; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Tanaka, Tomoaki; Nakayama, Toshinori] Japan Sci & Technol Agcy, CREST, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017; Tumes, Damon J/B-9917-2009	Nakayama, Toshinori/0000-0002-1434-2007; Tumes, Damon J/0000-0001-5709-857X; Hosokawa, Hiroyuki/0000-0002-9592-2889	Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Manpei Suzuki Diabetes Foundation; Kanae Foundation for the Promotion of Medical Science;  [26221305];  [24592083];  [26460569];  [24790461];  [23790522]; Grants-in-Aid for Scientific Research [24390239, 15K08524] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Manpei Suzuki Diabetes Foundation; Kanae Foundation for the Promotion of Medical Science; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research S 26221305, C 24592083, and 26460569 and Exploratory Research and Young Scientists B Grants 24790461 and 23790522; the Takeda Science Foundation; the Astellas Foundation for Research on Metabolic Disorders; the Uehara Memorial Foundation; the Manpei Suzuki Diabetes Foundation; and the Kanae Foundation for the Promotion of Medical Science.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Campbell M, 2012, J BIOL CHEM, V287, P5806, DOI 10.1074/jbc.M111.289496; Chen YH, 2012, CELL REP, V2, P1197, DOI 10.1016/j.celrep.2012.10.012; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karlen S, 1996, BLOOD, V88, P211; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nakamura A, 2011, ENDOCR J, V58, P123, DOI 10.1507/endocrj.K10E-246; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Wang J, 2006, INT IMMUNOL, V18, P313, DOI 10.1093/intimm/dxh370; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13095	13103		10.1074/jbc.M114.621524	http://dx.doi.org/10.1074/jbc.M114.621524			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861992	Green Published, hybrid			2022-12-26	WOS:000354975700013
J	Trubitsyna, M; Grey, H; Houston, DR; Finnegan, DJ; Richardson, JM				Trubitsyna, Maryia; Grey, Heather; Houston, Douglas R.; Finnegan, David J.; Richardson, Julia M.			Structural Basis for the Inverted Repeat Preferences of mariner Transposases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLEEPING-BEAUTY; TERMINAL REPEATS; DNA TRANSPOSONS; BINDING DOMAIN; GENE-TRANSFER; COMPLEX; CELLS; CONSERVATION; INVOLVEMENT; EVOLUTION	The inverted repeat (IR) sequences delimiting the left and right ends of many naturally active mariner DNA transposons are non-identical and have different affinities for their transposase. We have compared the preferences of two active mariner transposases, Mos1 and Mboumar-9, for their imperfect transposon IRs in each step of transposition: DNA binding, DNA cleavage, and DNA strand transfer. A 3.1 angstrom resolution crystal structure of the Mos1 paired-end complex containing the pre-cleaved left IR sequences reveals the molecular basis for the reduced affinity of the Mos1 transposase DNA-binding domain for the left IR as compared with the right IR. For both Mos1 and Mboumar-9, in vitro DNA transposition is most efficient when the preferred IR sequence is present at both transposon ends. We find that this is due to the higher efficiency of cleavage and strand transfer of the preferred transposon end. We show that the efficiency of Mboumar-9 transposition is improved almost 4-fold by changing the 3' base of the preferred Mboumar-9 IR from guanine to adenine. This preference for adenine at the reactive 3' end for both Mos1 and Mboumar-9 may be a general feature of mariner transposition.	[Trubitsyna, Maryia; Finnegan, David J.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Grey, Heather; Houston, Douglas R.; Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Inst Struct & Mol Biol, Edinburgh EH9 3BF, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Richardson, JM (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	Julia.Richardson@ed.ac.uk	Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; Trubitsyna, Maryia/0000-0002-1347-6134; Houston, Douglas/0000-0002-3469-1546	Wellcome Trust [085176/Z/08/Z]; Darwin Trust of Edinburgh Ph.D. Scholarship	Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust of Edinburgh Ph.D. Scholarship	This work was supported by Wellcome Trust Grant 085176/Z/08/Z (to J. M. R.) and a Darwin Trust of Edinburgh Ph.D. Scholarship (to M. T.).	Ammar Ismahen, 2012, Methods Mol Biol, V859, P229, DOI 10.1007/978-1-61779-603-6_13; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P58, DOI 10.1007/s004380000386; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P51, DOI 10.1007/s004380000385; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bigot Y, 2005, J MOL BIOL, V351, P108, DOI 10.1016/j.jmb.2005.05.006; Bouuaert CC, 2014, NUCLEIC ACIDS RES, V42, P5799, DOI 10.1093/nar/gku172; Bouuaert CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00668; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Clark KJ, 2009, NUCLEIC ACIDS RES, V37, P1239, DOI 10.1093/nar/gkn1025; Cuypers MG, 2013, NUCLEIC ACIDS RES, V41, P2020, DOI 10.1093/nar/gks1295; Damasceno JD, 2010, GENETICA, V138, P301, DOI 10.1007/s10709-009-9406-7; Delauriere L, 2009, GENETICA, V137, P9, DOI 10.1007/s10709-009-9370-2; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dornan J, 2015, NUCLEIC ACIDS RES, V43, P2424, DOI 10.1093/nar/gkv096; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hancock SP, 2013, NUCLEIC ACIDS RES, V41, P6750, DOI 10.1093/nar/gkt357; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Lampe DJ, 2010, GENETICA, V138, P499, DOI 10.1007/s10709-009-9401-z; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lee I, 2003, NUCLEIC ACIDS RES, V31, P4531, DOI 10.1093/nar/gkg499; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu DX, 2014, NUCLEIC ACIDS RES, V42, P2637, DOI 10.1093/nar/gkt1218; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Palomeque T, 2006, GENE, V371, P194, DOI 10.1016/j.gene.2005.11.032; Richardson JM, 2004, ACTA CRYSTALLOGR D, V60, P962, DOI 10.1107/S0907444904003798; Richardson JM, 2007, ACTA CRYSTALLOGR F, V63, P434, DOI 10.1107/S1744309107019045; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Sherman A, 1998, NAT BIOTECHNOL, V16, P1050, DOI 10.1038/3497; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Trubitsyna M, 2014, BIOCHEMISTRY-US, V53, P682, DOI 10.1021/bi401193w; Wolkowicz UM, 2014, ACS CHEM BIOL, V9, P743, DOI 10.1021/cb400791u; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	38	4	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13531	13540		10.1074/jbc.M115.636704	http://dx.doi.org/10.1074/jbc.M115.636704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869132	Green Published, hybrid			2022-12-26	WOS:000354975700047
J	Maestri, R; Fornel, R; Galiano, D; de Freitas, TRO				Maestri, Renan; Fornel, Rodrigo; Galiano, Daniel; de Freitas, Thales R. O.			Niche Suitability Affects Development: Skull Asymmetry Increases in Less Suitable Areas	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; SPECIES DISTRIBUTION; PRIORITY AREAS; SPATIAL AUTOCORRELATION; POTENTIAL DISTRIBUTION; ECOLOGICAL THEORY; CONSERVATION; POPULATIONS; PATTERNS; RODENTIA	For conservation purposes, it is important to take into account the suitability of a species to particular habitats; this information may predict the long-term survival of a species. In this sense, morphological measures of developmental stress, such as fluctuating asymmetry, can be proxies for an individual's performance in different regions. In this study, we conducted tests to determine whether areas with different levels of suitability for a species (generated by ecological niche models) were congruent with morphological markers that reflect environmental stress and morphological variance. We generated a Maxent niche model and compared the suitability assessments of several areas with the skull morphology data (fluctuating asymmetry and morphological disparity) of populations of the Atlantic forest endemic to Brazil rodent Akodon cursor. Our analyses showed a significant negative relationship between suitability levels and fluctuating asymmetry levels, which indicates that in less suitable areas, the individuals experience numerous disturbances during skull ontogeny. We have not found an association between morphological variance and environmental suitability. As expected, these results suggest that in environments with a lower suitability, developmental stress is increased. Such information is helpful in the understanding of the species evolution and in the selection of priority areas for the conservation of species.	[Maestri, Renan] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Porto Alegre, RS, Brazil; [Fornel, Rodrigo] Univ Reg Integrada Alto Uruguai & Missoes, Programa Posgrad Ecol, Erechim, RS, Brazil; [Galiano, Daniel] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [de Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Maestri, R (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Porto Alegre, RS, Brazil.	renanmaestri@gmail.com	Maestri, Renan/L-2637-2015; Galiano, Daniel/O-1671-2013; Freitas, Thales Renato Ochotorena de/G-1160-2012; Fornel, Rodrigo/D-7538-2017; Galiano, Daniel/ABV-4574-2022	Maestri, Renan/0000-0001-9134-2943; Galiano, Daniel/0000-0003-1428-8634; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; 	Coordenadoria de Aperfeicoamento Pessoal (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq; CAPES; Fundacao de Amparo a Pesquisa do Estado do RS (Fapergs)	Coordenadoria de Aperfeicoamento Pessoal (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do RS (Fapergs)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	RM and DG received student fellowships from the Coordenadoria de Aperfeicoamento Pessoal (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), respectively. TROF received financial support from CNPq, CAPES, and Fundacao de Amparo a Pesquisa do Estado do RS (Fapergs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alvarado-Serrano DF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-160; Aparicio JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P273, DOI 10.1007/s002650000302; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Begon M., 2009, ECOLOGY INDIVIDUALS; Bergstrom CA, 2000, BEHAVIOUR, V137, P1097, DOI 10.1163/156853900502457; Bernardo-Silva J, 2012, NAT CONSERVACAO, V10, P207, DOI 10.4322/natcon.2012.026; Bonn A, 1996, OECOLOGIA, V108, P596, DOI 10.1007/BF00329031; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Butler DW, 2009, BIOL CONSERV, V142, P2202, DOI 10.1016/j.biocon.2009.04.023; Cadee N, 2000, J EVOLUTION BIOL, V13, P359; Cardini A, 2007, J BIOGEOGR, V34, P1663, DOI 10.1111/j.1365-2699.2007.01731.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; Christoff AU, 2000, J MAMMAL, V81, P838, DOI 10.1644/1545-1542(2000)081<0838:DOANSO>2.3.CO;2; Christoff AU, 2008, IUCN 2014 IUCN RED L; Cooley JR, 2004, ETHOLOGY, V110, P745, DOI 10.1111/j.1439-0310.2004.00993.x; Culumber ZW, 2013, NATURWISSENSCHAFTEN, V100, P801, DOI 10.1007/s00114-013-1072-z; DeLeon VB, 2007, AM J PHYS ANTHROPOL, V132, P520, DOI 10.1002/ajpa.20549; Diniz J, 2009, TREE GENET GENOMES, V5, P617, DOI 10.1007/s11295-009-0214-0; Doko T., 2008, ISPRS 2008, P267; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Ducarme Frederic, 2013, BIOSCIENCES MASTER R, P1, DOI DOI 10.1080/08927936.2015.1052279; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Galeotti P, 2005, EVOL ECOL, V19, P405, DOI 10.1007/s10682-005-8309-z; Galiano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097301; Galiano D, 2013, MAMMALIA, V77, P173, DOI 10.1515/mammalia-2011-0128; Gangestad SW, 1999, J EVOLUTION BIOL, V12, P402, DOI 10.1046/j.1420-9101.1999.00039.x; Gaubert P, 2006, BIOL CONSERV, V130, P106, DOI 10.1016/j.biocon.2005.12.006; Geise Lena, 2012, Mammalian Species, P33, DOI 10.1644/893.1; Gkaraveli A, 2004, BIOL CONSERV, V115, P395, DOI 10.1016/S0006-3207(03)00155-1; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Klingenberg CP, 2010, ALCOHOL, V44, P649, DOI 10.1016/j.alcohol.2009.10.016; Klingenberg Christian Peter, 2003, P427; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Maestri R, 2014, ACTA THERIOL, V59, P427, DOI 10.1007/s13364-014-0177-x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Martinez JJ, 2014, BIOL J LINN SOC, V112, P180, DOI 10.1111/bij.12268; May SE, 2011, BIOL CONSERV, V144, P1441, DOI 10.1016/j.biocon.2011.01.013; Meloro C, 2014, EVOL BIOL, V41, P38, DOI 10.1007/s11692-013-9244-5; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nori J, 2013, BIOL CONSERV, V159, P507, DOI 10.1016/j.biocon.2012.11.020; OWEN RD, 1990, TEX J SCI, V42, P319; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pearson R. G., 2007, SYNTHESIS AM MUSEUM, V50; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Polak M, 2008, EVOL BIOL, V35, P208, DOI 10.1007/s11692-008-9032-9; Prieto MH, 2005, EVOL ECOL, V19, P517, DOI 10.1007/s10682-005-0883-6; R Core Team, 2014, R LANG STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Rohlf, 2010, TPSDIG2 VERSION 216; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Sokal RR, 1998, BIOL J LINN SOC, V65, P41, DOI 10.1111/j.1095-8312.1998.tb00350.x; VANVALEN L, 1962, EVOLUTION, V16, P125; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; WARD RE, 1991, J CRAN GENET DEV BIO, V11, P156; Willmore KE, 2005, EVOLUTION, V59, P898; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	75	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122412	10.1371/journal.pone.0122412	http://dx.doi.org/10.1371/journal.pone.0122412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874364	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800056
J	Abbott, MJ; Battaglia, LL				Abbott, Matthew J.; Battaglia, Loretta L.			Purple Pitcher Plant (Sarracenia rosea) Dieback and Partial Community Disassembly following Experimental Storm Surge in a Coastal Pitcher Plant Bog	PLOS ONE			English	Article							SEA-LEVEL RISE; CLIMATE-CHANGE; MULTIVARIATE-ANALYSIS; HURRICANES KATRINA; NORTH-CAROLINA; UNITED-STATES; WEEKS BAY; DISTURBANCE; IMPACT; MISSISSIPPI	Sea-level rise and frequent intense hurricanes associated with climate change will result in recurrent flooding of inland systems such as Gulf Coastal pitcher plant bogs by storm surges. These surges can transport salt water and sediment to freshwater bogs, greatly affecting their biological integrity. Purple pitcher plants (Sarracenia rosea) are Gulf Coast pitcher plant bog inhabitants that could be at a disadvantage under this scenario because their pitcher morphology may leave them prone to collection of saline water and sediment after a surge. We investigated the effects of storm surge water salinity and sediment type on S. rosea vitality, plant community structure, and bog soil-water conductivity. Plots (containing >= 1 ramet of S. rosea) were experimentally flooded with fresh or saline water crossed with one of three sediment types (local, foreign, or no sediment). There were no treatment effects on soil-water conductivity; nevertheless, direct exposure to saline water resulted in significantly lower S. rosea cover until the following season when a prescribed fire and regional drought contributed to the decline of all the S. rosea to near zero percent cover. There were also significant differences in plant community structure between treatments over time, reflecting how numerous species increased in abundance and a few species decreased in abundance. However, in contrast to S. rosea, most of the other species in the community appeared resilient to the effects of storm surge. Thus, although the community may be somewhat affected by storm surge, those few species that are particularly sensitive to the storm surge disturbance will likely drop out of the community and be replaced by more resilient species. Depending on the longevity of these biological legacies, Gulf Coastal pitcher plant bogs may be incapable of fully recovering if they become exposed to storm surge more frequently due to climate change.	[Abbott, Matthew J.] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA; So Illinois Univ, Ctr Ecol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Abbott, MJ (corresponding author), So Illinois Univ, Dept Plant Biol, Mail Code 6509, Carbondale, IL 62901 USA.	mabbott259@gmail.com			United States Department of Defense's SERDP program	United States Department of Defense's SERDP program	This project was funded by a grant from the United States Department of Defense's SERDP program (http://www.serdp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Battaglia LL, 2012, WETLAND HABITATS OF NORTH AMERICA: ECOLOGY AND CONSERVATION CONCERNS, P75; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Brewer JS, 2011, J ECOL, V99, P1219, DOI 10.1111/j.1365-2745.2011.01846.x; CHRISTENSEN NL, 1977, OECOLOGIA, V31, P27, DOI 10.1007/BF00348706; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Clarke KR, 1999, ENVIRON TOXICOL CHEM, V18, P118, DOI 10.1002/etc.5620180205; Clewell A., 1985, GUIDE VASCULAR PLANT; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; FOLKERTS GW, 1982, AM SCI, V70, P260; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Goddard J, 2007, P ENTOMOL SOC WASH, V109, P684; Griffiths ME, 2006, J COASTAL RES, V22, P1417, DOI 10.2112/03-0032.1; Grinsted A, 2013, P NATL ACAD SCI USA, V110, P5369, DOI 10.1073/pnas.1209980110; Hanson PJ, 2000, SCI TOTAL ENVIRON, V262, P205, DOI 10.1016/S0048-9697(00)00523-4; Hook D.D., 1991, J COASTAL RES, P291; IPCC, 2007, PHYS SCI BAS; Klos RJ, 2009, ECOL APPL, V19, P699, DOI 10.1890/08-0330.1; Lam NSN, 2011, J COASTAL RES, P1707; Mckee KL, 2009, WETLANDS, V29, P2, DOI 10.1672/08-32.1; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Middleton BA, 2009, WETLANDS, V29, P54, DOI 10.1672/08-18.1; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Naczi Robert F. C., 1999, SIDA Contributions to Botany, V18, P1183; NOAA, 2012, NOWDATA WEATH AV 192; Peet R. K., 1993, P TALL TIMB FIR EC C, P45; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; REED DJ, 1989, ESTUARIES, V12, P222, DOI 10.2307/1351901; Rhoades JD., 1996, METHODS SOIL ANAL 3, V5, P417; Rodgers JC, 2009, ESTUAR COAST, V32, P496, DOI 10.1007/s12237-009-9138-z; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Simkin SM, 2001, J TORREY BOT SOC, V128, P208, DOI 10.2307/3088712; Tate AS, 2013, J VEG SCI, V24, P46, DOI 10.1111/j.1654-1103.2012.01447.x; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; Wang H, 2010, J HYDROMETEOROL, V11, P1007, DOI 10.1175/2010JHM1229.1; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448	41	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125475	10.1371/journal.pone.0125475	http://dx.doi.org/10.1371/journal.pone.0125475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874369	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100296
J	Ota, H; Takehara, N; Aonuma, T; Kabara, M; Matsuki, M; Yamauchi, A; Takeuchi, T; Kawabe, J; Hasebe, N				Ota, Hisanobu; Takehara, Naofumi; Aonuma, Tatsuya; Kabara, Maki; Matsuki, Motoki; Yamauchi, Atsushi; Takeuchi, Toshiharu; Kawabe, Jun-ichi; Hasebe, Naoyuki			Association between Microalbuminuria Predicting In-Stent Restenosis after Myocardial Infarction and Cellular Senescence of Endothelial Progenitor Cells	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR-DISEASE; ALBUMIN EXCRETION; VASCULAR REPAIR; ARTERY-DISEASE; HEART-DISEASE; DNA-DAMAGE; MOBILIZATION; RISK; DYSFUNCTION	Objective Relationship between microalbuminuria and worse outcome of coronary artery disease patients is discussed, but its underlying pathophysiological mechanism remains unclear. We investigated the role of microalbuminuria to the function of endothelial progenitor cells (EPCs), that might affect to outcome of acute myocardial infarction (AMI) patients. Methods Forty-five AMI patients were divided into two groups according to their urinary albumin excretion: normal (n = 24) and microalbuminuria (>30 mg/day, n = 21). At day-2 and day-7 after AMI onset, circulating-EPCs (CD34(+)Flk1(+)) were quantified by flow cytometry. The number of lectin-acLDL-positive cultured-EPCs immobilized on fibronectin was determined. To assess the cellular senescence of cultured-EPCs, the expression level of sirtuin-1 mRNA and the number of SA-beta-gal positive cell were evaluated. Angiographic late in-stent loss after percutaneous coronary intervention (PCI) was evaluated at a six-month follow-up. Results No significant differences in coronary risk and the extent of myocardial damage were observed between the two groups. Late in-stent loss at the six-month follow-up was significantly higher in the microalbuminuria group (normal : microalbuminuria = 0.76 +/- 0.34 : 1.18 +/- 0.57 mm, p=0.021). The number of circulating-EPCs was significantly increased in microalbuminuria group at day-7, however, improved adhesion of EPCs was observed in normal group but not in microalbuminuria group from baseline to day-7 (+3.1 +/- 8.3 : -1.3 +/- 4.4 %: p<0.05). On the other hand, in microalbuminuria group at day-7, the level of sirtuin-1 mRNA expression of cultured-EPCs was significantly decreased (7.1 +/- 8.9 : 2.5 +/- 3.7 fold, p<0.05), which was based on the negative correlation between the level of sirtuin-1 mRNA expression and the extent of microalbuminuria. The ratio of SA-beta-gal-positive cells in microalbuminuria group was increased compared to that of normal group. Conclusions Microalbuminuria in AMI patients is closely associated with functional disorder of EPCs via cellular senescence, that predicts the aggravation of coronary remodeling after PCI.	[Ota, Hisanobu; Aonuma, Tatsuya; Matsuki, Motoki; Yamauchi, Atsushi; Takeuchi, Toshiharu; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan; [Takehara, Naofumi; Kabara, Maki; Kawabe, Jun-ichi] Asahikawa Med Univ, Dept Cardiovasc Regenerat & Innovat, Asahikawa, Hokkaido, Japan	Asahikawa Medical College; Asahikawa Medical College	Takehara, N (corresponding author), Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan.	takenao1@mac.com		Aonuma, Tatsuya/0000-0002-6838-2813	Grants-in-Aid for Scientific Research [26461052] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Berton G, 2008, AM HEART J, V156, P760, DOI 10.1016/j.ahj.2008.05.021; Berton G, 2010, CLIN CARDIOL, V33, P508, DOI 10.1002/clc.20792; Bonello L, 2012, J THROMB HAEMOST, V10, P1906, DOI 10.1111/j.1538-7836.2012.04854.x; De Winter RJ, 2010, JACC-CARDIOVASC INTE, V3, P87, DOI 10.1016/j.jcin.2009.11.006; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Heper G, 2002, ANGIOLOGY, V53, P287, DOI 10.1177/000331970205300306; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Huang PH, 2010, J HYPERTENS, V28, P1655, DOI 10.1097/HJH.0b013e32833a4d0a; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; Koulouris S, 2005, AM HEART J, V149, P840, DOI 10.1016/j.ahj.2004.07.031; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Leor J, 2006, J AM COLL CARDIOL, V48, P1588, DOI 10.1016/j.jacc.2006.07.032; Ling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050739; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Ota H, 2013, J CARDIOL, V62, P277, DOI 10.1016/j.jjcc.2013.05.002; Padfield GJ, 2013, HEART, V99, P791, DOI 10.1136/heartjnl-2012-302949; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Pelliccia F, 2010, JACC-CARDIOVASC INTE, V3, P78, DOI 10.1016/j.jcin.2009.10.020; Perticone F, 2007, J NEPHROL, V20, pS56; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Schiele F, 2009, AM HEART J, V157, P327, DOI 10.1016/j.ahj.2008.09.018; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Schober A, 2005, AM J CARDIOL, V96, P1116, DOI 10.1016/j.amjcard.2005.06.042; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tentolouris N, 2007, DIABETES CARE, V30, P2909, DOI 10.2337/dc07-0633; Wang P, 2014, CARDIOVASC RES, V104, P477, DOI 10.1093/cvr/cvu220	30	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123733	10.1371/journal.pone.0123733	http://dx.doi.org/10.1371/journal.pone.0123733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874702	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100205
J	Zimmermann, B; Tkalcec, Z; Mesic, A; Kohler, A				Zimmermann, Boris; Tkalcec, Zdenko; Mesic, Armin; Kohler, Achim			Characterizing Aeroallergens by Infrared Spectroscopy of Fungal Spores and Pollen	PLOS ONE			English	Article							ALLERGIC RHINITIS; IDENTIFICATION; CLASSIFICATION; DIVERSITY; MICROSPECTROSCOPY; DISCRIMINATION; MOISTURE; ASTHMA; URBAN; TOOL	Background Fungal spores and plant pollen cause respiratory diseases in susceptible individuals, such as asthma, allergic rhinitis and hypersensitivity pneumonitis. Aeroallergen monitoring networks are an important part of treatment strategies, but unfortunately traditional analysis is time consuming and expensive. We have explored the use of infrared spectroscopy of pollen and spores for an inexpensive and rapid characterization of aeroallergens. Methodology The study is based on measurement of spore and pollen samples by single reflectance attenuated total reflectance Fourier transform infrared spectroscopy (SR-ATR FTIR). The experimental set includes 71 spore (Basidiomycota) and 121 pollen (Pinales, Fagales and Poales) samples. Along with fresh basidiospores, the study has been conducted on the archived samples collected within the last 50 years. Results The spectroscopic-based methodology enables clear spectral differentiation between pollen and spores, as well as the separation of confamiliar and congeneric species. In addition, the analysis of the scattering signals inherent in the infrared spectra indicates that the FTIR methodology offers indirect estimation of morphology of pollen and spores. The analysis of fresh and archived spores shows that chemical composition of spores is well preserved even after decades of storage, including the characteristic taxonomy-related signals. Therefore, biochemical analysis of fungal spores by FTIR could provide economical, reliable and timely methodologies for improving fungal taxonomy, as well as for fungal identification and monitoring. This proof of principle study shows the potential for using FTIR as a rapid tool in aeroallergen studies. In addition, the presented method is ready to be immediately implemented in biological and ecological studies for direct measurement of pollen and spores from flowers and sporocarps.	[Zimmermann, Boris; Kohler, Achim] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Tkalcec, Zdenko; Mesic, Armin] Ru Er Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia	Norwegian University of Life Sciences	Zimmermann, B (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway.	boris.zimmermann@nmbu.no	Tkalčec, Zdenko/ABF-2269-2020; Zimmermann, Boris/N-8297-2014; Mešić, Armin/AAJ-1858-2020; Zimmermann, Boris/GVS-6235-2022	Zimmermann, Boris/0000-0001-5046-520X; Mešić, Armin/0000-0002-4479-600X; Zimmermann, Boris/0000-0001-5046-520X; Kohler, Achim/0000-0001-5759-1989; Tkalcec, Zdenko/0000-0002-1148-9425	European Commission [328289]; Ministry of Education, Sciences and Sports of the Republic of Croatia [098-0982904-2927, 098-0982934-2719]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education, Sciences and Sports of the Republic of Croatia	The European Commission through the Seventh Framework Programme, project No. 328289 (BZ AK); The Ministry of Education, Sciences and Sports of the Republic of Croatia, projects No. 098-0982904-2927 (BZ) and No. 098-0982934-2719 (AM ZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; [Anonymous], [No title captured]; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Atkinson RW, 2006, OCCUP ENVIRON MED, V63, P580, DOI 10.1136/oem.2005.024448; Besancenot JP, 2012, REV MAL RESPIR, V29, P1238, DOI 10.1016/j.rmr.2012.07.007; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Carinanos P, 1999, AEROBIOLOGIA, V15, P177, DOI DOI 10.1023/A:1007590023585; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; D'Amato G, 2002, ALLERGY, V57, P30, DOI 10.1034/j.1398-9995.57.s72.5.x; De Gussem K, 2007, ANAL BIOANAL CHEM, V387, P2823, DOI 10.1007/s00216-007-1150-1; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Douhan GW, 2011, FUNGAL BIOL-UK, V115, P569, DOI 10.1016/j.funbio.2011.03.005; Flannigan B, 1997, J AEROSOL SCI, V28, P381, DOI 10.1016/S0021-8502(96)00441-7; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Ghosal S, 2012, ENVIRON SCI TECHNOL, V46, P6088, DOI 10.1021/es203782j; Gottardini E, 2007, AEROBIOLOGIA, V23, P211, DOI 10.1007/s10453-007-9065-z; Hassett C. C., 2008, Allergy and allergic diseases. Volume 1: the scientific basis of allergy, P963; Trejo FH, 2013, ANN AGR ENV MED, V20, P657; Hong TD, 1997, ANN BOT-LONDON, V79, P121, DOI 10.1006/anbo.1996.0316; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Ivleva NP, 2005, ANAL BIOANAL CHEM, V381, P261, DOI 10.1007/s00216-004-2942-1; Kohler A, 2008, APPL SPECTROSC, V62, P259, DOI 10.1366/000370208783759669; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; Mularczyk-Oliwa M, 2012, SPECTROCHIM ACTA A, V97, P246, DOI 10.1016/j.saa.2012.05.063; Oliveira M, 2009, AEROBIOLOGIA, V25, P85, DOI 10.1007/s10453-009-9112-z; Pappas CS, 2003, APPL SPECTROSC, V57, P23, DOI 10.1366/000370203321165160; Parnmen S, 2012, PLOS ONE, V7; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Rivera-Mariani FE, 2012, AEROBIOLOGIA, V28, P83, DOI 10.1007/s10453-011-9234-y; Rivera-Mariani FE, 2011, INT ARCH ALLERGY IMM, V155, P322, DOI 10.1159/000321610; Schoenwetter WF, 2000, ALLERGY ASTHMA PROC, V21, P1, DOI 10.2500/108854100778248971; Schulte F, 2009, ANAL CHEM, V81, P8426, DOI 10.1021/ac901389p; Schulte F, 2008, ANAL CHEM, V80, P9551, DOI 10.1021/ac801791a; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Zervakis GI, 2012, FUNGAL BIOL-UK, V116, P715, DOI 10.1016/j.funbio.2012.04.006; Zhao RL, 2008, J ZHEJIANG UNIV-SC B, V9, P779, DOI 10.1631/jzus.B0860012; Zimmermann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095417; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zimmermann B, 2010, APPL SPECTROSC, V64, P1364, DOI 10.1366/000370210793561664	41	32	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124240	10.1371/journal.pone.0124240	http://dx.doi.org/10.1371/journal.pone.0124240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867755	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000352845100249
J	Feng, WQ; Guo, JJ; Huang, HY; Xia, B; Liu, HY; Li, J; Lin, SL; Li, TY; Liu, JJ; Li, H				Feng, Wenqiang; Guo, Juanjuan; Huang, Haiyan; Xia, Bo; Liu, Hongya; Li, Jie; Lin, Shaolin; Li, Tiyuan; Liu, Jianjun; Li, Hui			Human Normal Bronchial Epithelial Cells: A Novel In Vitro Cell Model for Toxicity Evaluation	PLOS ONE			English	Article							EXPRESSION; RESPONSES; ALVEOLAR; DIOXIDE; INDUCE; FATE	Human normal cell-based systems are needed for drug discovery and toxicity evaluation. hTERT or viral genes transduced human cells are currently widely used for these studies, while these cells exhibited abnormal differentiation potential or response to biological and chemical signals. In this study, we established human normal bronchial epithelial cells (HNBEC) using a defined primary epithelial cell culture medium without transduction of exogenous genes. This system may involve decreased IL-1 signaling and enhanced Wnt signaling in cells. Our data demonstrated that HNBEC exhibited a normal diploid karyotype. They formed well-defined spheres in matrigel 3D culture while cancer cells (HeLa) formed disorganized aggregates. HNBEC cells possessed a normal cellular response to DNA damage and did not induce tumor formation in vivo by xenograft assays. Importantly, we assessed the potential of these cells in toxicity evaluation of the common occupational toxicants that may affect human respiratory system. Our results demonstrated that HNBEC cells are more sensitive to exposure of 10 similar to 20 nm-sized SiO2, Cr(VI) and B(a)P compared to 16HBE cells (a SV40-immortalized human bronchial epithelial cells). This study provides a novel in vitro human cells-based model for toxicity evaluation, may also be facilitating studies in basic cell biology, cancer biology and drug discovery.	[Feng, Wenqiang; Guo, Juanjuan; Li, Hui] Wuhan Univ, Sch Basic Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Feng, Wenqiang; Guo, Juanjuan; Liu, Hongya; Li, Hui] Wuhan Univ, Shenzhen R&D Ctr State Key Lab Virol, Shenzhen, Guangdong, Peoples R China; [Huang, Haiyan; Xia, Bo; Li, Jie; Liu, Jianjun] Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen, Guangdong, Peoples R China; [Lin, Shaolin; Li, Tiyuan] Shenzhen Peoples Hosp, Shenzhen, Guangdong, Peoples R China	Wuhan University; Wuhan University; Shenzhen Center for Disease Control & Prevention (SZCDC); Jinan University	Li, H (corresponding author), Wuhan Univ, Sch Basic Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	somhli@whu.edu.cn	GUO, JUAN/HIK-2220-2022	Xia, Bo/0000-0002-0628-1910	Science and Technology Program of Shenzhen [GJHZ20130417155931486, JCYJ20140419141154244, CXZZ20140902162618036]	Science and Technology Program of Shenzhen	This work was supported by the Science and Technology Program of Shenzhen (No. GJHZ20130417155931486; JCYJ20140419141154244; CXZZ20140902162618036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chen Y, 2004, TOXICOL IND HEALTH, V20, P21, DOI 10.1191/0748233704th190oa; Chen Z, 2008, ENVIRON SCI TECHNOL, V42, P8985, DOI 10.1021/es800975u; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ding X, 2014, TOXICOL LETT, V228, P25, DOI 10.1016/j.toxlet.2014.04.010; Fessart D, 2013, EUR RESPIR J, V42, P1345, DOI 10.1183/09031936.00118812; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Gilbert B, 2012, ACS NANO, V6, P4921, DOI 10.1021/nn300425a; Gong CM, 2012, TOXICOL LETT, V209, P264, DOI 10.1016/j.toxlet.2012.01.007; Hamouchene H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-333; Huang HY, 2012, EXP CELL RES, V318, P682, DOI 10.1016/j.yexcr.2012.01.007; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kondo M, 2013, BIOMATERIALS, V34, P121, DOI 10.1016/j.biomaterials.2012.09.036; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056815, 10.1371/journal.pone.0055680]; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; McCullough SD, 2014, AM J RESP CELL MOL, V51, P426, DOI 10.1165/rcmb.2013-0515OC; Okoturo-Evans O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072363; Sergent JA, 2012, ANN OCCUP HYG, V56, P622, DOI 10.1093/annhyg/mes005; Umannova L, 2011, TOXICOL LETT, V206, P121, DOI 10.1016/j.toxlet.2011.06.029; Ursini CL, 2014, J APPL TOXICOL, V34, P1209, DOI 10.1002/jat.3038; Xia B, 2011, TOXICOL LETT, V205, P140, DOI 10.1016/j.toxlet.2011.05.1032; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1	27	63	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123520	10.1371/journal.pone.0123520	http://dx.doi.org/10.1371/journal.pone.0123520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861018	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300101
J	Shrivastava, R; Koster, D; Kalme, S; Mayor, S; Neerathilingam, M				Shrivastava, Rohini; Koester, Darius; Kalme, Sheetal; Mayor, Satyajit; Neerathilingam, Muniasamy			Tailor-Made Ezrin Actin Binding Domain to Probe Its Interaction with Actin In-Vitro	PLOS ONE			English	Article							SUPPORTED LIPID-BILAYERS; ERM PROTEINS; PLASMA-MEMBRANE; TERMINAL DOMAIN; MICROSCOPY; LINKER; CELLS	Ezrin, a member of the ERM (Ezrin/Radixin/Moesin) protein family, is an Actin-plasma membrane linker protein mediating cellular integrity and function. In-vivo study of such interactions is a complex task due to the presence of a large number of endogenous binding partners for both Ezrin and Actin. Further, C-terminal actin binding capacity of the full length Ezrin is naturally shielded by its N-terminal, and only rendered active in the presence of Phosphatidylinositol bisphosphate (PIP2) or phosphorylation at the C-terminal threonine. Here, we demonstrate a strategy for the design, expression and purification of constructs, combining the Ezrin C-terminal actin binding domain, with functional elements such as fusion tags and fluorescence tags to facilitate purification and fluorescence microscopy based studies. For the first time, internal His tag was employed for purification of Ezrin actin binding domain based on in-silico modeling. The functionality (Ezrin-actin interaction) of these constructs was successfully demonstrated by using Total Internal Reflection Fluorescence Microscopy. This design can be extended to other members of the ERM family as well.	[Shrivastava, Rohini; Kalme, Sheetal; Neerathilingam, Muniasamy] Ctr Cellular & Mol Platforms NCBS TIFR, Prot Technol Core, GKVK Post, Bangalore, Karnataka, India; [Koester, Darius; Mayor, Satyajit] Tata Inst Fundamental Res GKVK, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Neerathilingam, M (corresponding author), Ctr Cellular & Mol Platforms NCBS TIFR, Prot Technol Core, GKVK Post, Bangalore, Karnataka, India.	munish@ccamp.res.in	/AAO-4852-2020; Köster, Darius Vasco/Y-1387-2019	Köster, Darius Vasco/0000-0001-8530-5476	Indo Finland; TIFR, Department of Biotechnology, India	Indo Finland; TIFR, Department of Biotechnology, India	This study was supported by Indo Finland and TIFR, Department of Biotechnology, India.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bretscher A, 1997, J CELL SCI, V110, P3011; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; KELLOGG DR, 1988, DEVELOPMENT, V103, P675; KUBALEK EW, 1994, J STRUCT BIOL, V113, P117, DOI 10.1006/jsbi.1994.1039; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Maniti O, 2013, BIOCHIMIE, V95, P3, DOI 10.1016/j.biochi.2012.09.033; Mingeot-Leclercq MP, 2008, NAT PROTOC, V3, P1654, DOI 10.1038/nprot.2008.149; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866	21	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123428	10.1371/journal.pone.0123428	http://dx.doi.org/10.1371/journal.pone.0123428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860910	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300099
J	Bywater, RP				Bywater, Robert Paul			Prediction of Protein Structural Features from Sequence Data Based on Shannon Entropy and Kolmogorov Complexity	PLOS ONE			English	Article							SECONDARY STRUCTURE; CLASSIFICATION; DEFINITION; RESIDUES; FAMILIES; CONTACTS; FOLD	While the genome for a given organism stores the information necessary for the organism to function and flourish it is the proteins that are encoded by the genome that perhaps more than anything else characterize the phenotype for that organism. It is therefore not surprising that one of the many approaches to understanding and predicting protein folding and properties has come from genomics and more specifically from multiple sequence alignments. In this work I explore ways in which data derived from sequence alignment data can be used to investigate in a predictive way three different aspects of protein structure: secondary structures, inter-residue contacts and the dynamics of switching between different states of the protein. In particular the use of Kolmogorov complexity has identified a novel pathway towards achieving these goals.	Univ Oxford Magdalen Coll, Oxford OX1 4AU, England	University of Oxford	Bywater, RP (corresponding author), Univ Oxford Magdalen Coll, Oxford OX1 4AU, England.	robpbyw@gmail.com	Bywater, Robert Paul/AAY-1093-2020	Bywater, Robert Paul/0000-0002-3047-8123				ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brunak S, 1996, PROTEINS, V25, P237, DOI 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3.3.CO;2-Y; Bywater RP, 2013, J BIOMOL STRUCT DYN, V31, P351, DOI 10.1080/07391102.2012.703062; Crippen G. M., 1988, DISTANCE GEOMETRY AN; Dai Q, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-152; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012256; Ferragina P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-252; Friedberg I, 2002, PROTEIN SCI, V11, P350, DOI 10.1110/ps.18602; Hayashida M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S13; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Ison JC, 2000, PROTEINS, V40, P330, DOI 10.1002/(SICI)1097-0134(20000801)40:2<330::AID-PROT120>3.3.CO;2-V; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOLMOGOROV AN, 1968, INT J COMPUT MATH, V2, P157, DOI 10.1080/00207166808803030; La Rosa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S4; Lund O, 1996, PROTEIN SCI, V5, P2217, DOI 10.1002/pro.5560051108; MACKAY AL, 1974, ACTA CRYSTALLOGR A, VA 30, P440, DOI 10.1107/S0567739474000945; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Oliveira L, 2003, PROTEINS, V52, P544, DOI 10.1002/prot.10490; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; R Core Team, 2018, R LANG ENV STAT COMP; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Seddon GM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120087; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Su JG, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651480; Szabo N, 1996, INTRO ALGORITHMIC IN; Tao Xie, 1998, FEBS Letters, V434, P93, DOI 10.1016/S0014-5793(98)00955-7; Taylor WR, 2013, CURR OPIN STRUC BIOL, V23, P473, DOI 10.1016/j.sbi.2013.04.001; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Williams Robert W, 2013, Intrinsically Disord Proteins, V1, pe25724, DOI 10.4161/idp.25724	40	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119306	10.1371/journal.pone.0119306	http://dx.doi.org/10.1371/journal.pone.0119306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856073	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500007
J	Na, LX; Wu, XY; Feng, RN; Li, J; Han, TS; Lin, LQ; Lan, L; Yang, C; Li, Y; Sun, CH				Na, Lixin; Wu, Xiaoyan; Feng, Rennan; Li, Jie; Han, Tianshu; Lin, Liqun; Lan, Li; Yang, Chao; Li, Ying; Sun, Changhao			The Harbin Cohort Study on Diet, Nutrition and Chronic Non-Communicable Diseases: Study Design and Baseline Characteristics	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; METABOLIC PROFILE; CHINESE ADULTS; LIFE-STYLE; PREVALENCE; HEALTH; MORTALITY; SHANGHAI; MEN	Diet and nutrition have been reported to be associated with many common chronic diseases and blood-based assessment would be vital to investigate the association and mechanism, however, blood-based prospective studies are limited. The Harbin Cohort Study on Diet, Nutrition and Chronic Non-communicable Diseases was set up in 2010. From 2010 to 2012, 9,734 participants completed the baseline survey, including demographic characteristics, dietary intake, lifestyles and physical condition, and anthropometrics. A re-survey on 490 randomly selected participants was done by using the same methods which were employed in the baseline survey. For all participants, the mean age was 50 years and 36% of them were men. Approximately 99.4 % of cohort members donated blood samples. The mean total energy intake was 2671.7 kcal/day in men and 2245.9 kcal/day in women, the mean body mass index was 25.7 kg/m(2) in men and 24.6 kg/m(2) in women, with 18.4% being obese (>= 28 kg/m(2)), 12.7% being diabetic, and 29.5% being hypertensive. A good agreement was obtained for the physical measurements between the baseline survey and re-survey. The resources from the cohort and its fasting and postprandial blood samples collected both at baseline and in each follow-up will be valuable and powerful in investigating relationship between diet, nutrition and chronic diseases and discovering novel blood biomarkers and the metabolism of these biomarkers related to chronic diseases.	[Na, Lixin; Wu, Xiaoyan; Feng, Rennan; Li, Jie; Han, Tianshu; Lin, Liqun; Li, Ying; Sun, Changhao] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Natl Key Discipline, Harbin, Peoples R China; [Lan, Li; Yang, Chao] Harbin Ctr Dis Control & Prevent, Harbin, Peoples R China	Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Natl Key Discipline, Harbin, Peoples R China.	liying_helen@163.com; changhaosun2002@163.com	SUN, CHANG/GXM-3680-2022	Li, Jie/0000-0002-8359-3440; ying, li/0000-0002-7595-2474	National 12th Five-Year Scientific and Technical Program of China [2012BAI02B00]; State Key Program of National Natural Science of China [81130049]; National Natural Science Foundation of China [81202282]	National 12th Five-Year Scientific and Technical Program of China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National 12th Five-Year Scientific and Technical Program of China (grant 2012BAI02B00), State Key Program of National Natural Science of China (grant 81130049), and National Natural Science Foundation of China (grant 81202282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PREV CHRON DIS VIT I; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a; Chu X, 2013, DIABETES, V62, P561, DOI 10.2337/db12-0139; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Gurdeniz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069589; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Lee SA, 2008, OBESITY, V16, P1440, DOI 10.1038/oby.2008.58; Liu LY, 2013, CLIN CHEM, V59, P1338, DOI 10.1373/clinchem.2012.200527; Liu LY, 2013, J CHROMATOGR B, V927, P97, DOI 10.1016/j.jchromb.2013.01.038; Liu LY, 2010, J CHROMATOGR B, V878, P2817, DOI 10.1016/j.jchromb.2010.08.035; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Oliveira-Campos M, 2013, CIENC SAUDE COLETIVA, V18, P873, DOI [10.1590/S1413-81232013000300033, 10.1590/S1413-81232013000800033]; Omoleke SA, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.87.1899; Phaswana-Mafuya N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20936; Sai XY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-290; Shen GQ, 2011, J PROTEOME RES, V10, P1953, DOI 10.1021/pr101198q; Lopes ACS, 2011, CAD SAUDE PUBLICA, V27, P1185, DOI 10.1590/S0102-311X2011000600015; Takata Y, 2013, NUTR CANCER, V65, P51, DOI 10.1080/01635581.2013.741757; Wang C, 2011, J CHROMATOGR B, V879, P2871, DOI 10.1016/j.jchromb.2011.08.014; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang MQ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-86; Wenzhi W, 2009, CHIN J FRONT MED SCI, V1, P49; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Wu G, 2010, CHINESE J WOMEN CHIL, V1, P51; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	40	25	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122598	10.1371/journal.pone.0122598	http://dx.doi.org/10.1371/journal.pone.0122598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856294	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500044
J	Pomey, MP; Ghadiri, DP; Karazivan, P; Fernandez, N; Clavel, N				Pomey, Marie-Pascale; Ghadiri, Djahanchah P.; Karazivan, Philippe; Fernandez, Nicolas; Clavel, Nathalie			Patients as Partners: A Qualitative Study of Patients' Engagement in Their Health Care	PLOS ONE			English	Article							SHARED DECISION-MAKING; SELF-MANAGEMENT; CHRONIC DISEASE; INTERVENTIONS; EDUCATION; MODEL	To advocate for patients to be more actively involved with the healthcare services they receive, particularly patients living with chronic illness, the Faculty of Medicine of the University of Montreal and its affiliated hospitals developed the Patients as Partners concept where the patient is considered a full-fledged partner of the health care delivery team and the patient's experiential knowledge is recognized. This study aims to show how patients view their engagement with healthcare professionals regarding their direct care. Using theoretical sampling, 16 semi-structured interviews were conducted with patients with chronic illness who were familiar with the concept of Patients as Partners. Data analysis followed a constructivist grounded theory approach. Patients describe themselves as proactively engaging in three types of practice, regardless of health professionals' openness to their role as partners. The first is a process of continuous learning that allows them to acquire experiential knowledge about their health, as well as scientific information and technical know-how. The second involves their assessment of the healthcare they receive, in terms of its quality and how it aligns with their personal preferences. It includes their assessment of the quality of their relationship with the health professional and of the latter's scientific knowledge and technical know-how. The third type, adaptation practices, builds on patients' learning and assessments to compensate for and adapt to what has been perceived as optimal or non-optimal health or healthcare circumstances. Patients appear to play a more active and less docile role in their own direct care than suggested so far in the literature, regardless of the degree of reciprocity of the partnership or the degree to which the health professional seeks to encourage patient engagement.	[Pomey, Marie-Pascale; Clavel, Nathalie] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada; [Ghadiri, Djahanchah P.] HEC Montreal, Dept Management, Montreal, PQ, Canada; [Karazivan, Philippe] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Fernandez, Nicolas] Univ Quebec, Fac Sci Educ, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; Universite de Montreal; HEC Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Pomey, MP (corresponding author), Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada.	marie-pascale.pomey@umontreal.ca	Pomey, Marie-Pascale/AAL-9609-2021	Fernandez, Nicolas/0000-0002-3840-2641				Barello S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/905934; Barlow JH, 2004, CHILD CARE HLTH DEV, V30, P637, DOI 10.1111/j.1365-2214.2004.00474.x; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Battersby MW, 2008, AUST J PRIM HEALTH, V14, P66, DOI 10.1071/PY08009; Bauman AE, 2003, MED J AUSTRALIA, V179, P253, DOI 10.5694/j.1326-5377.2003.tb05532.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Charmaz K., 2006, CONSTRUCTING GROUNDE, DOI [10.1093/geront/gns046, DOI 10.1093/GERONT/GNS046]; Cottingham AH, 2008, J GEN INTERN MED, V23, P715, DOI 10.1007/s11606-008-0543-y; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Coulter A, 2012, J AMBUL CARE MANAG, V35, P80, DOI 10.1097/JAC.0b013e318249e0fd; (CPASS) Centre de pedagogie appliquee aux sciences de la sante, 2013, GUID IMPL PART SOINS; Creswell J. W., 2014, RES DESIGN QUALITATI; CSBE) Commissaire a la sante et au bien-etre, 2010, INF DROITS SENS RESP; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Edwards M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-130; Fox S, 2013, PEW INTERNET AM LIFE; Gerring J, 2007, CASE STUDY RES PRINC; Glaser B. G., 2009, DISCOVERY GROUNDED T; Golay A, 2010, COLLECTION ED PATIEN; Grande SW, 2014, PATIENT EDUC COUNS, V95, P281, DOI 10.1016/j.pec.2014.01.016; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Health BCMo, 2011, PAT PART NOTH ME ME, p18p; Hibbard JH, 2010, PATIENT EDUC COUNS, V78, P377, DOI 10.1016/j.pec.2009.12.015; Ho JK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3300; Jouet E, 2010, PRATIQUES FORMATION, P58, DOI DOI 10.1016/J.SCITOTENV; Jouet E, 2012, SOCIALNO DELO, V51, P87; Karazivan P, ACAD MED IN PRESS; Karazivan P, 2011, POINT ADM SANTE SERV, V7, P6, DOI [10.1016/S0140-6736(14)60844-8, DOI 10.1016/S0140-6736(14)60844-8]; Lebel P, 2014, PROGRAMME PARTENAIRE; Legare F, 2012, PATIENT, V5, P1, DOI 10.2165/11592180-000000000-00000; Lehman WEK, 2002, J SUBST ABUSE TREAT, V22, P197, DOI 10.1016/S0740-5472(02)00233-7; LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612; LORIG K, 1984, GERONTOLOGIST, V24, P455; (NHS) National Health Service, 2001, EXP PAT NEW APPR CHR; (OMS) Organisation Mondiale de la Sante, 1998, PROGR INF CONT PROF, P51; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Picker Institute, 2013, PAT CTR CAR ROAD AH; Pomey MP, 2014, LE VIRAGE PATIENT PA; Robinson S, 2012, SOC SCI MED, V75, P2386, DOI 10.1016/j.socscimed.2012.09.014; Stewart M, 2000, J FAM PRACTICE, V49, P796; Stewart M, 1995, PATIENT CTR MED TRAN; Tattersall R, 2002, CLIN MED, V2, P227, DOI 10.7861/clinmedicine.2-3-227; Vanier M-C, 2014, MAC FDN C ENG PAT FA; Vanier Marie-Claude, 2013, J Allied Health, V42, pe97; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wyatt S, 2008, HEALTH TECHNOL SOC, P1	48	84	84	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122499	10.1371/journal.pone.0122499	http://dx.doi.org/10.1371/journal.pone.0122499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856569	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500040
J	Vesterinen, HM; Connick, P; Irvine, CMJ; Sena, ES; Egan, KJ; Carmichael, GG; Tariq, A; Pavitt, S; Chataway, J; Macleod, MR; Chandran, S				Vesterinen, Hanna M.; Connick, Peter; Irvine, Cadi M. J.; Sena, Emily S.; Egan, Kieren J.; Carmichael, Gary G.; Tariq, Afiyah; Pavitt, Sue; Chataway, Jeremy; Macleod, Malcolm R.; Chandran, Siddharthan			Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis	PLOS ONE			English	Article							DOUBLE-BLIND; ANIMAL-MODELS; FLUOXETINE; IBUDILAST; THERAPY; QUALITY; TRIAL	Objective To develop and implement an evidence based framework to select, from drugs already licenced, candidate oral neuroprotective drugs to be tested in secondary progressive multiple sclerosis. Design Systematic review of clinical studies of oral putative neuroprotective therapies in MS and four other neurodegenerative diseases with shared pathological features, followed by systematic review and meta-analyses of the in vivo experimental data for those interventions. We presented summary data to an international multi-disciplinary committee, which assessed each drug in turn using pre-specified criteria including consideration of mechanism of action. Results We identified a short list of fifty-two candidate interventions. After review of all clinical and pre-clinical evidence we identified ibudilast, riluzole, amiloride, pirfenidone, fluoxetine, oxcarbazepine, and the polyunsaturated fatty-acid class (Linoleic Acid, Lipoic acid; Omega-3 fatty acid, Max EPA oil) as lead candidates for clinical evaluation. Conclusions We demonstrate a standardised and systematic approach to candidate identification for drug rescue and repurposing trials that can be applied widely to neurodegenerative disorders.	[Vesterinen, Hanna M.; Irvine, Cadi M. J.; Sena, Emily S.; Egan, Kieren J.; Carmichael, Gary G.; Tariq, Afiyah; Macleod, Malcolm R.] Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Connick, Peter; Chandran, Siddharthan] Univ Edinburgh, Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland; [Pavitt, Sue] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Chataway, Jeremy] Natl Hosp Neurol & Neurosurg, London, England	University of Edinburgh; University of Edinburgh; University of Leeds; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Macleod, MR (corresponding author), Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland.	malcolm.macleod@ed.ac.uk; siddharthan.chandran@ed.ac.uk	Macleod, Malcolm Robert/B-2052-2010; Pavitt, Sue H/B-6383-2009	Macleod, Malcolm Robert/0000-0001-9187-9839; Pavitt, Susan/0000-0001-7447-440X; Connick, Peter/0000-0002-3892-8037; Chandran, Siddharthan/0000-0001-6827-1593; Egan, Kieren/0000-0002-1639-4281; Sena, Emily S/0000-0002-3282-8502	MS Society [946/11]; MRC [MC_PC_13089] Funding Source: UKRI; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	MS Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement	This work was funded by MS Society 946/11 (http://www.mssociety.org.uk/.) No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Arun T, 2013, BRAIN, V136, P106, DOI 10.1093/brain/aws325; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; BATES D, 1989, J NEUROL NEUROSUR PS, V52, P18, DOI 10.1136/jnnp.52.1.18; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cavalla D, 2013, DRUG DISCOV TODAY, V18, P523, DOI 10.1016/j.drudis.2012.12.009; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; Gibson SB, 2012, SEMIN NEUROL, V32, P173, DOI 10.1055/s-0032-1329193; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; Kapoor R, 2006, CURR OPIN NEUROL, V19, P255, DOI 10.1097/01.wco.0000227034.85576.16; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kong EKC, 2002, NEUROCHEM RES, V27, P113, DOI 10.1023/A:1014862808126; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; MCALPINE D, 2006, MCALPINES MULTIPLE S; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; Meerpohl JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035732; Mostert JP, 2008, J NEUROL NEUROSUR PS, V79, P1027, DOI 10.1136/jnnp.2007.139345; Mostert Jop, 2013, ISRN Neurol, V2013, P370943, DOI 10.1155/2013/370943; Mostert JP, 2006, NEUROSCI LETT, V402, P22, DOI 10.1016/j.neulet.2006.03.042; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P1, DOI 10.1038/nrd3776; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P399, DOI 10.1038/nrd3473; Ricigliano VAG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071198; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Schwab M, 2012, NATURE, V483, P267, DOI 10.1038/483267a; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Solaro C, 2007, NEUROL SCI, V28, P156, DOI 10.1007/s10072-007-0811-3; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Van der Worp HB, 2010, PLOS MED, V7, DOI [10.1371/journal.pmed.1000250, DOI 10.1371/JOURNAL.PMED.1000250]; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Walker JE, 2005, MULT SCLER J, V11, P149, DOI 10.1191/1352458505ms1134oa; World Health Organization (WHO), 2008, ATL MULT SCLER RES W	43	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0117705	10.1371/journal.pone.0117705	http://dx.doi.org/10.1371/journal.pone.0117705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856304	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352588500002
J	Cameron, K; Najmudin, S; Alves, VD; Bayer, EA; Smith, SP; Bule, P; Waller, H; Ferreira, LMA; Gilbert, HJ; Fontes, CMGA				Cameron, Kate; Najmudin, Shabir; Alves, Victor D.; Bayer, Edward A.; Smith, Steven P.; Bule, Pedro; Waller, Helen; Ferreira, Luis M. A.; Gilbert, Harry J.; Fontes, Carlos M. G. A.			Cell-surface Attachment of Bacterial Multienzyme Complexes Involves Highly Dynamic Protein-Protein Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL BINDING MODE; ACETIVIBRIO-CELLULOLYTICUS; COHESIN DOMAIN; DOCKERIN; CELLULOSOME; SCAFFOLDIN; NANOMACHINES; CONTAINS; SYSTEM; GENOME	Protein-protein interactions play a pivotal role in the assembly of the cellulosome, one of nature's most intricate nanomachines dedicated to the depolymerization of complex carbohydrates. The integration of cellulosomal components usually occurs through the binding of type I dockerin modules located at the C terminus of the enzymes to cohesin modules located in the primary scaffoldin subunit. Cellulosomes are typically recruited to the cell surface via type II cohesin-dockerin interactions established between primary and cell-surface anchoring scaffoldin subunits. In contrast with type II interactions, type I dockerins usually display a dual binding mode that may allow increased conformational flexibility during cellulosome assembly. Acetivibrio cellulolyticus produces a highly complex cellulosome comprising an unusual adaptor scaffoldin, ScaB, which mediates the interaction between the primary scaffoldin, ScaA, through type II cohesin-dockerin interactions and the anchoring scaffoldin, ScaC, via type I cohesin-dockerin interactions. Here, we report the crystal structure of the type I ScaB dockerin in complex with a type I ScaC cohesin in two distinct orientations. The data show that the ScaB dockerin displays structural symmetry, reflected by the presence of two essentially identical binding surfaces. The complex interface is more extensive than those observed in other type I complexes, which results in an ultra-high affinity interaction (K-a similar to 10(12) M). A subset of ScaB dockerin residues was also identified as modulating the specificity of type I cohesin-dockerin interactions in A. cellulolyticus. This report reveals that recruitment of cellulosomes onto the cell surface may involve dockerins presenting a dual binding mode to incorporate additional flexibility into the quaternary structure of highly populated multienzyme complexes.	[Cameron, Kate; Najmudin, Shabir; Alves, Victor D.; Bule, Pedro; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] ULisboa, CIISA, Fac Med Vet, Polo Univ Alto da Ajuda, P-1300477 Lisbon, Portugal; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Waller, Helen; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Weizmann Institute of Science; Queens University - Canada; Newcastle University - UK	Najmudin, S (corresponding author), ULisboa, CIISA, Fac Med Vet, Polo Univ Alto da Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	shabir@fmv.ulisboa.pt	Bule, Pedro/W-6838-2019	Bule, Pedro/0000-0003-2531-9926; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Smith, Steven/0000-0003-2710-4400	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012]; European Union [263916, 283570]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Union(European Commission)	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) Grants PTDC/BIA-PRO/103980/2008 and EXPL/BIA-MIC/1176/2012, European Union Seventh Framework Programme FP7 2007-2013 under the WallTraC Project Grant 263916, and BioStruct-X Grant 283570.	Artzi L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-100; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Cameron K, 2012, ACTA CRYSTALLOGR F, V68, P1030, DOI 10.1107/S1744309112031922; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dassa B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-210; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Ding SY, 1999, J BACTERIOL, V181, P6720, DOI 10.1128/JB.181.21.6720-6729.1999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Hamberg Y, 2014, PEERJ, V2, DOI 10.7717/peerj.636; KHAN AW, 1980, J GEN MICROBIOL, V121, P499; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/j.jmb.2007.08.007; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Xu Q, 2004, J BACTERIOL, V186, P5782, DOI 10.1128/JB.186.17.5782-5789.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003	28	16	16	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13578	13590		10.1074/jbc.M114.633339	http://dx.doi.org/10.1074/jbc.M114.633339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855788	hybrid, Green Published			2022-12-26	WOS:000354975700051
J	Eller, J; Zarnadze, S; Bauerle, P; Dugladze, T; Gloveli, T				Eller, Joanna; Zarnadze, Shota; Bauerle, Peter; Dugladze, Tamar; Gloveli, Tengis			Cell Type-Specific Separation of Subicular Principal Neurons during Network Activities	PLOS ONE			English	Article							ELECTROPHYSIOLOGICALLY-DEFINED CLASSES; TEMPORAL-LOBE EPILEPSY; RAT VENTRAL SUBICULUM; LIMBIC GAMMA RHYTHMS; IN-VITRO; PYRAMIDAL NEURONS; INTRINSIC-PROPERTIES; REGULAR-SPIKING; HIPPOCAMPUS; OSCILLATIONS	The hippocampal output structure, the subiculum, expresses two major memory relevant network rhythms, sharp wave ripple and gamma frequency oscillations. To this date, it remains unclear how the two distinct types of subicular principal cells, intrinsically bursting and regular spiking neurons, participate in these two network rhythms. Using concomitant local field potential and intracellular recordings in an in vitro mouse model that allows the investigation of both network rhythms, we found a cell type-specific segregation of principal neurons into participating intrinsically bursting and non-participating regular spiking cells. However, if regular spiking cells were kept at a more depolarized level, they did participate in a specific manner, suggesting a potential bimodal working model dependent on the level of excitation. Furthermore, intrinsically bursting and regular spiking cells exhibited divergent intrinsic membrane and synaptic properties in the active network. Thus, our results suggest a cell-type-specific segregation of principal cells into two separate groups during network activities, supporting the idea of two parallel streams of information processing within the subiculum.	[Eller, Joanna; Zarnadze, Shota; Bauerle, Peter; Dugladze, Tamar; Gloveli, Tengis] Charite, Inst Neurophysiol, Cellular & Network Physiol Grp, D-13353 Berlin, Germany; [Dugladze, Tamar] Cluster Excellence NeuroCure, Berlin, Germany; [Gloveli, Tengis] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gloveli, T (corresponding author), Charite, Inst Neurophysiol, Cellular & Network Physiol Grp, D-13353 Berlin, Germany.	tengis.gloveli@charite.de		Bauerle, Peter/0000-0002-1675-6553; Dugladze, Tamar/0000-0002-4946-3984; Gloveli, Tengis/0000-0002-2209-375X	DFG [GL 254/5-2]; BMBF (BCCN II) and Einstein Foundation Berlin [A-2013-176]; Cluster Neurocure (Female PostDoc project)	DFG(German Research Foundation (DFG)); BMBF (BCCN II) and Einstein Foundation Berlin(Federal Ministry of Education & Research (BMBF)); Cluster Neurocure (Female PostDoc project)	This study was supported by the DFG (GL 254/5-2), BMBF (BCCN II) and Einstein Foundation Berlin (A-2013-176) to TG, and Cluster Neurocure (Female PostDoc project) to TD. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Behr J, 1996, NEUROSCI LETT, V220, P41, DOI 10.1016/S0304-3940(96)13242-0; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Colgin LL, 2010, PHYSIOLOGY, V25, P319, DOI 10.1152/physiol.00021.2010; Colling SB, 1998, J NEUROPHYSIOL, V80, P155, DOI 10.1152/jn.1998.80.1.155; D'Antuono M, 2001, J NEUROPHYSIOL, V86, P1164, DOI 10.1152/jn.2001.86.3.1164; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; FINCH DM, 1983, BRAIN RES, V271, P201, DOI 10.1016/0006-8993(83)90283-4; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Greene JRT, 1997, J COMP NEUROL, V380, P395, DOI 10.1002/(SICI)1096-9861(19970414)380:3<395::AID-CNE8>3.0.CO;2-Y; Greene JRT, 1996, J NEUROPHYSIOL, V76, P1657, DOI 10.1152/jn.1996.76.3.1657; Greene JRT, 1997, NEUROSCIENCE, V80, P95, DOI 10.1016/S0306-4522(97)00073-0; HABLITZ JJ, 1981, CELL MOL NEUROBIOL, V1, P325, DOI 10.1007/BF00716267; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; Jung HY, 2001, J NEUROSCI, V21, P3312, DOI 10.1523/JNEUROSCI.21-10-03312.2001; Kawasaki H, 1999, J NEUROPHYSIOL, V82, P2590, DOI 10.1152/jn.1999.82.5.2590; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Kintscher M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045039; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MASON A, 1993, BRAIN RES, V600, P174, DOI 10.1016/0006-8993(93)90418-M; MATTIA D, 1993, J NEUROPHYSIOL, V70, P1244, DOI 10.1152/jn.1993.70.3.1244; Naber PA, 1998, J COMP NEUROL, V393, P284; Norimoto H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02696; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Panuccio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050241; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Stanford IM, 1998, J NEUROPHYSIOL, V80, P162, DOI 10.1152/jn.1998.80.1.162; Stewart M, 1997, BRAIN RES, V769, P71, DOI 10.1016/S0006-8993(97)00690-2; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; SWANSON LW, 1975, SCIENCE, V189, P303, DOI 10.1126/science.49928; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wu CP, 2006, J PHYSIOL-LONDON, V576, P457, DOI 10.1113/jphysiol.2006.114918; Zylla MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080718	46	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123636	10.1371/journal.pone.0123636	http://dx.doi.org/10.1371/journal.pone.0123636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874555	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700034
J	Varga, A; Gyulavari, P; Greff, Z; Futosi, K; Nemeth, T; Simon-Szabo, L; Kerekes, K; Szantai-Kis, C; Brauswetter, D; Kokas, M; Borbely, G; Erdei, A; Mocsai, A; Keri, G; Vantus, T				Varga, Attila; Gyulavari, Pal; Greff, Zoltan; Futosi, Krisztina; Nemeth, Tamas; Simon-Szabo, Laura; Kerekes, Krisztina; Szantai-Kis, Csaba; Brauswetter, Diana; Kokas, Marton; Borbely, Gabor; Erdei, Anna; Mocsai, Attila; Keri, Gyorgy; Vantus, Tibor			Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; PERMANENT CELL-LINE; MAST-CELLS; MOLECULAR-CLONING; DRUG DISCOVERY; D ACTIVATION; PHOSPHORYLATION; NEUTROPHILS; FAMILY; VIVO	Emerging evidence suggests that the vascular endothelial growth factor receptor 2 (VEGFR2) and protein kinase D1 (PKD1) signaling axis plays a critical role in normal and pathological angiogenesis and inflammation related processes. Despite all efforts, the currently available therapeutic interventions are limited. Prior studies have also proved that a multiple target inhibitor can be more efficient compared to a single target one. Therefore, development of novel inflammatory pathway-specific inhibitors would be of great value. To test this possibility, we screened our molecular library using recombinant kinase assays and identified the previously described compound VCC251801 with strong inhibitory effect on both VEGFR2 and PKD1. We further analyzed the effect of VCC251801 in the endothelium- derived EA.hy926 cell line and in different inflammatory cell types. In EA.hy926 cells, VCC251801 potently inhibited the intracellular activation and signaling of VEGFR2 and PKD1 which inhibition eventually resulted in diminished cell proliferation. In this model, our compound was also an efficient inhibitor of in vitro angiogenesis by interfering with endothelial cell migration and tube formation processes. Our results from functional assays in inflammatory cellular models such as neutrophils and mast cells suggested an anti-inflammatory effect of VCC251801. The neutrophil study showed that VCC251801 specifically blocked the immobilized immune-complex and the adhesion dependent TNF-alpha-fibrinogen stimulated neutrophil activation. Furthermore, similar results were found in mast cell degranulation assay where VCC251801 caused significant reduction of mast cell response. In summary, we described a novel function of a multiple kinase inhibitor which strongly inhibits the VEGFR2-PKD1 signaling and might be a novel inhibitor of pathological inflammatory pathways.	[Varga, Attila; Gyulavari, Pal; Borbely, Gabor; Keri, Gyorgy] Semmelweis Univ, Hungarian Acad Sci, Pathobiochem Res Grp, H-1085 Budapest, Hungary; [Greff, Zoltan; Szantai-Kis, Csaba; Keri, Gyorgy] Vichem Chem Res Ltd, Budapest, Hungary; [Futosi, Krisztina; Nemeth, Tamas; Mocsai, Attila] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary; [Simon-Szabo, Laura; Kerekes, Krisztina; Erdei, Anna] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Brauswetter, Diana; Kokas, Marton; Keri, Gyorgy; Vantus, Tibor] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Vichem Chemie Research Ltd.; Semmelweis University; Eotvos Lorand University; Semmelweis University	Vantus, T (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	vantus.tibor@med.semmelweis-univ.hu	Németh, Tamás/O-1968-2017	Németh, Tamás/0000-0001-6854-4301; Erdei, Anna/0000-0002-3622-6680; Futosi, Krisztina/0000-0002-1661-4635; Szantai-Kis, Csaba/0000-0002-5240-845X	Anyos Jedlik [NKFP-A1-0069/2006]; National Office for Research and Technology (Hungary) [KMR-12-1-2012-0074]; National Development Agency (Hungary); European Community [HEALTH-F4-2011-282095]	Anyos Jedlik; National Office for Research and Technology (Hungary)(National Office for Research and Technology); National Development Agency (Hungary); European Community(European Commission)	This study was supported by Anyos Jedlik award number NKFP-A1-0069/2006 to AM, GK and TV by National Office for Research and Technology (Hungary), supporting experimental work, focusing on drug screening and neutrophil studies; KMR-12-1-2012-0074 to GK by National Development Agency (Hungary), supporting experimental work in cell culture; The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement no HEALTH-F4-2011-282095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Aranda E, 2009, BIOL RES, V42, P377, DOI [/S0716-97602009000300012, 10.4067/S0716-97602009000300012]; Barvian M, 2000, J MED CHEM, V43, P4606, DOI 10.1021/jm000271k; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Broekman F, 2011, WORLD J CLIN ONCOL, V2, P80, DOI 10.5306/wjco.v2.i2.80; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; D'Haene N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067029; Davidson-Moncada JK, 2002, BIOCHEM J, V363, P95, DOI 10.1042/0264-6021:3630095; de Paulis A, 2006, J IMMUNOL, V177, P7322, DOI 10.4049/jimmunol.177.10.7322; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; ERDEI A, 1995, INT IMMUNOL, V7, P1433, DOI 10.1093/intimm/7.9.1433; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Evans IM, 2011, IUBMB LIFE, V63, P258, DOI 10.1002/iub.456; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Futosi K, 2012, BLOOD, V119, P4981, DOI 10.1182/blood-2011-07-369041; Guo JX, 2013, CANCER CHEMOTH PHARM, V71, P331, DOI 10.1007/s00280-012-2010-z; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ittner A, 2012, J EXP MED, V209, P2229, DOI 10.1084/jem.20120677; Keri G, 2005, ASSAY DRUG DEV TECHN, V3, P543, DOI 10.1089/adt.2005.3.543; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kovacs M, 2014, J EXP MED, V211, P1993, DOI 10.1084/jem.20132496; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Lee JH, 2011, J IMMUNOL, V187, P1807, DOI 10.4049/jimmunol.1100296; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Murphy TR, 2007, J IMMUNOL, V179, P7876, DOI 10.4049/jimmunol.179.11.7876; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Ni Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073149; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785, DOI 10.1248/bpb.34.1785; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Verzoni E, 2014, PHARMACOGEN PERS MED, V7, P107, DOI 10.2147/PGPM.S37098; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yamashita K, 2010, INT IMMUNOPHARMACOL, V10, P277, DOI 10.1016/j.intimp.2009.11.011	56	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124234	10.1371/journal.pone.0124234	http://dx.doi.org/10.1371/journal.pone.0124234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874616	Green Published, gold			2022-12-26	WOS:000353014700060
J	Huang, LN; Jun, SH; Drubach, N; Dahan, MH				Huang, Lina N.; Jun, Sunny H.; Drubach, Nathalie; Dahan, Michael H.			Predictors of In Vitro Fertilization Outcomes in Women with Highest Follicle-Stimulating Hormone Levels >= 12 IU/L: A Prospective Cohort Study	PLOS ONE			English	Article							IVF; AGE; PATIENT; EMBRYOS; DECLINE; FSH	Objective The purpose of this study is to evaluate factors predictive of outcomes in women with highest follicle-stimulating hormone (FSH) levels >= 12 IU/L on basal testing, undergoing in vitro fertilization (IVF). Methods A prospective cohort study was conducted at Stanford University Hospital in the Reproductive Endocrinology and Infertility Center for 12 months. Women age 21 to 43 undergoing IVF with highest FSH levels on baseline testing were included. Donor/Recipient and frozen embryo cycles were excluded from this study. Prognostic factors evaluated in association with clinical pregnancy rates were type of infertility diagnosis and IVF stimulation parameters. Results The current study found that factors associated with clinical pregnancy were: increased number of mature follicles on the day of triggering, number of oocytes retrieved, number of Metaphase II oocytes if intracytoplasmic sperm injection was done, and number of embryos developed 24 hours after retrieval. Conclusions Our findings suggest that it would be beneficial for women with increased FSH levels to attempt a cycle of IVF. Results of ovarian stimulation, especially embryo quantity appear to be the best predictors of IVF outcomes and those can only be obtained from a cycle of IVF. Therefore, increased basal FSH levels should not discourage women from attempting a cycle of IVF.	[Huang, Lina N.; Dahan, Michael H.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Jun, Sunny H.; Drubach, Nathalie] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA	McGill University; Stanford University	Dahan, MH (corresponding author), McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada.	dahanhaim@hotmail.com	Dahan, Michael/K-2116-2015	Dahan, Michael/0000-0002-8121-7708	Women's Reproductive Health Research (WRHR) PROGRAM NICHD through the National Institutes of Health (NIH) [5 K12 HD01249]	Women's Reproductive Health Research (WRHR) PROGRAM NICHD through the National Institutes of Health (NIH)	This research was supported by: Women's Reproductive Health Research (WRHR) PROGRAM NICHD through the National Institutes of Health (NIH), 5 K12 HD01249. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2004, HUM REPROD, V19, P893, DOI 10.1093/humrep/deh141; Banerjee P, 2010, P NATL ACAD SCI USA, V107, P13570, DOI 10.1073/pnas.1002296107; Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228; Check JH, 1998, GYNECOL OBSTET INVES, V45, P217, DOI 10.1159/000009970; Choi B, 2013, FERTIL STERIL, V99, P1905, DOI 10.1016/j.fertnstert.2013.02.016; Cooper AR, 2011, FERTIL STERIL, V95, P1890, DOI 10.1016/j.fertnstert.2010.01.016; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Griesinger G, 2010, SEMIN REPROD MED, V28, P493, DOI 10.1055/s-0030-1265676; Huang LN, 2015, REPROD BIOMED ONLINE, V30, P128, DOI 10.1016/j.rbmo.2014.10.004; Hull MGR, 1996, FERTIL STERIL, V65, P783, DOI 10.1016/S0015-0282(16)58214-4; Kornafel KL, 2007, FERTIL STERIL, V87, P1253, DOI 10.1016/j.fertnstert.2006.11.056; Levi AJ, 2001, FERTIL STERIL, V76, P666, DOI 10.1016/S0015-0282(01)02017-9; Nasseri A, 1999, FERTIL STERIL, V71, P715, DOI 10.1016/S0015-0282(98)00525-1; Nayot D, 2013, J ASSIST REPROD GEN, V30, P1439, DOI 10.1007/s10815-013-0079-x; Practice Comm Amer Soc Reprod Med, 2015, FERTIL STERIL, V103, pE9, DOI [10.1016/j.fertnstert.2014.12.093, 10.1016/j.fertnstert.2012.09.036]; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Sabatin L, 2008, REPROD BIOMED ONLINE, V17, P10, DOI 10.1016/S1472-6483(10)60287-8; SCOTT RT, 1989, FERTIL STERIL, V51, P651; Sharif K, 1998, BRIT J OBSTET GYNAEC, V105, P107, DOI 10.1111/j.1471-0528.1998.tb09360.x; SPEROFF L, 1994, CURR OPIN OBSTET GYN, V6, P115; Thum MY, 2009, J ASSIST REPROD GEN, V26, P313, DOI 10.1007/s10815-009-9313-y; TONER JP, 1991, FERTIL STERIL, V55, P784; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015; Venetis CA, 2010, ANN NY ACAD SCI, V1205, P199, DOI 10.1111/j.1749-6632.2010.05665.x; Weinerman R, 2012, SEMIN REPROD MED, V30, P77, DOI 10.1055/s-0032-1307415	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124789	10.1371/journal.pone.0124789	http://dx.doi.org/10.1371/journal.pone.0124789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867175	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100272
J	Diaz-Hernandez, JI; Sebastian-Serrano, A; Gomez-Villafuertes, R; Diaz-Hernandez, M; Miras-Portugal, MT				Ignacio Diaz-Hernandez, Juan; Sebastian-Serrano, Alvaro; Gomez-Villafuertes, Rosa; Diaz-Hernandez, Miguel; Teresa Miras-Portugal, Mara			Age-Related Nuclear Translocation of P2X6 Subunit Modifies Splicing Activity Interacting with Splicing Factor 3A1	PLOS ONE			English	Article							P2X(6) RECEPTORS; ATP; SENESCENCE; IDENTIFICATION; SPLICEOSOME; INHIBITION; EXPRESSION; SPECKLES; PROTEINS; COMPLEX	P2X receptors are ligand-gated ion channels sensitive to extracellular nucleotides formed by the assembling of three equal or different P2X subunits. In this work we report, for the first time, the accumulation of the P2X6 subunit inside the nucleus of hippocampal neurons in an age-dependent way. This location is favored by its anchorage to endoplasmic reticulum through its N-terminal domain. The extracellular domain of P2X6 subunit is the key to reach the nucleus, where it presents a speckled distribution pattern and is retained by interaction with the nuclear envelope protein spectrin alpha 2. The in vivo results showed that, once inside the nucleus, P2X6 subunit interacts with the splicing factor 3A1, which ultimately results in a reduction of the mRNA splicing activity. Our data provide new insights into post-transcriptional regulation of mRNA splicing, describing a novel mechanism that could explain why this process is sensitive to changes that occur with age.	[Ignacio Diaz-Hernandez, Juan; Sebastian-Serrano, Alvaro; Gomez-Villafuertes, Rosa; Diaz-Hernandez, Miguel; Teresa Miras-Portugal, Mara] Univ Complutense Madrid, Sch Vet, Dept Biochem & Mol Biol, Madrid, Spain; [Ignacio Diaz-Hernandez, Juan; Sebastian-Serrano, Alvaro; Gomez-Villafuertes, Rosa; Diaz-Hernandez, Miguel; Teresa Miras-Portugal, Mara] Hosp Clin San Carlos, Inst Invest Sanitaria, IdISSC, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos	Diaz-Hernandez, M (corresponding author), Univ Complutense Madrid, Sch Vet, Dept Biochem & Mol Biol, Madrid, Spain.	migueldiaz@vet.ucm.es	Díaz-Hernandez, Juan Ignacio/L-6973-2014; Gomez-Villafuertes, Rosa/L-7181-2014; Sebastian-Serrano, Alvaro/Q-5982-2018	Díaz-Hernandez, Juan Ignacio/0000-0003-2507-5888; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Fundacion Marcelino Botin; Ministerio de Ciencia e Innovacion [BFU2011-24743, BFU-2012-31195]; Spanish Ion Channel Initiative [CSD2008-00005]	Fundacion Marcelino Botin; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ion Channel Initiative	This work has been supported by research from Fundacion Marcelino Botin (MTM), Ministerio de Ciencia e Innovacion (BFU2011-24743 (MTM) and BFU-2012-31195 (MDH)) and the Spanish Ion Channel Initiative (CSD2008-00005) (MTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson L, 2002, NATURE, V420, P42, DOI 10.1038/420042a; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Collo G, 1996, J NEUROSCI, V16, P2495; da Silva RL, 2007, EXP PHYSIOL, V92, P139, DOI 10.1113/expphysiol.2006.035543; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Geng YQ, 2010, BIOCHEM BIOPH RES CO, V396, P866, DOI 10.1016/j.bbrc.2010.05.011; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Pankratov YV, 2002, J NEUROSCI, V22, P8363; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Sebastian-Serrano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031590; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Sridharan DM, 2006, CELL BIOL INT, V30, P866, DOI 10.1016/j.cellbi.2006.06.005; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123121	10.1371/journal.pone.0123121	http://dx.doi.org/10.1371/journal.pone.0123121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874565	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100138
J	Juhlen, R; Idkowiak, J; Taylor, AE; Kind, B; Arlt, W; Huebner, A; Koehler, K				Juehlen, Ramona; Idkowiak, Jan; Taylor, Angela E.; Kind, Barbara; Arlt, Wiebke; Huebner, Angela; Koehler, Katrin			Role of ALADIN in Human Adrenocortical Cells for Oxidative Stress Response and Steroidogenesis	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; WD-REPEAT PROTEIN; TRIPLE-A-SYNDROME; GLUCOCORTICOID DEFICIENCY; GENE-EXPRESSION; FERRITIN; APRATAXIN; TRANSLOCATION; PUBLICATION; AAAS	Triple A syndrome is caused by mutations in AAASencoding the protein ALADIN. We investigated the role of ALADIN in the human adrenocortical cell line NCI-H295R1 by either overexpression or down-regulation of ALADIN. Our findings indicate that AAAS knock-down induces a down-regulation of genes coding for type II microsomal cytochrome P450 hydroxylases CYP17A1 and CYP21A2 and their electron donor enzyme cytochrome P450 oxidoreductase, thereby decreasing biosynthesis of precursor metabolites required for glucocorticoid and androgen production. Furthermore we demonstrate that ALADIN deficiency leads to increased susceptibility to oxidative stress and alteration in redox homeostasis after paraquat treatment. Finally, we show significantly impaired nuclear import of DNA ligase 1, aprataxin and ferritin heavy chain 1 in ALADIN knock-down cells. We conclude that down-regulating ALADIN results in decreased oxidative stress response leading to alteration in steroidogenesis, highlighting our knock-down cell model as an important in-vitro tool for studying the adrenal phenotype in triple A syndrome.	[Juehlen, Ramona; Kind, Barbara; Huebner, Angela; Koehler, Katrin] Tech Univ Dresden, Med Fak Carl Gustav Carus, Klin & Poliklin Kinder & Jugendmed, Dresden, Germany; [Idkowiak, Jan; Taylor, Angela E.; Arlt, Wiebke] Univ Birmingham, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Birmingham	Juhlen, R (corresponding author), Tech Univ Dresden, Med Fak Carl Gustav Carus, Klin & Poliklin Kinder & Jugendmed, Dresden, Germany.	ramona.juehlen@uniklinikum-dresden.de	Idkowiak, Jan/R-9990-2019; Arlt, Wiebke/B-6310-2009	Arlt, Wiebke/0000-0001-5106-9719; Huebner, Angela/0000-0003-1338-5192; Taylor, Angela, E/0000-0002-5835-5643; Koehler, Katrin/0000-0002-9407-1410; Idkowiak, Jan/0000-0001-9181-3995; Juhlen, Ramona/0000-0002-5689-9030	Deutsche Forschungsgemeinschaft [HU 895/5-1]; Visiting Scholarship of the European Society for Paediatric Endocrinology awarded; Medical Research Council UK [0900567, G1001964]; Cancer Research UK [15622] Funding Source: researchfish; Medical Research Council [G116/172, G1001964, G0900567] Funding Source: researchfish; MRC [G0900567, G1001964] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Visiting Scholarship of the European Society for Paediatric Endocrinology awarded; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Deutsche Forschungsgemeinschaft grant HU 895/5-1 (Clinical Research Unit 252) to AH, a Visiting Scholarship of the European Society for Paediatric Endocrinology awarded to RJ and the Medical Research Council UK (Program Grant 0900567, to WA; Research Training Fellowship G1001964, to JI, http://www.dfg.de/, http://www.eurospe.org/, http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Alesci S, 2002, P NATL ACAD SCI USA, V99, P7484, DOI 10.1073/pnas.062170099; Alkhateeb AA, 2010, BBA-GEN SUBJECTS, V1800, P793, DOI 10.1016/j.bbagen.2010.03.017; ALLGROVE J, 1978, LANCET, V1, P1284; Bureik M, 2002, BIOL CHEM, V383, P1537, DOI 10.1515/BC.2002.174; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai C, 2008, DEV DYNAM, V237, P2676, DOI 10.1002/dvdy.21494; Cai CX, 2001, J CELL SCI, V114, P2327; Clark AJL, 1998, ENDOCR REV, V19, P828, DOI 10.1210/er.19.6.828; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Haring R, 2013, J MOL ENDOCRINOL, V50, P73, DOI 10.1530/JME-12-0185; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hirano M, 2006, P NATL ACAD SCI USA, V103, P2298, DOI 10.1073/pnas.0505598103; Huebner A, 2006, MOL CELL BIOL, V26, P1879, DOI 10.1128/MCB.26.5.1879-1887.2006; KAWAMOTO T, 1992, P NATL ACAD SCI USA, V89, P1458, DOI 10.1073/pnas.89.4.1458; Kind B, 2010, J MOL MED, V88, P1233, DOI 10.1007/s00109-010-0661-y; Kind B, 2009, BIOCHEM BIOPH RES CO, V390, P205, DOI 10.1016/j.bbrc.2009.09.080; Koehler K, 2013, HORM METAB RES, V45, P102, DOI 10.1055/s-0032-1331196; Koehler K, 2008, EUR J HUM GENET, V16, P1499, DOI 10.1038/ejhg.2008.132; Krumbholz M, 2006, BIOCHEM CELL BIOL, V84, P243, DOI 10.1139/O05-198; Matkovic U, 2009, J CELL PHYSIOL, V220, P45, DOI 10.1002/jcp.21727; Milenkovic T, 2010, EUR J PEDIATR, V169, P1323, DOI 10.1007/s00431-010-1222-7; Misaggi R, 2014, GENE, V535, P327, DOI 10.1016/j.gene.2013.10.067; Nogueira EF, 2009, J MOL ENDOCRINOL, V42, P319, DOI 10.1677/JME-08-0112; Prasad R, 2013, ENDOCRINOLOGY, V154, P3209, DOI 10.1210/en.2013-1241; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Storr HL, 2009, MOL ENDOCRINOL, V23, P2086, DOI 10.1210/me.2009-0056; Thompson KJ, 2002, J CELL SCI, V115, P2165; Tsigos C, 1999, ARCH MED RES, V30, P475, DOI 10.1016/S0188-0128(99)00057-3; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang T, 2012, HORM METAB RES, V44, P245, DOI 10.1055/s-0031-1298019; Yamazumi Y, 2009, BIOCHEM BIOPH RES CO, V389, P100, DOI 10.1016/j.bbrc.2009.08.096	40	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124582	10.1371/journal.pone.0124582	http://dx.doi.org/10.1371/journal.pone.0124582			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867024	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100267
J	Lim, KC; Lim, PE; Chong, VC; Loh, KH				Lim, Kean Chong; Lim, Phaik-Eem; Chong, Ving Ching; Loh, Kar-Hoe			Molecular and Morphological Analyses Reveal Phylogenetic Relationships of Stingrays Focusing on the Family Dasyatidae (Myliobatiformes)	PLOS ONE			English	Article							HIMANTURA; ELASMOBRANCHII; RAY	Elucidating the phylogenetic relationships of the current but problematic Dasyatidae (Order Myliobatiformes) was the first priority of the current study. Here, we studied three molecular gene markers of 43 species (COI gene), 33 species (ND2 gene) and 34 species (RAG1 gene) of stingrays to draft out the phylogenetic tree of the order. Nine character states were identified and used to confirm the molecularly constructed phylogenetic trees. Eight or more clades (at different hierarchical level) were identified for COI, ND2 and RAG1 genes in the Myliobatiformes including four clades containing members of the present Dasyatidae, thus rendering the latter non-monophyletic. The uncorrected p-distance between these four 'Dasytidae' clades when compared to the distance between formally known families confirmed that these four clades should be elevated to four separate families. We suggest a revision of the present classification, retaining the Dasyatidae (Dasyatis and Taeniurops species) but adding three new families namely, Neotrygonidae (Neotrygon and Taeniura species), Himanturidae (Himantura species) and Pastinachidae (Pastinachus species). Our result indicated the need to further review the classification of Dasyatis microps. By resolving the non-monophyletic problem, the suite of nine character states enables the natural classification of the Myliobatiformes into at least thirteen families based on morphology.	[Lim, Kean Chong; Lim, Phaik-Eem; Chong, Ving Ching] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Lim, Phaik-Eem; Chong, Ving Ching; Loh, Kar-Hoe] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chong, VC (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	chong@um.edu.my	CHONG, VING/B-4645-2009; Loh, Kar-Hoe/A-1750-2012; LIM, Phaik Eem/B-5331-2010	CHONG, VING/0000-0003-0331-768X; Loh, Kar-Hoe/0000-0001-8406-6485; LIM, Phaik Eem/0000-0001-9186-1487	Japan International Centre for Agricultural Sciences (JIRCAS) [57-02-03-1005]; UM Research Grant (UMRG) [RG191-121SUS]; UM IPPP Grant [PG103-2012B]	Japan International Centre for Agricultural Sciences (JIRCAS); UM Research Grant (UMRG); UM IPPP Grant	We thank Japan International Centre for Agricultural Sciences (JIRCAS) 57-02-03-1005, UM Research Grant (UMRG) RG191-121SUS and UM IPPP Grant-PG103-2012B for the financial support of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschliman NC, 2011, THESIS FLORIDA STATE; Aschliman NC, 2012, CRC MAR BIOL SER, P57; Carpenter K. E., 1999, LIVING MARINE RESOUR, V3, P1397; Carpenter KE, 2002, FAO SPECIES IDENTIFI, V5, P1; Cerutti-Pereyra F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036479; COMPAGNO LJV, 1982, ENVIRON BIOL FISH, V7, P321, DOI 10.1007/BF00005567; Silva João Paulo C.B. da, 2011, Pap. Avulsos Zool. (São Paulo), V51, P139, DOI 10.1590/S0031-10492011000800001; Daley RK, 2002, FIELD GUIDE AUSTR SH; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Last P. R., 2010, DESCRIPTIONS NEW SHA; Last P.R., 2008, DESCRIPTIONS NEW AUS; Last P.R., 2010, SHARKS RAYS BORNEO; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Last Peter R., 2010, Aqua, V16, P37; Manjaji-Matsumoto BM, 2006, ICHTHYOL RES, V53, P290, DOI 10.1007/s10228-006-0350-6; McEachran JD, 2004, CRC MAR BIOL SER, P79; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Naylor Gavin J.P., 2005, P1; NISHIDA K, 1988, JPN J ICHTHYOL, V35, P115; Nishida K, 1990, ELASMOBRANCHS LIVING, P327; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ruhfel BR, 2013, INT J PLANT SCI, V174, P910, DOI 10.1086/670668; Ruocco NL, 2012, ZOOL STUD, V51, P862; Serena F., 2005, FIELD IDENTIFICATION, P97; Serra-Pereira B, 2011, ZOOL SCR, V40, P76, DOI 10.1111/j.1463-6409.2010.00461.x; StatSoft Inc, 1997, EL STAT TXB; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vidthayanon Chavalit, 2005, Natural History Bulletin of the Siam Society, V53, P123; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; White W.T., 2006, EC IMPORTANT SHARKS; Yano K, 2005, SHARKS RAYS MALAYSIA; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120518	10.1371/journal.pone.0120518	http://dx.doi.org/10.1371/journal.pone.0120518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867639	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100023
J	Ngan, LTM; Jang, MJ; Kwon, MJ; Ahn, YJ				Luong Thi My Ngan; Jang, Myeong Jin; Kwon, Min Jung; Ahn, Young Joon			Antiviral Activity and Possible Mechanism of Action of Constituents Identified in Paeonia lactiflora Root toward Human Rhinoviruses	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; RECEPTOR; RIBAVIRIN; 1,2,3,4,6-PENTA-O-GALLOYL-BETA-D-GLUCOSE; EXPRESSION; INHIBITORS; DISCOVERY; AGENTS; ICAM-1; ALPHA	Human rhinoviruses (HRVs) are responsible for more than half of all cases of the common cold and cost billions of USD annually in medical visits and missed school and work. An assessment was made of the antiviral activities and mechanisms of action of paeonol (PA) and 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG) from Paeonia lactiflora root toward HRV-2 and HRV-4 in MRC5 cells using a tetrazolium method and real-time quantitative reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay. Results were compared with those of a reference control ribavirin. Based on 50% inhibitory concentration values, PGG was 13.4 and 18.0 times more active toward HRV-2 (17.89 mu M) and HRV-4 (17.33 mu M) in MRC5 cells, respectively, than ribavirin. The constituents had relatively high selective index values (3.3->8.5). The 100 mu g/mL PA and 20 mu g/mL PGG did not interact with the HRV-4 particles. These constituents inhibited HRV-4 infection only when they were added during the virus inoculation (0 h), the adsorption period of HRVs, but not after 1 h or later. Moreover, the RNA replication levels of HRVs were remarkably reduced in the MRC5 cultures treated with these constituents. These findings suggest that PGG and PA may block or reduce the entry of the viruses into the cells to protect the cells from the virus destruction and abate virus replication, which may play an important role in interfering with expressions of rhinovirus receptors (intercellular adhesion molecule-1 and low-density lipoprotein receptor), inflammatory cytokines (interleukin (IL)-6, IL-8, tumor necrosis factor, interferon beta, and IL-1 beta), and Toll-like receptor, which resulted in diminishing symptoms induced by HRV. Global efforts to reduce the level of synthetic drugs justify further studies on P. lactiflora root-derived materials as potential anti-HRV products or lead molecules for the prevention or treatment of HRV.	[Luong Thi My Ngan] Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh, Vietnam; [Jang, Myeong Jin; Kwon, Min Jung; Ahn, Young Joon] Seoul Natl Univ, Dept Agr Biotechnol, Biomodulat Major, Seoul, South Korea	Vietnam National University Hochiminh City; Seoul National University (SNU)	Ahn, YJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Biomodulat Major, Seoul, South Korea.	yjahn@snu.ac.kr		Luong, Ngan/0000-0003-0500-007X	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Funding: This work was carried out with the support by the Brain Korea 21 PLUS through the National Research Foundation of Korea funded by the Ministry of Education of the Korean Government to Y.J. Ahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Chiang LC, 2003, J ANTIMICROB CHEMOTH, V52, P194, DOI 10.1093/jac/dkg291; Choi HJ, 2010, LETT APPL MICROBIOL, V51, P1, DOI 10.1111/j.1472-765X.2010.02845.x; Choi HJ, 2009, PHYTOMEDICINE, V16, P35, DOI 10.1016/j.phymed.2008.10.012; Choi HJ, 2010, PHYTOTHER RES, V24, P1292, DOI 10.1002/ptr.3101; Choi HJ, 2009, ANTIVIR RES, V81, P77, DOI 10.1016/j.antiviral.2008.10.002; Couch RB, 2006, ELS             0424, DOI [10.1038/npg.els.0004240, DOI 10.1038/NPG.ELS.0004240]; DETOMMASI N, 1992, J NAT PROD, V55, P1067, DOI 10.1021/np50086a006; Garozzo Adriana, 2007, Antiviral Chemistry & Chemotherapy, V18, P277; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; ISHITSUKA H, 1982, ANTIMICROB AGENTS CH, V22, P611, DOI 10.1128/AAC.22.4.611; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Jang YJ, 2009, ANTIVIR RES, V81, P226, DOI 10.1016/j.antiviral.2008.12.001; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Jiangsu New Medical College, 1977, DICT CHIN TRAD MED, V1; Kitazato K, 2007, DRUG DISCOV THER, V1, P14; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SJ, 2006, BIOL PHARM BULL, V29, P2131, DOI 10.1248/bpb.29.2131; Liu A.-L., 2012, DIETARY PHYTOCHEMICA, V978, P93, DOI [10.1007/978-94-007-3926-0_3, DOI 10.1007/978-94-007-3926-0_3]; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; Luong TMN, 2012, J AGR FOOD CHEM, V60, P9062, DOI 10.1021/jf3035034; Morgan D M, 1998, Methods Mol Biol, V79, P179; Newcomb DC, 2007, AM J PHYSIOL-LUNG C, V293, pL1021, DOI 10.1152/ajplung.00060.2007; Nizamutdinova IT, 2007, INT IMMUNOPHARMACOL, V7, P343, DOI 10.1016/j.intimp.2006.11.004; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Pitkaranta A, 1997, J CLIN MICROBIOL, V35, P1791; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Pourianfar HR, 2012, INDIAN J VIROL, V23, P303, DOI 10.1007/s13337-012-0105-0; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Roelen CAM, 2011, WORK, V39, P305, DOI 10.3233/WOR-2011-1178; Rollinger JM, 2008, J MED CHEM, V51, P842, DOI 10.1021/jm701494b; Rollinger JM, 2011, MED RES REV, V31, P42, DOI 10.1002/med.20176; Rollinger JM, 2009, PLANTA MED, V75, P195, DOI 10.1055/s-0028-1088397; SAKAR MK, 1993, PHYTOCHEMISTRY, V33, P171, DOI 10.1016/0031-9422(93)85416-O; Savolainen Carita, 2003, Paediatr Respir Rev, V4, P91, DOI 10.1016/S1526-0542(03)00030-7; Spasova M, 2008, BIOORGAN MED CHEM, V16, P7457, DOI 10.1016/j.bmc.2008.06.010; Suzuki T, 2002, AM J RESP CRIT CARE, V165, P1113, DOI 10.1164/ajrccm.165.8.2103094; Tang W., 1992, CHINESE DRUGS PLANT; TSUCHIYA Y, 1985, CHEM PHARM BULL, V33, P3881, DOI 10.1248/cpb.33.3881; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Turner RB, 2001, ANTIVIR RES, V49, P1, DOI 10.1016/S0166-3542(00)00135-2; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; VANHOOF L, 1984, PLANTA MED, V50, P513, DOI 10.1055/s-2007-969786; VLIETINCK AJ, 1991, J ETHNOPHARMACOL, V32, P141, DOI 10.1016/0378-8741(91)90112-Q; Waterer G, 2009, RESPIROLOGY, V14, P651, DOI 10.1111/j.1440-1843.2009.01554.x; Whiteman SC, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-8; Williams J E, 2001, Altern Med Rev, V6, P567; Yasuda H, 2006, EUR RESPIR J, V28, P51, DOI 10.1183/09031936.06.00058505; Zhao WH, 2007, J CHROMATOGR B, V850, P523, DOI 10.1016/j.jchromb.2006.11.002	56	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121629	10.1371/journal.pone.0121629	http://dx.doi.org/10.1371/journal.pone.0121629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860871	gold, Green Submitted, Green Published			2022-12-26	WOS:000352590300028
J	Ple, C; Fan, Y; Yahia, SA; Vorng, H; Everaere, L; Chenivesse, C; Balsamelli, J; Azzaoui, I; de Nadai, P; Wallaert, B; Lazennec, G; Tsicopoulos, A				Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Lazennec, Gwendal; Tsicopoulos, Anne			Polycyclic Aromatic Hydrocarbons Reciprocally Regulate IL-22 and IL-17 Cytokines in Peripheral Blood Mononuclear Cells from Both Healthy and Asthmatic Subjects	PLOS ONE			English	Article							CD4(+) T-CELLS; AIRWAY INFLAMMATION; IMMUNE-RESPONSES; RECEPTOR; DIESEL; DIFFERENTIATION; ACTIVATION; CHEMOKINE; HYPERRESPONSIVENESS; RECRUITMENT	Pollution, including polycyclic aromatic hydrocarbons (PAH), may contribute to increased prevalence of asthma. PAH can bind to the Aryl hydrocarbon Receptor (AhR), a transcription factor involved in Th17/Th22 type polarization. These cells produce IL17A and IL-22, which allow neutrophil recruitment, airway smooth muscle proliferation and tissue repair and remodeling. Increased IL-17 and IL-22 productions have been associated with asthma. We hypothesized that PAH might affect, through their effects on AhR, IL-17 and IL-22 production in allergic asthmatics. Activated peripheral blood mononuclear cells (PBMCs) from 16 nonallergic nonasthmatic (NA) and 16 intermittent allergic asthmatic (AA) subjects were incubated with PAH, and IL-17 and IL-22 productions were assessed. At baseline, activated PBMCs from AA exhibited an increased IL-17/IL-22 profile compared with NA subjects. Diesel exhaust particle (DEP)-PAH and Benzo[a]Pyrene (B[a]P) stimulation further increased IL-22 but decreased IL-17A production in both groups. The PAH-induced IL-22 levels in asthmatic patients were significantly higher than in healthy subjects. Among PBMCs, PAH-induced IL-22 expression originated principally from single IL-22-but not from IL-17-expressing CD4 T cells. The Th17 transcription factors RORA and RORC were down regulated, whereas AhR target gene CYP1A1 was upregulated. IL-22 induction by DEP-PAH was mainly dependent upon AhR whereas IL-22 induction by B[a] P was dependent upon activation of PI3K and JNK. Altogether, these data suggest that DEP-PAH and B[a]P may contribute to increased IL22 production in both healthy and asthmatic subjects through mechanisms involving both AhR-dependent and -independent pathways.	[Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] INSERM, U1019, F-59019 Lille, France; [Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] CNRS, UMR 8204, F-59000 Lille, France; [Ple, Coline; Fan, Ying; Yahia, Saliha Ait; Vorng, Han; Everaere, Laetitia; Chenivesse, Cecile; Balsamelli, Joanne; Azzaoui, Imane; de Nadai, Patricia; Wallaert, Benoit; Tsicopoulos, Anne] Univ Lille Nord France, F-59000 Lille, France; [Wallaert, Benoit; Tsicopoulos, Anne] Clin Malad Resp, F-59037 Lille, France; [Wallaert, Benoit; Tsicopoulos, Anne] Ctr Hosp, F-59037 Lille, France; [Wallaert, Benoit; Tsicopoulos, Anne] Univ Lille, F-59037 Lille, France; [Lazennec, Gwendal] CNRS SysDiag, UMR3145 Cap Delta, F-34184 Montpellier 4, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Tsicopoulos, A (corresponding author), INSERM, U1019, F-59019 Lille, France.	anne.tsicopoulos@pasteur-lille.fr	SALIHA, AIT YAHIA/B-8269-2018; Tsicopoulos, Anne/C-2260-2019	SALIHA, AIT YAHIA/0000-0003-1108-4222; Tsicopoulos, Anne/0000-0002-1579-2763; de NADAI, Patricia/0000-0001-6084-7447; Azzaoui, Imane/0000-0001-5603-6780; Lazennec, Gwendal/0000-0002-8522-1763	Agence Nationale de la Recherche (ANR CES); Region Nord Pas de Calais (IRENI); FEDER; Santelys	Agence Nationale de la Recherche (ANR CES)(French National Research Agency (ANR)); Region Nord Pas de Calais (IRENI)(Region Hauts-de-France); FEDER(European Commission); Santelys	This study was supported by research grants from Agence Nationale de la Recherche (ANR CES), Region Nord Pas de Calais (IRENI), FEDER and Santelys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Azzaoui I, 2011, BLOOD, V118, P3549, DOI 10.1182/blood-2011-02-338780; Bayram H, 2006, EUR RESPIR J, V27, P705, DOI 10.1183/09031936.06.00012805; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; Bossard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044787; Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741; Chang Y, 2012, FASEB J, V26, P5152, DOI 10.1096/fj.12-208033; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Chang Y, 2010, FASEB J, V24, P5063, DOI 10.1096/fj.10-162560; Chenivesse C, 2012, J IMMUNOL, V189, P128, DOI 10.4049/jimmunol.1003616; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fahy O, 2002, J IMMUNOL, V168, P5912, DOI 10.4049/jimmunol.168.11.5912; Farfariello V, 2011, PEDIAT ALLERG IMM-UK, V22, P419, DOI 10.1111/j.1399-3038.2010.01116.x; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Guyot E, 2013, DRUG DISCOV TODAY, V18, P479, DOI 10.1016/j.drudis.2012.11.014; Heo Y, 2001, TOXICOLOGY, V159, P143, DOI 10.1016/S0300-483X(00)00418-2; Hiyoshi K, 2005, CLIN EXP ALLERGY, V35, P1243, DOI 10.1111/j.1365-2222.2005.02297.x; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; IMADA M, 1995, INT IMMUNOL, V7, P229, DOI 10.1093/intimm/7.2.229; Johnson JR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-118; Kadkhoda K, 2005, TOXICOL LETT, V157, P31, DOI 10.1016/j.toxlet.2005.01.002; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Larsen M, 2011, EUR J IMMUNOL, V41, P2596, DOI 10.1002/eji.201041131; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li Y, 1998, J IMMUNOL, V161, P7007; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Senechal S, 2003, AM J RESP CRIT CARE, V168, P215, DOI 10.1164/rccm.200211-1289OC; Stacey MA, 2014, CELL HOST MICROBE, V15, P471, DOI 10.1016/j.chom.2014.03.003; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	52	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122372	10.1371/journal.pone.0122372	http://dx.doi.org/10.1371/journal.pone.0122372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860963	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300043
J	Park, J; Wicki, J; Knoblaugh, SE; Chamberlain, JS; Lee, D				Park, Joshua; Wicki, Jacqueline; Knoblaugh, Sue E.; Chamberlain, Jeffrey S.; Lee, Donghoon			Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy	PLOS ONE			English	Article							MDX MOUSE MODEL; SKELETAL-MUSCLE; MAGNETIZATION-TRANSFER; MICRODYSTROPHIN EXPRESSION; NEUROMUSCULAR DISORDERS; BIOPSY; DIFFUSION; RELAXATION; PHENOTYPE; DELIVERY	The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx(4cv) mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy.	[Park, Joshua; Lee, Donghoon] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Wicki, Jacqueline; Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Knoblaugh, Sue E.] Fred Hutchinson Canc Res Ctr, Comparat Med Shared Resources, Seattle, WA 98104 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lee, D (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.	dhoonlee@uw.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	National Institute Health (NIH) [R21EB008166]; NIH [R37AR040864, S10RR029021]; Provost office and Department of Radiology at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR065139, R37AR040864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008166] Funding Source: NIH RePORTER	National Institute Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Provost office and Department of Radiology at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institute Health (NIH) R21EB008166: http://www.nibib.nih.gov, NIH R37AR040864: http://www.niams.nih.gov, NIH S10RR029021 and Bridge funding from the Provost office and Department of Radiology at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, RADIOLOGY, V259, P127, DOI 10.1148/radiol.10091648; Athanasopoulos T, 2004, GENE THER, V11, pS109, DOI 10.1038/sj.gt.3302379; Banks GB, 2007, HUM MOL GENET, V16, P2105, DOI 10.1093/hmg/ddm158; Banks GB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000958; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe; COGGAN AR, 1995, J GERONTOL A-BIOL, V50, P30; COLE WC, 1993, MAGNET RESON MED, V29, P19, DOI 10.1002/mrm.1910290106; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Emery AEH, 2003, DUCHENNE MUSCULAR DY; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fabb SA, 2002, HUM MOL GENET, V11, P733, DOI 10.1093/hmg/11.7.733; Feng S, 2014, J MAGN RESON IMAGING, V40, P779, DOI 10.1002/jmri.24417; Filosto M, 2007, NEUROLOGY, V68, P181, DOI 10.1212/01.wnl.0000252252.29532.cc; Finanger EL, 2012, PHYS MED REH CLIN N, V23, P1, DOI 10.1016/j.pmr.2011.11.004; FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2; Gadian DG, 1995, NUCLEAR MAGNETIC RES; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HADAR H, 1983, AM J ROENTGENOL, V141, P895, DOI 10.2214/ajr.141.5.895; HAZLEWOOD CF, 1974, BIOPHYS J, V14, P583, DOI 10.1016/S0006-3495(74)85937-0; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kobayashi YM, 2012, NEUROMUSCULAR DISORD, V22, P34, DOI 10.1016/j.nmd.2011.08.001; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1987, J NEURORADIOLOGY, V14, P295; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; MATTILA KT, 1995, MAGN RESON MED, V33, P185, DOI 10.1002/mrm.1910330207; McDaniel JD, 1999, J COMPUT ASSIST TOMO, V23, P609, DOI 10.1097/00004728-199907000-00023; Mercuri E, 2005, CURR OPIN NEUROL, V18, P526, DOI 10.1097/01.wco.0000183947.01362.fe; Pacak CA, 2007, MOL THER, V15, P1775, DOI 10.1038/sj.mt.6300246; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; POSSE S, 1993, RADIOLOGY, V188, P719, DOI 10.1148/radiology.188.3.8351339; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Prayson RA, 2006, AM J CLIN PATHOL, V126, P843, DOI 10.1309/78B3MOTGJYT4RUUM; Qiao Y, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-73; Rall Susanne, 2012, Acta Myol, V31, P117; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Roth SM, 2000, EUR J APPL PHYSIOL, V83, P239, DOI 10.1007/s004210000287; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Salinero-Panigua E, 2004, REV NEUROLOGIA, V39, P821, DOI 10.33588/rn.3909.2003521; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Sinclair CDJ, 2010, MAGN RESON MED, V64, P1739, DOI 10.1002/mrm.22562; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; van Nierop BJ, 2010, J BIOMECH, V43, P570, DOI 10.1016/j.jbiomech.2009.07.043; Verhaert D, 2011, CIRC-CARDIOVASC IMAG, V4, P67, DOI 10.1161/CIRCIMAGING.110.960740; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Watchko J, 2002, HUM GENE THER, V13, P1451, DOI 10.1089/10430340260185085; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025	56	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124914	10.1371/journal.pone.0124914	http://dx.doi.org/10.1371/journal.pone.0124914			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856443	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500124
J	Rahman, F; Cotterchio, M; Cleary, SP; Gallinger, S				Rahman, Farah; Cotterchio, Michelle; Cleary, Sean P.; Gallinger, Steven			Association between Alcohol Consumption and Pancreatic Cancer Risk: A Case-Control Study	PLOS ONE			English	Article							COHORT-CONSORTIUM PANSCAN; POOLED-ANALYSIS; NETHERLANDS COHORT; CIGARETTE-SMOKING; DNA-ADDUCTS; TOBACCO; POLYMORPHISMS; EPIDEMIOLOGY; METAANALYSIS; HISTORY	Purpose Evidence is inconsistent regarding alcohol and pancreatic cancer risk, although heavy drinking may increase risk. Methods A population-based case-control study was conducted using 345 pancreas cancer cases diagnosed 2011-2012 and 1,285 frequency-matched controls from Ontario, Canada. Logistic regression was used to evaluate alcohol consumption and pancreatic cancer risk; data was also stratified by sex and smoking status to assess interaction. Results Alcohol consumption was not associated with pancreatic cancer risk (age-adjusted odds ratio=0.78, 95% CI: 0.58, 1.05 for 1 - 3 drinks/week; age-adjusted odds ratio=0.86, 95% CI: 0.63, 1.17 for 4 - 20 drinks/week), however there was a non-significant increased risk for heavy drinkers consuming >= 21 drinks/week (age-adjusted odds ratio=1.35, 95% CI: 0.81, 2.27). Cigarette smoking modified the alcohol-cancer relationship; among current smokers, heavy alcohol consumption was associated with a significantly increased pancreatic cancer risk (age-adjusted odds ratio=4.04, 95% CI: 1.58, 10.37), whereas this significant association with heavy drinking was not observed among non-smokers (age-adjusted odds ratio=2.01, 95% CI: 0.50, 8.18). Furthermore, light - moderate alcohol intake was associated with increased pancreas cancer risk among current smokers. Conclusions While alcohol was not significantly associated with pancreatic cancer risk, smoking status modified this relationship such that among current smokers, alcohol intake was associated with a greater than two-fold increased risk of pancreatic cancer. The results should be interpreted with caution due to small sample sizes within subgroups and correction for multiple comparisons should be considered. These findings should be replicated in larger studies where more precise estimates of risk can be obtained.	[Rahman, Farah; Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cotterchio, Michelle] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Cleary, Sean P.] Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Cleary, Sean P.] Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Toronto Gen Hosp, Div Gen Surg, Toronto, ON, Canada	University of Toronto; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Rahman, F (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	farah.rahman@mail.utoronto.ca	Gallinger, Steven/E-4575-2013	Cotterchio, Michelle/0000-0003-2862-7895; , Farah/0000-0002-0569-1467; Cleary, Sean/0000-0002-5274-9983	National Institutes of Health (as part of PACGENE consortium) [RO1 CA97075]; Canadian Institutes of Health Research [MOP-106631]; Dr. James Rossiter MPH Practicum Award; NATIONAL CANCER INSTITUTE [R01CA097075] Funding Source: NIH RePORTER	National Institutes of Health (as part of PACGENE consortium); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dr. James Rossiter MPH Practicum Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health (RO1 CA97075 to SG, as part of PACGENE consortium, http://www.nih.gov/), the Canadian Institutes of Health Research (MOP-106631 to MC, http://www.cihr-irsc.gc.ca/e/193.html), and the Dr. James Rossiter MPH Practicum Award (to FR, http://www.cihr-irsc.gc.ca/e/48447.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; Anderson MA, 2012, AM J GASTROENTEROL, V107, P1730, DOI 10.1038/ajg.2012.288; [Anonymous], 2013, CAN CANC STAT 2013; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Austin MA, 2013, CANCER EPIDEM BIOMAR, V22, P1913, DOI 10.1158/1055-9965.EPI-13-0518; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Bosetti C, 2012, ANN ONCOL, V23, P1880, DOI 10.1093/annonc/mdr541; Chowdhury P, 2006, WORLD J GASTROENTERO, V12, P7421, DOI 10.3748/wjg.v12.i46.7421; Chu D, 2010, J PANCREAS, V11, P203; Cotterchio M, 2014, CANCER EPIDEM BIOMAR, V23, P469, DOI 10.1158/1055-9965.EPI-13-0965; Duell EJ, 2012, MOL CARCINOGEN, V51, P40, DOI 10.1002/mc.20786; EKBOM A, 1994, J NATL CANCER I, V86, P625, DOI 10.1093/jnci/86.8.625; Genkinger JM, 2011, INT J CANCER, V129, P1708, DOI 10.1002/ijc.25794; Genkinger JM, 2009, CANCER EPIDEM BIOMAR, V18, P765, DOI 10.1158/1055-9965.EPI-08-0880; Gupta S, 2010, CANCER CAUSE CONTROL, V21, P1047, DOI 10.1007/s10552-010-9533-6; Heinen MM, 2010, CANCER EPIDEM BIOMAR, V19, P1612, DOI 10.1158/1055-9965.EPI-10-0121; Heinen MM, 2009, AM J EPIDEMIOL, V169, P1233, DOI 10.1093/aje/kwp028; Herreros-Villanueva M, 2013, WORLD J GASTROENTERO, V19, P638, DOI 10.3748/wjg.v19.i5.638; Jiao L, 2009, AM J EPIDEMIOL, V169, P1043, DOI 10.1093/aje/kwp034; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Li DH, 2006, CARCINOGENESIS, V27, P103, DOI 10.1093/carcin/bgi171; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li DH, 2002, MUTAT RES-GEN TOX EN, V513, P37, DOI 10.1016/S1383-5718(01)00291-1; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Lucenteforte E, 2012, ANN ONCOL, V23, P374, DOI 10.1093/annonc/mdr120; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Meskar A, 2001, PATHOL BIOL, V49, P696, DOI 10.1016/S0369-8114(01)00235-8; Michaud DS, 2010, CANCER CAUSE CONTROL, V21, P1213, DOI 10.1007/s10552-010-9548-z; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Rohrmann S, 2009, CANCER CAUSE CONTROL, V20, P785, DOI 10.1007/s10552-008-9293-8; Shin EJ, 2012, GASTROENTEROL CLIN N, V41, P143, DOI 10.1016/j.gtc.2011.12.001; Tramacere I, 2010, INT J CANCER, V126, P1474, DOI 10.1002/ijc.24936; Villeneuve PJ, 2000, EUR J CANCER PREV, V9, P49, DOI 10.1097/00008469-200002000-00007; Vrieling A, 2010, INT J CANCER, V126, P2394, DOI 10.1002/ijc.24907; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wang MY, 1998, CANCER RES, V58, P38; Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zavoral M, 2011, WORLD J GASTROENTERO, V17, P2897, DOI 10.3748/wjg.v17.i24.2897; Zheng W, 1993, CANCER CAUSE CONTROL, V4, P477	45	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124489	10.1371/journal.pone.0124489	http://dx.doi.org/10.1371/journal.pone.0124489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856529	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500116
J	Woolcott, OO; Richey, JM; Kabir, M; Chow, RH; Iyer, MS; Kirkman, EL; Stefanovski, D; Lottati, M; Kim, SP; Harrison, LN; Ionut, V; Zheng, D; Hsu, IR; Catalano, KJ; Chiu, JD; Bradshaw, H; Wu, Q; Bergman, RN				Woolcott, Orison O.; Richey, Joyce M.; Kabir, Morvarid; Chow, Robert H.; Iyer, Malini S.; Kirkman, Erlinda L.; Stefanovski, Darko; Lottati, Maya; Kim, Stella P.; Harrison, L. Nicole; Ionut, Viorica; Zheng, Dan; Hsu, Isabel R.; Catalano, Karyn J.; Chiu, Jenny D.; Bradshaw, Heather; Wu, Qiang; Bergman, Richard N.			High-Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets	PLOS ONE			English	Article							PERIPHERAL CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; BETA-CELL; PANCREATIC-ISLETS; VANILLOID RECEPTORS; ADIPOSE-TISSUE; MOUSE ISLETS; FULL AGONIST; RAT-BRAIN; SECRETION	Background Obesity has been associated with elevated plasma anandamide levels. In addition, anandamide has been shown to stimulate insulin secretion in vitro, suggesting that anandamide might be linked to hyperinsulinemia. Objective To determine whether high-fat diet-induced insulin resistance increases anandamide levels and potentiates the insulinotropic effect of anandamide in isolated pancreatic islets. Design and Methods Dogs were fed a high-fat diet (n = 9) for 22 weeks. Abdominal fat depot was quantified by MRI. Insulin sensitivity was assessed by the euglycemic-hyperinsulinemic clamp. Fasting plasma endocannabinoid levels were analyzed by liquid chromatography-mass spectrometry. All metabolic assessments were performed before and after fat diet regimen. At the end of the study, pancreatic islets were isolated prior to euthanasia to test the in vitro effect of anandamide on islet hormones. mRNA expression of cannabinoid receptors was determined in intact islets. The findings in vitro were compared with those from animals fed a control diet (n = 7). Results Prolonged fat feeding increased abdominal fat content by 81.3 +/- 21.6% (mean +/- S.E.M, P<0.01). In vivo insulin sensitivity decreased by 31.3 +/- 12.1% (P<0.05), concomitant with a decrease in plasma 2-arachidonoyl glycerol (from 39.1 +/- 5.2 to 15.7 +/- 2.0 nmol/L) but not anandamide, oleoyl ethanolamide, linoleoyl ethanolamide, or palmitoyl ethanolamide. In control-diet animals (body weight: 28.8 +/- 1.0 kg), islets incubated with anandamide had a higher basal and glucose-stimulated insulin secretion as compared with no treatment. Islets from fat-fed animals (34.5 +/- 1.3 kg; P<0.05 versus control) did not exhibit further potentiation of anandamide-induced insulin secretion as compared with control-diet animals. Glucagon but not somatostatin secretion in vitro was also increased in response to anandamide, but there was no difference between groups (P = 0.705). No differences in gene expression of CB1R or CB2R between groups were found. Conclusions In canines, high-fat diet-induced insulin resistance does not alter plasma anandamide levels or further potentiate the insulinotropic effect of anandamide in vitro.	[Woolcott, Orison O.; Kabir, Morvarid; Iyer, Malini S.; Stefanovski, Darko; Kim, Stella P.; Ionut, Viorica; Wu, Qiang; Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Richey, Joyce M.; Chow, Robert H.; Lottati, Maya; Harrison, L. Nicole; Zheng, Dan; Hsu, Isabel R.; Catalano, Karyn J.; Chiu, Jenny D.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Kirkman, Erlinda L.] Univ So Calif, Dept Anim Resources, Los Angeles, CA 90033 USA; [Bradshaw, Heather] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Cedars Sinai Medical Center; University of Southern California; University of Southern California; Indiana University System; Indiana University Bloomington	Woolcott, OO (corresponding author), Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA.	Orison.Woolcott@cshs.org	Woolcott, Orison O./AAQ-3440-2020; Kolka, Cathryn/B-1526-2015; Kabir, Morvarid/P-8154-2018	Woolcott, Orison O./0000-0003-2905-972X; Kolka, Cathryn/0000-0002-6636-7062; Iyer, Malini S./0000-0001-7776-7216; Bergman, Richard/0000-0003-1539-4471; Kabir, Morvarid/0000-0003-0880-3767	Sanofiaventis; National Institutes of Health [DK29867, DK27619, DK60623, GM85791]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027619, R01DK060623, R01DK027619, R01DK029867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085791] Funding Source: NIH RePORTER	Sanofiaventis(Sanofi-Aventis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Sanofiaventis (to RNB) and the National Institutes of Health (Grants DK29867 and DK27619 to RNB; and DK60623 and GM85791 to RHC). The funders, including the NIH, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; Ader M, 2005, DIABETES, V54, P862, DOI 10.2337/diabetes.54.3.862; Ader M, 2014, DIABETES, V63, P1914, DOI 10.2337/db13-1215; Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; AMMON HPT, 1991, J ENDOCRINOL, V128, P27, DOI 10.1677/joe.0.1280027; Anderson RL, 2013, EUR J PHARMACOL, V706, P56, DOI 10.1016/j.ejphar.2013.02.034; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Correa F, 2009, BIOCHEM PHARMACOL, V77, P86, DOI 10.1016/j.bcp.2008.09.014; De Petrocellis L, 2009, CELL CALCIUM, V45, P611, DOI 10.1016/j.ceca.2009.03.003; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli S, 2014, OBESITY, V22, pE70, DOI 10.1002/oby.20728; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Ginsberg HN, 2009, OBESITY, V17, P1821, DOI 10.1038/oby.2009.107; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Hamilton LC., 2008, STAT STATA UPDATED V, P387; HAYEK A, 1979, DIABETES, V28, P565, DOI 10.2337/diabetes.28.6.565; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1581, DOI 10.1152/ajpendo.00351.2006; Kim SP, 2012, AM J PHYSIOL-ENDOC M, V302, pE1261, DOI 10.1152/ajpendo.00496.2011; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Li C, 2011, DIABETES OBES METAB, V13, P903, DOI 10.1111/j.1463-1326.2011.01422.x; Li C, 2010, ISLETS, V2, P293, DOI 10.4161/isl.2.5.12729; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Malenczyk K, 2013, J BIOL CHEM, V288, P32685, DOI 10.1074/jbc.M113.478354; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matsumoto I, 2004, TRANSPLANTATION, V78, P880, DOI 10.1097/01.TP.0000134396.03440.1E; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Reggio PH, 2010, CURR MED CHEM, V17, P1468, DOI 10.2174/092986710790980005; Richey JM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1311, DOI 10.1152/ajpendo.90972.2008; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Roberts LA, 2002, BRIT J PHARMACOL, V137, P421, DOI 10.1038/sj.bjp.0704904; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Shen MX, 1996, J NEUROSCI, V16, P4322; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Song S, 2012, DIABETOLOGIA, V55, pS163; Song ZH, 1999, MOL PHARMACOL, V56, P834; STAGNER JI, 1988, DIABETES, V37, P1715, DOI 10.2337/diabetes.37.12.1715; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Tharp WG, 2008, BIOCHEM BIOPH RES CO, V372, P595, DOI 10.1016/j.bbrc.2008.05.077; Troy-Fioramonti S, 2015, DIABETES, V64, P808, DOI 10.2337/db14-0721; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Valk P, 1997, BLOOD, V90, P1448, DOI 10.1182/blood.V90.4.1448.1448_1448_1457; Vilches-Flores A, 2013, CLIN SCI, V124, P467, DOI 10.1042/CS20120447; Vilches-Flores A, 2010, REGUL PEPTIDES, V163, P81, DOI 10.1016/j.regpep.2010.04.013; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Woolcott OO, 2012, PANCREAS, V41, P31, DOI 10.1097/MPA.0b013e318221fd0e; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708; ZIELMANN S, 1985, N-S ARCH PHARMACOL, V329, P299, DOI 10.1007/BF00501884	71	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123558	10.1371/journal.pone.0123558	http://dx.doi.org/10.1371/journal.pone.0123558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855974	Green Published, gold			2022-12-26	WOS:000352588500097
J	Yuan, JP; Wang, LW; Qu, AP; Chen, JM; Xiang, QM; Chen, C; Sun, SR; Pang, DW; Liu, J; Li, Y				Yuan, Jing Ping; Wang, Lin Wei; Qu, Ai Ping; Chen, Jia Mei; Xiang, Qing Ming; Chen, Chuang; Sun, Sheng-Rong; Pang, Dai-Wen; Liu, Juan; Li, Yan			Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer	PLOS ONE			English	Article							KI-67 LABELING INDEX; MOLECULAR CLASSIFICATION; PROGNOSTIC VALUE; PROLIFERATION INDEX; INTERNATIONAL KI67; ANTIBODY; REPRODUCIBILITY; RECOMMENDATIONS; QUANTIFICATION; EXPRESSION	Background As a marker for tumor cell proliferation, Ki67 has important impacts on breast cancer (BC) prognosis. Although immunohistochemical staining is the current standard method, variations in analytical practice make it difficult for pathologists to manually measure Ki67 index. This study was to develop a fluorescent spectrum-based quantitative analysis of Ki67 expression by quantum-dots (QDs) multiple imaging technique. Methods A QDs-based in situ multiple fluorescent imaging method was developed, which stained nuclear Ki67 as red signal and cytoplasmic cytokeratin (CK) as green signal. Both Ki67 and CK signals were automatically separated and quantified by professional spectrum analysis software. This technique was applied to tissue microarrays from 240 BC patients. Both Ki67 and CK values, and Ki67/CK ratio were obtained for each patient, and their prognostic value on 5-year disease free survival was assessed. Results This method simultaneously stains nuclear Ki67 and cytoplasmic CK with clear signal contrast, making it easy for signal separation and quantification. The total fluorescent signal intensities of both Ki67 sum and CK sum were obtained, and Ki67/CK ratio calculated. Ki67 sum and Ki67/CK ratio were each attributed into two grades by X-tile software based on the best P value principle. Multivariate analysis showed Ki67 grade (P = 0.047) and Ki67/CK grade (P = 0.004) were independent prognostic factors. Furthermore, area under curve (AUC) of ROC analysis for Ki67/CK grade (AUC: 0.683, 95%CI: 0.613-0.752) was higher than Ki67 grade (AUC: 0.665, 95%CI: 0.596-0.734) and HER-2 gene (AUC: 0.586, 95%CI: 0.510-0.661), but lower than N stage (AUC: 0.760, 95%CI: 0.696-0.823) and histological grade (AUC: 0.756, 95%CI: 0.692-0.820) on predicting the risk for recurrence. Conclusions A QDs-based quantitative and in situ multiple imaging on Ki67 and CK was developed to improve Ki67 assessment in BC, and Ki67/CK grade had better performance than Ki67 grade in predicting prognosis.	[Yuan, Jing Ping; Wang, Lin Wei; Chen, Jia Mei; Xiang, Qing Ming; Li, Yan] Wuhan Univ, Zhongnan Hosp, Dept Oncol, Hubei Key Lab Tumor Biol Behav, Wuhan 430072, Hubei, Peoples R China; [Yuan, Jing Ping; Wang, Lin Wei; Chen, Jia Mei; Xiang, Qing Ming; Li, Yan] Hubei Canc Clin Study Ctr, Wuhan, Hubei, Peoples R China; [Qu, Ai Ping; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Hubei, Peoples R China; [Chen, Chuang; Sun, Sheng-Rong] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan 430072, Hubei, Peoples R China; [Pang, Dai-Wen] Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Coll Chem & Mol Sci,State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Pang, Dai-Wen] Wuhan Univ, Wuhan Inst Biotechnol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University	Li, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Oncol, Hubei Key Lab Tumor Biol Behav, Wuhan 430072, Hubei, Peoples R China.	liyansd2@163.com			Key Project of the National Natural Science Foundation of China [81230031/H18]; National Science Foundation of China [81201196/H18]; Program for New Century Excellent Talents in Universities [NCET-10-0644]; Key Project of the Fundamental Research Fund for the Central Universities [303274028]; Natural Science Funds of Hubei Province [2014CFB397]	Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Key Project of the Fundamental Research Fund for the Central Universities; Natural Science Funds of Hubei Province	This work is supported by Key Project of the National Natural Science Foundation of China (81230031/H18), the National Science Foundation of China (81201196/H18), Program for New Century Excellent Talents in Universities (NCET-10-0644), the Key Project of the Fundamental Research Fund for the Central Universities (303274028), the Natural Science Funds of Hubei Province (2014CFB397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chen C, 2012, NANOMEDICINE-UK, V7, P411, DOI [10.2217/NNM.12.9, 10.2217/nnm.12.9]; Chen C, 2011, BIOMATERIALS, V32, P7592, DOI 10.1016/j.biomaterials.2011.06.029; Chen C, 2010, BIOMATERIALS, V31, P8818, DOI 10.1016/j.biomaterials.2010.07.091; Cummings MC, 2011, PATHOLOGY, V43, P1, DOI 10.1097/PAT.0b013e328341e0b5; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Engels CC, 2013, BREAST CANCER RES TR, V142, P323, DOI 10.1007/s10549-013-2748-y; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Ferguson NL, 2013, BREAST J, V19, P22, DOI 10.1111/tbj.12059; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Geyer FC, 2012, ADV ANAT PATHOL, V19, P39, DOI 10.1097/PAP.0b013e31823fafa0; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Guiu S, 2012, ANN ONCOL, V23, P2997, DOI 10.1093/annonc/mds586; Hama Y, 2007, BREAST CANCER RES TR, V103, P23, DOI 10.1007/s10549-006-9347-0; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hu WQ, 2014, BIOMATERIALS, V35, P4125, DOI 10.1016/j.biomaterials.2014.01.059; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; LOPEZ F, 1991, CYTOMETRY, V12, P42, DOI 10.1002/cyto.990120107; Luo Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-24; Peng CW, 2011, BIOMATERIALS, V32, P2907, DOI 10.1016/j.biomaterials.2010.12.053; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Reyal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055901; Romero Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-118; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sun JZ, 2014, INT J NANOMED, V9, P1339, DOI 10.2147/IJN.S58881; Tambasco M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-140; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Tawfik O, 2007, VIRCHOWS ARCH, V450, P627, DOI 10.1007/s00428-007-0400-0; van de Vijver M., 2012, WHO CLASSIFICATION T; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Voros A, 2013, PATHOBIOLOGY, V80, P111, DOI 10.1159/000343795; Voros A, 2013, PATHOL ONCOL RES; Wang LW, 2014, ASIAN PAC J CANCER P, V15, P1621, DOI 10.7314/APJCP.2014.15.4.1621; Wang LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082314; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yang XQ, 2011, ASIAN PAC J CANCER P, V12, P3101; Yerushalmi Rinat, 2010, Lancet Oncol, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zabaglo L, 2010, J CLIN PATHOL, V63, P800, DOI 10.1136/jcp.2010.077578; Zhang H, 2009, BREAST CANCER RES TR, V114, P277, DOI 10.1007/s10549-008-0014-5	47	55	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122734	10.1371/journal.pone.0122734	http://dx.doi.org/10.1371/journal.pone.0122734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856425	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500053
J	Prickaerts, P; Niessen, HEC; Dahlmans, VEH; Spaapen, F; Salvaing, J; Vanhove, J; Geijselaers, C; Bartels, SJJ; Partouns, I; Neumann, D; Speel, EJ; Takihara, Y; Wouters, BG; Voncken, JW				Prickaerts, Peggy; Niessen, Hanneke E. C.; Dahlmans, Vivian E. H.; Spaapen, Frank; Salvaing, Juliette; Vanhove, Jolien; Geijselaers, Claudia; Bartels, Stefanie J. J.; Partouns, Iris; Neumann, Dietbert; Speel, Ernst-Jan; Takihara, Yoshihiro; Wouters, Bradly G.; Voncken, Jan Willem			MK3 Modulation Affects BMI1-Dependent and Independent Cell Cycle Check-Points	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAMMARY EPITHELIAL-CELLS; CHROMATIN-ASSOCIATION; INDUCED SENESCENCE; NEGATIVE FEEDBACK; INK4A/ARF LOCUS; INK4A-ARF LOCUS; MAPKAP KINASES; POLYCOMB; CANCER	Although the MK3 gene was originally found deleted in some cancers, it is highly expressed in others. The relevance of MK3 for oncogenesis is currently not clear. We recently reported that MK3 controls ERK activity via a negative feedback mechanism. This prompted us to investigate a potential role for MK3 in cell proliferation. We here show that overexpression of MK3 induces a proliferative arrest in normal diploid human fibroblasts, characterized by enhanced expression of replication stress- and senescence-associated markers. Surprisingly, MK3 depletion evokes similar senescence characteristics in the fibroblast model. We previously identified MK3 as a binding partner of Polycomb Repressive Complex 1 (PRC1) proteins. In the current study we show that MK3 overexpression results in reduced cellular EZH2 levels and concomitant loss of epigenetic H3K27me3-marking and PRC1/chromatin-occupation at the CDKN2A/INK4A locus. In agreement with this, the PRC1 oncoprotein BMI1, but not the PCR2 protein EZH2, bypasses MK3-induced senescence in fibroblasts and suppresses P16INK4A expression. In contrast, BMI1 does not rescue the MK3 loss-of-function phenotype, suggesting the involvement of multiple different checkpoints in gain and loss of MK3 function. Notably, MK3 ablation enhances proliferation in two different cancer cells. Finally, the fibroblast model was used to evaluate the effect of potential tumorigenic MK3 driver-mutations on cell proliferation and M/SAPK signaling imbalance. Taken together, our findings support a role for MK3 in control of proliferation and replicative life-span, in part through concerted action with BMI1, and suggest that the effect of MK3 modulation or mutation on M/SAPK signaling and, ultimately, proliferation, is cell context-dependent.	[Prickaerts, Peggy; Dahlmans, Vivian E. H.; Spaapen, Frank; Salvaing, Juliette; Vanhove, Jolien; Geijselaers, Claudia; Bartels, Stefanie J. J.; Partouns, Iris; Neumann, Dietbert; Voncken, Jan Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Speel, Ernst-Jan] Maastricht Univ, Med Ctr, Dept Pathol, NL-6200 MD Maastricht, Netherlands; [Takihara, Yoshihiro] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Stem Cell Biol, Hiroshima, Japan; [Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Wouters, Bradly G.] Univ Hlth Network, Campbell Family Inst Canc Res, Dept Radiat Oncol, Toronto, ON, Canada; [Wouters, Bradly G.] Univ Hlth Network, Campbell Family Inst Canc Res, Dept Med Biophys, Toronto, ON, Canada; [Wouters, Bradly G.] Maastricht Univ, Maastricht Radiat Oncol MaastRO Lab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Hiroshima University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Maastricht University	Voncken, JW (corresponding author), Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	w.voncken@maastrichtuniversity.nl	Niessen, Hanneke/B-7699-2009; Wouters, Bradly/T-1525-2017	Niessen, Hanneke/0000-0002-2639-0938; Wouters, Bradly/0000-0002-8187-592X; Neumann, Dietbert/0000-0002-4316-684X	Netherlands organization for Scientific Research (ZonMW-NWO) [908-02-040, 016.046.362, 864.10.007]; transnational University Limburg grant; Netherlands Genome Initiative (NGI) [050-72-422]; EMBO	Netherlands organization for Scientific Research (ZonMW-NWO)(Netherlands Organization for Scientific Research (NWO)); transnational University Limburg grant; Netherlands Genome Initiative (NGI); EMBO(European Molecular Biology Organization (EMBO))	Netherlands organization for Scientific Research (ZonMW-NWO): Research Support grant 908-02-040 (JWV), VIDI grant 016.046.362 (JWV); transnational University Limburg grant (JWV, BGW); Netherlands Genome Initiative (NGI) fellowship 050-72-422 (HN) and EMBO fellowship (HN). Netherlands Organization for Scientific Research (ZonMW-NWO): VIDI grant 864.10.007 (DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRULAND OS, 1988, CANCER RES, V48, P5302; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Debacq-Chainiaux F, 2010, ADV EXP MED BIOL, V694, P126; Di Micco R, 2007, TRENDS CELL BIOL, V17, P529, DOI 10.1016/j.tcb.2007.07.012; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Huysentruyt CJR, 2011, HISTOPATHOLOGY, V58, P1048, DOI 10.1111/j.1365-2559.2011.03859.x; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Kia SK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-16; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Maruyama J, 2009, CURR MED CHEM, V16, P1229, DOI 10.2174/092986709787846613; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MUNGER K, 1992, CANCER SURV, V12, P197; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Prickaerts P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-12; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; REYNOLDS PA, 2006, J BIOL CHEM; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schwermann J, 2009, EMBO J; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sithanandam G, 1996, MOL CELL BIOL, V16, P868; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Sng JCG, 2004, BIOL PHARM BULL, V27, P606, DOI 10.1248/bpb.27.606; So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; SPEEL EJM, 1992, J HISTOCHEM CYTOCHEM, V40, P1299, DOI 10.1177/40.9.1506667; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tang X, 2004, ONCOGENE; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; VIRE E, 2005, NATURE; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005	80	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0118840	10.1371/journal.pone.0118840	http://dx.doi.org/10.1371/journal.pone.0118840			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853770	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400002
J	He, K; Zheng, X; Li, M; Zhang, L; Yu, J				He, K.; Zheng, X.; Li, M.; Zhang, L.; Yu, J.			mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation	ONCOGENE			English	Article							NF-KAPPA-B; TRANSLATION INITIATION; COLORECTAL-CANCER; MAMMALIAN TARGET; MULTIPLE-MYELOMA; KINASE INHIBITOR; PHASE-II; PUMA; PATHWAY; STRESS	The mammalian target of rapamycin (mTOR) is commonly activated in colon cancer. mTOR complex 1 (mTORC1) is a major downstream target of the PI3K/ATK pathway and activates protein synthesis by phosphorylating key regulators of messenger RNA translation and ribosome synthesis. Rapamycin analogs Everolimus and Temsirolimus are non-ATP-competitive mTORC1 inhibitors, and suppress proliferation and tumor angiogenesis and invasion. We now show that apoptosis plays a key role in their anti-tumor activities in colon cancer cells and xenografts through the DR5, FADD and caspase-8 axis, and is strongly enhanced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and 5-fluorouracil. The induction of DR5 by rapalogs is mediated by the ER stress regulator and transcription factor CHOP, but not the tumor suppressor p53, on rapid and sustained inhibition of 4E-BP1 phosphorylation, and attenuated by eIF4E expression. ATP-competitive mTOR/PI3K inhibitors also promote DR5 induction and FADD-dependent apoptosis in colon cancer cells. These results establish activation of ER stress and the death receptor pathway as a novel anticancer mechanism of mTOR inhibitors.	[He, K.; Zheng, X.; Li, M.; Yu, J.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [He, K.; Zheng, X.; Li, M.; Zhang, L.; Yu, J.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Zhang, L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Hillman Canc Ctr Res Pavil,Suite 2-26h,5117 Ctr A, Pittsburgh, PA 15213 USA.	yuj2@upmc.edu	Zhang, Lin/A-7389-2009; Yu, Jian/A-8301-2009	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000	NIH [CA129829, CA106348, CA172136]; American Cancer Society [RGS-10-124-01-CCE];  [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA172136, R01CA129829, R01CA106348, R01CA121105, P30CA047904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bert Vogelstein (Howard Hughes Medical Institute, Johns Hopkins University) for p53-KO HCT116, Richard J. Youle (NIH) for BAX/BAK-DKO HCT116 cells, Shi-Yong Sun (Emory University) for FADD-DN construct and Nahum Sonenberg (McGill University) for eIF4E construct. This work is supported by NIH grant CA129829, American Cancer Society grant RGS-10-124-01-CCE (YJ) and NIH grants CA106348, CA172136 (ZL). This project used the UPCI shared facilities including flow cytometry, animal and histopathology and were supported in part by award P30CA047904.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Descamps G, 2012, BRIT J CANCER, V106, P1660, DOI 10.1038/bjc.2012.139; Ducker GS, 2014, ONCOGENE, V33, P1590, DOI 10.1038/onc.2013.92; Dudgeon C, 2012, ONCOGENE, V31, P4848, DOI 10.1038/onc.2011.644; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; Fan SQ, 2010, NEOPLASIA, V12, P346, DOI 10.1593/neo.10144; Fournier MJ, 2013, MOL CELL BIOL, V33, P2285, DOI 10.1128/MCB.01517-12; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; HALL PA, 1994, J CELL SCI, V107, P3569; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasty P, 2014, CANCER PREV RES, V7, P169, DOI 10.1158/1940-6207.CAPR-13-0299; He K, 2013, MOL CANCER THER, V12, P2559, DOI 10.1158/1535-7163.MCT-13-0284; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kim DD, 2012, EXPERT OPIN INV DRUG, V21, P1775, DOI 10.1517/13543784.2012.721353; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043158; Sun Q, 2007, MOL CANCER THER, V6, P3180, DOI 10.1158/1535-7163.MCT-07-0265; Sun QH, 2011, CLIN CANCER RES, V17, P2361, DOI 10.1158/1078-0432.CCR-10-2262; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yellen P, 2013, CANCER LETT, V333, P239, DOI 10.1016/j.canlet.2013.01.041; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang L, 2013, CURR COLORECT CANC R, V9, P331, DOI 10.1007/s11888-013-0188-z; Zhang YJ, 2009, ANN SURG ONCOL, V16, P2617, DOI 10.1245/s10434-009-0555-9; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zheng XN, 2013, MOL CANCER THER, V12, P777, DOI 10.1158/1535-7163.MCT-12-1146	53	61	67	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					148	157		10.1038/onc.2015.79	http://dx.doi.org/10.1038/onc.2015.79			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25867072	Green Accepted			2022-12-26	WOS:000368193900002
J	O'Callaghan, P; Li, JP; Lannfelt, L; Lindahl, U; Zhang, X				O'Callaghan, Paul; Li, Jin-Ping; Lannfelt, Lars; Lindahl, Ulf; Zhang, Xiao			Microglial Heparan Sulfate Proteoglycans Facilitate the Cluster-of-Differentiation 14 (CD14)/Toll-like Receptor 4 (TLR4)-Dependent Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CD14; LIPOPOLYSACCHARIDE; ASTROCYTES; EXPRESSION; ACTIVATION; BETA; LPS; GLYCOSAMINOGLYCAN; INDUCTION	Microglia rapidly mount an inflammatory response to pathogens in the central nervous system (CNS). Heparan sulfate proteoglycans (HSPGs) have been attributed various roles in inflammation. To elucidate the relevance of microglial HSPGs in a pro-inflammatory response we isolated microglia from mice over-expressing heparanase (Hpa-tg), the HS-degrading endoglucuronidase, and challenged them with lipopolysaccharide (LPS), a bacterial endotoxin. Prior to LPS-stimulation, the LPS-receptor cluster-of-differentiation 14 (CD14) and Toll-like receptor 4 (TLR4; essential for the LPS response) were similarly expressed in Ctrl and Hpa-tg microglia. However, compared with Ctrl microglia, Hpa-tg cells released significantly less tumor necrosis factor-alpha (TNF alpha), essentially failed to up-regulate interleukin-1 beta (IL1 beta) and did not initiate synthesis of proCD14. Isolated primary astroyctes expressed TLR4, but notably lacked CD14 and in contrast to microglia, LPS challenge induced a similar TNF alpha response in Ctrl and Hpa-tg astrocytes, while neither released IL1 beta. The astrocyte TNF alpha-induction was thus attributed to CD14-independent TLR4 activation and was unaffected by the cells HS status. Equally, the suppressed LPS-response in Hpa-tg microglia indicated a loss of CD14-dependent TLR4 activation, suggesting that microglial HSPGs facilitate this process. Indeed, confocal microscopy confirmed interactions between microglial HS and CD14 in LPS-stimulated microglia and a potential HS-binding motif in CD14 was identified. We conclude that microglial HSPGs facilitate CD14-dependent TLR4 activation and that heparanase can modulate this mechanism.	[O'Callaghan, Paul] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, S-75123 Uppsala, Sweden; [O'Callaghan, Paul; Li, Jin-Ping; Lindahl, Ulf] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Sci Life Lab, S-75123 Uppsala, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Neurosci, Biomed Ctr, S-75123 Uppsala, Sweden; [Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab C11, Mol Geriatr, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	O'Callaghan, P (corresponding author), Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Husargatan 3, S-75123 Uppsala, Sweden.	paul.ocallaghan@mcb.uu.se; xiao.zhang@neuro.uu.se	O'Callaghan, Paul/T-5308-2018	O'Callaghan, Paul/0000-0003-3117-5367	Swedish Research Council [2003-5546]; Vetenskapradet grant [K2012-67X-21128-04-4]; Landstinget i Uppsala lan; Polysackaridforskning AB Uppsala; Alzheimerfonden; Demensforbundet; Stohnes Stiftelse; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vetenskapradet grant; Landstinget i Uppsala lan; Polysackaridforskning AB Uppsala; Alzheimerfonden; Demensforbundet; Stohnes Stiftelse; Swedish Brain Foundation	This work was supported by The Swedish Research Council Grant number 2003-5546, Vetenskapradet grant number K2012-67X-21128-04-4, Landstinget i Uppsala lan, Polysackaridforskning AB Uppsala, Alzheimerfonden, Demensforbundet, Stohnes Stiftelse, and The Swedish Brain Foundation.	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; BAZIL V, 1989, MOL IMMUNOL, V26, P657, DOI 10.1016/0161-5890(89)90048-5; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Cauwels A, 1999, J IMMUNOL, V162, P4762; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; Deininger MH, 2003, ACTA NEUROPATHOL, V106, P271, DOI 10.1007/s00401-003-0727-9; Doviner V, 2006, MODERN PATHOL, V19, P878, DOI 10.1038/modpathol.3800603; El Khoury J, 2010, NAT MED, V16, P1369, DOI 10.1038/nm1210-1369; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Hailey KL, 2009, J BIOL CHEM, V284, P26137, DOI 10.1074/jbc.M109.027375; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirshoren N, 2014, J CELL MOL MED, V18, P181, DOI 10.1111/jcmm.12179; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; LEE SC, 1993, J IMMUNOL, V150, P2659; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Low PC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4450; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Ryu Keun-Young, 2012, Exp Neurobiol, V21, P151, DOI 10.5607/en.2012.21.4.151; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang X, 2012, ACTA NEUROPATHOL, V124, P465, DOI 10.1007/s00401-012-0997-1	55	35	36	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14904	14914		10.1074/jbc.M114.634337	http://dx.doi.org/10.1074/jbc.M114.634337			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25869127	hybrid, Green Published			2022-12-26	WOS:000356177300010
J	Ratsitorahina, M; Rahelinirina, S; Michault, A; Rajerison, M; Rajatonirina, S; Richard, V				Ratsitorahina, Maherisoa; Rahelinirina, Soanandrasana; Michault, Alain; Rajerison, Minoarisoa; Rajatonirina, Soatiana; Richard, Vincent		2011 Surveillance Workshop Grp	Has Madagascar Lost Its Exceptional Leptospirosis Free-Like Status?	PLOS ONE			English	Article							INDIAN-OCEAN; HUMANS; UNION	Background Leptospirosis is a widespread but underreported cause of morbidity and mortality. It has rarely been reported in either humans or animals in Madagascar. Methods We conducted a cross-sectional survey of the inhabitants in Moramanga, Madagascar, in June 2011, to estimate the prevalence of human infection using the microscopic agglutination test (MAT). This activity was carried out as part of a workshop implemented by the Pasteur Institute of Madagascar, focusing on surveillance with a one week field study and targeting the health staff of the district level. Results In total, we sampled 678 inhabitants from 263 households. The sex ratio (M/F) was 0.65 and the mean age 26.7 years. We obtained a value of 2.9% for the first recorded seroprevalence of this disease in the human community of Moramanga. Questionnaire responses revealed frequent contacts between humans and rodents in Moramanga. However, activities involving cattle were identified as a risk factor significantly associated with seropositivity (OR=3). Conclusion Leptospirosis remains a neglected disease in Madagascar. This study highlights the need to quantify the public health impact of this neglected disease in a more large scale, in all the country and to establish point-of-care laboratories in remote areas.	[Ratsitorahina, Maherisoa; Rajatonirina, Soatiana; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Rahelinirina, Soanandrasana; Rajerison, Minoarisoa] Inst Pasteur Madagascar, Plague Unit, Antananarivo, Madagascar; [Michault, Alain] Ctr Hosp Univ CHU Sud, Biol Unit, St Pierre, Reunion, France; [Michault, Alain] Ctr Hosp Univ CHU Sud, Virol Unit, St Pierre, Reunion, France; [Michault, Alain] Ctr Hosp Univ CHU Sud, Parasitol Unit, St Pierre, Reunion, France; [Richard, Vincent] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; CHU Reunion; CHU Reunion; CHU Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Richard, V (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, BP 1274, Antananarivo, Madagascar.	vrichard@pasteur.sn		Vincent, RICHARD/0000-0002-6961-1753	Pasteur Institute of Madagascar	Pasteur Institute of Madagascar	This network was supported by the Pasteur Institute of Madagascar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BRYGOO E R, 1956, Bull Soc Pathol Exot Filiales, V49, P686; BUCK G, 1956, Bull Soc Pathol Exot Filiales, V49, P681; Desvars A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-80; Duplantier J, 2004, NATURAL HIST MADAGAS, P158; DUVAL G, 1991, REV EPIDEMIOL SANTE, V39, P135; Faine S, 1984, 67 WHO; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Gomard Y, 2014, EMERG INFECT DIS, V20, P720, DOI 10.3201/eid2004.131207; Lagadec E, 2012, EMERG INFECT DIS, V18, P1696, DOI 10.3201/eid1810.111898; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LHUILLIER M, 1978, Archives de l'Institut Pasteur de Madagascar, V46, P429; Paganin F, 2007, INTENS CARE MED, V33, P1959, DOI 10.1007/s00134-007-0776-y; R Development Core Team, 2010, LANG ENV STAT COMP; Rahelinirina S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014111; Ralaiarijaona R. L., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P34; SILVERIE R, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P346; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Yersin C, 1998, AM J TROP MED HYG, V59, P933, DOI 10.4269/ajtmh.1998.59.933	20	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122683	10.1371/journal.pone.0122683	http://dx.doi.org/10.1371/journal.pone.0122683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874381	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700021
J	Ciesielska, A; Sharma, N; Beyer, J; Forsayeth, J; Bankiewicz, K				Ciesielska, Agnieszka; Sharma, Nitasha; Beyer, Janine; Forsayeth, John; Bankiewicz, Krystof			Carbidopa-Based Modulation of the Functional Effect of the AAV2-hAADC Gene Therapy in 6-OHDA Lesioned Rats	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; PARKINSONS-DISEASE; L-DOPA; AAV-HAADC; LEVODOPA; STRIATUM; PLASMA; METABOLISM; PRIMATES; MONKEYS	Progressively blunted response to L-DOPA in Parkinson's disease (PD) is a critical factor that complicates long-term pharmacotherapy in view of the central importance of this drug in management of the PD-related motor disturbance. This phenomenon is likely due to progressive loss of one of the key enzymes involved in the biosynthetic pathway for dopamine in the basal ganglia: aromatic L-amino acid decarboxylase (AADC). We have developed a gene therapy based on an adeno-associated virus encoding human AADC (AAV2-hAADC) infused into the Parkinsonian striatum. Although no adverse clinical effects of the AAV2-hAADC gene therapy have been observed so far, the ability to more precisely regulate transgene expression or transgene product activity could be an important long-term safety feature. The present study was designed to define pharmacological regulation of the functional activity of AAV2-hAADC transgene product by manipulating L-DOPA and carbidopa (AADC inhibitor) administration in hemi-parkinsonian rats. Thirty days after unilateral striatal infusion of AAV2-hAADC, animals displayed circling behavior and acceleration of dopamine metabolism in the lesioned striatum after administration of a low dose of L-DOPA (5 mg/kg) co-administered with 1.25 mg/kg of carbidopa. This phenomenon was not observed in control AAV2-GFP-treated rats. Withdrawal of carbidopa from a daily L-DOPA regimen decreased the peripheral L-DOPA pool, resulting in almost total loss of L-DOPA-induced behavioral response in AAV2-hAADC rats and a significant decline in striatal dopamine turnover. The serum L-DOPA level correlated with the magnitude of circling behavior in AAV2-hAADC rats. Additionally, AADC activity in homogenates of lesioned striata transduced by AAV2-AADC was 10-fold higher when compared with AAV2-GFP-treated control striata, confirming functional transduction. Our data suggests that the pharmacological regulation of circulating L-DOPA might be effective in the controlling of function of AAV2-hAADC transgene product in PD gene therapy.	[Ciesielska, Agnieszka; Sharma, Nitasha; Beyer, Janine; Forsayeth, John; Bankiewicz, Krystof] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bankiewicz, K (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	Krystof.Bankiewicz@ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073940] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS073940] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGID Y, 1989, MOVEMENT DISORD, V4, pS126, DOI 10.1002/mds.870040514; Bankiewicz KS, 2006, EXP NEUROL, V197, P363, DOI 10.1016/j.expneurol.2005.10.022; Bankiewicz KS, MOL THER, V14, P564; CHASE TN, 1993, ADV NEUROL, V60, P181; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Ciesielska A, 2013, MOL THER, V21, P158, DOI 10.1038/mt.2012.167; DeJesus OT, 1997, J NUCL MED, V38, P630; Deleu D, 2002, CLIN PHARMACOKINET, V41, P261, DOI 10.2165/00003088-200241040-00003; Doudet DJ, 1999, J CEREBR BLOOD F MET, V19, P278, DOI 10.1097/00004647-199903000-00006; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; ELLENBERG JH, 1991, NEUROLOGY, V41, P14, DOI 10.1212/WNL.41.5_Suppl_2.14; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; GANCHER ST, 1987, NEUROLOGY, V37, P940, DOI 10.1212/WNL.37.6.940; HEFTI F, 1981, J PHARMACOL EXP THER, V217, P189; Hornykiewicz O, 1966, PHARMACOL REV, V18, P925; Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113; Jonkers N, 2001, J NEURAL TRANSM, V108, P559, DOI 10.1007/s007020170056; Jordan S, 1997, BRAIN RES, V750, P264, DOI 10.1016/S0006-8993(96)01366-2; Manfredi G, 2011, METHODS MOL BIOL, Vxv, P1; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; NAGATSU T, 1979, ANAL BIOCHEM, V100, P160, DOI 10.1016/0003-2697(79)90126-X; Okereke CS, 2002, J PHARM PHARM SCI, V5, P146; Paxinos G., 2004, J CHEM INF MODEL, V5th; PEPPE A, 1995, NEUROLOGY, V45, P1144, DOI 10.1212/WNL.45.6.1144; Pilling JB, 1975, J NEUROL NEUROSUR PS, V38, P135; Rainero I, 1988, ITAL J NEUROL SCI, P225; ROSE S, 1988, MOVEMENT DISORD, V3, P117, DOI 10.1002/mds.870030203; ROSSOR MN, 1980, J NEUROL SCI, V46, P385, DOI 10.1016/0022-510X(80)90063-5; Sanchez-Pernaute R, 2001, MOL THER, V4, P324, DOI 10.1006/mthe.2001.0466; SCARR E, 1994, NEUROCHEM RES, V19, P153, DOI 10.1007/BF00966810; Tayarani-Binazir KA, 2010, EUR J PHARMACOL, V635, P109, DOI 10.1016/j.ejphar.2010.03.006; TOLOSA ES, 1975, NEUROLOGY, V25, P177, DOI 10.1212/WNL.25.2.177; Westerink BHC, 2000, J CHROMATOGR B, V747, P21, DOI 10.1016/S0378-4347(00)00338-8	33	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122708	10.1371/journal.pone.0122708	http://dx.doi.org/10.1371/journal.pone.0122708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860990	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300058
J	Fukumoto, M; Kurisu, S; Yamada, T; Takenawa, T				Fukumoto, Miki; Kurisu, Shusaku; Yamada, Tesshi; Takenawa, Tadaomi			alpha-Actinin-4 Enhances Colorectal Cancer Cell Invasion by Suppressing Focal Adhesion Maturation	PLOS ONE			English	Article							ALPHA-ACTININ; STRESS FIBERS; GENE AMPLIFICATION; MOTILITY; SRC; EXPRESSION; ZYXIN; PHOSPHORYLATION; INVASIVENESS; PROGRESSION	alpha-Actinins (ACTNs) are known to crosslink actin filaments at focal adhesions in migrating cells. Among the four isoforms of mammalian ACTNs, ACTN1 and ACTN4 are ubiquitously expressed. Recently, ACTN4 was reported to enhance cancer cell motility, invasion, and metastasis. However, the mechanism by which ACTN4 drives these malignant phenotypes remains unclear. Here, we show that ACTN4, but not ACTN1, induces the formation of immature focal adhesions in DLD-1 cells, leading to the rapid turnover of focal adhesions. Interestingly, zyxin (ZYX) assembly to focal adhesions was markedly decreased in ACTN4-expressing DLD-1 cells, while the recruitment of paxillin (PAX) occurred normally. On the other hand, in ACTN1-expressing DLD-1 cells, PAX and ZYX were normally recruited to focal adhesions, suggesting that ACTN4 specifically impairs focal adhesion maturation by inhibiting the recruitment of ZYX to focal complexes. Using purified recombinant proteins, we found that ZYX binding to ACTN4 was defective under conditions where ZYX binding to ACTN1 was observed. Furthermore, Matrigel invasion of SW480 cells that express high endogenous levels of ACTN4 protein was inhibited by ectopic expression of ACTN1. Altogether, our results suggest that ZYX defective binding to ACTN4, which occupies focal adhesions instead of ACTN1, induces the formation of immature focal adhesions, resulting in the enhancement of cell motility and invasion.	[Fukumoto, Miki; Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kurisu, Shusaku] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Yamada, Tesshi] Natl Canc Ctr, Div Pathol, Res Inst, Tokyo 1040045, Japan	Kobe University; Kobe University; National Cancer Center - Japan	Takenawa, T (corresponding author), Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Kurisu, Shusaku/AAB-1799-2022	Kurisu, Shusaku/0000-0002-4876-4419	Japan Society for the Promotion of Science (JSPS) through JSPS [25860215]; JSPS [23227005]	Japan Society for the Promotion of Science (JSPS) through JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) through JSPS Grants-in-Aid for Scientific Research Grant 25860215 (to S. Kurisu) and JSPS Grants-in-Aid for Scientific Research Grant 23227005 (to T. Takenawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BELKIN AM, 1987, FEBS LETT, V220, P291, DOI 10.1016/0014-5793(87)80832-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Miller NLG, 2013, J CELL SCI, V126, P5074, DOI 10.1242/jcs.135509; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Noro R, 2013, ANN ONCOL, V24, P2594, DOI 10.1093/annonc/mdt293; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579185; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Welsch T, 2009, PANCREAS, V38, P968, DOI 10.1097/MPA.0b013e3181b28d6f; Yamamoto S, 2012, HISTOPATHOLOGY, V60, P1073, DOI 10.1111/j.1365-2559.2011.04163.x; Yoshii H, 2013, ONCOL REP, V30, P1073, DOI 10.3892/or.2013.2577; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	47	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120616	10.1371/journal.pone.0120616	http://dx.doi.org/10.1371/journal.pone.0120616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860875	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300014
J	He, XY; Riceberg, J; Pulukuri, SM; Grossman, S; Shinde, V; Shah, P; Brownell, JE; Dick, L; Newcomb, J; Bence, N				He, Xingyue; Riceberg, Jessica; Pulukuri, Sai M.; Grossman, Steve; Shinde, Vaishali; Shah, Pooja; Brownell, James E.; Dick, Larry; Newcomb, John; Bence, Neil			Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; SUMOYLATION; INHIBITOR; UBC9; EXPRESSION; ENZYME; IDENTIFICATION; SYSTEM; ROUTES	SUMOylation is a post-translational ubiquitin-like protein modification pathway that regulates important cellular processes including chromosome structure, kinetochore function, chromosome segregation, nuclear and sub-nuclear organization, transcription and DNA damage repair. There is increasing evidence that the SUMO pathway is dysregulated in cancer, raising the possibility that modulation of this pathway may have therapeutic potential. To investigate the importance of the SUMO pathway in the context of cancer cell proliferation and tumor growth, we applied lentivirus-based short hairpin RNAs (shRNA) to knockdown SUMO pathway genes in human cancer cells. shRNAs for SAE2 and UBC9 reduced SUMO conjugation activity and inhibited proliferation of human cancer cells. To expand upon these observations, we generated doxycycline inducible conditional shRNA cell lines for SAE2 to achieve acute and reversible SAE2 knockdown. Conditional SAE2 knockdown in U2OS and HCT116 cells slowed cell growth in vitro, and SAE2 knockdown induced multiple terminal outcomes including apoptosis, endoreduplication and senescence. Multinucleated cells became senescent and stained positive for the senescence marker, SA-beta Gal, and displayed elevated levels of p53 and p21. In an attempt to explain these phenotypes, we confirmed that loss of SUMO pathway activity leads to a loss of SUMOylated Topoisomerase II alpha and the appearance of chromatin bridges which can impair proper cytokinesis and lead to multinucleation. Furthermore, knockdown of SAE2 induces disruption of PML nuclear bodies which may further promote apoptosis or senescence. In an in vivo HCT116 xenograft tumor model, conditional SAE2 knockdown strongly impaired tumor growth. These data demonstrate that the SUMO pathway is required for cancer cell proliferation in vitro and tumor growth in vivo, implicating the SUMO pathway as a potential cancer therapeutic target.	[He, Xingyue; Riceberg, Jessica; Pulukuri, Sai M.; Grossman, Steve; Shinde, Vaishali; Shah, Pooja; Brownell, James E.; Dick, Larry; Newcomb, John] Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA; [Bence, Neil] Nurix Inc, San Francisco, CA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	He, XY (corresponding author), Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA.	xingyue.he@takeda.com; nbence@nurix-inc.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405	Takeda Pharmaceuticals International Co.	Takeda Pharmaceuticals International Co.	Takeda Pharmaceuticals International Co. provided complete financial support for the study design, data collection and analysis, decision to publish, preparation of the manuscript, and salaries for authors XH, JR, SP, SG, VS, PS, JB, LD, JN, and NB, during the time when studies were conducted. The specific roles of these authors are articulated in the 'author contributions' section.	Almedawar S, 2012, CURR BIOL, V22, P1576, DOI 10.1016/j.cub.2012.06.046; Ban R, 2011, GENES CELLS, V16, P652, DOI 10.1111/j.1365-2443.2011.01521.x; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen Shi-Feng, 2011, Chin J Cancer, V30, P638, DOI 10.5732/cjc.011.10084; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Dieckhoff P, 2004, MOL MICROBIOL, V51, P1375, DOI 10.1046/j.1365-2958.2003.03910.x; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hirohama M, 2013, ACS CHEM BIOL, V8, P2635, DOI 10.1021/cb400630z; Hoellein A, 2014, BLOOD, V124, P2081, DOI 10.1182/blood-2014-06-584524; Ivanschitz L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00171; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Kanakousaki K, 2012, DEVELOPMENT, V139, P2751, DOI 10.1242/dev.082974; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim YS, 2013, CHEM BIOL, V20, P604, DOI 10.1016/j.chembiol.2013.04.001; Kumar A, 2013, BIOORG MED CHEM LETT, V23, P5145, DOI 10.1016/j.bmcl.2013.07.022; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Moschos SJ, 2007, ONCOGENE, V26, P4216, DOI 10.1038/sj.onc.1210216; Moschos SJ, 2010, HUM PATHOL, V41, P1286, DOI 10.1016/j.humpath.2010.02.007; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Robinson HMR, 2007, CELL CYCLE, V6, P1265, DOI 10.4161/cc.6.10.4225; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Swords RT, 2015, BRIT J HEMA IN PRESS; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	48	44	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123882	10.1371/journal.pone.0123882	http://dx.doi.org/10.1371/journal.pone.0123882			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860128	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300119
J	Gracia, IS; Suarez, OD; Garcia, GB; Kim, TK				Serrano Gracia, Ismael; Deniz Suarez, Oscar; Bueno Garcia, Gloria; Kim, Tae-Kyun			Fast Fight Detection	PLOS ONE			English	Article							VIOLENT SCENES; RECOGNITION; MOVIES; AUDIO	Action recognition has become a hot topic within computer vision. However, the action recognition community has focused mainly on relatively simple actions like clapping, walking, jogging, etc. The detection of specific events with direct practical use such as fights or in general aggressive behavior has been comparatively less studied. Such capability may be extremely useful in some video surveillance scenarios like prisons, psychiatric centers or even embedded in camera phones. As a consequence, there is growing interest in developing violence detection algorithms. Recent work considered the well-known Bag-of-Words framework for the specific problem of fight detection. Under this framework, spatio-temporal features are extracted from the video sequences and used for classification. Despite encouraging results in which high accuracy rates were achieved, the computational cost of extracting such features is prohibitive for practical applications. This work proposes a novel method to detect violence sequences. Features extracted from motion blobs are used to discriminate fight and non-fight sequences. Although the method is outperformed in accuracy by state of the art, it has a significantly faster computation time thus making it amenable for real-time applications.	[Serrano Gracia, Ismael; Deniz Suarez, Oscar; Bueno Garcia, Gloria] ETSI Ind, Dept Syst Engn & Automat, Ciudad Real, Castilla La Man, Spain; [Kim, Tae-Kyun] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England	Imperial College London	Gracia, IS (corresponding author), ETSI Ind, Dept Syst Engn & Automat, Ciudad Real, Castilla La Man, Spain.	ismael.serrano@uclm.es; oscar.deniz@uclm.es; gloria.bueno@uclm.es	Bueno, Gloria/K-6286-2014	Bueno, Gloria/0000-0002-7345-4869; Serrano Gracia, Ismael/0000-0002-3869-9369	Spain's Ministry of Economy and Competitiveness [TIN2011-24367]; European Union's Horizon research and innovation programme [643924]	Spain's Ministry of Economy and Competitiveness; European Union's Horizon research and innovation programme	This work has been partially supported by Project TIN2011-24367 from Spain's Ministry of Economy and Competitiveness. Also it has been partially supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No 643924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nievas EB, 2011, LECT NOTES COMPUT SC, V6855, P332, DOI 10.1007/978-3-642-23678-5_39; Chen DT, 2008, IEEE ENG MED BIO, P5238, DOI 10.1109/IEMBS.2008.4650395; Chen LH, 2011, INT J PATTERN RECOGN, V25, P1161, DOI 10.1142/S0218001411009056; Chen M., 2010, P IEEE INFOCOM, P1, DOI DOI 10.1145/1730836.1730838; Cheng W.H, 2003, P 5 ACM SIGMM INT WO, P109, DOI DOI 10.1145/973264.973282; Clarin C.T., 2005, TECHNICAL REPORT; Demarty C., 2012, MEDIAEVAL 2012 WORKS; Deniz O., 2014, 9 INT C COMP VIS THE; Giannakopoulos T, 2006, LECT NOTES COMPUT SC, V3955, P502; Giannakopoulos T, 2010, LECT NOTES ARTIF INT, V6040, P91, DOI 10.1007/978-3-642-12842-4_13; Gong Y, 2008, LECT NOTES COMPUT SC, V5353, P317, DOI 10.1007/978-3-540-89796-5_33; Goto S, 2014, COMPUTER SCI; Guha T, 2012, IEEE T PATTERN ANAL, V34, P1576, DOI 10.1109/TPAMI.2011.253; Hassner T, 2012, 3 IEEE INT WORKSH SO; Heng Wang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3169, DOI 10.1109/CVPR.2011.5995407; Laptev I, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P432, DOI 10.1109/iccv.2003.1238378; Lin JA, 2009, LECT NOTES COMPUT SC, V5879, P930; Nam J, 1998, 1998 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL 1, P353, DOI 10.1109/ICIP.1998.723496; Patnaik S., 2012, SOFT COMPUTING TECHN; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Shian- Ru K, 2013, REV VIDEO BASED HUMA, V2, P88, DOI [10. 3390/ computers2020088, DOI 10.3390/C0MPUTERS2020088]; Soomro Khurram, 2012, DATASET 101 HUMAN AC, V2; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Wang D, 2012, 2012 IEEE NINTH INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL-BASED SURVEILLANCE (AVSS), P54, DOI 10.1109/AVSS.2012.16; Wang KY, 2012, COMM COM INF SC, V321, P137; Zajdel W, 2007, 2007 IEEE CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P200, DOI 10.1109/AVSS.2007.4425310; Zou X., 2012, ISCIDE, P347	27	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120448	10.1371/journal.pone.0120448	http://dx.doi.org/10.1371/journal.pone.0120448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860667	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300012
J	Sonoda, Y; Gohda, T; Suzuki, Y; Omote, K; Ishizaka, M; Matsuoka, J; Tomino, Y				Sonoda, Yuji; Gohda, Tomohito; Suzuki, Yusuke; Omote, Keisuke; Ishizaka, Masanori; Matsuoka, Joe; Tomino, Yasuhiko			Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTORS; ACID-BINDING PROTEIN; KIDNEY-FUNCTION; ALPHA; EXPRESSION; PATHOGENESIS; INFLAMMATION; ALBUMINURIA; PROGRESSION; ACTIVATION	The current study aimed to examine whether the levels of TNF receptors 1 and 2 (TNFR1 and TNFR2) in serum and urine were associated with other markers of kidney injury and renal histological findings, including TNFR expression, in IgA nephropathy (IgAN). The levels of the parameters of interest were measured by immunoassay in 106 biopsy-proven IgAN patients using samples obtained immediately before renal biopsy and in 34 healthy subjects. Renal histological findings were evaluated using immunohistochemistry. The levels of serum TNFRs were higher in IgAN patients than in healthy subjects. The levels of both TNFRs in serum or urine were strongly correlated with each other (r > 0.9). Serum TNFR levels were positively correlated with the urinary protein to creatinine ratio (UPCR) and four markers of tubular damage of interest (N-acetyl-beta-D-glucosaminidase [NAG], beta 2 microglobulin [beta 2m], liver-type fatty acid-binding protein [L-FABP], and kidney injury molecule-1 [KIM-1]) and negatively correlated with estimated glomerular filtration rate (eGFR). Patients in the highest tertile of serum TNFR levels showed more severe renal interstitial fibrosis than did those in the lowest or second tertiles. The tubulointerstitial TNFR2-, but not TNFR1-, positive area was significantly correlated with the serum levels of TNFRs and eGFR. Stepwise multiple regression analysis revealed that elevated serum TNFR1 or TNFR2 levels were a significant determinant of renal interstitial fibrosis after adjusting for eGFR, UPCR, and other markers of tubular damage. In conclusion, elevated serum TNFR levels were significantly associated with the severity of renal interstitial fibrosis in IgAN patients. However, the source of TNFRs in serum and urine remains unclear.	[Sonoda, Yuji; Gohda, Tomohito; Suzuki, Yusuke; Omote, Keisuke; Ishizaka, Masanori; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Matsuoka, Joe] Juntendo Univ, Fac Med, Clin Res Ctr, Tokyo, Japan	Juntendo University; Juntendo University	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp	GOHDA, TOMOHITO/Y-6867-2019	GOHDA, TOMOHITO/0000-0002-0513-4433				Al-Lamki RS, 2010, AM J PATHOL, V177, P943, DOI 10.2353/ajpath.2010.091218; BOHLE A, 1994, EXP NEPHROL, V2, P205; Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; DAMICO G, 1987, Q J MED, V64, P709; Fukuta H, 2008, CIRC J, V72, P212, DOI 10.1253/circj.72.212; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Hasegawa M, 2009, NEPHRON CLIN PRACT, V113, pC222, DOI 10.1159/000235242; Hoffmann U, 2009, AM J TRANSPLANT, V9, P675, DOI 10.1111/j.1600-6143.2008.02536.x; Idasiak-Piechocka I, 2010, NEPHROL DIAL TRANSPL, V25, P3948, DOI 10.1093/ndt/gfq310; Kanaguchi Y, 2011, NEPHROL DIAL TRANSPL, V26, P3465, DOI 10.1093/ndt/gfr110; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Lee JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058007; Fernandez-Real JM, 2012, ACTA DIABETOL, V49, P301, DOI 10.1007/s00592-011-0349-y; Miura Y, 2011, TRANSPLANTATION, V91, P78, DOI 10.1097/TP.0b013e3181ff4f7f; Miyazawa I, 2011, DIABETES RES CLIN PR, V92, P174, DOI 10.1016/j.diabres.2011.01.008; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ng DPK, 2008, DIABETOLOGIA, V51, P2318, DOI 10.1007/s00125-008-1162-1; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Niewczas MA, 2009, CLIN J AM SOC NEPHRO, V4, P62, DOI 10.2215/CJN.03010608; Reinhold SW, 2012, CYTOKINE, V57, P379, DOI 10.1016/j.cyto.2011.12.006; RISDON RA, 1968, LANCET, V2, P363; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Servais A, 2007, TRANSPLANTATION, V84, P1595, DOI 10.1097/01.tp.0000295749.50525.bd; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	34	38	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122212	10.1371/journal.pone.0122212	http://dx.doi.org/10.1371/journal.pone.0122212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860248	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300036
J	Wang, Q; Li, XF; Ren, SX; Cheng, NN; Zhao, MC; Zhang, YS; Li, JY; Cai, WJ; Zhao, C; Cao, W; Zhou, CC				Wang, Qi; Li, Xuefei; Ren, Shengxiang; Cheng, Ningning; Zhao, Mingchuan; Zhang, Yishi; Li, Jiayu; Cai, Weijing; Zhao, Chao; Cao, Wa; Zhou, Caicun			Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							FAMILY; PROTEINS; PARALOGS; GENES; IMMUNOTHERAPY; EXPRESSION; CARCINOMA; BIOMARKER; PROSTATE; TARGETS	Background POTEE (POTE ankyrin domain family, member E) is a newly identified cancer-testis antigen that has been found to be expressed in a wide variety of human cancers including cancers of the colon, prostate, lung, breast, ovary, and pancreas. Aim To measure the serum levels of POTEE in patients with non-small-cell lung cancer (NSCLC) and to explore the clinical significance of POTEE in NSCLC. Patients and Methods 104 NSCLC patients, 66 benign lung disease patients and 80 healthy volunteers were enrolled in this study from May 2013 to February 2014. Serum POTEE levels were measured using enzyme-linked immunosorbent assay (ELISA). Numerical variables were recorded as means +/- standard deviation (SD) and analyzed by independent t tests. Categorical variables were calculated as rates and were analyzed using a chi(2) test or Fisher's exact test. Survival curves were estimated and compared using the Kaplan-Meier method and log-rank tests. Results Serum POTEE levels were significantly higher in NSCLC patients than in benign lung disease patients and healthy controls (mean +/- SD [pg/ml], 324.38 +/- 13.84 vs. 156.93 +/- 17.38 and 139.09 +/- 15.80, P < 0.001) and were significantly correlated with TNM stage. Survival analysis revealed that patients with low serum POTEE had longer progression-free survival (PFS) than those with high serum POTEE (P=0.021). Cox multivariate analysis indicated that POTEE was an independent prognostic factor of progression-free survival (P=0.009, hazard ratio, 2.440). Conclusions Serum POTEE level in NSCLC patients is associated with TNM stage and is a potential prognostic factor.	[Wang, Qi; Li, Xuefei; Ren, Shengxiang; Cheng, Ningning; Zhao, Mingchuan; Zhang, Yishi; Li, Jiayu; Cai, Weijing; Zhao, Chao; Cao, Wa; Zhou, Caicun] Tongji Univ, Sch Med, Inst Canc, Dept Lung Canc & Immunol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China	Tongji University	Zhou, CC (corresponding author), Tongji Univ, Sch Med, Inst Canc, Dept Lung Canc & Immunol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China.	caicunzhoudr@163.com			National Natural Science Foundation of China [81401890, 81372392]; Key Project of the Science and Technology Commission of Shanghai Municipality [11JC1411300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Science and Technology Commission of Shanghai Municipality	This study was supported by grants from the National Natural Science Foundation of China (no. 81401890 and no. 81372392) and the Key Project of the Science and Technology Commission of Shanghai Municipality (no. 11JC1411300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruga A, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-61; Bera TK, 2008, STEM CELLS DEV, V17, P325, DOI 10.1089/scd.2007.0079; Bera TK, 2012, BIOCHEM BIOPH RES CO, V417, P1271, DOI 10.1016/j.bbrc.2011.12.125; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Bera TK, 2004, GENE, V337, P45, DOI 10.1016/j.gene.2004.05.009; Bera TK, 2002, P NATL ACAD SCI USA, V99, P16975, DOI 10.1073/pnas.262655399; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen ZG, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-10; Das S, 2007, BIOCHEM BIOPH RES CO, V363, P751, DOI 10.1016/j.bbrc.2007.09.045; Ghafouri-Fard S, 2009, ARCH IRAN MED, V12, P395; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Hofmann M, 2002, CANCER CYTOPATHOL, V96, P187, DOI 10.1002/cncr.10622; Hoon DSB, 2001, J INVEST DERMATOL, V117, P375, DOI 10.1046/j.0022-202x.2001.01417.x; Huang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064365; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kuang P, 2012, LUNG CANCER, V77, P427, DOI 10.1016/j.lungcan.2012.03.016; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Liu XP, 2011, BRAIN RES, V1391, P125, DOI 10.1016/j.brainres.2011.03.042; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mou DC, 2002, BRIT J CANCER, V86, P110, DOI 10.1038/sj.bjc.6600016; Obara W, 2012, JPN J CLIN ONCOL, V42, P591, DOI 10.1093/jjco/hys069; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Redfield SM, 2013, AM J CANCER RES, V3, P278; Rosenberg SA, 1999, CA-CANCER J CLIN, V49, P70, DOI 10.3322/canjclin.49.2.70; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Tufman A, 2010, CANCER BIOMARK, V6, P123, DOI 10.3233/CBM-2009-0124	30	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122792	10.1371/journal.pone.0122792	http://dx.doi.org/10.1371/journal.pone.0122792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860145	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300063
J	Chai, J; Feng, RJ; Shi, HR; Ren, MY; Zhang, YD; Wang, JY				Chai, Juan; Feng, Renjun; Shi, Hourui; Ren, Mengyun; Zhang, Yindong; Wang, Jingyi			Bioinformatic Identification and Expression Analysis of Banana MicroRNAs and Their Targets	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; PLANT MICRORNAS; SMALL RNAS; MIRNAS; SEQUENCE; PREDICTION; STRESS; GENOME; GENES; RICE	MicroRNAs (miRNAs) represent a class of endogenous non-coding small RNAs that play important roles in multiple biological processes by degrading targeted mRNAs or repressing mRNA translation. Thousands of miRNAs have been identified in many plant species, whereas only a limited number of miRNAs have been predicted in M. acuminata (A genome) and M. balbisiana (B genome). Here, previously known plant miRNAs were BLASTed against the Expressed Sequence Tag (EST) and Genomic Survey Sequence (GSS), a database of banana genes. A total of 32 potential miRNAs belonging to 13 miRNAs families were detected using a range of filtering criteria. 244 miRNA: target pairs were subsequently predicted, most of which encode transcription factors or enzymes that participate in the regulation of development, growth, metabolism, and other physiological processes. In order to validate the predicted miRNAs and the mutual relationship between miRNAs and their target genes, qRT-PCR was applied to detect the tissue-specific expression levels of 12 putative miRNAs and 6 target genes in roots, leaves, flowers, and fruits. This study provides some important information about banana pre-miRNAs, mature miRNAs, and miRNA target genes and these findings can be applied to future research of miRNA functions.	[Chai, Juan; Feng, Renjun; Shi, Hourui; Ren, Mengyun; Wang, Jingyi] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Minist Agr, Haikou, Hainan, Peoples R China; [Shi, Hourui; Ren, Mengyun; Zhang, Yindong] Hainan Univ, Coll Agron, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University	Wang, JY (corresponding author), Hainan Univ, Coll Agron, Haikou, Hainan, Peoples R China.	23300558@163.com; wangjingyi@itbb.org.cn	WANG, JINGYI/GSJ-1241-2022		Natural Science Foundation of Hainan Province [312050, 312051]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB130201]; National Natural Science Foundation of China [31201603]; Major Technology Project of Hainan Province [ZDZX2013023-1]	Natural Science Foundation of Hainan Province; National Nonprofit Institute Research Grant of CATAS-ITBB; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Technology Project of Hainan Province	JYW and RJF received the grants from the Natural Science Foundation of Hainan Province (No. 312050, 312051), JYW received the grants from the National Nonprofit Institute Research Grant of CATAS-ITBB (No. ITBB130201), and RJF received the grants from the National Natural Science Foundation of China (No. 31201603) and the Major Technology Project of Hainan Province (No. ZDZX2013023-1). The grants from No. 312050 and ITBB130201 had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Archak Sunil, 2007, Genomics Proteomics & Bioinformatics, V5, P196, DOI 10.1016/S1672-0229(08)60007-8; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baurens FC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-149; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; Dong QH, 2012, J HERED, V103, P268, DOI 10.1093/jhered/esr127; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Du JF, 2010, CHINESE SCI BULL, V55, P1263, DOI 10.1007/s11434-010-0035-4; FAOSTAT, BAN PROD; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Gorodkin J, 2006, COMPUT BIOL CHEM, V30, P249, DOI 10.1016/j.compbiolchem.2006.04.006; Hake S, 2003, CURR BIOL, V13, pR851, DOI 10.1016/j.cub.2003.10.021; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khvorova A, 2007, CELL, V131, P41, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Liang G, 2013, PLANTA, V238, P739, DOI 10.1007/s00425-013-1929-6; Liu ZH, 2010, J INTEGR PLANT BIOL, V52, P670, DOI 10.1111/j.1744-7909.2010.00959.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martens S, 2003, BIOCHEM ENG J, V14, P227, DOI 10.1016/S1369-703X(02)00224-3; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Pani A, 2013, GENOM DATA, V1, P2, DOI 10.1016/j.gdata.2013.06.001; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simmonds N. W., 1962, EVOLUTION BANANAS, P101; Song C, 2010, PLANT BIOLOGY, V12, P927, DOI 10.1111/j.1438-8677.2009.00300.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Ye KY, 2013, GENES GENOM, V35, P377, DOI 10.1007/s13258-013-0070-z; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	65	22	25	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123083	10.1371/journal.pone.0123083	http://dx.doi.org/10.1371/journal.pone.0123083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856313	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500072
J	Liao, Y; Chen, JW; Brandt, BW; Zhu, YF; Li, J; van Loveren, C; Deng, DM				Liao, Ying; Chen, Jianwei; Brandt, Bernd Willem; Zhu, Yuanfang; Li, Jiyao; van Loveren, Cor; Deng, Dong Mei			Identification and Functional Analysis of Genome Mutations in a Fluoride-Resistant Streptococcus mutans Strain	PLOS ONE			English	Article							HUMAN DENTAL PLAQUE; WIDE ASSOCIATION; SODIUM-FLUORIDE; READ ALIGNMENT; EXPRESSION; SPECIFICITY; TRANSPORT; BACTERIA; ENOLASE; ENAMEL	It is known that fluoride-resistant microorganisms are different from fluoride-sensitive ones in growth, adherence and metabolic activity. It was hypothesized that these phenotypic differences were due to stable genotypic changes in the fluoride-resistant strains. However, until now, no studies have reported these genotypic changes. The aim of this study is to identify such changes in a fluoride-resistant Streptococcus mutans strain (C180-2FR) using whole-genome shotgun (WGS) sequencing and to examine the potential function of the identified mutations by comparing gene expression between the fluoride-sensitive (C180-2) and C180-2FR strains. We performed 50 bp paired-end Illumina shotgun sequencing for both strains. Through extensive bioinformatic analysis, we were able to identify 8 single nucleotide polymorphisms (SNPs) in the genome of C180-2FR, which were further confirmed by Sanger sequencing. Expression of the genes containing or in proximity to the SNPs in C180-2 and C180-2FR was then quantified by real-time PCR. A gene cluster containing genes coding for fluoride antiporters was up-regulated 10-fold in C180-2FR when compared to that in C180-2, independent of growth phase. Two SNPs are located in this gene cluster, one in its promoter region and the other in its protein-coding region. In addition, one gene, which codes for a putative glycerol uptake facilitator protein, was found to be down-regulated by 60% in C180-2FR at an early growth phase. The promoter region of this gene contained a SNP. No difference in expression was found for the other SNP-containing genes. In summary, using WGS sequencing, we were able to uncover genetic changes in the genome of a fluoride-resistant strain. These findings can provide new insights into the mechanism of microbial fluoride resistance.	[Liao, Ying; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Liao, Ying; Brandt, Bernd Willem; van Loveren, Cor; Deng, Dong Mei] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Liao, Ying; Brandt, Bernd Willem; van Loveren, Cor; Deng, Dong Mei] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Chen, Jianwei; Zhu, Yuanfang] BGI Shenzhen, Shenzhen, Peoples R China	Sichuan University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Beijing Genomics Institute (BGI)	Deng, DM (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands.	d.deng@acta.nl	Deng, Dongmei/V-9230-2017; Liao, Ying/AAE-6821-2020; Chen, Jianwei/GQH-8813-2022	Chen, Jianwei/0000-0003-2332-4609; Brandt, Bernd/0000-0002-1155-1989	National Natural Science Foundation of China [81371135]; "Twelfth Five-Year" National Science and Technology Support Project [20911BAZ03171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Twelfth Five-Year" National Science and Technology Support Project	This research was supported by the National Natural Science Foundation of China (No. 81371135) and "Twelfth Five-Year" National Science and Technology Support Project (20911BAZ03171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Alam MT, 2014, GENOME BIOL EVOL, V6, P1174, DOI 10.1093/gbe/evu092; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Amaechi BT, 2013, CARIES RES, V47, P399, DOI 10.1159/000348589; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Bartholmes P MA, 1990, J DENT RES, V69, P825; BIRKELAND JM, 1978, CARIES RES, V12, P38, DOI 10.1159/000260364; Bowden G H, 1990, J Dent Res, V69 Spec No, P653; Bowden GH, 1990, J DENT RES, V69, P682; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BRUSSOCK SM, 1987, J DENT RES, V66, P1594, DOI 10.1177/00220345870660101701; Bryant J, 2012, FUTURE MICROBIOL, V7, P1283, DOI [10.2217/FMB.12.108, 10.2217/fmb.12.108]; BUNICK FJ, 1981, INFECT IMMUN, V34, P856, DOI 10.1128/IAI.34.3.856-863.1981; CHANSLEY PE, 1989, INFECT IMMUN, V57, P1968, DOI 10.1128/IAI.57.7.1968-1970.1989; CURRAN TM, 1994, FEMS MICROBIOL LETT, V119, P283; DESTOPPELAAR JD, 1967, ARCH ORAL BIOL, V12, P1199, DOI 10.1016/0003-9969(67)90069-6; DIRKS OB, 1978, CARIES RES, V12, P7, DOI 10.1159/000260359; Froger A, 2001, MICROBIOL-SGM, V147, P1129, DOI 10.1099/00221287-147-5-1129; Fu D, 2002, NOVART FDN SYMP, V245, P51; HAMILTON IR, 1969, CAN J MICROBIOL, V15, P287, DOI 10.1139/m69-052; HELDERMAN WHV, 1983, ARCH ORAL BIOL, V28, P599; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hoelscher GL, 1996, CURR MICROBIOL, V32, P156, DOI 10.1007/s002849900028; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LI YH, 1994, J DENT RES, V73, P1615, DOI 10.1177/00220345940730100601; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lynch R J M, 2012, Adv Dent Res, V24, P63, DOI 10.1177/0022034512454295; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Sheng J Y, 2000, Chin J Dent Res, V3, P7; Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; STRECKFUSS JL, 1980, J DENT RES, V59, P151, DOI 10.1177/00220345800590021501; ten Cate JM, 2004, CARIES RES, V38, P254, DOI 10.1159/000077763; Van Loveren C, 1990, J Dent Res, V69 Spec No, P676; van Loveren C, 2008, CARIES RES, V42, P429, DOI 10.1159/000159606; VANLOVEREN C, 1991, J DENT RES, V70, P1491, DOI 10.1177/00220345910700120401; VANLOVEREN C, 1991, ORAL MICROBIOL IMMUN, V6, P288; VANLOVEREN C, 1991, CARIES RES, V25, P424, DOI 10.1159/000261405; Zhu LK, 2012, ARCH ORAL BIOL, V57, P10, DOI 10.1016/j.archoralbio.2011.06.011	44	22	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122630	10.1371/journal.pone.0122630	http://dx.doi.org/10.1371/journal.pone.0122630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856576	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500047
J	Samra, S; Ghanim, M; Protasov, A; Branco, M; Mendel, Z				Samra, Shahar; Ghanim, Murad; Protasov, Alex; Branco, Manuela; Mendel, Zvi			Genetic Diversity and Host Alternation of the Egg Parasitoid Ooencyrtus pityocampae between the Pine Processionary Moth and the Caper Bug	PLOS ONE			English	Article							THAUMETOPOEA-WILKINSONI TAMS; TRICHOGRAMMA-PLATNERI NAGARKATTI; SCHIFF LEP; BIOLOGICAL-CONTROL; DNA POLYMORPHISM; HYMENOPTERA; CATERPILLAR; BATCHES; ISRAEL; APHID	The increased use of molecular tools for species identification in recent decades revealed that each of many apparently generalist parasitoids are actually a complex of morphologically similar congeners, most of which have a rather narrow host range. Ooencyrtus pityocampae (OP), an important egg parasitoid of the pine processionary moth (PPM), is considered a generalist parasitoid. OP emerges from PPM eggs after winter hibernation, mainly in spring and early summer, long before the eggs of the next PPM generation occurs. The occurrence of OP in eggs of the variegated caper bug (CB) Stenozygum coloratum in spring and summer suggests that OP populations alternate seasonally between PPM and CB. However, the identity of OP population on CB eggs seemed uncertain; unlike OP-PPM populations, the former displayed apparently high male/female ratios and lack of attraction to the PPM sex pheromone. We studied the molecular identities of the two populations since the morphological identification of the genus Ooencyrtus, and OP in particular, is difficult. Sequencing of COI and ITS2 DNA fragments and AFLP analysis of individuals from both hosts revealed no apparent differences between the OP-PPM and the OP-CB populations for both the Israeli and the Turkish OPs, which therefore supported the possibility of host alternation. Sequencing data extended our knowledge of the genetic structure of OP populations in the Mediterranean area, and revealed clear separation between East and West Mediterranean populations. The overall level of genetic diversity was rather small, with the Israeli population much less diverse than all others; possible explanations for this finding are discussed. The findings support the possibility of utilizing the CB and other hosts for enhancing biological control of the PPM.	[Samra, Shahar; Ghanim, Murad; Protasov, Alex; Mendel, Zvi] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel; [Samra, Shahar] Hebrew Univ Jerusalem, Fac Agr, IL-76100 Rehovot, Israel; [Branco, Manuela] Univ Tecn Lisboa, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Universidade de Lisboa	Samra, S (corresponding author), Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel.	Shaharsm1@gmail.com	Branco, Manuela/D-5274-2011	Branco, Manuela/0000-0002-8140-1257	Keren Kayemeth LeIsrael/The Jewish National Fund [131-1619-13]	Keren Kayemeth LeIsrael/The Jewish National Fund	This study was funded by The Keren Kayemeth LeIsrael/The Jewish National Fund (Project # 131-1619-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL H. G., 1933, ZOOGEOGRAPHICA, V2, P1; AMSEL HANS GEORG, 1935, VEROFFENTL DEUTSCHEN KOLON U UEBERSEE MUS BREMEN, V1, P223; [Anonymous], 1939, FOREST PROTECTION RE, P1936; [Anonymous], 2012, CHROMASPRO 1 6; Avci M, 2003, PHYTOPARASITICA, V31, P118, DOI 10.1007/BF02980780; Avci M, 2014, PROCESSIONARY MOTHS; Baker DA, 2003, MOL ECOL, V12, P3303, DOI 10.1046/j.1365-294X.2003.02010.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BATTISTI A, 1988, Redia, V71, P321; BATTISTI A, 1989, ENTOMOPHAGA, V34, P29, DOI 10.1007/BF02372584; Bell G, 1982, MASTERPIECE NATURE E; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Biger N, 2004, GREEN DRESS COUNTRY; Binazzi F, 2013, REDIA, V96, P79; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Borghuis A, 2004, BIOL CONTROL, V30, P90, DOI 10.1016/j.biocontrol.2003.09.015; BUXTON RD, 1983, OUTLOOK AGR, V12, P34, DOI 10.1177/003072708301200106; Chao A, 2010, PROGRAM USERS GUIDE; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; CHOW A, 1991, ECOL ENTOMOL, V16, P403, DOI 10.1111/j.1365-2311.1991.tb00233.x; Conti E, 2004, BIOL CONTROL, V29, P435, DOI 10.1016/j.biocontrol.2003.08.009; CORNELL H, 1978, ECOLOGY, V59, P297, DOI 10.2307/1936375; Devkota B., 1992, Bollettino di Zoologia Agraria e di Bachicoltura, V24, P147; DIXON AFG, 1971, ANN APPL BIOL, V68, P135, DOI 10.1111/j.1744-7348.1971.tb06450.x; DOUTT RL, 1959, ANNU REV ENTOMOL, V4, P161, DOI 10.1146/annurev.en.04.010159.001113; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frere I., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P581; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HALPERIN J, 1990, J APPL ENTOMOL, V110, P1, DOI 10.1111/j.1439-0418.1990.tb00088.x; HALPERIN J, 1990, J APPL ENTOMOL, V109, P425, DOI 10.1111/j.1439-0418.1990.tb00073.x; Halperin J., 1968, La-Yaaran, V18, P117; HALPERIN J, 1980, PHYTOPARASITICA, V8, P83, DOI 10.1007/BF02994502; Halperin J, 1983, SPECIAL PUBLICATION, P71; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hodar JA, 2004, BIODIVERS CONSERV, V13, P493, DOI 10.1023/B:BIOC.0000009495.95589.a7; Jiggins FM, 2003, GENETICS, V164, P5; Karshon R, 1981, NATURAL OCCURRENCES, P71; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kerdelhue C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-220; KITT J, 1993, J APPL ENTOMOL, V115, P484, DOI 10.1111/j.1439-0418.1993.tb00418.x; Kolaczan CR, 2009, J EVOLUTION BIOL, V22, P1275, DOI 10.1111/j.1420-9101.2009.01742.x; Kugler J., 1985, PLANTS ANIMALS LAND; McDougall SJ, 1997, J APPL ENTOMOL, V121, P205, DOI 10.1111/j.1439-0418.1997.tb01394.x; MENDEL Z, 1990, J APPL ENTOMOL, V109, P311, DOI 10.1111/j.1439-0418.1990.tb00056.x; Mirchev P, 2004, J APPL ENTOMOL, V128, P533, DOI 10.1111/j.1439-0418.2004.00837.x; Mizrachi A., 2006, SEASONAL ACTIVITY AS; Mohammadpour M, 2014, BIOCONTROL, V59, P279, DOI 10.1007/s10526-014-9565-z; NEMEC V, 1985, ENTOMOL GEN, V10, P253; Noyes JS, 2014, WORLD WIDE WEB ELECT; PALMER SC, 1992, BIOCHEM SYST ECOL, V20, P219, DOI 10.1016/0305-1978(92)90056-J; Paulus J, 1912, NATURWISSENSCHAFTLIC, P436; Quicke D. L. J., 1997, PARASITIC WASPS; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Rossbach A, 2005, J INSECT BEHAV, V18, P491, DOI 10.1007/s10905-005-5607-9; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samra S, 2014, ALON HANOTEA, V68, P38; Santos HM, 2013, ECOL EVOL, V3, P5098, DOI 10.1002/ece3.865; Schmidt GH, 1997, PHYTOPARASITICA, V25, P275; Schmidt GH, 1999, J APPL ENTOMOL, V123, P449, DOI 10.1046/j.1439-0418.1999.00405.x; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; Simonato M, 2010, THESIS PADOVA U; Simonato M, 2012, ENTOMOL EXP APPL, V145, P124, DOI 10.1111/j.1570-7458.2012.01321.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; STARY P, 1993, J APPL ENTOMOL, V116, P187, DOI 10.1111/j.1439-0418.1993.tb01187.x; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; TAJIMA F, 1989, GENETICS, V123, P585; TIBERI R, 1990, J APPL ENTOMOL, V110, P14, DOI 10.1111/j.1439-0418.1990.tb00090.x; TSANKOV G, 1990, J APPL ENTOMOL, V110, P7, DOI 10.1111/j.1439-0418.1990.tb00089.x; Tsankov G, 1996, J APPL ENTOMOL, V120, P93, DOI 10.1111/j.1439-0418.1996.tb01572.x; Tsankov G., 1995, Bollettino di Zoologia Agraria e di Bachicoltura, V27, P53; Tsankov Georgi, 1999, Journal of the Entomological Research Society, V1, P1; Vet LEM, 1992, ECOLOGY INFOCHEMICAL; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waage J., 1986, INSECT PARASITOIDS; Weisser WW, 1997, J APPL ENTOMOL, V121, P23, DOI 10.1111/j.1439-0418.1997.tb01365.x; WILKINSON D. C., 1926, BULL ENT RES [LONDON], V17, P163; Yotoko KSC, 2006, J ZOOL SYST EVOL RES, V44, P265, DOI 10.1111/j.1439-0469.2006.00377.x; Zhao H., 1990, Chinese Journal of Biological Control, V6, P186; Zovi D, 2008, ECOLOGY, V89, P1388, DOI 10.1890/07-0883.1	84	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122788	10.1371/journal.pone.0122788	http://dx.doi.org/10.1371/journal.pone.0122788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856082	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500056
J	Wei, C; Wang, ZT; Song, ZC; Wang, KX; Wang, D; Au, WWL; Zhang, Y				Wei, Chong; Wang, Zhitao; Song, Zhongchang; Wang, Kexiong; Wang, Ding; Au, Whitlow W. L.; Zhang, Yu			Acoustic Property Reconstruction of a Neonate Yangtze Finless Porpoise's (Neophocaena asiaeorientalis) Head Based on CT Imaging	PLOS ONE			English	Article							BAIJI LIPOTES-VEXILLIFER; BEAM FORMATION; SOUND; PHOCAENOIDES	The reconstruction of the acoustic properties of a neonate finless porpoise's head was performed using X-ray computed tomography (CT). The head of the deceased neonate porpoise was also segmented across the body axis and cut into slices. The averaged sound velocity and density were measured, and the Hounsfield units (HU) of the corresponding slices were obtained from computed tomography scanning. A regression analysis was employed to show the linear relationships between the Hounsfield unit and both sound velocity and density of samples. Furthermore, the CT imaging data were used to compare the HU value, sound velocity, density and acoustic characteristic impedance of the main tissues in the porpoise's head. The results showed that the linear relationships between HU and both sound velocity and density were qualitatively consistent with previous studies on Indo-pacific humpback dolphins and Cuvier's beaked whales. However, there was no significant increase of the sound velocity and acoustic impedance from the inner core to the outer layer in this neonate finless porpoise's melon.	[Wei, Chong; Zhang, Yu] Xiamen Univ, Minist Educ, Key Lab Underwater Acoust Commun & Marine Informa, Xiamen 361005, Fujian, Peoples R China; [Wei, Chong; Au, Whitlow W. L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Song, Zhongchang] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen 361005, Peoples R China; [Zhang, Yu] Xiamen Univ, Coll Ocean & Sci, Xiamen 361005, Peoples R China	Xiamen University; University of Hawaii System; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; Xiamen University	Wang, D (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	wangd@ihb.ac.cn; yuzhang@xmu.edu.cn	Wei, Chong/E-2488-2019	Wei, Chong/0000-0002-2359-9285; Wang, Zhi-Tao/0000-0002-5734-7385	National Science Foundation of China [41276040, 11174240, 31170501, 31070347]; Natural Science Foundation of Fujian Province of China [2012J06010]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; China Scholarship Council; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; China Scholarship Council(China Scholarship Council); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was financially supported in part by the National Science Foundation of China [grants no. 41276040, no. 11174240, no. 31170501 and no. 31070347], the Natural Science Foundation of Fujian Province of China [grant no. 2012J06010], Ministry of Science and Technology of China [grant no. 2011BAG07B05-3], and State Oceanic Administration of China [grant no. 201105011-3]. One of the authors, Chong Wei, is supported by the China Scholarship Council. The Project was sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2001, J ACOUST SOC AM, V109, P1723, DOI 10.1121/1.1356705; Akamatsu T, 2002, FISHERIES SCI, V68, P294, DOI 10.2331/fishsci.68.sup1_294; AROYAN JL, 1992, J ACOUST SOC AM, V92, P2539, DOI 10.1121/1.404424; Aroyan JL, 2001, J ACOUST SOC AM, V110, P3305, DOI 10.1121/1.1401757; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford TW, 2014, BIOACOUSTICS, V23, P161, DOI 10.1080/09524622.2013.843061; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Cranford TW, 1996, J MORPHOL, V228, P223; Duck F.A., 1990, MED PHYS, V18; Duggan ZPZ, 2009, J COMP PHYSIOL B, V179, P783, DOI 10.1007/s00360-009-0360-6; HUA M, 1987, Acta Theriologica Sinica, V7, P85; Jing X, 1982, SCI CHINA, V2, P233; Krysl P, 2008, INT J NUMER METH ENG, V74, P754, DOI 10.1002/nme.2192; Krysl P, 2006, J ACOUST SOC AM, V120, P2328, DOI 10.1121/1.2257988; Li S, 1998, J ACOUST SOC AM, V117, P3288; Li SH, 2007, J ACOUST SOC AM, V121, P3938, DOI 10.1121/1.2721658; Robb RA, 1998, INTRO CHEM SEA; Soldevilla MS, 2005, J EXP BIOL, V208, P2319, DOI 10.1242/jeb.01624; Wang D, 2013, IUCN TED LIST THREAT; Wang Ding, 1996, Acta Hydrobiologica Sinica, V20, P127; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wei C., 2013, TECHNICAL ACOUSTIC 2, V32, P34; Wei C, 2014, J ACOUST SOC AM, V136, P423, DOI 10.1121/1.4883597	25	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121442	10.1371/journal.pone.0121442	http://dx.doi.org/10.1371/journal.pone.0121442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856588	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500019
J	Periwal, V; Patowary, A; Vellarikkal, SK; Gupta, A; Singh, M; Mittal, A; Jeyapaul, S; Chauhan, RK; Singh, AV; Singh, PK; Garg, P; Katoch, VM; Katoch, K; Chauhan, DS; Sivasubbu, S; Scaria, V				Periwal, Vinita; Patowary, Ashok; Vellarikkal, Shamsudheen Karuthedath; Gupta, Anju; Singh, Meghna; Mittal, Ashish; Jeyapaul, Shamini; Chauhan, Rajendra Kumar; Singh, Ajay Vir; Singh, Pravin Kumar; Garg, Parul; Katoch, Viswa Mohan; Katoch, Kiran; Chauhan, Devendra Singh; Sivasubbu, Sridhar; Scaria, Vinod			Comparative Whole-Genome Analysis of Clinical Isolates Reveals Characteristic Architecture of Mycobacterium tuberculosis Pangenome	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANT STRAINS; SEQUENCE; TOOL; EVOLUTION; ALIGNMENT; COMPLEX; GENES; IDENTIFICATION; ANNOTATION	The tubercle complex consists of closely related mycobacterium species which appear to be variants of a single species. Comparative genome analysis of different strains could provide useful clues and insights into the genetic diversity of the species. We integrated genome assemblies of 96 strains from Mycobacterium tuberculosis complex (MTBC), which included 8 Indian clinical isolates sequenced and assembled in this study, to understand its pangenome architecture. We predicted genes for all the 96 strains and clustered their respective CDSs into homologous gene clusters (HGCs) to reveal a hard-core, soft-core and accessory genome component of MTBC. The hard-core (HGCs shared amongst 100% of the strains) was comprised of 2,066 gene clusters whereas the soft-core (HGCs shared amongst at least 95% of the strains) comprised of 3,374 gene clusters. The change in the core and accessory genome components when observed as a function of their size revealed that MTBC has an open pangenome. We identified 74 HGCs that were absent from reference strains H37Rv and H37Ra but were present in most of clinical isolates. We report PCR validation on 9 candidate genes depicting 7 genes completely absent from H37Rv and H37Ra whereas 2 genes shared partial homology with them accounting to probable insertion and deletion events. The pangenome approach is a promising tool for studying strain specific genetic differences occurring within species. We also suggest that since selecting appropriate target genes for typing purposes requires the expected target gene be present in all isolates being typed, therefore estimating the core-component of the species becomes a subject of prime importance.	[Periwal, Vinita; Scaria, Vinod] CSIR, IGIB, GN Ramachandran Knowledge Ctr Genome Informat, Delhi 110007, India; [Patowary, Ashok; Vellarikkal, Shamsudheen Karuthedath; Singh, Meghna; Mittal, Ashish; Jeyapaul, Shamini; Chauhan, Rajendra Kumar; Sivasubbu, Sridhar] CSIR, IGIB, Genom & Mol Med, Delhi 110007, India; [Singh, Ajay Vir; Singh, Pravin Kumar; Garg, Parul; Katoch, Viswa Mohan; Katoch, Kiran; Chauhan, Devendra Singh] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Tajganj 282001, Agra, India; [Gupta, Anju] CSIR, Open Source Drug Discovery Unit, New Delhi 110001, India; [Periwal, Vinita; Vellarikkal, Shamsudheen Karuthedath; Singh, Meghna] AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; Academy of Scientific & Innovative Research (AcSIR)	Sivasubbu, S (corresponding author), CSIR, IGIB, Genom & Mol Med, Mall Rd, Delhi 110007, India.	sridhar@igib.in; vinods@igib.in	Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022; Singh, Pushpendra/T-4248-2018; Singh, Ajay/AAF-4414-2020; Patowary, Ashok/AAT-5305-2020; Singh, Meghna/AAV-5262-2020; Scaria, Vinod/AAS-3151-2021	Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Singh, Pushpendra/0000-0002-7277-115X; Patowary, Ashok/0000-0001-7507-3907; PERIWAL, VINITA/0000-0002-3583-0413; Scaria, Vinod/0000-0001-7644-7181; Chauhan, Devendra Singh/0000-0001-6519-3200; Singh, Meghna/0000-0002-7907-6571; Chauhan, Rajendra Kumar/0000-0002-3904-5332	Council of Scientific and Industrial Research (CSIR) India through Open Source Drug Discovery (OSDD) Programme [HCP001]; CSIR, India [SIP006, FAC002]	Council of Scientific and Industrial Research (CSIR) India through Open Source Drug Discovery (OSDD) Programme; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The project was funded by Council of Scientific and Industrial Research (CSIR) India through Open Source Drug Discovery (OSDD) Programme (HCP001). The Sequencing facility is supported through SIP006 and FAC002 Grant from CSIR, India and the computational analysis was performed at the CSIR centre for in-silico Biology at CSIR Institute of Genomics and Integrative Biology (IGIB).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asif SM, 2009, BIOINFORMATION, V4, P245, DOI 10.6026/97320630004245; Azhikina T, 2006, RES MICROBIOL, V157, P282, DOI 10.1016/j.resmic.2005.08.002; Bazira J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-81; Behr MA, 2013, ADV EXP MED BIOL, V783, P81, DOI 10.1007/978-1-4614-6111-1_4; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Doddapaneni H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-225; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-469; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; MILLAR JW, 1979, LANCET, V1, P1176; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Patowary A, 2012, HUM MUTAT, V33, P1133, DOI 10.1002/humu.22091; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Power PM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-273; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rowland K., 2012, TOTALLY DRUG RESISTA; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sougakoff W, 2011, CLIN MICROBIOL INFEC, V17, P800, DOI 10.1111/j.1469-0691.2011.03577.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Trost B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-258; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Vishnoi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-373; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zakham Fathiah, 2012, Microb Inform Exp, V2, P7, DOI 10.1186/2042-5783-2-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	62	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122979	10.1371/journal.pone.0122979	http://dx.doi.org/10.1371/journal.pone.0122979			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853708	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400090
J	Wang, YQ; Fukuda, T; Isaji, T; Lu, JS; Im, S; Hang, QL; Gu, W; Hou, SC; Ohtsubo, K; Gu, JG				Wang, Yuqin; Fukuda, Tomohiko; Isaji, Tomoya; Lu, Jishun; Im, Sanghun; Hang, Qinglei; Gu, Wei; Hou, Sicong; Ohtsubo, Kazuaki; Gu, Jianguo			Loss of alpha 1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways	FASEB JOURNAL			English	Article						N-glycosylation; glycosyltransferase; cell proliferation	INDUCED HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; ACQUIRED-RESISTANCE; CORE FUCOSYLATION; FUCOSE; CANCER; GROWTH; MECHANISMS; MET; EXPRESSION	Up-regulation of core fucosylation catalyzed by alpha 1,6-fucosyltransferase (Fut8) has been observed in hepatocellular carcinoma (HCC). Here, to explore the role of Fut8 expression in hepatocarcinogensis, we established the chemical-induced HCC models in the male wildtype (WT; Fut8(+/+)), hetero (Fut8(+/-)), and knockout (KO; Fut8(-/-)) mice by use of diethylnitrosamine (DEN) and pentobarbital (PB). In the Fut8(+/+) and Fut8(+/-) mice, multiple large and vascularized nodules were induced with an increased expression of Fut8 after DEN and PB treatment. However, the formation of HCC in Fut8(-/-) mice was suppressed almost completely. This potent inhibitory effect of Fut8 deficiency on tumorigenesis was also confirmed by the abolished tumor formation of Fut8 KO human hepatoma cell line cells by use of a xenograft tumor model. Furthermore, loss of the Fut8 gene resulted in attenuated responses to epidermal growth factor (EGF) and hepatocyte growth factor (HGF) in the HepG2 cell line, which provides the possible mechanisms for the contribution of Fut8 to hepatocarcinogensis. Taken together, our study clearly demonstrated that core fucosylation acts as a critical functional modulator in the liver and implicated Fut8 as a prognostic marker, as well as a novel, therapeutic target for HCC.	[Wang, Yuqin; Fukuda, Tomohiko; Isaji, Tomoya; Lu, Jishun; Im, Sanghun; Hang, Qinglei; Gu, Wei; Hou, Sicong; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan; [Ohtsubo, Kazuaki; Gu, Jianguo] Kumamoto Univ, Fac Life Sci, Dept Analyt Biochem, Kumamoto 860, Japan	Tohoku Medical & Pharmaceutical University; Kumamoto University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Hang, Qinglei/GOP-0218-2022; Gu, Jianguo/ABC-9257-2020	Hang, Qinglei/0000-0003-0419-6621; 	Challenging Exploratory Research Grant [15K14408]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [15H04354];  [24590087];  [23790363]; Grants-in-Aid for Scientific Research [15K14408] Funding Source: KAKEN	Challenging Exploratory Research Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Yuka Kobayashi (J-Oil Mills, Tokyo, Japan) for providing the PhoSL, Dr. Maeda Kento (Kumamoto University, Japan) for technical assistance, and Dr. Lucas Revillon (Tohoku Pharmaceutical University) for the language modification of this manuscript. This work was partially supported by a Grant-in-Aid for Scientific Research 15H04354 to J.G. and 24590087 to T.F.; Challenging Exploratory Research Grant 15K14408 to J.G.; Young Scientists (B) Grant 23790363 to K.O.; Japan Society for the Promotion of Science; and Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Biname F, 2008, MOL BIOL CELL, V19, P945, DOI 10.1091/mbc.E07-09-0967; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; HUTCHINSON WL, 1991, HEPATOLOGY, V13, P683, DOI 10.1002/hep.1840130412; Jacinto FV, 2007, DNA REPAIR, V6, P1155, DOI 10.1016/j.dnarep.2007.03.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Noda K, 2003, CANCER RES, V63, P6282; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wang MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06145; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Yamashita F, 1996, GASTROENTEROLOGY, V111, P996, DOI 10.1016/S0016-5085(96)70067-7; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhu AX, 2010, ANN SURG ONCOL, V17, P1247, DOI 10.1245/s10434-010-0975-6	46	63	68	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3217	3227		10.1096/fj.15-270710	http://dx.doi.org/10.1096/fj.15-270710			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25873065				2022-12-26	WOS:000358796900011
J	Liu, W; Liu, JJ; Yin, DX; Zhao, XW				Liu, Wei; Liu, Jianjun; Yin, Dongxue; Zhao, Xiaowen			Influence of Ecological Factors on the Production of Active Substances in the Anti-Cancer Plant Sinopodophyllum hexandrum (Royle) TS Ying	PLOS ONE			English	Article							PODOPHYLLUM-HEXANDRUM; GENETIC DIVERSITY; SECONDARY METABOLITES; SICHUAN PROVINCE; LIGNANS; CONSERVATION; GLYCOSIDES; ETOPOSIDE; PELTATUM; LEAVES	The quality of traditional Chinese herbal medicine, which plays a very important role in the health system of China, is determined by the active substances produced by the plants. The type, content, and proportion of these substances may vary depending on ecological factors in areas where the plants are grown. Sinopodophyllum hexandrum (Royle) T.S. Ying, an endangered plant species with great medical value, was investigated in eight production locations representative of its natural geographical distribution range in China. The correlation between the contents of the active ingredients extracted from the roots and rhizomes of S. hexandrum and the ecological factors were evaluated step-by-step using a series of computational biology methodologies. The results showed that ecological factors had significant effects on the contents but not on the types of the active ingredients in eight production locations. The primary ecological factors influencing the active substances included the annual average precipitation, July mean temperature, frost-free period, sunshine duration, soil pH, soil organic matter, and rapidly available potassium in the soil. The annual average precipitation was the most important determinant factor and was significantly and negatively correlated with the active ingredient contents (P < 0.001). In contrast, organic matter was the most important limiting factor and was significantly and positively correlated with the active substances. These ecological factors caused 98.13% of the total geographical variation of the active ingredient contents. The climate factors contributed more to the active ingredient contents than did the soil factors. It was concluded that from the view of the contents of the secondary metabolites and ecological factors of each growing location, in Jingyuan, Ningxia Province, and Yongdeng, Gansu Province, conditions were favorable to the production of podophyllotoxin and lignans, whereas in Shangri-La, Yunnan Province, and Nyingchi, Tibet, conditions were favorable to the production of quercetin and kaempferol.	[Liu, Wei; Liu, Jianjun; Yin, Dongxue; Zhao, Xiaowen] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Liu, JJ (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	ljj@nwsuaf.edu.cn			Forestry Research Foundation for the Public Service Industry of China [200904004]	Forestry Research Foundation for the Public Service Industry of China	This work was supported by the program from the Forestry Research Foundation for the Public Service Industry of China (Grant numbers: 200904004; http://english.forestry.gov.cn/web/index.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2008, AFR J BIOTECHNOL, V7, P1028; Alam MA, 2009, INDIAN J BIOTECHNOL, V8, P391; AYRES DC, 1976, J CHEM SOC PERK T 1, P832, DOI 10.1039/p19760000832; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cai M, 2006, J CHROMATOGR B, V844, P301, DOI 10.1016/j.jchromb.2006.07.043; Canel C, 2001, PLANTA MED, V67, P97, DOI 10.1055/s-2001-10636; Cao GH, 1998, J NUTR, V128, P2383, DOI 10.1093/jn/128.12.2383; Carollo C, 2007, ANGIOLOGY, V58, P92, DOI 10.1177/0003319706295478; Chattopadhyay S, 2004, NAT PROD RES, V18, P51, DOI 10.1080/1057563031000122095; Chen WL, 2007, CHIN OPT LETT, V5, P706; Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), 2007, COP14 PROP, V27, P1; Dong JE, 2011, IND CROP PROD, V34, P1607, DOI 10.1016/j.indcrop.2011.06.007; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Editorial committee of Flora of China, 2011, FLORA CHINA, V19; FAY DA, 1985, J LIQ CHROMATOGR, V8, P1501, DOI 10.1080/01483918508067160; Fuglevand G, 1996, PLANT CELL, V8, P2347, DOI 10.1105/tpc.8.12.2347; Garson D., PATH ANAL; Giri A, 2000, CYTOTECHNOLOGY, V34, P17, DOI 10.1023/A:1008138230896; Goel H. C., 1998, Indian Journal of Experimental Biology, V36, P583; HOLTHUIS JJM, 1988, PHARM WEEKBLAD, V10, P101, DOI 10.1007/BF01959294; Hu SL, 1998, GEOAUTHENTHIC TRADIT; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; INAMORI Y, 1986, CHEM PHARM BULL, V34, P3928; KAMIL WM, 1986, PHYTOCHEMISTRY, V25, P2093, DOI 10.1016/0031-9422(86)80072-3; Kong Y, 2010, FITOTERAPIA, V81, P367, DOI 10.1016/j.fitote.2009.11.003; KRESTA JV, 1991, CAN J CHEM ENG, V69, P35, DOI 10.1002/cjce.5450690105; Lata H, 2010, IN VITRO CELL DEV-PL, V46, P22, DOI 10.1007/s11627-009-9243-5; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Lin MC, 2008, J FOOD DRUG ANAL, V16, P29; Liu GS, 2007, WASTE MANAGE, V27, P345, DOI 10.1016/j.wasman.2006.03.010; Liu J, 2002, METEOROLOGY; Liu T. C., 1995, PANAX QUINQUEFOLIUM; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110500; Lu GH, 2005, J CHROMATOGR A, V1073, P383, DOI 10.1016/j.chroma.2004.11.080; [鲁守平 LU Shouping], 2006, [天然产物研究与开发, Natural Product R & D], V18, P1027; MACGREGOR JF, 1994, AICHE J, V40, P826, DOI 10.1002/aic.690400509; Nadeem M, 2000, BIOL CONSERV, V92, P121, DOI 10.1016/S0006-3207(99)00059-2; Oksman-Caldentey KM, 2004, TRENDS PLANT SCI, V9, P433, DOI 10.1016/j.tplants.2004.07.006; Penuelas J, 1997, J CHEM ECOL, V23, P979, DOI 10.1023/B:JOEC.0000006383.29650.d7; Piovoso M, 1992, AM CONTR C, P2359; Purohit MC, 1999, CURR SCI INDIA, V77, P1078; Reddy PB, 2008, ARCH PHARM, V341, P126, DOI 10.1002/ardp.200700116; Rice-Evans C, 2001, CURR MED CHEM, V8, P797, DOI 10.2174/0929867013373011; Rickard-Bon SE, 2003, MED AROM PLANTS, V34, P181; Searles PS, 2001, OECOLOGIA, V127, P1, DOI 10.1007/s004420000592; STAHELIN HF, 1991, CANCER RES, V51, P5; Sun YJ, 2011, BIOORG MED CHEM LETT, V21, P3794, DOI 10.1016/j.bmcl.2011.04.036; Svensson B, 2003, SCAND J RHEUMATOL, V32, P83, DOI 10.1080/03009740310000085; TZENG SH, 1991, THROMB RES, V64, P91, DOI 10.1016/0049-3848(91)90208-E; Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007; Wilson KE, 1998, PHOTOCHEM PHOTOBIOL, V67, P547, DOI 10.1111/j.1751-1097.1998.tb09092.x; Wise BM, 1996, J PROCESS CONTR, V6, P329, DOI 10.1016/0959-1524(96)00009-1; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wulff Anu, 1999, Boreal Environment Research, V4, P77; Xiao M, 2006, J INTEGR PLANT BIOL, V48, P1140, DOI 10.1111/j.1744-7909.2006.00304.x; Xiao M, 2006, BIOCHEM GENET, V44, P44, DOI 10.1007/s10528-006-9006-5; Yang LW, 2005, J CHROMATOGR A, V1070, P35, DOI 10.1016/j.chroma.2005.02.081; Yeh YL, 2004, CAN J CIVIL ENG, V31, P56, DOI 10.1139/L03-074; Yin DX, 2014, BIORESOURCE TECHNOL, V166, P373, DOI 10.1016/j.biortech.2014.05.037; Zhao CQ, 2011, CHINESE CHEM LETT, V22, P181, DOI 10.1016/j.cclet.2010.10.013; Zhao CQ, 2001, CHEM PHARM BULL, V49, P1474, DOI 10.1248/cpb.49.1474; Zhou Y, 2008, CHROMATOGRAPHIA, V68, P781, DOI 10.1365/s10337-008-0786-0; Zhu CG, 2004, DRUG EVAL, V1, P306; Zhu R.B., 2001, CHINESE J AGR METEOR, V22, P19; Zidorn C, 2001, TAXON, V50, P115, DOI 10.2307/1224515; Zobayed SMA, 2005, PLANT PHYSIOL BIOCH, V43, P977, DOI 10.1016/j.plaphy.2005.07.013	66	29	33	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122981	10.1371/journal.pone.0122981	http://dx.doi.org/10.1371/journal.pone.0122981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874701	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800085
J	Badding, MA; Schwegler-Berry, D; Park, JH; Fix, NR; Cummings, KJ; Leonard, SS				Badding, Melissa A.; Schwegler-Berry, Diane; Park, Ju-Hyeong; Fix, Natalie R.; Cummings, Kristin J.; Leonard, Stephen S.			Sintered Indium-Tin Oxide Particles Induce Pro-Inflammatory Responses In Vitro, in Part through Inflammasome Activation	PLOS ONE			English	Article							NALP3 INFLAMMASOME; PRODUCTION FACILITY; PULMONARY TOXICITY; INHALATION; IL-1-BETA; MONOCYTES; CRYSTALS; RELEASE; CYTOTOXICITY; MACROPHAGES	Indium-tin oxide (ITO) is used to make transparent conductive coatings for touch-screen and liquid crystal display electronics. As the demand for consumer electronics continues to increase, so does the concern for occupational exposures to particles containing these potentially toxic metal oxides. Indium-containing particles have been shown to be cytotoxic in cultured cells and pro-inflammatory in pulmonary animal models. In humans, pulmonary alveolar proteinosis and fibrotic interstitial lung disease have been observed in ITO facility workers. However, which ITO production materials may be the most toxic to workers and how they initiate pulmonary inflammation remain poorly understood. Here we examined four different particle samples collected from an ITO production facility for their ability to induce pro-inflammatory responses in vitro. Tin oxide, sintered ITO (SITO), and ventilation dust particles activated nuclear factor kappa B (NF kappa B) within 3 h of treatment. However, only SITO induced robust cytokine production (IL-1 beta, IL-6, TNF alpha, and IL-8) within 24 h in both RAW 264.7 mouse macrophages and BEAS-2B human bronchial epithelial cells. Our lab and others have previously demonstrated SITO-induced cytotoxicity as well. These findings suggest that SITO particles activate the NLRP3 inflammasome, which has been implicated in several immune-mediated diseases via its ability to induce IL-1 beta release and cause subsequent cell death. Inflammasome activation by SITO was confirmed, but it required the presence of endotoxin. Further, a phagocytosis assay revealed that pre-uptake of SITO or ventilation dust impaired proper macrophage phagocytosis of E. coli. Our results suggest that adverse inflammatory responses to SITO particles by both macrophage and epithelial cells may initiate and propagate indium lung disease. These findings will provide a better understanding of the molecular mechanisms behind an emerging occupational health issue.	[Badding, Melissa A.; Schwegler-Berry, Diane; Fix, Natalie R.; Leonard, Stephen S.] NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA; [Park, Ju-Hyeong; Cummings, Kristin J.] NIOSH, Div Resp Dis Studies, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Badding, MA (corresponding author), NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA.	mbadding@cdc.gov			NIOSH intramural National Occupational Research Agenda (NORA) grant	NIOSH intramural National Occupational Research Agenda (NORA) grant	This work was supported by a NIOSH intramural National Occupational Research Agenda (NORA) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badding MA, 2014, J TOXICOL ENV HEAL A, V77, P1193, DOI 10.1080/15287394.2014.920757; Badding MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101310; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Biswas R, 2011, PULM MED, V2011, DOI 10.1155/2011/105707; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chonan T, 2007, EUR RESPIR J, V29, P317, DOI 10.1183/09030936.00020306; Cummings KJ, 2013, AM J IND MED, V56, P300, DOI 10.1002/ajim.22125; Cummings KJ, 2012, CHEST, V141, P1512, DOI 10.1378/chest.11-1880; Cummings KJ, 2010, AM J RESP CRIT CARE, V181, P458, DOI 10.1164/rccm.200907-1022CR; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gilbert Y, 2010, J APPL MICROBIOL, V108, P437, DOI 10.1111/j.1365-2672.2009.04433.x; Gwinn WM, 2013, TOXICOL SCI, V135, P414, DOI 10.1093/toxsci/kft154; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamaguchi T, 2008, OCCUP ENVIRON MED, V65, P51, DOI 10.1136/oem.2006.029124; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Homma T, 2003, J OCCUP HEALTH, V45, P137, DOI 10.1539/joh.45.137; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim BC, 2002, MATER LETT, V52, P114, DOI 10.1016/S0167-577X(01)00377-9; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Leonard SS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-32; Lison D, 2009, TOXICOL SCI, V108, P472, DOI 10.1093/toxsci/kfp014; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; MILTON DK, 1992, ENVIRON RES, V57, P212, DOI 10.1016/S0013-9351(05)80081-7; Miyauchi H, 2012, J OCCUP HEALTH, V54, P103, DOI 10.1539/joh.11-0233-OA; Nagano K, 2011, J OCCUP HEALTH, V53, P234, DOI 10.1539/joh.10-0053-BR; Nagano K, 2011, J OCCUP HEALTH, V53, P51, DOI 10.1539/joh.L10128; Nakano M, 2009, J OCCUP HEALTH, V51, P513, DOI 10.1539/joh.L9077; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; NIOSH, 2012, US DEP HLTH HUM SERV, V2012-146; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sandberg WJ, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-32; Tanaka A, 2010, J OCCUP HEALTH, V52, P14, DOI 10.1539/joh.L9097; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Udawatte CP, 2001, J AM CERAM SOC, V84, P251, DOI 10.1111/j.1151-2916.2001.tb00645.x	44	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124368	10.1371/journal.pone.0124368	http://dx.doi.org/10.1371/journal.pone.0124368			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874458	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100255
J	Guaita, M; Melia, U; Vallverdu, M; Caminal, P; Vilaseca, I; Montserrat, JM; Gaig, C; Salamero, M; Santamaria, J				Guaita, Marc; Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere; Vilaseca, Isabel; Montserrat, Josep M.; Gaig, Carles; Salamero, Manel; Santamaria, Joan			Regularity of Cardiac Rhythm as a Marker of Sleepiness in Sleep Disordered Breathing	PLOS ONE			English	Article							AUTONOMIC INFORMATION-FLOW; HEART-RATE-VARIABILITY; LATENCY TEST; PRACTICE PARAMETERS; DAYTIME SLEEPINESS; WAKEFULNESS TEST; MAINTENANCE; AROUSAL; SCALE; ONSET	Aim The present study aimed to analyse the autonomic nervous system activity using heart rate variability (HRV) to detect sleep disordered breathing (SDB) patients with and without excessive daytime sleepiness (EDS) before sleep onset. Methods Two groups of 20 patients with different levels of daytime sleepiness -sleepy group, SG; alert group, AG-were selected consecutively from a Maintenance of Wakefulness Test (MWT) and Multiple Sleep Latency Test (MSLT) research protocol. The first waking 3-min window of RR signal at the beginning of each nap test was considered for the analysis. HRV was measured with traditional linear measures and with time-frequency representations. Non-linear measures -correntropy, CORR; auto-mutual-information function, AMIF-were used to describe the regularity of the RR rhythm. Statistical analysis was performed with non-parametric tests. Results Non-linear dynamic of the RR rhythm was more regular in the SG than in the AG during the first wakefulness period of MSLT, but not during MWT. AMIF (in high-frequency and in Total band) and CORR (in Total band) yielded sensitivity > 70%, specificity >75% and an area under ROC curve >0.80 in classifying SG and AG patients. Conclusion The regularity of the RR rhythm measured at the beginning of the MSLT could be used to detect SDB patients with and without EDS before the appearance of sleep onset.	[Guaita, Marc; Vilaseca, Isabel; Montserrat, Josep M.; Gaig, Carles; Salamero, Manel; Santamaria, Joan] Hosp Clin Barcelona, Multidisciplinary Unit Sleep Disorders, Barcelona, Spain; [Guaita, Marc; Salamero, Manel; Santamaria, Joan] IDIBAPS, Barcelona, Spain; [Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere] CIBER, BBN, BarcelonaTech, Ctr Biomed Engn Res,Dept ESAII, Barcelona, Spain; [Vilaseca, Isabel] Hosp Clin Barcelona, Dept Otorhinolaryngol, Barcelona, Spain; [Vilaseca, Isabel; Montserrat, Josep M.] CIBERES, Madrid, Spain; [Vilaseca, Isabel; Montserrat, Josep M.; Salamero, Manel; Santamaria, Joan] Univ Barcelona, Sch Med, Barcelona, Spain; [Montserrat, Josep M.] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain; [Gaig, Carles; Santamaria, Joan] Hosp Clin Barcelona, Dept Neurol, Barcelona, Spain; [Gaig, Carles; Santamaria, Joan] Ciber Enfermedades Neurol CIBERNED, Barcelona, Spain; [Salamero, Manel] Hosp Clin Barcelona, Dept Psychiat, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona	Guaita, M (corresponding author), Hosp Clin Barcelona, Multidisciplinary Unit Sleep Disorders, Barcelona, Spain.	marcguaita@gmail.com; jsantama@clinic.ub.es	Vilaseca, Isabel/J-1528-2019	Vilaseca, Isabel/0000-0003-4399-5522; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Melia, Umberto/0000-0003-3033-0505	FIS [PI07/0318]; FEDER; CICYT [TEC2013-44666-R]; Spanish Government [FPU AP2009-0858]	FIS(Instituto de Salud Carlos III); FEDER(European Commission); CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by FIS PI07/0318 to MS, cofinanced by FEDER. Barcelona Tech group was supported by the CICYT grant TEC2013-44666-R and the Research Fellowship Grant FPU AP2009-0858 from the Spanish Government.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Bonnet MH, 2005, SLEEP, V28, P685, DOI 10.1093/sleep/28.6.685; Bonnet MH, 1999, J SLEEP RES, V8, P247, DOI 10.1046/j.1365-2869.1999.00168.x; Bonnet MH, 2001, SLEEP, V24, P441, DOI 10.1093/sleep/24.4.441; Bonnet MH, 2000, PHYSIOL BEHAV, V71, P485, DOI 10.1016/S0031-9384(00)00353-X; Burgess HJ, 1999, PSYCHOPHYSIOLOGY, V36, P298, DOI 10.1017/S0048577299980198; Camm AJ, 1996, EUR HEART J, V17, P354; Carrington MJ, 2005, J APPL PHYSIOL, V98, P468, DOI 10.1152/japplphysiol.00702.2004; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chervin RD, 1999, NEUROLOGY, V52, P125, DOI 10.1212/WNL.52.1.125; Chervin RD, 2000, CHEST, V118, P372, DOI 10.1378/chest.118.2.372; Chua ECP, 2012, SLEEP, V35, P325, DOI 10.5665/sleep.1688; Claria F, 2005, PHYSIOL MEAS, V29, P401; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; De Gennaro L, 2005, J SLEEP RES, V14, P107, DOI 10.1111/j.1365-2869.2005.00444.x; Doghramji K, 1993, ELECTROENCEPHALOGR C, V103, P554; Donadio V, 2007, J SLEEP RES, V16, P327, DOI 10.1111/j.1365-2869.2007.00602.x; Goncalves MA, 2004, CHEST, V125, P2091, DOI 10.1378/chest.125.6.2091; Hoyer D, 2005, IEEE T BIO-MED ENG, V52, P584, DOI 10.1109/TBME.2005.844023; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Lombardi C, 2008, J SLEEP RES, V17, P263, DOI 10.1111/j.1365-2869.2008.00659.x; Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631; McCullagh P., 1990, GEN LINEAR MODELS, V2nd; Melia U, 2014, PHYSIOL MEAS, V35, P2067, DOI 10.1088/0967-3334/35/10/2067; Palacios M, 2007, PHYSIOL MEAS, V28, P677, DOI 10.1088/0967-3334/28/6/006; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pivik RT, 1996, J SLEEP RES, V5, P33, DOI 10.1046/j.1365-2869.1996.d01-50.x; Porta A, 2007, AM J PHYSIOL-HEART C, V293, pH702, DOI 10.1152/ajpheart.00006.2007; SANGAL RB, 1992, CHEST, V101, P898, DOI 10.1378/chest.101.4.898; Santamaria I, 2006, IEEE T SIGNAL PROCES, V54, P2187, DOI 10.1109/TSP.2006.872524; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Shinar Z, 2006, AUTON NEUROSCI-BASIC, V130, P17, DOI 10.1016/j.autneu.2006.04.006	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122645	10.1371/journal.pone.0122645	http://dx.doi.org/10.1371/journal.pone.0122645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860587	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300053
J	Jelesijevic, T; Zimmerman, SM; Harvey, SB; Mead, DG; Shaffer, TL; Estes, DM; Michel, F; Quinn, FD; Hogan, RJ; Lafontaine, ER				Jelesijevic, Tomislav; Zimmerman, Shawn M.; Harvey, Stephen B.; Mead, Daniel G.; Shaffer, Teresa L.; Estes, D. Mark; Michel, Frank; Quinn, Frederick D.; Hogan, Robert J.; Lafontaine, Eric R.			Use of the Common Marmoset to Study Burkholderia mallei Infection	PLOS ONE			English	Article							GLANDERS; MODEL; MELIOIDOSIS	Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. malleiand there is concern regarding its use as a biothreat agent. Thus, experiments were performed to establish a non-human primate model of intranasal infection to study the organism and develop countermeasures. Groups of marmosets (Callithrix jacchus) were inoculated intranasally with B. mallei strain ATCC 23344 and monitored for clinical signs of illness for up to 13 days. We discovered that 83% of marmosets inoculated with doses of 2.5 X 10(4) to 2.5 X 10(5) bacteria developed acute lethal infection within 3-4 days. Signs of disease were severe and included lethargy, inappetence, conjunctivitis, mucopurulent and hemorrhagic nasal discharges, and increased respiratory effort with abdominal lifts. Burkholderia mallei was cultured from the lungs, spleen and liver of these animals, and pathologic examination of tissues revealed lesions characteristic of glanders. Challenge experiments also revealed that 91% of animals infected with doses ranging from 25 to 2.5 X 10(3) bacteria exhibited mild non-specific signs of illness and were culture negative. One marmoset inoculated with 2.5 X 10(3) organisms developed moderate signs of disease and reached humane end-points 8 days post-infection. The liver and spleen of this animal were colonized with the agent and pathological analysis of tissues showed nasal, splenic and hepatic lesions. Taken together, these data indicate that the marmoset is a suitable model to study respiratory infection by B. mallei.	[Jelesijevic, Tomislav; Zimmerman, Shawn M.; Estes, D. Mark; Quinn, Frederick D.; Hogan, Robert J.; Lafontaine, Eric R.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Harvey, Stephen B.; Mead, Daniel G.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA; [Shaffer, Teresa L.] Univ Georgia, Franklin Coll Arts & Sci, Dept Microbiol, Athens, GA USA; [Jelesijevic, Tomislav; Michel, Frank; Hogan, Robert J.] Univ Georgia, Coll Vet Med, Dept Vet Biosci & Diagnost Imaging, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lafontaine, ER (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	elafon10@uga.edu			NIAID [U01 AI082103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082103] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIAID award U01 AI082103. The funders had no input in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Alibek K, 1999, BIOHAZARD CHILLING T; [Anonymous], 1971, IMMUNOBIOLOGII; Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Carr-Gregory B, 2007, MED ASPECTS BIOL WAR, P121; da Silva KPC, 2013, BRAZ J MICROBIOL, V44, P179, DOI 10.1590/S1517-83822013005000022; Derbyshire JB, 2002, CAN VET J, V43, P722; DeShazer D, 2001, MICROB PATHOGENESIS, V30, P253, DOI 10.1006/mpat.2000.0430; Duval CW, 1907, J EXP MED, V9, P352, DOI 10.1084/jem.9.4.352; Dvorak GD, 2008, JAVMA-J AM VET MED A, V233, P570, DOI 10.2460/javma.233.4.570; FERSTER LN, 1982, ARK PATOL, V44, P24; Fritz DL, 1999, VET PATHOL, V36, P276, DOI 10.1354/vp.36-4-276; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Howe C., 1950, OXFORD MED, P185; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Khan I, 2013, TRANSBOUND EMERG DIS, V60, P204, DOI 10.1111/j.1865-1682.2012.01342.x; Khomiakov Iu N, 1998, Zh Mikrobiol Epidemiol Immunobiol, P70; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Lehavi O, 2002, HAREFUAH, V141, P88; Lever MS, 2003, J MED MICROBIOL, V52, P1109, DOI 10.1099/jmm.0.05180-0; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Manzeniuk IN, 1996, MINISTERSTVO MEDITSI, V41, P13; MILLER WR, 1948, J BACTERIOL, V55, P127, DOI 10.1128/JB.55.1.127-135.1948; Nelson M, 2014, INT J EXP PATHOL, V95, P378, DOI 10.1111/iep.12105; Nelson M, 2011, INT J EXP PATHOL, V92, P428, DOI 10.1111/j.1365-2613.2011.00791.x; Neubauer H., 1997, Revue Internationale des Services de Sante des Forces Armees, V70, P258; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Reed L.J., 1938, AM J HYG, V27, P793; Regis E, 1999, BIOL DOOM; Robins G, 1906, STUDIES ROYAL VICTOR, V1, P1; Saqib M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-214; Scholz HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003195; SHARRER GT, 1995, AGR HIST, V69, P79; Slater J, 2013, VET REC, V173, P186, DOI 10.1136/vr.f5260; Smart JK, 1997, TXB MILITARY MED, P16; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Van Zandt KE, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-131; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; Wernery U, 2011, EMERG INFECT DIS, V17, P1277, DOI 10.3201/eid1707.110222; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Wheelis M., 1999, BIOLOGICAL TOXIN WEA, P35; Woods DE, 2002, TRENDS MICROBIOL, V10, P483, DOI 10.1016/S0966-842X(02)02464-2	47	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124181	10.1371/journal.pone.0124181	http://dx.doi.org/10.1371/journal.pone.0124181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860021	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300132
J	Knapp, M; Rezac, M				Knapp, Michal; Rezac, Milan			Even the Smallest Non-Crop Habitat Islands Could Be Beneficial: Distribution of Carabid Beetles and Spiders in Agricultural Landscape	PLOS ONE			English	Article							GROUND BEETLES; SPECIES RICHNESS; PATCH SIZE; DIVERSITY; BIODIVERSITY; ASSEMBLAGES; COLEOPTERA; ABUNDANCE; ARANEAE; FIELD	Carabid beetles and ground-dwelling spiders inhabiting agroecosystems are beneficial organisms with a potential to control pest species. Intensification of agricultural management and reduction of areas covered by non-crop vegetation during recent decades in some areas has led to many potentially serious environmental problems including a decline in the diversity and abundance of beneficial arthropods in agricultural landscapes. This study investigated carabid beetle and spider assemblages in non-crop habitat islands of various sizes (50 to 18,000 square metres) within one large field, as well as the arable land within the field, using pitfall traps in two consecutive sampling periods (spring to early summer and peak summer). The non-crop habitat islands situated inside arable land hosted many unique ground-dwelling arthropod species that were not present within the surrounding arable land. Even the smallest non-crop habitat islands with areas of tens of square metres were inhabited by assemblages substantially different from these inhabiting arable land and thus enhanced the biodiversity of agricultural landscapes. The non-crop habitat area substantially affected the activity density, recorded species richness and recorded species composition of carabid and ground-dwelling spider assemblages; however, the effects were weakened when species specialised to non-crop habitats species were analysed separately. Interestingly, recorded species richness of spiders increased with non-crop habitat area, whereas recorded species richness of carabid beetles exhibited an opposite trend. There was substantial temporal variation in the spatial distribution of ground-dwelling arthropods, and contrasting patterns were observed for particular taxa (carabid beetles and spiders). In general, local environmental conditions (i.e., non-crop habitat island tree cover, shrub cover, grass cover and litter depth) were better determinants of arthropod assemblages than non-crop habitat island size, indicating that the creation of quite small but diversified (e.g., differing in vegetation cover) non-crop habitat islands could be the most efficient tool for the maintenance and enhancement of diversity of ground-dwelling carabids and spiders in agricultural landscapes.	[Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Rezac, Milan] Crop Res Inst, Grp Funct Biodivers, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Crop Research Institute (CRI)	Knapp, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	knapp@fzp.czu.cz	Řezáč, Milan/ABE-8186-2020; Knapp, Michal/AAF-4864-2020	Knapp, Michal/0000-0003-4487-7317; Rezac, Milan/0000-0003-4373-7064	grants IGA - Czech University of Life Sciences Prague [42900/1312/3166, 42110/1312/3164]	grants IGA - Czech University of Life Sciences Prague	The study was financially supported by grants IGA #42900/1312/3166 and #42110/1312/3164 awarded by the Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, CARABIDAE CZECH SLOV; Aviron S, 2005, AGR ECOSYST ENVIRON, V108, P205, DOI 10.1016/j.agee.2005.02.004; Baines M, 1998, ECOGRAPHY, V21, P74, DOI 10.1111/j.1600-0587.1998.tb00395.x; Batary P, 2012, AGR ECOSYST ENVIRON, V146, P130, DOI 10.1016/j.agee.2011.10.018; Bell JR, 2002, AGR ECOSYST ENVIRON, V93, P295, DOI 10.1016/S0167-8809(01)00343-7; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Cameron KH, 2012, J INSECT CONSERV, V16, P523, DOI 10.1007/s10841-011-9438-z; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Carvalheiro LG, 2012, J APPL ECOL, V49, P1373, DOI 10.1111/j.1365-2664.2012.02217.x; Castellazzi MS, 2007, AGR ECOSYST ENVIRON, V118, P339, DOI 10.1016/j.agee.2006.06.003; Crowley MJ, 2012, R BOOK; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Desender K, 2010, BIOL CONSERV, V143, P1549, DOI 10.1016/j.biocon.2010.03.039; Diekotter T, 2013, INSECT CONSERV DIVER, V6, P607, DOI 10.1111/icad.12015; Diekotter T, 2010, AGR ECOSYST ENVIRON, V137, P108, DOI 10.1016/j.agee.2010.01.008; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fournier E, 2001, LANDSCAPE ECOL, V16, P17, DOI 10.1023/A:1008115516551; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Geiger F, 2009, BIOCONTROL, V54, P529, DOI 10.1007/s10526-008-9206-5; Hambler C., 2013, CONSERVATION; Hancock MH, 2012, INSECT CONSERV DIVER, V5, P312, DOI 10.1111/j.1752-4598.2011.00162.x; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Holland JM, 2005, J APPL ECOL, V42, P1140, DOI 10.1111/j.1365-2664.2005.01083.x; Jonsson M, 2009, ECOGRAPHY, V32, P963, DOI 10.1111/j.1600-0587.2009.05784.x; Knapp M, 2012, EUR J ENTOMOL, V109, P419, DOI 10.14411/eje.2012.054; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Laura Moreno M, 2013, J INSECT SCI, V13; Leps J, 2014, MULTIVARIATE ANAL EC; Lindborg R, 2014, BIOL CONSERV, V169, P206, DOI 10.1016/j.biocon.2013.11.015; LOBL I., 2003, ARCHOSTEMATA MYXOPHA, V1, P1, DOI DOI 10.1673/031.013.12601; Lovei GL, 2006, GLOBAL ECOL BIOGEOGR, V15, P283, DOI 10.1111/j.1466-8238.2005.00221.x; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Magura T, 2007, AGR ECOSYST ENVIRON, V119, P396, DOI 10.1016/j.agee.2006.08.014; Marc P, 1999, AGR ECOSYST ENVIRON, V74, P229, DOI 10.1016/S0167-8809(99)00038-9; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Oberg S, 2007, AGR ECOSYST ENVIRON, V122, P211, DOI 10.1016/j.agee.2006.12.034; Platnick N.I., 2012, WORLD SPIDER CATALOG; Pluess T, 2010, AGR ECOSYST ENVIRON, V137, P68, DOI 10.1016/j.agee.2009.12.020; R Development Core Team, LANG ENV STAT COMP; Ribera I, 2001, ECOLOGY, V82, P1112, DOI 10.1890/0012-9658(2001)082[1112:EOLDAS]2.0.CO;2; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Roume A, 2011, AGR FOREST ENTOMOL, V13, P395, DOI 10.1111/j.1461-9563.2011.00534.x; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Saska P, 2013, J APPL ECOL, V50, P181, DOI 10.1111/1365-2664.12023; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Sunderland K, 2000, ENTOMOL EXP APPL, V95, P1, DOI 10.1023/A:1003986225443; Thomas CFG, 2001, J APPL ECOL, V38, P100, DOI 10.1046/j.1365-2664.2001.00574.x; THOMAS MB, 1992, J APPL ECOL, V29, P524, DOI 10.2307/2404521; Torma A, 2014, AGR ECOSYST ENVIRON, V196, P42, DOI 10.1016/j.agee.2014.06.021; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Wamser S, 2012, INSECT CONSERV DIVER, V5, P9, DOI 10.1111/j.1752-4598.2010.00110.x; Weibull AC, 2003, BIODIVERS CONSERV, V12, P1335, DOI 10.1023/A:1023617117780; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Woodcock BA, 2014, J APPL ECOL, V51, P142, DOI 10.1111/1365-2664.12171; Zhao ZH, 2013, BASIC APPL ECOL, V14, P472, DOI 10.1016/j.baae.2013.06.002	67	46	54	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123052	10.1371/journal.pone.0123052	http://dx.doi.org/10.1371/journal.pone.0123052			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859850	gold, Green Submitted, Green Published			2022-12-26	WOS:000352590300075
J	Long, YH; Ye, H				Long, Yan-Hua; Ye, Hong			Filled Pause Refinement Based on the Pronunciation Probability for Lecture Speech	PLOS ONE			English	Article							DISFLUENCIES; ERROR	Nowadays, although automatic speech recognition has become quite proficient in recognizing or transcribing well-prepared fluent speech, the transcription of speech that contains many disfluencies remains problematic, such as spontaneous conversational and lecture speech. Filled pauses (FPs) are the most frequently occurring disfluencies in this type of speech. Most recent studies have shown that FPs are widely believed to increase the error rates for state-of-the-art speech transcription, primarily because most FPs are not well annotated or provided in training data transcriptions and because of the similarities in acoustic characteristics between FPs and some common non-content words. To enhance the speech transcription system, we propose a new automatic refinement approach to detect FPs in British English lecture speech transcription. This approach combines the pronunciation probabilities for each word in the dictionary and acoustic language model scores for FP refinement through a modified speech recognition forced-alignment framework. We evaluate the proposed approach on the Reith Lectures speech transcription task, in which only imperfect training transcriptions are available. Successful results are achieved for both the development and evaluation datasets. Acoustic models trained on different styles of speech genres have been investigated with respect to FP refinement. To further validate the effectiveness of the proposed approach, speech transcription performance has also been examined using systems built on training data transcriptions with and without FP refinement.	[Long, Yan-Hua; Ye, Hong] Shanghai Normal Univ, Elect & Informat Engn Dept, Shanghai, Peoples R China	Shanghai Normal University	Long, YH (corresponding author), Shanghai Normal Univ, Elect & Informat Engn Dept, Shanghai, Peoples R China.	yanhua@shnu.edu.cn			Shanghai Science and Technology Development Funds [14YF1409300]; Research Foundation of Young Teachers Program in University of Shanghai [ZZshsf14026]; Jiangsu Higher Institutions' Key Research Base for Philosophy and Social Sciences [2010JDXM024]	Shanghai Science and Technology Development Funds; Research Foundation of Young Teachers Program in University of Shanghai; Jiangsu Higher Institutions' Key Research Base for Philosophy and Social Sciences	This work was partially funded by the Shanghai Science and Technology Development Funds (Grant No. 14YF1409300), the Research Foundation of Young Teachers Program in University of Shanghai (Grant No. ZZshsf14026) and the Jiangsu Higher Institutions' Key Research Base for Philosophy and Social Sciences (Grant No. 2010JDXM024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell J, 2012, SPEECH COMMUN, V54, P459, DOI 10.1016/j.specom.2011.10.010; An GZ, 2013, INTERSPEECH, P178; Audhkhasi K, 2009, INT CONF ACOUST SPEE, P4857, DOI 10.1109/ICASSP.2009.4960719; Bell PJ, 2012, IEEE W SP LANG TECH, P324, DOI 10.1109/SLT.2012.6424244; Benus S., 2012, P 3 IEEE C COGN INF; Bisani M, 2008, SPEECH COMMUN, V50, P434, DOI 10.1016/j.specom.2008.01.002; Braunschweiler N, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2222; Corley M, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00068.x; Dall R, 2014, INTERSPEECH, P51; Dufour R, 2014, SPEECH COMMUN, V56, P1, DOI 10.1016/j.specom.2013.07.007; Fraundorf SH, 2011, J MEM LANG, V65, P161, DOI 10.1016/j.jml.2011.03.004; Georgila Kallirroi, 2009, P HUM LANG TECHN 200, P109; Godfrey J.J., 1997, SWITCHBOARD 1 RELEAS; Goldwater S, 2010, SPEECH COMMUN, V52, P181, DOI 10.1016/j.specom.2009.10.001; Jonathan F, 1998, 1997 ENGLISH BROADCA; KNESER R, 1995, INT CONF ACOUST SPEE, P181, DOI 10.1109/ICASSP.1995.479394; Kumar N., 1997, THESIS J HOPKINS U; Lafferty J, 2001, CONDITIONAL RANDOM F, P282; Lease M, 2006, IEEE T AUDIO SPEECH, V14, P1566, DOI 10.1109/TASL.2006.878269; Long Y, 2013, INTERSPEECH, P2186; Martin A., 1997, P EUR C SPEECH COMM; Medeiros H, 2013, INTERSPEECH, P2628; Moniz H, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P1959; Povey D, 2002, INT CONF ACOUST SPEE, P105; Robinson A., 1996, BRIT ENGLISH EXAMPLE; Shriberg E., 2005, INTERSPEECH 2005, P1781; Shriberg E, 1999, INT C PHON SCI SAN F, P612; Shriberg E, 1996, P INT C SPOK LANG PR, V96, P3; Tranter SE, 2004, P 2004 RICH TRANSCR; Wang D, 2004, P IEEE INT C AC SPEE, pI; Wang W, 2013, HLT NAACL, P703; Young S., 2009, HTK BOOK; Zwarts S, 2011, P 49 ANN M ASS COMP, V1, P703	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123466	10.1371/journal.pone.0123466	http://dx.doi.org/10.1371/journal.pone.0123466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860959	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300100
J	Palmer, K; Horn, MA				Palmer, Katharina; Horn, Marcus A.			Denitrification Activity of a Remarkably Diverse Fen Denitrifier Community in Finnish Lapland Is N-Oxide Limited	PLOS ONE			English	Article							NITROUS-OXIDE; MICROBIAL COMMUNITIES; WATER-TABLE; NOSZ GENES; N2O; NITRATE; BACTERIA; METHANE; RESPONSES; FLUXES	Peatlands cover more than 30% of the Finnish land area and impact N2O fluxes. Denitrifiers release N2O as an intermediate or end product. In situ N2O emissions of a near pH neutral pristine fen soil in Finnish Lapland were marginal during gas chamber measurements. However, nitrate and ammonium fertilization significantly stimulated in situ N2O emissions. Stimulation with nitrate was stronger than with ammonium. N2O was produced and subsequently consumed in gas chambers. In unsupplemented anoxic microcosms, fen soil produced N2O only when acetylene was added to block nitrous oxide reductase, suggesting complete denitrification. Nitrate and nitrite stimulated denitrification in fen soil, and maximal reaction velocities (v(max)) of nitrate or nitrite dependent denitrification where 18 and 52 nmol N2O h(-1) g(DW)(-1), respectively. N2O was below 30% of total produced N gases in fen soil when concentrations of nitrate and nitrite were <500 mu M. v(max) for N2O consumption was up to 36 nmol N2O h(-1) gDW(-1). Denitrifier diversity was assessed by analyses of narG, nirK/nirS, and nosZ (encoding nitrate-, nitrite-, and nitrous oxide reductases, respectively) by barcoded amplicon pyrosequencing. Analyses of similar to 14,000 quality filtered sequences indicated up to 25 species-level operational taxonomic units (OTUs), and up to 359 OTUs at 97% sequence similarity, suggesting diverse denitrifiers. Phylogenetic analyses revealed clusters distantly related to publicly available sequences, suggesting hitherto unknown denitrifiers. Representatives of species-level OTUs were affiliated with sequences of unknown soil bacteria and Actinobacterial, Alpha-, Beta-, Gamma-, and Delta-Proteobacterial sequences. Comparison of the 4 gene markers at 97% similarity indicated a higher diversity of narG than for the other gene markers based on Shannon indices and observed number of OTUs. The collective data indicate (i) a high denitrification and N2O consumption potential, and (ii) a highly diverse, nitrate limited denitrifier community associated with potential N2O fluxes in a pH-neutral fen soil.	[Palmer, Katharina; Horn, Marcus A.] Univ Bayreuth, Dept Ecol Microbiol, Bayreuth, Germany	University of Bayreuth	Horn, MA (corresponding author), Univ Bayreuth, Dept Ecol Microbiol, Bayreuth, Germany.	marcus.horn@uni-bayreuth.de	Horn, Marcus A./E-3726-2013	Horn, Marcus A./0000-0001-8510-9651; Kujala, Katharina/0000-0003-3697-8521	German Research Foundation (DFG) [HO 4020/2-2]; German Academic Exchange Service (DAAD); LAPBIAT (part of the 6th EU Framework Program "Infrastructures"); DFG; University of Bayreuth	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); LAPBIAT (part of the 6th EU Framework Program "Infrastructures"); DFG(German Research Foundation (DFG)); University of Bayreuth	Funding of consumables was provided by the German Research Foundation (DFG), grant HO 4020/2-2. Funding of KP's stay in Finland and infrastructure at the field site were provided by the German Academic Exchange Service (DAAD) and LAPBIAT (part of the 6th EU Framework Program "Infrastructures"), respectively. Publication was funded by DFG and the University of Bayreuth in the funding programme "Open Access Publishing". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA JS, 1995, BIOTECHNOL BIOENG, V46, P476, DOI 10.1002/bit.260460512; Blicher-Mathiesen G, 1999, J ENVIRON QUAL, V28, P257, DOI 10.2134/jeq1999.00472425002800010031x; Braker G, 2011, ADV APPL MICROBIOL, V75, P33, DOI 10.1016/B978-0-12-387046-9.00002-5; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Demaneche S, 2009, APPL ENVIRON MICROB, V75, P534, DOI 10.1128/AEM.01706-08; Eurola S, 1984, EUROPEAN MIRES, P11, DOI [10.1016/b978-0-12-505580-2.50006-4, DOI 10.1016/B978-0-12-505580-2.50006-4]; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Goldberg SD, 2008, ISOT ENVIRON HEALT S, V44, P377, DOI 10.1080/10256010802507433; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jahangir MMR, 2012, AGR ECOSYST ENVIRON, V147, P13, DOI 10.1016/j.agee.2011.04.015; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Jones CM, 2011, FEMS MICROBIOL ECOL, V76, P541, DOI 10.1111/j.1574-6941.2011.01071.x; Kirchman DL, 2001, DEEP-SEA RES PT II, V48, P4179, DOI 10.1016/S0967-0645(01)00085-6; Kolb Steffen, 2012, Front Microbiol, V3, P78, DOI 10.3389/fmicb.2012.00078; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lohila A, 2010, EUR J SOIL SCI, V61, P651, DOI 10.1111/j.1365-2389.2010.01265.x; MAHNE I, 1995, APPL ENVIRON MICROB, V61, P1110, DOI 10.1128/AEM.61.3.1110-1115.1995; Maljanen M, 2010, BIOGEOSCIENCES, V7, P2711, DOI 10.5194/bg-7-2711-2010; Mannisto MK, 2006, SYST APPL MICROBIOL, V29, P229, DOI 10.1016/j.syapm.2005.09.001; MARTIKAINEN PJ, 1993, NATURE, V366, P51, DOI 10.1038/366051a0; Marushchak ME, 2011, GLOBAL CHANGE BIOL, V17, P2601, DOI 10.1111/j.1365-2486.2011.02442.x; Moore TR, 1998, CLIMATIC CHANGE, V40, P229, DOI 10.1023/A:1005408719297; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Palmer K, 2012, APPL ENVIRON MICROB, V78, P5584, DOI 10.1128/AEM.00810-12; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Palmer K, 2010, APPL ENVIRON MICROB, V76, P1125, DOI 10.1128/AEM.02256-09; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Persoh D, 2008, J MICROBIOL METH, V75, P19, DOI 10.1016/j.mimet.2008.04.009; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ratkowsky D., 1983, NONLINEAR REGRESSION; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rich JJ, 2003, APPL ENVIRON MICROB, V69, P5974, DOI 10.1128/AEM.69.10.5974-5982.2003; Roobroeck D, 2010, EUR J SOIL SCI, V61, P662, DOI 10.1111/j.1365-2389.2010.01269.x; ROULET N, 1992, TELLUS B, V44, P100, DOI 10.1034/j.1600-0889.1992.t01-1-00002.x; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Singh BK, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c1; Smith KA, 1997, GLOBAL CHANGE BIOL, V3, P327, DOI 10.1046/j.1365-2486.1997.00100.x; Takakai F, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000521; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; van Cleemput O, 1998, NUTR CYCL AGROECOSYS, V52, P187, DOI 10.1023/A:1009728125678; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Whitman WB, 2012, BERGEYS MANUAL OF SY; YOSHINARI T, 1976, BIOCHEM BIOPH RES CO, V69, P705, DOI 10.1016/0006-291X(76)90932-3; Zaprasis A, 2010, APPL ENVIRON MICROB, V76, P119, DOI 10.1128/AEM.01727-09; Zenova GM, 2011, EURASIAN SOIL SCI+, V44, P417, DOI 10.1134/S1064229311040132; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	59	27	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123123	10.1371/journal.pone.0123123	http://dx.doi.org/10.1371/journal.pone.0123123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860353	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300079
J	Rausch, JW; Tian, MJ; Li, YJ; Angelova, L; Bagaya, BS; Krebs, KC; Qian, F; Zhu, CW; Arts, EJ; Le Grice, SFJ; Gao, Y				Rausch, Jason W.; Tian, Meijuan; Li, Yuejin; Angelova, Lora; Bagaya, Bernard S.; Krebs, Kendall C.; Qian, Feng; Zhu, Chuanwu; Arts, Eric J.; Le Grice, Stuart F. J.; Gao, Yong			SiRNA-Induced Mutation in HIV-1 Polypurine Tract Region and Its Influence on Viral Fitness	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRAND DNA-SYNTHESIS; TYPE-1 REVERSE-TRANSCRIPTASE; SEQUENCE FEATURES IMPORTANT; RIBONUCLEASE-H; SUBSTRATE-SPECIFICITY; RNA/DNA HYBRID; PRIMER; INTEGRASE	Converting single-stranded viral RNA into double stranded DNA for integration is an essential step in HIV-1 replication. Initial polymerization of minus-strand DNA is primed from a host derived tRNA, whereas subsequent plus-strand synthesis requires viral primers derived from the 3' and central polypurine tracts (3' and cPPTs). The 5' and 3' termini of these conserved RNA sequence elements are precisely cleaved by RT-associated RNase H to generate specific primers that are used to initiate plus-strand DNA synthesis. In this study, siRNA wad used to produce a replicative HIV-1 variant contained G(-1) A and T(-16) A substitutions within/adjacent to the 3'PPT sequence. Introducing either or both mutations into the 3'PPT region or only the G(-1) A substitution in the cPPT region of NL4-3 produced infectious virus with decreased fitness relative to the wild-type virus. In contrast, introducing the T(-16) A or both mutations into the cPPT rendered the virus(es) incapable of replication, most likely due to the F185L integrase mutation produced by this nucleotide substitution. Finally, the effects of G(-1) A and T(-16) A mutations on cleavage of the 3'PPT were examined using an in vitro RNase H cleavage assay. Substrate containing both mutations was miscleaved to a greater extent than either wild-type substrate or substrate containing the T(-16) A mutation alone, which is consistent with the observed effects of the equivalent nucleotide substitutions on the replication fitness of NL4-3 virus. In conclusion, siRNA targeting of the HIV-1 3'PPT region can substantially suppress virus replication, and this selective pressure can be used to generate infectious virus containing mutations within or near the HIV-1 PPT. Moreover, in-depth analysis of the resistance mutations demonstrates that although virus containing a G(-1) A mutation within the 3'PPT is capable of replication, this nucleotide substitution shifts the 3'-terminal cleavage site in the 3'PPT by one nucleotide (nt) and significantly reduces viral fitness.	[Rausch, Jason W.; Le Grice, Stuart F. J.] Frederick Natl Lab Canc Res, HIV Drug Resistance Program, Frederick, MD USA; [Tian, Meijuan; Li, Yuejin; Angelova, Lora; Krebs, Kendall C.; Gao, Yong] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Bagaya, Bernard S.; Gao, Yong] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Qian, Feng; Zhu, Chuanwu] Suzhou Fifth Peoples Hosp, Suzhou, Jiangsu, Peoples R China; [Arts, Eric J.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; Case Western Reserve University; Western University (University of Western Ontario)	Gao, Y (corresponding author), Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA.	yong.gao@case.edu	Angelova, Lora/AAG-3211-2020; LI, Yue/GRS-8071-2022	Angelova, Lora/0000-0003-2496-9310; Arts, Eric/0000-0002-4880-7968; Ssentalo Bagaya, Bernard/0000-0002-3847-2615	National Institutes of Health [R01 AI49170, R01 AI84816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI084816, R01AI049170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by the National Institutes of Health (grant R01 AI49170 and grant R01 AI84816 to YG and EJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Abraha Awet, 2005, Methods Mol Biol, V304, P355; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Brin E, 2002, J BIOL CHEM, V277, P18357, DOI 10.1074/jbc.M201354200; BUSHMAN FD, 1990, J VIROL, V64, P5645, DOI 10.1128/JVI.64.11.5645-5648.1990; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; CHARNEAU P, 1991, J VIROL, V65, P2415, DOI 10.1128/JVI.65.5.2415-2421.1991; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Dash C, 2004, J BIOL CHEM, V279, P37095, DOI 10.1074/jbc.M403306200; DeStefano JJ, 2006, NUCLEIC ACIDS RES, V34, P130, DOI 10.1093/nar/gkj426; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Dudley DM, 2009, BIOTECHNIQUES, V46, P458, DOI 10.2144/000113119; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, BIOCHEMISTRY-US, V30, P7041, DOI 10.1021/bi00243a001; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gao Y, 2004, J VIROL, V78, P5390, DOI 10.1128/JVI.78.10.5390-5401.2004; Gao Y, 2008, J VIROL, V82, P2938, DOI 10.1128/JVI.02126-07; Han GW, 1997, J MOL BIOL, V269, P811, DOI 10.1006/jmbi.1997.1085; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; HUBER HE, 1990, J BIOL CHEM, V265, P10565; HUNGNES O, 1992, VIROLOGY, V190, P440, DOI 10.1016/0042-6822(92)91230-R; Iglesias C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-92; Ilyinskii PO, 1998, EMBO J, V17, P3766, DOI 10.1093/emboj/17.13.3766; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Kelleher CD, 2000, J BIOL CHEM, V275, P13061, DOI 10.1074/jbc.275.17.13061; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kopka ML, 2003, J MOL BIOL, V334, P653, DOI 10.1016/j.jmb.2003.09.057; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; LAFEMINA RL, 1991, J VIROL, V65, P5624, DOI 10.1128/JVI.65.10.5624-5630.1991; Lankas F, 2002, BIOPHYS J, V82, P2592, DOI 10.1016/S0006-3495(02)75601-4; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; Lener D, 2003, J BIOL CHEM, V278, P26526, DOI 10.1074/jbc.M302374200; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Lobritz MA, 2007, J VIROL, V81, P8258, DOI 10.1128/JVI.02739-06; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Marozsan AJ, 2003, J VIROL METHODS, V111, P111, DOI 10.1016/S0166-0934(03)00166-6; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; McWilliams MJ, 2003, J VIROL, V77, P11150, DOI 10.1128/JVI.77.20.11150-11157.2003; Moore Dawn M, 2005, Methods Mol Biol, V304, P369; PANGANIBAN AT, 1983, NATURE, V306, P155, DOI 10.1038/306155a0; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; PULLEN KA, 1992, J VIROL, V66, P367, DOI 10.1128/JVI.66.1.367-373.1992; PULLEN KA, 1993, J BIOL CHEM, V268, P6221; RATTRAY AJ, 1989, J MOL BIOL, V208, P445, DOI 10.1016/0022-2836(89)90508-1; Rausch JW, 2007, NUCLEIC ACIDS RES, V35, P256, DOI 10.1093/nar/gkl909; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rausch JW, 2003, P NATL ACAD SCI USA, V100, P11279, DOI 10.1073/pnas.1932546100; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SMITH JS, 1992, J BIOL CHEM, V267, P15071; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; TELESNITSKY A, 1992, J VIROL, V66, P615, DOI 10.1128/JVI.66.2.615-622.1992; Telesnitsky A, 1997, REVERSE TRANSCRIPTAS; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; WHITCOMB JM, 1992, ANNU REV CELL BIOL, V8, P275, DOI 10.1146/annurev.cb.08.110192.001423	64	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122953	10.1371/journal.pone.0122953	http://dx.doi.org/10.1371/journal.pone.0122953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860884	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300070
J	Wang, ZG; Martorell, BC; Walchli, T; Vogel, O; Fischer, J; Born, W; Vogel, J				Wang, Zhenghui; Martorell, Belen Canto; Waelchli, Thomas; Vogel, Olga; Fischer, Jan; Born, Walter; Vogel, Johannes			Calcitonin Gene-Related Peptide (CGRP) Receptors Are Important to Maintain Cerebrovascular Reactivity in Chronic Hypertension	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ACTIVITY-MODIFYING PROTEIN-1; ANTIHYPERTENSIVE TREATMENT; TRANSGENIC MICE; ONE-CLIP; AUTOREGULATION; ADRENOMEDULLIN; 2-KIDNEY; INCREASE	Cerebral blood flow autoregulation (CA) shifts to higher blood pressures in chronic hypertensive patients, which increases their risk for brain damage. Although cerebral vascular smooth muscle cells express the potent vasodilatatory peptides calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) and their receptors (calcitonin receptor-like receptor (Calclr), receptor-modifying proteins (RAMP) 1 and 2), their contribution to CA during chronic hypertension is poorly understood. Here we report that chronic (10 weeks) hypertensive (one-kidney-one-clip-method) mice overexpressing the Calclr in smooth muscle cells (CLR-tg), which increases the natural sensitivity of the brain vasculature to CGRP and AM show significantly better blood pressure drop-induced cerebrovascular reactivity than wt controls. Compared to sham mice, this was paralleled by increased cerebral CGRP-binding sites (receptor autoradiography), significantly in CLR-tg but not wt mice. AM-binding sites remained unchanged. Whereas hypertension did not alter RAMP-1 expression (droplet digital (dd) PCR) in either mouse line, RAMP-2 expression dropped significantly in both mouse lines by about 65%. Moreover, in wt only Calclr expression was reduced by about 70% parallel to an increase of smooth muscle actin (Acta2) expression. Thus, chronic hypertension induces a stoichiometric shift between CGRP and AM receptors in favor of the CGRP receptor. However, the parallel reduction of Calclr expression observed in wt mice but not CLR-tg mice appears to be a key mechanism in chronic hypertension impairing cerebrovascular reactivity.	[Wang, Zhenghui; Martorell, Belen Canto; Vogel, Olga; Vogel, Johannes] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich, Swiss Ctr Regenerat Med, Grp CNS Angiogenesis & Neurovasc Link, Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich, Swiss Ctr Regenerat Med, Phys Scientist Program, Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich Hosp, Div Neurosurg, CH-8091 Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich Hosp, Div Surg Res, CH-8091 Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich Hosp, Mol Neurooncol Lab, CH-8091 Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Waelchli, Thomas] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Fischer, Jan; Born, Walter] Univ Zurich, Orthoped Univ Hosp Zurich, Res Lab Calcium Metab, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Vogel, J (corresponding author), Univ Zurich, Inst Vet Physiol, Zurich, Switzerland.	jvogel@vetphys.uzh.ch		Walchli, Thomas/0000-0002-8961-6551; Vogel, Johannes/0000-0003-4181-4521	Swiss National Science Foundation [310000_120321/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (310000_120321/1, to J.V.).	Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Chrissobolis S, 2010, STROKE, V41, P2329, DOI 10.1161/STROKEAHA.110.589648; Deng PY, 2004, REGUL PEPTIDES, V119, P155, DOI 10.1016/j.regpep.2004.01.011; Deng PY, 2003, REGUL PEPTIDES, V114, P175, DOI 10.1016/S0167-0115(03)00124-1; Deschepper CF, 2004, J APPL PHYSIOL, V97, P369, DOI 10.1152/japplphysiol.00073.2004; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Edvinsson L, 2014, ACTA PHYSIOL, V210, P811, DOI 10.1111/apha.12213; Edvinsson L, 2010, NEUROTHERAPEUTICS, V7, P164, DOI 10.1016/j.nurt.2010.02.004; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; HARPER SL, 1987, CIRC RES, V60, P229, DOI 10.1161/01.RES.60.2.229; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; HENKE H, 1985, BRAIN RES, V360, P165, DOI 10.1016/0006-8993(85)91232-6; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; HONG KW, 1994, AM J PHYSIOL, V266, pH11, DOI 10.1152/ajpheart.1994.266.1.H11; Immink RV, 2004, CIRCULATION, V110, P2241, DOI 10.1161/01.CIR.0000144472.08647.40; Ittner LM, 2008, CLIN SCI, V114, P49, DOI 10.1042/CS20070163; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Kunz TH, 2007, AM J PHYSIOL-HEART C, V293, pH2155, DOI 10.1152/ajpheart.00629.2007; MASUDA A, 1992, J HYPERTENS, V10, P1499, DOI 10.1097/00004872-199210120-00010; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mitchell A, 2005, HERZ, V30, P401, DOI 10.1007/s00059-005-2711-8; Pedersen TF, 2003, AM J PHYSIOL-HEART C, V285, pH1097, DOI 10.1152/ajpheart.00098.2003; Pemu PI, 2008, J CLIN HYPERTENS, V10, P406, DOI 10.1111/j.1751-7176.2008.06552.x; Pondel MD, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-7; PORTALUPPI F, 1992, J HYPERTENS, V10, P1227, DOI 10.1097/00004872-199210000-00017; SCHIFTER S, 1991, AM J HYPERTENS, V4, P565, DOI 10.1093/ajh/4.7.565; Scott D, 2013, AM J PHYSIOL-LUNG C, V304, pL70, DOI 10.1152/ajplung.00342.2012; Shin HK, 2004, CLIN EXP PHARMACOL P, V31, P1, DOI 10.1111/j.1440-1681.2004.03943.x; Stachniak TJE, 2003, J NEUROENDOCRINOL, V15, P840, DOI 10.1046/j.1365-2826.2003.01064.x; STRANDGAARD S, 1976, CIRCULATION, V53, P720, DOI 10.1161/01.CIR.53.4.720; STRANDGAARD S, 1975, CIRC RES, V37, P164, DOI 10.1161/01.RES.37.2.164; Tejada Thor, 2006, Curr Cardiol Rep, V8, P418, DOI 10.1007/s11886-006-0099-6; VORSTRUP S, 1984, STROKE, V15, P312, DOI 10.1161/01.STR.15.2.312; Wang ZH, 2010, EXP BRAIN RES, V207, P249, DOI 10.1007/s00221-010-2447-4; WERBER AH, 1990, CAN J PHYSIOL PHARM, V68, P476, DOI 10.1139/y90-067; Wiesel P, 1997, HYPERTENSION, V29, P1025, DOI 10.1161/01.HYP.29.4.1025; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007	38	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123697	10.1371/journal.pone.0123697	http://dx.doi.org/10.1371/journal.pone.0123697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860809	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352590300111
J	Yamamichi, N; Shimamoto, T; Takahashi, Y; Sakaguchi, Y; Kakimoto, H; Matsuda, R; Kataoka, Y; Saito, I; Tsuji, Y; Yakabi, S; Takeuchi, C; Minatsuki, C; Niimi, K; Asada-Hirayama, I; Nakayama, C; Ono, S; Kodashima, S; Yamaguchi, D; Fujishiro, M; Yamaji, Y; Wada, R; Mitsushima, T; Koike, K				Yamamichi, Nobutake; Shimamoto, Takeshi; Takahashi, Yu; Sakaguchi, Yoshiki; Kakimoto, Hikaru; Matsuda, Rie; Kataoka, Yosuke; Saito, Itaru; Tsuji, Yosuke; Yakabi, Seiichi; Takeuchi, Chihiro; Minatsuki, Chihiro; Niimi, Keiko; Asada-Hirayama, Itsuko; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Yamaguchi, Daisuke; Fujishiro, Mitsuhiro; Yamaji, Yutaka; Wada, Ryoichi; Mitsushima, Toru; Koike, Kazuhiko			Trend and Risk Factors of Diverticulosis in Japan: Age, Gender, and Lifestyle/Metabolic-Related Factors May Cooperatively Affect on the Colorectal Diverticula Formation	PLOS ONE			English	Article							COLONIC DIVERTICULOSIS; REFLUX DISEASE; EPIDEMIOLOGY; ASSOCIATION; CONSUMPTION; PREVALENCE; OBESITY; FIBER; DIET	Background Despite the marked increase of diverticulosis, its risk factors have not been adequately elucidated. We therefore aim to identify significantly associated factors with diverticulosis. We also aim to investigate the present state of diverticulosis in Japan. Methods We reviewed the medical records from 1990 to 2010 that included the data of consecutive 62,503 asymptomatic colonoscopy examinees from the general population in Japan. Most recent 3,327 examinees were analyzed with 16 background factors. Results Among the 62,503 subjects (47,325 men and 15,178 women; 52.1 +/- 9.2 years old), diverticulosis was detected in 11,771 subjects (18.8%; 10,023 men and 1,748 women). The incidences of diverticulosis in 1990-2000 and 2001-2010 were respectively 13.0% (3,771 of 29,071) and 23.9% (8,000 of 33,432): the latter was much higher than the former in all age groups and for both genders. Considering the anatomical locations of colorectal diverticula, left-sided ones have markedly increased with age but not significantly changed with times. Univariate analyses of the 3,327 subjects showed significant association of diverticulosis with four basic factors (age, sex, body mass index, blood pressure), three life style-related factor (smoking, drinking, severe weight increase in adulthood), and two blood test values (triglyceride, HbA1c). The multiple logistic analysis calculating standardized coefficients (beta) and odds ratio (OR) demonstrated that age (beta = 0.217-0.674, OR = 1.24-1.96), male gender (beta = 0.185, OR = 1.20), smoking (beta = 0.142-0.200, OR = 1.15-1.22), severe weight increase in adulthood (beta = 0.153, OR = 1.17), HbA1c (beta = 0.136, OR = 1.15), drinking (beta = 0.109, OR = 1.11), and serum triglyceride (beta = 0.098, OR = 1.10) showed significantly positive association with diverticulosis whereas body mass index and blood pressure did not. Conclusions The large-scale data of asymptomatic colonoscopy examinees from the general population from 1990 to 2010 indicated that the prevalence of diverticulosis is still increasing in Japan. Age, male gender, smoking, severe weight increase in adulthood, serum HbA1c, drinking, and serum triglyceride showed significant positive association with diverticulosis.	[Yamamichi, Nobutake; Shimamoto, Takeshi; Takahashi, Yu; Sakaguchi, Yoshiki; Kakimoto, Hikaru; Matsuda, Rie; Kataoka, Yosuke; Saito, Itaru; Tsuji, Yosuke; Yakabi, Seiichi; Takeuchi, Chihiro; Minatsuki, Chihiro; Niimi, Keiko; Asada-Hirayama, Itsuko; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Yamaguchi, Daisuke; Fujishiro, Mitsuhiro; Yamaji, Yutaka; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Shimamoto, Takeshi; Wada, Ryoichi; Mitsushima, Toru] Kameda Med Ctr Makuhari, Mihama Ku, Chiba, Japan	University of Tokyo	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	藤城, 光弘/AAN-3131-2020; Yamaguchi, Daisuke/V-1990-2019; Ono, Satoshi/AFP-6208-2022	Yamaguchi, Daisuke/0000-0001-9782-9998; Takeuchi, Chihiro/0000-0002-2746-9189; Sakaguchi, Yoshiki/0000-0001-5078-3750	Japan Society for the Promotion of Science [25460381]; Smoking Research Foundation of Japan; Grants-in-Aid for Scientific Research [25460381] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant number: 25460381), and also partly supported by a grant from the Smoking Research Foundation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoori Walid H., 1995, Annals of Epidemiology, V5, P221, DOI 10.1016/1047-2797(94)00109-7; ALDOORI WH, 1994, AM J CLIN NUTR, V60, P757, DOI 10.1093/ajcn/60.5.757; BURKITT DP, 1972, LANCET, V1, P1408; Delvaux M, 2003, ALIMENT PHARM THERAP, V18, P71, DOI 10.1046/j.0953-0673.2003.01720.x; Dobbins C, 2006, COLORECTAL DIS, V8, P37, DOI 10.1111/j.1463-1318.2005.00847.x; Faucheron JL, 2013, COLORECTAL DIS, V15, pE266, DOI 10.1111/codi.12137; GEAR JSS, 1979, LANCET, V1, P511; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; Heise CP, 2008, J GASTROINTEST SURG, V12, P1309, DOI 10.1007/s11605-008-0492-0; Higuchi S, 2007, ADDICTION, V102, P1849, DOI 10.1111/j.1360-0443.2007.01902.x; Hirata T, 2008, WORLD J GASTROENTERO, V14, P2411, DOI 10.3748/wjg.14.2411; Hjern F, 2011, BRIT J SURG, V98, P997, DOI 10.1002/bjs.7477; Hjern F, 2012, AM J GASTROENTEROL, V107, P296, DOI 10.1038/ajg.2011.352; Jeyarajah S, 2008, INT J COLORECTAL DIS, V23, P619, DOI 10.1007/s00384-008-0446-8; Jun S, 2002, BEST PRACT RES CL GA, V16, P529, DOI 10.1053/bega.2002.0328; Kawamori R, 2002, DIABETES-METAB RES, V18, pS9, DOI 10.1002/dmrr.296; KUBO A, 1983, JPN J MED, V22, P185; KYLE J, 1975, BRIT J SURG, V62, P537, DOI 10.1002/bjs.1800620709; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Martel J, 2008, J CLIN GASTROENTEROL, V42, P1125, DOI 10.1097/MCG.0b013e3181865f18; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Miura S, 2000, DIS COLON RECTUM, V43, P1383, DOI 10.1007/BF02236634; Morimoto A., 2010, JMAJ - Japan Medical Association Journal, V53, P36; Muhammad A, 2014, INT J COLORECTAL DIS, V29, P947, DOI 10.1007/s00384-014-1908-9; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; NAKADA I, 1995, DIS COLON RECTUM, V38, P755, DOI 10.1007/BF02048036; NARASAKA T, 1975, TOHOKU J EXP MED, V115, P271, DOI 10.1620/tjem.115.271; Niikura R, 2013, WORLD J GASTROENTERO, V19, P2362, DOI 10.3748/wjg.v19.i15.2362; Nukada A, 1973, J Hum Ergol (Tokyo), V1, P29; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Rosemar A, 2008, DIS COLON RECTUM, V51, P450, DOI 10.1007/s10350-007-9172-5; Sharara AI, 2013, J CLIN GASTROENTEROL, V47, P420, DOI 10.1097/MCG.0b013e31826be847; Sherwin R, 2012, J CLIN ENDOCR METAB, V97, P4293, DOI 10.1210/jc.2012-3487; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996; Sugihara K, 1987, Ann Acad Med Singap, V16, P504; Takahashi Y, 2014, J GASTROENTEROL, V49, P882, DOI 10.1007/s00535-013-0832-z; Tonnesen H, 1999, BRIT J SURG, V86, P1067, DOI 10.1046/j.1365-2168.1999.01171.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamamichi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111359; Yamamichi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088277; Yamamichi N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-45	43	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123688	10.1371/journal.pone.0123688	http://dx.doi.org/10.1371/journal.pone.0123688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860671	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300110
J	Zhang, Y; Zhao, P; Dong, ZM; Wang, DD; Guo, PC; Guo, XM; Song, QR; Zhang, WW; Xia, QY				Zhang, Yan; Zhao, Ping; Dong, Zhaoming; Wang, Dandan; Guo, Pengchao; Guo, Xiaomeng; Song, Qianru; Zhang, Weiwei; Xia, Qingyou			Comparative Proteome Analysis of Multi-Layer Cocoon of the Silkworm, Bombyx mori	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; PROTEASE INHIBITOR; PROTEINASE K; IDENTIFICATION; PEPTIDES; SEQUENCE	Bombyx mori cocoon has a multi-layer structure that provides optimal protection for silkworm pupa. Research on the mechanical properties of the multi-layer structure revealed structure-property relationships of the cocoon. Here, we investigated the protein components of the B. mori cocoon in terms of its multi-layer structure. Liquid chromatography-tandem mass spectrometry identified 286 proteins from the multiple cocoon layers. In addition to fibroins and sericins, we identified abundant protease inhibitors, seroins and proteins of unknown function. By comparing protein abundance across layers, we found that the outermost layer contained more sericin1 and protease inhibitors and the innermost layer had more seroin1. As many as 36 protease inhibitors were identified in cocoons, showing efficient inhibitory activities against a fungal protease. Thus, we propose that more abundant protease inhibitors in the outer cocoon layers may provide better protection for the cocoon. This study increases our understanding of the multi-layer mechanism of cocoons, and helps clarify the biological characteristics of cocoons. The data have been deposited to the ProteomeXchange with identifier PXD001469.	[Zhang, Yan; Zhao, Ping; Dong, Zhaoming; Wang, Dandan; Guo, Pengchao; Guo, Xiaomeng; Song, Qianru; Zhang, Weiwei; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	xiaqy@swu.edu.cn	Dong, Zhaoming/AAW-3060-2021; guo, peng/AAG-4052-2019; Dong, Zhaoming/AAK-1802-2021; Guo, Peng/GWC-0572-2022	Dong, Zhaoming/0000-0001-5665-9953; Dong, Zhaoming/0000-0001-5665-9953; 	National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; National Natural Science Foundation of China [31172157]; China Postdoctoral Science Foundation [2013M540695, 2014T70843]; fundamental research funds for the central universities of China [XDJK2014C048]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); fundamental research funds for the central universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2012CB114600), the National Hi-Tech Research and Development Program of China (2011AA100306), the National Natural Science Foundation of China (31172157), the China Postdoctoral Science Foundation (2013M540695, 2014T70843), and the fundamental research funds for the central universities of China (XDJK2014C048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai H., 1997, INT J WILD SILKMOTH, V3, P79; Blossman-Myer B, 2010, COMP BIOCHEM PHYS A, V155, P259, DOI 10.1016/j.cbpa.2009.11.007; Chen FJ, 2013, J EXP BIOL, V216, P2648, DOI 10.1242/jeb.082545; Chen FJ, 2012, J R SOC INTERFACE, V9, P2299, DOI 10.1098/rsif.2011.0887; Chen FJ, 2012, ACTA BIOMATER, V8, P2620, DOI 10.1016/j.actbio.2012.03.043; Chen WQ, 2010, PROTEOMICS, V10, P369, DOI 10.1002/pmic.200900624; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062; Dong ZM, 2013, J PROTEOME RES, V12, P5213, DOI 10.1021/pr4005772; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; EGUCHI M, 1993, COMP BIOCHEM PHYS B, V104, P537, DOI 10.1016/0305-0491(93)90279-E; GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9; Gauthier N, 2004, J INSECT PHYSIOL, V50, P1065, DOI 10.1016/j.jinsphys.2004.09.008; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; KELLENBERGER C, 1995, J BIOL CHEM, V270, P25514, DOI 10.1074/jbc.270.43.25514; Kludkiewicz B, 2009, INSECT BIOCHEM MOLEC, V39, P938, DOI 10.1016/j.ibmb.2009.11.005; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P937, DOI 10.1515/bchm2.1976.357.2.937; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Kurioka Akira, 1999, Journal of Sericultural Science of Japan, V68, P397; Li YS, 2015, INSECT BIOCHEM MOLEC, V57, P11, DOI 10.1016/j.ibmb.2014.11.006; Li YS, 2012, INSECT BIOCHEM MOLEC, V42, P766, DOI 10.1016/j.ibmb.2012.07.004; Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nirmala X, 2001, INSECT MOL BIOL, V10, P437, DOI 10.1046/j.0962-1075.2001.00282.x; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Palmieri G, 2009, J PROTEOME RES, V8, P327, DOI 10.1021/pr800587t; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pham TN, 1996, J BIOCHEM, V119, P428; Singh CP, 2014, CELL MICROBIOL, V16, P1354, DOI 10.1111/cmi.12294; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Weisman S, 2008, BIOMACROMOLECULES, V9, P3065, DOI 10.1021/bm8005853; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04428; Zhang J, 2013, MAT SCI ENG C-MATER, V33, P3206, DOI 10.1016/j.msec.2013.03.051; Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004; Zurovec M, 1998, J BIOL CHEM, V273, P15423, DOI 10.1074/jbc.273.25.15423	40	30	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123403	10.1371/journal.pone.0123403	http://dx.doi.org/10.1371/journal.pone.0123403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860555	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300095
J	Lee, SY; Kim, M; Jung, S; Lee, SH; Lee, JH				Lee, Sae Young; Kim, Minjoo; Jung, Saem; Lee, Sang-Hyun; Lee, Jong Ho			Altered Plasma Lysophosphatidylcholines and Amides in Non-Obese and Non-Diabetic Subjects with Borderline-To-Moderate Hypertriglyceridemia: A Case-Control Study	PLOS ONE			English	Article							DICARBOXYLIC-ACIDS; OXIDATIVE STRESS; METABOLITES; IDENTIFICATION; BIOSYNTHESIS; PERFORMANCE; DISEASE; ALPHA; OBESE; FAT	Hypertriglyceridemia (HTG) is a risk factor for atherosclerotic cardiovascular disease (CVD). We investigated alterations in plasma metabolites associated with borderline-to-moderate HTG (triglycerides (TG) 150-500 mg/dL). Using UPLC-LTQ-Orbitrap mass spectrometry analysis, the metabolomics profiles of 111 non-diabetic and non-obese individuals with borderline-to-moderate HTG were compared with those of 111 age-and sex-matched controls with normotriglyceridemia (NTG, TG < 150 mg/dL). When compared to the NTG control group, the HTG group exhibited higher plasma levels of lysophosphatidylcholines (lysoPCs), including C14: 0 (q = 0.001) and C16: 0 (q = 1.8E-05), and several amides, including N-ethyldodecanamide (q = 2.9E-05), N-propyldodecanamide (q = 3.5E-05), palmitoleamide (q = 2.9E-06), and palmitic amide (q = 0.019). The metabolomic profiles of the HTG group also exhibited lower plasma levels of cis-4-octenedioic acid (q< 1.0E-9) and docosanamide (q = 0.002) compared with those of the NTG controls. LysoPC 16: 0 and palmitoleamide emerged as the primary metabolites able to discriminate the HTG group from the NTG group in a partial least-squares discriminant analysis and were positively associated with the fasting triglyceride levels. We identified alterations in lysoPCs, amides, and cis-4-octenedioic acid among non-diabetic and non-obese individuals with borderline-to-moderate HTG. These results provide novel insights into the metabolic alterations that occur in the early metabolic stages of HTG. This information may facilitate the design of early interventions to prevent disease progression.	[Lee, Sae Young] Yonsei Univ, Interdisciplinary Course Sci Aging, Seoul 120749, South Korea; [Kim, Minjoo; Lee, Jong Ho] Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul 120749, South Korea; [Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea; [Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Brain Korea PLUS Project 21, Dept Food & Nutr, Seoul 120749, South Korea; [Lee, Sang-Hyun] Natl Hlth Insurance Corp Ilsan Hosp, Dept Family Practice, Goyang, South Korea; [Lee, Jong Ho] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System	Lee, JH (corresponding author), Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul 120749, South Korea.	jhleeb@yonsei.ac.kr			Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2012M3A9C4048762]	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation	This work was supported by the Bio-Synergy Research Project (NRF-2012M3A9C4048762) of the Ministry of Science, ICT and Future Planning through the National Research Foundation.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cui Y, 2014, J NEUROPATH EXP NEUR, V73, P954, DOI 10.1097/NEN.0000000000000116; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; Eisinger K, 2014, EXP MOL PATHOL, V97, P37, DOI 10.1016/j.yexmp.2014.05.002; Eriksson L., 2006, MULTI AND MEGAVARIAT; Farrell EK, 2012, J LIPID RES, V53, P247, DOI 10.1194/jlr.M018606; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; HINE DG, 1984, BIOMED MASS SPECTROM, V11, P332, DOI 10.1002/bms.1200110704; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; JIN SJ, 1989, J LIPID RES, V30, P1611; JIN SJ, 1990, BIOCHEMISTRY-US, V29, P8540, DOI 10.1021/bi00489a006; Jung S, 2015, METABOLOMICS, V11, P40, DOI 10.1007/s11306-014-0669-3; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096735; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Merkler DJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P430, DOI 10.1006/abbi.1996.0272; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Rizzo M, 2005, J ATHEROSCLER THROMB, V12, P237, DOI 10.5551/jat.12.237; Sahebkar A, 2014, PROG LIPID RES, V56, P47, DOI 10.1016/j.plipres.2014.07.002; Sasabe N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-48; Simental-Mendia LE, 2013, DIABETES-METAB RES, V29, P214, DOI 10.1002/dmrr.2379; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; TSERNG KY, 1990, J LIPID RES, V31, P763; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wilcox BJ, 1999, BIOCHEMISTRY-US, V38, P3235, DOI 10.1021/bi982255j; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Yang L, 2008, CHEM RES TOXICOL, V21, P2280, DOI 10.1021/tx800225q	38	6	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123306	10.1371/journal.pone.0123306	http://dx.doi.org/10.1371/journal.pone.0123306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856314	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500086
J	Li, X; Ju, Q; Jie, WC; Li, F; Jiang, XJ; Hu, JJ; Qu, MJ				Li, Xiao; Ju, Qian; Jie, Wencai; Li, Fei; Jiang, Xiaojing; Hu, Jingjing; Qu, Mingjing			Chemosensory Gene Families in Adult Antennae of Anomala corpulenta Motschulsky (Coleoptera: Scarabaeidae: Rutelinae)	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; PHEROMONE DETECTION; RECEPTORS; TRANSCRIPTOME; ANNOTATION; MOTH; IDENTIFICATION; LOCALIZATION; PURIFICATION; EVOLUTION	Background The metallic green beetle, Anomala corpulenta (Coleoptera: Scarabaeidae: Rutelinae), is a destructive pest in agriculture and horticulture throughout Asia, including China. Olfaction plays a crucial role in the survival and reproduction of A. corpulenta. As a non-model species, A. corpulenta is poorly understood, and information regarding the molecular mechanisms underlying olfaction in A. corpulenta and other scarab species is scant. Methodology/Principle Findings We assembled separate antennal transcriptome for male and female A. corpulenta using Illumina sequencing technology. The relative abundance of transcripts with gene ontology annotations, including those related to olfaction in males and females was highly similar. Transcripts encoding 15 putative odorant binding proteins, five chemosensory proteins, one sensory neuron membrane protein, 43 odorant receptors, eight gustatory receptors, and five ionotropic receptors were identified. The sequences of all of these chemosensory-related transcripts were confirmed using reverse transcription polymerase chain reaction (RTPCR), and direct DNA sequencing. The expression patterns of 54 putative chemosensory genes were analyzed using quantitative real time RT-PCR (qRT-PCR). Antenna-specific expression was detected for many of these genes, suggesting that they may have important functions in semiochemical detection. Conclusions The identification of a large number of chemosensory proteins provides a major resource for the study of the molecular mechanism of odorant detection in A. corpulenta and its chemical ecology. The genes identified, especially those that were expressed at high levels in the antennae may represent novel molecular targets for the development of population control strategies based on the manipulation of chemoreception-driven behaviors.	[Li, Xiao; Ju, Qian; Jiang, Xiaojing; Hu, Jingjing; Qu, Mingjing] Shandong Peanut Res Inst, Qingdao 266100, Shandong, Peoples R China; [Jie, Wencai; Li, Fei] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Qu, MJ (corresponding author), Shandong Peanut Res Inst, Fushan Rd 126, Qingdao 266100, Shandong, Peoples R China.	13455277580@163.com		Li, Xiao/0000-0002-0505-1654	China Agriculture Research System [CARS-14]; Shandong Foundation for Outstanding Young Scientists [BS2010NY022]; Agriculture Science Technology Achievement Transformation Fund [2013GB2C620547]; Open Fund Project of the Key Laboratory of Crop Comprehensive Management of Biological Disasters, Ministry of Education, Nanjing Agricultural University [IMCDP201304]	China Agriculture Research System; Shandong Foundation for Outstanding Young Scientists; Agriculture Science Technology Achievement Transformation Fund; Open Fund Project of the Key Laboratory of Crop Comprehensive Management of Biological Disasters, Ministry of Education, Nanjing Agricultural University	This study was supported by awards and grants from the China Agriculture Research System (CARS-14); the Shandong Foundation for Outstanding Young Scientists (BS2010NY022); the Agriculture Science Technology Achievement Transformation Fund (2013GB2C620547); and the Open Fund Project of the Key Laboratory of Crop Comprehensive Management of Biological Disasters, Ministry of Education, Nanjing Agricultural University (IMCDP201304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Field LM, 2000, INSECT MOL BIOL, V9, P545, DOI 10.1046/j.1365-2583.2000.00221.x; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo M, 2014, INT J BIOL SCI, V10, P1, DOI 10.7150/ijbs.7624; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; WEI XT, 1995, BIOL CONTROL, V5, P290, DOI 10.1006/bcon.1995.1036; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Zhang J, 2014, INSECT SCI IN PRESS, DOI [10.1111/1744-7917.12131, DOI 10.1111/1744-7917.12131]; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748	62	36	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121504	10.1371/journal.pone.0121504	http://dx.doi.org/10.1371/journal.pone.0121504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856077	Green Published, gold			2022-12-26	WOS:000352588500021
J	Bitocchi, E; Bellucci, E; Rau, D; Albertini, E; Rodriguez, M; Veronesi, F; Attene, G; Nanni, L				Bitocchi, Elena; Bellucci, Elisa; Rau, Domenico; Albertini, Emidio; Rodriguez, Monica; Veronesi, Fabio; Attene, Giovanna; Nanni, Laura			European Flint Landraces Grown In Situ Reveal Adaptive Introgression from Modern Maize	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; ESTIMATING POPULATION-STRUCTURE; GENE FLOW; DIVERGENT SELECTION; AFLP; DIVERSITY; HYBRIDIZATION; DOMESTICATION; POLYMORPHISM; DOMINANT	We have investigated the role of selection in the determination of the detected levels of introgression from modern maize hybrid varieties into maize landraces still cultivated in situ in Italy. We exploited the availability of a historical collection of landraces undertaken before the introduction and widespread use of modern maize, to analyse genomic changes that have occurred in these maize landraces over 50 years of co-existence with hybrid varieties. We have combined a previously published SSR dataset (n=21) with an AFLP loci dataset (n=168) to provide higher resolution power and to obtain a more detailed picture. We show that selection pressures for adaptation have favoured new alleles introduced by migration from hybrids. This shows the potential for analysis of historical introgression even over this short period of 50 years, for an understanding of the evolution of the genome and for the identification of its functionally important regions. Moreover, this demonstrates that landraces grown in situ represent almost unique populations for use for such studies when the focus is on the domesticated plant. This is due to their adaptation, which has arisen from their dynamic evolution under a continuously changing agro-ecological environment, and their capture of new alleles from hybridisation. We have also identified loci for which selection has inhibited introgression from modern germplasm and has enhanced the distinction between landraces and modern maize. These loci indicate that selection acted in the past, during the formation of the flint and dent gene pools. In particular, the locus showing the strongest signals of selection is a Misfit transposable element. Finally, molecular characterisation of the same samples with two different molecular markers has allowed us to compare their performances. Although the genetic-diversity and population-structure analyses provide the same global qualitative pattern, which thus provides the same inferences, there are differences related to their natures and characteristics.	[Bitocchi, Elena; Bellucci, Elisa; Nanni, Laura] Univ Politecn Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Rau, Domenico; Rodriguez, Monica; Attene, Giovanna] Univ Sassari, Dept Agr, I-07100 Sassari, Italy; [Albertini, Emidio; Veronesi, Fabio] Univ Perugia, Dept Agr Food & Environm Sci, I-06100 Perugia, Italy	Marche Polytechnic University; University of Sassari; University of Perugia	Bitocchi, E (corresponding author), Univ Politecn Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	e.bitocchi@univpm.it	Bitocchi, Elena/J-7996-2019; Nanni, Laura/HDN-7936-2022; Bellucci, Elisa/AAS-9237-2021; Rodriguez, Monica/G-6731-2012; Albertini, Emidio/F-7393-2014	Bitocchi, Elena/0000-0002-2152-4634; Rodriguez, Monica/0000-0001-8926-2987; Veronesi, Fabio/0000-0001-7884-6987; Rau, Domenico/0000-0002-5294-9053; Albertini, Emidio/0000-0003-2585-5649	Universita Politecnica delle Marche	Universita Politecnica delle Marche	This work was funded by Universita Politecnica delle Marche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Anderson E., 1949, INTROGRESSIVE HYBRID; [Anonymous], 1999, POPGENE VERSION 1 3; Arnaud JF, 2003, P ROY SOC B-BIOL SCI, V270, P1565, DOI 10.1098/rspb.2003.2407; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bellucci E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083891; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Bitocchi E, 2009, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.1339, DOI 10.5061/DRYAD.1339]; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Garoia F, 2007, MOL ECOL, V16, P1377, DOI 10.1111/j.1365-294X.2007.03247.x; Goettel W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000516; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KIMURA M, 1964, GENETICS, V49, P725; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; Mariette S, 2002, SILVAE GENET, V51, P72; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; NEI M, 1974, GENETICS, V76, P379; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Papa R, 2005, THEOR APPL GENET, V111, P1147, DOI 10.1007/s00122-005-0045-9; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Papa R, 2007, ANN BOT-LONDON, V100, P1039, DOI 10.1093/aob/mcm151; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Roques S, 1999, MOL ECOL, V8, P1703, DOI 10.1046/j.1365-294x.1999.00759.x; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang QH, 2006, P NATL ACAD SCI USA, V103, P17644, DOI 10.1073/pnas.0603080103; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Woodhead M, 2005, MOL ECOL, V14, P1681, DOI 10.1111/j.1365-294X.2005.02543.x; Wu YR, 2009, THEOR APPL GENET, V119, P721, DOI 10.1007/s00122-009-1083-5; Xia HB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016189, 10.1371/journal.pone.0028553]; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	83	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121381	10.1371/journal.pone.0121381	http://dx.doi.org/10.1371/journal.pone.0121381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853809	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400037
J	Moleirinho, A; Lopes, AM; Seixas, S; Morales-Hojas, R; Prata, MJ; Amorim, A				Moleirinho, Ana; Lopes, Alexandra M.; Seixas, Susana; Morales-Hojas, Ramiro; Prata, Maria J.; Amorim, Antonio			Distinctive Patterns of Evolution of the delta-Globin Gene (HBD) in Primates	PLOS ONE			English	Article							FUNCTIONAL DIVERSIFICATION; PURIFYING SELECTION; SUBSTITUTION MODELS; SEQUENCE-ANALYSIS; FETAL-HEMOGLOBIN; MOSAIC STRUCTURE; BETA; CONVERSION; RECOMBINATION; DUPLICATION	In most vertebrates, hemoglobin (Hb) is a heterotetramer composed of two dissimilar globin chains, which change during development according to the patterns of expression of alpha- and beta-globin family members. In placental mammals, the beta-globin cluster includes three early-expressed genes, epsilon(HBE)-gamma(HBG)-psi beta(HBBP1), and the late expressed genes, delta (HBD) and beta (HBB). While HBB encodes the major adult beta-globin chain, HBD is weakly expressed or totally silent. Paradoxically, in human populations HBD shows high levels of conservation typical of genes under strong evolutionary constraints, possibly due to a regulatory role in the fetal-to-adult switch unique of Anthropoid primates. In this study, we have performed a comprehensive phylogenetic and comparative analysis of the two adult beta-like globin genes in a set of diverse mammalian taxa, focusing on the evolution and functional divergence of HBD in primates. Our analysis revealed that anthropoids are an exception to a general pattern of concerted evolution in placental mammals, showing a high level of sequence conservation at HBD, less frequent and shorter gene conversion events. Moreover, this lineage is unique in the retention of a functional GATA-1 motif, known to be involved in the control of the developmental expression of the beta-like globin genes. We further show that not only the mode but also the rate of evolution of the delta-globin gene in higher primates are strictly associated with the fetal/adult beta-cluster developmental switch. To gain further insight into the possible functional constraints that have been shaping the evolutionary history of HBD in primates, we calculated dN/dS (omega) ratios under alternative models of gene evolution. Although our results indicate that HBD might have experienced different selective pressures throughout primate evolution, as shown by different. values between apes and Old World Monkeys + New World Monkeys (0.06 versus 0.43, respectively), these estimates corroborated a constrained evolution for HBD in Anthropoid lineages, which is unlikely to be related to protein function. Collectively, these findings suggest that sequence change at the delta-globin gene has been under strong selective constraints over 65 Myr of primate evolution, likely due to a regulatory role in ontogenic switches of gene expression.	[Moleirinho, Ana; Lopes, Alexandra M.; Seixas, Susana; Prata, Maria J.; Amorim, Antonio] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Moleirinho, Ana; Lopes, Alexandra M.; Seixas, Susana; Prata, Maria J.; Amorim, Antonio] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4100 Porto, Portugal; [Moleirinho, Ana; Prata, Maria J.; Amorim, Antonio] Univ Porto, Fac Sci, Dept Biol, P-4100 Porto, Portugal; [Morales-Hojas, Ramiro] Pirbright Inst, Compton Lab, Genet & Genom Grp, Compton, Berkshire, England	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Moleirinho, A (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.	amoleirinho@ipatimup.pt	Amorim, Antonio/A-7938-2008; Prata, Maria João/A-6945-2010; Seixas, Susana/I-5084-2013; Lopes, Alexandra/B-1616-2013	Amorim, Antonio/0000-0002-7518-6247; Prata, Maria João/0000-0002-0583-1028; Seixas, Susana/0000-0002-7035-7422; Lopes, Alexandra/0000-0003-3539-2318	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-MET/110323/2009]; FCT [SFRH / BD / 73508 / 2010, SFRH / BPD / 73366 / 2010]; POPH-QREN Promotion of scientific employment; European Social Fund; national funds of the Ministry of Education and Science; FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH-QREN Promotion of scientific employment; European Social Fund(European Social Fund (ESF)); national funds of the Ministry of Education and Science; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) (PTDC/SAU-MET/110323/2009). AM and AML are supported by fellowrships from FCT (SFRH / BD / 73508 / 2010 and SFRH / BPD / 73366 / 2010, respectively). SS is supported by POPH-QREN Promotion of scientific employment, by the European Social Fund, and by national funds of the Ministry of Education and Science. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2004, J MOL EVOL, V59, P177, DOI 10.1007/s00239-004-2612-0; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; BANK A, 1980, SCIENCE, V207, P486, DOI 10.1126/science.7352255; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Beauchemin H, 2009, MOL CELL BIOL, V29, P1635, DOI 10.1128/MCB.01735-08; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; BOYER SH, 1971, BIOCHEM GENET, V5, P405, DOI 10.1007/BF00487132; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHANG LYE, 1984, J MOL BIOL, V180, P767, DOI 10.1016/0022-2836(84)90256-0; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DEBRUIN SH, 1973, BIOCHIM BIOPHYS ACTA, V295, P490, DOI 10.1016/0005-2795(73)90044-5; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Gaudry MJ, 2014, GENOME BIOL EVOL, V6, P1219, DOI 10.1093/gbe/evu097; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GOODMAN M, 1987, COLD SPRING HARB SYM, V52, P875, DOI 10.1101/SQB.1987.052.01.096; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; GOODMAN M, 1984, J MOL BIOL, V180, P803, DOI 10.1016/0022-2836(84)90258-4; HARDIES SC, 1984, J BIOL CHEM, V259, P3748; Hardison R, 1998, J EXP BIOL, V201, P1099; Hardison R, 2001, DISORDERS OF HEMOGLO; HARDISON RC, 1984, MOL BIOL EVOL, V1, P302; HARDISON RC, 1984, MOL BIOL EVOL, V1, P390; Hardison RC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011627; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P2589, DOI 10.1093/molbev/msn200; Hoffmann FG, 2007, MOL BIOL EVOL, V24, P1982, DOI 10.1093/molbev/msm127; Hoffmann FG, 2010, MOL BIOL EVOL, V27, P1126, DOI 10.1093/molbev/msp325; Holwerda Sjoerd, 2012, Frontiers in Genetics, V3, P217, DOI 10.3389/fgene.2012.00217; JEFFREYS AJ, 1982, J MOL BIOL, V156, P487, DOI 10.1016/0022-2836(82)90262-5; Johnson RM, 2002, COMP BIOCHEM PHYS A, V133, P877, DOI 10.1016/S1095-6433(02)00205-2; Keys JR, 2008, BRIT J HAEMATOL, V141, P398, DOI 10.1111/j.1365-2141.2008.07065.x; KOOP BF, 1989, J BIOL CHEM, V264, P68; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MARTIN SL, 1983, J MOL BIOL, V164, P513, DOI 10.1016/0022-2836(83)90048-7; MARTIN SL, 1980, P NATL ACAD SCI-BIOL, V77, P3563, DOI 10.1073/pnas.77.6.3563; MATSUDA M, 1992, BLOOD, V80, P1347; Miller M.A., 2010, P GAT COMP ENV WORKS; Moleirinho A, 2013, GENOME BIOL EVOL, V5, P559, DOI 10.1093/gbe/evt029; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Opazo JC, 2008, P NATL ACAD SCI USA, V105, P12950, DOI 10.1073/pnas.0804392105; Opazo JC, 2008, P NATL ACAD SCI USA, V105, P1590, DOI 10.1073/pnas.0710531105; Opazo JC, 2009, MOL BIOL EVOL, V26, P1469, DOI 10.1093/molbev/msp064; OTTOLENGHI S, 1979, NATURE, V278, P654, DOI 10.1038/278654a0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Patel VS, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-34; Petronella N, 2014, GENOMICS, V103, P40, DOI 10.1016/j.ygeno.2013.10.004; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Prychitko T, 2005, MOL PHYLOGENET EVOL, V35, P225, DOI 10.1016/j.ympev.2004.11.002; Rambaut A., 2014, TRACER V1 6; RANNEY HM, 1993, AM J HEMATOL, V42, P107, DOI 10.1002/ajh.2830420121; Ristaldi MS, 1999, BLOOD CELL MOL DIS, V25, P193, DOI 10.1006/bcmd.1999.0245; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; SMITH JM, 1992, J MOL EVOL, V34, P126; Song G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-226; SPRITZ RA, 1988, MOL BIOL EVOL, V5, P21; Stamatakis A, 2014, RAXML VERSION 8 A TO; STEINBERG MH, 1991, BLOOD, V78, P2165; Steinberg MH, 2009, DISORDERS OF HEMOGLO; Storz JF, 2013, MOL PHYLOGENET EVOL, V66, P469, DOI 10.1016/j.ympev.2012.07.013; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; TAGLE DA, 1991, J BIOL CHEM, V266, P7469; Tang DC, 1997, BLOOD, V90, P421; Tang DC, 1998, BRIT J HAEMATOL, V103, P835, DOI 10.1046/j.1365-2141.1998.01052.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; VINCENT KA, 1989, J MOL BIOL, V207, P465, DOI 10.1016/0022-2836(89)90457-9; Webster MT, 2003, HUM GENET, V113, P123, DOI 10.1007/s00439-003-0954-0; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao ZM, 1998, J MOL EVOL, V46, P494, DOI 10.1007/PL00013147	92	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123365	10.1371/journal.pone.0123365	http://dx.doi.org/10.1371/journal.pone.0123365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853817	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400100
J	Paulus, A; Chitta, KS; Wallace, PK; Advani, PP; Akhtar, S; Kuranz-Blake, M; Ailawadhi, S; Chanan-Khan, AA				Paulus, Aneel; Chitta, Kasyapa S.; Wallace, Paul K.; Advani, Pooja P.; Akhtar, Sharoon; Kuranz-Blake, Maja; Ailawadhi, Sikander; Chanan-Khan, Asher A.			Immunophenotyping of Waldenstroms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications	PLOS ONE			English	Article							BONE-MARROW; LYMPHOPLASMACYTIC LYMPHOMA; ABERRANT EXPRESSION; IN-VITRO; DIAGNOSIS; THROMBOPOIETIN; ESTABLISHMENT; PROGRESSION; LEUKEMIA; MUTATION	Waldenstroms macroglobulinemia (WM) is a subtype of Non-Hodgkin's lymphoma in which the tumor cell population is markedly heterogeneous, consisting of immunoglobulin-M secreting B-lymphocytes, plasmacytoid lymphocytes and plasma cells. Due to rarity of disease and scarcity of reliable preclinical models, many facets of WM molecular and phenotypic architecture remain incompletely understood. Currently, there are 3 human WM cell lines that are routinely used in experimental studies, namely, BCWM. 1, MWCL-1 and RPCI-WM1. During establishment of RPCI-WM1, we observed loss of the CD19 and CD20 antigens, which are typically present on WM cells. Intrigued by this observation and in an effort to better define the immunophenotypic makeup of this cell line, we conducted a more comprehensive analysis for the presence or absence of other cell surface antigens that are present on the RPCI-WM1 model, as well as those on the two other WM cell lines, BCWM. 1 and MWCL-1. We examined expression of 65 extracellular and 4 intracellular antigens, comprising B-cell, plasma cell, T-cell, NK-cell, myeloid and hematopoietic stem cell surface markers by flow cytometry analysis. RPCI-WM1 cells demonstrated decreased expression of CD19, CD20, and CD23 with enhanced expression of CD28, CD38 and CD184, antigens that were differentially expressed on BCWM. 1 and MWCL-1 cells. Due to increased expression of CD184/CXCR4 and CD38, RPCI-WM1 represents a valuable model in which to study the effects anti-CXCR4 or anti-CD38 targeted therapies that are actively being developed for treatment of hematologic cancers. Overall, differences in surface antigen expression across the 3 cell lines may reflect the tumor clone population predominant in the index patients, from whom the cell lines were developed. Our analysis defines the utility of the most commonly employed WM cell lines as based on their immunophenotype profiles, highlighting unique differences that can be further studied for therapeutic exploit.	[Paulus, Aneel; Chitta, Kasyapa S.; Akhtar, Sharoon; Kuranz-Blake, Maja] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Wallace, Paul K.] Roswell Pk Canc Inst, Dept Flow & Image Cytometry, Buffalo, NY 14263 USA; [Advani, Pooja P.; Ailawadhi, Sikander; Chanan-Khan, Asher A.] Mayo Clin, Dept Internal Med, Div Hematol & Oncol, Jacksonville, FL 32224 USA	Mayo Clinic; Roswell Park Cancer Institute; Mayo Clinic	Chanan-Khan, AA (corresponding author), Mayo Clin, Dept Internal Med, Div Hematol & Oncol, Jacksonville, FL 32224 USA.	chanan-khan.asher@mayo.edu	Wallace, PK/ABB-7704-2022	Wallace, PK/0000-0001-7823-9917; Akhtar, Sharoon/0000-0003-3428-3769; Blake, Maja/0000-0002-2916-846X	Leukemia Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Leukemia Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AC-K received support from Leukemia Lymphoma Society (no number assigned). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SM, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.4; Ansell SM, 2010, MAYO CLIN PROC, V85, P824, DOI 10.4065/mcp.2010.0304; Barakat FH, 2011, AM J CLIN PATHOL, V135, P365, DOI 10.1309/AJCP15YFULCZHZVH; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belaaloui G, 2003, LEUKEMIA, V17, P1137, DOI 10.1038/sj.leu.2402916; Bergsagel FL, 2008, BLOOD, V112, P917, DOI 10.1182/blood-2008-05-154831; Chitta KS, 2013, LEUKEMIA LYMPHOMA, V54, P387, DOI 10.3109/10428194.2012.713481; Chng WJ, 2006, BLOOD, V108, P2755, DOI 10.1182/blood-2006-02-005488; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Drexler HG, 2008, LEUKEMIA RES, V32, P1669, DOI 10.1016/j.leukres.2008.04.016; Drexler HG, 2013, LEUKEMIA LYMPHOMA, V54, P224, DOI 10.3109/10428194.2012.727418; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Goteri G, 2006, INT J IMMUNOPATH PH, V19, P421, DOI 10.1177/039463200601900218; Groves FD, 1998, CANCER-AM CANCER SOC, V82, P1078; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Iijima K, 2000, LEUKEMIA, V14, P1598, DOI 10.1038/sj.leu.2401893; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Jani P, 2007, AM J HEMATOL, V82, P73, DOI 10.1002/ajh.20747; Kaleem Z, 2001, AM J CLIN PATHOL, V115, P396; Kaushansky K, 2009, BEST PRACT RES CL HA, V22, P495, DOI 10.1016/j.beha.2009.08.004; Konoplev S, 2005, AM J CLIN PATHOL, V124, P414, DOI 10.1309/3G1XDX0DVHBNVKB4; Kuhne MR, 2013, CLIN CANCER RES, V19, P357, DOI 10.1158/1078-0432.CCR-12-2333; Kularatne SA, 2014, ANGEW CHEM INT ED EN; Laubach JP, 2014, EXPERT OPIN INV DRUG, V23, P445, DOI 10.1517/13543784.2014.889681; Morice WG, 2009, MODERN PATHOL, V22, P807, DOI 10.1038/modpathol.2009.34; Nakase K, 1996, AM J CLIN PATHOL, V105, P761; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Ngo HT, 2008, BLOOD, V112, P150, DOI 10.1182/blood-2007-12-129395; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Paiva B, 2014, LEUKEMIA, V28, P166, DOI 10.1038/leu.2013.124; Paulus A, 2014, BRIT J HAEMATOL, V164, P352, DOI 10.1111/bjh.12633; Reichert JM, 2014, MABS-AUSTIN, V6, P5, DOI 10.4161/mabs.27333; Robak T, 2002, LEUKEMIA LYMPHOMA, V43, P2343, DOI 10.1080/1042819021000040044; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; SCHMITT C, 1991, CLIN EXP IMMUNOL, V85, P168; Sekhar J, 2012, LEUKEMIA LYMPHOMA, V53, P1625, DOI 10.3109/10428194.2012.656103; THOMAS X, 1995, LEUKEMIA, V9, P249; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Varghese AM, 2009, CLIN LYMPHOMA MYELOM, V9, P53, DOI 10.3816/CLM.2009.n.013; Wotherspoon A, 2000, CURR DIAGN PATHOL, V6, P55; Yuasa H, 2002, BIOCHEM BIOPH RES CO, V298, P731, DOI 10.1016/S0006-291X(02)02524-X	45	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122338	10.1371/journal.pone.0122338	http://dx.doi.org/10.1371/journal.pone.0122338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853860	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400065
J	Bushman, JD; Ye, WL; Liman, ER				Bushman, Jeremy D.; Ye, Wenlei; Liman, Emily R.			A proton current associated with sour taste: distribution and functional properties	FASEB JOURNAL			English	Article						PKD2L1; ion channel; pH; acid; sensory transduction	INFLUENZA-A VIRUS; RECEPTOR-CELLS; TRANSIENT RECEPTOR; SELECTIVITY FILTER; INTRACELLULAR PH; ION-CHANNEL; VOLTAGE; PKD2L1; MOUSE; PATHWAYS	Sour taste is detected by taste receptor cells that respond to acids through yet poorly understood mechanisms. The cells that detect sour express the protein PKD2L1, which is not the sour receptor but nonetheless serves as a useful marker for sour cells. By use of mice in which the PKD2L1 promoter drives expression of yellow fluorescent protein, we previously reported that sour taste cells from circumvallate papillae in the posterior tongue express a proton current. To establish a correlation between this current and sour transduction, we examined its distribution by patch-clamp recording. We find that the current is present in PKD2L1-expressing taste cells from mouse circumvallate, foliate, and fungiform papillae but not in a variety of other cells, including spinal cord neurons that express PKD2L1. We describe biophysical properties of the current, including pH-dependent Zn2+ inhibition, lack of voltage-dependent gating, and activation atmodest pH values (6.5) that elicit action potentials in isolated cells. Consistent with a channel that is constitutively open, the cytosol of sour taste cells is acidified. These data define a functional signature for the taste cell proton current and indicate that its expression is mostly restricted to the subset of taste cells that detect sour.	[Bushman, Jeremy D.; Ye, Wenlei; Liman, Emily R.] Univ So Calif, Neurobiol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Liman, ER (corresponding author), Univ So Calif, Neurobiol Sect, 3641 Watt Way, Los Angeles, CA 90089 USA.	liman@usc.edu	Liman, Emily/AAC-7383-2021; Ye, Wenlei/S-1012-2016	Ye, Wenlei/0000-0002-4694-1493; liman, emily/0000-0003-4765-5496	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01DC013741, F32DC013971]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC013971, R01DC013741] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Eric Mulhall for expert technical assistance and Radhika Palkar and David McKemy for assistance with isolating spinal neurons and for providing neuro2a cells. This work was supported by U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders Grants R01DC013741 (to E.R.L.) and F32DC013971 (to J.D.B.).	Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0799; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DeSimone JA, 2011, CHEM SENSES, V36, P389, DOI 10.1093/chemse/bjq148; Djenoune L., FRONT NEUROANAT, V8, P26; FOGEL M, 1972, P NATL ACAD SCI USA, V69, P690, DOI 10.1073/pnas.69.3.690; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Higuchi T, 2014, PFLUG ARCH EUR J PHY, V466, P1933, DOI 10.1007/s00424-013-1439-1; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 1997, AM J PHYSIOL-CELL PH, V273, pC1008, DOI 10.1152/ajpcell.1997.273.3.C1008; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Morgan D, 2013, J GEN PHYSIOL, V142, P625, DOI 10.1085/jgp.201311045; Mould JA, 2000, J BIOL CHEM, V275, P31038, DOI 10.1074/jbc.M003663200; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Orts-Del'Immagine A, 2012, J PHYSIOL-LONDON, V590, P3719, DOI 10.1113/jphysiol.2012.227959; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ramsey IS, 2010, NAT STRUCT MOL BIOL, V17, P869, DOI 10.1038/nsmb.1826; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shimizu T, 2011, PFLUG ARCH EUR J PHY, V461, P507, DOI 10.1007/s00424-011-0934-5; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007	48	29	30	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3014	3026		10.1096/fj.14-265694	http://dx.doi.org/10.1096/fj.14-265694			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857556	Green Published			2022-12-26	WOS:000356859100029
J	McAtee, CO; Berkebile, AR; Elowsky, CG; Fangman, T; Barycki, JJ; Wahl, JK; Khalimonchuk, O; Naslavsky, N; Caplan, S; Simpson, MA				McAtee, Caitlin O.; Berkebile, Abigail R.; Elowsky, Christian G.; Fangman, Teresa; Barycki, Joseph J.; Wahl, James K., III; Khalimonchuk, Oleh; Naslavsky, Naava; Caplan, Steve; Simpson, Melanie A.			Hyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; EXPRESSION; INTEGRIN; ACID; METASTASIS; MIGRATION; CD44	Hyaluronan (HA) turnover accelerates metastatic progression of prostate cancer in part by increasing rates of tumor cell proliferation and motility. To determine the mechanism, we overexpressed hyaluronidase 1 (Hyal1) as a fluorescent fusion protein and examined its impact on endocytosis and vesicular trafficking. Overexpression of Hyal1 led to increased rates of internalization of HA and the endocytic recycling marker transferrin. Live imaging of Hyal1, sucrose gradient centrifugation, and specific colocalization of Rab GTPases defined the subcellular distribution of Hyal1 as early and late endosomes, lysosomes, and recycling vesicles. Manipulation of vesicular trafficking by chemical inhibitors or with constitutively active and dominant negative Rab expression constructs caused atypical localization of Hyal1. Using the catalytically inactive point mutant Hyal1-E131Q, we found that enzymatic activity of Hyal1 was necessary for normal localization within the cell as Hyal1-E131Q was mainly detected within the endoplasmic reticulum. Expression of a HA-binding point mutant, Hyal1-Y202F, revealed that secretion of Hyal1 and concurrent reuptake from the extracellular space are critical for rapid HA internalization and cell proliferation. Overall, excess Hyal1 secretion accelerates endocytic vesicle trafficking in a substrate-dependent manner, promoting aggressive tumor cell behavior.	[McAtee, Caitlin O.; Berkebile, Abigail R.; Barycki, Joseph J.; Khalimonchuk, Oleh; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Elowsky, Christian G.; Fangman, Teresa] Univ Nebraska, Morrison Microscopy Facil, Lincoln, NE 68588 USA; [Wahl, James K., III] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68503 USA; [Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve; Simpson, Melanie A.] Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Simpson, MA (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr N246, 1901 Vine St, Lincoln, NE 68588 USA.	msimpson2@unl.edu	Regan, Clinton/E-6250-2012; Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health [R01 CA165574, R01 GM087455, R01 GM074876]; Institutional Development Award from the NIGMS [5P30GM106397]; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE [R01CA165574] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, P30GM106397, R01GM087455, R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award from the NIGMS; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA165574 (to M. A. S.), R01 GM087455 and R01 GM074876 (to S. C.) and by Institutional Development Award 5P30GM106397 from the NIGMS (to M. A. S. and S. C.). This work was also supported by a Nebraska Research Initiative grant (to M. A. S. and S. C.).	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; Anttila MA, 2000, CANCER RES, V60, P150; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Bharadwaj AG, 2011, EXP CELL RES, V317, P1214, DOI 10.1016/j.yexcr.2011.01.026; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Gomez CS, 2009, J UROLOGY, V182, P1350, DOI 10.1016/j.juro.2009.06.070; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Koshkaryev A, 2012, CANCER BIOL THER, V13, P50, DOI 10.4161/cbt.13.1.18871; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; KROGSTAD DJ, 1987, AM J TROP MED HYG, V36, P213, DOI 10.4269/ajtmh.1987.36.213; McAtee CO, 2014, ADV CANCER RES, V123, P1, DOI 10.1016/B978-0-12-800092-2.00001-0; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Vigetti D, 2014, FEBS J, V281, P4980, DOI 10.1111/febs.12938; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	35	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13144	13156		10.1074/jbc.M115.647446	http://dx.doi.org/10.1074/jbc.M115.647446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855794	Green Published, hybrid			2022-12-26	WOS:000354975700017
J	Vangansbeke, D; Audenaert, J; Nguyen, DT; Verhoeven, R; Gobin, B; Tirry, L; De Clercq, P				Vangansbeke, Dominiek; Audenaert, Joachim; Duc Tung Nguyen; Verhoeven, Ruth; Gobin, Bruno; Tirry, Luc; De Clercq, Patrick			Diurnal Temperature Variations Affect Development of a Herbivorous Arthropod Pest and its Predators	PLOS ONE			English	Article							TETRANYCHUS-URTICAE ACARI; NEOSEIULUS-CALIFORNICUS ACARI; 2-SPOTTED SPIDER-MITES; FLUCTUATING TEMPERATURES; PHYTOSEIULUS-PERSIMILIS; CONSTANT TEMPERATURES; DEPENDENT DEVELOPMENT; CLIMATE-CHANGE; HEAT-SHOCK; JENSENS INEQUALITY	The impact of daily temperature variations on arthropod life history remains woefully understudied compared to the large body of research that has been carried out on the effects of constant temperatures. However, diurnal varying temperature regimes more commonly represent the environment in which most organisms thrive. Such varying temperature regimes have been demonstrated to substantially affect development and reproduction of ectothermic organisms, generally in accordance with Jensen's inequality. In the present study we evaluated the impact of temperature alternations at 4 amplitudes (DTR0, +5, +10 and + 15 degrees C) on the developmental rate of the predatory mites Phytoseiulus persimilis Athias-Henriot and Neoseiulus californicus McGregor (Acari: Phytoseiidae) and their natural prey, the two-spotted spider mite Tetranychus urticae Koch (Acari: Tetranychidae). We have modelled their developmental rates as a function of temperature using both linear and nonlinear models. Diurnally alternating temperatures resulted in a faster development in the lower temperature range as compared to their corresponding mean constant temperatures, whereas the opposite was observed in the higher temperature range. Our results indicate that Jensen's inequality does not suffice to fully explain the differences in developmental rates at constant and alternating temperatures, suggesting additional physiological responses play a role. It is concluded that diurnal temperature range should not be ignored and should be incorporated in predictive models on the phenology of arthropod pests and their natural enemies and their performance in biological control programmes.	[Vangansbeke, Dominiek; Duc Tung Nguyen; Tirry, Luc; De Clercq, Patrick] Univ Ghent, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Audenaert, Joachim; Verhoeven, Ruth; Gobin, Bruno] PCS Ornamental Plant Res, B-9070 Destelbergen, Belgium; [Duc Tung Nguyen] Vietnam Natl Univ Agr, Dept Entomol, Hanoi, Vietnam	Ghent University; Vietnam National University of Agriculture (VNUA)	Vangansbeke, D (corresponding author), Univ Ghent, Dept Crop Protect, Lab Agrozool, Coupure Links 653, B-9000 Ghent, Belgium.	dominiek.vangansbeke@Ugent.be	De Clercq, Patrick/B-5721-2015; Nguyen, Duc Tung/P-1316-2017	De Clercq, Patrick/0000-0003-0664-1602; Nguyen, Duc Tung/0000-0002-8954-3604	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [090931]; PCS-Ornamental Plant Research	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); PCS-Ornamental Plant Research	This study was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen http://www.iwt.be/) (Project number 090931). Co-authors Joachim Audenaert, Ruth Verhoeven and Bruno Gobin are employed by PCSOrnamental Plant Research. PCS-Ornamental Plant Research provided support in the form of salaries for authors JA, RV and BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Fenollosa E, 2014, PEST MANAG SCI, V70, P853, DOI 10.1002/ps.3678; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AYRES MP, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P75; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; BECK SD, 1983, J INSECT PHYSIOL, V29, P107, DOI 10.1016/0022-1910(83)90113-0; BEHRENS W, 1983, OECOLOGIA, V59, P279, DOI 10.1007/BF00378849; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Bryant SR, 1999, EUR J ENTOMOL, V96, P143; Bryon A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-815; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Davis JA, 2006, ENVIRON ENTOMOL, V35, P1461, DOI 10.1603/0046-225X(2006)35[1461:EOHAFT]2.0.CO;2; DECLERCQ P, 1992, CAN ENTOMOL, V124, P125; Dieleman JA, 2005, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2005.691.3; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; EICHMEIER J, 1960, J ECON ENTOMOL, V53, P661, DOI 10.1093/jee/53.4.661; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Fantinou AA, 2003, ENVIRON ENTOMOL, V32, P1337, DOI 10.1603/0046-225X-32.6.1337; Garcia-Ruiz E, 2011, ENVIRON ENTOMOL, V40, P939, DOI 10.1603/EN11080; Gerson U, 2012, ANNU REV ENTOMOL, V57, P229, DOI 10.1146/annurev-ento-120710-100639; Gotoh T, 2014, EXP APPL ACAROL, V64, P465, DOI 10.1007/s10493-014-9841-8; Greco NM, 2005, EXP APPL ACAROL, V37, P57, DOI 10.1007/s10493-005-0067-7; HAGSTRUM DW, 1991, ANN ENTOMOL SOC AM, V84, P369, DOI 10.1093/aesa/84.4.369; HAGSTRUM DW, 1970, ANN ENTOMOL SOC AM, V63, P1385, DOI 10.1093/aesa/63.5.1385; HONEK A, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P401; Honek Alois, 1999, Entomological Science, V2, P615; Huffaker Carl B., 1944, ANN ENT SOC AMER, V37, P1, DOI 10.1093/aesa/37.1.1; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Korner O, 2003, COMPUT ELECTRON AGR, V39, P39, DOI 10.1016/S0168-1699(03)00006-1; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; LEWONTIN RC, 1965, GENETICS COLONIZING; LIU SS, 1995, ANN ENTOMOL SOC AM, V88, P107, DOI 10.1093/aesa/88.2.107; Logan JD, 2006, ECOL MODEL, V196, P471, DOI 10.1016/j.ecolmodel.2006.02.034; Maeda T, 2000, EXP APPL ACAROL, V24, P415, DOI 10.1023/A:1006449108245; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Messelink GJ, 2014, BIOCONTROL, V59, P377, DOI 10.1007/s10526-014-9579-6; Moerkens R, 2011, AGR FOREST ENTOMOL, V13, P301, DOI 10.1111/j.1461-9563.2011.00525.x; MORI H, 1966, CAN J ZOOLOG, V44, P483, DOI 10.1139/z66-047; Morrison WR, 2014, PEST MANAG SCI, V70, P1105, DOI 10.1002/ps.3654; MYSTER J, 1995, SCI HORTIC-AMSTERDAM, V62, P205, DOI 10.1016/0304-4238(95)00783-P; Otsuka Y, 1997, GENES GENET SYST, V72, P19, DOI 10.1266/ggs.72.19; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pedigo LP, 1998, ENTOMOLOGY PEST MANA; Ratte H.T., 1985, P33; Rhodes EM, 2006, EXP APPL ACAROL, V39, P213, DOI 10.1007/s10493-006-9005-6; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Roy M, 2002, ENVIRON ENTOMOL, V31, P177, DOI 10.1603/0046-225X-31.1.177; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; SCHOWALTER T. D., 2006, INSECT ECOLOGY ECOSY; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Smallwood PD, 1996, AM ZOOL, V36, P392; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; TANIGOSHI LK, 1976, ANN ENTOMOL SOC AM, V69, P712, DOI 10.1093/aesa/69.4.712; Tantau HJ, 1998, MATH COMPUT SIMULAT, V48, P93, DOI 10.1016/S0378-4754(98)00145-1; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Vangansbeke D, 2013, EXP APPL ACAROL, V61, P285, DOI 10.1007/s10493-013-9704-8; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; Walzer A, 2007, BIOL CONTROL, V41, P42, DOI 10.1016/j.biocontrol.2006.11.012; Weintraub P, 2008, EXP APPL ACAROL, V45, P29, DOI 10.1007/s10493-008-9169-3; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Xu XM, 1996, PLANT PATHOL, V45, P163, DOI 10.1046/j.1365-3059.1996.d01-134.x	65	35	36	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124898	10.1371/journal.pone.0124898	http://dx.doi.org/10.1371/journal.pone.0124898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874697	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800154
J	Drumond, MA; Guimaraes, AQ; da Silva, RHP				Drumond, Maria Auxiliadora; Guimaraes, Artur Queiroz; Pereira da Silva, Raquel Hosken			The Role of Local Knowledge and Traditional Extraction Practices in the Management of Giant Earthworms in Brazil	PLOS ONE			English	Article							ECOLOGICAL KNOWLEDGE; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; INDIGENOUS KNOWLEDGE; AUTOTOMY; MAMMALS; OLIGOCHAETA; PERCEPTIONS; SCIENCE; FAUNA	The giant earthworm, Rhinodrilus alatus (Righi 1971), has been captured in the southeastern Brazilian Cerrado biome for approximately 80 years and used as bait for amateur fishing throughout Brazil. Local knowledge and traditional extraction practices are crucial for the establishment of management strategies for the species because, although its extraction involves conflicts and social and environmental impacts, the species is one of the major sources of income for approximately 3,000 people, especially for members of an Afro-descendant community that has approximately 2,000 inhabitants. Participatory tools, such as seasonal calendar, transect walks and participatory maps, were individually or collectively used with extractors and traders (former extractors), and 129 semi-structured and unstructured interviews were conducted with the same individuals between 2005 and 2012. The capture of Rhinodrilus alatus was observed in different seasons and areas of occurrence of the species in 17 municipalities, where this giant earthworm is the only species extracted for trade. All information obtained was verified by community members in 17 meetings. The extractors have an extensive knowledge of the life history, behavior, distribution, and possible impacts of climate change on the species. Different capture techniques, which have different impacts, are used during the dry and rainy seasons and are passed by the extractors through the generations. Local knowledge contributed to the establishment of agreements for the use of capture techniques that have less impact, to the expansion of scientific knowledge and the reassessment of the conservation status of Rhinodrilus alatus. The present study may serve as an example for management projects for other giant earthworm species in other regions of Brazil and in other countries.	[Drumond, Maria Auxiliadora] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Drumond, Maria Auxiliadora; Guimaraes, Artur Queiroz; Pereira da Silva, Raquel Hosken] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Drumond, MA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	alatus@ufmg.br	Drumond, Maria A/C-9582-2016	Drumond, Maria A/0000-0002-0677-6673	Instituto Estadual de Florestas de Minas Gerais; Pro-Reitoria de Pesquisa; Pro-Reitoria de Extensao of Universidade Federal de Minas Gerais; Ministerio Publico do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conservacao Internacional do Brasil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Instituto Estadual de Florestas de Minas Gerais; Pro-Reitoria de Pesquisa; Pro-Reitoria de Extensao of Universidade Federal de Minas Gerais; Ministerio Publico do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conservacao Internacional do Brasil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Instituto Estadual de Florestas de Minas Gerais (www.ief.mg.gov.br); Pro-Reitoria de Pesquisa (www.ufmg.br/prpq) and Pro-Reitoria de Extensao (www2.ufmg.br/proex) of Universidade Federal de Minas Gerais (www.ufmg.br); Ministerio Publico do Estado de Minas Gerais (www.mpmg.mp.br); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (www.fapemig.br); Conservacao Internacional do Brasil (www.conservacao.org); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvard MS, 1997, CONSERV BIOL, V11, P977, DOI 10.1046/j.1523-1739.1997.96047.x; Alvares F, 2011, INNOVATION-ABINGDON, V24, P313, DOI 10.1080/13511610.2011.592049; Alves RRN, 2011, J ETHNOBIOL ETHNOMED, V7, DOI [10.1186/1746-4269-7-9, 10.1186/1746-4269-7-22]; Alves RRN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI [10.1186/1746-4269-5-1, 10.1186/1746-4269-5-12]; [Anonymous], 1997, FENCES SEEKING SOCIA; Anthwal A, 2010, RESOUR CONSERV RECY, V54, P962, DOI 10.1016/j.resconrec.2010.02.003; Atiyeh RM, 2002, BIORESOURCE TECHNOL, V84, P7, DOI 10.1016/S0960-8524(02)00017-2; Balamurugan M, 2009, J ETHNOPHARMACOL, V121, P330, DOI 10.1016/j.jep.2008.10.021; Balram S, 2004, BIODIVERS CONSERV, V13, P1195, DOI 10.1023/B:BIOC.0000018152.11643.9c; Barbraud C, 2011, J ANIM ECOL, V80, P89, DOI 10.1111/j.1365-2656.2010.01752.x; Bender MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110332; Berkes F., 1998, LINKING SOCIAL ECOLO, P1; Berkes F., 1998, LINKING SOCIAL ECOLO, P98; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; Bonaldo S. M., 2004, Fitopatologia Brasileira, V29, P128, DOI 10.1590/S0100-41582004000200002; Brown G.G., 2007, MINHOCAS AM LATINA B, P297; Carvalho AM, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-36; Catania KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003472; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; CHAMBERS R, 1994, WORLD DEV, V22, P1437, DOI 10.1016/0305-750X(94)90030-2; Chan KY, 2001, PEDOBIOLOGIA, V45, P272, DOI 10.1078/0031-4056-00084; CHANG YM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEQ079; Charnley S, 2007, FOREST ECOL MANAG, V246, P14, DOI 10.1016/j.foreco.2007.03.047; Cook TC, 2015, MAR POLICY, V51, P573, DOI 10.1016/j.marpol.2014.09.020; Cooper EL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164152; Cooper EL, 2004, ADV EXP MED BIOL, V546, P359; Costa Neto E. M., 2000, HUM ECOL REV, V7, P41; CPRM-Servico Geologico do Brasil, 2014, 1 CPRM; Csuzdi C, 2011, ZOOL ANZ, V250, P2, DOI 10.1016/j.jcz.2010.10.001; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; de Garine-Wichatitsky M, 2013, COMP IMMUNOL MICROB, V36, P321, DOI 10.1016/j.cimid.2012.10.007; de Souza JB, 2014, TROP CONSERV SCI, V7, P145, DOI 10.1177/194008291400700105; Diaz-Guisado D, 2006, J EXP MAR BIOL ECOL, V338, P73, DOI 10.1016/j.jembe.2006.06.037; Dominguez J, 2004, SOIL ZOOLOGY SUSTAIN, P369; Drumond MA, 2014, BRAZ J BIOL, V73, P699, DOI 10.1590/S1519-69842013000400004; Drumond M. A., 2012, BIODIVERS BRAS, V2, P134; Drumond M. A., 2009, TECNICAS FERRAMENTAS, V2; Drumond Maria Auxiliadora, 2008, MG Biota, V1, P5; EISNER T, 1983, P NATL ACAD SCI-BIOL, V80, P3382, DOI 10.1073/pnas.80.11.3382; Fernandes-Ferreira H, 2012, BIODIVERS CONSERV, V21, P221, DOI 10.1007/s10531-011-0179-9; Lopez-Arevalo HF, 2011, BIOL CONSERV, V144, P1451, DOI 10.1016/j.biocon.2011.01.014; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; GADGIL M, 1993, AMBIO, V22, P151; Gilchrist G, 2007, ECOL SOC, V12; Grech A, 2014, BIODIVERS CONSERV, V23, P3319, DOI 10.1007/s10531-014-0783-6; Hanazaki N, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-36; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Holling CS, 2009, LINKING SOCIAL ECOLO, P342; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; James SW, 2006, SOIL BIODIVERSITY IN AMAZONIAN AND OTHER BRAZILIAN ECOSYSTEMS, P56, DOI 10.1079/9781845930325.0056; Alonso-Castro AJ, 2014, J ETHNOPHARMACOL, V152, P53, DOI 10.1016/j.jep.2014.01.005; KASTER JL, 1979, T AM MICROSC SOC, V98, P473, DOI 10.2307/3225736; Lee K.N., 1999, CONSERV ECOL, V3, P3, DOI DOI 10.5751/ES-00131-030203; Lynam T, 2007, ECOL SOC, V12; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MAIORANA VC, 1977, NATURE, V265, P533, DOI 10.1038/265533a0; Mantilla J, 1996, REV FORESTAL CENTROA, V14, P15; MARENGO J. A., 2010, NOVA ACTA LEOPOLDINA, V112, P1; Maxwell J.A., 2013, QUALITATIVE RES DESI, V3rd; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Mitchell T., 2012, RESILIENCE RISK MANA; Mitra O, 2009, BIOL LETTERS, V5, P16, DOI 10.1098/rsbl.2008.0456; Mittermeier Russell A., 2004, P1; Moreno AG, 2004, CAN J ZOOL, V82, P1000, DOI 10.1139/Z04-056; Mosleh YY, 2005, ECOTOXICOLOGY, V14, P559; Newmaster AF, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-37; Alves RRN, 2012, ETHNOBIOL CONSERV, V1, DOI [10.15451/ec2012-8-1.2-1-69, 10.15451/ec2012-8-1.7-1-21, 10.15451/ec2012-8-1.1-1-03]; Alves RRN, 2012, ENVIRON MONIT ASSESS, V184, P6877, DOI 10.1007/s10661-011-2465-0; Nyberg B., 1999, INTRO GUIDE ADAPTIVE; O'Donnell KP, 2010, ANIM CONSERV, V13, P526, DOI 10.1111/j.1469-1795.2010.00377.x; Padmanaba M, 2013, ENVIRON MANAGE, V52, P348, DOI 10.1007/s00267-013-0051-7; Pahl-Wostl C., 2007, Ecology and Society, V12, P30; Paoletti MG, 2000, P ROY SOC B-BIOL SCI, V267, P2247, DOI 10.1098/rspb.2000.1275; Paoletti MG, 2003, P ROY SOC B-BIOL SCI, V270, P249, DOI 10.1098/rspb.2002.2141; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Pezzuti J.C.B., 2004, JANELAS BIODIVERSIDA, P213; Pitt AL, 2012, BIODIVERS CONSERV, V21, P51, DOI 10.1007/s10531-011-0160-7; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; RAW F, 1959, NATURE, V184, P1661, DOI 10.1038/1841661a0; Reynolds J.W., 1972, American Journal of Nursing, V72, P1273; Righi G, 1998, LIVRO VERMELHO ESPEC, P579; Rocha-Mendes F, 2005, REV BRAS ZOOL, V22, P991, DOI 10.1590/S0101-81752005000400027; Russell IC, 2012, ICES J MAR SCI, V69, P1563, DOI 10.1093/icesjms/fsr208; Scarlett L, 2013, ECOL SOC, V18, DOI 10.5751/ES-05762-180326; Shanley P, 2006, ECOL SOC, V11; Sharma S., 2005, J AM SCI, V1, P4; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Steyaert P, 2007, ECOL SOC, V12; TAMPI P. R. S., 1959, JOUR MAR BIOL ASSOC INDIA, V1, P250; Turvey ST, 2014, BIOL CONSERV, V169, P189, DOI 10.1016/j.biocon.2013.11.018; Turvey ST, 2013, BIOL CONSERV, V157, P352, DOI 10.1016/j.biocon.2012.07.016; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Valsecchi Joao, 2009, Uakari, V5, P33; Verdejo ME, 2003, DIAGNOSTICO RURAL PA; Wallace A. R., 1853, VIAGENS PELOS RIOS A; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Younsi M, 2010, MEDITERR MAR SCI, V11, P185, DOI 10.12681/mms.101; ZHANG FX, 1992, SOIL BIOL BIOCHEM, V24, P1247; Ziembicki MR, 2013, BIOL CONSERV, V157, P78, DOI 10.1016/j.biocon.2012.07.004; Zuniga MC, 2013, APPL SOIL ECOL, V69, P61, DOI 10.1016/j.apsoil.2013.03.001	101	7	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123913	10.1371/journal.pone.0123913	http://dx.doi.org/10.1371/journal.pone.0123913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874618	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700052
J	Gao, DF; Hao, GH; Meng, Z; Ning, N; Yang, G; Liu, ZW; Dong, X; Niu, XL				Gao, Dengfeng; Hao, Guanghua; Meng, Zhe; Ning, Ning; Yang, Guang; Liu, Zhongwei; Dong, Xin; Niu, Xiaolin			Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; NECROSIS-FACTOR-ALPHA; PPAR-GAMMA; TRANSCRIPTION FACTOR; INCREASED EXPRESSION; TYPE-1 RECEPTOR; ROSIGLITAZONE; INHIBITION; PATHWAY; KRUPPEL-LIKE-FACTOR-5	Kruppel-like factor (KLF) 5, which initiates vascular smooth muscle cell (VSMC) proliferation, also participates in Angiotensin (Ang) II-induced vascular remodeling. The protective effect of rosiglitazone on vascular remodeling may be due to their impact on VSMC proliferation. However, the underlying mechanisms involved remain unclear. This study was designed to investigate whether the antiproliferation effects of rosiglitazone are mediated by regulating Ang II/KLF5 response. We found that, in aortas of Ang II-infused rats, vascular remodeling and KLF5 expression were markedly increased, and its target gene cyclin D1 was overexpressed. Co-treatment with rosiglitazone diminished these changes. In growth-arrested VSMCs, PPAR-gamma agonists (rosiglitazone and 15d-PGJ2) dose-dependently inhibited Ang II-induced cell proliferation and expression of KLF5 and cyclin D1. Moreover, these effects were attenuated by the PPAR- gamma antagonists GW9662, bisphenol A diglycidyl ether and PPAR- gamma specific siRNA. Furthermore, rosiglitazone inhibited Ang II-induced phosphorylation of protein kinase C (PKC) zeta and extracellular signal-regulated kinase (ERK) 1/2 and activation of early growth response protein (Egr). In conclusion, in Ang II-stimulated VSMCs, rosiglitazone might have an antiproliferative effect through mechanisms that include reducing KLF5 expression, and a crosstalk between PPAR-. and PKC zeta/ERK1/2/ Egr may be involved in. These findings not only provide a previously unrecognized mechanism by which PPAR- gamma agonists inhibit VSMC proliferation, but also document a novel evidence for the beneficial vascular effect of PPAR- gamma activation.	[Gao, Dengfeng; Hao, Guanghua; Meng, Zhe; Yang, Guang; Liu, Zhongwei; Dong, Xin; Niu, Xiaolin] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China; [Ning, Ning] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Nucl Med, Xian 710004, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Gao, DF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China.	gaomedic@163.com			National Natural Science Foundation of China [30900617]; science and technology project of Shaanxi Province [2014k11-02-01-12]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology project of Shaanxi Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by a grant from National Natural Science Foundation of China (No. 30900617 to DG), the science and technology project of Shaanxi Province (No. 2014k11-02-01-12 to NN), and the Fundamental Research Funds for the Central Universities (to DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafford R, 2006, SURGERY, V140, P289, DOI 10.1016/j.surg.2006.04.004; Bai YP, 2007, BIOCHEM BIOPH RES CO, V360, P20, DOI 10.1016/j.bbrc.2007.05.222; Chang SJ, 2009, MOL BIOL REP, V36, P2165, DOI 10.1007/s11033-008-9430-1; de Oliveira Silva-Junior G, 2009, EXP TOXICOL PATHOL; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gao DF, 2007, BIOCHEM PHARMACOL, V73, P185, DOI 10.1016/j.bcp.2006.09.019; Gao DF, 2006, BIOL PHARM BULL, V29, P2004, DOI 10.1248/bpb.29.2004; Gizard F, 2008, PPAR RES, V2008, DOI 10.1155/2008/429123; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; HAN EKH, 1995, CARCINOGENESIS, V16, P2423, DOI 10.1093/carcin/16.10.2423; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Iglarz M, 2003, ARTERIOSCL THROM VAS, V23, P45, DOI 10.1161/01.ATV.0000047447.67827.CD; Isenovic ER, 2010, ANGIOLOGY, V61, P357, DOI 10.1177/0003319709358693; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Kim JS, 2012, CELL BIOL INT, V36, P305, DOI 10.1042/CBI20100524; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Li Jingjue, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P109; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Liu YH, 2012, HYPERTENSION, V60, P1471, DOI 10.1161/HYPERTENSIONAHA.112.198887; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Lombardi A, 2008, ARTERIOSCL THROM VAS, V28, P718, DOI 10.1161/ATVBAHA.107.160713; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Nagai R, 2003, ADV EXP MED BIOL, V538, P57; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Qin HD, 2009, J CELL PHYSIOL, V221, P387, DOI 10.1002/jcp.21865; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rizzoni D, 2009, BLOOD PRESSURE, V18, P242, DOI 10.1080/08037050903254923; Satoh H, 1999, BIOCHEM BIOPH RES CO, V254, P757, DOI 10.1006/bbrc.1998.0126; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Solinil A, 2008, DIABETES-METAB RES, V24, P197, DOI 10.1002/dmrr.781; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Sugawara A, 2001, HYPERTENS RES, V24, P229, DOI 10.1291/hypres.24.229; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Takeda K, 2000, CIRCULATION, V102, P1834; Verrier E, 2004, CIRC RES, V94, P1515, DOI 10.1161/01.RES.0000130527.92537.06; Wakino S, 2001, J BIOL CHEM, V276, P47650, DOI 10.1074/jbc.M108719200; Wan HY, 2012, TRANSL RES, V160, P153, DOI 10.1016/j.trsl.2012.02.003; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Whiteside C, 2009, EXP DIABETES RES, DOI 10.1155/2009/910783; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574	47	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123724	10.1371/journal.pone.0123724	http://dx.doi.org/10.1371/journal.pone.0123724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874449	Green Submitted, gold, Green Published			2022-12-26	WOS:000353014700040
J	Santos, RV; Bastos, JL; Cruz, OG; Longo, LAFD; Flowers, NM; Pereira, NDM				Santos, Ricardo Ventura; Bastos, Joao Luiz; Cruz, Oswaldo Goncalves; Ferreira de Barros Longo, Luciene Aparecida; Flowers, Nancy May; Martins Pereira, Nilza de Oliveira			Parity of Indigenous and Non-Indigenous Women in Brazil: Does the Reported Number of Children Born Depend upon Who Answers National Census Questions?	PLOS ONE			English	Article							LATIN-AMERICA; HEALTH	Taking parity as the main analytic variable, the objective of this study is to investigate whether the patterns of response to national census questions in Brazil differ when Indigenous and non-Indigenous women are compared, taking into consideration whether the information was provided by the women directly or by a proxy respondent (another household member or a non-resident). We use data on children ever born to Indigenous and non-Indigenous women from two Brazilian regions, the Northeast and the North. Data on the number of household members, total household rooms, interviewee's color/race, educational attainment, age, parity, and type of respondent were obtained from the 2010 Brazilian census. The relation between color/race and reported parity, as well as the impact of the type of respondent on this association were assessed with the Zero-inflated Negative Binomial regression, stratified by region (North and Northeast) and urban/rural status. Just over half of census interviewees answered directly the census questions (51.2% in the North and 54.4% in the Northeast). Indigenous women in the North region had the highest percentage of interviews carried out with a non-resident (12.7% total; 15.0% and 3.0% in rural and urban areas, respectively). Regardless of color/race, paritymeans were considerably higher when the question was answered by the woman directly (93.5%-101.4% and 15.6%-21.7% higher, compared co-resident and non-resident based answers, respectively). Parity underreporting was particularly strong in Indigenous women living in the rural North (16.0% less in comparison to White women). Proxy respondents tend to underestimate the count of children, particularly among Indigenous women from the North. The implementation of certain methodological alternatives in the Brazilian national censuses, such as the selection and training of census takers to work specifically in Indigenous territories, might be a productive means to improve data collection.	[Santos, Ricardo Ventura] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [Bastos, Joao Luiz] Univ Fed Santa Catarina, Dept Saude Publ, Florianopolis, SC, Brazil; [Cruz, Oswaldo Goncalves] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, RJ, Brazil; [Ferreira de Barros Longo, Luciene Aparecida] Inst Brasileiro Geog & Estat, Unidade Estadual Minas Gerais, Belo Horizonte, MG, Brazil; [Flowers, Nancy May] CUNY Hunter Coll, New York, NY 10021 USA; [Martins Pereira, Nilza de Oliveira] Inst Brasileiro Geog & Estat, Diretoria Pesquisas, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Santa Catarina (UFSC); Fundacao Oswaldo Cruz; City University of New York (CUNY) System; Hunter College (CUNY)	Santos, RV (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.	santos@ensp.fiocruz.br	Bastos, Joao L/K-8362-2015; Bastos, Joao/AAG-4560-2019	Bastos, Joao L/0000-0002-1816-0745; Bastos, Joao/0000-0002-1816-0745	Brazilian National Research Council (CNPq) [304.358/2014-2]; Research Support Foundation of the State of Rio de Janeiro (FAPERJ) [E-26/102.352/2013]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors thank the Brazilian National Research Council (CNPq) and the Research Support Foundation of the State of Rio de Janeiro (FAPERJ), which funded the research that resulted in this paper through grants 304.358/2014-2 and E-26/102.352/2013, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CENS DEM 2010 CAR GE; Axelsson P, 2011, INDIGENOUS PEOPLES D, P1; Azevedo MM, 2011, POVOS INDIGENAS BRAS, P25; Cardoso Andrey Moreira, 2005, Cad. Saúde Pública, V21, P1602, DOI 10.1590/S0102-311X2005000500035; Carvalho José Alberto Magno de, 2005, Rev. bras. estud. popul., V22, P351, DOI 10.1590/S0102-30982005000200011; Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52; Coimbra Jr CEA, 2004, LOST PARADISES ETHIC, P89; Cooke Martin, 2007, BMC Int Health Hum Rights, V7, P9, DOI 10.1186/1472-698X-7-9; Del Popolo F, 2011, DERECHO INFORM PUEBL; Del Popolo F, 2008, PUEBLOS INDIGENAS AF; Department of Economic and Social Affairs, 2009, STAT WORLDS IND PEOP; Frutos ND, 2004, ATLAS COMUNIDADES IN; Goldani AM, 2009, COMPLETING FERTILITY, P331; Goncalves JMM, 1995, IBGE RETRATO HIST; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; HEMMING J, 1987, AMAZON FRONTIER DEFE; IBGE, 2012, BRAS 500 AN POV; IBGE, 2010, CENS DEM 2010 NUPC F; IBGE, 2013, MET CENS DEM 2010; IBGE (The Brazilian Institute of Statistics and Geography), 2005, TEND DEM AN IND COM; Incayawar M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-27; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, CENS DEM 2010 MAN RE; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2006, EST SEC 20; Kertzer D.I., 2002, CENSUS IDENTITY POLI; McSweeney K, 2005, LAT AM RES REV, V40, P3, DOI 10.1353/lar.2005.0012; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Morning A, 2008, POPUL RES POLICY REV, V27, P239, DOI 10.1007/s11113-007-9062-5; Nobles M., 2000, SHADES CITIZENSHIP R; Oliveira-Filho JP, 2011, RIO DE JANEIRO CAPA, DOI [10.5603/CJ.a2013.0129, DOI 10.5603/CJ.A2013.0129]; PAGLIARO H, 2005, DEMOGRAFIA POVOS IND; Pan American Health Organization, 2006, HLTH IND PEOPL AM; Perz SG, 2008, LAT AM RES REV, V43, P7, DOI 10.1353/lar.0.0019; Potter JE, 2010, POPUL DEV REV, V36, P283, DOI 10.1111/j.1728-4457.2010.00330.x; Ricardo F., 2011, POVOS INDIGENAS BRAS; Santos RV, 2011, CAD SAUDE PUBLICA, V27, P1049, DOI 10.1590/S0102-311X2011000600001; Skold Peter, 2011, INDIGENOUS PEOPLES D, P295	36	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123826	10.1371/journal.pone.0123826	http://dx.doi.org/10.1371/journal.pone.0123826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874712	Green Published, gold			2022-12-26	WOS:000353014700046
J	Bartolome, N; Segarra, S; Artieda, M; Francino, O; Sanchez, E; Szczypiorska, M; Casellas, J; Tejedor, D; Cerdeira, J; Martnez, A; Velasco, A; Sanchez, A				Bartolome, Nerea; Segarra, Sergi; Artieda, Marta; Francino, Olga; Sanchez, Elisenda; Szczypiorska, Magdalena; Casellas, Joaquim; Tejedor, Diego; Cerdeira, Joaquin; Martnez, Antonio; Velasco, Alfonso; Sanchez, Armand			A Genetic Predictive Model for Canine Hip Dysplasia: Integration of Genome Wide Association Study (GWAS) and Candidate Gene Approaches	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ELBOW DYSPLASIA; OSTEOARTHRITIS; JOINT; SUSCEPTIBILITY; IDENTIFICATION; DISCOVERY; LAXITY; DOGS	Canine hip dysplasia is one of the most prevalent developmental orthopedic diseases in dogs worldwide. Unfortunately, the success of eradication programs against this disease based on radiographic diagnosis is low. Adding the use of diagnostic genetic tools to the current phenotype-based approach might be beneficial. The aim of this study was to develop a genetic prognostic test for early diagnosis of hip dysplasia in Labrador Retrievers. To develop our DNA test, 775 Labrador Retrievers were recruited. For each dog, a blood sample and a ventrodorsal hip radiograph were taken. Dogs were divided into two groups according to their FCI hip score: control (A/B) and case (D/E). C dogs were not included in the sample. Genetic characterization combining a GWAS and a candidate gene strategy using SNPs allowed a case-control population association study. A mathematical model which included 7 SNPs was developed using logistic regression. The model showed a good accuracy (Area under the ROC curve = 0.85) and was validated in an independent population of 114 dogs. This prognostic genetic test represents a useful tool for choosing the most appropriate therapeutic approach once genetic predisposition to hip dysplasia is known. Therefore, it allows a more individualized management of the disease. It is also applicable during genetic selection processes, since breeders can benefit from the information given by this test as soon as a blood sample can be collected, and act accordingly. In the authors' opinion, a shift towards genomic screening might importantly contribute to reducing canine hip dysplasia in the future. In conclusion, based on genetic and radiographic information from Labrador Retrievers with hip dysplasia, we developed an accurate predictive genetic test for early diagnosis of hip dysplasia in Labrador Retrievers. However, further research is warranted in order to evaluate the validity of this genetic test in other dog breeds.	[Bartolome, Nerea; Artieda, Marta; Szczypiorska, Magdalena; Tejedor, Diego; Martnez, Antonio] Progenika Biopharma SA, Grifols Co, Derio, Bizkaia, Spain; [Segarra, Sergi; Velasco, Alfonso] Bioiberica SA, Barcelona, Spain; [Francino, Olga; Sanchez, Elisenda; Casellas, Joaquim; Sanchez, Armand] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Dels Aliments, Serv Vet Genet Mol, E-08193 Barcelona, Spain; [Cerdeira, Joaquin] Ctr Vet Aluche Las Aguilas, Madrid, Spain	Grifols; Bioiberica; Autonomous University of Barcelona	Bartolome, N (corresponding author), Progenika Biopharma SA, Grifols Co, Derio, Bizkaia, Spain.	nerea.bartolome@progenika.grifols.com	Francino, Olga/K-5683-2017; Sanchez, Armand/L-7905-2015	Francino, Olga/0000-0002-9022-3835; Sanchez, Armand/0000-0001-9160-1124; Segarra, Sergi/0000-0002-6680-4146; Casellas, Joaquim/0000-0002-4982-3556	Basque Government [IG-2011/0000745, IG-2012/0000068]; Bioiberica SA	Basque Government(Basque Government); Bioiberica SA	This work has been supported by Grants IG-2011/0000745 and IG-2012/0000068 from the Basque Government and by the corporate sponsor Bioiberica SA. The funder Bioiberica SA provided support in the form of salaries and research materials for authors AV and SS, while Progenika Biopharma SA provided support in the form of salaries for authors NB, MA, MS, DT, and AM, but neither company had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Balsa A, 2010, RHEUMATOLOGY, V49, P458, DOI 10.1093/rheumatology/kep380; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Distl O, 2008, P 14 EUR SOC VET ORT, pS61; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Fels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096618; FLUCKIGER M, 1995, SCHWEIZ ARCH TIERH, V137, P243; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guo G, 2011, OSTEOARTHR CARTILAGE, V19, P420, DOI 10.1016/j.joca.2010.12.011; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Kaneene JB, 2009, VET SURG, V38, P398, DOI 10.1111/j.1532-950X.2008.00475.x; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Leppanen M, 2000, J SMALL ANIM PRACT, V41, P19, DOI 10.1111/j.1748-5827.2000.tb03130.x; Leppanen M, 1999, PREV VET MED, V42, P121, DOI 10.1016/S0167-5877(99)00059-8; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Moonga BS, 1996, CALCIFIED TISSUE INT, V59, P105, DOI 10.1007/s002239900095; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Proserpio V, 2013, GENE DEV, V27, P1299, DOI 10.1101/gad.217240.113; Rodriguez-Lopez J, 2009, OSTEOARTHR CARTILAGE, V17, P321, DOI 10.1016/j.joca.2008.07.012; Sanchez-Molano E, 2014, J ANIM BREED GENET, V131, P134, DOI 10.1111/jbg.12056; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Stock KF, 2010, J ANIM BREED GENET, V127, P42, DOI 10.1111/j.1439-0388.2009.00809.x; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Willis MB, 1997, J AM VET MED ASSOC, V210, P1480; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	46	21	22	8	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122558	10.1371/journal.pone.0122558	http://dx.doi.org/10.1371/journal.pone.0122558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874693	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100084
J	Beck, H; Titze, SI; Hubner, S; Busch, M; Schlieper, G; Schultheiss, UT; Wanner, C; Kronenberg, F; Krane, V; Eckardt, KU; Kottgen, A				Beck, Hanna; Titze, Stephanie I.; Huebner, Silvia; Busch, Martin; Schlieper, Georg; Schultheiss, Ulla T.; Wanner, Christoph; Kronenberg, Florian; Krane, Vera; Eckardt, Kai-Uwe; Koettgen, Anna		GCKD Investigators	Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; MEN BORN; EPIDEMIOLOGY; INSUFFICIENCY; POPULATION; DIAGNOSIS; DEATH; CLASSIFICATION; ASSOCIATION	Background and Aims Chronic kidney disease (CKD) is a risk factor for development and progression of heart failure (HF). CKD and HF share common risk factors, but few data exist on the prevalence, signs and symptoms as well as correlates of HF in populations with CKD of moderate severity. We therefore aimed to examine the prevalence and correlates of HF in the German Chronic Kidney Disease (GCKD) study, a large observational prospective study. Methods and Results We analyzed data from 5,015 GCKD patients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73m(2) or with an eGFR >= 60 and overt proteinuria (>500 mg/d). We evaluated a definition of HF based on the Gothenburg score, a clinical HF score used in epidemiological studies (Gothenburg HF), and self-reported HF. Factors associated with HF were identified using multivariable adjusted logistic regression. The prevalence of Gothenburg HF was 43% (ranging from 24% in those with eGFR >90 to 59% in those with eGFR<30 ml/min/1.73m2). The corresponding estimate for self-reported HF was 18% (range 5%-24%). Lower eGFR was significantly and independently associated with the Gothenburg definition of HF (p-trend <0.001). Additional significantly associated correlates included older age, female gender, higher BMI, hypertension, diabetes mellitus, valvular heart disease, anemia, sleep apnea, and lower educational status. Conclusions The burden of self-reported and Gothenburg HF among patients with CKD is high. The proportion of patients who meet the criteria for Gothenburg HF in a European cohort of patients with moderate CKD is more than twice as high as the prevalence of self-reported HF. However, because of the shared signs, symptoms and medications of HF and CKD, the Gothenburg score cannot be used to reliably define HF in CKD patients. Our results emphasize the need for early screening for HF in patients with CKD.	[Beck, Hanna; Schultheiss, Ulla T.; Koettgen, Anna] Univ Freiburg, Med Ctr, Div Nephrol, Dept Med, D-79106 Freiburg, Germany; [Titze, Stephanie I.; Huebner, Silvia; Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Busch, Martin] Univ Jena, Dept Internal Med 3, Jena, Germany; [Schlieper, Georg] Rhein Westfal TH Aachen, Fac Med, Div Nephrol & Clin Immunol, Aachen, Germany; [Wanner, Christoph; Krane, Vera] Univ Wurzburg, Div Nephrol, Dept Internal Med 1, Wurzburg, Germany; [Wanner, Christoph; Krane, Vera] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria	University of Freiburg; University of Erlangen Nuremberg; Friedrich Schiller University of Jena; RWTH Aachen University; University of Wurzburg; University of Wurzburg; Medical University of Innsbruck	Kottgen, A (corresponding author), Univ Freiburg, Med Ctr, Div Nephrol, Dept Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	anna.koettgen@uniklinik-freiburg.de	Weissensteiner, Hansi/AAT-1789-2021; Baid-Agrawal, Seema/HGB-9062-2022; Ekici, Arif B/C-3971-2013; Kronenberg, Florian/B-1736-2008	Weissensteiner, Hansi/0000-0002-2871-8669; Baid-Agrawal, Seema/0000-0001-8192-1079; Ekici, Arif B/0000-0001-6099-7066; Kronenberg, Florian/0000-0003-2229-1120; Kielstein, Jan/0000-0001-8110-9064; Gefeller, Olaf/0000-0002-8985-7582; Lorenzen, Johan/0000-0002-9132-948X; Schultheiss, Ulla T/0000-0002-7541-5310; Ganslandt, Thomas/0000-0001-6864-8936	German Ministry of Education and Research (BMBF) [01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821]; KfH Foundation for Preventive Medicine; Emmy Noether Programme of the German Research Foundation (DFG) [KO-3598/2-1]; German Ministry of Education and Research (Comprehensive Heart Failure Center) [01GL0304]; Medical Research Foundation at the University of Erlangen-Nurnberg (Forschungsstiftung Medizin)	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); KfH Foundation for Preventive Medicine; Emmy Noether Programme of the German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (Comprehensive Heart Failure Center); Medical Research Foundation at the University of Erlangen-Nurnberg (Forschungsstiftung Medizin)	The GCKD Study is funded by grants from the German Ministry of Education and Research (BMBF) (www.gesundheitsforschung-bmbf.de/de/2101.php; grant number 01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820 und 01ER 0821) and the KfH Foundation for Preventive Medicine (www.kfh-stiftung-praeventivmedizin.de/stiftung.html). AK was funded by the Emmy Noether Programme of the German Research Foundation (DFG KO-3598/2-1). VK and CW were supported by the German Ministry of Education and Research (project 01GL0304: Comprehensive Heart Failure Center). SH was supported by a grant from the Medical Research Foundation at the University of Erlangen-Nurnberg (Forschungsstiftung Medizin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bagshaw SM, 2010, NEPHROL DIAL TRANSPL, V25, P1406, DOI 10.1093/ndt/gfq066; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Cerasola G, 2011, J NEPHROL, V24, P1, DOI 10.5301/JN.2010.2030; Chae CU, 2003, AM J CARDIOL, V92, P682, DOI 10.1016/S0002-9149(03)00822-1; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Damman K, 2013, EUR HEART J; Dhingra R, 2011, CIRC-HEART FAIL, V4, P138, DOI 10.1161/CIRCHEARTFAILURE.109.899070; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456; ERIKSSON H, 1988, ACTA MED SCAND, V223, P197; ERIKSSON H, 1987, EUR HEART J, V8, P1007, DOI 10.1093/oxfordjournals.eurheartj.a062365; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fonseca C, 2004, EUR J HEART FAIL, V6, P813, DOI 10.1016/j.ejheart.2004.08.003; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Kuznik A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-132; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Meyer S, 2013, EUR HEART J, V34, P2538, DOI 10.1093/eurheartj/eht152; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Shlipak MG, 2011, J CARD FAIL, V17, P17, DOI 10.1016/j.cardfail.2010.08.009; van Deursen VM, 2014, EUR J HEART FAIL, V16, P103, DOI 10.1002/ejhf.30; WHO Collaborating Centre for Drug Statistics Methodology, 2012, WHO COLLABORATING CT; WILHELMSEN L, 1989, EUR HEART J, V10, P13, DOI 10.1093/eurheartj/10.suppl_C.13	38	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122552	10.1371/journal.pone.0122552	http://dx.doi.org/10.1371/journal.pone.0122552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874373	Green Published, gold			2022-12-26	WOS:000352845100082
J	Luallen, RJ; Bakowski, MA; Troemel, ER				Luallen, Robert J.; Bakowski, Malina A.; Troemel, Emily R.			Characterization of Microsporidia-Induced Developmental Arrest and a Transmembrane Leucine-Rich Repeat Protein in Caenorhabditis elegans	PLOS ONE			English	Article							LYSOSOME-RELATED ORGANELLES; C. ELEGANS; RNA INTERFERENCE; GROWTH-FACTOR; BINDING; BIOGENESIS; PATHOGEN; PATHWAY; FAMILY; GENES	Microsporidia comprise a highly diverged phylum of intracellular, eukaryotic pathogens, with some species able to cause life-threatening illnesses in immunocompromised patients. To better understand microsporidian infection in animals, we study infection of the genetic model organism Caenorhabditis elegans and a species of microsporidia, Nematocida parisii, which infects Caenorhabditis nematodes in the wild. We conducted a targeted RNAi screen for host C. elegans genes important for infection and growth of N. parisii, using nematode larval arrest as an assay for infection. Here, we present the results of this RNAi screen, and our analyses on one of the RNAi hits from the screen that was ultimately not corroborated by loss of function mutants. This hit was an RNAi clone against F56A8.3, a conserved gene that encodes a transmembrane protein containing leucine-rich repeats (LRRs), a domain found in numerous pathogen receptors from other systems. This RNAi clone caused C. elegans to be resistant to infection by N. parisii, leading to reduced larval arrest and lower pathogen load. Characterization of the endogenous F56A8.3 protein revealed that it is expressed in the intestine, localized to the membrane around lysosomerelated organelles (LROs), and exists in two different protein isoforms in C. elegans. We used the CRISPR-Cas9 system to edit the F56A8.3 locus and created both a frameshift mutant resulting in a truncated protein and a complete knockout mutant. Neither of these mutants was able to recapitulate the infection phenotypes of the RNAi clone, indicating that the RNAi-mediated phenotypes are due to an off-target effect of the RNAi clone. Nevertheless, this study describes microsporidia-induced developmental arrest in C. elegans, presents results from an RNAi screen for host genes important for microsporidian infection, and characterizes aspects of the conserved F56A8.3 gene and its protein product.	[Luallen, Robert J.; Bakowski, Malina A.; Troemel, Emily R.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Troemel, ER (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	etroemel@ucsd.edu		Luallen, Robert/0000-0001-7657-2791	National Science Foundation Graduate Research Fellowship; National Institutes of Health Cell and Molecular Genetics Training Grant [T32 GM008666]; NIAID [R01 AI087528]; Searle Scholars Program; Packard Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, T32GM007240] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Cell and Molecular Genetics Training Grant; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Searle Scholars Program; Packard Foundation(The David & Lucile Packard Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Graduate Research Fellowship to RJL, (https://www.nsfgrfp.org), the National Institutes of Health Cell and Molecular Genetics Training Grant (T32 GM008666) to RJL, (http://www.nih.gov), by NIAID R01 AI087528 (http://www.niaid.nih.gov/), the Searle Scholars Program (http://www.searlescholars.net/), Packard Foundation (http://www.packard.org/) and Burroughs Wellcome Fund (http://www.bwfund.org/grant-programs/infectious-diseases/investigators-in-pathogenesis-of-infectious-disease) to ERT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P341; Bakowski MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004200; Becnel James J., 1999, P447; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; BRENNER S, 1974, GENETICS, V77, P71; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Delahaye JL, 2014, MOL BIOL CELL, V25, P1073, DOI 10.1091/mbc.E13-09-0521; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier Elizabeth S, 2005, Expert Rev Anti Infect Ther, V3, P419, DOI 10.1586/14787210.3.3.419; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Estes KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002227; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Hope IA, 2003, GENE, V304, P43, DOI 10.1016/S0378-1119(02)01175-7; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; King SM, 2002, SEMIN CELL DEV BIOL, V13, P293, DOI 10.1016/S1084952102000599; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Ma ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084137; McGhee James D, 2007, WormBook, P1; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; OpenWetWare, 2013, ROUND THE HORN SIT D; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabbitts BM, 2008, GENETICS, V180, P857, DOI 10.1534/genetics.108.093534; Radman I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076019; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Skjerpen CS, 2002, J BIOL CHEM, V277, P23864, DOI 10.1074/jbc.M112193200; Szumowski SC, 2014, P NATL ACAD SCI USA, V111, P8215, DOI 10.1073/pnas.1400696111; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Williams BAP, 2009, CELL MICROBIOL, V11, P1551, DOI 10.1111/j.1462-5822.2009.01362.x; Zhen Y, 2012, TRAFFIC, V13, P650, DOI 10.1111/j.1600-0854.2012.01341.x; Zhou HM, 1998, J NEUROSCI, V18, P10438	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124065	10.1371/journal.pone.0124065	http://dx.doi.org/10.1371/journal.pone.0124065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874557	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100237
J	Wilmut, K; Du, WC; Barnett, AL				Wilmut, Kate; Du, Wenchong; Barnett, Anna L.			How Do I Fit through That Gap? Navigation through Apertures in Adults with and without Developmental Coordination Disorder	PLOS ONE			English	Article							VISUAL GUIDANCE; OLDER-ADULTS; CHILDREN; WALKING; INFORMATION; LOCOMOTION	During everyday life we move around busy environments and encounter a range of obstacles, such as a narrow aperture forcing us to rotate our shoulders in order to pass through. In typically developing individuals the decision to rotate the shoulders is body scaled and this movement adaptation is temporally and spatially tailored to the size of the aperture. This is done effortlessly although it actually involves many complex skills. For individuals with Developmental Coordination Disorder (DCD) moving in a busy environment and negotiating obstacles presents a real challenge which can negatively impact on safety and participation in motor activities in everyday life. However, we have a limited understanding of the nature of the difficulties encountered. Therefore, this current study considered how adults with DCD make action judgements and movement adaptations while navigating apertures. Fifteen adults with DCD and 15 typically developing (TD) controls passed through a series of aperture sizes which were scaled to body size (0.9-2.1 times shoulder width). Spatial and temporal characteristics of movement were collected over the approach phase and while crossing the aperture. The decision to rotate the shoulders was not scaled in the same way for the two groups, with the adults with DCD showing a greater propensity to turn for larger apertures compared to the TD adults when body size alone was accounted for. However, when accounting for degree of lateral trunk movement and variability on the approach, we no longer saw differences between the two groups. In terms of the movement adaptations, the adults with DCD approached an aperture differently when a shoulder rotation was required and then adapted their movement sooner compared to their typical peers. These results point towards an adaptive strategy in adults with DCD which allows them to account for their movement difficulties and avoid collision.	[Wilmut, Kate; Du, Wenchong; Barnett, Anna L.] Oxford Brookes Univ, Percept & Mot Anal Lab, Oxford OX3 0BP, England	Oxford Brookes University	Wilmut, K (corresponding author), Oxford Brookes Univ, Percept & Mot Anal Lab, Oxford OX3 0BP, England.	k.wilmut@brookes.ac.uk		Du, Wenchong/0000-0002-5115-7214	Economic and Social Research Council [ES/J02015X/1]; ESRC [ES/J02015X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work received support from the Economic and Social Research Council- awarded to KW and AB. http://www.esrc.ac.uk/. ES/J02015X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AL, 2015, PHYS OCCUP THER PEDI, V35, P103, DOI 10.3109/01942638.2014.957430; Bruininks RH, 2005, BRUININKS OSERETSKY; Conners CK, 2009, CONNERS ADULT ADHD R, DOI [10.1177/1087054708326109, DOI 10.1177/1087054708326109]; Deconinck FJA, 2006, CHILD CARE HLTH DEV, V32, P711, DOI 10.1111/j.1365-2214.2006.00685.x; Deconinck FJA, 2010, GAIT POSTURE, V32, P327, DOI 10.1016/j.gaitpost.2010.05.018; Deconinck FJA, 2006, MOTOR CONTROL, V10, P125, DOI 10.1123/mcj.10.2.125; Du W, HUMAN MOVEMENT UNPUB; Gentle J, 2015, WALKING PATTERNS IND; Geuze RH, 2007, COORDINATION DEV, P9; Hackney AL, 2013, GAIT POSTURE, V37, P93, DOI 10.1016/j.gaitpost.2012.06.020; Hackney AL, 2011, GAIT POSTURE, V33, P733, DOI 10.1016/j.gaitpost.2011.02.019; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Higuchi T, 2006, EXP BRAIN RES, V175, P50, DOI 10.1007/s00221-006-0525-4; Hyde C, 2011, BRAIN COGNITION, V75, P232, DOI 10.1016/j.bandc.2010.12.004; Kirby A., 2008, ADULT DEV COORDINATI; Kirby A, 2010, RES DEV DISABIL, V31, P131, DOI 10.1016/j.ridd.2009.08.010; Lingam R, 2009, PEDIATRICS, V123, pE693, DOI 10.1542/peds.2008-1770; LOSSE A, 1991, DEV MED CHILD NEUROL, V33, P55, DOI 10.1111/j.1469-8749.1991.tb14785.x; Mandich A, 2003, BRAIN COGNITION, V51, P346, DOI 10.1016/S0278-2626(03)00039-3; Mon-Williams M, 2005, Q J EXP PSYCHOL-A, V58, P1249, DOI 10.1080/02724980443000575; Montagne G, 2002, EXP BRAIN RES, V143, P133, DOI 10.1007/s00221-001-0990-8; Purcell C, 2001, DEVELOPMENTAL SCI, V15, P299; Snapp-Childs W, 2009, EXP BRAIN RES, V198, P527, DOI 10.1007/s00221-009-1944-9; Sugden D., 2006, LEEDS CONSENSUS STAT; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Wilmut K, 2008, EXP BRAIN RES, V191, P403, DOI 10.1007/s00221-008-1532-4; Wilmut K, 2013, RES DEV DISABIL, V34, P174, DOI 10.1016/j.ridd.2012.07.020; Wilmut K, 2011, EXP BRAIN RES, V210, P185, DOI 10.1007/s00221-011-2614-2; Wilmut K, 2010, HUM MOVEMENT SCI, V29, P289, DOI 10.1016/j.humov.2010.01.001	30	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124695	10.1371/journal.pone.0124695	http://dx.doi.org/10.1371/journal.pone.0124695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874635	Green Published, Green Accepted, gold			2022-12-26	WOS:000352845100268
J	Chen, Y; Zhang, J; Lu, Y; Wang, LB				Chen, Yan; Zhang, Jin; Lu, Yong; Wang, Libo			Immunosuppression in Early Postnatal Days Induces Persistent and Allergen-Specific Immune Tolerance to Asthma in Adult Mice	PLOS ONE			English	Article							PERIPHERAL TOLERANCE; AIRWAY INFLAMMATION; T-CELLS; INDUCTION; BLOCKADE; THYMUS; TRANSPLANTATION; MECHANISMS; RECEPTOR; CTLA4IG	Bronchial asthma is a chronic airway inflammatory condition with high morbidity, and effective treatments for asthma are limited. Allergen-specific immunotherapy can only induce peripheral immune tolerance and is not sustainable. Exploring new therapeutic strategies is of great clinical importance. Recombinant adenovirus (rAdV) was used as a vector to make cells expressing cytotoxic T lymphocyte-associated antigen-4-immunoglobulin (CTLA4Ig) a soluble CTLA4 immunoglobulin fusion protein. Dendritic cells (DCs) were modified using the rAdVs together with allergens. Then these modified DCs were transplanted to mice before allergen sensitization. The persistence and specificity of immune tolerance were evaluated in mice challenged with asthma allergens at 3 and 7 months. DCs modified by CTLA4Ig showed increased IL-10 secretion, decreased IL-12 secretion, and T cell stimulation in vitro. Mice treated with these DCs in the early neonatal period developed tolerance against the allergens that were used to induce asthma in the adult stage. Asthma symptoms, lung damage, airway reactivity, and inflammatory response all improved. Humoral immunity indices showed that this therapeutic strategy strongly suppressed mice immune responses and was maintained for as long as 7 months. Furthermore, allergen cross-sensitization and challenge experiments demonstrated that this immune tolerance was allergen-specific. Treatment with CTLA4Ig modified DCs in the early neonatal period, inducing persistent and allergen-specific immune tolerance to asthma in adult mice. Our results suggest that it may be possible to develop a vaccine for asthma.	[Chen, Yan; Zhang, Jin; Lu, Yong; Wang, Libo] Fudan Univ, Dept Resp Med, Childrens Hosp, Shanghai 200433, Peoples R China	Fudan University	Chen, Y (corresponding author), Fudan Univ, Dept Resp Med, Childrens Hosp, Shanghai 200433, Peoples R China.	chenyancy@fudan.edu.cn; libowang@fudan.edu.cn			National Natural Science Foundation of China [30600684, 30901623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30600684 and 30901623). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; Al-Alawi M, 2014, AM J MED, V127, P370, DOI 10.1016/j.amjmed.2013.12.013; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen Y, 2014, INT J MOL SCI, V15, P15304, DOI 10.3390/ijms150915304; De Leval L, 1998, J VIROL, V72, P5285, DOI 10.1128/JVI.72.6.5285-5290.1998; De Leval L, 1999, IMMUNOLOGY, V98, P630, DOI 10.1046/j.1365-2567.1999.00900.x; Fujita Hiroyuki, 2012, Clin Transl Allergy, V2, P2, DOI 10.1186/2045-7022-2-2; Gaffin JM, 2011, CLIN PEDIATR, V50, P133, DOI 10.1177/0009922810384720; Goldman M, 2009, CLIN EXP IMMUNOL, V156, P185, DOI 10.1111/j.1365-2249.2009.03887.x; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Henry E, 2008, J IMMUNOL, V181, P7230, DOI 10.4049/jimmunol.181.10.7230; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Jutel Marek, 2014, Curr Treat Options Allergy, V1, P213; Kimzey SL, 2004, J IMMUNOL, V173, P632, DOI 10.4049/jimmunol.173.1.632; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Reyes-Garcia MG, 2013, BIOMED RES INT, V2013; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sastre B, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/645383; Seyfert-Margolis V, 2010, PEDIATR CLIN N AM, V57, P523, DOI 10.1016/j.pcl.2010.01.015; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Sun LN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/206929; Suzuki J, 2010, CELL TRANSPLANT, V19, P253, DOI 10.3727/096368909X480314; Tang AM, 1996, J IMMUNOL, V157, P117; Tang AM, 1997, EUR J IMMUNOL, V27, P3143, DOI 10.1002/eji.1830271210; Tian CR, 2004, J IMMUNOL, V173, P7217, DOI 10.4049/jimmunol.173.12.7217; van Wijk F, 2007, BIOMED PHARMACOTHER, V61, P8, DOI 10.1016/j.biopha.2006.11.003; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; von Bubnoff D, 2001, J ALLERGY CLIN IMMUN, V108, P329, DOI 10.1067/mai.2001.117457; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Ying L, 2011, CLIN EXP IMMUNOL, V165, P130, DOI 10.1111/j.1365-2249.2011.04405.x; Zhang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063775	37	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122990	10.1371/journal.pone.0122990	http://dx.doi.org/10.1371/journal.pone.0122990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860995	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300072
J	Grauso, L; Mariggio, S; Corda, D; Fontana, A; Cutignano, A				Grauso, Laura; Mariggio, Stefania; Corda, Daniela; Fontana, Angelo; Cutignano, Adele			An Improved UPLC-MS/MS Platform for Quantitative Analysis of Glycerophosphoinositol in Mammalian Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; METABOLITES; PHOSPHOINOSITIDES; GROWTH	The glycerophosphoinositols constitute a class of biologically active lipid-derived mediators whose intracellular levels are modulated during physiological and pathological cell processes. Comprehensive assessment of the role of these compounds expands beyond the cellular biology of lipids and includes rapid and unambiguous measurement in cells and tissues. Here we describe a sensitive and simple liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantitative analysis of the most abundant among these phosphoinositide derivatives in mammalian cells, the glycerophosphoinositol (GroPIns). The method has been developed in mouse Raw 264.7 macrophages with limits of quantitation at 3 ng/ml. Validation on the same cell line showed excellent response in terms of linear dynamic range (from 3 to 3,000 ng/ml), intra-day and inter-day precision (coefficient of variation <= 7.10%) and accuracy (between 98.1 and 109.0%) in the range 10-320 ng/ml. As proof of concept, a simplified analytical platform based on this method and external calibration was also tested on four stimulated and unstimulated cell lines, including Raw 264.7 macrophages, Jurkat T-cells, A375MM melanoma cells and rat basophilic leukemia RBL-2H3 cells. The results indicate a wide variation in GroPIns levels among different cell lines and stimulation conditions, although the measurements were always in line with the literature. No significant matrix effects were observed thus indicating that the here proposed method can be of general use for similar determinations in cells of different origin.	[Grauso, Laura; Fontana, Angelo; Cutignano, Adele] CNR, Ist Chim Biomol, I-80078 Naples, Italy; [Mariggio, Stefania; Corda, Daniela] CNR, Ist Biochim Prot, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Cutignano, A (corresponding author), CNR, Ist Chim Biomol, Via Campi Flegrei 34, I-80078 Naples, Italy.	adele.cutignano@icb.cnr.it	Fontana, Angelo/C-3354-2012; Fontana, Angelo/AAO-2741-2021; Mariggio', Stefania/H-5467-2015; Cutignano, Adele/C-3343-2012; Corda, Daniela/K-6385-2016	Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Mariggio', Stefania/0000-0002-6397-3016; Cutignano, Adele/0000-0003-3035-9252; Corda, Daniela/0000-0002-3614-751X; Grauso, Laura/0000-0001-9165-8796	Programma Operativo Nazionale [01/00117, 01/00862]; Italian Association for Cancer Research Grant (Milan, Italy) [IG10341]; FaReBio di Qualita Ministry of Economy and Finance; PRIN project [2012CK5RPF_05];  [FIT DM 24/09/2009];  [Legge 46/82]	Programma Operativo Nazionale; Italian Association for Cancer Research Grant (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); FaReBio di Qualita Ministry of Economy and Finance; PRIN project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ; 	This work was supported by Programma Operativo Nazionale 01/00117 (AF), Programma Operativo Nazionale 01/00862 (DC), the Italian Association for Cancer Research Grant IG10341 (Milan, Italy, DC), grant FIT DM 24/09/2009, Legge 46/82 and FaReBio di Qualita Ministry of Economy and Finance (DC), and PRIN project 2012CK5RPF_05 (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Berrie CP, 2002, EUR J CANCER, V38, P2463, DOI 10.1016/S0959-8049(02)00485-9; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Falasca M, 1996, EUR J BIOCHEM, V241, P386, DOI 10.1111/j.1432-1033.1996.00386.x; Kopp F, 2010, CHEM BIOL, V17, P831, DOI 10.1016/j.chembiol.2010.06.009; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; MAZZOLA G, 1984, ANAL BIOCHEM, V141, P137, DOI 10.1016/0003-2697(84)90436-6; MORSE MJ, 1987, PLANT PHYSIOL, V83, P640, DOI 10.1104/pp.83.3.640; Patrussi L, 2007, CELL SIGNAL, V19, P2351, DOI 10.1016/j.cellsig.2007.07.014; Patrussi L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00213; Sun T, 2012, J CHROMATOGR B, V897, P1, DOI 10.1016/j.jchromb.2012.03.034; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; U.S. FDA, 1998, GUIDANCE IND BIOANAL; VALITUTTI S, 1991, CELL SIGNAL, V3, P321, DOI 10.1016/0898-6568(91)90061-X; Zizza P, 2012, J BIOL CHEM, V287, P16849, DOI 10.1074/jbc.M111.309419	21	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123198	10.1371/journal.pone.0123198	http://dx.doi.org/10.1371/journal.pone.0123198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860666	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300082
J	Kakaire, O; Byamugisha, JK; Tumwesigye, NM; Gamzell-Danielsson, K				Kakaire, Othman; Byamugisha, Josaphat Kayogoza; Tumwesigye, Nazarius Mbona; Gamzell-Danielsson, Kristina			Prevalence and Factors Associated with Sexually Transmitted Infections among HIV Positive Women Opting for Intrauterine Contraception	PLOS ONE			English	Article							KENYAN SEX WORKERS; MALE CIRCUMCISION; YOUNG-ADULTS; SOUTH-AFRICA; RISK-FACTORS; DISEASES; TRANSMISSION; TANZANIA; UGANDA; VULNERABILITY	Background Women living with HIV/AIDS (WLHA) are a high risk group for sexually transmitted infections (STIs). However, the majority of women with STIs are asymptomatic. Data on prevalence of STIs among WLHA in Uganda are limited. The objective of the study was to determine prevalence and factors associated with STIs among WLHA opting for intrauterine contraceptive device (IUD). Methods Three hundred fifty one WLHA deemed free of STIs using a syndromic logarithm were enrolled into the study. Endo-cervical swabs were taken before IUD insertion and PCR test for Nisseria gonorrhea (NG), Trichomonas vaginalis (TV) and Chlamydia trachomatis (CT) infections conducted. Results Participants' mean age was 29.4 +/- 6.2 years, 83% were under 35years, 50% had secondary education and 73% were married. The majority (69%) had disclosed their HIV sero status to their spouses, 82% used Cotrimoxazole prophylaxis, 70% were on antiretroviral therapy, 90% had CD4 count greater than 350, about 60% reported condoms use and 70% were of parity 2-4. Over 50% of the participants' spouses were older than 35 years and 72% had attained secondary education. STIs prevalence was 11.1%, (95% CI 7.8-14.4) and individual prevalence for TV, NG, and CT was 5.9%, 5.4% and 0.9% respectively. Factors independently associated with STI were having primary or less education (OR=2.3, 95% CI: 1.09 - 4.85) having a spouse of primary or less education ( OR=3.3, 95% CI: 1.6 - 6.78) and muslim faith ( OR= 0.2, 95% CI: 0.04 - 0.78). Conclusion STI prevalence was 11.1%. TV and NG were the commonest STIs in this population. Having primary or less education for both participant and spouse was associated with increased risk while being of muslim faith was associated with reduced risk of STI.	[Kakaire, Othman; Byamugisha, Josaphat Kayogoza] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Gamzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden	Makerere University; Makerere University; Karolinska Institutet; Karolinska University Hospital	Kakaire, O (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Mulago Hosp Complex,Old Mulago Hill, Kampala, Uganda.	kakaireothman@hotmail.com	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative from the Office of Global AIDS Coordinator [5R24TW008886]; U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health; Swedish International Development Agency, Swedish Research Council (SIDA/VR); FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER	Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative from the Office of Global AIDS Coordinator; U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health; Swedish International Development Agency, Swedish Research Council (SIDA/VR); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was made possible by Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative grant number 5R24TW008886 from the Office of Global AIDS Coordinator and the U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health. Additional funding was from the Swedish International Development Agency, Swedish Research Council (SIDA/VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel Elizabeth, 2004, Health Care Women Int, V25, P761, DOI 10.1080/07399330490475601; Arbabi Mohsen, 2014, Iran J Reprod Med, V12, P507; Asavapiriyanont S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-373; CDC U. S, 2013, SEL PRACT REC CONTR; Chanakira E, 2014, INT J STD AIDS; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Djoba Siawaya JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090174, DOI 10.1371/J0URNAL.P0NE.0090174]; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Harling G, 2013, SEX TRANSM DIS, V40, P575, DOI 10.1097/OLQ.0b013e31829529cf; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Hook Er., 1999, SEX TRANSM DIS; Jones R, 2007, AIDS BEHAV, V11, P812, DOI 10.1007/s10461-006-9194-3; JUDSON FN, 1990, MED CLIN N AM, V74, P1353, DOI 10.1016/S0025-7125(16)30485-0; Kapiga SH, 2006, AIDS CARE, V18, P379, DOI 10.1080/09540120500465012; Katz BP, 1990, CHLAMYDIA INFECT, P567; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kaul R, 1997, SEX TRANSM DIS, V24, P387, DOI 10.1097/00007435-199708000-00001; Kwena ZA, 2014, SEX TRANSM INFECT, V90, P139, DOI 10.1136/sextrans-2013-051168; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Maughan-Brown B, 2013, SEX HEALTH, V10, P246, DOI 10.1071/SH12148; Mayer KH, 2012, SEX TRANSM DIS, V39, P1, DOI 10.1097/OLQ.0b013e31823b1922; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Mohllajee AP, 2005, AM J PREV MED, V28, P483, DOI 10.1016/j.amepre.2005.02.008; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Ncube N M, 2012, Ghana Med J, V46, P27; Rassjo EB, 2006, J ADOLESCENT HEALTH, V38, P213, DOI 10.1016/j.jadohealth.2004.10.011; Roberts ST, 2006, ARCH PSYCHIAT NURS, V20, P32, DOI 10.1016/j.apnu.2005.08.008; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Seth P, 2011, WOMEN HEALTH ISS, V21, P130, DOI 10.1016/j.whi.2010.10.005; Sinei S K, 1988, J Obstet Gynaecol East Cent Africa, V7, P71; Singa B, 2013, SEX TRANSM DIS, V40, P148, DOI 10.1097/OLQ.0b013e31827aab89; Stam WE, 1980, SEXUALLY TRANSMITTED, P181; Tenkorang EY, 2012, ARCH SEX BEHAV, V41, P1353, DOI 10.1007/s10508-012-9960-4; Turner AN, 2008, SEX TRANSM DIS, V35, P689, DOI 10.1097/OLQ.0b013e31816b1fcc; Tyndall MW, 1999, SEX TRANSM DIS, V26, P476, DOI 10.1097/00007435-199909000-00010; Ukwuani FA, 2003, JAIDS-J ACQ IMM DEF, V34, P203, DOI 10.1097/00126334-200310010-00011; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Venkatesh KK, 2011, SEX TRANSM DIS, V38, P562, DOI 10.1097/OLQ.0b013e31820a8c2c; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; World Health Organization, 2012, GLOB PREV INC SEL CU	49	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122400	10.1371/journal.pone.0122400	http://dx.doi.org/10.1371/journal.pone.0122400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25859659	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300046
J	Komiyama, T; Hirokawa, T; Sato, K; Oka, A; Kamiguchi, H; Nagata, E; Sakura, H; Otsuka, K; Kobayashi, H				Komiyama, Tomoyoshi; Hirokawa, Takatsugu; Sato, Kyoko; Oka, Akira; Kamiguchi, Hiroshi; Nagata, Eiichiro; Sakura, Hiroshi; Otsuka, Kuniaki; Kobayashi, Hiroyuki			Relationship between Human Evolution and Neurally Mediated Syncope Disclosed by the Polymorphic Sites of the Adrenergic Receptor Gene alpha 2B-AR	PLOS ONE			English	Article							MITOCHONDRIAL GENOME VARIATION; PROTEIN; PREDICTION; DELETION; HISTORY; DIVERSIFICATION	The objective of this study was to clarify the effects of disease on neurally mediated syncope (NMS) during an acute stress reaction. We analyzed the mechanism of the molecular interaction and the polymorphisms of the alpha-2 adrenoreceptor (alpha 2B-AR) gene as the potential psychiatric cause of incentive stress. We focused on the following three genotypes of the repeat polymorphism site at Glu 301-303 in the a2B-AR gene: Glu12/12, Glu12/9, and Glu9/9. On the basis of our clinical research, NMS is likely to occur in people with the Glu12/9 heterotype. To verify this, we assessed this relationship with the interaction of Gi protein and adenylate cyclase by in silico analysis of the Glu12/9 heterotype. By measuring the difference in the dissociation time of the Gi-alpha subunit twice, we found that the Glu12/9 heterotype suppressed the action of adenylate cyclase longer than the Glu homotypes. As this difference in the Glu repeat number effect is thought to be one of the causes of NMS, we investigated the evolutionary significance of the Glu repeat number. Glu8 was originally repeated in simians, while the Glu12 repeats occurred over time during the evolution of bipedalism in humans. Taken with the Glu12 numbers, NMS would likely become a defensive measure to prevent significant blood flow to the human brain.	[Komiyama, Tomoyoshi; Kobayashi, Hiroyuki] Tokai Univ, Dept Clin Pharmacol, Sch Med, Isehara, Kanagawa 2591193, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Koto Ku, Tokyo 1350064, Japan; [Sato, Kyoko; Sakura, Hiroshi; Otsuka, Kuniaki] Tokyo Womens Med Univ, Med Ctr East, Arakawa Ku, Tokyo 1168567, Japan; [Oka, Akira] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 2591193, Japan; [Kamiguchi, Hiroshi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa 2591193, Japan; [Nagata, Eiichiro] Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa 2591193, Japan	Tokai University; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Women's Medical University; Tokai University; Tokai University; Tokai University	Komiyama, T (corresponding author), Tokai Univ, Dept Clin Pharmacol, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	komiyama@tokai-u.jp		Komiyama, Tomoyoshi/0000-0003-2138-0084	Ministry of Education, Culture, Sports, Science and Technology [60439685, 22590797]; Auxiliary Plan for Fellowship of Tokai University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Auxiliary Plan for Fellowship of Tokai University	This study was supported in part by a Grant-in-Aid for Scientific Research (C) 60439685 and 22590797 from the Ministry of Education, Culture, Sports, Science and Technology. In addition, this research was supported by the Auxiliary Plan for Fellowship of Tokai University.	Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Blain H-A, 2013, JOURNAL OF HUMAN EVO; BRASS LF, 1986, J BIOL CHEM, V261, P6838; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Chiou KL, 2011, MOL PHYLOGENET EVOL, V59, P736, DOI 10.1016/j.ympev.2011.03.025; Colman N, 2004, CLIN AUTON RES, V14, P9, DOI 10.1007/s10286-004-1003-3; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Ekokoski E, 2000, EXTRACELLULAR ATP AS; Ensemble, 2010, THE NEANDERTHAL GENO; Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jackson EK, 2012, PRIMER AUTONOMIC NER, P215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P558, DOI 10.1007/s00586-011-1939-7; Lei XM, 2012, NEUROPSYCHOPHARMACOL, V37, P1115, DOI 10.1038/npp.2011.266; Matsui Atsushi, 2007, Mammal Study, V32, P7, DOI 10.3106/1348-6160(2007)32[7:DOACLM]2.0.CO;2; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meinkoth JL, 1994, REVERSIBLE PROTEIN P, P179; Mikkelsen TS, 2005, NATURE; Mosqueda-Garcia R, 1995, DISORDERS AUTONOMIC, P25; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Muszkat M, 2005, PHARMACOGENET GENOM, V15, P407, DOI 10.1097/01213011-200506000-00006; Muszkat M, 2010, J HYPERTENS, V28, P278, DOI 10.1097/HJH.0b013e328333d212; NEI M, 1974, AM J HUM GENET, V26, P421; Nguyen K, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-5; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Preuschoft H, 2004, J ANAT, V204, P363, DOI 10.1111/j.0021-8782.2004.00303.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson D, 1995, DISORDERS OF THE AUT; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saltamavros AD, 2007, CLIN AUTON RES, V17, P112, DOI 10.1007/s10286-007-0403-6; Sato K, 2013, THE AUTONOMIC NERVOU, V50, P126; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Secher B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-109; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; Snapir A, 2001, J AM COLL CARDIOL, V37, P1516, DOI 10.1016/S0735-1097(01)01201-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tayel SI, 2012, THE APPLICATION OF C, V5, P111, DOI [10.2147/TACG.S33814, DOI 10.2147/TACG.S33814]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno LM, 2006, INT J OBESITY, V30, P214, DOI 10.1038/sj.ijo.0803140; van Dijk JG, 2003, CLIN AUTON RES, V13, P247, DOI 10.1007/s10286-003-0099-1; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xie HG, 2000, CLIN PHARMACOL THER, V67, P670, DOI 10.1067/mcp.2000.106293	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120788	10.1371/journal.pone.0120788	http://dx.doi.org/10.1371/journal.pone.0120788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860977	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300016
J	Martinez-Donate, AP; Rangel, MG; Rhoads, N; Zhang, X; Hovell, M; Magis-Rodriguez, C; Gonzalez-Fagoaga, E				Martinez-Donate, Ana P.; Rangel, Maria Gudelia; Rhoads, Natalie; Zhang, Xiao; Hovell, Melbourne; Magis-Rodriguez, Carlos; Gonzalez-Fagoaga, Eduardo			Identifying Opportunities to Increase HIV Testing among Mexican Migrants: A Call to Step Up Efforts in Health Care and Detention Settings	PLOS ONE			English	Article							UNITED-STATES; RISK-FACTORS; INFECTION; PREVENTION; BARRIERS; JAILS	HIV testing and counseling is a critical component of HIV prevention efforts and core element of current "treatment as prevention" strategies. Mobility, low education and income, and limited access to health care put Latino migrants at higher risk for HIV and represent barriers for adequate levels of HIV testing in this population. We examined correlates of, and missed opportunities to increase, HIV testing for circular Mexican migrants in the U.S. We used data from a probability-based survey of returning Mexican migrants ( N=1161) conducted in the border city of Tijuana, Mexico. We estimated last 12-months rates of HIV testing and the percentage of migrants who received other health care services or were detained in an immigration center, jail, or prison for 30 or more days in the U.S., but were not tested for HIV. Twenty-two percent of migrants received HIV testing in the last 12 months. In general, utilization of other health care services or detention for 30 or more days in the U.S. was a significant predictor of last 12-months HIV testing. Despite this association, we found evidence of missed opportunities to promote testing in healthcare and/or correctional or immigration detention centers. About 27.6% of migrants received other health care and/or were detained at least 30 days but not tested for HIV. Health care systems, jails and detention centers play an important role in increasing access to HIV testing among circular migrants, but there is room for improvement. Policies to offer opt-out, confidential HIV testing and counseling to Mexican migrants in these settings on a routine and ethical manner need to be designed and pilot tested. These policies could increase knowledge of HIV status, facilitate engagement in HIV treatment among a highly mobile population, and contribute to decrease incidence of HIV in the host and receiving communities.	[Martinez-Donate, Ana P.; Rhoads, Natalie; Zhang, Xiao] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Rangel, Maria Gudelia; Gonzalez-Fagoaga, Eduardo] El Colegio Frontera Norte, Tijuana, Mexico; [Hovell, Melbourne] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Magis-Rodriguez, Carlos] Ctr Invest Infecc Transmis Sexual, Programa VIH & SIDA Ciudad Mexico, Mexico City, DF, Mexico	University of Wisconsin System; University of Wisconsin Madison; Colegio Frontera Norte; California State University System; San Diego State University	Martinez-Donate, AP (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA.	martinezdona@wisc.edu		Zhang, Xiao/0000-0001-8043-1721; Magis-Rodriguez, Carlos/0000-0001-5481-1253	National Institutes of Health/National Institute of Child Health and Human Development [1 R01-HD046886-01A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046886] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by Grant 1 R01-HD046886-01A2 (PI: AMD) from the National Institutes of Health/National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuedo-Dorantes C, 2013, DEMOGRAPHY, V50, P1067, DOI 10.1007/s13524-013-0200-x; [Anonymous], 2009, FORC AP BY NUMB NONC; Arya M, 2013, AIDS PATIENT CARE ST, V27, P38, DOI 10.1089/apc.2012.0230; Bernstein N., 2012, NY TIMES; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson Bernard M, 2009, Virtual Mentor, V11, P974, DOI 10.1001/virtualmentor.2009.11.12.pfor1-0912; Bronfman M., 1998, MIGRACION SIDA MEXIC; Bureau of Justice Statistics, 2009, HIV PRIS 2007 2008; Centers for Diseases Control and Prevention, 2014, HIV CORR SETT; Chin T, 2013, AIDS PATIENT CARE ST, V27, P392, DOI 10.1089/apc.2013.0099; Cohn D, 2009, MEXICAN IMMIGRANTS M; Crabtree-Ramirez B, 2012, SALUD PUBLICA MEXICO, V54, P506, DOI 10.1590/S0036-36342012000500007; Department of Homeland Security, 2006, TREATM IMM DET HOUS; Ejebe IH, 2015, PREV MED, V71, P57, DOI 10.1016/j.ypmed.2014.12.004; El Colegio de la Frontera Norte, 2013, BAS DAT ENC MIGR FRO; Espinoza L, 2012, JAIDS-J ACQ IMM DEF, V60, P205, DOI 10.1097/QAI.0b013e31824d9a29; Fenton Kevin A, 2007, Top HIV Med, V15, P146; Fish D, 2014, GUIDE HIV AIDS CLIN; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Garfield R DA, 2014, COVERAGE GAP UNINSUR; Gayet C, 2000, ENFERM INFEC MICR CL, V20, P134; Rangel MG, 2012, AIDS BEHAV, V16, P1630, DOI 10.1007/s10461-012-0196-z; Hall HI, 2013, AIDS BEHAV, V17, P1632, DOI 10.1007/s10461-013-0426-z; Hirsch JS, 2002, AM J PUBLIC HEALTH, V92, P1227, DOI 10.2105/AJPH.92.8.1227; Hugo G, 2013, MIGRATION POLICY I, V7, P1; Human Rights Watch, 2007, CHRON IND HIV AIDS S; Instituto Nacional de Migracion, 2013, B MENS EST MIGR 2013; Joint United Nations Programme on HIV/AIDS (UNAIDS), 1993, WHO GUID HIV INF AID; Levy Vivian, 2007, J Immigr Minor Health, V9, P49; Lopez-Quintero C, 2005, AIDS PATIENT CARE ST, V19, P672, DOI 10.1089/apc.2005.19.672; Lucas A, 2013, AIDS, V27, P795, DOI 10.1097/QAD.0b013e32835c54f9; Magis-Rodriguez C, 2014, ENGAGEMENT HIV CARE; Martinez-Donate Ana P, 2014, Int J Migr Bord Stud, V1, P57; Martinez-Donate AP, 2015, AM J PUBLIC HEALTH, V105, P497, DOI 10.2105/AJPH.2014.302336; Moyer LB, 2008, DRUG ALCOHOL REV, V27, P39, DOI 10.1080/09595230701710845; *NAT COMM CORR HLT, 2002, HLTH STAT SOON TO BE; National institute of Corrections, 2011, 2011 OP MAN ICE PERF; Organista KC, 2004, JAIDS-J ACQ IMM DEF, V37, pS227, DOI 10.1097/01.qai.0000141250.08475.91; PA/ MidAtlantic AIDS Education Training Center at the Health Federation of Philadelphia, 2013, FREQ ASK QUEST 4 GEN; Painter TM, 2008, AIDS BEHAV, V12, P213, DOI 10.1007/s10461-007-9220-0; Priest D., 2008, WASHINGTON POST; Roser MA, 2012, NOT JOINING MEDICAID; Sanchez MA, 2012, JAIDS-J ACQ IMM DEF, V61, P610, DOI 10.1097/QAI.0b013e318273b651; Sena AC, 2010, AIDS PATIENT CARE ST, V24, P165, DOI 10.1089/apc.2009.0135; Solomon L, 2014, HEALTH AFFAIR, V33, P434, DOI 10.1377/hlthaff.2013.1115; Solorio MR, 2004, JAIDS-J ACQ IMM DEF, V37, pS240, DOI 10.1097/01.qai.0000141251.16099.74; Statewide AIDS Services Delivery Consortium Advisory Group New York State Department of Health and AIDS Institute, 2007, MIGR SEAS FARMW HLTH; Tang JJ, 2011, PUBLIC HEALTH REP, V126, P338, DOI 10.1177/003335491112600306; The Kaiser Family Foundation, 2014, HIV TEST US; Thrun MW, 2014, LGBT HEALTH, V1, P75, DOI 10.1089/lgbt.2014.0007; U.S. Immigration and Customs Enforcement (ICE), 2013, FY 2013 ICE IMM REM; UNAIDS, 2006, KEEP BEST CHANG REST; Venters Homer D, 2009, Health Hum Rights, V11, P89; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004	56	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123631	10.1371/journal.pone.0123631	http://dx.doi.org/10.1371/journal.pone.0123631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860261	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300106
J	Sheu, MJ; Hsieh, MJ; Chiang, WL; Yang, SF; Lee, HL; Lee, LM; Yeh, CB				Sheu, Ming-Jen; Hsieh, Ming-Ju; Chiang, Whei-Ling; Yang, Shun-Fa; Lee, Hsiang-Lin; Lee, Liang-Ming; Yeh, Chao-Bin			Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; HUMAN BREAST; PATHOLOGICAL DEVELOPMENT; GENE POLYMORPHISMS; GASTRIC-CANCER; RISK-FACTORS; FGFR4; EXPRESSION; HEPATITIS	Background Fibroblast growth factor receptor 4 (FGFR4) polymorphisms are positively correlated with tumor progression in numerous malignant tumors. However, the association between FGFR4 genetic variants and the risk of hepatocellular carcinoma (HCC) has not yet been determined. In this study, we investigated the potential associations of FGFR4 single nucleotide polymorphisms (SNPs) with HCC susceptibility and its clinicopathological characteristics. Methodology/Principal Findings Four SNPs in FGFR4 (rs1966265, rs351855, rs2011077, and rs7708357) were analyzed among 884 participants, including 595 controls and 289 patients with HCC. The samples were further analyzed to clarify the associations between these gene polymorphisms and the risk of HCC, and the impact of these SNPs on the susceptibility and clinicopathological characteristics of HCC. After adjusting for other covariants, HCC patients who carrying at least one A genotype (GA and AA) at rs351855 were observed to have a higher risk of liver cirrhosis compared with those carrying the wild-type genotype (GG) (OR: 2.113, 95% CI: 1.188-3.831). Moreover, the patients with at least one A genotype were particularly showed a high level of alpha-fetoprotein (AFP). Conclusions Our findings suggest that genetic polymorphism in FGFR4 rs351855 may be associated with the risk of HCC coupled with liver cirrhosis and may markedly increase the AFP level in Taiwanese patients with HCC. In addition, this is the first study that evaluated the risk factors associated with FGFR4 polymorphism variants in Taiwanese patients with HCC.	[Sheu, Ming-Jen] Chi Mei Med Ctr, Dept Gastroenterol & Hepatol, Tainan, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] Chung Shan Med Univ, Sch Optometry, Taichung, Taiwan; [Hsieh, Ming-Ju; Yang, Shun-Fa; Lee, Hsiang-Lin] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiang, Whei-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Chiang, Whei-Ling; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan; [Lee, Hsiang-Lin] Chung Shan Med Univ Hosp, Dept Surg, Taichung 40201, Taiwan; [Lee, Liang-Ming] Taipei Med Univ, Dept Urol, Wan Fang Hosp, Taipei, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung 40201, Taiwan	Chi Mei Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeh, CB (corresponding author), Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan.	sky5ff@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234; Yeh, Chao-Bin/0000-0002-3978-5576	Chung Shan Medical University Hospital [CSH-2014-C-019]; Chung Shan Medical University Hospital; Chi-Mei Foundation Medical Center [CSMU-CMMC-103-06]	Chung Shan Medical University Hospital; Chung Shan Medical University Hospital; Chi-Mei Foundation Medical Center	This study was supported by research grants from Chung Shan Medical University Hospital, (CSH-2014-C-019) and Chung Shan Medical University Hospital and Chi-Mei Foundation Medical Center (CSMU-CMMC-103-06). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2014, BRIT J CANCER, V110, P1088, DOI 10.1038/bjc.2013.769; Ansell A, 2009, ORAL ONCOL, V45, P23, DOI 10.1016/j.oraloncology.2008.03.007; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Chen ZX, 2013, INT J MED SCI, V10, P1868, DOI 10.7150/ijms.6868; Chien MH, 2011, J SURG ONCOL, V104, P798, DOI 10.1002/jso.22037; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FitzGerald LM, 2009, PROSTATE CANCER P D, V12, P192, DOI 10.1038/pcan.2008.46; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Gospodarowicz D, 1975, Adv Metab Disord, V8, P301; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Hsieh MC, 2014, J CLIN LAB ANAL, V28, P237, DOI 10.1002/jcla.21672; Huang YW, 2013, CLIN INFECT DIS, V57, P1695, DOI 10.1093/cid/cit603; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; JACQUEMIER J, 1994, INT J CANCER, V59, P373, DOI 10.1002/ijc.2910590314; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Ma ZY, 2008, INT J CANCER, V123, P2574, DOI 10.1002/ijc.23578; Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Rezvani M, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/932356; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Shen YY, 2013, WORLD J GASTROENTERO, V19, P4568, DOI 10.3748/wjg.v19.i28.4568; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; Tiong KH, 2013, APOPTOSIS, V18, P1447, DOI 10.1007/s10495-013-0886-7; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Tsai MC, 2007, J GASTROEN HEPATOL, V22, P92, DOI 10.1111/j.1440-1746.2006.04489.x; Tsou AP, 1998, GENOMICS, V50, P331, DOI 10.1006/geno.1998.5338; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Weinmann A, 2014, J CLIN GASTROENTEROL, V48, P279, DOI 10.1097/MCG.0b013e3182a8a793; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Xu W, 2010, EUR J CANCER, V46, P3332, DOI 10.1016/j.ejca.2010.06.017; Yang Y, 2012, MOL CARCINOGEN, V51, P515, DOI 10.1002/mc.20805; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Zhong SL, 2013, MOL BIOL REP, V40, P3181, DOI 10.1007/s11033-012-2392-3; Zhuang LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061361	39	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122961	10.1371/journal.pone.0122961	http://dx.doi.org/10.1371/journal.pone.0122961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860955	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300071
J	Benton, G; DeGray, G; Kleinman, HK; George, J; Arnaoutova, I				Benton, Gabriel; DeGray, Gerald; Kleinman, Hynda K.; George, Jay; Arnaoutova, Irina			In Vitro Microtumors Provide a Physiologically Predictive Tool for Breast Cancer Therapeutic Screening	PLOS ONE			English	Article							STROMAL CELLS; TUMOR-GROWTH; STEM-CELLS; HYPOXIA; INVASION; CONTRIBUTES; INVASIVENESS; ANGIOGENESIS; EXPRESSION; PACLITAXEL	Many anti-cancer drugs fail in human trials despite showing efficacy in preclinical models. It is clear that the in vitro assays involving 2D monoculture do not reflect the complex extracellular matrix, chemical, and cellular microenvironment of the tumor tissue, and this may explain the failure of 2D models to predict clinical efficacy. We first optimized an in vitro microtumor model using a tumor-aligned ECM, a tumor-aligned medium, MCF-7 and MDA-MB- 231 breast cancer spheroids, human umbilical vein endothelial cells, and human stromal cells to recapitulate the tissue architecture, chemical environment, and cellular organization of a growing and invading tumor. We assayed the microtumor for cell proliferation and invasion in a tumor-aligned extracellular matrix, exhibiting collagen deposition, acidity, glucose deprivation, and hypoxia. We found maximal proliferation and invasion when the multicellular spheroids were cultured in a tumor-aligned medium, having low pH and low glucose, with 10% fetal bovine serum under hypoxic conditions. In a 7-day assay, varying doses of fluorouracil or paclitaxel had differential effects on proliferation for MCF-7 and MDA-MB-231 tumor spheroids in microtumor compared to 2D and 3D monoculture. The microtumors exhibited a tumor morphology and drug response similar to published xenograft data, thus demonstrating a more physiologically predictive in vitro model.	[Benton, Gabriel; DeGray, Gerald; Kleinman, Hynda K.; George, Jay; Arnaoutova, Irina] Trevigen Inc, Gaithersburg, MD USA		Benton, G (corresponding author), Trevigen Inc, Gaithersburg, MD USA.	gbenton@trevigen.com		Benton, Gabriel/0000-0003-4244-5764	SBIR [HHSN261201300042C]	SBIR	This work was funded by SBIR contract number HHSN261201300042C issued by the National Cancer Institute. Trevigen Inc. provided support in the form of salaries for authors [GB, GD, JG, IA] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FORBES; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Benton G, 2014, ADV DRUG DELIV REV; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Bocci G, 2006, CLIN PHARMACOL THER, V80, P384, DOI 10.1016/j.clpt.2006.06.007; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Dai Y, 2011, INT J RADIAT ONCOL, V81, P521, DOI 10.1016/j.ijrobp.2011.04.027; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; EISENHAUER EA, 1994, J CLIN ONCOL, V12, P2654, DOI 10.1200/JCO.1994.12.12.2654; Flach EH, 2011, MOL PHARMACEUT, V8, P2039, DOI 10.1021/mp200421k; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Guth U, 2008, CANCER DETECT PREV, V32, P224, DOI 10.1016/j.cdp.2008.04.002; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Huang X, 2014, ONCOL LETT, V8, P1217, DOI 10.3892/ol.2014.2259; Ji F, 2013, INT J ONCOL, V42, P1578, DOI 10.3892/ijo.2013.1878; Kang NH, 2012, CANCER GENE THER, V19, P412, DOI 10.1038/cgt.2012.15; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Marconi C., 2013, Experimental Oncology, V35, P187; Nakayama S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2231; Neiva KG, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-99; Nowicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081859; Olsen C., 2010, BMC CANCER, V10, P1; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Parks SK, 2013, J CELL PHYSIOL, V228, P1854, DOI 10.1002/jcp.24346; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peppicelli S, 2014, CANCER METAST REV, V33, P823, DOI 10.1007/s10555-014-9506-4; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi CY, 2013, CELL PHYSIOL BIOCHEM, V32, P561, DOI 10.1159/000354460; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Suzuki K, 2011, MOL MED, V17, P579, DOI 10.2119/molmed.2010.00157; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Thoma CR, 2014, ADV DRUG DELIVERY RE; VESCIO RA, 1991, P NATL ACAD SCI USA, V88, P5163, DOI 10.1073/pnas.88.12.5163; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wu WJ, 2010, ONCOL REP, V23, P255, DOI 10.3892/or_00000631; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zeng W, CANC LETT; Zhang B, 2012, J HUAZHONG U SCI-MED, V32, P173, DOI 10.1007/s11596-012-0031-9	52	47	47	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123312	10.1371/journal.pone.0123312	http://dx.doi.org/10.1371/journal.pone.0123312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856378	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500087
J	Jiang, KZ; Zhang, NW; Zhang, H; Wang, JM; Qian, MR				Jiang, Kezhi; Zhang, Ningwen; Zhang, Hu; Wang, Jianmei; Qian, Mingrong			Investigation on the Gas-Phase Decomposition of Trichlorfon by GC-MS and Theoretical Calculation	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDES; PYROLYSIS; DIPTEREX; NANOPARTICLES	The gas phase pyrolysis of trichlorfon was investigated by the on-line gas chromatography mass spectrometry (GC-MS) pyrolysis and theoretical calculations. Two reaction channels were proposed in the pyrolytic reaction, by analyzing the detected pyrolytic products in the total ion chromatography, including 2,2,2-trichloroacetaldehyde, dimethyl phosphite, and dichlorvos. Theoretical calculations showed that there is an intramolecular hydrogen bond between the hydroxyl group and the phosphate O atom in trichlorfon, through which the hydroxyl H atom can be easily transferred to phosphate O atom to trigger two pyrolytic channels. In path-a, migration of H atom results in direct decomposition of trichlorfon to give 2,2,2-trichloroacetaldehyde and dimethyl phosphite in one step. In path-b, migration of H atom in trichlorfon is combined with formation of the O-P bond to give an intermediate, followed by HCl elimination to afford dichlorvos. Path-a is kinetically more favorable than path-b, which is consistent with the GC-MS results.	[Jiang, Kezhi; Zhang, Ningwen] Hangzhou Normal Univ, Key Lab Organosilicon Chem & Mat Technol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hu; Wang, Jianmei; Qian, Mingrong] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Zhejiang Academy of Agricultural Sciences	Qian, MR (corresponding author), Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China.	qianmr@mail.zaas.ac.cn	Wang, Jianmei/HHZ-0585-2022		National Science Foundation of China [21205025]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received financial support from the National Science Foundation of China (No. 21205025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Perez-Serradilla JA, 2010, CHROMATOGRAPHIA, V71, P899, DOI 10.1365/s10337-010-1575-0; BLOTNY G, 1980, J CHROMATOGR, V193, P61, DOI 10.1016/S0021-9673(00)81444-2; Chai MK, 2009, FOOD CHEM, V117, P561, DOI 10.1016/j.foodchem.2009.04.034; Fang T, 2012, J ENVIRON SCI-CHINA, V24, P1149, DOI 10.1016/S1001-0742(11)60882-6; Foresman J. B, 1996, EXPLORING CHEM ELECT, V2nd; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; GAIND VS, 1990, ANALYST, V115, P143, DOI 10.1039/an9901500143; Garcia JL, 2002, J ORG CHEM, V67, P2755, DOI 10.1021/jo016209s; Jiang KZ, 2009, J PHYS CHEM A, V113, P697, DOI 10.1021/jp808273m; Li LQ, 2014, SPECTROSC SPECT ANAL, V34, P122, DOI 10.3964/j.issn.1000-0593(2014)01-0122-06; Li Z, 2014, SENSOR ACTUAT B-CHEM, V193, P205, DOI 10.1016/j.snb.2013.11.096; Liu T, 2011, SENSOR ACTUAT B-CHEM, V160, P1255, DOI 10.1016/j.snb.2011.09.059; Perez-Ruiz T, 2005, ANAL CHIM ACTA, V540, P383, DOI 10.1016/j.aca.2005.03.055; Qi TT, 2013, J PHYS CHEM A, V117, P11115, DOI 10.1021/jp4081096; Sanz CP, 2004, ANAL CHIM ACTA, V524, P265, DOI 10.1016/j.aca.2004.06.024; Singh V, 2003, J CHROMATOGR A, V1010, P243, DOI 10.1016/S0021-9673(03)01123-3; Wang C, 2011, J SEP SCI, V34, P3231, DOI 10.1002/jssc.201100661; YAMASHITA K, 1962, Ind Med Surg, V31, P170; Zhang X, 2013, BIOSENS BIOELECTRON, V41, P669, DOI 10.1016/j.bios.2012.09.047; Zou CY, 2014, J PHYS CHEM B, V118, P6302, DOI 10.1021/jp501925a	20	7	7	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121389	10.1371/journal.pone.0121389	http://dx.doi.org/10.1371/journal.pone.0121389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856549	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500018
J	Luo, XS; Liu, F; Wang, X; Yang, Q; Wang, SB; Zhou, XY; Qian, YL; Yang, J; Levin, LS				Luo, Xusong; Liu, Fei; Wang, Xi; Yang, Qun; Wang, Shoubao; Zhou, Xianyu; Qian, Yunliang; Yang, Jun; Levin, Lawrence Scott			Region-Oriented and Staged Treatment Strategy in Reconstruction of Severe Cervical Contracture	PLOS ONE			English	Article							POSTBURN MENTOSTERNAL CONTRACTURES; NECK RECONSTRUCTION; CERVICOMENTAL-ANGLE; FLAP; CLASSIFICATION; PLATYSMA; HEAD	Introduction Severe cervical contracture after burns causes obvious impairment of neck movement and the aesthetic silhouette. Although various surgical techniques for treatment have been described, there is not a definitive strategy to guide treatment. Over the past 6 years, we have been utilizing a region-oriented and staged treatment strategy to guide reconstruction of severe cervical contracture. Satisfactory results have been achieved with this strategy. Methods The first stage of treatment focuses on the anterior cervical region and submental region. Procedures include cicatrix resection, contracture release, division and elevation of the platysma to form two platysma flaps, and skin grafting. Three to six months later, the second stage treatment is performed, which localize to the mental region. This includes scar resection, correction of the lower lip eversion, and reconstruction with free (para) scapular skin flap. Three subtypes of cervicomental angle that we proposed were measured as quantitative tool for evaluation of the reconstruction. Results 4 patients who completed the treatment were reviewed. By the 3rd postoperative month, their CM angles changed significantly: the soft tissue CM angle was reduced from 135.0 degrees +/- 17.3 degrees to 111.1 degrees +/- 11.3 degrees, the osseous CM angle increased from 67.1 degrees +/- 9.0 degrees to 90.5 degrees +/- 11.6 degrees and the dynamic CM angle increased from 21.9 degrees +/- 8.7 degrees to 67.4 degrees +/- 13.1 degrees. 22 in 24 (91.7%) of these patients gained notable improvement of cervical motion and aesthetic contour. Conclusions Our results suggest that the region-oriented and staged treatment strategy can achieve satisfactory functional and aesthetic results, combining usage of both skin graft and skin flap while minimizing the donor site morbidity.	[Luo, Xusong; Liu, Fei; Wang, Xi; Yang, Qun; Wang, Shoubao; Zhou, Xianyu; Qian, Yunliang; Yang, Jun] Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China; [Levin, Lawrence Scott] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	Shanghai Jiao Tong University; University of Pennsylvania; Pennsylvania Medicine	Yang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China.	yj55569@hotmail.com; scott.levin@uphs.upenn.edu			Guidance Foundation of Science and Technology Committee of Shanghai [10411964200]; National Natural Science Foundation of China [81171833, 81371701]	Guidance Foundation of Science and Technology Committee of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Guidance Foundation of Science and Technology Committee of Shanghai (grant No. 10411964200), National Natural Science Foundation of China (grant No. 81171833, 81371701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung KC, 2009, PLAST RECONSTR SURG, V123, P1385, DOI 10.1097/PRS.0b013e31819f25ff; Dayan SH, 2010, PLAST RECONSTR SURG, V126, p141E, DOI 10.1097/PRS.0b013e3181e3b55b; Grevious MA, 2008, J CRANIOFAC SURG, V19, P1010, DOI 10.1097/SCS.0b013e318175f468; Huang CY, 2013, BURNS, V39, P507, DOI 10.1016/j.burns.2012.07.006; Hyakusoku H, 2010, COLOR ATLAS BURN REC; Imanishi N, 2005, PLAST RECONSTR SURG, V115, P1018, DOI 10.1097/01.PRS.0000154211.52778.71; Kumar B, 2011, ACTA ANAESTH BELG, V62, P95; Matsumine H, 2008, PLAST RECONSTR SURG, V122, P782, DOI 10.1097/PRS.0b013e318180ed43; Motamed S, 2008, BURNS, V34, P878, DOI 10.1016/j.burns.2007.11.018; Olasz L, 2011, J ORAL MAXIL SURG, V69, P1242, DOI 10.1016/j.joms.2010.02.046; Onah II, 2005, ARCH SURG-CHICAGO, V140, P671, DOI 10.1001/archsurg.140.7.671; Ono S, 2012, PLAST RECONSTR SURG, V129, P879, DOI 10.1097/PRS.0b013e318244230b; Pallua N, 1997, PLAST RECONSTR SURG, V99, P1878, DOI 10.1097/00006534-199706000-00011; Parrett BM, 2007, PLAST RECONSTR SURG, V120, P1871, DOI 10.1097/01.prs.0000287272.28417.14; Rebelo M, 2009, J PLAST RECONSTR AES, V62, P137, DOI 10.1016/j.bjps.2008.05.033; Tsai FC, 2006, BURNS, V32, P626, DOI 10.1016/j.burns.2005.12.009; Vu QV, 2009, PLAST RECONSTR SURG, V123, P1471, DOI 10.1097/PRS.0b013e3181a205ba; Walden JL, 2000, ANN PLAS SURG, V45, P162, DOI 10.1097/00000637-200045020-00011; Zhang YX, 2010, ANN PLAS SURG, V65, P528, DOI 10.1097/SAP.0b013e3181cc29e7	19	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122669	10.1371/journal.pone.0122669	http://dx.doi.org/10.1371/journal.pone.0122669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855973	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500048
J	Saint-Macary, ME; Barbisan, C; Gagey, MJ; Frelin, O; Beffa, R; Lebrun, MH; Droux, M				Saint-Macary, Marie Emmanuelle; Barbisan, Crystel; Gagey, Marie Josephe; Frelin, Oceane; Beffa, Roland; Lebrun, Marc Henri; Droux, Michel			Methionine Biosynthesis is Essential for Infection in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; S-ADENOSYLMETHIONINE; ASPERGILLUS-NIDULANS; GENE; METHYLMETHIONINE; HOMOCYSTEINE; GRISEA; ACCUMULATION; PURIFICATION; METABOLISM	Methionine is a sulfur amino acid standing at the crossroads of several biosynthetic pathways. In fungi, the last step of methionine biosynthesis is catalyzed by a cobalamine-independent methionine synthase (Met6, EC 2.1.1.14). In the present work, we studied the role of Met6 in the infection process of the rice blast fungus, Magnaporthe oryzae. To this end MET6 null mutants were obtained by targeted gene replacement. On minimum medium, MET6 null mutants were auxotrophic for methionine. Even when grown in presence of excess methionine, these mutants displayed developmental defects, such as reduced mycelium pigmentation, aerial hypha formation and sporulation. They also displayed characteristic metabolic signatures such as increased levels of cysteine, cystathionine, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine while methionine and glutathione levels remained unchanged. These metabolic perturbations were associated with the over-expression of MgCBS1 involved in the reversed transsulfuration pathway that metabolizes homocysteine into cysteine and MgSAM1 and MgSAHH1 involved in the methyl cycle. This suggests a physiological adaptation of M. oryzae to metabolic defects induced by the loss of Met6, in particular an increase in homocysteine levels. Pathogenicity assays showed that MET6 null mutants were non-pathogenic on both barley and rice leaves. These mutants were defective in appressorium-mediated penetration and invasive infectious growth. These pathogenicity defects were rescued by addition of exogenous methionine and S-methylmethionine. These results show that M. oryzae cannot assimilate sufficient methionine from plant tissues and must synthesize this amino acid de novo to fulfill its sulfur amino acid requirement during infection.	[Saint-Macary, Marie Emmanuelle; Gagey, Marie Josephe; Frelin, Oceane; Lebrun, Marc Henri; Droux, Michel] UCB, INSA, BCS, Bayer CropSci,CNRS,MAP,UMR 5240, F-69263 Lyon, France; [Barbisan, Crystel; Beffa, Roland] Bayer CropSci, Dept Biochem, F-69263 Lyon, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Bayer AG; Bayer CropScience	Lebrun, MH (corresponding author), UCB, INSA, BCS, Bayer CropSci,CNRS,MAP,UMR 5240, F-69263 Lyon, France.	marc-henri.lebrun@versailles.inra.fr		LEBRUN, marc-henri/0000-0003-1562-1902; Droux, Michel/0000-0001-5635-2046	French Ministry of Industry; Bayer CropScience (CIFRE fellowship)	French Ministry of Industry; Bayer CropScience (CIFRE fellowship)	Marie-Emmanuelle Saint-Macary and Oceane Frelin PhD fellowships were funded by the French Ministry of Industry and Bayer CropScience (CIFRE fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhadere PV, 1999, MOL PLANT MICROBE IN, V12, P129, DOI 10.1094/MPMI.1999.12.2.129; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bourgis F, 1999, PLANT CELL, V11, P1485, DOI 10.1105/tpc.11.8.1485; Capdevila A, 1998, ANAL BIOCHEM, V264, P180, DOI 10.1006/abio.1998.2839; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Collemare J, 2008, NEW PHYTOL, V179, P196, DOI 10.1111/j.1469-8137.2008.02459.x; CSAIKL U, 1986, GENE, V46, P207, DOI 10.1016/0378-1119(86)90405-1; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Eggermont K, 1996, PLANT MOL BIOL REP, V14, P273, DOI 10.1007/BF02671663; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; Fernandez J, 2014, ANNU REV PHYTOPATHOL, V52, P81; Ferrer JL, 2004, J BIOL CHEM, V279, P44235, DOI 10.1074/jbc.C400325200; Fischer JA, 2001, FUNGAL GENET BIOL, V34, P21, DOI 10.1006/fgbi.2001.1287; Fu J, 2013, FUNGAL BIOL-UK, V117, P13, DOI 10.1016/j.funbio.2012.11.001; Fujita Y, 2006, MICROBIOL-SGM, V152, P397, DOI 10.1099/mic.0.28398-0; Grynberg M, 2001, BBA-GENE STRUCT EXPR, V1519, P78, DOI 10.1016/S0167-4781(01)00224-X; Kacprzak MM, 2003, BIOCHEM J, V376, P517, DOI 10.1042/BJ20030747; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Lo SCC, 2002, EUKARYOT CELL, V1, P311, DOI 10.1128/EC.1.2.311-314.2002; McCann MP, 2008, FUNGAL GENET BIOL, V45, pS77, DOI 10.1016/j.fgb.2008.05.006; Menegus F, 2004, J PLANT PHYSIOL, V161, P725, DOI 10.1078/0176-1617-01081; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; PASZEWSKI A, 1975, J BACTERIOL, V124, P893, DOI 10.1128/JB.124.2.893-904.1975; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; Pieniazek A, 1973, ACTA BIOCHIM POL, V20, P159; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; RAVANEL S, 1995, ARCH BIOCHEM BIOPHYS, V316, P572, DOI 10.1006/abbi.1995.1077; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Sienko M, 2009, CURR GENET, V55, P561, DOI 10.1007/s00294-009-0269-3; Solomon PS, 2003, MOL PLANT PATHOL, V4, P203, DOI 10.1046/j.1364-3703.2003.00161.x; Solomon PS, 2001, PLANTA, V213, P241, DOI 10.1007/s004250000500; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 2007, ADV GENET, V57, P175, DOI 10.1016/S0065-2660(06)57005-1; Yan X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076914	45	29	30	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0111108	10.1371/journal.pone.0111108	http://dx.doi.org/10.1371/journal.pone.0111108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856162	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500001
J	Sun, XJ; Yang, AG; Wu, BA; Zhou, LQ; Liu, ZH				Sun, Xiujun; Yang, Aiguo; Wu, Biao; Zhou, Liqing; Liu, Zhihong			Characterization of the Mantle Transcriptome of Yesso Scallop (Patinopecten yessoensis): Identification of Genes Potentially Involved in Biomineralization and Pigmentation	PLOS ONE			English	Article							MOLLUSK SHELL FORMATION; CALMODULIN-LIKE PROTEIN; PEARL OYSTER; NACREOUS LAYER; KEY MACROMOLECULE; MATRIX PROTEIN; RNA-SEQ; LOCALIZATION; TISSUE; SKIN	The Yesso scallop Patinopecten yessoensis is an economically important marine bivalve species in aquaculture and fishery in Asian countries. However, limited genomic resources are available for this scallop, which hampers investigations into molecular mechanisms underlying their unique biological characteristics, such as shell formation and pigmentation. Mantle is the special tissue of P. yessoensis that secretes biomineralization proteins inducing shell deposition as well as pigmentation on the shells. However, a current deficiency of transcriptome information limits insight into mechanisms of shell formation and pigmentation in this species. In this study, the transcriptome of the mantle of P. yessoensis was deeply sequenced and characterized using Illumina RNA-seq technology. A total of 86,521 unique transcripts are assembled from 55,884,122 reads that passed quality filters, and annotated, using Gene Ontology classification. A total of 259 pathways are identified in the mantle transcriptome, including the calcium signaling and melanogenesis pathways. A total of 237 unigenes that are homologous to 102 reported biomineralization genes are identified, and 121 unigenes that are homologous to 93 known proteins related to melanin biosynthesis are found. Twenty-three annotated unigenes, which are mainly homologous to calmodulin and related proteins, Ca2+/calmodulin-dependent protein kinase, adenylate/guanylate cyclase, and tyrosinase family are potentially involved in both biomineralization and melanin biosynthesis. It is suggested that these genes are probably not limited in function to induce shell deposition by calcium metabolism, but may also be involved in pigmentation of the shells of the scallop. This potentially supports the idea that there might be a link between calcium metabolism and melanin biosynthesis, which was previously found in vertebrates. The findings presented here will notably advance the understanding of the sophisticated processes of shell formation as well as shell pigmentation in P. yessoensis and other bivalve species, and also provide new evidence on gene expression for the understanding of pigmentation and biomineralization not only in invertebrates but also probably in vertebrates.	[Sun, Xiujun; Yang, Aiguo; Wu, Biao; Zhou, Liqing; Liu, Zhihong] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Yang, AG (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	yangag@ysfri.ac.cn			Independent Innovation Funds of Shandong Province [2013CXC80202]; Emerging Strategic Industries Project of Qingdao City [13-4-1-60hy]; Key Laboratory of Mariculture (KLM), Ministry of Education, OUC	Independent Innovation Funds of Shandong Province; Emerging Strategic Industries Project of Qingdao City; Key Laboratory of Mariculture (KLM), Ministry of Education, OUC	This work was supported by the grants from Independent Innovation Funds of Shandong Province (2013CXC80202), Emerging Strategic Industries Project of Qingdao City (13-4-1-60hy), and the Key Laboratory of Mariculture (KLM), Ministry of Education, OUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; [Anonymous], 1983, SHELL FORMATION MO 1; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Cai Zhongqiang, 2014, International Journal of Biology, V6, P37; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; COBABE EA, 1995, GEOCHIM COSMOCHIM AC, V59, P87, DOI 10.1016/0016-7037(94)00374; Colihueque N, 2010, REV FISH BIOL FISHER, V20, P71, DOI 10.1007/s11160-009-9121-6; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang Z, 2008, PROG NAT SCI-MATER, V18, P405, DOI 10.1016/j.pnsc.2007.11.011; Freer A, 2014, MAR BIOTECHNOL, V16, P34, DOI 10.1007/s10126-013-9516-1; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HERMANN A, 1995, COMP BIOCHEM PHYS B, V111, P337, DOI 10.1016/0305-0491(94)00218-J; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang J, 2007, BBA-GEN SUBJECTS, V1770, P1037, DOI 10.1016/j.bbagen.2007.03.006; Ito H., 1991, SCALLOPS BIOL ECOLOG, P1024; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Jones DB, 2013, MAR BIOTECHNOL, V15, P647, DOI 10.1007/s10126-013-9514-3; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Roy N, 2012, J EXP ZOOL PART B, V318B, P353, DOI 10.1002/jez.b.22452; Li Q, 2007, AQUACULTURE, V269, P211, DOI 10.1016/j.aquaculture.2007.04.017; Li S, 2005, FEBS J, V272, P4899, DOI 10.1111/j.1742-4658.2005.04899.x; Lin Aiguang, 2010, Journal of the Chinese Ceramic Society, V38, P504; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Mann S., 2002, BIOMINERALIZATION PR; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Niecke M, 2003, OECOLOGIA, V137, P153, DOI 10.1007/s00442-003-1307-3; Palumbo A, 2003, PIGM CELL RES, V16, P517, DOI 10.1034/j.1600-0749.2003.00080.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roulin A, 2006, NATURWISSENSCHAFTEN, V93, P426, DOI 10.1007/s00114-006-0128-8; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Schonitzer V, 2011, BIOCHEM BIOPH RES CO, V415, P586, DOI 10.1016/j.bbrc.2011.10.109; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; Shi YH, 2013, MAR BIOTECHNOL, V15, P175, DOI 10.1007/s10126-012-9476-x; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Veis A., 1990, SCIENCE, V247, P1129; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Weiss IM, 2006, FEBS LETT, V580, P1846, DOI 10.1016/j.febslet.2006.02.044; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Werner GDA, 2013, MAR BIOTECHNOL, V15, P230, DOI 10.1007/s10126-012-9481-0; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; [杨爱国 Yang Aiguo], 2004, [海洋水产研究, Marine Fisheries Research], V25, P1; Yang Hui-Ping, 2001, Acta Zoologica Sinica, V47, P459; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Q, 2000, MAR SCI, V24, P14; Zheng HP, 2013, AQUAC RES, V44, P1229, DOI 10.1111/j.1365-2109.2012.03124.x	70	56	63	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122967	10.1371/journal.pone.0122967	http://dx.doi.org/10.1371/journal.pone.0122967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856556	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500068
J	van Breugel, P; Kindt, R; Lilleso, JPB; van Breugel, M				van Breugel, Paulo; Kindt, Roeland; Lilleso, Jens-Peter Barnekow; van Breugel, Michiel			Environmental Gap Analysis to Prioritize Conservation Efforts in Eastern Africa	PLOS ONE			English	Article							PROTECTED AREAS; BIODIVERSITY CONSERVATION; CONSERVING BIODIVERSITY; SPECIES RICHNESS; LAND; DIVERSITY; ECOREGIONS; HOTSPOTS; FOREST; INDICATORS	Countries in eastern Africa have set aside significant proportions of their land for protection. But are these areas representative of the diverse range of species and habitats found in the region? And do conservation efforts include areas where the state of biodiversity is likely to deteriorate without further interventions? Various studies have addressed these questions at global and continental scales. However, meaningful conservation decisions are required at finer geographical scales. To operate more effectively at the national level, finer scale baseline data on species and on higher levels of biological organization such as the eco-regions are required, among other factors. Here we adopted a recently developed high-resolution potential natural vegetation (PNV) map for eastern Africa as a baseline to more effectively identify conservation priorities. We examined how well different potential natural vegetations (PNVs) are represented in the protected area (PA) network of eastern Africa and used a multivariate environmental similarity index to evaluate biases in PA versus PNV coverage. We additionally overlaid data of anthropogenic factors that potentially influence the natural vegetation to assess the level of threat to different PNVs. Our results indicate substantial differences in the conservation status of PNVs. In addition, particular PNVs in which biodiversity protection and ecological functions are at risk due to human influences are revealed. The data and approach presented here provide a step forward in developing more transparent and better informed translation from global priorities to regional or national implementation in eastern Africa, and are valid for other geographic regions.	[van Breugel, Paulo; Lilleso, Jens-Peter Barnekow] Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Nat & Biomass, DK-1958 Frederiksberg C, Denmark; [van Breugel, Paulo; Kindt, Roeland] World Agroforestry Ctr, Nairobi, Kenya; [van Breugel, Michiel] Natl Univ Singapore, Dept Biol Sci, Yale NUS Coll, Singapore 138614, Singapore; [van Breugel, Michiel] Ciudad Panam, Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Panama City, Panama; [van Breugel, Michiel] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	University of Copenhagen; CGIAR; World Agroforestry (ICRAF); National University of Singapore; Yale NUS College; Smithsonian Institution; Smithsonian Tropical Research Institute; National University of Singapore	van Breugel, P (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Nat & Biomass, Rolighedsvej 23, DK-1958 Frederiksberg C, Denmark.	p.vanbreugel@gmail.com	Lillesø, Jens-Peter Barnekow B/F-4455-2015; Kindt, Roeland/AAV-3346-2020	Lillesø, Jens-Peter Barnekow B/0000-0003-1418-3496; Kindt, Roeland/0000-0002-7672-0712; van Breugel, Paulo/0000-0001-9579-0831	Consultative Research Committee for Development Research (FFU) [10-095-LIFE]	Consultative Research Committee for Development Research (FFU)	The research presented was funded by a grant from the Consultative Research Committee for Development Research (FFU) under project 10-095-LIFE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Adams WM, 2001, ORYX, V35, P193, DOI 10.1017/S0030605300031847; Ahmed AGM, 2003, POSTDROUGHT RECOVERY; Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; [Anonymous], 1995, GLOBAL BIODIVERSITY; Araujo MB, 2003, ECOGRAPHY, V26, P380, DOI 10.1034/j.1600-0587.2003.03625.x; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Balletto E, 2010, ITAL J ZOOL, V77, P2, DOI 10.1080/11250000902758923; Beggs PJ, 2013, ATMOS ENVIRON, V68, P112, DOI 10.1016/j.atmosenv.2012.11.044; BELBIN L, 1993, BIOL CONSERV, V66, P223, DOI 10.1016/0006-3207(93)90007-N; Bertzky B., 2012, PROTECTED PLANET REP; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bray DB, 2003, CONSERV BIOL, V17, P672, DOI 10.1046/j.1523-1739.2003.01639.x; Brooks JS, 2006, CONSERV BIOL, V20, P1528, DOI 10.1111/j.1523-1739.2006.00506.x; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bunce RGH, 2013, ECOL INDIC, V33, P19, DOI 10.1016/j.ecolind.2012.07.014; Burgess N., 2004, Terrestrial ecoregions of Africa and Madagascar: a conservation assessment; Burgess N, 2013, CEE 10 007; Burgess ND, 2006, BIOL CONSERV, V127, P383, DOI 10.1016/j.biocon.2005.08.018; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CGIAR-CSI, 2008, CGIAR CSI SRTM 90M D; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chape S., 2009, BIOSCIENCE, V59, P623; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; da Fonseca GAB, 2000, NATURE, V405, P393, DOI 10.1038/35013249; Davis S.D., 2013, VERSION 1 0 DIGITAL, P1994; De Leeuw P. N., 1995, World Animal Review (Multilingual Edition), V83, P47; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Duputie A, 2014, GLOBAL ECOL BIOGEOGR, V23, P457, DOI 10.1111/geb.12118; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; ESA, 2007, GLOBCOVER 2005 06 VE; Faith DP, 2003, ECOGRAPHY, V26, P374, DOI 10.1034/j.1600-0587.2003.03300.x; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 1997, EVALUATION EFFECTIVE; Forero-Medina G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013210; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Fritz S, 2012, ENVIRON MODELL SOFTW, V31, P110, DOI 10.1016/j.envsoft.2011.11.015; Fritz S, 2009, REMOTE SENS-BASEL, V1, P345, DOI 10.3390/rs1030345; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Funk SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008923; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gordon JE, 2012, P GEOLOGIST ASSOC, V123, P1, DOI 10.1016/j.pgeola.2011.08.002; Gorenflo LJ, 2011, ECOL STUD-ANAL SYNTH, V214, P153, DOI 10.1007/978-3-642-16707-2_9; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; GRASS Development Team, 2014, GEOGR RES AN SUPP SY; Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016; Gryseels G., 1988, CASE STUDY BASO WORE; Hayes TM, 2006, WORLD DEV, V34, P2064, DOI 10.1016/j.worlddev.2006.03.002; Hazen HD, 2004, PHYS GEOGR, V25, P499, DOI 10.2747/0272-3646.25.6.499; Hazen H, 2007, PROF GEOGR, V59, P256, DOI 10.1111/j.1467-9272.2007.00611.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; IUCN and UNEP-WCMC, 2013, WORLD DAT PROT AR WD; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; JRC, 2003, GLOB LAND COV 2000 D; Kier G, 2001, BIODIVERS CONSERV, V10, P1513, DOI 10.1023/A:1011812528849; Kruska RL, 2003, AGR SYST, V77, P39, DOI 10.1016/S0308-521X(02)00085-9; Kuper W, 2004, ANN MO BOT GARD, V91, P525; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Leroux SJ, 2010, BIOL CONSERV, V143, P609, DOI 10.1016/j.biocon.2009.11.018; Leverington F, 2010, MANAGEMENT EFFECTIVE, P87; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lindenmayer DB, 2009, LANDSCAPE ECOL, V24, P1091, DOI 10.1007/s10980-008-9244-5; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; LP DAAC, 2009, MODIS LAND COV TYP Y; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Neumann RP, 2001, AFRICA, V71, P641, DOI 10.2307/1161583; Neumann RP., 1995, ECUMENE, V2, P149, DOI DOI 10.1177/147447409500200203; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Ovaskainen O, 2002, J THEOR BIOL, V218, P419, DOI 10.1006/jtbi.2002.3089; Overton JM, 2001, SCI CONSERVATION, V174, P1; Panitsa M, 2011, J NAT CONSERV, V19, P269, DOI 10.1016/j.jnc.2011.04.001; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Peters H, 2015, GLOBAL CHANGE BIOL, V21, P618, DOI 10.1111/gcb.12749; Pfeifer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039337; Powell GVN, 2000, BIOL CONSERV, V93, P35, DOI 10.1016/S0006-3207(99)00115-9; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; Pressey RL, 2001, CONSERV BIOL, V15, P275, DOI 10.1046/j.1523-1739.2001.99541.x; Redford KH, 2003, CONSERV BIOL, V17, P647; Robbins P., 2012, POLITICAL ECOLOGY; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez JP, 2007, SCIENCE, V317, P755, DOI 10.1126/science.1145560; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scherr SJ, 2008, PHILOS T R SOC B, V363, P477, DOI 10.1098/rstb.2007.2165; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Somodi I, 2012, J VEG SCI, V23, P590, DOI 10.1111/j.1654-1103.2011.01378.x; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; The World Bank, 2012, WORLDBANK DATA; Thompson M, 2002, HUM ECOL, V30, P107, DOI 10.1023/A:1014519113923; Tikkanen OP, 2007, BIOL CONSERV, V140, P359, DOI 10.1016/j.biocon.2007.08.020; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Trakhtenbrot A, 2005, ECOL APPL, V15, P335, DOI 10.1890/04-0077; UN-Habitat, 2008, STAT AFR CIT FRAM AD; Van Breugel P, 2015, ALTERNATIVE SIMPLIFI; Van Breugel P, 2012, POTENTIAL NATURAL VE; Van Breugel P, 2011, POTENTIAL NATURAL VE, P139; Vistnets I, 2001, GLOBAL METHODOLOGY M; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Watson JEM, 2009, DIVERS DISTRIB, V15, P1028, DOI 10.1111/j.1472-4642.2009.00601.x; White F., 1983, VEGETATION AFRICA DE, P1876; Wikramanayake E, 2002, CONSERV BIOL, V16, P238, DOI 10.1046/j.1523-1739.2002.01403.x; Wild R, 2009, SACRED NATURAL SITES; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO, P131; Woodley S., 2012, PARKS, V18, P23, DOI DOI 10.2305/IUCN.CH.2012.PARKS-18-1.SW.EN; Zachos F.E., 2011, BIODIVERSITY HOTSPOT	130	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121444	10.1371/journal.pone.0121444	http://dx.doi.org/10.1371/journal.pone.0121444			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25855968	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500020
J	Xifro, X; Vidal-Sancho, L; Boadas-Vaello, P; Turrado, C; Alberch, J; Puig, T; Verdu, E				Xifro, Xavier; Vidal-Sancho, Laura; Boadas-Vaello, Pere; Turrado, Carlos; Alberch, Jordi; Puig, Teresa; Verdu, Enrique			Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FATTY-ACID SYNTHASE; NF-KAPPA-B; GREEN TEA POLYPHENOLS; SPINAL-CORD; CENTRAL SENSITIZATION; ANTICANCER ACTIVITY; MUTANT HUNTINGTIN; GALLATE; MECHANISMS	Neuropathic pain is common in peripheral nerve injury and often fails to respond to ordinary medication. Here, we investigated whether the two novel epigallocatechin-3-gallate (EGCG) polyphenolic derivatives, compound 23 and 30, reduce the neuropathic pain in mice chronic constriction nerve injury (CCI). First, we performed a dose-response study to evaluate nociceptive sensation after administration of EGCG and its derivatives 23 and 30, using the Hargreaves test at 7 and 21 days after injury (dpi). We daily administered EGCG, 23 and 30 (10 to 100 mg/Kg; i.p.) during the first week post-CCI. None of the doses of compound 23 caused significant pain diminution, whereas 50mg/kg was optimal for both EGCG and 30 to delay the latency of paw withdrawal. With 50 mg/Kg, we showed that EGCC prevented the thermal hyperalgesia from 7 to 21 dpi and compound 30 from 14 to 56 dpi. To evaluate the molecular mechanisms underpinning why EGCG and compound 30 differentially prevented the thermal hyperalgesia, we studied several biochemical parameters in the dorsal horn of the spinal cord at 14 and 56 dpi. We showed that the effect observed with EGCG and compound 30 was related to the inhibition of fatty acid synthase (FASN), a known target of these polyphenolic compounds. Additionally, we observed that EGCG and compound 30 reduced the expression of CCI-mediated inflammatory proteins and the nuclear localization of nuclear factor-kappa B at 14 dpi, but not at 56 dpi. We also strongly detected a decrease of synaptic plasma membrane levels of N-methyl-D-asparte receptor 2B in CCI-mice treated with compound 30 at 56 dpi. Altogether, compound 30 reduced the chronic thermal hyperalgesia induced by CCI better than the natural compound EGCG. Thus, our findings provide a rationale for the preclinical development of compound 30 as an agent to treat neuropathic pain.	[Xifro, Xavier; Vidal-Sancho, Laura; Boadas-Vaello, Pere; Puig, Teresa; Verdu, Enrique] Univ Girona UdG, Fac Med, Dept Ciencias Med, Grp Invest Anat Clin Embriol Neurociencia & Oncol, Girona, Spain; [Xifro, Xavier; Vidal-Sancho, Laura; Alberch, Jordi] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Barcelona 7, Spain; [Xifro, Xavier; Vidal-Sancho, Laura; Alberch, Jordi] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Xifro, Xavier; Vidal-Sancho, Laura; Alberch, Jordi] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Turrado, Carlos] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ 1, Lab Quim Med, E-28040 Madrid, Spain	Universitat de Girona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; Complutense University of Madrid	Puig, T (corresponding author), Univ Girona UdG, Fac Med, Dept Ciencias Med, Grp Invest Anat Clin Embriol Neurociencia & Oncol, Girona, Spain.	teresa.puig@udg.edu; enric.verdu@udg.edu	Xifro, Xavier/ABH-2365-2020; Alberch, Jordi/K-5702-2014; Boadas-Vaello, Pere/L-1040-2015; Verdú, Enrique/L-1956-2015	Xifro, Xavier/0000-0002-7417-9475; Alberch, Jordi/0000-0002-8684-2721; Boadas-Vaello, Pere/0000-0001-8497-1207; Verdú, Enrique/0000-0002-0816-1146	Spanish Ministerio de Economia y Competitividad [SAF2011-29507]; Accions Singulars de R+D (Sing 12/17) del Vicerrectorat de Recerca de la Universitat de Girona; RecerCaixa, Spain; Spanish Ministerio de Economia y Competitividad (MINECO) [SAF2010-22198-C02-01]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Accions Singulars de R+D (Sing 12/17) del Vicerrectorat de Recerca de la Universitat de Girona; RecerCaixa, Spain; Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government)	This study was supported by grants from RecerCaixa2010 (EV and TP), Spain, from the Spanish Ministerio de Economia y Competitividad (SAF2011-29507, XX and JA) and Accions Singulars de R+D (Sing 12/17) del Vicerrectorat de Recerca de la Universitat de Girona (PBV). CT was a fellow of Spanish Ministerio de Economia y Competitividad (MINECO, SAF2010-22198-C02-01, CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Anglada-Huguet M, 2012, J NEUROCHEM, V121, P639, DOI 10.1111/j.1471-4159.2012.07711.x; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Choi JI, 2012, NEUROSCI LETT, V510, P53, DOI 10.1016/j.neulet.2011.12.070; Cohen SP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7656; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Jackson Kenneth C 2nd, 2006, Pain Pract, V6, P27; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P31; Khalatbary AR, 2010, BRAIN RES, V1306, P168, DOI 10.1016/j.brainres.2009.09.109; Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007; Ko GD, 2010, CLIN J PAIN, V26, P168, DOI 10.1097/AJP.0b013e3181bb8533; Koh SH, 2006, NEUROSCI LETT, V395, P103, DOI 10.1016/j.neulet.2005.10.056; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Kuang X, 2012, EUR J PHARMACOL, V676, P51, DOI 10.1016/j.ejphar.2011.11.037; Landis-Piwowar K, 2013, EXPERT OPIN THER PAT, V23, P189, DOI 10.1517/13543776.2013.743993; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Lu H, 2003, DRUG METAB DISPOS, V31, P452, DOI 10.1124/dmd.31.4.452; Martin YB, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-8; Muller C, 2010, FREE RADICAL RES, V44, P1425, DOI 10.3109/10715762.2010.512919; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Pan ZH, 1996, P NATL ACAD SCI USA, V93, P15423, DOI 10.1073/pnas.93.26.15423; Perez J, 2005, ANESTH ANALG, V101, P444, DOI 10.1213/01.ANE.0000158469.11775.52; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Puig T, 2009, CLIN CANCER RES, V15, P7608, DOI 10.1158/1078-0432.CCR-09-0856; Qiu S, 2011, SEMIN CELL DEV BIOL, V22, P521, DOI 10.1016/j.semcdb.2011.06.003; Renno WM, 2014, NEUROPHARMACOLOGY, V77, P100, DOI 10.1016/j.neuropharm.2013.09.013; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Sun T, 2006, BRIT J ANAESTH, V97, P553, DOI 10.1093/bja/ael209; Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005; Tian W, 2013, NEUROCHEM RES, V38, P772, DOI 10.1007/s11064-013-0976-5; Torres-Peraza JF, 2008, NEUROBIOL DIS, V29, P409, DOI 10.1016/j.nbd.2007.10.003; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wei IH, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-52; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Xifro X, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-74; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15	52	25	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123122	10.1371/journal.pone.0123122	http://dx.doi.org/10.1371/journal.pone.0123122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855977	gold, Green Published			2022-12-26	WOS:000352588500076
J	Fontaine, SN; Rauch, JN; Nordhues, BA; Assimon, VA; Stothert, AR; Jinwal, UK; Sabbagh, JJ; Chang, L; Stevens, SM; Zuiderweg, ERP; Gestwicki, JE; Dickey, CA				Fontaine, Sarah N.; Rauch, Jennifer N.; Nordhues, Bryce A.; Assimon, Victoria A.; Stothert, Andrew R.; Jinwal, Umesh K.; Sabbagh, Jonathan J.; Chang, Lyra; Stevens, Stanley M., Jr.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.; Dickey, Chad A.			Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; RESPONSE REGULATOR GRP78/BIP; NUCLEOTIDE-BINDING DOMAIN; ATP HYDROLYTIC ACTIVITY; HIGH-THROUGHPUT SCREEN; FAST AXONAL-TRANSPORT; MOLECULAR CHAPERONES; COGNATE PROTEIN; HEAT-SHOCK-PROTEIN-70 HSP70; MICROTUBULE DYNAMICS	The constitutively expressed heat shock protein 70 kDa (Hsc70) is a major chaperone protein responsible for maintaining proteostasis, yet how its structure translates into functional decisions regarding client fate is still unclear. We previously showed that Hsc70 preserved aberrant Tau, but it remained unknown if selective inhibition of the activity of this Hsp70 isoform could facilitate Tau clearance. Using single point mutations in the nucleotide binding domain, we assessed the effect of several mutations on the functions of human Hsc70. Biochemical characterization revealed that one mutation abolished both Hsc70 ATPase and refolding activities. This variant resembled the ADP-bound conformer at all times yet remained able to interact with cofactors, nucleotides, and substrates appropriately, resembling a dominant negative Hsc70 (DN-Hsc70). We then assessed the effects of this DN-Hsc70 on its client Tau. DN-Hsc70 potently facilitated Tau clearance via the proteasome in cells and brain tissue, in contrast to wild type Hsc70 that stabilized Tau. Thus, DN-Hsc70 mimics the action of small molecule pan Hsp70 inhibitors with regard to Tau metabolism. This shift in Hsc70 function by a single point mutation was the result of a change in the chaperome associated with Hsc70 such that DN-Hsc70 associated more with Hsp90 and DnaJ proteins, whereas wild type Hsc70 was more associated with other Hsp70 isoforms. Thus, isoform-selective targeting of Hsc70 could be a viable therapeutic strategy for tauopathies and possibly lead to new insights in chaperone complex biology.	[Fontaine, Sarah N.; Nordhues, Bryce A.; Stothert, Andrew R.; Sabbagh, Jonathan J.; Dickey, Chad A.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Coll Med, Tampa, FL 33613 USA; [Fontaine, Sarah N.; Nordhues, Bryce A.; Sabbagh, Jonathan J.; Dickey, Chad A.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Jinwal, Umesh K.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33613 USA; [Rauch, Jennifer N.; Stevens, Stanley M., Jr.] Univ S Florida, Deparment Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Rauch, Jennifer N.; Assimon, Victoria A.; Chang, Lyra; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA; [Zuiderweg, Erik R. P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Dickey, CA (corresponding author), Dept Mol Med, 4001 E Fletcher Ave MDC 36, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Regan, Clinton/E-6250-2012; Rauch, Jennifer/AGI-2683-2022; Fontaine, Sarah/P-6536-2016	Rauch, Jennifer/0000-0001-6853-5915; Chang, Chia Yin/0000-0002-9608-4952; Stevens, Stanley/0000-0002-1399-0256	National Institutes of Health [NS073899, 2R01NS059690, AG042813]; Veterans Health Administration (VHA) [BX001637]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690, R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042813] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration (VHA)(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NS073899 (to C. A. D.), 2R01NS059690 (to E. R. P. Z. and J. E. G.), and AG042813 (to J. E. G.) and Veterans Health Administration (VHA) Grant BX001637 (to C. A. D.).	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Agueli C, 2001, BIOCHEM J, V360, P413, DOI 10.1042/0264-6021:3600413; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P679, DOI 10.1016/B978-012164491-8/50010-5; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Choi MC, 2009, BIOPHYS J, V97, P519, DOI 10.1016/j.bpj.2009.04.047; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; General IJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003624; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; Howe MK, 2014, CHEM BIOL, V21, P1648, DOI 10.1016/j.chembiol.2014.10.016; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Joglekar AP, 2005, EUR J CELL BIOL, V84, P529, DOI 10.1016/j.ejcb.2004.12.028; Johnson ER, 1999, BIOCHEMISTRY-US, V38, P10823, DOI 10.1021/bi990816g; Kang YL, 2014, J MED CHEM, V57, P1188, DOI 10.1021/jm401551n; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; MCKAY DB, 1993, ADV PROTEIN CHEM, V44, P67, DOI 10.1016/S0065-3233(08)60564-1; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; OBRIEN MC, 1993, J BIOL CHEM, V268, P24323; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Panjwani N, 1999, J IMMUNOL, V163, P1936; QUENOUILLE MH, 1956, BIOMETRIKA, V43, P353; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Rosso SM, 2002, ANN NEUROL, V51, P373, DOI 10.1002/ana.10140; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; SCHMID SL, 1985, J BIOL CHEM, V260, P57; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taldone T, 2014, J MED CHEM, V57, P1208, DOI 10.1021/jm401552y; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Turturici G, 2008, J MOL HISTOL, V39, P571, DOI 10.1007/s10735-008-9197-7; Wang YP, 2012, BIOCHEM SOC T, V40, P644, DOI 10.1042/BST20120071; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; Wisen S, 2008, BIOORG MED CHEM LETT, V18, P60, DOI 10.1016/j.bmcl.2007.11.027; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Wittung-Stafshede P, 2003, BIOCHEMISTRY-US, V42, P4937, DOI 10.1021/bi027333o; Yuan AD, 2000, CELL MOL NEUROBIOL, V20, P623, DOI 10.1023/A:1007090422866; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108; Zylicz M, 2001, IUBMB LIFE, V51, P283	68	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13115	13127		10.1074/jbc.M115.637595	http://dx.doi.org/10.1074/jbc.M115.637595			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25864199	Green Published, hybrid			2022-12-26	WOS:000354975700015
J	Miller, MB; Vishwanatha, KS; Mains, RE; Eipper, BA				Miller, Megan B.; Vishwanatha, Kurutihalli S.; Mains, Richard E.; Eipper, Betty A.			An N-terminal Amphipathic Helix Binds Phosphoinositides and Enhances Kalirin Sec14 Domain-mediated Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BINDING; SECRETORY GRANULES; NMDA RECEPTOR; PROTEIN; PEPTIDES; LOCALIZATION; INHIBITION; COMPLEXES; DEFECTS; ISOFORM	Previous studies revealed an essential role for the lipid-binding Sec14 domain of kalirin (KalSec14), but its mechanism of action is not well understood. Because alternative promoter usage appends unique N-terminal peptides to the KalSec14 domain, we used biophysical, biochemical, and cell biological approaches to examine the two major products, bKalSec14 and cKalSec14. Promoter B encodes a charged, unstructured peptide, whereas promoter C encodes an amphipathic helix (Kal-Chelix). Both bKalSec14 and cKalSec14 interacted with lipids in PIP strip and liposome flotation assays, with significantly greater binding by cKalSec14 in both assays. Disruption of the hydrophobic face of the Kal-C-helix in cKalSec14(KKED) eliminated its increased liposome binding. Although cKalSec14 showed significantly reduced binding to liposomes lacking phosphatidylinositol phosphates or cholesterol, liposome binding by bKalSec14 and cKalSec14(KKED) was not affected. When expressed in AtT-20 cells, bKalSec14-GFP was diffusely localized, whereas cKalSec14-GFP localized to the trans-Golgi network and secretory granules. The amphipathic C-helix was sufficient for this localization. When AtT-20 cells were treated with a cell-permeant derivative of the Kal-C-helix (Kal-C-helixArg(9)), we observed increased secretion of a product stored in mature secretory granules, with no effect on basal secretion; a cell-permeant control peptide (Kal-C-helix(KKED)-Arg(9)) did not have this effect. Through its ability to control expression of a novel, phosphoinositide-binding amphipathic helix, Kalrn promoter usage is expected to affect function.	[Miller, Megan B.; Vishwanatha, Kurutihalli S.; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Dept Neurosci, Ctr Hlth, Farmington, CT 06030 USA; [Eipper, Betty A.] Univ Connecticut, Dept Mol Biol & Biophys, Ctr Hlth, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Eipper, BA (corresponding author), Univ Connecticut, Dept Neurosci, Ctr Hlth, 263 Farmington Ave,MC 3401, Farmington, CT 06030 USA.	eipper@uchc.edu	Regan, Clinton/E-6250-2012	Rao, Vishwanatha/0000-0001-9471-807X	National Institutes of Health [DK-032948]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032948, R56DK032948, R37DK032948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-032948.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bonnemaison M, 2014, TRAFFIC, V15, P1099, DOI 10.1111/tra.12194; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Gupta AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033863; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Huang S, 2014, BONE, V60, P235, DOI 10.1016/j.bone.2013.12.023; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Kiraly DD, 2011, J NEUROSCI, V31, P12554, DOI 10.1523/JNEUROSCI.3143-11.2011; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Lemtiri-Chlieh F, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-126; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Ma XM, 2014, MOL BIOL CELL, V25, P1458, DOI 10.1091/mbc.E13-04-0215; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Mains RE, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-20; Mandela P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-136; Manneville JB, 2012, METHOD CELL BIOL, V108, P47, DOI 10.1016/B978-0-12-386487-1.00003-1; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; Miller MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Niu Y, 2013, NAT CELL BIOL, V15, P417, DOI 10.1038/ncb2710; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Prosser DC, 2010, TRAFFIC, V11, P1347, DOI 10.1111/j.1600-0854.2010.01100.x; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; Spijker S, 1999, FASEB J, V13, P735, DOI 10.1096/fasebj.13.6.735; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Ueda S, 2004, CELL SIGNAL, V16, P899, DOI 10.1016/j.cellsig.2004.01.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Vishwanatha KS, 2012, BIOCHEMISTRY-US, V51, P5663, DOI 10.1021/bi300583s; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wu JH, 2013, ARTERIOSCL THROM VAS, V33, P702, DOI 10.1161/ATVBAHA.112.300234; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yan Y, 2015, CEREB CORTEX, V25, P3487, DOI 10.1093/cercor/bhu182; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509	61	11	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13541	13555		10.1074/jbc.M115.636746	http://dx.doi.org/10.1074/jbc.M115.636746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861993	hybrid, Green Published			2022-12-26	WOS:000354975700048
J	Wang, W; Huang, X; Xin, HB; Fu, MG; Xue, AM; Wu, ZH				Wang, Wei; Huang, Xuan; Xin, Hong-Bo; Fu, Mingui; Xue, Aimin; Wu, Zhao-Hui			TRAF Family Member-associated NF-kappa B Activator (TANK) Inhibits Genotoxic Nuclear Factor kappa B Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON ANTIVIRAL RESPONSE; DNA-DAMAGE; LINEAR UBIQUITINATION; NEGATIVE REGULATOR; CELL-SURVIVAL; UP-REGULATION; PROTEIN TANK; CROSS-TALK; KINASE; STRESS	DNA damage-induced NF-kappa B activation plays a critical role in regulating cellular response to genotoxic stress. However, the molecular mechanisms controlling the magnitude and duration of this genotoxic NF-kappa B signaling cascade are poorly understood. We recently demonstrated that genotoxic NF-kappa B activation is regulated by reversible ubiquitination of several essential mediators involved in this signaling pathway. Here we show that TRAF family member-associated NF-kappa B activator (TANK) negatively regulates NF-kappa B activation by DNA damage via inhibiting ubiquitination of TRAF6. Despite the lack of a deubiquitination enzyme domain, TANK has been shown to negatively regulate the ubiquitination of TRAF proteins. We found TANK formed a complex with MCPIP1 (also known as ZC3H12A) and a deubiquitinase, USP10, which was essential for the USP10-dependent deubiquitination of TRAF6 and the resolution of genotoxic NF-kappa B activation upon DNA damage. Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated deletion of TANK in human cells significantly enhanced NF-kappa B activation by genotoxic treatment, resulting in enhanced cell survival and increased inflammatory cytokine production. Furthermore, we found that the TANK-MCPIP1-USP10 complex also decreased TRAF6 ubiquitination in cells treated with IL-1 beta or LPS. In accordance, depletion of USP10 enhanced NF-kappa B activation induced by IL-1 beta or LPS. Collectively, our data demonstrate that TANK serves as an important negative regulator of NF-kappa B signaling cascades induced by genotoxic stress and IL-1R/Toll-like receptor stimulation in a manner dependent on MCPIP1/USP10-mediated TRAF6 deubiquitination.	[Wang, Wei; Wu, Zhao-Hui] Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, Memphis, TN 38163 USA; [Wang, Wei; Wu, Zhao-Hui] Univ Tennessee, Ctr Canc Res, Hlth Sci Ctr, Memphis, TN 38163 USA; [Huang, Xuan; Xin, Hong-Bo] Nanchang Univ, Inst Translat Med, Nanchang 330031, Peoples R China; [Fu, Mingui] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Xue, Aimin] Fudan Univ, Shanghai Med Coll, Dept Forens Med, Shanghai 200032, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Nanchang University; University of Missouri System; University of Missouri Kansas City; Fudan University	Wu, ZH (corresponding author), Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, 19 S Manassas St, Memphis, TN 38163 USA.	zwu6@uthsc.edu			NCI/National Institutes of Health [R01CA149251]; American Cancer Society [RSG-13-186-01-CSM]; National Institute of Health [R21AI103618]; NATIONAL CANCER INSTITUTE [R01CA149251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103618] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NCI/National Institutes of Health grant R01CA149251 (to Z. W.). This work was also supported by American Cancer Society Grant RSG-13-186-01-CSM (to Z. W.).; Supported by National Institute of Health Grant R21AI103618.	Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lee MH, 2011, MOL CELL, V43, P180, DOI 10.1016/j.molcel.2011.06.017; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wu ZH, 2013, CURR PHARM DESIGN, V19, P3263, DOI 10.2174/1381612811319180010; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	46	55	59	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13372	13385		10.1074/jbc.M115.643767	http://dx.doi.org/10.1074/jbc.M115.643767			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861989	hybrid, Green Published			2022-12-26	WOS:000354975700034
J	Braun, F; Hamelin, J; Bonnafous, A; Delgenes, N; Steyer, JP; Patureau, D				Braun, Florence; Hamelin, Jerome; Bonnafous, Anais; Delgenes, Nadine; Steyer, Jean-Philippe; Patureau, Dominique			Similar PAH Fate in Anaerobic Digesters Inoculated with Three Microbial Communities Accumulating Either Volatile Fatty Acids or Methane	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; RDNA SEQUENCE-ANALYSIS; ACTIVATED-SLUDGE; DEGRADATION; DIVERSITY; BIODEGRADATION; PCR; PHENANTHRENE; NAPHTHALENE; SEDIMENT	Urban sludge produced on wastewater treatment plants are often contaminated by organic pollutants such as polycyclic aromatic hydrocarbons (PAH). Their removal under methanogenic conditions was already reported, but the factors influencing this removal remain unclear. Here, we determined the influence of microbial communities on PAH removal under controlled physico-chemical conditions. Twelve mesophilic anaerobic digesters were inoculated with three microbial communities extracted from ecosystems with contrasting pollution histories: a PAH contaminated soil, a PCB contaminated sediment and a low contaminated anaerobic sludge. These anaerobic digesters were operated during 100 days in continuous mode. A sterilised activated sludge, spiked with 13 PAH at concentrations usually encountered in full-scale wastewater treatment plants, was used as substrate. The dry matter and volatile solid degradation, the biogas production rate and composition, the volatile fatty acids (VFA) production and the PAH removals were monitored. Bacterial and archaeal communities were compared in abundance (qPCR), in community structure (SSCP fingerprinting) and in dominant microbial species (454-pyrosequencing). The bioreactors inoculated with the community extracted from low contaminated anaerobic sludge showed the greater methane production. The PAH removals ranged from 10% to 30%, respectively, for high and low molecular weight PAH, whatever the inoculums tested, and were highly correlated with the dry matter and volatile solid removals. The microbial community structure and diversity differed with the inoculum source; this difference was maintained after the 100 days of digestion. However, the PAH removal was not correlated to these diverse structures and diversities. We hence obtained three functional stable consortia with two contrasted metabolic activities, and three different pictures of microbial diversity, but similar PAH and matter removals. These results confirm that PAH removal depends on the molecule type and on the solid matter removal. But, as PAH elimination is similar whether the solid substrate is degraded into VFA or into methane, it seems that the fermentative communities are responsible for their elimination.	[Braun, Florence; Hamelin, Jerome; Bonnafous, Anais; Delgenes, Nadine; Steyer, Jean-Philippe; Patureau, Dominique] INRA, UR0050, Lab Biotechnol Environm, F-11100 Narbonne, France; [Braun, Florence] French Environm & Energy Management Agcy, ADEME, F-49004 Angers 01, France	INRAE	Patureau, D (corresponding author), INRA, UR0050, Lab Biotechnol Environm, Ave Etangs, F-11100 Narbonne, France.	dominique.patureau@supagro.inra.fr	Hamelin, Jérôme/F-4981-2013	Hamelin, Jérôme/0000-0003-3601-6349; Steyer, Jean-Philippe/0000-0003-0467-8081	'Agence de l'Environnement et de la Maitrise de l'Energie' (ADEME) [0906C0008]; 'Programme National de Recherche sur les Perturbateurs Endocriniens' (PNRPE); 'Institut National de la Recherche Agronomique' (INRA)	'Agence de l'Environnement et de la Maitrise de l'Energie' (ADEME); 'Programme National de Recherche sur les Perturbateurs Endocriniens' (PNRPE); 'Institut National de la Recherche Agronomique' (INRA)	This work was supported by the 'Agence de l'Environnement et de la Maitrise de l'Energie' (ADEME), ADEME convention number: 0906C0008, from the 'Programme National de Recherche sur les Perturbateurs Endocriniens' (PNRPE), and 'Institut National de la Recherche Agronomique' (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Lara CA, 2008, CHEM ENG PROCESS, V47, P1968, DOI 10.1016/j.cep.2007.12.007; Barret M, 2010, WATER RES, V44, P3797, DOI 10.1016/j.watres.2010.04.031; Berdugo-Clavijo C, 2012, FEMS MICROBIOL ECOL, V81, P124, DOI 10.1111/j.1574-6941.2012.01328.x; Bertin L, 2007, WATER RES, V41, P2407, DOI 10.1016/j.watres.2007.02.046; Blanchard G, 2010, MUTOSS UNIFIED MUTIP; Blanchard M, 2004, ENVIRON RES, V95, P184, DOI 10.1016/j.envres.2003.07.003; Braun F, 2011, APPL ENVIRON MICROB, V77, P8487, DOI 10.1128/AEM.05549-11; Bueche M, 2013, APPL ENVIRON MICROB, V79, P5302, DOI 10.1128/AEM.01376-13; Cea-Barcia G, 2013, INT J CHEM ENG, V2013, DOI 10.1155/2013/450542; Chang BV, 2008, B ENVIRON CONTAM TOX, V80, P145, DOI 10.1007/s00128-007-9333-1; Chang W, 2006, BIOTECHNOL LETT, V28, P425, DOI 10.1007/s10529-005-6073-3; Chiu PC, 2001, APPL ENVIRON MICROB, V67, P2371, DOI 10.1128/AEM.67.5.2371-2374.2001; Christensen N, 2004, WATER SCI TECHNOL, V50, P237, DOI 10.2166/wst.2004.0580; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2009, MICROB BIOTECHNOL, V2, P566, DOI 10.1111/j.1751-7915.2009.00096.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng J, 2012, ENVIRON SCI POLLUT R, V19, P1097, DOI 10.1007/s11356-011-0620-3; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Haegeman B, 2014, MICROB ECOL, V68, P169, DOI 10.1007/s00248-014-0394-5; Lu XY, 2011, APPL MICROBIOL BIOT, V89, P1357, DOI 10.1007/s00253-010-3072-7; Michelland RJ, 2009, MOL ECOL RESOUR, V9, P1359, DOI 10.1111/j.1755-0998.2009.02609.x; Mirza R, 2012, WATER AIR SOIL POLL, V223, P189, DOI 10.1007/s11270-011-0850-5; Musat F, 2009, ENVIRON MICROBIOL, V11, P209, DOI 10.1111/j.1462-2920.2008.01756.x; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rockne KJ, 2001, WATER RES, V35, P291, DOI 10.1016/S0043-1354(00)00246-3; Roesch L. F. W., 2007, ISME J, P1, DOI DOI 10.1038/ISMEJ.2007.94; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Sany SBT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094907; Sen B, 2008, J APPL MICROBIOL, V105, P2123, DOI 10.1111/j.1365-2672.2008.03911.x; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; Talbot G, 2008, WATER RES, V42, P513, DOI 10.1016/j.watres.2007.08.003; Tarnawski S, 2006, SOIL BIOL BIOCHEM, V38, P1193, DOI 10.1016/j.soilbio.2005.10.003; Team RDC, 2010, R LANG ENV STAT COMP; Thavamani P, 2012, ENVIRON MONIT ASSESS, V184, P3875, DOI 10.1007/s10661-011-2230-4; Trably E, 2004, INT J ENVIRON AN CH, V84, P995, DOI 10.1080/03067310412331298412; Trably E, 2003, WATER SCI TECHNOL, V48, P53, DOI 10.2166/wst.2003.0220; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Yang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086441; Youngsoon Um, 2004, ISOLATION CHARACTERI; Yuan SY, 2007, J ENVIRON SCI HEAL B, V42, P63, DOI 10.1080/03601230601020860; Zhang SY, 2012, BIODEGRADATION, V23, P221, DOI 10.1007/s10532-011-9501-1; Zumstein E, 2000, ENVIRON MICROBIOL, V2, P69, DOI 10.1046/j.1462-2920.2000.00072.x	47	18	18	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125552	10.1371/journal.pone.0125552	http://dx.doi.org/10.1371/journal.pone.0125552			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874750	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800158
J	Dhar, G; Sen, S; Chaudhuri, G				Dhar, Gautam; Sen, Suvajit; Chaudhuri, Gautam			Acid Gradient across Plasma Membrane Can Drive Phosphate Bond Synthesis in Cancer Cells: Acidic Tumor Milieu as a Potential Energy Source	PLOS ONE			English	Article							ATP SYNTHASE; INORGANIC-PYROPHOSPHATE; EXTRACELLULAR PH; METABOLISM; MICROENVIRONMENT; PHOSPHORYLATION; GLYCOLYSIS; INHIBITORS; DIFFUSION; ADENOSINE	Aggressive cancers exhibit an efficient conversion of high amounts of glucose to lactate accompanied by acid secretion, a phenomenon popularly known as the Warburg effect. The acidic microenvironment and the alkaline cytosol create a proton-gradient (acid gradient) across the plasma membrane that represents proton-motive energy. Increasing experimental data from physiological relevant models suggest that acid gradient stimulates tumor proliferation, and can also support its energy needs. However, direct biochemical evidence linking extracellular acid gradient to generation of intracellular ATP are missing. In this work, we demonstrate that cancer cells can synthesize significant amounts of phosphate-bonds from phosphate in response to acid gradient across plasma membrane. The noted phenomenon exists in absence of glycolysis and mitochondrial ATP synthesis, and is unique to cancer. Biochemical assays using viable cancer cells, and purified plasma membrane vesicles utilizing radioactive phosphate, confirmed phosphate-bond synthesis from free phosphate (Pi), and also localization of this activity to the plasma membrane. In addition to ATP, predominant formation of pyrophosphate (PPi) from Pi was also observed when plasma membrane vesicles from cancer cells were subjected to trans-membrane acid gradient. Cancer cytosols were found capable of converting PPi to ATP, and also stimulate ATP synthesis from Pi from the vesicles. Acid gradient created through glucose metabolism by cancer cells, as observed in tumors, also proved critical for phosphate-bond synthesis. In brief, these observations reveal a role of acidic tumor milieu as a potential energy source and may offer a novel therapeutic target.	[Dhar, Gautam; Sen, Suvajit; Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Sen, Suvajit; Chaudhuri, Gautam] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Dhar, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gdhar99@gmail.com; gchaudhuri@mednet.ucla.edu			Carl and Roberta Deutsch Foundation	Carl and Roberta Deutsch Foundation	This work was supported by grants to GC from the Carl and Roberta Deutsch Foundation and Kelly Day. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; Bhujwalla ZM, 2002, NMR BIOMED, V15, P114, DOI 10.1002/nbm.743; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Chi SL, 2006, CANCER RES, V66, P875, DOI 10.1158/0008-5472.CAN-05-2806; DAVIES JM, 1993, BIOCHIM BIOPHYS ACTA, V1141, P29, DOI 10.1016/0005-2728(93)90185-I; Drose S, 1997, J EXP BIOL, V200, P1; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fitzgerald RC, 1997, J CELL SCI, V110, P663; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Helenius M, 2012, BBA-MOL CELL RES, V1823, P1967, DOI 10.1016/j.bbamcr.2012.08.001; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Lehninger A., 1993, PRINCIPLES BIOCH; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitchell P, 1977, Annu Rev Biochem, V46, P996, DOI 10.1146/annurev.bi.46.070177.005024; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; NG TC, 1989, RADIOLOGY, V170, P875, DOI 10.1148/radiology.170.3.2916046; OBERHAENSLI RD, 1986, LANCET, V2, P8, DOI 10.1016/S0140-6736(86)92558-4; Quillen EE, 2006, J BIOL CHEM, V281, P20728, DOI 10.1074/jbc.M513042200; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; VAUPEL P, 1989, CANCER RES, V49, P6449; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZACHOWSKI A, 1974, BIOCHEM BIOPH RES CO, V57, P787, DOI 10.1016/0006-291X(74)90615-9	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124070	10.1371/journal.pone.0124070	http://dx.doi.org/10.1371/journal.pone.0124070			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874623	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800130
J	Chen, T; Wang, QQ; Qin, Y; Chen, X; Yang, XX; Lou, W; Zhou, MK; He, GX; Lu, K				Chen, Tao; Wang, Qiqi; Qin, Yu; Chen, Xi; Yang, Xiaoxiong; Lou, Wei; Zhou, Mikang; He, Guangxue; Lu, Kai			Knowledge, Attitudes and Practice of Desalinated Water among Professionals in Health and Water Departments in Shengsi, China: A Qualitative Study	PLOS ONE			English	Article							DRINKING-WATER; CARDIOVASCULAR MORTALITY; MAGNESIUM; CALCIUM; FUTURE; RISK	Desalination has been considered as an essential way to solve water stress all over the world. Most of previous studies focused on its environmental impacts, energy consumption and desalination technologies rather than human health. However, the safety of desalinated water remains unclear. This study was undertaken to investigate the knowledge, attitude and practice (KAP) of the residents in an island county in eastern China to desalinated water. Seventeen people working in medical and water industries were recruited, and focus group discussion and in-depth interview were conducted among them. Our results showed that the majority of people interviewed knew the definition and local supply pattern of desalinated water, while some of them showed some concern about the safety and nutrition of desalinated water. Current drinking water standard has no specific item for desalination, so we strongly suggest issuing a standard for desalinated water.	[Chen, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Qiqi; Qin, Yu; He, Guangxue; Lu, Kai] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Chen, Xi; Yang, Xiaoxiong] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Beijing, Peoples R China; [Yang, Xiaoxiong; Lou, Wei; Zhou, Mikang] Shengsi Cty Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Lu, K (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	lukai263@126.com		Chen, Xi/0000-0002-7775-8210	public science and technology research funds projects of ocean [201305039-6]; research special fund for public welfare industry of health [201302004]	public science and technology research funds projects of ocean; research special fund for public welfare industry of health	This study was supported by: the public science and technology research funds projects of ocean (grant no. 201305039-6) (http://www.soa.gov.cn/); the research special fund for public welfare industry of health (grant no. 201302004) (http://www.nhfpc.gov.cn/qjjys/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUIDELINES FOR DRINK; Chiu HF, 2011, J TOXICOL ENV HEAL A, V74, P62, DOI 10.1080/15287394.2010.514236; Cotruvo J, 2010, DESALINATION TECHNOL; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Kousa A, 2004, J EPIDEMIOL COMMUN H, V58, P136, DOI 10.1136/jech.58.2.136; Marque S, 2003, EUR J EPIDEMIOL, V18, P305, DOI 10.1023/A:1023618728056; Ministry of Health of People's Republic of China Standard for drinking water quality, 2006, GB5749 2006; Ministry of Science and Technology of People's Republic of China & National Development and Reform Commission, 2012, THE 12TH FIVE YEAR P; Nerbrand C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-21; Ni H, 2010, CHINESE J HEALTH LAB, V20, P162; Penate B, 2012, DESALINATION, V284, P1, DOI 10.1016/j.desal.2011.09.010; Service RF, 2006, SCIENCE, V313, P1088, DOI 10.1126/science.313.5790.1088; Tsiourtis NX, 2001, DESALINATION, V141, P223, DOI 10.1016/S0011-9164(01)85001-3; von Medeazza GLM, 2005, DESALINATION, V185, P57, DOI 10.1016/j.desal.2005.03.071; WHO, WHO HSE WSH 11 03 20; WHO, 2009, BORON IN DRINKING WA; Zhang, 2007, CHIN J HLTH LAB TECH, V17, P371, DOI [10.3969/j.issn.1004-8685.2007.02.081, DOI 10.3969/J.ISSN.1004-8685.2007.02.081]; Zhang YongLi, 2012, Journal of Environmental & Occupational Medicine, V29, P681; Zhao HX, 2001, DIABETIC MED, V18, P709, DOI 10.1046/j.1464-5491.2001.00554.x; [赵欣 Zhao Xin], 2013, [环境与健康杂志, Journal of Environment and Health], V30, P335	20	15	15	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118360	10.1371/journal.pone.0118360	http://dx.doi.org/10.1371/journal.pone.0118360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874459	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100005
J	Corneli, A; Perry, B; Agot, K; Ahmed, K; Malamatsho, F; Van Damme, L				Corneli, Amy; Perry, Brian; Agot, Kawango; Ahmed, Khatija; Malamatsho, Fulufhelo; Van Damme, Lut			Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; TENOFOVIR GEL; ACCEPTABILITY; MICROBICIDE; PARTICIPANTS; INFECTION; MISCONCEPTION; INTERVENTION	Introduction FEM-PrEP did not demonstrate a reduction in HIV acquisition because of low study pill adherence. Yet, plasma and intracellular drug concentrations indicated that some participants had evidence of recent pill use. We conducted a follow-up study to identify, among other topics, participants' reasons for taking the study pill. Methods Qualitative, semi-structured interviews (SSIs) were conducted with 88 FEM-PrEP participants. Participants were purposefully selected based on their adherence drug concentrations collected during FEM-PrEP and placed into three adherence interview groups: "high," "moderate," and "none/scarce." Participants in the high and moderate groups described reasons why they adhered most or some of the time, including factors that facilitated their adherence. Participants in all groups described what they believed made it possible for other FEM-PrEP participants to adhere. In addition, 224 FEM-PrEP participants reported on their reasons for taking the study pills through a quantitative, audio computer-assisted self-interview (ACASI). Thematic analysis and descriptive statistics were used to analyze the qualitative and quantitative data, respectively. Results Five themes were identified from the SSIs as facilitating factors of adherence: 1) participants' support for the research, 2) HIV risk reduction, 3) routine formation and use of tools, 4) adherence counseling, and 5) partner awareness and support. Participants described similar facilitators when they spoke about other participants' adherence. Among the 172 participants who reported in ACASI that they had taken a study pill, wanting to help answer the research question was the most frequently stated reason for taking the pills (94%, n = 161). We also found evidence of preventive misconception. Conclusions Adherence was facilitated by personal motivations, such as risk reduction and interest in the research outcome, and by adherence strategies consisting of external cues, reminders, and support. These findings can inform future HIV prevention clinical trials and the rollout of effective antiretroviral-based HIV prevention technologies for women.	[Corneli, Amy; Perry, Brian; Van Damme, Lut] FHI 360, Durham, NC 27701 USA; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Ahmed, Khatija; Malamatsho, Fulufhelo] Setshaba Res Ctr, Soshanguve, South Africa	FHI 360	Corneli, A (corresponding author), FHI 360, Durham, NC 27701 USA.	acorneli@fhi360.org		ahmed, khatija/0000-0003-0309-1641; Corneli, Amy/0000-0002-4629-4329; Perry, Brian/0000-0002-4648-7673	United States Agency for International Development (USAID); Contraceptive and Reproductive Health Technologies and Research Utilization Program; Preventive Technologies Agreement [GHO A 00 09 00016-00]; Bill & Melinda Gates Foundation; NIH [P30 AI50410]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies and Research Utilization Program; Preventive Technologies Agreement; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	FEM-PrEP was conducted under two grants funded by the United States Agency for International Development (USAID): the Contraceptive and Reproductive Health Technologies and Research Utilization Program, and the Preventive Technologies Agreement No. GHO A 00 09 00016-00. Early support was also provided by the Bill & Melinda Gates Foundation. The drug concentration analyses were performed using equipment provided by the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot K, 2014, AIDS BEHAV; Amico KR, 2013, AIDS BEHAV, V17, P2143, DOI 10.1007/s10461-013-0429-9; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bayer AM, 2010, CULT HEALTH SEX, V12, P771, DOI [10.1080/13691058.2010.488299, 10.1080/13691051003728599]; Carballo-Dieguez A, 2007, AIDS CARE, V19, P1026, DOI 10.1080/09540120701294237; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Corneli A, 2014, CONFERENCE ON RETROV; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Corneli AL, 2015, JAIDS-J ACQ IMM DEF, V68, P578, DOI 10.1097/QAI.0000000000000525; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Dellar RC, 2014, AIDS BEHAV, V18, P1746, DOI 10.1007/s10461-014-0771-6; Donnell D, 2014, J ACQUIR IMMUNE DEFI; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2012, APPLIED THEMATIC ANA; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Lanham Michele, 2014, J Int AIDS Soc, V17, P19159, DOI 10.7448/IAS.17.3.19159; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McLellan E., 2003, FIELD METHOD, V15, P63, DOI [DOI 10.1177/1525822X02239573, 10.1177/1525822X02239573]; Mensch BS, 2008, INT FAM PLAN PERSPEC, V34, P169, DOI 10.1363/ifpp.34.169.08; Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Psaros C, 2014, JAIDS-J ACQ IMM DEF, V66, P522, DOI 10.1097/QAI.0000000000000212; QSR International Pty Ltd, 2013, NVIVO QUALITATIVE DA; Simon AE, 2007, AM J PREV MED, V32, P370, DOI 10.1016/j.amepre.2007.01.007; Sugarman J, 2015, AM J BIOETH EMP RESE; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van der Straten A, 2014, AIDS BEHAV; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Woodsong C, 2004, INT FAM PLAN PERSPEC, V30, P94, DOI 10.1363/3009404; Woodsong C, 2012, AIDS BEHAV, V16, P785, DOI 10.1007/s10461-011-0027-7	33	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125458	10.1371/journal.pone.0125458	http://dx.doi.org/10.1371/journal.pone.0125458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867624	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100293
J	Koga, M; Gilbert, M; Li, JJ; Yuki, N				Koga, Michiaki; Gilbert, Michel; Li, Jianjun; Yuki, Nobuhiro			Complex of GM1-and GD1a-Like Lipo-Oligosaccharide Mimics GM1b, Inducing Anti-GM1b Antibodies	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; MOTOR AXONAL NEUROPATHY; CAMPYLOBACTER-JEJUNI; CLINICAL-FEATURES; FISHER-SYNDROME; GANGLIOSIDE; LIPOOLIGOSACCHARIDE; IGG; ANTIGENS; MODEL	Objective Molecular mimicry between Campylobacter jejuni lipo-oligosaccharides (LOSs) and human gangliosides GM1 and GD1a induces the production of anti-GM1 and anti-GD1a antibodies, and the development of Guillain-Barre syndrome. Complexes of two different gangliosides form new molecular shapes capable of enhancing recognition by anti-ganglioside antibodies. To test the hypothesis that the complex of GM1-like and GD1a-like LOSs of C. jejuni induces the development of anti-GM1b antibodies in Guillain-Barre syndrome patients. Methods Mass spectrometry analysis determined the LOS outer core structures, with which mice were immunized. IgG antibodies to single gangliosides and complex of gangliosides were tested in sera from Guillain-Barre syndrome patients from whom C. jejuni LOS had been isolated. Results Two isolates from GBS patients who had anti-GM1b antibodies, but neither anti-GM1 nor -GD1a antibodies, expressed both GM1-like and GD1a-like LOSs, but not GM1b-like LOS. Anti-GM1b antibodies were induced in one of the mice immunized with the C. jejuni bearing GM1-like and GD1a-like LOS. Sera from 20 patients had antibodies to the complex of GM1 and GD1a, all of which carried anti-GM1b reactivity. Five of these sera harbored neither anti-GM1 nor anti-GD1a antibodies. IgG antibodies to the complex were absorbed by GM1b, but by neither GM1 nor GD1a. Conclusions GM1-like and GD1a-like LOSs form a GM1b epitope, inducing the development of anti-GM1b antibodies in patients with Guillain-Barre syndrome subsequent to C. jejuni enteritis. Here, we present a new paradigm that the complex of two different structures forms a new molecular mimicry, inducing the production of autoantibodies.	[Koga, Michiaki; Yuki, Nobuhiro] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Koga, Michiaki] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan; [Gilbert, Michel; Li, Jianjun] Natl Res Council Canada, Human Hlth Therapeut, Ottawa, ON, Canada; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Dokkyo Medical University; Yamaguchi University; National Research Council Canada; National University of Singapore; National University of Singapore	Yuki, N (corresponding author), Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan.	mdcyuki@nus.edu.sg	Koga, Michiaki/L-4825-2019	Koga, Michiaki/0000-0002-1356-955X; Li, Jianjun/0000-0002-6531-3687; Gilbert, Michel/0000-0002-0204-4408	Human Frontier Science Program [RGP0038/2003-C]; Singapore National Medical Research Council IRG [10nov086]; Singapore National Medical Research Council [CSA/047/2012]; Grants-in-Aid for Scientific Research [15K08464] Funding Source: KAKEN	Human Frontier Science Program(Human Frontier Science Program); Singapore National Medical Research Council IRG(National Medical Research Council, Singapore); Singapore National Medical Research Council(National Medical Research Council, Singapore); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Human Frontier Science Program RGP0038/2003-C, www.hfsp.org/funding/research-grants; Singapore National Medical Research Council IRG 10nov086, www.nmrc.gov.sg/; Singapore National Medical Research Council CSA/047/2012, www.nmrc.gov.sg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Funakoshi K, 2009, J NEUROL NEUROSUR PS, V80, P60, DOI 10.1136/jnnp.2008.154351; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005; Greenshields KN, 2009, J CLIN INVEST, V119, P595, DOI 10.1172/JCI37338; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Koga M, 2005, J NEUROL NEUROSUR PS, V76, P1736, DOI 10.1136/jnnp.2005.065359; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Koga M, 2002, J NEUROL NEUROSUR PS, V72, P767, DOI 10.1136/jnnp.72.6.767; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Kuijf ML, 2007, J NEUROIMMUNOL, V188, P69, DOI 10.1016/j.jneuroim.2007.05.014; Kusunoki S, 1996, NEUROLOGY, V47, P237, DOI 10.1212/WNL.47.1.237; Li JJ, 2005, ELECTROPHORESIS, V26, P3360, DOI 10.1002/elps.200500145; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Ogawara K, 2003, J NEUROL SCI, V210, P41, DOI 10.1016/S0022-510X(03)00013-3; Rinaldi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082337; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Willison HJ, 2013, TRENDS IMMUNOL, V34, P453, DOI 10.1016/j.it.2013.05.001; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Yuki N, 1997, J NEUROIMMUNOL, V74, P30, DOI 10.1016/S0165-5728(96)00201-9; Yuki N, 2000, ANN NEUROL, V47, P314, DOI 10.1002/1531-8249(200003)47:3<314::AID-ANA6>3.3.CO;2-3	24	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124004	10.1371/journal.pone.0124004	http://dx.doi.org/10.1371/journal.pone.0124004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867522	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100232
J	Liu, Y; Han, J; Liu, DD; Gu, DD; Wang, YP; Liao, YC; Wen, XX				Liu, Yang; Han, Juan; Liu, Didi; Gu, Dandan; Wang, Yongping; Liao, Yuncheng; Wen, Xiaoxia			Effect of Plastic Film Mulching on the Grain Filling and Hormonal Changes of Maize under Different Irrigation Conditions	PLOS ONE			English	Article							WATER-USE EFFICIENCY; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; CYTOKININ CONTENT; LOESS PLATEAU; ABSCISIC-ACID; SOIL; WHEAT; GROWTH; YIELD	Plastic film mulching (PM) is widely utilized for maize production in China. However, the effect of PM on the grain yield of crops has not been established, and the biochemical mechanism underlying the increase or decrease in grain yield under PM is not yet understood. Grain filling markedly affects the grain yield. The objective of this study was to investigate the effects of PM on maize grain filling under different irrigation levels and the relationship of such effects with hormonal changes. In the present study, PM was compared with traditional nonmulching management (TN) under 220 mm, 270 mm and 320 mm irrigation amount, and the grain filling characters of the grains located in various parts of the ear and the hormonal changes in the grains were measured. The results indicated that at 220 mm irrigation, PM significantly increased the grain filling rate of the middle and basal grains and decreased the grain filling rate of the upper grains. At 270 mm irrigation, the PM significantly increased the grain filling rate of the all grains. At 320 mm irrigation, the PM only significantly increased the grain filling rate of the upper grains. The IAA, Z+ZR and ABA content in the grains was positively correlated with the grain weight and grain-filling rates; however, the ETH evolution rate of the grains was negatively correlated with the grain weight and grain-filling rates. These results show that the effect of PM on maize grain filling is related to the irrigation amount and that the grain position on the ear and the grain filling of the upper grains was more sensitive to PM and irrigation than were the other grains. In addition, the PM and irrigation regulated the balance of hormones rather than the content of individual hormones to affect the maize grain filling.	[Liu, Yang; Han, Juan; Liu, Didi; Wang, Yongping; Liao, Yuncheng; Wen, Xiaoxia] Northwest A&F Univ, Coll Agron, Yangling 712100, Peoples R China; [Gu, Dandan] Northwest A&F Univ, Coll Plant Protect, Yangling 712100, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wen, XX (corresponding author), Northwest A&F Univ, Coll Agron, Yangling 712100, Peoples R China.	wenxiaoxia@126.com			National Natural Science Foundation of China [31301260]; Doctor Subject Foundation of the Ministry of Education of China [20120204120020]; Fundamental Research Funds for the Central Universities of China [QN2013003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Subject Foundation of the Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Project No. 31301260), the Doctor Subject Foundation of the Ministry of Education of China (Project No. 20120204120020), and the Fundamental Research Funds for the Central Universities of China (Project No. QN2013003). In this paper, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELTRANO J, 1994, PLANT GROWTH REGUL, V15, P107, DOI 10.1007/BF00024098; Bu LD, 2013, AGR WATER MANAGE, V123, P71, DOI 10.1016/j.agwat.2013.03.015; Cao JS, 2012, J FOOD AGRIC ENVIRON, V10, P519; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; DIETRICH JT, 1995, PLANT PHYSIOL BIOCH, V33, P327; EEUWENS CJ, 1975, J EXP BOT, V26, P1, DOI 10.1093/jxb/26.1.1; Gu XY, 2012, J FOOD AGRIC ENVIRON, V10, P560; Han J, 2014, FIELD CROP RES, V155, P202, DOI 10.1016/j.fcr.2013.09.004; He R.X., 1999, J SHANXI AGR U, V19, P16; KUROGOCHI S, 1979, PLANTA, V146, P185, DOI 10.1007/BF00388230; Li FM, 2004, AGR WATER MANAGE, V67, P77, DOI 10.1016/j.agwat.2004.02.001; Li XY, 2001, AGR WATER MANAGE, V50, P173, DOI 10.1016/S0378-3774(01)00105-6; Li YS, 2007, SOIL TILL RES, V93, P370, DOI 10.1016/j.still.2006.05.010; Liu CA, 2013, EUR J SOIL BIOL, V57, P9, DOI 10.1016/j.ejsobi.2013.03.007; Liu JL, 2014, AGR ECOSYST ENVIRON, V188, P20, DOI 10.1016/j.agee.2014.02.010; Liu Y, 2013, FIELD CROP RES, V144, P43, DOI 10.1016/j.fcr.2013.01.009; Liu YE, 2010, CROP SCI, V50, P215, DOI 10.2135/cropsci2009.04.0186; MICHAEL G, 1972, CROP SCI, V12, P162, DOI 10.2135/cropsci1972.0011183X001200020002x; MORRIS RO, 1993, AUST J PLANT PHYSIOL, V20, P621, DOI 10.1071/PP9930621; Ren X, 2010, J AGRON CROP SCI, V196, P109, DOI 10.1111/j.1439-037X.2009.00401.x; Ren XiaoLong, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P45; Ren XL, 2008, AGR WATER MANAGE, V95, P1293, DOI 10.1016/j.agwat.2008.05.007; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAHA S, 1986, Canadian Journal of Botany, V64, P2068, DOI 10.1139/b86-271; SETH AK, 1967, J EXP BOT, V18, P65, DOI 10.1093/jxb/18.1.65; SINGH G, 1982, Plant Physiology and Biochemistry, V9, P22; Song G., 2000, J HENAN AGR U, V34, P213; SUZUKI Y, 1981, PLANT CELL PHYSIOL, V22, P1085; [王永平 Wang Yongping], 2014, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V23, P28; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xin N., 1998, AGR ARID REGIONS NO; Xu GW, 2007, FIELD CROP RES, V101, P53, DOI 10.1016/j.fcr.2006.09.008; Xu YunJi, 2013, Acta Agronomica Sinica, V39, P1452, DOI 10.3724/SP.J.1006.2013.01452; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang JC, 2008, PLANTA, V228, P137, DOI 10.1007/s00425-008-0725-1; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang MF, 1993, MAIZE SCI, V1, P29; Zhang SL, 2013, FIELD CROP RES, V151, P9, DOI 10.1016/j.fcr.2013.07.005; Zhao H, 2014, FIELD CROP RES, V161, P137, DOI 10.1016/j.fcr.2014.02.013; ZHU Q, 1988, Acta Agronomica Sinica, V14, P182	45	12	15	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122791	10.1371/journal.pone.0122791	http://dx.doi.org/10.1371/journal.pone.0122791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867028	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100100
J	Braczkowski, AR; Balme, GA; Dickman, A; Macdonald, DW; Fattebert, J; Dickerson, T; Johnson, P; Hunter, L				Braczkowski, Alex Richard; Balme, Guy Andrew; Dickman, Amy; Macdonald, David Whyte; Fattebert, Julien; Dickerson, Tristan; Johnson, Paul; Hunter, Luke			Who Bites the Bullet First? The Susceptibility of Leopards Panthera pardus to Trophy Hunting	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; LION POPULATION; CONSERVATION; DISPERSAL; SELECTIVITY; IMPACT; TRAP; PREY	Reliable data is fundamentally important for managing large carnivore populations, and vital for informing hunting quota levels if those populations are subject to trophy hunting. Camera-trapping and spoor counts can provide reliable population estimates for many carnivores, but governments typically lack the resources to implement such surveys over the spatial scales required to inform robust quota setting. It may therefore be prudent to shift focus away from estimating population size and instead focus on monitoring population trend. In this paper we assess the susceptibility of African leopards Panthera pardus to trophy hunting. This has management ramifications, particularly if the use of harvest composition is to be explored as a metric of population trend. We explore the susceptibility of different leopard age and sex cohorts to trophy hunting; first by examining their intrinsic susceptibility to encountering trophy hunters using camera-traps as surrogates, and second by assessing their extrinsic susceptibility using photographic questionnaire surveys to determine their attractiveness to hunters. We show that adult male and female leopards share similar incident rates to encountering hunters but adult males are the most susceptible to hunting due to hunter preference for large trophies. In contrast, sub-adult leopards rarely encounter hunters and are the least attractive trophies. We suggest that our findings be used as a foundation for the exploration of a harvest composition scheme in the Kwazulu-Natal and Limpopo provinces where post mortem information is collected from hunted leopards and submitted to the local provincial authorities.	[Braczkowski, Alex Richard; Dickman, Amy; Macdonald, David Whyte; Johnson, Paul] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford, England; [Braczkowski, Alex Richard; Balme, Guy Andrew; Fattebert, Julien; Dickerson, Tristan; Hunter, Luke] Panthera, New York, NY USA; [Balme, Guy Andrew] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Dickman, Amy] Ruaha Carnivore Project, Iringa, Tanzania; [Fattebert, Julien; Hunter, Luke] Univ Kwazulu Natal, Sch Life Sci, Durban, South Africa	University of Oxford; University of Cape Town; University of Kwazulu Natal	Braczkowski, AR (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Oxford, England.	alexander.braczkowski@gmail.com	Fattebert, Julien/I-8126-2019; Hunter, Luke T.B./H-3324-2019	Fattebert, Julien/0000-0001-5510-6804; Hunter, Luke T.B./0000-0001-9653-6544; Braczkowski, Alexander/0000-0002-0099-7803	Panthera Foundation; Albert and Didi Hartog and the Timbo-Stitching Foundation	Panthera Foundation; Albert and Didi Hartog and the Timbo-Stitching Foundation	This research was funded by the Panthera Foundation, Albert and Didi Hartog and the Timbo-Stitching Foundation. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2005, WILDLIFE SOC B, V33, P179, DOI 10.2193/0091-7648(2005)33[179:EEOPTA]2.0.CO;2; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme GA, 2010, BIOL CONSERVATION WI; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2014, CONSERV LETT, V7, P3, DOI 10.1111/conl.12028; Balme GA, 2013, ANIM BEHAV, V86, P791, DOI 10.1016/j.anbehav.2013.07.019; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Barnhurst D, 1986, THESIS UTAH STATE U; Beecham J., 1980, Bear Biology Association Conference Series, P201; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Booth VR, 2009, COMP PRICES HUNTING; Braczkowski AR, PLOS ONE; Bunnefeld N, 2009, J ANIM ECOL, V78, P485, DOI 10.1111/j.1365-2656.2008.01500.x; Clark T.W., 2005, COEXISTING LARGE CAR; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Crosmary WG, 2013, ANIM CONSERV, V16, P648, DOI 10.1111/acv.12043; Daly B, 2005, P WORKSH CONS BREED; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Dutta T, 2012, CONSERV GENET RESOUR, V4, P665, DOI 10.1007/s12686-012-9618-5; Fattebert J, 2013, THESIS U KWAZULU NAT; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Grant TL, 2012, THESIS RHODES U GRAH; Hunter L., 2018, FIELD GUIDE CARNIVOR; Leader-Williams N, 2001, SCIENCE, V293, P2203; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; LITVAITIS JA, 1994, WILDLIFE SOC B, V22, P604; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Maputla NW, 2013, AFR J ECOL, V51, P422, DOI 10.1111/aje.12047; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Martin RB, 1988, SRUVEY STATUS LEOPAR; Martins Q, 2013, AFR J ECOL, V51, P571, DOI 10.1111/aje.12068; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; MITHTHAPALA S, 1989, J ZOOL, V218, P527, DOI 10.1111/j.1469-7998.1989.tb04996.x; Mizutani F, 1998, J ZOOL, V244, P269, DOI 10.1111/j.1469-7998.1998.tb00031.x; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; Noyce KV, 2001, URSUS-SERIES, V12, P211; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; R Core Team, 2018, R LANG ENV STAT COMP; Spong Goran, 2000, Conservation Genetics, V1, P169, DOI 10.1023/A:1026543308136; SUNQUIST ME, 1983, J MAMMAL, V64, P337, DOI 10.2307/1380574; Venables WN., 2002, MODERN APPL STAT S 4; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; [No title captured]	48	9	9	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123100	10.1371/journal.pone.0123100	http://dx.doi.org/10.1371/journal.pone.0123100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860139	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300077
J	Campbell, CL; Torres-Perez, F; Acuna-Retamar, M; Schountz, T				Campbell, Corey L.; Torres-Perez, Fernando; Acuna-Retamar, Mariana; Schountz, Tony			Transcriptome Markers of Viral Persistence in Naturally-Infected Andes Virus (Bunyaviridae) Seropositive Long-Tailed Pygmy Rice Rats	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HANTAVIRUS PULMONARY SYNDROME; SIN NOMBRE HANTAVIRUS; RETINOID-X-RECEPTOR; CD4 T-CELLS; GENE-EXPRESSION; SEOUL-VIRUS; RIG-I; INTERFERON; RESPONSES	Long-tailed pygmy rice rats (Oligoryzomys longicaudatus) are principal reservoir hosts of Andes virus (ANDV) (Bunyaviridae), which causes most hantavirus cardiopulmonary syndrome cases in the Americas. To develop tools for the study of the ANDV-host interactions, we used RNA-Seq to generate a de novo transcriptome assembly. Splenic RNA from five rice rats captured in Chile, three of which were ANDV-infected, was used to generate an assembly of 66,173 annotated transcripts, including noncoding RNAs. Phylogenetic analysis of selected predicted proteins showed similarities to those of the North American deer mouse (Peromyscus maniculatus), the principal reservoir of Sin Nombre virus (SNV). One of the infected rice rats had about 50-fold more viral burden than the others, suggesting acute infection, whereas the remaining two had levels consistent with persistence. Differential expression analysis revealed distinct signatures among the infected rodents. The differences could be due to 1) variations in viral load, 2) dimorphic or reproductive differences in splenic homing of immune cells, or 3) factors of unknown etiology. In the two persistently infected rice rats, suppression of the JAK-STAT pathway at Stat5b and Ccnot1, elevation of Casp1, RIG-I pathway factors Ppp1cc and Mff, and increased FC receptor-like transcripts occurred. Caspase-1 and Stat5b activation pathways have been shown to stimulate T helper follicular cell (TFH) development in other species. These data are also consistent with reports suggestive of TFH stimulation in deer mice experimentally infected with hantaviruses. In the remaining acutely infected rice rat, the apoptotic pathway marker Cox6a1 was elevated, and putative anti-viral factors Abcb1a, Fam46c, Spp1, Rxra, Rxrb, Trmp2 and Trim58 were modulated. Transcripts for preproenkephalin (Prenk) were reduced, which may be predictive of an increased T cell activation threshold. Taken together, this transcriptome dataset will permit rigorous examination of rice rat-ANDV interactions and may lead to better understanding of virus ecology.	[Campbell, Corey L.; Schountz, Tony] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Torres-Perez, Fernando] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile; [Acuna-Retamar, Mariana] Univ Chile, Fac Vet & Pecuarias, Santiago, Chile	Colorado State University; Pontificia Universidad Catolica de Valparaiso; Universidad de Chile	Campbell, CL (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.	corey.campbell@colostate.edu	Schountz, Tony/I-2161-2017; Torres-Perez, Fernando/B-5002-2008	Torres-Perez, Fernando/0000-0001-8655-7288; Campbell, Corey L./0000-0002-6384-1259	FONDECYT [1110664]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5U19AI045452]; NIH [2U01A1045452]; USA NIH [AI054461]; Department of Microbiology, Immunology and Pathology, CSU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI054461, U19AI045452] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology, Immunology and Pathology, CSU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by FONDECYT 1110664, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, grant 5U19AI045452, and NIH 2U01A1045452 (FTP), and USA NIH grant AI054461 and startup funds provided by the Department of Microbiology, Immunology and Pathology, CSU (TS).	Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cautivo K, 2014, VIRUSES-BASEL, V6, P2028, DOI 10.3390/v6052028; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui HC, 2014, EUR J IMMUNOL, V44, P2085, DOI 10.1002/eji.201344126; De Leon-Nava MA, 2009, J STEROID BIOCHEM, V113, P57, DOI 10.1016/j.jsbmb.2008.11.003; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gronholm J, 2012, FASEB J, V26, P1239, DOI 10.1096/fj.11-195875; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hammerbeck CD, 2011, J VIROL, V85, P9929, DOI 10.1128/JVI.05356-11; Hannah MF, 2008, BRAIN BEHAV IMMUN, V22, P503, DOI 10.1016/j.bbi.2007.10.005; He S, 2013, BLOOD, V121, P4663, DOI 10.1182/blood-2012-07-441360; Heward JA, 2014, TRENDS IMMUNOL; Hjelle B, 2010, VIRUSES-BASEL, V2, P2559, DOI 10.3390/v2122559; Hook S, 2003, J NEUROIMMUNOL, V140, P61, DOI 10.1016/S0165-5728(03)00168-1; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Huang YP, 2005, WORLD J GASTROENTERO, V11, P5659, DOI 10.3748/wjg.v11.i36.5659; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Ivanova LB, 2014, ENVIRON MICROBIOL, V16, P1069, DOI 10.1111/1462-2920.12310; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kariwa H, 1996, ARCH VIROL, V141, P2327, DOI 10.1007/BF01718634; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Li AM, 2013, INT J BIOCHEM CELL B, V45, P858, DOI 10.1016/j.biocel.2013.01.008; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Medina RA, 2009, J VIROL, V83, P2446, DOI 10.1128/JVI.01057-08; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Mills JN, 2008, INFECT DIS WILD MAMM, P254; Mo R, 2005, J IMMUNOL, V174, P6023, DOI 10.4049/jimmunol.174.10.6023; Montoya-Ruiz C, 2014, VIRUSES-BASEL, V6, P1274, DOI 10.3390/v6031274; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Prescott J, 2013, IMMUNOLOGY, V140, P168, DOI 10.1111/imm.12116; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rosa EST, 2005, VECTOR-BORNE ZOONOT, V5, P11, DOI 10.1089/vbz.2005.5.11; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Samrat SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086567; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2014, J VIROL, V88, P8319, DOI 10.1128/JVI.00004-14; Schountz T, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-18; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Spiropoulou CF, 2013, VIRULENCE, V4, P525, DOI 10.4161/viru.25569; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Torres-Perez F, 2004, AM J TROP MED HYG, V70, P305, DOI 10.4269/ajtmh.2004.70.305; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; Wang K, 2012, BRAZ J MED BIOL RES, V45, P1112, DOI 10.1590/S0100-879X2012007500130; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu XH, 2013, INFLAMM RES, V62, P929, DOI 10.1007/s00011-013-0631-2; Xu DM, 2004, IMMUNOL CELL BIOL, V82, P462, DOI 10.1111/j.0818-9641.2004.01274.x; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yilmaz G, 2011, J CLIN VIROL, V50, P209, DOI 10.1016/j.jcv.2010.11.014; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	84	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122935	10.1371/journal.pone.0122935	http://dx.doi.org/10.1371/journal.pone.0122935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856432	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500067
J	Jacquez, GM; Shi, C; Meliker, JR				Jacquez, Geoffrey M.; Shi, Chen; Meliker, Jaymie R.			Local Bladder Cancer Clusters in Southeastern Michigan Accounting for Risk Factors, Covariates and Residential Mobility	PLOS ONE			English	Article							BONFERRONI PROCEDURE; LIFETIME EXPOSURE; DRINKING-WATER; MULTIPLE TESTS; BREAST-CANCER; DISEASE; ERROR	Background In case control studies disease risk not explained by the significant risk factors is the unexplained risk. Considering unexplained risk for specific populations, places and times can reveal the signature of unidentified risk factors and risk factors not fully accounted for in the case-control study. This potentially can lead to new hypotheses regarding disease causation. Methods Global, local and focused Q-statistics are applied to data from a population-based case-control study of 11 southeast Michigan counties. Analyses were conducted using both year- and age-based measures of time. The analyses were adjusted for arsenic exposure, education, smoking, family history of bladder cancer, occupational exposure to bladder cancer carcinogens, age, gender, and race. Results Significant global clustering of cases was not found. Such a finding would indicate large-scale clustering of cases relative to controls through time. However, highly significant local clusters were found in Ingham County near Lansing, in Oakland County, and in the City of Jackson, Michigan. The Jackson City cluster was observed in working-ages and is thus consistent with occupational causes. The Ingham County cluster persists over time, suggesting a broad-based geographically defined exposure. Focused clusters were found for 20 industrial sites engaged in manufacturing activities associated with known or suspected bladder cancer carcinogens. Set-based tests that adjusted for multiple testing were not significant, although local clusters persisted through time and temporal trends in probability of local tests were observed. Conclusion Q analyses provide a powerful tool for unpacking unexplained disease risk from case-control studies. This is particularly useful when the effect of risk factors varies spatially, through time, or through both space and time. For bladder cancer in Michigan, the next step is to investigate causal hypotheses that may explain the excess bladder cancer risk localized to areas of Oakland and Ingham counties, and to the City of Jackson.	[Jacquez, Geoffrey M.; Shi, Chen] SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA; [Jacquez, Geoffrey M.] BioMedware Inc, Ann Arbor, MI USA; [Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Grad Program Publ Hlth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jacquez, GM (corresponding author), SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA.	geoff.jacquez@gmail.com		Meliker, Jaymie/0000-0002-6408-8596	National Cancer Institute [R44CA117171, R44CA135818]; NATIONAL CANCER INSTITUTE [R44CA117171, R44CA135818] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the National Cancer Institute R44CA117171 and R44CA135818. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, TOX REL INV TRI DAT; BioMedware, 2013, SPAC V 3 6, V3. 6; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; CUZICK J, 1990, J ROY STAT SOC B MET, V52, P73; Goldberg D W, 2007, URISA J, V19, P33, DOI DOI 10.1079/9781780640891.0051; Goldberg DW, 2012, SPAT SPATIO-TEMPORAL, V3, P1, DOI 10.1016/j.sste.2012.02.001; Goovaerts P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-32; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; IARC, 2012, IARC MON EV CARC R C, V100C, P41; Jacquez Geoffrey M, 2005, Environ Health, V4, P4, DOI 10.1186/1476-069X-4-4; Jacquez GM, 2014, INT J ENV RES PUB HE, V11, P271, DOI 10.3390/ijerph110100271; Jacquez GM, 2012, SPAT SPATIO-TEMPORAL, V3, P7, DOI 10.1016/j.sste.2012.02.002; Jacquez GM, 2009, SAGE HDB SPATIAL ANA, P355; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2004, SATSCAN V4 0 SOFTWAR; Lawson AB, 1989, SCORE TESTS DETECTIO; Meliker JR, 2008, ENVIRON RES, V106, P42, DOI 10.1016/j.envres.2007.09.001; Meliker JR, 2007, INT ARCH OCC ENV HEA, V80, P184, DOI 10.1007/s00420-006-0119-2; Meliker JR, 2010, ANN EPIDEMIOL, V20, P750, DOI 10.1016/j.annepidem.2010.06.012; Meliker JR, 2010, CANCER CAUSE CONTROL, V21, P745, DOI 10.1007/s10552-010-9503-z; Meliker JR, 2009, CANCER CAUSE CONTROL, V20, P1061, DOI 10.1007/s10552-009-9312-4; Nordsborg RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060800; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Patil GP, 2006, ENVIRON ECOL STAT, V13, P365, DOI 10.1007/s10651-006-0017-5; Schmiedel S, 2011, CANCER CAUSE CONTROL, V22, P849, DOI 10.1007/s10552-011-9755-2; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sloan CD, 2013, PLOS ONE IN PRESS; Sloan CD, 2012, SPAT SPATIO-TEMPORAL, V3, P297, DOI 10.1016/j.sste.2012.09.002; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; WALLER LA, 1995, STAT MED, V14, P3, DOI 10.1002/sim.4780140103; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124516	10.1371/journal.pone.0124516	http://dx.doi.org/10.1371/journal.pone.0124516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856581	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500117
J	Jodal, A; Pape, F; Becker-Pauly, C; Maas, O; Schibli, R; Behe, M				Jodal, Andreas; Pape, Fabienne; Becker-Pauly, Christoph; Maas, Ole; Schibli, Roger; Behe, Martin			Evaluation of In-111-Labelled Exendin-4 Derivatives Containing Different Meprin beta-Specific Cleavable Linkers	PLOS ONE			English	Article							GLP-1 RECEPTOR; ALPHA-SUBUNIT; SUBSTRATE; LINKAGES	Background Cleavable linkers, which are specifically cleaved by defined conditions or enzymes, are powerful tools that can be used for various purposes. Amongst other things, they have been successfully used to deliver toxic payloads as prodrugs into target tissues. In this work novel linker sequences targeting meprin beta, a metalloprotease expressed in the kidney brush-border membrane, were designed and included in the sequence of three radiolabelled exendin-4 derivatives. As radiolabelled exendin-4 derivatives strongly accumulate in the kidneys, we hypothesised that specific cleavage of the radiolabelled moiety at the kidney brush-border membrane would allow easier excretion of the activity into the urine and therefore improve the pharmacological properties of the peptide. Results The insertion of a cleavable linker did not negatively influence the in vitro properties of the peptides. They showed a good affinity to the GLP-1 receptor expressed in CHL cells, a high internalisation and sufficiently high stability in fresh human blood plasma. In vitro digestion with recombinant meprin beta rapidly metabolised the corresponding linker sequences. After 60 min the majority of the corresponding peptides were digested and at the same time the anticipated fragments were formed. The peptides were also quickly metabolised in CD1 nu/nu mouse kidney homogenates. Immunofluorescence staining of meprin beta in kidney sections confirmed the expression of the protease in the kidney brush-border membrane. Biodistribution in GLP-1 receptor positive tumour-xenograft bearing mice revealed high specific uptake of the In-111-labelled tracers in receptor positive tissue. Accumulation in the kidneys, however, was still high and comparable to the lead compound In-111-Ex4NOD40. Conclusion In conclusion, we show that the concept of cleavable linkers specific for meprin beta is feasible, as the peptides are rapidly cleaved by the enzyme while retaining their biological properties.	[Jodal, Andreas; Pape, Fabienne; Schibli, Roger; Behe, Martin] Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI USZ, Villigen, Switzerland; [Pape, Fabienne; Schibli, Roger] ETH, Dept Chem & Appl Biosci, Zurich, Switzerland; [Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Kiel, Germany; [Maas, Ole] Univ Basel Hosp, Div Nucl Med, Dept Radiol & Nucl Med, CH-4031 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kiel; University of Basel	Behe, M (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI USZ, Villigen, Switzerland.	martin.behe@psi.ch	Becker-Pauly, Christoph/B-7569-2011	Schibli, Roger/0000-0002-1537-3833	Seventh Framework Programme [222980, 602812]; Juvenile Diabetes Research Foundation International [37-2012-4]; Deutsche Forschungsgemeinschaft [SFB 877/2];  [A9]	Seventh Framework Programme(European Commission); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the following sources of funding: Seventh Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm) grant numbers 222980 and 602812; Juvenile Diabetes Research Foundation International (http://jdrf.org/) grant number 37-2012-4; and Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) grant number SFB 877/2 2014; Projekt A9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa H, 2013, BIOCONJUGATE CHEM, V24, P291, DOI 10.1021/bc300428b; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; Bodei L, 2008, EUR J NUCL MED MOL I, V35, P1847, DOI 10.1007/s00259-008-0778-1; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Brom M, 2014, DIABETOLOGIA, V57, P950, DOI 10.1007/s00125-014-3166-3; Brom M, 2012, CONTRAST MEDIA MOL I, V7, P160, DOI 10.1002/cmmi.475; Chen YJ, 2014, BIOMATERIALS, V35, P304, DOI 10.1016/j.biomaterials.2013.09.100; Christ E, 2013, LANCET DIABETES ENDO, V1, P115, DOI 10.1016/S2213-8587(13)70049-4; Fujioka Y, 2005, BIOCONJUGATE CHEM, V16, P1610, DOI 10.1021/bc050211z; Gotthardt M, 2007, J NUCL MED, V48, P596, DOI 10.2967/jnumed.106.036020; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jodal A, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0031-9; Leriche G, 2012, BIOORGAN MED CHEM, V20, P571, DOI 10.1016/j.bmc.2011.07.048; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; Pattou F, 2010, NEW ENGL J MED, V363, P1289, DOI 10.1056/NEJMc1004547; Sloniec J, 2013, J PHYS CHEM B, V117, P14336, DOI 10.1021/jp409388b; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Trejtnar F, 2002, Q J NUCL MED, V46, P181; Uehara T, 2014, BIOCONJUGATE CHEM, V25, P2038, DOI 10.1021/bc5004058; VANEYLL B, 1994, FEBS LETT, V348, P7, DOI 10.1016/0014-5793(94)00553-2; Vegt E, 2011, EUR J NUCL MED MOL I, V38, P623, DOI 10.1007/s00259-010-1685-9; Wessels BW, 2008, J NUCL MED, V49, P1884, DOI 10.2967/jnumed.108.053173; Wild D, 2006, J NUCL MED, V47, P2025; Yim CB, 2013, NUCL MED BIOL, V40, P1006, DOI 10.1016/j.nucmedbio.2013.06.012; Zhang W, 2011, BIOORG MED CHEM LETT, V21, P1452, DOI 10.1016/j.bmcl.2011.01.013	32	16	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123443	10.1371/journal.pone.0123443	http://dx.doi.org/10.1371/journal.pone.0123443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855967	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500090
J	Luo, BL; Chen, XY; Ding, LQ; Huang, YH; Zhou, J; Yang, TT				Luo, Bang-lin; Chen, Xiao-yan; Ding, Lin-qiao; Huang, Yu-han; Zhou, Ji; Yang, Tian-tian			Response Characteristics of Soil Fractal Features to Different Land Uses in Typical Purple Soil Watershed	PLOS ONE			English	Article							PARTICLE-SIZE DISTRIBUTIONS; MULTIFRACTAL CHARACTERIZATION; LASER DIFFRACTION; CHINA; FRAGMENTATION; MODEL; BASIN	As a fundamental characteristic of soil physical properties, the soil Particle Size Distribution (PSD) is important in the research on soil moisture migration, solution transformation, and soil erosion. In this research, the PSD characteristics with distinct methods in different land uses are analyzed. The results show that the upper bound of the volume domain of the clay domain ranges from 5.743 mu m to 5.749 mu m for all land-use types. For the silt domain of purple soil, the value ranges among 286.852 similar to 286.966 mu m. For all purple soil land-use types, the order of the volume domain fractal dimensions is D-clay<D-silt<D-sand. However, the values of D-silt and D-sand in the Pinus massoniana Lamb, Robinia pseudoacacia L and Ipomoea batatas are all higher than the corresponding values in the Citrus reticulate Blanco and Setaria viridis. Moreover, in all the land-use types, all of the parameters in volume domain fractal dimension (D-vi) are higher than the corresponding parameter values from the United States Department of Agriculture (D-vi(U)). The correlation study between the volume domain fractal dimension and the soil properties shows that the intensity of correlation to the soil texture and soil organic matter has the order as: D-silt>D-silt(U)>D-sand(U)>D-sand and D-silt>D-silt(U)>D-sand>D-sand(U), respectively. As it is compared with all D-vi, the D-silt has the most significant correlativity to the soil texture and organic matter in different land uses of the typical purple soil watersheds. Therefore, D-silt will be a potential indictor for evaluating the proportion of fine particles in the PSD, as well as a key measurement in soil quality and productivity studies.	[Luo, Bang-lin; Chen, Xiao-yan; Ding, Lin-qiao; Huang, Yu-han] Southwest Univ, Minist Educ, Coll Resources & Environm, Key Lab Ecoenvironm Three Gorges Reg, Chongqing, Peoples R China; [Zhou, Ji] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Yang, Tian-tian] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA USA	Southwest University - China; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of California System; University of California Irvine	Chen, XY (corresponding author), Southwest Univ, Minist Educ, Coll Resources & Environm, Key Lab Ecoenvironm Three Gorges Reg, Chongqing, Peoples R China.	c400716@126.com	Yang, Tiantian/P-5989-2016; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022	Yang, Tiantian/0000-0002-0148-396X; 	Fundamental Research Funds for the Central Universities [XDJK2011C013]; National Technology Support Program [2011BAD31B03]; Construction Funds for Ecology Key Disciplines for Project 211 Southwest University, National Key Basic Special Foundation Project of China [2010CB95160402]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Technology Support Program; Construction Funds for Ecology Key Disciplines for Project 211 Southwest University, National Key Basic Special Foundation Project of China	This work was funded by Fundamental Research Funds for the Central Universities (XDJK2011C013); National Technology Support Program(2011BAD31B03); Construction Funds for Ecology Key Disciplines for Project 211 Southwest University, National Key Basic Special Foundation Project of China (2010CB95160402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya LM, 2010, SOIL SCI SOC AM J, V74, P33, DOI 10.2136/sssaj2009.0022; Bittelli M, 1999, SOIL SCI SOC AM J, V63, P782, DOI 10.2136/sssaj1999.634782x; Caniego FJ, 2005, ECOL MODEL, V182, P291, DOI 10.1016/j.ecolmodel.2004.04.014; [程先富 Cheng Xianfu], 2003, [地理科学, Scientia Geographica Sinica], V23, P617; Dane JH, 2002, SOIL SCI SOC AM 4; Dumanski J, 2000, AGR ECOSYST ENVIRON, V81, P93, DOI 10.1016/S0167-8809(00)00183-3; Falconer K., 2014, FRACTAL GEOMETRY MAT; Huang GH, 2005, GEODERMA, V127, P52, DOI 10.1016/j.geoderma.2004.11.016; Huang GuanHua, 2002, Acta Pedologica Sinica, V39, P490; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; MANDELBORT B. B., 1982, FRACTAL GEOMETRY NAT, P45; Mandelort BB, 1977, FRACTALS FORM CHANCE; Martin MA, 2002, SOIL TILL RES, V64, P113, DOI 10.1016/S0167-1987(01)00249-5; Miao CY, 2011, GLOBAL PLANET CHANGE, V76, P196, DOI 10.1016/j.gloplacha.2011.01.008; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; PERFECT E, 1993, SOIL SCI SOC AM J, V57, P896, DOI 10.2136/sssaj1993.03615995005700040003x; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Posadas AND, 2001, SOIL SCI SOC AM J, V65, P1361, DOI 10.2136/sssaj2001.6551361x; Prosperini N, 2008, GEODERMA, V145, P185, DOI 10.1016/j.geoderma.2008.03.004; RIEU M, 1991, SOIL SCI SOC AM J, V55, P1231, DOI 10.2136/sssaj1991.03615995005500050006x; Scott WT, 1989, SOIL SCI SOC AM J, V53, P987; Scott WT, 1992, SOIL SCI SOC AM J, V56, P362; Segal E, 2009, SOIL SCI, V174, P639, DOI 10.1097/SS.0b013e3181c2a928; Su YZ, 2004, SOIL TILL RES, V75, P27, DOI 10.1016/S0167-1987(03)00157-0; Sun QH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/015001; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; [王德 WANG De], 2007, [生态学报, Acta Ecologica Sinica], V27, P3081; Wang GL, 2005, ACTA PEDOLOGICA SINI, V42, P546; WU Q, 1993, SOIL SCI SOC AM J, V57, P883, DOI 10.2136/sssaj1993.03615995005700040001x; Yang JingLing, 2008, Acta Pedologica Sinica, V45, P413; Yang P.L, 1993, CHINESE SCI BULL, V38, P1896, DOI DOI 10.1360/csb1993-38-20-1896; [张金池 ZHANG JinChi], 2008, [生态学报, Acta Ecologica Sinica], V28, P2199; Zhang Z, 2008, PARTICUOLOGY, V6, P157, DOI 10.1016/j.partic.2008.03.001; Zhao WenZhi, 2002, Acta Pedologica Sinica, V39, P877	34	5	6	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122842	10.1371/journal.pone.0122842	http://dx.doi.org/10.1371/journal.pone.0122842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856376	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500059
J	Shi, D; Dai, C; Qin, J; Gu, W				Shi, D.; Dai, C.; Qin, J.; Gu, W.			Negative regulation of the p300-p53 interplay by DDX24	ONCOGENE			English	Article							BOX RNA HELICASES; IN-VITRO; KAPPA-B; TRANSCRIPTIONAL REGULATION; P53 RESPONSE; ACETYLATION; CANCER; MUTATIONS; CELLS; ACTIVATION	Numerous studies indicate that p300 acts as a key transcriptional cofactor in vivo, at least, in part, by modulating activities of p53 by acetylation. Nevertheless, the regulation of the p53-p300 interplay is not completely understood. Here, we have identified the DEAD (Asp-Glu-Ala-Asp) box RNA helicase 24 (DDX24) as a novel regulator of the p300-p53 axis. We found that DDX24 interacts with p300, and this interaction leads to suppression of p300-mediated acetylation of p53. Notably, RNA interference-mediated knockdown of endogenous DDX24 significantly increases the acetylation levels of endogenous p53 in human cancer cells and subsequently promotes p53-mediated activation of its transcriptional targets such as p21 and p53 upregulated modulator of apoptosis (PUMA). In contrast, DDX24 expression inhibits the p300-p53 interaction and suppresses p300-mediated acetylation of p53. Moreover, DDX24 is overexpressed in human cancer cells and reduction of DDX24 protein levels by RNA interference induces cell cycle arrest and senescence in a p53-dependent manner. These results reveal DDX24 as an important regulator of p300 and suggest that the modulation of the p53-p300 interplay by DDX24 is critical in controlling p53 activities in human cancer cells.	[Shi, D.; Dai, C.; Gu, W.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY USA; [Qin, J.] Baylor Coll Med, Dept Biochem, One Baylor Plaza, Houston, TX 77030 USA; [Qin, J.] Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA	Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, ICRC BLDG 609A,1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			National Cancer Institute of the National Institutes of Health [5RO1 CA172023, 5RO1 CA166294, 5RO1CA085533, 2P01CA080058]; NIH cancer biology training grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [R01CA085533, P01CA080058, R01CA166294, R01CA172023, R01CA169246] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH cancer biology training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health under Award 5RO1 CA172023, 5RO1 CA166294, 5RO1CA085533 and 2P01CA080058 to WG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. D Shi is also supported by NIH cancer biology training grant T32-CA09503. We especially thank Dr Ruping Sun for his help with the analysis of TCGA database.	Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fukawa T, 2012, CANCER RES, V72, P5867, DOI 10.1158/0008-5472.CAN-12-1645; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2013, RNA BIOL, V10, P121, DOI 10.4161/rna.23312; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gustafson EA, 2010, BIOCHEM BIOPH RES CO, V395, P1, DOI 10.1016/j.bbrc.2010.02.172; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Ma Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003721; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nakagawa Y, 1999, BRIT J CANCER, V80, P914, DOI 10.1038/sj.bjc.6690441; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Payne EM, 2011, BLOOD, V118, P903, DOI 10.1182/blood-2010-11-318022; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thomasova D, 2012, NEOPLASIA, V14, P1097, DOI 10.1593/neo.121534; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Yamauchi T, 2014, MOL CELL BIOL, V34, P3321, DOI 10.1128/MCB.00320-14; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhao Hong, 2013, Methods Mol Biol, V965, P83, DOI 10.1007/978-1-62703-239-1_5; Zhao Y, 2000, GENOMICS, V67, P351, DOI 10.1006/geno.2000.6255; Zhu YH, 2012, PROG MOL BIOL TRANSL, V106, P307, DOI 10.1016/B978-0-12-396456-4.00001-8	47	22	23	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					528	536		10.1038/onc.2015.77	http://dx.doi.org/10.1038/onc.2015.77			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25867071	Green Accepted			2022-12-26	WOS:000369056700012
J	Shields-Cutler, RR; Crowley, JR; Hung, CS; Stapleton, AE; Aldrich, CC; Marschall, J; Henderson, JP				Shields-Cutler, Robin R.; Crowley, Jan R.; Hung, Chia S.; Stapleton, Ann E.; Aldrich, Courtney C.; Marschall, Jonas; Henderson, Jeffrey P.			Human Urinary Composition Controls Antibacterial Activity of Siderocalin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); host-pathogen interaction; infectious disease; iron; metabolomics; siderophore; NGAL; lipocalin 2; siderocalin; urinary tract infection	ESCHERICHIA-COLI; QUANTITATIVE-ANALYSIS; IRON ACQUISITION; METABOLIC-FATE; SIDEROPHORE; YERSINIABACTIN; ENTEROBACTIN; IDENTIFICATION; EVASION; CELLS	Background: During urinary tract infections, humans secrete the protein siderocalin to block bacterial iron uptake. Results: Human urinary pH and metabolite composition strongly affect siderocalin's antibacterial activity. Conclusion: Siderocalin uses a subset of urinary metabolites as cofactors to withhold iron from E. coli in competition with the bacterial siderophore enterobactin. Significance: Therapeutic control of urinary composition may facilitate an important innate antibacterial defense. During Escherichia coli urinary tract infections, cells in the human urinary tract release the antimicrobial protein siderocalin (SCN; also known as lipocalin 2, neutrophil gelatinase-associated lipocalin/NGAL, or 24p3). SCN can interfere with E. coli iron acquisition by sequestering ferric iron complexes with enterobactin, the conserved E. coli siderophore. Here, we find that human urinary constituents can reverse this relationship, instead making enterobactin critical for overcoming SCN-mediated growth restriction. Urinary control of SCN activity exhibits wide ranging individual differences. We used these differences to identify elevated urinary pH and aryl metabolites as key biochemical host factors controlling urinary SCN activity. These aryl metabolites are well known products of intestinal microbial metabolism. Together, these results identify an innate antibacterial immune interaction that is critically dependent upon individualistic chemical features of human urine.	[Shields-Cutler, Robin R.; Hung, Chia S.; Marschall, Jonas; Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, Dept Med, St Louis, MO 63110 USA; [Shields-Cutler, Robin R.; Hung, Chia S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Crowley, Jan R.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Stapleton, Ann E.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Aldrich, Courtney C.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Marschall, Jonas] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Marschall, Jonas] Univ Bern, CH-3010 Bern, Switzerland	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Bern; University Hospital of Bern; University of Bern	Henderson, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, 660 S Euclid Ave, St Louis, MO 63110 USA.	jhenderson@DOM.wustl.edu	Hung, Chia-Suei/G-6167-2010; Henderson, Jeffrey P/D-3337-2015; Marschall, Jonas/AAF-6425-2019; Regan, Clinton/E-6250-2012; Stapleton, Ann E/N-2428-2015	Marschall, Jonas/0000-0002-0052-3210; Stapleton, Ann E/0000-0003-0130-8659; Hung, Chia-Suei/0000-0001-9844-9954	National Institutes of Health from NIDDK [R01DK099534, P50DK064540]; National Center for Advancing Translational Sciences [UL1TR000448]; Longer Life Foundation; United States Public Health Service [P41RR000954, P30DK020579, P30HL101263, P30DK056341]; National Institutes of Health [T32GM007067-37, AI070219, U54CK000162, K12HD001459]; Monsanto Excellence Fund Graduate Fellowship; Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program; Career Award for Medical Scientists from the Burroughs Welcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P50DK064540, R01DK099534, P30DK056341, R01DK088830] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Longer Life Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monsanto Excellence Fund Graduate Fellowship; Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program; Career Award for Medical Scientists from the Burroughs Welcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK099534 and P50DK064540 from NIDDK. This work was also supported by National Center for Advancing Translational Sciences Grant UL1TR000448 and the Longer Life Foundation. Mass spectrometry was supported by United States Public Health Service Grants P41RR000954, P30DK020579, P30HL101263 and P30DK056341.; Supported by National Institutes of Health Grant T32GM007067-37 and a Monsanto Excellence Fund Graduate Fellowship.; Supported by National Institutes of Health Grant AI070219.; Supported by National Institutes of Health Grants U54CK000162 and K12HD001459 and the Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program.; Recipient of a Career Award for Medical Scientists from the Burroughs Welcome Fund. To whom correspondence should be addressed: Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-747-0240; Fax: 314-454-8294; E-mail: jhenderson@DOM.wustl.edu.	Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Bachman MA, 2012, MBIO, V3, DOI 10.1128/mBio.00224-11; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; BOOTH AN, 1959, J BIOL CHEM, V234, P3014; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; BROCK JH, 1991, INFECT IMMUN, V59, P3185, DOI 10.1128/IAI.59.9.3185-3190.1991; CARMELLA SG, 1982, FOOD CHEM TOXICOL, V20, P587, DOI 10.1016/S0278-6915(82)80068-9; Chaturvedi KS, 2014, ACS CHEM BIOL, V9, P551, DOI 10.1021/cb400658k; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gonthier MP, 2003, J NUTR, V133, P461, DOI 10.1093/jn/133.2.461; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hoette TM, 2011, ACS CHEM BIOL, V6, P1327, DOI 10.1021/cb200331g; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hung C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086009; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Lang R, 2006, J AGR FOOD CHEM, V54, P5755, DOI 10.1021/jf061118n; Luo MK, 2006, ACS CHEM BIOL, V1, P29, DOI 10.1021/cb0500034; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Lv HT, 2011, ANALYST, V136, P4752, DOI 10.1039/c1an15590c; Marschall J, 2012, CLIN INFECT DIS, V54, P1692, DOI 10.1093/cid/cis252; MATZANKE BF, 1986, J BACTERIOL, V167, P674, DOI 10.1128/jb.167.2.674-680.1986; Miethke M, 2006, FEBS J, V273, P409, DOI 10.1111/j.1742-4658.2005.05077.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Perez-Jimenez J, 2010, AM J CLIN NUTR, V92, P801, DOI 10.3945/ajcn.2010.29924; Perry RD, 1999, MICROBIOL-UK, V145, P1181, DOI 10.1099/13500872-145-5-1181; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Sieniawska CE, 2012, ANN CLIN BIOCHEM, V49, P341, DOI 10.1258/acb.2011.011179; Sikora AL, 2010, BIOCHEMISTRY-US, V49, P3648, DOI 10.1021/bi100350c; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Wang JH, 2010, SEMIN NEPHROL, V30, P500, DOI 10.1016/j.semnephrol.2010.07.007; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Yi L, 2006, ANAL BIOANAL CHEM, V386, P666, DOI 10.1007/s00216-006-0495-1	53	38	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15949	15960		10.1074/jbc.M115.645812	http://dx.doi.org/10.1074/jbc.M115.645812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25861985	Green Published, hybrid			2022-12-26	WOS:000356930100005
J	Stolzenberg, S; Quick, M; Zhao, CF; Gotfryd, K; Khelashvili, G; Gether, U; Loland, CJ; Javitch, JA; Noskov, S; Weinstein, H; Shi, L				Stolzenberg, Sebastian; Quick, Matthias; Zhao, Chunfeng; Gotfryd, Kamil; Khelashvili, George; Gether, Ulrik; Loland, Claus J.; Javitch, Jonathan A.; Noskov, Sergei; Weinstein, Harel; Shi, Lei			Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter: Sodium Symporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; ION SELECTIVITY; OCCLUDED STATE; OUTWARD-OPEN; LEUT; SUBSTRATE; PROTEIN; SITE	Neurotransmitter: sodium symporters (NSSs) terminate neurotransmission by Na+-dependent reuptake of released neurotransmitters. Previous studies suggested that Na+-binding reconfigures dynamically coupled structural elements in an allosteric interaction network (AIN) responsible for function-related conformational changes, but the intramolecular pathway of this mechanism has remained uncharted. We describe a new approach for the modeling and analysis of intramolecular dynamics in the bacterial NSS homolog LeuT. From microsecond-scale molecular dynamics simulations and cognate experimental verifications in both LeuT and human dopamine transporter (hDAT), we apply the novel method to identify the composition and the dynamic properties of their conserved AIN. In LeuT, two different perturbations disrupting Na+ binding and transport (i.e. replacing Na+ with Li+ or the Y268A mutation at the intracellular gate) affect the AIN in strikingly similar ways. In contrast, other mutations that affect the intracellular gate (i.e. R5A and D369A) do not significantly impair Na+ cooperativity and transport. Our analysis shows these perturbations to have much lesser effects on the AIN, underscoring the sensitivity of this novel method to the mechanistic nature of the perturbation. Notably, this set of observations holds as well for hDAT, where the aligned Y335A, R60A, and D436A mutations also produce different impacts on Na+ dependence. Thus, the detailed AIN generated from our method is shown to connect Na+ binding with global conformational changes that are critical for the transport mechanism. That the AIN between the Na+ binding sites and the intracellular gate in bacterial LeuT resembles that in eukaryotic hDAT highlights the conservation of allosteric pathways underlying NSS function.	[Stolzenberg, Sebastian; Khelashvili, George; Weinstein, Harel; Shi, Lei] Cornell Univ, Dept Physiol & Biophys, New York, NY 10065 USA; [Weinstein, Harel; Shi, Lei] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Stolzenberg, Sebastian] Cornell Univ, Dept Phys, Ithaca, NY 14850 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Zhao, Chunfeng; Noskov, Sergei] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Zhao, Chunfeng; Noskov, Sergei] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Gotfryd, Kamil; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Shi, Lei] NIDA, Computat Chem & Mol Biophys Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Cornell University; Cornell University; Cornell University; Columbia University; Columbia University; New York State Psychiatry Institute; University of Calgary; University of Calgary; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Weinstein, H (corresponding author), Weill Cornell Med Coll, 1300 York Ave,Box 75, New York, NY 10065 USA.	haw2002@med.cornell.edu; les2007@med.cornell.edu	WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020; Gourdon, Pontus/E-1076-2014; Loland, Claus/E-5975-2014	WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Gourdon, Pontus/0000-0002-8631-3539; Gotfryd, Kamil/0000-0002-0299-0779; Gether, Ulrik/0000-0002-0020-3807; Loland, Claus/0000-0002-1773-1446; Noskov, Sergei/0000-0001-7769-335X; Javitch, Jonathan/0000-0001-7395-2967	United States Department of Energy Office of Science User Facility [DE-AC05-00OR22725]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000606] Funding Source: NIH RePORTER	United States Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank MiEstrella Miller-Cruz and Trang Nguyen for the preparation of bacterial membrane vesicles and the purification of LeuT variants and Lone Rosenquist for technical assistance in the hDAT experiments. Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022); the resources of the Oak Ridge Leadership Computing Facility, which is a United States Department of Energy Office of Science User Facility supported under Contract DE-AC05-00OR22725; the West-Grid/Compute Canada facilities; and the local Tielemann, Noskov, and Kusalik cluster supported by the Canadian Foundation for Innovation.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Khelashvili G, 2015, PROTEINS, V83, P952, DOI 10.1002/prot.24792; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LeVine MV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003603; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Newman AH, 2009, TOP MED CHEM SER, V4, P95, DOI 10.1007/7355_2008_027; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	42	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13992	14003		10.1074/jbc.M114.625343	http://dx.doi.org/10.1074/jbc.M114.625343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869126	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000355313000030
J	Hishiki, A; Hara, K; Ikegaya, Y; Yokoyama, H; Shimizu, T; Sato, M; Hashimoto, H				Hishiki, Asami; Hara, Kodai; Ikegaya, Yuzu; Yokoyama, Hideshi; Shimizu, Toshiyuki; Sato, Mamoru; Hashimoto, Hiroshi			Structure of a Novel DNA-binding Domain of Helicase-like Transcription Factor (HLTF) and Its Functional Implication in DNA Damage Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE REPETITIVE SEQUENCES; UBIQUITIN LIGASE; STRANDED-DNA; HUMAN SHPRH; REPLICATION; REPAIR; PCNA; TRANSLOCASE; INSTABILITY; ZRANB3	HLTF (helicase-like transcription factor) is a yeast RAD5 homolog found in mammals. HLTF has E3 ubiquitin ligase and DNA helicase activities, and plays a pivotal role in the template-switching pathway of DNA damage tolerance. HLTF has an N-terminal domain that has been designated the HIRAN (HIP116 and RAD5 N-terminal) domain. The HIRAN domain has been hypothesized to play a role in DNA binding; however, the structural basis of, and functional evidence for, the HIRAN domain in DNA binding has remained unclear. Here we show for the first time the crystal structure of the HIRAN domain of human HLTF in complex with DNA. The HIRAN domain is composed of six beta-strands and two alpha-helices, forming an OB-fold structure frequently found in ssDNA-binding proteins, including in replication factor A(RPA). Interestingly, this study reveals that the HIRAN domain interacts with not only with a single-stranded DNA but also with a duplex DNA. Furthermore, the structure unexpectedly clarifies that the HIRAN domain specifically recognizes the 3'-end of DNA. These results suggest that the HIRAN domain functions as a sensor to the 3'-end of the primer strand at the stalled replication fork and that the domain facilitates fork regression. HLTF is recruited to a damaged site through the HIRAN domain at the stalled replication fork. Furthermore, our results have implications for the mechanism of template switching.	[Hishiki, Asami; Hara, Kodai; Ikegaya, Yuzu; Yokoyama, Hideshi; Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228002, Japan; [Hishiki, Asami; Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hishiki, Asami] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hashimoto, Hiroshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	University of Shizuoka; Yokohama City University; Sanford Burnham Prebys Medical Discovery Institute; University of Tokyo; Osaka University	Hashimoto, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228002, Japan.	hash@u-shizuoka-ken.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789; hara, kodai/0000-0002-1586-6312; Yokoyama, Hideshi/0000-0002-3137-2793	KAKENHI [23770125, 26440034, 25121728, 25291017]; National Project on Protein Structural and Functional Analyses (Protein 3000 Project); Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [26440034] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Project on Protein Structural and Functional Analyses (Protein 3000 Project); Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grants 23770125, 26440034, 25121728, and 25291017), the National Project on Protein Structural and Functional Analyses (Protein 3000 Project), and the Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to A. H., T. S., M. S., and H. H.). This work was also supported by grants from the Takeda Science Foundation and the Naito Foundation (to H. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkovics P, 2014, NUCLEIC ACIDS RES, V42, P1711, DOI 10.1093/nar/gkt1040; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Friedberg EC, 2014, DNA REPAIR MUTAGENES; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ikegaya Y., 2015, ACTA CRYS F IN PRESS; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025	33	50	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13215	13223		10.1074/jbc.M115.643643	http://dx.doi.org/10.1074/jbc.M115.643643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25858588	Green Published, hybrid			2022-12-26	WOS:000354975700023
J	Kim, W; Kim, HD; Jung, Y; Kim, J; Chung, J				Kim, Wonho; Kim, Hag Dong; Jung, Youjin; Kim, Joon; Chung, Jongkyeong			Drosophila Low Temperature Viability Protein 1 (LTV1) Is Required for Ribosome Biogenesis and Cell Growth Downstream of Drosophila Myc (dMyc)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; C-MYC; CYTOPLASMIC MATURATION; PRE-RIBOSOMES; SUBUNIT; RNA; TRANSCRIPTION; CANCER; GENES	During animal development, various signaling pathways converge to regulate cell growth. In this study, we identified LTV1 as a novel cell growth regulator in Drosophila. LTV1 mutant larvae exhibited developmental delays and lethality at the second larval stage. Using biochemical studies, we discovered that LTV1 interacted with ribosomal protein S3 and co-purified with free 40S ribosome subunits. We further demonstrated that LTV1 is crucial for ribosome biogenesis through 40S ribosome subunit synthesis and preribosomal RNA processing, suggesting that LTV1 is required for cell growth by regulating protein synthesis. We also demonstrated that Drosophila Myc (dMyc) directly regulates LTV1 transcription and requires LTV1 to stimulate ribosome biogenesis. Importantly, the loss of LTV1 blocked the cell growth and endoreplication induced by dMyc. Combined, these results suggest that LTV1 is a key downstream factor of dMyc-induced cell growth by properly maintaining ribosome biogenesis.	[Kim, Wonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151742, South Korea; [Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Hag Dong; Jung, Youjin; Kim, Joon] Korea Univ, Div Life Sci, Biochem Lab, Seoul 136701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); Korea University	Kim, J (corresponding author), Korea Univ, Div Life Sci, Biochem Lab, Seoul 136701, South Korea.	joonkim@korea.ac.kr; jkc@snu.ac.kr			National Creative Research Initiatives Program [2010-0018291]; Korean Ministry of Science, ICT and Future Planning [2012R1A2A1A01009027]; BK21 Plus Program	National Creative Research Initiatives Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science, ICT and Future Planning; BK21 Plus Program	This work was supported by National Creative Research Initiatives Program Grant 2010-0018291, Korean Ministry of Science, ICT and Future Planning Grant 2012R1A2A1A01009027, and BK21 Plus Program.	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Budirahardja Y, 2009, DEVELOPMENT, V136, P2861, DOI 10.1242/dev.021931; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; LONG EO, 1980, J MOL BIOL, V138, P873, DOI 10.1016/0022-2836(80)90070-4; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Merwin JR, 2014, GENETICS, V198, P1071, DOI 10.1534/genetics.114.168294; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Mitchell NC, 2010, DEVELOPMENT, V137, P2875, DOI 10.1242/dev.049585; Moy TI, 2002, J CELL SCI, V115, P2985; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Neto-Silva RM, 2009, ANNU REV CELL DEV BI, V25, P197, DOI 10.1146/annurev.cellbio.24.110707.175242; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; SEDLAK BJ, 1984, DEV BIOL, V104, P489, DOI 10.1016/0012-1606(84)90106-4; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; XU T, 1993, DEVELOPMENT, V117, P1223; Yang JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2469; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	43	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13591	13604		10.1074/jbc.M114.607036	http://dx.doi.org/10.1074/jbc.M114.607036			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25858587	hybrid, Green Published			2022-12-26	WOS:000354975700052
J	Cai, XR; Zhou, QC; Yu, J; Feng, YZ; Xian, ZH; Yang, WC; Mo, XK				Cai, Xiang-Ran; Zhou, Qing-Chun; Yu, Juan; Feng, You-Zhen; Xian, Zhao-Hui; Yang, Wen-Cai; Mo, Xu-Kai			Assessment of Renal Function in Patients with Unilateral Ureteral Obstruction Using Whole-Organ Perfusion Imaging with 320-Detector Row Computed Tomography	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; NONINVASIVE MEASUREMENT; TUBULAR DYNAMICS; MULTIDETECTOR CT; BLOOD-FLOW; HEMODYNAMICS; NEPHROPATHY; ABDOMEN; LIVER; MODEL	Background Obstructed nephropathy is a common complication of several disease processes. Accurate evaluation of the functional status of the obstructed kidney is important to achieve a good outcome. The purpose of this study was to investigate renal cortical and medullary perfusion changes associated with unilateral ureteral obstruction (UUO) using whole-organ perfusion imaging with 320-detector row computed tomography (CT). Methodology/Principle Findings Sixty-four patients with UUO underwent whole-organ CT perfusion imaging. Patients were divided into 3 groups, mild, moderate, and severe, based on hydronephrosis severity. Twenty sex-and age-matched patients without renal disease, who referred to abdominal CT, were chosen as control subjects. Mean cortical and medullary perfusion parameters of obstructed and contralateral kidneys were compared, and mean perfusion ratios between obstructed and contralateral kidneys were calculated and compared. Mean cortical or medullary blood flow (BF) and blood volume (BV) of the obstructed kidneys in the moderate UUO and BF, BV, and clearance (CL) in the severe UUO were significantly lower than those of the contralateral kidneys (p < 0.05). The mean cortical or medullary BF of the obstructed kidney in the moderate UUO, and BF, BV, and CL in the severe UUO were significantly lower than those of the kidneys in control subjects (p < 0.05). Mean cortical or medullary BF of the non-obstructed kidneys in the severe UUO were statistically greater than that of normal kidneys in control subjects (p < 0.05). An inverse correlation was observed between cortical and medullary perfusion ratios and grades of hydronephosis (p < 0.01). Conclusions/Significance Perfusion measurements of the whole kidney can be obtained with 320-detector row CT, and estimated perfusion ratios have potential for quantitatively evaluating UUO renal injury grades.	[Cai, Xiang-Ran; Feng, You-Zhen; Xian, Zhao-Hui; Yang, Wen-Cai; Mo, Xu-Kai] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Zhou, Qing-Chun] Nanhua Univ, Nanhua Affiliated Hosp, Dept Urol, Hengyang, Hunan, Peoples R China; [Yu, Juan] Shenzhen Second Peoples Hosp, Dept Radiol, Shenzhen, Guangdong, Peoples R China	Jinan University; University of South China; Second People's Hospital of Shenzhen	Cai, XR (corresponding author), Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China.	caixran@163.com						Blomley MJK, 1999, EUR J RADIOL, V30, P214, DOI 10.1016/S0720-048X(99)00014-5; Brix G, 2004, EUR RADIOL, V14, P1275, DOI 10.1007/s00330-004-2267-7; Chang J, 2011, J VET SCI, V12, P393, DOI 10.4142/jvs.2011.12.4.393; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085522; Daghini E, 2007, RADIOLOGY, V243, P405, DOI 10.1148/radiol.2432060655; Dawson P, 2006, EUR J RADIOL, V60, P331, DOI 10.1016/j.ejrad.2006.06.023; ELDER JS, 1995, J UROLOGY, V154, P719, DOI 10.1016/S0022-5347(01)67143-X; Grenier N, 2013, Diagn Interv Imaging, V94, P1313, DOI 10.1016/j.diii.2013.08.018; Hegarty NJ, 2001, KIDNEY INT, V59, P1059, DOI 10.1046/j.1523-1755.2001.00589.x; Itano NB, 2001, J UROLOGY, V166, P2530, DOI 10.1016/S0022-5347(05)65629-7; Kambadakone AR, 2009, RADIOL CLIN N AM, V47, P161, DOI 10.1016/j.rcl.2008.11.003; Kanda T, 2012, EUR J RADIOL, V81, P2470, DOI 10.1016/j.ejrad.2011.10.009; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Krier JD, 2001, AM J PHYSIOL-RENAL, V281, pF630, DOI 10.1152/ajprenal.2001.281.4.F630; Lemoine S, 2011, RADIOLOGY, V260, P414, DOI 10.1148/radiol.11101317; Lerman LO, 1999, J AM SOC NEPHROL, V10, P1455; Liu X, 2009, RADIOLOGY, V253, P98, DOI [10.1148/radiol.2531081677, 10.1148/radiol.2531081677/-/DC1]; LOO MH, 1988, WORLD J UROL, V6, P53, DOI 10.1007/BF00326844; Mazzei MA, 2013, ACTA RADIOL, V54, P805, DOI 10.1177/0284185113484643; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; Moos SI, 2013, EUR J RADIOL, V82, pE387, DOI 10.1016/j.ejrad.2013.04.029; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; Ohno Y, 2011, RADIOLOGY, V258, P599, DOI 10.1148/radiol.10100245; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pelaez LI, 2005, NEPHROL DIAL TRANSPL, V20, P83, DOI 10.1093/ndt/gfh556; RAGI I, 1981, International Urology and Nephrology, V13, P237, DOI 10.1007/BF02082421; SATOH N, 1991, Nippon Acta Radiologica, V51, P1346; SHEEHAN SJ, 1994, UROL RES, V22, P279, DOI 10.1007/BF00297195; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Tantawy MN, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-168; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; Yilmaz O, 2009, J PEDIATR SURG, V44, P1977, DOI 10.1016/j.jpedsurg.2009.01.072; Zhong JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074365	33	11	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122454	10.1371/journal.pone.0122454	http://dx.doi.org/10.1371/journal.pone.0122454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874690	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800058
J	Brederoo, SG; Bos, LS; Dragoy, O; Bastiaanse, R; Baggio, G				Brederoo, Sanne Goren; Bos, Laura Simone; Dragoy, Olga; Bastiaanse, Roelien; Baggio, Giosue			Gamma Oscillations as a Neural Signature of Shifting Times in Narrative Language	PLOS ONE			English	Article							SEMANTIC VIOLATION; EEG; RESPONSES; N400; MEG	Verbs and other temporal expressions allow speakers to specify the location of events in time, as well as to move back and forth in time, shifting in a narrative between past, present and future. The referential flexibility of temporal expressions is well understood in linguistics but its neurocognitive bases remain unknown. We aimed at obtaining a neural signature of shifting times in narrative language. We recorded and analyzed event-related brain potentials (ERPs) and oscillatory responses to the adverb 'now' and to the second main verb in Punctual ('An hour ago the boy stole a candy and now he peeled the fruit') and Iterative ('The entire afternoon the boy stole candy and now he peeled the fruit') contexts. 'An hour ago' introduces a time frame that lies entirely in the past, 'now' shifts the narrative to the present, and 'peeled' shifts it back to the past. These two referential shifts in Punctual contexts are expected to leave very similar traces on neural responses. In contrast, 'The entire afternoon' specifies a time frame that may encompass past, present and future, such that both 'now' and 'peeled' are consistent with it. Here, no time shift is required. We found no difference in ERPs between Punctual and Iterative contexts either at 'now' or at the second verb. However, reference shifts modulated oscillatory signals. 'Now' and the second verb in Punctual contexts resulted in similar responses: an increase in gamma power with a left-anterior distribution. Gamma bursts were absent in Iterative contexts. We propose that gamma oscillations here reflect the binding of temporal variables to the values allowed by constraints introduced by temporal expressions in discourse.	[Brederoo, Sanne Goren; Bos, Laura Simone; Dragoy, Olga; Bastiaanse, Roelien] Univ Groningen, Ctr Language & Cognit, Groningen, Netherlands; [Brederoo, Sanne Goren; Bos, Laura Simone] Univ Groningen, Univ Med Ctr Groningen, NeuroImaging Ctr, NL-9713 AV Groningen, Netherlands; [Dragoy, Olga] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Baggio, Giosue] Scuola Int Super Studi Avanzati, Brain & Language Lab, Trieste, Italy; [Baggio, Giosue] Norwegian Univ Sci & Technol, Dept Language & Literature, Language Acquisit & Language Proc Lab, Trondheim, Norway	University of Groningen; University of Groningen; HSE University (National Research University Higher School of Economics); International School for Advanced Studies (SISSA); Norwegian University of Science & Technology (NTNU)	Baggio, G (corresponding author), Scuola Int Super Studi Avanzati, Brain & Language Lab, Trieste, Italy.	giosue.baggio@ntnu.no	Dragoy, Olga/AAD-7823-2019; Bastiaanse, Roelien/I-9209-2017; Dragoy, Olga/A-2365-2014	Bastiaanse, Roelien/0000-0002-4818-0763; Baggio, Giosue/0000-0001-5086-0365; Dragoy, Olga/0000-0002-6777-5164; Brederoo, Sanne/0000-0001-9608-0954	European Masters in Clinical Linguistics; Basic Research Program at the National Research University Higher School of Economics	European Masters in Clinical Linguistics; Basic Research Program at the National Research University Higher School of Economics	The work of Olga Dragoy was supported by a visiting scholar Erasmus Mundus Grant from the European Masters in Clinical Linguistics and the Basic Research Program at the National Research University Higher School of Economics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GRONINGEN DISSERTATI, V42; Baggio G, 2008, J MEM LANG, V59, P36, DOI 10.1016/j.jml.2008.02.005; Baggio G, 2012, HBK PHILOS SCI, P325; Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Baggio G, 2010, J COGNITIVE NEUROSCI, V22, P2131, DOI 10.1162/jocn.2009.21303; Baggio G, 2008, LANG LEARN, V58, P35, DOI 10.1111/j.1467-9922.2008.00460.x; Baggio Giosue, 2012, OXFORD HDB COMPOSITI, P657; Bar-Hillel Y., 1954, MIND, V63, P359, DOI DOI 10.1093/MIND/LXIII.251.359; Bastiaansen M, 2006, PROG BRAIN RES, V159, P179, DOI 10.1016/S0079-6123(06)59012-0; Bos LS, 2013, J NEUROLINGUIST, V26, P283, DOI 10.1016/j.jneuroling.2012.10.001; Braeutigam S, 2001, COGNITIVE BRAIN RES, V10, P365, DOI 10.1016/S0926-6410(00)00055-0; Comrie Bernard, 1985, TENSE, DOI [10.1017/CBO9781139165815, DOI 10.1017/CBO9781139165815]; Corazza E, 2004, SYNTHESE, V138, P289, DOI 10.1023/B:SYNT.0000013244.65400.a0; Dilligham Pierson C, 1901, POND PEOPLE; Dragoy O, 2012, J MEM LANG, V66, P307, DOI 10.1016/j.jml.2011.09.001; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fonseca A, 2015, BRAIN RES, V1604, P1, DOI 10.1016/j.brainres.2015.01.030; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Grossmann A., 1989, WAVELETS TIME FREQUE, DOI DOI 10.1007/978-3-642-97177-8_1; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hoeks JCJ, 2004, COGNITIVE BRAIN RES, V19, P59, DOI 10.1016/j.cogbrainres.2003.10.022; Hunter Julie, 2012, Logic, Language and Meaning. 18th Amsterdam Colloquium. Revised Selected Papers, P371, DOI 10.1007/978-3-642-31482-7_38; Hunter J, 2013, J SEMANT, V30, P381, DOI 10.1093/jos/ffs013; KAMP H, 1971, THEORIA, V37, P227; Kamp H, 1993, INTRO MODEL THEORETI; KAPLAN D., 1989, THEMES KAPLAN, P481; Kuperberg GR, 2010, J COGNITIVE NEUROSCI, V22, P2685, DOI 10.1162/jocn.2009.21333; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; NIGAM A, 1992, J COGNITIVE NEUROSCI, V4, P15, DOI 10.1162/jocn.1992.4.1.15; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Paczynski M, 2014, J COGNITIVE NEUROSCI, V26, P1905, DOI 10.1162/jocn_a_00638; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Penolazzi B, 2009, NEUROSCI LETT, V465, P74, DOI 10.1016/j.neulet.2009.08.065; Predelli S, 1998, MIND LANG, V13, P400, DOI 10.1111/1468-0017.00083; Prior Arthur, 1968, NOUS, V2, P101; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Recanati F., 2001, TEXTE, V127, P115; SAG IA, 1984, LINGUIST PHILOS, V7, P325, DOI 10.1007/BF00627709; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sinha C, 2014, ANN NY ACAD SCI, V1326, P72, DOI 10.1111/nyas.12491; SMITH Q, 1989, SYNTHESE, V78, P167, DOI 10.1007/BF00869371; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; VanLambalgen M, 2005, EXPLOR SEMANT, P1, DOI 10.1002/9780470759257; Voltolini A, 2006, SYNTHESE, V153, P23, DOI 10.1007/s11229-006-0001-5; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	52	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121146	10.1371/journal.pone.0121146	http://dx.doi.org/10.1371/journal.pone.0121146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874576	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100036
J	Graesboll, K; Kirkeby, C; Nielsen, SS; Christiansen, LE				Graesboll, Kaare; Kirkeby, Carsten; Nielsen, Soren Saxmose; Christiansen, Lasse Engbo			Danish Holsteins Favor Bull Offspring: Biased Milk Production as a Function of Fetal Sex, and Calving Difficulty	PLOS ONE			English	Article							CALF BIRTH-WEIGHT; CATTLE; YIELD; COWS; SELECTION; EASE	In a previous study from 2014 it was found that US Holstein cows that gave birth to heifer calves produced more milk than cows having bull calves. We wanted to assess whether this is also true for Danish cattle. Data from 578 Danish Holstein herds were analysed with a mixed effect model and contrary to the findings in the US, we found that cows produced higher volumes of milk if they had a bull calf compared to a heifer calf. We found a significantly higher milk production of 0.28% in the first lactation period for cows giving birth to a bull calf, compared to a heifer calf. This difference was even higher when cows gave birth to another bull calf, so having two bull calves resulted in a difference of 0.52% in milk production compared to any other combination of sex of the offspring. Furthermore, we found that farmer assisted calvings were associated with a higher milk yield. Cows with no farmer assistance or with veterinary assistance during the most recent calving produced less milk. There were also indications that dams would favor a bull fetus by decreasing milk production during the second pregnancy if the calf born in the first parity was a heifer. We hypothesize that size of calves is a confounding factor for milk production. However, calving weight was not available in the present data set to test this hypothesis.	[Graesboll, Kaare; Christiansen, Lasse Engbo] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Kirkeby, Carsten] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark; [Nielsen, Soren Saxmose] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Graesboll, K (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	kagr@dtu.dk	Kirkeby, Carsten/GVS-8137-2022	Christiansen, Lasse Engbo/0000-0001-5019-1931; Graesboll, Kaare/0000-0002-6258-8212; Nielsen, Soren/0000-0003-2417-0787; Kirkeby, Carsten/0000-0001-9292-5526	GUDP under the Danish Directorate for Food, Fisheries and Agriculture [34009-13-0596]	GUDP under the Danish Directorate for Food, Fisheries and Agriculture	This study carried out under the iCull project funded by GUDP under the Danish Directorate for Food, Fisheries and Agriculture grant no. 34009-13-0596 (http://naturerhverv.dk/tvaergaaende/gudp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrier AC, 2011, J DAIRY SCI, V94, P1804, DOI 10.3168/jds.2010-3641; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BYERS JA, 1990, BEHAV ECOL SOCIOBIOL, V26, P157; CHEW BP, 1981, J DAIRY SCI, V64, P2401, DOI 10.3168/jds.S0022-0302(81)82863-9; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Eaglen SAE, 2011, J DAIRY SCI, V94, P5413, DOI 10.3168/jds.2010-4040; FORTIN A, 1980, J ANIM SCI, V51, P604, DOI 10.2527/jas1980.513604x; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Kertz AF, 1997, J DAIRY SCI, V80, P525, DOI 10.3168/jds.S0022-0302(97)75966-6; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; R Core Team, 2018, R LANG ENV STAT COMP; SIEBER M, 1989, J DAIRY SCI, V72, P2402, DOI 10.3168/jds.S0022-0302(89)79373-5; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WILMINK JBM, 1987, LIVEST PROD SCI, V17, P1, DOI 10.1016/0301-6226(87)90049-2	15	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124051	10.1371/journal.pone.0124051	http://dx.doi.org/10.1371/journal.pone.0124051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874441	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100236
J	Kasthurinaidu, SP; Ramasamy, T; Ayyavoo, J; Dave, DK; Adroja, DA				Kasthurinaidu, Senthilkumar Pitchalu; Ramasamy, Thirumurugan; Ayyavoo, Jayachitra; Dave, Dhvani Kirtikumar; Adroja, Divya Anantray			GST M1-T1 null Allele Frequency Patterns in Geographically Assorted Human Populations: A Phylogenetic Approach	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GENETIC POLYMORPHISMS; ESOPHAGEAL CANCER; ORAL-CANCER; NECK-CANCER; CYP1A1; RISK; SUSCEPTIBILITY; GENOTYPE; NAT2	Genetic diversity in drug metabolism and disposition is mainly considered as the outcome of the inter-individual genetic variation in polymorphism of drug-xenobiotic metabolizing enzyme (XME). Among the XMEs, glutathione-S-transferases (GST) gene loci are an important candidate for the investigation of diversity in allele frequency, as the deletion mutations in GST M1 and T1 genotypes are associated with various cancers and genetic disorders of all major Population Affiliations (PAs). Therefore, the present population based phylogenetic study was focused to uncover the frequency distribution pattern in GST M1 and T1 null genotypes among 45 Geographically Assorted Human Populations (GAHPs). The frequency distribution pattern for GST M1 and T1 null alleles have been detected in this study using the data derived from literatures representing 44 populations affiliated to Africa, Asia, Europe, South America and the genome of PA from Gujarat, a region in western India. Allele frequency counting for Gujarat PA and scattered plot analysis for geographical distribution among the PAs were performed in SPSS-21. The GST M1 and GST T1 null allele frequencies patterns of the PAs were computed in Seqboot, Gendist program of Phylip software package (3.69 versions) and Unweighted Pair Group method with Arithmetic Mean in Mega-6 software. Allele frequencies from South African Xhosa tribe, East African Zimbabwe, East African Ethiopia, North African Egypt, Caucasian, South Asian Afghanistan and South Indian Andhra Pradesh have been identified as the probable seven patterns among the 45 GAHPs investigated in this study for GST M1-T1 null genotypes. The patternized null allele frequencies demonstrated in this study for the first time addresses the missing link in GST M1-T1 null allele frequencies among GAHPs.	[Kasthurinaidu, Senthilkumar Pitchalu; Dave, Dhvani Kirtikumar; Adroja, Divya Anantray] Shree M&N Virani Sci Coll, Dept Biotechnol, Rajkot 360005, Gujarat, India; [Kasthurinaidu, Senthilkumar Pitchalu; Ayyavoo, Jayachitra] Madurai Kamaraj Univ, Sch Biotechnol, Dept Plant Biotechnol, Madurai 625021, Tamil Nadu, India; [Ramasamy, Thirumurugan] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli 620024, Tamil Nadu, India	Madurai Kamaraj University; Bharathidasan University	Ramasamy, T (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli 620024, Tamil Nadu, India.	ramthiru72@gmail.com						Abbas A, 2004, WORLD J GASTROENTERO, V10, P3389; Adams CH, 2003, CLIN CHEM LAB MED, V41, P600, DOI 10.1515/CCLM.2003.090; Agusa T, 2010, TOXICOL APPL PHARM, V242, P352, DOI 10.1016/j.taap.2009.11.007; Amtha R, 2009, ASIAN PAC J CANCER P, V10, P21; Anantharaman D, 2007, CARCINOGENESIS, V28, P1455, DOI 10.1093/carcin/bgm038; ArunKumar G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050269; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Ben Salah G, 2012, GENE, V498, P317, DOI 10.1016/j.gene.2012.01.054; Binkova B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2; Bu H, 2007, ONCOL REP, V17, P859; Buch S, 2001, EUR J CLIN PHARMACOL, V57, P553; Buch SC, 2002, CARCINOGENESIS, V23, P803, DOI 10.1093/carcin/23.5.803; Buchard A, 2007, J MOL DIAGN, V9, P612, DOI 10.2353/jmoldx.2007.070030; Dandara C, 2002, CLIN CHEM LAB MED, V40, P952, DOI 10.1515/CCLM.2002.167; Dialyna IA, 2003, ONCOL REP, V10, P1829; Ebeshi BU, 2011, J MED GENET GENOMICS, V3, P56; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Field JS, 2005, J WORLD PREHIST, V19, P1, DOI 10.1007/s10963-005-9000-6; Fujihara Junko, 2009, Leg Med (Tokyo), V11 Suppl 1, pS408, DOI 10.1016/j.legalmed.2009.01.073; Gajecka M, 2005, MUTAT RES-FUND MOL M, V574, P112, DOI 10.1016/j.mrfmmm.2005.01.027; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Ghosh T, 2012, MOL BIOL REP, V39, P9383, DOI 10.1007/s11033-012-1802-x; Gra O, 2010, GENET TEST MOL BIOMA, V14, P329, DOI 10.1089/gtmb.2009.0158; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Hamdy SI, 2003, BRIT J CLIN PHARMACO, V55, P560, DOI 10.1046/j.1365-2125.2003.01786.x; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Huang K, 2006, CANCER CAUSE CONTROL, V17, P385, DOI 10.1007/s10552-005-0424-1; Jain M, 2006, CANCER LETT, V242, P60, DOI 10.1016/j.canlet.2005.10.034; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kim WJ, 2002, UROLOGY, V60, P913, DOI 10.1016/S0090-4295(02)01892-7; Konwar R, 2010, ASIAN PAC J CANCER P, V11, P1067; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LEE EJD, 1995, PHARMACOGENETICS, V5, P332, DOI 10.1097/00008571-199510000-00010; Magno LAV, 2009, PHARMACOLOGY, V83, P231, DOI 10.1159/000205823; Mishra Dhruva K, 2004, Asian Pac J Cancer Prev, V5, P362; Naveen AT, 2004, EUR J CLIN PHARMACOL, V60, P403, DOI 10.1007/s00228-004-0779-3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; O'Donnell PH, 2009, CLIN CANCER RES, V15, P4806, DOI 10.1158/1078-0432.CCR-09-0344; Piacentini S, 2011, MOL BIOL REP, V38, P1225, DOI 10.1007/s11033-010-0221-0; Polimanti R, 2013, GENE, V512, P102, DOI 10.1016/j.gene.2012.09.113; Rimando MG, 2008, BIOSCIENCE REP, V28, P117, DOI 10.1042/BSR20070010; Rossini Ana, 2002, Genetics and Molecular Research, V1, P233; Saadat M., 2007, International Journal of Cancer Research (USA), V3, P74; Sabitha K, 2008, AFR J BIOTECHNOL, V7, P3853; Saify K, 2012, MOL BIOL REP, V39, P7855, DOI 10.1007/s11033-012-1628-6; Saijo N, 2013, YONSEI MED J, V54, P1, DOI 10.3349/ymj.2013.54.1.1; Senthilkumar KP, 2014, MOL BIOL REP, V41, P5635, DOI 10.1007/s11033-014-3433-x; Shaikh RS, 2010, ENVIRON TOXICOL PHAR, V30, P76, DOI 10.1016/j.etap.2010.04.002; Shukla D, 2012, BIOMED PAP, V156, P253, DOI 10.5507/bp.2012.013; Sikdar Nilabja, 2005, International Journal of Human Genetics, V5, P37; Singh M, 2008, MUTAT RES-FUND MOL M, V638, P184, DOI 10.1016/j.mrfmmm.2007.10.003; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sreelekha TT, 2001, ORAL ONCOL, V37, P593, DOI 10.1016/S1368-8375(01)00028-8; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Thier R, 2003, INT J HYG ENVIR HEAL, V206, P149, DOI 10.1078/1438-4639-00209; Toncheva DI, 2004, J NEPHROL, V17, P384	61	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118660	10.1371/journal.pone.0118660	http://dx.doi.org/10.1371/journal.pone.0118660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867025	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100009
J	Lo, SL; Chiong, R; Cornforth, D				Lo, Siaw Ling; Chiong, Raymond; Cornforth, David			Using Support Vector Machine Ensembles for Target Audience Classification on Twitter	PLOS ONE			English	Article							PREDICTION; TEXT	The vast amount and diversity of the content shared on social media can pose a challenge for any business wanting to use it to identify potential customers. In this paper, our aim is to investigate the use of both unsupervised and supervised learning methods for target audience classification on Twitter with minimal annotation efforts. Topic domains were automatically discovered from contents shared by followers of an account owner using Twitter Latent Dirichlet Allocation (LDA). A Support Vector Machine (SVM) ensemble was then trained using contents from different account owners of the various topic domains identified by Twitter LDA. Experimental results show that the methods presented are able to successfully identify a target audience with high accuracy. In addition, we show that using a statistical inference approach such as bootstrapping in over-sampling, instead of using random sampling, to construct training datasets can achieve a better classifier in an SVM ensemble. We conclude that such an ensemble system can take advantage of data diversity, which enables real-world applications for differentiating prospective customers from the general audience, leading to business advantage in the crowded social media space.	[Lo, Siaw Ling; Chiong, Raymond; Cornforth, David] Univ Newcastle, Sch Design Commun & Informat Technol, Callaghan, NSW 2308, Australia	University of Newcastle	Lo, SL (corresponding author), Univ Newcastle, Sch Design Commun & Informat Technol, Callaghan, NSW 2308, Australia.	siawling.lo@uon.edu.au		Lo, Siaw Ling/0000-0002-8749-0473				Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cambria E, 2013, IEEE INTELL SYST, V28, P30, DOI 10.1109/MIS.2013.140; Cambria E, 2013, BIOL INSPIR COGN ARC, V4, P41, DOI 10.1016/j.bica.2013.02.003; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; da Silva NFF, 2014, DECIS SUPPORT SYST, V66, P170, DOI 10.1016/j.dss.2014.07.003; Dietterich T. G., 1995, CS9501101 ARXIV; Ding JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511-S11; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Hassan A, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P357, DOI 10.1109/SocialCom.2013.56; HONG L., 2013, P 6 ACM INT C WEB SE, P557, DOI DOI 10.1145/2433396.2433467; Ikeda K, 2013, KNOWL-BASED SYST, V51, P35, DOI 10.1016/j.knosys.2013.06.020; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Kim HC, 2003, PATTERN RECOGN, V36, P2757, DOI 10.1016/S0031-3203(03)00175-4; Li XC, 2008, ENG APPL ARTIF INTEL, V21, P785, DOI 10.1016/j.engappai.2007.07.001; Liu Y, 2006, LECT NOTES ARTIF INT, V3918, P107; Lo SL, 2015, PROCEEDINGS OF THE 18TH ASIA PACIFIC SYMPOSIUM ON INTELLIGENT AND EVOLUTIONARY SYSTEMS, VOL 1, P325, DOI 10.1007/978-3-319-13359-1_26; Lo SL, 2015, PROCEEDINGS OF ELM 2, P417; Mahmud J., 2012, ICWSM, V12, P511; Michelson M., 2010, P 4 WORKSH AN NOIS U, P73, DOI DOI 10.1145/1871840.1871852; Pennacchiotti M., 2011, P 17 ACM SIGKDD INT, P430, DOI DOI 10.1145/2020408.2020477; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Rao Delip, 2010, P 2 INT WORKSH SEARC, P37, DOI DOI 10.1145/1871985.1871993; Ren Ye, 2012, 2012 15th International Conference on Information Fusion (FUSION 2012), P917; Shaikh GR, 2013, INT J ENG RES TECHNO, V2, P37; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Tao Yang, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P684; Willett P, 2006, PROGRAM-ELECTRON LIB, V40, P219, DOI 10.1108/00330330610681295; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Yang MC, 2014, EXPERT SYST APPL, V41, P4330, DOI 10.1016/j.eswa.2013.12.051; Zeng D, 2010, IEEE INTELL SYST, V25, P13, DOI 10.1109/MIS.2010.151; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	34	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122855	10.1371/journal.pone.0122855	http://dx.doi.org/10.1371/journal.pone.0122855			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874768	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100109
J	Xu, L; Xu, WS; Jiang, Y; Hu, F; Li, HX				Xu, Li; Xu, Wensi; Jiang, Ying; Hu, Feng; Li, Huixin			Effects of Interactions of Auxin-Producing Bacteria and Bacterial-Feeding Nematodes on Regulation of Peanut Growths	PLOS ONE			English	Article							IAA-PRODUCING BACTERIA; PLANT-GROWTH; NITROGEN MINERALIZATION; ARABIDOPSIS-THALIANA; ROOT-GROWTH; SOIL; BACILLUS; PROTOZOA; RHIZOSPHERE; DIVERSITY	The influences of an IAA (indole-3-acetic acid)-producing bacterium (Bacillus megaterium) and two bacterial-feeding nematodes (Cephalobus sp. or Mesorhabditis sp.) on the growth of peanut (Arachis hypogaea L. cv. Haihua 1) after various durations of time were investigated in natural soils. The addition of bacteria and nematodes and incubation time all significantly affected plant growth, plant root growth, plant nutrient concentrations, soil nutrient concentrations, soil microorganisms and soil auxin concentration. The addition of nematodes caused greater increases in these indices than those of bacteria, while the addition of the combination of bacteria and nematodes caused further increases. After 42-day growth, the increases in soil respiration differed between the additions of two kinds of nematodes because of differences in their life strategies. The effects of the bacteria and nematodes on the nutrient and hormone concentrations were responsible for the increases in plant growth. These results indicate the potential for promoting plant growth via the addition of nematodes and bacteria to soil.	[Xu, Li; Xu, Wensi; Jiang, Ying; Hu, Feng; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing, Jiangsu, Peoples R China.	huixinli@njau.edu.cn	Li, huixin/H-5573-2011		National Foundation of Sciences in China [30970537]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Foundation of Sciences in China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Foundation of Sciences in China (grant 30970537) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphei J, 1996, OECOLOGIA, V106, P111, DOI 10.1007/BF00334413; Armada E, 2014, MICROB ECOL, V67, P410, DOI 10.1007/s00248-013-0326-9; Bjornlund L, 2012, EUR J SOIL BIOL, V50, P28, DOI 10.1016/j.ejsobi.2011.11.012; Blanc C, 2006, EUR J SOIL BIOL, V42, pS70, DOI 10.1016/j.ejsobi.2006.06.003; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Buchan D, 2013, SOIL BIOL BIOCHEM, V60, P142, DOI 10.1016/j.soilbio.2013.01.022; Chakraborty U, 2006, J BASIC MICROB, V46, P186, DOI 10.1002/jobm.200510050; Cheng YH, 2011, NEMATOLOGY, V13, P369, DOI 10.1163/138855410X528253; Diaz SA, 2014, APPL ENVIRON MICROB, V80, P5411, DOI 10.1128/AEM.01037-14; Djigal D, 2004, SOIL BIOL BIOCHEM, V36, P323, DOI 10.1016/j.soilbio.2003.10.007; Egamberdieva D, 2009, ACTA PHYSIOL PLANT, V31, P861, DOI 10.1007/s11738-009-0297-0; Etesami H, 2014, J PLANT GROWTH REGUL, V33, P654, DOI 10.1007/s00344-014-9415-3; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; Frankenberger JWT, 1995, PHYTOHORMONES SOILS, P35; Goodfriend WL, 2000, PLANT SOIL, V223, P23, DOI 10.1023/A:1004756832367; Grewal PS, 2006, BIOL CONTROL, V38, P54, DOI 10.1016/j.biocontrol.2005.09.004; GRIFFITHS BS, 1994, PLANT SOIL, V164, P25, DOI 10.1007/BF00010107; Hu P, 2001, CHINESE J ANAL LAB, V20, P8, DOI DOI 10.3969/J.ISSN.1000-0720.2001.06.003; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Koberl M, 2013, FEMS MICROBIOL LETT, V342, P168, DOI 10.1111/1574-6968.12089; Kumar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106041; Ladygina N, 2009, FEMS MICROBIOL ECOL, V69, P53, DOI 10.1111/j.1574-6941.2009.00687.x; Liu ZZ, 2013, APPL MICROBIOL BIOT, V97, P10081, DOI 10.1007/s00253-013-5247-5; Lopez-Bucio J, 2007, MOL PLANT MICROBE IN, V20, P207, DOI 10.1094/MPMI-20-2-0207; Mao XF, 2007, SOIL BIOL BIOCHEM, V39, P1816, DOI 10.1016/j.soilbio.2007.01.027; Mao XF, 2006, SOIL BIOL BIOCHEM, V38, P1615, DOI 10.1016/j.soilbio.2005.12.002; Moens T, 1999, MAR ECOL PROG SER, V176, P165, DOI 10.3354/meps176165; Moghaddam MR, 2014, BIOCONTROL SCI TECHN, V24, P279, DOI 10.1080/09583157.2013.858100; Neher DA, 2001, J NEMATOL, V33, P161; Nykyri J, 2014, PLANT PATHOL, V63, P747, DOI 10.1111/ppa.12159; Ortiz-Castro R, 2008, PLANT SIGNAL BEHAV, V3, P263, DOI 10.4161/psb.3.4.5204; Porcel R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-36; Salinas KA, 2007, PEDOBIOLOGIA, V51, P55, DOI 10.1016/j.pedobi.2006.12.003; Sebastian W, 2013, NEMATOLOGY, V15, P291; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; Standing D, 2006, MICROB ECOL, V52, P444, DOI 10.1007/s00248-006-9119-8; Zhou DM, 2014, BIOCONTROL SCI TECHN, V24, P1451, DOI 10.1080/09583157.2014.945899	39	71	72	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124361	10.1371/journal.pone.0124361	http://dx.doi.org/10.1371/journal.pone.0124361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867954	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100253
J	Zanette, DL; Lorenzi, JCC; Panepucci, RA; Palma, PVB; dos Santos, DF; Prata, KL; Silva, WA				Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.			Simvastatin Modulates Mesenchymal Stromal Cell Proliferation and Gene Expression	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; IN-VITRO; STATINS; GROWTH; FIBROBLASTS; DIFFERENTIATION; APOPTOSIS; DISEASE; PROGRESSION	Statins are widely used hypocholesterolemic drugs that block the mevalonate pathway, responsible for the biosysnthesis of cholesterol. However, statins also have pleiotropic effects that interfere with several signaling pathways. Mesenchymal stromal cells (MSC) are a heterogeneous mixture of cells that can be isolated from a variety of tissues and are identified by the expression of a panel of surface markers and by their ability to differentiate in vitro into osteocytes, adipocytes and chondrocytes. MSC were isolated from amniotic membranes and bone marrows and characterized based on ISCT (International Society for Cell Therapy) minimal criteria. Simvastatin-treated cells and controls were directly assayed by CFSE (Carboxyfluorescein diacetate succinimidyl ester) staining to assess their cell proliferation and their RNA was used for microarray analyses and quantitative PCR (qPCR). These MSC were also evaluated for their ability to inhibit PBMC (peripheral blood mononuclear cells) proliferation. We show here that simvastatin negatively modulates MSC proliferation in a dose-dependent way and regulates the expression of proliferation-related genes. Importantly, we observed that simvastatin increased the percentage of a subset of smaller MSC, which also were actively proliferating. The association of MSC decreased size with increased pluripotency and the accumulating evidence that statins may prevent cellular senescence led us to hypothesize that simvastatin induces a smaller subpopulation that may have increased ability to maintain the entire pool of MSC and also to protect them from cellular senescence induced by long-term cultures/passages in vitro. These results may be important to better understand the pleiotropic effects of statins and its effects on the biology of cells with regenerative potential.	[Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Silva, Wilson Arajo, Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil; [Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.] Reg Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.] Ctr Cell Based Therapy CEPID FAPESP, Ribeirao Preto, SP, Brazil; [Zanette, Dalila Luciola; Cetrulo Lorenzi, Julio Cesar; Panepucci, Rodrigo Alexandre; Bonini Palma, Patricia Vianna; dos Santos, Daiane Fernanda; Prata, Karen Lima; Silva, Wilson Arajo, Jr.] Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Zanette, DL (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.	zanettedl@gmail.com	ZANETTE, DALILA/Q-3541-2016; Prata, Karen/I-4568-2013; Lorenzi, Julio/S-2394-2019; Panepucci, Rodrigo A/C-2365-2012; Silva Jr, Wilson Araújo/E-9487-2011; CTC USP, CEPID 13 18/J-8951-2014	Lorenzi, Julio/0000-0003-2492-3961; Panepucci, Rodrigo A/0000-0002-1119-4352; Silva Jr, Wilson Araújo/0000-0001-9364-2886; zanette, dalila l./0000-0001-9397-4127; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2009/09443-2, 2013/08135-2]; CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support for this work was provided by grants 2009/09443-2 and 2013/08135-2, Sao Paulo Research Foundation (FAPESP) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccardi V, 2013, FASEB J, V27, P3879, DOI 10.1096/fj.13-232066; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Du J, 2013, AM J PHYSL CELL PHYS; El-Karim EA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-89; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567; Gong M, 2013, INT J BIOCHEM CELL B, V45, P866, DOI 10.1016/j.biocel.2013.01.002; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Kim YW, 2010, CANCER RES TREAT, V42, P82, DOI 10.4143/crt.2010.42.2.82; Kok SH, 2013, ARTHRITIS RHEUM-US, V65, P639, DOI 10.1002/art.37807; Kubota T, 2004, BIOCHEM PHARMACOL, V67, P2175, DOI 10.1016/j.bcp.2004.02.037; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Liu SW, 2009, MOL CELL BIOCHEM, V331, P173, DOI 10.1007/s11010-009-0155-9; Liu YJ, 2010, HYPERTENSION, V56, P445, DOI 10.1161/HYPERTENSIONAHA.110.150102; Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; Martens JWM, 2003, THROMB HAEMOSTASIS, V89, P393; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Olivieri F, 2012, CURR VASC PHARMACOL, V10, P216, DOI 10.2174/157016112799305076; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Poggi A, 2011, CURR MED CHEM, V18, P5196, DOI 10.2174/092986711798184244; Rasmusson I, 2005, EXP CELL RES, V305, P33, DOI 10.1016/j.yexcr.2004.12.013; Sala SG, 2008, J PHARMACOL EXP THER, V324, P352, DOI 10.1124/jpet.107.128959; Sassano A, 2009, MOL CANCER THER, V8, P615, DOI 10.1158/1535-7163.MCT-08-1196; Saulnier N, 2011, CYTOTHERAPY, V13, P329, DOI 10.3109/14653249.2010.515576; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Shi YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045354; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Sokalska A, 2013, J CLIN ENDOCR METAB, V98, pE463, DOI 10.1210/jc.2012-3402; Spampanato C, 2012, INT J ONCOL, V40, P935, DOI 10.3892/ijo.2011.1273; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi S, 2008, AM J PHYSIOL-LUNG C, V294, pL882, DOI 10.1152/ajplung.00238.2007; Takeda I, 2007, CANCER SCI, V98, P890, DOI 10.1111/j.1349-7006.2007.00471.x; Tu YS, 2011, EUR J PHARMACOL, V670, P356, DOI 10.1016/j.ejphar.2011.09.031; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834; van de Donk NWCJ, 2002, LEUKEMIA, V16, P1362, DOI 10.1038/sj.leu.2402501; Whitfield MJ, 2013, STEM CELL RES, V11, P1365, DOI 10.1016/j.scr.2013.09.004; Wood WG, 2013, MOL NEUROBIOL, V48, P308, DOI 10.1007/s12035-013-8496-5; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang YC, 2008, CHEMOTHERAPY, V54, P438, DOI 10.1159/000158663	46	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120137	10.1371/journal.pone.0120137	http://dx.doi.org/10.1371/journal.pone.0120137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874574	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100020
J	Pfahler, S; Distl, O				Pfahler, Sophia; Distl, Ottmar			Effective Population Size, Extended Linkage Disequilibrium and Signatures of Selection in the Rare Dog Breed Lundehund	PLOS ONE			English	Article							ARTIFICIAL SELECTION; SYNAPTIC PLASTICITY; HOMOZYGOSITY; GENOME; GENES; RUNS; DOMESTICATION; ASSOCIATION; ADAPTATION; EXPRESSION	The Lundehund is an old dog breed with remarkable anatomical features including polydactyly in all four limbs and extraordinary flexibility of the spine. We genotyped 28 Lundehund using the canine Illumina high density beadchip to estimate the effective population size (N-e) and inbreeding coefficients as well as to identify potential regions of positive selection. The decay of linkage disequilibrium was slow with r(2) = 0.95 in 50 kb distance. The last 7-200 generations ago, Ne was at 10-13. An increase of N-e was noted in the very recent generations with a peak value of 19 for N-e at generation 4. The FROH estimated for 50-, 65- and 358-SNP windows were 0.87, 087 and 0.81, respectively. The most likely estimates for F-ROH after removing identical-by-state segments due to linkage disequilibria were at 0.80-0.81. The extreme loss of heterozygosity has been accumulated through continued inbreeding over 200 generations within a probably closed population with a small effective population size. The mean inbreeding coefficient based on pedigree data for the last 11 generations (F-Ped = 0.10) was strongly biased downwards due to the unknown coancestry of the founders in this pedigree data. The long-range haplotype test identified regions with genes involved in processes of immunity, olfaction, woundhealing and neuronal development as potential targets of selection. The genes QSOX2, BMPR1B and PRRX2 as well as MYOM1 are candidates for selection on the Lundehund characteristics small body size, increased number of digits per paw and extraordinary mobility, respectively.	[Pfahler, Sophia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, D-30559 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Bunteweg 17p, D-30559 Hannover, Germany.	ottmar.distl@tiho-hannover.de			University of Veterinary Medicine Hannover	University of Veterinary Medicine Hannover	Funding of this research was by private breeders and internal funds of the University of Veterinary Medicine Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Berghoff N, 2007, COMP CONT EDUC PRACT, V29, P456; Biesecker LG, 2011, DEV DYNAM, V240, P931, DOI 10.1002/dvdy.22609; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Espelien IS, 2013, J INT SOC PRESERVATI, V35, P37; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Flower DR, 1996, BIOCHEM J, V318, P1; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Haass NK, 1996, J CELL BIOL, V134, P731, DOI 10.1083/jcb.134.3.731; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Jin JZ, 2006, DEV DYNAM, V235, P547, DOI 10.1002/dvdy.20642; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; King MDA, 2014, J NEUROCHEM, V128, P391, DOI 10.1111/jnc.12462; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li Y, 2014, MOL BIOL EVOL, V31, P1200, DOI 10.1093/molbev/msu070; Li Y, 2013, MOL BIOL EVOL, V30, P1867, DOI 10.1093/molbev/mst088; Lu MF, 1999, DEV BIOL, V205, P145, DOI 10.1006/dbio.1998.9116; Lv D, 2011, EUR J CANCER, V47, P2068, DOI 10.1016/j.ejca.2011.04.021; Herrero-Medrano JM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-106; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Melis C, 2013, ANIM GENET, V44, P348, DOI 10.1111/age.12000; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Park K, 2008, GENETICS, V179, P2163, DOI 10.1534/genetics.108.087114; Parker CL, 2002, MOL IMMUNOL, V39, P453, DOI 10.1016/S0161-5890(02)00121-9; Pfahler S, 2014, ANIM GENET, V45, P154, DOI 10.1111/age.12084; Pinotsis N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001261; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Scraggs E, 2014, J ANIM BREED GENET, V131, P3, DOI 10.1111/jbg.12066; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; Stern JA, 2013, MAMM GENOME, V24, P409, DOI 10.1007/s00335-013-9474-y; SVED J A, 1971, Theoretical Population Biology, V2, P125; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voorbij AMWY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027940; Wong AK, 2012, ANIM BIOTECHNOL, V23, P241, DOI 10.1080/10495398.2012.717151; Wrede J, 2003, OPTI MATE 3 81 MANAG; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhang ZY, 2000, DEV BIOL, V220, P154, DOI 10.1006/dbio.2000.9637	54	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122680	10.1371/journal.pone.0122680	http://dx.doi.org/10.1371/journal.pone.0122680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860808	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300055
J	Pirone-Davies, C; Hoffmann, M; Roberts, RJ; Muruvanda, T; Timme, RE; Strain, E; Luo, Y; Payne, J; Luong, K; Song, Y; Tsai, YC; Boitano, M; Clark, TA; Korlach, J; Evans, PS; Allard, MW				Pirone-Davies, Cary; Hoffmann, Maria; Roberts, Richard J.; Muruvanda, Tim; Timme, Ruth E.; Strain, Errol; Luo, Yan; Payne, Justin; Luong, Khai; Song, Yi; Tsai, Yu-Chih; Boitano, Matthew; Clark, Tyson A.; Korlach, Jonas; Evans, Peter S.; Allard, Marc W.			Genome-Wide Methylation Patterns in Salmonella enterica Subsp enterica Serovars	PLOS ONE			English	Article							DNA ADENINE METHYLATION; SINGLE-MOLECULE; ESCHERICHIA-COLI; RESTRICTION; METHYLTRANSFERASE; SPECIFICITIES; ENZYMES; GENES	The methylation of DNA bases plays an important role in numerous biological processes including development, gene expression, and DNA replication. Salmonella is an important foodborne pathogen, and methylation in Salmonella is implicated in virulence. Using single molecule real-time (SMRT) DNA-sequencing, we sequenced and assembled the complete genomes of eleven Salmonella enterica isolates from nine different serovars, and analysed the whole-genome methylation patterns of each genome. We describe 16 distinct N-6-methyladenine (m6A) methylated motifs, one N-4-methylcytosine (m4C) motif, and one combined m6A-m4C motif. Eight of these motifs are novel, i.e., they have not been previously described. We also identified the methyltransferases (MTases) associated with 13 of the motifs. Some motifs are conserved across all Salmonella serovars tested, while others were found only in a subset of serovars. Eight of the nine serovars contained a unique methylated motif that was not found in any other serovar (most of these motifs were part of Type I restriction modification systems), indicating the high diversity of methylation patterns present in Salmonella.	[Pirone-Davies, Cary; Hoffmann, Maria; Muruvanda, Tim; Timme, Ruth E.; Payne, Justin; Evans, Peter S.; Allard, Marc W.] US FDA, Ctr Food Safety & Appl Nutr, Off Regulatory Sci, Div Microbiol, College Pk, MD 20993 USA; [Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA; [Strain, Errol; Luo, Yan] US FDA, Ctr Food Safety & Appl Nutr, Off Analyt & Outreach, College Pk, MD USA; [Luong, Khai; Song, Yi; Tsai, Yu-Chih; Boitano, Matthew; Clark, Tyson A.; Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA	US Food & Drug Administration (FDA); New England Biolabs; US Food & Drug Administration (FDA)	Pirone-Davies, C (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Off Regulatory Sci, Div Microbiol, College Pk, MD 20993 USA.	cary.pirone@fda.hhs.gov		Roberts, Richard/0000-0002-4348-0169; Timme, Ruth/0000-0002-9705-5897; Song, Yi/0000-0003-0125-6019; Tsai, Yu-Chih/0000-0002-2958-0278; Clark, Tyson/0000-0002-7779-3227	Center for Food Safety and Applied Nutrition at the US Food and Drug Administration; National Institutes of Health [1R44GM105125]; Research Fellowship Program for Center for Food Safety and Applied Nutrition; New England Biolabs; Pacific Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM105125] Funding Source: NIH RePORTER	Center for Food Safety and Applied Nutrition at the US Food and Drug Administration; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fellowship Program for Center for Food Safety and Applied Nutrition; New England Biolabs; Pacific Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Center for Food Safety and Applied Nutrition at the US Food and Drug Administration, http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/; the National Institutes of Health (grant number 1R44GM105125 to RJR), www.nih.gov; and the Research Fellowship Program for Center for Food Safety and Applied Nutrition, administered by the Oak Ridge Associated Universities to CPD. New England Biolabs and Pacific Biosciences provided support in the form of salaries for authors RJR, KL, YS, YCT, MB, TAC, and JK, but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. However, they did participate in analysis of some of the data; RJR identified methyltransferases in the genomes sequenced, and KL, YS, YCT, MB, TAC, and JK helped assemble several of the genomes. The specific roles of these authors are articulated in the 'author contributions' section.	Allard MW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00081-13; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Blumenthal RM, 2002, MODERN MICROBIAL GEN, P177, DOI [10.1002/047122197X.ch7, DOI 10.1002/047122197X.CH7]; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Broadbent SE, 2007, J BACTERIOL, V189, P4325, DOI 10.1128/JB.01854-06; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cota I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036863; Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; Evans PS, 2014, GENOME ANNOUNC, V2; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; HALE WB, 1994, J BACTERIOL, V176, P3438, DOI 10.1128/jb.176.11.3438-3441.1994; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hoffmann M., 2013, GENOME ANNOUNC, V1; Hoffmann M, GENOME ANNO IN PRESS; Huehn S, 2009, APPL ENVIRON MICROB, V75, P1011, DOI 10.1128/AEM.02187-08; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Loenen W.A., 2013, NUCL ACIDS RES; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5222, DOI 10.1093/nar/gkp535; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schouler C, 1998, MOL MICROBIOL, V28, P169, DOI 10.1046/j.1365-2958.1998.00787.x; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Ventura M, 2006, APPL ENVIRON MICROB, V72, P3130, DOI 10.1128/AEM.72.5.3130-3146.2006; WOODBURY CP, 1980, J BIOL CHEM, V255, P1526; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	40	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123639	10.1371/journal.pone.0123639	http://dx.doi.org/10.1371/journal.pone.0123639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860355	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300107
J	Trujillo-de Santiago, G; Portales-Cabrera, CG; Portillo-Lara, R; Araiz-Hernandez, D; Del Barone, MC; Garcia-Lopez, E; Rojas-de Gante, C; De Santiago-Miramontes, MD; Segoviano-Ramirez, JC; Garcia-Lara, S; Rodriguez-Gonzalez, CA; Alvarez, MM; Di Maio, E; Iannace, S				Trujillo-de Santiago, Grissel; Guadalupe Portales-Cabrera, Cynthia; Portillo-Lara, Roberto; Araiz-Hernandez, Diana; Del Barone, Maria Cristina; Garcia-Lopez, Erika; Rojas-de Gante, Cecilia; de los Angeles De Santiago-Miramontes, Maria; Carlos Segoviano-Ramirez, Juan; Garcia-Lara, Silverio; Angel Rodriguez-Gonzalez, Ciro; Moises Alvarez, Mario; Di Maio, Ernesto; Iannace, Salvatore			Supercritical CO2 Foaming of Thermoplastic Materials Derived from Maize: Proof-of-Concept Use in Mammalian Cell Culture Applications	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BONE REGENERATION; ZEIN FILMS; SCAFFOLDS; BIOCOMPATIBILITY; MICROSTRUCTURE; PCL; BIODEGRADATION; MORPHOLOGY; COMPOSITE	Background Foams are high porosity and low density materials. In nature, they are a common architecture. Some of their relevant technological applications include heat and sound insulation, lightweight materials, and tissue engineering scaffolds. Foams derived from natural polymers are particularly attractive for tissue culture due to their biodegradability and bio-compatibility. Here, the foaming potential of an extensive list of materials was assayed, including slabs elaborated from whole flour, the starch component only, or the protein fraction only of maize seeds. Methodology/Principal Findings We used supercritical CO2 to produce foams from thermoplasticized maize derived materials. Polyethylene-glycol, sorbitol/glycerol, or urea/formamide were used as plasticizers. We report expansion ratios, porosities, average pore sizes, pore morphologies, and pore size distributions for these materials. High porosity foams were obtained from zein thermoplasticized with polyethylene glycol, and from starch thermoplasticized with urea/formamide. Zein foams had a higher porosity than starch foams (88% and 85%, respectively) and a narrower and more evenly distributed pore size. Starch foams exhibited a wider span of pore sizes and a larger average pore size than zein (208.84 vs. 55.43 mu m(2), respectively). Proof-of-concept cell culture experiments confirmed that mouse fibroblasts (NIH 3T3) and two different prostate cancer cell lines (22RV1, DU145) attached to and proliferated on zein foams. Conclusions/Significance We conducted screening and proof-of-concept experiments on the fabrication of foams from cereal-based bioplastics. We propose that a key indicator of foamability is the strain at break of the materials to be foamed (as calculated from stress vs. strain rate curves). Zein foams exhibit attractive properties (average pore size, pore size distribution, and porosity) for cell culture applications; we were able to establish and sustain mammalian cell cultures on zein foams for extended time periods.	[Trujillo-de Santiago, Grissel; Guadalupe Portales-Cabrera, Cynthia; Portillo-Lara, Roberto; Araiz-Hernandez, Diana; Rojas-de Gante, Cecilia; Garcia-Lara, Silverio; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico; [Trujillo-de Santiago, Grissel; Moises Alvarez, Mario] Harvard MIT Helath Sci & Technol, Brigham & Womens Hosp, Cambridge, MA USA; [Del Barone, Maria Cristina; Iannace, Salvatore] CNR, Inst Polymers Composites & Biomat, I-80125 Naples, Italy; [Garcia-Lopez, Erika; Angel Rodriguez-Gonzalez, Ciro] Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, Monterrey, Nuevo Leon, Mexico; [de los Angeles De Santiago-Miramontes, Maria] Univ Autonoma Agr Antonio Narro, Dept Prod Anim, Torreon, Coahuila, Mexico; [Carlos Segoviano-Ramirez, Juan] Univ Autonoma Nuevo Leon, Unidad Bioimagen Microscopia, Monterrey, Nuevo Leon, Mexico; [Di Maio, Ernesto] Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy	Tecnologico de Monterrey; Harvard University; Brigham & Women's Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); Tecnologico de Monterrey; Universidad Autonoma de Nuevo Leon; University of Naples Federico II	Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	mario.alvarez@itesm.mx; edimaio@unina.it	Di Maio, Ernesto/A-6517-2012; Portillo-Lara, Roberto/AAX-5002-2020; García-Lara, Silverio/D-9687-2012; García-Lara, Silverio/B-5746-2009; Segoviano-Ramírez, Juan-Carlos/AAH-5763-2020	Di Maio, Ernesto/0000-0002-3276-174X; Portillo-Lara, Roberto/0000-0002-1781-3126; García-Lara, Silverio/0000-0002-3463-957X; García-Lara, Silverio/0000-0002-3463-957X; Segoviano-Ramírez, Juan-Carlos/0000-0001-9169-2118	Tecnologico de Monterrey [CAT-122]; FEMSA; CONACYT [45964]	Tecnologico de Monterrey; FEMSA; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The financial support of Tecnologico de Monterrey (through the seed fund CAT-122), and FEMSA (through the seed fund for Nutrigenomics Reseach), and CONACYT (through the doctoral scholarship 45964 provided to GTdS) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039; Barrios M, 2013, CRYOGENICS, V55-56, P12, DOI 10.1016/j.cryogenics.2012.11.004; Bhamidipati M, 2013, TISSUE ENG PART B-RE, V19, P221, DOI 10.1089/ten.teb.2012.0361; Cardoso ECL, 2013, RADIAT PHYS CHEM, V84, P170, DOI 10.1016/j.radphyschem.2012.06.023; Castillejo M, 2012, APPL SURF SCI, V258, P8919, DOI 10.1016/j.apsusc.2012.05.118; Chanvrier H, 2006, CARBOHYD POLYM, V65, P346, DOI 10.1016/j.carbpol.2006.01.027; Chiu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060728; Corradini Elisângela, 2007, Mat. Res., V10, P227, DOI 10.1590/S1516-14392007000300002; Corre YM, 2011, J SUPERCRIT FLUID, V58, P177, DOI 10.1016/j.supflu.2011.03.006; Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221; da Silva A, 2013, J APPL POLYM SCI, V130, P3043, DOI 10.1002/app.39526; DANZER LA, 1976, CAN J BIOCHEM CELL B, V54, P196, DOI 10.1139/o76-030; De Barros MA, 2013, MICROSC RES TECHNIQ, V76, P388, DOI 10.1002/jemt.22178; Di Maio E, 2010, J POLYM ENVIRON, V18, P626, DOI 10.1007/s10924-010-0224-x; Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084; Ferkl P, 2013, CHEM ENG SCI, V97, P50, DOI 10.1016/j.ces.2013.04.018; Gillgren T, 2010, J MATER SCI, V45, P5762, DOI 10.1007/s10853-010-4649-3; Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019; Han YL, 2014, COLLOID SURFACE B, V120, P55, DOI 10.1016/j.colsurfb.2014.04.019; Krogars K, 2003, INT J PHARM, V251, P205, DOI 10.1016/S0378-5173(02)00585-9; Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058; Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1; LeBlon CE, 2013, J APPL POLYM SCI, V128, P2701, DOI 10.1002/app.38321; Marrazzo C, 2008, POLYM ENG SCI, V48, P336, DOI 10.1002/pen.20937; Marrazzo C, 2008, J CELL PLAST, V44, P37, DOI 10.1177/0021955X07079147; Moraes C, 2012, ANN BIOMED ENG, V40, P1211, DOI 10.1007/s10439-011-0455-6; Mosanenzadeh SG, 2013, POLYM ENG SCI, V53, P1979, DOI 10.1002/pen.23443; Murua-Pagola B, 2009, J FOOD ENG, V91, P380, DOI 10.1016/j.jfoodeng.2008.09.035; Oh DS, 2013, CERAM INT, V39, P8401, DOI 10.1016/j.ceramint.2013.04.021; Oke MO, 2013, J FOOD PROCESS PRES, V37, P456, DOI 10.1111/j.1745-4549.2011.00661.x; Oliviero M, 2010, J APPL POLYM SCI, V115, P277, DOI 10.1002/app.31116; Peltola P, 2006, POLYM ENG SCI, V46, P995, DOI 10.1002/pen.20586; Peng X, 2013, J CELL PLAST, V49, P147, DOI 10.1177/0021955X13477439; Pushpadass HA, 2008, STARCH-STARKE, V60, P527, DOI 10.1002/star.200800713; Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006; Rojas-de Gante C, 2010, Patent application number, Patent No. [PCT/MX2009/000092, 2009000092]; Salerno A, 2007, INT POLYM PROC, V22, P480, DOI 10.3139/217.2065; Salerno A, 2011, J CELL PLAST, V47, P245, DOI 10.1177/0021955X11404832; Salerno A, 2012, J POROUS MAT, V19, P181, DOI 10.1007/s10934-011-9458-9; Salerno A, 2014, EUR POLYM J, V51, P1, DOI 10.1016/j.eurpolymj.2013.11.015; Salerno A, 2010, COMPOS SCI TECHNOL, V70, P1838, DOI 10.1016/j.compscitech.2010.06.014; Salerno A, 2010, J MATER SCI-MATER M, V21, P2569, DOI 10.1007/s10856-010-4119-0; Song SA, 2013, COMPOS SCI TECHNOL, V76, P45, DOI 10.1016/j.compscitech.2012.12.018; Thielen M, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/025001; Tillekeratne M, 2000, POLYM INT, V49, P127, DOI 10.1002/(SICI)1097-0126(200001)49:1<127::AID-PI320>3.0.CO;2-B; Trujillo-de Santiago G, 2015, J POLYM ENVIRON, V23, P72, DOI 10.1007/s10924-014-0708-1; Trujillo-de Santiago G, 2014, J POLYM ENVIRON, V22, P508, DOI 10.1007/s10924-014-0685-4; Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017; Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330; White LJ, 2012, ACTA BIOMATER, V8, P61, DOI 10.1016/j.actbio.2011.07.032; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071563; Wysokowski M, 2013, INT J BIOL MACROMOL, V62, P94, DOI 10.1016/j.ijbiomac.2013.08.039; Yamane T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073988; Yang M-Y, 2014, J BIOMED MA IN PRESS; Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056; Zhang WH, 2013, J APPL POLYM SCI, V130, P3066, DOI 10.1002/app.39523; Zullo R, 2009, CARBOHYD POLYM, V77, P376, DOI 10.1016/j.carbpol.2009.01.007	57	5	5	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122489	10.1371/journal.pone.0122489	http://dx.doi.org/10.1371/journal.pone.0122489			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859853	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300047
J	Gomez, P; Bennie, J; Gaston, KJ; Buckling, A				Gomez, Pedro; Bennie, Jonathan; Gaston, Kevin J.; Buckling, Angus			The Impact of Resource Availability on Bacterial Resistance to Phages in Soil	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; COMMUNITY; PARASITE; BACTERIOPHAGE; PRODUCTIVITY; ADAPTATION; ENRICHMENT; DIVERSITY; EVOLUTION; DRIVES	Resource availability can affect the coevolutionary dynamics between host and parasites, shaping communities and hence ecosystem function. A key finding from theoretical and in vitro studies is that host resistance evolves to greater levels with increased resources, but the relevance to natural communities is less clear. We took two complementary approaches to investigate the effect of resource availability on the evolution of bacterial resistance to phages in soil. First, we measured the resistance and infectivity of natural communities of soil bacteria and phage in the presence and absence of nutrient-providing plants. Second, we followed the real-time coevolution between defined bacteria and phage populations with resource availability manipulated by the addition or not of an artificial plant root exudate. Increased resource availability resulted in increases in bacterial resistance to phages, but without a concomitant increase in phage infectivity. These results suggest that phages may have a reduced impact on the control of bacterial densities and community composition in stable, high resource environments.	[Gomez, Pedro; Buckling, Angus] Univ Exeter, Biosci, Penryn TR10 9FE, Cornwall, England; [Bennie, Jonathan; Gaston, Kevin J.; Buckling, Angus] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England	University of Exeter; University of Exeter	Gomez, P (corresponding author), CSIC, CEBAS, Dept Stress Biol & Plant Pathol, Campus Espinardo, Murcia 30100, Spain.	pglopez@cebas.csic.es	Gómez López, Pedro/H-2230-2012; López, Pedro Gómez/M-4712-2019	Gómez López, Pedro/0000-0003-2830-4105; López, Pedro Gómez/0000-0003-2830-4105; Gaston, Kevin J./0000-0002-7235-7928; Buckling, Angus/0000-0003-1170-4604; Bennie, Jonathan/0000-0003-4394-2041	NERC; BBSRC; Royal Society; European Research Council [268504]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission)	The work was supported by NERC, the AXA research fund, BBSRC, the Royal Society (A. B.), and European Research Council funding under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268504 (K.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bohannan BJM, 1999, EVOLUTION, V53, P292, DOI 10.1111/j.1558-5646.1999.tb05355.x; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Boots M, 2011, AM NAT, V178, P214, DOI 10.1086/660833; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Gomez P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2297; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Harrison E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0937; Hochberg ME, 1998, AM NAT, V152, P620, DOI 10.1086/286194; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Lopez-Pascua LDC, 2010, J EVOLUTION BIOL, V23, P207, DOI 10.1111/j.1420-9101.2009.01877.x; McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; Mostowy R, 2011, P ROY SOC B-BIOL SCI, V278, P2283, DOI 10.1098/rspb.2010.2359; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pascua LL, 2014, ECOL LETT, V17, P1380, DOI 10.1111/ele.12337; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thomson BC, 2010, MICROB ECOL, V59, P335, DOI 10.1007/s00248-009-9575-z; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08	32	22	23	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123752	10.1371/journal.pone.0123752	http://dx.doi.org/10.1371/journal.pone.0123752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856079	Green Submitted, gold, Green Published			2022-12-26	WOS:000352588500105
J	Kypridemos, C; Bandosz, P; Hickey, GL; Guzman-Castillo, M; Allen, K; Buchan, I; Capewell, S; O'Flaherty, M				Kypridemos, Chris; Bandosz, Piotr; Hickey, Graeme L.; Guzman-Castillo, Maria; Allen, Kirk; Buchan, Iain; Capewell, Simon; O'Flaherty, Martin			Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991-2012: A Modelling Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; SERUM-CHOLESTEROL; UNITED-KINGDOM; TIME TRENDS; ADHERENCE; HEALTH; DIET; INEQUALITIES; METAANALYSIS	Background Serum total cholesterol is one of the major targets for cardiovascular disease prevention. Statins are effective for cholesterol control in individual patients. At the population level, however, their contribution to total cholesterol decline remains unclear. The aim of this study was to quantify the contribution of statins to the observed fall in population mean cholesterol levels in England over the past two decades, and explore any differences between socioeconomic groups. Methods and Findings This is a modelling study based on data from the Health Survey for England. We analysed changes in observed mean total cholesterol levels in the adult England population between 1991-92 (baseline) and 2011-12. We then compared the observed changes with a counterfactual 'no statins' scenario, where the impact of statins on population total cholesterol was estimated and removed. We estimated uncertainty intervals (UI) using Monte Carlo simulation, where confidence intervals (CI) were impractical. In 2011-12, 13.2%(95% CI: 12.5-14.0%) of the English adult population used statins at least once per week, compared with 1991-92 when the proportion was just 0.5% (95% CI: 0.3-1.0%). Between 1991-92 and 2011-12, mean total cholesterol declined from 5.86 mmol/L (95% CI: 5.82-5.90) to 5.17 mmol/L (95% CI: 5.14-5.20). For 2011-12, mean total cholesterol was lower in more deprived groups. In our 'no statins' scenario we predicted a mean total cholesterol of 5.36 mmol/L (95% CI: 5.33-5.40) for 2011-12. Statins were responsible for approximately 33.7% (95% UI: 28.9-38.8%) of the total cholesterol reduction since 1991-92. The statin contribution to cholesterol reduction was greater among the more deprived groups of women, while showing little socio-economic gradient among men. Conclusions Our model suggests that statins explained around a third of the substantial falls in total cholesterol observed in England since 1991. Approximately two thirds of the cholesterol decrease can reasonably be attributed non-pharmacological determinants.	[Kypridemos, Chris; Bandosz, Piotr; Guzman-Castillo, Maria; Allen, Kirk; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Bandosz, Piotr] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Hickey, Graeme L.] Univ Liverpool, Epidemiol & Populat Hlth Inst Infect & Global Hlt, Liverpool L69 3BX, Merseyside, England; [Allen, Kirk] Univ Lancaster, Lancaster Med Sch, Lancaster, England; [Buchan, Iain] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester, Lancs, England	University of Liverpool; Fahrenheit Universities; Medical University Gdansk; University of Liverpool; Lancaster University; University of Manchester	Kypridemos, C (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	c.kypridemos@liverpool.ac.uk	Buchan, Iain E/H-5767-2013; Bandosz, Piotr/E-4964-2017; Kypridemos, Chris/I-4172-2019; Shao, Ruitai/AAU-7642-2021	Buchan, Iain E/0000-0003-3392-1650; Kypridemos, Chris/0000-0002-0746-9229; O'Flaherty, Martin/0000-0001-8944-4131	UK Department of Health; Health and Social Care Information Centre; Medical Research Council Health eResearch Centre [MR/K006665/1]; Medical Research Council [MC_PC_13042, MR/K006665/1, G0900847] Funding Source: researchfish; MRC [MR/K006665/1, G0900847] Funding Source: UKRI	UK Department of Health; Health and Social Care Information Centre; Medical Research Council Health eResearch Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The HSE 1991-92 was funded by the UK Department of Health (https://www.gov.uk/government/organisations/department-of-health). The HSE for 2011 and 2012 was funded by the Health and Social Care Information Centre (http://www.hscic.gov.uk/). This project was supported in part by Medical Research Council Health eResearch Centre grant MR/K006665/1 (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; [Anonymous], 2014, R LANG ENV STAT COMP; Ashworth M, 2007, J PUBLIC HEALTH-UK, V29, P40, DOI 10.1093/pubmed/fdl068; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Blackman T, 2007, BRIT MED J, V334, P902, DOI 10.1136/bmj.39163.563519.55; Boniface S, 2012, HLTH SURVEY ENGLAND; Bouchard MH, 2007, BRIT J CLIN PHARMACO, V63, P698, DOI 10.1111/j.1365-2125.2006.02828.x; Bridges S., 2013, HLTH SURVEY ENGLAND; BRUNNER EJ, 1993, ATHEROSCLEROSIS, V102, P195, DOI 10.1016/0021-9150(93)90162-N; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-641; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chaudhry HJ, 2008, CURR ATHEROSCLER REP, V10, P19, DOI 10.1007/s11883-008-0004-4; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Cochran WG., 1963, SAMPLING TECHNIQUES; Cohen JD, 2010, AM J CARDIOL, V106, P969, DOI 10.1016/j.amjcard.2010.05.030; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 P; Department of Health, PHARM PRESCR STAT; Edwards Jayne E, 2003, BMC Fam Pract, V4, P18, DOI 10.1186/1471-2296-4-18; Ekstrom C., 2014, MESS MISCELLANEOUS E; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Franks P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-68; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; Gazmararian JA, 2006, J GEN INTERN MED, V21, P1215, DOI 10.1111/j.1525-1497.2006.00591.x; Health and Social Care Information Centre, 2013, PRESCR COST AN 2012; Health and Social Care Information Centre, 2011, PRESCR COST AN 2011; Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Jorgensen T, 2013, EUR J PREV CARDIOL, V20, P409, DOI 10.1177/2047487312441726; Kong SXD, 1997, CLIN THER, V19, P778, DOI 10.1016/S0149-2918(97)80102-6; Korn E, 1998, SURV METHODOL, V24, P193; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lumley T., 2013, SURVEY ANAL COMPLEX; Morton GM, 1995, J HUM NUTR DIET, V8, P429, DOI 10.1111/j.1365-277X.1995.tb00338.x; NatCen Social Research, 2011, HLTH SURV ENGL; NatCen Social Research University College London Department of Epidemiology and Public Health, 2014, HLTH SURV ENGL; National Clinical Guideline Center, 2014, LIP MOD CARD RISK AS; Office for National Statistics, 2012, STAND OCC CLASS SOC; Office of Population Censuses and Surveys. Social Survey Division, 1997, HLTH SURV ENGL 1991; Ohlsson H, 2010, J EPIDEMIOL COMMUN H, V64, P678, DOI 10.1136/jech.2008.081166; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; Stocks NP, 2004, MED J AUSTRALIA, V180, P229, DOI 10.5694/j.1326-5377.2004.tb05891.x; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sugiyama T, 2014, JAMA INTERN MED, V174, P1038, DOI 10.1001/jamainternmed.2014.1927; The Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group, GLOB BURD MET RISK F; Thompson R, 2014, NICE STATIN LETT LAT; Thomsen RW, 2005, BRIT J CLIN PHARMACO, V60, P534, DOI 10.1111/j.1365-2125.2005.02494.x; Thorsson B, 2013, EUR HEART J, V34, P1778, DOI 10.1093/eurheartj/ehs395; Townsend N, 2012, CORONARY HEART DIS S; UK Data Service, HLTH SURV ENGL 1991; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Valsta LM, 2010, PUBLIC HEALTH NUTR, V13, P932, DOI 10.1017/S1368980010001126; Wallach-Kildemoes H, 2013, EUR J CLIN PHARMACOL, V69, P1553, DOI 10.1007/s00228-013-1488-6; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3937; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611	63	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123112	10.1371/journal.pone.0123112	http://dx.doi.org/10.1371/journal.pone.0123112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856394	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500074
J	Singh, P; Mohanta, TK; Sinha, AK				Singh, Pallavi; Mohanta, Tapan Kumar; Sinha, Alok Krishna			Unraveling the Intricate Nexus of Molecular Mechanisms Governing Rice Root Development: OsMPK3/6 and Auxin-Cytokinin Interplay	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; VASCULAR DIFFERENTIATION; STOMATAL DEVELOPMENT; PLANT MAPK; ARABIDOPSIS; CELL; EXPRESSION; TRANSPORT; STRESS; MPK6	The root system is an imperative component of a plant, involved in water and nutrient acquisition from the soil. Any subtle change in the root system may lead to drastic changes in plant productivity. Both auxin and cytokinin are implicated in regulating various root developmental aspects. One of the major signaling cascades facilitating various hormonal and developmental allocations is the Mitogen Activated Protein Kinase (MAPK) cascade. Innumerable efforts have been made to unravel the complex nexus involved in rice root development. In spite of a plethora of studies, a comprehensive study aiming to decipher the plausible cross-talk of MAPK signaling module with auxin and cytokinin signaling components in rice is missing. In the present study, extensive phenomics analysis of different stages of rice roots; transcript profiling by qRT-PCR of entire gene family of MAPK, MAPKK and PIN genes; as well as protein level and activity of potential MAPKs was investigated using western and immuno kinase assays both on auxin and cytokinin treatment. The above study led to the identification of various novel rice root specific phenotypic traits by using GiA roots software framework. High expression profile of OsMPK3/6, OsMKK4/5 and OsPIN 1b/9 and their marked transcript level modulation in response to both auxin and cytokinin was observed. Finally, the protein levels and activity assay further substantiated our present findings. Thus, OsMPK3/6-OsMKK4/5 module is elucidated as the putative, key player in auxin-cytokinin interaction augmenting their role by differentially regulating the expression patterns of OsPIN 1b/9 in root development in rice.	[Singh, Pallavi; Mohanta, Tapan Kumar; Sinha, Alok Krishna] Natl Inst Plant Genome Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Sinha, AK (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	alok@nipgr.ac.in	Singh, Pallavi/AAU-2254-2020; Mohanta, Tapan Kumar/F-9907-2018	Singh, Pallavi/0000-0003-3694-6378; Mohanta, Tapan Kumar/0000-0002-3196-7746	Department of Biotechnology (DBT), Govt of India, New Delhi [BT/PR3298/AGR/2/812/2011]	Department of Biotechnology (DBT), Govt of India, New Delhi(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology (DBT), Govt of India, New Delhi, DBT Sanction Order No.: BT/PR3298/AGR/2/812/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2006, ANN BOT-LONDON, V97, P883, DOI 10.1093/aob/mcl027; Aloni R, 2013, PLANTA, V238, P819, DOI 10.1007/s00425-013-1927-8; Bielach A, 2012, PHILOS T R SOC B, V367, P1469, DOI 10.1098/rstb.2011.0233; Bishopp A, 2011, CURR OPIN PLANT BIOL, V14, P10, DOI 10.1016/j.pbi.2010.08.014; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Doczi R, 2012, TRENDS PLANT SCI, V17, P518, DOI 10.1016/j.tplants.2012.05.009; Durbak A, 2012, CURR OPIN PLANT BIOL, V15, P92, DOI 10.1016/j.pbi.2011.12.004; Fridman Y, 2014, GENE DEV, V28, P912, DOI 10.1101/gad.239335.114; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Han S, 2014, J PLANT PHYSIOL, V171, P26, DOI 10.1016/j.jplph.2013.09.023; Hirt H, 2000, P NATL ACAD SCI USA, V97, P2405, DOI 10.1073/pnas.97.6.2405; Hord CLH, 2008, MOL PLANT, V1, P645, DOI 10.1093/mp/ssn029; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Jones B, 2010, PLANT CELL, V22, P2956, DOI 10.1105/tpc.110.074856; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bucio JS, 2014, J EXP BOT, V65, P169, DOI 10.1093/jxb/ert368; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Muller J, 2010, PLANT J, V61, P234, DOI 10.1111/j.1365-313X.2009.04046.x; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Raghuram B, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29804; Raina SK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-134; Rao KP, 2011, ARCH BIOCHEM BIOPHYS, V506, P73, DOI 10.1016/j.abb.2010.11.006; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saini S, 2013, PLANT CELL REP, V32, P741, DOI 10.1007/s00299-013-1430-5; Samaj J, 2003, CELL BIOL INT, V27, P257, DOI 10.1016/S1065-6995(02)00344-X; Samajova O, 2013, BIOTECHNOL ADV, V31, P118, DOI 10.1016/j.biotechadv.2011.12.002; Sethi V, 2014, PLANT CELL, V26, P3343, DOI 10.1105/tpc.114.128702; Singh R, 2013, PLANT CELL REP, V32, P923, DOI 10.1007/s00299-013-1437-y; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Smekalova V, 2014, NEW PHYTOL; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Wankhede DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065011; Zeng QN, 2011, PLANT SIGNAL BEHAV, V6, P1436, DOI 10.4161/psb.6.10.17089; Zhang XD, 2008, PLANT SIGNAL BEHAV, V3, P272, DOI 10.4161/psb.3.4.5230	50	33	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123620	10.1371/journal.pone.0123620	http://dx.doi.org/10.1371/journal.pone.0123620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856151	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500099
J	Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P				Troppan, Katharina; Hofer, Sybille; Wenzl, Kerstin; Lassnig, Markus; Pursche, Beata; Steinbauer, Elisabeth; Wiltgen, Marco; Zulus, Barbara; Renner, Wilfried; Beham-Schmid, Christine; Deutsch, Alexander; Neumeister, Peter			Frequent Down Regulation of the Tumor Suppressor Gene A20 in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; CELL LYMPHOMA; MARGINAL ZONE; TNFAIP3 A20; MUTATIONS; DISEASE; EXPRESSION; ABNORMALITIES; ACTIVATION; PATHWAYS	Multiple myeloma (MM) is a malignant clonal expansion of plasma cells in the bone marrow and belongs to the mature B-cell neoplams. The pathogenesis of MM is associated with constitutive NF-kappa B activation. However, genetic alterations causing constitutive NF-kappa B activation are still incompletely understood. Since A20 (TNFAIP3) is a suppressor of the NF-kappa B pathway and is frequently inactivated in various lymphoid malignancies, we investigated the genetic and epigenetic properties of A20 in MM. In total, of 46 patient specimens analyzed, 3 single base pair exchanges, 2 synonymous mutations and one missense mutation were detected by direct sequencing. Gene copy number analysis revealed a reduced A20 gene copy number in 8 of 45 (17.7%) patients. Furthermore, immunohistochemical staining confirmed that A20 expression correlates with the reduction of A20 gene copy number. These data suggest that A20 contributes to tumor formation in a significant fraction of myeloma patients.	[Troppan, Katharina; Hofer, Sybille; Wenzl, Kerstin; Lassnig, Markus; Pursche, Beata; Deutsch, Alexander; Neumeister, Peter] Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria; [Steinbauer, Elisabeth; Beham-Schmid, Christine] Med Univ Graz, Inst Pathol, Graz, Austria; [Wiltgen, Marco] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Zulus, Barbara; Renner, Wilfried] Med Univ Graz, Div Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Deutsch, A (corresponding author), Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria.	alexander.deutsch@medunigraz.at	Prochazka, Katharina/F-3639-2017; Deutsch, Alexander AJ/F-2168-2010	Prochazka, Katharina/0000-0002-7201-5987; Deutsch, Alexander AJ/0000-0003-0914-2809	Fellinger Krebsforschung; Land Steiermark; Hygienefond; Jubilaeumsfond der OENB; TART-Funding-Program of the Medical University of Graz	Fellinger Krebsforschung; Land Steiermark; Hygienefond; Jubilaeumsfond der OENB; TART-Funding-Program of the Medical University of Graz	This work was supported by grants from Fellinger Krebsforschung, Land Steiermark, Hygienefond, and Jubilaeumsfond der OENB and by the START-Funding-Program of the Medical University of Graz and the city of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Braggio E, 2012, MODERN PATHOL, V25, P651, DOI 10.1038/modpathol.2011.213; Braggio E, 2009, CANCER RES, V69, P3579, DOI 10.1158/0008-5472.CAN-08-3701; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Chanudet E, 2010, LEUKEMIA, V24, P483, DOI 10.1038/leu.2009.234; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Crawford LJ, 2012, MULTIPLE MYELOMA OVE, P1; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Deutsch AJA, 2008, J PATHOL, V215, P431, DOI 10.1002/path.2372; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Jensen F., 2007, INTRO COMPUTATIONAL; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim WS, 2007, GENE CHROMOSOME CANC, V46, P776, DOI 10.1002/gcc.20463; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Mohamed AN, 2007, AM J HEMATOL, V82, P1080, DOI 10.1002/ajh.20998; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ni H, 2001, BRIT J HAEMATOL, V115, P279, DOI 10.1046/j.1365-2141.2001.03102.x; Nocturne G, 2013, BLOOD, V122, P4068, DOI 10.1182/blood-2013-05-503383; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rinaldi A, 2008, ASH ANNUAL MEETING A, V112, P622; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Thelander EF, 2008, LEUKEMIA LYMPHOMA, V49, P477, DOI 10.1080/10428190701817282; Wiltgen M, 2009, CURR BIOINFORM, V4, P54, DOI 10.2174/157489309787158170	39	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123922	10.1371/journal.pone.0123922	http://dx.doi.org/10.1371/journal.pone.0123922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856582	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500109
J	Ge, C; Zhao, G; Li, Y; Li, H; Zhao, X; Pannone, G; Bufo, P; Santoro, A; Sanguedolce, F; Tortorella, S; Mattoni, M; Papagerakis, S; Keller, ET; Franceschi, RT				Ge, C.; Zhao, G.; Li, Y.; Li, H.; Zhao, X.; Pannone, G.; Bufo, P.; Santoro, A.; Sanguedolce, F.; Tortorella, S.; Mattoni, M.; Papagerakis, S.; Keller, E. T.; Franceschi, R. T.			Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease	ONCOGENE			English	Article							SIGNAL-REGULATED KINASE; TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; MOUSE MODEL; IN-VIVO; GENE; ACTIVATION; ANDROGEN; PROTEIN; EXPRESSION	The osteogenic transcription factor, Runx2, is abnormally expressed in prostate cancer (PCa) and associated with metastatic disease. During bone development, Runx2 is activated by signals known to be hyperactive in PCa including the RAS/MAP kinase pathway, which phosphorylates Runx2 on multiple serine residues including S301 and S319 (equivalent to S294 and S312 in human Runx2). This study examines the role of these phosphorylation sites in PCa. Runx2 was preferentially expressed in more invasive PCa cell lines (PC34C4-2B4LNCaP). Furthermore, analysis using a P-S319-Runx2-specific antibody revealed that the ratio of P-S319-Runx2/total Runx2 as well as P-ERK/total ERK was highest in PC3 followed by C4-2B and LNCaP cells. These results were confirmed by immunofluorescence confocal microscopy, which showed a higher percentage of PC3 cells staining positive for P-S319-Runx2 relative to C4-2B and LNCaP cells. Phosphorylated Runx2 had an exclusively nuclear localization. When expressed in prostate cell lines, wild-type Runx2 increased metastasis-associated gene expression, in vitro migratory and invasive activity as well as in vivo growth of tumor cell xenografts. In contrast, S301A/S319A phosphorylation site mutations greatly attenuated these Runx2 responses. Analysis of tissue microarrays from 129 patients revealed strong nuclear staining with the P-S319-Runx2 antibody in primary PCas and metastases. P-S319-Runx2 staining was positively correlated with Gleason score and occurrence of lymph node metastases while little or no Runx2 phosphorylation was seen in normal prostate, benign prostate hyperplasia or prostatitis indicating that Runx2 S319 phosphorylation is closely associated with PCa induction and progression towards an aggressive phenotype. These studies establish the importance of Runx2 phosphorylation in prostate tumor growth and highlight its value as a potential diagnostic marker and therapeutic target.	[Ge, C.; Zhao, G.; Li, Y.; Li, H.; Zhao, X.; Papagerakis, S.; Franceschi, R. T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, 1011N Univ Ave, Ann Arbor, MI 48109 USA; [Pannone, G.; Bufo, P.; Santoro, A.; Sanguedolce, F.; Tortorella, S.; Mattoni, M.] Univ Foggia, Dept Clin & Expt Med, Sect Anat Pathol, Foggia, Italy; [Bufo, P.] RCCS Ctr Riferimento Oncol Basilicata Rionero Vul, Potenza, Italy; [Papagerakis, S.] Univ Michigan, Sch Med, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA; [Keller, E. T.] Univ Michigan, Sch Med, Lab Anim Med, Ann Arbor, MI 48109 USA; [Franceschi, R. T.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Foggia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Franceschi, RT (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, 1011N Univ Ave, Ann Arbor, MI 48109 USA.	rennyf@umich.edu	santoro, angela/AAC-2025-2019; FRANCESCHI, RENNY/K-3533-2019; Santoro, Angela/AAC-5833-2022; Keller, Evan T/M-1446-2016	santoro, angela/0000-0002-6964-5152; Keller, Evan T/0000-0002-7592-7535; Sanguedolce, Francesca/0000-0001-7459-3521	Department of Defense [W81XWH-11-1-0317]; National Institutes of Health [P01 CA093900]; I.R.C.C.S Centro di Riferimento Oncologico Della Basilicata Rionero in Vulture; NATIONAL CANCER INSTITUTE [R01CA108975, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011723, K12DE023574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES010016] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I.R.C.C.S Centro di Riferimento Oncologico Della Basilicata Rionero in Vulture; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by award number W81XWH-11-1-0317 from the Department of Defense (to RTF), and P01 CA093900 from the National Institutes of Health (EK) and I.R.C.C.S Centro di Riferimento Oncologico Della Basilicata Rionero in Vulture (PB). The pOPN-Luc plasmid was a generous gift from Dr. Martha Somerman (NIDCR).	AKECH J, 2009, ONCOGENE, V2009, P1; Aytes A, 2013, P NATL ACAD SCI USA, V110, pE3506, DOI 10.1073/pnas.1303558110; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Browne G, 2012, BRIT J CANCER, V107, P1714, DOI 10.1038/bjc.2012.455; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; Chua CW, 2009, CLIN CANCER RES, V15, P4322, DOI 10.1158/1078-0432.CCR-08-3157; Fatherazi S, 2009, J DENT RES, V88, P39, DOI 10.1177/0022034508328072; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Gioeli D, 1999, CANCER RES, V59, P279; Goh YM, 2010, J BIOL CHEM, V285, P10122, DOI 10.1074/jbc.M109.071381; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Gupta A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-66; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kim HR, 2008, J CELL BIOCHEM, V105, P1048, DOI 10.1002/jcb.21906; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Li Y, 2012, J BONE MINER RES, V27, P1263, DOI 10.1002/jbmr.1574; Li Y, 2010, J BONE MINER RES, V25, P154, DOI 10.1359/jbmr.090705; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pande S, 2013, J CELL PHYSIOL, V228, P1784, DOI 10.1002/jcp.24339; Pockwinse SM, 2006, J CELL PHYSIOL, V206, P354, DOI 10.1002/jcp.20469; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THALMANN GN, 1994, CANCER RES, V54, P2577; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; van der Deen M, 2010, J CELL BIOCHEM, V109, P828, DOI 10.1002/jcb.22463; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; WARE JL, 1982, J UROLOGY, V128, P1064, DOI 10.1016/S0022-5347(17)53345-5; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yoshimi M, 2012, EUR J IMMUNOL, V42, P1044, DOI 10.1002/eji.201040746; Yun SJ, 2012, PROSTATE CANCER P D, V15, P369, DOI 10.1038/pcan.2012.31; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411; ZHENG CF, 1993, J BIOL CHEM, V268, P23933	54	44	44	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					366	376		10.1038/onc.2015.91	http://dx.doi.org/10.1038/onc.2015.91			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25867060	Green Accepted			2022-12-26	WOS:000369055300010
J	Zunino, B; Rubio-Patino, C; Villa, E; Meynet, O; Proics, E; Cornille, A; Pommier, S; Mondragon, L; Chiche, J; Bereder, JM; Carles, M; Ricci, JE				Zunino, B.; Rubio-Patino, C.; Villa, E.; Meynet, O.; Proics, E.; Cornille, A.; Pommier, S.; Mondragon, L.; Chiche, J.; Bereder, J-M; Carles, M.; Ricci, J-E			Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90	ONCOGENE			English	Article							PERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; DENDRITIC CELL; CANCER; TUMOR; HEAT-SHOCK-PROTEIN-90; IMMUNOSURVEILLANCE; INHIBITION; APOPTOSIS	The occurrence of peritoneal carcinomatosis is a major cause of treatment failure in colorectal cancer and is considered incurable. However, new therapeutic approaches have been proposed, including cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Although HIPEC has been effective in selected patients, it is not known how HIPEC prolongs a patient's lifespan. Here, we have demonstrated that HIPEC-treated tumor cells induce the activation of tumor-specific T cells and lead to vaccination against tumor cells in mice. We have established that this effect results from the HIPEC-mediated exposure of heat shock protein (HSP) 90 at the plasma membrane. Inhibition or blocking of HSP90, but not HSP70, prevented the HIPECmediated antitumoral vaccination. Our work raises the possibility that the HIPEC procedure not only kills tumor cells but also induces an efficient anticancer immune response, therefore opening new opportunities for cancer treatment.	[Zunino, B.; Rubio-Patino, C.; Villa, E.; Meynet, O.; Proics, E.; Cornille, A.; Pommier, S.; Mondragon, L.; Chiche, J.; Carles, M.; Ricci, J-E] Ctr Mediterraneen Med Mol C3M, INSERM, U1065, Equipe Controle Metab Morts Cellulaires, F-06204 Nice 03, France; [Zunino, B.; Rubio-Patino, C.; Villa, E.; Meynet, O.; Proics, E.; Cornille, A.; Pommier, S.; Mondragon, L.; Chiche, J.; Carles, M.; Ricci, J-E] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France; [Zunino, B.; Pommier, S.; Carles, M.; Ricci, J-E] CHU Nice, Dept Anesthesie Reanimat, F-06202 Nice, France; [Bereder, J-M] CHU Nice, Serv Chirurg Gen & Cancerol Digest, F-06202 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice	Ricci, JE (corresponding author), Ctr Mediterraneen Med Mol C3M, INSERM, U1065, Equipe Controle Metab Morts Cellulaires, 151 Route St Antoine de Ginestiere,BP 23194, F-06204 Nice 03, France.	ricci@unice.fr	Martinez, Laura Mondragon/P-1670-2018; Martinez, Laura Mondragon/X-1577-2019; Ricci, Jean Ehrland/I-7117-2016; Chiche, Johanna/P-6382-2016; Carles, Michel/CAH-0065-2022; RICCI, Jean Ehrland/AAS-4379-2020	Martinez, Laura Mondragon/0000-0002-3257-045X; Martinez, Laura Mondragon/0000-0002-3257-045X; Ricci, Jean Ehrland/0000-0003-1585-8117; Chiche, Johanna/0000-0001-5276-1125; RICCI, Jean Ehrland/0000-0003-1585-8117; CARLES, MICHEL/0000-0001-5485-1511; Rubio-Patino, Camila/0000-0002-0489-2419	Fondation ARC (Association pour la Recherche sur le Cancer); Agence Nationale de la Recherche (LABEX SIGNALIFE) [ANR-11-LABX-0028-01]; Fondation ARC; la Ville de Nice; Fondation pour la Recherche Medicale (FRM); la Fondation de France	Fondation ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (LABEX SIGNALIFE)(French National Research Agency (ANR)); Fondation ARC; la Ville de Nice; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); la Fondation de France(Fondation de France)	We gratefully acknowledge the Centre Mediterraneen de Medecine Moleculaire animal room and imaging facilities. We thank Jozef Bossowski, Drs Raucoules and Benchimol, Benjamin Lefebvre and all of the operating room and surgical digestive service nurses for their help. This work was supported by the Fondation ARC (Association pour la Recherche sur le Cancer), the Agence Nationale de la Recherche (LABEX SIGNALIFE ANR-11-LABX-0028-01). CRP is supported by the Fondation ARC, LM is supported by la Ville de Nice and by Fondation pour la Recherche Medicale (FRM) and JC is supported by la Fondation de France.	Bae J, 2007, J IMMUNOL, V178, P7730, DOI 10.4049/jimmunol.178.12.7730; Beneteau M, 2012, P NATL ACAD SCI USA, V109, P20071, DOI 10.1073/pnas.1206360109; Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO;2; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Elias D, 2009, J CLIN ONCOL, V27, P681, DOI 10.1200/JCO.2008.19.7160; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; Kepp O, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.955691; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Klaver YLB, 2010, BRIT J SURG, V97, P1874, DOI 10.1002/bjs.7249; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Pelz JOW, 2013, ANN SURG ONCOL, V20, P1105, DOI 10.1245/s10434-012-2784-6; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Schmitt E, 2006, CANCER RES, V66, P4191, DOI 10.1158/0008-5472.CAN-05-3778; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Spiliotis JD, 2010, HEPATO-GASTROENTEROL, V57, P1173; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Sugarbaker PH, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/623417; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Wilke CM, 2010, INT J CANCER, V127, P748, DOI 10.1002/ijc.25464; Yang XJ, 2009, ANN SURG ONCOL, V16, P345, DOI 10.1245/s10434-008-0226-2; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	26	34	45	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					261	268		10.1038/onc.2015.82	http://dx.doi.org/10.1038/onc.2015.82			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25867070				2022-12-26	WOS:000368193900012
J	Norris, KL; Hao, R; Chen, LF; Lai, CH; Kapur, M; Shaughnessy, PJ; Chou, D; Yan, J; Taylor, JP; Engelender, S; West, AE; Lim, KL; Yao, TP				Norris, Kristi L.; Hao, Rui; Chen, Liang-Fu; Lai, Chun-Hsiang; Kapur, Meghan; Shaughnessy, Peter J.; Chou, Dennis; Yan, Jin; Taylor, J. Paul; Engelender, Simone; West, Anna E.; Lim, Kah-Leong; Yao, Tso-Pang			Convergence of Parkin, PINK1, and alpha-Synuclein on Stress-induced Mitochondrial Morphological Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY FORMATION; HUMAN-CELLS; DISEASE; MITOPHAGY; FUSION; PROTEIN; SYNPHILIN-1; MEMBRANE; UBIQUITINATION; DEGENERATION	Mutations in PARKIN (PARK2), an ubiquitin ligase, cause early onset Parkinson disease. Parkin was shown to bind, ubiquitinate, and target depolarized mitochondria for destruction by autophagy. This process, mitophagy, is considered crucial for maintaining mitochondrial integrity and suppressing Parkinsonism. Here, we report that under moderate mitochondrial stress, parkin does not translocate to mitochondria to induce mitophagy; rather, it stimulates mitochondrial connectivity. Mitochondrial stress-induced fusion requires PINK1 (PARK6), mitofusins, and parkin ubiquitin ligase activity. Upon exposure to mitochondrial toxins, parkin binds alpha-synuclein (PARK1), and in conjunction with the ubiquitin-conjugating enzyme Ubc13, stimulates K63-linked ubiquitination. Importantly, alpha-synuclein inactivation phenocopies parkin overexpression and suppresses stress-induced mitochondria fission, whereas Ubc13 inactivation abrogates parkin-dependent mitochondrial fusion. The convergence of parkin, PINK1, and alpha-synuclein on mitochondrial dynamics uncovers a common function of these PARK genes in the mitochondrial stress response and provides a potential physiological basis for the prevalence of alpha-synuclein pathology in Parkinson disease.	[Norris, Kristi L.; Hao, Rui; Lai, Chun-Hsiang; Kapur, Meghan; Shaughnessy, Peter J.; Chou, Dennis; Yan, Jin; Yao, Tso-Pang] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Chen, Liang-Fu; West, Anna E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Engelender, Simone] Technion Israel Inst Technol, Rappaport Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel; [Engelender, Simone] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Duke University; Duke University; St Jude Children's Research Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National University of Singapore	Yao, TP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	tsopang.yao@dm.duke.edu	Lim, Kah-Leong/AAY-3308-2020; Taylor, J. Paul/N-2482-2018; soler, martha maricel m gomez/L-6025-2014; Lim, Kah/L-5426-2019; Regan, Clinton/E-6250-2012	Taylor, J. Paul/0000-0002-5794-0349; soler, martha maricel m gomez/0000-0002-4412-8108; Engelender, Simone/0000-0001-7401-6855; Lim, Kah-Leong/0000-0002-5440-2588	National Institutes of Health [T32-CA-059365, 1R01DA033610, 2R01-NS054022]; Leukemia and Lymphoma Society [5396-11]; NATIONAL CANCER INSTITUTE [T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T32-CA-059365 (to K. L. N.), 1R01DA033610 (to A. E. W.), and 2R01-NS054022 (to T. P. Y.) and Leukemia and Lymphoma Society Grant 5396-11 (to K. L. N.).	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Chan N. C., 2011, HUMAN MOL GENET; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; DEXTER DT, 1994, ANN NEUROL, V35, P38, DOI 10.1002/ana.410350107; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Miyakawa S, 2013, MOVEMENT DISORD, V28, P388, DOI 10.1002/mds.25346; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Musgrove REJ, 2013, NEUROTOX RES, V23, P358, DOI 10.1007/s12640-012-9352-5; Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	45	55	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13862	13874		10.1074/jbc.M114.634063	http://dx.doi.org/10.1074/jbc.M114.634063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25861987	Green Published, hybrid			2022-12-26	WOS:000355313000019
J	De Niz, M; Helm, S; Horstmann, S; Annoura, T; del Portillo, HA; Khan, SM; Heussler, VT				De Niz, Mariana; Helm, Susanne; Horstmann, Sebastian; Annoura, Takeshi; del Portillo, Hernando A.; Khan, Shahid M.; Heussler, Volker T.			In Vivo and In Vitro Characterization of a Plasmodium Liver Stage-Specific Promoter	PLOS ONE			English	Article							FIREFLY LUCIFERASE; EXOERYTHROCYTIC SCHIZONTS; DNA-BINDING; BIOLUMINESCENCE; ANTIGEN; LOCALIZATION; INHIBITION; DISCOVERY; PARASITES; PROTEINS	Little is known about stage-specific gene regulation in Plasmodium parasites, in particular the liver stage of development. We have previously described in the Plasmodium berghei rodent model, a liver stage-specific (lisp2) gene promoter region, in vitro. Using a dual luminescence system, we now confirm the stage specificity of this promoter region also in vivo. Furthermore, by substitution and deletion analyses we have extended our in vitro characterization of important elements within the promoter region. Importantly, the dual luminescence system allows analyzing promoter constructs avoiding mouse-consuming cloning procedures of transgenic parasites. This makes extensive mutation and deletion studies a reasonable approach also in the malaria mouse model. Stage-specific expression constructs and parasite lines are extremely valuable tools for research on Plasmodium liver stage biology. Such reporter lines offer a promising opportunity for assessment of liver stage drugs, characterization of genetically attenuated parasites and liver stage-specific vaccines both in vivo and in vitro, and may be key for the generation of inducible systems.	[De Niz, Mariana; Heussler, Volker T.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Helm, Susanne; Horstmann, Sebastian] Bernhard Nocht Inst Trop Med, Mol Parasitol, D-20359 Hamburg, Germany; [Annoura, Takeshi; Khan, Shahid M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden, Netherlands; [Annoura, Takeshi] NIID, Dept Parasitol, Tokyo, Japan; [del Portillo, Hernando A.] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [del Portillo, Hernando A.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	University of Bern; Bernhard Nocht Institut fur Tropenmedizin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institute of Infectious Diseases (NIID); ISGlobal; CRESIB; ICREA	De Niz, M (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	mariana.denizhidalgo@izb.unibe.ch	Heussler, Volker/H-9322-2019; Annoura, Takeshi/AAS-7911-2021; del Portillo Obando, Hernando A/L-2131-2014	Heussler, Volker/0000-0001-8028-9825; Khan, Shahid/0000-0002-0533-4670; De Niz, Mariana/0000-0001-6987-6789; del Portillo Obando, Hernando A/0000-0002-5278-3452	Swiss National Foundation [310030_140691/1]; Swiss SystemsX Consortium; European Union [242095]; ICREA Funding Source: Custom	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss SystemsX Consortium; European Union(European Commission); ICREA(ICREA)	This work was supported by the Swiss National Foundation grant to VH (310030_140691/1), the Swiss SystemsX Consortium and European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095: EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; Annoura Takeshi, 2013, Methods Mol Biol, V923, P429; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; ATKINSON CT, 1989, AM J TROP MED HYG, V40, P131, DOI 10.4269/ajtmh.1989.40.131; ATKINSON CT, 1992, AM J TROP MED HYG, V46, P533, DOI 10.4269/ajtmh.1992.46.533; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/NMETH.2839, 10.1038/nmeth.2839]; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Hasenkamp S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-58; Hasenkamp S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-42; Helm S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013653; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Keyaerts M, 2012, PLOS ONE, V7, P374, DOI 10.1371/journal.pone.0030061; Kimura T, 2010, J GENE MED, V12, P528, DOI 10.1002/jgm.1463; Lin Jing-Wen, 2013, Methods Mol Biol, V923, P507; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; McNabb DS, 2005, EUKARYOT CELL, V4, P1539, DOI 10.1128/EC.4.9.1539-1549.2005; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Miller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060820; Mwakingwe A, 2009, J INFECT DIS, V200, P1470, DOI 10.1086/606115; Nagel A, 2013, INT J PARASITOL, V43, P503, DOI 10.1016/j.ijpara.2013.01.010; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Nganou-Makamdop K, 2012, PARASITE IMMUNOLOGY; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Orito Y, 2013, MOL MICROBIOL, V87, P66, DOI 10.1111/mmi.12083; Ploemen I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-350; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Szarecka A, 2007, BIOPHYS J, V93, P1895, DOI 10.1529/biophysj.106.102780; Vilalta M, 2009, BIOMATERIALS, V30, P4986, DOI 10.1016/j.biomaterials.2009.05.056; Wendt MK, 2011, JOVE-J VIS EXP, DOI 10.3791/3245; Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	51	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123473	10.1371/journal.pone.0123473	http://dx.doi.org/10.1371/journal.pone.0123473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874388	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800101
J	Mester, D; Ronin, Y; Schnable, P; Aluru, S; Korol, A				Mester, David; Ronin, Yefim; Schnable, Patrick; Aluru, Srinivas; Korol, Abraham			Fast and Accurate Construction of Ultra-Dense Consensus Genetic Maps Using Evolution Strategy Optimization	PLOS ONE			English	Article							ALGORITHMS	Our aim was to develop a fast and accurate algorithm for constructing consensus genetic maps for chip-based SNP genotyping data with a high proportion of shared markers between mapping populations. Chip-based genotyping of SNP markers allows producing high-density genetic maps with a relatively standardized set of marker loci for different mapping populations. The availability of a standard high-throughput mapping platform simplifies consensus analysis by ignoring unique markers at the stage of consensus mapping thereby reducing mathematical complicity of the problem and in turn analyzing bigger size mapping data using global optimization criteria instead of local ones. Our three-phase analytical scheme includes automatic selection of similar to 100-300 of the most informative (resolvable by recombination) markers per linkage group, building a stable skeletal marker order for each data set and its verification using jackknife re-sampling, and consensus mapping analysis based on global optimization criterion. A novel Evolution Strategy optimization algorithm with a global optimization criterion presented in this paper is able to generate high quality, ultra-dense consensus maps, with many thousands of markers per genome. This algorithm utilizes "potentially good orders" in the initial solution and in the new mutation procedures that generate trial solutions, enabling to obtain a consensus order in reasonable time. The developed algorithm, tested on a wide range of simulated data and real world data (Arabidopsis), outperformed two tested state-of-the-art algorithms by mapping accuracy and computation time.	[Mester, David; Ronin, Yefim; Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Schnable, Patrick] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Aluru, Srinivas] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA USA	University of Haifa; Iowa State University; Iowa State University	Mester, D (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	dmester@research.haifa.ac.il; korol@research.haifa.ac.il		Schnable, Patrick/0000-0001-9169-5204				Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Chen X, 2010, J COMPUT BIOL, V17, P1561, DOI 10.1089/cmb.2009.0268; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-407; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; FLOOD MM, 1956, OPER RES, V4, P61, DOI 10.1287/opre.4.1.61; Jackson BN, 2008, IEEE ACM T COMPUT BI, V5, P161, DOI 10.1109/TCBB.2007.70221; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; Kwitek AE, 2001, GENOME RES, V11, P1935, DOI 10.1101/gr.173701; Mester D, 2003, GENETICS, V165, P2269; Mester D, 2010, GEN-RES ISSUES, P1; Mester DI, 2006, COMPUT BIOL CHEM, V30, P12, DOI 10.1016/j.compbiolchem.2005.09.007; Mester DI, 2004, COMPUT BIOL CHEM, V28, P281, DOI 10.1016/j.compbiolchem.2004.08.003; Or I., 1976, THESIS N W U US; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Ronin Y, 2012, G3-GENES GENOM GENET, V2, P537, DOI 10.1534/g3.112.002428; Ronin Y, 2015, P 12 IWGS IN PRESS; Salome PA, 2012, HEREDITY, V108, P447, DOI 10.1038/hdy.2011.95; Sewell MM, 1999, GENETICS, V151, P321; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Williams R.W., 2001, GENOME BIOL, V2; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Wu Y, 2008, PLOS GENET, V10, DOI [10.1371/journal.pgen.1000212e, DOI 10.1371/JOURNAL.PGEN.1000212E]; Wu Y, 2008, P LSS COMP SYST BIOI, P285; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Yap IV, 2003, GENETICS, V165, P2235	28	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122485	10.1371/journal.pone.0122485	http://dx.doi.org/10.1371/journal.pone.0122485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867943	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100076
J	Du, YF; Seibenhener, ML; Yan, J; Jiang, J; Wooten, MC				Du, Yifeng; Seibenhener, Michael L.; Yan, Jin; Jiang, Jianxiong; Wooten, Michael C.			aPKC Phosphorylation of HDAC6 Results in Increased Deacetylation Activity	PLOS ONE			English	Article							PROTEIN-KINASE-C; 2 CATALYTIC DOMAINS; ZETA-PKC; P62; GROWTH; ACTIVATION; INHIBITOR; TUBULIN; AURORA; CELLS	The Class II histone deacetylase, HDAC6, has been shown to be involved in cell motility, aggresome formation and mitochondria transport. HDAC6 deacetylase activity regulates alpha-tubulin acetylation levels and thus plays a critical role in these processes. In turn, HDAC6 activity can be regulated by interaction with various proteins including multiple kinases. Kinase mediated phosphorylation of HDAC6 can lead to either increased or reduced activity. Our previous research has shown that sequestosome1/p62 (SQSTM1/p62) interacts with HDAC6 and regulates its activity. As SQSTM1/p62 is a scaffolding protein known to interact directly with the zeta isoform of Protein Kinase C (PKC zeta), we sought to examine if HDAC6 could be a substrate for PKC zeta phosphorylation and if so, how its activity might be regulated. Our data demonstrate that HDAC6 is not only present in a protein complex with PKC. but can also be phosphorylated by PKC zeta. We also show that specific phosphorylation of HDAC6 by PKC. increases HDAC6 deacetylase activity resulting in reduced acetylated tubulin levels. Our findings provide novel insight into the molecular mechanism by which HDAC6, PKC. and SQSTM1/p62 function together in protein aggregate clearance. These results also highlight a new research direction which may prove fruitful for understanding the underlying cause of several neurodegenerative diseases.	[Du, Yifeng; Seibenhener, Michael L.; Wooten, Michael C.] Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA; [Yan, Jin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Jiang, Jianxiong] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH 45267 USA	Auburn University System; Auburn University; University of Kentucky; University System of Ohio; University of Cincinnati	Wooten, MC (corresponding author), Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA.	wootemc@auburn.edu	Jiang, Jianxiong/A-1987-2010	Jiang, Jianxiong/0000-0003-3955-8928	 [NIH-2RO1NS033661]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033661] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-2RO1NS033661 (MCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Calderilla-Barbosa L, 2014, J CELL SCI, V127, P4052, DOI 10.1242/jcs.152363; Chattopadhyay S, 2013, MBIO, V4, DOI [10.1128/mBio.00636-12, DOI 10.1128/MBI0.00636-12]; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; He Q, 2014, MOL BIOL CELL, V25, P1715, DOI 10.1091/mbc.E13-12-0730; Hiruma Y, 2009, BLOOD, V113, P4894, DOI 10.1182/blood-2008-08-173948; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Lafarga V, 2012, CELL ADHES MIGR, V6, P495, DOI 10.4161/cam.21585; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sokal R. R., 2012, BIOMETRY; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Xiao HL, 2013, CELL MOL LIFE SCI, V70, P3057, DOI 10.1007/s00018-012-1192-1; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076016; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123191	10.1371/journal.pone.0123191	http://dx.doi.org/10.1371/journal.pone.0123191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860570	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300081
J	Ma, XF; Qiu, YW; Tian, JZ; Wang, JH; Li, SM; Zhan, WF; Wang, TY; Zeng, SQ; Jiang, GH; Xu, YK				Ma, Xiaofen; Qiu, Yingwei; Tian, Junzhang; Wang, Jinhui; Li, Shumei; Zhan, Wenfeng; Wang, Tianyue; Zeng, Shaoqing; Jiang, Guihua; Xu, Yikai			Aberrant Default-Mode Functional and Structural Connectivity in Heroin-Dependent Individuals	PLOS ONE			English	Article							NETWORK CONNECTIVITY; DECISION-MAKING; BRAIN; MEMORY; ARCHITECTURE; IMPULSIVITY; COMPONENTS; ADDICTION; CORTEX; ATLAS	Background Little is known about connectivity within the default mode network (DMN) in heroin-dependent individuals (HDIs). In the current study, diffusion-tensor imaging (DTI) and resting-state functional MRI (rs-fMRI) were combined to investigate both structural and functional connectivity within the DMN in HDIs. Methods Fourteen HDIs and 14 controls participated in the study. Structural (path length, tracts count, (fractional anisotropy) FA and (mean diffusivity) MD derived from DTI tractography) and functional (temporal correlation coefficient derived from rs-fMRI) DMN connectivity changes were examined in HDIs. Pearson correlation analysis was performed to compare the structural/functional indices and duration of heroin use/Iowa gambling task(IGT) performance in HDIs. Results HDIs had lower FA and higher MD in the tract connecting the posterior cingulate cortex/precuneus (PCC/PCUN) to right parahippocampal gyrus (PHG), compared to the controls. HDIs also had decreased FA and track count in the tract connecting the PCC/PCUN and medial prefrontal cortex (MPFC), as well as decreased functional connectivity between the PCC/PCUN and bilateral PHG and MPFC, compared to controls. FA values for the tract connecting PCC/PCUN to the right PHG and connecting PCC/PCUN to the MPFC were negatively correlated to the duration of heroin use. The temporal correlation coefficients between the PCC/PCUN and the MPFC, and the FA values for the tract connecting the PCC/PCUN to the MPFC were positively correlated to IGT performance in HDIs. Conclusions Structural and functional connectivity within the DMN are both disturbed in HDIs. This disturbance progresses as duration of heroin use increases and is related to deficits in decision making in HDIs.	[Ma, Xiaofen; Wang, Tianyue; Xu, Yikai] Southern Medial Univ, Nanfang Hosp, Dept Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Qiu, Yingwei; Tian, Junzhang; Li, Shumei; Zhan, Wenfeng; Wang, Tianyue; Zeng, Shaoqing; Jiang, Guihua] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wang, Jinhui] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Jinhui] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Southern Medical University - China; Hangzhou Normal University	Jiang, GH (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	jiangguihua177@163.com; mayuqin2004@163.com	Wang, jinhui/AAF-8668-2019	Tian, Junzhang/0000-0002-6212-1882; Qiu, Yingwei/0000-0003-1298-8506	National Natural Science Foundation of China [81471639]; Science and Technology Planning Project of Guangdong Province, China [2011B031800044, 2012B031800170, 2012A030400019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This research was supported by grants from National Natural Science Foundation of China (No. 81471639); The Science and Technology Planning Project of Guangdong Province, China (No. 2011B031800044, 2012B031800170, 2012A030400019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bora E, 2012, ADDICT BIOL, V17, P141, DOI 10.1111/j.1369-1600.2010.00266.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chen B, 2008, MAGN RESON IMAGING, V26, P103, DOI 10.1016/j.mri.2007.05.003; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fingelkurts AA, 2009, INT J NEUROSCI, V119, P1469, DOI 10.1080/00207450903007985; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Goh JOS, 2011, AGING DIS, V2, P30; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Ornstein TJ, 2000, NEUROPSYCHOPHARMACOL, V23, P113, DOI 10.1016/S0893-133X(00)00097-X; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qiu YW, 2013, NEUROSCI LETT, V538, P43, DOI 10.1016/j.neulet.2013.01.019; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Qiu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063212; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zhao LY, 2009, PSYCHOPHARMACOLOGY, V203, P599, DOI 10.1007/s00213-008-1406-2	52	33	36	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120861	10.1371/journal.pone.0120861	http://dx.doi.org/10.1371/journal.pone.0120861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25859661	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300018
J	Schwager, C; Kull, S; Krause, S; Schocker, F; Petersen, A; Becker, WM; Jappe, U				Schwager, Christian; Kull, Skadi; Krause, Susanne; Schocker, Frauke; Petersen, Arnd; Becker, Wolf-Meinhard; Jappe, Uta			Development of a Novel Strategy to Isolate Lipophilic Allergens (Oleosins) from Peanuts	PLOS ONE			English	Article							SEED OIL BODIES; BODY PROTEINS; SOYBEAN OIL; ISOFORMS; IDENTIFICATION; EXTRACTION; SESAME; POLYACRYLAMIDE; STABILIZATION; PURIFICATION	Background Peanut allergy is one of the most severe class I food allergies with increasing prevalence. Especially lipophilic allergens, such as oleosins, were found to be associated with severe symptoms, but are usually underrepresented in diagnostic extracts. Therefore, this study focused on isolation, molecular characterization and assessment of the allergenicity of peanut oleosins. Methods and Results A comprehensive method adapted for the isolation of peanut oil bodies of high purity was developed comprising a stepwise removal of seed storage proteins from oil bodies. Further separation of the oil body constituents, including the allergens Ara h 10, Ara h 11, the presumed allergen oleosin 3 and additional oleosin variants was achieved by a single run on a preparative electrophoresis cell. Protein identification realized by N-terminal sequencing, peptide mass fingerprinting and homology search revealed the presence of oleosins, steroleosins and a caleosin. Immunoblot analysis with sera of peanut-allergic individuals illustrated the IgE-binding capacity of peanut-derived oleosins. Conclusion Our method is a novel way to isolate all known immunologically distinct peanut oleosins simultaneously. Moreover, we were able to provide evidence for the allergenicity of oleosins and thus identified peanut oleosins as probable candidates for component-resolved allergy diagnosis.	[Schwager, Christian; Kull, Skadi; Krause, Susanne; Schocker, Frauke; Petersen, Arnd; Becker, Wolf-Meinhard; Jappe, Uta] German Ctr Lung Res DZL, Airway Res Ctr North, Res Ctr Borstel, Div Clin & Mol Allergol, Borstel, Germany; [Jappe, Uta] Univ Lubeck, Dept Dermatol Allergol & Venereol, Lubeck, Germany	Forschungszentrum Borstel; University of Lubeck	Jappe, U (corresponding author), German Ctr Lung Res DZL, Airway Res Ctr North, Res Ctr Borstel, Div Clin & Mol Allergol, Borstel, Germany.	ujappe@fz-borstel.de			German Research Foundation [JA 1007/2-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (http://www.dfg.de/) Grant no. JA 1007/2-1. Receiver of funding: UJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GG, 2012, FOOD CHEM, V134, P1919, DOI 10.1016/j.foodchem.2012.03.114; Akkerdaas JH, 2006, MOL NUTR FOOD RES, V50, P18, DOI 10.1002/mnfr.200500147; Alexander LG, 2002, PLANTA, V214, P546, DOI 10.1007/s004250100655; Bhatla SC, 2010, BIOTECHNOL ADV, V28, P293, DOI 10.1016/j.biotechadv.2010.01.001; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Bublin M, 2014, J ALLERGY CLIN IMMUN, V134, P521, DOI 10.1016/j.jaci.2014.04.015; Cabanos C, 2011, PROTEIN J, V30, P457, DOI 10.1007/s10930-011-9351-z; Chang MT, 2013, J AGR FOOD CHEM, V61, P9666, DOI 10.1021/jf4019195; Chen ECF, 1998, PLANT CELL PHYSIOL, V39, P935, DOI 10.1093/oxfordjournals.pcp.a029457; Chen YM, 2010, J AGR FOOD CHEM, V58, P7402, DOI 10.1021/jf1006159; Chiang CJ, 2010, J AGR FOOD CHEM, V58, P11695, DOI 10.1021/jf102944c; DRIESSEN HPC, 1985, CRIT REV BIOCHEM MOL, V18, P281, DOI 10.3109/10409238509086784; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Haider SR, 2010, ANAL BIOANAL CHEM, V397, P655, DOI 10.1007/s00216-010-3588-9; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Iwanaga D, 2007, J AGR FOOD CHEM, V55, P8711, DOI 10.1021/jf071008w; Jolivet P, 2004, PLANT PHYSIOL BIOCH, V42, P501, DOI 10.1016/j.plaphy.2004.04.006; Jolivet P, 2013, PROTEOMICS, V13, P1836, DOI 10.1002/pmic.201200431; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kim H, 2007, BIOTECHNOL BIOPROC E, V12, P542, DOI 10.1007/BF02931352; Kobayashi S, 2012, BIOSCI BIOTECH BIOCH, V76, P1182, DOI 10.1271/bbb.120063; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leduc V, 2006, ALLERGY, V61, P349, DOI 10.1111/j.1398-9995.2006.01013.x; LEE K, 1995, PLANT J, V7, P603, DOI 10.1046/j.1365-313X.1995.7040603.x; LI M, 1992, J BIOL CHEM, V267, P8245; Lin LJ, 2005, PLANT PHYSIOL BIOCH, V43, P770, DOI 10.1016/j.plaphy.2005.07.008; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Maurer S, 2013, J PHYS CHEM B, V117, P13872, DOI 10.1021/jp403893n; Millichip M, 1996, BIOCHEM J, V314, P333, DOI 10.1042/bj3140333; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Nikiforidis CV, 2009, J AGR FOOD CHEM, V57, P5591, DOI 10.1021/jf900771v; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Olszewski A, 1998, CLIN EXP ALLERGY, V28, P850, DOI 10.1046/j.1365-2222.1998.00325.x; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Permyakov SE, 2012, CELL CALCIUM, V52, P366, DOI 10.1016/j.ceca.2012.06.002; Petersen A, 2006, CLIN EXP ALLERGY, V36, P840, DOI 10.1111/j.1365-2222.2006.02505.x; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; Pons L, 1998, J CHROMATOGR B, V706, P131, DOI 10.1016/S0378-4347(97)00530-6; Pons L, 2005, PLANT PHYSIOL BIOCH, V43, P659, DOI 10.1016/j.plaphy.2005.06.002; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Ring J, 2007, J EUR ACAD DERMATOL, V21, P452, DOI 10.1111/j.1468-3083.2006.02133.x; Rodelas AJD, 2008, PHILIPP AGRIC SCI, V91, P389; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; SMYTH DG, 1979, NATURE, V279, P252, DOI 10.1038/279252a0; Souci S, 2000, FOOD COMPOSITION NUT, P1014; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x; Tai SSK, 2002, BIOSCI BIOTECH BIOCH, V66, P2146, DOI 10.1271/bbb.66.2146; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Tzen JTC, 1998, J BIOCHEM-TOKYO, V123, P318, DOI 10.1093/oxfordjournals.jbchem.a021939; TZEN JTC, 1990, PLANT PHYSIOL, V94, P1282, DOI 10.1104/pp.94.3.1282; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; Tzen JTC, 1997, J BIOCHEM-TOKYO, V121, P762, DOI 10.1093/oxfordjournals.jbchem.a021651; Vargo KB, 2014, LANGMUIR, V30, P11292, DOI 10.1021/la502664e; Waschatko G, 2012, J PHYS CHEM B, V116, P10832, DOI 10.1021/jp211871v; White BL, 2013, J AGR FOOD CHEM, V61, P3957, DOI 10.1021/jf400184y; White DA, 2008, FOOD HYDROCOLLOID, V22, P1224, DOI 10.1016/j.foodhyd.2007.07.004; Zuidmeer-Jongejan L, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-4	62	31	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123419	10.1371/journal.pone.0123419	http://dx.doi.org/10.1371/journal.pone.0123419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860789	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300097
J	Szalai, G; Romero, R; Chaiworapongsa, T; Xu, Y; Wang, B; Ahn, H; Xu, ZH; Chiang, PJ; Sundell, B; Wang, R; Jiang, Y; Plazyo, O; Olive, M; Tarca, AL; Dong, Z; Qureshi, F; Papp, Z; Hassan, SS; Hernandez-Andrade, E; Than, NG				Szalai, Gabor; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Yi; Wang, Bing; Ahn, Hyunyoung; Xu, Zhonghui; Chiang, Po Jen; Sundell, Birgitta; Wang, Rona; Jiang, Yang; Plazyo, Olesya; Olive, Mary; Tarca, Adi L.; Dong, Zhong; Qureshi, Faisal; Papp, Zoltan; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor			Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; UTERINE PERFUSION-PRESSURE; FOR-GESTATIONAL-AGE; CIRCULATING ANGIOGENIC FACTORS; FACTOR RECEPTOR-1 CONCENTRATION; ELEVATED LIVER-ENZYMES; NITRIC-OXIDE SYNTHESIS; INNATE-IMMUNE-SYSTEM; GOMBE NATIONAL-PARK; BLOOD-PRESSURE	Objective Most anti-angiogenic preeclampsiamodels in rodents utilized the overexpression of a truncated soluble fms-like tyrosine kinase-1 (sFlt-1) not expressed in any species. Other limitations of mouse preeclampsiamodels included stressful blood pressure measurements and the lack of postpartum monitoring. We aimed to 1) develop a mouse model of preeclampsia by administering the most abundant human placental sFlt-1 isoform (hsFlt-1-e15a) in preeclampsia; 2) determine blood pressures in non-stressed conditions; and 3) develop a survival surgery that enables the collection of fetuses and placentas and postpartum (PP) monitoring. Methods Pregnancy status of CD-1 mice was evaluated with high-frequency ultrasound on gestational days (GD) 6 and 7. Telemetry catheters were implanted in the carotid artery on GD7, and their positions were verified by ultrasound on GD13. Mice were injected through tail-vein with adenoviruses expressing hsFlt-1-e15a (n = 11) or green fluorescent protein (GFP; n = 9) on GD8/GD11. Placentas and pups were delivered by cesarean section on GD18 allowing PP monitoring. Urine samples were collected with cystocentesis on GD6/GD7, GD13, GD18, and PPD8, and albumin/creatinine ratios were determined. GFP and hsFlt-1-e15a expression profiles were determined by qRT-PCR. Aortic ring assays were performed to assess the effect of hsFlt-1-e15a on endothelia. Results Ultrasound predicted pregnancy on GD7 in 97% of cases. Cesarean section survival rate was 100%. Mean arterial blood pressure was higher in hsFlt-1-e15a-treated than in GFP-treated mice (. MAP = 13.2 mmHg, p = 0.00107; GD18). Focal glomerular changes were found in hsFlt-1-e15a -treated mice, which had higher urine albumin/creatinine ratios than controls (109.3 +/- 51.7 mu g/mg vs. 19.3 +/- 5.6 mu g/mg, p = 4.4x10(-2); GD18). Aortic ring assays showed a 46% lesser microvessel outgrowth in hsFlt-1-e15a-treated than in GFP-treated mice (p = 1.2x10(-2)). Placental and fetal weights did not differ between the groups. One mouse with liver disease developed early-onset preeclampsia-like symptoms with intrauterine growth restriction (IUGR). Conclusions A mouse model of late-onset preeclampsia was developed with the overexpression of hsFlt-1-e15a, verifying the in vivo pathologic effects of this primate-specific, predominant placental sFlt-1 isoform. HsFlt-1-e15a induced early-onset preeclampsia-like symptoms associated with IUGR in a mouse with a liver disease. Our findings support that hsFlt-1-e15a is central to the terminal pathway of preeclampsia, and it can induce the full spectrum of symptoms in this obstetrical syndrome.	[Szalai, Gabor; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Yi; Wang, Bing; Ahn, Hyunyoung; Xu, Zhonghui; Chiang, Po Jen; Sundell, Birgitta; Wang, Rona; Jiang, Yang; Plazyo, Olesya; Olive, Mary; Tarca, Adi L.; Dong, Zhong; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Olive, Mary] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Tarca, Adi L.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Qureshi, Faisal] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Papp, Zoltan; Than, Nandor Gabor] Semmelweis Univ, Kutvolgyi Clin Block, Matern Private Dept, H-1085 Budapest, Hungary; [Than, Nandor Gabor] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Than, Nandor Gabor] Semmelweis Univ, Dept Pathol & Expt Canc 1, H-1085 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	romeror@mail.nih.gov; nthan@med.wayne.edu	Than, Nandor G/N-1442-2016; Xu, Zhonghui/F-3353-2018; Romero, Roberto/A-5268-2019	Xu, Zhonghui/0000-0002-6469-9178; Plazyo, Olesya/0000-0002-6859-7590; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH [HHSN275201300006C]; NIH Center [P30CA22453]; Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum [LP2014-7/2014]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH; NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch (NICHD/NIH). Manuscript writing was supported, in part, by the Hungarian Academy of Sciences Momentum Grant "LP2014-7/2014" (to NGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Agostinis C, 2010, J IMMUNOL, V185, P4420, DOI 10.4049/jimmunol.0903215; Ahmed A, 2011, THROMB RES, V127, pS72, DOI 10.1016/S0049-3848(11)70020-2; Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Alfaidy N, 2013, ANTIOXID REDOX SIGN, V18, P400, DOI 10.1089/ars.2012.4637; [Anonymous], 2011, HD X11 DEVICE SURGIC, P32; BAIRD JN, 1981, AM J OBSTET GYNECOL, V141, P345; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balogh A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.023; Barton JR, 2004, CLIN PERINATOL, V31, P807, DOI 10.1016/j.clp.2004.06.008; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Baxter JSK, 2004, OBSTET GYNECOL SURV, V59, P838, DOI 10.1097/01.ogx.0000146948.19308.c5; Bdolah Y, 2005, CROAT MED J, V46, P728; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Berkane N, 2007, NEPHROL DIAL TRANSPL, V22, P2753, DOI 10.1093/ndt/gfm429; Bohlender J, 2000, J AM SOC NEPHROL, V11, P2056, DOI 10.1681/ASN.V11112056; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; BROSENS IA, 1977, CLIN OBSTET GYNAECOL, V4, P573; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens I, 2010, HUM REPROD, V25, P569, DOI 10.1093/humrep/dep474; Brown SD, 2006, COMPARATIVE MED, V56, P262; Buhimschi CS, 2010, AM J PATHOL, V177, P197, DOI 10.2353/ajpath.2010.091209; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Burke SD, 2010, AM J REPROD IMMUNOL, V63, P472, DOI 10.1111/j.1600-0897.2010.00818.x; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Byers BD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.044; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Cao Junran, 2012, Front Psychiatry, V3, P28, DOI 10.3389/fpsyt.2012.00028; Carlson SH, 2000, HYPERTENSION, V35, pE1, DOI 10.1161/01.HYP.35.2.e1; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010; CAVANAGH D, 1977, AM J OBSTET GYNECOL, V128, P75, DOI 10.1016/0002-9378(77)90296-4; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2002, AM J OBSTET GYNECOL, V187, P889, DOI 10.1067/mob.2002.127309; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P41, DOI 10.1080/14767050701831397; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P25, DOI 10.1080/14767050701832833; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chaiworapongsa T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.002; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; CLARK KE, 1982, AM J PHYSIOL, V242, pH297, DOI 10.1152/ajpheart.1982.242.2.H297; COMBS CA, 1993, AM J OBSTET GYNECOL, V169, P215; Conway BR, 2012, J AM SOC NEPHROL, V23, P405, DOI 10.1681/ASN.2011060577; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; Davisson RL, 2002, HYPERTENSION, V39, P337, DOI 10.1161/hy02t2.102904; De P, 2009, EXP CELL RES, V315, P248, DOI 10.1016/j.yexcr.2008.10.003; Dekker G, 2007, J REPROD IMMUNOL, V76, P8, DOI 10.1016/j.jri.2007.03.015; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Doridot L, 2014, ANTIOXID REDOX SIGN, V21, P819, DOI 10.1089/ars.2013.5661; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Erez O, 2007, J MATERN-FETAL NEO M, V20, P661, DOI 10.1080/14767050701495011; Erez O, 2008, J MATERN-FETAL NEO M, V21, P855, DOI 10.1080/14767050802361872; Erez O, 2009, J MATERN-FETAL NEO M, V22, P662, DOI 10.1080/14767050902801751; Eshkoli T, 2013, J MATERN-FETAL NEO M, V26, P116, DOI 10.3109/14767058.2012.722725; Espinoza J, 2006, J PERINAT MED, V34, P447, DOI 10.1515/JPM.2006.089; Falcao S, 2009, HYPERTENSION, V54, P1401, DOI 10.1161/HYPERTENSIONAHA.109.137356; Falcao S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.003; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; GABER LW, 1994, BAILLIERE CLIN OB GY, V8, P443, DOI 10.1016/S0950-3552(05)80330-X; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gilbert JS, 2007, HYPERTENSION, V50, P1142, DOI 10.1161/HYPERTENSIONAHA.107.096594; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Girardi G, 2011, THROMB RES, V127, pS43, DOI 10.1016/S0049-3848(11)70012-3; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P389, DOI 10.1080/14767050802046069; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Granger JP, 2006, METH MOLEC MED, V122, P383; Haram K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-8; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205; Hernandez-Andrade E, 2014, ULTRASOUND MED BIOL, V40, P351, DOI 10.1016/j.ultrasmedbio.2013.09.026; Hernandez-Andrade E, 2013, CURR OPIN OBSTET GYN, V25, P138, DOI 10.1097/GCO.0b013e32835e0e9c; Hernandez-Andrade E, 2012, PRENATAL DIAG, V32, P103, DOI 10.1002/pd.2913; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hertig A, 2008, EUR J OBSTET GYN R B, V140, P138, DOI 10.1016/j.ejogrb.2007.09.007; Hertig A, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.006; Heydarian M, 2009, PLACENTA, V30, P250, DOI 10.1016/j.placenta.2008.12.010; Higgins JR, 1998, AM J OBSTET GYNECOL, V179, P464, DOI 10.1016/S0002-9378(98)70380-1; HODARI AA, 1967, AM J OBSTET GYNECOL, V97, P597, DOI 10.1016/0002-9378(67)90448-6; Hoogstraten-Miller SL, 2008, CURR PROTOC IMMUNOL; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Irani RA, 2010, HYPERTENSION, V55, P1246, DOI 10.1161/HYPERTENSIONAHA.110.150540; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Jose Pinheiro DB, 2013, R PACKAGE VERSION 3; Kaidi S, 2007, LAB ANIM-UK, V41, P388, DOI 10.1258/002367707781282839; Kalkunte S, 2010, AM J PATHOL, V177, P2387, DOI 10.2353/ajpath.2010.100475; Kalkunte S, 2009, J REPROD IMMUNOL, V83, P134, DOI 10.1016/j.jri.2009.08.006; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Karumanchi SA, 2007, AM J OBSTET GYNECOL, V196, P287, DOI 10.1016/j.ajog.2007.02.013; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Khalil RA, 2002, AM J PHYSIOL-REG I, V283, pR29, DOI 10.1152/ajpregu.00762.2001; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim JS, 2007, PLACENTA, V28, P571, DOI 10.1016/j.placenta.2006.07.007; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Kliman HJ, 2012, REPROD SCI, V19, P16, DOI 10.1177/1933719111424445; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Kondo K, 1998, GENE, V208, P297, DOI 10.1016/S0378-1119(98)00006-7; KRAAYENBRINK AA, 1993, AM J OBSTET GYNECOL, V169, P160, DOI 10.1016/0002-9378(93)90154-B; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; Kramer K, 2000, LAB ANIM, V34, P272, DOI 10.1258/002367700780384663; Krishnamurthy U, 2014, GYNECOL OBSTET INVES, V78, P33, DOI 10.1159/000362552; KRISTAL MB, 1980, NEUROSCI BIOBEHAV R, V4, P141, DOI 10.1016/0149-7634(80)90012-3; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, P478, DOI 10.1161/01.ATV.0000153088.15433.8f; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; LaMarca BBD, 2005, HYPERTENSION, V46, P1022, DOI 10.1161/01.HYP.0000175476.26719.36; Leno-Duran E, 2010, PLACENTA, V31, P731, DOI 10.1016/j.placenta.2010.06.002; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Li J, 2012, AM J PHYSIOL-HEART C, V303, pH1, DOI 10.1152/ajpheart.00117.2012; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; LONG PA, 1980, BRIT J OBSTET GYNAEC, V87, P13, DOI 10.1111/j.1471-0528.1980.tb04419.x; LOSONCZY G, 1992, AM J MED SCI, V303, P233, DOI 10.1097/00000441-199204000-00005; Lu FX, 2007, AM J OBSTET GYNECOL, V197, pS141, DOI 10.1016/j.ajog.2007.10.558; Lu F, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.10.008; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Mateus J, 2011, AM J PHYSIOL-HEART C, V301, pH1781, DOI 10.1152/ajpheart.00373.2011; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; Matthys LA, 2004, AM J OBSTET GYNECOL, V190, P1464, DOI 10.1016/j.ajog.2004.02.037; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; McCarthy FP, 2011, PLACENTA, V32, P413, DOI 10.1016/j.placenta.2011.03.010; Mcgowen MR, 2014, INT J DEV BIOL, V58, P155, DOI 10.1387/ijdb.140020dw; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; National Research Council of the National Academies, 2011, GUIDE FOR THE CARE A; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P820, DOI 10.3109/14767050903366119; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P476, DOI 10.3109/14767050903216033; Orshal JM, 2004, HYPERTENSION, V43, P434, DOI 10.1161/01.HYP.0000113044.46326.98; PAGE E W, 1948, Obstet Gynecol Surv, V3, P615, DOI 10.1097/00006254-194810000-00002; PAGE ERNEST W., 1949, CALIFORNIA MED, V70, P1; Paidas MJ, 2005, SEMIN PERINATOL, V29, P150, DOI 10.1053/j.semperi.2005.05.008; Pallares P, 2008, THERIOGENOLOGY, V70, P44, DOI 10.1016/j.theriogenology.2008.02.012; Pallares P, 2009, REPROD FERT DEVELOP, V21, P283, DOI 10.1071/RD08124; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Podjarny E, 1998, J AM SOC NEPHROL, V9, P9; Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263; Preedy, 2012, HDB GROWTH GROWTH MO, P1867; Rajakumar A, 2009, PLACENTA, V30, P25, DOI 10.1016/j.placenta.2008.10.006; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rasmussen S, 2003, OBSTET GYNECOL, V101, P575, DOI 10.1016/S0029-7844(02)03071-5; Rath W, 2000, J PERINAT MED, V28, P249, DOI 10.1515/JPM.2000.033; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Reimer T, 2012, J MATERN FETAL NEONA; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Rigo J, 2000, HYPERTENS PREGNANCY, V19, P163, DOI 10.1081/PRG-100100132; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Roberts JM, 1999, AM J KIDNEY DIS, V33, P992, DOI 10.1016/S0272-6386(99)70439-7; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Romero R, 2009, J MATERN-FETAL NEO M, V22, P636, DOI 10.1080/14767050902784171; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; SALAS SP, 1995, HYPERTENSION, V26, P1019, DOI 10.1161/01.HYP.26.6.1019; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Shesely EG, 2001, AM J OBSTET GYNECOL, V185, P1198, DOI 10.1067/mob.2001.118142; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shibuya M, 2011, P JPN ACAD B-PHYS, V87, P167, DOI 10.2183/pjab.87.167; Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283; Sholook MM, 2007, AM J PHYSIOL-HEART C, V293, pH2080, DOI 10.1152/ajpheart.00667.2007; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2006, SEMIN PERINATOL, V30, P16, DOI 10.1053/j.semperi.2006.01.008; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Siddiqui AH, 2011, AM J HYPERTENS, V24, P606, DOI 10.1038/ajh.2010.247; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Slevin JC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-10; Smith GCS, 2009, CURR OPIN OBSTET GYN, V21, P111, DOI 10.1097/GCO.0b013e328328cf7d; Staff AC, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.036; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; STOUT C, 1969, AM J OBSTET GYNECOL, V105, P212, DOI 10.1016/0002-9378(69)90060-X; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sunderland N, 2011, AM J REPROD IMMUNOL, V65, P533, DOI 10.1111/j.1600-0897.2010.00929.x; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Szalai G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110867; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Tanaka K, 1997, JPN J CANCER RES, V88, P867, DOI 10.1111/j.1349-7006.1997.tb00463.x; Taylor RN, 1998, SEMIN REPROD ENDOCR, V16, P17, DOI 10.1055/s-2007-1016249; Terio KA, 2011, J ZOO WILDLIFE MED, V42, P597, DOI 10.1638/2010-0237.1; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Than NG, 2014, PLACENTA, V35, P855, DOI 10.1016/j.placenta.2014.07.015; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Than NG, 2008, VIRCHOWS ARCH, V453, P387, DOI 10.1007/s00428-008-0658-x; Than NG, 2008, AM J REPROD IMMUNOL, V60, P333, DOI 10.1111/j.1600-0897.2008.00631.x; Than NG, 2012, REPROD SCI, V19, P14, DOI 10.1177/1933719111431678; Theiler K, 1989, THE HOUSE MOUSE ATLA; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Thomas C, 2007, ANIMAL, V1, P1, DOI 10.1017/S1751731107658467; THORNTON JG, 1992, AM J OBSTET GYNECOL, V167, P240, DOI 10.1016/S0002-9378(11)91665-2; Turnbull DH, 1999, COMPUT MED IMAG GRAP, V23, P25, DOI 10.1016/S0895-6111(98)00060-3; Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Van Vliet BN, 2000, J PHARMACOL TOXICOL, V44, P361, DOI 10.1016/S1056-8719(00)00126-X; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2012, CLIN SCI, V122, P43, DOI 10.1042/CS20110097; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; von Dadelszen P, 2009, SEMIN PERINATOL, V33, P152, DOI 10.1053/j.semperi.2009.02.009; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang HM, 2003, MOL REPROD DEV, V65, P123, DOI 10.1002/mrd.10308; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Weed S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.003; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159, DOI 10.1016/S0002-9378(16)32330-4; Whitehead CL, 2011, BJOG-INT J OBSTET GY, V118, P1268, DOI 10.1111/j.1471-0528.2011.02962.x; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; *WHO, 2005, THE WORLD HEALTH REP; Wildman DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024509; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Woods AK, 2011, HYPERTENSION, V57, P94, DOI 10.1161/HYPERTENSIONAHA.110.160242; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zenclussen AC, 2004, EUR J IMMUNOL, V34, P377, DOI 10.1002/eji.200324469; Zhao Xin, 2011, Curr Protoc Mouse Biol, V1, P105; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; Zhou YQ, 2002, PHYSIOL GENOMICS, V10, P113, DOI 10.1152/physiolgenomics.00119.2001	281	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119547	10.1371/journal.pone.0119547	http://dx.doi.org/10.1371/journal.pone.0119547			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860260	gold, Green Published, Green Accepted			2022-12-26	WOS:000352590300008
J	[Anonymous]				[Anonymous]			Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; NEUROFILAMENT LIGHT; UP-REGULATION; CXCL13; NEOPTERIN; IMMUNE; MACROPHAGES; DISEASE; MARKER	Background Expression of soluble CD163 (sCD163), a macrophage/microglia biomarker, is increased in inflammatory conditions, and sCD163 levels in the cerebrospinal fluid (CSF) have recently been shown to be elevated in patients with multiple sclerosis (MS): the sCD163 CSF/serum ratio was elevated in patients with relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and clinically isolated syndrome (CIS) compared with symptomatic controls. Objective To investigate the contributions of the sCD163 CSF/serum ratio to a biomarker panel focusing on inflammation and axonal degeneration in newly diagnosed MS; thus optimising a diagnostic biomarker panel for MS. Methods After a full MS diagnostic work-up, including collection of paired samples of CSF and serum, 125 patients were included in this study. Patients were divided into groups based on their diagnosis, and patients with normal clinical and paraclinical findings were defined as symptomatic controls. Serum and CSF levels, ratios, and indices of sCD163, CXCL13, osteopontin, neopterin, and CSF levels of neurofilament light polypeptide were determined by enzyme-linked immunosorbent assays (ELISAs). For sCD163 the results constitute a post-hoc analysis of already published data. Results All tested biomarkers, notably the sCD163 ratio, the CXCL13 ratio, the NEO ratio, the CSF level of NfL, the IgG index, and the serum level of OPN, were significantly correlated to RRMS, PPMS, and/or CIS. The individual biomarkers in single tests had a lower performance than the IgG index, however, their combined receiver operating characteristic (ROC) curve demonstrated excellent diagnostic discriminatory power. Conclusion The biomarker panel showed distinct profiles for each patient group and could be a valuable tool for clinical differentiation of MS subgroups. The combined ROC analysis showed that sCD163 contributes positively as a diagnostic marker to a panel of established MS biomarkers. Patients with PPMS were demonstrated to have significantly elevated levels of both inflammatory and degenerative markers.						Carstensen, Mikkel/0000-0001-5676-1173; Christensen, Tove/0000-0003-3977-6677; Moller, Holger Jon/0000-0001-7687-5995; Rasmussen, Peter Vestergaard/0000-0001-6417-7743; Petersen, Thor/0000-0001-5633-2600	Danish Multiple Sclerosis Society [8990, 14567]; Riisfort Foundation [15399]; Aase and Einar Danielsen's Foundation [904587]; Jascha Foundation [3099]; Dagmar Marshalls Fond	Danish Multiple Sclerosis Society; Riisfort Foundation; Aase and Einar Danielsen's Foundation; Jascha Foundation; Dagmar Marshalls Fond	This study was funded by The Danish Multiple Sclerosis Society, grant number(s): 8990 and 14567, funder URL: http://scleroseforeningen.dk/, The Riisfort Foundation, grant no. 15399, URL: http://www.riisfort.dk/riisfort-fonden/, the Aase and Einar Danielsen's Foundation; grant no 904587; URL: http://www.danielsensfond.dk/, The Jascha Foundation, grant no. 3099 URL: http://www.jaschafonden.dk/, and the Dagmar Marshalls Fond, grant no. N/A URL: N/A (it is a small Danish Foundation; applications via solicitor Oluf Engell; Bruun & Hjejle; Amagertorv 24; 1160 KobenhavnK). HJM and Aarhus University have received royalties from IQ-products, NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2013, MULT SCLER J, V19, P1204, DOI 10.1177/1352458512473362; [Anonymous], 2003, STATA TIP 1 THE EFOR; Avsar T, 2012, MULT SCLER J, V18, P1081, DOI 10.1177/1352458511433303; Bartos A, 2007, ACTA NEUROL SCAND, V116, P100, DOI 10.1111/j.1600-0404.2006.00794.x; Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Centonze D, 2010, CELL DEATH DIFFER, V17, P1083, DOI 10.1038/cdd.2009.179; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Correale J, 2014, MULT SCLER J, V20, P1288, DOI 10.1177/1352458514533230; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Dobson R, 2013, ACTA NEUROL SCAND, V128, P321, DOI 10.1111/ane.12119; Edwards KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081007; Ehling R, 2004, MULT SCLER J, V10, P601, DOI 10.1191/1352458504ms1100oa; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Giovannoni G, 1997, BRAIN, V120, P1, DOI 10.1093/brain/120.1.1; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Katsavos S, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/340508; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Kivisakk P, 2014, MULT SCLER J, V20, P438, DOI 10.1177/1352458513503052; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lieury A, 2014, GLIA, V62, P1645, DOI 10.1002/glia.22705; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moller HJ, 2004, EUR J HAEMATOL, V72, P135, DOI 10.1046/j.0902-4441.2003.00193.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P29, DOI 10.1080/003655102762377466; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; OTT M, 1993, J NEUROL, V241, P108, DOI 10.1007/BF00869773; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ragheb S, 2011, MULT SCLER J, V17, P819, DOI 10.1177/1352458511398887; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Semra YK, 2002, J NEUROIMMUNOL, V122, P132, DOI 10.1016/S0165-5728(01)00455-6; SHAW CE, 1995, J NEUROL, V242, P53, DOI 10.1007/BF00887815; Sinclair C, 2005, NEUROPATH APPL NEURO, V31, P292, DOI 10.1111/j.1365-2990.2004.00638.x; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Stilund M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098588; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tumani H, 2009, NEUROBIOL DIS, V35, P117, DOI 10.1016/j.nbd.2009.04.010; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; WERNERFELMAYER G, 1990, CANCER RES, V50, P2863; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006; Ziemann U, 2011, PROG NEUROBIOL, V95, P670, DOI 10.1016/j.pneurobio.2011.04.007	72	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119681	10.1371/journal.pone.0119681	http://dx.doi.org/10.1371/journal.pone.0119681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860354	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300009
J	Frikha, Z; Girerd, N; Huttin, O; Courand, PY; Bozec, E; Olivier, A; Lamiral, Z; Zannad, F; Rossignol, P				Frikha, Zied; Girerd, Nicolas; Huttin, Olivier; Courand, Pierre Yves; Bozec, Erwan; Olivier, Arnaud; Lamiral, Zohra; Zannad, Faiez; Rossignol, Patrick			Reproducibility in Echocardiographic Assessment of Diastolic Function in a Population Based Study (The STANISLAS Cohort Study)	PLOS ONE			English	Article							LEFT-VENTRICULAR DIMENSIONS; HEART-FAILURE; RECOMMENDATIONS; INTEROBSERVER; INTRAOBSERVER; RELAXATION	Introduction There is limited evidence regarding intra-observer and inter-observer variations in echocardiographic measurements of diastolic function. This study aimed to assess this reproducibly within a population-based cohort study. Methods Sixty subjects in sinus rhythm were randomly selected among 4th visit participants of the STANISLAS Cohort (Lorraine region, France). This 4th examination systematically included M-mode, 2-dimensional, DTI and pulsed-wave Doppler echocardiograms. Reproducibility of variables was studied by intra-class correlation coefficients (ICC) and Bland Altman plots. Results Our population was on average middle-aged (50 +/- 14y), overweight (BMI = 26 +/- 6kg/m(2)) and non-smoking (87%) with a quarter of the participants having self-declared hypertension or treated with anti-hypertensive medication(s). Intra-observer ICC were > 0.90 for all analyzed parameters except for left ventricular ejection fraction (LVEF) which was 0.89 (0.81-0.93). The mean relative intra-observer differences were small and limits of agreement of relative differences were narrow for all considered parameters (<5% and <15% respectively). Inter-observer ICC were > 0.90 for all analyzed parameters except for LVEF (ICC = 0.87) and both mitral and pulmonary A wave duration (0.83 and 0.73 respectively). The mean relative inter-observer differences were <5% for all parameters except for pulmonary A wave duration (mean difference = 6.5%). Limits of agreement of relative differences were narrow (<15%), except for mitral A wave duration and velocity (both <20%) as well as left ventricular mass and pulmonary A wave duration (both <30%). Intra-observer agreements with regard to the presence and severity of diastolic dysfunction were excellent (Kappa = 0.93 (0.83-1.00) and 0.88 (0.75-0.99), respectively). Conclusion In this validation study within the STANISLAS cohort, diastolic function echocardiographic parameters were found to be highly reproducible. Diastolic dysfunction consequently appears as a highly effective clinical and research tool.	[Frikha, Zied; Girerd, Nicolas; Bozec, Erwan; Lamiral, Zohra; Zannad, Faiez; Rossignol, Patrick] Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 9501, Nancy, France; [Huttin, Olivier; Lamiral, Zohra] Ctr Hosp Univ Nancy, Inst Lorrain Coeur & Vaisseaux, Serv Cardiol, Nancy, France; [Courand, Pierre Yves] Hosp Civils Lyon, Hop Croix Rousse, European Soc Hypertens Excellence Ctr, Federat Cardiol, F-69004 Lyon, France; [Courand, Pierre Yves] Univ Lyon 1, Genom Fonctionnelle Hypertens Arterielle, EA 4173, F-69100 Villeurbanne, France; [Courand, Pierre Yves] Hop Nord Ouest, F-69400 Villefranche, France	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rossignol, P (corresponding author), Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 9501, Nancy, France.	p.rossignol@chu-nancy.fr	Courand, Pierre-Yves/O-1054-2016; HUttin, Olivier/AAW-8052-2020; Zannad, Faiez/K-4649-2019; GIRERD, Nicolas/D-5493-2011	Courand, Pierre-Yves/0000-0003-3199-7977; Girerd, Nicolas/0000-0002-3278-2057	Nancy CHU; Lorraine Region; Programme Hospitalier de Recherche Clinique Interregional (BioSe); 7th EU-FP MEDIA project (FP7) [261409]; HOMAGE (FP7) [305507]; FIBRO-TARGETS project (FP7) [602904]	Nancy CHU; Lorraine Region(Region Grand-Est); Programme Hospitalier de Recherche Clinique Interregional (BioSe); 7th EU-FP MEDIA project (FP7); HOMAGE (FP7); FIBRO-TARGETS project (FP7)	This study was sponsored by Nancy CHU and granted by the Lorraine Region, the Programme Hospitalier de Recherche Clinique Interregional (BioSe), the 7th EU-FP MEDIA project (FP7 #261409), the HOMAGE (FP7 #305507) and the FIBRO-TARGETS project (FP7 #602904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; GALDERISI M, 1992, AM J CARDIOL, V70, P1341, DOI 10.1016/0002-9149(92)90772-Q; GRANDITS GA, 1994, CONTROL CLIN TRIALS, V15, P395, DOI 10.1016/0197-2456(94)90035-3; Hatle L, 2007, EUR HEART J, V28, P2421, DOI 10.1093/eurheartj/ehm412; Kuecherer H F, 1991, J Am Soc Echocardiogr, V4, P203; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; LADIPO GOA, 1980, BRIT HEART J, V44, P284; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Last JM, DICT EPIDEMIOLOGY; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Otterstad JE, 1997, EUR HEART J, V18, P507; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; SCHIEKEN RM, 1979, AM J EPIDEMIOL, V110, P504, DOI 10.1093/oxfordjournals.aje.a112831; SPIRITO P, 1988, EUR HEART J, V9, P879, DOI 10.1093/oxfordjournals.eurheartj.a062582; Unzek S, 2011, JACC-CARDIOVASC IMAG, V4, P460, DOI 10.1016/j.jcmg.2011.01.016; Valantine H A, 1990, J Am Soc Echocardiogr, V3, P276; VALDEZ RS, 1979, CIRCULATION, V60, P921, DOI 10.1161/01.CIR.60.4.921; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	21	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122336	10.1371/journal.pone.0122336	http://dx.doi.org/10.1371/journal.pone.0122336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853818	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400064
J	Hu, ZX; Wan, XB; Hao, R; Zhang, H; Li, L; Li, L; Xie, Q; Wang, P; Gao, YB; Chen, S; Wei, M; Luan, ZD; Zhang, AQ; Huang, N; Chen, L				Hu, Zexi; Wan, Xiaobo; Hao, Rui; Zhang, Heng; Li, Li; Li, Lin; Xie, Qiang; Wang, Peng; Gao, Yibo; Chen, She; Wei, Min; Luan, Zhidong; Zhang, Aiqun; Huang, Niu; Chen, Liang			Phosphorylation of Mutationally Introduced Tyrosine in the Activation Loop of HER2 Confers Gain-of-Function Activity	PLOS ONE			English	Article							KINASE DOMAIN; BREAST-CANCER; ERBB2; RECEPTOR; RESISTANCE; MECHANISM; INHIBITOR; LAPATINIB; FORMS; KIT	Amplification, overexpression, and somatic mutation of the HER2 gene have been reported to play a critical role in tumorigenesis of various cancers. The HER2 H878Y mutation was recently reported in 11% of hepatocellular carcinoma (HCC) patients. However, its functional impact on the HER2 protein and its role in tumorigenesis has not been determined. Here, we show that HER2 H878Y is a gain-of-function mutation. Y878 represents a phosphorylation site, and phospho-Y878 interacts with R898 residue to stabilize the active conformation of HER2, thereby enhancing its kinase activity. H878Y mutant is transforming and the transformed cells are sensitive to HER2 kinase inhibitors. Thus, our study reveals the following novel mechanism underlying the tumorigenic function of the HER2 H878Y mutation: the introduction of a tyrosine residue into the kinase activation loop via mutagenesis modulates the conformation of the kinase, thereby enhancing its activity.	[Hu, Zexi] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Hu, Zexi; Wan, Xiaobo; Li, Li; Li, Lin; Chen, She; Huang, Niu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hao, Rui; Wei, Min] BeiGene Beijing Co Ltd, Beijing 102206, Peoples R China; [Zhang, Heng] Cent Hosp Lishui City, Lishui 323000, Zhejiang, Peoples R China; [Xie, Qiang] Fuzhou Pulm Hosp Fujian, Fujian 350008, Peoples R China; [Wang, Peng] Beijing Ditan Hosp, Beijing 100015, Peoples R China; [Gao, Yibo] Inst Canc Res, Dept Thorac Surg, Beijing 100021, Peoples R China; [Gao, Yibo] Hosp Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Luan, Zhidong] Liaoning Med Univ, Jinzhou 121001, Liaoning, Peoples R China; [Zhang, Aiqun] 301 Hosp, Gen Hosp Peoples Liberat Army, Beijing 100853, Peoples R China; [Chen, Liang] Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	Beijing Normal University; National Institute of Biological Sciences, Beijing; Capital Medical University; Jinzhou Medical University; National Institute of Biological Sciences, Beijing	Chen, L (corresponding author), Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China.	chenliang@nibs.ac.cn	Gao, Yi-Bo/AAP-4866-2020; Huang, Niu/J-9656-2012	Gao, Yi-Bo/0000-0002-0501-9814; Huang, Niu/0000-0002-6912-033X; Chen, Liang/0000-0001-7300-6604	Chinese Ministry of Science and Technology [2011CB812401]; National Natural Science Foundation of China [81472606]; National Science and Technology Major Project for Infectious Diseases of China [2012ZX10002-017]; BeiGene (Beijing) Co., Ltd.	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project for Infectious Diseases of China; BeiGene (Beijing) Co., Ltd.	Funding was provided by the Chinese Ministry of Science and Technology grant 2011CB812401 to LC, National Natural Science Foundation of China grant 81472606 to LC, National Science and Technology Major Project for Infectious Diseases of China 2012ZX10002-017 to AZ (http://www.most.gov.cn/eng/). BeiGene (Beijing) Co., Ltd. provided support in the form of salaries for authors RH and MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Bekaii-Saab T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-278; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Katterle Y, 2004, BRIT J CANCER, V90, P230, DOI 10.1038/sj.bjc.6601506; Kim SY, 2011, BIOCHEM BIOPH RES CO, V410, P224, DOI 10.1016/j.bbrc.2011.05.111; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; PELES E, 1991, EMBO J, V10, P2077, DOI 10.1002/j.1460-2075.1991.tb07739.x; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Sendur MAN, 2012, CURR MED RES OPIN, V28, P1709, DOI 10.1185/03007995.2012.728132; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Woodman SE, 2010, BIOCHEM PHARMACOL, V80, P568, DOI 10.1016/j.bcp.2010.04.032; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan GG, 2008, CELL SIGNAL, V20, P1284, DOI 10.1016/j.cellsig.2008.02.017	29	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123623	10.1371/journal.pone.0123623	http://dx.doi.org/10.1371/journal.pone.0123623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853726	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400109
J	Pereira, L; Choquet, C; Perozziello, A; Wargon, M; Juillien, G; Colosi, L; Hellmann, R; Ranaivoson, M; Casalino, E				Pereira, Laurent; Choquet, Christophe; Perozziello, Anne; Wargon, Mathias; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique			Unscheduled-Return-Visits after an Emergency Department (ED) Attendance and Clinical Link between Both Visits in Patients Aged 75 Years and Over: A Prospective Observational Study	PLOS ONE			English	Article							HOSPITAL READMISSIONS; HIGH-RISK; ADMISSIONS; CARE; QUALITY	Background Predictors of unscheduled return visits (URV), best time-frame to evaluate URV rate and clinical relationship between both visits have not yet been determined for the elderly following an ED visit. Methods We conducted a prospective-observational study including 11,521 patients aged >= 75-years and discharged from ED (5,368 patients (53.5%)) or hospitalized after ED visit (6,153 patients). Logistic Regression and time-to-failure analyses including Cox proportional model were performed. Results Mean time to URV was 17 days; 72-hour, 30-day and 90-day URV rates were 1.8%, 6.1% and 10% respectively. Multivariate analysis indicates that care-pathway and final disposition decisions were significantly associated with a 30-day URV. Thus, we evaluated predictors of 30-day URV rates among non-admitted and hospitalized patient groups. By using the Cox model we found that, for non-admitted patients, triage acuity and diagnostic category and, for hospitalized patients, that visit time (day, night) and diagnostic categories were significant predictors (p< 0.001). For URV, we found that 25% were due to closely related-clinical conditions. Time lapses between both visits constituted the strongest predictor of closely related-clinical conditions. Conclusion Our study shows that a decision of non-admission in emergency departments is linked with an accrued risk of URV, and that some diagnostic categories are also related for non- admitted and hospitalized subjects alike. Our study also demonstrates that the best time frame to evaluate the URV rate after an ED visit is 30 days, because this is the time period during which most URVs and cases with close clinical relationships between two visits are concentrated. Our results suggest that URV can be used as an indicator or quality.	[Pereira, Laurent; Choquet, Christophe; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique] Univ Hosp Bichat Claude Bernard, AP HP, Emergency Dept, Paris, France; [Pereira, Laurent; Choquet, Christophe; Perozziello, Anne; Wargon, Mathias; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique] Study Grp Efficiency & Qual, Emergency Dept, Paris, France; [Pereira, Laurent; Choquet, Christophe; Perozziello, Anne; Wargon, Mathias; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique] Nonscheduled Act Dept, Paris, France; [Perozziello, Anne] Univ Hosp Bichat Claude Bernard, Med Informat Syst Program PMSI, Paris, France; [Wargon, Mathias] Hop St Camille, Bry Sur Marne, France; [Casalino, Enrique] Univ Paris Diderot, Sorbonne Paris Cite, REMES, EA 7334, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Casalino, E (corresponding author), Univ Hosp Bichat Claude Bernard, AP HP, Emergency Dept, Paris, France.	enrique.casalino@bch.aphp.fr	Casalino, Enrique/GYU-1974-2022	Casalino, Enrique/0000-0002-4352-6729				[Anonymous], 2008, EMERGENCY READMISSIO; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Bianco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048263; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Carret ML, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-131; de Stampa M, 2010, INT J INTEGR CARE, V10; Department of Health, 2010, A E CLIN QUAL IND IM; Epstein AM, 2009, NEW ENGL J MED, V360, P1457, DOI 10.1056/NEJMe0901006; Fan LJ, 2015, EMERG MED J, V32, P738, DOI 10.1136/emermed-2014-203770; Foo CL, 2012, AUSTRALAS J AGEING, V31, P40, DOI 10.1111/j.1741-6612.2010.00499.x; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; George G, 2006, EMERG MED J, V23, P379, DOI 10.1136/emj.2005.029793; Gruneir Andrea, 2011, Open Med, V5, pe104; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Hampton T, 2008, JAMA-J AM MED ASSOC, V299, P2613, DOI 10.1001/jama.299.22.2613; Hastings SN, 2011, AM J MANAG CARE, V17, pE215; Huang AR, 2011, CAN GERIATR J, V14, P100, DOI [10.5770/cgj.v14i4.8, 10.57700/cgj.v14i4.8]; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; KEITH KD, 1989, ANN EMERG MED, V18, P964, DOI 10.1016/S0196-0644(89)80461-5; Laniece I, 2008, AGE AGEING, V37, P416, DOI 10.1093/ageing/afn093; Lowthian J, 2013, INTERN MED J, V43, P554, DOI 10.1111/imj.12061; McBride S, 2008, PARAMETERS FOR THE A, P4; McCusker J, 2006, J GERONTOL A-BIOL, V61, P53, DOI 10.1093/gerona/61.1.53; McCusker J, 2007, ACAD EMERG MED, V14, P426, DOI 10.1197/j.aem.2006.11.020; McCusker J, 2012, J AM GERIATR SOC, V60, P1534, DOI 10.1111/j.1532-5415.2012.04058.x; Newnham HH, 2012, MED J AUSTRALIA, V196, P101, DOI 10.5694/mja11.10619; ODWYER F, 1991, ARCH EMERG MED, V8, P196; Roberts C, 2005, STAT METHODS MED RES, V14, P493, DOI 10.1191/0962280205sm413oa; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Silow-Carroll S, REDUCING HOSPITAL RE; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Trivedy CR, 2015, EMERG MED J, V32, P324, DOI 10.1136/emermed-2013-202719; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Zapatero A, 2012, EUR J INTERN MED, V23, P451, DOI 10.1016/j.ejim.2012.01.005	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123803	10.1371/journal.pone.0123803	http://dx.doi.org/10.1371/journal.pone.0123803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853822	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400118
J	Pi, C; Allott, EH; Ren, D; Poulton, S; Lee, SYR; Perkins, S; Everett, ML; Holzknecht, ZE; Lin, SS; Parker, W				Pi, Cinthia; Allott, Emma H.; Ren, Daniel; Poulton, Susan; Lee, S. Y. Ryan; Perkins, Sarah; Everett, Mary Lou; Holzknecht, Zoie E.; Lin, Shu S.; Parker, William			Increased Biodiversity in the Environment Improves the Humoral Response of Rats	PLOS ONE			English	Article							NATURAL ANTIBODIES; HYGIENE HYPOTHESIS; SPECIFICITY; IGG	Previous studies have compared the immune systems of wild and of laboratory rodents in an effort to determine how laboratory rodents differ from their naturally occurring relatives. This comparison serves as an indicator of what sorts of changes might exist between modern humans living in Western culture compared to our hunter-gatherer ancestors. However, immunological experiments on wild-caught animals are difficult and potentially confounded by increased levels of stress in the captive animals. In this study, the humoral immune responses of laboratory rats in a traditional laboratory environment and in an environment with enriched biodiversity were examined following immunization with a panel of antigens. Biodiversity enrichment included colonization of the laboratory animals with helminths and co-housing the laboratory animals with wild-caught rats. Increased biodiversity did not apparently affect the IgE response to peanut antigens following immunization with those antigens. However, animals housed in the enriched biodiversity setting demonstrated an increased mean humoral response to T-independent and T-dependent antigens and increased levels of "natural" antibodies directed at a xenogeneic protein and at an autologous tissue extract that were not used as immunogens.	[Pi, Cinthia; Ren, Daniel; Poulton, Susan; Lee, S. Y. Ryan; Everett, Mary Lou; Holzknecht, Zoie E.; Lin, Shu S.; Parker, William] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Allott, Emma H.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perkins, Sarah] Cardiff Sch Biosci, Cardiff, S Glam, Wales	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Cardiff University	Parker, W (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	bparker@duke.edu		Parker, William/0000-0003-3644-9152	Coalition for SafeMinds	Coalition for SafeMinds	This work was supported in part by the Coalition for SafeMinds (http://www.safeminds.org/) to WP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; AlBalaghi S, 1996, SCAND J IMMUNOL, V44, P470, DOI 10.1046/j.1365-3083.1996.d01-338.x; Arai H. P., 1980, BIOL TAPEWORM HYMENO; Bilbo SD, 2011, MED HYPOTHESES, V77, P494, DOI 10.1016/j.mehy.2011.06.019; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; de Jonge JD, 2007, METHODS, V41, P99, DOI 10.1016/j.ymeth.2006.09.004; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Leon-Cabrera S, 2014, INT J BIOL SCI, V10, P948, DOI 10.7150/ijbs.9033; Lesher A, 2006, IMMUNOL CELL BIOL, V84, P374, DOI 10.1111/j.1440-1711.2006.01440.x; Lin SS, 2012, J EVOLUTIONARY MED, V1, P1; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Parker W, 1997, J CLIN IMMUNOL, V17, P311, DOI 10.1023/A:1027378716015; Parker W, 2012, CURR MED RES OPIN, V28, P1193, DOI 10.1185/03007995.2012.695731; Parker William, 2002, P87; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Trama AM, 2012, CELL MOL IMMUNOL, V9, P163, DOI 10.1038/cmi.2011.61; TURMAN MA, 1991, TRANSPLANTATION, V52, P710, DOI 10.1097/00007890-199110000-00024; Vollmers HP, 2007, J AUTOIMMUN, V29, P295, DOI 10.1016/j.jaut.2007.07.013; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016	20	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120255	10.1371/journal.pone.0120255	http://dx.doi.org/10.1371/journal.pone.0120255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853852	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352478400011
J	Heiss, M; Hellstrom, M; Kalen, M; May, T; Weber, H; Hecker, M; Augustin, HG; Korff, T				Heiss, Maximilian; Hellstrom, Mats; Kalen, Mattias; May, Tobias; Weber, Holger; Hecker, Markus; Augustin, Hellmut G.; Korff, Thomas			Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro	FASEB JOURNAL			English	Article						HUVEC; VEGF; tip cells	INHIBITS SPROUTING ANGIOGENESIS; EXPRESSION; PROTEIN; RECEPTOR; CD34; DIFFERENTIATION; MIGRATION; EXHIBIT; MODELS; DOMAIN	Given the need for robust and cost-efficient in vitro models to study angiogenesis and reproducibly analyze potential pro-and antiangiogenic compounds in preclinical studies, we developed a 3-dimensional in vitro angiogenesis assay that is based on collagen gel-embedded, size-defined spheroids generated from cultured human umbilical vein endothelial cells (HUVECs). Despite its wide distribution, limitations, sensitivity, robustness, and improvements, the capacity of this assay for functional screening purposes has not been elucidated thus far. By using time-lapse video microscopy, we show that tip cells lead the formation of capillary-like and partially lumenized sprouts originating from the spheroids. Angiogenic sprouting from spheroids generated from 5 different primary cultured human endothelial cell types was induced by physiologic concentrations of vascular endothelial cell growth factor 165. Based on this assay system, we determined the capacity of 880 approved drugs to interfere with or boost angiogenic sprouting, thereby assessing their putative angiogenesis-related side effects or novel applications. However, although this assay allowed for a rapid and reproducible determination of functional IC50 values of individual compounds, the sprouting results were partially affected by the HUVEC passage number and donor variability. To overcome this limitation, immortalized HUVECs (iHUVECs) showing a more homogenous response in terms of proliferation and sprouting over multiple population doublings were used in the course of this study. Collectively, the spheroid-based angiogenesis assay provides a sensitive and versatile tool to study the impact of pro-and antiangiogenic determinants on multiple steps of the angiogenic cascade. It is compatible with different endothelial cell types and allows use of iHUVECs to improve its overall robustness.	[Heiss, Maximilian; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, D-69120 Heidelberg, Germany; [Hellstrom, Mats; Kalen, Mattias] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [May, Tobias] InSCREENeX GmbH, Braunschweig, Germany; [Weber, Holger] ProQinase GmbH, Freiburg, Germany; [Augustin, Hellmut G.] Heidelberg Univ, Med Fac Mannheim CBTM, Div Vasc Biol & Tumor Angiogenesis, D-69120 Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr Heidelberg, Div Vasc Oncol & Metastasis, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Uppsala University; ProQinase; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Korff, T (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242	Deutsche Forschungsgemeinschaft (Ursula M. Handel Animal Welfare Award) [SFB TR 23]	Deutsche Forschungsgemeinschaft (Ursula M. Handel Animal Welfare Award)	The authors gratefully acknowledge the excellent technical assistance provided by Ender Serbest and Gudrun Scheib. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB TR 23, project sections A3, C5 and C6; Ursula M. Handel Animal Welfare Award).	Adam MG, 2013, CIRC RES, V113, P1206, DOI 10.1161/CIRCRESAHA.113.301686; Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Asif AR, 2009, J PROTEOME RES, V8, P3161, DOI 10.1021/pr800998k; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; BAUMHUETER S, 1994, BLOOD, V84, P2554; Cattaruzza M, 2004, CIRC RES, V95, P841, DOI 10.1161/01.RES.0000145359.47708.2f; Cines DB, 1998, BLOOD, V91, P3527; DELIA D, 1993, BLOOD, V81, P1001; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; FINA L, 1990, BLOOD, V75, P2417; Gautier B, 2011, CHEM BIOL, V18, P1631, DOI 10.1016/j.chembiol.2011.10.016; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hada K, 2012, BIOORGAN MED CHEM, V20, P1442, DOI 10.1016/j.bmc.2011.12.058; IruelaArispe ML, 1997, THROMB HAEMOSTASIS, V78, P672; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Korff T, 1999, J CELL SCI, V112, P3249; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; PAULY RR, 1992, CIRCULATION, V86, P68; Seki M, 2000, INT J ONCOL, V17, P525; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Weber H, 2008, TOXICOL IN VITRO, V22, P531, DOI 10.1016/j.tiv.2007.09.014; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zhong L, 2005, BBA-GEN SUBJECTS, V1722, P254, DOI 10.1016/j.bbagen.2004.12.015	32	120	122	3	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3076	3084		10.1096/fj.14-267633	http://dx.doi.org/10.1096/fj.14-267633			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25857554				2022-12-26	WOS:000356859100034
J	Dominianni, C; Sinha, R; Goedert, JJ; Pei, ZH; Yang, LY; Hayes, RB; Ahn, JY				Dominianni, Christine; Sinha, Rashmi; Goedert, James J.; Pei, Zhiheng; Yang, Liying; Hayes, Richard B.; Ahn, Jiyoung			Sex, Body Mass Index, and Dietary Fiber Intake Influence the Human Gut Microbiome	PLOS ONE			English	Article							FECAL MICROBIOTA; INTESTINAL MICROBIOME; COLORECTAL-CANCER; OBESITY; DIVERSITY; BUTYRATE; ECOLOGY; GENDER; BIFIDOBACTERIA; DETERMINANTS	Increasing evidence suggests that the composition of the human gut microbiome is important in the etiology of human diseases; however, the personal factors that influence the gut microbiome composition are poorly characterized. Animal models point to sex hormone-related differentials in microbiome composition. In this study, we investigated the relationship of sex, body mass index (BMI) and dietary fiber intake with the gut microbiome in 82 humans. We sequenced fecal 16S rRNA genes by 454 FLX technology, then clustered and classified the reads to microbial genomes using the QIIME pipeline. Relationships of sex, BMI, and fiber intake with overall gut microbiome composition and specific taxon abundances were assessed by permutational MANOVA and multivariate logistic regression, respectively. We found that sex was associated with the gut microbiome composition overall (p=0.001). The gut microbiome in women was characterized by a lower abundance of Bacteroidetes (p=0.03). BMI (>25 kg/m(2) vs. <25 kg/m(2)) was associated with the gut microbiome composition overall (p=0.05), and this relationship was strong in women (p=0.03) but not in men (p=0.29). Fiber from beans and from fruits and vegetables were associated, respectively, with greater abundance of Actinobacteria (p=0.006 and false discovery rate adjusted q=0.05) and Clostridia (p=0.009 and false discovery rate adjusted q=0.09). Our findings suggest that sex, BMI, and dietary fiber contribute to shaping the gut microbiome in humans. Better understanding of these relationships may have significant implications for gastrointestinal health and disease prevention.	[Dominianni, Christine; Hayes, Richard B.; Ahn, Jiyoung] NYU, Sch Med, Dept Populat Hlth, New York, NY 11201 USA; [Pei, Zhiheng; Hayes, Richard B.; Ahn, Jiyoung] NYU, Perlmutter Canc Ctr, New York, NY USA; [Sinha, Rashmi; Goedert, James J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pei, Zhiheng] New York Vet Affairs Med Ctr, Dept Pathol & Lab Med, New York, NY USA; [Pei, Zhiheng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Pei, Zhiheng; Yang, Liying] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; New York University	Ahn, JY (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 11201 USA.	Jiyoung.Ahn@nyumc.org	Sinha, Rashmi/G-7446-2015	Sinha, Rashmi/0000-0002-2466-7462; Hayes, Richard/0000-0002-0918-661X; Yang, Liying/0000-0003-1442-4915; Ahn, Jiyoung/0000-0002-2900-2304; Pei, Zhiheng/0000-0001-8570-6747	National Cancer Institute [R03CA159414, R21CA183887, R01CA159036, UH3CA140233]; National Institutes of Health Human Microbiome Project; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL CANCER INSTITUTE [R01CA159036, ZIACP010214, R21CA183887, P30CA016087, UH3CA140233, R03CA159414] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Human Microbiome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grants R03CA159414, R21CA183887, R01CA159036 and UH3CA140233 from the National Cancer Institute (http://www.cancer.gov/researchandfunding) (JA) and National Institutes of Health Human Microbiome Project (http://grants.nih.gov/grants/oer.htm) and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (http://www.research.va.gov/) (ZP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benus RFJ, 2010, BRIT J NUTR, V104, P693, DOI 10.1017/S0007114510001030; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; Classification BMI, 2006, CLASSIFICATION BMI G; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degen LP, 1996, GUT, V39, P299, DOI 10.1136/gut.39.2.299; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253; Gaskins AJ, 2009, AM J CLIN NUTR, V90, P1061, DOI 10.3945/ajcn.2009.27990; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; LAMPE JW, 1993, GUT, V34, P531, DOI 10.1136/gut.34.4.531; Landa-Habana L, 2004, PLANT FOOD HUM NUTR, V59, P133, DOI 10.1007/s11130-004-4307-5; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lewis SJ, 1997, GUT, V41, P245, DOI 10.1136/gut.41.2.245; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Nielsen DS, 2014, FEBS LETT; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; PROBERT CSJ, 1995, QJM-MON J ASSOC PHYS, V88, P311; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; SCHIFFMAN MH, 1989, CANCER RES, V49, P1322; SCHIFFMAN MH, 1989, CANCER RES, V49, P3420; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Stipanuk M, 2013, BIOCH PHYSL MOL ASPE; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Versini M, 2014, AUTOIMMUNITY REV; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Whelan K, 2005, J NUTR, V135, P1896, DOI 10.1093/jn/135.8.1896; Willett W., 2012, NUTR EPIDEMIOLOGY; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yadav BS, 2009, INT J FOOD SCI NUTR, V60, P258, DOI 10.1080/09637480902970975; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	58	232	245	10	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124599	10.1371/journal.pone.0124599	http://dx.doi.org/10.1371/journal.pone.0124599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874569	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800147
J	Endres, RG				Endres, Robert G.			Bistability: Requirements on Cell-Volume, Protein Diffusion, and Thermodynamics	PLOS ONE			English	Article							SINGLE-MOLECULE EVENT; ESCHERICHIA-COLI; STOCHASTIC SIMULATION; CHEMICAL-REACTIONS; BACTERIAL-CELL; FLUCTUATION THEOREM; ENTROPY PRODUCTION; PHASE-TRANSITIONS; HYSTERESIS; SYSTEMS	Bistability is considered wide-spread among bacteria and eukaryotic cells, useful e.g. for enzyme induction, bet hedging, and epigenetic switching. However, this phenomenon has mostly been described with deterministic dynamic or well-mixed stochastic models. Here, we map known biological bistable systems onto the well-characterized biochemical Schlogl model, using analytical calculations and stochastic spatiotemporal simulations. In addition to network architecture and strong thermodynamic driving away from equilibrium, we show that bistability requires fine-tuning towards small cell volumes (or compartments) and fast protein diffusion (well mixing). Bistability is thus fragile and hence may be restricted to small bacteria and eukaryotic nuclei, with switching triggered by volume changes during the cell cycle. For large volumes, single cells generally loose their ability for bistable switching and instead undergo a first-order phase transition.	[Endres, Robert G.] Dept Life Sci, London, England; [Endres, Robert G.] Ctr Integrat Syst Biol & Bioinformat, London, England		Endres, RG (corresponding author), Dept Life Sci, London, England.	r.endres@imperial.ac.uk			Leverhulme- Trust [RPG-181]; European Research Council [280492-PPHPI]	Leverhulme- Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	Work was funded by Leverhulme- Trust Grant N. RPG-181 (http://www.leverhulme.ac.uk/) and European Research Council Starting-Grant N. 280492-PPHPI (http://erc.europa.eu/starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ANDRESEN B, 1984, J CHEM PHYS, V81, P4676, DOI 10.1063/1.447402; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Botello E, 1998, J BACTERIOL, V180, P6364; Boulineau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061686; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Choi PJ, 2010, J MOL BIOL, V396, P230, DOI 10.1016/j.jmb.2009.11.035; Dewar RC, 2005, J PHYS A-MATH GEN, V38, pL371, DOI 10.1088/0305-4470/38/21/L01; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DYKMAN MI, 1994, J CHEM PHYS, V100, P5735, DOI 10.1063/1.467139; EBELING W, 1979, PHYSICA A, V98, P587, DOI 10.1016/0378-4371(79)90157-2; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gaspard P, 2004, J CHEM PHYS, V120, P8898, DOI 10.1063/1.1688758; Ge H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148103; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glansdorf P, 1971, THERMODYNAMIC THEORY; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; HANGGI P, 1984, PHYS REV A, V29, P371, DOI 10.1103/PhysRevA.29.371; Hermsen R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002265; Hoffmann M, 2014, SOFT MATTER, V10, P2388, DOI 10.1039/c3sm52251b; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Kaizu K, 2014, BIOPHYS J, V106, P976, DOI 10.1016/j.bpj.2013.12.030; Kalwarczyk T, 2012, BIOINFORMATICS, V28, P2971, DOI 10.1093/bioinformatics/bts537; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; KURTZ TG, 1971, J APPL PROBAB, V8, P344, DOI 10.2307/3211904; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P32, DOI 10.1073/pnas.97.1.32; LUO JL, 1984, Z PHYS B CON MAT, V56, P165, DOI 10.1007/BF01469698; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; NICOLIS G, 1977, PHYS LETT A, V62, P469, DOI 10.1016/0375-9601(77)90069-X; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; SAWADA Y, 1981, PROG THEOR PHYS, V66, P68, DOI 10.1143/PTP.66.68; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Schrodinger E, 1944, MALIA KOUKIA; Shimizu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023953; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Tanase-Nicola S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.040103; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Vellela M, 2007, B MATH BIOL, V69, P1727, DOI 10.1007/s11538-006-9188-3; Vellela M, 2009, J R SOC INTERFACE, V6, P925, DOI 10.1098/rsif.2008.0476; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zaritsky A, 2011, MICROBIOL-SGM, V157, P1876, DOI 10.1099/mic.0.049403-0; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96; Zuk PJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055002	64	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121681	10.1371/journal.pone.0121681	http://dx.doi.org/10.1371/journal.pone.0121681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874711	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800028
J	Agrawal, P; Miryala, S; Varshney, U				Agrawal, Priyanka; Miryala, Sandeep; Varshney, Umesh			Use of Mycobacterium smegmatis Deficient in ADP-Ribosyltransferase as Surrogate for Mycobacterium tuberculosis in Drug Testing and Mutation Analysis	PLOS ONE			English	Article							DNA-DAMAGING AGENTS; RNA-POLYMERASE; RESISTANT TUBERCULOSIS; RIFAMPICIN; PROTECTION; MUTANTS; REPAIR; RIBOSYLATION; INHIBITION; EMERGENCE	Rifampicin (Rif) is a first line drug used for tuberculosis treatment. However, the emergence of drug resistant strains has necessitated synthesis and testing of newer analogs of Rif. Mycobacterium smegmatis is often used as a surrogate for M. tuberculosis. However, the presence of an ADP ribosyltransferase (Arr) in M. smegmatis inactivates Rif, rendering it impractical for screening of Rif analogs or other compounds when used in conjunction with them (Rif/Rif analogs). Rifampicin is also used in studying the role of various DNA repair enzymes by analyzing mutations in RpoB (a subunit of RNA polymerase) causing Rif resistance. These analyses use high concentrations of Rif when M. smegmatis is used as model. Here, we have generated M. smegmatis strains by deleting arr (Delta arr). The M. smegmatis Delta arr strains show minimum inhibitory concentration (MIC) for Rif which is similar to that for M. tuberculosis. The MICs for isoniazid, pyrazinamide, ethambutol, ciprofloxacin and streptomycin were essentially unaltered for M. smegmatis Delta arr. The growth profiles and mutation spectrum of Delta arr and, Delta arr combined with Delta udgB (udgB encodes a DNA repair enzyme that excises uracil) strains were similar to their counterparts wild-type for arr. However, the mutation spectrum of Delta fpg Delta arr strain differed somewhat from that of the Delta fpg strain (fpg encodes a DNA repair enzyme that excises 8-oxo-G). Our studies suggest M. smegmatis Delta arr strain as an ideal model system in drug testing and mutation spectrum determination in DNA repair studies.	[Agrawal, Priyanka; Miryala, Sandeep; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Varshney, Umesh/Q-6914-2019		Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (UV) (http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cavusoglu C, 2004, CLIN MICROBIOL INFEC, V10, P662, DOI 10.1111/j.1469-0691.2004.00917.x; DABBS ER, 1995, ANTIMICROB AGENTS CH, V39, P1007, DOI 10.1128/AAC.39.4.1007; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Dey A, 2010, MICROBIOL-SGM, V156, P873, DOI 10.1099/mic.0.033670-0; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Jain R, 2007, DNA REPAIR, V6, P1774, DOI 10.1016/j.dnarep.2007.06.009; Kurthkoti K, 2008, MICROBIOL-SGM, V154, P2776, DOI 10.1099/mic.0.2008/019638-0; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Kurthkoti K, 2010, MICROBIOL-SGM, V156, P88, DOI 10.1099/mic.0.033621-0; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Malshetty V, 2010, MICROBIOL-SGM, V156, P1565, DOI 10.1099/mic.0.036970-0; Malshetty VS, 2010, MICROBIOL-SGM, V156, P940, DOI 10.1099/mic.0.034363-0; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Mohammad A., 2013, WORLD J ORGANIC CHEM, V1, P14; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Nigam A, 2014, J BIOL CHEM, V289, P21142, DOI 10.1074/jbc.M114.572636; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Sambrook J, 1989, MOL CLONING; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shiloh MU, 2010, CURR OPIN MICROBIOL, V13, P86, DOI 10.1016/j.mib.2009.11.006; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stallings CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021807; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEHRLI W, 1971, BACTERIOL REV, V35, P290, DOI 10.1128/MMBR.35.3.290-309.1971	32	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122076	10.1371/journal.pone.0122076	http://dx.doi.org/10.1371/journal.pone.0122076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874691	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000352845100057
J	Da Guan, W; Gong, XY; Mok, CKP; Chen, TT; Wu, SG; Pan, SH; Cowling, BJ; Yang, ZF; Chen, DH				Da Guan, Wen; Gong, Xiao Yan; Mok, Chris Ka Pun; Chen, Ting Ting; Wu, Shi Guan; Pan, Si Hua; Cowling, Benjamin John; Yang, Zi Feng; Chen, De Hui			Surveillance for Seasonal Influenza Virus Prevalence in Hospitalized Children with Lower Respiratory Tract Infection in Guangzhou, China during the Post-Pandemic Era	PLOS ONE			English	Article							PNEUMONIA; H1N1	Background Influenza A(H1N1)pdm09, A(H3N2) and B viruses have co-circulated in the human population since the swine-origin human H1N1 pandemic in 2009. While infections of these subtypes generally cause mild illnesses, lower respiratory tract infection (LRTI) occurs in a portion of children and required hospitalization. The aim of our study was to estimate the prevalence of these three subtypes and compare the clinical manifestations in hospitalized children with LRTI in Guangzhou, China during the post-pandemic period. Methods Children hospitalized with LRTI from January 2010 to December 2012 were tested for influenza A/B virus infection from their throat swab specimens using real-time PCR and the clinical features of the positive cases were analyzed. Results Of 3637 hospitalized children, 216 (5.9%) were identified as influenza A or B positive. Infection of influenza virus peaked around March in Guangzhou each year from 2010 to 2012, and there were distinct epidemics of each subtype. Influenza A(H3N2) infection was more frequently detected than A(H1N1)pdm09 and B, overall. The mean age of children with influenza A virus (H1N1/H3N2) infection was younger than those with influenza B (34.4 months/32.5 months versus 45 months old; p < 0.005). Co-infections of influenza A/B with mycoplasma pneumoniae were found in 44/216 (20.3%) children. Conclusions This study contributes the understanding to the prevalence of seasonal influenza viruses in hospitalized children with LRTI in Guangzhou, China during the post pandemic period. High rate of mycoplasma pneumoniae co-infection with influenza viruses might contribute to severe disease in the hospitalized children.	[Da Guan, Wen; Chen, Ting Ting; Wu, Shi Guan; Pan, Si Hua; Yang, Zi Feng; Chen, De Hui] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Gong, Xiao Yan; Chen, De Hui] Guangzhou Med Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Mok, Chris Ka Pun] Univ Hong Kong, HKU Li Ka Shing Fac Med, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Mok, Chris Ka Pun] Univ Hong Kong, HKU Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China; [Cowling, Benjamin John] Univ Hong Kong, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yang, ZF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	jeffyah@163.com; cdh84@126.com	Cowling, Benjamin John/C-4263-2009; Mok, Chris Ka Pun/ABD-2667-2021	Cowling, Benjamin John/0000-0002-6297-7154; Mok, Chris Ka Pun/0000-0002-0525-6772	Municipal Science and Technology Bureau Foundation of Guangzhou [2014Y2-00031]; Emergency Response Project of Ministry of Science and Technology of China [KJYJ-2013-01-05]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX10004006]; University Grants Committee, Hong Kong [AoE/M-12/06]	Municipal Science and Technology Bureau Foundation of Guangzhou; Emergency Response Project of Ministry of Science and Technology of China; National Science and Technology Major Project of the Ministry of Science and Technology of China; University Grants Committee, Hong Kong	This study was financially supported by Municipal Science and Technology Bureau Foundation of Guangzhou (Grant no. Grant no. 2014Y2-00031), Emergency Response Project of Ministry of Science and Technology of China (Grant no. KJYJ-2013-01-05), National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant no. 2014ZX10004006). CKPM and BC were supported by funding by grant AoE/M-12/06 from the University Grants Committee, Hong Kong.	Bagdure D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015173; Centers for Disease Control and Prevention (CDC), 2009, CDC PROT REAL TIM RT; Chiu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021837; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cowling BJ, 2014, VACCINE; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Dangi T, 2014, INDIAN J MED RES, V139, P418; Dhanoa A, 2009, VIROL J, V8, P1; Eurosurveillance Editorial Team, 2010, EURO SURVEILL, V15; Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647; Kashyap S, 2010, LUNG INDIA, V27, P75, DOI 10.4103/0970-2113.63611; Lin JY, 2013, J THORAC DIS, V5, pS109, DOI 10.3978/j.issn.2072-1439.2013.08.09; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Liu CL, 2010, CHINESE MED J-PEKING, V123, P3444, DOI 10.3760/cma.j.issn.0366-6999.2010.23.013; Le MN, 2014, INFLUENZA OTHER RESP, V8, P389, DOI 10.1111/irv.12244; Peltola V, 2003, CLIN INFECT DIS, V36, P299, DOI 10.1086/345909; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Shen CF, 2008, J MICROBIOL IMMUNOL, V41, P294; Stripeli F, 2013, PAEDIAT INT CHILD HL; Turbelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065919; Wong JY, 2013, EPIDEMIOLOGY, V24, P830, DOI 10.1097/EDE.0b013e3182a67448; Yang ZF, 2012, JPN J INFECT DIS, V65, P208, DOI 10.7883/yoken.65.208; Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205	24	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120983	10.1371/journal.pone.0120983	http://dx.doi.org/10.1371/journal.pone.0120983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867910	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100030
J	Li, C; Wu, AC; Go, RM; Malouf, J; Turner, MS; Malde, AK; Mark, AE; Gilbert, RG				Li, Cheng; Wu, Alex Chi; Go, Rob Marc; Malouf, Jacob; Turner, Mark S.; Malde, Alpeshkumar K.; Mark, Alan E.; Gilbert, Robert G.			The Characterization of Modified Starch Branching Enzymes: Toward the Control of Starch Chain-Length Distributions	PLOS ONE			English	Article							SLOWLY DIGESTIBLE STARCH; ALPHA-AMYLASE; CRYSTAL-STRUCTURE; CYCLODEXTRIN GLYCOSYLTRANSFERASE; I BEI; RICE; AMYLOSE; ENDOSPERM; GLYCOGEN; BIOSYNTHESIS	Starch is a complex branched glucose polymer whose branch molecular weight distribution (the chain-length distribution, CLD) influences nutritionally important properties such as digestion rate. Chain-stopping in starch biosynthesis is by starch branching enzyme (SBE). Site-directed mutagenesis was used to modify SBEIIa from Zea mays (mSBEIIa) to produce mutants, each differing in a single conserved amino-acid residue. Products at different times from in vitro branching were debranched and the time evolution of the CLD measured by size-exclusion chromatography. The results confirm that Tyr352, Glu513, and Ser349 are important for mSBEIIa activity while Arg456 is important for determining the position at which the linear glucan is cut. The mutant mSBEIIa enzymes have different activities and suggest the length of the transferred chain can be varied by mutation. The work shows analysis of the molecular weight distribution can yield information regarding the enzyme branching sites useful for development of plants yielding starch with improved functionality.	[Li, Cheng; Wu, Alex Chi; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Li, Cheng; Wu, Alex Chi; Go, Rob Marc; Malouf, Jacob; Turner, Mark S.; Gilbert, Robert G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Nutr & Food Sci, Brisbane, Qld, Australia; [Turner, Mark S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Malde, Alpeshkumar K.; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	Huazhong University of Science & Technology; University of Queensland; University of Queensland; University of Queensland	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China.	b.gilbert@uq.edu.au	MALDE, Alpesh/A-5341-2010; Mark, Alan E/A-8799-2011; Wu, Alex/C-3513-2017; Gilbert, Robert G/C-5660-2009	MALDE, Alpesh/0000-0002-8181-1619; Mark, Alan E/0000-0001-5880-4798; Wu, Alex/0000-0002-6612-7691; Gilbert, Robert G/0000-0001-6988-114X; Turner, Mark/0000-0003-2770-852X	1000-Talents Program of the Chinese Foreign Experts Bureau; Australian Research Council [DP130102153]	1000-Talents Program of the Chinese Foreign Experts Bureau; Australian Research Council(Australian Research Council)	This work was supported by the 1000-Talents Program of the Chinese Foreign Experts Bureau (www.1000plan.org) to RGG and the Australian Research Council (www.arc.gov.au) DP130102153 to AEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; BYRNES SE, 1995, J NUTR, V125, P1430; Cao HP, 1996, J PROTEIN CHEM, V15, P291, DOI 10.1007/BF01887118; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Castro J, 2005, LAT TRADE, V13, P6; Cave RA, 2009, BIOMACROMOLECULES, V10, P2245, DOI 10.1021/bm900426n; Chaen K, 2012, BIOCHEM BIOPH RES CO, V424, P508, DOI 10.1016/j.bbrc.2012.06.145; DEDECKERE EAM, 1995, BRIT J NUTR, V73, P287, DOI 10.1079/BJN19950030; Ferguson LR, 2000, NUTR CANCER, V36, P230, DOI 10.1207/S15327914NC3602_13; Flipse E, 1996, PLANTA, V198, P340, DOI 10.1007/BF00620049; Gilbert RG, 2011, ANAL BIOANAL CHEM, V399, P1425, DOI 10.1007/s00216-010-4435-8; Goncalves P, 2013, CURR DRUG METAB, V14, P994; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438; Hasjim J, 2010, BIOMACROMOLECULES, V11, P3600, DOI 10.1021/bm101053y; Hazard B, 2012, CROP SCI, V52, P1754, DOI 10.2135/cropsci2012.02.0126; Hernandez JM, 2008, BIOMACROMOLECULES, V9, P954, DOI 10.1021/bm701213p; Jenkins DJA, 1998, J AM COLL NUTR, V17, P609, DOI 10.1080/07315724.1998.10718810; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Johnston KL, 2010, DIABETIC MED, V27, P391, DOI 10.1111/j.1464-5491.2010.02923.x; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; Keeling PL, 2010, ANNU REV FOOD SCI T, V1, P271, DOI 10.1146/annurev.food.102308.124214; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar V, 2010, CARBOHYD RES, V345, P893, DOI 10.1016/j.carres.2010.02.007; Kuriki T, 1996, J PROTEIN CHEM, V15, P305, DOI 10.1007/BF01887119; Kuriki T, 1997, J BIOL CHEM, V272, P28999, DOI 10.1074/jbc.272.46.28999; Lehmann U, 2007, TRENDS FOOD SCI TECH, V18, P346, DOI 10.1016/j.tifs.2007.02.009; Libessart N, 1998, ARCH BIOCHEM BIOPHYS, V360, P135, DOI 10.1006/abbi.1998.0960; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MARTIN C, 1995, PLANT CELL, V7, P971, DOI 10.1105/tpc.7.7.971; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mikkelsen R, 2001, ARCH BIOCHEM BIOPHYS, V385, P372, DOI 10.1006/abbi.2000.2164; Nakamura Y., 2011, Journal of Applied Glycoscience, V58, P119, DOI 10.5458/jag.jag.JAG-2010_015; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; Nielsen TH, 2002, J BIOL CHEM, V277, P20249, DOI 10.1074/jbc.M201866200; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Qian MX, 2001, BIOCHEMISTRY-US, V40, P7700, DOI 10.1021/bi0102050; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Regina A, 2010, J EXP BOT, V61, P1469, DOI 10.1093/jxb/erq011; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schrodinger L.L.C., 2009, PYMOL MOL GRAPHICS S; Sestili F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-144; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vilaplana F, 2010, J SEP SCI, V33, P3537, DOI 10.1002/jssc.201000525; Witt T, 2010, J AGR FOOD CHEM, V58, P8444, DOI 10.1021/jf101063m; Wu AC, 2014, CARBOHYD POLYM, V114, P36, DOI 10.1016/j.carbpol.2014.08.001; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768; Wu AC, 2010, BIOMACROMOLECULES, V11, P3539, DOI 10.1021/bm1010189; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang G, 2008, J AGR FOOD CHEM, V56, P4686, DOI 10.1021/jf072822m	69	27	28	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125507	10.1371/journal.pone.0125507	http://dx.doi.org/10.1371/journal.pone.0125507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874689	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100298
J	Carty, N; Berson, N; Tillack, K; Thiede, C; Scholz, D; Kottig, K; Sedaghat, Y; Gabrysiak, C; Yohrling, G; von der Kammer, H; Ebneth, A; Mack, V; Munoz-Sanjuan, I; Kwak, S				Carty, Nikisha; Berson, Nadege; Tillack, Karsten; Thiede, Christina; Scholz, Diana; Kottig, Karsten; Sedaghat, Yalda; Gabrysiak, Christina; Yohrling, George; von der Kammer, Heinz; Ebneth, Andreas; Mack, Volker; Munoz-Sanjuan, Ignacio; Kwak, Seung			Characterization of HTT Inclusion Size, Location, and Timing in the zQ175 Mouse Model of Huntington's Disease: An In Vivo High-Content Imaging Study	PLOS ONE			English	Article							MUTANT HUNTINGTIN; EARLY MOTOR; CAG REPEAT; MICE; EXPRESSION; LENGTH; ONSET	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene. Major pathological hallmarks of HD include inclusions of mutant huntingtin (mHTT) protein, loss of neurons predominantly in the caudate nucleus, and atrophy of multiple brain regions. However, the early sequence of histological events that manifest in region-and cell-specific manner has not been well characterized. Here we use a high-content histological approach to precisely monitor changes in HTT expression and characterize deposition dynamics of mHTT protein inclusion bodies in the recently characterized zQ175 knock-in mouse line. We carried out an automated multi-parameter quantitative analysis of individual cortical and striatal cells in tissue slices from mice aged 2-12 months and confirmed biochemical reports of an age-associated increase in mHTT inclusions in this model. We also found distinct regional and subregional dynamics for inclusion number, size and distribution with subcellular resolution. We used viral-mediated suppression of total HTT in the striatum of zQ175 mice as an example of a therapeutically-relevant but heterogeneously transducing strategy to demonstrate successful application of this platform to quantitatively assess target engagement and outcome on a cellular basis.	[Carty, Nikisha; Berson, Nadege; Tillack, Karsten; Thiede, Christina; Scholz, Diana; Kottig, Karsten; Sedaghat, Yalda; Gabrysiak, Christina; von der Kammer, Heinz; Ebneth, Andreas; Mack, Volker] Evotec AG, Hamburg, Germany; [Yohrling, George; Munoz-Sanjuan, Ignacio; Kwak, Seung] CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA	Evotec	Kwak, S (corresponding author), CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA.	Seung.kwak@chdifoundation.org		Carty, Nikisha/0000-0002-0824-3897	CHDI Foundation	CHDI Foundation	This work was supported by CHDI Foundation, a privately-funded nonprofit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organization Evotec AG under a fee-for-service agreements. The authors listed all contributed to the conception, planning, and direction of the research, including generation, analysis, and interpretation of the data. The specific roles of these authors are articulated in the author contributions section.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Menalled L, 2009, SOC NEUR ANN C; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Minderer M, 2012, J PHYSIOL-LONDON, V590, P99, DOI 10.1113/jphysiol.2011.219014; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Nedelec Jean-Francois J, 2004, Dialogues Clin Neurosci, V6, P227; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	28	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123527	10.1371/journal.pone.0123527	http://dx.doi.org/10.1371/journal.pone.0123527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859666	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300102
J	Li, X; Zhou, J; Huang, KC; Tang, FX; Zhou, H; Wang, SS; Jia, Y; Sun, HY; Ma, D; Li, S				Li, Xiong; Zhou, Jin; Huang, Kecheng; Tang, Fangxu; Zhou, Hang; Wang, Shaoshuai; Jia, Yao; Sun, Haiying; Ma, Ding; Li, Shuang			The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; NODAL METASTASIS; SCC ANTIGEN; LEVEL	Objective Neoadjuvant chemotherapy (NACT) could affect the levels of squamous cell carcinoma antigen (SCC-Ag). This study evaluates the predictive value of pre- and posttreatment SCC-Ag levels in patients with cervical cancer who were treated with NACT followed by radical surgery. Methods A total of 286 patients with Stage IB1-IIIB squamous cell carcinoma of the uterine cervix who were treated with NACT followed by radical hysterectomy were analyzed retrospectively. The relationship between SCC-Ag levels, the clinicopathologic parameters, the response to NACT and the three-year survival rate was investigated. Results The levels of SCC-Ag were elevated (>3.5 ng/mL) in 43.8% of patients before NACT, and 13.0% of patients after NACT. Pre- and posttreatment levels of SCC-Ag correlated with the response to NACT (P = 0.010, and P<0.001), deep stromal infiltration (P = 0.041, and P = 0.006), and lymph node status (P<0.001, and P<0.001). In the multivariate analysis, the elevated pretreatment level of SCC-Ag was demonstrated to be an independent risk factor for Lymph node metastases (P<0.001). Patients with both pre- and posttreatment SCC-Ag levels <= 3.5 ng/mL showed the best 3-year disease-free survival (DFS) and 3-year overall survival (OS) compared with patients with either pre- or posttreatment levels >3.5 ng/mL (P<0.001, and P<0.001, respectively). A multivariate analysis showed that posttreatment SCC-Ag levels were a strong independent predictor of OS (P = 0.001) and DFS ( P = 0.012). Conclusion Elevated pretreatment levels of SCC-Ag (>3.5 ng/mL) indicated a poor response to NACT and a higher risk of lymph node metastases. Elevated posttreatment levels of SCC-Ag were correlated with poor DFS and OS.	[Li, Xiong; Zhou, Jin; Huang, Kecheng; Tang, Fangxu; Zhou, Hang; Wang, Shaoshuai; Jia, Yao; Sun, Haiying; Ma, Ding; Li, Shuang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhou, Jin] Wuhan Univ, Renmin Hosp, Ctr Canc, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.	dma@tjh.tjmu.edu.cn; lee5190008@126.com	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Li, Shuang/0000-0002-9193-0320	Key Basic Research and Development Program Foundation of China (973 Program) [2015CB553903, 2009CB521806]; National Natural Science Foundation of China [81230038, 81472783, 81272422, 81172464, 81090414, 81101964]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2015CB553903, 2009CB521806) and was supported by grants from the National Natural Science Foundation of China (No. 81230038; 81472783; 81272422; 81172464; 81090414; 81101964). No other potential conflict of interest relevant to this article was reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVALLLUNDQVIST EH, 1992, EUR J CANCER, V28A, P1695, DOI 10.1016/0959-8049(92)90071-9; Bae SN, 1997, GYNECOL ONCOL, V64, P418, DOI 10.1006/gyno.1996.4589; Bolger BS, 1997, GYNECOL ONCOL, V65, P309, DOI 10.1006/gyno.1997.4619; BRIOSCHI PA, 1991, INT J CANCER, V47, P376, DOI 10.1002/ijc.2910470311; CROMBACH G, 1989, DEUT MED WOCHENSCHR, V114, P700, DOI 10.1055/s-2008-1066658; CROMBACH G, 1989, CANCER, V63, P1337, DOI 10.1002/1097-0142(19890401)63:7<1337::AID-CNCR2820630719>3.0.CO;2-J; Duk JM, 1996, J CLIN ONCOL, V14, P111, DOI 10.1200/JCO.1996.14.1.111; Eskander RN, 2014, J GYNECOL ONCOL, V25, P249, DOI 10.3802/jgo.2014.25.3.249; Gaarenstroom KN, 2000, GYNECOL ONCOL, V77, P164, DOI 10.1006/gyno.2000.5732; GAARENSTROOM KN, 1995, CANCER-AM CANCER SOC, V76, P807, DOI 10.1002/1097-0142(19950901)76:5<807::AID-CNCR2820760515>3.0.CO;2-M; Hong JH, 1998, INT J RADIAT ONCOL, V41, P823, DOI 10.1016/S0360-3016(98)00147-3; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kim DY, 2014, BRIT J CANCER, V110, P34, DOI 10.1038/bjc.2013.718; Lin H, 2000, ACTA OBSTET GYN SCAN, V79, P140, DOI 10.1034/j.1600-0412.2000.079002140.x; Massuger LFAG, 1997, GYNECOL ONCOL, V64, P473, DOI 10.1006/gyno.1996.4581; PATSNER B, 1989, OBSTET GYNECOL, V74, P786; SCAMBIA G, 1994, J CLIN ONCOL, V12, P2309, DOI 10.1200/JCO.1994.12.11.2309; Schmidt-Rhode P, 1988, Int J Biol Markers, V3, P87; Sturgeon CM, 2010, CLIN CHEM, V56, pE1, DOI 10.1373/clinchem.2009.133124; Takeshima N, 1998, GYNECOL ONCOL, V68, P263, DOI 10.1006/gyno.1998.4939	22	23	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122361	10.1371/journal.pone.0122361	http://dx.doi.org/10.1371/journal.pone.0122361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860888	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300042
J	Lin, YL; Ma, LT; Lee, YR; Lin, SS; Wang, SY; Chang, TT; Shaw, JF; Li, WH; Chu, FH				Lin, Yan-Liang; Ma, Li-Ting; Lee, Yi-Ru; Lin, Shih-Shun; Wang, Sheng-Yang; Chang, Tun-Tschu; Shaw, Jei-Fu; Li, Wen-Hsiung; Chu, Fang-Hua			MicroRNA-Like Small RNAs Prediction in the Development of Antrodia cinnamomea	PLOS ONE			English	Article							GENOME SEQUENCE; IDENTIFICATION; FUNGUS; ANNOTATION; GENE; RECONSTRUCTION; BIOGENESIS; MECHANISMS; GENERATION; INSIGHTS	Antrodia cinnamomea, a precious, host-specific brown-rot fungus that has been used as a folk medicine in Taiwan for centuries is known to have diverse bioactive compounds with potent pharmaceutical activity. In this study, different fermentation states of A. cinnamomea (wild-type fruiting bodies and liquid cultured mycelium) were sequenced using the next-generation sequencing (NGS) technique. A 45.58 Mb genome encoding 6,522 predicted genes was obtained. High quality reads were assembled into a total of 13,109 unigenes. Using a previously constructed pipeline to search for microRNAs (miRNAs), we then identified 4 predicted conserved miRNA and 63 novel predicted miRNA-like small RNA (milRNA) candidates. Target prediction revealed several interesting proteins involved in tri-terpenoid synthesis, mating type recognition, chemical or physical sensory protein and transporters predicted to be regulated by the miRNAs and milRNAs.	[Lin, Yan-Liang; Ma, Li-Ting; Lee, Yi-Ru; Chu, Fang-Hua] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Lin, Shih-Shun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Wang, Sheng-Yang] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Wang, Sheng-Yang] Acad Sinica, Biotechnol Res Ctr, Agr, Taipei 115, Taiwan; [Wang, Sheng-Yang] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Tun-Tschu] Taiwan Forestry Res Inst, Div Forest Protect, Taipei, Taiwan; [Shaw, Jei-Fu] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Li, Wen-Hsiung] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Li, Wen-Hsiung] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Chu, Fang-Hua] Natl Taiwan Univ, Expt Forest, Nan Tou, Taiwan	National Taiwan University; National Taiwan University; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; I Shou University; Academia Sinica - Taiwan; University of Chicago; National Taiwan University	Chu, FH (corresponding author), Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan.	fhchu@ntu.edu.tw	Wang, Sheng-Yang/M-9656-2019; Lin, Shih-Shun/HCH-9241-2022; Ma, Li-Ting/GQB-3044-2022	Wang, Sheng-Yang/0000-0002-8579-3569; LIN, SHIH-SHUN/0000-0002-7295-5004; CHU, FANG-HUA/0000-0003-2299-5013; Ma, Li-Ting/0000-0001-6028-0831; Li, Wen-Hsiung/0000-0003-1086-1456	National Science Council [NSC-101-2911-I-005-301, NSC-102-2911- I-005-301]; Ministry of Education, Taiwan, under the Development Plan for World Class University and Research Centers of Excellence plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, under the Development Plan for World Class University and Research Centers of Excellence plan	This work was supported by the National Science Council (NSC-101-2911-I-005-301, NSC-102-2911- I-005-301), and the Ministry of Education, Taiwan, under the Development Plan for World Class University and Research Centers of Excellence plan.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chang TC, 2012, THESIS NATL TAIWAN U; Chang TT, 2004, BOT BULL ACAD SINICA, V45, P347; Chang YM, 2010, FEBS LETT, V584, P2028, DOI 10.1016/j.febslet.2009.12.035; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104956; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chu FH, 2008, MYCOL RES, V112, P1421, DOI 10.1016/j.mycres.2008.06.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du YC, 2012, PHYTOMEDICINE, V19, P788, DOI 10.1016/j.phymed.2012.03.014; Fernandez-Aguado M, 2014, METAB ENG, V22, P89, DOI 10.1016/j.ymben.2014.01.004; Geethangili M., 2011, EVID BASED COMPLEMEN; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LAI MH, 1994, GENE, V140, P41; Larsen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009780; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin YL, 2011, INT J MED MUSHROOMS, V13, P473, DOI 10.1615/IntJMedMushr.v13.i5.70; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu MC, 2013, PHARMACOL THERAPEUT, V139, P124, DOI 10.1016/j.pharmthera.2013.04.001; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Shen YC, 2004, PLANTA MED, V70, P310, DOI 10.1055/s-2004-818941; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu SH, 1997, BOT BULL ACAD SINICA, V38, P273; Wymelenberg A.V., 2006, FUNGAL GENET BIOL, V43, P343, DOI [DOI 10.1016/J.FGB.2006.01.003, 10.1016/J.FGB.2006.01.003]; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001	49	19	20	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123245	10.1371/journal.pone.0123245	http://dx.doi.org/10.1371/journal.pone.0123245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860872	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300084
J	Linzen, U; Lilischkis, R; Pandithage, R; Schilling, B; Ullius, A; Luscher-Firzlaff, J; Kremmer, E; Luscher, B; Vervoorts, J				Linzen, Ulrike; Lilischkis, Richard; Pandithage, Ruwin; Schilling, Britta; Ullius, Andrea; Luescher-Firzlaff, Juliane; Kremmer, Elisabeth; Luescher, Bernhard; Vervoorts, Joerg			ING5 Is Phosphorylated by CDK2 and Controls Cell Proliferation Independently of p53	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; GENE FAMILY; EXPRESSION; CANCER; ACETYLATION; PROTEIN; TRANSCRIPTION; RECOGNITION; GROWTH	Inhibitor of growth (ING) proteins have multiple functions in the control of cell proliferation, mainly by regulating processes associated with chromatin regulation and gene expression. ING5 has been described to regulate aspects of gene transcription and replication. Moreover deregulation of ING5 is observed in different tumors, potentially functioning as a tumor suppressor. Gene transcription in late G1 and in S phase and replication is regulated by cyclin- dependent kinase 2 (CDK2) in complex with cyclin E or cyclin A. CDK2 complexes phosphorylate and regulate several substrate proteins relevant for overcoming the restriction point and promoting S phase. We have identified ING5 as a novel CDK2 substrate. ING5 is phosphorylated at a single site, threonine 152, by cyclin E/CDK2 and cyclin A/CDK2 in vitro. This site is also phosphorylated in cells in a cell cycle dependent manner, consistent with it being a CDK2 substrate. Furthermore overexpression of cyclin E/CDK2 stimulates while the CDK2 inhibitor p27(KIP1) represses phosphorylation at threonine 152. This site is located in a bipartite nuclear localization sequence but its phosphorylation was not sufficient to deregulate the subcellular localization of ING5. Although ING5 interacts with the tumor suppressor p53, we could not establish p53-dependent regulation of cell proliferation by ING5 and by phospho-site mutants. Instead we observed that the knockdown of ING5 resulted in a strong reduction of proliferation in different tumor cell lines, irrespective of the p53 status. This inhibition of proliferation was at least in part due to the induction of apoptosis. In summary we identified a phosphorylation site at threonine 152 of ING5 that is cell cycle regulated and we observed that ING5 is necessary for tumor cell proliferation, without any apparent dependency on the tumor suppressor p53.	[Linzen, Ulrike; Lilischkis, Richard; Pandithage, Ruwin; Schilling, Britta; Ullius, Andrea; Luescher-Firzlaff, Juliane; Luescher, Bernhard; Vervoorts, Joerg] Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, D-52057 Aachen, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	RWTH Aachen University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Luscher, B (corresponding author), Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, Pauwelsstr 30, D-52057 Aachen, Germany.	luescher@rwth-aachen.de; jvervoorts-weber@ukaachen.de	; Luscher, Bernhard/A-7330-2011	Vervoorts, Jorg/0000-0002-3251-6496; Luscher, Bernhard/0000-0002-9622-8709	Deutsche Forschungsgemeinschaft DFG [LU466/14-1]; Deutsche Krebshilfe/German Cancer Aid [109061]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutsche Krebshilfe/German Cancer Aid(Deutsche Krebshilfe)	This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (LU466/14-1) and the Deutsche Krebshilfe/German Cancer Aid (109061) to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borkosky SS, 2010, ONCOL RES, V18, P509, DOI 10.3727/096504010X12704916124864; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campos EI, 2004, CELL MOL LIFE SCI, V61, P2597, DOI 10.1007/s00018-004-4199-4; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Cengiz B, 2007, ORAL ONCOL, V43, P241, DOI 10.1016/j.oraloncology.2006.03.004; Cengiz B, 2010, INT J CANCER, V127, P2088, DOI 10.1002/ijc.25224; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Copeland NA, 2010, J CELL SCI, V123, P1108, DOI 10.1242/jcs.059345; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Federico M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-208; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Foster JS, 2003, J BIOL CHEM, V278, P41355, DOI 10.1074/jbc.M302830200; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Garate M, 2007, FASEB J, V21, P3705, DOI 10.1096/fj.07-8069com; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gong W, 2006, MOL CELLULAR BIOL, V26; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Kataoka H, 2003, CANCER RES, V63, P5785; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Li XH, 2010, J CANCER RES CLIN, V136, P1573, DOI 10.1007/s00432-010-0815-x; Liu MH, 2013, PANCREAS, V42, P1169, DOI 10.1097/MPA.0b013e3182962acb; Liu NS, 2013, CANCER RES, V73, P3749, DOI 10.1158/0008-5472.CAN-12-3684; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Mitra J, 2004, ONCOGENE, V23, P3361, DOI 10.1038/sj.onc.1207446; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park SH, 2014, NUCLEIC ACIDS RES, V42, P6196, DOI 10.1093/nar/gku263; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; PRICE BD, 1995, ONCOGENE, V11, P73; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Shah S, 2009, BIOCHEM CELL BIOL, V87, P117, DOI 10.1139/O08-107; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 2000, CANCER RES, V60, P3689; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shiseki M, 2003, CANCER RES, V63, P2373; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Thalappilly S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021065; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Xing YN, 2011, HUM PATHOL, V42, P25, DOI 10.1016/j.humpath.2010.05.024; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021505; Zhang H, 2007, MOL CELL, V25, P175, DOI 10.1016/j.molcel.2007.01.008; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng HC, 2011, HUM PATHOL, V42, P424, DOI 10.1016/j.humpath.2009.12.018	78	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123736	10.1371/journal.pone.0123736	http://dx.doi.org/10.1371/journal.pone.0123736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860957	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300113
J	Pant, M; Sopariwala, DH; Bal, NC; Lowe, J; Delfin, DA; Rafael-Fortney, J; Periasamy, M				Pant, Meghna; Sopariwala, Danesh H.; Bal, Naresh C.; Lowe, Jeovanna; Delfin, Dawn A.; Rafael-Fortney, Jill; Periasamy, Muthu			Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; MDX-MOUSE; ENERGY-METABOLISM; OXIDATIVE-PHOSPHORYLATION; SARCOLIPIN; EXPRESSION; MICE; PATHOLOGY; PROTEIN; THERMOGENESIS	The utrophin-dystrophin deficient (DKO) mouse model has been widely used to understand the progression of Duchenne muscular dystrophy (DMD). However, it is unclear as to what extent muscle pathology affects metabolism. Therefore, the present study was focused on understanding energy expenditure in the whole animal and in isolated extensor digitorum longus (EDL) muscle and to determine changes in metabolic enzymes. Our results show that the 8 week-old DKO mice consume higher oxygen relative to activity levels. Interestingly the EDL muscle from DKO mouse consumes higher oxygen per unit integral force, generates less force and performs better in the presence of pyruvate thus mimicking a slow twitch muscle. We also found that the expression of hexokinase 1 and pyruvate kinase M2 was upregulated several fold suggesting increased glycolytic flux. Additionally, there is a dramatic increase in dynamin-related protein 1 (Drp 1) and mitofusin 2 protein levels suggesting increased mitochondrial fission and fusion, a feature associated with increased energy demand and altered mitochondrial dynamics. Collectively our studies point out that the dystrophic disease has caused significant changes in muscle metabolism. To meet the increased energetic demand, upregulation of metabolic enzymes and regulators of mitochondrial fusion and fission is observed in the dystrophic muscle. A better understanding of the metabolic demands and the accompanied alterations in the dystrophic muscle can help us design improved intervention therapies along with existing drug treatments for the DMD patients.	[Pant, Meghna; Sopariwala, Danesh H.; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Lowe, Jeovanna; Delfin, Dawn A.; Rafael-Fortney, Jill] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Periasamy, M (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	periasamy.1@osu.edu			National Institutes of Health [R01-HL088555, R01 DK098240-01]; American Diabetes Association for basic science Research Award [7-13-BS-131]; Muscular Dystrophy Association; NIH [R01 NS082868]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001448, UL1TR001449] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association for basic science Research Award; Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants to MP R01-HL088555 and R01 DK098240-01, American Diabetes Association for basic science Research Award (7-13-BS-131) to MP; Muscular Dystrophy Association and NIH R01 NS082868 to JRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00371; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Baker PE, 2006, NEUROGENETICS, V7, P81, DOI 10.1007/s10048-006-0031-7; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; CHI MMY, 1987, METABOLISM, V36, P761, DOI 10.1016/0026-0495(87)90113-2; CHINET AE, 1994, EXPERIENTIA, V50, P602, DOI 10.1007/BF01921731; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; DUNN JF, 1993, P ROY SOC B-BIOL SCI, V251, P201, DOI 10.1098/rspb.1993.0030; EMERY A, 1995, NEUROMUSCULAR DISORD, V5, P521, DOI 10.1016/0960-8966(95)98952-S; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; FELLOWS IW, 1989, CLIN NUTR, V8, P135, DOI 10.1016/0261-5614(89)90062-9; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Goyenvalle A, 2012, HUM MOL GENET, V21, P2559, DOI 10.1093/hmg/dds082; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Hawley JA, 2006, ESSAYS BIOCHEM, V42, P1, DOI 10.1042/bse0420001; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; MILLAR NC, 1992, AM J PHYSIOL, V262, pC1239, DOI 10.1152/ajpcell.1992.262.5.C1239; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; PHILLIPS SK, 1993, J PHYSIOL-LONDON, V462, P135, DOI 10.1113/jphysiol.1993.sp019547; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; Rafael JA, 2000, HUM MOL GENET, V9, P1357, DOI 10.1093/hmg/9.9.1357; Rafael JA, 2000, MICROSC RES TECHNIQ, V48, P155, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<155::AID-JEMT4>3.0.CO;2-0; Schneider JS, 2013, J MUSCLE RES CELL M, V34, P349, DOI 10.1007/s10974-013-9350-0; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Sesaki H, 2014, BBA-MOL BASIS DIS, V1842, P1179, DOI 10.1016/j.bbadis.2013.11.024; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Spassov A, 2011, EXP TOXICOL PATHOL, V63, P549, DOI 10.1016/j.etp.2010.04.006; STRICKLAND JM, 1975, NATURE, V253, P464, DOI 10.1038/253464b0; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Terrill JR, 2013, FEBS J, V280, P4149, DOI 10.1111/febs.12142; Torres CAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063608; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; ZATZ M, 1978, J NEUROL SCI, V36, P349, DOI 10.1016/0022-510X(78)90043-6; Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; ZURLO F, 1994, METABOLISM, V43, P481, DOI 10.1016/0026-0495(94)90081-7	64	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123875	10.1371/journal.pone.0123875	http://dx.doi.org/10.1371/journal.pone.0123875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859846	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300117
J	Rochman, Y; Yukawa, M; Kartashov, AV; Barski, A				Rochman, Yrina; Yukawa, Masashi; Kartashov, Andrey V.; Barski, Artem			Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; MOLECULAR-MECHANISMS; AIRWAY EOSINOPHILIA; CO-STIMULATION; MURINE MODEL; DOUBLE-BLIND; ANERGY; INDUCTION; TOLERANCE; P27(KIP1)	` During activation, T cells integrate multiple signals from APCs and cytokine milieu. The blockade of these signals can have clinical benefits as exemplified by CTLA4-Ig, which blocks interaction of B7 co-stimulatory molecules on APCs with CD28 on T cells. Variants of CTLA4-Ig, abatacept and belatacept are FDA approved as immunosuppressive agents in arthritis and transplantation, yet murine studies suggested that CTLA4-Ig could be beneficial in a number of other diseases. However, detailed analysis of human CD4 cell hyporesponsivness induced by CTLA4-Ig has not been performed. Herein, we established a model to study the effect of CTLA4-Ig on the activation of human naive T cells in a human mixed lymphocytes system. Comparison of human CD4 cells activated in the presence or absence of CTLA4-Ig showed that co-stimulation blockade during TCR activation does not affect NFAT signaling but results in decreased activation of NF-kappa B and AP-1 transcription factors followed by a profound decrease in proliferation and cytokine production. The resulting T cells become hyporesponsive to secondary activation and, although capable of receiving TCR signals, fail to proliferate or produce cytokines, demonstrating properties of anergic cells. However, unlike some models of T cell anergy, these cells did not possess increased levels of the TCR signaling inhibitor CBLB. Rather, the CTLA4-Ig-induced hyporesponsiveness was associated with an elevated level of p27(kip1) cyclin-dependent kinase inhibitor.	[Rochman, Yrina; Yukawa, Masashi; Kartashov, Andrey V.; Barski, Artem] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45220 USA; [Rochman, Yrina; Yukawa, Masashi; Kartashov, Andrey V.; Barski, Artem] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Rochman, Yrina] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH USA; [Barski, Artem] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Barski, A (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45220 USA.	Artem.Barski@cchmc.org		Yukawa, Masashi/0000-0003-1798-2410; Kartashov, Andrey/0000-0001-9102-5681; Barski, Artem/0000-0002-1861-5316	Children's Hospital Research Foundation; National Heart, Lung and Blood Institute; National Institutes of Health career transition award [K22 HL098691]; PHS Grant (Digestive Health Center) [P30 DK078392]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL098691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Children's Hospital Research Foundation; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health career transition award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS Grant (Digestive Health Center); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part by the Children's Hospital Research Foundation, a National Heart, Lung and Blood Institute, National Institutes of Health career transition award to A.B. (K22 HL098691), and the PHS Grant P30 DK078392 (Digestive Health Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barbosa Ramiro S., 2012, J ROBOTICS, V2012, P1; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Caporali R, 2014, AUTOIMMUN REV, V13, P49, DOI 10.1016/j.autrev.2013.06.008; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Kartashov AV, 2014, BIORXIV 012799; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Mayer L, 2012, GASTROENTEROLOGY, V143, P13, DOI 10.1053/j.gastro.2012.05.015; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parulekar AD, 2013, AM J RESP CRIT CARE, V187, P494, DOI 10.1164/rccm.201207-1205OC; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Powell JD, 2001, EUR J IMMUNOL, V31, P3737, DOI 10.1002/1521-4141(200112)31:12<3737::AID-IMMU3737>3.0.CO;2-G; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Rowell EA, 2006, J IMMUNOL, V177, P5169, DOI 10.4049/jimmunol.177.8.5169; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sandborn WJ, 2012, GASTROENTEROLOGY, V143, P62, DOI 10.1053/j.gastro.2012.04.010; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; VanOosterhout AJM, 1997, AM J RESP CELL MOL, V17, P386, DOI 10.1165/ajrcmb.17.3.2679; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Wekerle T, 2012, TRANSPL INT, V25, P139, DOI 10.1111/j.1432-2277.2011.01386.x; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342	45	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122198	10.1371/journal.pone.0122198	http://dx.doi.org/10.1371/journal.pone.0122198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860138	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300035
J	Nielsen, MV; Amemasor, S; Agyekum, A; Loag, W; Marks, F; Sarpong, N; Dekker, D; Adu-Sarkodie, Y; May, J				Nielsen, Maja Verena; Amemasor, Solomon; Agyekum, Alex; Loag, Wibke; Marks, Florian; Sarpong, Nimako; Dekker, Denise; Adu-Sarkodie, Yaw; May, Juergen			Clinical Indicators for Bacterial Co-Infection in Ghanaian Children with P-falciparum Infection	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; AFRICAN CHILDREN; MALARIA; BACTEREMIA; AREA; IMPACT	Differentiation of infectious causes in severely ill children is essential but challenging in sub-Saharan Africa. The aim of the study was to determine clinical indicators that are able to identify bacterial co-infections in P. falciparum infected children in rural Ghana. In total, 1,915 severely ill children below the age of 15 years were recruited at Agogo Presbyterian Hospital in Ghana between May 2007 and February 2011. In 771 (40%) of the children malaria parasites were detected. This group was analyzed for indicators of bacterial co-infections using bivariate and multivariate regression analyses with 24 socio-economic variables, 16 terms describing medical history and anthropometrical information and 68 variables describing clinical symptoms. The variables were tested for sensitivity, specificity, positive predictive value and negative predictive value. In 46 (6.0%) of the children with malaria infection, bacterial co-infection was detected. The most frequent pathogens were non-typhoid salmonellae (45.7%), followed by Streptococcus spp. (13.0%). Coughing, dehydration, splenomegaly, severe anemia and leukocytosis were positively associated with bacteremia. Domestic hygiene and exclusive breastfeeding is negatively associated with bacteremia. In cases of high parasitemia (>10,000/mu l), a significant association with bacteremia was found for splenomegaly (OR 8.8; CI 1.6-48.9), dehydration (OR 18.2; CI 2.0-166.0) and coughing (OR 9.0; CI 0.7-118.6). In children with low parasitemia, associations with bacteremia were found for vomiting (OR 4.7; CI 1.4-15.8), severe anemia (OR 3.3; CI 1.0-11.1) and leukocytosis (OR 6.8 CI 1.9-24.2). Clinical signs of impaired microcirculation were negatively associated with bacteremia. Ceftriaxone achieved best coverage of isolated pathogens. The results demonstrate the limitation of clinical symptoms to determine bacterial co-infections in P. falciparum infected children. Best clinical indicators are dependent on the parasitemia level. Even with a moderate sensitivity of >60%, only low positive predictive values can be obtained due to low prevalence of bacteremia. Rapid testing for distinguishing parasitemia and bacteremia is essential.	[Nielsen, Maja Verena; Loag, Wibke; Dekker, Denise; May, Juergen] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, D-20359 Hamburg, Germany; [Amemasor, Solomon; Agyekum, Alex; Loag, Wibke; Sarpong, Nimako] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Marks, Florian] Int Vaccine Inst, Seoul, South Korea; [Sarpong, Nimako; May, Juergen] German Ctr Infect Res DZIF, Partner Site Hamburg Borstel Lubeck, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; International Vaccine Institute; German Center for Infection Research	Nielsen, MV (corresponding author), Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	maja.v.nielsen@googlemail.com		May, Jurgen/0000-0001-7831-8420; Marks, Florian/0000-0002-6043-7170	Swiss Foundation; International Vaccine Institute, Seoul, South Korea	Swiss Foundation(Swiss National Science Foundation (SNSF)); International Vaccine Institute, Seoul, South Korea	This study was funded by a Swiss Foundation and the International Vaccine Institute, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2009, WORLD MAL REP 2009; Ayoola OO, 2002, J HEALTH POPUL NUTR, V20, P223; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Choge JK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-332; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Evans JA, 2006, J PEDIATR-US, V149, P676, DOI 10.1016/j.jpeds.2006.07.040; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ghana. Cities & Urban Localities, 2011, CIT URB LOC CENS DAT; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Kahama-Maro J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-332; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Lathia T B, 2004, Indian J Med Sci, V58, P239; Lokken KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004049; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Planche T, 2003, CLIN INFECT DIS, V37, P890, DOI 10.1086/377536; Renner LA, 2007, PEDIATR INFECT DIS J, V26, P356, DOI 10.1097/01.inf.0000258693.19247.8e; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schwarz NG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-319; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; WHO Management of the child with a serious infection or severe malnutrition, 2000, WHO MAN CHILD SER IN	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122139	10.1371/journal.pone.0122139	http://dx.doi.org/10.1371/journal.pone.0122139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856341	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500031
J	Nieuwstadt, HA; Kassar, ZAM; van der Lugt, A; Breeuwer, M; van der Steen, AFW; Wentzel, JJ; Gijsen, FJH				Nieuwstadt, Harm A.; Kassar, Zaid A. M.; van der Lugt, Aad; Breeuwer, Marcel; van der Steen, Anton F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.			A Computer-Simulation Study on the Effects of MRI Voxel Dimensions on Carotid Plaque Lipid-Core and Fibrous Cap Segmentation and Stress Modeling	PLOS ONE			English	Article							BLACK-BLOOD MRI; ATHEROSCLEROTIC PLAQUE; HIGH-RESOLUTION; SPATIAL-RESOLUTION; REPRODUCIBILITY; COMPONENTS; LESIONS; BURDEN; MOTION	Background The benefits of a decreased slice thickness and/or in-plane voxel size in carotid MRI for atherosclerotic plaque component quantification accuracy and biomechanical peak cap stress analysis have not yet been investigated in detail because of practical limitations. Methods In order to provide a methodology that allows such an investigation in detail, numerical simulations of a T1-weighted, contrast-enhanced, 2D MRI sequence were employed. Both the slice thickness (2 mm, 1 mm, and 0.5 mm) and the in plane acquired voxel size (0.62x0.62 mm(2) and 0.31x0.31 mm(2)) were varied. This virtual MRI approach was applied to 8 histology-based 3D patient carotid atherosclerotic plaque models. Results A decreased slice thickness did not result in major improvements in lumen, vessel wall, and lipid-rich necrotic core size measurements. At 0.62x0.62 mm2 in-plane, only a 0.5 mm slice thickness resulted in improved minimum fibrous cap thickness measurements (a 2-3 fold reduction in measurement error) and only marginally improved peak cap stress computations. Acquiring voxels of 0.31x0.31 mm(2) in-plane, however, led to either similar or significantly larger improvements in plaque component quantification and computed peak cap stress. Conclusions This study provides evidence that for currently-used 2D carotid MRI protocols, a decreased slice thickness might not be more beneficial for plaque measurement accuracy than a decreased in-plane voxel size. The MRI simulations performed indicate that not a reduced slice thickness (i.e. more isotropic imaging), but the acquisition of anisotropic voxels with a relatively smaller in-plane voxel size could improve carotid plaque quantification and computed peak cap stress accuracy.	[Nieuwstadt, Harm A.; Kassar, Zaid A. M.; van der Steen, Anton F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.] Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands; [Kassar, Zaid A. M.; van der Lugt, Aad] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Breeuwer, Marcel] Philips Healthcare, Best, Netherlands; [Breeuwer, Marcel] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [van der Steen, Anton F. W.] Delft Univ Technol, Dept Imaging Sci & Technol, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Philips; Philips Healthcare; Eindhoven University of Technology; Delft University of Technology	Gijsen, FJH (corresponding author), Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands.	f.gijsen@erasmusmc.nl			Dutch Heart Foundation [01C-202]; Philips Healthcare	Dutch Heart Foundation(Netherlands Heart Foundation); Philips Healthcare	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Dutch Heart Foundation. Philips Healthcare provided partial support in the form of a salary for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Al-Kwifi O, 2004, MAGN RESON MED, V52, P605, DOI 10.1002/mrm.20185; Antiga L, 2008, MAGN RESON MED, V60, P1020, DOI 10.1002/mrm.21758; Balu N, 2008, J MAGN RESON IMAGING, V27, P918, DOI 10.1002/jmri.21282; Balu N, 2007, MAGN RESON MED, V57, P592, DOI 10.1002/mrm.21160; Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Benoit-Cattin H, 2005, J MAGN RESON, V173, P97, DOI 10.1016/j.jmr.2004.09.027; Cai JM, 2005, CIRCULATION, V112, P3437, DOI 10.1161/CIRCULATIONAHA.104.528174; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Coombs BD, 2001, STROKE, V32, P2516, DOI 10.1161/hs1101.098663; Dong L, 2010, J MAGN RESON IMAGING, V32, P452, DOI 10.1002/jmri.22274; Gao H, 2009, J MAGN RESON IMAGING, V30, P85, DOI 10.1002/jmri.21799; Gonzalez Ballester MA, 2002, MED IMAGE ANAL, V6, P389, DOI 10.1016/S1361-8415(02)00061-0; Groen HC, 2010, J BIOMECH, V43, P2087, DOI 10.1016/j.jbiomech.2010.04.005; Hacklander T, 2005, ACAD RADIOL, V12, P85, DOI 10.1016/j.acra.2004.09.011; Hofman JMA, 2006, MAGN RESON MED, V55, P790, DOI 10.1002/mrm.20828; Holzapfel GA, 2014, J BIOMECH, V47, P859, DOI 10.1016/j.jbiomech.2014.01.011; Klepaczko A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093689; Li B, 2013, MAGN RESON MED, V70, P1347, DOI 10.1002/mrm.24579; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Liu WB, 2012, J MAGN RESON IMAGING, V35, P812, DOI 10.1002/jmri.22886; Luk-Pat GT, 1999, MAGNET RESON MED, V42, P762, DOI 10.1002/(SICI)1522-2594(199910)42:4<762::AID-MRM19>3.0.CO;2-M; Nieuwstadt HA, 2013, J BIOMECH, V46, P689, DOI 10.1016/j.jbiomech.2012.11.042; Nieuwstadt HA, 2014, MAGN RESON MED, V72, P188, DOI 10.1002/mrm.24905; Nieuwstadt HA, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026178; Ronen RR, 2006, MAGN RESON MED, V56, P290, DOI 10.1002/mrm.20956; Schar M, 2003, J MAGN RESON IMAGING, V17, P538, DOI 10.1002/jmri.10287; Speelman L, 2011, J BIOMECH, V44, P2376, DOI 10.1016/j.jbiomech.2011.07.004; Stocker T, 2010, MAGN RESON MED, V64, P186, DOI 10.1002/mrm.22406; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932; Truijman MTB, 2014, INT J STROKE, V9, P747, DOI 10.1111/ijs.12167; Underhill HR, 2010, NAT REV CARDIOL, V7, P165, DOI 10.1038/nrcardio.2009.246; van Wijk DF, 2014, MAGN RESON MATER PHY, V27, P219, DOI 10.1007/s10334-013-0407-2; Watanabe Y, 2010, NEURORADIOLOGY, V52, P253, DOI 10.1007/s00234-010-0663-z; Xanthis CG, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-48; Yuan C, 2001, RADIOLOGY, V221, P285, DOI 10.1148/radiol.2212001612; Yuan C, 2004, J MAGN RESON IMAGING, V19, P710, DOI 10.1002/jmri.20070	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123031	10.1371/journal.pone.0123031	http://dx.doi.org/10.1371/journal.pone.0123031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856094	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500070
J	Peres, EA; Sobral-Souza, T; Perez, MF; Bonatelli, IAS; Silva, DP; Silva, MJ; Solferini, VN				Peres, Elen A.; Sobral-Souza, Thadeu; Perez, Manolo F.; Bonatelli, Isabel A. S.; Silva, Daniel P.; Silva, Marcio J.; Solferini, Vera N.			Pleistocene Niche Stability and Lineage Diversification in the Subtropical Spider Araneus omnicolor (Araneidae)	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; SEX-BIASED DISPERSAL; POPULATION-GROWTH; NEOTROPICAL BIODIVERSITY; HISTORICAL BIOGEOGRAPHY; SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; BAYESIAN-INFERENCE; CLIMATIC CHANGES; PHYLOGEOGRAPHY	The influence of Quaternary climate oscillations on the diversification of the South American fauna is being increasingly explored. However, most of these studies have focused on taxa that are endemic to tropical environments, and relatively few have treated organisms restricted to subtropical biomes. Here we used an integrative phylogeographical framework to investigate the effects of these climate events on the ecological niche and genetic patterns of the subtropical orb-weaver spider Araneus omnicolor (Araneidae). We analyzed the mitochondrial (Cytochrome Oxidase I, COI) and nuclear (Internal Transcribed Subunit II, ITS2) DNA of 130 individuals throughout the species' range, and generated distribution models in three different climate scenarios [present, Last Glacial Maximum (LGM), and Last Interglacial Maximum (LIG)]. Additionally, we used an Approximate Bayesian Computation (ABC) approach to compare possible demographic scenarios and select the hypothesis that better explains the genetic patterns of A. omnicolor. We obtained high haplotype diversity but low nucleotide variation among sequences. The population structure and demographic analyses showed discrepancies between markers, suggesting male-biased dispersal in the species. The time-calibrated COI phylogenetic inference showed a recent diversification of lineages (Middle/Late Pleistocene), while the paleoclimate modeling indicated niche stability since similar to 120 Kya. The ABC results agreed with the niche models, supporting a panmictic population as the most likely historical scenario for the species. These results indicate that A. omnicolor experienced no niche or population reductions during the Late Pleistocene, despite the intense landscape modifications that occurred in the subtropical region, and that other factors beside LGM and LIG climate oscillations might have contributed to the demographic history of this species. This pattern may be related to the high dispersal ability and wide environmental tolerance of A. omnicolor, highlighting the need for more phylogeographical studies with invertebrates and other generalist taxa, in order to understand the effects of Quaternary climate changes on Neotropical biodiversity.	[Peres, Elen A.; Sobral-Souza, Thadeu; Solferini, Vera N.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil; [Perez, Manolo F.; Bonatelli, Isabel A. S.] Univ Fed Sao Carlos, Dept Biol, Sorocaba, SP, Brazil; [Silva, Daniel P.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Silva, Marcio J.] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Carlos; Universidade Federal do Para; Universidade Estadual de Campinas	Solferini, VN (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil.	veras@unicamp.br	Perez, Manolo Fernandez/H-2243-2012; Solferini, Vera/E-9121-2012; Bonatelli, Isabel A. S./D-2361-2015; Peres, Elen Arroyo/A-2253-2014; UNICAMP, CCES -/J-7787-2015; Silva, Daniel Paiva/F-8052-2010; Sobral-Souza, Thadeu/O-1068-2017	Perez, Manolo Fernandez/0000-0002-4642-7793; Solferini, Vera/0000-0001-6582-1449; Peres, Elen Arroyo/0000-0002-2118-2144; Silva, Daniel Paiva/0000-0002-2457-6245; Sobral Souza, Thadeu/0000-0002-2367-2315; da Silva Bonatelli, Isabel Aparecida/0000-0002-0930-1411	FAPESP [2012/02526-7]; CNPq fellowship	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from FAPESP (2012/02526-7) to VNS. EAP, MFP, and IASB had FAPESP fellowships and TSS had a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, J ARACHNOL, V38, P377, DOI 10.1636/B10-01.1; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batalha H, 2012, MOL PHYLOGENET EVOL, V65, P892, DOI 10.1016/j.ympev.2012.08.010; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Behling H, 1998, REV PALAEOBOT PALYNO, V99, P143, DOI 10.1016/S0034-6667(97)00044-4; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Cabanne GS, 2007, BIOL J LINN SOC, V91, P73, DOI 10.1111/j.1095-8312.2007.00775.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval Ana Carolina, 2014, Proc Biol Sci, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Chang J, 2007, MOL PHYLOGENET EVOL, V42, P104, DOI 10.1016/j.ympev.2006.06.013; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; De Almeida MC, 2010, INSECT CONSERV DIVER, V3, P252, DOI 10.1111/j.1752-4598.2010.00096.x; De Re FC, 2014, BIOL J LINN SOC, V112, P55, DOI 10.1111/bij.12244; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot JF, 2006, MOL ECOL NOTES, V6, P627, DOI 10.1111/j.1471-8286.2006.01355.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Framenau VW, 2010, ARTHROPOD SYST PHYLO, V68, P79; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P238, DOI 10.1006/mpev.2000.0882; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Ledru MP, 2005, QUATERNARY RES, V64, P444, DOI 10.1016/j.yqres.2005.08.006; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Legrand RS, 2000, BIOL J LINN SOC, V71, P643, DOI 10.1006/bijl.2000.0466; LEVI H W, 1991, Bulletin of the Museum of Comparative Zoology, V152, P167; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; MANTEL N, 1967, CANCER RES, V27, P209; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Oliveira AT, 2015, J PLANT ECOL, V8, P242, DOI 10.1093/jpe/rtt058; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pinheiro F, 2011, J BIOGEOGR, V38, P1923, DOI 10.1111/j.1365-2699.2011.02539.x; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Rambaut A., 2007, TRACER V1 4; Rambaut A., 2009, FIGTREE; RAMBO BALDUINO, 1950, AN BOT HERBARIO BARBOSA RODRIGUES", V2, P125; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tax DMJ, 2004, MACH LEARN, V54, P45, DOI 10.1023/B:MACH.0000008084.60811.49; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vanzolini P.E., 1981, Papeis Avulsos de Zoologia (Sao Paulo), V34, P251; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	90	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121543	10.1371/journal.pone.0121543	http://dx.doi.org/10.1371/journal.pone.0121543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856149	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500022
J	Zhang, LL; Mu, GG; Ding, QS; Li, YX; Shi, YB; Dai, JF; Yu, HG				Zhang, Ling-Li; Mu, Gang-Gang; Ding, Qian-Shan; Li, Yan-Xia; Shi, Yun-Bo; Dai, Jin-Fen; Yu, Hong-Gang			Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROMOTES TUMOR PROGRESSION; FACTOR-KAPPA-B; COLORECTAL-CANCER; CELL-MIGRATION; GASTRIC-CANCER; IN-VIVO; SURVIVAL; SUPPRESSION; EXPRESSION	The tumor suppressor gene phosphatase and tensin homolog (PTEN) is frequently mutated in colon cancer. However, the potential contribution of loss of PTEN to colon cancer progression remains unclear. In this study, we demonstrated that PTEN overexpression or knockdown in Lovo colon cancer cells decreased or increased paxillin expression, respectively. Moreover, paxillin reversed PTEN-mediated inhibition of Lovo cell invasion and migration. Overexpression of PTEN in an orthotropic colon cancer nude mice model inhibited tumor formation and progression. In addition, PTEN protein level was negatively correlated with that of paxillin in human colon cancer tissues. Mechanistically, we identified three NF-kappa B binding sites on paxillin promoter and confirmed that paxillin was a direct transcriptional target of NF-kappa B. Our findings reveal a novel mechanism by which PTEN inhibits the progression of colon cancer by inhibiting paxillin expression downstream of PI3K/AKT/NF kappa B pathway. Thereby, PTEN/PI3K/AKT/NF-kappa B/paxillin signaling cascade is an attractive therapeutic target for colon cancer progression.	[Zhang, Ling-Li; Mu, Gang-Gang; Ding, Qian-Shan; Li, Yan-Xia; Dai, Jin-Fen; Yu, Hong-Gang] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430060, Peoples R China; [Zhang, Ling-Li] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450000, Henan Province, Peoples R China; [Shi, Yun-Bo] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450000, Henan Province, Peoples R China	Wuhan University; Zhengzhou University; Zhengzhou University	Yu, HG (corresponding author), Wuhan Univ, Inst Gastroenterol & Hepatol, Renmin Hosp, Dept Gastroenterol, Jiefang Rd 238, Wuhan 430060, Peoples R China.	yhgwhu@gmail.com			National Natural Science Foundation of China and China [81172350]; Fundamental Research Funds for the Chinese Central Universities [201130202020016]	National Natural Science Foundation of China and China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Chinese Central Universities	This work was supported by the National Natural Science Foundation of China (Grant 81172350) and China and the Fundamental Research Funds for the Chinese Central Universities (Grant 201130202020016).	Chatzizacharias NA, 2007, EXPERT OPIN THER TAR, V11, P1315, DOI 10.1517/14728222.11.10.1315; Chen DL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-277; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Haier J, 2002, ONCOGENE, V21, P1450, DOI 10.1038/sj.onc.1205213; Herlevsen M, 2007, BIOCHEM BIOPH RES CO, V352, P549, DOI 10.1016/j.bbrc.2006.11.067; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hwang PH, 2001, CANCER LETT, V172, P83, DOI 10.1016/S0304-3835(01)00632-2; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Ko BS, 2010, LIFE SCI, V86, P199, DOI 10.1016/j.lfs.2009.12.003; Kotelevets L, 2001, J CELL BIOL, V155, P1129, DOI 10.1083/jcb.200105109; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Seidler J, 2005, RADIOTHER ONCOL, V76, P129, DOI 10.1016/j.radonc.2005.06.018; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sun Y, 2014, CLIN INVEST MED, V37, pE131; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Wu DW, 2014, CARCINOGENESIS, V35, P1823, DOI 10.1093/carcin/bgu102; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102; Zhang LL, 2013, MOL MED REP, V7, P1387, DOI 10.3892/mmr.2013.1400; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	32	74	82	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15018	15029		10.1074/jbc.M115.641407	http://dx.doi.org/10.1074/jbc.M115.641407			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25873394	hybrid, Green Published			2022-12-26	WOS:000356177300018
J	Yasuda, Y; Fujita, M; Koike, E; Obata, K; Shiota, M; Kotani, Y; Musha, T; Tsuji-Kawahara, S; Satou, T; Masuda, S; Okano, J; Yamasaki, H; Okumoto, K; Uesugi, T; Nakao, S; Hoshiai, H; Mandai, M				Yasuda, Yoshiko; Fujita, Mitsugu; Koike, Eiji; Obata, Koshiro; Shiota, Mitsuru; Kotani, Yasushi; Musha, Terunaga; Tsuji-Kawahara, Sachiyo; Satou, Takao; Masuda, Seiji; Okano, Junko; Yamasaki, Harufumi; Okumoto, Katsumi; Uesugi, Tadao; Nakao, Shinichi; Hoshiai, Hiroshi; Mandai, Masaki			Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction	PLOS ONE			English	Article							NITRIC-OXIDE; UTERINE CERVIX; EXPRESSION; CANCER; INDUCTION; MYOGLOBIN; HYPOXIA; CARCINOMA; GROWTH; IDENTIFICATION	The aim of this study is to explore a cause-oriented therapy for patients with uterine cervical cancer that expresses erythropoietin (Epo) and its receptor (EpoR). Epo, by binding to EpoR, stimulates the proliferation and differentiation of erythroid progenitor cells into hemoglobin-containing red blood cells. In this study, we report that the HeLa cells in the xenografts expressed epsilon,gamma, and a globins as well as myoglobin (Mb) to produce tetrameric alpha 2 epsilon 2 and alpha 2 gamma 2 and monomeric Mb, most of which were significantly suppressed with an EpoR antagonist EMP9. Western blotting revealed that the EMP9 treatment inhibited the AKT-pAKT, MAPKs-pMAPKs, and STAT5-pSTAT5 signaling pathways. Moreover, the treatment induced apoptosis and suppression of the growth and inhibited the survival through disruption of the harmonized hemoprotein syntheses in the tumor cells concomitant with destruction of vascular nets in the xenografts. Furthermore, macrophages and natural killer (NK) cells with intense HIF-1 alpha expression recruited significantly more in the degenerating foci of the xenografts. These findings were associated with the enhanced expressions of nNOS in the tumor cells and iNOS in macrophages and NK cells in the tumor sites. The treated tumor cells exhibited a substantial number of perforations on the cell surface, which indicates that the tumors were damaged by both the nNOS-induced nitric oxide (NO) production in the tumor cells as well as the iNOS-induced NO production in the innate immune cells. Taken together, these data suggest that HeLa cells constitutively acquire e,. and Mb synthetic capacity for their survival. Therefore, EMP9 treatment might be a cause-oriented and effective therapy for patients with squamous cell carcinoma of the uterine cervix.	[Yasuda, Yoshiko; Koike, Eiji; Kotani, Yasushi; Yamasaki, Harufumi; Hoshiai, Hiroshi; Mandai, Masaki] Kinki Univ Fac Med, Dept Obstet, Osaka, Japan; [Yasuda, Yoshiko; Koike, Eiji; Kotani, Yasushi; Yamasaki, Harufumi; Hoshiai, Hiroshi; Mandai, Masaki] Kinki Univ Fac Med, Dept Gynecol, Osaka, Japan; [Fujita, Mitsugu] Kinki Univ Fac Med, Dept Microbiol, Osaka, Japan; [Obata, Koshiro] Nara Hosp Kinki Univ Fac Med, Dept Obstet & Gynecol, Nara, Japan; [Shiota, Mitsuru] Kawasaki Med Sch, Dept Gynecol Oncol, Kurashiki, Okayama, Japan; [Musha, Terunaga] Medicalcourt Hachinohe West Hosp, Dept Gynecol, Hachinohe, Aomori, Japan; [Tsuji-Kawahara, Sachiyo] Kinki Univ Fac Med, Dept Immunol, Osaka, Japan; [Satou, Takao; Uesugi, Tadao] Kinki Univ Fac Med, Dept Pathol, Osaka, Japan; [Masuda, Seiji] Kyoto Univ, Grad Sch Biostudies, Lab Mol Biol Bioresponse, Kyoto 6068502, Japan; [Okano, Junko] Shiga Univ Med Sci, Div Anat & Cell Biol, Otsu, Shiga 52021, Japan; [Okumoto, Katsumi] Kinki Univ Fac Med, Lifesci Inst, Osaka, Japan; [Nakao, Shinichi] Kinki Univ Fac Med, Dept Anesthesiol, Osaka, Japan	Kawasaki Medical School; Kyoto University; Shiga University of Medical Science	Yasuda, Y (corresponding author), Kinki Univ Fac Med, Dept Obstet, Osaka, Japan.	y1126yas@med.kindai.ac.jp	Fujita, Mitsugu/A-6690-2009	Fujita, Mitsugu/0000-0002-0000-9879	Promotion and Mutual Aid-Co-operation for Private Schools of Japan; Japan Society for the Promotion of Science [24700998]; University Research Grant from Kinki University [SR08]; Grants-in-Aid for Scientific Research [25660295] Funding Source: KAKEN	Promotion and Mutual Aid-Co-operation for Private Schools of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University Research Grant from Kinki University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the following grants: Promotion and Mutual Aid-Co-operation for Private Schools of Japan (YY); Grants-in-Aid for Young Scientist (B) (MF: No. 24700998) from the Japan Society for the Promotion of Science; and the University Research Grant (MF: No. SR08) from Kinki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; Blackwell KL, 2003, CANCER RES, V63, P6162; Brookes M, 1998, CLIN EMBRYOLOGY COLO, P142; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; da Silva CS, 2010, CLINICS, V65, P575, DOI 10.1590/S1807-59322010000600003; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eggen T, 2011, ANTICANCER RES, V31, P2319; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gadducci A, 2010, ONCOL LETT, V1, P3, DOI 10.3892/ol_00000001; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson DL, 1998, BIOCHEMISTRY-US, V37, P3699, DOI 10.1021/bi971956y; Katsumura KR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015412; KRANTZ S B, 1991, Blood, V77, P419; Leo C, 2006, CLIN CANCER RES, V12, P6894, DOI 10.1158/1078-0432.CCR-06-1285; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; Lopez TV, 2011, INT J CANCER, V129, P2566, DOI 10.1002/ijc.25935; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moore MAS, 1997, STEM CELLS, V15, P239, DOI 10.1002/stem.5530150832; NIJHOF W, 1987, EXP HEMATOL, V15, P779; Nishio N, 2012, J IMMUNOTHER, V35, P598, DOI 10.1097/CJI.0b013e31826a745a; Ohba N, 2004, NEUROSCI LETT, V359, P159, DOI 10.1016/j.neulet.2004.02.029; Shenouda G, 2006, INT J GYNECOL CANCER, V16, P752, DOI 10.1111/j.1525-1438.2006.00357.x; Shiota M, 2013, CONGENIT ANOM, V53, P18, DOI 10.1111/j.1741-4520.2012.00382.x; Wunderlich C, 2003, CIRC RES, V92, P1352, DOI 10.1161/01.RES.0000079026.70629.E5; Xu W M, 1998, Cell Res, V8, P251; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yasuda M, 2007, INT J CLIN ONCOL, V12, P455, DOI 10.1007/s10147-007-0714-6; YASUDA Y, 1993, DEV GROWTH DIFFER, V35, P711; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yasuda Y, 2002, CARCINOGENESIS, V23, P1797, DOI 10.1093/carcin/23.11.1797; Yasuda Y, 2001, MARC MALPIG SYMP SER, V8, P215; Yasuda Y, 2001, BRIT J CANCER, V84, P836, DOI 10.1054/bjoc.2000.1666; Yasuda Y, 2011, J CANC THER, V2, P40; Yasuda Y, 2010, ANAT SCI INT, V85, P204, DOI 10.1007/s12565-010-0081-7; Yasuda Y, 2010, REC ADV BIOL BIOMED, P337; Yasuda Yoshiko, 2007, Congenital Anomalies, V47, P22, DOI 10.1111/j.1741-4520.2006.00137.x	54	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122458	10.1371/journal.pone.0122458	http://dx.doi.org/10.1371/journal.pone.0122458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874769	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800059
J	Bai, H; Wang, ZX; Hu, R; Kan, TT; Li, Y; Zhang, XS; Zhang, JL; Lian, L; Han, HB; Lian, ZX				Bai, Hai; Wang, Zhixian; Hu, Rui; Kan, Tongtong; Li, Yan; Zhang, Xiaosheng; Zhang, Jinlong; Lian, Ling; Han, Hongbing; Lian, Zhengxing			A 90-Day Toxicology Study of Meat from Genetically Modified Sheep Overexpressing TLR4 in Sprague-Dawley Rats	PLOS ONE			English	Article							SAFETY ASSESSMENT; LIPOPOLYSACCHARIDE; PROTEIN; ANIMALS; CATTLE	Genetic modification offers alternative strategies to traditional animal breeding. However, the food safety of genetically modified (GM) animals has attracted increasing levels of concern. In this study, we produced GM sheep overexpressing TLR4, and the transgene-positive off springs (F1) were confirmed using the polymerase chain reaction (PCR) and Southern blot. The expression of TLR4 was 2.5-fold compared with that of the wild-type (WT) sheep samples. During the 90-day safety study, Sprague-Dawley rats were fed with three different dietary concentrations (3.75%, 7.5%, and 15% wt/wt) of GM sheep meat, WT sheep meat or a commercial diet (CD). Blood samples from the rats were collected and analyzed for hematological and biochemical parameters, and then compared with hematological and biochemical reference ranges. Despite a few significant differences among the three groups in some parameters, all other values remained within the normal reference intervals and thus were not considered to be affected by the treatment. No adverse diet-related differences in body weights or relative organ weights were observed. Furthermore, no differences were observed in the gross necropsy findings or microscopic pathology of the rats whose diets contained the GM sheep meat compared with rats whose diets contained the WT sheep meat. Therefore, the present 90-day rat feeding study suggested that the meat of GM sheep overexpressing TLR4 had no adverse effect on Sprague-Dawley rats in comparison with WT sheep meat. These results provide valuable information regarding the safety assessment of meat derived from GM animals.	[Bai, Hai; Wang, Zhixian; Hu, Rui; Kan, Tongtong; Li, Yan; Lian, Ling; Han, Hongbing; Lian, Zhengxing] China Agr Univ, Beijing Key Lab Anim Genet Improvement, Beijing 100094, Peoples R China; [Bai, Hai] Shanxi Datong Univ, Sch Life Sci, Datong, Shanxi, Peoples R China; [Zhang, Xiaosheng; Zhang, Jinlong] Tianjin Inst Anim Sci, Tianjin, Peoples R China	China Agricultural University; Shanxi Datong University	Han, HB (corresponding author), China Agr Univ, Beijing Key Lab Anim Genet Improvement, Beijing 100094, Peoples R China.	hanhongbing@cau.edu.cn; lianzhx@cau.edu.cn			Chinese Universities Scientific Fund [2014JD016]; National Transgenic Creature Breeding Grand Project [2013ZX08008-005]	Chinese Universities Scientific Fund; National Transgenic Creature Breeding Grand Project	This work was supported by grants from Chinese Universities Scientific Fund (2014JD016) and National Transgenic Creature Breeding Grand Project (2013ZX08008-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2501; Bihl F, 2003, J IMMUNOL, V170, P6141, DOI 10.4049/jimmunol.170.12.6141; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CLEMENTS JE, 1994, VIROLOGY, V200, P370, DOI 10.1006/viro.1994.1201; Deng SL, 2013, THERIOGENOLOGY, V80, P50, DOI 10.1016/j.theriogenology.2013.03.008; Deng SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047118; EC, 2013, OJEU, VL157, P1; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang Jikun, 2003, 195 IDS; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; Kampfmann I, 2012, VET CLIN PATH, V41, P228, DOI 10.1111/j.1939-165X.2012.00427.x; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Liu S, 2013, FOOD CHEM TOXICOL, V57, P314, DOI 10.1016/j.fct.2013.04.003; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; MULLER M, 1994, REPROD FERT DEVELOP, V6, P605, DOI 10.1071/RD9940605; MURRAY JD, 1989, REPROD FERT DEVELOP, V1, P147, DOI 10.1071/RD9890147; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richards HA, 2003, J NUTR, V133, P1909, DOI 10.1093/jn/133.6.1909; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sengupta P, 2012, BIOMED, V2, P81; Swanson KS, 2004, J ANIM SCI, V82, P1713; Tang MX, 2012, TRANSGENIC RES, V21, P499, DOI 10.1007/s11248-011-9550-6; Tang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052507; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Whitelaw CBA, 2005, REV SCI TECH OIE, V24, P275, DOI 10.20506/rst.24.1.1569; Williams P, 2007, NUTR DIET, V64, pS113, DOI 10.1111/j.1747-0080.2007.00197.x; Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029; Yang XZ, 2007, P NATL ACAD SCI USA, V104, P13859, DOI 10.1073/pnas.0706163104; Zhou GH, 2012, MEAT SCI, V92, P188, DOI 10.1016/j.meatsci.2012.04.016	34	11	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121636	10.1371/journal.pone.0121636	http://dx.doi.org/10.1371/journal.pone.0121636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874566	Green Published, gold			2022-12-26	WOS:000352845100044
J	Benavides, MV; Sonstegard, TS; Kemp, S; Mugambi, JM; Gibson, JP; Baker, RL; Hanotte, O; Marshall, K; Van Tassell, C				Benavides, Magda Vieira; Sonstegard, Tad S.; Kemp, Stephen; Mugambi, John M.; Gibson, John P.; Baker, Robert Leyden; Hanotte, Olivier; Marshall, Karen; Van Tassell, Curtis			Identification of Novel Loci Associated with Gastrointestinal Parasite Resistance in a Red Maasai x Dorper Backcross Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; HAEMONCHUS-CONTORTUS; NEMATODE PARASITES; MERINO SHEEP; TRICHOSTRONGYLUS-COLUBRIFORMIS; GENE-EXPRESSION; BODY-WEIGHT; MUCUS; LAMBS	Gastrointestinal (GI) parasitic infection is the main health constraint for small ruminant production, causing loss of weight and/or death. Red Maasai sheep have adapted to a tropical environment where extreme parasite exposure is a constant, especially with highly pathogenic Haemonchus contortus. This breed has been reported to be resistant to gastrointestinal parasite infection, hence it is considered an invaluable resource to study associations between host genetics and resistance. The aim of this study was to identify polymorphisms strongly associated with host resistance in a double backcross population derived from Red Maasai and Dorper sheep using a SNP-based GWAS analysis. The animals that were genotyped represented the most resistant and susceptible individuals based on the tails of phenotypic distribution (10% each) for average faecal egg counts (AVFEC). AVFEC, packed cell volume (AVPCV), and live weight (AVLWT) were adjusted for fixed effects and co-variables, and an association analysis was run using EMMAX. Revised significance levels were calculated using 100,000 permutation tests. The top five significant SNP markers with - log10 p-values >3.794 were observed on five different chromosomes for AVFEC, and BLUPPf90/PostGSf90 results confirmed EMMAX significant regions for this trait. One of these regions included a cluster of significant SNP on chromosome (Chr) 6 not in linkage disequilibrium to each other. This genomic location contains annotated genes involved in cytokine signalling, haemostasis and mucus biosynthesis. Only one association detected on Chr 7 was significant for both AVPCV and AVLWT. The results generated here reveal candidate immune variants for genes involved in differential response to infection and provide additional SNP marker information that has potential to aid selection of resistance to gastrointestinal parasites in sheep of a similar genetic background to the double backcross population.	[Benavides, Magda Vieira] EMBRAPA, LabEx USA, Brasilia, DF, Brazil; [Sonstegard, Tad S.; Van Tassell, Curtis] USDA ARS, Beltsville Agr Res Ctr, Anim Genom & Improvement Lab, Beltsville, MD 20705 USA; [Kemp, Stephen; Marshall, Karen] ILRI, Anim Biosci, Nairobi, Kenya; [Mugambi, John M.] KARI, Natl Vet Res Ctr, Muguga, Kenya; [Gibson, John P.] Univ New England, Ctr Genet Anal & Applicat, Armidale, NSW, Australia; [Baker, Robert Leyden] Whangamata, Waikato, New Zealand; [Hanotte, Olivier] Univ Nottingham, Med & Hlth Sci, Nottingham NG7 2RD, England	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA); CGIAR; International Livestock Research Institute (ILRI); University of New England; University of Nottingham	Benavides, MV (corresponding author), EMBRAPA, LabEx USA, Brasilia, DF, Brazil.	magda.benavides@embrapa.br	Benavides, M/F-6643-2015; Van Tassell, Curtis P./O-4247-2019	Benavides, M/0000-0002-0219-3163; Van Tassell, Curtis P./0000-0002-8416-2087; Gibson, John/0000-0003-0371-2401; Hanotte, Olivier/0000-0002-2877-4767; kemp, stephen/0000-0003-4041-1720	Embrapa; USDA Agricultural Research Service [1265-31000-093-00D]	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Embrapa funded DNA genotyping and data analysis, and supported MB at the Embrapa LabEx programme; Research project 1265-31000-093-00D (AGIL) from the USDA Agricultural Research Service funded CVT and TSS; CVT will cover PLOS ONE submission fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; ALBERS GAA, 1989, AUST J AGR RES, V40, P419, DOI 10.1071/AR9890419; Araujo RN, 2009, VET PARASITOL, V162, P106, DOI 10.1016/j.vetpar.2008.12.017; Arranz JJ, 2004, 12 REUN NAC MEJ GEN, P4; Baker RL, 2004, ANIM SCI, V79, P343, DOI 10.1017/S1357729800090214; Balic A, 2006, PARASITE IMMUNOL, V28, P107, DOI 10.1111/j.1365-3024.2006.00816.x; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; Beh KJ, 2002, ANIM GENET, V33, P97, DOI 10.1046/j.1365-2052.2002.00829.x; BELL AE, 1984, INT J BIOL MACROMOL, V6, P309, DOI 10.1016/0141-8130(84)90015-1; Beraldi D, 2007, INT J PARASITOL, V37, P121, DOI 10.1016/j.ijpara.2006.09.007; Besier RB, 2003, AUST J EXP AGR, V43, P1383, DOI 10.1071/EA02229; Biffa Demelash, 2006, Animal Health Research Reviews, V7, P107, DOI 10.1017/S1466252307001132; Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006; Bishop SC, 2004, ANIM SCI, V78, P185, DOI 10.1017/S1357729800053972; Bisset SA, 1996, VET PARASITOL, V61, P249, DOI 10.1016/0304-4017(95)00836-5; Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7; Bouix J, 1998, INT J PARASITOL, V28, P1797, DOI 10.1016/S0020-7519(98)00147-7; CHURCHILL GA, 1994, GENETICS, V138, P963; Diez-Tascon C, 2002, 7 WORLD C GEN APPL L, P4; Dominik S, 2005, GENET SEL EVOL, V37, pS83, DOI 10.1051/gse:2004027; DOUCH PGC, 1983, INT J PARASITOL, V13, P207, DOI 10.1016/0020-7519(83)90014-0; DOUCH PGC, 1995, LIVEST PROD SCI, V41, P121, DOI 10.1016/0301-6226(94)00046-A; Eady SJ, 1998, AUST J AGR RES, V49, P1201, DOI 10.1071/A98069; Eady SJ, 1996, AUST J AGR RES, V47, P895, DOI 10.1071/AR9960895; Ellis NA, 2009, P ASS ADV ANIMAL BRE, V18, P4; Else KJ, 1998, INT J PARASITOL, V28, P1145, DOI 10.1016/S0020-7519(98)00087-3; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Ge T, 2012, NEUROIMAGE, V63, P858, DOI 10.1016/j.neuroimage.2012.07.012; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Guo YF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-429; Gururaja TL, 1999, BBA-PROTEIN STRUCT M, V1431, P107, DOI 10.1016/S0167-4838(99)00034-5; Gutierrez-Gil B, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-46; Hadjipavlou G, 2009, ANIM GENET, V40, P165, DOI 10.1111/j.1365-2052.2008.01814.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; KELLY EAB, 1991, J IMMUNOL, V147, P306; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Louie K, 2007, INT J PARASITOL, V37, P233, DOI 10.1016/j.ijpara.2006.09.013; Maizels RM, 1998, CURR BIOL, V8, pR711, DOI 10.1016/S0960-9822(98)70455-5; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Marshall K, 2013, ANIM GENET, V44, P285, DOI 10.1111/j.1365-2052.2012.02401.x; Marshall K, 2009, ANIM GENET, V40, P262, DOI 10.1111/j.1365-2052.2008.01836.x; Matika O, 2011, ANIM GENET, V42, P172, DOI 10.1111/j.1365-2052.2010.02121.x; McEwan J., 1995, P AUSTR ASS AN BREED, P4; McEwan JC, 1992, P NZ SOC ANIMAL PROD, P4; McKay DM, 2003, J PARASITOL, V89, P188, DOI 10.1645/0022-3395(2003)089[0188:SIAARF]2.0.CO;2; McRae AF, 2005, ANIM SCI, V80, P135, DOI 10.1079/ASC41040135; MILLER HRP, 1987, PARASITOLOGY, V94, pS77, DOI 10.1017/S0031182000085838; MILLER HRP, 1981, IMMUNOLOGY, V44, P419; Miller J E, 2006, J Anim Sci, V84 Suppl, pE124; Morris C. A, 1998, WORLD C GEN APPL LIV, P295; Morris CA, 2005, NEW ZEAL J AGR RES, V48, P1, DOI 10.1080/00288233.2005.9513625; Morris CA, 1995, BREEDING RESISTANCE, P22; Mugambi JM, 2005, SMALL RUMINANT RES, V56, P239, DOI 10.1016/j.smallrumres.2004.06.003; Mugambi JM, 1996, RES VET SCI, V61, P218, DOI 10.1016/S0034-5288(96)90066-1; Mugambi JM, 1997, VET PARASITOL, V69, P265, DOI 10.1016/S0304-4017(96)01128-4; Nde PN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00337; Pennock JL, 2006, CHEM IMMUNOL ALLERGY, V90, P128, DOI 10.1159/000088885; Riggio V, 2013, HEREDITY, V110, P420, DOI 10.1038/hdy.2012.90; Robertson JO, 2009, THROMB RES, V123, P644, DOI 10.1016/j.thromres.2008.07.003; Rowe A, 2008, VET PARASITOL, V154, P71, DOI 10.1016/j.vetpar.2008.02.014; Salle G, 2012, J ANIM SCI, V90, P4690, DOI 10.2527/jas.2012-5121; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Silva MVB, 2012, ANIM GENET, V43, P63, DOI 10.1111/j.1365-2052.2011.02202.x; Sykes AR, 2003, AUST J EXP AGR, V43, P1393, DOI 10.1071/EA02228; Woolaston RR, 1996, ANIM SCI, V62, P451, DOI 10.1017/S1357729800014995; Woolaston RR, 1996, INT J PARASITOL, V26, P845, DOI 10.1016/S0020-7519(96)80054-3	71	59	64	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122797	10.1371/journal.pone.0122797	http://dx.doi.org/10.1371/journal.pone.0122797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867089	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100101
J	Guo, LL; Liu, W; Lu, TT; Guo, WJ; Gao, J; Luo, Q; Wu, XF; Sun, Y; Wu, XD; Shen, Y; Xu, Q				Guo, Lele; Liu, Wen; Lu, Tingting; Guo, Wenjie; Gao, Jian; Luo, Qiong; Wu, Xuefeng; Sun, Yang; Wu, Xudong; Shen, Yan; Xu, Qiang			Decrease of Functional Activated T and B Cells and Treatment of Glomerulonephitis in Lupus-Prone Mice Using a Natural Flavonoid Astilbin	PLOS ONE			English	Article							TARGETED THERAPIES; IMMUNOSUPPRESSIVE ACTIVITY; DENDRITIC CELLS; TNF-ALPHA; ERYTHEMATOSUS; DAMAGE; COSTIMULATION; LYMPHOCYTES; DYSFUNCTION; METABOLITE	Treatment of systemic lupus erythematosus (SLE), a chronic inflammatory disease, involves the long-term use of immunosuppressive agents with significant side effects. New therapeutic approaches are being explored to find better treatment possibilities. In this study, age-matched female MRL/lpr mice were treated orally with a natural flavonoid astilbin. Astilbin administration started either at week 8 or week 12 of age though week 20. In the early treatment regimen, the treatment with astilbin reduced splenomegaly/lymphomegaly, autoantibody production and ameliorated lupus nephitis. Several serum cytokines were significantly decreased upon treatment including IFN-g, IL-17A, IL-1b, TNF-a and IL-6. Both spleen CD44(hi)CD62L(lo) activated T cells and CD138(+)B220(-) plasma cells greatly declined. Furthermore, astilbin treatment resulted in decreased mitochondrial membrane potential in activated T cells and downregulated expression of the co-stimulatory molecules CD80 and CD86 on LPS stimulated B cells. Similar but less profound effectiveness was observed in the mice with established disease in the late treatment regimen. These results indicate that the natural product astilbin can mitigate disease development in lupus-prone mice by decreasing functional activated T and B cells.	[Guo, Lele; Liu, Wen; Lu, Tingting; Guo, Wenjie; Gao, Jian; Luo, Qiong; Wu, Xuefeng; Sun, Yang; Wu, Xudong; Shen, Yan; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Shen, Y (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	shenyan@nju.edu.cn; molpharm@163.com	Guo, Wenjie/AAQ-7553-2020; Gao, Jian/AAU-8293-2021	Gao, Jian/0000-0002-2722-7067	National Natural Science Foundation of China [81330079, 31370900, 81373466]; Natural Science Foundation of Jiangsu Province [BK20131282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (Nos. 81330079, 31370900, 81373466) and the Natural Science Foundation of Jiangsu Province (No. BK20131282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Cai Y, 2003, INFLAMM RES, V52, P334, DOI 10.1007/s00011-003-1179-3; Chen T, 1999, PLANTA MED, V65, P56, DOI 10.1055/s-1999-13963; Chen T H, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P382; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Ding YB, 2014, BIOCHEM BIOPH RES CO, V446, P529, DOI 10.1016/j.bbrc.2014.02.136; Fei MJ, 2005, J ALLERGY CLIN IMMUN, V116, P1350, DOI 10.1016/j.jaci.2005.08.032; Giltiay NV, 2013, J IMMUNOL, V191, P2155, DOI 10.4049/jimmunol.1300152; Grech P, 2013, LUPUS, V22, P978, DOI 10.1177/0961203313499417; Guo JM, 2007, CLIN CHEM, V53, P465, DOI 10.1373/clinchem.2006.077297; Haraguchi H, 1996, BIOSCI BIOTECH BIOCH, V60, P945, DOI 10.1271/bbb.60.945; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Ichinose K, 2011, ARTHRITIS RHEUM-US, V63, P523, DOI 10.1002/art.30085; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Liang BL, 2000, J IMMUNOL, V165, P3436, DOI 10.4049/jimmunol.165.6.3436; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; Lu LD, 2011, J IMMUNOL, V187, P3840, DOI 10.4049/jimmunol.1101228; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Mok CC, 2014, EXPERT OPIN EMERG DR, V19, P303, DOI 10.1517/14728214.2014.894018; Mok CC, 2014, EXPERT OPIN BIOL TH, V14, P773, DOI 10.1517/14712598.2014.895810; Mosca M, 2013, CLIN EXP RHEUMATOL, V31, pS82; Nagy G, 2005, CRIT REV IMMUNOL, V25, P123, DOI 10.1615/CritRevImmunol.v25.i2.30; Robak E, 2012, CURR MED CHEM, V19, P438, DOI 10.2174/092986712803414312; Roth R, 1996, J IMMUNOL, V157, P2924; Tang JY, 2013, J CHROMATOGR B, V929, P56, DOI 10.1016/j.jchromb.2013.04.018; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Vincent FB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4277; Wang J, 2004, J PHARM PHARMACOL, V56, P495, DOI 10.1211/0022357023033; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Xu Q, 1999, EUR J PHARMACOL, V377, P93, DOI 10.1016/S0014-2999(99)00401-X; Yan R, 2001, PHARMACOL RES, V44, P135, DOI 10.1006/phrs.2001.0838; Yi HW, 2008, INT IMMUNOPHARMACOL, V8, P1467, DOI 10.1016/j.intimp.2008.06.006; Zou S, 2010, TRANSPL P, V42, P3798, DOI 10.1016/j.transproceed.2010.06.031	36	69	73	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124002	10.1371/journal.pone.0124002	http://dx.doi.org/10.1371/journal.pone.0124002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867237	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100231
J	Schock, SN; Young, JA; He, TH; Sun, YF; Winoto, A				Schock, Suruchi N.; Young, Jennifer A.; He, Tina H.; Sun, Yuefang; Winoto, Astar			Deletion of FADD in Macrophages and Granulocytes Results in RIP3-and MyD88-Dependent Systemic Inflammation	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; DENDRITIC CELLS; PROGRAMMED NECROSIS; NLRP3 INFLAMMASOME; T-CELLS; DEATH; APOPTOSIS; KINASE; NECROPTOSIS; ACTIVATION	Myeloid cells, which include monocytes, macrophages, and granulocytes, are important innate immune cells, but the mechanism and downstream effect of their cell death on the immune system is not completely clear. Necroptosis is an alternate form of cell death that can be triggered when death receptor-mediated apoptosis is blocked, for example, in stimulated Fas-associated Death Domain (FADD) deficient cells. We report here that mice deficient for FADD in myeloid cells (mFADD(-/-)) exhibit systemic inflammation with elevated inflammatory cytokines and increased levels of myeloid and B cell populations while their dendritic and T cell numbers are normal. These phenotypes were abolished when RIP3 deficiency was introduced, suggesting that systemic inflammation is caused by RIP3-dependent necroptotic and/or inflammatory activity. We further found that loss of MyD88 can rescue the systemic inflammation observed in these mice. These phenotypes are surprisingly similar to that of dendritic cell (DC)-specific FADD deficient mice with the exception that DC numbers are normal in mFADD(-/-)mice. Together these data support the notion that innate immune cells are constantly being stimulated through the MyD88-dependent pathway and aberrations in their cell death machinery can result in systemic effects on the immune system.	[Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu			National Institutes of Health [R01 AI095299, T32 AI100829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095299, T32AI100829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R01 AI095299 and T32 AI100829). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FK, 2015, ANNU REV IMMUNOL, V33, P41; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hochweller K, 2009, BLOOD, V114, P4411, DOI 10.1182/blood-2008-11-188045; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Young JA, 2013, CELL REP, V3, P1932, DOI 10.1016/j.celrep.2013.04.033; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	52	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124391	10.1371/journal.pone.0124391	http://dx.doi.org/10.1371/journal.pone.0124391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874713	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100257
J	Sprehn, CG; Blum, MJ; Quinn, TP; Heins, DC				Sprehn, C. Grace; Blum, Michael J.; Quinn, Thomas P.; Heins, David C.			Landscape Genetics of Schistocephalus solidus Parasites in Threespine Stickleback (Gasterosteus aculeatus) from Alaska	PLOS ONE			English	Article							3-SPINED STICKLEBACKS; NATURAL-POPULATIONS; GAVIA-IMMER; HOST-SPECIFICITY; LOCAL ADAPTATION; FLOW; DIFFERENTIATION; DISPERSAL; SOFTWARE; HISTORY	The nature of gene flow in parasites with complex life cycles is poorly understood, particularly when intermediate and definitive hosts have contrasting movement potential. We examined whether the fine-scale population genetic structure of the diphyllobothriidean cestode Schistocephalus solidus reflects the habits of intermediate threespine stickleback hosts or those of its definitive hosts, semi-aquatic piscivorous birds, to better understand complex host-parasite interactions. Seventeen lakes in the Cook Inlet region of south-central Alaska were sampled, including ten in the Matanuska-Susitna Valley, five on the Kenai Peninsula, and two in the Bristol Bay drainage. We analyzed sequence variation across a 759 bp region of the mitochondrial DNA (mtDNA) cytochrome oxidase I region for 1,026 S. solidus individuals sampled from 2009-2012. We also analyzed allelic variation at 8 microsatellite loci for 1,243 individuals. Analysis of mtDNA haplotype and microsatellite genotype variation recovered evidence of significant population genetic structure within S. solidus. Host, location, and year were factors in structuring observed genetic variation. Pair-wise measures revealed significant differentiation among lakes, including a pattern of isolation-by-distance. Bayesian analysis identified three distinct genotypic clusters in the study region, little admixture within hosts and lakes, and a shift in genotype frequencies over time. Evidence of fine-scale population structure in S. solidus indicates that movement of its vagile, definitive avian hosts has less influence on gene flow than expected based solely on movement potential. Observed patterns of genetic variation may reflect genetic drift, behaviors of definitive hosts that constrain dispersal, life history of intermediate hosts, and adaptive specificity of S. solidusto intermediate host genotype.	[Sprehn, C. Grace; Blum, Michael J.; Heins, David C.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Blum, Michael J.] Tulane Univ, Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70118 USA; [Quinn, Thomas P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Tulane University; Tulane University; Xavier University of Louisiana; University of Washington; University of Washington Seattle	Sprehn, CG (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	csprehn@tulane.edu		Sprehn, Charlotte/0000-0002-4164-4246	Newcomb College Institute at Tulane University	Newcomb College Institute at Tulane University	Laboratory funding was provided by the Newcomb College Institute at Tulane University (http://tulane.edu/newcomb/).	Barber I, 2010, PARASITOLOGY, V137, P411, DOI 10.1017/S0031182009991466; Barr JF, 1996, HYDROBIOLOGIA, V321, P119, DOI 10.1007/BF00023169; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Bartolome C, 2011, ORG DIVERS EVOL, V11, P307, DOI 10.1007/s13127-011-0052-4; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Binz T, 2000, MOL ECOL, V9, P1926, DOI 10.1046/j.1365-294x.2000.01073-5.x; Blasco-Costa I, 2012, MOL ECOL, V21, P207, DOI 10.1111/j.1365-294X.2011.05374.x; BLOUIN MS, 1992, EVOLUTION, V46, P470, DOI 10.1111/j.1558-5646.1992.tb02052.x; BLOUIN MS, 1995, GENETICS, V141, P1007; Bouzid W, 2008, INT J PARASITOL, V38, P1465, DOI 10.1016/j.ijpara.2008.03.008; BRATEN T, 1966, PARASITOLOGY, V56, pP5, DOI 10.1017/S0031182000071687; Caldera EJ, 2008, EVOL ECOL RES, V10, P575; Copp GH, 2003, ANN ZOOL FENN, V40, P341; Criscione CD, 2008, PARASITE, V15, P439, DOI 10.1051/parasite/2008153439; Criscione CD, 2006, EVOLUTION, V60, P553, DOI 10.1111/j.0014-3820.2006.tb01136.x; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Criscione CD, 2004, EVOLUTION, V58, P198, DOI 10.1111/j.0014-3820.2004.tb01587.x; Davies CM, 1999, PARASITOLOGY, V119, P295, DOI 10.1017/S0031182099004722; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dybdahl MF, 1996, EVOLUTION, V50, P2264, DOI [10.1111/j.1558-5646.1996.tb03615.x, 10.2307/2410696]; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Franke F, 2014, FISH SHELLFISH IMMUN, V36, P130, DOI 10.1016/j.fsi.2013.10.019; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; HAFNER JC, 1983, SYST ZOOL, V32, P1, DOI 10.2307/2413215; Hafner MS, 2003, COPHYLOGENY POCKET G, P350; Heins DC, 2010, PARASITOLOGY, V137, P1681, DOI 10.1017/S003118201000048X; Heins DC, 2008, BEHAVIOUR, V145, P625, DOI 10.1163/156853908792451412; Heins DC, 2010, BIOL J LINN SOC, V100, P835, DOI 10.1111/j.1095-8312.2010.01486.x; Hendry AP, 2004, EVOLUTION, V58, P2319; Henrich T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-33; HILBURN LR, 1986, HEREDITY, V57, P67, DOI 10.1038/hdy.1986.88; HILBURN LR, 1986, HEREDITY, V57, P113, DOI 10.1038/hdy.1986.94; Humple DL, 2009, GENETIC STRUCTURE DE; Jarne P, 2001, PARASITOLOGY, V123, pS27, DOI 10.1017/S0031182001007715; Johnson LS, 2004, J BIOGEOGR, V31, P1073, DOI 10.1111/j.1365-2699.2004.01078.x; Johnson S.G., 1997, EXS, V82, P263; Kenow KP, 2002, WATERBIRDS, V25, P449, DOI 10.1675/1524-4695(2002)025[0449:UOSTTI]2.0.CO;2; Lamphere BA, 2012, ECOL FRESHW FISH, V21, P75, DOI 10.1111/j.1600-0633.2011.00525.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MCMANUS DP, 1985, J HELMINTHOL, V59, P323, DOI 10.1017/S0022149X00025906; Moore JS, 2009, PHILOS T R SOC B, V364, P1533, DOI 10.1098/rstb.2009.0007; NADLER SA, 1995, J PARASITOL, V81, P395, DOI 10.2307/3283821; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Nishimura N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022505; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PENNYCUICK L, 1971, PARASITOLOGY, V63, P389, DOI 10.1017/S0031182000079920; Piper W, 2011, AM SCI, V99, P220, DOI 10.1511/2011.90.220; Piper WH, 1997, J WILDLIFE MANAGE, V61, P1253, DOI 10.2307/3802124; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Price P. W., 1980, EVOLUTIONARY BIOL PA; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2005, EVOLUTION, V59, P296, DOI 10.1111/j.0014-3820.2005.tb00990.x; REIMCHEN TE, 1980, CAN FIELD NAT, V94, P398; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggles AK, 1991, HABITAT SELECTION CO; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smyth J., 1962, INTRO ANIMAL PARASIT; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Thomas L. J., 1947, Journal of Parasitology Lancaster, V33, P10; Todd CD, 2004, CAN J FISH AQUAT SCI, V61, P1176, DOI 10.1139/F04-069; Ward AJW, 2013, BEHAVIOUR, V150, P1689, DOI 10.1163/1568539X-00003115; Wedekind C, 1997, PARASITOLOGY, V115, P317, DOI 10.1017/S0031182097001406	68	25	25	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122307	10.1371/journal.pone.0122307	http://dx.doi.org/10.1371/journal.pone.0122307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874710	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100061
J	Parra-Rojas, J; Moreno, AA; Mitina, I; Orellana, A				Parra-Rojas, Juan; Moreno, Adrian A.; Mitina, Irina; Orellana, Ariel			The Dynamic of the Splicing of bZIP60 and the Proteins Encoded by the Spliced and Unspliced mRNAs Reveals Some Unique Features during the Activation of UPR in Arabidopsis thaliana	PLOS ONE			English	Article							RETICULUM STRESS-RESPONSE; TRANSCRIPTION FACTOR; ER STRESS; CELL FATE; IRE1; TRANSFORMATION; DISSOCIATION; MECHANISM; LIGASE; SENSOR	The unfolded protein response (UPR) is a signaling pathway that is activated when the workload of the endoplasmic reticulum (ER) is surpassed. IRE1 is a sensor involved in triggering the UPR and plays a key role in the unconventional splicing of an mRNA leading to the formation of a transcription factor that up-regulates the transcription of genes that play a role in restoring the homeostasis in the ER. In plants, bZIP60 is the substrate for IRE1; however, questions such as what is the dynamics of the splicing of bZIP60 and the fate of the proteins encoded by the spliced and unspliced forms of the mRNA, remain unanswered. In the present work, we analyzed the processing of bZIP60 by determining the levels of the spliced form mRNA in plants exposed to different conditions that trigger UPR. The results show that induction of ER stress increases the content of the spliced form of bZIP60 (bZIP60s) reaching a maximum, that depending on the stimuli, varied between 30 min or 2 hrs. In most cases, this was followed by a decrease in the content. In contrast to other eukaryotes, the splicing never occurred to full extent. The content of bZIP60s changed among different organs upon induction of the UPR suggesting that splicing is regulated differentially throughout the plant. In addition, we analyzed the distribution of a GFP-tagged version of bZIP60 when UPR was activated. A good correlation between splicing of bZIP60 and localization of the protein in the nucleus was observed. No fluorescence was observed under basal conditions, but interestingly, the fluorescence was recovered and found to co-localize with an ER marker upon treatment with an inhibitor of the proteasome. Our results indicate that the dynamics of bZIP60, both the mRNA and the protein, are highly dynamic processes which are tissue-specific and stimulus-dependent.	[Parra-Rojas, Juan; Moreno, Adrian A.; Mitina, Irina; Orellana, Ariel] Univ Andres Bello, Fac Ciencias Biol, FONDAP Ctr Genome Regulat, Ctr Biotecnol Vegetal, Santiago, Chile	Universidad Andres Bello	Orellana, A (corresponding author), Univ Andres Bello, Fac Ciencias Biol, FONDAP Ctr Genome Regulat, Ctr Biotecnol Vegetal, Santiago, Chile.	aorellana@unab.cl	Moreno, Adrian/H-4956-2019; Orellana, Ariel/AAE-4866-2021; Orellana, Ariel/E-2166-2014	Orellana, Ariel/0000-0002-9243-808X; Orellana, Ariel/0000-0002-9243-808X; Moreno, Adrian/0000-0001-5125-2927; Parra, Juan/0000-0002-3111-0603	FONDECYT [1110954]; FONDAP Centro de Regulacion del Genoma [15090007]; Fundacion ciencia para la vida [PFB 16]; Iniciativa Cientifica Milenio [P10-062-F]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP Centro de Regulacion del Genoma(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fundacion ciencia para la vida; Iniciativa Cientifica Milenio	1. FONDECYT 1110954 (http://ri.conicyt.cl/575/article-40406.html) (AO) FONDAP Centro de Regulacion del Genoma 15090007 (http://www.conicyt.cl/fondap/centros-fondap/crg/) (AO) Fundacion ciencia para la vida PFB 16 (http://ri.conicyt.cl/575/article-27894.html) (AO) Iniciativa Cientifica Milenio P10-062-F (http://www.iniciativamilenio.cl/centros/nucleos_det.php?id=29) (AO) 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chawla A, 2011, J CELL BIOL, V193, P41, DOI 10.1083/jcb.201008071; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lu SJ, 2012, MOL PLANT, V5, P504, DOI 10.1093/mp/ssr115; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Nagashima Y, 2014, PLANT CELL PHYSIOL, V55, P1772, DOI 10.1093/pcp/pcu108; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Oikawa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051290; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Weber K, 1972, Methods Enzymol, V26, P3; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	35	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122936	10.1371/journal.pone.0122936	http://dx.doi.org/10.1371/journal.pone.0122936			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860807	Green Published, gold			2022-12-26	WOS:000352590300069
J	Wang, YF; Lv, JP; Cheng, Y; Du, JP; Chen, DG; Li, CT; Zhang, J				Wang, Yufang; Lv, Junping; Cheng, Yao; Du, Jipei; Chen, Degao; Li, Chengtao; Zhang, Ji			Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; CANCER-CELLS; OVERCOMING RESISTANCE; CARCINOMA-CELLS; EXTRACT; INHIBITION; BAX; MITOCHONDRIA; MCL-1; ACTIVATION	Melanoma is an aggressive skin cancer. Unfortunately, there is currently no chemotherapeutic agent available to significantly prolong the survival of the most patients with metastatic melanomas. Here we report that the Ginkgo biloba extract (EGb761), one of the most widely sold herbal supplements in the world, potently induces apoptosis in human melanoma cells by disturbing the balance between pro-and anti-apoptosis Bcl-2 family proteins. Treatment with EGb761 induced varying degrees of apoptosis in melanoma cell lines but not in melanocytes. Induction of apoptosis was caspase-dependent and appeared to be mediated by the mitochondrial pathway, in that it was associated with reduction in mitochondrial membrane potential and activation of Bax and Bak. Although EGb761 did not cause significant change in the expression levels of the BH3-only Bcl-2 family proteins Bim, Puma, Noxa, and Bad, it significantly downregulated Mcl-1 in sensitive but not resistant melanoma cells, suggesting a major role of Mcl-1 in regulating apoptosis of melanoma cells induced by EGb761. Indeed, siRNA knockdown of Mcl-1 enhanced EGb761-induced apoptosis, which was associated with increased activation of Bax and Bak. Taken together, these results demonstrate that EGb761 kills melanoma cells through the mitochondrial apoptotic pathway, and that Mcl-1 is a major regulator of sensitivity of melanoma cells to apoptosis induced by EGb761. Therefore, EGb761 with or without in combination with targeting Mcl-1 may be a useful strategy in the treatment of melanoma.	[Wang, Yufang; Cheng, Yao; Du, Jipei; Chen, Degao] Sichuan Univ, Sch Preclin & Forens Med, Dept Pathophysiol, Chengdu 610064, Peoples R China; [Lv, Junping] Beijing Inst Biomed, Dept Pharmacol, Beijing, Peoples R China; [Li, Chengtao] Inst Forens Sci, Shanghai Key Lab Forens Med, Minist Justice, Shanghai, Peoples R China; [Zhang, Ji] Sichuan Univ, Sch Preclin & Forens Med, Dept Forens Genet, Chengdu 610064, Peoples R China	Sichuan University; Institute of Forensic Science Ministry of Justice PRC; Sichuan University	Zhang, J (corresponding author), Sichuan Univ, Sch Preclin & Forens Med, Dept Forens Genet, Chengdu 610064, Peoples R China.	zhangj@scu.edu.cn		Li, Chengtao/0000-0001-6852-9144	National Nature Science Foundation [81201560, 81471551]; priming scientific research foundation for the junior teachers of medicine in Sichuan University [2012SCU11020]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); priming scientific research foundation for the junior teachers of medicine in Sichuan University	This work was supported by research grants from the National Nature Science Foundation (81201560 and 81471551); the priming scientific research foundation for the junior teachers of medicine in Sichuan University (2012SCU11020).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; DEFEUDIS FV, 1991, LIFE SCI, V49, P689, DOI 10.1016/0024-3205(91)90101-G; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fabrega A, 2012, THERIOGENOLOGY, V78, P867, DOI 10.1016/j.theriogenology.2012.03.039; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gohil K, 2002, CELL MOL BIOL, V48, P625; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; Hersey P, 2008, ADV EXP MED BIOL, V615, P105, DOI 10.1007/978-1-4020-6554-5_6; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2011, CLIN CANCER RES, V17, P721, DOI 10.1158/1078-0432.CCR-10-2225; Jung IH, 2012, EXP MOL MED, V44, P311, DOI 10.3858/emm.2012.44.5.035; Kim KS, 2005, ORAL ONCOL, V41, P383, DOI 10.1016/j.oraloncology.2004.09.013; Limberg, 1976, TECHNIQUES CLIN APPL; Liu XP, 2007, LIFE SCI, V80, P1586, DOI 10.1016/j.lfs.2007.01.034; Lu G, 2006, BRAIN RES, V1090, P23, DOI 10.1016/j.brainres.2006.02.138; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Mutoh M, 2000, CARCINOGENESIS, V21, P959, DOI 10.1093/carcin/21.5.959; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18; Uzdensky AB, 2013, CURR CANCER DRUG TAR, V13, P843; Vilar JB, 2009, GENET MOL RES, V8, P328, DOI 10.4238/vol8-1gmr519; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wouters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076550; Xiaodong Liu GY, 1992, J PRACTICAL ONCOLOGY, V3, P2; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zekanowski C, 2001, J MED SCREEN, V8, P132, DOI 10.1136/jms.8.3.132; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084; Zhang XD, 2001, CANCER RES, V61, P7339; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750; Zixin Li LW, 1988, CHINESE OBSTETRICS G, V23, P3	50	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124812	10.1371/journal.pone.0124812	http://dx.doi.org/10.1371/journal.pone.0124812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860257	Green Submitted, Green Published, gold			2022-12-26	WOS:000352590300148
J	Kollitz, EM; Zhang, GZ; Hawkins, MB; Whitfield, GK; Reif, DM; Kullman, SW				Kollitz, Erin M.; Zhang, Guozhu; Hawkins, Mary Beth; Whitfield, G. Kerr; Reif, David M.; Kullman, Seth W.			Molecular Cloning, Functional Characterization, and Evolutionary Analysis of Vitamin D Receptors Isolated from Basal Vertebrates	PLOS ONE			English	Article							NUCLEAR HORMONE-RECEPTORS; RETINOID-X-RECEPTOR; GENOME DUPLICATION; 1,25-DIHYDROXYVITAMIN D-3; CONFORMATIONAL-CHANGES; TELEOST FISH; GENE; ACID; BINDING; LIGAND	The vertebrate genome is a result of two rapid and successive rounds of whole genome duplication, referred to as 1R and 2R. Furthermore, teleost fish have undergone a third whole genome duplication (3R) specific to their lineage, resulting in the retention of multiple gene paralogs. The more recent 3R event in teleosts provides a unique opportunity to gain insight into how genes evolve through specific evolutionary processes. In this study we compare molecular activities of vitamin D receptors (VDR) from basal species that diverged at key points in vertebrate evolution in order to infer derived and ancestral VDR functions of teleost paralogs. Species include the sea lamprey (Petromyzon marinus), a 1R jawless fish; the little skate (Leucoraja erinacea), a cartilaginous fish that diverged after the 2R event; and the Senegal bichir (Polypterus senegalus), a primitive 2R ray-finned fish. Saturation binding assays and gel mobility shift assays demonstrate high affinity ligand binding and classic DNA binding characteristics of VDR has been conserved across vertebrate evolution. Concentration response curves in transient transfection assays reveal EC50 values in the low nanomolar range, however maximum transactivational efficacy varies significantly between receptor orthologs. Protein-protein interactions were investigated using co-transfection, mammalian 2-hybrid assays, and mutations of coregulator activation domains. We then combined these results with our previous study of VDR paralogs from 3R teleosts into a bioinformatics analysis. Our results suggest that 1, 25D(3) acts as a partial agonist in basal species. Furthermore, our bioinformatics analysis suggests that functional differences between VDR orthologs and paralogs are influenced by differential protein interactions with essential coregulator proteins. We speculate that we may be observing a change in the pharmacodynamics relationship between VDR and 1, 25D(3) throughout vertebrate evolution that may have been driven by changes in protein-protein interactions between VDR and essential coregulators.	[Kollitz, Erin M.; Kullman, Seth W.] N Carolina State Univ, Dept Biol Sci, Program Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Zhang, Guozhu; Reif, David M.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Hawkins, Mary Beth; Reif, David M.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Whitfield, G. Kerr] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Arizona	Kullman, SW (corresponding author), N Carolina State Univ, Dept Biol Sci, Program Environm & Mol Toxicol, Raleigh, NC 27695 USA.	swkullma@ncsu.edu		Kullmam, Seth/0000-0002-6029-2266; Reif, David/0000-0001-7815-6767; Kollitz, Erin/0000-0003-1769-1496	National Science Foundation [IOS0818799]; Mount Desert Island Biological Laboratory; North Carolina State University; National Institute of Environmental Health Sciences Training Grant [T32-ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007329, T32ES007046, P30ES025128] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Mount Desert Island Biological Laboratory; North Carolina State University; National Institute of Environmental Health Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation grant IOS0818799 (to SWK); a Stan and Judy Fellowship from the Mount Desert Island Biological Laboratory (to EMK); a Dissertation Completion Grant from North Carolina State University (to EMK); and National Institute of Environmental Health Sciences Training Grant T32-ES007046 (to EMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2004, MOL ENDOCRINOL, V18, P43, DOI 10.1210/me.2003-0244; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Bettoun DJ, 2003, MOL ENDOCRINOL, V17, P2320, DOI 10.1210/me.2003-0148; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; Carlberg C, 2004, J STEROID BIOCHEM, V89-90, P227, DOI 10.1016/j.jsbmb.2004.03.112; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Force A, 1999, GENETICS, V151, P1531; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hawkins MB, 2004, ENDOCRINOLOGY, V145, P2968, DOI 10.1210/en.2003-0806; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Howarth DL, 2009, THESIS DUKE U DURHAM; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; JONES BB, 1995, MOL CELL BIOL, V15, P5226; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kobayashi T, 1991, VITAMIN D GENE REGUL; Kollitz EM, 2014, ENDOCRINOLOGY, V155, P4641, DOI 10.1210/en.2014-1505; Laudet V, 2002, NUCL RECEPTOR FACTSB; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li YC, 1997, ENDOCRINOLOGY, V138, P2347, DOI 10.1210/en.138.6.2347; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045650; Lock EJ, 2010, AQUACULT NUTR, V16, P100, DOI 10.1111/j.1365-2095.2009.00722.x; MACDONALD PN, 1993, MOL CELL BIOL, V13, P5907, DOI 10.1128/MCB.13.9.5907; Maglich JM, 2003, NUCLEIC ACIDS RES, V31, P4051, DOI 10.1093/nar/gkg444; Metpally RPR, 2007, J BIOSCIENCES, V32, P43, DOI 10.1007/s12038-007-0005-4; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ohno S., 1970, P1; PELEG S, 1995, J BIOL CHEM, V270, P10551, DOI 10.1074/jbc.270.18.10551; Pierens SL, 2015, J STEROID BIOCHEM, V145, P58, DOI 10.1016/j.jsbmb.2014.10.005; Ploner A, 2012, HEATPLUS HEATMAPS RO; RCoreTeam, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Rozen S, 2000, BIOINFORMATICS METHO; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Shaffer PL, 2004, VITAM HORM, V68, P257; Shaffer PL, 2004, J STEROID BIOCHEM, V89-90, P215, DOI 10.1016/j.jsbmb.2004.03.084; Suzuki T, 2000, BIOCHEM BIOPH RES CO, V270, P40, DOI 10.1006/bbrc.2000.2378; Takeuchi A, 1991, VITAMIN D GENE REGUL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson PD, 1998, J BIOL CHEM, V273, P8483, DOI 10.1074/jbc.273.14.8483; Thompson PD, 2001, J MOL ENDOCRINOL, V27, P211, DOI 10.1677/jme.0.0270211; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Whitfield GK, 2003, ENDOCRINOLOGY, V144, P2704, DOI 10.1210/en.2002-221101	65	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122853	10.1371/journal.pone.0122853	http://dx.doi.org/10.1371/journal.pone.0122853			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855982	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500062
J	Maduna, PH; Dolan, M; Kondlo, L; Mabuza, H; Dlamini, JN; Polis, M; Mnisi, T; Orsega, S; Maja, P; Ledwaba, L; Molefe, T; Sangweni, P; Malan, L; Matchaba, G; Khabo, P; Grandits, G; Neaton, JD				Maduna, Patrick H.; Dolan, Matt; Kondlo, Lwando; Mabuza, Honey; Dlamini, Judith N.; Polis, Mike; Mnisi, Thabo; Orsega, Susan; Maja, Patrick; Ledwaba, Lotty; Molefe, Thuthukile; Sangweni, Phumelele; Malan, Lisette; Matchaba, Gugu; Khabo, Paul; Grandits, Greg; Neaton, James D.			Morbidity and Mortality According to Latest CD4+Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa	PLOS ONE			English	Article							NON-AIDS EVENTS; STARTING ANTIRETROVIRAL THERAPY; CD4 CELL COUNTS; SHORT-TERM RISK; INFECTED ADULTS; FOLLOW-UP; NONFATAL AIDS; ALL-CAUSE; DEATH; SETTINGS	Background Short-term morbidity and mortality rates for HIV positive soldiers in the South African National Defence Force (SANDF) would inform decisions about deployment and HIV disease management. Risks were determined according to the latest CD4+ cell count and use of antiretroviral therapy (ART) for HIV positive individuals in the SANDF and their dependents. Methods and Findings A total of 7,114 participants were enrolled and followed for mortality over a median of 4.7 years (IQR: 1.9, 7.1 years). For a planned subset (5,976), progression of disease (POD) and grade 4, potentially life-threatening events were also ascertained. CD4+ count and viral load were measured every 3 to 6 months. Poisson regression was used to compare event rates by latest CD4+ count (<50, 50-99, 100-199, 200-349, 350-499, 500+) with a focus on upper three strata, and to estimate relative risks (RRs) (ART/no ART). Median entry CD4+ was 207 cells/mm(3). During follow-up over 70% were prescribed ART. Over follow-up 1,226 participants died; rates ranged from 57.6 (<50 cells) to 0.8 (500+ cells) per 100 person years (py). Compared to those with latest CD4+ 200-349 (2.2/100py), death rates were significantly lower (p<0.001), as expected, for those with 350-499 (0.9/100py) and with 500+ cells (0.8/100py). The composite outcome of death, POD or grade 4 events occurred in 2,302 participants (4,045 events); rates were similar in higher CD4+ count strata (9.4 for 350-499 and 7.9 for 500+ cells) and lower than those with counts 200-349 cells (13.5) (p<0.001). For those with latest CD4+ 350+ cells, 63% of the composite outcomes (680 of 1,074) were grade 4 events. Conclusion Rates of morbidity and mortality are lowest among those with CD4+ count of 350 or higher and rates do not differ for those with counts of 350-499 versus 500+ cells. Grade 4 events are the predominant morbidity for participants with CD4+ counts of 350+ cells.	[Maduna, Patrick H.; Mabuza, Honey; Mnisi, Thabo; Malan, Lisette] South African Natl Def Forces, South Africa Mil Hlth Serv, Pretoria, South Africa; [Dolan, Matt] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Kondlo, Lwando; Dlamini, Judith N.; Maja, Patrick; Ledwaba, Lotty; Molefe, Thuthukile; Sangweni, Phumelele; Matchaba, Gugu; Khabo, Paul] Charisma Healthcare Solut, Pretoria, South Africa; [Polis, Mike; Orsega, Susan] NIAID, NIH, Bethesda, MD 20892 USA; [Grandits, Greg; Neaton, James D.] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities	Neaton, JD (corresponding author), Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA.	jim@ccbr.umn.edu			Phidisa Project; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; South African National Defence Force; United States National Institutes of Health; United States Department of Defense	Phidisa Project; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); South African National Defence Force; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense)	Funding for the Phidisa Project, the Phidisa I and II studies, and this substudy were provided by the South African National Defence Force, the United States National Institutes of Health and the United States Department of Defense. SAIC-Frederick, Inc. helped fund the study through the employment of Beth Basseler and Xiao Liu who contributed to the study. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; Babiker AG, 2013, CLIN TRIALS, V10, pS5, DOI 10.1177/1740774512440342; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Brennan AT, 2013, TROP MED INT HEALTH, V18, P619, DOI 10.1111/tmi.12079; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Deuffic-Burban S, 2007, EUR J EPIDEMIOL, V22, P737, DOI 10.1007/s10654-007-9175-5; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Floyd S, 2012, TROP MED INT HEALTH, V17, pe84, DOI 10.1111/j.1365-3156.2012.03032.x; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gabillard D, 2013, JAIDS-J ACQ IMM DEF, V62, P555, DOI 10.1097/QAI.0b013e3182821821; Hassan AS, 2012, TROP MED INT HEALTH, V17, P82, DOI 10.1111/j.1365-3156.2011.02889.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lewden C, 2012, JAIDS-J ACQ IMM DEF, V59, P213, DOI 10.1097/QAI.0b013e31823b837e; Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4; Losina E, 2007, ANTIVIR THER, V12, P543; Lucero C, 2013, AIDS RES HUM RETROV, V29, P1161, DOI [10.1089/aid.2012.0367, 10.1089/AID.2012.0367]; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; National Department of Health, 2010, CLIN GUID MAN HIV AI; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Phillips AN, 2006, CURR OPIN HIV AIDS, V1, P43, DOI 10.1097/01.COH.0000194106.12816.b1; Phillips AN, 2007, AIDS, V21, P1717; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Preisser JS, 1996, BIOMETRIKA, V83, P551, DOI 10.1093/biomet/83.3.551; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Reekie J, 2011, AIDS, V25, P2259, DOI 10.1097/QAD.0b013e32834cdb4b; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Tawfik L, 2006, IMPACT HIV AIDS HLTH; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121843	10.1371/journal.pone.0121843	http://dx.doi.org/10.1371/journal.pone.0121843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856495	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500026
J	McCullagh, BN; Costello, CM; Li, LL; O'Connell, C; Codd, M; Lawrie, A; Morton, A; Kiely, DG; Condliffe, R; Elliot, C; McLoughlin, P; Gaine, S				McCullagh, Brian N.; Costello, Christine M.; Li, Lili; O'Connell, Caroline; Codd, Mary; Lawrie, Allan; Morton, Allison; Kiely, David G.; Condliffe, Robin; Elliot, Charles; McLoughlin, Paul; Gaine, Sean			Elevated Plasma CXCL12 alpha Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; SURVIVAL; HYPOXIA; PATHOGENESIS; ADHESION; CXCR7; CELLS	Rationale Recent work in preclinical models suggests that signalling via the pro-angiogenic and pro-inflammatory cytokine, CXCL12 (SDF-1), plays an important pathogenic role in pulmonary hypertension (PH). The objective of this study was to establish whether circulating concentrations of CXCL12 alpha were elevated in patients with PAH and related to mortality. Methods Plasma samples were collected from patients with idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue diseases (CTD-PAH) attending two pulmonary hypertension referral centres (n = 95) and from age and gender matched healthy controls (n = 44). Patients were subsequently monitored throughout a period of five years. Results CXCL12 alpha concentrations were elevated in PAH groups compared to controls (P<0.05) and receiver-operating-characteristic analysis showed that plasma CXCL12 alpha concentrations discriminated patients from healthy controls (AUC 0.80, 95% confidence interval 0.73-0.88). Kaplan Meier analysis indicated that elevated plasma CXCL12a concentration was associated with reduced survival (P<0.01). Multivariate Cox proportional hazards model showed that elevated CXCL12 alpha independently predicted (P<0.05) earlier death in PAH with a hazard ratio (95% confidence interval) of 2.25 (1.01-5.00). In the largest subset by WHO functional class (Class 3, 65% of patients) elevated CXCL12 alpha independently predicted (P<0.05) earlier death, hazard ratio 2.27 (1.05-4.89). Conclusions Our data show that elevated concentrations of circulating CXCL12 alpha in PAH predicted poorer survival. Furthermore, elevated circulating CXCL12 alpha was an independent risk factor for death that could potentially be included in a prognostic model and guide therapy.	[McCullagh, Brian N.; Costello, Christine M.; Li, Lili; O'Connell, Caroline; McLoughlin, Paul] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland; [Codd, Mary] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 4, Ireland; [Lawrie, Allan] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Morton, Allison] No Gen Hosp, Dept Cardiol, Sheffield S5 7AU, S Yorkshire, England; [Kiely, David G.; Condliffe, Robin; Elliot, Charles] Royal Hallamshire Hosp, Sheffield Pulm Vasc Dis Unit, Sheffield S10 2JF, S Yorkshire, England; [McCullagh, Brian N.; O'Connell, Caroline; Gaine, Sean] Mater Misericordiae Univ Hosp, Pulm Hypertens Unit, Dublin 7, Ireland	University College Dublin; University College Dublin; University of Sheffield; Northern General Hospital; University of Sheffield; Mater Misericordiae University Hospital; University College Dublin	McLoughlin, P (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland.	paul.mcloughlin@ucd.ie	Lawrie, Allan/A-2708-2012	Lawrie, Allan/0000-0003-4192-9505; Gaine, Sean/0000-0002-5941-684X; McLoughlin, Paul/0000-0001-6200-016X; Condliffe, Robin/0000-0002-3492-4143	Health Research Board; Higher Education Authority (Programme for Research in Third Level Institutions) of Ireland and Science Foundation Ireland; Actelion-Newman Fellowship; Medical Research Council Career Development Award [G0800318]; British Heart Foundation [PG/11/116/29288]; National Institute for Health Research Sheffield Cardiovascular Biomedical Research Unit; MRC [G0800318] Funding Source: UKRI; British Heart Foundation [FS/13/48/30453] Funding Source: researchfish; Medical Research Council [G0800318] Funding Source: researchfish	Health Research Board; Higher Education Authority (Programme for Research in Third Level Institutions) of Ireland and Science Foundation Ireland(Science Foundation Ireland); Actelion-Newman Fellowship; Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Sheffield Cardiovascular Biomedical Research Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Health Research Board, the Higher Education Authority (Programme for Research in Third Level Institutions) of Ireland and Science Foundation Ireland, an Actelion-Newman Fellowship (BM), a Medical Research Council Career Development Award (G0800318, AL), a British Heart Foundation clinical project grant (PG/11/116/29288), National Institute for Health Research Sheffield Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the patients and staff at the participating centres in the study.	Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Benza RL, 2012, THROMB HAEMOSTASIS, V108, P1049, DOI 10.1160/TH11-11-0821; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Costello CM, 2008, AM J PHYSIOL-LUNG C, V295, pL272, DOI 10.1152/ajplung.00358.2007; Costello CM, 2012, EUR RESPIR J, V39, P1415, DOI 10.1183/09031936.00044911; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Farha S, 2011, BLOOD, V117, P3485, DOI 10.1182/blood-2010-09-306357; Gambaryan N, 2011, EUR RESPIR J, V37, P1392, DOI 10.1183/09031936.00045710; Hashimoto K, 2004, CIRC J, V68, P227, DOI 10.1253/circj.68.227; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Kiely DG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2028; Kuhn KP, 2003, AM J RESP CRIT CARE, V167, P580, DOI 10.1164/rccm.200204-333OC; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Raychaudhuri B, 2002, J BIOL CHEM, V277, P33344, DOI 10.1074/jbc.M203567200; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Rhodes CJ, 2011, HEART, V97, P1054, DOI 10.1136/hrt.2011.224857; Sartina E, 2012, PEDIATR RES, V71, P682, DOI 10.1038/pr.2012.30; Satoh K, 2009, CARDIOVASC RES, V81, P226, DOI 10.1093/cvr/cvn244; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; Young KC, 2009, CIRC RES, V104, P1293, DOI 10.1161/CIRCRESAHA.109.197533; Yu LY, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-21	30	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123709	10.1371/journal.pone.0123709	http://dx.doi.org/10.1371/journal.pone.0123709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856504	Green Accepted, gold, Green Published			2022-12-26	WOS:000352588500103
J	Mostafavi, L; Marfori, W; Arellano, C; Tognolini, A; Speier, W; Adibi, A; Ruehm, SG				Mostafavi, Leila; Marfori, Wanda; Arellano, Cesar; Tognolini, Alessia; Speier, William; Adibi, Ali; Ruehm, Stefan G.			Prevalence of Coronary Artery Disease Evaluated by Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Calcifications	PLOS ONE			English	Article							HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR MORTALITY; ASSOCIATION; MAMMOGRAMS; CALCIUM	To assess the correlation between breast arterial calcifications (BAC) on digital mammography and the extent of coronary artery disease (CAD) diagnosed with dual source coronary computed tomography angiography (CTA) in a population of women both symptomatic and asymptomatic for coronary artery disease. 100 consecutive women (aged 34 - 86 years) who underwent both coronary CTA and digital mammography were included in the study. Health records were reviewed to determine the presence of cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes mellitus, and smoking. Digital mammograms were reviewed for the presence and degree of BAC, graded in terms of severity and extent. Coronary CTAs were reviewed for CAD, graded based on the extent of calcified and non-calcified plaque, and the degree of major vessel stenosis. A four point grading scale was used for both coronary CTA and mammography. The overall prevalence of positive BAC and CAD in the studied population were 12% and 29%, respectively. Ten of the 12 patients with moderate or advanced BAC on mammography demonstrated moderate to severe CAD as determined by coronary CTA. For all women, the positive predictive value of BAC for CAD was 0.83 and the negative predictive value was 0.78. The presence of BAC on mammography appears to correlate with CAD as determined by coronary CTA (Spearman's rank correlation coefficient = 0.48, p<.000001). Using logistic regression, the inclusion of BAC as a feature in CAD predication significantly increased classification results (p=0.04).	[Mostafavi, Leila; Arellano, Cesar; Tognolini, Alessia; Adibi, Ali; Ruehm, Stefan G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Marfori, Wanda] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Speier, William] Univ Calif Irvine, Dept Radiol Sci, Med Imaging Informat, Irvine, CA 92717 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine	Mostafavi, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA.	Lmostafavi@mednet.ucla.edu	Speier, William/H-9974-2019; Mostafavi, Leila/AAA-3236-2022	Speier, William/0000-0002-0890-8684; Mostafavi, Leila/0000-0002-8383-3678				Adkins JR, 2007, AM SURGEON, V73, P717; BAUM JK, 1980, RADIOLOGY, V136, P61, DOI 10.1148/radiology.136.1.7384525; Braun TM, 2008, BIOSTATISTICS, V9, P364, DOI 10.1093/biostatistics/kxm036; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Cetin M, 2004, CLIN RADIOL, V59, P92, DOI 10.1016/j.crad.2003.09.007; Cox J, 2002, J MED SCREEN, V9, P38, DOI 10.1136/jms.9.1.38; Crystal P, 2000, AM J CARDIOL, V86, P216, DOI 10.1016/S0002-9149(00)00860-2; Crystal P, 2004, J WOMENS HEALTH, V13, P390, DOI 10.1089/154099904323087079; Dale PS, 2008, J SURG RES, V148, P1, DOI 10.1016/j.jss.2007.08.022; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; Ferreira EMPF, 2007, ACAD RADIOL, V14, P144, DOI 10.1016/j.acra.2006.10.017; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hekimoglu B, 2012, JBR-BTR, V95, P229, DOI 10.5334/jbr-btr.626; Henkin Y, 2003, J MED SCREEN, V10, P139, DOI 10.1258/096914103769011049; Iribarren C, 2004, J WOMENS HEALTH, V13, P381, DOI 10.1089/154099904323087060; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Kataoka M, 2006, AM J ROENTGENOL, V187, P73, DOI 10.2214/AJR.05.0365; Kemmeren JM, 1996, RADIOLOGY, V201, P75, DOI 10.1148/radiology.201.1.8816524; Kemmeren JM, 1998, AM J EPIDEMIOL, V147, P333, DOI 10.1093/oxfordjournals.aje.a009455; Kim HJ, 1999, RADIOGRAPHICS, V19, P1401, DOI 10.1148/radiographics.19.5.g99se221401; Kohli P, 2010, CIRCULATION, V122, P2570, DOI 10.1161/CIRCULATIONAHA.109.914754; Lerman A, 2006, J AM COLL CARDIOL, V47, p59S, DOI 10.1016/j.jacc.2004.10.083; Maas AHEM, 2004, AM J CARDIOL, V94, P655, DOI 10.1016/j.amjcard.2004.05.036; Maas AHEM, 2007, EUR J RADIOL, V63, P396, DOI 10.1016/j.ejrad.2007.02.009; Maas AHEM, 2006, RADIOLOGY, V240, P33, DOI 10.1148/radiol.2401050170; Markopoulos C, 2004, ACTA RADIOL, V45, P726, DOI 10.1080/02841850410008261; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; MOSHYEDI AC, 1995, RADIOLOGY, V194, P181, DOI 10.1148/radiology.194.1.7997548; MURABITO JM, 1990, AM J MED, V89, P297, DOI 10.1016/0002-9343(90)90341-A; NIELSEN BB, 1985, ACTA PATH MICRO IM A, V93, P13; Pecchi Annarita, 2003, Radiol Med, V106, P305; Quyyumi AA, 2006, J AM COLL CARDIOL, V47, p66S, DOI 10.1016/j.jacc.2004.11.075; Rafeh NA, 2012, J WOMENS HEALTH, V21, P1053, DOI 10.1089/jwh.2011.3388; Rotter MA, 2008, MENOPAUSE, V15, P276, DOI 10.1097/gme.0b013e3181405d0a; Sarrafzadegann N, 2009, East Mediterr Health J, V15, P1474; Shah N, 2014, CARDIOL REV, V22, P69, DOI 10.1097/CRD.0b013e318295e029; Topal U, 2007, EUR J RADIOL, V63, P391, DOI 10.1016/j.ejrad.2007.01.035; vanNoord PAH, 1996, EUR J CANCER PREV, V5, P483; Zgheib MH, 2010, RADIOLOGY, V254, P367, DOI 10.1148/radiol.09090102	39	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122289	10.1371/journal.pone.0122289	http://dx.doi.org/10.1371/journal.pone.0122289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856075	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500035
J	Zhao, MX; Geekiyanage, N; Xu, JC; Khin, MM; Nurdiana, DR; Paudel, E; Harrison, RD				Zhao, Mingxu; Geekiyanage, Nalaka; Xu, Jianchu; Khin, Myo Myo; Nurdiana, Dian Ridwan; Paudel, Ekananda; Harrison, Rhett Daniel			Structure of the Epiphyte Community in a Tropical Montane Forest in SW China	PLOS ONE			English	Article							VASCULAR EPIPHYTES; DIVERSITY PATTERNS; LOWLAND; NESTEDNESS; ECOLOGY; CANOPY; RICHNESS; GRADIENT; VERACRUZ	Vascular epiphytes are an understudied and particularly important component of tropical forest ecosystems. However, owing to the difficulties of access, little is known about the properties of epiphyte-host tree communities and the factors structuring them, especially in Asia. We investigated factors structuring the vascular epiphyte-host community and its network properties in a tropical montane forest in Xishuangbanna, SW China. Vascular epiphytes were surveyed in six plots located in mature forests. Six host and four micro-site environmental factors were investigated. Epiphyte diversity was strongly correlated with host size (DBH, diameter at breast height), while within hosts the highest epiphyte diversity was in the middle canopy and epiphyte diversity was significantly higher in sites with canopy soil or a moss mat than on bare bark. DBH, elevation and stem height explained 22% of the total variation in the epiphyte species assemblage among hosts, and DBH was the most important factor which alone explained 6% of the variation. Within hosts, 51% of the variation in epiphyte assemblage composition was explained by canopy position and substrate, and the most important single factor was substrate which accounted for 16% of the variation. Analysis of network properties indicated that the epiphyte host community was highly nested, with a low level of epiphyte specialization, and an almost even interaction strength between epiphytes and host trees. Together, these results indicate that large trees harbor a substantial proportion of the epiphyte community in this forest.	[Zhao, Mingxu; Xu, Jianchu; Paudel, Ekananda; Harrison, Rhett Daniel] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Zhao, Mingxu; Paudel, Ekananda] Univ Chinese Acad Sci, Beijing, Peoples R China; [Geekiyanage, Nalaka] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Lab Trop Forest Resources & Environm, Kitashirakawa Oiwake, Kyoto, Japan; [Geekiyanage, Nalaka] Rajarata Univ Sri Lanka, Fac Agr, Dept Plant Sci, Anuradhapura, Sri Lanka; [Zhao, Mingxu; Xu, Jianchu; Paudel, Ekananda; Harrison, Rhett Daniel] World Agroforestry Ctr, East Asia Off, Kunming, Yunnan, Peoples R China; [Khin, Myo Myo] Wildlife Conservat Soc, Yangon, Myanmar; [Nurdiana, Dian Ridwan] Indonesian Inst Sci, Cibodas Bot Garden, Cianjur, West Java, Indonesia	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kyoto University; Rajarata University of Sri Lanka; Indonesian Institute of Sciences	Harrison, RD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	r.harrison@cgiar.org	Xu, Jianchu/Y-2890-2019; Geekiyanage, Nalaka/AAB-6171-2021	Geekiyanage, Nalaka/0000-0002-7400-3453; Harrison, Rhett/0000-0001-9055-3546	GTZ/BMZ [08.7860.3-001.00]; GIZ [13.1432.7-001.00]; Centre for Mountain Ecosystem Studies; Advanced Fieldcourse in Ecology and Conservation-Xishuangbanna Tropical Botanic Garden	GTZ/BMZ; GIZ; Centre for Mountain Ecosystem Studies; Advanced Fieldcourse in Ecology and Conservation-Xishuangbanna Tropical Botanic Garden	This research was supported in part by the following grants; GTZ/BMZ (Project No. 08.7860.3-001.00) and GIZ (Project No. 13.1432.7-001.00) both to Jianchu Xu. Funding for Mingxu Zhao and Myo Myo Khin was provided by the Centre for Mountain Ecosystem Studies. Other authors were funded by Advanced Fieldcourse in Ecology and Conservation-Xishuangbanna Tropical Botanic Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1981, OIKOS, V37, P199, DOI 10.2307/3544465; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Beckett Stephen J, 2014, F1000Res, V3, P185, DOI 10.12688/f1000research.4831.1; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brualdi RA, 1999, OECOLOGIA, V119, P256, DOI 10.1007/s004420050784; Burns KC, 2007, J ECOL, V95, P1142, DOI 10.1111/j.1365-2745.2007.01267.x; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Burns KC, 2008, BOTANY, V86, P1252, DOI 10.1139/B08-084; Cardelus CL, 2009, PLANT SOIL, V318, P47, DOI 10.1007/s11104-008-9816-9; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; CORNELISSEN JHC, 1989, J TROP ECOL, V5, P131, DOI 10.1017/S0266467400003400; Dhanmanonda P., 1996, THAI J FOR, V15, P81; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Flores-Palacios A, 2006, J BIOGEOGR, V33, P323, DOI 10.1111/j.1365-2699.2005.01382.x; Freiberg M, 1996, BIOTROPICA, V28, P345, DOI 10.2307/2389198; Freiberg M, 2000, J TROP ECOL, V16, P673, DOI 10.1017/S0266467400001644; Freiberg Martin, 1997, Selbyana, V18, P77; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Harrison RD, 2003, BIOL J LINN SOC, V78, P439, DOI 10.1046/j.0024-4066.2002.00205.x; HIETZ P, 1995, J VEG SCI, V6, P487, DOI 10.2307/3236347; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Koster N, 2011, BIOTROPICA, V43, P685, DOI 10.1111/j.1744-7429.2011.00759.x; Kreft H, 2004, J BIOGEOGR, V31, P1463, DOI 10.1111/j.1365-2699.2004.01083.x; Kromer T, 2007, PLANT ECOL, V189, P261, DOI 10.1007/s11258-006-9182-8; Kromer T, 2005, J BIOGEOGR, V32, P1799, DOI 10.1111/j.1365-2699.2005.01318.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuper W, 2004, J BIOGEOGR, V31, P1477, DOI 10.1111/j.1365-2699.2004.01093.x; Laube S, 2006, ANN BOT-LONDON, V97, P1103, DOI 10.1093/aob/mcl067; Mehltreter K, 2005, J TROP ECOL, V21, P651, DOI 10.1017/S0266467405002683; Nadkarni NM, 2002, PEDOBIOLOGIA, V46, P24, DOI 10.1078/0031-4056-00110; Normann F, 2010, ECOL INDIC, V10, P1111, DOI 10.1016/j.ecolind.2010.03.008; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Rosell JA, 2014, NEW PHYTOL, V201, P486, DOI 10.1111/nph.12541; SANFORD WW, 1968, J ECOL, V56, P697, DOI 10.2307/2258101; Sayago R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2821; Shaw D.C., 2004, FOREST CANOPIES, P73, DOI DOI 10.1016/B978-012457553-0/50008-3; Sillett SC, 2004, FOREST CANOPIES, P151, DOI [DOI 10.1016/B978-012457553-0/50013-7, 10.1016/B978-012457553-0/50013-7]; Haristoy CT, 2014, SOIL SCI SOC AM J, V78, pS118, DOI 10.2136/sssaj2013.07.0300nafsc; TERSTEEGE H, 1989, BIOTROPICA, V21, P331, DOI 10.2307/2388283; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Wang H, 2001, GUIHAIA, V21, P303; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wu Z, 2014, FLORA CHINA, V1-25; Xu JC, 2009, ECOL SOC, V14; Yang J., 2008, THESIS CHINESE ACAD; Zhang LW, 2010, BIOTROPICA, V42, P464, DOI 10.1111/j.1744-7429.2009.00607.x; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067; Zotz G, 2008, PLANT ECOL, V195, P131, DOI 10.1007/s11258-007-9310-0; Zotz G, 2013, BOT J LINN SOC, V171, P453, DOI 10.1111/boj.12010	59	33	37	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122210	10.1371/journal.pone.0122210	http://dx.doi.org/10.1371/journal.pone.0122210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856457	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500033
J	Kim, YJ; Kim, JH; Lee, KJ; Choi, MM; Kim, YH; Rhie, GE; Yoo, CK; Cha, K; Shin, NR				Kim, Yun Jeong; Kim, Jeong-Hee; Lee, Kwang-Jun; Choi, Myung-Min; Kim, Yeon Hee; Rhie, Gi-eun; Yoo, Cheon-Kwon; Cha, Kiweon; Shin, Na-Ri			Botulinum Neurotoxin Type A Induces TLR2-Mediated Inflammatory Responses in Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TUMOR-NECROSIS-FACTOR; CELL-WALL COMPONENTS; INNATE IMMUNITY; NEGATIVE REGULATOR; HUMAN-MONOCYTES; HOST-DEFENSE; IFN-GAMMA; TOXIN; LIPOPOLYSACCHARIDE	Botulinum neurotoxin type A (BoNT/A) is the most potent protein toxin and causes fatal flaccid muscle paralysis by blocking neurotransmission. Application of BoNT/A has been extended to the fields of therapeutics and biodefense. Nevertheless, the global response of host immune cells to authentic BoNT/A has not been reported. Employing microarray analysis, we performed global transcriptional profiling of RAW264.7 cells, a murine alveolar macrophage cell line. We identified 70 genes that were modulated following 1 nM BoNT/A treatment. The altered genes were mainly involved in signal transduction, immunity and defense, protein metabolism and modification, neuronal activities, intracellular protein trafficking, and muscle contraction. Microarray data were validated with real-time RT-PCR for seven selected genes including tlr2, tnf, inos, ccl4, slpi, stx11, and irg1. Proinflammatory mediators such as nitric oxide (NO) and tumor necrosis factor alpha (TNF alpha) were induced in a dose-dependent manner in BoNT/A-stimulated RAW264.7 cells. Increased expression of these factors was inhibited by monoclonal anti-Toll-like receptor 2 (TLR2) and inhibitors specific to intracellular proteins such as c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK). BoNT/A also suppressed lipopolysaccharide-induced NO and TNFa production from RAW264.7 macrophages at the transcription level by blocking activation of JNK, ERK, and p38 MAPK. As confirmed by TLR2-/- knock out experiments, these results suggest that BoNT/A induces global gene expression changes in host immune cells and that host responses to BoNT/A proceed through a TLR2-dependent pathway, which is modulated by JNK, ERK, and p38 MAPK.	[Kim, Yun Jeong; Kim, Jeong-Hee; Lee, Kwang-Jun; Choi, Myung-Min; Kim, Yeon Hee; Rhie, Gi-eun; Yoo, Cheon-Kwon; Cha, Kiweon; Shin, Na-Ri] Korea Ctr Dis Control & Prevent, Ctr Infect Dis, Korea Natl Inst Hlth, Div High Risk Pathogen Res, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Cha, K (corresponding author), Korea Ctr Dis Control & Prevent, Ctr Infect Dis, Korea Natl Inst Hlth, Div High Risk Pathogen Res, Cheongju, South Korea.	kiweoncha@naver.com; shinnari1@hanmail.net			Korea National Institute of Health grant [4840-300-210-13]	Korea National Institute of Health grant	These studies were supported by Korea National Institute of Health grant 4840-300-210-13. The funder had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Adekar SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017491; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; Cheng H, 2011, J BIOL CHEM, V286, P18013, DOI 10.1074/jbc.M111.221028; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; DasGupa BR, 1989, BOTULINUM NEUROTOXIN, P53; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; IMAMURA K, 1989, MOL CELL BIOL, V9, P2239, DOI 10.1128/MCB.9.5.2239; Jang J, 2011, INFECT IMMUN, V79, P3846, DOI 10.1128/IAI.01145-10; Jankovic J, 2009, TOXICON, V54, P614, DOI 10.1016/j.toxicon.2008.11.013; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Katz HR, 2007, IMMUNOL REV, V217, P222, DOI 10.1111/j.1600-065X.2007.00522.x; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lee JC, 2005, MICROBIOL-SGM, V151, P3739, DOI 10.1099/mic.0.28421-0; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Liang S, 2009, VACCINE, V27, P4302, DOI 10.1016/j.vaccine.2009.05.027; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Malizio CJ, 2000, METH MOL B, V145, P27; McKiernan PJ, 2011, BIOCHEM SOC T, V39, P1421, DOI 10.1042/BST0391421; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moon SK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-12; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riekenberg S, 2009, FEBS J, V276, P649, DOI 10.1111/j.1742-4658.2008.06813.x; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Tacket CO MA Rogawski Academic Press Inc., 1989, BOTULINUM NEUROTOXIN, P351; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taysse L, 2005, TOXICOL PATHOL, V33, P336, DOI 10.1080/01926230590922884; Triantafilou M, 2007, CELL MICROBIOL, V9, P2880, DOI 10.1111/j.1462-5822.2007.01003.x; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vroling AB, 2011, MOL IMMUNOL, V48, P630, DOI 10.1016/j.molimm.2010.11.002; White GE, 2011, J MOL HISTOL, V42, P137, DOI 10.1007/s10735-011-9317-7; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13	52	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120840	10.1371/journal.pone.0120840	http://dx.doi.org/10.1371/journal.pone.0120840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853816	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400019
J	Oudejans, MG; Visser, F; Englund, A; Rogan, E; Ingram, SN				Oudejans, Machiel G.; Visser, Fleur; Englund, Anneli; Rogan, Emer; Ingram, Simon N.			Evidence for Distinct Coastal and Offshore Communities of Bottlenose Dolphins in the North East Atlantic	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; POPULATION-STRUCTURE; GENETIC DIFFERENTIATION; BAY; ECOLOGY; SIZE; CONSERVATION; MOVEMENTS; SARASOTA; BYCATCH	Bottlenose dolphin stock structure in the northeast Atlantic remains poorly understood. However, fine scale photo-id data have shown that populations can comprise multiple overlapping social communities. These social communities form structural elements of bottlenose dolphin (Tursiops truncates) populations, reflecting specific ecological and behavioural adaptations to local habitats. We investigated the social structure of bottlenose dolphins in the waters of northwest Ireland and present evidence for distinct inshore and offshore social communities. Individuals of the inshore community had a coastal distribution restricted to waters within 3 km from shore. These animals exhibited a cohesive, fission-fusion social organisation, with repeated resightings within the research area, within a larger coastal home range. The offshore community comprised one or more distinct groups, found significantly further offshore (>4 km) than the inshore animals. In addition, dorsal fin scarring patterns differed significantly between inshore and offshore communities with individuals of the offshore community having more distinctly marked dorsal fins. Specifically, almost half of the individuals in the offshore community (48%) had characteristic stereotyped damage to the tip of the dorsal fin, rarely recorded in the inshore community (7%). We propose that this characteristic is likely due to interactions with pelagic fisheries. Social segregation and scarring differences found here indicate that the distinct communities are likely to be spatially and behaviourally segregated. Together with recent genetic evidence of distinct offshore and coastal population structures, this provides evidence for bottlenose dolphin inshore/offshore community differentiation in the northeast Atlantic. We recommend that social communities should be considered as fundamental units for the management and conservation of bottlenose dolphins and their habitat specialisations.	[Oudejans, Machiel G.] Dulra Res, Heiloo, Netherlands; [Oudejans, Machiel G.; Visser, Fleur] Kelp Marine Res, Hoorn, Netherlands; [Visser, Fleur] Leiden Univ, Behav Biol Grp, Leiden, Netherlands; [Englund, Anneli; Rogan, Emer; Ingram, Simon N.] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Ingram, Simon N.] Univ Plymouth, Sch Marine Sci & Engn, Marine Vertebrate Res Grp, Plymouth PL4 8AA, Devon, England	Leiden University; Leiden University - Excl LUMC; University College Cork; University of Plymouth	Oudejans, MG (corresponding author), Dulra Res, Heiloo, Netherlands.	machiel.oudejans@gmail.com		Visser, Fleur/0000-0003-1024-3244	Science Foundation Ireland; National Parks and Wildlife Service; Heritage Council; Fiontar Bellacorick Fund; Dulra Research; Kelp Marine Research	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Parks and Wildlife Service; Heritage Council; Fiontar Bellacorick Fund; Dulra Research; Kelp Marine Research	Data collection was funded from a number of different sources and the authors are grateful to Science Foundation Ireland, The National Parks and Wildlife Service, The Heritage Council and the Fiontar Bellacorick Fund for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dulra Research and Kelp Marine Research provided support in the form of salaries for authors MGO and FV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen SJ, 2010, FINAL REPORT FISHERI; Alves F, 2013, AQUAT CONSERV, V23, P758, DOI 10.1002/aqc.2332; Anderwald P, 2012, J MAR BIOL ASSOC UK, V92, P1757, DOI 10.1017/S0025315412001397; [Anonymous], 2009, ATLAS COMMERCIAL FIS; [Anonymous], 1983, SIERRA CLUB HDB WHAL; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Baird RW, 2015, MAR MAMMAL SCI, V31, P579, DOI 10.1111/mms.12177; Baird RW, 2005, PAC SCI, V59, P593, DOI 10.1353/psc.2005.0042; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Bearzi Maddalena, 2005, Journal of Cetacean Research and Management, V7, P75; Bearzi M, 2009, MAR FRESHWATER RES, V60, P584, DOI 10.1071/MF08279; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Caldwell M., 2001, THESIS U MIAMI MIAMI THESIS U MIAMI MIAMI; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; CHU K, 1988, CAN J ZOOL, V66, P416, DOI 10.1139/z88-059; CODA, 2008, CET OFFSH DISTR AB E; Connor RC, 2000, CETACEAN SOCIETIES, P91; Corkeron PJ, 1987, AQUAT MAMM, V13, P11; Couperus A.S., 1997, Journal of Northwest Atlantic Fishery Science, V22, P209; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Defran RH, 1999, MAR MAMMAL SCI, V15, P366, DOI 10.1111/j.1748-7692.1999.tb00807.x; Defran RH, 1999, MAR MAMMAL SCI, V15, P381, DOI 10.1111/j.1748-7692.1999.tb00808.x; Heithaus MR, 2001, MAR MAMMAL SCI, V17, P526, DOI 10.1111/j.1748-7692.2001.tb01002.x; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, P ROY SOC B-BIOL SCI, V265, P1177, DOI 10.1098/rspb.1998.0416; Ingram S. N., 2000, THESIS U COLL CORK; Ingram SN, 2002, MAR ECOL PROG SER, V244, P247, DOI 10.3354/meps244247; IRVINE AB, 1981, FISH B-NOAA, V79, P671; Jaiteh VF, 2013, MAR MAMMAL SCI, V29, pE266, DOI 10.1111/j.1748-7692.2012.00620.x; Kenney R.D., 1990, P369; Louis M, 2014, MOL ECOL, V23, P857, DOI 10.1111/mec.12653; Luksenburg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088988; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Mirimin L, 2011, ANIM CONSERV, V14, P342, DOI 10.1111/j.1469-1795.2010.00432.x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; O'Brien Joanne M., 2010, Journal of Cetacean Research and Management, V11, P69; Oudejans Machiel G., 2010, Irish Naturalists' Journal, V31, P46; Perrin WF, 2011, MAR MAMMAL SCI, V27, P769, DOI 10.1111/j.1748-7692.2010.00442.x; Querouil S, 2007, CONSERV GENET, V8, P1405, DOI 10.1007/s10592-007-9291-5; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Robinson Kevin P., 2012, Journal of Cetacean Research and Management, V12, P365; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Scott M.D., 1990, P235; Silva MA, 2008, MAR BIOL, V156, P179, DOI 10.1007/s00227-008-1075-z; Tezanos-Pinto G, 2009, J HERED, V100, P11, DOI 10.1093/jhered/esn039; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Torres LG, 2003, MAR MAMMAL SCI, V19, P502, DOI 10.1111/j.1748-7692.2003.tb01317.x; Urian KW, 2009, MAR MAMMAL SCI, V25, P619, DOI 10.1111/j.1748-7692.2009.00284.x; Wells R, 1987, CURRENT MAMMOLOGY; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Wells RS, 1997, MAR MAMMAL SCI, V13, P475, DOI 10.1111/j.1748-7692.1997.tb00654.x; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; Wiszniewski J, 2009, ANIM BEHAV, V77, P1449, DOI 10.1016/j.anbehav.2009.02.025; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	64	13	14	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122668	10.1371/journal.pone.0122668	http://dx.doi.org/10.1371/journal.pone.0122668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853823	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400074
J	Papale, E; Gamba, M; Perez-Gil, M; Martin, VM; Giacoma, C				Papale, Elena; Gamba, Marco; Perez-Gil, Monica; Martin, Vidal Martel; Giacoma, Cristina			Dolphins Adjust Species-Specific Frequency Parameters to Compensate for Increasing Background Noise	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; WHALES ORCINUS-ORCA; STENELLA-COERULEOALBA; ACOUSTIC PARAMETERS; SPOTTED DOLPHINS; VESSEL NOISE; WHISTLES; SIGNALS; IDENTIFICATION; COMMUNICATION	An increase in ocean noise levels could interfere with acoustic communication of marine mammals. In this study we explored the effects of anthropogenic and natural noise on the acoustic properties of a dolphin communication signal, the whistle. A towed array with four elements was used to record environmental background noise and whistles of short-beaked common-, Atlantic spotted-and striped-dolphins in the Canaries archipelago. Four frequency parameters were measured from each whistle, while Sound Pressure Levels (SPL) of the background noise were measured at the central frequencies of seven one-third octave bands, from 5 to 20 kHz. Results show that dolphins increase the whistles' frequency parameters with lower variability in the presence of anthropogenic noise, and increase the end frequency of their whistles when confronted with increasing natural noise. This study provides the first evidence that the synergy among SPLs has a role in shaping the whistles' structure of these three species, with respect to both natural and anthropogenic noise.	[Papale, Elena; Gamba, Marco; Giacoma, Cristina] Univ Turin, Life Sci & Syst Biol Dept, Turin, Italy; [Perez-Gil, Monica; Martin, Vidal Martel] Soc Study Cetaceans Canary Archipelago SECAC, Lanzarote, Spain	University of Turin	Papale, E (corresponding author), Univ Turin, Life Sci & Syst Biol Dept, Turin, Italy.	elena.papale@iamc.cnr.it	Gamba, Marco/I-1184-2012; Martin, Vidal/GLR-0396-2022	Gamba, Marco/0000-0001-9545-2242; GIACOMA, Cristina/0000-0002-8429-7723; papale, elena/0000-0002-5150-9240	EU LIFE programme, project LIFE INDEMARES [LIFE 07/NAT/E/000732]; Fundacion Biodiversidad under the Spanish Ministry of Environment, Rural and Marine Affairs (project ZEC-TURSIOPS)	EU LIFE programme, project LIFE INDEMARES; Fundacion Biodiversidad under the Spanish Ministry of Environment, Rural and Marine Affairs (project ZEC-TURSIOPS)	Data collection by SECAC was funded by the EU LIFE programme, project LIFE INDEMARES (LIFE 07/NAT/E/000732), and the Fundacion Biodiversidad under the Spanish Ministry of Environment, Rural and Marine Affairs (project ZEC-TURSIOPS).	Ansmann IC, 2007, J MAR BIOL ASSOC UK, V87, P19, DOI 10.1017/S0025315407054963; AU WWL, 1985, J ACOUST SOC AM, V77, P726, DOI 10.1121/1.392341; Azevedo AF, 2010, J ACOUST SOC AM, V127, P2646, DOI 10.1121/1.3308469; Azzolin M, 2014, J ACOUST SOC AM, V135, P502, DOI 10.1121/1.4845275; Azzolin M, 2013, J ACOUST SOC AM, V134, P694, DOI 10.1121/1.4808329; Baron SC, 2008, MAR MAMMAL SCI, V24, P42, DOI 10.1111/j.1748-7692.2007.00168.x; Bateson M., 2007, INT J COMP PSYCHOL, V20, P169; Boersma P., 2013, PRAAT DOING PHONETIC; Branstetter BK, 2013, J ACOUST SOC AM, V133, P1811, DOI 10.1121/1.4789939; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Ding Wang, 1995, P299; Dolman SJ, 2006, SC58E22 INT WHAL COM; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Gelfand S. A., 2004, HEARING INTRO PSYCHO; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; La Manna G, 2013, AQUAT CONSERV, V23, P745, DOI 10.1002/aqc.2355; Lammers MO, 2003, J ACOUST SOC AM, V114, P1629, DOI 10.1121/1.1596173; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Luis AR, 2014, MAR MAMMAL SCI, V30, P1417, DOI 10.1111/mms.12125; Maciej P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023015; May-Collado LJ, 2008, J MAMMAL, V89, P1229, DOI 10.1644/07-MAMM-A-310.1; Miksis-Olds JL, 2009, J ACOUST SOC AM, V125, P1806, DOI 10.1121/1.3068455; Morisaka T, 2005, FISHERIES SCI, V71, P568, DOI 10.1111/j.1444-2906.2005.01001.x; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Oswald JN, 2007, J ACOUST SOC AM, V122, P587, DOI 10.1121/1.2743157; Papale E, 2014, ETHOL ECOL EVOL, V26, P392, DOI 10.1080/03949370.2013.851122; Papale E, 2013, J ACOUST SOC AM, V133, P1126, DOI 10.1121/1.4774274; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Petrella V, 2009, THESIS; Rendell LE, 1999, J ZOOL, V249, P403, DOI 10.1017/S0952836999009875; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x; STEINER WW, 1981, BEHAV ECOL SOCIOBIOL, V9, P241, DOI 10.1007/BF00299878; Tyack Peter L., 1997, Bioacoustics, V8, P21	45	42	42	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121711	10.1371/journal.pone.0121711	http://dx.doi.org/10.1371/journal.pone.0121711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853825	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400046
J	Chen, JJ; Huang, NS; Xue, JY; Quan, CL; Tan, YL; Liu, GY; Shao, ZM; Wu, J				Chen, Jia-jian; Huang, Nai-si; Xue, Jing-yan; Quan, Chen-lian; Tan, Yu-long; Liu, Guang-yu; Shao, Zhi-min; Wu, Jiong			Surgical Management for Early-Stage Bilateral Breast Cancer Patients in China	PLOS ONE			English	Article							SENTINEL LYMPH-NODE; PARADIGM SHIFT; RECONSTRUCTION; MASTECTOMY	Background The aim of this study was to investigate the current surgical management strategy for bilateral breast cancer (BBC) patients and to assess the changes in this strategy in China. Methods This is a retrospective review of all patients with early-stage BBC who underwent surgical treatment at the Fudan University Shanghai Cancer Center between June 2007 and June 2014. Results A total of 15,337 patients with primary breast cancer were identified. Of these patients, 218 (1.5%) suffered from synchronous bilateral breast cancer (sBBC), and 296 (2.0%) suffered from metachronous bilateral breast cancer (mBBC). Patients with a lobular carcinoma component, those with estrogen receptor-positive cancer, and those with an accompanying sclerosing adenosis in the affected breast tended to develop BBC. The rates of bilateral mastectomy, breast conserving therapy, reconstruction, and combined surgeries were 86.2%, 6.4%, 3.7%, and 3.7%, respectively, for patients with sBBC and 81.1%, 4.4%, 3.0%, and 11.5%, respectively, for patients with mBBC. The interval between bilateral cancers, age at first diagnosis of breast cancer, histopathological type, and stage have significant impacts on the choice of surgery for patients with BBC. Conclusions Bilateral mastectomy was the dominant surgical management for patients with BBC in China, despite the increased application of breast reconstruction surgery observed in recent years. Bilateral prosthetic breast reconstruction was the ideal choice for patients with sBBC. Chinese surgeons should take responsibility for patient education and inform their patients about their surgical options.	[Chen, Jia-jian; Huang, Nai-si; Xue, Jing-yan; Liu, Guang-yu; Shao, Zhi-min; Wu, Jiong] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Chen, Jia-jian; Huang, Nai-si; Xue, Jing-yan; Quan, Chen-lian; Tan, Yu-long; Liu, Guang-yu; Shao, Zhi-min; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	wujiong1122@vip.sina.com		CHEN, Jiajian/0000-0001-9202-404X	Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau [20124Y067]; National Natural Science Foundation of China [81302297]	Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants from the Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau (No.20124Y067), and the National Natural Science Foundation of China (No.81302297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2013, EJSO-EUR J SURG ONC, V39, P320, DOI 10.1016/j.ejso.2012.12.015; Albornoz CR, 2013, PLAST RECONSTR SURG, V131, P15, DOI 10.1097/PRS.0b013e3182729cde; Black DM, 2013, GLAND SURG, V2, P120, DOI 10.3978/j.issn.2227-684X.2013.06.01; Cemal Y, 2013, PLAST RECONSTR SURG, V131, p320E, DOI 10.1097/PRS.0b013e31827cf576; Chen JJ, 2009, EJSO-EUR J SURG ONC, V35, P921, DOI 10.1016/j.ejso.2009.01.009; Chen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095185; Chen JJ, 2011, CRIT REV ONCOL HEMAT, V79, P293, DOI 10.1016/j.critrevonc.2010.06.008; Cotlar Alvin M, 2003, Curr Surg, V60, P329, DOI 10.1016/S0149-7944(02)00777-8; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Jagsi R, 2014, J CLIN ONCOL, V32, P919, DOI 10.1200/JCO.2013.52.2284; Kayar R, 2011, BREAST CANCER-BASIC, V5, P43, DOI 10.4137/BCBCR.S6128; Li J, 2008, J COMMUN NETW-S KOR, V10, P10, DOI 10.1109/JCN.2008.6388323; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Qiao Q, 1997, AESTHET PLAST SURG, V21, P362, DOI 10.1007/s002669900139; Roostaeian J, 2011, CURR OPIN OBSTET GYN, V23, P44, DOI 10.1097/GCO.0b013e328340e18a; Schubart JR, 2014, ANN SURG ONCOLOGY; Sinno S, 2014, PLASTIC SURGICAL NUR, V34, P6; Sinno Sammy, 2014, Plast Surg Nurs, V34, P141, DOI 10.1097/PSN.0000000000000048; Tan BK, 2014, ARCH PLAST SURG-APS, V41, P366, DOI 10.5999/aps.2014.41.4.366; Zhang L, 2012, PSYCHO-ONCOLOGY, V21, P488, DOI 10.1002/pon.1922; Zhong T, 2014, J CLIN ONCOL, V32, P2133, DOI 10.1200/JCO.2013.53.0774	22	9	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122692	10.1371/journal.pone.0122692	http://dx.doi.org/10.1371/journal.pone.0122692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874699	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100095
J	Chou, ML; Bailey, A; Avory, T; Tanimoto, J; Burnouf, T				Chou, Ming Li; Bailey, Andy; Avory, Tiffany; Tanimoto, Junji; Burnouf, Thierry			Removal of Transmissible Spongiform Encephalopathy Prion from Large Volumes of Cell Culture Media Supplemented with Fetal Bovine Serum by Using Hollow Fiber Anion-Exchange Membrane Chromatography	PLOS ONE			English	Article							BLOOD COMPONENTS; PLASMA; AGENT; INFECTIVITY; PROTEIN; MANUFACTURE	Cases of variant Creutzfeldt-Jakob disease in people who had consumed contaminated meat products from cattle with bovine spongiform encephalopathy emphasize the need for measures aimed at preventing the transmission of the pathogenic prion protein (PrPSc) from materials derived from cattle. Highly stringent scrutiny is required for fetal bovine serum (FBS), a growth-medium supplement used in the production of parenteral vaccines and therapeutic recombinant proteins and in the ex vivo expansion of stem cells for transplantation. One such approach is the implementation of manufacturing steps dedicated to removing PrPSc from materials containing FBS. We evaluated the use of the QyuSpeed D (QSD) adsorbent hollow-fiber anion-exchange chromatographic column (Asahi Kasei Medical, Tokyo, Japan) for the removal of PrPSc from cell culture media supplemented with FBS. We first established that QSD filtration had no adverse effect on the chemical composition of various types of culture media supplemented with 10% FBS or the growth and viability characteristics of human embryonic kidney (HEK293) cells, baby hamster kidney (BHK-21) cells, African green monkey kidney (Vero) cells, and Chinese hamster ovary (CHO-k1) cells propagated in the various culture-medium filtrates. We used a 0.6-mL QSD column for removing PrPSc from up to 1000 mL of Dulbecco's modified Eagle's medium containing 10% FBS previously spiked with the 263K strain of hamster-adapted scrapie. The Western blot analysis, validated alongside an infectivity assay, revealed that the level of PrPSc in the initial 200mL flow-through was reduced by 2.5 to > 3 log(10), compared with that of the starting material. These results indicate that QSD filtration removes PrPSc from cell culture media containing 10% FBS, and demonstrate the ease with which QSD filtration can be implemented in at industrial-scale to improve the safety of vaccines, therapeutic recombinant proteins, and ex vivo expanded stem cells produced using growth media supplemented with FBS.	[Chou, Ming Li] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Bailey, Andy; Avory, Tiffany] ViruSure, A-1220 Vienna, Austria; [Tanimoto, Junji] Asahi Kasei Med Co Ltd, Tokyo, Japan; [Burnouf, Thierry] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan	Taipei Medical University; Taipei Medical University	Burnouf, T (corresponding author), Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243	Asahi Kasei Medical Co., Ltd., Bioprocess division (Tokyo, Japan) through Taipei Medical University; ViruSure; Asahi Kasei Medical	Asahi Kasei Medical Co., Ltd., Bioprocess division (Tokyo, Japan) through Taipei Medical University; ViruSure; Asahi Kasei Medical	This study was funded by Asahi Kasei Medical Co., Ltd., Bioprocess division (Tokyo, Japan) through a research contract agreement with Taipei Medical University. Asahi Kasei Medical provided support in the form of salaries for author JT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the author contributions section. ViruSure provided support in the form of salaries for authors AB and TA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Agency EM, 1996, CPMPBWP26895 AG EM; Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; [Anonymous], 2011, OFFICIAL J EUROPEAN; [Anonymous], 2010, TAS33059 LTD AKMC; [Anonymous], 1998, OECD SERIES PRINCIPL, P17; Avgoustiniatos ES, 2012, CELL TRANSPLANT, V21, P2805, DOI 10.3727/096368912X653138; Bailey AC, 1999, IDRUGS INVESTIGATION; Brockbank KGM, 2011, CELLS TISSUES ORGANS, V193, P264, DOI 10.1159/000321166; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Burnouf T, 2006, TRANSFUS CLIN BIOL, V13, P320, DOI 10.1016/j.tracli.2006.11.001; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094020; CPMP, 2003, CPMPBWP513603; Foster PR, 2004, VOX SANG, V86, P92, DOI 10.1111/j.0042-9007.2004.00403.x; Foster PR, 2000, VOX SANG, V78, P86, DOI 10.1159/000031156; Foster PR, 1999, TRANSFUSION MED, V9, P3; Gstraunthaler G, 2013, CYTOTECHNOLOGY, V65, P791, DOI 10.1007/s10616-013-9633-8; Jochems CEA, 2002, ATLA-ALTERN LAB ANIM, V30, P219, DOI 10.1177/026119290203000208; Lee DC, 2001, TRANSFUSION, V41, P449, DOI 10.1046/j.1537-2995.2001.41040449.x; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; MILLSON GC, 1971, J COMP PATHOL, V81, P255, DOI 10.1016/0021-9975(71)90100-9; Neisser-Svae A, 2009, VOX SANG, V97, P226, DOI 10.1111/j.1423-0410.2009.01206.x; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Reichl HE, 2002, VOX SANG, V83, P137, DOI 10.1046/j.1423-0410.2002.00211.x; Robinson MM, 1996, DEV BIOL STAND, V88, P237; Shih DT, 2014, N BIOTECHNOL; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Van Holten RW, 2003, VOX SANG, V85, P20, DOI 10.1046/j.1423-0410.2003.00312.x; Vey M, 2002, BIOLOGICALS, V30, P187, DOI 10.1006/biol.2002.0327; WHO, 2006, WHO GUID TISS INF DI	32	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122300	10.1371/journal.pone.0122300	http://dx.doi.org/10.1371/journal.pone.0122300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874629	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100060
J	Jiang, JY; Wen, W; Brown, DA; Crawford, J; Thalamuthu, A; Smith, E; Breit, SN; Liu, T; Zhu, WL; Brodaty, H; Baune, BT; Trollor, JN; Sachdev, PS				Jiang, Jiyang; Wen, Wei; Brown, David A.; Crawford, John; Thalamuthu, Anbupalam; Smith, Evelyn; Breit, Samuel N.; Liu, Tao; Zhu, Wanlin; Brodaty, Henry; Baune, Bernhard T.; Trollor, Julian N.; Sachdev, Perminder S.			The Relationship of Serum Macrophage Inhibitory Cytokine-1 Levels with Gray Matter Volumes in Community-Dwelling Older Individuals	PLOS ONE			English	Article							ACTIVATED GENE NAG-1; INFLAMMATORY RESPONSE; BRAIN ATROPHY; EXPRESSION; MIC-1/GDF15; MIC-1; INTERLEUKIN-6; HIPPOCAMPAL; NEURONS; MEMORY	Using circulating inflammatory markers and magnetic resonance imaging (MRI), recent studies have associated inflammation with brain volumetric measures. Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) is a divergent transforming growth factor - beta (TGF-beta) superfamily cytokine. To uncover the underlying mechanisms of the previous finding of a negative association between MIC-1/GDF15 serum levels and cognition, the present study aimed to examine the relationship of circulating MIC-1/GDF15 levels with human brain gray matter (GM) volumes, in a community-dwelling sample aged 70-90 years over two years (Wave 1: n = 506, Wave 2: n = 327), of which the age-related brain atrophy had been previously well defined. T1-weighted MRI scans were obtained at both waves and analyzed using the FMRIB Software Library and FreeSurfer. The results showed significantly negative associations between MIC-1/GDF15 serum levels and both subcortical and cortical GM volumes. GM volumes of the whole brain, cortex, temporal lobe, thalamus and accumbens showed significant mediating effects on the associations between MIC-1/GDF15 serum levels and global cognition scores. Increases in MIC-1/GDF15 serum levels were associated with decreases in cortical and subcortical GM volume over two years. In conclusion, MIC-1/GDF15 serum levels were inversely associated with GM volumes both cross-sectionally and longitudinally.	[Jiang, Jiyang; Wen, Wei; Crawford, John; Thalamuthu, Anbupalam; Smith, Evelyn; Brodaty, Henry; Trollor, Julian N.; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, CHeBA, Randwick, NSW, Australia; [Wen, Wei; Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW 2031, Australia; [Brown, David A.; Breit, Samuel N.] St Vincents Hosp, Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia; [Brown, David A.; Breit, Samuel N.] Univ New S Wales, Darlinghurst, NSW, Australia; [Liu, Tao] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China; [Zhu, Wanlin] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Brodaty, Henry] Prince Wales Hosp, Aged Care Psychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Baune, Bernhard T.] Univ Adelaide, Sch Med, Discipline Psychiat, Adelaide, SA, Australia; [Trollor, Julian N.] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Beihang University; Beijing Normal University; University of New South Wales Sydney; University of Adelaide; University of New South Wales Sydney	Wen, W (corresponding author), Univ New S Wales, Sch Psychiat, CHeBA, Randwick, NSW, Australia.	w.wen@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Jiang, Jiyang/AAD-6296-2019; Thalamuthu, Anbupalam/Z-5545-2019	Sachdev, Perminder/0000-0002-9595-3220; Jiang, Jiyang/0000-0002-2147-6302; Thalamuthu, Anbupalam/0000-0002-7114-1260; Liu, Tao/0000-0002-7783-3073; Wen, Wei/0000-0003-2753-3870; Brown, David/0000-0003-1382-9419; Trollor, Julian/0000-0002-7685-2977; Smith, Evelyn/0000-0002-9142-986X	National Health and Medical Research Council (NHMRC) [350833, 510175, 510124]; Australian Research Council [DP0774213, DP0773584, LP0669645]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This research was supported by the National Health and Medical Research Council (NHMRC, https://www.nhmrc.gov.au/, NHMRC Program Grant ID 350833, NHMRC Project Grant ID 510175 and NHMRC Project Grant ID 510124), and the Australian Research Council (http://www.arc.gov.au/, DP0774213, DP0773584 and LP0669645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2012, ONCOGENE, V31, P4139, DOI 10.1038/onc.2011.572; [Anonymous], 1981, WAIS R MANUAL; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baune BT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-125; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P23, DOI 10.1177/0891988708328216; Benton AL, 1996, DER BENTON TEST; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Brown DA, 2007, ARTHRITIS RHEUM, V56, P753, DOI 10.1002/art.22410; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Di Napoli M, 2001, THROMB RES, V103, P261, DOI 10.1016/S0049-3848(01)00290-0; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Ferrari N, 2005, CLIN CANCER RES, V11, P4610, DOI 10.1158/1078-0432.CCR-04-2210; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fuchs T, 2013, AGING CELL, V12, P882, DOI 10.1111/acel.12116; Hamdani N, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0387-y; Huh SJ, 2010, AM J PATHOL, V176, P2948, DOI 10.2353/ajpath.2010.090963; Jefferson AL, 2007, NEUROLOGY, V68, P1032, DOI 10.1212/01.wnl.0000257815.20548.df; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Johnen H, 2012, CARDIOVASC PATHOL, V21, P499, DOI 10.1016/j.carpath.2012.02.003; Kannan K, 2000, FEBS LETT, V470, P77, DOI 10.1016/S0014-5793(00)01291-6; Kaplan E., 2001, THE BOSTON NAMING TE; Kesler S, 2013, BRAIN BEHAV IMMUN, V30, pS109, DOI 10.1016/j.bbi.2012.05.017; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779; Lindahl B, 2013, CLIN CHEM, V59, P1550, DOI 10.1373/clinchem.2013.212811; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Muller N, 2012, ADV PROTEIN CHEM STR, V88, P49, DOI 10.1016/B978-0-12-398314-5.00003-9; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Strauss E, 2006, COMPENDIUM OF NEUROP; Strelau J, 2000, J NEUROSCI, V20, P8597; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Taki Y, 2013, HUM BRAIN MAPP, V34, P2418, DOI 10.1002/hbm.22073; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Willette AA, 2013, AGE, V35, P2215, DOI 10.1007/s11357-013-9518-y	62	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123399	10.1371/journal.pone.0123399	http://dx.doi.org/10.1371/journal.pone.0123399			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867953	gold, Green Published			2022-12-26	WOS:000352845100173
J	Lenoir-Wijnkoop, I; Gerlier, L; Bresson, JL; Le Pen, C; Berdeaux, G				Lenoir-Wijnkoop, Irene; Gerlier, Laetitia; Bresson, Jean-Louis; Le Pen, Claude; Berdeaux, Gilles			Public Health and Budget Impact of Probiotics on Common Respiratory Tract Infections: A Modelling Study	PLOS ONE			English	Article							FERMENTED DAIRY PRODUCT; INFLUENZA-LIKE ILLNESS; DOUBLE-BLIND; RISK; CHILDREN; COLDS; CARE; TRANSMISSION; CONSUMPTION; SYMPTOMS	Objectives Two recent meta-analyses by the York Health Economics Consortium (YHEC) and Cochrane demonstrated probiotic efficacy in reducing the duration and number of common respiratory tract infections (CRTI) and associated antibiotic prescriptions. A health-economic analysis was undertaken to estimate the public health and budget consequences of a generalized probiotic consumption in France. Methods A virtual age-and gender-standardized population was generated using a Markov microsimulation model. CRTI risk factors incorporated into this model were age, active/passive smoking and living in a community setting. Incidence rates and resource utilization were based on the 2011-2012 flu season and retrieved from the French GPs Sentinelles network. Results of both meta-analyses were independently applied to the French population to estimate CRTI events, assuming a generalized probiotic use compared to no probiotics during winter months: -0.77 days/CRTI episode (YHEC scenario) or odds-ratio 0.58 for >= 1 CRTI episode (Cochrane scenario) with vs. without probiotics. Economic perspectives were National Health System (NHS), society, family. Outcomes included cost savings related to the reduced numbers of CRTI episodes, days of illness, number of antibiotic courses, sick leave days, medical and indirect costs. Results For France, generalized probiotic use would save 2.4 million CRTI-days, 291,000 antibiotic courses and 581,000 sick leave days, based on YHEC data. Applying the Cochrane data, reductions were 6.6 million CRTI days, 473,000 antibiotic courses and 1.5 million sick days. From the NHS perspective, probiotics' economic impact was about (sic)14.6 million saved according to YHEC and (sic)37.7 million according to Cochrane. Higher savings were observed in children, active smokers and people with more frequent human contacts. Conclusions Public health and budget impact of probiotics are substantial, whether they reduce CRTI episodes frequency or duration. Noteworthy, the 2011-12 winter CRTI incidence was low and this analysis focused on the fraction of CRTI patients consulting a practitioner.	[Lenoir-Wijnkoop, Irene] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands; [Lenoir-Wijnkoop, Irene] Danone Co, Publ Hlth & Sci Relat, Paris, France; [Gerlier, Laetitia; Berdeaux, Gilles] IMS RWES HEOR, Vilvoorde, Belgium; [Bresson, Jean-Louis] Univ Descartes, Hop Necker Enfants Malad, Paris, France; [Le Pen, Claude] Univ Paris 09, Paris, France	Utrecht University; Danone Nutricia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	Lenoir-Wijnkoop, I (corresponding author), Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands.	P.I.Lenoir-Wijnkoop@uu.nl		Gerlier, Laetitia/0000-0003-0061-0194	Global Alliance for Probiotics (GAP); Danone; IMS RWES HEOR	Global Alliance for Probiotics (GAP); Danone(Danone Nutricia); IMS RWES HEOR(Health Economics & Outcomes Research Ltd)	This study was funded by an unrestricted grant from the Global Alliance for Probiotics (GAP. URL: http://www.gap-probiotics.org). GAP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ILW is employed by Danone, LG is employed by IMS RWES HEOR and GB was employed by IMS RWES HEOR during the course of the study. Danone and IMS RWES HEOR provided support in the form of salaries for authors ILW, LG and GB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arroll B, 2011, AM FAM PHYSICIAN, V84, P1390; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bensenor IM, 2001, ANN EPIDEMIOL, V11, P225, DOI 10.1016/S1047-2797(00)00214-3; Berdeaux G, 1998, QUAL LIFE RES, V7, P501, DOI 10.1023/A:1008874324258; Berggren A, 2011, EUR J NUTR, V50, P203, DOI 10.1007/s00394-010-0127-6; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bramley TJ, 2002, J OCCUP ENVIRON MED, V44, P822, DOI 10.1097/00043764-200209000-00004; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Caceresa P, 2010, J PEDIAT INFECT DISE, V5, P353, DOI 10.3233/JPI-2010-0267; Cohen JM, 2003, M S-MED SCI, V19, P239; Cohen JM, 2007, 12 JOURNEE NATL GROG, V15; de Vrese M, 2005, CLIN NUTR, V24, P481, DOI 10.1016/j.clnu.2005.02.006; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; FLEMING DM, 1988, J ROY COLL GEN PRACT, V38, P159; Gueyffier F, 2012, THERAPIE, V67, P367, DOI 10.2515/therapie/2012042; Guillemard E, 2010, BRIT J NUTR, V103, P58, DOI 10.1017/S0007114509991395; Guillemard E, 2010, J AM COLL NUTR, V29, P455, DOI 10.1080/07315724.2010.10719882; Hao QK, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006895.pub2, 10.1002/14651858.CD006895.pub3]; Haute Autorite de Sante, 2011, CHOIX METH EV EC HAS; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hojsak I, 2010, CLIN NUTR, V29, P312, DOI 10.1016/j.clnu.2009.09.008; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; Jefferson T, 2011, COCHRANE DB SYST REV, V7; Kang EJ, 2013, KOREAN J FAM MED, V34, P2, DOI 10.4082/kjfm.2013.34.1.2; Kekkonen RA, 2007, INT J SPORT NUTR EXE, V17, P352, DOI 10.1123/ijsnem.17.4.352; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kim SY, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006362.pub2; King S, 2014, BRIT J NUTR; Lenoir-Wijnkoop I, 2007, NUTR REV, V65, P469, DOI [10.1301/nr.2007.nov.469-489, 10.1111/j.1753-4887.2007.tb00272.x]; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Mosnier A, 2002, 7 JOURNEE NATL GROG; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Nichol KL, 2005, CLIN INFECT DIS, V40, P1263, DOI 10.1086/429237; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; Rautava S, 2009, BRIT J NUTR, V101, P1722, DOI 10.1017/S0007114508116282; Sanders ME, 2014, ANN NY ACAD SCI, V1309, P19, DOI 10.1111/nyas.12377; Schlundt J, 2002, REPORT JOINT FAO WHO; Simasek M, 2007, AM FAM PHYSICIAN, V75, P515; Smerud Hilde Kloster, 2008, Microbial Ecology in Health and Disease, V20, P80, DOI 10.1080/08910600801924928; Turchet P, 2003, J Nutr Health Aging, V7, P75; van Cauwenberge P, 1999, CLIN THER, V21, P404, DOI 10.1016/S0149-2918(00)88296-X; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Vingilis E, 1999, CAN FAM PHYSICIAN, V45, P2644	47	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122765	10.1371/journal.pone.0122765	http://dx.doi.org/10.1371/journal.pone.0122765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859849	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300061
J	Brehler, ACE; Hartmann, W; Wiebe, S; Kerkhoff, A; Schliemann, C; Palmes, D; Senninger, N; Lenze, F; Ullerich, H; Berdel, WE; Kessler, T				Brehler, Ann-Christin E.; Hartmann, Wolfgang; Wiebe, Stefanie; Kerkhoff, Andrea; Schliemann, Christoph; Palmes, Daniel; Senninger, Norbert; Lenze, Frank; Ullerich, Hansjoerg; Berdel, Wolfgang E.; Kessler, Torsten			Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases	PLOS ONE			English	Article							ESMO CLINICAL RECOMMENDATIONS; GASTRIC-CANCER; ESOPHAGEAL; CAPECITABINE; OXALIPLATIN; CHEMORADIOTHERAPY; 5-FLUOROURACIL; MULTICENTER; PANITUMUMAB; EPIRUBICIN	Background Perioperative chemotherapy increases the overall and progression-free survival of patients suffering from resectable adenocarcinomas of the lower esophagus, gastroesophageal junction and stomach (GEC). Comparing different chemotherapy regimens platin-based protocols with 5-fluorouracil (5-FU)/calcium folinate (CF) or oral fluoropyrimidines were favorable in terms of efficacy and side-effects. However, there is no consensus which regimen is the most efficacious. Methods 42 consecutive patients with resectable GEC (UICC II and III) were treated with 3 pre- and postoperative chemotherapy cycles each consisting of epirubicin, oxaliplatin and capecitabine (EOX). We analyzed the overall survival, progression-free survival and toxicity retrospectively in comparison to published data. Results The median overall survival in our cohort was 29 months and the progression-free survival was 17 months. The most frequent grade 3 and 4 toxicities during preoperative chemotherapy were diarrhea (16.7%), leukocytopenia (9.5%) and nausea (9.5%); overall 38.1% of our patients suffered from grade 3 or 4 toxicity. Surgery was carried out in 83% of our patients, 69% of those achieved R0 resection. Conclusion Comparing our data with the results of previously published randomized trials EOX is at least non-inferior with regard to overall survival, progression-free survival and toxicity. In conclusion, EOX is an appropriate perioperative therapy for patients with resectable GEC.	[Brehler, Ann-Christin E.; Wiebe, Stefanie; Kerkhoff, Andrea; Schliemann, Christoph; Berdel, Wolfgang E.; Kessler, Torsten] Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany; [Hartmann, Wolfgang] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Palmes, Daniel; Senninger, Norbert] Univ Munster, Dept Gen & Visceral Surg, D-48149 Munster, Germany; [Lenze, Frank; Ullerich, Hansjoerg] Univ Munster, Dept Med, Gastroenterol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Kessler, T (corresponding author), Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany.	torstenkessler@uni-muenster.de	Hartmann, Wolfgang/G-1893-2017; Kessler, Torsten/S-3319-2016	Hartmann, Wolfgang/0000-0002-7609-5021; Kessler, Torsten/0000-0001-7679-5362				Baldus SE, 2004, PATHOLOGE, V25, P421, DOI 10.1007/s00292-004-0697-2; Cunningham D, 2008, ANN ONCOL, V19, P23, DOI 10.1093/annonc/mdn075; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Faivre J, 1998, EUR J CANCER, V34, P2167, DOI 10.1016/S0959-8049(98)00329-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferri LE, 2012, ANN ONCOL, V23, P1512, DOI 10.1093/annonc/mdr465; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Gomez-Martin C, 2012, CLIN TRANSL ONCOL, V14, P689, DOI 10.1007/s12094-012-0858-3; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Homann N, 2012, INT J CANCER, V130, P1706, DOI 10.1002/ijc.26180; Lorenzen S, 2013, BRIT J CANCER, V108, P519, DOI 10.1038/bjc.2012.588; Mariette C, 2011, LANCET ONCOL, V12, P296, DOI 10.1016/S1470-2045(10)70125-X; Norman G, 2010, HEALTH TECHNOL ASSES, V14, P11, DOI 10.3310/hta14suppl2/02; Okines AFC, 2010, J CLIN ONCOL, V28, P3945, DOI 10.1200/JCO.2010.29.2847; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Sehdev A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-66; Stahl M, 2008, ANN ONCOL, V19, P21, DOI 10.1093/annonc/mdn074; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	23	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122974	10.1371/journal.pone.0122974	http://dx.doi.org/10.1371/journal.pone.0122974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855972	Green Published, gold			2022-12-26	WOS:000352588500069
J	Mantel, B; Stoffregen, TA; Campbell, A; Bardy, BG				Mantel, Bruno; Stoffregen, Thomas A.; Campbell, Alain; Bardy, Benoit G.			Exploratory Movement Generates Higher-Order Information That Is Sufficient for Accurate Perception of Scaled Egocentric Distance	PLOS ONE			English	Article							MOTION PARALLAX; PSYCHOMETRIC FUNCTION; SPACE-PERCEPTION; DEPTH; AFFORDANCES; HEAVINESS; SIGNALS; FUSION	Body movement influences the structure of multiple forms of ambient energy, including optics and gravito-inertial force. Some researchers have argued that egocentric distance is derived from inferential integration of visual and non-visual stimulation. We suggest that accurate information about egocentric distance exists in perceptual stimulation as higher-order patterns that extend across optics and inertia. We formalize a pattern that specifies the egocentric distance of a stationary object across higher-order relations between optics and inertia. This higher-order parameter is created by self-generated movement of the perceiver in inertial space relative to the illuminated environment. For this reason, we placed minimal restrictions on the exploratory movements of our participants. We asked whether humans can detect and use the information available in this higher-order pattern. Participants judged whether a virtual object was within reach. We manipulated relations between body movement and the ambient structure of optics and inertia. Judgments were precise and accurate when the higher-order optical-inertial parameter was available. When only optic flow was available, judgments were poor. Our results reveal that participants perceived egocentric distance from the higher-order, optical-inertial consequences of their own exploratory activity. Analysis of participants' movement trajectories revealed that self-selected movements were complex, and tended to optimize availability of the optical-inertial pattern that specifies egocentric distance. We argue that accurate information about egocentric distance exists in higher-order patterns of ambient energy, that self-generated movement can generate these higher-order patterns, and that these patterns can be detected and used to support perception of egocentric distance that is precise and accurate.	[Mantel, Bruno; Bardy, Benoit G.] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Mantel, Bruno; Campbell, Alain] Normandie Univ, Caen, France; [Mantel, Bruno] Univ Caen Basse Normandie, Ctr Etudes Sport & Act Motrices, Caen, France; [Stoffregen, Thomas A.] Univ Minnesota, Affordance Percept Act Lab, Minneapolis, MN USA; [Campbell, Alain] Univ Caen Basse Normandie, Lab Math Nicolas Oresme, UMR 6139, Caen, France; [Campbell, Alain] CNRS, Caen, France; [Bardy, Benoit G.] Inst Univ France, Paris, France	Universite de Montpellier; Universite de Caen Normandie; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France	Bardy, BG (corresponding author), Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France.	benoit.bardy@univ-montp1.fr	Stoffregen, Thomas/ABC-8710-2021; Bardy, Benoît/AAU-3078-2021	Bardy, Benoit/0000-0001-9272-1734	ENACTIVE, a network of Excellence of the European Union [FP6-IST-022114]	ENACTIVE, a network of Excellence of the European Union	This research was funded by ENACTIVE, a network of Excellence of the European Union (FP6-IST-022114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Amazeen EL, 2011, ECOL PSYCHOL, V23, P1, DOI 10.1080/10407413.2011.539100; BEALL AC, 1995, P SOC PHOTO-OPT INS, V2411, P288, DOI 10.1117/12.207547; BINGHAM GP, 1994, ECOL PSYCHOL, V6, P219, DOI 10.1207/s15326969eco0603_4; Bingham GP, 1998, J EXP PSYCHOL HUMAN, V24, P145, DOI 10.1037/0096-1523.24.1.145; BOOTSMA R J, 1992, Ecological Psychology, V4, P1; CARELLO C, 1992, PERCEPT PSYCHOPHYS, V51, P580, DOI 10.3758/BF03211655; CARELLO C, 1989, Ecological Psychology, V1, P27, DOI 10.1207/s15326969eco0101_3; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; Cornus S, 1999, ECOL PSYCHOL, V11, P249, DOI 10.1207/s15326969eco1104_1; Creem-Regehr SH, 2005, PERCEPTION, V34, P191, DOI 10.1068/p5144; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P679, DOI 10.1037/0096-1523.21.3.679; ELLARD CG, 1984, BEHAV BRAIN RES, V14, P29, DOI 10.1016/0166-4328(84)90017-2; ERIKSSON ES, 1974, PERCEPT PSYCHOPHYS, V16, P197, DOI 10.3758/BF03203274; ERIKSSON ES, 1973, PERCEPT PSYCHOPHYS, V13, P379, DOI 10.3758/BF03205789; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FALMAGNE JC, 1986, HDB PERCEPTION HUMAN, V1, P1; FERRIS SH, 1972, J EXP PSYCHOL, V95, P258, DOI 10.1037/h0033605; Fisher N. I., 1987, STAT ANAL SPHERICAL, V343, DOI [10.1017/CBO9780511623059, DOI 10.1017/CB09780511623059, 10. 1017/CBO9780511623059]; Gardner DL, 2001, ECOL PSYCHOL, V13, P245, DOI 10.1207/S15326969ECO1304_01; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1966, SENSES CONSIDERED PE; GOGEL WC, 1979, VISION RES, V19, P1161, DOI 10.1016/0042-6989(79)90013-0; GOGEL WC, 1973, PERCEPT PSYCHOPHYS, V13, P284, DOI 10.3758/BF03214141; Gomer JA, 2009, PRESENCE-TELEOP VIRT, V18, P304, DOI 10.1162/pres.18.4.304; Guillaud E, 2006, J NEUROPHYSIOL, V95, P1134, DOI 10.1152/jn.00453.2005; HEFT H, 1993, ECOL PSYCHOL, V5, P255, DOI 10.1207/s15326969eco0503_3; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Johansson G, 1973, PERCEPTION, V2, P136; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; LONGUETHIGGINS HC, 1986, VISION RES, V26, P181, DOI 10.1016/0042-6989(86)90079-9; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; LOOMIS JM, 2003, VIRTUAL ADAPTIVE ENV, P21; Mantel B, 2007, STUDIES PERCEPTION A, P222; Mantel B, 2010, ECOL PSYCHOL, V22, P192, DOI 10.1080/10407413.2010.496665; Mardia KV, 2000, DIRECTIONAL STAT; Mark LS, 1997, J EXP PSYCHOL HUMAN, V23, P1365, DOI 10.1037/0096-1523.23.5.1365; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; MAROTTA JJ, 1995, EXP BRAIN RES, V104, P107; Michaels C.F., 1981, DIRECT PERCEPTION; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; Panerai F, 2002, PERCEPT PSYCHOPHYS, V64, P717, DOI 10.3758/BF03194739; Peh CH, 2002, VISION RES, V42, P1991, DOI 10.1016/S0042-6989(02)00120-7; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Poulton E.C., 1989, BIAS QUANTIFYING JUD; RUNESON S, 1988, J EXP PSYCHOL HUMAN, V14, P295, DOI 10.1037/0096-1523.14.2.295; Sedgwick H., 1986, HDB PERCEPTION HUMAN, V1, P1; SMETS GJF, 1987, PERCEPT MOTOR SKILL, V64, P1023, DOI 10.2466/pms.1987.64.3c.1023; SOLOMON HY, 1988, J EXP PSYCHOL HUMAN, V14, P404, DOI 10.1037/0096-1523.14.3.404; Stappers PJ, 1992, THESIS DELFT U; Stoffregen TA, 2004, BEHAV BRAIN SCI, V27, P892, DOI 10.1017/S0140525X04270200; Stoffregen TA, 2001, BEHAV BRAIN SCI, V24, P195, DOI 10.1017/S0140525X01003946; Streit M, 2007, PSYCHON B REV, V14, P1001, DOI 10.3758/BF03194135; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Turvey MT, 2007, HUM MOVEMENT SCI, V26, P657, DOI 10.1016/j.humov.2007.04.002; Turvey MT, 2014, J MOTOR BEHAV, V46, P143, DOI 10.1080/00222895.2013.798252; TURVEY MT, 1981, COGNITION, V9, P237, DOI 10.1016/0010-0277(81)90002-0; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; WALLACE GK, 1959, J EXP BIOL, V36, P512; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; Watt SJ, 2003, J EXP PSYCHOL HUMAN, V29, P404, DOI 10.1037/0096-1523.29.2.404; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wickelgren EA, 2000, PERCEPT PSYCHOPHYS, V62, P1051, DOI 10.3758/BF03212088; YONAS A, 1993, CHILD DEV, V64, P298, DOI 10.1111/j.1467-8624.1993.tb02911.x	68	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120025	10.1371/journal.pone.0120025	http://dx.doi.org/10.1371/journal.pone.0120025			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856410	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500012
J	Troup, GJ; Navarini, L; Liverani, FS; Drew, SC				Troup, Gordon J.; Navarini, Luciano; Liverani, Furio Suggi; Drew, Simon C.			Stable Radical Content and Anti-Radical Activity of Roasted Arabica Coffee: From In-Tact Bean to Coffee Brew	PLOS ONE			English	Article							ELECTRON-SPIN-RESONANCE; ANTIOXIDANTS; SPECTROSCOPY; VITRO; ACIDS; CHROMATOGRAPHY; MELANOIDINS; STABILITY; DISEASE; HEALTH	The roasting of coffee beans generates stable radicals within melanoidins produced by non-enzymatic browning. Roasting coffee beans has further been suggested to increase the antioxidant (AO) capacity of coffee brews. Herein, we have characterized the radical content and AO capacity of brews prepared from Coffea arabica beans sourced directly from an industrial roasting plant. In-tact beans exhibited electron paramagnetic resonance signals arising from Fe3+, Mn2+ and at least three distinct stable radicals as a function of roasting time, whose intensity changed upon grinding and ageing. In coffee brews, the roasting-induced radicals were harboured within the high molecular weight (> 3 kD) melanoidin-containing fraction at a concentration of 15 nM and was associated with aromatic groups within the melanoidins. The low molecular weight (< 3 kD) fraction exhibited the highest AO capacity using DPPH as an oxidant. The AO activity was not mediated by the stable radicals or by metal complexes within the brew. While other non-AO functions of the roasting-induced radical and metal complexes may be possible in vivo, we confirm that the in vitro antiradical activity of brewed coffee is dominated by low molecular weight phenolic compounds.	[Troup, Gordon J.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia; [Navarini, Luciano; Liverani, Furio Suggi] Illycaffe Spa, I-34147 Trieste, Italy; [Drew, Simon C.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia	Monash University; University of Melbourne	Drew, SC (corresponding author), Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia.	sdrew@unimelb.edu.au	Drew, Simon/ABB-8102-2021	Drew, Simon/0000-0002-1459-9865	Future Fellowship [FT110100199]	Future Fellowship(Australian Research Council)	SCD was supported by a Future Fellowship (FT110100199) administered by the Australian Research Council (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. illycaffe Spa provided support in the form of salaries for authors (LN and FSL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; [Anonymous], 1966, INTRO ELECT PARAMAGN; BAESSO ML, 1990, Z LEBENSM UNTERS FOR, V191, P24, DOI 10.1007/BF01202360; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Bekedam EK, 2008, J AGR FOOD CHEM, V56, P4597, DOI 10.1021/jf8004004; Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006; Brezova V, 2009, FOOD CHEM, V114, P859, DOI 10.1016/j.foodchem.2008.10.025; de Toledo RA, 2009, INT J ENVIRON AN CH, V89, P1099, DOI 10.1080/03067310903094487; del Castillo MD, 2005, EUR FOOD RES TECHNOL, V221, P471, DOI 10.1007/s00217-005-1209-1; GONIS J, 1995, FREE RADICAL RES, V23, P393, DOI 10.1080/1071576042000191790; Goodman BA, 2011, FOOD CHEM, V125, P248, DOI 10.1016/j.foodchem.2010.07.072; Goodman BA, 2015, PROCESSING IMPACT AC, P559; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Ionita P, 2005, CHEM PAP, V59, P11; Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a; Kenche V, 2013, OXID ANTIOXID MED SC, V2, P255; Komes D, 2014, PROCESSING AND IMPACT ON ANTIOXIDANTS IN BEVERAGES, P87, DOI 10.1016/B978-0-12-404738-9.00010-6; LICHT BH, 1992, FOOD CHEM TOXICOL, V30, P365, DOI 10.1016/0278-6915(92)90062-P; OLSSON L, 1974, J CHROMATOGR, V93, P189, DOI 10.1016/S0021-9673(00)83030-7; Opitz SEW, 2014, FOODS, V3, P586, DOI 10.3390/foods3040586; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Pascual EC, 2002, J AGR FOOD CHEM, V50, P6114, DOI 10.1021/jf020352k; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Pilbrow J. R., 1990, TRANSITION ION ELECT; Polovka M, 2006, J FOOD NUTR RES, V45, P1; POVICH MJ, 1975, ANAL CHEM, V47, P346, DOI 10.1021/ac60352a039; Rufian-Henares JA, 2007, FOOD RES INT, V40, P995, DOI 10.1016/j.foodres.2007.05.002; SMITH RM, 1987, SCI TOTAL ENVIRON, V64, P125, DOI 10.1016/0048-9697(87)90127-6; Smrke S, 2013, FOOD FUNCT, V4, P1082, DOI 10.1039/c3fo30377b; Sulaiman Shaida Fariza, 2011, Journal of Dietary Supplements, V8, P293, DOI 10.3109/19390211.2011.593618; Tai J, 2010, NUTR CANCER, V62, P1044, DOI 10.1080/01635581.2010.492083; Vitaglione P, 2012, FOOD FUNCT, V3, P916, DOI 10.1039/c2fo30037k; Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Yeretzian C, 2012, FOOD CHEM, V131, P811, DOI 10.1016/j.foodchem.2011.09.048	35	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122834	10.1371/journal.pone.0122834	http://dx.doi.org/10.1371/journal.pone.0122834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856192	gold, Green Published			2022-12-26	WOS:000352588500057
J	Veit, TD; Chies, JAB; Switala, M; Wagner, B; Horn, PA; Busatto, M; Brenol, CV; Brenol, JCT; Xavier, RM; Rebmann, V				Veit, Tiago Degani; Bogo Chies, Jose Artur; Switala, Magdalena; Wagner, Bettina; Horn, Peter A.; Busatto, Mauricio; Brenol, Claiton Viegas; Tavares Brenol, Joao Carlos; Xavier, Ricardo Machado; Rebmann, Vera			The Paradox of High Availability and Low Recognition of Soluble HLA-G by LILRB1 Receptor in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; G MESSENGER-RNA; G EXPRESSION; IN-VITRO; MOLECULES; BLOOD; CELLS; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISMS	HLA-G is a regulatory molecule involved in immunologic tolerance. Growing evidence indicates that HLA-G plays a role in the regulation of inflammatory processes and autoimmune diseases. This study aimed at a systematic evaluation of soluble HLA-G (sHLA-G) in plasma of rheumatoid arthritis (RA) patients with long-lasting chronic inflammation. RA patients (n= 68) and healthy controls (n= 26) had their plasmatic sHLA-G measured by ELISA whereas the binding capability of sHLA-G to its cognate LILRB1 receptor was measured by a Luminex-based assay. All subjects were PCR-genotyped for HLA-G 14bp polymorphism (rs66554220). Significantly higher sHLA-G levels were observed in patients (p<0.001), however no significant differences were observed in LILRB1 binding capacity between RA patients and controls. Remarkably, the proportion of patients presenting specific binding of sHLA-G to LILRB1 was significantly decreased as compared to controls (56% vs. 81%, p=0.027). Patients without rheumatoid factor (RF-) were significantly overrepresented in the group of patients positive for LILRB1 binding as compared to patients without LILRB1 binding (31% vs 10%, p= 0.033). Furthermore, methotrexate treated patients (n= 58) revealed significantly lower LILRB1 binding to sHLA-G molecules than non-treated patients (medians: 12.2 vs. 67.7 units/ml, p=0.031). Unlike in controls, no significant differences in sHLA-G levels were observed among patients grouped by 14pb genotype. Thus, in a substantial number of late RA patients, the circulating sHLA-G molecules are impaired regarding LILRB1 recognition, meaning that although increased levels are observed; these molecules are not qualified to exert their protective functions against inflammation. Our findings offer new insights into the immunopathology of RA patients with long-lasting anti-RA-treatment and highlight the importance to also measure the binding capability of sHLA-G to LILRB1.	[Veit, Tiago Degani; Bogo Chies, Jose Artur; Busatto, Mauricio] Univ Fed Rio Grande do Sul, Lab Imunogenet, Porto Alegre, RS, Brazil; [Switala, Magdalena; Wagner, Bettina; Horn, Peter A.; Rebmann, Vera] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Brenol, Claiton Viegas; Tavares Brenol, Joao Carlos; Xavier, Ricardo Machado] Hosp Clin Porto Alegre, Serv Reumatol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; University of Duisburg Essen	Rebmann, V (corresponding author), Univ Fed Rio Grande do Sul, Lab Imunogenet, Porto Alegre, RS, Brazil.	Vera.Rebmann@uk-essen.de	Brenol, Claiton V/D-5235-2009; Brenol, João Carlos Tavares/V-7062-2019; Xavier, Ricardo Machado/G-4426-2012; Chies, Jose/K-9664-2015	Brenol, Claiton V/0000-0003-0229-7912; Brenol, João Carlos Tavares/0000-0002-8745-566X; Xavier, Ricardo Machado/0000-0001-6570-4533; Chies, Jose/0000-0001-7025-0660; Veit, Tiago/0000-0002-7390-4583	German Academic Exchange Service (DAAD) [54391617]; German-Brazilian DAAD/CAPES PROBRAL 1 collaboration [382/12]; OPEN Access funding program "Open Access Publizieren" of the "Deutsche Forschungsgemeinschaft (DFG)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German-Brazilian DAAD/CAPES PROBRAL 1 collaboration; OPEN Access funding program "Open Access Publizieren" of the "Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the German Academic Exchange Service (DAAD, grant 54391617), German-Brazilian DAAD/CAPES PROBRAL 1 collaboration (grant 382/12), OPEN Access funding program "Open Access Publizieren" of the "Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2007, EUR J IMMUNOL, V37, P1924, DOI 10.1002/eji.200737089; Apps R, 2011, MOL HUM REPROD, V17, P577, DOI 10.1093/molehr/gar022; Aractingi S, 2001, AM J PATHOL, V159, P71, DOI 10.1016/S0002-9440(10)61675-6; Baricordi Olavio R., 2008, Inflammation & Allergy Drug Targets, V7, P67, DOI 10.2174/187152808785107615; Carosella ED, 2001, TRENDS IMMUNOL, V22, P553, DOI 10.1016/S1471-4906(01)02007-5; Carosella ED, 2011, BLOOD, V118, P6499, DOI 10.1182/blood-2011-07-370742; Chen XY, 2008, TISSUE ANTIGENS, V72, P335, DOI 10.1111/j.1399-0039.2008.01107.x; Cordero EAA, 2009, TISSUE ANTIGENS, V74, P308, DOI 10.1111/j.1399-0039.2009.01331.x; Fainardi E, 2003, J NEUROIMMUNOL, V142, P149, DOI 10.1016/S0165-5728(03)00266-2; Fainardi E, 2011, CELL MOL LIFE SCI, V68, P433, DOI 10.1007/s00018-010-0584-3; FERRAZ MB, 1990, J RHEUMATOL, V17, P813; FUJII T, 1994, J IMMUNOL, V153, P5516; Gonzalez A, 2012, CRIT REV CL LAB SCI, V49, P63, DOI 10.3109/10408363.2012.677947; Gonzalez A, 2011, CLIN CHEM, V57, P1013, DOI 10.1373/clinchem.2010.159673; Hviid TV, 2002, TISSUE ANTIGENS, V60, P122, DOI 10.1034/j.1399-0039.2002.600202.x; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Kanai T, 2001, MOL HUM REPROD, V7, P195, DOI 10.1093/molehr/7.2.195; Kapasi K, 2000, IMMUNOLOGY, V101, P191, DOI 10.1046/j.1365-2567.2000.00109.x; Khosrotehrani K, 2001, J INVEST DERMATOL, V117, P750, DOI 10.1046/j.0022-202x.2001.01487.x; KIRSZENBAUM M, 1994, P NATL ACAD SCI USA, V91, P4209, DOI 10.1073/pnas.91.10.4209; Kuroki K, 2013, HUM IMMUNOL, V74, P433, DOI 10.1016/j.humimm.2012.11.060; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Mitsdoerffer M, 2005, J NEUROIMMUNOL, V159, P155, DOI 10.1016/j.jneuroim.2004.09.016; Naji A, 2012, LEUKEMIA, V26, P1889, DOI 10.1038/leu.2012.62; Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X; Prigione I, 2011, RHEUMATOLOGY, V50, P966, DOI 10.1093/rheumatology/keq418; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Rebmann V, 2007, HUM IMMUNOL, V68, P251, DOI 10.1016/j.humimm.2006.11.003; Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x; Rizzo R, 2013, HUM IMMUNOL; Rizzo R, 2006, PHARMACOGENET GENOM, V16, P615, DOI 10.1097/01.fpc.0000230115.41828.3a; Rosadoab S, 2008, HUM IMMUNOL, V69, P9, DOI 10.1016/j.humimm.2007.11.001; Schutt P, 2010, HUM IMMUNOL, V71, P489, DOI 10.1016/j.humimm.2010.02.015; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Torres MI, 2004, INT IMMUNOL, V16, P579, DOI 10.1093/intimm/dxh061; Veit Tiago Degani, 2010, Current Immunology Reviews, V6, P1; Verbruggen LA, 2006, HUM IMMUNOL, V67, P561, DOI 10.1016/j.humimm.2006.03.023; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Zhang MH, 2009, TRANSPLANTATION, V87, P8, DOI 10.1097/TP.0b013e31818b6141; Zilberman S, 2012, EUR J IMMUNOL, V42, P1599, DOI 10.1002/eji.201141761	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123838	10.1371/journal.pone.0123838	http://dx.doi.org/10.1371/journal.pone.0123838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853899	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400120
J	Yokosaka, T; Kuroki, S; Nishida, S; Watanabe, J				Yokosaka, Takumi; Kuroki, Scinob; Nishida, Shin'ya; Watanabe, Junji			Apparent Time Interval of Visual Stimuli Is Compressed during Fast Hand Movement	PLOS ONE			English	Article							VELOCITY-DEPENDENT SUPPRESSION; SACCADIC EYE-MOVEMENTS; PERCEIVED DURATION; VOLUNTARY ACTION; TACTILE STIMULI; ATTENTION; PERCEPTION; INTERFERENCE; LOCALIZATION; REDUCTION	The influence of body movements on visual time perception is receiving increased attention. Past studies showed apparent expansion of visual time before and after the execution of hand movements and apparent compression of visual time during the execution of eye movements. Here we examined whether the estimation of sub-second time intervals between visual events is expanded, compressed, or unaffected during the execution of hand movements. The results show that hand movements, at least the fast ones, reduced the apparent time interval between visual events. A control experiment indicated that the apparent time compression was not produced by the participants' involuntary eye movements during the hand movements. These results, together with earlier findings, suggest hand movement can change apparent visual time either in a compressive way or in an expansive way, depending on the relative timing between the hand movement and visual stimulus.	[Yokosaka, Takumi; Kuroki, Scinob; Nishida, Shin'ya; Watanabe, Junji] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Yokosaka, T (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	yokosaka.takumi@lab.ntt.co.jp		Yokosaka, Takumi/0000-0003-3429-744X; Kuroki, Scinob/0000-0002-7585-0099	NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation	NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation	NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation, provided support in the form of salaries for authors TY, SK, SN and JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; Ariff G, 2002, J NEUROSCI, V22, P7721; Brown SW, 2006, MEM COGNITION, V34, P1464, DOI 10.3758/BF03195911; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burr D, 2006, CURR BIOL, V16, pR847, DOI 10.1016/j.cub.2006.08.075; Carlini A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05363; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; DASSONVILLE P, 1995, EXP BRAIN RES, V106, P434; Dewey JA, 2013, CONSCIOUS COGN, V22, P987, DOI 10.1016/j.concog.2013.06.007; Dieter KC, 2014, PSYCHOL SCI, V25, P66, DOI 10.1177/0956797613497968; Efron B., 1993, MONOGRAPHS STAT APPL; Forster B, 2007, NEUROSCI LETT, V419, P142, DOI 10.1016/j.neulet.2007.04.027; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hagura N, 2012, P ROY SOC B-BIOL SCI, V279, P4399, DOI 10.1098/rspb.2012.1339; Hass J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038092; Ibbotson MR, 2006, CURR BIOL, V16, pR834, DOI 10.1016/j.cub.2006.08.081; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Maij F, 2013, J NEUROPHYSIOL, V110, P2661, DOI 10.1152/jn.00971.2012; Maij F, 2011, EXP BRAIN RES, V213, P223, DOI 10.1007/s00221-011-2680-5; Mattes S, 1998, PERCEPT PSYCHOPHYS, V60, P1305, DOI 10.3758/BF03207993; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; MITRANI L, 1970, VISION RES, V10, P411, DOI 10.1016/0042-6989(70)90121-5; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Press C, 2014, J EXP PSYCHOL GEN, V143, P1787, DOI 10.1037/a0037650; RAUCH R, 1985, ELECTROEN CLIN NEURO, V62, P421, DOI 10.1016/0168-5597(85)90051-6; Schutz AC, 2010, VISION RES, V50, P2702, DOI 10.1016/j.visres.2010.07.022; STEVENSON SB, 1986, VISION RES, V26, P1815, DOI 10.1016/0042-6989(86)90133-1; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Terao M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011214; Tomassini A, 2014, J NEUROSCI, V34, P9164, DOI 10.1523/JNEUROSCI.2782-13.2014; Tomassini A, 2012, J NEUROPHYSIOL, V108, P2092, DOI 10.1152/jn.00238.2012; Tomassini A, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00051; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Vercher JL, 1997, BIOL CYBERN, V77, P267, DOI 10.1007/s004220050387; Watanabe J, 2009, EXP BRAIN RES, V193, P483, DOI 10.1007/s00221-009-1711-y; Yamamoto K, 2012, J VISION, V12, DOI 10.1167/12.4.1; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551; Yeshurun Y, 2008, VIS COGN, V16, P826, DOI 10.1080/13506280701588022; ZUBER BL, 1966, EXP NEUROL, V16, P65, DOI 10.1016/0014-4886(66)90087-2	45	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124901	10.1371/journal.pone.0124901	http://dx.doi.org/10.1371/journal.pone.0124901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853892	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400147
J	Schenk, B; Fulda, S				Schenk, B.; Fulda, S.			Reactive oxygen species regulate Smac mimetic/TNF alpha-induced necroptotic signaling and cell death	ONCOGENE			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE; PROGRAMMED NECROSIS; COMPLEX I; APOPTOSIS; DOWNSTREAM; ACTIVATION; RESISTANCE; RIP3; FADD	Necroptosis represents a key programmed cell death pathway involved in various physiological and pathophysiological conditions. However, the role of reactive oxygen species (ROS) in necroptotic signaling has remained unclear. In the present study, we identify ROS as critical regulators of BV6/tumor necrosis factor-alpha (TNF alpha)-induced necroptotic signaling and cell death. We show that BV6/TNF alpha-induced cell death depends on ROS production, as several ROS scavengers such as butylated hydroxyanisole, N-acetylcysteine, alpha-tocopherol and ethyl pyruvate significantly rescue cell death. Before cell death, BV6/TNF alpha-stimulated ROS generation promotes stabilization of the receptor-interacting protein kinase 1 (RIP1)/RIP3 necrosome complex via a potential positive feedback loop, as on the one hand radical scavengers attenuate RIP1/RIP3 necrosome assembly and phosphorylation of mixed lineage kinase domain like (MLKL), but on the other hand silencing of RIP1 or RIP3 reduces ROS production. Although MLKL knockdown effectively decreases BV6/TNF alpha-induced cell death, it does not affect RIP1/RIP3 interaction and only partly reduces ROS generation. Moreover, the deubiquitinase cylindromatosis (CYLD) promotes BV6/TNF alpha-induced ROS generation and necrosome assembly even in the presence of BV6, as CYLD silencing attenuates these events. Genetic silencing of phosphoglycerate mutase 5 or dynamin-related protein 1 (Drp1) fails to protect against BV6/TNF alpha-induced cell death. By demonstrating that ROS are involved in regulating BV6/TNF alpha-induced necroptotic signaling, our study provides new insights into redox regulation of necroptosis.	[Schenk, B.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60054 Frankfurt, Germany; [Fulda, S.] German Canc Consortium DKTK, Heidelberg, Germany; [Fulda, S.] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60054 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft [SFB815]; BMBF	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	We thank D Vucic (Genentech Inc., South San Francisco, CA, USA) for providing Smac mimetic, X Wang (Beijing, China) for providing anti-RIP3 and anti-PGAM5 antibodies and C Hugenberg for expert secretarial assistance. This work has been partially supported by the Deutsche Forschungsgemeinschaft (SFB815) and the BMBF.	Arslan SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026069; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen TY, 2009, FREE RADICAL BIO MED, V46, P643, DOI 10.1016/j.freeradbiomed.2008.11.022; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coupienne I, 2011, PHOTOCH PHOTOBIO SCI, V10, P1868, DOI 10.1039/c1pp05213f; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Fulda S, 2000, BLOOD, V95, P301, DOI 10.1182/blood.V95.1.301.001k24_301_308; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Held JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.013037; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Huang CY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.149; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kikuchi M, 2012, J BIOL CHEM, V287, P41165, DOI 10.1074/jbc.M112.419747; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Laukens B, 2011, NEOPLASIA, V13, P971, DOI 10.1593/neo.11610; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Shindo R, 2015, BIOCHEM BIOPH RES CO, V436, P212; Shulga N, 2014, J CELL SCI, V127, P896, DOI 10.1242/jcs.140764; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Song KJ, 2011, PARASITE IMMUNOL, V33, P390, DOI 10.1111/j.1365-3024.2011.01297.x; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Ye YC, 2012, INT IMMUNOPHARMACOL, V14, P674, DOI 10.1016/j.intimp.2012.08.003; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	53	152	160	2	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2015	34	47					5796	5806		10.1038/onc.2015.35	http://dx.doi.org/10.1038/onc.2015.35			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW5KV	25867066				2022-12-26	WOS:000365035200003
J	Jiao, RB; Postnikoff, S; Harkness, TA; Arnason, TG				Jiao, Rubin; Postnikoff, Spike; Harkness, Troy A.; Arnason, Terra G.			The SNF1 Kinase Ubiquitin-associated Domain Restrains Its Activation, Activity, and the Yeast Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; allosteric regulation; AMP-activated kinase (AMPK); FOXO; oxidative stress; Saccharomyces cerevisiae; SNF1 kinase; UBA domain	AMPK HOMOLOG SNF1; PROTEIN-PROTEIN INTERACTIONS; HUMAN SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CELL-CYCLE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GAMMA-SUBUNIT; PHOSPHORYLATION	Background: The UBA domain in the AMP kinase family is poorly defined. Results: This motif restrains kinase activity, resulting in decreased life span and oxidative stress resistance. Conclusion: This inhibitory domain has defined influences with FOXOs on stress and aging. Significance: The overactive kinase created by UBA mutations has positive stress resistance and aging influences that may translate to human metabolic benefits. The enzyme family of heterotrimeric AMP-dependent protein kinases is activated upon low energy states, conferring a switch toward energy-conserving metabolic pathways through immediate kinase actions on enzyme targets and delayed alterations in gene expression through its nuclear relocalization. This family is evolutionarily conserved, including the presence of a ubiquitin-associated (UBA) motif in most catalytic subunits. The potential for the UBA domain to promote protein associations or direct subcellular location, as seen in other UBA-containing proteins, led us to query whether the UBA domain within the yeast AMP-dependent protein kinase ortholog, SNF1 kinase, was important in these aspects of its regulation. Here, we demonstrate that conserved UBA motif mutations significantly alter SNF1 kinase activation and biological activity, including enhanced allosteric subunit associations and increased oxidative stress resistance and life span. Significantly, the enhanced UBA-dependent longevity and oxidative stress response are at least partially dependent on the Fkh1 and Fkh2 stress response transcription factors, which in turn are shown to influence Snf1 gene expression.	[Jiao, Rubin; Postnikoff, Spike; Harkness, Troy A.; Arnason, Terra G.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; [Arnason, Terra G.] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan	Arnason, TG (corresponding author), Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 5E5, Canada.	terra.arnason@usask.ca		Harkness, Troy/0000-0002-8271-7229	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council and Canadian Institutes of Health Research (to T. A.).	Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Amodeo GA, 2010, BIOCHEM BIOPH RES CO, V397, P197, DOI 10.1016/j.bbrc.2010.05.083; Andersson L, 2003, BIOCHEM SOC T, V31, P232, DOI 10.1042/BST0310232; Ashrafi K, 2000, GENE DEV, V14, P1872; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; CARLSON M, 1981, GENETICS, V98, P25; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Dubacq C, 2004, MOL CELL BIOL, V24, P2560, DOI 10.1128/MCB.24.6.2560-2572.2004; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Goldstein A, 1975, Methods Enzymol, V42, P504; Greene NP, 2012, AM J PHYSIOL-ENDOC M, V303, pE1212, DOI 10.1152/ajpendo.00309.2012; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Harkness T., 2014, BIOCHEM PHARMACOL, V2, P151; Harkness TAA, 2004, GENETICS, V168, P759, DOI 10.1534/genetics.104.027771; Harkness TAA, 2002, GENETICS, V162, P615; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Iniesta AA, 2012, J BACTERIOL, V194, P5875, DOI 10.1128/JB.01110-12; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Rodriguez-Colman MJ, 2013, BBA-MOL CELL RES, V1833, P2004, DOI 10.1016/j.bbamcr.2013.02.015; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Lam YY, 2013, EXP GERONTOL, V48, P1018, DOI 10.1016/j.exger.2013.04.005; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Ostrow AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087647; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183; Postnikoff SDL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002583; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rudolph MJ, 2010, ACTA CRYSTALLOGR F, V66, P999, DOI 10.1107/S1744309110028265; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Sanz P, 2000, GENETICS, V154, P99; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Simpson-Lavy KJ, 2013, P NATL ACAD SCI USA, V110, P17432, DOI 10.1073/pnas.1304839110; Sproul K, 2009, EUR J ENDOCRINOL, V161, P405, DOI 10.1530/EJE-09-0245; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wilson MA, 2011, MOL CELL BIOL, V31, P3126, DOI 10.1128/MCB.01350-10; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Yeo WK, 2008, J APPL PHYSIOL, V105, P1519, DOI 10.1152/japplphysiol.90540.2008; Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	74	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15393	15404		10.1074/jbc.M115.647032	http://dx.doi.org/10.1074/jbc.M115.647032			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25869125	Green Published, hybrid			2022-12-26	WOS:000356527400008
J	Rosenthal, AK; Gohr, CM; Mitton-Fitzgerald, E; Grewal, R; Ninomiya, J; Coyne, CB; Jackson, WT				Rosenthal, Ann K.; Gohr, Claudia M.; Mitton-Fitzgerald, Elizabeth; Grewal, Rupinder; Ninomiya, James; Coyne, Carolyn B.; Jackson, William T.			Autophagy Modulates Articular Cartilage Vesicle Formation in Primary Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM PYROPHOSPHATE DIHYDRATE; MATRIX VESICLES; CELL-DEATH; UNCONVENTIONAL SECRETION; OSTEOARTHRITIC CARTILAGE; ACTIVATION; PROTEIN; ELABORATION; MICROVILLI; MECHANISM	Chondrocyte-derived extracellular organelles known as articular cartilage vesicles (ACVs) participate in non-classical protein secretion, intercellular communication, and pathologic calcification. Factors affecting ACV formation and release remain poorly characterized; although in some cell types, the generation of extracellular vesicles is associated with up-regulation of autophagy. We sought to determine the role of autophagy in ACV production by primary articular chondrocytes. Using an innovative dynamic model with a light scatter nanoparticle counting apparatus, we determined the effects of autophagy modulators on ACV number and content in conditioned medium from normal adult porcine and human osteoarthritic chondrocytes. Healthy articular chondrocytes release ACVs into conditioned medium and show significant levels of ongoing autophagy. Rapamycin, which promotes autophagy, increased ACV numbers in a dose- and time-dependent manner associated with increased levels of autophagy markers and autophagosome formation. These effects were suppressed by pharmacologic autophagy inhibitors and short interfering RNA for ATG5. Caspase-3 inhibition and a Rho/ROCK inhibitor prevented rapamycin-induced increases in ACV number. Osteoarthritic chondrocytes, which are deficient in autophagy, did not increase ACV number in response to rapamycin. SMER28, which induces autophagy via an mTOR-independent mechanism, also increased ACV number. ACVs induced under all conditions had similar ecto-enzyme specific activities and types of RNA, and all ACVs contained LC3, an autophagosome-resident protein. These findings identify autophagy as a critical participant in ACV formation, and augment our understanding of ACVs in cartilage disease and repair.	[Rosenthal, Ann K.; Gohr, Claudia M.; Mitton-Fitzgerald, Elizabeth; Grewal, Rupinder] Zablocki VA Med Ctr, Dept Med, Div Rheumatol, Milwaukee, WI 53295 USA; [Ninomiya, James] Med Coll Wisconsin, Dept Orthoped Surg, Milwaukee, WI 53226 USA; [Jackson, William T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Jackson, William T.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosenthal, AK (corresponding author), Zablocki VA Med Ctr, Rheumatol Sect, Cc-111W,5000 W Natl Ave, Milwaukee, WI 53295 USA.	ann.rosenthal@va.gov	Regan, Clinton/E-6250-2012		Veteran's Affairs Research Service; Dept. of Veteran's Affairs [101BX000812]; National Institutes of Health [R01-AI104928]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104928] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001143, I01BX000812] Funding Source: NIH RePORTER	Veteran's Affairs Research Service(US Department of Veterans Affairs); Dept. of Veteran's Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Veteran's Affairs Research Service with a Merit Review Grant from the Dept. of Veteran's Affairs (to A. K. R., 101BX000812) and National Institutes of Health Grant R01-AI104928 (to W. T. J.).	Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; ARKESTEIJN CLM, 1976, J CLIN CHEM CLIN BIO, V14, P155; Bovellan M, 2010, FEBS J, V277, P58, DOI 10.1111/j.1742-4658.2009.07412.x; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Derfus B, 1998, CALCIFIED TISSUE INT, V63, P258, DOI 10.1007/s002239900523; DERFUS BA, 1992, ARTHRITIS RHEUM, V35, P231, DOI 10.1002/art.1780350218; Derfus BA, 1996, CONNECT TISSUE RES, V35, P337, DOI 10.3109/03008209609029209; Derfus BA, 2001, OSTEOARTHR CARTILAGE, V9, P189, DOI 10.1053/joca.2000.0375; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Godin CM, 2010, MOL PHARMACOL, V77, P903, DOI 10.1124/mol.110.063859; Gottlieb RA, 2013, AUTOPHAGY IN HEALTH AND DISEASE, P3, DOI 10.1016/B978-0-12-385101-7.00001-2; HALE JE, 1987, J BIOL CHEM, V262, P1916; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Jaovisidha K, 2002, OSTEOARTHR CARTILAGE, V10, P646, DOI 10.1053/joca.2002.0722; Kalamida D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102408; Kulich I, 2014, INT J MOL SCI, V15, P7462, DOI 10.3390/ijms15057462; Lee SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019163; de Figueroa PL, 2015, ARTHRITIS RHEUMATOL, V67, P966, DOI 10.1002/art.39025; Manjithaya R, 2010, AUTOPHAGY, V6, P650, DOI 10.4161/auto.6.5.12066; MITCHELL PG, 1992, ARTHRITIS RHEUM, V35, P343, DOI 10.1002/art.1780350314; Mitton E, 2009, BIOCHEM BIOPH RES CO, V388, P533, DOI 10.1016/j.bbrc.2009.08.038; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26; ROSENTHAL AK, 1991, ARTHRITIS RHEUM, V34, P904, DOI 10.1002/art.1780340717; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; ROY S, 1968, ANN RHEUM DIS, V27, P544, DOI 10.1136/ard.27.6.544; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Wang A.L, 2009, PLOS ONE, V4, pe5304, DOI DOI 10.1371/JOURNAL.PONE.0004160; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	41	21	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13028	13038		10.1074/jbc.M114.630558	http://dx.doi.org/10.1074/jbc.M114.630558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869133	Green Published, hybrid			2022-12-26	WOS:000354975700005
J	Huang, P; Zhang, YY; Lu, XM; Xu, Y; Wang, J; Zhang, Y; Yu, RB; Su, J				Huang, Peng; Zhang, Yuanyuan; Lu, Xiaomei; Xu, Yin; Wang, Jie; Zhang, Yun; Yu, Rongbin; Su, Jing			Association of Polymorphisms in HLA Antigen Presentation-Related Genes with the Outcomes of HCV Infection	PLOS ONE			English	Article							MHC CLASS-I; TAPASIN; VIRUS; IMMUNOLOGY; EXPRESSION; PEPTIDE; TAP; MAP	Antigen-presentation genes play a vital role in the pathogenesis of HCV infection. However, the relationship of variants of these genes with spontaneous outcomes of HCV infection has not been fully investigated. To explore novel loci in the Chinese population, 34 tagging-SNPs in 9 candidate genes were genotyped for their associations with the outcomes of HCV infection. The distributions of different genotypes and haplotypes were compared among 773 HCV-negative controls, 246 subjects with HCV natural clearance, and 218 HCV persistent carriers recruited from hemodialysis patients and intravenous drug users. Our study implicated that TAP2, HLA-DOA, HLA-DOB, and tapasin loci were novel candidate regions for susceptibility to HCV infection and viral clearance in the Chinese population. Logistic regression analyses showed that TAP2 rs1800454 A (OR = 1.48, P = 0.002) and HLA-DOB rs2071469 G (OR = 1.23, P = 0.048) were significantly associated with increased susceptibility to establishment of HCV infection. However, high-risk behavior exposure and age were stronger predictors of HCV infection. Mutation of tapasin rs9277972 T (OR = 1.57, P = 0.043) increased the risk of HCV chronicity, and HLA-DOA rs3128935 C (OR = 0.62, P = 0.019) increased the chance of viral resolution. With regards to the effect of rs3128925, interactions were found with high-risk behavior (P = 0.013) and age (P = 0.035). The risk effect of rs3128925 T for persistent HCV infection was higher in injecting drug users (vs. dialysis patients) and in subjects >= 40 years old (vs. <40 years old).	[Huang, Peng; Zhang, Yuanyuan; Lu, Xiaomei; Xu, Yin; Yu, Rongbin; Su, Jing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostatist, Nanjing, Jiangsu, Peoples R China; [Wang, Jie] Nanjing Med Univ, Kangda Coll, Dept Gen Practice, Nanjing, Jiangsu, Peoples R China; [Zhang, Yun] Med Inst Nanjing Army, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yu, RB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostatist, Nanjing, Jiangsu, Peoples R China.	rongbinyu@njmu.edu.cn; sujing@njmu.edu.cn			National Natural Science Foundation of China [81102164, 81102165, 81273146]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (Grant No. 81102164 to JS, No. 81102165 to JS, and No. 81273146 to YZ), http://www.nsfc.gov.cn/. The work was also supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (to Nanjing Medical University, major of public health and preventive medicine), http://english.jsjyt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Ashraf S, 2013, HEPATOLOGY, V58, P881, DOI 10.1002/hep.26415; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Chen RH, 2006, J CLIN LAB ANAL, V20, P93, DOI 10.1002/jcla.20107; Cui Q, 2010, J BIOMED RES, V24, P374, DOI 10.1016/S1674-8301(10)60050-4; Cui Q, 2011, INFECT GENET EVOL, V11, P1682, DOI 10.1016/j.meegid.2011.06.016; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Inglis TJJ, 2003, MICROBIOLOGY INFECT, P19; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Penfornis A, 2002, HUM IMMUNOL, V63, P61, DOI 10.1016/S0198-8859(01)00365-2; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Sugimoto Y, 2002, J VIRAL HEPATITIS, V9, P377, DOI 10.1046/j.1365-2893.2002.00365.x; Yu MC, 2004, CLIN RHEUMATOL, V23, P35, DOI 10.1007/s10067-003-0769-3	24	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123513	10.1371/journal.pone.0123513	http://dx.doi.org/10.1371/journal.pone.0123513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874709	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100183
J	Martinez-Garcia, PM; Ramos, C; Rodriguez-Palenzuela, P				Manuel Martinez-Garcia, Pedro; Ramos, Cayo; Rodriguez-Palenzuela, Pablo			T346Hunter: A Novel Web-Based Tool for the Prediction of Type III, Type IV and Type VI Secretion Systems in Bacterial Genomes	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; PROTEIN; GENE; IDENTIFICATION; MELIOIDOSIS	T346Hunter (Type Three, Four and Six secretion system Hunter) is a web-based tool for the identification and localisation of type III, type IV and type VI secretion systems (T3SS, T4SS and T6SS, respectively) clusters in bacterial genomes. Non-flagellar T3SS (NF-T3SS) and T6SS are complex molecular machines that deliver effector proteins from bacterial cells into the environment or into other eukaryotic or prokaryotic cells, with significant implications for pathogenesis of the strains encoding them. Meanwhile, T4SS is a more functionally diverse system, which is involved in not only effector translocation but also conjugation and DNA uptake/release. Development of control strategies against bacterial-mediated diseases requires genomic identification of the virulence arsenal of pathogenic bacteria, with T3SS, T4SS and T6SS being major determinants in this regard. Therefore, computational methods for systematic identification of these specialised machines are of particular interest. With the aim of facilitating this task, T346Hunter provides a user-friendly web-based tool for the prediction of T3SS, T4SS and T6SS clusters in newly sequenced bacterial genomes. After inspection of the available scientific literature, we constructed a database of hidden Markov model (HMM) protein profiles and sequences representing the various components of T3SS, T4SS and T6SS. T346Hunter performs searches of such a database against user-supplied bacterial sequences and localises enriched regions in any of these three types of secretion systems. Moreover, through the T346Hunter server, users can visualise the predicted clusters obtained for approximately 1700 bacterial chromosomes and plasmids. T346Hunter offers great help to researchers in advancing their understanding of the biological mechanisms in which these sophisticated molecular machines are involved. T346Hunter is freely available at http://bacterial-virulence-factors.cbgp.upm.es/T346Hunter.	[Manuel Martinez-Garcia, Pedro; Ramos, Cayo] Univ Malaga, IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Area Genet,Fac Ciencias, E-29071 Malaga, Spain; [Manuel Martinez-Garcia, Pedro; Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain; [Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Rodriguez-Palenzuela, P (corresponding author), Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Biotecnol & Genom Plantas, Parque Cient & Tecnol,Campus Montegancedo, Madrid 28223, Spain.	pablo.rpalenzuela@upm.es	RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; RAMOS, CAYO/G-3818-2011	RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; RAMOS, CAYO/0000-0002-2362-5041; Martinez Garcia, Pedro Manuel/0000-0002-2119-2465	Ministerio de Economia y Competitividad, Spain [AGL2011-30343-C02-01]; Campus de Excelencia Internacional Andalucia Tech	Ministerio de Economia y Competitividad, Spain; Campus de Excelencia Internacional Andalucia Tech	This research has been supported by project grant AGL2011-30343-C02-01 from the Ministerio de Economia y Competitividad, Spain (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en). PMMG was supported by the Campus de Excelencia Internacional Andalucia Tech (http://www.andaluciatech.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bi DX, 2013, NUCLEIC ACIDS RES, V41, pD660, DOI 10.1093/nar/gks1248; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; D'Cruze T, 2011, INFECT IMMUN, V79, P3659, DOI 10.1128/IAI.01351-10; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li PL, 1998, J BACTERIOL, V180, P6164; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Nandi T, 2014, GENOME RES; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pundhir S, 2011, BIOINFORMATION, V6, P380, DOI 10.6026/97320630006380; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Souza RC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-172; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Wandersman C, 2013, RES MICROBIOL, V164, P683, DOI 10.1016/j.resmic.2013.03.008; Wang YJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-66; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	41	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119317	10.1371/journal.pone.0119317	http://dx.doi.org/10.1371/journal.pone.0119317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867189	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100014
J	Zhao, YJ; Zeng, C; Massiah, MA				Zhao, Yunjie; Zeng, Chen; Massiah, Michael A.			Molecular Dynamics Simulation Reveals Insights into the Mechanism of Unfolding by the A130T/V Mutations within the MID1 Zinc-Binding Bbox1 Domain	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; OPITZ G/BBB SYNDROME; SERINE/THREONINE PHOSPHATASES; UBIQUITIN LIGASE; PP2A; ALPHA4; DEGRADATION; RING; KEY	The zinc-binding Bbox1 domain in protein MID1, a member of the TRIM family of proteins, facilitates the ubiquitination of the catalytic subunit of protein phosphatase 2A and alpha4, a protein regulator of PP2A. The natural mutation of residue A130 to a valine or threonine disrupts substrate recognition and catalysis. While NMR data revealed the A130T mutant Bbox1 domain failed to coordinate both structurally essential zinc ions and resulted in an unfolded structure, the unfolding mechanism is unknown. Principle component analysis revealed that residue A130 served as a hinge point between the structured beta-strand-turn-beta-strand (beta-turn-beta) and the lasso-like loop sub-structures that constitute loop1 of the beta beta alpha-RING fold that the Bbox1 domain adopts. Backbone RMSD data indicate significant flexibility and departure from the native structure within the first 5 ns of the molecular dynamics (MD) simulation for the A130V mutant (> 6 angstrom) and after 30 ns for A130T mutant (> 6 angstrom). Overall RMSF values were higher for the mutant structures and showed increased flexibility around residues 125 and 155, regions with zinc-coordinating residues. Simulated pKa values of the sulfhydryl group of C142 located near A130 suggested an increased in value to similar to 9.0, paralleling the increase in the apparent dielectric constants for the small cavity near residue A130. Protonation of the sulfhydryl group would disrupt zinc-coordination, directly contributing to unfolding of the Bbox1. Together, the increased motion of residues of loop 1, which contains four of the six zinc-binding cysteine residues, and the increased pKa of C142 could destabilize the structure of the zinc-coordinating residues and contribute to the unfolding.	[Zhao, Yunjie; Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Zeng, Chen] Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Peoples R China; [Massiah, Michael A.] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Washington University; Huazhong University of Science & Technology; George Washington University	Zeng, C (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.	chenz@gwu.edu; massiah@gwu.edu			National Science Foundation (US) [1052520, 0941228]	National Science Foundation (US)(National Science Foundation (NSF))	The work was supported by funds from the National Science Foundation (US): 1052520 (MAM) and 0941228 (CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109154; Cox TC, 2004, CLIN GENET, V65, P163, DOI 10.1111/j.0009-9163.2004.00225.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Du HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107428; Du HJ, 2013, J BIOL CHEM, V288, P21341, DOI 10.1074/jbc.M113.481093; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ferrentino R, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9480; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kerrigan John E, 2013, Methods Mol Biol, V993, P95, DOI 10.1007/978-1-62703-342-8_7; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Winter J, 2003, HUM GENET, V112, P249, DOI 10.1007/s00439-002-0901-5; Wright KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107537; Xu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01895; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhao YJ, 2013, TRANSCR-AUSTIN, V4, P227, DOI 10.4161/trns.27368; Zhao YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00734	42	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124377	10.1371/journal.pone.0124377	http://dx.doi.org/10.1371/journal.pone.0124377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874572	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100256
J	Saengsuwan, J; Nef, T; Laubacher, M; Hunt, KJ				Saengsuwan, Jittima; Nef, Tobias; Laubacher, Marco; Hunt, Kenneth J.			Comparison of Peak Cardiopulmonary Performance Parameters on a Robotics-Assisted Tilt Table, a Cycle and a Treadmill	PLOS ONE			English	Article							MAXIMAL HEART-RATE; OXYGEN-UPTAKE; WORK RATE; EXERCISE; REPRODUCIBILITY; ARM; FEASIBILITY; ERGOMETRY; VALIDITY; PROTOCOL	Robotics-assisted tilt table (RATT) technology provides body support, cyclical stepping movement and physiological loading. This technology can potentially be used to facilitate the estimation of peak cardiopulmonary performance parameters in patients who have neurological or other problems that may preclude testing on a treadmill or cycle ergometer. The aim of the study was to compare the magnitude of peak cardiopulmonary performance parameters including peak oxygen uptake (VO2peak) and peak heart rate (HRpeak) obtained from a robotics-assisted tilt table (RATT), a cycle ergometer and a treadmill. The strength of correlations between the three devices, test-retest reliability and repeatability were also assessed. Eighteen healthy subjects performed six maximal exercise tests, with two tests on each of the three exercise modalities. Data from the second tests were used for the comparative and correlation analyses. For nine subjects, test-retest reliability and repeatability of VO2peak and HRpeak were assessed. Absolute VO2peak from the RATT, the cycle ergometer and the treadmill was (mean (SD)) 2.2 (0.56), 2.8 (0.80) and 3.2 (0.87) L/min, respectively (p < 0.001). HRpeak from the RATT, the cycle ergometer and the treadmill was 168 (9.5), 179 (7.9) and 184 (6.9) beats/min, respectively (p < 0.001). VO2peak and HRpeak from the RATT vs the cycle ergometer and the RATT vs the treadmill showed strong correlations. Test-retest reliability and repeatability were high for VO2peak and HRpeak for all devices. The results demonstrate that the RATT is a valid and reliable device for exercise testing. There is potential for the RATT to be used in severely impaired subjects who cannot use the standard modalities.	[Saengsuwan, Jittima; Laubacher, Marco; Hunt, Kenneth J.] Bern Univ Appl Sci, Dept Engn & Informat Technol, Div Mech Engn, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [Saengsuwan, Jittima; Nef, Tobias] Univ Bern, Gerontechnol & Rehabil Res Grp, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Saengsuwan, Jittima] Khon Kaen Univ, Dept Phys Med & Rehabil, Fac Med, Khon Kaen, Thailand	University of Bern; Khon Kaen University	Saengsuwan, J (corresponding author), Bern Univ Appl Sci, Dept Engn & Informat Technol, Div Mech Engn, Inst Rehabil & Performance Technol, Burgdorf, Switzerland.	jittima.saengsuwan@bfh.ch		Nef, Tobias/0000-0002-8069-9450; Hunt, Kenneth/0000-0002-6521-9455				ASTRAND PO, 1961, J APPL PHYSIOL, V16, P977; Bichsel L, 2011, AT-AUTOM, V59, P622, DOI 10.1524/auto.2011.0953; Billinger SA, 2008, J STRENGTH COND RES, V22, P1556, DOI 10.1519/JSC.0b013e3181739dd7; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Carter H, 2000, J APPL PHYSIOL, V89, P899, DOI 10.1152/jappl.2000.89.3.899; Faff J, 2007, BIOL SPORT, V24, P129; FAIRBARN MS, 1994, CHEST, V105, P1365, DOI 10.1378/chest.105.5.1365; GARRARD CS, 1986, RESPIRATION, V49, P94, DOI 10.1159/000194865; Hunt KJ, 2008, BIOMED SIGNAL PROCES, V3, P278, DOI 10.1016/j.bspc.2008.01.004; Jacobs PL, 2004, SPORTS MED, V34, P727, DOI 10.2165/00007256-200434110-00003; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Laubacher M, 2015, DISABIL REHABIL-ASSI, V10, P433, DOI 10.3109/17483107.2014.908246; LEE J, 1989, COMPUT BIOL MED, V19, P61, DOI 10.1016/0010-4825(89)90036-X; Marzolini S, 2012, STROKE, V43, P1075, DOI 10.1161/STROKEAHA.111.635128; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Myers J, 2010, ACSMS RESOURCES CLIN; NORDREHAUG JE, 1991, SCAND J CLIN LAB INV, V51, P655, DOI 10.3109/00365519109104577; Orr JL, 2013, ANAESTHESIA, V68, P497, DOI 10.1111/anae.12195; Pescatello L.S., 2014, ACSMS GUIDELINES EXE, V9; PINA IL, 1995, CIRCULATION, V91, P912, DOI 10.1161/01.CIR.91.3.912; Porszasz J, 2003, MED SCI SPORT EXER, V35, P1596, DOI 10.1249/01.MSS.0000084593.56786.DA; REYBROUCK T, 1975, J APPL PHYSIOL, V38, P774, DOI 10.1152/jappl.1975.38.5.774; Saengsuwan J, 2014, TECHNOL HEALTH CARE, V22, P179, DOI 10.3233/THC-140783; Schrieks IC, 2011, CLIN PHYSIOL FUNCT I, V31, P326, DOI 10.1111/j.1475-097X.2011.01014.x; Simmelink EK, 2009, INT J REHABIL RES, V32, P324, DOI 10.1097/MRR.0b013e328325a8a8; Simonson SR, 2003, BIOL SPORT, V20, P3; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; TAMMEMAGI MC, 1995, J CLIN EPIDEMIOL, V48, P1123, DOI 10.1016/0895-4356(94)00243-J; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122767	10.1371/journal.pone.0122767	http://dx.doi.org/10.1371/journal.pone.0122767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860019	Green Published, gold			2022-12-26	WOS:000352590300062
J	Wang, D; Li, TT; Ye, GT; Shen, ZY; Hu, YF; Mou, TY; Yu, J; Li, SH; Liu, H; Li, GX				Wang, Da; Li, Tingting; Ye, Gengtai; Shen, Zhiyong; Hu, Yanfeng; Mou, Tingyu; Yu, Jiang; Li, Sihao; Liu, Hao; Li, Guoxin			Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) Is Associated with Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							END-PRODUCTS RAGE; TARGETING RECEPTOR; SOLUBLE RECEPTOR; TUMOR-GROWTH; EXPRESSION; RISK; ANGIOGENESIS; AMPHOTERIN; BLOCKADE; LIGAND	Background The receptor for advanced glycation endproducts (RAGE) is an oncogenic multidisciplinary trans-membranous receptor, which is overexpressed in multiple human cancers. Recently, it has been shown that RAGE is also involved in carcinogenesis and tumor invasion. In this study, we investigated the expression levels and prognostic value of RAGE in primary gastric cancers (GC). Methods We investigated RAGE expression in primary GC and paired normal gastric tissue by real-time quantitative RT-PCR (n = 30) and Western blotting analysis (n = 30). Additionally, we performed immunohistochemistry on 180 paraffin-embedded GC specimens, 69 matched normal specimens. Results RAGE was overexpressed in GC compared with the adjacent noncancerous tissues (P<0.001), and higher RAGE expression significantly correlated with the histological grade (P = 0.002), nodal status(P = 0.025), metastasis status(P = 0.002), and American Joint Committee on Cancer stage (P = 0.020). Furthermore, upregulation of RAGE expression is an independent prognostic factor in multivariate analysis using the Cox regression model (P = 0.001). Conclusions RAGE Overexpression may be a useful marker to predict GC progression and poor prognosis.	[Wang, Da; Li, Tingting; Ye, Gengtai; Shen, Zhiyong; Hu, Yanfeng; Mou, Tingyu; Yu, Jiang; Li, Sihao; Liu, Hao; Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Li, Sihao] SCNU, Affiliated High Sch, Int Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; South China Normal University	Liu, H (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.	wonder0618.dw@gmail.com	Liu, Hao/I-9884-2019; Shen, Zhiyong/AAD-7957-2019	Liu, Hao/0000-0003-1227-2954; Shen, Zhiyong/0000-0003-4950-2434	Program of the National Key Clinical Medical Specialty; Research Fund of Public welfare in Health Industry [201402015]; Major Program of Science and Technology Program of Guangzhou [201300000087]; National Key Technology RD Program [2013BAI05B00]	Program of the National Key Clinical Medical Specialty; Research Fund of Public welfare in Health Industry; Major Program of Science and Technology Program of Guangzhou; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by The Program of the National Key Clinical Medical Specialty, the Research Fund of Public welfare in Health Industry (No. 201402015), the Major Program of Science and Technology Program of Guangzhou (No. 201300000087), and The National Key Technology R&D Program (No. 2013BAI05B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; DiNorcia J, 2012, J GASTROINTEST SURG, V16, P104, DOI 10.1007/s11605-011-1754-9; Elangovan I, 2012, BIOCHEM BIOPH RES CO, V417, P1133, DOI 10.1016/j.bbrc.2011.12.060; Gu HJ, 2008, CLIN CANCER RES, V14, P3627, DOI 10.1158/1078-0432.CCR-07-4808; Heijmans J, 2013, ONCOGENE, V32, P1202, DOI 10.1038/onc.2012.119; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Ito R, 2014, J SURG RES, V192, P503, DOI 10.1016/j.jss.2014.06.028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Liang HS, 2011, CANCER LETT, V313, P91, DOI 10.1016/j.canlet.2011.08.028; Liu DN, 2013, GASTRIC CANCER, V16, P498, DOI 10.1007/s10120-013-0232-3; Moy KA, 2013, HEPATOLOGY, V57, P2338, DOI 10.1002/hep.26264; Radia AM, 2013, INT J MOL SCI, V14, P7959, DOI 10.3390/ijms14047959; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Sasahira T, 2007, VIRCHOWS ARCH, V450, P287, DOI 10.1007/s00428-006-0359-2; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Xu XC, 2013, EUR J HISTOCHEM, V57, P240, DOI 10.4081/ejh.2013.e36; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045	26	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122697	10.1371/journal.pone.0122697	http://dx.doi.org/10.1371/journal.pone.0122697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860956	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300057
J	Wang, XM; Soetaert, K; Peirs, P; Kalai, M; Fontaine, V; Dehaye, JP; Lefevre, P				Wang, Xiao Ming; Soetaert, Karine; Peirs, Priska; Kalai, Michael; Fontaine, Veronique; Dehaye, Jean Paul; Lefevre, Philippe			Biochemical Analysis of the NAD(+)-Dependent Malate Dehydrogenase, a Substrate of Several Serine/Threonine Protein Kinases of Mycobacterium tuberculosis	PLOS ONE			English	Article							STRESS-RESPONSE; METABOLISM; SURVIVAL; PKND; PHOSPHORYLATION; GENOME; DOMAIN; TRANSPORTER; PERSISTENCE; ADAPTATION	PknD is one of the eleven eukaryotic-like serine/threonine protein kinases (STPKs) of Mycobacterium tuberculosis (Mtb). In vitro phosphorylation assays with the active recombinant PknD showed that the intracellular protein NAD(+)-dependent malate dehydrogenase (MDH) is a substrate of this kinase. MDH, an energy-supplying enzyme, catalyzes the interconversion of malate and oxaloacetate and plays crucial roles in several metabolic pathways including the citric acid cycle. The phosphorylation site was identified on threonine residues and the phosphorylation inhibited the MDH activity. In vitro, the recombinant MDH could also be phosphorylated by at least five other STPKs, PknA, PknE, PknH, PknJ, and PknG. Immunoprecipitation analysis revealed that MDH was hyperphosphorylated in the bacteria at the beginning of the stationary and under oxygen-limited conditions by STPKs other than PknD. On the contrary, when PknD-deficient mutant mycobacteria were grown in a phosphate-depleted medium, MDH was not detectably phosphorylated. These results suggest that although the MDH is a substrate of several mycobacterial STPKs, the activity of these kinases can depend on the environment, as we identified PknD as a key element in the MDH phosphorylation assay under phosphate-poor conditions.	[Wang, Xiao Ming; Soetaert, Karine; Peirs, Priska; Kalai, Michael] Sci Inst Publ Hlth, Direct Communicable & Infect Dis, B-1180 Brussels, Belgium; [Fontaine, Veronique; Dehaye, Jean Paul; Lefevre, Philippe] Univ Libre Bruxelles, Fac Pharm, Unite Microbiol Pharmaceut & Hyg, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Lefevre, P (corresponding author), Univ Libre Bruxelles, Fac Pharm, Unite Microbiol Pharmaceut & Hyg, Blvd Triomphe,CP205-2, B-1050 Brussels, Belgium.	philefev@ulb.ac.be		Fontaine, Veronique/0000-0001-7588-5462	FRSM (Belgian Fund for Medical Scientific Research) [3.4.511.07]	FRSM (Belgian Fund for Medical Scientific Research)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the grant no 3.4.511.07 from the FRSM (Belgian Fund for Medical Scientific Research).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Baer CE, 2014, J BIOL CHEM, V289, P20422, DOI 10.1074/jbc.M114.559054; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; BIRKTOFT JJ, 1989, BIOCHEM SOC T, V17, P301, DOI 10.1042/bst0170301; Bishai W, 2000, NATURE, V406, P683, DOI 10.1038/35021159; Bloom BR, 1999, NAT MED, V5, P872, DOI 10.1038/11309; BREITER DR, 1994, PROTEIN SCI, V3, P2023, DOI 10.1002/pro.5560031115; CANNATA JJB, 1984, MOL BIOCHEM PARASIT, V11, P37, DOI 10.1016/0166-6851(84)90053-7; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Jiang X, 2006, MICROB DRUG RESIST, V12, P231, DOI 10.1089/mdr.2006.12.231; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Kusebauch U, 2014, P NATL ACAD SCI USA, V111, P9265, DOI 10.1073/pnas.1323894111; Lee JJ, 2014, NEW MICROBIOL, V37, P525; Lefevre P, 1997, J BACTERIOL, V179, P2900, DOI 10.1128/jb.179.9.2900-2906.1997; Li J, 2000, J CELL SCI, V113, P4143; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Smith CV, 2004, TUBERCULOSIS, V84, P45, DOI 10.1016/j.tube.2003.08.019; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Ventura M, 2013, MOL MICROBIOL, V90, P356, DOI 10.1111/mmi.12368; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006	53	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123327	10.1371/journal.pone.0123327	http://dx.doi.org/10.1371/journal.pone.0123327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860441	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300094
J	Li, YM; Zhou, WM; Zhao, YJ; Wang, YQ; Xie, ZD; Lou, YL; Tan, WJ				Li, Yamin; Zhou, Weimin; Zhao, Yanjie; Wang, Yanqun; Xie, Zhengde; Lou, Yongliang; Tan, Wenjie			Molecular Typing and Epidemiology Profiles of Human Adenovirus Infection among Paediatric Patients with Severe Acute Respiratory Infection in China	PLOS ONE			English	Article							KOREAN CHILDREN; TRACT INFECTION; GENOME SEQUENCE; IDENTIFICATION; RECOMBINATION; DIAGNOSIS; DISEASE	Background Human adenoviruses (HAdVs) have been recognised as pathogens that cause a broad spectrum of diseases. The studies on HAdV infection among children with severe acute respiratory infection (SARI) are limited. Objective To investigate the prevalence, epidemiology, and genotype of HAdV among children with SARI in China. Study Design Nasopharyngeal aspirates (NPAs) or induced sputum (IS) was collected from hospitalised children with SARIs in Beijing (representing Northern China; n = 259) and Zhejiang Province (representing Eastern China; n = 293) from 2007 to 2010. The prevalence of HAdV was screened by polymerase chain reaction (PCR), followed by sequence typing of PCR fragments that targeted the second half of the hexon gene. In addition, co-infection with other human respiratory viruses, related epidemiological profiles and clinical presentations were investigated. Results and Conclusions In total, 76 (13.8%) of 552 SARI patients were positive for HAdV, and the infection rates of HAdV in Northern and Eastern China were 20.1%(n = 52) and 8.2% (n = 24), respectively. HAdV co-infection with other respiratory viruses was frequent (infection rates: Northern China, 90.4%; Eastern China, 70.8%). The peak seasons for HAdV-B infection was winter and spring. Additionally, members of multiple species (Human mastadenovirus B, C, D and E) were circulating among paediatric patients with SARI, of which HAdV-B (34/52; 65.4%) and HAdV-C (20/24, 83.3%) were the most predominant in Northern and Eastern China, respectively. These findings provide a benchmark for future epidemiology and prevention strategies for HAdV.	[Li, Yamin; Zhou, Weimin; Wang, Yanqun; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Zhao, Yanjie; Lou, Yongliang] Wenzhou Med Univ, Inst Med Virol, Wenzhou, Zhejiang, Peoples R China; [Xie, Zhengde] BCH CMU, Beijing Pediat Res Inst, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University	Tan, WJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.	tanwj28@163.com	wang, yanqun/AGZ-1821-2022		State Megaproject for Infectious Disease Research of China [2013ZX10004-001, 2013ZX10004601, 2013ZX10004-605]	State Megaproject for Infectious Disease Research of China	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2013ZX10004-001, 2013ZX10004601 and 2013ZX10004-605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas KZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-15; Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Biere B, 2010, J CLIN VIROL, V47, P366, DOI 10.1016/j.jcv.2010.01.005; BOURSNELL MEG, 1981, VIROLOGY, V112, P198, DOI 10.1016/0042-6822(81)90625-5; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Elizabet GR, 2010, PRINCIPLES PRACTICE, P2077; Hage E, 2014, J INFECTION, V69, P490, DOI 10.1016/j.jinf.2014.06.015; Han Guiyuan, 2013, Virologica Sinica, V28, P103, DOI 10.1007/s12250-013-3308-7; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; Kaneko H, 2009, J GEN VIROL, V90, P1471, DOI 10.1099/vir.0.009225-0; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; Lu MP, 2013, WORLD J PEDIATR, V9, P346, DOI 10.1007/s12519-013-0431-3; Lukashev AN, 2008, J GEN VIROL, V89, P380, DOI 10.1099/vir.0.83057-0; McLaughlin J., 2010, Morbidity and Mortality Weekly Report, V59, P6; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; SaitohInagawa W, 1996, J CLIN MICROBIOL, V34, P2113, DOI 10.1128/JCM.34.9.2113-2116.1996; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Shimada Y, 2004, J CLIN MICROBIOL, V42, P1577, DOI 10.1128/JCM.42.4.1577-1584.2004; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075208; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 2010, J CLIN VIROL, V47, P282, DOI 10.1016/j.jcv.2009.12.014; Xie L, 2012, J CLIN MICROBIOL, V50, P1879, DOI 10.1128/JCM.06523-11; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	32	28	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123234	10.1371/journal.pone.0123234	http://dx.doi.org/10.1371/journal.pone.0123234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856575	Green Published, gold, Green Submitted			2022-12-26	WOS:000352588500081
J	Serth, K; Schuster-Gossler, K; Kremmer, E; Hansen, B; Marohn-Kohn, B; Gossler, A				Serth, Katrin; Schuster-Gossler, Karin; Kremmer, Elisabeth; Hansen, Birte; Marohn-Koehn, Britta; Gossler, Achim			O-Fucosylation of DLL3 Is Required for Its Function during Somitogenesis	PLOS ONE			English	Article							LUNATIC-FRINGE; DROSOPHILA-MELANOGASTER; TRANSMEMBRANE PROTEIN; SIGNAL-TRANSDUCTION; SEGMENTATION CLOCK; NOTCH INHIBITION; NERVOUS-SYSTEM; DELTA-HOMOLOG; GENE; EXPRESSION	Delta-like 3 (DLL3) is a member of the DSL family of Notch ligands in amniotes. In contrast to DLL1 and DLL4, the other Delta-like proteins in the mouse, DLL3 does not bind in trans to Notch and does not activate the receptor, but shows cis-interaction and cis-inhibitory properties on Notch signaling in vitro. Loss of the DSL protein DLL3 in the mouse results in severe somite patterning defects, which are virtually indistinguishable from the defects in mice that lack lunatic fringe (LFNG), a glycosyltransferase involved in modifying Notch signaling. Like LFNG, DLL3 is located within the trans-Golgi, however, its biochemical function is still unclear. Here, we show that i) both proteins interact, ii) epidermal growth factor like repeats 2 and 5 of DLL3 are O-fucosylated at consensus sites for POFUT1, and iii) further modified by FNG proteins in vitro. Embryos double homozygous for null mutations in DII3 and Lfng are phenotypically indistinguishable from the single mutants supporting a potential common function. Mutation of the O-fucosylation sites in DLL3 does not disrupt the interaction of DLL3 with LFNG or full length Notch1or DLL1, and O-fucosylation-deficient DLL3 can still inhibit Notch in cis in vitro. However, in contrast to wild type DLL3, O-fucosylation-deficient DLL3 cannot compensate for the loss of endogenous DLL3 during somitogenesis in the embryo. Together our results suggest that the cis-inhibitory activity of DLL3 observed in cultured cells might not fully reflect its assumed essential physiological property, suggest that DLL3 and LFNG act together, and strongly supports that modification of DLL3 by O-linked fucose is essential for its function during somitogenesis.	[Serth, Katrin; Schuster-Gossler, Karin; Hansen, Birte; Marohn-Koehn, Britta; Gossler, Achim] Hannover Med Sch, Inst Mol Biol OE5250, D-30625 Hannover, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gossler, A (corresponding author), Hannover Med Sch, Inst Mol Biol OE5250, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gossler.achim@mh-hannover.de			German Research Council (DFG) [GO 449/9-3]; Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"	German Research Council (DFG)(German Research Foundation (DFG)); Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"	This work was supported by a grant of the German Research Council (DFG; http://www.dfg.de) to AG (GO 449/9-3), and by funding of the Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy" (http://www.mh-hannover.de/rebirth.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047785; Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Ben Abdelkhalek H, 2004, GENE DEV, V18, P1725, DOI 10.1101/gad.303504; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kageyama R, 2007, DEV DYNAM, V236, P1403, DOI 10.1002/dvdy.21114; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Loomes KM, 2007, DEV DYNAM, V236, P2943, DOI 10.1002/dvdy.21296; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Maatman R, 1997, DEVELOPMENT, V124, P4019; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Muller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088571; NAGY A, 1990, DEVELOPMENT, V110, P815; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2007, Cold Spring Harb Symp Quant Biol, V72, P445, DOI 10.1101/sqb.2007.72.016; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Schuster-Gossler K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-6; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Sewell W, 2009, DEV BIOL, V329, P400, DOI 10.1016/j.ydbio.2009.02.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; THOMAS U, 1991, DEVELOPMENT, V111, P749; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; Wang Y, 1996, GLYCOBIOLOGY, V6, P837, DOI 10.1093/glycob/6.8.837; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	72	37	39	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123776	10.1371/journal.pone.0123776	http://dx.doi.org/10.1371/journal.pone.0123776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856312	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500106
J	Cue, D; Junecko, JM; Lei, MG; Blevins, JS; Smeltzer, MS; Lee, CY				Cue, David; Junecko, Jennifer M.; Lei, Mei G.; Blevins, Jon S.; Smeltzer, Mark S.; Lee, Chia Y.			SaeRS-Dependent Inhibition of Biofilm Formation in Staphylococcus aureus Newman	PLOS ONE			English	Article							2-COMPONENT SYSTEM SAERS; SENSOR KINASE SAES; REGULATORY SYSTEM; STRAIN NEWMAN; RNA-SEQ; EPIDERMIDIS; VIRULENCE; LOCUS; HOST; PATHOGENESIS	The SaeRS two-component regulatory system of Staphylococcus aureus is known to affect the expression of many genes. The SaeS protein is the histidine kinase responsible for phosphorylation of the response regulator SaeR. In S. aureus Newman, the sae system is constitutively expressed due to a point mutation in saeS, relative to other S. aureus strains, which results in substitution of proline for leucine at amino acid 18. Strain Newman is unable to form a robust biofilm and we report here that the biofilm-deficient phenotype is due to the saeS(P) allele. Replacement of the Newman saeS(P)with saeS(L), or deletion of saeRS, resulted in a biofilm-proficient phenotype. Newman culture supernatants were observed to inhibit biofilm formation by other S. aureusstrains, but did not affect biofilm formation by S. epidermidis. Culture supernatants of Newman saeS(L)or Newman Delta saeRS had no significant effect on biofilm formation. The inhibitory factor was inactivated by incubation with proteinase K, but survived heating, indicating that the inhibitory protein is heat-stable. The inhibitory protein was found to affect the attachment step in biofilm formation, but had no effect on preformed biofilms. Replacement of saeS(L) with saeS(P) in the biofilm-proficient S. aureus USA300 FPR3757 resulted in the loss of biofilm formation. Culture supernatants of USA300 FPR3757 saeS(P), did not inhibit biofilm formation by other staphylococci, suggesting that the inhibitory factor is produced but not secreted in the mutant strain. A number of biochemical methods were utilized to isolate the inhibitory protein. Although a number of candidate proteins were identified, none were found to be the actual inhibitor. In an effort to reduce the number of potential inhibitory genes, RNA-Seq analyses were done with wild-type strain Newman and the saeS(L) and Delta saeRS mutants. RNA-Seq results indicated that sae regulates many genes that may affect biofilm formation by Newman.	[Cue, David; Junecko, Jennifer M.; Lei, Mei G.; Blevins, Jon S.; Smeltzer, Mark S.; Lee, Chia Y.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Lee, CY (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	clee2@uams.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Diseases [AI113766, AI067857, AI087678, AI074935]; National Institutes of Health [P20GM103429, P30GM103450, P20GM103625]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087678, R01AI113766, R56AI074935, R01AI074935, R01AI067857, R56AI113766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P20GM103625, P30GM103450] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institute of Allergy and Infectious Diseases (AI113766 and AI067857 to CL, AI087678 to JB, AI074935 to MS). The authors also acknowledge the UAMS proteomic core and sequencing core, which are supported in part by National Institutes of Health grants P20GM103429, P30GM103450, and P20GM103625, for proteomic and sequencing analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2012, J MED MICROBIOL, V61, P1062, DOI 10.1099/jmm.0.040758-0; Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Beenken KE, 2014, MOL MICROBIOL, V92, P1299, DOI 10.1111/mmi.12629; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Flack CE, 2014, P NATL ACAD SCI USA, V111, pE2037, DOI 10.1073/pnas.1322125111; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hirschhausen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040353; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Jeong DW, 2012, MOL MICROBIOL, V86, P331, DOI 10.1111/j.1365-2958.2012.08198.x; Jeong DW, 2011, J BACTERIOL, V193, P4672, DOI 10.1128/JB.00353-11; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Lei MG, 2011, J BACTERIOL, V193, P5231, DOI 10.1128/JB.05454-11; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Memmi G, 2012, J BACTERIOL, V194, P759, DOI 10.1128/JB.06261-11; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2014, METHODS MOL BIOL, V1106, P17, DOI 10.1007/978-1-62703-736-5_2; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Quiles-Puchalt N, 2014, P NATL ACAD SCI USA, V111, P6016, DOI 10.1073/pnas.1320538111; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; SUGAI M, 1990, J BACTERIOL, V172, P6494, DOI 10.1128/jb.172.11.6494-6498.1990; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852	51	37	37	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123027	10.1371/journal.pone.0123027	http://dx.doi.org/10.1371/journal.pone.0123027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853849	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400092
J	Hein, SJ; Lehmann, LH; Kossack, M; Juergensen, L; Fuchs, D; Katus, HA; Hassel, D				Hein, Selina J.; Lehmann, Lorenz H.; Kossack, Mandy; Juergensen, Lonny; Fuchs, Dieter; Katus, Hugo A.; Hassel, David			Advanced Echocardiography in Adult Zebrafish Reveals Delayed Recovery of Heart Function after Myocardial Cryoinjury	PLOS ONE			English	Article							SPECKLE TRACKING; REGENERATION; MODEL; CONDUCTION; FAILURE; SYSTEM; STRAIN; TIME	Translucent zebrafish larvae represent an established model to analyze genetics of cardiac development and human cardiac disease. More recently adult zebrafish are utilized to evaluate mechanisms of cardiac regeneration and by benefiting from recent genome editing technologies, including TALEN and CRISPR, adult zebrafish are emerging as a valuable in vivo model to evaluate novel disease genes and specifically validate disease causing mutations and their underlying pathomechanisms. However, methods to sensitively and noninvasively assess cardiac morphology and performance in adult zebrafish are still limited. We here present a standardized examination protocol to broadly assess cardiac performance in adult zebrafish by advancing conventional echocardiography with modern speckle-tracking analyses. This allows accurate detection of changes in cardiac performance and further enables highly sensitive assessment of regional myocardial motion and deformation in high spatio-temporal resolution. Combining conventional echocardiography measurements with radial and longitudinal velocity, displacement, strain, strain rate and myocardial wall delay rates after myocardial cryoinjury permitted to non-invasively determine injury dimensions and to longitudinally follow functional recovery during cardiac regeneration. We show that functional recovery of cryoinjured hearts occurs in three distinct phases. Importantly, the regeneration process after cryoinjury extends far beyond the proposed 45 days described for ventricular resection with reconstitution of myocardial performance up to 180 days post-injury (dpi). The imaging modalities evaluated here allow sensitive cardiac phenotyping and contribute to further establish adult zebrafish as valuable cardiac disease model beyond the larval developmental stage.	[Hein, Selina J.; Lehmann, Lorenz H.; Kossack, Mandy; Juergensen, Lonny; Katus, Hugo A.; Hassel, David] Univ Heidelberg Hosp, Dept Med 3, Cardiol, D-69120 Heidelberg, Germany; [Hein, Selina J.; Lehmann, Lorenz H.; Kossack, Mandy; Juergensen, Lonny; Katus, Hugo A.; Hassel, David] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg, Heidelberg, Germany; [Fuchs, Dieter] FUJIFILM VisualSonics Inc, Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Fujifilm Corporation	Hassel, D (corresponding author), Univ Heidelberg Hosp, Dept Med 3, Cardiol, D-69120 Heidelberg, Germany.	david.hassel@med.uni-heidelberg.de	Lehmann, Lorenz/AAP-9161-2021; Hein, Selina/AAA-5673-2022	Lehmann, Lorenz/0000-0001-5077-8580; Hein, Selina/0000-0003-0139-4200; Fuchs, Dieter/0000-0002-9516-2875	Heidelberg Medical School; Molecular Medicine Partnership Unit (MMPU) of the University of Heidelberg; German Center for Cardiovascular Diseases (DZHK); BMBF (German Ministry of Education and Research); Deutsche Forschungsgemeinschaft (DFG) [HA 52819/4-1]; Ministry for Science, Research and Arts of Baden-Wuerttemberg (MWK); Deutsche Stiftung fur Herzforschung (DSHF); Federal Ministry of Education and Research (BMBF) [01ZX1409A]; Klaus-Tschira and Dietmar-Hopp Stiftung	Heidelberg Medical School; Molecular Medicine Partnership Unit (MMPU) of the University of Heidelberg; German Center for Cardiovascular Diseases (DZHK); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry for Science, Research and Arts of Baden-Wuerttemberg (MWK); Deutsche Stiftung fur Herzforschung (DSHF); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Klaus-Tschira and Dietmar-Hopp Stiftung	SH was supported by the Rahel-Goitein-Straus research fellowship of Heidelberg Medical School. LHL was supported by a fellowship of the Molecular Medicine Partnership Unit (MMPU) of the University of Heidelberg. DH, MK, LHL and HAK was supported by the German Center for Cardiovascular Diseases (DZHK, Partnersite Heidelberg/Mannheim) and by the BMBF (German Ministry of Education and Research). DH was supported by the Deutsche Forschungsgemeinschaft (DFG; HA 52819/4-1), the Ministry for Science, Research and Arts of Baden-Wuerttemberg (MWK), the Deutsche Stiftung fur Herzforschung (DSHF) and the Federal Ministry of Education and Research (BMBF; 01ZX1409A). This work was supported by generous donations from the Klaus-Tschira and Dietmar-Hopp Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Blessberger H, 2010, HEART, V96, P2032, DOI 10.1136/hrt.2010.199885; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Dandel M, 2009, CURR CARDIOL REV, V5, P133, DOI 10.2174/157340309788166642; Ding YH, 2012, AUTOPHAGY, V8, P142, DOI 10.4161/auto.8.1.18536; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Foster FS, 2009, ULTRASOUND MED BIOL, V35, P1700, DOI 10.1016/j.ultrasmedbio.2009.04.012; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Goertz DE, 2000, ULTRASOUND MED BIOL, V26, P63, DOI 10.1016/S0301-5629(99)00101-5; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Ho YL, 2002, ULTRASOUND MED BIOL, V28, P1137, DOI 10.1016/S0301-5629(02)00564-1; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Huttner IG, 2013, J MOL CELL CARDIOL, V61, P123, DOI 10.1016/j.yjmcc.2013.06.005; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kabli S, 2006, ZEBRAFISH, V3, P431, DOI 10.1089/zeb.2006.3.431; Kalogirou S, 2014, CARDIOVASC RES, V104, P49, DOI 10.1093/cvr/cvu186; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lee SC, 2014, MOL GENET METAB, V112, P218, DOI 10.1016/j.ymgme.2014.04.005; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Liu JD, 2012, CIRC RES, V110, P870, DOI 10.1161/CIRCRESAHA.111.246504; Mahmoud AM, 2013, ULTRASONICS, V53, P727, DOI 10.1016/j.ultras.2012.10.017; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Nanna M, 2014, CURR OPIN CARDIOL, V29, P417, DOI 10.1097/HCO.0000000000000095; Parente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053748; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Rao KD, 2009, J BIOPHOTONICS, V2, P288, DOI 10.1002/jbio.200910032; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Sun L, 2008, ULTRASOUND MED BIOL, V34, P31, DOI 10.1016/j.ultrasmedbio.2007.07.002; Sun L, 2008, ULTRASON, P1738, DOI 10.1109/ULTSYM.2008.0426; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; Swillens A, 2010, IEEE T ULTRASON FERR, V57, P327, DOI 10.1109/TUFFC.2010.1413; Teske Arco J, 2007, Cardiovasc Ultrasound, V5, P27; Thorstensen A, 2011, EUR J ECHOCARDIOGR, V12, P924, DOI 10.1093/ejechocard/jer178; Volkers M, 2012, J CELL SCI, V125, P287, DOI 10.1242/jcs.090464; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Xiong JW, 2013, BIRTH DEFECTS RES C, V99, P160, DOI 10.1002/bdrc.21039; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Zhang KW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000550; Zhou XW, 2013, IEEE T ULTRASON FERR, V60, P718, DOI 10.1109/TUFFC.2013.2620	57	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122665	10.1371/journal.pone.0122665	http://dx.doi.org/10.1371/journal.pone.0122665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853735	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400073
J	Li, RWS; Yang, C; Chan, SW; Hoi, MPM; Lee, SMY; Kwan, YW; Leung, GPH				Li, Rachel Wai Sum; Yang, Cui; Chan, Shun Wan; Hoi, Maggie Pui Man; Lee, Simon Ming Yuen; Kwan, Yiu Wa; Leung, George Pak Heng			Relaxation Effect of Abacavir on Rat Basilar Arteries	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS; REVERSE-TRANSCRIPTASE INHIBITORS; ADENOSINE-INDUCED DILATION; DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; HIV-INFECTED PATIENTS; MYOCARDIAL-INFARCTION; ANTIRETROVIRAL THERAPY; SMOOTH-MUSCLE	Background The use of abacavir has been linked with increased cardiovascular risk in patients with human immunodeficiency virus infection; however, the mechanism involved remains unclear. We hypothesize that abacavir may impair endothelial function. In addition, based on the structural similarity between abacavir and adenosine, we propose that abacavir may affect vascular contractility through endogenous adenosine release or adenosine receptors in blood vessels. Methods The relaxation effect of abacavir on rat basilar arteries was studied using the myograph technique. Cyclic GMP and AMP levels were measured by immunoassay. The effects of abacavir on nucleoside transporters were studied using radiolabeled nucleoside uptake experiments. Ecto-50 nucleotidase activity was determined by measuring the generation of inorganic phosphate using adenosine monophosphate as the substrate. Results Abacavir induced the relaxation of rat basilar arteries in a concentration-dependent manner. This relaxation was abolished when endothelium was removed. In addition, the relaxation was diminished by the nitric oxide synthase inhibitor, L-NAME, the guanylyl cyclase inhibitor, ODQ, and the protein kinase G inhibitor, KT5820. Abacavir also increased the cGMP level in rat basilar arteries. Abacavir-induced relaxation was also abolished by adenosine A2 receptor blockers. However, abacavir had no effect on ecto-5' nucleotidase and nucleoside transporters. Short-term and long-term treatment of abacavir did not affect acetylcholine- induced relaxation in rat basilar arteries. Conclusion Abacavir induces acute endothelium-dependent relaxation of rat basilar arteries, probably through the activation of adenosine A2 receptors in endothelial cells, which subsequently leads to the release of nitric oxide, resulting in activation of the cyclic guanosine monophosphate/protein kinase G-dependent pathway in vascular smooth muscle cells. It is speculated that abacavir-induced cardiovascular risk may not be related to endothelial dysfunction as abacavir does not impair relaxation of blood vessels. The most likely explanation of increased cardiovascular risk may be increased platelet aggregation as suggested by other studies.	[Li, Rachel Wai Sum; Leung, George Pak Heng] Univ Hong Kong, Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Yang, Cui] Yunnan Univ Nationalities, Sch Chem & Biotechnol, Key Lab Ethn Med Resource Chem, State Ethn Affairs Commiss & Minist Educ, Kunming, Peoples R China; [Chan, Shun Wan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chinese Med & Mol Pharmacol, Hong Kong, Hong Kong, Peoples R China; [Hoi, Maggie Pui Man; Lee, Simon Ming Yuen] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Kwan, Yiu Wa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Yunnan Minzu University; Hong Kong Polytechnic University; University of Macau; Chinese University of Hong Kong	Leung, GPH (corresponding author), Univ Hong Kong, Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	gphleung@hku.hk	Hoi, Maggie Pui Man/AAY-5962-2021; Kwan, Yiu Wa/R-6468-2018; Chan, Shun-Wan/K-9363-2013; Leung, George Pak Heng/B-4529-2009	Kwan, Yiu Wa/0000-0002-9024-1275; Chan, Shun-Wan/0000-0001-8238-798X; Leung, George Pak Heng/0000-0003-3529-9367; Hoi, Maggie Pui Man/0000-0003-2630-3707	RGC General Research Grant of Hong Kong [770109]; University of Hong Kong; GPHL	RGC General Research Grant of Hong Kong; University of Hong Kong(University of Hong Kong); GPHL	This work is financially supported by RGC General Research Grant of Hong Kong (project number: 770109). The University of Hong Kong and GPHL are the organization/person who receive the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2007, AM J PHYSIOL-HEART C, V292, pH719, DOI 10.1152/ajpheart.00593.2006; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Bienstock RJ, 2004, MITOCHONDRION, V4, P203, DOI 10.1016/j.mito.2004.05.018; Bo J, 2006, JAIDS-J ACQ IMM DEF, V42, P391, DOI 10.1097/01.qai.0000228790.40235.0c; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Conklin BS, 2004, CARDIOVASC RES, V63, P168, DOI 10.1016/j.cardiores.2004.03.020; CUSHING DJ, 1991, AM J PHYSIOL, V261, pH343, DOI 10.1152/ajpheart.1991.261.2.H343; Daluge SM, 1997, ANTIMICROB AGENTS CH, V41, P1082, DOI 10.1128/AAC.41.5.1082; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Falcinelli E, 2013, THROMB HAEMOSTASIS, V110, P349, DOI 10.1160/TH12-07-0504; FARACI FM, 1990, AM J PHYSIOL, V259, pH1216, DOI 10.1152/ajpheart.1990.259.4.H1216; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; FISCUS RR, 1985, BIOCHIM BIOPHYS ACTA, V846, P179, DOI 10.1016/0167-4889(85)90124-7; FISCUS RR, 1984, BIOCHIM BIOPHYS ACTA, V805, P382, DOI 10.1016/0167-4889(84)90022-3; FISCUS RR, 1984, J CYCLIC NUCL PROT, V9, P415; Foster RH, 1998, DRUGS, V55, P729, DOI 10.2165/00003495-199855050-00018; Goicoechea M, 2008, LANCET, V372, P803, DOI 10.1016/S0140-6736(08)61331-8; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammond E, 2008, AIDS, V22, P2540, DOI 10.1097/QAD.0b013e328319807f; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Hino A, 1996, NEUROSURGERY, V39, P562, DOI 10.1097/00006123-199609000-00026; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; KASUYA H, 1995, J NEUROSURG, V82, P250, DOI 10.3171/jns.1995.82.2.0250; Kim C, 2011, ANTIVIR THER, V16, P1335, DOI 10.3851/IMP1891; Kline MW, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e47; Kristoffersen US, 2009, HIV MED, V10, P627, DOI 10.1111/j.1468-1293.2009.00733.x; Lasley RD, 2007, AM J PHYSIOL-HEART C, V292, pH426, DOI 10.1152/ajpheart.00675.2006; Li RWS, 2008, AM J PHYSIOL-HEART C, V295, pH1177, DOI 10.1152/ajpheart.91513.2007; Li RWS, 2007, EUR J PHARMACOL, V568, P75, DOI 10.1016/j.ejphar.2007.04.033; Marchetti G, 2008, CLIN INFECT DIS, V47, P1495, DOI 10.1086/593110; Martin A, 2010, AIDS, V24, P2657, DOI 10.1097/QAD.0b013e32833f147f; Martinez E, 2010, AIDS, V24, pF1, DOI 10.1097/QAD.0b013e32833562c5; Minuesa G, 2008, J PHARMACOL EXP THER, V324, P558, DOI 10.1124/jpet.107.131482; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; Murphy K, 2003, MOL PHARMACOL, V64, P640, DOI 10.1124/mol.64.3.640; Ngai AC, 2001, AM J PHYSIOL-HEART C, V280, pH2329, DOI 10.1152/ajpheart.2001.280.5.H2329; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Oxhorn B C, 2000, AACN Clin Issues, V11, P241, DOI 10.1097/00044067-200005000-00007; Padilla S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-40; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pellicelli AM, 1998, ANGIOLOGY, V49, P1005, DOI 10.1177/000331979804901206; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Phillis John W., 2004, Critical Reviews in Neurobiology, V16, P237, DOI 10.1615/CritRevNeurobiol.v16.i4.20; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sands WA, 2005, IMMUNOL LETT, V101, P1, DOI 10.1016/j.imlet.2005.04.005; Schafer JJ, 2010, PHARMACOTHERAPY, V30, P1072, DOI 10.1592/phco.30.10.1072; Schinazi RF, 2011, ANTIMICROB AGENTS CH, V55, P2054, DOI 10.1128/AAC.01700-10; Shimokawa H, 2001, DIALOG CARDIOVASC ME, V6, P235; Sobey CG, 1998, STROKE, V29, P1439, DOI 10.1161/01.STR.29.7.1439; Sutliff RL, 2002, AM J PHYSIOL-HEART C, V283, pH2363, DOI 10.1152/ajpheart.00151.2002; Tabrizchi R, 2001, PHARMACOL THERAPEUT, V91, P133, DOI 10.1016/S0163-7258(01)00152-8; Teixeira CE, 2006, HYPERTENSION, V47, P596, DOI 10.1161/01.HYP.0000199914.36936.1b; Thomas SA, 2004, CURR PHARM DESIGN, V10, P1313, DOI 10.2174/1381612043384835; Wang XW, 2009, AM J PATHOL, V174, P771, DOI 10.2353/ajpath.2009.080157; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; West GA, 2003, J CARDIOVASC PHARM, V41, P444, DOI 10.1097/00005344-200303000-00013	66	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123043	10.1371/journal.pone.0123043	http://dx.doi.org/10.1371/journal.pone.0123043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853881	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400093
J	Nelson, J; Wu, Y; Jiang, XH; Berretta, R; Houser, S; Choi, E; Wang, JF; Huang, J; Yang, XF; Wang, H				Nelson, Jun; Wu, Yi; Jiang, Xiaohua; Berretta, Remus; Houser, Steven; Choi, Eric; Wang, Jingfeng; Huang, Jian; Yang, Xiaofeng; Wang, Hong			Hyperhomocysteinemia suppresses bone marrow CD34(+)/VEGF receptor 2(+) cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of beta 1-integrin in progenitor cell migration and adhesion	FASEB JOURNAL			English	Article						vascular remodeling; cell therapy; endothelial repair	CYSTATHIONINE BETA-SYNTHASE; STEM-CELLS; UREMIC TOXINS; REENDOTHELIALIZATION; HOMOCYSTEINE; TRANSPLANTATION; DEFICIENT; GROWTH; DIFFERENTIATION; ATHEROSCLEROSIS	Hyperhomocysteinemia (HHcy) impairs re-endothelialization and accelerates vascular remodeling. The role of CD34(+)/VEGF receptor (VEGFR) 2(+) progenitor cells (PCs) in vascular repair in HHcy is unknown. We studied the effect of HHcy on PCs and its role in vascular repair in severe HHcy (similar to 150 mu M), which was induced in cystathionine-beta synthase heterozygous mice fed a high-methionine diet for 8 weeks. Vascular injury was introduced by carotid air-dry endothelium-denudation. CD34(+)/VEGFR2(+) cells were examined by flow cytometry. HHcy reduced bonemarrow (BM) CD34(+)/VEGFR2(+) cells and suppressed replenishment of postinjury CD34(+)/VEGFR2(+) cells in peripheral blood (PB). Donor green fluorescent protein-positive PC homing to the injured vessel was reduced in HHcy after CD34(+) PCs from enhanced green fluorescent protein mice were adoptively transferred following carotid injury. CD34(+) PC transfusion partially reversed HHcy-suppressed re-endothelialization and HHcy-induced neointimal formation. Furthermore, homocysteine (Hcy) inhibited proliferation, adhesion, and migration and suppressed beta 1-integrin expression and activity in human CD34(+) endothelial colony-forming cells (ECFCs) isolated from PBs in a dose-dependent manner. A functional-activating beta 1-integrin antibody rescued Hcy-suppressed adhesion and migration in CD34(+) ECFCs. In conclusion, HHcy reduces BM CD34(+)/VEGFR2(+) generation and suppresses CD34(+)/VEGFR2(+) cell mobilization and homing to the injured vessel via beta 1-integrin inhibition, which partially contributes to impaired re-endothelialization and vascular remodeling.	[Nelson, Jun; Jiang, Xiaohua; Choi, Eric; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Ctr Metab Dis Res, Philadelphia, PA 19140 USA; [Nelson, Jun; Jiang, Xiaohua; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Wu, Yi; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Berretta, Remus; Houser, Steven; Yang, Xiaofeng; Wang, Hong] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Berretta, Remus; Houser, Steven] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Choi, Eric] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19140 USA; [Wang, Jingfeng] Zhongshan Univ, Sch Med, Sun Yixian Mem Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Huang, Jian] Temple Univ, Sch Med, Dept Pathol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wang, H (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Ctr Metab Dis Res, 3500 North Broad St, Philadelphia, PA 19140 USA.	hongw@temple.edu	wang, jing/GRS-7509-2022		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL67033, HL77288, HL82774, HL110764, HL117654, HL9445, HL108910, HL116917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110764, R01HL077288, R01HL108910, R01HL116917, F32HL009445, R01HL067033, R01HL117654, R01HL082774] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the contributions of Catherine Yu (Department of Genetics and Molecular Biology, North-western University, Evanston, IL, USA) and Valeria Chernaya (Department of Biology, Temple University, Philadelphia, PA, USA) for English editing. This work was supported in part by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL67033, HL77288, HL82774, HL110764, and HL117654 (to H.W.), and HL9445, HL108910, and HL116917 (to X.Y.). The authors declare no conflicts of interest.	Alam MM, 2009, J CEREBR BLOOD F MET, V29, P157, DOI 10.1038/jcbfm.2008.99; Bogdanski P, 2012, CLIN CHEM LAB MED, V50, P1107, DOI 10.1515/cclm-2011-0856; Breen DM, 2009, ARTERIOSCL THROM VAS, V29, P1060, DOI 10.1161/ATVBAHA.109.185447; Carmeliet P, 1997, AM J PATHOL, V150, P761; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Delva P, 2007, J HYPERTENS, V25, P127, DOI 10.1097/HJH.0b013e3280109271; Duan HX, 2006, THROMB HAEMOSTASIS, V96, P807, DOI 10.1160/TH06-04-0199; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Hagensen MK, 2012, CARDIOVASC RES, V93, P223, DOI 10.1093/cvr/cvr278; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Huang CY, 2011, ACTA CARDIOL, V66, P773, DOI 10.1080/AC.66.6.2136962; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Jamaluddin MS, 2007, BLOOD, V110, P3648, DOI 10.1182/blood-2007-06-096701; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; Jourde-Chiche N, 2009, J THROMB HAEMOST, V7, P1576, DOI 10.1111/j.1538-7836.2009.03540.x; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kokubo T, 2007, J VASC SURG, V45, p33A, DOI 10.1016/j.jvs.2007.02.069; Korta K, 2013, POSTEP HIG MED DOSW, V67, P982, DOI 10.5604/17322693.1067258; Liao D, 2006, CIRC RES, V99, P598, DOI 10.1161/01.RES.0000242559.42077.22; Lin HH, 2009, J THROMB HAEMOST, V7, P1401, DOI 10.1111/j.1538-7836.2009.03478.x; Mano R, 2009, ATHEROSCLEROSIS, V204, P544, DOI 10.1016/j.atherosclerosis.2008.09.035; McIlhenny SE, 2010, TISSUE ENG PT A, V16, P245, DOI [10.1089/ten.tea.2009.0238, 10.1089/ten.TEA.2009.0238]; Nakajima M, 2006, CELL BIOL INT, V30, P239, DOI 10.1016/j.cellbi.2005.11.003; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Tan HM, 2006, CARDIOVASC RES, V69, P253, DOI 10.1016/j.cardiores.2005.08.016; Trabetti E, 2008, J APPL GENET, V49, P267, DOI 10.1007/BF03195624; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang H, 2004, CIRC RES, V94, P843, DOI 10.1161/01.RES.0000120864.21172.5A; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380; Wara AK, 2013, ARTERIOSCL THROM VAS, V33, P1552, DOI 10.1161/ATVBAHA.112.300655; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Weiss Daniel J, 2006, Proc Am Thorac Soc, V3, P193, DOI 10.1513/pats.200601-013MS; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Wu Y, 2010, J THROMB HAEMOST, V8, P185, DOI 10.1111/j.1538-7836.2009.03662.x; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]	50	25	26	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3085	3099		10.1096/fj.14-267989	http://dx.doi.org/10.1096/fj.14-267989			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25854700	Green Published			2022-12-26	WOS:000356859100035
J	Cook, JR; Langlet, F; Kido, Y; Accili, D				Cook, Joshua R.; Langlet, Fanny; Kido, Yoshiaki; Accili, Domenico			Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; DEPENDENT DIABETES-MELLITUS; HEPATIC LIPID-ACCUMULATION; FATTY LIVER-DISEASE; RAT HEPATOCYTES; GLUCOSE-PRODUCTION; KINASE-ACTIVITY; CIRCULATING MONOCYTES; PRIMARY CULTURES; NATURAL-HISTORY	The development of insulin resistance (IR) in the liver is a key pathophysiologic event in the development of type 2 diabetes. Although insulin loses its ability to suppress glucose production, it largely retains its capacity to drive lipogenesis. This selective IR results in the characteristic hyperglycemia and dyslipidemia of type 2 diabetes. The delineation of two branched pathways of insulin receptor (InsR) signaling to glucose versus triglyceride production, one through FoxO and the other through SREBP-1c, provides a mechanism to account for this pathophysiological abnormality. We tested the complementary hypothesis that selective IR arises due to different intrinsic sensitivities of glucose production versus de novo lipogenesis to insulin as a result of cell-autonomous down-regulation of InsR number in response to chronic hyperinsulinemia. We demonstrate in mouse primary hepatocytes that chronic hyperinsulinemia abrogates insulin's inhibition of glucose production, but not its stimulation of de novo lipogenesis. Using a competitive inhibitor of InsR, we show that there is a 4-fold difference between levels of InsR inhibition required to cause resistance of glucose production versus lipogenesis to the actions of insulin. Our data support a parsimonious model in which differential InsR activation underlies the selective IR of glucose production relative to lipogenesis, but both processes require signaling through Akt1/2.	[Cook, Joshua R.; Langlet, Fanny; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Kido, Yoshiaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 6500017, Japan	Columbia University; Kobe University	Accili, D (corresponding author), Dept Med, 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu	Regan, Clinton/E-6250-2012	Cook, Joshua Robert/0000-0001-6004-0504	National Institutes of Health [DK100038, DK57539, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608, F30DK100038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK100038, DK57539 (to D. A.), and DK63608 (to Columbia University Diabetes Research Center).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; AMATRUDA JM, 1982, DIABETES, V31, P145, DOI 10.2337/diabetes.31.2.145; ARNER P, 1983, J CLIN INVEST, V72, P1729, DOI 10.1172/JCI111132; ARNER P, 1986, J CLIN INVEST, V77, P1716, DOI 10.1172/JCI112492; BAR RS, 1976, J CLIN INVEST, V58, P1123, DOI 10.1172/JCI108565; BLACKARD WG, 1978, ENDOCRINOLOGY, V103, P548, DOI 10.1210/endo-103-2-548; Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; CARO JF, 1986, J CLIN INVEST, V78, P249, DOI 10.1172/JCI112558; CARO JF, 1980, J BIOL CHEM, V255, P52; CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958; CARO JF, 1989, DIABETES METAB REV, V5, P665, DOI 10.1002/dmr.5610050804; COMI RJ, 1987, J CLIN INVEST, V79, P453, DOI 10.1172/JCI112833; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; FEHLMANN M, 1982, P NATL ACAD SCI-BIOL, V79, P5921, DOI 10.1073/pnas.79.19.5921; FREIDENBERG GR, 1987, J CLIN INVEST, V79, P240, DOI 10.1172/JCI112789; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; GOODNER CJ, 1988, DIABETES, V37, P1316, DOI 10.2337/diabetes.37.10.1316; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; HURRELL DG, 1989, ENDOCRINOLOGY, V125, P2454, DOI 10.1210/endo-125-5-2454; KAHN CR, 1972, BIOCHEM BIOPH RES CO, V48, P135, DOI 10.1016/0006-291X(72)90354-3; KATO S, 1982, J BIOCHEM-TOKYO, V92, P699, DOI 10.1093/oxfordjournals.jbchem.a133981; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; MARBAN SL, 1990, CLIN RES, V38, pA768; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; OLEFSKY JM, 1976, J CLIN INVEST, V57, P1165, DOI 10.1172/JCI108384; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; PONTIROLI AE, 1992, DIABETOLOGIA, V35, P294, DOI 10.1007/BF00400934; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; TAKAYAMA S, 1988, J CLIN ENDOCR METAB, V66, P992, DOI 10.1210/jcem-66-5-992; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	59	51	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13972	13980		10.1074/jbc.M115.638197	http://dx.doi.org/10.1074/jbc.M115.638197			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873396	Green Published, hybrid			2022-12-26	WOS:000355313000028
J	Aibar, A; Chanal, J				Aibar, Alberto; Chanal, Julien			Physical Education: The Effect of Epoch Lengths on Children's Physical Activity in a Structured Context	PLOS ONE			English	Article							ACCELEROMETERS; CALIBRATION	Background Despite a consensus emerging that affirms that shorter epochs should be used in youth to correctly register physical activity levels in free-living conditions, little is known about its effect on children's physical activity conducted in structured periods of time. This study analyzed the effect that epoch length (1, 2, 3, 5, 10, 15, 30 and 60s) may have on different physical activity intensities in physical education lessons. Methods A sample of 1912 individualmeasures of physical education lessons were measured with a GT3X accelerometer. Data were collected from 1227 Swiss Elementary school students recruited in 17 elementary schools. PE lessons lasted from 45 minutes to one and a half hours. Data, originally collected in 1-s epoch, were then reintegrated into 2s, -3s -5s -10s -15s 30s -60s epochs. Results Longer epochs were associated with higher levels of light (F = 8197.6, p < .001), moderate (F = 2708.17, p < .001), and moderate-to-vigorous physical activity (F = 888.08, p < .001). However, longer epochs showed lower levels of sedentary activity (F = 31714.33, p < .001) and vigorous physical activity (F = 1910.97, p < .001). Bias increased in all PA intensities when shorter epochs were compared with longer epochs. There were statistically significant differences in compliance with physical education guidelines (chi(2) = 989.27, p < .001), showing higher levels with longer epochs. Conclusion PA context may have some influence on the effects that epoch length have on PA estimates, more specifically on MVPA. Nevertheless, the use of a high-frequency sampling interval should be used to more accurately assess children's PA.	[Aibar, Alberto; Chanal, Julien] Univ Geneva, Geneva, Switzerland; [Chanal, Julien] Distance Learning Univ, Brig, Switzerland	University of Geneva	Aibar, A (corresponding author), Univ Geneva, Geneva, Switzerland.	aibar@unizar.es	Solana, Alberto Aibar/R-1123-2018	Solana, Alberto Aibar/0000-0001-9126-5976	Swiss National Science Foundation [SNF 100014_132010 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by a research grant from the Swiss National Science Foundation (SNF 100014_132010 / 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar A, 2014, J SPORT MED PHYS FIT, V54, P326; Ayabe Makoto, 2013, BMC Res Notes, V6, P20, DOI 10.1186/1756-0500-6-20; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Berman N, 1998, AM J HUM BIOL, V10, P289, DOI 10.1002/(SICI)1520-6300(1998)10:3<289::AID-AJHB4>3.0.CO;2-E; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fairclough S., 2002, EUR PHYS EDUC REV, V8, P69, DOI DOI 10.1177/1356336X020081005; Gabriel Kelley Pettee, 2010, Int J Behav Nutr Phys Act, V7, P53, DOI 10.1186/1479-5868-7-53; Garriguet D, 2014, HEALTH REP, V25, P3; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Orme M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-34; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Ridgers ND, 2011, EUR J SPORT SCI, V11, P205, DOI 10.1080/17461391.2010.501116; SALLIS JF, 1991, RES Q EXERCISE SPORT, V62, P124, DOI 10.1080/02701367.1991.10608701; Sanders T, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084323, 10.1371/journal.pone.0092040]; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	26	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121238	10.1371/journal.pone.0121238	http://dx.doi.org/10.1371/journal.pone.0121238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874641	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100038
J	Garrido, P; Ribeiro, S; Fernandes, J; Vala, H; Bronze-Da-Rocha, E; Rocha-Pereira, P; Belo, L; Costa, E; Santos-Silva, A; Reis, F				Garrido, Patrcia; Ribeiro, Sandra; Fernandes, Joao; Vala, Helena; Bronze-da-Rocha, Elsa; Rocha-Pereira, Petronila; Belo, Luis; Costa, Elisio; Santos-Silva, Alice; Reis, Flavio			Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; REGULATORY PEPTIDE HEPCIDIN; GENE-EXPRESSION; TUBULOINTERSTITIAL HYPOXIA; DISEASE PATIENTS; FAILURE; HEALTH; ACCUMULATION; CONSEQUENCE; VARIABILITY	Anemia is a common complication of chronic kidney disease (CKD) that develops early and its severity increases as renal function declines. It is mainly due to a reduced production of erythropoietin (EPO) by the kidneys; however, there are evidences that iron metabolism disturbances increase as CKD progresses. Our aim was to study the mechanisms underlying the development of anemia of CKD, as well as renal damage, in the remnant kidney rat model of CKD induced by 5/6 nephrectomy. This model of CKD presented a sustained degree of renal dysfunction, with mild and advanced glomerular and tubulointerstitial lesions. Anemia developed 3 weeks after nephrectomy and persisted throughout the protocol. The remnant kidney was still able to produce EPO and the liver showed an increased EPO gene expression. In spite of the increased EPO blood levels, anemia persisted and was linked to low serum iron and transferrin levels, while serum interleukin (IL)-6 and high sensitivity C-reactive protein (hsCRP) levels showed the absence of systemic inflammation. The increased expression of duodenal ferroportin favours iron absorption; however, serum iron is reduced which might be due to iron leakage through advanced kidney lesions, as showed by tubular iron accumulation. Our data suggest that the persistence of anemia may result from disturbances in iron metabolism and by an altered activity/function of EPO as a result of kidney cell damage and a local inflammatory milieu, as showed by the increased gene expression of different inflammatory proteins in the remnant kidney. In addition, this anemia and the associated kidney hypoxia favour the development of fibrosis, angiogenesis and inflammation that may underlie a resistance to EPO stimuli and reduced iron availability. These findings might contribute to open new windows to identify putative therapeutic targets for this condition, as well as for recombinant human EPO (rHuEPO) resistance, which occurs in a considerable percentage of CKD patients.	[Garrido, Patrcia; Fernandes, Joao; Reis, Flavio] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Lab Pharmacol & Expt Therapeut, Coimbra, Portugal; [Garrido, Patrcia; Fernandes, Joao; Reis, Flavio] Univ Coimbra, Inst Biomed Imaging & Life Sci CNC IBILI, Res Unit, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Ribeiro, Sandra; Bronze-da-Rocha, Elsa; Belo, Luis; Costa, Elisio; Santos-Silva, Alice] Univ Porto, Fac Pharm, Biochem Lab, Res Unit Appl Mol Biosci UCIBIO,REQUIMTE,Dept Bio, P-4100 Porto, Portugal; [Vala, Helena] Polytech Inst Viseu, Agrarian Sch Viseu, Ctr Studies Educ Technol & Hlth CI&DETS, Viseu, Portugal; [Rocha-Pereira, Petronila] Univ Beira Interior, Res Ctr Hlth Sci, Covilha, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Instituto Politecnico de Viseu; Universidade da Beira Interior	Reis, F (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Lab Pharmacol & Expt Therapeut, Coimbra, Portugal.	freis@fmed.uc.pt	Fernandes, Joao C/AAF-2091-2019; Bronze-da-Rocha, Elsa M R/K-2723-2013; Santos-Silva, Alice/K-2326-2013; Costa, Elisio MS/K-1990-2013; Belo, Luís FBA/K-5878-2013; Santos-Silva, Alice/AAC-7082-2020; Reis, Flávio/E-7077-2016; Rocha-Pereira, Petronila/K-3102-2013	Fernandes, Joao C/0000-0003-1556-1698; Bronze-da-Rocha, Elsa M R/0000-0002-3571-2513; Santos-Silva, Alice/0000-0002-2565-3169; Costa, Elisio MS/0000-0003-1158-1480; Belo, Luís FBA/0000-0002-3941-6850; Santos-Silva, Alice/0000-0002-2565-3169; Reis, Flávio/0000-0003-3401-9554; Rocha-Pereira, Petronila/0000-0002-7985-1494; Vala, Helena/0000-0001-6829-4867; Ribeiro, Sandra/0000-0003-3505-1310; Garrido, Patricia/0000-0002-0457-6790	Portuguese Foundation for Science and Technology (FCT); COMPETE-FEDER;  [POPH/FSE: PTDC/SAU-TOX/114253/2009];  [SFRH/BD/61020/2009];  [SFRH/BD/79875/2011];  [SFRH/BPD/81968/2011];  [PEst-C/SAU/UI3282/2011];  [PEst-C/SAU/UI3282/2013];  [PEst-OE/CED/UI4016/2014 (CIDETS)];  [UID/NEU/04539/2013 (CNC.IBILI)]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); COMPETE-FEDER; ; ; ; ; ; ; ; 	This work was supported by the Portuguese Foundation for Science and Technology (FCT), COMPETE-FEDER and POPH/FSE: PTDC/SAU-TOX/114253/2009, SFRH/BD/61020/2009, SFRH/BD/79875/2011, SFRH/BPD/81968/2011, PEst-C/SAU/UI3282/2011 and 2013, PEst-OE/CED/UI4016/2014 (CI&DETS) and UID/NEU/04539/2013 (CNC.IBILI). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; ALFREY AC, 1989, KIDNEY INT, V36, P753, DOI 10.1038/ki.1989.259; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Babitt JL, 2010, AM J KIDNEY DIS, V55, P726, DOI 10.1053/j.ajkd.2009.12.030; Beaumont C, 2004, M S-MED SCI, V20, P68, DOI 10.1051/medsci/200420168; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; BRENNER BM, 1992, J CARDIOVASC PHARM, V19, pS1, DOI 10.1097/00005344-199219006-00002; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Collins AJ, 2002, KIDNEY INT, V61, pS44, DOI 10.1046/j.1523-1755.61.s80.9.x; Costa E, 2008, ACTA HAEMATOL-BASEL, V120, P11, DOI 10.1159/000149496; Eckardt KU, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01525.x; Egrie JC, 2002, ONCOLOGY-NY, V16, P13; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Fernandez-Fresnedo G, 2006, J AM SOC NEPHROL, V17, pS246, DOI 10.1681/ASN.2006080921; FINE LG, 1986, KIDNEY INT, V29, P619, DOI 10.1038/ki.1986.45; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Garrido P, 2009, RENAL FAILURE, V31, P833, DOI 10.3109/08860220903151435; Garrido P, 2013, FRONTIERS IN DRUG DI, P89; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hamada Y, 2008, NEPHROL DIAL TRANSPL, V23, P1886, DOI 10.1093/ndt/gfm900; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Jairam A, 2010, Indian J Nephrol, V20, P125, DOI 10.4103/0971-4065.70840; Jelkmann W, 2007, METHOD ENZYMOL, V435, P179, DOI 10.1016/S0076-6879(07)35010-6; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Liu Jiannong, 2009, Ther Clin Risk Manag, V5, P319; Liu ZC, 2003, RENAL FAILURE, V25, P935, DOI 10.1081/JDI-120026028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P288, DOI 10.1093/ndt/gfg489; MALT RA, 1969, NEW ENGL J MED, V280, P1446, DOI 10.1056/NEJM196906262802606; Malyszko J, 2007, KIDNEY BLOOD PRESS R, V30, P15, DOI 10.1159/000098522; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mayer G, 2011, NEPHROL DIAL TRANSPL, V26, P1132, DOI 10.1093/ndt/gfq832; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; PETERS G, 1978, YALE J BIOL MED, V51, P235; Peyssonnaux C, 2008, CELL CYCLE, V7, P28, DOI 10.4161/cc.7.1.5145; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; REMUZZI A, 1991, KIDNEY INT, V39, P647, DOI 10.1038/ki.1991.77; Remuzzi G, 2002, ANN INTERN MED, V136, P604, DOI 10.7326/0003-4819-136-8-200204160-00010; Robinson BM, 2005, KIDNEY INT, V68, P2323, DOI 10.1111/j.1523-1755.2005.00693.x; Rodriguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656; SASAKI H, 1987, J BIOL CHEM, V262, P12059; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; SILVERBERG D, 2003, NEPHROL DIAL TRAN S8, V18, P7, DOI DOI 10.1093/ndt//gfg1084; Staples AO, 2009, CLIN J AM SOC NEPHRO, V4, P48, DOI 10.2215/CJN.05301107; Sun CC, 2013, NEPHROL DIAL TRANSPL, V28, P1733, DOI 10.1093/ndt/gfs584; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; TAKEUCHI M, 1991, Glycobiology, V1, P337, DOI 10.1093/glycob/1.4.337; Teixeira M, 2012, J PHARM BIOALLIED SC, V4, P76, DOI 10.4103/0975-7406.92743; Volke M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007875; Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1; Weisbord SD, 2008, HEMODIAL INT, V12, P6, DOI 10.1111/j.1542-4758.2008.00233.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wexler D, 2005, NEPHROL DIAL TRAN S7, V20, DOI [10.1093/ndt/gfh1101, DOI 10.1093/NDT/GFH1101]; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058	70	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124048	10.1371/journal.pone.0124048	http://dx.doi.org/10.1371/journal.pone.0124048			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867633	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100235
J	Aybek, S; Nicholson, TR; O'Daly, O; Zelaya, F; Kanaan, RA; David, AS				Aybek, Selma; Nicholson, Timothy R.; O'Daly, Owen; Zelaya, Fernando; Kanaan, Richard A.; David, Anthony S.			Emotion-Motion Interactions in Conversion Disorder: An fMRI Study	PLOS ONE			English	Article							MOTOR INHIBITION; LIFE EVENTS; PAIN; PROJECTIONS; FEAR	Objectives To evaluate the neural correlates of implicit processing of negative emotions in motor conversion disorder (CD) patients. Methods An event related fMRI task was completed by 12 motor CD patients and 14 matched healthy controls using standardised stimuli of faces with fearful and sad emotional expressions in comparison to faces with neutral expressions. Temporal changes in the sensitivity to stimuli were also modelled and tested in the two groups. Results We found increased amygdala activation to negative emotions in CD compared to healthy controls in region of interest analyses, which persisted over time consistent with previous findings using emotional paradigms. Furthermore during whole brain analyses we found significantly increased activation in CD patients in areas involved in the 'freeze response' to fear (periaqueductal grey matter), and areas involved in self-awareness and motor control (cingulate gyrus and supplementary motor area). Conclusions In contrast to healthy controls, CD patients exhibited increased response amplitude to fearful stimuli over time, suggesting abnormal emotional regulation (failure of habituation / sensitization). Patients with CD also activated midbrain and frontal structures that could reflect an abnormal behavioral-motor response to negative including threatening stimuli. This suggests a mechanism linking emotions to motor dysfunction in CD.	[Aybek, Selma; Nicholson, Timothy R.; David, Anthony S.] Kings Coll London, Inst Psychiat, Sect Cognit Neuropsychiat, London SE5 8AF, England; [Aybek, Selma] Univ Geneva, Lab Behav Neurol & Imaging Cognit Fundamental Neu, Geneva, Switzerland; [O'Daly, Owen; Zelaya, Fernando] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London SE5 8AF, England; [Kanaan, Richard A.] Univ Melbourne, Austin Hlth, Dept Psychiat, Heidelberg, Vic 3084, Australia	University of London; King's College London; University of Geneva; University of London; King's College London; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Aybek, S (corresponding author), Kings Coll London, Inst Psychiat, Sect Cognit Neuropsychiat, London SE5 8AF, England.	selma.aybek@unige.ch	; David, Anthony/C-1315-2011; aybek, selma/G-7836-2016	Nicholson, Timothy/0000-0002-2350-2332; David, Anthony/0000-0003-0967-774X; Edwards, Anthony David/0000-0003-4801-7066; aybek, selma/0000-0002-7877-6760; Zelaya, Fernando/0000-0002-9525-1560	UK Medical Research Council Milstein Grant; Boursiere d'Excellence grant (University of Geneva); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; NIHR; MRC; Medical Research Council [MR/J004162/1, G0701055] Funding Source: researchfish; National Institute for Health Research [CL-2009-17-006] Funding Source: researchfish; MRC [G0701055, MR/J004162/1] Funding Source: UKRI	UK Medical Research Council Milstein Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boursiere d'Excellence grant (University of Geneva); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by a UK Medical Research Council Milstein Grant. S.A. was supported by the Boursiere d'Excellence grant (University of Geneva). T.R.N. and A.S.D. were supported by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London. F.Z. received funding support from NIHR and the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; An X, 1998, J COMP NEUROL, V401, P455; Aybek S, 2010, J PSYCHOSOM RES, V68, P606; Aybek S, 2014, JAMA PSYCHIAT, V71, P52, DOI 10.1001/jamapsychiatry.2013.2842; Bakvis P, 2010, EPILEPSIA, V51, P752, DOI 10.1111/j.1528-1167.2009.02394.x; Bakvis P, 2009, EPILEPSY BEHAV, V16, P558, DOI 10.1016/j.yebeh.2009.09.006; Brown G., 1978, SOCIAL ORIGINS DEPRE; Bryant RA, 2011, J ABNORM PSYCHOL, P1, DOI [10. 1037/ a0020797, DOI 10.1037/A0020797]; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Bzdok D, 2013, HUM BRAIN MAPP, V34, P3247, DOI 10.1002/hbm.22138; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; Demenescu LR, 2011, PSYCHOL MED, V41, P2253, DOI 10.1017/S0033291711000596; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Hermans EJ, 2013, NEUROIMAGE, V66, P278, DOI 10.1016/j.neuroimage.2012.10.063; HORVATH T, 1980, AM J PSYCHIAT, V137, P217; Kanaan RAA, 2007, PSYCHOSOM MED, V69, P202, DOI 10.1097/PSY.0b013e31802e4297; Kozlowska K, 2013, PSYCHOSOM MED, V75, P272, DOI 10.1097/PSY.0b013e318286be43; Kozlowska Kasia, 2007, Clin Child Psychol Psychiatry, V12, P487, DOI 10.1177/1359104507080977; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Mailis-Gagnon A, 2003, NEUROLOGY, V60, P1501, DOI 10.1212/WNL.60.9.1501; Maizels M, 2012, HEADACHE, V52, P1553, DOI 10.1111/j.1526-4610.2012.02209.x; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Mattavelli G., 2013, SOCIAL COGNITIVE AFF; Miquel TT, 2006, BRAIN RES, V1076, P42, DOI 10.1016/j.brainres.2005.12.095; Nelson H., 1991, NATL ADULT READING T; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Saj A, 2009, JAMA-J AM MED ASSOC, V302, P2552, DOI 10.1001/jama.2009.1834; Stone J, 2011, MOVEMENT DISORD, V26, P1787, DOI 10.1002/mds.23882; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; van Beilen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025918; van der Kruijs SJM, 2012, J NEUROL NEUROSUR PS, V83, P239, DOI 10.1136/jnnp-2011-300776; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Voon V, 2011, MOVEMENT DISORD, V26, P2396, DOI 10.1002/mds.23890; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Werring DJ, 2004, PSYCHOL MED, V34, P583, DOI 10.1017/S0033291703008985; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Young AW, 2002, FACIAL EXPRESSIONS E; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	98	98	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123273	10.1371/journal.pone.0123273	http://dx.doi.org/10.1371/journal.pone.0123273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859660	gold, Green Published			2022-12-26	WOS:000352590300088
J	Ghosh, M; Dwyer-Nield, LD; Kwon, JB; Barthel, L; Janssen, WJ; Merrick, DT; Keith, RL				Ghosh, Moumita; Dwyer-Nield, Lori D.; Kwon, Jennifer B.; Barthel, Lea; Janssen, William J.; Merrick, Daniel T.; Keith, Robert L.			Tracheal Dysplasia Precedes Bronchial Dysplasia in Mouse Model of N-Nitroso Trischloroethylurea Induced Squamous Cell Lung Cancer	PLOS ONE			English	Article							AIRWAY STEM-CELLS; BASAL-CELLS; IN-VITRO; QUANTITATIVE ASSESSMENT; LESIONS; DIFFERENTIATION; EXPRESSION; CHEMOPREVENTION; MAINTENANCE; GROWTH	Squamous cell lung cancer (SCC) is the second leading cause of lung cancer death in the US and has a 5-year survival rate of only 16%. Histological changes in the bronchial epithelium termed dysplasia are precursors to invasive SCC. However, the cellular mechanisms that cause dysplasia are unknown. To fill this knowledge gap, we used topical application of N-nitroso-tris chloroethylurea (NTCU) for 32 weeks to induce squamous dysplasia and SCC in mice. At 32 weeks the predominant cell type in the dysplastic airways was Keratin (K) 5 and K14 expressing basal cells. Notably, basal cells are extremely rare in the normal mouse bronchial epithelium but are abundant in the trachea. We therefore evaluated time-dependent changes in tracheal and bronchial histopathology after NTCU exposure (4, 8, 12, 16, 25 and 32 weeks). We show that tracheal dysplasia occurs significantly earlier than that of the bronchial epithelium (12 weeks vs. 25 weeks). This was associated with increased numbers of K5(+)/K14(+) tracheal basal cells and a complete loss of secretory (Club cell secretory protein expressing CCSP+) and ciliated cells. TUNEL staining of NTCU treated tissues confirmed that the loss of CCSP+ and ciliated cells was not due to apoptosis. However, mitotic index (measured by bromodeoxyuridine incorporation) showed that NTCU treatment increased proliferation of K5(+) basal cells in the trachea, and altered bronchial mitotic population from CCSP+ to K5(+) basal cells. Thus, we demonstrate that NTCU-induced lung epithelial dysplasia starts in the tracheal epithelium, and is followed by basal cell metaplasia of the bronchial epithelium. This analysis extends our knowledge of the NTCU-SCC model by defining the early changes in epithelial cell phenotypes in distinct airway locations, and this may assist in identifying new targets for future chemoprevention studies.	[Ghosh, Moumita; Kwon, Jennifer B.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Dwyer-Nield, Lori D.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Barthel, Lea; Janssen, William J.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Keith, Robert L.] Denver Veteran Affairs Med Ctr, Div Pulm Sci & Crit Care Med, Dept Med, Denver, CO USA; [Merrick, Daniel T.] Univ Colorado, Dept Pathol, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Ghosh, M (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	ghoshm@njhealth.org			FAMRI [YCSA 113259]; NCI [R01 CA132552-05]; NIH [P50-CA058187]; Lung cancer prevention award [AWD 120560]; Department of Veterans Affairs;  [HL107686]; NATIONAL CANCER INSTITUTE [P50CA058187, R01CA132552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109517, K18HL107686] Funding Source: NIH RePORTER	FAMRI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung cancer prevention award; Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following funding: (HL107686, MG), FAMRI (YCSA 113259, MG), NCI R01 CA132552-05 (LDD), NIH SPORE in lung cancer (P50-CA058187, RLK, DTM), Lung cancer prevention award (AWD 120560, DTM) and Department of Veterans Affairs Merit Review program (RLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Banerjee AK, 2009, J THORAC ONCOL, V4, P545, DOI 10.1097/JTO.0b013e31819667bd; Brechbuhl HM, 2011, AM J PATHOL, V179, P367, DOI 10.1016/j.ajpath.2011.03.016; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Dakir ELH, 2008, CARCINOGENESIS, V29, P2377, DOI 10.1093/carcin/bgn190; Evans MJ, 2004, CLIN EXP ALLERGY, V34, P1131, DOI 10.1111/j.1365-2222.2004.02004.x; Ghosh M, 2013, STEM CELLS, V31, P2767, DOI 10.1002/stem.1440; Ghosh M, 2013, AM J RESP CELL MOL, V49, P1127, DOI 10.1165/rcmb.2013-0049OC; Ghosh M, 2011, AM J RESP CELL MOL, V45, P459, DOI 10.1165/rcmb.2010-0314OC; Ghosh M, 2011, AM J RESP CELL MOL, V45, P403, DOI 10.1165/rcmb.2010-0283OC; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hudish TM, 2011, CANCER PREV RES, V5, P283; Ishida-Yamamoto A, 1998, EXP DERMATOL, V7, P1, DOI 10.1111/j.1600-0625.1998.tb00295.x; JETTEN AM, 1989, ENVIRON HEALTH PERSP, V80, P149, DOI 10.2307/3430740; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kelly K, 2009, CANCER PREV RES, V2, P440, DOI 10.1158/1940-6207.CAPR-08-0136; Khojasteh M, 2012, ANAL QUANT CYTOL, V34, P120; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128; Merrick DT, 2006, CLIN CANCER RES, V12, P2281, DOI 10.1158/1078-0432.CCR-05-2291; Miller YE, 2007, CANCER EPIDEM BIOMAR, V16, P2425, DOI 10.1158/1055-9965.EPI-07-0220; Nicholson AG, 2001, HISTOPATHOLOGY, V38, P202, DOI 10.1046/j.1365-2559.2001.01078.x; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; REHM S, 1991, AM J PATHOL, V139, P413; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Van Winkle LS, 2004, J APPL PHYSIOL, V97, P2355, DOI 10.1152/japplphysiol.00470.2004; Wang Y, 2004, CANCER RES, V64, P1647, DOI 10.1158/0008-5472.CAN-03-3273; Xiao ZX, 2013, CANCER CELL, V23, P527, DOI 10.1016/j.ccr.2013.03.009; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122823	10.1371/journal.pone.0122823	http://dx.doi.org/10.1371/journal.pone.0122823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860262	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300064
J	Han, XP; Wang, XW; Yan, XY; Wang, BH				Han, Xiao-Pu; Wang, Xiang-Wen; Yan, Xiao-Yong; Wang, Bing-Hong			Cascading Walks Model for Human Mobility Patterns	PLOS ONE			English	Article							SCALING LAWS; HEAVY TAILS; PREDICTABILITY	Background Uncovering the mechanism behind the scaling laws and series of anomalies in human trajectories is of fundamental significance in understanding many spatio-temporal phenomena. Recently, several models, e.g. the explorations-returns model (Song et al., 2010) and the radiation model for intercity travels (Simini et al., 2012), have been proposed to study the origin of these anomalies and the prediction of human movements. However, an agent-based model that could reproduce most of empirical observations without priori is still lacking. Methodology/Principal Findings In this paper, considering the empirical findings on the correlations of move-lengths and staying time in human trips, we propose a simple model which is mainly based on the cascading processes to capture the human mobility patterns. In this model, each long-range movement activates series of shorter movements that are organized by the law of localized explorations and preferential returns in prescribed region. Conclusions/Significance Based on the numerical simulations and analytical studies, we show more than five statistical characters that are well consistent with the empirical observations, including several types of scaling anomalies and the ultraslow diffusion properties, implying the cascading processes associated with the localized exploration and preferential returns are indeed a key in the understanding of human mobility activities. Moreover, the model shows both of the diverse individual mobility and aggregated scaling displacements, bridging the micro and macro patterns in human mobility. In summary, our model successfully explains most of empirical findings and provides deeper understandings on the emergence of human mobility patterns.	[Han, Xiao-Pu] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou 311121, Zhejiang, Peoples R China; [Han, Xiao-Pu; Yan, Xiao-Yong] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou 311121, Zhejiang, Peoples R China; [Wang, Xiang-Wen] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Wang, Xiang-Wen; Wang, Bing-Hong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Yan, Xiao-Yong] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Yan, Xiao-Yong] Shijiazhuang Tiedao Univ, Dept Transportat Engn, Shijiazhuang 050043, Peoples R China; [Yan, Xiao-Yong] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610051, Peoples R China	Hangzhou Normal University; Hangzhou Normal University; Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing Normal University; Shijiazhuang Tiedao University; University of Electronic Science & Technology of China	Han, XP (corresponding author), Hangzhou Normal Univ, Inst Informat Econ, Hangzhou 311121, Zhejiang, Peoples R China.	xp@hznu.edu.cn	Yan, Xiao-Yong/P-6027-2018; Wang, Xiangwen/AAR-6326-2021; Han, Xiao-Pu/E-8401-2010	Yan, Xiao-Yong/0000-0003-2091-6967; Wang, Xiangwen/0000-0002-4755-4639	National Natural Science Foundation of China [11205040, 11105024, 61304177, 11305043, 11275186]; Zhejiang Provincial Natural Science Foundation of China [LY12A05003]; Hangzhou Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Hangzhou Normal University	This work is supported by the National Natural Science Foundation of China (11205040, 11105024, 61304177, 11305043, 11275186), and the Zhejiang Provincial Natural Science Foundation of China under the grant No. LY12A05003, and the research startup fund of Hangzhou Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; Gallotti R, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113920010; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Peng CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034487; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Rhe I., 2008, P IEEE INFOCOM, P924; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sinatra R, 2014, ENTROPY-SWITZ, V16, P543, DOI 10.3390/e16010543; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Veneziano D, ARXIV11013719; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Yan XY, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/120506; Zhao ZD, 2012, CHAOS, V22, DOI 10.1063/1.4730750; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677	43	1	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124800	10.1371/journal.pone.0124800	http://dx.doi.org/10.1371/journal.pone.0124800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860140	gold, Green Published, Green Submitted			2022-12-26	WOS:000352590300147
J	Lambert, D; Carrillo, CD; Koziol, AG; Manninger, P; Blais, BW				Lambert, Dominic; Carrillo, Catherine D.; Koziol, Adam G.; Manninger, Paul; Blais, Burton W.			GeneSippr: A Rapid Whole-Genome Approach for the Identification and Characterization of Foodborne Pathogens such as Priority Shiga Toxigenic Escherichia coli	PLOS ONE			English	Article							VIRULENCE; SEQUENCE; SURVEILLANCE; OUTBREAK; SYSTEM; O26	The timely identification and characterization of foodborne bacteria for risk assessment purposes is a key operation in outbreak investigations. Current methods require several days and/or provide low-resolution characterization. Here we describe a whole-genome-sequencing (WGS) approach (GeneSippr) enabling same-day identification of colony isolates recovered from investigative food samples. The identification of colonies of priority Shiga-toxigenic Escherichia coli (STEC) (i.e., serogroups O26, O45, O103, O111, O121, O145 and O157) served as a proof of concept. Genomic DNA was isolated from single colonies and sequencing was conducted on the Illumina MiSeq instrument with raw data sampling from the instrument following 4.5 hrs of sequencing. Modeling experiments indicated that datasets comprised of 21-nt reads representing approximately 4-fold coverage of the genome were sufficient to avoid significant gaps in sequence data. A novel bioinformatic pipeline was used to identify the presence of specific marker genes based on mapping of the short reads to reference sequence libraries, along with the detection of dispersed conserved genomic markers as a quality control metric to assure the validity of the analysis. STEC virulence markers were correctly identified in all isolates tested, and single colonies were identified within 9 hrs. This method has the potential to produce high-resolution characterization of STEC isolates, and whole-genome sequence data generated following the GeneSippr analysis could be used for isolate identification in place of lengthy biochemical characterization and typing methodologies. Significant advantages of this procedure include ease of adaptation to the detection of any gene marker of interest, as well as to the identification of other foodborne pathogens for which genomic markers have been defined.	[Lambert, Dominic; Carrillo, Catherine D.; Koziol, Adam G.; Manninger, Paul; Blais, Burton W.] Canadian Food Inspect Agcy, Sci Branch, Ottawa Lab Carling, Res & Dev, Ottawa, ON, Canada	Canadian Food Inspection Agency	Blais, BW (corresponding author), Canadian Food Inspect Agcy, Sci Branch, Ottawa Lab Carling, Res & Dev, Ottawa, ON, Canada.	Burton.Blais@inspection.gc.ca	Carrillo, Catherine/X-2714-2019	Carrillo, Catherine/0000-0002-2334-8718	Canadian Safety and Security Program [CSSP-2013-TI-1145]	Canadian Safety and Security Program	The sequencing instrument was purchased through funding provided by the Canadian Safety and Security Program (CSSP-2013-TI-1145). Budget for materials and reagents was provided by the Canadian Food Inspection Agency, technology development funds.	Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Blais BW, 2012, J FOOD PROTECT, V75, P1691, DOI 10.4315/0362-028X.JFP-12-116; Deer DM, 2010, LETT APPL MICROBIOL, V50, P366, DOI 10.1111/j.1472-765X.2010.02804.x; Delannoy S, 2013, J CLIN MICROBIOL, V51, P1083, DOI 10.1128/JCM.02864-12; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Eppinger M, 2015, GUT MICROBES, V6, P194, DOI 10.4161/19490976.2014.969979; Evans PS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01154-13; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Franz E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/j.ijfoodmicro.2014.07.002; Gill A, 2012, J FOOD PROTECT, V75, P827, DOI 10.4315/0362-028X.JFP-11-395; Gilmour MW, 2006, J CLIN MICROBIOL, V44, P449, DOI 10.1128/JCM.44.2.449-458.2006; Gordon A, 2010, FASTX TOOLKIT FASTQA; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huszczynski G, 2013, J FOOD PROTECT, V76, P1689, DOI 10.4315/0362-028X.JFP-13-059; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martinez-Perez A, 2010, FOOD CONTROL, V21, P1354, DOI 10.1016/j.foodcont.2010.04.009; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Postingl H., SEQUENCE MAPPING ALI; Prager R, 2005, INT J MED MICROBIOL, V295, P29, DOI 10.1016/j.ijmm.2004.12.009; Prager R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095379; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; Shringi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051572; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Trees E, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00718-14; U.S. Department of Agriculture F.S. and I.S. (USDA-FSIS), 2011, FED REGISTER, V76, P58157; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	37	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122928	10.1371/journal.pone.0122928	http://dx.doi.org/10.1371/journal.pone.0122928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860693	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300068
J	Lee, JS; Kim, DH; Lee, HJ; Kim, HJ; Koo, JW; Choi, HG; Park, B; Hong, SK				Lee, Joong Seob; Kim, Dong Hyun; Lee, Hyo Jeong; Kim, Hyung Jong; Koo, Ja Won; Choi, Hyo Geun; Park, Bumjung; Hong, Sung Kwang			Lipid Profiles and Obesity as Potential Risk Factors of Sudden Sensorineural Hearing Loss	PLOS ONE			English	Article							CARDIOVASCULAR RISK; MEDICAL LITERATURE; CRITICAL-APPRAISAL; BLOOD-VISCOSITY	Objectives The objective of our study was to establish whether increased lipid profiles and obesity affect the prevalence and prognosis of sudden sensorineural hearing loss (SSNHL). Methods This was a case-controlled study with a longitudinal design. According to our criteria, 324 patients with SSNHL were included in this study. To manage potential covariates, 972 subjects with normal hearing from the Korean National Health and Nutrition Examination Survey were matched as control group according to their propensity scores. Age, level of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and body mass index (BMI) were obtained from the clinical data. Multivariate logistic regression analysis was used to investigate the association between SSNHL and lipid profiles or obesity in the 1296 subjects. Multivariate Cox regression analysis was used to determine whether lipid profiles and obesity are prognostic factors in patients with SSNHL. Results Mean body weight, BMI, TC, and TG were significantly higher in patients with SSNHL compared with control subjects (p<0.05). However, LDL-C values did not differ significantly between the two groups. Subjects with elevated TC and TG levels had a 2.20-(95% CI 1.50-3.24) and 1.50-fold (95% CI 1.08-2.08) increased odds, respectively, of SSNHL compared with subjects with normal TC and TG levels. Subjects with grade III BMI had a 1.59-fold (95% CI 1.17-2.16) increased odds of SSNHL. Multivariate Cox regression analyses revealed that BMI was an independent risk factor of treatment outcome, as patients with BMI >= 27.5 were less likely to achieve complete recovery than those with BMI <27.5 (p<0.05). Conclusions The results of this study revealed that elevated TC and TG levels and increased BMI are significantly associated with the prevalence of SSNHL and its prognosis, indicating that vascular compromise may play an important role in the pathogenesis of SSNHL.	[Lee, Joong Seob; Kim, Dong Hyun; Lee, Hyo Jeong; Kim, Hyung Jong; Choi, Hyo Geun; Park, Bumjung; Hong, Sung Kwang] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Koo, Ja Won] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea	Hallym University; Seoul National University (SNU)	Hong, SK (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	skhong96@hallym.ac.kr	Choi, Hyo Geun/K-4461-2019; Lee, Hyo-Jeong/AAK-7973-2020	Choi, Hyo Geun/0000-0003-1655-9549; Lee, Hyo-Jeong/0000-0003-2258-0803	Hallym University Research Fund [HURF-2014-27]; National Research Foundation (NRF) of Korea grants - Korean Government [NRF-2014R1A1A2A16054791]	Hallym University Research Fund; National Research Foundation (NRF) of Korea grants - Korean Government	The corresponding author, SKH, received the funds, Hallym University Research Fund 2014 (HURF-2014-27) and National Research Foundation (NRF) of Korea grants funded by Korean Government (NRF-2014R1A1A2A16054791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Ballesteros F, 2012, AUDIOL NEURO-OTOL, V17, P400, DOI 10.1159/000341989; Ballesteros F, 2009, AUDIOL NEURO-OTOL, V14, P139, DOI 10.1159/000171475; Cadoni G, 2007, OTOL NEUROTOL, V28, P878; Cadoni G, 2010, ANN OTO RHINOL LARYN, V119, P82, DOI 10.1177/000348941011900203; Ciccone MM, 2012, ATHEROSCLEROSIS, V225, P511, DOI 10.1016/j.atherosclerosis.2012.10.024; GATEHOUSE S, 1989, ARCH OTOLARYNGOL, V115, P1227; Hansen BB, 2008, STAT MED, V27, P2050, DOI 10.1002/sim.3208; Jellinger PS, 2012, ENDOCR PRACT, V18, P270, DOI 10.4158/EP.18.2.269; Kim DR, 2011, OTOL NEUROTOL, V32, P1596, DOI 10.1097/MAO.0b013e31823558a0; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; MILLER JM, 1988, AM J OTOLARYNG, V9, P302, DOI 10.1016/S0196-0709(88)80038-3; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; Shamai L, 2011, OBES SURG, V21, P42, DOI 10.1007/s11695-010-0170-7; Shiwaku K, 2004, LANCET, V363, P1077, DOI 10.1016/S0140-6736(04)15856-X; SIEGEL LG, 1975, OTOLARYNG CLIN N AM, V8, P467; Skeggs JW, 2002, J LIPID RES, V43, P1264, DOI 10.1194/jlr.M100431-JLR200; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; ULLRICH D, 1992, EUR ARCH OTO-RHINO-L, V249, P273, DOI 10.1007/BF00714491; Westreich D, 2011, PHARMACOEPIDEM DR S, V20, P317, DOI 10.1002/pds.2074; Yavuz E, 2005, J NEUROSCI METH, V147, P55, DOI 10.1016/j.jneumeth.2005.03.004	24	26	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122496	10.1371/journal.pone.0122496	http://dx.doi.org/10.1371/journal.pone.0122496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860024	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300048
J	Clark, DB; Hurtado, J; Saatchi, SS				Clark, David B.; Hurtado, Johanna; Saatchi, Sassan S.			Tropical Rain Forest Structure, Tree Growth and Dynamics along a 2700-m Elevational Transect in Costa Rica	PLOS ONE			English	Article							MOUNT-KINABALU; RANGE SHIFTS; BIOMASS; CLIMATE; GRADIENTS; MORTALITY	Rapid biological changes are expected to occur on tropical elevational gradients as species migrate upslope or go extinct in the face of global warming. We established a series of 9 1-ha plots in old-growth tropical rainforest in Costa Rica along a 2700 m relief elevational gradient to carry out long-term monitoring of tropical rain forest structure, dynamics and tree growth. Within each plot we mapped, identified, and annually measured diameter for all woody individuals with stem diameters >10 cm for periods of 3-10 years. Wood species diversity peaked at 400-600 m and decreased substantially at higher elevations. Basal area and stem number varied by less than two-fold, with the exception of the 2800 m cloud forest summit, where basal area and stem number were approximately double that of lower sites. Canopy gaps extending to the forest floor accounted for <3% of microsites at all elevations. Height of highest crowns and the coefficient of variation of crown height both decreased with increasing elevation. Rates of turnover of individuals and of stand basal area decreased with elevation, but rates of diameter growth and stand basal area showed no simple relation to elevation. We discuss issues encountered in the design and implementation of this network of plots, including biased sampling, missing key meteorological and biomass data, and strategies for improving species-level research. Taking full advantage of the major research potential of tropical forest elevational transects will require sustaining and extending ground based studies, incorporation of new remotely-sensed data and data-acquisition platforms, and new funding models to support decadal research on these rapidly-changing systems.	[Clark, David B.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Hurtado, Johanna] Org Trop Studies, La Selva Biol Stn, Puerto Viejo de Sarapiqui, Heredia, Costa Rica; [Saatchi, Sassan S.] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of Missouri System; University of Missouri Saint Louis; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Clark, DB (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	dbclark50@yahoo.com	Saatchi, Sassan/AAQ-2649-2021		Tropical Ecology Assessment and Monitoring program (TEAM) of Conservational International; NASA Terrestrial Ecology grant [11-TE11-0100]	Tropical Ecology Assessment and Monitoring program (TEAM) of Conservational International; NASA Terrestrial Ecology grant	JH and DBC received funding from the Tropical Ecology Assessment and Monitoring program (TEAM) of Conservational International (http://www.teamnetwork.org/). DBC and SSS were funded by NASA Terrestrial Ecology grant 11-TE11-0100 (http://cce.nasa.gov/cce/terrestrial.htm). The funders had no role in study design, data collection	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Beck E., 2008, V198, P1; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark DB, 2004, ECOL LETT, V7, P52, DOI 10.1046/j.1461-0248.2003.00547.x; Clark DB, 1990, REPROD ECOLOGY TROPI, P291; Clark DB, 2002, ECOLOGIA CONSERVACIO, P193, DOI [10.1016/j.watres.2013.08.031, DOI 10.1016/J.WATRES.2013.08.031]; Clark DA, 2007, BIOTROPICA, V39, P4, DOI 10.1111/j.1744-7429.2006.00227.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Clark DA, 2011, BIOTROPICA, V43, P31, DOI 10.1111/j.1744-7429.2010.00654.x; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V38, P783, DOI [10.1111/j.1365-2699.2010.02444.x, DOI 10.1111/J.1365-2699.2010.02444.X]; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Fisher JB, 2013, OECOLOGIA, V172, P889, DOI 10.1007/s00442-012-2522-6; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P161, DOI 10.1080/17550874.2013.820806; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Gradstein RS, 2010, TROPICAL MOUNTAIN FO; Hartshorn GS, 1988, TROPICAL RAINFORESTS, P281; HEANEY A, 1990, J TROP ECOL, V6, P307, DOI 10.1017/S0266467400004557; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Holdridge L. R., 1971, Forest environments in tropical life zones: a pilot study.; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Lloyd J, 2009, ECOL LETT, V12, pE19, DOI 10.1111/j.1461-0248.2009.01326.x; Losos L, 2004, TROPICAL FOREST DIVE, P645; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; Richards PW, 1996, TROPICAL RAIN FOREST, P575; Scatena FN, 2011, TROPICAL MONTANE CLO, P3, DOI DOI 10.1017/CBO9780511778384.003; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Spracklen DV, 2014, BIOGEOSCIENCES, V11, P2741, DOI 10.5194/bg-11-2741-2014; Stocker T., 2013, COMPUTATIONAL GEOMET, DOI 10.1017/ CBO9781107415324; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	43	39	43	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122905	10.1371/journal.pone.0122905	http://dx.doi.org/10.1371/journal.pone.0122905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856163	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500064
J	Djomehri, SI; Candell, S; Case, T; Browning, A; Marshall, GW; Yun, WB; Lau, SH; Webb, S; Ho, SP				Djomehri, Sabra I.; Candell, Susan; Case, Thomas; Browning, Alyssa; Marshall, Grayson W.; Yun, Wenbing; Lau, S. H.; Webb, Samuel; Ho, Sunita P.			Mineral Density Volume Gradients in Normal and Diseased Human Tissues	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; HUMAN CEMENTUM; HUMAN TEETH; QUANTITATIVE-EVALUATION; MECHANICAL-PROPERTIES; DENTAL CALCULUS; TRACE-ELEMENTS; CARIES; ZINC; MICROANALYSIS	Clinical computed tomography provides a single mineral density (MD) value for heterogeneous calcified tissues containing early and late stage pathologic formations. The novel aspect of this study is that, it extends current quantitative methods of mapping mineral density gradients to three dimensions, discretizes early and late mineralized stages, identifies elemental distribution in discretized volumes, and correlates measured MD with respective calcium (Ca) to phosphorus (P) and Ca to zinc (Zn) elemental ratios. To accomplish this, MD variations identified using polychromatic radiation from a high resolution micro-computed tomography (micro-CT) benchtop unit were correlated with elemental mapping obtained from a microprobe X-ray fluorescence (XRF) using synchrotron monochromatic radiation. Digital segmentation of tomograms from normal and diseased tissues (N=5 per group; 40-60 year old males) contained significant mineral density variations (enamel: 2820-3095mg/cc, bone: 570-1415mg/cc, cementum: 1240-1340mg/cc, dentin: 1480-1590mg/cc, cementum affected by periodontitis: 1100-1220mg/cc, hypomineralized carious dentin: 345-1450mg/cc, hypermineralized carious dentin: 1815-2740mg/cc, and dental calculus: 1290-1770mg/cc). A plausible linear correlation between segmented MD volumes and elemental ratios within these volumes was established, and Ca/P ratios for dentin (1.49), hypomineralized dentin (0.32-0.46), cementum (1.51), and bone (1.68) were observed. Furthermore, varying Ca/Zn ratios were distinguished in adapted compared to normal tissues, such as in bone (855-2765) and in cementum (595-990), highlighting Zn as an influential element in prompting observed adaptive properties. Hence, results provide insights on mineral density gradients with elemental concentrations and elemental footprints that in turn could aid in elucidating mechanistic processes for pathologic formations.	[Djomehri, Sabra I.; Marshall, Grayson W.; Ho, Sunita P.] Univ San Francisco, Div Biomat & Bioengn, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94117 USA; [Candell, Susan; Case, Thomas; Browning, Alyssa; Yun, Wenbing; Lau, S. H.] Xradia Inc, Pleasanton, CA USA; [Webb, Samuel] Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	University of San Francisco; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Ho, SP (corresponding author), Univ San Francisco, Div Biomat & Bioengn, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94117 USA.	sunita.ho@ucsf.edu	Webb, Samuel M/D-4778-2009; Ho, Sunita P/B-1084-2008	Webb, Samuel M/0000-0003-1188-0464; Marshall, Grayson W/0000-0001-8921-3253	National Institute of Health (NIH)-National Institute of Dental and Craniofacial Research (NIDCR) [R00DE018212, S10RR026645]; NIH/NIDCR [R01DE022032, R01DE016849]; Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, University of California San Francisco (UCSF); U.S. Department of Energy [DE-AC02-76SF00515]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016849, R01DE022032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018212, R01DE011526] Funding Source: NIH RePORTER	National Institute of Health (NIH)-National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, University of California San Francisco (UCSF); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institute of Health (NIH)-National Institute of Dental and Craniofacial Research (NIDCR) R00DE018212 (SPH); S10RR026645 (SPH); NIH/NIDCR R01DE022032 (SPH); NIH/NIDCR R01DE016849 (GWM); Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, University of California San Francisco (UCSF). Work at SSRL was supported by the U.S. Department of Energy under contract number DE-AC02-76SF00515. Xradia Inc., provided support in the form of salaries for authors SC, TC, AB, WYand SHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017; Abraham J, 2005, J BIOMED MATER RES A, V75A, P623, DOI 10.1002/jbm.a.30484; Abraham J, 2002, ANAL CHEM, V74, P324, DOI 10.1021/ac0106389; Alvarez-Perez MA, 2005, MICROSC MICROANAL, V11, P313, DOI 10.1017/S1431927605050221; Andrews JC, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012081; Andrews JC, 2011, MICROSC RES TECHNIQ, V74, P671, DOI 10.1002/jemt.20907; Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231; Arnold WH, 2001, CALCIFIED TISSUE INT, V69, P268, DOI 10.1007/s002230020023; Arola D, 2005, BIOMATERIALS, V26, P4051, DOI 10.1016/j.biomaterials.2004.10.029; Arzate H, 2000, J DENT RES, V79, P28, DOI 10.1177/00220345000790010301; ATTRAMADAL A, 1976, ACTA ODONTOL SCAND, V34, P127, DOI 10.3109/00016357609002559; Bazin D, 2008, J SYNCHROTRON RADIAT, V15, P506, DOI 10.1107/S0909049508014556; Bjorndal L, 2002, ENDOD TOPICS, V2, P2, DOI [10.1034/j.1601-1546.2002.30124.x, DOI 10.1034/J.1601-1546.2002.30124.X, 10.1034/j.1601-1546.2002.20102.x, DOI 10.1034/J.1601-1546.2002.20102.X]; Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; Bosshardt DD, 1997, PERIODONTOL 2000, V13, P41, DOI 10.1111/j.1600-0757.1997.tb00095.x; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Burwell AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038852; Carter Y, 2013, J STRUCT BIOL, V183, P519, DOI 10.1016/j.jsb.2013.07.004; Clementino-Luedemann TNR, 2006, DENT MATER J, V25, P113, DOI 10.4012/dmj.25.113; Davis GR, 1996, PHYSIOL MEAS, V17, P121, DOI 10.1088/0967-3334/17/3/001; Digabel H, 1978, P 2 EUR S QUANT AN M, V19, P8; Dowker SEP, 2003, CARIES RES, V37, P237, DOI 10.1159/000070865; Drzazga Z, 2007, BIOFACTORS, V30, P243, DOI 10.1002/biof.5520300405; Elam WT, 2002, RADIAT PHYS CHEM, V63, P121, DOI 10.1016/S0969-806X(01)00227-4; Entezari V, 2012, BONE, V50, P611, DOI 10.1016/j.bone.2011.10.004; Farah RA, 2010, J DENT, V38, P50, DOI 10.1016/j.jdent.2009.09.002; Frost HM, 1964, BONE BIODYN, V315, P1; FURSETH R, 1968, ARCH ORAL BIOL, V13, P1197, DOI 10.1016/0003-9969(68)90075-7; FUSAYAMA T, 1979, OPER DENT, V4, P63; GlenHaduch E, 1997, AM J PHYS ANTHROPOL, V103, P201, DOI 10.1002/(SICI)1096-8644(199706)103:2<201::AID-AJPA5>3.0.CO;2-W; GRON P, 1967, HELV ODONTOL ACTA, V11, P71; Hayashizaki J, 2008, ARCH ORAL BIOL, V53, P168, DOI 10.1016/j.archoralbio.2007.09.003; Ho SP, 2004, J BIOMED MATER RES A, V68A, P343, DOI 10.1002/jbm.a.20061; Ho SP, 2013, BONE, V57, P455, DOI 10.1016/j.bone.2013.09.007; Ho SP, 2009, DENT MATER, V25, P1195, DOI 10.1016/j.dental.2009.04.005; HOUNSFIELD GN, 1980, SCIENCE, V210, P22, DOI 10.1126/science.6997993; Hurng JM, 2011, BIOMATERIALS, V32, P7106, DOI 10.1016/j.biomaterials.2011.06.021; Jang AT, 2014, J MECH BEHAV BIOMED, V39, P184, DOI 10.1016/j.jmbbm.2014.07.015; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; Khan A, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P185; Kim I, 2007, CLIN ANAT, V20, P27, DOI 10.1002/ca.20265; Kinney J, 1993, SCANNING MICROSCOPY, V8, P204; Kinney JH, 2005, BIOMATERIALS, V26, P3363, DOI 10.1016/j.biomaterials.2004.09.004; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; KINNEY JH, 1995, J DENT RES, V74, P1179, DOI 10.1177/00220345950740050601; KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197; KNUUTTILA M, 1980, SCAND J DENT RES, V88, P513; KNUUTTILA M, 1979, SCAND J DENT RES, V87, P192; Kukacka Jiri, 2005, Biomedical Papers (Olomouc), V149, P225; Kyriazis Vassilios, 2004, ScientificWorldJournal, V4, P1027; LIEBERMAN DE, 1994, J ARCHAEOL SCI, V21, P525, DOI 10.1006/jasc.1994.1052; Lin JD, 2013, ACTA BIOMATER, V9, P4787, DOI 10.1016/j.actbio.2012.08.021; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Liu KZ, 2006, BBA-MOL BASIS DIS, V1762, P775, DOI 10.1016/j.bbadis.2006.05.014; Magloire H, 2001, Adv Dent Res, V15, P46; Martin RR, 2007, J ARCHAEOL SCI, V34, P936, DOI 10.1016/j.jas.2006.09.018; Martin RR, 2010, J SYNCHROTRON RADIAT, V17, P263, DOI 10.1107/S0909049509052807; Martin RR, 2004, J ENVIRON MONITOR, V6, P783, DOI 10.1039/b408525f; McMaster W., 1969, UCRL50174 LAWR RAD L; Moon PC, 2010, OPEN DENT J, V4, P147, DOI 10.2174/1874210601004010147; Nagase H, 1992, Matrix Suppl, V1, P237; NALBANDIAN JOHN, 1960, JOUR DENTAL RES, V39, P598, DOI 10.1177/00220345600390032101; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Neves AD, 2010, DENT MATER, V26, P579, DOI 10.1016/j.dental.2010.01.012; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OGAWA K, 1983, J DENT RES, V62, P7, DOI 10.1177/00220345830620011701; Omae M, 2009, DENT MATER J, V28, P471, DOI 10.4012/dmj.28.471; Oprea C, 2009, APPL RADIAT ISOTOPES, V67, P2142, DOI 10.1016/j.apradiso.2009.04.017; Pemmer B, 2013, BONE, V57, P184, DOI 10.1016/j.bone.2013.07.038; Pugach MK, 2009, J DENT RES, V88, P71, DOI 10.1177/0022034508327552; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rossi M, 2004, NUCL INSTRUM METH B, V213, P747, DOI 10.1016/S0168-583X(03)01697-5; SCHUPBACH P, 1992, CARIES RES, V26, P153, DOI 10.1159/000261436; Schwass DR, 2009, CARIES RES, V43, P314, DOI 10.1159/000226230; SMITH AJ, 1995, INT J DEV BIOL, V39, P273; Sulkala M, 2001, J DENT RES, V80, P1545, DOI 10.1177/00220345010800061301; Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; Ten Cate A, 1998, OR HIST DEV STRUCT F, P497; Thompson A, 2009, LBNLPUB490; Webb SM, 2011, AIP CONF PROC, V1365, P196, DOI 10.1063/1.3625338; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; WEINMANN J P, 1955, Oral Surg Oral Med Oral Pathol, V8, P1074, DOI 10.1016/0030-4220(55)90058-X; ZANDER H. A., 1958, JOUR DENTAL RES, V37, P1035; Zheng L, 2003, EUR J ORAL SCI, V111, P243, DOI 10.1034/j.1600-0722.2003.00038.x	89	42	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121611	10.1371/journal.pone.0121611	http://dx.doi.org/10.1371/journal.pone.0121611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856386	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500024
J	Funchal, GA; Jaeger, N; Czepielewski, RS; Machado, MS; Muraro, SP; Stein, RT; Bonorino, CBC; Porto, BN				Funchal, Giselle A.; Jaeger, Natalia; Czepielewski, Rafael S.; Machado, Mileni S.; Muraro, Stefanie P.; Stein, Renato T.; Bonorino, Cristina B. C.; Porto, Barbara N.			Respiratory Syncytial Virus Fusion Protein Promotes TLR-4-Dependent Neutrophil Extracellular Trap Formation by Human Neutrophils	PLOS ONE			English	Article							NADPH OXIDASE; SUBGROUP-B; IN-VITRO; KAPPA-B; MEDIATE; MYELOPEROXIDASE; INFECTION; ELASTASE; GLYCOPROTEINS; INFLAMMATION	Acute viral bronchiolitis by Respiratory Syncytial Virus (RSV) is the most common respiratory illness in children in the first year of life. RSV bronchiolitis generates large numbers of hospitalizations and an important burden to health systems. Neutrophils and their products are present in the airways of RSV-infected patients who developed increased lung disease. Neutrophil Extracellular Traps (NETs) are formed by the release of granular and nuclear contents of neutrophils in the extracellular space in response to different stimuli and recent studies have proposed a role for NETs in viral infections. In this study, we show that RSV particles and RSV Fusion protein were both capable of inducing NET formation by human neutrophils. Moreover, we analyzed the mechanisms involved in RSV Fusion protein-induced NET formation. RSV F protein was able to induce NET release in a concentration-dependent fashion with both neutrophil elastase and myeloperoxidase expressed on DNA fibers and F protein-induced NETs was dismantled by DNase treatment, confirming that their backbone is chromatin. This viral protein caused the release of extracellular DNA dependent on TLR-4 activation, NADPH Oxidase-derived ROS production and ERK and p38 MAPK phosphorylation. Together, these results demonstrate a coordinated signaling pathway activated by F protein that led to NET production. The massive production of NETs in RSV infection could aggravate the inflammatory symptoms of the infection in young children and babies. We propose that targeting the binding of TLR-4 by F protein could potentially lead to novel therapeutic approaches to help control RSV-induced inflammatory consequences and pathology of viral bronchiolitis.	[Funchal, Giselle A.; Machado, Mileni S.; Muraro, Stefanie P.; Porto, Barbara N.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Clin & Expt Immunol Lab, Porto Alegre, RS, Brazil; [Funchal, Giselle A.; Jaeger, Natalia; Czepielewski, Rafael S.; Bonorino, Cristina B. C.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Cellular & Mol Immunol Lab, Porto Alegre, RS, Brazil; [Stein, Renato T.; Porto, Barbara N.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Infant Ctr, Porto Alegre, RS, Brazil; [Funchal, Giselle A.; Jaeger, Natalia; Czepielewski, Rafael S.; Machado, Mileni S.; Muraro, Stefanie P.; Stein, Renato T.; Bonorino, Cristina B. C.; Porto, Barbara N.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Inst Biomed Res, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Porto, BN (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Clin & Expt Immunol Lab, Porto Alegre, RS, Brazil.	barbara.porto@pucrs.br	Czepielewski, Rafael/ABB-7858-2021; Muraro, Stefanie P/AAM-2017-2021; Muraro, Stefanie P/M-6705-2013; Stein, Renato Tetelbom/K-2568-2014; Bonorino, Cristina/U-2780-2019	Czepielewski, Rafael/0000-0002-2475-3838; Muraro, Stefanie P/0000-0002-5105-6659; Muraro, Stefanie P/0000-0002-5105-6659; Jaeger, Natalia/0000-0003-2875-8297; STEIN, RENATO/0000-0003-0269-0757	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472406/2010-8]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [11/1904-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant nr. 472406/2010-8, and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) grant nr. 11/1904-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Emboriadou M, 2007, ANN CLIN LAB SCI, V37, P79; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Jaovisidha P, 1999, J IMMUNOL, V163, P2816; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kahn JS, 1999, VIROLOGY, V254, P81, DOI 10.1006/viro.1998.9535; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lindemans CA, 2006, J IMMUNOL, V176, P5529, DOI 10.4049/jimmunol.176.9.5529; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; McCormick A, 2010, MICROBES INFECT, V12, P928, DOI 10.1016/j.micinf.2010.06.009; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mejias Asuncion, 2005, Pediatr Infect Dis J, V24, pS189, DOI 10.1097/01.inf.0000188196.87969.9a; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Stoppelenburg AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078461; STOTT EJ, 1985, ARCH VIROL, V84, P1, DOI 10.1007/BF01310552; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Teran LM, 1997, AM J RESP CRIT CARE, V155, P1362, DOI 10.1164/ajrccm.155.4.9105080; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Wang S Z, 2000, Respirology, V5, P1, DOI 10.1046/j.1440-1843.2000.00219.x; Wang SZ, 1998, EUR RESPIR J, V12, P612, DOI 10.1183/09031936.98.12030612; Wardini AB, 2010, J GEN VIROL, V91, P259, DOI 10.1099/vir.0.014613-0; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	53	96	104	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124082	10.1371/journal.pone.0124082	http://dx.doi.org/10.1371/journal.pone.0124082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856628	gold, Green Submitted, Green Published			2022-12-26	WOS:000352588500110
J	Nicoli, E; Syga, MI; Bosetti, M; Shastri, VP				Nicoli, Elena; Syga, Marie Isabel; Bosetti, Michela; Shastri, V. Prasad			Enhanced Gene Silencing through Human Serum Albumin-Mediated Delivery of Polyethylenimine-siRNA Polyplexes	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VIVO; NANOPARTICLES; MECHANISM; EXPRESSION; CAVEOLAE; CANCER; SIZE; ENDOCYTOSIS; STRATEGIES	Small interfering RNA (siRNA) targeted therapeutics (STT) offers a compelling alternative to tradition medications for treatment of genetic diseases by providing a means to silence the expression of specific aberrant proteins, through interference at the expression level. The perceived advantage of siRNA therapy is its ability to target, through synthetic antisense oligonucleotides, any part of the genome. Although STT provides a high level of specificity, it is also hindered by poor intracellular uptake, limited blood stability, high degradability and nonspecific immune stimulation. Since serum proteins has been considered as useful vehicles for targeting tumors, in this study we investigated the effect of incorporation of human serum albumin (HSA) in branched polyethylenimine (bPEI)-siRNA polyplexes in their internalization in epithelial and endothelial cells. We observed that introduction of HSA preserves the capacity of bPEI to complex with siRNA and protect it against extracellular endonucleases, while affording significantly improved internalization and silencing efficiency, compared to bPEI-siRNA polyplexes in endothelial and metastatic breast cancer epithelial cells. Furthermore, the uptake of the HSA-bPEI-siRNA ternary polyplexes occurred primarily through a caveolae-mediated endocytosis, thus providing evidence for a clear role for HSA in polyplex internalization. These results provide further impetus to explore the role of serum proteins in delivery of siRNA.	[Nicoli, Elena; Bosetti, Michela] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Novara, Italy; [Nicoli, Elena; Syga, Marie Isabel; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Freiburg, Germany; [Syga, Marie Isabel] Univ Freiburg, BIOSS, Ctr Biol Signalling Studies, Freiburg, Germany	University of Eastern Piedmont Amedeo Avogadro; University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, Freiburg, Germany.	prasad.shastri@gmail.com	Bosetti, Michela/AAR-9556-2021	Bosetti, Michela/0000-0002-3682-8702	5th INTERREG Upper Rhine Program (Project A21: NANO@MATRIX); German Federal Government; State Government (Centre for Biological Signalling Studies, BIOSS); State Government [EXC 294]	5th INTERREG Upper Rhine Program (Project A21: NANO@MATRIX); German Federal Government; State Government (Centre for Biological Signalling Studies, BIOSS); State Government	This work was funded by the 5th INTERREG Upper Rhine Program (Project A21: NANO@MATRIX), the excellence initiative of the German Federal and State Governments (grant EXC 294; Centre for Biological Signalling Studies, BIOSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2011, CELL BIOCHEM BIOPHYS, V61, P277, DOI 10.1007/s12013-011-9201-9; Aigner A, 2006, J BIOTECHNOL, V124, P12, DOI 10.1016/j.jbiotec.2005.12.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrabino S, 2005, J GENE MED, V7, P1555, DOI 10.1002/jgm.799; Desai N, 2009, TRANSL ONCOL, V2, P59, DOI 10.1593/tlo.09109; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Han JF, 2014, SMALL, V10, P524, DOI 10.1002/smll.201301992; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kanasty RL, 2012, MOL THER, V20, P513, DOI 10.1038/mt.2011.294; Kang JH, 2012, J CONTROL RELEASE, V163, P119, DOI 10.1016/j.jconrel.2012.08.030; Kim JA, 2012, NAT NANOTECHNOL, V7, P62, DOI [10.1038/nnano.2011.191, 10.1038/NNANO.2011.191]; Kim SI, 2009, J HEPATOL, V50, P479, DOI 10.1016/j.jhep.2008.10.029; Kratz F, 1998, DRUG DELIV, V5, P281, DOI 10.3109/10717549809065759; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Lavie Y, 2001, ADV DRUG DELIVER REV, V49, P317, DOI 10.1016/S0169-409X(01)00144-2; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Malek A, 2009, TOXICOL APPL PHARM, V236, P97, DOI 10.1016/j.taap.2009.01.014; Malik AB, 2009, J MED SCI, V2, P13; McDaneld TG, 2009, J ANIM SCI, V87, pE21, DOI 10.2527/jas.2008-1303; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Connor TP, 2006, NAT REV GENET, V7, P261, DOI 10.1038/nrg1829; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Pan T, 2009, J LUMIN, V129, P741, DOI 10.1016/j.jlumin.2009.02.006; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X; SCHNITZER JE, 1992, AM J PHYSIOL, V263, pH1872, DOI 10.1152/ajpheart.1992.263.6.H1872; Singh HD, 2010, ACTA BIOMATER, V6, P4277, DOI 10.1016/j.actbio.2010.06.017; Son S, 2013, BIOMATERIALS, V34, P9475, DOI 10.1016/j.biomaterials.2013.08.085; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Voigt J, 2014, P NATL ACAD SCI USA, V111, P2942, DOI 10.1073/pnas.1322356111; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Zuckerman JE, 2014, P NATL ACAD SCI USA, V111, P11449, DOI 10.1073/pnas.1411393111	36	31	32	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122581	10.1371/journal.pone.0122581	http://dx.doi.org/10.1371/journal.pone.0122581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856158	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500043
J	Trtikova, M; Wikmark, OG; Zemp, N; Widmer, A; Hilbeck, A				Trtikova, Miluse; Wikmark, Odd Gunnar; Zemp, Niklaus; Widmer, Alex; Hilbeck, Angelika			Transgene Expression and Bt Protein Content in Transgenic Bt Maize (MON810) under Optimal and Stressful Environmental Conditions	PLOS ONE			English	Article							MESSENGER-RNA; CRY1AB; COTTON; RESISTANCE; ABUNDANCE; ENDOTOXIN; LESSONS; TOXIN; GENE	Bt protein content in transgenic insect resistant (Bt) maize may vary between tissues within plants and between plants growing under different environmental conditions. However, it is unknown whether and how Bt protein content correlates with transgene expression, and whether this relationship is influenced by stressful environmental conditions. Two Bt maize varieties containing the same transgene cassette (MON 810) were grown under optimal and stressful conditions. Before and during stress exposure, the upper leaves were analysed for transgene expression using quantitative RT-PCR and for Bt content using ELISA. Under optimal conditions there was no significant difference in the transgene expression between the two investigated Bt maize varieties whereas Bt protein content differed significantly. Transgene expression was correlated with Bt protein content in only one of the varieties. Under stressful environmental conditions we found similar transgene expressions as under optimal conditions but Bt content responded differently. These results suggest that Bt content is not only controlled by the transgene expression but is also dependent on the genetic background of the maize variety. Under stressful conditions the concentration of Bt protein is even more difficult to predict.	[Trtikova, Miluse; Zemp, Niklaus; Widmer, Alex; Hilbeck, Angelika] ETH, IBZ, Plant Ecol Genet, CH-8092 Zurich, Switzerland; [Wikmark, Odd Gunnar; Hilbeck, Angelika] Genok Ctr Biosafety, N-9294 Tromso, Norway	Swiss Federal Institutes of Technology Domain; ETH Zurich	Trtikova, M (corresponding author), ETH, IBZ, Plant Ecol Genet, Univ Str 16, CH-8092 Zurich, Switzerland.	miluse.trtikova@env.ethz.ch	Zemp, Niklaus/K-7467-2012; Widmer, Alex/B-6841-2009	Zemp, Niklaus/0000-0002-0991-5130; Widmer, Alex/0000-0001-8253-5137; Wikmark, Odd-Gunnar/0000-0002-8005-138X	ETH Zurich; Genok; Manfred-Hermsen-Stiftung fur Natur und Umwelt; Testbiotech	ETH Zurich(ETH Zurich); Genok; Manfred-Hermsen-Stiftung fur Natur und Umwelt; Testbiotech	This research was funded by ETH Zurich, Genok, Manfred-Hermsen-Stiftung fur Natur und Umwelt and Testbiotech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk JJ, 2009, TRANSGENIC RES, V18, P143, DOI 10.1007/s11248-008-9198-z; Bruns HA, 2003, AGRON J, V95, P207, DOI 10.2134/agronj2003.0207; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Coll A, 2009, TRANSGENIC RES, V18, P801, DOI 10.1007/s11248-009-9266-z; Corrado G, 2009, BIOTECHNOL ADV, V27, P733, DOI 10.1016/j.biotechadv.2009.05.006; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; FAOSTAT, 2012, FOOD AGR COMM PROD; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Li MY, 2013, J INTEGR AGR, V12, P436, DOI [10.1016/S2095-3119(13)60244-0, 10.1016/s2095-3119(13)60244-0]; La Paz JL, 2010, PLANT MOL BIOL, V74, P563, DOI 10.1007/s11103-010-9696-2; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; MEYER P, 1992, MOL GEN GENET, V231, P345, DOI 10.1007/BF00292701; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Olsen KM, 2005, J ECON ENTOMOL, V98, P1382, DOI 10.1603/0022-0493-98.4.1382; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Szekacs A, 2010, ENVIRON TOXICOL CHEM, V29, P182, DOI 10.1002/etc.5; Szekacs A, 2010, ANAL BIOANAL CHEM, V396, P2203, DOI 10.1007/s00216-009-3384-6; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185	26	41	43	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123011	10.1371/journal.pone.0123011	http://dx.doi.org/10.1371/journal.pone.0123011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853814	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400091
J	Paul, SS; Sil, P; Haldar, S; Mitra, S; Chattopadhyay, K				Paul, Simanta Sarani; Sil, Pallabi; Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda			Subtle Change in the Charge Distribution of Surface Residues May Affect the Secondary Functions of Cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CARDIOLIPIN INTERACTION; STRUCTURAL TRANSITIONS; MITOCHONDRIAL PATHWAY; PEROXIDASE-ACTIVITY; APOPTOTIC ACTIVITY; HORSE HEART; ACETIC-ACID; PROTEIN; RELEASE	Although the primary function of cytochrome c (cyt c) is electron transfer, the protein caries out an additional secondary function involving its interaction with membrane cardiolipin (CDL), its peroxidase activity, and the initiation of apoptosis. Whereas the primary function of cyt c is essentially conserved, its secondary function varies depending on the source of the protein. We report here a detailed experimental and computational study, which aims to understand, at the molecular level, the difference in the secondary functions of cyt c obtained from horse heart (mammalian) and Saccharomyces cerevisiae (yeast). The conformational landscape of cyt c has been found to be heterogeneous, consisting of an equilibrium between the compact and extended conformers as well as the oligomeric species. Because the determination of relative populations of these conformers is difficult to obtain by ensemble measurements, we used fluorescence correlation spectroscopy (FCS), a method that offers single-molecule resolution. The population of different species is found to depend on multiple factors, including the protein source, the presence of CDL and urea, and their concentrations. The complex interplay between the conformational distribution and oligomerization plays a crucial role in the variation of the pre-apoptotic regulation of cyt c observed from different sources. Finally, computational studies reveal that the variation in the charge distribution at the surface and the charge reversal sites may be the key determinant of the conformational stability of cyt c.	[Paul, Simanta Sarani; Sil, Pallabi; Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda] CSIR Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, K (corresponding author), CSIR Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570	network project grant (UNSEEN) from the Council of Scientific and Industrial Research (CSIR), India; Indian National Science Academy (INSA)	network project grant (UNSEEN) from the Council of Scientific and Industrial Research (CSIR), India; Indian National Science Academy (INSA)	This study was funded by a network project grant (UNSEEN) from the Council of Scientific and Industrial Research (CSIR), India.r Recipient of a senior scientist award grant from the Indian National Science Academy (INSA).	Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; BLAUER G, 1993, BIOCHEMISTRY-US, V32, P6674, DOI 10.1021/bi00077a021; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Diederix REM, 2002, BIOCHEMISTRY-US, V41, P13067, DOI 10.1021/bi0260841; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Giannattasio S, 2008, FEBS LETT, V582, P1519, DOI 10.1016/j.febslet.2008.03.048; Godoy LC, 2009, P NATL ACAD SCI USA, V106, P2653, DOI 10.1073/pnas.0809279106; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Guaragnella N, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00070; Haldar S, 2015, LANGMUIR, V31, P4213, DOI 10.1021/la5029993; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Haldar S, 2010, J BIOL CHEM, V285, P25314, DOI 10.1074/jbc.M110.116673; Hanske J, 2012, P NATL ACAD SCI USA, V109, P125, DOI 10.1073/pnas.1112312108; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Hong YN, 2012, J AM CHEM SOC, V134, P18713, DOI 10.1021/ja307426k; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jemmerson R, 1999, BIOCHEMISTRY-US, V38, P3599, DOI 10.1021/bi9809268; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; McClelland LJ, 2014, P NATL ACAD SCI USA, V111, P6648, DOI 10.1073/pnas.1323828111; Miyamoto S, 2012, PHOTOCH PHOTOBIO SCI, V11, P1536, DOI 10.1039/c2pp25119a; Mueller GP, 2007, J BIOL CHEM, V282, P22364, DOI 10.1074/jbc.M701801200; Muenzner J, 2014, CHEM PHYS LIPIDS, V179, P57, DOI 10.1016/j.chemphyslip.2013.11.002; Muenzner J, 2013, J PHYS CHEM B, V117, P12878, DOI 10.1021/jp402104r; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Nantes IL, 2010, METHODS MOL BIOL, V606, P147, DOI 10.1007/978-1-60761-447-0_12; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Patriarca A, 2012, ARCH BIOCHEM BIOPHYS, V522, P62, DOI 10.1016/j.abb.2012.03.028; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; PINHEIRO TJT, 1994, BIOCHIMIE, V76, P489, DOI 10.1016/0300-9084(94)90173-2; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Santucci R, 2010, EXPERT REV PROTEOMIC, V7, P507, DOI 10.1586/EPR.10.50; Sarkar S, 2014, BIOCHEMISTRY-US, V53, P1393, DOI 10.1021/bi4014837; Sen Mojumdar S, 2012, J PHYS CHEM B, V116, P12189, DOI 10.1021/jp307297s; Sinibaldi F, 2008, BIOCHEMISTRY-US, V47, P6928, DOI 10.1021/bi800048v; Sinibaldi F, 2013, BIOCHEMISTRY-US, V52, P4578, DOI 10.1021/bi400324c; Sinibaldi F, 2011, J INORG BIOCHEM, V105, P1365, DOI 10.1016/j.jinorgbio.2011.07.022; Sukhotnik I, 2005, EUR J PEDIATR SURG, V15, P229, DOI 10.1055/s-2005-865766; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Wang ZH, 2011, ORG BIOMOL CHEM, V9, P4766, DOI 10.1039/c1ob05552f; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200	64	20	20	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14476	14490		10.1074/jbc.M114.607010	http://dx.doi.org/10.1074/jbc.M114.607010			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25873393	Green Published, hybrid			2022-12-26	WOS:000355754600018
J	Khomami, MB; Tehrani, FR; Hashemi, S; Farahmand, M; Azizi, F				Khomami, Mahnaz Bahri; Tehrani, Fahimeh Ramezani; Hashemi, Somayeh; Farahmand, Maryam; Azizi, Fereidoun			Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; HEALTH; PREVALENCE; ASSOCIATION; ADOLESCENTS; POPULATION; CRITERIA	Introduction Polycystic ovary syndrome is a common endocrine disorder affecting women both physically and psychologically and can lead to a poor quality of life compared to their normal counterparts. The aim of the present study was to assess the impact of various clinical features of polycystic ovary syndrome on the health-related quality of life of Iranian women diagnosed with this syndrome. Materials and Methods A total of 796 women diagnosed with polycystic ovary syndrome, aged 15-49 years, completed the questionnaires, interviews, and medical assessments required for this study. A reliable and validated Persian version of the health-related quality of life questionnaire for polycystic ovary syndrome patients was used. Linear regression models were used to assess the association between the symptoms of polycystic ovary syndrome and health-related quality of life. Results The mean age of participants was 28.02 years. 35.4% of the subjects were classified as overweight or obese. Hirsutism, was reported to have the strongest impact on the patients' health-related quality of life, followed in descending order by body mass index, irregular menses and infertility. The relative level of hirsutism was directly proportional to decrease in health-related quality of life score (p<0.001). Conclusions The results of the study found that hirsutism had the strongest impact on the health-related quality of life measures in Iranian women diagnosed with polycystic ovary syndrome. Health care officials need to evaluate in depth the effect of each clinical feature of polycystic ovary syndrome separately and design management strategies, keeping in mind the psychological and physical manifestations.	[Khomami, Mahnaz Bahri; Tehrani, Fahimeh Ramezani; Hashemi, Somayeh; Farahmand, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, 24 Parvaneh,Yaman St,POB 19395-4763, Tehran, Iran.	ramezani@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; Tehrani, Fahimeh Ramezani/H-6133-2017; Khomami, Mahnaz Bahri/AAR-4972-2021	Azizi, Fereidoun/0000-0002-6470-2517; Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Khomami, Mahnaz Bahri/0000-0002-5955-1283	Research Institute for Endocrine Sciences [427]	Research Institute for Endocrine Sciences	This study was funded by the Research Institute for Endocrine Sciences (grant number: 427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acmaz G, 2013, SCI WORLD J, DOI 10.1155/2013/851815; Amini L GB, 2011, PAYESH J, V11, P213; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Barnard L, 2007, HUM REPROD, V22, P2279, DOI 10.1093/humrep/dem108; Bazarganipour F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-141; Bazarganipour F, 2012, HUM REPROD, V27, P2729, DOI 10.1093/humrep/des199; Brady C, 2009, DRUG HEALTHC PATIENT, V1, P9; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Clark Charlotte M, 2014, Skinmed, V12, P84; Cronin L, 1998, J CLIN ENDOCR METAB, V83, P1976, DOI 10.1210/jc.83.6.1976; Ekback M, 2009, HEALTH CARE WOMEN IN, V30, P358, DOI 10.1080/07399330902785133; Fauser BCJM, 2012, HUM REPROD, V27, P14, DOI 10.1093/humrep/der396; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Hahn S, 2005, EUR J ENDOCRINOL, V153, P853, DOI 10.1530/eje.1.02024; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hartman EE, 2007, PEDIATRICS, V119, pE374, DOI 10.1542/peds.2006-0212; Hobbs L, 2000, Skin Therapy Lett, V5, P1; Janssen O, 2007, ADROGEN EXCESS DISOR, P343; Jones GL, 2011, JOGNN-J OBST GYN NEO, V40, P577, DOI 10.1111/j.1552-6909.2011.01279.x; Katulski K, 2012, ARCH PERINAT MED, V18, P148; Kumarapeli V, 2008, AM J EPIDEMIOL, V168, P321, DOI 10.1093/aje/kwn137; Kumarapeli VL, 2011, BJOG-INT J OBSTET GY, V118, P319, DOI 10.1111/j.1471-0528.2010.02799.x; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Li YA, 2011, FERTIL STERIL, V96, P452, DOI 10.1016/j.fertnstert.2011.05.072; Lujan ME, 2008, J OBSTET GYNAECOL CA, V30, P671, DOI 10.1016/S1701-2163(16)32915-2; McCook JG, 2005, JOGNN-J OBST GYN NEO, V34, P12, DOI 10.1177/0884217504272945; Merkin SS, 2011, J WOMENS HEALTH, V20, P413, DOI 10.1089/jwh.2010.2303; Moran C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/317241; Musmar S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-47; Pastore LM, 2011, J PSYCHOSOM RES, V71, P270, DOI 10.1016/j.jpsychores.2011.02.005; Qin JZ, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-56; Rayis Duria A, 2010, BMC Res Notes, V3, P327, DOI 10.1186/1756-0500-3-327; Schmid J, 2004, HUM REPROD, V19, P2251, DOI 10.1093/humrep/deh432; Shen WJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003646; Snyder BS, 2006, JOGNN-J OBST GYN NEO, V35, P385, DOI 10.1111/J.1552-6909.2006.00047.x; Spencer James M, 2007, J Drugs Dermatol, V6, P788; Stener-Victorin E, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-131; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-39; Thomson RL, 2010, FERTIL STERIL, V94, P1812, DOI 10.1016/j.fertnstert.2009.11.001; Trent ME, 2002, ARCH PEDIAT ADOL MED, V156, P556, DOI 10.1001/archpedi.156.6.556; Xiang SK, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/173281	42	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123608	10.1371/journal.pone.0123608	http://dx.doi.org/10.1371/journal.pone.0123608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874409	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800108
J	Klein, TA; Kim, HC; Chong, ST; Kim, JA; Lee, SY; Kim, WK; Nunn, PV; Song, JW				Klein, Terry A.; Kim, Heung-Chul; Chong, Sung-Tae; Kim, Jeong-Ah; Lee, Sook-Young; Kim, Won-Keun; Nunn, Peter V.; Song, Jin-Won			Hantaan Virus Surveillance Targeting Small Mammals at Nightmare Range, a High Elevation Military Training Area, Gyeonggi Province, Republic of Korea	PLOS ONE			English	Article							FIRING POINTS 10; HANTAVIRUS INFECTION; ECOLOGICAL SURVEILLANCE; HEMORRHAGIC-FEVER; ETIOLOGIC AGENT; MYODES-REGULUS; PUUMALA VIRUS; MUJU VIRUS; SEOUL; TRANSMISSION	Rodent-borne disease surveillance was conducted at Nightmare Range (NM-R), near the demilitarized zone in northeast Gyeonggi Province, Republic of Korea, to identify hemorrhagic fever with renal syndrome (HFRS) risks for a mountainous high-elevation (500 m) military training site. Monthly surveys were conducted from January 2008-December 2009. A total of 1,720 small mammals were captured belonging to the Orders Rodentia [Families, Sciuridae (1 species) and Muridae (7 species)] and Soricomorpha [Family, Soricidae (1species)]. Apodemus agrarius, the primary reservoir for Hantaan virus (HTNV), accounted for 89.9% (1,546) of all small mammals captured, followed by Myodes regulus (4.0%), Crocidura lasiura (3.9%), Micromys minutus (1.4%), Mus musculus (0.3%), Microtus fortis(0.2%), Apodemus peninsulae (0.2%), Tamias sibiricus (0.1%), and Rattus norvegicus(< 0.1%). Three species were antibody-positive (Ab+) for hantaviruses: A. agrarius (8.2%), M. minutus (4.2%), and C. lasiura (1.5%). HTNV specific RNA was detected in 93/127 Ab+ A. agrarius, while Imjin virus specific RNA was detected in 1/1 Ab+ C. lasiura. Overall, hantavirus Ab+ rates for A. agrariusincreased with weight (age) and were significantly higher among males (10.9%) than females (5.1%) (P<0.0001). High A. agrariusgravid rates during the fall (August-September) were associated with peak numbers of HFRS cases in Korea that followed high gravid rates. From 79 RT-PCR positive A. agrarius, 12 HTNV RNA samples were sequenced and compared phylogenetically based on a 320 nt sequence from the G(C) glycoprotein-encodingM segment. These results demonstrate that the HTNV isolates from NM-R are distinctly separated from HTNV isolated from the People's Republic of China. These studies provide for improved disease risk assessments that identify military activities, rodent HTNV rates, and other factors associated with the transmission of hantaviruses during field training exercises.	[Klein, Terry A.] 65th Med Brigade US Army MEDDAC Korea, Force Hlth Protect & Prevent Med, Unit 15281, APO, AP 96205 USA; [Kim, Heung-Chul; Chong, Sung-Tae; Nunn, Peter V.] 65th Med Brigade, Multifunct Med Battal 168, Med Detachment 5, APO, AP 96205 USA; [Kim, Jeong-Ah; Lee, Sook-Young; Kim, Won-Keun; Song, Jin-Won] Korea Univ, Inst Biomed Sci & Food Safety, Coll Med, Dept Microbiol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Song, JW (corresponding author), Korea Univ, Inst Biomed Sci & Food Safety, Coll Med, Dept Microbiol, 126-1,5-ga Anam Dong, Seoul 136705, South Korea.	jwsong@korea.ac.kr	Song, Jin/HHS-8731-2022		Division of Global Emerging Infections Surveillance and Response System (GEIS) Operations, Armed Forces Health Surveillance Center, Silver Spring, MD; Public Health Command Region-Pacific, Camp Zama, Japan, Agency for Defense Development [UE134020ID]; Institute of Biomedical Science & Food Safety, Korea University, Seoul, ROK	Division of Global Emerging Infections Surveillance and Response System (GEIS) Operations, Armed Forces Health Surveillance Center, Silver Spring, MD; Public Health Command Region-Pacific, Camp Zama, Japan, Agency for Defense Development; Institute of Biomedical Science & Food Safety, Korea University, Seoul, ROK	Funding for portions of this work was provided by the Division of Global Emerging Infections Surveillance and Response System (GEIS) Operations, Armed Forces Health Surveillance Center, Silver Spring, MD, the Public Health Command Region-Pacific, Camp Zama, Japan, Agency for Defense Development (UE134020ID), and the Institute of Biomedical Science & Food Safety, Korea University, Seoul, ROK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek LJ, 2006, J MED VIROL, V78, P290, DOI 10.1002/jmv.20538; Baek LJ, 2002, J MICROBIOL BIOTECHN, V12, P53; Cho HW, 2002, INTERVIROLOGY, V45, P328, DOI 10.1159/000067925; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hong HK, 1984, THESIS INCHON U, V6, P417; Huggins John W., 1997, P745; KANG S W, 1971, Korean Journal of Zoology, V14, P57; Kim HC, 2011, J VECTOR ECOL, V36, P42, DOI 10.1111/j.1948-7134.2011.00139.x; Kim HC, 2007, MIL MED, V172, P759, DOI 10.7205/MILMED.172.7.759; Klein TA, 2012, VECTOR-BORNE ZOONOT, V12, P674, DOI 10.1089/vbz.2011.0618; Klein TA, 2011, J VECTOR ECOL, V36, P373, DOI 10.1111/j.1948-7134.2011.00178.x; Koichiro T, 2013, MOL BIOL EVOL, V28, P2731; Korean Centers for Disease Control and Prevention (KCDC), DIS WEB STAT SYST DIS WEB STAT SYST; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Lee HW, 1972, REPT NAT I HLTH KORE, V9, P295; Lee JG, 2014, VIRUSES-BASEL, V6, P1701, DOI 10.3390/v6041701; Mackelprang R, 2001, EMERG INFECT DIS, V7, P480, DOI 10.3201/eid0703.017328; Mills JN, 1995, METHODS TRAPPING SAM, P1; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; O'Guinn ML, 2008, J VECTOR ECOL, V33, P370, DOI 10.3376/1081-1710-33.2.370; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; PON E, 1990, AM J TROP MED HYG, V42, P612, DOI 10.4269/ajtmh.1990.42.612; Sachar DS, 2003, MIL MED, V168, P231, DOI 10.1093/milmed/168.3.231; Sames WJ, 2009, J VECTOR ECOL, V34, P225, DOI [10.1111/j.1948-7134.2009.00030.x, 10.3376/038.034.0208]; Song JW, 2009, EMERG INFECT DIS, V15, P1833, DOI 10.3201/eid1511.090076; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Song JS, 1971, REPT NAT I HLTH KORE, V8, P117; Song JW, 2000, VIRUS GENES, V21, P227, DOI 10.1023/A:1008199800011; Song JW, 1998, J KOREAN SOC VIROL, V28, P287; Song KJ, 2007, J GEN VIROL, V88, P3121, DOI 10.1099/vir.0.83139-0; USFK Reg 40-1, 2000, PREV SURV TREATM HEM; XIAO SY, 1992, J GEN VIROL, V73, P567; XIAO SY, 1994, VIROLOGY, V198, P205, DOI 10.1006/viro.1994.1023	35	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0118483	10.1371/journal.pone.0118483	http://dx.doi.org/10.1371/journal.pone.0118483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874643	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800002
J	Ahn, J; Shin, S; Suh, Y; Park, JY; Hwang, S; Lee, K				Ahn, Jinsoo; Shin, Sangsu; Suh, Yeunsu; Park, Ju Yeon; Hwang, Seongsoo; Lee, Kichoon			Identification of the Avian RBP7 Gene as a New Adipose-Specific Gene and RBP7 Promoter-Driven GFP Expression in Adipose Tissue of Transgenic Quail	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; TRIGLYCERIDE LIPASE; NUTRITIONAL REGULATION; CLONING; FAT; METABOLISM; ENHANCER; ACID	The discovery of an increasing number of new adipose-specific genes has significantly contributed to our understanding of adipose tissue biology and the etiology of obesity and its related diseases. In the present study, comparison of gene expression profiles among various tissues was performed by analysis of chicken microarray data, leading to identification of RBP7 as a novel adipose-specific gene in chicken. Adipose-specific expression of RBP7 in the avian species was further confirmed at the protein and mRNA levels. Examination of the transcription factor binding sites within the chicken RBP7 promoter by Matinspector software revealed potential binding sites for adipogenic transcription factors. This led to the hypothesis that the RBP7 promoter can be utilized to overexpress a transgene in adipose tissue in order to further investigate the function of a transgene in adipose tissue. Several lines of transgenic quail containing a green fluorescent protein (GFP) gene under the control of the RBP7 promoter were generated using lentivirus-mediated gene transfer. The GFP expression in transgenic quail was specific to adipose tissue and increased after adipocyte differentiation. This expression pattern was consistent with endogenous RBP7 expression, suggesting the RBP7 promoter is sufficient to overexpress a gene of interest in adipose tissue at later developmental stages. These findings will lead to the establishment of a novel RBP7 promoter cassette which can be utilized for overexpressing genes of interest in adipose tissue in vivo to study the function of genes in adipose tissue development and lipid metabolism.	[Ahn, Jinsoo; Shin, Sangsu; Suh, Yeunsu; Hwang, Seongsoo; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Ahn, Jinsoo; Lee, Kichoon] Ohio State Univ, Interdisciplinary PhD Program Nutr, Columbus, OH 43210 USA; [Shin, Sangsu] Pusan Natl Univ, Life & Ind Convergence Res Inst, Miryang, Gyeongnam, South Korea; [Park, Ju Yeon] Ohio State Univ, Dept Biol Sci, Columbus, OH 43210 USA; [Hwang, Seongsoo] Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, Gyeonggi, South Korea	Ohio State University; Ohio State University; Pusan National University; Ohio State University; National Institute of Animal Science, Republic of Korea	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu			Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2010-65206-20716]; National Research Foundation of Korea Agenda Program [PJ009457]; SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants at The Ohio State University [2014090, 2013-044]	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture; National Research Foundation of Korea Agenda Program(National Research Foundation of Korea); SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants at The Ohio State University	This work was supported by the Agriculture and Food Research Initiative Competitive Grant no. 2010-65206-20716 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture to KL (http://www.csrees.usda.gov/fo/funding.cfm), the National Research Foundation of Korea Agenda Program no. PJ009457 to KL (http://www.nrf.re.kr/nrf_eng_cms), and by SEEDS: The Ohio Agricultural Research and Development Center (OARDC) Research Enhancement Competitive Grants Program no. 2014090 and 2013-044 at The Ohio State University to JA and KL (http://oardc.osu.edu/seeds/t08_pageview/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lee K, 2009, POULTRY SCI, V88, P620, DOI 10.3382/ps.2008-00265; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li X, 2012, J ANIM SCI, V90, P4346, DOI 10.2527/jas.2012-5151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Oh SA, 2011, J ANIM SCI, V89, P367, DOI 10.2527/jas.2010-3339; Piantedosi R, 2005, J BIOL CHEM, V280, P24286, DOI 10.1074/jbc.M503906200; Poynter Greg, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.emo112; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Sato Y, 2013, DEV GROWTH DIFFER, V55, P406, DOI 10.1111/dgd.12058; Serr J, 2011, J ANIM SCI, V89, P3490, DOI 10.2527/jas.2011-3897; Serr J, 2009, POULTRY SCI, V88, P2585, DOI 10.3382/ps.2009-00265; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Shin SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100905; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064483; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Yang SJ, 2013, LIPIDS, V48, P13, DOI 10.1007/s11745-012-3742-6; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	31	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124768	10.1371/journal.pone.0124768	http://dx.doi.org/10.1371/journal.pone.0124768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867079	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100271
J	Tian, FX; Wang, T; Xie, YL; Zhang, J; Hu, JJ				Tian, Fengxia; Wang, Tan; Xie, Yuli; Zhang, Jin; Hu, Jianjun			Genome-Wide Identification, Classification, and Expression Analysis of 14-3-3 Gene Family in Populus	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; TRANSCRIPTOME ANALYSIS; MAXIMUM-LIKELIHOOD; PROTEIN-STRUCTURE; STRESS TOLERANCE; DUPLICATE GENES; ARABIDOPSIS; PLANT	Background In plants, 14-3-3 proteins are encoded by a large multigene family and are involved in signaling pathways to regulate plant development and protection from stress. Although twelve Populus 14-3-3s were identified based on the Populus trichocarpa genome V1.1 in a previous study, no systematic analysis including genome organization, gene structure, duplication relationship, evolutionary analysis and expression compendium has been conducted in Populus based on the latest P. trichocarpa genome V3.0. Principal Findings Here, a comprehensive analysis of Populus 14-3-3 family is presented. Two new 14-3-3 genes were identified based on the latest P. trichocarpa genome. In P. trichocarpa, fourteen 14-3-3 genes were grouped into epsilon and non-epsilon group. Exon-intron organizations of Populus 14-3-3s are highly conserved within the same group. Genomic organization analysis indicated that purifying selection plays a pivotal role in the retention and maintenance of Populus 14-3-3 family. Protein conformational analysis indicated that Populus 14-3-3 consists of a bundle of nine a-helices (alpha 1-alpha 9); the first four are essential for formation of the dimer, while alpha 3, alpha 5, alpha 7, and alpha 9 form a conserved peptide-binding groove. In addition, alpha 1, alpha 3, alpha 5, alpha 7, and alpha 9 were evolving at a lower rate, while alpha 2, alpha 4, and alpha 6 were evolving at a relatively faster rate. Microarray analyses showed that most Populus 14-3-3s are differentially expressed across tissues and upon exposure to various stresses. Conclusions The gene structures and their coding protein structures of Populus 14-3-3s are highly conserved among group members, suggesting that members of the same group might also have conserved functions. Microarray and qRT-PCR analyses showed that most Populus 14-3-3s were differentially expressed in various tissues and were induced by various stresses. Our investigation provided a better understanding of the complexity of the 14-3-3 gene family in poplars.	[Tian, Fengxia; Wang, Tan; Xie, Yuli] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang, Henan, Peoples R China; [Tian, Fengxia; Wang, Tan; Xie, Yuli; Zhang, Jin; Hu, Jianjun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China	Nanyang Normal College; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhang, J (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.	Zhang007jin@163.com; Hujj@caf.ac.cn	Zhang, Jin/J-9618-2019	Zhang, Jin/0000-0002-8397-5078	National Nonprofit Institute Research Grant of CAF [TGB2013009, CAFYBB2014ZX001-4]; China Postdoctoral Science Foundation [2014M550104]	National Nonprofit Institute Research Grant of CAF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Nonprofit Institute Research Grant of CAF [TGB2013009] and [CAFYBB2014ZX001-4] to JJH and the China Postdoctoral Science Foundation [2014M550104] to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; CHANDLER PM, 1994, ANNU REV PLANT PHYS, V45, P113, DOI 10.1146/annurev.pp.45.060194.000553; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; Cotelle V, 2000, EMBO J, V19, P2869, DOI 10.1093/emboj/19.12.2869; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Ferl RJ, 2002, GENOME BIOL, V3; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fulgosi H, 2002, PLANT MOL BIOL, V50, P1019, DOI 10.1023/A:1021295604109; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Ko JH, 2012, PLANT BIOTECHNOL J, V10, P587, DOI 10.1111/j.1467-7652.2012.00690.x; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Liu YanJing, 2010, Journal of Beijing Forestry University, V32, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU GH, 1992, P NATL ACAD SCI USA, V89, P11490, DOI 10.1073/pnas.89.23.11490; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P661, DOI 10.1016/j.semcdb.2011.09.011; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Pertl H, 2005, PLANT BIOLOGY, V7, P140, DOI 10.1055/s-2005-837583; Pertl H, 2010, PLANT PHYSIOL, V154, P1921, DOI 10.1104/pp.110.165696; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roberts MR, 2002, PLANT MOL BIOL, V50, P1031, DOI 10.1023/A:1021261614491; Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vuttipongchaikij S, 2012, NEW PHYTOL, V195, P585, DOI 10.1111/j.1469-8137.2012.04196.x; Weston DJ, 2011, PLANT CELL ENVIRON, V34, P1488, DOI 10.1111/j.1365-3040.2011.02347.x; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan JQ, 2004, PLANT CELL PHYSIOL, V45, P1007, DOI 10.1093/pcp/pch115; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang XH, 2009, PLANT J, V60, P539, DOI 10.1111/j.1365-313X.2009.03978.x; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	70	36	40	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123225	10.1371/journal.pone.0123225	http://dx.doi.org/10.1371/journal.pone.0123225			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867623	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100153
J	Cacciatore, I; Di Giulio, M; Fornasari, E; Di Stefano, A; Cerasa, LS; Marinelli, L; Turkez, H; Di Campli, E; Di Bartolomeo, S; Robuffo, I; Cellini, L				Cacciatore, Ivana; Di Giulio, Mara; Fornasari, Erika; Di Stefano, Antonio; Cerasa, Laura Serafina; Marinelli, Lisa; Turkez, Hasan; Di Campli, Emanuela; Di Bartolomeo, Soraya; Robuffo, Iole; Cellini, Luigina			Carvacrol Codrugs: A New Approach in the Antimicrobial Plan	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESSENTIAL OILS; PRODRUG; BACTERIA; BIOFILM; OREGANO; THYMOL; AGENTS; ACID	Objective The increasing prevalence of antibiotic-resistant bacterial infections led to identify alternative strategies for a novel therapeutic approach. In this study, we synthesized ten carvacrol codrugs - obtained linking the carvacrol hydroxyl group to the carboxyl moiety of sulphur-containing amino acids via an ester bond - to develop novel compounds with improved antimicrobial and antibiofilm activities and reduced toxicity respect to carvacrol alone. Method All carvacrol codrugs were screened against a representative panel of Gram positive (S. aureus and S. epidermidis), Gram negative (E. coli and P. aeruginosa) bacterial strains and C. albicans, using broth microdilution assays. Findings Results showed that carvacrol codrug 4 possesses the most notable enhancement in the anti-bacterial activity displaying MIC and MBC values equal to 2.5 mg/mL for all bacterial strains, except for P. aeruginosa ATCC 9027 (MIC and MBC values equal to 5 mg/mL and 10 mg/mL, respectively). All carvacrol codrugs 1-10 revealed good antifungal activity against C. albicans ATCC 10231. The cytotoxicity assay showed that the novel carvacrol codrugs did not produce human blood hemolysis at their MIC values except for codrugs 8 and 9. In particular, deepened experiments performed on carvacrol codrug 4 showed an interesting antimicrobial effect on the mature biofilm produced by E. coli ATCC 8739, respect to the carvacrol alone. The antimicrobial effects of carvacrol codrug 4 were also analyzed by TEM evidencing morphological modifications in S. aureus, E. coli, and C. albicans. Conclusion The current study presents an insight into the use of codrug strategy for developing carvacrol derivatives with antibacterial and antibiofilm potentials, and reduced cytotoxicity.	[Cacciatore, Ivana; Di Giulio, Mara; Fornasari, Erika; Di Stefano, Antonio; Cerasa, Laura Serafina; Marinelli, Lisa; Turkez, Hasan; Di Campli, Emanuela; Di Bartolomeo, Soraya; Cellini, Luigina] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Turkez, Hasan] Erzurum Tech Univ, Dept Mol Biol & Genet, Fac Sci, Erzurum, Turkey; [Robuffo, Iole] CNR, Inst Mol Genet, Sect Chieti, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Erzurum Technical University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Cacciatore, I (corresponding author), Univ G dAnnunzio, Dept Pharm, Chieti, Italy.	cacciatore@unich.it	Türkez, Hasan/AAQ-4905-2020; Robuffo, Iole/O-2918-2015	Robuffo, Iole/0000-0001-5883-4225; cacciatore, ivana/0000-0001-6253-0443; DI CAMPLI, Emanuela/0000-0001-5311-2848; DI STEFANO, Antonio/0000-0002-3042-2234; DI GIULIO, MARA/0000-0002-8375-9404; MARINELLI, LISA/0000-0001-8611-6538; Cellini, Luigina/0000-0003-4068-9124	Foundation Carichieti, Abruzzo-Italy	Foundation Carichieti, Abruzzo-Italy	Support was provided by Foundation Carichieti, Abruzzo-Italy.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Ait-Ouazzou A, 2013, J APPL MICROBIOL, V114, P173, DOI 10.1111/jam.12028; Arabaci T, 2013, ACTA ODONTOL SCAND, V71, P1255, DOI 10.3109/00016357.2012.757646; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Aslam S, 2011, INT J ARTIF ORGANS, V34, P752, DOI 10.5301/ijao.5000024; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Baldassarre L, 2012, J PEPT SCI, V18, P567, DOI 10.1002/psc.2435; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P800, DOI 10.1128/AAC.00603-08; BERGERON RJ, 1980, J MED CHEM, V23, P1130, DOI 10.1021/jm00184a013; Bertling A, 2010, THROMB HAEMOSTASIS, V104, P270, DOI 10.1160/TH09-11-0769; Borde AS, 2012, EUR J PHARM BIOPHARM, V80, P630, DOI 10.1016/j.ejpb.2011.11.011; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Burt SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093414; Cacciatore I., 2003, Farmaco (Lausanne), V58, P787, DOI 10.1016/S0014-827X(03)00135-6; Cacciatore I, 2005, AMINO ACIDS, V28, P77, DOI 10.1007/s00726-004-0142-0; Cacciatore I, 2013, PHARMACEUTICALS, V6, P54, DOI 10.3390/ph6010054; Cacciatore I, 2013, CHEMMEDCHEM, V8, P1818, DOI 10.1002/cmdc.201300295; Cacciatore I, 2012, CHEMMEDCHEM, V7, P2021, DOI 10.1002/cmdc.201200320; Cingolani GM, 2000, BIOORG MED CHEM LETT, V10, P1385, DOI 10.1016/S0960-894X(00)00249-3; Cirioni O, 2013, PEPTIDES, V40, P77, DOI 10.1016/j.peptides.2012.12.002; Das N, 2010, EUR J PHARM SCI, V41, P571, DOI 10.1016/j.ejps.2010.09.014; Di Stefano A, 2009, MICROB BIOTECHNOL, V2, P634, DOI 10.1111/j.1751-7915.2009.00120.x; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Fujisawa H, 2009, BIOSCI BIOTECH BIOCH, V73, P1948, DOI 10.1271/bbb.90096; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Goto M, 2001, J PHARM PHARMACOL, V53, P1711, DOI 10.1211/0022357011778115; Hansen T, 2011, J MED CHEM, V54, P858, DOI 10.1021/jm101327d; Harris JC, 2001, APPL MICROBIOL BIOT, V57, P282, DOI 10.1007/s002530100722; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Iannitelli A, 2011, INT J MOL SCI, V12, P5039, DOI 10.3390/ijms12085039; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Johnson SA, 2002, J APPL MICROBIOL, V93, P336, DOI 10.1046/j.1365-2672.2002.01691.x; Karkabounas S., 2006, Experimental Oncology, V28, P121; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Minelli A, 2012, AMINO ACIDS, V43, P1359, DOI 10.1007/s00726-011-1210-x; NISHINO T, 1975, JPN J MICROBIOL, V19, P53, DOI 10.1111/j.1348-0421.1975.tb00847.x; Nostro A., 2012, DRUG DISCOVERY, V7, P28, DOI DOI 10.2174/157489112799829684; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2009, J MED MICROBIOL, V58, P791, DOI 10.1099/jmm.0.009274-0; Patruno A, 2015, MOL PHARMACEUT, V12, P66, DOI 10.1021/mp500431r; PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643; Sozio P, 2013, MOLECULES, V18, P10747, DOI 10.3390/molecules180910747; Sozio P, 2013, EUR J PHARM SCI, V49, P187, DOI 10.1016/j.ejps.2013.02.013; Tran CD, 2010, SCAND J GASTROENTERO, V45, P1424, DOI 10.3109/00365521.2010.506245; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Veldhuizen EJA, 2006, J AGR FOOD CHEM, V54, P1874, DOI 10.1021/jf052564y; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140; Zotti M, 2013, MOLECULES, V18, P6161, DOI 10.3390/molecules18066161	49	42	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120937	10.1371/journal.pone.0120937	http://dx.doi.org/10.1371/journal.pone.0120937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859852	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300019
J	Ding, YN; Gu, DF; Zhang, YX; Han, WJ; Liu, HL; Qu, Q				Ding, Yanan; Gu, Dongfeng; Zhang, Yanxuan; Han, Wenjie; Liu, Hengliang; Qu, Qingshan			Significantly Increased Visceral Adiposity Index in Prehypertension	PLOS ONE			English	Article							METABOLIC-SYNDROME; CARDIOMETABOLIC RISK; NONHYPERTENSIVE PARTICIPANTS; CARDIOVASCULAR RISK; KIDNEY-DISEASE; BLOOD-PRESSURE; HYPERTENSION; PROGRESSION; OBESITY; BURDEN	Background The prevalence of prehypertension has increased in China, and prehypertension frequently progress to hypertension over a short time period; both have become public health problems. Therefore, this study was conducted to determine the relationship between the Visceral Adiposity Index (VAI) and blood pressure (BP) in China. Methods A cross-sectional epidemiological survey was conducted in China using a stratified random cluster sampling method. Sex-specific VAI quartile cut-off points were used as follows: 0.88, 1.41, 2.45 in males and 0.85, 1.33, 2.22 in females. Prehypertension and hypertension were each defined according to The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines. A multivariate logistic analysis was conducted to analyze the relationship among VAI, prehypertension and hypertension. Results The ORs for prehypertension and hypertension in the upper quartiles of the VAI were 1.514 (1.074-2.133), P=0.018 and 1.660 (1.084-2.542), P=0.020, in males, after adjusting for age, education, smoking habits, alcohol consumption, physical activity, serum creatinine, fasting glucose, and plasma insulin. Following further adjustments for the above confounders, chronic kidney disease, and diabetes, the ORs for prehypertension and hypertension in the upper quartile of the VAI were 1.660 1.533 (1.086-2.165), P=0.015, and 1.743 (1.133-2.680), P=0.011, in males. The ORs for prehypertension and hypertension in the upper quartile of the VAI were 1.691 (1.223-2.338), P=0.001, and 1.682 (1.162-2.435), P=0.006, in females, after adjusting for age, education, smoking habits, alcohol consumption, physical activity, serum creatinine, fasting glucose, and plasma insulin. Following further adjustments for the above confounders, chronic kidney disease, and diabetes, the ORs for prehypertension and hypertension in the upper quartile of the VAI were 1.688 (1.220-2.334), P=0.002, and 1.657 (1.141-2.406), P=0.008, in females. Conclusions A higher VAI was positively associated with both prehypertension and hypertension in both males and females. It is both essential and urgent that clinicians take steps to control and prevent visceral adiposity.	[Ding, Yanan; Han, Wenjie; Liu, Hengliang] Southeast Med Univ, Peoples Hosp Zhengzhou, Div Cardiovasc Med, Zhengzhou, Peoples R China; [Gu, Dongfeng; Zhang, Yanxuan; Qu, Qingshan] Southeast Med Univ, Peoples Hosp Zhengzhou, Dept Nephrol, Zhengzhou, Peoples R China; [Gu, Dongfeng; Zhang, Yanxuan; Qu, Qingshan] Southeast Med Univ, Peoples Hosp Zhengzhou, Transplantat Ctr, Zhengzhou, Peoples R China		Qu, Q (corresponding author), Southeast Med Univ, Peoples Hosp Zhengzhou, Dept Nephrol, Zhengzhou, Peoples R China.	13703717386@163.com			Diagnosis and Treatment of Atherosclerosis and Related Diseases [096SYJH33114]; Zhengzhou Municipal Science and Technology Research and Development Commission	Diagnosis and Treatment of Atherosclerosis and Related Diseases; Zhengzhou Municipal Science and Technology Research and Development Commission	This study was supported by the following science foundations and grants as the Diagnosis and Treatment of Atherosclerosis and Related Diseases (No.: 096SYJH33114), which was supported by Zhengzhou Municipal Science and Technology Research and Development Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-183; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2011, HUM REPROD, V26, P1486, DOI 10.1093/humrep/der088; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Chen C, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-108; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chong EW, 2009, ARCH OPHTHALMOL-CHIC, V127, P1640, DOI 10.1001/archophthalmol.2009.298; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Du T, 2015, NUTR METAB CARDIOVAS, V25, P100, DOI 10.1016/j.numecd.2014.07.006; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Eknoyan G, 2001, AM J KIDNEY DIS, V37, pS5, DOI 10.1016/S0272-6386(01)70004-2; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-960; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mannisto T, 2013, CIRCULATION, V127, P681, DOI 10.1161/CIRCULATIONAHA.112.128751; Mazzuca E, 2014, J SLEEP RES, V23, P13, DOI 10.1111/jsr.12088; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P1245, DOI 10.1038/ajh.2011.134; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Russo GT, 2015, J ENDOCRINOL INVEST, V38, P81, DOI 10.1007/s40618-014-0163-9; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stepien M, 2014, ANGIOLOGY, V65, P333, DOI 10.1177/0003319713485807; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104365; Zhang HF, 2006, J HYPERTENS, V24, P1719, DOI 10.1097/01.hjh.0000242395.07473.92; Zoccali C, 2002, CURR HYPERTENS REP, V4, P381, DOI 10.1007/s11906-002-0068-4	38	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123414	10.1371/journal.pone.0123414	http://dx.doi.org/10.1371/journal.pone.0123414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860643	Green Published, gold, Green Submitted			2022-12-26	WOS:000352590300096
J	Guo, AJ; Cai, JP; Luo, XN; Zhang, SH; Hou, JL; Li, H; Cai, XP				Guo, Aijiang; Cai, Jianping; Luo, Xuenong; Zhang, Shaohua; Hou, Junling; Li, Hui; Cai, Xuepeng			Cloning and Characterization of Three Eimeria tenella Lipid Phosphate Phosphatases	PLOS ONE			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; MIGRATING GERM-CELLS; ACID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; RAT-LIVER; ENDOPLASMIC-RETICULUM; MULTIPLE GENES; SEQUENCE MOTIF; IDENTIFICATION	Although lipid phosphate phosphatases (LPPs) play an important role in cellular signaling in addition to lipid biosynthesis, little is thus far known about parasite LPPs. In this study, we characterized three Eimeria tenella cDNA clones encoding LPP named EtLPP1, EtLPP2 and EtLPP3. Key structural features previously described in LPPs, including the three conserved domains proposed as catalytic sites, a single conserved N-glycosylation site, and putative transmembrane domains were discovered in the three resulting EtLPP amino acid sequences. Expression of His6-tagged EtLPP1, -2, and -3 in HEK293 cells produced immunoreactive proteins with variable molecular sizes, suggesting the presence of multiple forms of each of the three EtLPPs. The two faster-migrating protein bands below each of the three EtLPP proteins were found to be very similar to the porcine 35-kDa LPP enzyme in their molecular size and the extent of their N-glycosylation, suggesting that the three EtLPPs are partially N-glycosylated. Kinetic analyses of the activity of the three enzymes against PA, LPA, C1P and S1P showed that Km values for each of the substrates were (in mu M) 284, 46, 28, and 22 for EtLPP1; 369, 179, 237, and 52 for EtLPP2; and 355, 83, and 260 for EtLPP3. However, EtLPP3 showed negligible activity on S1P. These results confirmed that the three EtLPPs have broad substrate specificity. The results also indicated that despite structural similarities, the three EtLPPs may play distinct functions through their different models of substrate preference. Furthermore, particularly high expression levels of the three EtLPP genes were detected in the sporozoite stage of the E. tenella life cycle (p<0.001), suggesting that their encoded proteins might play an important biological function in the sporozoite stage.	[Guo, Aijiang; Cai, Jianping; Luo, Xuenong; Zhang, Shaohua; Hou, Junling; Li, Hui; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Guo, Aijiang; Luo, Xuenong] Jiangsu Co Innovat Ctr Prevent & Control Importan, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Guo, AJ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	guoaijiang@caas.cn			National Natural Science Foundation of China [30872369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by Grant # 30872369 (http://www.nsfc.gov.cn/) from National Natural Science Foundation of China, to AJG. The funders had no role in study design, data-collection and analysis, decision to publish, or preparation of the manuscript.	Barila D, 1996, J BIOL CHEM, V271, P29928, DOI 10.1074/jbc.271.47.29928; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Burnett C, 2003, EMBO REP, V4, P793, DOI 10.1038/sj.embor.embor900; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; FLEMING IN, 1995, BIOCHEM J, V308, P983, DOI 10.1042/bj3080983; Guo AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064236; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; Hooks SB, 1998, FEBS LETT, V427, P188, DOI 10.1016/S0014-5793(98)00421-9; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; Kai M, 1997, J BIOL CHEM, V272, P24572; KANOH H, 1992, J BIOL CHEM, V267, P25309; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Roberts R, 1998, J BIOL CHEM, V273, P22059; Siess EA, 1996, FEBS LETT, V381, P169, DOI 10.1016/0014-5793(96)00111-1; SIMONS BH, 1995, EUR J BIOCHEM, V229, P566, DOI 10.1111/j.1432-1033.1995.tb20499.x; SMITH SW, 1957, J BIOL CHEM, V228, P915; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Stukey J, 1997, PROTEIN SCI, V6, P469; Sun LY, 2005, MOL CELL BIOCHEM, V272, P91, DOI 10.1007/s11010-005-7640-6; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; XIE MQ, 1990, PARASITOL RES, V76, P566, DOI 10.1007/BF00932562; Zhang N, 2000, GENESIS, V27, P137, DOI 10.1002/1526-968X(200008)27:4<137::AID-GENE10>3.0.CO;2-4; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181; Zhang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3134, DOI 10.1271/bbb.80305	44	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122736	10.1371/journal.pone.0122736	http://dx.doi.org/10.1371/journal.pone.0122736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25861032	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300059
J	Iizuka-Kogo, A; Senda, T; Akiyama, T; Shimomura, A; Nomura, R; Hasegawa, Y; Yamamura, K; Kogo, H; Sawai, N; Matsuzaki, T				Iizuka-Kogo, Akiko; Senda, Takao; Akiyama, Tetsu; Shimomura, Atsushi; Nomura, Ryuji; Hasegawa, Yoshimi; Yamamura, Ken-ichi; Kogo, Hiroshi; Sawai, Nobuhiko; Matsuzaki, Toshiyuki			Requirement of DLG1 for Cardiovascular Development and Tissue Elongation during Cochlear, Enteric, and Skeletal Development: Possible Role in Convergent Extension	PLOS ONE			English	Article							PLANAR CELL POLARITY; CARDIAC OUTFLOW TRACT; SECONDARY HEART FIELD; NEURAL-TUBE CLOSURE; MAMMALIAN INNER-EAR; VENTRICULAR SEPTUM; CREST CELLS; FRIZZLED 2; MICE; MOUSE	The Dlg1 gene encodes a member of the MAGUK protein family involved in the polarization of epithelial cells. Null mutant mice for the Dlg1 gene (Dlg1(-/-) mice) exhibit respiratory failure and cyanosis, and die soon after birth. However, the cause of this neonatal lethality has not been determined. In the present study, we further examined Dlg1(-/-) mice and found severe defects in the cardiovascular system, including ventricular septal defect, persistent truncus arteriosus, and double outlet right ventricle, which would cause the neonatal lethality. These cardiovascular phenotypes resemble those of mutant mice lacking planar cell polarity (PCP) genes and support a recent notion that DLG1 is involved in the PCP pathway. We assessed the degree of involvement of DLG1 in the development of other organs, as the cochlea, intestine, and skeleton, in which PCP signaling has been suggested to play a role. In the organ of Corti, tissue elongation was inhibited accompanied by disorganized arrangement of the hair cell rows, while the orientation of the stereocilia bundle was normal. In the sternum, cleft sternum, abnormal calcification pattern of cartilage, and disorganization of chondrocytes were observed. Furthermore, shortening of the intestine, sternum, and long bones of the limbs was observed. These phenotypes of Dlg1(-/-) mice involving cellular disorganization and insufficient tissue elongation strongly suggest a defect in the convergent extension movements in these mice. Thus, our present results provide a possibility that DLG1 is particularly required for convergent extension among PCP signaling-dependent processes.	[Iizuka-Kogo, Akiko; Senda, Takao; Shimomura, Atsushi; Nomura, Ryuji; Hasegawa, Yoshimi] Fujita Hlth Univ, Sch Med, Dept Anat 1, Aichi, Japan; [Iizuka-Kogo, Akiko; Kogo, Hiroshi; Sawai, Nobuhiko; Matsuzaki, Toshiyuki] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Gunma, Japan; [Senda, Takao] Gifu Univ, Grad Sch Med, Dept Anat, Gifu, Japan; [Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan; [Shimomura, Atsushi] Hlth Sci Univ Hokkaido, Sch Psychol Sci, Dept Commun Disorders, Sapporo, Hokkaido, Japan; [Yamamura, Ken-ichi] Kumamoto Univ, Div Dev Genet, Inst Resource Dev, Kumamoto, Japan	Fujita Health University; Gunma University; Gifu University; University of Tokyo; Health Sciences University of Hokkaido; Kumamoto University	Iizuka-Kogo, A (corresponding author), Fujita Hlth Univ, Sch Med, Dept Anat 1, Aichi, Japan.	akogo@gunma-u.ac.jp	Kogo, Hiroshi/AAB-8467-2019	Kogo, Hiroshi/0000-0003-0584-7158	Japan Society for the Promotion of Science [19790158, 22790193, 25460240]; Grants-in-Aid for Scientific Research [25460240, 24592567] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Young Scientists (B) (19790158 and 22790193) and a Grant-in-Aid for Scientific Research (C) (25460240) to AIK from Japan Society for the Promotion of Science (www.jsps.go.jp). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MJ, 2009, DEVELOPMENT, V136, P3463, DOI 10.1242/dev.040592; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Chacon-Heszele MF, 2012, DEVELOPMENT, V139, P968, DOI 10.1242/dev.065326; Chen P, 1999, DEVELOPMENT, V126, P1581; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Farlie Peter G, 2004, Birth Defects Res C Embryo Today, V72, P173, DOI 10.1002/bdrc.20013; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Henderson DJ, 2001, CIRC RES, V89, P6, DOI 10.1161/hh1301.092497; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Iizuka-Kogo A, 2005, HISTOCHEM CELL BIOL, V123, P67, DOI 10.1007/s00418-004-0729-2; Iizuka-Kogo A, 2007, DEVELOPMENT, V134, P1799, DOI 10.1242/dev.02830; Iizuka-Kogo A, 2013, ANAT REC, V296, P1936, DOI 10.1002/ar.22814; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kawakami M, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-68; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Mauser JF, 2012, PLOS ONE, V7, P118, DOI 10.1371/journal.pone.0029611; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Parker M, 2010, J VISUALIZED EXPT; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Rivera C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054410; Sakai Kazuyoshi, 2004, Okajimas Folia Anatomica Japonica, V81, P25, DOI 10.2535/ofaj.81.25; Scherptong RWC, 2012, DEV DYNAM, V241, P1413, DOI 10.1002/dvdy.23833; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sinha T, 2012, DEV BIOL, V370, P135, DOI 10.1016/j.ydbio.2012.07.023; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Waldo K, 1998, DEV BIOL, V196, P129, DOI 10.1006/dbio.1998.8860; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001	54	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123965	10.1371/journal.pone.0123965	http://dx.doi.org/10.1371/journal.pone.0123965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860837	Green Published, Green Submitted, gold			2022-12-26	WOS:000352590300126
J	Valley, CC; Liu, S; Lidke, DS; Lidke, KA				Valley, Christopher C.; Liu, Sheng; Lidke, Diane S.; Lidke, Keith A.			Sequential Superresolution Imaging of Multiple Targets Using a Single Fluorophore	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; MOLECULE LOCALIZATION; DIFFRACTION-LIMIT; RESOLUTION LIMIT; FLUORESCENCE; DEPLETION; ENDOCYTOSIS; ACCURACY; BLINKING; BINDING	Fluorescence superresolution (SR) microscopy, or fluorescence nanoscopy, provides nanometer scale detail of cellular structures and allows for imaging of biological processes at the molecular level. Specific SR imaging methods, such as localization-based imaging, rely on stochastic transitions between on (fluorescent) and off (dark) states of fluorophores. Imaging multiple cellular structures using multi-color imaging is complicated and limited by the differing properties of various organic dyes including their fluorescent state duty cycle, photons per switching event, number of fluorescent cycles before irreversible photobleaching, and overall sensitivity to buffer conditions. In addition, multiple color imaging requires consideration of multiple optical paths or chromatic aberration that can lead to differential aberrations that are important at the nanometer scale. Here, we report a method for sequential labeling and imaging that allows for SR imaging of multiple targets using a single fluorophore with negligible cross-talk between images. Using brightfield image correlation to register and overlay multiple image acquisitions with similar to 10 nm overlay precision in the x-y imaging plane, we have exploited the optimal properties of AlexaFluor647 for dSTORM to image four distinct cellular proteins. We also visualize the changes in co-localization of the epidermal growth factor (EGF) receptor and clathrin upon EGF addition that are consistent with clathrin-mediated endocytosis. These results are the first to demonstrate sequential SR (s-SR) imaging using direct stochastic reconstruction microscopy (dSTORM), and this method for sequential imaging can be applied to any superresolution technique.	[Valley, Christopher C.; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Valley, Christopher C.; Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Liu, Sheng; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Lidke, KA (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.	klidke@unm.edu			National Science Foundation, U.S. [NSF 0954836, NSF MCB-0845062]; Human Frontiers Science Program [HFSP RGP0027/2012]; New Mexico Spatiotemporal Modeling Center via the National Institutes of Health, U.S. [NIH P50GM085273]; Division Of Physics [0954836] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0845062] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	National Science Foundation, U.S.(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); New Mexico Spatiotemporal Modeling Center via the National Institutes of Health, U.S.; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the National Science Foundation, U.S., NSF 0954836 (KAL) and NSF MCB-0845062 (DSL) and the Human Frontiers Science Program, HFSP RGP0027/2012 (DSL). Additional support was provided to the New Mexico Spatiotemporal Modeling Center via the National Institutes of Health, U.S., NIH P50GM085273 (CCV, SL, DSL, KAL).	Altman RB, 2012, NAT METHODS, V9, P428, DOI 10.1038/nmeth.1988; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cordes T, 2010, J AM CHEM SOC, V132, P2404, DOI 10.1021/ja9099714; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lidke DS, 2012, J CELL SCI, V125, P2571, DOI 10.1242/jcs.090027; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Liu S, 2014, CHEMPHYSCHEM, V15, P696, DOI 10.1002/cphc.201300758; Liu S, 2013, OPT EXPRESS, V21, P29462, DOI 10.1364/OE.21.029462; McGorty Ryan, 2013, Opt Nanoscopy, V2, DOI 10.1186/2192-2853-2-3; Mlodzianoski MJ, 2009, OPT EXPRESS, V17, P8264, DOI 10.1364/OE.17.008264; Muller CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198101; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Olivier N, 2013, BIOMED OPT EXPRESS, V4, P885, DOI 10.1364/BOE.4.000885; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Quan TW, 2011, OPT EXPRESS, V19, P16963, DOI 10.1364/OE.19.016963; Quirin S, 2012, P NATL ACAD SCI USA, V109, P675, DOI 10.1073/pnas.1109011108; Ram S, 2009, OPT EXPRESS, V17, P6881, DOI 10.1364/OE.17.006881; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schafer P, 2013, ANAL CHEM, V85, P3393, DOI 10.1021/ac400035k; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shelby SA, 2013, BIOPHYS J, V105, P2343, DOI 10.1016/j.bpj.2013.09.049; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115512; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Yan Q, 2014, CHEMPHYSCHEM, V15, P687, DOI 10.1002/cphc.201300757; Zheng QS, 2012, J PHYS CHEM LETT, V3, P2200, DOI 10.1021/jz300670p; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	59	58	60	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123941	10.1371/journal.pone.0123941	http://dx.doi.org/10.1371/journal.pone.0123941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860558	Green Submitted, gold, Green Published			2022-12-26	WOS:000352590300123
J	Berenstein, AJ; Pinero, J; Furlong, LI; Chernomoretz, A				Jose Berenstein, Ariel; Pinero, Janet; Ines Furlong, Laura; Chernomoretz, Ariel			Mining the Modular Structure of Protein Interaction Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; CARTOGRAPHY; CENTRALITY; DYNAMICS; MEDICINE; DISEASES; CANCER; GENES; SET	Background Cluster-based descriptions of biological networks have received much attention in recent years fostered by accumulated evidence of the existence of meaningful correlations between topological network clusters and biological functional modules. Several well-performing clustering algorithms exist to infer topological network partitions. However, due to respective technical idiosyncrasies they might produce dissimilar modular decompositions of a given network. In this contribution, we aimed to analyze how alternative modular descriptions could condition the outcome of follow-up network biology analysis. Methodology We considered a human protein interaction network and two paradigmatic cluster recognition algorithms, namely: the Clauset-Newman-Moore and the infomap procedures. We analyzed to what extent both methodologies yielded different results in terms of granularity and biological congruency. In addition, taking into account Guimera's cartographic role characterization of network nodes, we explored how the adoption of a given clustering methodology impinged on the ability to highlight relevant network meso-scale connectivity patterns. Results As a case study we considered a set of aging related proteins and showed that only the high-resolution modular description provided by infomap, could unveil statistically significant associations between them and inter/intra modular cartographic features. Besides reporting novel biological insights that could be gained from the discovered associations, our contribution warns against possible technical concerns that might affect the tools used to mine for interaction patterns in network biology studies. In particular our results suggested that sub-optimal partitions from the strict point of view of their modularity levels might still be worth being analyzed when meso-scale features were to be explored in connection with external source of biological knowledge.	[Jose Berenstein, Ariel; Chernomoretz, Ariel] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Jose Berenstein, Ariel; Chernomoretz, Ariel] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires, Buenos Aires, DF, Argentina; [Pinero, Janet; Ines Furlong, Laura] Univ Pompeu Fabra, Hosp Mar Med Res Inst IMIM, Res Programme Biomed Informat GRIB, Barcelona 08003, Spain; [Chernomoretz, Ariel] Fdn Inst Leloir, Lab Biol Sistemas Integrat, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Leloir Institute	Chernomoretz, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Pabellon 1,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.	achernomoretz@leloir.org.ar	Piñero, Janet/O-6583-2016; Gasull, Martina/J-4076-2019; Furlong, Laura I./AAX-1376-2020	Piñero, Janet/0000-0003-1244-7654; Furlong, Laura I./0000-0002-9383-528X	CONICET [PIP0087]; UBACyT [20020110200314]; ISCIII-FEDER [PI13/00082, CP10/00524]; IMI JU [115002, 115191]; IMI JU (EU); IMI JU (EFPIA company)	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT; ISCIII-FEDER(Spanish Government); IMI JU; IMI JU (EU); IMI JU (EFPIA company)	CONICET (grant PIP0087), UBACyT (grant 20020110200314), ISCIII-FEDER (PI13/00082 and CP10/00524), IMI JU (grant agreements no [115002] (eTOX) and no [115191] (Open PHACTS)], resources of which are composed of financial contribution from the EU's FP7 (FP7/2007-2013) and EFPIA companies' in kind contribution). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Aldecoa R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02216; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyd-Kirkup JD, 2013, EPIGENOMICS-UK, V5, P205, DOI [10.2217/EPI.13.5, 10.2217/epi.13.5]; Budovsky A, 2009, MECH AGEING DEV, V130, P33, DOI 10.1016/j.mad.2008.04.002; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Chang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep01691; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Ferrarini L, 2005, BIOINFORMATICS, V21, P338, DOI 10.1093/bioinformatics/bti004; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hwang W, 2006, P 12 ACM SIGKDD INT, P20; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lambiotte R., 2010, MOD OPT MOB AD HOC W; Lancichinetti A., 2009, PHYS REV E; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pritykin Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003243; Promislow DEL, 2004, P ROY SOC B-BIOL SCI, V271, P1225, DOI 10.1098/rspb.2004.2732; R Core Team, 2021, R LANGUAGE ENV STAT; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Song J, 2013, PLOS COMPUT BIOL, V9; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West J, 2013, P NATL ACAD SCI USA, V110, P14138, DOI 10.1073/pnas.1307242110; Witten TM, 2007, CHEM BIODIVERS, V4, P2639, DOI 10.1002/cbdv.200790216; Wolfson M, 2009, INT J BIOCHEM CELL B, V41, P516, DOI 10.1016/j.biocel.2008.08.026; Xiang J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30301-2; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	63	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122477	10.1371/journal.pone.0122477	http://dx.doi.org/10.1371/journal.pone.0122477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856434	Green Submitted, Green Published, gold			2022-12-26	WOS:000352588500039
J	Roach, DR; Garrett, WM; Welch, G; Caperna, TJ; Talbot, NC; Shapiro, EM				Roach, Dwayne R.; Garrett, Wesley M.; Welch, Glenn; Caperna, Thomas J.; Talbot, Neil C.; Shapiro, Erik M.			Magnetic Cell Labeling of Primary and Stem Cell-Derived Pig Hepatocytes for MRI-Based Cell Tracking of Hepatocyte Transplantation	PLOS ONE			English	Article							IRON-OXIDE PARTICLES; ACUTE LIVER-FAILURE; PORCINE HEPATOCYTES; CONTINUOUS-CULTURE; SINGLE CELLS; LINE; MPIOS; SURVIVAL; MODEL; POLY(LACTIDE-CO-GLYCOLIDE)	Pig hepatocytes are an important investigational tool for optimizing hepatocyte transplantation schemes in both allogeneic and xenogeneic transplant scenarios. MRI can be used to serially monitor the transplanted cells, but only if the hepatocytes can be labeled with a magnetic particle. In this work, we describe culture conditions for magnetic cell labeling of cells from two different pig hepatocyte cell sources; primary pig hepatocytes (ppHEP) and stem cell-derived hepatocytes (PICM-19FF). The magnetic particle is a micron-sized iron oxide particle (MPIO) that has been extensively studied for magnetic cell labeling for MRI-based cell tracking. ppHEP could endocytose MPIO with labeling percentages as high as 70%, achieving iron content as high as similar to 55 pg/cell, with > 75% viability. PICM-19FF had labeling > 97%, achieving iron content similar to 38 pg/cell, with viability > 99%. Extensive morphological and functional assays indicated that magnetic cell labeling was benign to the cells. The results encourage the use of MRI-based cell tracking for the development and clinical use of hepatocyte transplantation methodologies. Further, these results generally highlight the importance of functional cell assays in the evaluation of contrast agent biocompatibility.	[Roach, Dwayne R.; Shapiro, Erik M.] Michigan State Univ, Dept Radiol, Mol & Cellular Imaging Lab, E Lansing, MI 48824 USA; [Roach, Dwayne R.; Garrett, Wesley M.; Welch, Glenn; Caperna, Thomas J.; Talbot, Neil C.] USDA, Beltsville Agr Res Ctr, ARS, Anim Biosci & Biotechnol Lab, Beltsville, MD USA	Michigan State University; United States Department of Agriculture (USDA)	Shapiro, EM (corresponding author), Michigan State Univ, Dept Radiol, Mol & Cellular Imaging Lab, E Lansing, MI 48824 USA.	erik.shapiro@rad.msu.edu	Roach, Dwayne R./AAK-1307-2020	Roach, Dwayne R./0000-0002-2069-8915				Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Bennewitz MF, 2012, MOL IMAGING BIOL, V14, P676, DOI 10.1007/s11307-012-0553-3; Benoist S, 2001, J HEPATOL, V35, P208, DOI 10.1016/S0168-8278(01)00085-X; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Caperna TJ, 2013, DOMEST ANIM ENDOCRIN, V45, P154, DOI 10.1016/j.domaniend.2013.08.003; CAPERNA TJ, 1985, J ANIM SCI, V61, P1576, DOI 10.2527/jas1985.6161576x; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chouhan M, 2012, INT J ARTIF ORGANS, V35, P450, DOI 10.5301/ijao.5000096; Ciria R, 2012, LIVER TRANSPLANT, V18, P1324, DOI 10.1002/lt.23532; Cooper DKC, 2013, J BIOMED RES, V27, P249, DOI 10.7555/JBR.27.20130063; Cormode DP, 2011, BIOCONJUGATE CHEM, V22, P353, DOI 10.1021/bc1003179; Dhawan A, 2010, METHODS MOL BIOL, V640, P525, DOI 10.1007/978-1-60761-688-7_29; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Fox IJ, 2004, AM J TRANSPLANT, V4, P7, DOI 10.1111/j.1600-6135.2004.0340.x; Granot D, 2014, MAGN RESON MED, V71, P1238, DOI 10.1002/mrm.24741; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; Hickey RD, 2014, LIVER TRANSPL; Huebert RC, 2014, MAYO CLIN PROC, V89, P414, DOI 10.1016/j.mayocp.2013.10.023; Hughes RD, 2012, TRANSPLANTATION, V93, P342, DOI 10.1097/TP.0b013e31823b72d6; Ito M, 2009, J HEPATO-BILIARY-PAN, V16, P97, DOI 10.1007/s00534-008-0023-0; Katsuda Takeshi, 2012, J Stem Cells, V7, P1; Ketkar-Atre A, 2014, BIOMATERIALS, V35, P1015, DOI 10.1016/j.biomaterials.2013.10.029; Kircher MF, 2003, CANCER RES, V63, P6838; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Landis CS, 2006, HEPATOLOGY, V44, P1250, DOI 10.1002/hep.21382; Liu W, 2009, MAGN RESON MED, V61, P761, DOI 10.1002/mrm.21923; Maruyama M, 2003, CELL TRANSPLANT, V12, P593, DOI 10.3727/000000003108747190; Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011; Meyburg J, 2009, CLIN TRANSPLANT, V23, P75, DOI 10.1111/j.1399-0012.2009.01113.x; Nagata H, 2003, TRANSPLANTATION, V76, P732, DOI 10.1097/01.TP.0000081560.16039.67; Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013; Nkansah MK, 2011, MAGN RESON MED, V65, P1776, DOI 10.1002/mrm.22765; Puppi J, 2014, CELL TRANSPLANT, V23, P329, DOI 10.3727/096368913X663596; Raschzok N, 2012, AM J ROENTGENOL, V198, P1417, DOI 10.2214/AJR.11.7742; Raschzok N, 2011, MOL IMAGING BIOL, V13, P613, DOI 10.1007/s11307-010-0405-y; Raschzok N, 2009, TISSUE ENG PART C-ME, V15, P681, DOI 10.1089/ten.tec.2008.0675; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2007, CONTRAST MEDIA MOL I, V2, P147, DOI 10.1002/cmmi.134; Shapiro EM, 2008, FUND BIOMED TECHNOL, V3, P141; Slotkin JR, 2007, NEUROTHERAPEUTICS, V4, P428, DOI 10.1016/j.nurt.2007.05.010; Soenen SJH, 2011, BIOMATERIALS, V32, P1748, DOI 10.1016/j.biomaterials.2010.11.005; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204; Talbot NC, 2013, J ANIM SCI, V91, P66, DOI 10.2527/jas.2012-5748; TALBOT NC, 1994, IN VITRO CELL DEV-AN, V30A, P851; TALBOT NC, 1994, IN VITRO CELL DEV-AN, V30A, P843; Talbot NC, 1996, EXP CELL RES, V225, P22, DOI 10.1006/excr.1996.0153; Talbot NC, 2007, IN VITRO CELL DEV-AN, V43, P72, DOI 10.1007/s11626-007-9014-8; Talbot NC, 2014, CYTOTECHNOLOGY, V66, P1, DOI 10.1007/s10616-013-9541-y; Talbot NC, 2010, IN VITRO CELL DEV-AN, V46, P746, DOI 10.1007/s11626-010-9336-9; Talbot NC, 2010, INT J ARTIF ORGANS, V33, P348, DOI 10.1177/039139881003300603; Tang KS, 2011, MOL IMAGING BIOL, V13, P819, DOI 10.1007/s11307-010-0437-3; Tang KS, 2011, MAGN RESON MED, V65, P1564, DOI 10.1002/mrm.22843; Than N.N., 2014, QJM; Willard RR, 2010, IN VITRO CELL DEV-AN, V46, P11, DOI 10.1007/s11626-009-9244-z; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; WYBENGA DR, 1971, CLIN CHEM, V17, P891	61	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123282	10.1371/journal.pone.0123282	http://dx.doi.org/10.1371/journal.pone.0123282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856627	Green Published, Green Submitted, gold			2022-12-26	WOS:000352588500082
J	Scofield, HN; Mattila, HR				Scofield, Hailey N.; Mattila, Heather R.			Honey Bee Workers That Are Pollen Stressed as Larvae Become Poor Foragers and Waggle Dancers as Adults	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA HYMENOPTERA; AMINO-ACID-COMPOSITION; WINTER COLONY LOSSES; NUTRITIONAL STRESS; PROTEIN-CONTENT; BRAIN-DEVELOPMENT; OVARY DEVELOPMENT; FOOD-DEPRIVATION; GENE-EXPRESSION	The negative effects on adult behavior of juvenile undernourishment are well documented in vertebrates, but relatively poorly understood in invertebrates. We examined the effects of larval nutritional stress on the foraging and recruitment behavior of an economically important model invertebrate, the honey bee (Apis mellifera). Pollen, which supplies essential nutrients to developing workers, can become limited in colonies because of seasonal dearths, loss of foraging habitat, or intensive management. However, the functional consequences of being reared by pollen-stressed nestmates remain unclear, despite growing concern that poor nutrition interacts with other stressors to exacerbate colony decline. We manipulated nurse bees' access to pollen and then assessed differences in weight, longevity, foraging activity, and waggle-dance behavior of the workers that they reared (who were co-fostered as adults). Pollen stress during larval development had far-reaching physical and behavioral effects on adult workers. Workers reared in pollen-stressed colonies were lighter and shorter lived than nestmates reared with adequate access to pollen. Proportionally fewer stressed workers were observed foraging and those who did forage started foraging sooner, foraged for fewer days, and were more likely to die after only a single day of foraging. Pollen- stressed workers were also less likely to waggle dance than their unstressed counterparts and, if they danced, the information they conveyed about the location of food was less precise. These performance deficits may escalate if long-term pollen limitation prevents stressed foragers from providing sufficiently for developing workers. Furthermore, the effects of brief pollen shortages reported here mirror the effects of other environmental stressors that limit worker access to nutrients, suggesting the likelihood of their synergistic interaction. Honey bees often experience the level of stress that we created, thus our findings underscore the importance of adequate nutrition for supporting worker performance and their potential contribution to colony productivity and quality pollination services.	[Scofield, Hailey N.; Mattila, Heather R.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	Wellesley College	Mattila, HR (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	hmattila@wellesley.edu			Essex County Beekeepers Association Grants Committee (Massachusetts, USA); Wellesley College; Knafel Endowed Chair in the Natural Sciences (Wellesley College); Wellesley's Summer Research Awards; Amabel Boyce James '74 Fund for Summer Research in the Sciences; Janina A. Longtine '76 Endowed Fund for Summer Research in the Natural Sciences; Sherman Fairchild Fund; Susan Todd Horton Class of 1910 Trust	Essex County Beekeepers Association Grants Committee (Massachusetts, USA); Wellesley College; Knafel Endowed Chair in the Natural Sciences (Wellesley College); Wellesley's Summer Research Awards; Amabel Boyce James '74 Fund for Summer Research in the Sciences; Janina A. Longtine '76 Endowed Fund for Summer Research in the Natural Sciences; Sherman Fairchild Fund; Susan Todd Horton Class of 1910 Trust	Research support was provided by the Essex County Beekeepers Association Grants Committee (Massachusetts, USA) and a Fiske Award from Wellesley College. Student support was provided by sponsors of Wellesley's Summer Research Awards, including the Amabel Boyce James '74 Fund for Summer Research in the Sciences, the Janina A. Longtine '76 Endowed Fund for Summer Research in the Natural Sciences, the Sherman Fairchild Fund, and the Susan Todd Horton Class of 1910 Trust. HRM was supported by a Knafel Endowed Chair in the Natural Sciences (Wellesley College). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Brodschneider R, 2009, APIDOLOGIE, V40, P441, DOI 10.1051/apido/2009006; Burns JG, 2012, P NATL ACAD SCI USA, V109, P17239, DOI 10.1073/pnas.1121265109; Carey JR, 2008, AGING CELL, V7, P470, DOI 10.1111/j.1474-9726.2008.00389.x; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Crespi EJ, 2013, INTEGR COMP BIOL, V53, P989, DOI 10.1093/icb/ict087; Daugherty THF, 2011, MOL ECOL, V20, P5337, DOI 10.1111/j.1365-294X.2011.05344.x; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; de Souza AS, 2011, NUTR REV, V69, P132, DOI 10.1111/j.1753-4887.2011.00374.x; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; DOULL K M, 1973, Apidologie, V4, P285, DOI 10.1051/apido:19730401; DUKAS R, 1994, ANIM BEHAV, V48, P1007, DOI 10.1006/anbe.1994.1333; DUSTMANN JH, 1988, APIDOLOGIE, V19, P245, DOI 10.1051/apido:19880304; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; EISCHEN FA, 1983, J APICULT RES, V22, P163, DOI 10.1080/00218839.1983.11100582; EISHCHEN FA, 1982, J APICULT RES, V21, P19, DOI 10.1080/00218839.1982.11100511; Farrar C. L., 1934, GLEAN BEE CULT, V62, P276; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Foley K, 2012, J INVERTEBR PATHOL, V111, P68, DOI 10.1016/j.jip.2012.06.006; Forkpah C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091180; FYG. W., 1959, BEE WORLD, V40, P57; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garedew A, 2004, APIDOLOGIE, V35, P419, DOI 10.1051/apido:2004032; GOODWIN RM, 1994, NEW ZEAL J CROP HORT, V22, P459, DOI 10.1080/01140671.1994.9513858; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; HASSANEIN MH, 1953, ANN APPL BIOL, V40, P418, DOI 10.1111/j.1744-7348.1953.tb01093.x; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; HELLMICH RL, 1986, APIDOLOGIE, V17, P13, DOI 10.1051/apido:19860102; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hodges F.E.D., 1950, BEE WORLD, V31, DOI [10.1080/0005772X.1950.11094617, DOI 10.1080/0005772X.1950.11094617, https://doi.org/10.1080/0005772X.1950.11094617]; Hoover SER, 2006, J COMP PHYSIOL B, V176, P55, DOI 10.1007/s00360-005-0032-0; Huang Zachary, 2012, Terrestrial Arthropod Reviews, V5, P175, DOI 10.1163/187498312X639568; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Janmaat AF, 2000, INSECT SOC, V47, P177, DOI 10.1007/PL00001698; JAY SC, 1993, APIDOLOGIE, V24, P557, DOI 10.1051/apido:19930603; JAY SC, 1964, CAN J ZOOLOG, V42, P455, DOI 10.1139/z64-039; JEFFREE EP, 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Kalev H, 2002, AM BEE J, V142, P675; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Koletzko B, 2011, AM J CLIN NUTR, V94, p2036S, DOI 10.3945/ajcn.111.018903; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Laus MF, 2011, INT J ENV RES PUB HE, V8, P590, DOI 10.3390/ijerph8020590; Li CC, 2014, ENTOMOL EXP APPL, V151, P19, DOI 10.1111/eea.12167; Li ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077354; Lummaa V, 2003, AM J HUM BIOL, V15, P370, DOI 10.1002/ajhb.10155; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; MacDougall-Shackleton SA, 2012, J ORNITHOL, V153, pS105, DOI 10.1007/s10336-011-0807-x; Malone LA, 2001, J INVERTEBR PATHOL, V77, P258, DOI 10.1006/jipa.2001.5028; Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2010, J APICULT RES, V49, P337, DOI 10.3896/IBRA.1.49.4.07; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Phoofolo MW, 2008, ENVIRON ENTOMOL, V37, P315, DOI 10.1603/0046-225X(2008)37[315:LLHRTF]2.0.CO;2; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Pravosudov VV, 2005, BEHAV NEUROSCI, V119, P1368, DOI 10.1037/0735-7044.119.5.1368; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; RINDERER TE, 1974, J INVERTEBR PATHOL, V23, P347, DOI 10.1016/0022-2011(74)90100-1; Saastamoinen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081289; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Somerville DC, 2006, AUST J EXP AGR, V46, P141, DOI 10.1071/EA03188; SPIVAK M, 1992, J APPL ECOL, V29, P150, DOI 10.2307/2404358; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; van Dooremalen C, 2013, J INSECT PHYSIOL, V59, P487, DOI 10.1016/j.jinsphys.2013.02.006; Vande Velde L, 2013, EVOL ECOL, V27, P221, DOI 10.1007/s10682-012-9580-4; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; WANG DER-I, 1965, J APICULT RES, V4, P3; WANG DI, 1970, J INVERTEBR PATHOL, V15, P202, DOI 10.1016/0022-2011(70)90235-1; WEBSTER TC, 1987, PHYSIOL ENTOMOL, V12, P225, DOI 10.1111/j.1365-3032.1987.tb00745.x; Winston M.L., 1991, BIOL HONEY BEE; WINSTON ML, 1992, AM SCI, V80, P374; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Xia SZ, 1997, PHYSIOL BEHAV, V62, P263, DOI 10.1016/S0031-9384(97)00113-3; Zhang YG, 2010, TOXICOL LETT, V193, P167, DOI 10.1016/j.toxlet.2010.01.002	115	64	64	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121731	10.1371/journal.pone.0121731	http://dx.doi.org/10.1371/journal.pone.0121731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853902	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400048
J	Sharma, SR; Giri, S; Timalsina, U; Bhandari, SS; Basyal, B; Wagle, K; Shrestha, L				Sharma, Sudesh Raj; Giri, Smith; Timalsina, Utsav; Bhandari, Sanjiv Sudarshan; Basyal, Bikash; Wagle, Kusum; Shrestha, Laxman			Low Birth Weight at Term and Its Determinants in a Tertiary Hospital of Nepal: A Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; GROWTH-RETARDATION; MATERNAL NUTRITION; MORBIDITY; MORTALITY; PRETERM; INFANTS; EPIDEMIOLOGY; PREMATURITY; DIARRHEA	Birth weight of a child is an important indicator of its vulnerability for childhood illness and chances of survival. A large number of infant deaths can be averted by appropriate management of low birth weight babies and prevention of factors associated with low birth weight. The prevalence of low birth weight babies in Nepal is estimated to be about 12-32%. Our study aimed at identifying major determinants of low birth weight among term babies in Nepal. A hospital-based retrospective case control study was conducted in maternity ward of Tribhuvan University Teaching Hospital from February to July 2011. A total of 155 LBW babies and 310 controls were included in the study. Mothers admitted to maternity ward during the study period were interviewed, medical records were assessed and anthropometric measurements were done. Risk factors, broadly classified into proximal and distal factors, were assessed for any association with birth of low-birth weight babies. Regression analysis revealed that a history of premature delivery (adjusted odds ratio; aOR5.24, CI 1.05-26.28), hard physical work during pregnancy (aOR1.48, CI 0.97-2.26), younger age of mother (aOR1.98, CI 1.15-3.41), mothers with haemoglobin level less than 11gm/dl (aOR0.51, CI0.24-1.07) and lack of consumption of nutritious food during pregnancy (aOR1.99, CI 1.28-3.10) were significantly associated with the birth of LBW babies. These factors should be addressed with appropriate measures so as to decrease the prevalence of low birth weight among term babies in Nepal.	[Sharma, Sudesh Raj; Timalsina, Utsav; Bhandari, Sanjiv Sudarshan; Basyal, Bikash; Shrestha, Laxman] Inst Med, Kathmandu, Nepal; [Giri, Smith] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Wagle, Kusum] Om Hlth Campus, Kathmandu, Nepal	University of Tennessee System; University of Tennessee Health Science Center	Sharma, SR (corresponding author), Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal.	yoursudesh@gmail.com		Basyal, Bikash/0000-0002-4217-0396; Sharma, Sudesh Raj/0000-0002-7880-5517				Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Acharya Pratima Poudel, 2004, Health Care Women Int, V25, P40, DOI 10.1080/07399330490253210; Agarwal A, 2011, PREVALENCE AND DETER, P48; Agarwal S, 2001, Indian Pediatr, V38, P1017; Ahmad Muhammad Owais, 2011, J Ayub Med Coll Abbottabad, V23, P77; ALBERTSSONWIKLAND K, 1994, ACTA PAEDIATR, V83, P64, DOI 10.1111/j.1651-2227.1994.tb13292.x; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34; AYLWARD GP, 1989, J PEDIATR-US, V115, P515, DOI 10.1016/S0022-3476(89)80273-2; Badshah S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-197; Bennett L, 2008, CASTE ETHNIC AND REG; Bhandari R, 2012, INT J CHRONIC OBSTR, V7, P253, DOI 10.2147/COPD.S28602; CASEY PH, 1991, J PEDIATR-US, V119, P599, DOI 10.1016/S0022-3476(05)82414-X; Choudhary A K, 2013, Indian J Public Health, V57, P20, DOI 10.4103/0019-557X.111362; Christian P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-58; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; de Moraes AB, 2012, CAD SAUDE PUBLICA, V28, P2293, DOI 10.1590/S0102-311X2012001400008; Deshmukh J S, 1998, Indian Pediatr, V35, P33; Dickute Jolanta, 2002, Medicina (Kaunas), V38, P321; Dim Cyril C, 2007, MedGenMed, V9, P11; Elhassan Elhassan M, 2010, BMC Res Notes, V3, P181, DOI 10.1186/1756-0500-3-181; Fall CHD, 2003, J NUTR, V133, p1747S, DOI 10.1093/jn/133.5.1747S; Fourn L, 1999, Sante, V9, P7; Gresham E, 2014, AM J CLIN NUTR, V100, P1298, DOI 10.3945/ajcn.113.080655; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Karkee R, 2015, MATERN CHILD HLTH J, V19, P1, DOI 10.1007/s10995-014-1489-9; Kayastha S, 2007, Nepal Med Coll J, V9, P266; Khanal V, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-4; Khanal V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-32; Khatun Selina, 2008, Bangladesh Med Res Counc Bull, V34, P81; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Levy A, EUROPEAN JOURNAL OF, V122, P182; Lira PIC, 1996, J PEDIATR-US, V128, P497, DOI 10.1016/S0022-3476(96)70360-8; Mahajan SD, 2004, ENDOCR RES, V30, P189, DOI 10.1081/ERC-200027380; MAVALANKAR DV, 1992, INT J EPIDEMIOL, V21, P263, DOI 10.1093/ije/21.2.263; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Ministry of Health and Population (MoHP) [Nepal] New ERA ICF International Inc., 2011, NEPAL DEMOGRAPHIC AN; MIRA/UNICEF Nepal, 2000, LOW BIRTH WEIGHT PRE; Phung H, 2003, EUR J EPIDEMIOL, V18, P235, DOI 10.1023/A:1023384213536; Rasmussen KM, 2001, J NUTR, V131, p590S, DOI 10.1093/jn/131.2.590S; READ JS, 1995, PAEDIATR PERINAT EP, V9, P351, DOI 10.1111/j.1365-3016.1995.tb00152.x; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Reichman NE, 1997, FAM PLANN PERSPECT, V29, P268, DOI 10.2307/2953415; Sekhavat L, 2011, HEMATOLOGY, V16, P373, DOI 10.1179/102453311X13085644680186; Singh S, 2011, INCIDENCE AND RISK F; Sreeramareddy CT, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-16; SUSSER M, 1975, LANCET, V2, P1145; UNICEF, 2009, THE STATE OF THE WOR; VICTORA CG, 1989, AM J EPIDEMIOL, V129, P1032, DOI 10.1093/oxfordjournals.aje.a115207; VILLAR J, 1986, EARLY HUM DEV, V14, P307, DOI 10.1016/0378-3782(86)90193-3; VILLAR J, 1982, AM J OBSTET GYNECOL, V143, P793, DOI 10.1016/0002-9378(82)90012-6; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 1993, INTERNATIONAL STATIS, P129; World Health Organization, 2000, MULTICENTRE STUDY ON; Yadav Hematram, 2013, Med J Malaysia, V68, P44	57	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123962	10.1371/journal.pone.0123962	http://dx.doi.org/10.1371/journal.pone.0123962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853813	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400127
J	Sun, LL; Xie, SB; Peng, GY; Wang, J; Li, YY; Qin, J; Zhong, DS				Sun, Linlin; Xie, Songbo; Peng, Guoyuan; Wang, Jian; Li, Yuanyuan; Qin, Juan; Zhong, Diansheng			Lonafarnib Is a Potential Inhibitor for Neovascularization	PLOS ONE			English	Article							FARNESYLTRANSFERASE INHIBITOR; PROTEIN FARNESYLTRANSFERASE; CELL-MIGRATION; ANGIOGENESIS; ATHEROSCLEROSIS; DISEASE	Atherosclerosis is a common cardiovascular disease that involves the build-up of plaque on the inner walls of the arteries. Intraplaque neovacularization has been shown to be essential in the pathogenesis of atherosclerosis. Previous studies showed that small-molecule compounds targeting farnesyl transferase have the ability to prevent atherosclerosis in apolipoprotein E-deficient mice, but the underlying mechanism remains to be elucidated. In this study, we found that lonafarnib, a specific inhibitor of farnesyl transferase, elicits inhibitory effect on vascular endothelial capillary assembly in vitro in a dose-dependent manner. In addition, we showed that lonafarnib treatment led to a dose-dependent decrease in scratch wound closure in vitro, whereas it had little effect on endothelial cell proliferation. These data indicate that lonafarnib inhibits neovascularization via directly targeting endothelial cells and disturbing their motility. Moreover, we demonstrated that pharmacological inhibition of farnesyl transferase by lonafarnib significantly impaired centrosome reorientation toward the leading edge of endothelial cells. Mechanistically, we found that the catalytic beta subunit of farnesyl transferase associated with a cytoskeletal protein important for the establishment and maintenance of cell polarity. Additionally, we showed that lonafarnib remarkably inhibited the expression of the cytoskeletal protein and interrupted its interaction with farnesyl transferase. Our findings thus offer novel mechanistic insight into the protective effect of farnesyl transferase inhibitors on atherosclerosis and provide encouraging evidence for the potential use of this group of agents in inhibiting plaque neovascularization.	[Sun, Linlin; Zhong, Diansheng] Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Tianjin, Peoples R China; [Zhong, Diansheng] Tianjin Med Univ, Gen Hosp, Dept Med Oncol, Tianjin, Peoples R China; [Xie, Songbo; Peng, Guoyuan; Wang, Jian; Li, Yuanyuan; Qin, Juan] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China	Tianjin Medical University; Tianjin Medical University; Nankai University	Zhong, DS (corresponding author), Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Tianjin, Peoples R China.	Zhongdsh@hotmail.com	li, yuanyuan/GZA-4435-2022; Qin, Juan/GQZ-4875-2022; Xie, Songbo/AAD-9850-2020; Qin, Juan/GNH-2502-2022	Qin, Juan/0000-0002-0821-6290; Qin, Juan/0000-0002-0821-6290	National Natural Science Foundation of China [31301160]; Tianjin Municipal Health Bureau [2011KZ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Health Bureau	This work was supported by grants from National Natural Science Foundation of China (31301160) and Tianjin Municipal Health Bureau (2011KZ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al Sabti H, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-49; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng C, 2013, TRENDS CARDIOVAS MED, V23, P153, DOI 10.1016/j.tcm.2012.10.004; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Gu WZ, 1999, EUR J CANCER, V35, P1394, DOI 10.1016/S0959-8049(99)00132-X; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Moulton KS, 2006, CURR OPIN LIPIDOL, V17, P548, DOI 10.1097/01.mol.0000245261.71129.f0; Scott AN, 2008, ANGIOGENESIS, V11, P337, DOI 10.1007/s10456-008-9115-3; Strickland C L, 1999, Curr Opin Drug Discov Devel, V2, P475; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200	18	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122830	10.1371/journal.pone.0122830	http://dx.doi.org/10.1371/journal.pone.0122830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853815	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400082
J	Xia, H; Hu, C; Zhang, DK; Tang, S; Zhang, Z; Kou, Z; Fan, ZJ; Bente, D; Zeng, CQ; Li, TX				Xia, Han; Hu, Cheng; Zhang, Dake; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Bente, Dennis; Zeng, Changqing; Li, Tianxian			Metagenomic Profile of the Viral Communities in Rhipicephalus spp. Ticks from Yunnan, China	PLOS ONE			English	Article							DISEASE VIRUS; BORNE; DIVERSITY; FEVER; PHLEBOVIRUS; REVEALS; BATS	Besides mosquitoes, ticks are regarded as the primary source of vector-borne infectious diseases. Indeed, a wide variety of severe infectious human diseases, including those involving viruses, are transmitted by ticks in many parts of the world. To date, there are no published reports on the use of next-generation sequencing for studying viral diversity in ticks or discovering new viruses in these arthropods from China. Here, Ion-torrent sequencing was used to investigate the presence of viruses in three Rhipicephalus spp. tick pools (NY-11, NY-13, and MM-13) collected from the Menglian district of Yunnan, China. The sequencing run resulted in 3,641,088, 3,106,733, and 3,871,851 reads in each tick pool after trimming. Reads and assembled contiguous sequences (contigs) were subject to basic local alignment search tool analysis against the GenBank database. Large numbers of reads and contigs related to known viral sequences corresponding to a broad range of viral families were identified. Some of the sequences originated from viruses that have not been described previously in ticks. Our findings will facilitate better understanding of the tick virome, and add to our current knowledge of disease-causing viruses in ticks living under natural conditions.	[Xia, Han; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Li, Tianxian] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Xia, Han; Bente, Dennis] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hu, Cheng] Wuhan Univ, Int Sch Software, Wuhan, Hubei, Peoples R China; [Zhang, Dake; Zeng, Changqing] Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Texas System; University of Texas Medical Branch Galveston; Wuhan University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zeng, CQ (corresponding author), Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, 1 Beichen West Rd, Beijing, Peoples R China.	czeng@big.ac.cn; litx@wh.iov.cn	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Ministry of Science and Technology of China [2013FY113500]; Chinese Academy of Sciences [INFOXXH12504-1-06]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Ministry of Science and Technology of China (grant No. 2013FY113500), Chinese Academy of Sciences (grant Nos. INFOXXH12504-1-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Biagini P, 2006, J MED VIROL, V78, P298, DOI 10.1002/jmv.20539; Bzhalava D, 2013, J DATA MIN GENOM PRO, V4, P134; Chen Z, 2008, SICHUAN J ZOOL, V27, P4; Chitimia L, 2009, PARASITOL RES, V105, P907, DOI 10.1007/s00436-009-1474-1; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de la Fuente J, 2008, FRONT BIOSCI, V1, P9; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0; Gibbs A, 1986, THE PLANT VIRUSES, P167; Gong ZD, 2001, CHINA J PEST CO, V2, P3; Havlikova S, 2013, ACTA VIROL, V57, P123, DOI 10.4149/av_2013_02_123; Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Jiang DH, 2013, ADV VIRUS RES, V86, P215, DOI 10.1016/B978-0-12-394315-6.00008-8; Karabatsos N., 1985, INTERNATIONAL CATALO; Kaufman WR, 2003, EXP PARASITOL, V104, P20, DOI 10.1016/S0014-4894(03)00113-9; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Lasecka L, 2014, ARCH VIROL, V159, P1249, DOI 10.1007/s00705-013-1940-z; Liu L, 2012, J BIOMED BIOTECHNOL, V50, P2881; Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Nersesov V. A., 2003, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P30; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14; Tokarz R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-26; Wang JL, 2009, EMERG INFECT DIS, V15, P326, DOI 10.3201/eid1502.080979; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wu XB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-119; Xia H, 2011, INT J INFECT DIS, V15, pE459, DOI 10.1016/j.ijid.2011.03.013; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	39	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121609	10.1371/journal.pone.0121609	http://dx.doi.org/10.1371/journal.pone.0121609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25867946	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300276
J	Ding, CJ; Lu, J; Song, ZQ				Ding, Changjiang; Lu, Jun; Song, Zhiqing			Electrohydrodynamic Drying of Carrot Slices	PLOS ONE			English	Article							EHD; AIR; KINETICS; APPLE; RICE	Carrots have one of the highest levels of carotene, and they are rich in vitamins, fiber and minerals. However, since fresh carrots wilt rapidly after harvest under inappropriate storage conditions, drying has been used to improve their shelf life and retain nutritional quality. Therefore, to further investigate the potential of this method, carrot slices were dried in an EHD system in order to study the effect of different voltages on drying rate. As measures of quality, carotene content and rehydration ratio were, respectively, compared against the conventional oven drying regime. Carotene, the main component of the dried carrot, and rehydration characteristics of the dried product can both indicate quality by physical and chemical changes during the drying process. Mathematical modeling and simulation of drying curves were also performed, using root mean square error, reduced mean square of the deviation and modeling efficiency as the primary criteria to select the equation that best accounts for the variation in the drying curves of the dried samples. Theoretically, the Page model was best suited for describing the drying rate curve of carrot slices at 10kV to 30kV. Experimentally, the drying rate of carrots was notably greater in the EHD system when compared to control, and quality, as determined by carotene content and rehydration ratio, was also improved when compared to oven drying. Therefore, this work presents a facile and effective strategy for experimentally and theoretically determining the drying properties of carrots, and, as a result, it provides deeper insight into the industrial potential of the EHD drying technique.	[Ding, Changjiang; Lu, Jun; Song, Zhiqing] Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China	Inner Mongolia University of Technology	Ding, CJ (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China.	ding9713@163.com	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	National Natural Science Foundations of China [51467015]; Natural Science Foundation of Inner Mongolia Autonomous Region of china [2013MS0106]; Science Foundation of Inner Mongolia of Technology [ZD201311]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region of china; Science Foundation of Inner Mongolia of Technology	This work was Supported by National Natural Science Foundations of China(No. 51467015), Natural Science Foundation of Inner Mongolia Autonomous Region of china (No. 2013MS0106) and Science Foundation of Inner Mongolia of Technology (No. ZD201311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemrajabi AA, 2012, DRY TECHNOL, V30, P88, DOI 10.1080/07373937.2011.608913; Bai YX, 2012, J AQUAT FOOD PROD T, V21, P238, DOI 10.1080/10498850.2011.590271; Bai YX, 2011, J FOOD PROCESS PRES, V35, P891, DOI 10.1111/j.1745-4549.2011.00542.x; Bai YX, 2013, LWT-FOOD SCI TECHNOL, V54, P570, DOI 10.1016/j.lwt.2013.06.026; Bai YX, 2011, INT J APPL ELECTROM, V36, P217, DOI 10.3233/JAE-2011-1361; Balcer BE, 2004, DRY TECHNOL, V22, P821, DOI 10.1081/DRT-120034265; Basiry M, 2010, J ELECTROSTAT, V68, P360, DOI 10.1016/j.elstat.2010.05.002; Cao W, 2004, BIOSYST ENG, V87, P445, DOI 10.1016/j.biosystemseng.2003.12.007; Celma AR, 2008, CHEM ENG PROCESS, V47, P1810, DOI 10.1016/j.cep.2007.10.003; Demir V, 2007, BIOSYST ENG, V98, P47, DOI 10.1016/j.biosystemseng.2007.06.011; Dinani ST, 2014, ENERG CONVERS MANAGE, V86, P70, DOI 10.1016/j.enconman.2014.05.010; Dinani ST, 2014, DRY TECHNOL, V32, P597, DOI 10.1080/07373937.2013.851086; Ding CJ, 2014, INT J APPL ELECTROM, V46, P455, DOI 10.3233/JAE-141781; Esehaghbeygi A, 2012, DRY TECHNOL, V30, P1644, DOI 10.1080/07373937.2012.701262; Esehaghbeygi A, 2011, J FOOD ENG, V104, P628, DOI 10.1016/j.jfoodeng.2011.01.032; Hashinaga F, 1999, DRY TECHNOL, V17, P479, DOI 10.1080/07373939908917547; Lai FC, 2002, DRY TECHNOL, V20, P1393, DOI 10.1081/DRT-120005858; Li FD, 2006, J FOOD ENG, V77, P275, DOI 10.1016/j.jfoodeng.2005.06.028; Li FD, 2005, DRY TECHNOL, V23, P565, DOI 10.1081/DRT-200054133; Li ZF, 2010, LWT-FOOD SCI TECHNOL, V43, P291, DOI 10.1016/j.lwt.2009.08.002; Meisami-asl E., 2009, Pakistan Journal of Nutrition, V8, P804; Menges HO, 2006, J FOOD ENG, V77, P119, DOI 10.1016/j.jfoodeng.2005.06.049; Pardeshi IL, 2010, FOOD BIOPROCESS TECH, V3, P415, DOI 10.1007/s11947-008-0100-z; Romano G, 2009, DRY TECHNOL, V27, P574, DOI 10.1080/00304940802716233; Senadeera W, 2003, J FOOD ENG, V58, P277, DOI 10.1016/S0260-8774(02)00386-2; Singh A, 2012, DRY TECHNOL, V30, P1812, DOI 10.1080/07373937.2012.708912; Srikiatden J, 2008, J FOOD ENG, V84, P516, DOI 10.1016/j.jfoodeng.2007.06.009; Wu BG, 2014, J FOOD PROCESS ENG, V37, P111, DOI 10.1111/jfpe.12066; Zhang J, 2000, J INNER MONGOLIA AGR, V21, P121; Zhang Y, 2014, J ELECTROSTAT, V72, P76, DOI 10.1016/j.elstat.2013.11.010	30	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124077	10.1371/journal.pone.0124077	http://dx.doi.org/10.1371/journal.pone.0124077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25835017	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800131
J	Xia, H; Wang, XM; Li, FB; Longuet, C; Vernet, G; Goletti, D; Zhao, YL; Lagrange, PH				Xia, Hui; Wang, Xiaomen; Li, Fabin; Longuet, Christophe; Vernet, Guy; Goletti, Delia; Zhao, Yanlin; Lagrange, Philippe H.			Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; CLINICAL UTILITY; INFECTION; LATENT; BCG; IMMUNODIAGNOSIS	Background Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (QFT-GIT) and tuberculin skin test (TST), in addition to microbiological results, as contributors for diagnosing active PTB in the PRC. Methods/Principal Findings A total of 300 PTB patients, 41 disease controls (DC) and 59 healthy community controls (HCC) were included prospectively between May 2010 and April 2011 from two provinces of the PRC (Heilongjiang and Zhejiang). The QFT-GIT and TST yielded an overall sensitivity for active TB of 80.9% and 86.2%, and a specificity of 36.6% and 26.8%, respectively. The province of origin and smear microscopy status did not significantly impact the diagnostic values for PTB. However, using the TST with a 10 mm cut-off point, a significantly higher proportion of LTBI was observed in the DC than the HCC (p=0.01). Discordant results between the QFT-GIT and TST were found among 1/3 of the PTB, HCC and DC. Two-thirds of the individuals presented TST-positive/QFT-GIT-negative discordant results. The TST-negative/QFT-GIT-positive result was not associated with age or bacillary load. Cumulative QFT-GIT and TST positive results increased the overall sensitivity (95.9%), but it was associated with a dramatic decrease of the overall specificity (24.8%) leading to a suboptimal PPV (80.1%) and a low NPV (61.1%). Conclusions/Significance The usefulness of the QFT-GIT to diagnose active TB in high TB-endemic countries remains doubtful because like the TST, the QFT-GIT cannot distinguish between LTBI and active TB. Used as single stand-alone tests, both the QFT-GIT and TST have very limited roles in the diagnosis of active PTB. However, the combined use of SM, the TST and QFT-GIT may allow for the exclusion of ATB.	[Xia, Hui; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China; [Wang, Xiaomen] TB Control Ctr Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China; [Li, Fabin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Longuet, Christophe; Vernet, Guy] Fdn Merieux, Lyon, France; [Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Lagrange, Philippe H.] Paris VII Denis Diderot Univ, Hop St Louis, AP HP, Microbiol Serv, Paris, France	Chinese Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; IRCCS Lazzaro Spallanzani; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhao, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China.	zhaoyanlin@chinatb.org; plagrange@sfr.fr	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Fondation Merieux	Fondation Merieux	Fondation Merieux funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bass Jr JB, 1993, TUBERCULOSIS A COMPR; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; CHEN ZR, 1982, CHINESE MED J-PEKING, V95, P437; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention, 2008, GUIDELINES FOR IMPLE; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention China TB control program, 2009, SPUTUM SMEAR MICROSC; Dai Y, 2012, EUR J CLIN MICROBIOL, V31, P3127, DOI 10.1007/s10096-012-1674-y; Delogu G, 2014, J RHEUMATOL, V41, P11, DOI 10.3899/jrheum.140097; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hu PL, 2014, CHINESE MED J-PEKING, V127, P3744, DOI 10.3760/cma.j.issn.0366-6999.20141004; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Li WM, 2007, SCAND J INFECT DIS, V39, P138, DOI 10.1080/00365540600951234; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Ministry of Health People's Republic of China Joint United Nations Program on HIV/AIDS World Health Organization, 2011, 2011 ESTIMATES FOR T; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Ou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094544; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Thompson ML, 2003, BIOSTATISTICS, V4, P341, DOI 10.1093/biostatistics/4.3.341; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; World Health Organization [WHO], 2014, WHO REPORT 2013; Zhang M, 2010, INT J TUBERC LUNG D, V14, P1556; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	50	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121021	10.1371/journal.pone.0121021	http://dx.doi.org/10.1371/journal.pone.0121021			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867946	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100031
J	Zhao, SY; Ding, C; He, JZ				Zhao, Siyan; Ding, Chang; He, Jianzhong			Detoxification of 1,1,2-Trichloroethane to Ethene by Desulfitobacterium and Identification of Its Functional Reductase Gene	PLOS ONE			English	Article							DEHALOCOCCOIDES-ETHENOGENES; SP NOV.; DEHALOGENASE; GROWTH; 1,1,2,2-TETRACHLOROETHANE; DECHLORINATION; SPP.	1,1,2-trichloroethane (1,1,2-TCA) has become a common groundwater pollutant due to historically extensive utilization, improper disposal, as well as from incomplete dechlorination of 1,1,2,2-tetrachloroethane. Currently, limited information is available on microbial detoxification of 1,1,2-TCA. Desulfitobacterium sp. strain PR, which was isolated from an anaerobic bioreactor maintained to dechlorinate chloroethenes/ethanes, exhibited the capacity to dechlorinate 1,1,1-trichloroethane and chloroform. In this study, the dechlorinating ability of strain PR was further explored. Strain PR showed the capability to dechlorinate 1,1,2-TCA (similar to 1.12 mM) predominantly to 1,2-dichloroethane (1,2-DCA) and chloroethane, and to trace amounts of vinyl chloride and ethene within 20 days. Strain PR coupled growth with dechlorination of 1,1,2-TCA to 1,2-DCA, while no cell growth was observed with dechlorination of 1,2-DCA to chloroethane. Later, through transcriptomic and enzymatic analysis, the reductive dehalogenase CtrA, which was previously reported to be responsible for 1,1,1-trichloroethane and chloroform dechlorination, was identified as the 1,1,2-TCA reductive dehalogenase. Since trichloroethene (TCE) is usually co-contaminated with 1,1,2-TCA, a co-culture containing Dehalococcoides mccartyi strain 11a capable of detoxifying TCE and 1,2-DCA and strain PR was established. Interestingly, this co-culture dechlorinated 1,1,2-TCA and TCE to the non-toxic end-product ethene within 48 days without chloroethane production. This novel pathway avoids production of the carcinogenic intermediate dechlorination product vinyl chloride, providing a more environmentally friendly strategy to treat 1,1,2-TCA.	[Zhao, Siyan; Ding, Chang; He, Jianzhong] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore	National University of Singapore	He, JZ (corresponding author), Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore.	jianzhong.he@nus.edu.sg	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council [102 101 0025]; National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme [NRF-CRP5-2009-05]	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme(National Research Foundation, Singapore)	This study was supported by Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council under project no.: 102 101 0025 and the National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme with a project no.: NRF-CRP5-2009-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; ATSDR, 2006, TOX PROF VIN CHLOR; ATSDR, 2010, TOX PROF 1 1 2 TRICH; Aulenta F, 2006, BIODEGRADATION, V17, P193, DOI 10.1007/s10532-005-4218-7; Bowman KS, 2013, INT J SYST EVOL MICR, V63, P1492, DOI 10.1099/ijs.0.045054-0; CASTRO CE, 1994, ENVIRON TOXICOL CHEM, V13, P429, DOI [10.1897/1552-8618(1994)13[429:BRDBMT]2.0.CO;2, 10.1002/etc.5620130310]; Chen C, 1996, ENVIRON SCI TECHNOL, V30, P542, DOI 10.1021/es9502987; Chow WL, 2010, ISME J, V4, P1020, DOI 10.1038/ismej.2010.27; Coons DE, 2000, CHEMICAL OXIDATION AND REACTIVE BARRIERS, P161; De Wildeman S, 2003, APPL ENVIRON MICROB, V69, P5643, DOI 10.1128/AEM.69.9.5643-5647.2003; Ding C, 2014, ENVIRON MICROBIOL, V15, P1462; FATHEPURE BZ, 1994, ENVIRON SCI TECHNOL, V28, P746, DOI 10.1021/es00053a031; Grostern A, 2006, APPL ENVIRON MICROB, V72, P428, DOI 10.1128/AEM.72.1.428-436.2006; He JZ, 2007, APPL ENVIRON MICROB, V73, P2847, DOI 10.1128/AEM.02574-06; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LK, 2010, APPL ENVIRON MICROB, V76, P794, DOI 10.1128/AEM.01872-09; Lee PKH, 2013, ENVIRON MICROBIOL, V15, P2293, DOI 10.1111/1462-2920.12099; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Maness AD, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-54; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Plagentz V, 2006, ENVIRON GEOL, V49, P684, DOI 10.1007/s00254-005-0106-z; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; Schiffmann CL, 2014, J PROTEOMICS, V98, P59, DOI 10.1016/j.jprot.2013.12.009	24	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119507	10.1371/journal.pone.0119507	http://dx.doi.org/10.1371/journal.pone.0119507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835017	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000009
J	Abebe, AS; Mikko, S; Johansson, AM				Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.			Genetic Diversity of Five Local Swedish Chicken Breeds Detected by Microsatellite Markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; MANAGEMENT; SOFTWARE; CLUSTERS; DISTANCE; NUMBER	This study aimed at investigating the genetic diversity, relationship and population structure of 110 local Swedish chickens derived from five breeds (Gotlandshona, Hedemorahona, Olandsk dvarghona, Skansk blommehona, and Bohuslan-Dals svarthona, in the rest of the paper the shorter name Svarthona is used) using 24 microsatellite markers. In total, one hundred thirteen alleles were detected in all populations, with a mean of 4.7 alleles per locus. For the five chicken breeds, the observed and expected heterozygosity ranged from 0.225 to 0.408 and from 0.231 to 0.515, with the lowest scores for the Svarthona and the highest scores for the Skansk blommehona breeds, respectively. Similarly, the average within breed molecular kinship varied from 0.496 to 0.745, showing high coancestry, with Skansk blommehona having the lowest and Svarthona the highest coancestry. Furthermore, all breeds showed significant deviations from Hardy-Weinberg expectations. Across the five breeds, the global heterozygosity deficit (FIT) was 0.545, population differentiation index (F-ST) was 0.440, and the global inbreeding of individuals within breed (F-IS) was 0.187. The phylogenetic relationships of chickens were examined using neighbor-joining trees constructed at the level of breeds and individual samples. The neighbor-joining tree constructed at breed level revealed two main clusters, with Hedemorahona and Olandsk dvarghona breeds in one cluster, and Gotlandshona and Svarthona breeds in the second cluster leaving the Skansk blommehona in the middle. Based on the results of the STRUCTURE analysis, the most likely number of clustering of the five breeds was at K = 4, with Hedemorahona, Gotlandshona and Svarthona breeds forming their own distinct clusters, while Olandsk dvarghona and Skansk blommehona breeds clustered together. Losses in the overall genetic diversity of local Swedish chickens due to breeds extinction varied from -1.46% to -6.723%. The results of the current study can be used as baseline genetic information for genetic conservation program, for instance, to control inbreeding and to implement further genetic studies in local Swedish chickens.	[Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences	Johansson, AM (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Anna.Johansson@slu.se	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	AMJ received funding for the collection of blood samples and genotyping from the Erik PhilipSorensen foundation (www.epss.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; Cuc NTK, 2010, ANIM GENET, V41, P545, DOI 10.1111/j.1365-2052.2010.02039.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Englund T, 2014, HEREDITAS, V151, P229, DOI 10.1111/hrd2.00064; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, AN PROD HLTH GUID, V9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granevitze Z, 2007, ANIM GENET, V38, P576, DOI 10.1111/j.1365-2052.2007.01650.x; Guo XQ, 1999, HUM HERED, V49, P112, DOI 10.1159/000022855; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaya M, 2008, BIOCHEM GENET, V46, P480, DOI 10.1007/s10528-008-9164-8; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Muchadeyi FC, 2007, ANIM GENET, V38, P332, DOI 10.1111/j.1365-2052.2007.01606.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; Rajkumar U., 2007, Indian Journal of Animal Sciences, V77, P1194; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tadano R, 2008, ANIM GENET, V39, P71, DOI 10.1111/j.1365-2052.2007.01690.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Zanetti E, 2010, POULTRY SCI, V89, P420, DOI 10.3382/ps.2009-00324	40	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120580	10.1371/journal.pone.0120580	http://dx.doi.org/10.1371/journal.pone.0120580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855978	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500013
J	Rana, Y; Haberer, J; Huang, HJ; Kambugu, A; Mukasa, B; Thirumurthy, H; Wabukala, P; Wagner, GJ; Linnemayr, S				Rana, Yashodhara; Haberer, Jessica; Huang, Haijing; Kambugu, Andrew; Mukasa, Barbara; Thirumurthy, Harsha; Wabukala, Peter; Wagner, Glenn J.; Linnemayr, Sebastian			Short Message Service (SMS)-Based Intervention to Improve Treatment Adherence among HIV-Positive Youth in Uganda: Focus Group Findings	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; ADOLESCENTS; INFORMATION; MOTIVATION	This paper presents one of the first qualitative studies to discuss programmatic barriers to SMS-based interventions for HIV-positive youth and discusses pathways through which youth perceive them to work. We conducted six focus groups with 20 male and 19 female HIV-positive youths in two clinics in Kampala, Uganda. We find that youth commonly use SMS as over 90% of this study's youths knew how to read, write and send messages and almost three-fourths of them had phones. Youth strongly felt that the success of this intervention hinged on ensuring confidentiality about their HIV-positive status. Key programmatic challenges discussed where restrictions on phone use and phone sharing that could exclude some youth. Participants felt that the intervention would improve their adherence by providing them with needed reminders and social support. Youths' suggestions about intervention logistics related to content, frequency, timing and two-way messages will be helpful to practitioners in the field.	[Rana, Yashodhara; Huang, Haijing; Wagner, Glenn J.; Linnemayr, Sebastian] RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA; [Haberer, Jessica] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Mukasa, Barbara; Wabukala, Peter] Mildmay Uganda, Kampala, Uganda; [Thirumurthy, Harsha] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	RAND Corporation; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill	Rana, Y (corresponding author), RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA.	yrana@rand.org	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	National Institute of Child Health and Human Development [R01HD074925]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was sponsored by Grant R01HD074925 from The National Institute of Child Health and Human Development (PI Sebastian Linnemayr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2005, AIDS CARE, V17, P661, DOI 10.1080/09540120500038058; [Anonymous], PUTT YOUNG PEOPL CTR; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; CRAMER J, 1995, EPILEPSIA, V36, P1111, DOI 10.1111/j.1528-1157.1995.tb00469.x; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gray WN, 2011, J HEALTH PSYCHOL, V16, P828, DOI 10.1177/1359105310394230; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kitara D L, 2012, Afr J Infect Dis, V6, P12; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Thaler R.H., 2021, NUDGE FINAL EDITION	25	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125187	10.1371/journal.pone.0125187	http://dx.doi.org/10.1371/journal.pone.0125187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25855978	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500115
J	Lodwick, RK; Nakagawa, F; van Sighem, A; Sabin, CA; Phillips, AN				Lodwick, Rebecca K.; Nakagawa, Fumiyo; van Sighem, Ard; Sabin, Caroline A.; Phillips, Andrew N.			Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; PREVALENCE; INFECTION; DISEASE; SIZE	Background It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART). Methods The method uses the concept that a predictable level of occurrence of AIDS or other HIV-related clinical symptoms which lead to presentation for care, and hence diagnosis of HIV, arises in undiagnosed people with a given CD4 count. The method requires surveillance data on numbers of new HIV diagnoses with HIV-related symptoms, and the CD4 count at diagnosis. The CD4 count-specific rate at which HIV-related symptoms develop are estimated from cohort data. 95% confidence intervals can be constructed using a simple simulation method. Results For example, if there were 13 HIV diagnoses with HIV-related symptoms made in one year with CD4 count at diagnosis between 150-199 cells/mm(3), then since the CD4 count-specific rate of HIV-related symptoms is estimated as 0.216 per person-year, the estimated number of person years lived in people with undiagnosed HIV with CD4 count 150-199 cells/mm3 is 13/0.216 = 60 (95% confidence interval: 29-100), which is considered an estimate of the number of people living with undiagnosed HIV in this CD4 count stratum. Conclusions The method is straightforward to implement within a short period once a surveillance system of all new HIV diagnoses, collecting data on HIV-related symptoms at diagnosis, is in place and is most suitable for estimating the number of undiagnosed people with CD4 count <200 cells/mm3 due to the low rate of developing HIV-related symptoms at higher CD4 counts. A potential source of bias is under-diagnosis and under-reporting of diagnoses with HIV-related symptoms. Although this method has limitations as with all approaches, it is important for prompting increased efforts to identify undiagnosed people, particularly those with low CD4 count, and for informing levels of unmet need for ART.	[Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Nakagawa, Fumiyo; Sabin, Caroline A.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands	University of London; University College London; University of London; University College London	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	HIV in Europe; European Centre for Disease Prevention and Control (ECDC) [FWC/ECDC/012/050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	HIV in Europe; European Centre for Disease Prevention and Control (ECDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: The authors acknowledge funding from HIV in Europe and European Centre for Disease Prevention and Control (ECDC) framework contract FWC/ECDC/012/050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR-MORBID MORTAL W, V41; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; British HIV Association Audit & Standards Sub-Committee, 2010 11 SURV HIV TES; BROOKMEYER R, 1986, LANCET, V2, P1320; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; European AIDS Clinical Society, 2011, EACS GUID VERS 6 1; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; Lyerla R, 2006, SEX TRANSM INFECT, V82, pIII41, DOI 10.1136/sti.2006.020198; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Porter K., 2011, COMMUNICATION; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570; Sweeting MJ, 2005, STAT MED, V24, P3991, DOI 10.1002/sim.2432; Van Sighem A, 2014, C RETR OPP INF CROI; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Working Group on Estimation of HIV Prevalence in Europe, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087	22	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121992	10.1371/journal.pone.0121992	http://dx.doi.org/10.1371/journal.pone.0121992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25855978	Green Published, gold			2022-12-26	WOS:000351277500146
